<SEC-DOCUMENT>0001766400-22-000044.txt : 20220228
<SEC-HEADER>0001766400-22-000044.hdr.sgml : 20220228
<ACCEPTANCE-DATETIME>20220228160600
ACCESSION NUMBER:		0001766400-22-000044
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		98
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220228
DATE AS OF CHANGE:		20220228

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Pennant Group, Inc.
		CENTRAL INDEX KEY:			0001766400
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38900
		FILM NUMBER:		22689323

	BUSINESS ADDRESS:	
		STREET 1:		1675 E. RIVERSIDE DRIVE, SUITE 150
		CITY:			EAGLE
		STATE:			ID
		ZIP:			83616
		BUSINESS PHONE:		2089576025

	MAIL ADDRESS:	
		STREET 1:		1675 E. RIVERSIDE DRIVE, SUITE 150
		CITY:			EAGLE
		STATE:			ID
		ZIP:			83616
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>pntg-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2022 Workiva--><!--r:6a149289-91af-40b5-8f3e-f8666bbd5c45,g:56c4c52a-4e81-467a-86f6-87d568a87628,d:878c6ec7c06b4a14a7fbd056397eb9d2--><html xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:pntg="http://pennantgroup.com/20211231" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>pntg-20211231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl80L2ZyYWc6NjA1OGI2NDcwMTVjNGZmMmI4YjVmYWRiOTM3OTlhZWMvdGFibGU6MmI0ZGEzYzRiYjdlNDJmYzljOThmZWE1MTQ3MmZkNDMvdGFibGVyYW5nZToyYjRkYTNjNGJiN2U0MmZjOWM5OGZlYTUxNDcyZmQ0M18wLTEtMS0xLTQyOTM0_768ce92a-b021-4d16-b854-1bdc9bbc05eb">0001766400</ix:nonNumeric><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl80L2ZyYWc6NjA1OGI2NDcwMTVjNGZmMmI4YjVmYWRiOTM3OTlhZWMvdGFibGU6MmI0ZGEzYzRiYjdlNDJmYzljOThmZWE1MTQ3MmZkNDMvdGFibGVyYW5nZToyYjRkYTNjNGJiN2U0MmZjOWM5OGZlYTUxNDcyZmQ0M18yLTEtMS0xLTQyOTM0_3d37fd38-fa52-48f1-9bdd-660d2429d71e">2021</ix:nonNumeric><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl80L2ZyYWc6NjA1OGI2NDcwMTVjNGZmMmI4YjVmYWRiOTM3OTlhZWMvdGFibGU6MmI0ZGEzYzRiYjdlNDJmYzljOThmZWE1MTQ3MmZkNDMvdGFibGVyYW5nZToyYjRkYTNjNGJiN2U0MmZjOWM5OGZlYTUxNDcyZmQ0M18zLTEtMS0xLTQyOTM0_59a69e00-ed22-4f75-a8be-37c7dd700d4a">FY</ix:nonNumeric><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl80L2ZyYWc6NjA1OGI2NDcwMTVjNGZmMmI4YjVmYWRiOTM3OTlhZWMvdGFibGU6MmI0ZGEzYzRiYjdlNDJmYzljOThmZWE1MTQ3MmZkNDMvdGFibGVyYW5nZToyYjRkYTNjNGJiN2U0MmZjOWM5OGZlYTUxNDcyZmQ0M180LTEtMS0xLTQyOTM0_b3fc6ec1-3c41-433e-a3d5-729dced6169b">false</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="i7e5a5757ae4345638434593287f327d1_I20191001" decimals="INF" name="pntg:SpinOffTransactionDistributionRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjAvZnJhZzpjOTA4NjA4MTRhYjY0MDg4YjhhMzY2YzZlZDMyYzRjMC90ZXh0cmVnaW9uOmM5MDg2MDgxNGFiNjQwODhiOGEzNjZjNmVkMzJjNGMwXzMxNA_db239c2b-609c-406d-a630-5f0a3523c90a">.50</ix:nonFraction><ix:nonNumeric contextRef="i2652a0d3863d49cfa54d2dbb7a690e3c_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYxNzc_c179bcbb-5edd-46f8-ac7b-9c974960a03d">P3Y0M0D</ix:nonNumeric><ix:nonNumeric contextRef="i4cd15a2a6a27445183cb22f7b6c7b21b_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzM1Mjk_ccbd4d6d-4bc1-4f64-a712-9a0de31e9ccd">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="i91b3a92c7481472dbec77f9233ecabdc_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzIyMg_b91d98ae-34f8-4760-a680-7806138f8865">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i41995e14a074437c84df40537f2238d0_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzEwOTk1MTE2MzA5MjU_3cc0a8cb-6980-4caa-9f55-af4c4d207bb0">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="pntg-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6abd4a4310074b4097aa0589993a20d0_I20220222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-02-22</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i6fe0ba45acf1463a9efa0125b5bbd460_I20210630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="if28ce3a43e8b460b988657b9a4224a4e_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd91651521da4c609cd12f37af52ba44_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifb3f0aba2eec4f708396a60e99675481_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ide2b3e36383446e7a915226ee5c83310_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a8ca1010c9b475d92df11e16146a5d8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i01fbcc736c2f4d88b3e0b648821e0ba8_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d956ca6cd1c408fae3c1c5b8a11d188_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i855d825b738d453698699f3f7321df6f_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia77015134f924c9fbf430ceacefda567_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i690e1ad892ed46a8bc17a390e883382b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5c4557ca296245b787f54721e8fb4fc7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a9a8de246d64eae8dd59832de0af5e7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5166a6bf5fa34ea4a777f2940c33fc70_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i53e93f7878814ac5ba917527e6bc6fdb_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5bfd4e9286bf4ca98e7e5f4e442a2026_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5b80432f9127486d82bf8a5566b3b726_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7504d19735f49cc9eea4e20bfed667a_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35bd8b5de02d40739ff3a3df8cfe4355_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7a6863ed0a604be89046cf3ba27d50b9_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie90f6d4e5d3849e5bcb29a785a2ddaac_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic350fc4ba36449e4872a8c4cc3fc52fb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if33183982ee24195bfee778d16529013_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2296c7a7384d4e56b1c183412b8e586e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i166349c580b648b886b6acee6a9a1cbb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99cc169c87d54cfbaeeb3b1336ab30eb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05bcdfdd5a524814835b5fe3930e4688_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95ba983a79d7440dbbf23a35c1171deb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic64854ee9b9849e0b09fa298cbfd3e99_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a5b873622de45afa65e19177ba49557_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia44088af8f1e46d1b16f10b9327f6cf5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d456b9856964a9b93a6df6f1fa39ccf_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iad9a8ecab0c04918aee8cdd00de80898_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95eabde00ded4cf097fa61177f5f5a10_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb984f908c724c4bbff50002d4aec555_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b5f6ca5bfb2481690e71d78cb6d8667_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i82251654ca3f4fc288f2fb5540302bd6_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7bd7edef27e34175800cc42062b7c736_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15a951b1e5734b3997d7829d03437e38_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i570ab8a66ef6484f8c4085965fb06999_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27c052df90b74bb0b3ea9126a1f86ca7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife1126ceed284fbdb9bf6b3dbab68da3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="agency"><xbrli:measure>pntg:agency</xbrli:measure></xbrli:unit><xbrli:context id="icc510d566b5a497d8c3bf8da297c74be_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e5a5757ae4345638434593287f327d1_I20191001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-10-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ia2439a6130274330bd9bb469dbc05ee6_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8a7e4cc4f1ef44e18318557df8f16b2c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae5c52d50c06400983c31c67aa43fc0a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pntg:AccruedWagesAndRelatedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2652a0d3863d49cfa54d2dbb7a690e3c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6001b46500b947f08cda938279f351a0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="community"><xbrli:measure>pntg:community</xbrli:measure></xbrli:unit><xbrli:context id="i0e8f395592e742f3ba6c06ba1409606c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i743dd5e050c24c6f903e2cd1bc39b900_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib4445accb5d94db3851353dbfa2ed4f3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ffd18948f6c4a1e9cdee019c70baf5e_D20190101-20191001"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-10-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1fcf346d3fa483083f350885e86c53f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:TransitionServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4727a9c1e3f3474da652ab9778b0c723_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:TransitionServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6798f615dd65498b96c25d713d9ea243_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:TransitionServicesAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69f3d63932564edfa50a96879cf88c45_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="property"><xbrli:measure>pntg:property</xbrli:measure></xbrli:unit><xbrli:context id="i8539c32fc47d41f7855d6538692f738d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ice5e4b95ef8a477bb882b9b591fb511b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9faefefa7c85403d9d9fba65201c913a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:OperatingLeaseRentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71dbacd7819b435d8e92bd5a906d4011_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:OperatingLeaseRentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1429b5ff57464841a7fd199281d35777_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:OperatingLeaseRentExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i815557615f93465196531049671aa210_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7fc9e1d6963b4b9eb991007f35b632c0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i06cec63574054d8fb69e409cc0711e6f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i663cd00e1ad6470dbb471e5fc87e9203_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifab97b7b0975436f83121c89244a55d3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f1a78bb16f147c18572f1380b8c667f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idca163657edf4bc2aca2d8b382f0f7b2_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i431551b89e134941b82c51244240a244_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9b3121c806bb417081699695640c414f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17b4bb1acf134933be5201416c719d6c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03057061bfb7409985a60619a19b48e6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ddd0deea9264c2889a8b36d67a563b0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30d0fef362f9476098b2e5f91ab55f41_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d0123d2512e41bfbbd00432a081dabd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idac1833793374955a04bd068e4506c0e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iac9f214a0b30486f90920ce93092e539_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05e5b7442b2e4748b8bc9f050198888e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf54a7dfae6a484abdd050e8ddda248a_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3cad94c3015b470d965cbc5ee38f4770_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id38b672538cd430abff250dfff0240b6_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib5365806816e44649649e52c6625abe4_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idf736e5de07e408db946428a0745839b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icea654d979af4e61816fbe050cb29db1_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8458a5a068c4090af7e21aad43775a0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8406e50463644fbdb227c6e79289ad64_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifdb705c6ba97400d913dd4a58f256b0e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7de26af2c3974c3eb74c36971003d68f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if26e6ee1ae2b4492b5956195b2492b91_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d63dc45c0b146cfb92561c882177fea_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f6f3d7d4c8a4c4caa054a915ffff62d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie381063adb71430c9c8b4f7607c9030f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic242ef7737ea4e8d8f2e0629c8af8812_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6cb3dbfbde247d28b978021dfabc07e_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i400c7c456591430da87c024511cdb9f8_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9994a97da124177acf7e325874bdc4a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9422adb47dd144de9fd4fb328368c4e3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8202cceeb8344c46a087879b40701124_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib8551d37adc147afa5952e88c48adde6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8ca13a6f741345fea9329cb059f1ed4b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2984f9f8dd8744ecbd977408c0e3b962_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i48f286f45fe449d6a5632e508d5c2057_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0599a83f392c492c8ca20b93a86ccd91_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i36bae4b32d354f01bfa55606e2bf53ff_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iccdbd602cb6b43c1b386f036f6f9c78b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i29892b01245e41eb84f75876a0351a3a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8bd2b41188c847e0ba8e9c40a817df93_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if4653a795c674a2a99639c0e0ca313f2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2eee5c7b272f4114a364a863a01dd73b_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d7797f8df2244b09c017060c787f7c4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07e05d97399f4e76ae18df53c721bcbc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i869ae7cc46294c22b376048f3f1d1a6d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if499ccd516774920992a7dec4b1cef2e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib32ab0952f954ffcac6e996208515105_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3e46c22d3f0f4b2d8bc8e8a60fc2ccc5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6b21bb23ad2d4d29ae1a573ce3633cf1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6adffdb90bb04f3ea1ba43662f341d52_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfddb8b08a444307a9d0127349167737_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i762cb9691e2742e883abaa93d43be077_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6ee634dbd9cf40079a3e668ce24a98e3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4566419dadde4c98a7120368b872f3da_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaaa4cbfc68844bf2ab83f3ee4d31a520_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5a2eb0a55f1548d09ebdd38af8a78640_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89476537bc774ebc87ef3b108c8f978e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i33675a436d3e40e985deb8177a576c9d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab8c34ad3ce545459293744ddcb6827c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i900aa21d63db4875b0f5ce732299844e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i49df9afbb9944bb4b9a18d9b551d87cc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78a868a69cef4c5fa0fad890560c7186_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i150c3c3a7f2441dba86ec0345435079c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i264e682f589d40f8996079dbbb6714ee_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i555f8697f79c4135bf985a88ac806168_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4264f7ca59794b258dcd7d108f89c4bb_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib11f67911ae04e9e9474289103ab7ca0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i993ccc72246c43c6882a67446f7e3d04_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia66c44f3f144416dbe4fb6670ae3d912_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0b8618d03b954dd9b12ccc9dc2633994_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d5ca24424934279961a03e8619d1a55_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18dd800368c0436f9fdaee03faceced1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26c2df1bf2f84583ad5e170e30ac0da6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i63ed1921de984ba2b86b439f98dd36dc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f79c51975d142fcb63efb2a71b34744_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if165ef086e644209a29aa525477fce96_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1ebf7bc335ba488f9cb8f70150a6bd1a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0325f33d9f364afd88fb10e9c56068e0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22dbeb2253784b39851f81d479af22fd_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32ea97b6e981410cbc2b5ebf32b066a3_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e919c640df94e919b7b44c94f671f8e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic5ffc58dbb624c40ac8f80c16398d43c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie112d35bfda34b3288ce4100b5cdf3cf_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f2f4fea3b5747c3907908c54f286f3a_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia630ac63be744170818adf1a6996df94_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib84e2fa7e66c4c8280ad68c7ca28d55c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic852038e4be24f098e1d5554086d7e6b_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i23e0fe4823904639ac80d8fdad567676_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0ea0e85a0e047b098694b3d6d36944a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31bba7ec3d96407896690fde2506a953_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iabbe1867eaad43e6b8ea27b135c22cfd_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51de978558994d7d85f12eee1b08a961_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icc4e373408b54afd8e67604fcad521cc_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57cdf4fb339b4e68892dc8149e2518b9_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb6560107a1842b88eb0a7a57c2f2031_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbb785491adf4226bb9a9857b10f52e9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4b47eeb041d04c25b8cd00f6bf592f7f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffbc90dc71cb4be1a22f4af87b57ff85_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i976083bf7720489d9ec3c392eb20769e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2df8a9f1fea242caaf3c3e4967630be6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a59a4ea155b45bfb972b34701628d91_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic8da0ae531824141a5fbf3f5f9b8abb5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70e465de07bc4489a1d93b090ad882d3_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1b3df8b0ec1847a485fa591f8a59348b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeCareAgenciesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifb52edba0b344f30ae760f39f36a33ba_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3b8477112444416aa795ea6a1381886_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie6f061c2888d4b629403b99a7a704501_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11b4722640e743ca9f00c59f8e177f35_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i960a0c21f35a47e1abe131c0263a41ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16a5a490d6884205a5e9dd42dbbb3399_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc65670bbb7246fa8052cb8e64d56db2_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i186dae40bd454249853b01c1eba9d848_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:ScrippsHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:OwnershipAxis">pntg:HomeHealthJointVentureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ff49407f6be490cad905da779b4d980_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:ScrippsHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18a947ebb0914b1a81c869f2499ef9ee_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">pntg:HospiceJoinVentureMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:ScrippsHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e1d06b38ad84064a8290b0beceb92d9_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:ScrippsHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1eedc1128d554ef1b5b1df73ddae1f03_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeCareAgenciesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia34b018da1b745588a4443489d6fd7a5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i091dbe9239e9447a88678cb20a666033_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:EnsignSubsidiaryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i727696b9c07044d1ae50621d44a2e115_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie51d580ad1694816b75edef851ee768f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic9b4d5180d754f1991716345bb9bfd11_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pntg:BusinessAcquisitions2019Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i22ba094ecdd748caa523069cfe03b1bb_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic989f4d1015643d8b1f921fe889e7655_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic76aa9c6653849259b83d26fe4a1a6e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i472b81765f954025a5079e55559a1cce_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i489985632d6945938dec271036a4ca11_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b29edf2eac54eb981cacc738f038708_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9ad5091204ea402db4f786593e9c88e3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i646d026e30024a759d2d20651293e096_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id8bee216f16649f4bd17307d4aca1e38_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i594abec2ef2e406b8dbe4ab6e7d5e8ee_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7266ba82d91645fe8dc1b6eb5c7fc950_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35d93aabb6ad43d4a0807093b6ff3cdd_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85977dbd3e304b269d60b79b21d58dd3_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i295733ffaf3446e09492cf5e0c2391e7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib53ed044a9784155997f65bf19912e24_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3953707a65c34f67a229dcf123865af0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc995fe4fa2343f99750c39392d1ca31_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87be8b1071da42259fd25653dc6e32b8_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2750bb749074a028d77edb545a82f0d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ed5cb11e8c74a8cab4af56099f9fe37_I20210223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8303ce9e51d4a7a9f23b6cb4859d119_D20210223-20210223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-23</xbrli:startDate><xbrli:endDate>2021-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7bcff1b3b19a471fbb07b38194bdf040_D20210223-20210223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-23</xbrli:startDate><xbrli:endDate>2021-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iff4b598798b347b1bad79e786d66d4ec_D20210223-20210223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-23</xbrli:startDate><xbrli:endDate>2021-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15fbe4ddfaed4fb2ab68184822fc9b20_D20210223-20210223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-23</xbrli:startDate><xbrli:endDate>2021-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id896243133374d5a85762f6aa03af650_D20210223-20210223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-23</xbrli:startDate><xbrli:endDate>2021-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie9d1d1fbe9ca4de3972432630165dd25_D20210223-20210223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-23</xbrli:startDate><xbrli:endDate>2021-02-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe0c05707f51401b8343fc06afba6d47_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i009062db7a07451db770939cb218b995_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia395591b1bb04bc59721af3b9e0057ad_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i324266d2a6034a369becaa333073dedc_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibca5874771a942ac8128f8834681ae6b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95a5ddcc5c1c4f24a7b7984fb2f61366_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7835b6571f414650b23c89f2da3e8e1d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i820fe8df97df45148956430597a8021c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic2d08a40a2ea4844850b407dc06a1380_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18d0ff58a4094edcab67e0572e47b712_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c42f8d3450a45bb97f418276e55401a_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i695c64b54bea4f3ea301a4f593b04c27_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i71a2785689d7485e88d7d7a0fd2e1588_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e98f7de032448e1bdb5e3acc586323d_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fba7cde195142a3978c879c27cb0bab_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2021Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icc2e87893a0146e3bc467cb6aa1d0766_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6c286ff8cbc4714836982d56e9417c0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2020Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddb04c9f35bb476b81dba3be31ee57a0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id19dc50301904b4ca1463fc976675c69_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2019Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie191aaa5b8784c6cb75b59a0e2300e56_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4cd15a2a6a27445183cb22f7b6c7b21b_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55dd760f997d474083702aac3bd35021_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icdcc7ffbdc094bad9d2c2e68f1561ed9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="facility"><xbrli:measure>pntg:facility</xbrli:measure></xbrli:unit><xbrli:context id="i91b3a92c7481472dbec77f9233ecabdc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4ca3f78db99945b69974d02c724d9240_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i41995e14a074437c84df40537f2238d0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8fb2a9d080dd42e58f04fb43fed99eb9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="arrangement"><xbrli:measure>pntg:arrangement</xbrli:measure></xbrli:unit><xbrli:context id="ibaa9096cc2bd4e858996c09298dd6eb0_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">pntg:FacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1309a04126c24144b850a38c0baa4831_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">pntg:FacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id61049412f5d48e69963ed0bcb95677c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">pntg:FacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i59c4cea8cd4b414fbbbcfe383d2f2015_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7385e6d9e8844d5b9ae1f8bed5241579_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if5ac6849e7e74533af722a23640f12d7_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ee98e79dbdf4459bb64dd4764f5f04c_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ief8be8ba89d54b41b5b925a9afe0bfd6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i828be32df55549349516ec453fb5f7fa_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i39dc640518df47b9a65a3d3dbeec9bd5_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a5ce69e0ffd47a7befd0d6c5941a09f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0169fb92128e49f58280fc837cf38434_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i930d5c4fd9b84161879c0000c0e816d2_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="review"><xbrli:measure>pntg:review</xbrli:measure></xbrli:unit><xbrli:unit id="record"><xbrli:measure>pntg:record</xbrli:measure></xbrli:unit><xbrli:context id="ie92494cf696341a4b8eb690958419fa7_I20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-02-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie6d715a9ac734e11ac6ce730afc95baa_D20220101-20220228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-02-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idcd019ebb6aa4404ad2ce8284c512582_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84a5a381cc15426491a05ab72627a087_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib75d5bc9e37c446180e5fa26fafb6083_I20220127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:AffiliatesOfEnsignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-01-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i941ffd2f6e49432b85465ef637f2d33d_D20210101-20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001766400</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1"></div><div style="min-height:36pt;width:100%"><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">_________________________________________________________________________________________________________________________________</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18yMTQ_700f82f4-6e4c-48cd-b12d-d3457ad6fcf7">10-K</ix:nonNumeric> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6NGQ5MTY5MjBiOWZkNDA0OTlmYWU0MTNkMTUwNDdhZGUvdGFibGVyYW5nZTo0ZDkxNjkyMGI5ZmQ0MDQ5OWZhZTQxM2QxNTA0N2FkZV8wLTAtMS0xLTQyMzAx_56464375-ee47-4bad-9f17-6cb71d0a9c08">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.</span></td></tr></table></div><div style="margin-top:3pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18yNDU_43cbbf99-5585-4734-9f86-a684f0aa2c42"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18yNDU_f85118b5-832a-46f2-a6e8-f111431d84f0">December&#160;31</ix:nonNumeric>, 2021</ix:nonNumeric>. </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:92.458%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6MjEyMTMxMDgzOGYzNDM2MmFmY2Q1N2FkMGRjN2NlODAvdGFibGVyYW5nZToyMTIxMzEwODM4ZjM0MzYyYWZjZDU3YWQwZGM3Y2U4MF8wLTAtMS0xLTQyMzA0_1a67c166-5cbf-4cd8-a33c-451f2ed8f437">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.</span></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> to </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission file number: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18zNTI_0cf8fa51-5368-4f4e-a8bb-aa6ceaa259e0">001-38900</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">_________________________________________________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM182NTk3MDY5NzcwMTA5_cf2c5287-54a0-4c65-9c98-b8d36de794e0">THE PENNANT GROUP, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Exact Name of Registrant as Specified in Its Charter)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6Y2ExOGJkMzQwMzE4NGE5YWIwZDdkZGFiNDFkYmFiZmUvdGFibGVyYW5nZTpjYTE4YmQzNDAzMTg0YTlhYjBkN2RkYWI0MWRiYWJmZV8wLTAtMS0xLTQyMzA3_28a03cb6-08c6-42fb-ada1-d758d903f8fb">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6Y2ExOGJkMzQwMzE4NGE5YWIwZDdkZGFiNDFkYmFiZmUvdGFibGVyYW5nZTpjYTE4YmQzNDAzMTg0YTlhYjBkN2RkYWI0MWRiYWJmZV8wLTEtMS0xLTQyMzEw_18faa445-6ace-4a57-bafd-d77d8d79faf1">83-3349931</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(State or Other Jurisdiction of</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(I.R.S. Employer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Incorporation or Organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM180OTU_d3bbd7fd-0833-4c7e-84a9-3918e187ebf6">1675 East Riverside Drive</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM180OTk_a3bf4d03-2410-4ba3-9746-8e7c61607c8c">Suite 150</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM181MDM_5ba4b833-f4a5-45c5-b188-6d8cc52c8f78">Eagle</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM181MDc_1954858a-54a3-4b99-afdd-152ffc0a2fa6">ID</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM181MDk_b983a147-aad2-4df7-8056-e6508dcdbee6">83616</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices and Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM181Njc_8bf76b3e-cd75-4484-92ed-c8cff15b4de7">(208)</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM181NzA_0b8d9a0e-1193-4462-98f4-dac791a720e7">506-6100</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:3pt;font-weight:700;line-height:120%">_________________________________________________________________________________________________________________________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:31.063%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.818%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.819%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6MjFkNDIzNWI4ZTU3NGQ1ZjgwYzRlNGFlNjAyNzEyMTMvdGFibGVyYW5nZToyMWQ0MjM1YjhlNTc0ZDVmODBjNGU0YWU2MDI3MTIxM18xLTAtMS0xLTQyMzEy_b37d85b1-ce2f-4bb1-86c7-67f48a02dc6b">Common Stock, par value $0.001 per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6MjFkNDIzNWI4ZTU3NGQ1ZjgwYzRlNGFlNjAyNzEyMTMvdGFibGVyYW5nZToyMWQ0MjM1YjhlNTc0ZDVmODBjNGU0YWU2MDI3MTIxM18xLTEtMS0xLTQyMzE1_76e51642-05a2-442e-9a44-56c2a6a33f0d">PNTG</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6MjFkNDIzNWI4ZTU3NGQ1ZjgwYzRlNGFlNjAyNzEyMTMvdGFibGVyYW5nZToyMWQ0MjM1YjhlNTc0ZDVmODBjNGU0YWU2MDI3MTIxM18xLTItMS0xLTQyMzE3_7dfb0f9e-4459-41c7-8614-d95a53ec2d44">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act: None</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule&#160;405 of the Securities Act, or the Act.&#160; </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18xMDIz_4aa62db7-43a0-4df7-afe8-0c7ae852d83f">No</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or Section&#160;15(d) of the Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18xMTYx_a3ba37ae-3d3a-49b2-8827-6315e0690eb3">No</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days. </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18xNTEy_bdfed933-eaab-4721-81ef-aa991fc0ed96">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files). </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18xODMy_a6925514-c778-4ee1-bada-472a672411cd">Yes</ix:nonNumeric> </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">ndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.348%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.495%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.298%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6NzUyYzkyYzY1OWU3NGM3N2E4MmJhOTc1MDRiNjExMDEvdGFibGVyYW5nZTo3NTJjOTJjNjU5ZTc0Yzc3YTgyYmE5NzUwNGI2MTEwMV8wLTAtMS0xLTU0MTg1_029b27ee-2dd2-4970-b13e-608aebb7bdfe">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6NzUyYzkyYzY1OWU3NGM3N2E4MmJhOTc1MDRiNjExMDEvdGFibGVyYW5nZTo3NTJjOTJjNjU5ZTc0Yzc3YTgyYmE5NzUwNGI2MTEwMV8wLTctMS0xLTQyMzgx_4af1e7f0-7808-4000-a7bc-4c9cd1473510">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6NzUyYzkyYzY1OWU3NGM3N2E4MmJhOTc1MDRiNjExMDEvdGFibGVyYW5nZTo3NTJjOTJjNjU5ZTc0Yzc3YTgyYmE5NzUwNGI2MTEwMV8wLTktMS0xLTQyMzgz_44993306-4e2c-4f11-9dce-80eab3fe3877">&#9744;</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18zNDUx_301ef13d-fd72-47ef-a30b-a855b3753c5b">&#9746;</ix:nonNumeric></span></div><div style="text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by a check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Exchange Act). </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18yOTAw_503a1fcb-ff12-4f12-8445-7ff269275cf8">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Yes </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of February&#160;28, 2022, <ix:nonFraction unitRef="shares" contextRef="i6abd4a4310074b4097aa0589993a20d0_I20220222" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18yOTIz_177cbd36-ff2e-43b7-8f8d-3598bd777f56">28,529,556</ix:nonFraction> shares of the registrant&#8217;s common stock were outstanding. The aggregate market value of the shares of common stock held by non-affiliates of the registrant on the last business day of the registrant's most recently completed second fiscal quarter (June 30, 2021) was approximately $<ix:nonFraction unitRef="usd" contextRef="i6fe0ba45acf1463a9efa0125b5bbd460_I20210630" decimals="-3" name="dei:EntityPublicFloat" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18zMjA3_d167ed3a-eb55-43f5-b654-ed9a28786051">1,143,039,000</ix:nonFraction> based upon the closing price of the common stock on such date. For purposes of this calculation, the registrant has excluded the market value of all common stock beneficially owned by all executive officers and directors of the registrant.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.784%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:2pt;text-align:center"><span><br/></span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note on Incorporation by Reference</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl83L2ZyYWc6NGQwMjYzZDE5ZDZlNDkwYTkzZGE5ZDQyYTI0OTBiOGIvdGV4dHJlZ2lvbjo0ZDAyNjNkMTlkNmU0OTBhOTNkYTlkNDJhMjQ5MGI4Yl83Njk2NTgxMzk0NzUy_87c92653-3978-4bcd-a268-399e40d75994" escape="true">Part&#160;III of this Form&#160;10-K incorporates information by reference from the Registrant's definitive proxy statement on Schedule 14A for the Registrant's 2022 Annual Meeting of Stockholders to be filed within 120&#160;days after the close of the fiscal year covered by this annual report.</ix:nonNumeric></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_10"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">THE PENNANT GROUP, INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT ON FORM 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021  </span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.766%"><tr><td style="width:1.0%"></td><td style="width:2.971%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.323%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:79.193%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part I.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_19">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_19">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_19">2</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_58">Item1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_58">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_58">17</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_61">Item 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_61">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_61">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_64">Item 2. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_64">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_64">26</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_67">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_67">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_67">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_70">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_70">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_70">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part II.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_76">Item 5. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_76">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_76">27</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_79">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_79">[Reserved</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_79">]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_79">28</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_82">Item 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_82">Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_82">28</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_91">Item 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_91">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_91">44</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_94">Item 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_94">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_94">44</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_97">Item 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_97">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_97">44</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_100">Item 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_100">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_100">44</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_103">Item 9B.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_103">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_103">46</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_1483">Item 9</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_1483">C</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_1483">.</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_1483">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_1483">46</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part III.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_109">Item 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_109">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_109">47</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_112">Item 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_112">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_112">47</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_115">Item 12. </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_115">Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_115">47</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_118">Item 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_118">Certain Relationships and Related Transactions and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_118">47</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_121">Item 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_121">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_121">47</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Part IV.</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_127">Item 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:0.75pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_127">Exhibits, Financial Statements and Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_127">48</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_130">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_130">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_130">50</a></span></div></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_133">Signatures</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reports, filings and other public announcements, including this Annual Report on Form 10-K may from time to time contain statements that do not directly or exclusively relate to historical facts. Such statements are &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, and typically include, but are not limited to, our expected future financial position, results of operations, cash flows, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities and plans and objectives of management. Forward-looking statements can often be identified by words such as &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;believe,&#8221; &#8220;seek,&#8221; &#8220;estimate,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;ongoing,&#8221; similar expressions, and variations or negatives of these words. Additionally, many of these risks and uncertainties are currently amplified by and will continue to be amplified by, or in the future may be amplified by, continued outbreaks of SARS-CoV-2, the virus that causes the disease COVID-19 (&#8220;COVID-19&#8221;). The developments with respect to COVID-19 and its impacts have occurred rapidly, and because of the unprecedented nature of the COVID-19 pandemic we are unable to predict the extent and duration of the adverse financial impact of COVID-19 on our business, financial condition and results of operations.  These statements are subject to the safe harbors created under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), and the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). These statements are not guarantees of future performance and are subject to risks, uncertainties and assumptions that are difficult to predict. Therefore, our actual results could differ materially and adversely from those expressed in any forward-looking statements as a result of various factors, some of which are listed in Part I, Item 1A., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, of this Annual Report on Form 10-K for the year ended December 31, 2021. Accordingly, you should not rely upon forward-looking statements as predictions of future events. These forward-looking statements speak only as of the date of this Annual Report, and are based on our current expectations, estimates and projections about our industry and business, management's beliefs, and certain assumptions made by us, all of which are subject to change. We undertake no obligation to revise or update publicly any forward-looking statement for any reason, except as otherwise required by law. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this Annual Report on Form&#160;10-K, the words, &#8220;Pennant,&#8221; &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our&#8221; and &#8220;us&#8221; refer to The Pennant Group, Inc. and its consolidated subsidiaries. All of our independent operating subsidiaries, and the Service Center (defined below) are operated by separate, wholly-owned, independent subsidiaries that have their own management, employees and assets. References herein to the consolidated &#8220;Company&#8221; and &#8220;its&#8221; assets and activities, as well as the use of the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and similar terms in this Annual Report are not meant to imply, nor should they be construed as meaning, that The Pennant Group, Inc. has direct operating assets, employees or revenue, or that any of the subsidiaries are operated by The Pennant Group, Inc.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pennant Group, Inc. is a holding company with no direct operating assets, employees or revenues. In addition, certain of our wholly-owned independent subsidiaries, collectively referred to as the &#8220;Service Center,&#8221; provide centralized accounting, payroll, human resources, information technology, legal, risk management, compliance oversight and other centralized services to the other independent operating subsidiaries through contractual relationships with such subsidiaries.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The address of our headquarters is 1675 East Riverside Drive, Suite 150, Eagle, ID 83616, and our telephone number is (208) 506-6100. Our corporate website is located at www.pennantgroup.com. The information contained in, or that can be accessed through, our website does not constitute a part of this Annual Report on form 10-K. </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_16"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I.</span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_19"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_22"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pennant Group, Inc. is a leading provider of high-quality healthcare services to patients or residents of all ages, including the growing senior population, in the United States. Through our innovative operating model, we strive to be the provider-of-choice in the communities we serve. On October&#160;1, 2019, we completed a spin-off from The Ensign Group, Inc. (&#8220;Ensign&#8221;) (NASDAQ: ENSG), our former parent company, which transferred all of its home health and hospice agencies and substantially all of its senior living businesses to us.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we operate multiple lines of business, including home health, hospice and senior living, throughout Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. We provide home health and hospice services through 88 agencies, and senior living services at 54 communities with 4,127 total units in our assisted living, independent living and memory care business. We derive revenue from a diversified blend of payors including Medicare and Medicaid programs, private pay patients and residents and managed care payors.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our key differentiators are our (1) innovative operating model that focuses on empowering and developing strong local leaders, (2) disciplined growth strategy, and (3) ability to achieve quality care outcomes in cost effective settings. In our experience, healthcare is a local endeavor, largely dependent upon personal and professional relationships, community reputation and an ability to adapt to the changing needs of patients, residents, partners and communities. As our operational leaders build strong relationships with key partners in their local communities, they are empowered to make informed and critical operational decisions that produce quality care outcomes and more effectively meet the needs of our patients and residents. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our home health and hospice businesses are able to achieve quality outcomes&#8212;as measured by multiple industry and value-based metrics (such as hospital readmission rates)&#8212;in cost effective settings. We believe our senior living business is able to offer our residents a safe and tailored quality-of-life at an affordable cost, thus appealing to a broad population. With our platform of diversified service offerings, we believe that we are well-positioned to take advantage of favorable demographic shifts as well as industry trends that reward providers offering quality care in lower cost settings. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Innovative Operating Model </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our innovative operating model is the foundation of our superior performance and success. Our operating model is founded on two core principles: (1) healthcare is a local business where providers are most successful when key operational decision-making meets local community needs and occurs close to patients or residents and employees, and (2) peer accountability from operational and resource partners is more effective at driving excellent clinical and financial results than traditional hierarchical or &#8220;top-down&#8221; accountability structures.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our model is innovative because each operation has been and will continue to be an independent operating subsidiary that functions under the direction of local clinical and operational leaders, each of whom are empowered to make decisions based on the unique needs of the patients or residents, partners and communities they serve. This is in contrast to typical models where control and key decision-making is centralized at the corporate level. Moreover, we utilize a &#8220;cluster model,&#8221; where every operation is part of a defined &#8220;cluster,&#8221; which is a group of geographically proximate operations working together to allow leaders to communicate and provide support and accountability to each other. Clusters create incentives for leaders to share best practices and real-time data and benchmark clinical and financial performance with their cluster partners. We believe this locally-driven data-sharing and peer accountability model is unique among healthcare and senior living providers and has proven effective in improving clinical care, enhancing patient and resident satisfaction and promoting operational efficiencies. This &#8220;cluster&#8221; operating model is the same model used by local leaders prior to our spin-off from Ensign in 2019 (further discussed below under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Company History</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and is key to the success of our future operations.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our organizational structure empowers our highly dedicated leaders and staff at the local level to make key decisions and creates a sense of ownership over operational and clinical results and the overall employee experience. Each operation&#8217;s leader and his or her staff are encouraged to make their operations the &#8220;provider of choice&#8221; in the communities they serve. To accomplish this goal, our leaders work closely with their clinical staff and our expert resources to identify unique patient and resident needs and priorities in their communities and to create superior service offerings tailored to those needs. We believe that our localized approach to program development and care leads prospective patients or residents and referral sources to choose or recommend our operations to others. Similarly, our emphasis on empowering local decision-makers encourages </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">leaders to strive to become the &#8220;employer of choice&#8221; in the communities they serve. One of our core values is the principle that the best patient care is provided by employees who experience significant work satisfaction because they are valued as individuals. Our leaders work hard to embody this core value and to attract, train and retain outstanding clinical staff by creating a work environment that fosters critical thinking, measurement, and relevance. Our local teams are motivated and empowered to quickly and proactively meet the needs of those they serve, without waiting for permission to act or being bound to a &#8220;one-size-fits-all&#8221; corporate strategy. In many markets, we attribute census growth and excellent clinical and financial outcomes to a healthy organizational culture built on these</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">principles. With strong employee satisfaction across the organization, we believe we can continue to attract and retain the best talent in our industries.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lastly, while our teams are local, they are also supported by cutting-edge systems and our &#8220;Service Center&#8221;, which is staffed with teams of subject-matter experts who advise regarding their respective fields of expertise, including information technology, compliance, human resources, accounting, payroll, legal, risk management, education and other services. The partnership and peer accountability that exists between our local leaders and Service Center resources allows each operation to improve while benefiting from the technical expertise, systems and accountability provided by our Service Center.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Partner of Choice in Local Healthcare Communities </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We view healthcare services primarily as a local business, driven by personal relationships, reputation and the ability to identify and address unmet community needs. We believe our success is largely driven by our ability to build strong relationships with key stakeholders within the local healthcare communities, leveraging our reputation for providing superior care. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we are a partner of choice to payors, providers, patients, residents and employees in the healthcare communities we serve. As a partner, we focus on improving care outcomes and the quality of life of our patients and residents in their home. Our local leadership approach facilitates the development of strong professional relationships within communities, which allows us to better understand and meet the needs of our partners. We believe our emphasis on working closely with other providers, payors, residents and patients yields unique, customized solutions and programs that meet local market needs and improve clinical outcomes, which in turn accelerates revenue growth and profitability. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a trusted partner to, and work closely with, payors and other acute and post-acute providers to deliver innovative healthcare solutions in lower cost settings. In the markets we serve, we have developed formal and informal preferred provider relationships with key referral sources and transitional care programs that result in better coordination within the care continuum. These partnerships have resulted in significant benefits to payors, patients, residents and other providers, including reduced hospital readmission rates, appropriate transitions within the care continuum, overall cost savings, increased patient satisfaction and improved quality outcomes. Positive, repeated interactions and data sharing result in strong local relationships and encourage referrals from our acute and post-acute care partners. As we continue to strengthen these formal and informal relationships and expand our referral base, we believe we will continue to drive revenue growth and operational results. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company History </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pennant Group, Inc. was incorporated as a Delaware corporation on January&#160;24, 2019, for the purpose of holding the home health and hospice agencies and substantially all of the senior living businesses of Ensign, which was formed in 1999 with the goal of establishing a new level of quality care within the skilled nursing industry. The name &#8220;Ensign&#8221; is synonymous with a &#8220;flag&#8221; or a &#8220;standard,&#8221; and refers to Ensign&#8217;s goal of setting the standard by which all others in its industry are measured. The name &#8220;Pennant&#8221; draws on similar imagery and themes to represent our mission of becoming the &#8220;Ensign&#8221; to the home health, hospice and senior living industries. We believe that, through our innovative operating model, we can foster a new level of patient care and professional competence at our independent operating subsidiaries and set new industry standards for quality home health and hospice and senior living services. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;1, 2019, Ensign completed the spin-off of Pennant effected through a tax-free distribution (except as to cash received in lieu of fractional shares) of substantially all of Pennant&#8217;s issued and outstanding common stock to the stockholders of Ensign, as a result of which Pennant became an independent, publicly-traded company (the &#8220;Spin-Off&#8221;). Following the Spin-Off, Ensign had no continuing ownership interest in Pennant. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent operating subsidiaries are organized into industry-specific portfolio companies, which we believe has enabled us to maintain a local, field-driven organizational structure, to attract qualified leaders and expert resources, and to effectively identify, acquire, and improve operations. Each of our portfolio companies has its own leader. These experienced </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and proven leaders are generally taken from the ranks of our operational leaders to serve as resources to independent operating subsidiaries within their own portfolio companies and have the primary responsibility for recruiting qualified talent, finding potential acquisition targets, and identifying other strategic and organic growth opportunities. We believe this decentralized organizational structure will continue to improve the quality of our recruiting and facilitate successful acquisitions. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two reportable segments: (1) home health and hospice services, which includes our home health, hospice and home care businesses; and (2) senior living services, which includes our assisted living, independent living and memory care communities. We also report an &#8220;all other&#8221; category that includes general and administrative expense. Our reporting segments are business units that offer different services and that are managed separately to provide greater visibility into those operations. For more information about our operating segments, as well as financial information, see &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and Note 6, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Segments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Consolidated and Combined Financial Statements. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_25"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Services </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Home Health&#160;and Hospice. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we provided home health and hospice services through 88 agencies. Our home health services consist of providing a combination of clinical services including nursing, speech, occupational and physical therapy, medical social work and home health aide services within a patient's home. Home health is often a cost-effective solution for patients and can also increase their quality of life by allowing them to receive excellent clinical services in the comfort and convenience of the patient's home. Our hospice services focus on the physical, spiritual and psychosocial needs of terminally ill patients and their families and consist primarily of clinical care, education and counseling. We generated approximately 70.0%, 70.3% and 68.6% of our home health and hospice revenue from Medicare during the years ended December 31, 2021, 2020 and 2019, respectively.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Living. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we provided assisted living, independent living and memory care services in&#160;54&#160;communities with&#160;4,127&#160;total units or rooms. Our senior living operations provide a variety of services tailored to our residents&#8217; needs, including residential accommodations, activities, meals, housekeeping and assistance in the activities of daily living to seniors who are independent or who require some support not at the level of clinical care provided in a skilled nursing facility. We generate revenue in these communities primarily from private pay sources, with a portion earned from Medicaid or other state-specific programs. We derived approximately 71.3%, 73.2% and 77.4% of our senior living revenue from private pay sources during the years ended December 31, 2021, 2020 and 2019, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_28"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Growth Strategy</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the following strategies are primarily responsible for our growth to date and will continue to drive the growth of our business: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Grow Talent Base and Develop Future Leaders.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our growth strategy is focused on expanding our talent base and developing future leaders. A key component of our organizational culture is our belief that strong local leadership is a primary ingredient to operational success. We use a multi-faceted strategy to identify and recruit proven business leaders from various industries and backgrounds. To develop these leaders, we have a rigorous &#8220;CEO-in-Training Program&#8221; that includes significant in-person instruction on leadership, clinical and operational topics as well as extensive on-the-ground training and active learning with key leaders from across the organization. After placement in a local operation, our leaders continue to receive training and regular feedback and support from operational, clinical and Service Center peers. We believe our model of empowering local leaders and providing them a platform of support from expert resources and systems will continue to attract and retain highly talented and entrepreneurial leaders. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Focus on Organic Growth.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe that we have a significant opportunity to drive organic growth within our current portfolio, including recently acquired operations. As we improve clinical outcomes, quality of care and operational results at each of our existing and newly acquired operations, we believe we will become a provider of choice in the communities we serve, which leads to census growth. Through this census growth, and as we continue to expand our service areas and offerings, we believe we will continue to translate revenue growth into bottom line success with rigorous adherence to our core operating principles. By effectively using data systems and analytics and embracing a culture of transparency and accountability, we tend to see our local leaders steadily improving operational results. We believe our unique operating model will continue to cultivate steady and consistent organic growth in the future. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pursue Disciplined Acquisition Strategy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disciplined acquisition and integration of strategic and underperforming operations is a key element of our past success and is integral to our future growth plans. We have historically successfully transitioned both turnaround and stable target businesses, transforming them into top-quality operations preferred by referral </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sources. We plan to continue to take advantage of the fragmented home health, hospice and senior living industries by being disciplined in acquiring strategic and underperforming operations within both our existing and new geographic markets. With experienced leaders in place at the local level and demonstrated success in improving operating conditions at acquired businesses, we believe we are well positioned to continue expanding our footprint through disciplined acquisitions. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leverage Our Operational Capabilities to Expand Partnerships. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our local leadership approach enables us to adapt to and efficiently meet the needs of our partners in the communities we serve. Our clinical and data analytics capabilities foster solutions and allow us to optimize clinical outcomes. We use this data to communicate with key partners in an effort to reduce overall cost of care and drive improved clinical outcomes. We will continue to expand formal and informal partnerships across the healthcare continuum by strategically investing in programs and data analytics that help us and our partners improve care transitions, achieve better outcomes and reduce costs. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_31"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Growth and Acquisition History </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Much of our historical growth can be attributed to our expertise in acquiring strategic and underperforming operations and transforming them into market leaders in clinical quality, staff competency and financial performance. Our local leaders are trained to identify these opportunities for long-term organic growth as we strive to become the provider of choice in our local communities. Accordingly, we plan to continue to drive organic growth and acquire additional operations in existing and new markets in a disciplined manner. </span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From 2013 to 2021, we grew our home health and hospice services and senior living services revenue by 561.0% or a compounded annual growth rate of 26.6%.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:center"><img src="pntg-20211231_g1.jpg" alt="pntg-20211231_g1.jpg" style="height:400px;margin-bottom:5pt;vertical-align:text-bottom;width:655px"/></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From 2013 to December&#160;31, 2021, we grew the number of our home health and hospice agencies and senior living units by 450.0% and 228.6%, respectively. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agency and Unit Growth Since 2013</span></div><div style="text-align:center"><img src="pntg-20211231_g2.jpg" alt="pntg-20211231_g2.jpg" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:340px"/><img src="pntg-20211231_g3.jpg" alt="pntg-20211231_g3.jpg" style="height:300px;margin-bottom:5pt;vertical-align:text-bottom;width:340px"/></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home health and hospice agencies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior living communities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior living units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total number of home health, hospice, and senior living operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We aim to continue to grow our revenue and earnings by expanding our existing operations and acquiring additional operations in existing and new markets. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_34"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Industry Trends </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare sector is one of the largest and fastest-growing sectors of the U.S. economy. According to the Centers for Medicare and Medicaid Services (&#8220;CMS&#8221;), national healthcare spending increased from 8.9% of U.S. GDP, or $253 billion, in 1980 to an estimated 19.7% of GDP, or $4.1 trillion, in 2020. CMS projects national healthcare spending will grow by an average of 5.4% annually from 2019 through 2028, accounting for approximately 19.7% of U.S. GDP, or approximately $6.2 trillion, in 2028. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The home health and hospice segment is growing within the overall healthcare landscape in the United States. According to Grandview Research, Inc.&#8217;s (&#8220;GVRI[&#8216;s]&#8221;) research, the home health market is estimated at approximately $299 billion and is expected to grow at a compounded annual growth rate (&#8220;CAGR&#8221;) 7.88% from 2021 to 2028. The hospice industry is estimated at approximately $29 billion and is projected to grow at an estimated CAGR of 8.6%. The senior living market is estimated at approximately $83 billion and is expected to expand at an estimated CAGR of 5.3% between 2021 to 2027. We believe that the industries in which we operate will continue to benefit from several macroeconomic and regulatory trends highlighted below: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increased Demand Driven by Aging Populations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As seniors account for an increasing percentage of the total U.S. population, we believe demand for home health and hospice will continue to increase and demand for senior living services will improve as operating conditions impacted by the COVID-19 pandemic return to normal. According to the U.S. Census Bureau in 2020, between 2016 and 2060, the number of individuals over 65 years old is projected to be one of the fastest growing segments of the United States population, growing from 15% to 23%. The Bureau expects this segment to increase nearly 92% to 94.7 million by 2060 (from 2016) as compared to the total U.S. population which is projected to increase by 25.2% over that same time period. Furthermore, the generation currently retiring has access to less post-retirement benefits and accumulated less savings than in the past, creating demand for more affordable senior housing and in-home care options. As a high-quality provider in lower cost settings, we believe we are well-positioned to benefit from this trend. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shift of Patient Care to Lower Cost Alternatives</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The growth of the senior population in the U.S. continues to increase healthcare costs, often at a rate faster than the available funding from government-sponsored healthcare programs. In response, government payors have adopted measures that encourage the treatment of patients in their homes and other cost-effective settings where the staffing requirements and associated costs are often significantly lower than the alternatives. With our emphasis on the home health, hospice and senior living industries, which are among the lowest cost settings within the post-acute care continuum, we expect this shift to continue to drive our growth. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transition to Value-Based Payment Models</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In response to rising healthcare spending, certain markets&#8217; commercial, government and other payors are shifting away from fee-for-service payment models toward value-based models, including risk-based payment models that tie financial incentives to quality, efficiency and coordination of care. We believe that payors will continue to emphasize reimbursement models driven by value and that our clinical outcomes combined with our services in cost effective settings will be increasingly rewarded. Many of our home health agencies already receive value-based payments, and we are well-positioned to capitalize on this trend as it unfolds across the markets we serve. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Acquisition and Consolidation Opportunities</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The home health, hospice and senior living industries are highly fragmented markets with thousands of small and regional providers and only a handful of large national players. There were over 11,000 Medicare-certified home health agencies operating in 2020, with the top ten largest operators accounting for approximately 26% of the market. There are approximately 4,500 hospice agencies in the U.S. with the top ten largest operators accounting for about 18% of the total market share. As with the home health and hospice industries, there is significant fragmentation in the senior housing industry, with the top 25 operators controlling only a quarter of the market. We believe that our strategy of acquiring strategic and underperforming operations in these highly fragmented markets will be an instrumental piece of our future growth. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Changing Regulatory Framework</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Regulations and reimbursement change frequently in our industries. Our model is designed to successfully navigate these regulatory and reimbursement changes. For example, effective January 1, 2020, CMS enacted additional changes to the Medicare home health prospective payment system (&#8220;HH PPS&#8221;) with the implementation of the Patient Driven Groupings Model (&#8220;PDGM&#8221;). As discussed in greater detail below under </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, this reimbursement structure involved case mix calculation methodology refinements, changes to low-utilization payment adjustment (&#8220;LUPA&#8221;) thresholds, the elimination of therapy thresholds, a change to the unit of payment from a 60-day episode to a 30-day period of care, and reduction in fiscal year 2020 and full elimination in fiscal year 2021 of requests for anticipated payments (&#8220;RAPs&#8221;). Beginning in fiscal year 2022, the CMS is replacing the RAP process with the home health Notice of Admission (&#8220;NOA&#8221;), which requires a single NOA filing that will cover continuous 30-day periods of care until the patient is discharged. This transition from RAP to NOA may cause delays in payment from CMS or even denial of payment, as the NOA process will be new for both CMS and the Company. Just as we have navigated other major reimbursement and regulatory changes, we believe that our unique operating model allowed us to transition to PDGM as local operations and clinical leaders, supported by our expert resources, effectively adapted to the new reimbursement environment.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_37"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Payor Sources </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive revenue primarily from Medicare and Medicaid programs,  managed care and private payors.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Medicare is a federal program that provides healthcare benefits to individuals who are 65 years of age or older or are disabled. The Medicare home health benefit is available both for patients who need care following discharge from an inpatient facility and patients who suffer from chronic conditions that require ongoing but intermittent care. The Medicare hospice benefit is also available to Medicare-eligible patients with terminal illnesses, certified by a physician, where life expectancy is six months or less. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Medicaid</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Medicaid is a program financed by state funds and matching federal funds administered by state agencies or managed care organizations on their behalf. Medicaid programs generally provide health benefits for qualifying individuals and may supplement Medicare benefits for the disabled and for persons aged 65 and older meeting financial eligibility requirements. Medicaid reimbursement formulas are established by each state with the approval of the federal government in accordance with federal guidelines. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Medicaid reimbursement varies from state to state and is based upon a number of different methodologies, including cost-based, prospective payment, case mixed adjusted payments, and negotiated rates. Rates are subject to a state&#8217;s annual budgetary requirements and funding, statutory and regulatory changes and interpretations and rulings by individual state agencies and State Plan Amendments approved by CMS. </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Managed Care and Private Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Managed care patients consist of individuals who are insured by certain third-party entities, or who are Medicare beneficiaries who have assigned their Medicare benefits to a managed care organization plan. Another type of insurance, long-term care insurance, is also becoming more widely available to consumers and is not expected to contribute significantly to industry revenues in the near term. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Private and Other Payors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> Private and other payors consist primarily of individuals, family members or other third parties who directly pay for the services we provide. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The following table sets forth our total revenue by payor source as a percent of revenue generated by each of our reportable segments and as a percentage of total revenue for the year ended December 31, 2021: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:35.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.111%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hospice Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">  </span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:80%"> </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_40"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reimbursement for Specific Services </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, adjustments to reimbursement under Medicare and Medicaid have had a significant effect on our revenue and results of operations. Recently enacted, pending and proposed legislation and administrative rulemaking at the federal and state levels could have similar effects on our business. Efforts to impose reduced reimbursement rates, greater discounts, cost sequestrations in federal spending bills passed by Congress, and more stringent cost controls by government and other payors are expected to continue for the foreseeable future and could adversely affect our business, financial condition and results of operations. Additionally, any delay or default by the federal or state governments in making Medicare and/or Medicaid reimbursement payments could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reimbursement for Home Health Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our home health business derives substantially all of its revenue from Medicare, managed care, and private pay sources, which may vary in the markets we serve. Our home health services generally consist of providing some combination of the services of registered nurses, speech, occupational and physical therapists, medical social workers and certified home health aides. Home health is often a cost-effective solution for patients and can also increase their quality of life and allow them to receive quality medical care in the comfort and convenience of a familiar setting. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reimbursement for Hospice Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hospice revenues are primarily derived from Medicare. We receive one of four predetermined rate categories based on four different levels of care provided: routine home care, continuous home care, inpatient respite care and general inpatient care. This payment structure is designed to include all of the services needed to manage a beneficiary&#8217;s care, consisting primarily of clinical care, education and counseling. These rates are subject to annual adjustments based on inflation and geographic wage considerations. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reimbursement for Senior Living Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Assisted living, independent living and memory care community revenue is primarily derived from private pay residents at rates we establish based upon the services we provide and market conditions in the area of operation. In addition, Medicaid or other state-specific programs in some states where we operate supplement payments for board and care services provided in assisted living and memory care communities. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_43"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The post-acute care industry is highly competitive, and we expect that the industry will become increasingly competitive in the future. The industry is highly fragmented and characterized by numerous local and regional providers, in addition to large national providers that have achieved geographic diversity and economies of scale. Some of our independent operating subsidiaries also compete with skilled nursing facilities, inpatient rehabilitation facilities and long-term acute care hospitals. Competitiveness may vary significantly from location to location, depending upon factors such as the number of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">competing operations, availability of services, expertise of staff, and the physical appearance and amenities of senior living communities. We believe that the primary competitive factors in the post-acute care industry are: </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:78.75pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.25pt">ability to attract and to retain qualified leaders and caregivers; </span></div><div style="margin-bottom:6pt;padding-left:78.75pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.25pt">reputation and achievements of quality healthcare outcomes and patient and resident satisfaction; </span></div><div style="margin-bottom:6pt;padding-left:78.75pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.25pt">attractiveness and location of senior living communities and other physical assets; </span></div><div style="margin-bottom:6pt;padding-left:78.75pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.25pt">the expertise and commitment of operational leaders and employees; and </span></div><div style="margin-bottom:6pt;padding-left:78.75pt;text-indent:-15.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:12.25pt">private equity and other firms with greater financial resources and/or lower costs of capital with similar asset acquisition objections. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We seek to compete effectively in each market by establishing a reputation within the local community as the &#8220;operation of choice.&#8221; This means that the operation leaders are generally free to discern and address the unique needs and priorities of healthcare professionals, customers and other stakeholders in the local community or market, and then create superior service offerings for that particular community or market that are calculated to encourage prospective customers and referral sources to choose or recommend the operation. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Increased competition could limit our ability to attract and retain patients and residents, maintain or increase rates of reimbursement or to expand our business. Some of our competitors have greater financial and other resources than we have, may have greater brand recognition and may be more established in their respective communities than we are. Competing companies may also offer newer or more recently renovated communities or different programs or services than we offer and may, therefore, attract individuals who are currently patients of our operations, potential residents of our facilities, or who are otherwise receiving our healthcare services. Other competitors may have lower expenses or other competitive advantages than us and, therefore, provide services at lower prices than we offer. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">There are few barriers to entry in the home health and hospice business in jurisdictions that do not require certificates of need or permits of approval. Our primary competition in these jurisdictions comes from local privately and publicly owned providers and hospital-owned healthcare providers. We compete based on the availability of personnel, the quality of services, expertise of visiting staff, and, in certain instances, on the price of our services. In addition, we compete with a number of non-profit organizations that finance acquisitions and capital expenditures on a tax-exempt basis and charity-funded programs that may have strong ties to their local medical communities and receive charitable contributions that are unavailable to us. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior living services also compete with local, regional and national companies. The primary competitive factors in these businesses include reputation, cost of services, quality of clinical services, responsiveness to patient/resident needs, location and the ability to provide support in other areas such as third-party reimbursement, information management and patient recordkeeping. The market for acquiring and/or operating senior living communities is highly competitive, and some of our present and potential senior living competitors have, or may obtain, greater financial resources than us and may have a lower cost of capital.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_46"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Competitive Strengths </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we are well positioned to benefit from the ongoing regulatory, reimbursement and demographic changes within the home health, hospice and senior living industries. We believe that we will achieve clinical, financial and cultural success as a direct result of the following key competitive strengths: </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Innovative Operating Model.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe healthcare should be operated primarily as a local business. Our local leadership-centered operating model encourages our leaders to make key operational decisions that meet the individualized needs of their patients, residents and community partners. Recognizing the local nature of our business, our leaders develop each operation&#8217;s reputation at the local level, rather than being bound by a traditional organization-wide branding strategy. In addition, our local leaders work closely with their cluster partners to share data and improve clinical and financial outcomes. Moreover, we do not maintain a traditional corporate headquarters, rather we operate our Service Center which supports operational results through world-class systems and by providing ancillary expertise in fields such as information technology, compliance, human resources, accounting, legal and education. This enables individual operations to function with the strength, synergies and economies of scale found in larger organizations, without the disadvantages of a top-down management structure or corporate hierarchy. We believe this approach is unique within our industries and allows us to preserve the &#8220;one-operation-at-a-time&#8221; focus and culture that has contributed to our success. </span></div><div style="padding-left:11.25pt;text-align:justify;text-indent:2.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Proven Track Record of Successful Acquisitions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We adhere to a disciplined acquisition strategy focused on sourcing and selectively acquiring operations within our target markets. Local leaders are heavily involved in the acquisition process and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are recognized and rewarded as these acquired operations become the provider of choice in the communities they serve. Through our innovative operating model and disciplined approach to strategic growth, we have completed and successfully transitioned dozens of value-add operations. Our expertise in acquiring and transforming strategic and underperforming operations allows us to consider a broad range of potential acquisition targets and will be a key element of our future success. </span></div><div style="padding-left:11.25pt;text-align:justify;text-indent:2.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Superior Clinical Outcomes and Quality Care. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue to achieve success by delivering high quality home health, hospice and senior living services. Using the CMS five-star quality rating criteria, our home health agencies achieved an average of 4.4 out of 5 stars across all agencies for the for the year ended December 31, 2021, compared to the industry average of 3.0 stars (see </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> below for further discussion on the five-star quality rating system). Our locally-driven, patient-centered approach to clinical care allows us to meet the unique needs of our patients, resulting in improved clinical outcomes, including reduced hospital readmission rates. These improved outcomes are driven by both our talented local clinicians and our data-driven analytical approach to patient care and risk stratification. We believe that our achievement of high-quality clinical outcomes positions us as a solution for patients, residents and referral sources, leading to census growth and improved profitability. </span></div><div style="padding-left:11.25pt;text-align:justify;text-indent:2.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diversified Portfolio by Payor and Services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2021, we operated 88 home health and hospice agencies and 54 senior living communities across 14 states. Because of this diversified portfolio, our blended payor mix was 49.3% Medicare, 13.3% Medicaid, 11.2% managed care and 26.2% private pay for the year ended December 31, 2021. Our balanced payor mix can provide greater business stability through economic cycles and mitigates volatility arising from government-driven reimbursement changes. For the year ended December 31, 2021, we generated 70.4% of our revenue from home health and hospice services and 29.6% of our revenue from senior living services. Our diversified service portfolio allows us to opportunistically execute on our acquisition strategy as valuations fluctuate over industry cycles. </span></div><div style="padding-left:11.25pt;text-align:justify;text-indent:2.25pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effective Talent Recruitment, Development and Retention. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we have been successful in attracting, developing and retaining outstanding business and clinical leaders to lead our independent operating subsidiaries. Our unique operating model, which emphasizes local decision making and team building, supported by our platform of expert resources and best-in-class systems, attracts a highly talented and entrepreneurial group of leaders. Our operational leaders are committed to ongoing training and participation in regular leadership development and educational programs. We believe that our commitment to professional development strengthens the quality of our operational leaders and staff and will continue to differentiate us from our competitors. </span></div><div style="text-align:justify"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_49"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Human Capital </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The operation of our home health and hospice operations and senior living communities requires a large number of highly skilled healthcare professionals and support staff. As of December&#160;31, 2021, we had 6,441 employees who were employed by our independent operating subsidiaries or our Service Center. None of those employees is subject to a collective bargaining agreement relating to our operations. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract and retain future leaders is critical to our ongoing success. Therefore, we are dedicated to continuously recruiting and developing a diverse group of capable leaders. As described in Item 1. Grow Talent Base and Develop Future Leaders, our CEO-in-Training program provides significant in-person instruction and extensive training with key leaders from across the organization to empower local leaders.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December 31, 2021, 56.7% of our total expenses were payroll related for our operations. Periodically, market forces, which vary by region, require that we increase wages in excess of general inflation or in excess of increases in reimbursement rates we receive. We believe that we staff appropriately, focusing primarily on the acuity level and day-to-day needs of our patients and residents. We seek to manage our labor costs by improving staff retention, improving operating efficiencies, maintaining competitive wage rates and benefits and reducing reliance on overtime compensation and temporary nursing agency services. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry as a whole has been experiencing shortages of qualified professional clinical staff. We believe that our ability to attract and retain qualified professional clinical staff stems from our ability to offer attractive wage and benefits packages, a high level of employee training, a culture that provides incentives for individual efforts and a quality work environment.   </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_52"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Government Regulation</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The laws and statutes affecting the regulatory landscape of the home health, hospice and senior living industries continue to expand. In addition to this changing regulatory environment, federal, state and local officials are </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">increasingly focusing their efforts on the enforcement of these laws. In order to operate our businesses, we must comply with federal, state and local laws relating to, among other things, licensure, delivery and adequacy of medical care, distribution of pharmaceuticals, equipment, personnel, operating policies, fire prevention, immigration, employment, rate-setting, billing and reimbursement, building codes and environmental protection. Additionally, we must also adhere to anti-kickback statutes, physician referral laws, and safety and health standards set by the Occupational Safety and Health Administration (&#8220;OSHA&#8221;). Changes in the law or new interpretations of existing laws may have an adverse impact on our methods and costs of doing business.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent operating subsidiaries are also subject to various regulations and licensing requirements promulgated by state and local health and social service agencies and other regulatory authorities. Requirements vary from state to state and these requirements can affect, among other things, personnel education and training, patient and personnel records, services, staffing levels, monitoring of patient wellness, patient furnishings, housekeeping services, dietary requirements, emergency plans and procedures, certification and licensing of staff prior to beginning employment, and patient rights. These laws and regulations could limit our ability to expand into new markets and to expand our services and facilities in existing markets.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All providers are subject to compliance with various federal, state and local statues and regulations in the U.S. and receive periodic inspection by state licensing agencies to review standards of medical care, equipment and safety.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conditions of Participation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our home health and hospice operations must comply with regulations promulgated by the United States Department of Health and Human Services (&#8220;HHS&#8221;) and CMS in order to participate in the Medicare program and receive Medicare payments. Among other things, these conditions of participation (the &#8220;CoPs&#8221;), relate to the type of operation, its personnel and its standards of medical care, as well as its compliance with state and local laws and regulations.   </span></div><div style="padding-left:36pt;text-align:justify;text-indent:40.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Home Health Quality Reporting Requirements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CoPs require home health agencies to submit quality reporting data through Outcome and Assessment Information Set (&#8220;OASIS&#8221;) assessments within 30 days of completing the assessment of the Medicare and Medicaid beneficiary as a condition of payment and for quality measurement purposes. If the OASIS assessment is not found in CMS's quality system upon receipt of a final claim for a home health episode and the receipt date of the claim is more than 30 days after the assessment completion date, CMS will deny the claim. Home health agencies that do not submit quality measure data to CMS incur a 2% reduction in their annual home health payment update. Under the rule, all home health agencies are required to timely submit both a Start of Care or Resumption of Care OASIS assessment and a Transfer or Discharge OASIS assessment for a minimum of 90% of all episodes. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, CMS requires that all Medicare certified home health and hospice agencies participate in the Consumer Assessment of Healthcare Providers and Systems (&#8220;CAHPS&#8221;). CAHPS surveys are designed to produce comparable data on the perspective of patients and their caregivers that allows meaningful and objective comparisons between agencies. Home health and hospice agencies that do not submit the required data incur a 2% reduction in their annual base rate payment update.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Home Health Star Rating</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a consumer tool for selecting a home health provider, CMS has used a five-star rating model to rate home health agencies since 2015. This Quality of Patient Care Star Rating is a summary measure of a home health agency&#8217;s performance based upon how well it provides patient care. CMS uses seven measurements indicating quality to determine its rating, including how often the agency initiated care in a timely manner, how often patients demonstrated improvements in ambulation, bed transferring, bathing, oral medication administration, decreased pain with activity, less shortness of breath, and decreased need for acute care hospitalization. According to CMS, a 3-star rating means the agency provides good quality of care. According to CMS Home Health Compare star rating criteria, our home health agencies have achieved an average of 4.4 out of 5 stars across all agencies compared to the industry average of 3.0 stars for the year ended December 31, 2021.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Home Health Reimbursement, including HH PPS and PDGM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To qualify for home health services, Medicare CoPs require that beneficiaries (1) be homebound (meaning that the beneficiary is unable to leave his/her home without a considerable and taxing effort); (2) require intermittent skilled nursing, physical therapy or speech therapy services; (3) have a face to face encounter that (a) has occurred no more than 90 days prior to the start of care or within 30 days after the start of care, (b) was related to the primary reason the patient requires home health services, and (c) was performed by a physician or allowed non-physician provider; and (4) receive treatment under a plan of care established and periodically reviewed by a physician.  </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through December 31, 2019, under the Medicare HH PPS, Medicare pays home health agencies a predetermined base payment adjusted for case-mix (the health condition and care needs of the beneficiary), as well as geographic differences in wages for home health agencies across the country. There are also outlier payments to account for beneficiaries who incur unusually large costs. For patients who do not receive at least a specified number of visits during their episode of care, HH PPS uses a low-utilization payment adjustment (&#8220;LUPA&#8221;). Until January 1, 2020, HH PPS provided home health agencies with payments for each 60-day episode of care for each beneficiary. There were no limits to the number of episodes an eligible beneficiary can receive. </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">In October 2019, CMS issued a final rule implementing PDGM. The PDGM reimbursement structure involves case mix calculation methodology refinements, changes to LUPA thresholds, the elimination of therapy thresholds, a change to the unit of payment from a 60-day episode to a 30-day payment period, and the reduction in fiscal year 2020 and full elimination in fiscal year 2021 of the RAP. Effective January 1, 2020, under PDGM the initial certification of patient eligibility, plan of care, and comprehensive assessment remains valid for 60-day episodes of care and payments for home health services are made based upon 30-day periods. During 2020, we received 20% of the estimated payment for a patient&#8217;s initial or subsequent period of care up-front (after the initial assessment is completed and upon initial billing) and the remaining 80% upon submission of the final claim following the 30-day period of care. Beginning on January 1, 2022, the RAP process is replaced by a home health agency filing a NOA to cover continuous 30-day periods of care until the patient is discharged.  Within five calendar days of beginning care, home health agencies must submit a NOA or else face a reduction in the payment that is equal to a 1/30th reduction of the expected wage and case-mix adjusted 30-day payment period for each day from the start of care, equal to the current late submission deduction for RAPs. PDGM&#8217;s ultimate impact will vary by provider based on factors including case-mix, admission source, and providers&#8217; ability to adapt to the new reimbursement model's coding and therapy thresholds. </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Home Health Value Based Purchasing (HH VBP)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The Center for Medicare and Medicaid Innovation (&#8220;Innovation Center&#8221;) implemented the original Home Health Value-Based Purchasing (&#8220;HHVBP&#8221;) Model from January 1, 2016 through December 31, 2021. The model was designed to support greater quality and efficiency of care among Medicare-certified Home Health Agencies (&#8220;HHA&#8221;) across the nation. The HHVBP Model supported efforts to build a health care system that delivers better care, spends health care dollars more wisely, and results in healthier people and communities. All Medicare-certified HHAs that provided services in Massachusetts, Maryland, North Carolina, Florida, Washington, Arizona, Iowa, Nebraska, and Tennessee competed on value, where payment was tied to quality performance. The overall purpose of the HHVBP Model was to improve the quality and delivery of home health care services to Medicare beneficiaries with specific goals to; provide incentives for better quality care with greater efficiency, study new potential quality and efficiency measures for appropriateness in the home health setting, and, enhance the public reporting process. The HHVBP Model was expanded nationwide in the Calendar Year (&#8220;CY&#8221;) 2022 HH PPS rule. In addition, the rule finalized the end of the HHVBP Model one year early for the HHAs in the nine original Model states, such that CY 2020 performance data will not be used to calculate a payment adjustment for HHAs in the nine states and will not have their payments impacted in CY 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The expanded HHVBP Model begins on January 1, 2022 and includes Medicare-certified HHAs in all fifty (50) states. Calendar Year 2022 is the pre-implementation year wherein CMS will provide HHAs with resources and training. This will allow HHAs time to prepare and learn about the expectations and requirements of the expanded HHVBP Model without risk to payments. The first full performance year for the expanded HHVBP Model is CY 2023 (beginning January 1, 2023). Calendar Year 2025 will be the first year when payment will be adjusted determined on CY 2023 performance. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Review Choice Demonstration for Home Health Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Review Choice Demonstration for Home Health Services (RCD) provides flexibility and choice for Home Health Agencies (HHAs), as well as risk-based changes to reduce burden on providers demonstrating compliance with Medicare home health policies. The demonstration is mandatory for all Medicare certified HHAs in 5 states Illinois, Ohio, North Carolina, Floria and Texas. Providers select from three initial choices:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:90pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Pre-claim review</span></div><div style="padding-left:90pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Post-payment review</span></div><div style="padding-left:90pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Minimal post-payment review with a 25% payment reduction</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a 6-month period, HHAs demonstrating compliance with Medicare rules through pre-claim review or postpayment review will have additional choices, including relief from most reviews except for a review of a small sample of claims. (To be eligible, HHAs must meet a 90% target full provisional affirmation rate based on a minimum 10 requests/claims submitted.) This program is designed to reduce the number of Medicare appeals, improve provider </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compliance with Medicare program requirements, should not delay care to Medicare beneficiaries, and does not alter the Medicare home health benefit.</span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hospice Reimbursement and Cap Amounts</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payments are based on daily rates for each day a beneficiary is enrolled in the hospice benefit and are subject to two annual caps. Rates are set based on specific levels of care, are adjusted by a wage index to reflect healthcare labor costs across the country and are established annually through federal legislation. The following are the four levels of care provided under the hospice benefit:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Routine Home Care (&#8220;RHC&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care that is not classified under any of the other levels of care, such as the work of nurses, social workers or home health aides.</span></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">General Inpatient Care. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pain control or acute or chronic symptom management that cannot be managed in a setting other than an inpatient Medicare-certified facility, such as a hospital, skilled nursing facility or hospice inpatient facility.</span></div><div style="margin-bottom:6pt;padding-left:90pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Continuous Home Care. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Care for patients experiencing a medical crisis that requires nursing services to achieve palliation and symptom control, if the agency provides a minimum of eight hours of care within a 24-hour period.</span></div><div style="padding-left:90pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Inpatient Respite Care.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term, inpatient care to give temporary relief to the caregiver who regularly provides care to the patient.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has established a two-tiered payment system for RHC. Hospices are reimbursed at a higher rate for RHC services provided from days of service one through 60 and then a lower rate for all subsequent days of service. CMS also provided for a Service Intensity Add-On, which increases payments for certain RHC services provided by registered nurses and social workers to hospice patients during the final seven days of life. </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare payments are subject to two fixed annual caps, which are assessed on a provider number basis, and are broken into an inpatient cap amount and an overall payment cap. These cap amounts are calculated and published by the Medicare fiscal intermediary on an annual basis covering the period from October 1 through September 30. The inpatient cap limits hospice care provided on an inpatient basis. This cap limits the number of days that are paid at the higher inpatient care rate to 20.0% of the total number of days of hospice care that are provided to all Medicare beneficiaries served by a provider. The daily rate for all days exceeding the cap is the standard RHC daily rate, and the provider must reimburse Medicare for any payments received in excess of that amount. The overall payment cap is calculated by the Medicare fiscal intermediary at the end of each hospice cap period to determine the maximum allowable payments to a hospice provider during the period. We estimate our potential cap exposure by using available information to compare our actual reimbursement for all hospice services provided during the period to the number of beneficiaries we served multiplied by the statutory per beneficiary cap amount. If payments received by any one of our hospice provider numbers exceeds either of these caps, we are required to reimburse Medicare for payments received in excess of the cap amounts. The hospice cap amount for the 2022 cap year is equal to the 2021 cap amount of $30,683.93 updated by 2% or $31,297.61 per beneficiary.  </span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Improving Medicare Post-Acute Care Transformation Act of 2014 (&#8220;IMPACT Act&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IMPACT Act requires the submission of standardized assessment data for quality improvement, payment and discharge planning purposes across the spectrum of post-acute care providers (&#8220;PACs&#8221;), including home health agencies. The IMPACT Act requires PACs to report: (1) standardized patient assessment data at admission and discharge; (2) new quality measures, including functional status, skin integrity, medication reconciliation, incidence of major falls, and patient preference regarding treatment and discharge; and (3) resource use measures, including Medicare spending per beneficiary, discharge to community, and hospitalization rates of potentially preventable readmissions for home health agencies. Failure to report such data when required would subject a PAC to a 2% reduction in market basket prices then in effect.</span></div><div style="padding-left:36pt;text-indent:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The IMPACT Act also included provisions impacting Medicare-certified hospices, including (1) increasing survey frequency for Medicare-certified hospices to once every 36 months, (2) imposing a medical review process for operations with a high percentage of stays in excess of 180 days, and (3) updating the annual aggregate Medicare payment cap.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hospice Quality Reporting Requirements (&#8220;HQRP&#8221;)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HQRP, mandated by the Patient Protection and Affordable Care Act, requires hospice agencies to submit required quality data for inclusion on the public facing Hospice Compare website </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hosted by CMS. Hospices that fail to meet quality reporting requirements receive a 2.0% reduction to the annual market basket update for the fiscal years 2021, 2022, and 2023. This reduction penalty will be increased to 4.0% beginning in fiscal year 2024. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Licensure and Certificates of Need (&#8220;CON&#8221;). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Home health, hospice and most senior living communities operate under licenses granted by the health authorities of their respective states. Some states require healthcare providers (including home health, hospice and most senior living providers) to obtain prior state approval for the purchase, construction or expansion of healthcare operations, or changes in services. Certain states, including a number in which we operate, carefully restrict new entrants into the market based on demographic and/or demonstrative usage of additional providers. These states limit the entry of new providers or services and the expansion of existing providers or services in their markets through a CON process, which is periodically evaluated and updated as required by applicable state law. For those states that require a CON, we must also complete a separate application process establishing a location and must receive required approvals. Washington and Montana are the only CON state in which we operate home health or hospice agencies.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Patient Protection and Affordable Care Act (&#8220;ACA&#8221;). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various healthcare reform provisions became law upon enactment of the ACA in 2010. The reforms contained in the ACA have affected our independent operating subsidiaries in some manner and are directed in large part at increased quality and cost reductions. These reforms include modifications to the conditions of qualification for payment, bundling of payments to cover both acute and post-acute care and the imposition of enrollment limitations on new providers. Presidential and congressional elections may result in significant changes in legislation, regulation, and implementation of Medicare, Medicaid, and government policy, along with potential changes to tax rates and other tax treatment of our operations. We continually monitor these developments so we can respond to the changing regulatory environment impacting our business.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Civil and Criminal Fraud and Abuse Laws and Enforcement. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various complex federal and state laws exist which govern a wide array of referrals, relationships and arrangements, and prohibit fraud by healthcare providers. Governmental agencies are devoting increasing attention and resources to such anti-fraud efforts. The Health Insurance Portability and Accountability Act of 1996 (&#8220;HIPAA&#8221;), and the Balanced Budget Act of 1997 (&#8220;BBA&#8221;) expanded the penalties for healthcare fraud. Additionally, in connection with our involvement with federal healthcare reimbursement programs, the government or those acting on its behalf may bring an action under the False Claims Act (&#8220;FCA&#8221;), alleging that a healthcare provider has defrauded the government by submitting a claim for items or services not rendered as claimed, which may include coding errors, billing for services not provided, and submitting false or erroneous cost reports. The Fraud Enforcement and Recovery Act of 2009 (&#8220;FERA&#8221;) expanded the scope of the FCA by, among other things, creating liability for knowingly and improperly avoiding repayment of an overpayment received from the government and broadening protections for whistleblowers. The FCA clarifies that if an item or service is provided in violation of the Anti-Kickback Statute, the claim submitted for those items or services is a false claim that may be prosecuted under the FCA as a false claim. Civil monetary penalties (&#8220;CMPs&#8221;) under the FCA range from approximately $11,803 to $23,607 and are adjusted annually for inflation. Under the qui tam or &#8220;whistleblower&#8221; provisions of the FCA, a private individual with knowledge of fraud may bring a claim on behalf of the federal government and receive a percentage of the federal government&#8217;s recovery. Due to these whistleblower incentives, lawsuits have become more frequent. Many states also have a false claim prohibition that mirrors or tracks the federal FCA. Federal law also provides that the Office of the Inspector General for HHS (&#8220;OIG&#8221;) has the authority to exclude individuals and entities from federally funded health care programs on a number of grounds, including, but not limited to, certain types of criminal offenses, licensure revocations or suspensions, and exclusion from state or other federal healthcare programs. In addition, CMS can recover overpayments from health care providers up to five years following the year in which payment was made.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Monitoring Compliance in our Operations. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a healthcare provider, we have a compliance program to help us comply with various requirements of federal, state and private healthcare programs. Our compliance program includes, among other things, (1) policies and procedures modeled after applicable laws, regulations, government manuals and industry practices and customs that govern the clinical, reimbursement and operational aspects of our subsidiaries; (2) training about our compliance process for the employees of our independent operating subsidiaries, our directors and officers; (3) training about Medicare and Medicaid laws, fraud and abuse prevention, clinical standards and practices, and claim submission and reimbursement policies and procedures for appropriate employees; and (4) internal controls that monitor, for example, the accuracy of claims, reimbursement submissions, cost reports and source documents, provision of patient care, services, and supplies as required by applicable standards and laws, accuracy of clinical assessment and treatment documentation, and implementation of judicial and regulatory requirements (e.g., background checks, licensing and training).</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, governmental agencies and other authorities periodically inspect our operations to assess our compliance with various standards, rules and regulations. The robust regulatory and enforcement environment continues to impact healthcare providers, especially in connection with responses to any alleged noncompliance identified in periodic surveys and other inspections by governmental authorities. Unannounced surveys or inspections generally occur at least annually at our independent operating subsidiaries and may also follow a government agency's receipt of a complaint about an operation. We </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are also subject to regulatory reviews relating to Medicare services, billings and potential overpayments resulting from the Recovery Audit Contractors, Zone Program Integrity Contractors, Program Safeguard Contractors, Unified Program Integrity Contractors, Supplemental Medical Review Contractors and Medicaid Integrity Contributors programs in which third party firms engaged by CMS conduct extensive reviews of claims data and medical and other records to identify potential improper payments under the Medicare programs. We must pass these inspections to maintain our licensure under state law, to obtain or maintain certification under the Medicare and Medicaid programs, to continue participation in the Veterans Administration (VA) program at some operations, and/or to comply with our provider contracts with managed care clients at many operations. From time to time, we, like others in the healthcare industry, may receive notices from federal and state regulatory agencies alleging that we failed to substantially comply with applicable standards, rules or regulations. These notices may require us to take corrective action, may impose CMPs for noncompliance, and may threaten or impose other operating restrictions. If our operations fail to comply with these directives or otherwise fail to comply substantially with licensure and certification laws, rules and regulations, we could lose our certification as a Medicare or Medicaid provider, lose our state licenses to operate and be subject to imposed fines and penalties. </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare operations in our industries with otherwise acceptable regulatory histories are generally given an opportunity to correct deficiencies and continue their participation in the Medicare and Medicaid programs by a certain date, usually within nine months, although where denial of payment or similar remedies are asserted, such interim remedies go into effect much sooner. Operations with poor regulatory histories continue to be classified by CMS as poor performing operations notwithstanding any intervening change in ownership, unless the new owner obtains a new Medicare provider agreement instead of assuming the operation's existing agreement. However, new owners (including us, historically) nearly always assume the existing Medicare provider agreement due to the difficulty and time delays generally associated with obtaining new Medicare certifications, especially in previously-certified locations with sub-par operating histories. Accordingly, operations that have poor regulatory histories before we acquire them may be more likely to have sanctions imposed upon them by CMS or state regulators. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Regulations Regarding Financial Arrangements. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We are also generally subject to federal and state laws that regulate financial arrangements by healthcare providers, such as the federal and state anti-kickback laws, the Stark laws, and various state anti-referral laws.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Anti-Kickback Statute, Section 1128B of the Social Security Act (the &#8220;Anti-Kickback Statute&#8221;) prohibits the knowing and willful offer, payment, solicitation, or receipt of any remuneration, directly or indirectly, overtly or covertly, in cash or in-kind, to induce the referral of an individual, in return for recommending, or to arrange for, the referral of an individual for any item or service payable under any federal healthcare program, including Medicare or Medicaid. The OIG has issued regulations that create &#8220;safe harbors&#8221; for certain conduct and business relationships that are deemed protected under the Anti-Kickback Statute. In order to receive safe harbor protection, all of the requirements of a safe harbor must be met. The fact that a given business arrangement does not fall within one of these safe harbors, however, does not render the arrangement per se illegal. Business arrangements of healthcare service providers that fail to satisfy the applicable safe harbor criteria, if investigated, will be evaluated based upon all facts and circumstances and risk increased scrutiny and possible sanctions by enforcement authorities.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the Anti-Kickback Statute can result in criminal penalties of up to $100,000 and ten years&#8217; imprisonment. Violations of the Anti-Kickback Statute can also result in CMPs of over $100,000 per violation (adjusted annually for inflation) and an assessment of up to three times the total amount of remuneration offered, paid, solicited, or received. Violation of the Anti-Kickback Statute may also result in an individual&#8217;s or organization&#8217;s exclusion from future participation in Medicare, Medicaid and other state and federal healthcare programs. State Medicaid programs are required to enact an anti-kickback statute. Many states in which we operate have adopted or are considering similar legislative proposals, some of which extend beyond the Medicaid program, to prohibit the payment or receipt of remuneration for the referral of patients regardless of the source of payment for the care. We believe that business practices of providers and financial relationships between providers have become subject to increased scrutiny as healthcare reform efforts continue at the federal and state levels.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to these regulations, we may face adverse consequences if we violate the federal Stark laws related to certain Medicare physician referrals. Section 1877 of the Social Security Act, commonly known as the &#8220;Stark Law,&#8221; provides that a physician may not refer a Medicare or Medicaid patient for a &#8220;designated health service&#8221; to an entity with which the physician or an immediate family member has a financial relationship unless the financial arrangement meets an exception under the Stark Law or its regulations. Any funds collected for an item or service resulting from a referral that violates the Stark Law must be repaid to Medicare or Medicaid, any other third-party payor, and the patient. In addition, CMPs, which are adjusted for annual inflation, and treble damages may be imposed for presenting or causing to be presented, a claim for a service rendered in violation of the Stark Law. These CMPs include a penalty of over $25,000 per prohibited claim, and over $170,000 for knowingly entering into certain prohibited cross-referral schemes (adjusted annually for inflation), and potential </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exclusion from Medicare for any person who presents or causes to be presented a bill or claim the person knows or should know is submitted in violation of the Stark laws. Many states have enacted healthcare provider referral laws that go beyond physician self-referrals or apply to a greater range of services than just the designated health services under the Stark Law.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulations Regarding Patient Record Confidentiality. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to laws and regulations enacted to protect the confidentiality of patient health information. For example, HHS has issued rules pursuant to HIPAA as amended by the Health Information Technology for Economic and Clinical Health (&#8220;HITECH&#8221;) Act, which relate to the privacy of certain patient information and provide patients with the right of access to their health information. These rules govern our use and disclosure of protected health information. We have established policies and procedures to comply with HIPAA privacy, security and breach notification requirements at our facilities and operations subject to HIPAA. We maintain a company-wide HIPAA compliance plan, which we believe complies with the HIPAA regulations. The HIPAA regulations have and will continue to impose significant costs on our facilities in order to comply with these standards. Our operations are also subject to any federal or state privacy-related laws that are more restrictive than the privacy regulations issued under HIPAA. These laws vary and could impose additional penalties for privacy and security breaches.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Antitrust Laws. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to federal and state antitrust laws. Enforcement of the antitrust laws against healthcare providers is common, and antitrust liability may arise in a wide variety of circumstances, including third party contracting, physician relations, joint venture, merger, affiliation and acquisition activities. In some respects, the application of federal and state antitrust laws to healthcare is still evolving, and enforcement activity by federal and state agencies appears to be increasing. At various times, healthcare providers and insurance and managed care organizations may be subject to an investigation by a governmental agency charged with the enforcement of antitrust laws or may be subject to administrative or judicial action by a federal or state agency or a private party. Violators of the antitrust laws could be subject to criminal and civil enforcement by federal and state agencies, as well as by private litigants.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulations Specific to Senior Living Communities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior living services revenue is primarily derived from private pay residents at rates we establish based upon the needs of the resident, the amount of services we provide the resident, and market conditions in the area of operation. In addition, Medicaid or other state-specific programs may supplement payments for board and care services provided in senior living communities. A majority of states provide, or are approved to provide, Medicaid payments for personal care and medical services to some residents in licensed senior living communities under waivers granted by or under Medicaid state plans approved by CMS. State Medicaid programs control costs for assisted living and other home- and community-based services by various means such as restrictive financial and functional eligibility standards, enrollment limits and waiting lists. States that administer Medicaid programs for services in senior living communities are responsible for monitoring the services at, and physical conditions of, the participating communities. As a result of the growth of assisted living in recent years, states have adopted licensing standards applicable to assisted living communities. Most state licensing standards apply to assisted living communities regardless of whether they accept Medicaid funding.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior living segment is subject to a variety of federal, state and local environmental laws and regulations. As a senior living services provider, we face regulatory requirements in areas of air and water quality control, medical and low-level radioactive waste management and disposal, asbestos management, response to mold and lead-based paint in our facilities and employee safety.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an operator of our communities, we also may be required to investigate and remediate hazardous substances that are located on and/or under the property, including any such substances that may have migrated off, or may have been discharged or transported from the property. Part of our operations involves the handling, use, storage, transportation, disposal and discharge of medical, biological, infectious, toxic, flammable and other hazardous materials, wastes, pollutants or contaminants. In addition, we are sometimes unable to determine with certainty whether prior uses of our communities and properties or surrounding properties may have produced continuing environmental contamination or noncompliance, particularly where the timing or cost of making such determinations is not deemed cost-effective. These activities, as well as the possible presence of such materials in, on and under our properties, may result in damage to individuals, property or the environment; may interrupt operations or increase costs; may result in legal liability, damages, injunctions or fines; may result in investigations, administrative proceedings, penalties or other governmental agency actions. Associated costs may not be covered by insurance.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_55"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Available Information</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the reporting requirements under the Securities Exchange Act of 1934, as amended (the Exchange Act). Consequently, we are required to file reports and information with the Securities and Exchange Commission (&#8220;SEC&#8221;), including reports on the following forms: annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. These reports and other information concerning our company may be accessed through the SEC&#8217;s website at http://www.sec.gov.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may also find on our website at www.pennantgroup.com electronic copies of our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. Such filings are placed on our website as soon as reasonably possible after they are filed with the SEC. All such filings are available free of charge. Information contained in our website is not deemed to be a part of this Annual Report on Form 10-K.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Factors -</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Based on the information currently known to us, we believe that the following information identifies material risk factors affecting our company. However, the risks and uncertainties we face are not limited to those described below. Additional risks and uncertainties may also adversely affect our business. If any of the following risks and uncertainties develops into actual events, these events could have a material adverse effect on our business, financial condition or results of operations. In such case, the trading price of our common stock could decline. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Industry</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Our revenue could be impacted by federal changes to reimbursement and other aspects of Medicare.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> We derived 49.3% of our revenue from the Medicare program for the year ended December 31, 2021, which is typical. In addition, other payors may use published Medicare rates as a basis for reimbursements. The Medicare program and its reimbursement rates, caps, deductibles and rules are subject to frequent change for a variety of reasons, each of which is discussed in Item 1., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">. Budget pressures also frequently lead the federal government to reduce or limit reimbursement rates under Medicare. Additionally, Medicare payments can be delayed or declined (including retroactively) due to determinations that certain costs, services or providers are not covered. Accordingly, if Medicare reimbursement rates are reduced or fail to increase as quickly as our costs, or if there are changes in the way these programs pay for services or what services or providers are covered, our business and results of operations would be adversely affected. CMS has also introduced in the past, and will likely introduce in the future, new payment models, such as value-based arrangements, in markets in which we operate. Those models may depend on the formation of preferred provider relationships among payors and providers. Our operations may not successfully implement or adapt to these changes and our operations could be materially impacted. As discussed below, Medicare reimbursement and participation may also be tied to the vaccination of employees pursuant to a new interim final rule published by CMS on November 5, 2021.  After initial litigation, the United States Supreme Court stayed injunctions that had been entered against CMS&#8217; enforcement of this rule as of January 13, 2022, allowing this interim final rule requiring employees of certain Medicare-participating facilities and services including home health agencies and hospices to be vaccinated, which affects our businesses and employees.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reductions in Medicaid reimbursement rates or changes in the rules governing the Medicaid program could have a material, adverse effect on our revenues, financial condition and results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We derived 13.3% of our revenue from Medicaid programs for the year ended December 31, 2021, which is typical. Medicaid is a state-administered program financed by both state funds and matching federal funds and its reimbursement rates and rules are subject to frequent change (including retroactively) at both the federal and state level, as discussed in Item 1., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any budget reductions or funding restrictions, discontinuance or reduction of federal matching, change in payment methodology or delays in states in which we operate could adversely affect our net patient service revenue and profitability. We can expect continuing cost containment pressures on Medicaid outlays for our services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reforms to the U.S. healthcare system continue to impose new requirements upon us and may lower our reimbursements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The ACA included sweeping changes to how healthcare is paid for and furnished in the United States. The ACA continues to face legal challenges and calls for repeal or amendment. We cannot predict what effect these challenges, or other legislative or regulatory changes (including, for instance, proposals for Medicare for All or public option insurers operated by one or more individual states), will have on our business, including the demand for our services or the amount of reimbursement available for those services. It is possible new laws may lower reimbursement or increase the cost of doing business and adversely affect our business. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to various government reviews, audits and investigations that could adversely affect our business, including an obligation to refund amounts previously paid to us, potential criminal charges, the imposition of fines, and/or the loss of our right to participate in Medicare and Medicaid programs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As discussed in greater detail in Item 1., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as a result of our participation in the Medicaid and Medicare programs, we are frequently subject to various governmental reviews, audits and investigations to verify our compliance with these programs. Private pay sources also reserve the right to conduct audits. Disagreements about billing and reimbursement are common in our industry due in part to the subjectivity </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inherent in patient diagnosis and care, record keeping, claims processing and other aspects of the patient service and reimbursement processes. An adverse review, audit or investigation could result in (1) an obligation to refund amounts previously paid to us by payors in amounts that could vastly exceed the revenue derived from claims actually reviewed in the audit, and could be material to our business; (2) state or federal agencies imposing fines, penalties and other sanctions on us; (3) suspension of Medicare or Medicaid payments (4) loss of our right to participate in the Medicare or Medicaid programs or one or more private payor networks; (5) an increase in private litigation against us; and (6) damage to our reputation in various markets.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In cases where claim and documentation review by any CMS contractor results in repeated poor performance, an operation can be subjected to protracted oversight, and sustained failure to demonstrate improvement towards meeting all claim filing and documentation requirements could ultimately lead to Medicare decertification. Additionally, both federal and state government agencies have heightened and coordinated civil and criminal enforcement efforts as part of numerous ongoing investigations of healthcare companies. The focus of these investigations includes, among other things: cost reporting and billing practices; quality of care; financial relationships with referral sources; and medical necessity of services provided. If any of our affiliated operations is decertified, loses its licenses, or is subject to criminal charges or civil claims, administrative sanctions or penalties, our revenue, financial condition or results of operations would be adversely affected. We or some of the key personnel of our independent operating subsidiaries could also be temporarily or permanently excluded from future participation in state and federal healthcare reimbursement programs such as Medicaid and Medicare. In addition, the report of such issues at any of our affiliated operations could harm our reputation for quality care and could cause us to be in default under some of our agreements, including agreements governing outstanding indebtedness. Responding to audits, litigation or enforcement efforts diverts material time, resources and attention, and could have a materially detrimental impact on our results of operations during and after any such investigation or proceedings, regardless of whether we prevail.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not operate in compliance with the extensive laws and regulations to which we are subject, or if these laws and regulations change, we could be required to make significant expenditures or change our operations to bring our operations into compliance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We, like other companies in the healthcare industry, are required to comply with extensive and complex laws and regulations at the federal, state and local government levels as discussed in greater detail in Item 1., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> These laws and regulations are subject to frequent and unpredictable change. If we fail to comply with these applicable laws and regulations, we could suffer civil or criminal penalties and other detrimental consequences, including denial of reimbursement, imposition of fines, temporary suspension of admission of new patients, suspension or decertification from the Medicaid and Medicare programs, restrictions on our ability to acquire new operations or expand or operate existing operations, the loss of our licenses to operate and the loss of our ability to participate in federal and state reimbursement programs. These laws and regulations are complex, and we do not always have the benefit of significant regulatory or judicial interpretation of these laws and regulations. Changing interpretations or enforcement of these laws and regulations could subject our current or past practices to allegations of impropriety or illegality or could require us to change our operations, equipment, personnel, services, capital expenditure programs and operating expenses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Public and government calls for increased survey and enforcement efforts toward our industries could result in increased scrutiny and potential sanctions or costly remedies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government authorities have increased the scope or number of inspections or surveys and the severity of consequent citations for alleged failure to comply with regulatory requirements.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in Item 1., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, from time to time in the ordinary course of business, we receive deficiency reports from state and federal regulatory bodies resulting from such inspections or surveys. Although most inspection deficiencies are resolved through an agreed-upon plan of corrective action, the reviewing agency typically has the authority to take further action against a licensed or certified operation, which could result in the imposition of fines, imposition of a provisional or conditional license, suspension or revocation of a license, suspension of new admission or bed holds, loss of certification as a provider under state or federal healthcare programs, or imposition of other sanctions, including criminal penalties.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, in some states, citations in one operation can impact other operations in the state. Revocation of a license or decertification at a given operation could therefore impair our ability to obtain new licenses or to renew existing licenses at other operations, which may also trigger defaults or cross-defaults under our leases and our credit arrangements, or adversely affect our ability to operate in the future. If state or federal regulators were to determine, formally or otherwise, that one operation&#8217;s regulatory history ought to impact another of our existing or prospective communities, this could also increase costs, result in increased scrutiny by state and federal survey agencies, and impact our expansion plans. In addition, from time to time, we may opt to voluntarily stop accepting new patients pending completion of a new state survey, to avoid straining staff and other resources while retraining staff, upgrading operating systems or making other operational improvements, all of which can impact our financial results.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Future cost containment initiatives undertaken by payors may limit our future revenue and profitability</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our Managed Care revenue and profitability may be affected by continuing efforts of third-party payors to maintain or reduce costs of healthcare by lowering payment rates, narrowing the scope of covered services and network providers, increasing case management review of services and negotiating pricing. In addition, sustained unfavorable economic conditions may affect the number of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">patients enrolled in managed care programs and the profitability of managed care companies, which could result in reduced revenue. There can be no assurance that third-party payors will make timely payments for our services, or that we will continue to maintain our current payor or revenue mix. We are continuing our efforts to develop our private pay sources of revenue. Any changes in payment levels from current or future third-party payors could have a material adverse effect on our business and combined financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Increased competition for, or a shortage of, nurses and other skilled personnel could increase our staffing and labor costs and negatively impact our operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Our success depends upon our ability to retain and attract nurses, certified nurse assistants, social workers and speech, physical and occupational therapists, as well as skilled personnel who are responsible for the day-to-day operations of each of our affiliated operations. If we fail to attract and retain qualified and skilled personnel, or if the associated costs increase, our independent operating subsidiaries&#8217; ability to conduct their business operations effectively could be harmed. Staffing challenges have increased during the pandemic due to health care worker burnout, COVID exposures, vaccine mandates, and wage inflation, increasing the competition for qualified staff and cost of retaining personnel. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on our management team and local leaders, and the loss of their services could harm our business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We believe that our success depends in part on the continued services of our executive management and local leadership teams. The loss of, or failure to recruit, such key personnel could have a material adverse effect on our business and could adversely affect our strategic relationships and impede our ability to execute our business strategies. The market for qualified individuals is highly competitive and finding and recruiting suitable replacements for our leaders may be difficult, time consuming and costly.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our hospice independent operating subsidiaries are subject to annual Medicare caps calculated by Medicare. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to our hospice independent operating subsidiaries, overall payments made by Medicare for each Medicare beneficiary are subject to caps calculated by Medicare, as discussed in greater detail in Item 1., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If payments received by any one of our hospice provider numbers exceeds the caps for the beneficiary, we are required to reimburse Medicare for payments received in excess of the caps, which could have a material adverse effect on our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches and other cyber-security incidents could subject us to significant liability.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our business is dependent on the proper functioning and availability of our computer systems and networks. Our safety and security measures designed to protect our information systems, data and patient health information and disaster recovery plan may not prevent damage, interruption, or breach of our information systems and operations. In addition, hardware, software or applications we develop or procure from third parties may contain defects in design or manufacture or other problems that could unexpectedly compromise the security of our information systems. Unauthorized parties may attempt to gain access to our systems or operations, or those of third parties with whom we do business, through fraud or other forms of deceiving our employees or contractors. In addition, costs and potential problems and interruptions associated with the implementation of new or upgraded systems and technology or with maintenance or adequate support of existing systems also could disrupt or reduce the efficiency of our operations. If a cyber-security attack or other unauthorized attempt to access our systems or operations were to be successful, it could result in the theft, destruction, loss, misappropriation or release of confidential information or intellectual property, and could cause operational or business delays or disruptions that may materially impact our ability to provide various healthcare services. Any successful cyber-security attack or other unauthorized attempt to access our systems or operations also could result in negative publicity which could damage our reputation or brand with our patients, referral sources, payors or other third parties and could subject us to substantial regulatory, civil or criminal penalties, fines, investigations and enforcement actions, including under HIPAA and other federal and state privacy laws, including, for example, the California Consumer Privacy Act, which includes a private right of action that may expose us to private litigation regarding our privacy practices and significant damages awards or settlements in civil litigation.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">State efforts to regulate or deregulate the healthcare services industry or the construction or expansion of the number of home health, hospice or senior living operations could impair our ability to expand or result in increased competition.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As discussed in greater detail in Item 1., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, our ability to acquire or establish new home health, hospice or senior living operations or expand or provide new services at existing operations would be adversely affected if we are unable to obtain the necessary approvals, if there are changes in the standards applicable to those approvals, or if we experience delays and increased expenses associated with obtaining those approvals. We may not be able to obtain licensure, CON approval, Medicare or Medicaid certification, Attorney General approval or other necessary approvals for future expansion projects. Conversely, and specific to the highly competitive senior living industry, the elimination or reduction of state regulations that limit the construction, expansion or renovation of new or existing communities could result in increased competition to us. In general, regulatory and other barriers to entry in the senior living industry are not prohibitive. Over the last several years, there has been a significant increase in the construction of new senior living communities, including in the markets where we provide services. This has resulted in increased competition in many of our markets. Such new competition may limit our ability to attract new residents, raise rents or otherwise expand our senior living business, which could have a material adverse effect on our revenues, results of operations and cash flow.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in federal and state employment-related laws and regulations could increase our cost of doing business.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our independent operating subsidiaries are subject to a variety of federal and state employment-related laws and regulations, including, but not limited to, the U.S. Fair Labor Standards Act which governs such matters as minimum wages, overtime and other working conditions, the Americans with Disabilities Act (the &#8220;ADA&#8221;) and similar state laws that provide civil rights protections to individuals with disabilities in the context of employment, public accommodations and other areas, the National Labor Relations Act, regulations of the Equal Employment Opportunity Commission, regulations of the Office of Civil Rights, regulations of state Attorneys General, family leave mandates and a variety of similar laws. Because labor represents a large portion of our operating costs, changes in federal and state employment-related laws and regulations could increase our cost of doing business. We also may be subject to employee-related claims such as wrongful discharge, discrimination or violation of equal employment law. Employment claims, such as wage and hour claims, frequently are the subject of class action lawsuits in many states in which our independent affiliates operate, including, for example, California.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Required regulatory approvals could delay or prohibit transfers of our healthcare operations, which could result in periods in which we are unable to receive reimbursement for such properties.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our independent operating subsidiaries must be licensed under applicable state law and, depending upon the type of operation, certified or approved as providers under the Medicare and/or Medicaid programs. In the process of acquiring or transferring operating assets, our operations must receive change of ownership approvals from state licensing agencies, Medicare and Medicaid, and third party payors. If there are any delays in receiving regulatory approvals from the applicable federal, state or local government agencies, or the inability to receive such approvals, such delays could result in delayed or lost reimbursement related to periods of service prior to the receipt of such approvals.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with federal and state fair housing, fire, safety and other regulations may require us to make unanticipated expenditures, which could be costly to us.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We must incur the expense of complying with the federal Fair Housing Act and similar state laws, and applicable fire and safety regulations, building codes and other land use regulations and food licensing or certification requirements as they may be adopted by governmental agencies and bodies from time to time and the expense may be substantial. Changes to these laws may require us to close operations, limit occupancy, or make other costly changes.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our revenue, financial condition and results of operations could be negatively impacted by any changes in the acuity mix of patients in our affiliated operations as well as payor mix and payment methodologies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our revenue is determined in part by the acuity of home health and hospice patients and senior living residents. Changes in the acuity level of patients we attract, as well as our payor mix among Medicare, Medicaid, managed care organizations and private payors, significantly affect our profitability because we generally receive higher reimbursement rates for high acuity patients and because the payors reimburse us at different rates. For the year ended December 31, 2021, 62.6% of our revenue was provided by government payors that reimburse us at predetermined rates, which is typical. If we fail to maintain our proportion of high acuity patients or if there is any significant increase in the percentage of the patients of our independent operating subsidiaries for whom we receive Medicaid reimbursement, our results of operations may be adversely affected. Among other initiatives, these payors attempt to control healthcare costs by contracting with healthcare providers to obtain services on a discounted basis. We believe that this trend will continue and may limit reimbursements for healthcare services. If insurers or managed care companies from whom we receive substantial payments were to reduce the amounts they pay for services, we may lose patients if we choose not to renew our contracts with these insurers at lower rates. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to litigation that could result in significant legal costs and large settlement amounts or damage awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our business involves a significant risk of liability given the age and health of the patients and residents of our independent operating subsidiaries and the services we provide. The frequency and severity of litigation in the healthcare industry has increased, due in part to large verdicts and punitive damage awards. Claims are filed based upon a wide variety of assertions and theories, including deficiencies in conditions of participation under certain state and federal healthcare programs and wage and hour class actions. Plaintiffs&#8217; attorneys have become increasingly aggressive in their pursuit of claims against healthcare providers, including home health, hospice and senior living providers, employing a wide variety of advertising and solicitation activities to generate more claims. The defense of lawsuits may result in significant legal costs, regardless of the outcome. Additionally, such litigation may result in increased liability insurance premiums and/or a decline in available insurance coverage levels, which could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Instances of noncompliance can decrease our revenue.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> As discussed under Item 1., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Monitoring Compliance in our Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">, we have internal compliance policies and procedures, including ongoing monitoring and controls, pursuant to which we have identified, and may in the future identify, deficiencies in the assessment of and recordkeeping for patients and residents. We must accrue liabilities for claim costs and interest and repay any amounts due in normal course. Failure to refund overpayments within required time frames (as described in greater detail under Item 1., Government Regulation) could result in FCA liability. Additionally, federal and state mandates for vaccination of employees&#8212;or in some cases, state actions </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">prohibiting vaccination&#8212;differ and may be difficult to comply with, and non-compliance may result in sanctions or other penalties assessed upon the Company. If future investigations ultimately result in findings of significant billing and reimbursement noncompliance, which require us to record significant additional provisions or remit payments, our business, financial condition and results of operations could be materially and adversely affected.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to complete future acquisitions at attractive prices or at all, which may adversely affect our revenue growth.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To date, our revenue growth has been significantly accelerated by our acquisition of new operations. Subject to general market conditions and the availability of essential resources and leadership within our company, we continue to seek home health, hospice and senior living acquisition opportunities that are consistent with our geographic, financial and operating objectives. We face competition for the acquisition of operations and businesses and expect this competition to increase. Based upon factors such as our ability to identify suitable acquisition candidates, the purchase price of the operations, prevailing market conditions, the availability of leadership to manage new operations and our own willingness to take on new operations, the rate at which we have historically acquired home health, hospice and senior living operations has fluctuated and we anticipate similar fluctuation in the future. Further, acquisitions may require financing, which may not be available to us or may be available to us only on terms that are not favorable. If funds are raised through the issuance of additional equity securities, the percentage ownership of our stockholders would be diluted, and any newly issued equity securities may have rights, preferences or privileges senior to those of our common stock. We may acquire operations that prove to be non-strategic or less desirable, and we may consider disposing of such operations or exchanging them for operations which are more desirable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to successfully integrate acquired operations, and we may not achieve the benefits we expect from our acquisitions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We may not be able to successfully or efficiently integrate new acquisitions with our existing independent operating subsidiaries, culture and systems. We also may determine that renovations of acquired operations and changes in staff and operating management personnel are necessary to successfully integrate those acquisitions into our existing operations. We may not be able to recover the costs incurred to reposition or renovate newly independent operating subsidiaries. The financial benefits we expect to realize from many of our acquisitions are largely dependent upon our ability to improve clinical performance, overcome regulatory deficiencies, rehabilitate or improve the reputation of the operations in the community, increase and maintain census, control costs, and in some cases change the patient acuity mix. Growth also places significant demands on our leaders and operational, financial and management information systems. If we are unable to accomplish any of these objectives at the independent operating subsidiaries we acquire, we will not realize the anticipated benefits and we may experience lower than anticipated profits, or even losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In undertaking acquisitions, we may be impacted by costs, liabilities and regulatory issues that may adversely affect our operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In undertaking acquisitions, we also may be adversely impacted by unforeseen liabilities attributable to the prior providers who operated the acquired operations, against whom we may have little or no recourse. Many operations we have historically acquired were underperforming prior to the acquisition. Even where operations have been improved, we still may face post-acquisition regulatory issues related to pre-acquisition events. These may include, without limitation, payment recoupment related to our predecessors&#8217; prior noncompliance, the imposition of fines, penalties, operational restrictions or special regulatory status. Further, we may incur post-acquisition compliance risk due to the difficulty or impossibility of immediately or quickly bringing non-compliant operations into full compliance. Diligence materials pertaining to acquisition targets, especially the underperforming operations that often represent the greatest opportunity for return, are often inadequate, inaccurate or impossible to obtain, sometimes requiring us to make acquisition decisions with incomplete information. Operations that we have acquired or may acquire in the future may generate unexpectedly low returns, may cause us to incur substantial losses, may require unexpected levels of management time, expenditures or other resources, or may otherwise not meet a risk profile that our investors find acceptable. We also incur regulatory risk in acquiring certain operations due to the licensing, certification and other regulatory requirements affecting our right to operate the acquired operations, which are frequently obtained post-closing. If we were denied licensure or certification for any reason, we might not realize the expected benefits of the acquisition and would likely incur unanticipated costs and other challenges which could cause our business to suffer.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our referral sources fail to view us as an attractive provider, or if our referral sources otherwise refer fewer patients or residents, our patient or resident base may decrease.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We rely on appropriate referrals from physicians, hospitals and other healthcare providers in the communities we serve to attract appropriate residents and patients to our affiliated operations. Our referral sources are not obligated to refer business to us and may refer business to other healthcare providers. If we lose, or fail to maintain, existing relationships with our referral resources, fail to develop new relationships, or if we are perceived by our referral sources as not providing high quality patient care, our census could decline and our patient mix could change. In addition, if any of our referral sources have a reduction in patients whom they can refer due to a decrease in their business, our census could decline and patient mix could change.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not achieve and maintain competitive quality of care ratings from CMS and private organizations engaged in similar monitoring activities, our business may be negatively affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Providing quality patient care is the cornerstone of our business. We believe that referral sources, residents and patients select us in large part because of our reputation for delivering quality care. If we should fail to attain our goals regarding acute care hospitalization readmission rates and other quality metrics, we expect our ability to generate referrals would be adversely impacted, which could have a material adverse effect upon our business and combined financial condition, results of operations and cash flows.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to obtain insurance, or if insurance becomes more costly for us to obtain, our business may be adversely affected.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> It may become more difficult and costly for us to obtain coverage for patient care liabilities and other risks, including property and casualty insurance. Our claims history, asset mix, or other factors may adversely affect our ability to obtain insurance at favorable rates. Our insurance carriers may require us to pay substantially higher premiums for the same or reduced coverage for insurance, including workers compensation, property and casualty, automobile, employment practices liability, directors and officers liability, employee healthcare and general and professional liability coverages.  Further, many claims and other risks we face are not insurable. Attributable to the COVID-19 pandemic, insurers may increase their exclusions of infectious diseases or raise costs of coverage significantly affecting our ability to obtain insurance coverage.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We retain certain risks related to our insurance coverage.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under its insurance policies, the Company bears the risk of loss up to specified deductible limits, which may be substantial if there is a surge in the volume of claims subject to the deductible. The Company recognizes obligations associated with these costs in the period in which a claim is incurred, including with respect to both reported claims and claims incurred but not reported. These costs generally are estimated based on our historical claims experience. Projections of self-insured retention losses are estimates that are subject to significant variability, and as a result, actual losses and expenses may be more or less than recorded liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The unionization of our workers may adversely affect our revenue and profitability. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, our employees have chosen not to unionize. If they decide to unionize, our cost of doing business could increase, our operations could experience disruption, and affected operations may no longer be economical to continue operating. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we lease all of our affiliated senior living communities, we could experience risks associated with leased property, including risks relating to lease termination, lease extensions and special charges, which could adversely affect our business, financial position or results of operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December 31, 2021, we leased all of our senior living communities and administrative offices. Most of our leases are triple-net leases, which means that, in addition to rent, we are required to pay for the costs related to the property (including property taxes, insurance, and maintenance and repair costs). Under certain master leases, a breach at a single community could subject one or more of the other communities covered by the same master lease to the same default risk. Failure to comply with provider requirements is a default under several of the leases and master lease agreements. In addition, lease defaults could trigger cross-default provisions in our outstanding debt arrangements and other leases. With an indivisible lease, it is difficult to restructure the composition of the portfolio or economic terms of the lease without the consent of the landlord.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A housing downturn could decrease demand for assisted living services.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Seniors often use the proceeds of home sales to fund their admission to assisted living communities. A downturn in the housing markets could adversely affect seniors&#8217; ability to afford our resident fees and entrance fees. If national or local housing markets enter a persistent decline, our occupancy rates, revenues, results of operations and cash flow could be negatively impacted.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to generate sufficient cash flow to cover required payments or meet operating covenants under our long-term debt and operating leases could result in defaults under such agreements and cross-defaults under other debt or operating lease arrangements, which could harm our independent operating subsidiaries and cause us to lose operations or experience foreclosures.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have significant future operating lease obligations. We intend to continue financing operations through long-term operating leases, mortgage financing and other types of financing, including borrowings under our future credit facilities we may obtain. We may not generate sufficient cash flow from operations to cover required interest, principal and lease payments. If we are unable to generate sufficient cash flow from operations in the future to service our debt or to make lease payments on our operating leases, we may be required, among other things, to seek additional financing in the debt or equity markets, refinance or restructure all or a portion of our indebtedness, sell selected assets, reduce or delay planned capital expenditures or delay or abandon desirable acquisitions. Such measures might not be sufficient to enable us to service our debt or to make lease payments on our operating leases. The failure to make required payments on our debt or operating leases or the delay or abandonment of our planned growth strategy could result in an adverse effect on our future ability to generate revenue and sustain profitability and subject us to foreclosure. In addition, any such financing, refinancing or sale of assets might not be available on terms that are economically favorable to us, or at all. Our financing arrangements contain restrictions, covenants and events of default that, among other things, could limit our ability to respond to market conditions, provide for capital investment needs or take advantage of business opportunities by restricting our ability to incur or guarantee additional </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">indebtedness or requiring us to offer to repurchase such indebtedness in the event of a change of control or a change of control triggering event; pay dividends or make distributions; make investments or acquisitions; sell, transfer or otherwise dispose of certain assets; create liens; consolidate or merge; enter into transactions with affiliates; and prepay and repurchase or redeem certain indebtedness. </span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">The condition of the financial markets, including volatility and deterioration in the capital and credit markets, could limit the availability of debt and equity financing sources to fund the capital and liquidity requirements of our business, as well as negatively impact or impair the value of our future portfolio of cash, cash equivalents and investments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> Credit markets are cyclical. Volatility in financial and credit markets may reduce the availability of certain types of debt financing and restrict the availability of credit. Further, we anticipate that our future cash, cash equivalents and investments may be held in a variety of interest-bearing instruments. As a result of the uncertain domestic and global political, credit and financial market conditions, investments in these types of instruments pose risks arising from liquidity and credit concerns.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Inflation may negatively impact profitability.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The annual inflation rate of 7% in 2021 has impacted our operations, placing upward pricing pressure on all things from wages to supplies to energy costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Inflation is expected to continue in 2022 and may affect the Company&#8217;s profit in providing services. We have historically derived a substantial portion of our revenue from the Medicare program. We also derive revenue from state Medicaid and similar reimbursement programs. Payments under these programs generally provide for reimbursement levels that are adjusted for inflation annually. These adjustments may not continue in the future, and even if received, such adjustments may not reflect the actual increase in our costs for providing healthcare services. Labor and supply expenses make up a substantial portion of our cost of services. Those expenses can be subject to increase in periods of rising inflation and when labor shortages occur in the marketplace.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delays in reimbursement may cause liquidity problems.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If we experience problems with our billing information systems or if issues arise with Medicare, Medicaid or other payors, we may encounter delays in our payment cycle. From time to time, we have experienced such delays as a result of government payors instituting planned reimbursement delays for budget balancing purposes or as a result of prepayment reviews. Some states in which we operate are operating with budget deficits or could have a budget deficit in the future, which may delay reimbursement in a manner that would adversely affect our liquidity. In addition, from time to time, procedural issues require us to resubmit claims before payment is remitted, which contributes to our aged receivables. Unanticipated delays in receiving reimbursement from state programs due to changes in their policies or billing or audit procedures may adversely impact our liquidity and working capital. As discussed in Item 1., </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Government Regulation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, with the elimination in fiscal year 2021 of RAPs and introduction of the NOA submission procedure, we may experience higher receivables and reduced cash flows as collections are delayed upon implementation. Beginning in fiscal year 2022, CMS is replacing the RAP process with the filing of a single NOA by home health agencies, which will cover continuous 30-day periods of care until the patient is discharged.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This transition may cause delays in payment from CMS or even denial of payment, as the NOA process will be new for both CMS and the Company.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with the regulations of the Department of Housing and Urban Development (&#8220;HUD&#8221;) may require us to make unanticipated expenditures which could increase our costs.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Seventeen of our affiliated senior living communities are currently subject to regulatory agreements with HUD that give the Commissioner of HUD broad authority to require us to be replaced as the operator of those communities in the event that the Commissioner determines there are operational deficiencies at such communities under HUD regulations. Compliance with HUD&#8217;s requirements can often be difficult because these requirements are not always consistent with the requirements of other federal and state agencies and, in some instances, may require us to make additional capital expenditures to meet HUD&#8217;s heightened requirements. Appealing a failed inspection can be costly and time-consuming and, if we do not successfully remediate the failed inspection, we could be precluded from obtaining HUD financing in the future or we may encounter limitations or prohibitions on our operation of HUD-insured communities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with existing environmental laws could result in increased expenditures, litigation and potential loss to our business and in our asset value.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our independent operating subsidiaries are subject to regulations under various federal, state and local environmental laws, primarily those relating to the handling, storage, transportation, treatment and disposal of medical waste; the identification and warning of the presence of asbestos-containing materials in buildings, as well as the encapsulation or removal of such materials; and the presence of other substances in the environment. The presence of such materials may be unknown and could result in remediation costs, fines, damages and other material harm to our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a holding company with no operations and rely upon our independent operating subsidiaries to provide us with the funds necessary to meet our financial obligations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are a holding company with no direct operating assets, employees or revenues. Each of our affiliated operations is operated through a separate, independent subsidiary, which has its own management, employees and assets. Our principal assets are the equity interests we directly or indirectly hold in our independent operating subsidiaries. As a result, we are dependent upon distributions from our subsidiaries to generate the funds necessary to meet our financial obligations. Our subsidiaries are legally distinct from us and have no obligation to make funds </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">available to us. The ability of our subsidiaries to make distributions to us will depend substantially on their respective operating results and will be subject to restrictions under, among other things, the laws of their jurisdiction of organization, which may limit the amount of funds available for distribution to investors or stockholders, agreements of those subsidiaries, the terms of our financing arrangements and the terms of any future financing arrangements of our subsidiaries.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Two of our directors continues to serve as a director on the Ensign board of directors, and ownership of shares of Ensign common stock or equity awards of Ensign by our directors and executive officers may create conflicts of interest or the appearance of conflicts of interest.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Two of our directors continues to serve on the Ensign board of directors and substantially all of our executive officers and some of our non-employee directors own shares of Ensign common stock. This could create, or appear to create, potential conflicts of interest when our or Ensign&#8217;s management or directors face decisions that could have different implications for us and Ensign, including the resolution of any dispute regarding the terms of the agreements governing the Spin-Off and the relationship between us and Ensign after the Spin-Off, any commercial agreements entered into in the future between us and Ensign and the allocation of such directors&#8217; time between us and Ensign.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Common Stock</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions in our organizational documents and Delaware law might discourage or delay acquisition attempts for us that you might consider favorable.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated certificate of incorporation and amended and restated bylaws may make the merger or acquisition of our company more difficult without the approval of our board of directors. Among other things, these provisions: allow us to authorize the issuance of undesignated preferred stock, the terms of which may be established and the shares of which may be issued without stockholder approval, and which may include super voting, special approval, dividend, or other rights or preferences superior to the rights of the holders of common stock; establish advance notice requirements for nominations for elections to our board or for proposing matters that can be acted upon by stockholders at stockholder meetings; create a classified board of directors whose members serve staggered three-year terms; and limit the ability of our stockholders to call and bring business before special meetings. Further, as a Delaware corporation, we are also subject to provisions of Delaware law, which may impair a takeover attempt that our stockholders may find beneficial. These provisions could discourage, delay or prevent a transaction involving a change in control of our company, including actions that our stockholders may deem advantageous, or negatively affect the trading price of our common stock. These provisions could also discourage proxy contests and make it more difficult for our stockholders to elect directors of their choosing and to cause us to take other corporate actions desired.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to COVID-19</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 has created new regulatory risks that impact our operations.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> COVID-19 has generated, and will likely continue to generate, dramatic and rapid changes in the laws affecting our operations. U.S. Federal, state, and local regulators have implemented new laws, rules, regulations, and orders, or waived or modified existing laws, rules and regulations for the duration of the COVID-19 public health emergency. Most of these changes have been made without following typical regulatory or legislative processes and procedures and have been announced via website postings or fact sheets with limited notice and without full regulations or guidance in place. While many of the changes are beneficial in that they reduce or eliminate statutory or regulatory requirements for healthcare providers during the COVID-19 public health emergency, we remain subject to the risk of inadvertent non-compliance due to the quantity, ambiguity and frequency of changes. The regulatory changes may also adversely effect our operations through increased legal and operational costs related to compliance with changes and monitoring for future changes. Further, the resumption of pre-COVID-19 regulatory requirements at the conclusion of the public health emergency may require significant operational changes on short notice.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">COVID-19 and related risks have affected and could materially affect our results of operations, financial position and/or liquidity.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> The global spread of COVID-19 and the various attempts to contain it have created significant volatility, uncertainty and economic disruption. See &#8220;Part I&#8212;Item 2&#8212;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8212;COVID-19</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8221; herein.  Now two years into the COVID-19 pandemic, many of the direct and indirect consequences of COVID-19 on our business are known, although new developments such as waves of COVID-19 variants and second-order effects such as supply chain issues are ongoing and the full range of their direct and indirect consequences on our business are not yet known. Risks presented by the ongoing effects of COVID-19 include the following:</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In addition to the hazards posed by COVID-19 itself, the disruption caused by repeated waves of COVID-19 variants, including breakthrough infections of fully vaccinated individuals, poses a risk to the Company for the foreseeable future due to the potential consequences of such variants on Company personnel, labor pool participants, availability of necessary supplies, continued adverse impact on move-in rates within senior living, and consequences for the broader economy. </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Decreased home health and hospice volumes and senior living occupancy, which has led to decreased revenue.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased costs and staffing requirements related to implementation of COVID-19 infection prevention protocols, including increased utilization of personal protective equipment (&#8220;PPE&#8221;), COVID-19 diagnostic testing and vaccination for staff and residents, and additional labor and cleaning supplies to frequently sterilize equipment and surfaces.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:14.5pt">Increased labor costs due to increased overtime or premium pay, paid leave, reduced labor force participation, wage pressure from competitors, workers becoming ineligible for employment due to COVID-19 vaccination requirements, mandatory testing costs, and the increased need for temporary labor to supplement our existing staffing as our front-line employees may become unable to work while awaiting the results of COVID-19 tests or as they recover from a COVID-19 infection.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Increased scrutiny by regulators of infection control and prevention measures, including imposition of new COVID-19 disease and mortality reporting requirements, and increased enforcement of resident rights&#8217; violations related to visitation.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Disruptions to supply chains which could negatively impact consistent and reliable delivery of PPE, sanitizing supplies, food, pharmaceuticals, and other goods.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">COVID-19 related illnesses in staff may impact the quality of care, which could lead to temporary staffing shortages or reliance on less experienced personnel.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Employee concerns related to workplace safety, including potential for increase in workers&#8217; compensation claims.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential increase in insurance premiums and COVID-19 related claims.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Inconsistent application or interpretation of modifications to regulatory requirements by surveyors.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential for continued inflation resulting from changes in economic conditions and steps taken by the federal government and the Federal Reserve in response to COVID-19, which could lead to higher inflation rates or longer-lasting inflation than anticipated, which could in turn lead to an increase in expenses, including rent expense under our triple net leases. All of the triple net leases in our senior living business contain annual rent escalators tied to year-over-year increases in various consumer price indices. While these leases contain provisions capping the increased rent expense each year, increased inflation could cause our rent expense in our senior living business to increase at a greater rate than in prior years.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">COVID-19 could lead to future litigation.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> COVID-19 has affected virtually all businesses in the country, and healthcare providers have been acutely impacted due to direct involvement with the virus. The challenges of dealing with a global pandemic have been amplified by supply shortages, lack of available tests, and constantly evolving information. It is likely that healthcare companies, including those in the post-acute care and senior living industries in which we operate, could become targets of plaintiffs&#8217; litigation, alleging negligence, wrongful death, and similar claims resulting from where cases of COVID-19 occurred in senior living communities and through the direct contact with COVID-19 positive patients of our home health and hospice providers . If we or our operations are subject to litigation of this nature, such litigation may result in legal fees, damages, fines or settlements in amounts that could be material.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rules mandating COVID-19 vaccination may subject us to penalties and other challenges.</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Various federal, state and local governments have issued, or indicated an intention to issue, COVID-19 vaccination requirements for health care workers and other workers. Most notably, on November 4, 2021, CMS issued an interim final rule requiring full vaccination of personnel working for operations reimbursed by Medicare or Medicaid. The United States Supreme Court upheld this mandate on January 13, 2022, and the compliance deadline for full vaccination ranges from February 28 (in states that did not challenge the mandate) to March 15, 2022 (in most other states) to March 21, 2022 (in Texas). </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">States where we operate have imposed their own vaccine mandates as well. During 2021, California, Colorado, Oregon and Washington each issued orders requiring that all or some employees and contractors of our independent operating subsidiaries be fully vaccinated. In addition, on December 22, 2021 California ordered that health care workers who are booster-eligible must receive a vaccine booster by February 1, 2022. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be subject to fines, penalties or judgments, or may otherwise be negatively impacted, if it is found not to have complied with any such current or future vaccination requirements. Current or prospective employees may oppose vaccination, making it more difficult to recruit or retain staff. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, as of January 2022, the FDA and CDC approved the use of COVID-19 vaccine booster shots for most individuals.</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company may be subject to fines, penalties, judgments, or otherwise be negatively impacted based on loss of skilled </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">workers or increased competition and cost to acquire skilled workers in the event of worker hesitancy or aversion to vaccine booster shots, or a change in the definition or understanding of &#8220;fully vaccinated&#8221; under CMS, OSHA or other state regulations that currently, or may in the future, require employees to have received booster shots to maintain their fully vaccinated status.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Expiration of Certain Waivers and Changes in CMS Reporting Practices.</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the COVID-19 pandemic, CMS issued numerous blanket waivers effective March 20, 2020, to ease reporting requirements and other administrative burdens on health care providers during the COVID-19 public health emergency.</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of these waivers have begun to expire, and more waivers may expire in 2022.</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">  </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expiration of these waivers may affect our operating costs due to the reinstitution of reporting regarding staffing data and other information that was not required to be reported during the COVID-19 public health emergency until the expiration of those waivers; the expiration of these waivers may additionally affect our ability to use certain billing codes when seeking reimbursement from Medicare or Medicaid, which may affect our financial performance.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_61"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1B. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unresolved Staff Comments</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_64"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Properties</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Service Center</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease two office locations to accommodate our Service Center. We lease approximately 14,287&#160;square feet of office space located at 1675 East Riverside Drive, Suite 150, Eagle, ID 83616, pursuant to a lease that expires March&#160;31, 2025. Our principal executive offices are located at the Service Center in Eagle, Idaho. We have two options to extend our lease term at this location for an additional five-year term for each option. In addition, we currently lease 6,209 rentable&#160;square feet of office space located at 1600 West Broadway Road, Suite 100, Tempe, Arizona 85282, pursuant to a lease that expires September&#160;30, 2024. We have one option to extend our lease term at this location for one additional five-year term. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Home Health and Hospice Agencies and Senior Living Communities</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we operated 88 home health, hospice and home care agencies in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. Office space is leased within geographies served by our agencies.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2021, we operated 54 affiliated senior living communities in Arizona, California, Nevada, Texas, Washington and Wisconsin, with 4127 Senior Living units. We lease all of our communities through long-term, triple-net lease arrangements.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides summary information regarding the locations of our home health and hospice agencies and our senior living communities and operational units as of December&#160;31, 2021: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.835%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.940%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">State</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health Agencies</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hospice Agencies</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Communities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Units</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arizona</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,249&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">California</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">761&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Colorado</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Idaho</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iowa</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Montana</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oklahoma</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oregon</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Texas</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">712&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Utah</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Washington</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">758&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wyoming</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_67"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are involved in various claims and lawsuits arising in the ordinary course of business, none of which, in the opinion of management, is expected to have a material adverse effect on our results of operations or financial condition. However, the results of such matters cannot be predicted with certainty and we cannot assure you that the ultimate resolution of any legal or administrative proceeding or dispute will not have a material adverse effect on our business, financial condition, results of operations and cash flows.&#160;See Note&#160;15, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Commitments and Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Audited Consolidated and Combined Financial Statements for a description of claims and legal actions arising in the ordinary course of our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_70"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Mine Safety Disclosures</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_73"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II.</span></div><div style="text-align:center"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_76"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market Information</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Common stock has traded under the symbol &#8220;PNTG&#8221; on the NASDAQ Global Select Market since our Spin-Off on October&#160;1, 2019. Prior to that date we were a subsidiary of Ensign, which trades under the ticker &#8220;ENSG&#8221; on the NASDAQ Global Select Market. As of February&#160;28, 2022, there were approximately 60 holders of record of our stock.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not intend to pay dividends on our common stock for the foreseeable future. Instead, we anticipate that all of our future earnings will be retained to support our operations and to finance the growth and development of our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1422"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Performance Graph</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">The following Stock Performance Graph and related information shall not be deemed &#8220;soliciting material&#8221; or &#8220;filed&#8221; with the SEC, nor should such information be incorporated by reference into any future filings under the Securities Act or the Exchange Act except to the extent that we specifically incorporate it by reference in such filing.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The graph below compares the cumulative total stockholder return on our common stock, $0.001 par value per share, during the period from the date of the Spin-Off on October 1, 2019, through December&#160;31, 2021, with the cumulative total return on the NASDAQ composite index and an industry peer group over the same period (assuming the investment of $100 in our common stock, the NASDAQ composite index and the industry peer group on October 1, 2019 and the reinvestment of dividends).  The peer group we selected is comprised of: Amedysis, Inc. (&#8220;AMED&#8221;), Addus Homecare Corporation (&#8220;ADUS&#8221;), Chemed Corporation (&#8220;CHE&#8221;), Encompass Health Corporation (&#8220;EHC&#8221;), LHC Group, Inc. (&#8220;LHCG&#8221;), Sonida Senior Living Inc., formerly known as Capital Senior Living Corporation (&#8220;SNDA&#8221;), and Brookdale Senior Living, Inc. (&#8220;BKD&#8221;). The cumulative total stockholder return on the following graph is historical and is not necessarily indicative of future stock price performance. No cash dividends have been paid on our common stock.</span></div><div><span><br/></span></div><div style="text-align:center"><img src="pntg-20211231_g4.jpg" alt="pntg-20211231_g4.jpg" style="height:212px;margin-bottom:5pt;vertical-align:text-bottom;width:687px"/></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.245%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.538%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.548%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">10/1/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6/30/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">3/31/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">6/30/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">9/30/2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">12/31/2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">PNTG</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">256&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">385&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">NASDAQ</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">127&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">183&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Peer Group</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">116&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">129&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">120&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_79"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">[Reserved]</span></div><div style="text-indent:36pt"><span><br/></span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_82"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7. &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following discussion should be read in conjunction with the consolidated and combined financial statements and accompanying notes, which appear elsewhere in this Annual Report. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Annual Report. See Item&#160;1A.,&#160;Risk Factors and Cautionary Note Regarding Forward-Looking Statements.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1273"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a leading provider of high-quality healthcare services to patients and residents of all ages, including the growing senior population, in the United States. We strive to be the provider of choice in the communities we serve through our innovative operating model. We operate in multiple lines of businesses including home health, hospice and senior living services across Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming. As of December&#160;31, 2021, our home health and hospice business provided home health, hospice and home care services from 88 agencies operating across 14 states, and our senior living business operated 54 senior living communities throughout seven states. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our affiliated home health and hospice agencies and senior living communities as of:</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:36.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.894%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.332%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.345%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2013</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2014</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2015</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2016</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2017</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2018</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home health and hospice agencies</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior living communities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior living units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,256&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,184&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,434&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,820&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,963&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,127&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total number of home health, hospice, and senior living operations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1282"></div><div style="padding-left:9pt;text-align:justify;text-indent:-6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COVID-19</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been, and we expect to continue to be, impacted by several factors related to the viral disease known as COVID-19 that may cause actual results to differ from our historical results or current expectations. Due to the COVID-19 pandemic, the results presented in this report are not necessarily indicative of future operating results. The situation surrounding COVID-19 remains fluid. We are actively managing our response in collaboration with government officials, team members and business partners, and we are assessing potential impacts to our financial position and operating results, as well as adverse developments in our business. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Home Health and Hospice</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">During the year ended December 31, 2021, the labor challenges experienced throughout the COVID-19 pandemic were exacerbated as cases rose sharply, leading to further wage pressure, increased overtime and greater use of agency and registry staffing resulting in challenges to properly staff referrals. Home health admissions during the second half of the year were impacted as more staff entered the quarantine protocol and by a significant decline in elective procedures, particularly in a few key markets and states that re-imposed temporary halts on such procedures.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Living</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 continues to impact all aspects of our senior living business and geographies, including impacts on our residents, team members, vendors and business partners. We experienced a decline in occupancy during the first quarter of the year followed by several months of increased occupancy that began in the second quarter and continued into the third quarter. Our occupancy began to decline in the latter part of September and our overall senior living occupancy has decreased since the onset of the COVID-19 pandemic due to a greater number of move outs net of move ins. We cannot be sure if or when the occupancy levels in our senior living communities will improve over multiple measurement periods or return to pre-pandemic levels. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Labor</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced and expect to continue to see increased labor costs due to greater competition for skilled workers, worker burnout, increased wage rates, increased overtime and premium pay, and the increased need for temporary labor to supplement our existing staffing. We are monitoring the ongoing impact of our COVID-19 response actions on our revenue and expenses, including labor acquisition and turnover costs that may be imposed by existing and anticipated state and federal vaccination mandates imposed for workers in home health agencies, senior living communities and other health care service providers. However, the extent to which COVID-19 will continue to impact our operations will depend on future developments, which remain uncertain and cannot be predicted with confidence, including the pace of spread and impact of other potential variant strains, and the actions taken to contain COVID-19 or treat its impact, among others.</span></div><div style="padding-left:9pt;text-align:justify;text-indent:-6.75pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1298"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Activities</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During 2021, we expanded our operations with the addition of five home health agencies, four hospice agencies and two home care agencies. We entered into a separate operations transfer agreement with the prior operator as part of each transaction. The aggregate value for these acquisitions was $14.1 million. For further discussion of our acquisitions, see Note 7, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acquisitions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the Notes to the consolidated and combined financial statements.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amended Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. On February&#160;23, 2021, we amended our existing revolving credit facility to increase our aggregate principal amount available from $75.0 million to $150.0 million.  </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Transaction.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> On January 27, 2022, certain of our affiliates entered into operations transfer agreements (collectively, the &#8220;Transfer Agreements&#8221;) with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#8220;Transaction&#8221;). The Transfer Agreements require one of the transferors to place in escrow $6.5&#160;million to cover post-closing capital expenditures and operating losses related to one of the communities. The closing of the Transaction is anticipated to occur in the first half of 2022, subject to receipt of applicable regulatory approvals and satisfaction of other customary closing conditions set forth in the Transfer Agreements. For further details about the impact of the transaction see Note 16, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Event.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1306"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trends</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since the pandemic began and until the first quarter of 2021, we experienced a steady decline in senior living occupancy as move-ins declined relative to move-outs due to the pandemic. Beginning in the second quarter of 2021, and continuing into the third quarter, we experienced a slight increase in our senior living occupancy; however with the emergence of the &#8220;Omicron&#8221; variant strain of COVID-19 in the fourth quarter we experienced a slight decrease in occupancy during the year ended December 31, 2021. We cannot be sure when the occupancy levels in our senior living communities will return to pre-pandemic levels. As uncertainty regarding the COVID-19 pandemic persists and with the resurgence in cases due to variant strains aggressively emerging, we could see a more prolonged recovery.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we acquire turnaround or start-up operations, we expect that our combined metrics may be impacted. We expect these metrics to vary from period to period based upon the maturity of the operations within our portfolio. We have generally experienced lower occupancy rates at our senior living communities and lower census at our home health and hospice agencies for recently acquired operations; as a result, we generally anticipate lower consolidated and segment margins during years of high acquisition growth. We established three start-up hospice agencies in Arizona, Texas and Washington, and one home care agency in Arizona during the year ended December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1314"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Regulation</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the United States and subsequent regulatory actions. The CARES Act contained provisions for accelerated or advance Medicare payments (&#8220;AAP&#8221;) to provide supporting cash flow to providers and suppliers combating the effects of the COVID-19 pandemic. We applied for and received $28.0 million in 2020. These funds are subject to automatic recoupment through offsets to new claims beginning one year after payment were issued. In April, 2021, CMS began to automatically recoup 25% of Medicare payments from individual agencies, which will continue for 11 months. At the end of the 11 months assuming full repayment has not occurred, recoupment will increase to 50% for another six months. Any balance outstanding after these two recoupment periods will be subject to repayment at a 4% interest rate. As of the year ended December 31, 2021, the Company had repaid $21.8 million of the AAP funds, with the remaining balance of $6.2 million recorded in other accrued liabilities on the consolidated balance sheets. We anticipate completing repayment of the AAP within the allotted recoupment periods.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CARES Act temporarily suspended the 2% sequestration payment adjustment on Medicare fee-for-service payment beginning May 1, 2020 and was extended through December 31, 2021. We recognized $3.6 million and $2.8 million in revenue related to the suspension of sequestration for the years ended December 31, 2021 and 2020, respectively, exclusive of our start-up operations. Further, the CARES Act payroll tax deferral program allowed employers to defer the deposit and payment of the employer&#8217;s portion of social security taxes that otherwise would be due between March 27, 2020, and December 31, 2020. The CARES Act permits employers to deposit half of these deferred payments by the end of 2021 and the other half by the end of 2022. We deferred approximately $7.8 million of employer-paid portion of social security tax. In the fourth quarter of the current year, we repaid $3.7 million and approximately $4.1 million of the balance remains deferred and is recorded in accrued wages and related liabilities on the consolidated balance sheets.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The American Rescue Plan Act of 2021 (the &#8220;ARP Act&#8221;) was enacted on March 11, 2021 in the United States. The ARP Act was designed to assist the country with the effects of the COVID-19 pandemic and included a number of tax components. The ARP Act&#8217;s primary tax impact on us is a new revenue raising provision that requires us to include the next five highest paid employees to the list of covered officers already subject to the IRC Section 162(m) wage limitation beginning in the 2027 tax year. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1322"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segments</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have two reportable segments: (1) home health and hospice services, which includes our home health, home care and hospice businesses; and (2) senior living services, which includes the operation of assisted living, independent living and </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">memory care communities. Our Chief Executive Officer, who is our Chief Operating Decision Maker (&#8220;CODM&#8221;), reviews financial information at the operating segment level using segment adjusted EBITDAR from operations. We also report an &#8220;all other&#8221; category that includes general and administrative expense from our Service Center.  </span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1330"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Performance Indicators</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage the fiscal aspects of our business by monitoring key performance indicators that affect our financial performance. These indicators and their definitions include the following:</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1338"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Home Health and Hospice Services</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Total home health admissions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The total admissions of home health patients, including new acquisitions, new admissions and readmissions.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Total Medicare home health admissions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Total admissions of home health patients, who are receiving care under Medicare reimbursement programs, including new acquisitions, new admissions and readmissions.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Average Medicare revenue per completed 60-day home health episode</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The average amount of revenue for each completed 60-day home health episode generated from patients who are receiving care under Medicare reimbursement programs.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Total hospice admissions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Total admissions of hospice patients, including new acquisitions, new admissions and recertifications.</span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Average hospice daily census</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The average number of patients who are receiving hospice care during any measurement period divided by the number of days during such measurement period. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Hospice Medicare revenue per day</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The average daily Medicare revenue recorded during any measurement period for services provided to hospice patients.</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our overall home health and hospice statistics for the periods indicated:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home health services:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total home health admissions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare home health admissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Medicare revenue per 60-day completed episode</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospice services:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total hospice admissions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average hospice daily census</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,083&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospice Medicare revenue per day</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.  </span></td></tr></table></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1347"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Living Services</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Occupancy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ratio of actual number of days our units are occupied during any measurement period to the number of units available for occupancy during such measurement period.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Average monthly revenue per occupied unit</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The revenue for senior living services during any measurement period divided by actual occupied senior living units for such measurement period divided by the number of months for such measurement period.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our senior living statistics for the periods indicated:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average monthly revenue per occupied unit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1355"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue Sources</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Home Health and Hospice Services </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Home Health</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive the majority of our home health revenue from Medicare and managed care. The Medicare payment is adjusted for differences between estimated and actual payment amounts, an inability to obtain appropriate billing documentation or authorizations acceptable to the payor and other reasons unrelated to credit risk. For Medicare episodes that began prior to January 1, 2020, home health agencies were reimbursed under the Medicare HH PPS, while Medicare periods of care that began on or after that date are reimbursed under the PDGM methodology. Under PDGM, Medicare provides agencies with payments for each 30-day period of care provided to beneficiaries. If a beneficiary is still eligible for care after the end of the first 30-day payment period, a second 30-day payment period can begin. There are no limits to the number of periods of care a beneficiary who remains eligible for the home health benefit can receive. While payment for each 30-day period of care is adjusted to reflect the beneficiary&#8217;s health condition and needs, a special outlier provision exists to ensure appropriate payment for those beneficiaries that have the most expensive care needs. The payment under the Medicare program is also adjusted for certain variables including, but not limited to: (a) a low utilization payment adjustment if the number of visits is below an established threshold that varies based on the diagnosis of a beneficiary; (b) a partial payment if the patient transferred to another provider or the Company received a patient from another provider before completing the period of care; (c) adjustment to the admission source of claim if it is determined that the patient had a qualifying stay in a post-acute care setting within 14 days prior to the start of a 30-day payment period; (d) the timing of the 30-day payment period provided to a patient in relation to the admission date, regardless of whether the same home health provider provided care for the entire series of episodes; (e) changes to the acuity of the patient during the previous 30-day period of care; (f) changes in the base payments established by the Medicare program; (g) adjustments to the base payments for case mix and geographic wages; and (h) recoveries of overpayments. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Hospice.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive the majority of our hospice business revenue from Medicare reimbursement. The estimated payment rates are calculated as daily rates for each of the levels of care we deliver. Rates are set based on specific levels of care, are adjusted by a wage index to reflect healthcare labor costs across the country and are established annually through federal legislation. The following are the four levels of care provided under the hospice benefit:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:13.8pt">Routine Home Care (&#8220;RHC&#8221;). </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care that is not classified under any of the other levels of care, such as the work of nurses, social workers or home health aides.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:13.8pt">General Inpatient Care. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pain control or acute or chronic symptom management that cannot be managed in a setting other than an inpatient Medicare-certified facility, such as a hospital, skilled nursing facility or hospice inpatient facility.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:13.8pt">Continuous Home Care. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care for patients experiencing a medical crisis that requires nursing services to achieve palliation and symptom control, if the agency provides a minimum of eight hours of care within a 24-hour period.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:100%;padding-left:13.8pt">Inpatient Respite Care.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term, inpatient care to give temporary relief to the caregiver who regularly provides care to the patient.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has established a two-tiered payment system for RHC. Hospices are reimbursed at a higher rate for RHC services provided from days of service 1 through 60 and a lower rate for all subsequent days of service. CMS also provided for a Service Intensity Add-On, which increases payments for certain RHC services provided by registered nurses and social workers to hospice patients during the final seven days of life. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medicare reimbursement is adjusted for an inability to obtain appropriate billing documentation or authorizations acceptable to the payor and other reasons unrelated to credit risk. Additionally, as Medicare hospice revenue is subject to an inpatient cap limit and an overall payment cap, we monitor our provider numbers and based upon empirical experience estimate amounts due back to Medicare to the extent that the cap has been exceeded.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Senior Living Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Within our senior living operations, we generate revenue primarily from private pay sources, with a portion earned from Medicaid or other state-specific programs.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1364"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Primary Components of Expense </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Services (excluding rent, general and administrative expense and depreciation and amortization)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Our cost of services represents the costs of operating our independent operating subsidiaries, which primarily consists of employee wages and related benefits, supplies, purchased services, and ancillary expenses such as the cost of pharmacy and therapy services provided to patients or residents. Cost of services also includes the cost of general and professional liability insurance and other general cost of services specifically attributable to our operations. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rent&#8212;Cost of Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Rent&#8212;cost of services consists solely of base minimum rent amounts payable under lease agreements to our landlords. Our subsidiaries lease and operate but do not own the underlying real estate at our operations, and these amounts do not include taxes, insurance, impounds, capital reserves or other charges payable under the applicable lease agreements. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;General and administrative expense consists primarily of payroll and related benefits and travel expenses for our Service Center personnel in providing training and other operational support. General and administrative expense also includes professional fees (such as accounting and legal fees), costs relating to our information systems, share-based compensation and rent for our Service Center offices.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Depreciation and Amortization</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#160;Property and equipment are recorded at their original historical cost. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from three to 15 years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1372"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies and Estimates</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our discussion and analysis of our financial condition and results of operations are based on our consolidated and combined financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles (&#8220;GAAP&#8221;). The preparation of these financial statements and related disclosures requires us to make judgments, estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. On an ongoing basis we review our judgments and estimates, including but not limited to those related to revenue, cost allocations, leases, intangible assets, goodwill, and income taxes. We base our estimates and judgments upon our historical experience, knowledge of current conditions and our belief of what could occur in the future considering available information, including assumptions that we believe to be reasonable under the circumstances. By their nature, these estimates and judgments are subject to an inherent degree of uncertainty, and actual results could differ materially from the amounts reported. While we believe that our estimates, assumptions, and judgments are reasonable, they are based on information available when the estimate was made. Refer to Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, within the Consolidated and Combined Financial Statements for further information on our critical accounting estimates and policies, which are as follows:</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Self-insurance reserves</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The valuation methods and assumptions used in estimating costs up to retention amounts to settle open claims of insureds and an estimate of the cost of insured claims up to retention amounts that have been incurred but not reported;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Revenue recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The amounts owed by private pay individuals for services and estimate of variable considerations to arrive at the transaction price, including methods and assumptions, used to determine settlements with Medicare and Medicaid adjustments due to audits and reviews;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Cost allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Consolidated and Combined Financial Statements include allocations of costs for certain shared services provided to the Company by Ensign subsidiaries prior to the spin-off on October&#160;1, 2019. These costs were allocated to the Company on a basis of revenue, location, employee count, or other measures;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We use our estimated incremental borrowing rate based on the information available at lease commencement date in determining the present value of future lease payments;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Acquisition accountin</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">g</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The assumptions used to allocate the purchase price paid for assets acquired and liabilities assumed in connection with our acquisitions; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Income taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The estimation of valuation allowance or the need for and magnitude of liabilities for uncertain tax position.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1380"></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information concerning recently issued accounting pronouncements which are not yet effective is included in Note 2, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation and Summary of Significant Accounting Policies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Consolidated and Combined Financial Statements. As of December 31, 2021, there were no recently issued accounting pronouncements that were expected to have an impact on the Company.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_85"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth details of our expenses and earnings as a percentage of total revenue for the periods indicated:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net income/ (loss)  attributable to noncontrolling interest</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to Pennant</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss attributable to noncontrolling interest for the year ended December 31, 2020 was less than 0.1% and thus not meaningful as a percentage of total revenue.</span></div></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated and Combined GAAP Financial Measures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">434,999&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">372,036&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">332,861&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,917&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,670&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain financial information regarding our reportable segments. General and administrative expenses are not allocated to the reportable segments and are included in &#8220;All Other&#8221;: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.859%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.501%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="21" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment GAAP Financial Measures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,694&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,565&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,517&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,208)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,659&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,953&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,762)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,624&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,907&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,354&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,344&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,107&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.543%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.864%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.869%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,784&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,675&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,810&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,863&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,191&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,975&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense)/ income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Segment EBITDAR from Operations:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Costs at start-up operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-Off related transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition services costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 related costs and supplies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(h)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Net income/ (loss)  attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(548)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,917&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,670&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:13.5pt;text-align:justify;text-indent:-13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations is net income/ (loss) attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, and, in order to view the operations performance on a comparable basis from period to period, certain adjustments including: (1) costs at start-up operations, (2) share-based compensation, (3) acquisition related costs, (4) Spin-Off transaction costs, (5) redundant and nonrecurring costs associated with the transition services agreement, (6) net income/ (loss) attributable to noncontrolling interest, (7) net COVID-19 related costs and (8) impairment of long-lived assets. General and administrative expenses are not allocated to the reportable segments, and are included as &#8220;All Other&#8221;, accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents results related to start-up operations.  This amount excludes rent and depreciation and amortization expense related to such operations.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense incurred which is included in cost of services and general and administrative expense. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition related costs that are not capitalizable.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs incurred related to the Spin-Off are included in general and administrative expense.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A portion of the costs incurred under the Transition Services Agreement identified as redundant or nonrecurring that are included in general and administrative expense. Fees incurred under the Transition Services Agreement, net of the Company&#8217;s payroll reimbursement, were $3,124, $5,536, and $2,982, for the years ended December 31, 2021, 2020 and 2019, respectively. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning in the first quarter of fiscal year 2021, we updated our definition of Segment Adjusted EBITDAR to no longer include an adjustment for COVID-19 expenses offset by the amount of sequestration relief. COVID-19 expenses continue to be part of daily operations for which less specific identification is visible. Furthermore, the sequestration relief was extended through December 31, 2021. Sequestration relief was $3,555 for the year ended December 31, 2021.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The 2020 amount represents incremental costs incurred as part of the Company's response to COVID-19 including direct medical supplies, labor, and other expenses, net of $2,765 in increased revenue related to the 2% payment increase in Medicare reimbursements for sequestration relief for the year ended December 31, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(h)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">On January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements (collectively, the &#8220;Transfer Agreements&#8221;) with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#8220;Transaction&#8221;). The closing of the Transaction is anticipated to occur in the first half of 2022. The Company impaired certain leasehold improvements included in property and equipment primarily  related to the operations included in the transaction with Ensign.</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Performance and Valuation Measures:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Consolidated and Combined Non-GAAP Financial Measures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance Metrics</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and Combined EBITDA</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,851&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and Combined Adjusted EBITDA</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,407&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,080&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,157&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation Metric</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and Combined Adjusted EBITDAR</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,874&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Segment Non-GAAP Measures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDA from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home health and hospice services</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior living services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,827&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative expenses are not allocated to any segment for purposes of determining segment profit or loss. </span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles Consolidated and Combined Net Income to Consolidated and Combined EBITDA, Consolidated and Combined Adjusted EBITDA and Consolidated and Combined Adjusted EBITDAR for the periods presented: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.613%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and Combined Net income</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,553&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Net (loss) income attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(548)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Provision for income taxes (benefit)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,085&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,941&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and Combined EBITDA</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,003&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,008&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,851&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Consolidated and Combined EBITDA</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Costs at start-up operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-Off related transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition services costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net COVID-19 related costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent related to items (a) above</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">223&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and Combined Adjusted EBITDA</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,407&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,080&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,157&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent related to items (a) above</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,467&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,950&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and Combined Adjusted EBITDAR</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,874&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents results related to start-up operations.  This amount excludes rent and depreciation and amortization expense related to such operations.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense incurred which is included in cost of services and general and administrative expense. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition related costs that are not capitalizable.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs incurred related to the Spin-Off are included in general and administrative expense.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A portion of the costs incurred under the Transition Services Agreement identified as redundant or nonrecurring that are included in general and administrative expense. Fees incurred under the Transition Services Agreement, net of the Company&#8217;s payroll reimbursement, were $3,124, $5,536, and $2,982, for the years ended December 31, 2021, 2020 and 2019, respectively. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning in the first quarter of fiscal year 2021, we updated our definition of Segment Adjusted EBITDAR to no longer include an adjustment for COVID-19 expenses offset by the amount of sequestration relief. COVID-19 expenses continue to be part of daily operations for which less specific identification is visible. Furthermore, the sequestration relief was extended through December 31, 2021. Sequestration relief was $3,555 for the year ended December 31, 2021.<br/></span><span style="font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><br/></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The 2020 amount represents incremental costs incurred as part of the Company's response to COVID-19 including direct medical supplies, labor, and other expenses, net of $2,765 in increased revenue related to the 2% payment increase in Medicare reimbursements for sequestration relief for the year ended December 31, 2020.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">On January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements (collectively, the &#8220;Transfer Agreements&#8221;) with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#8220;Transaction&#8221;). The closing of the Transaction is anticipated to occur in the first half of 2022. The Company impaired certain leasehold improvements included in property and equipment primarily  related to the operations included in the transaction with Ensign.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below reconciles Segment Adjusted EBITDAR from Operations to Segment Adjusted EBITDA from Operations for the periods presented:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:46.337%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.102%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,501&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,309&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,906&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,964&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,957&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent related to start-up operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(386)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDA from Operations</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,045&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,015&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,415&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,570&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,827&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,333&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion includes references to certain performance and valuation measures, which are non-GAAP financial measures, including Consolidated and Combined EBITDA, Consolidated and Combined Adjusted EBITDA, Segment Adjusted EBITDA from Operations, and Consolidated Adjusted EBITDAR (collectively, &#8220;Non-GAAP Financial Measures&#8221;).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP Financial Measures are used in addition to, and in conjunction with, results presented in accordance with GAAP and should not be relied upon to the exclusion of GAAP financial measures. Non-GAAP Financial Measures reflect an additional way of viewing aspects of our operations and company that, when viewed with our GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, we believe can provide a more comprehensive understanding of factors and trends affecting our business.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe these Non-GAAP Financial Measures are useful to investors and other external users of our financial statements regarding our results of operations because:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">they are widely used by investors and analysts in our industry as a supplemental measure to evaluate the overall performance of companies in our industry without regard to items such as interest expense, rent expense and depreciation and amortization, which can vary substantially from company to company depending on the book value of assets, the length of the lease to which the asset applies, the method by which assets were acquired, and differences in capital structures;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">they help investors evaluate and compare the results of our operations from period to period by removing the impact of our asset base and capital structure from our operating results; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Consolidated and Combined Adjusted EBITDAR is used by investors and analysts in our industry to value the companies in our industry without regard to capital structures. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use Non-GAAP Financial Measures:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">as measurements of our operating performance to assist us in comparing our operating performance on a consistent basis from period to period;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to allocate resources to enhance the financial performance of our business;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to assess the value of a potential acquisition;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to assess the value of a transformed operation&#8217;s performance;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to evaluate the effectiveness of our operational strategies; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">to compare our operating performance to that of our competitors.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically use Non-GAAP Financial Measures to compare the operating performance of each operation from period to period. We find that Non-GAAP Financial Measures are useful for this purpose because they do not include such costs as interest expense, income taxes, depreciation and amortization expense, which may vary from period-to-period depending upon various factors, including the method used to finance operations, the date of acquisition of a community or business, and the tax law of the state in which a business unit operates.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-GAAP Financial Measures have no standardized meaning defined by GAAP. Therefore, our Non-GAAP Financial Measures have limitations as  analytical tools, and they should not be considered in isolation, or as a substitute for analysis of our results as reported in accordance with GAAP. Some of these limitations are:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">they do not reflect our current or future cash requirements for capital expenditures or contractual commitments;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">they do not reflect changes in, or cash requirements for, our working capital needs;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">they do not reflect the net interest expense, or the cash requirements necessary to service interest or principal payments, on our debt;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">in the case of Consolidated and Combined Adjusted EBITDAR, it does not reflect rent expenses, which are normal and recurring operating expenses that are necessary to operate our leased operations;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">they do not reflect any income tax payments we may be required to make;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and these non-cash charges do not reflect any cash requirements for such replacements; and</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">other companies in our industry may calculate the same Non-GAAP Financial Measures differently than we do, which may limit their usefulness as comparative measures.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compensate for these limitations by using Non-GAAP Financial Measures only to supplement net income on a basis prepared in accordance with GAAP in order to provide a more complete understanding of the factors and trends affecting our business.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We strongly encourage investors to review our Consolidated and Combined Financial Statements, included in this report in their entirety and to not rely on any single financial measure. Because these Non-GAAP Financial Measures are not standardized, it may not be possible to compare these financial measures with other companies&#8217; Non-GAAP financial measures having the same or similar names. These Non-GAAP Financial Measures should not be considered a substitute for, nor superior to, financial results and measures determined or calculated in accordance with GAAP. We strongly urge you to review the reconciliation of income from operations to the Non-GAAP Financial Measures in the table presented above, along with our Financial Statements and related notes included elsewhere in this report.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the following Non-GAAP Financial Measures are useful to investors as key operating performance measures and valuation measures:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Measures:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated and Combined EBITDA</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe Consolidated and Combined EBITDA is useful to investors in evaluating our operating performance because it helps investors evaluate and compare the results of our operations from period to period by removing the impact of our asset base (depreciation and amortization expense) from our operating results.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate Consolidated and Combined EBITDA as net income, adjusted for net income/ (loss) attributable to noncontrolling interest, before (a)&#160;interest expense (b)&#160;provision for income taxes and (c)&#160;depreciation and amortization.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated and Combined Adjusted EBITDA</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adjust Consolidated and Combined EBITDA when evaluating our performance because we believe that the exclusion of certain additional items described below provides useful supplemental information to investors regarding our ongoing operating performance. We believe that the presentation of Consolidated and Combined Adjusted EBITDA, when considered with Consolidated and Combined EBITDA and GAAP net income is beneficial to an investor&#8217;s complete understanding of our operating performance.&#160;</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate Consolidated and Combined Adjusted EBITDA by adjusting Consolidated and Combined EBITDA to exclude the effects of non-core business items, which for the reported periods includes, to the extent applicable:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">costs at start-up operations;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">share-based compensation expense;</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acquisition related costs; </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Spin-Off related transaction costs;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">redundant or nonrecurring costs incurred as part of the Transition Services Agreement </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(as defined in Note 3, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions and Net Parent Investment</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">);</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">COVID-19 related costs and supplies; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">impairment of long-lived assets.</span></div><div style="text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Adjusted EBITDA from Operations</span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate Segment Adjusted EBITDA from Operations by adjusting Segment Adjusted EBITDAR from Operations to include rent-cost of services. We believe that the inclusion of rent-cost of services provides useful supplemental information to investors regarding our ongoing operating performance for each segment. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Valuation Measure</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">: </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated and Combined Adjusted EBITDAR</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use Consolidated and Combined Adjusted EBITDAR as one measure in determining the value of prospective acquisitions. It is also a measure commonly used by us, research analysts and investors to compare the enterprise value of different companies in the healthcare industry, without regard to differences in capital structures.&#160;Additionally, we believe the use of Consolidated and Combined Adjusted EBITDAR allows us, research analysts and investors to compare operational results of companies without regard to operating or financed leases. A significant portion of financed lease expenditures are recorded in interest, whereas operating lease expenditures are recorded in rent expense.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This measure is not displayed as a performance measure as it excludes rent expense, which is a normal and recurring operating expense and, as such, does not reflect our cash requirements for leasing commitments. Our presentation of Consolidated and Combined Adjusted EBITDAR should not be construed as a financial performance measure. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The adjustments made and previously described in the computation of Consolidated and Combined Adjusted EBITDA are also made when computing Consolidated and Combined Adjusted EBITDAR. We calculate Consolidated and Combined Adjusted EBITDAR by excluding rent-cost of services and rent related to start up operations from Consolidated and Combined Adjusted EBITDA.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1262"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December 31, 2021 Compared to the Year Ended December 31, 2020 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.905%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.355%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue Dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue Percentage</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue Dollars</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue Percentage</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home health and hospice services</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospice</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home care and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total home health and hospice services</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior living services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,294&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Home care and other revenue is included with home health revenue in other disclosures in this report.</span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated and combined revenue increased $48.7 million, or 12.5% driven by the net organic growth of existing operations across all segments of $36.8&#160;million or 9.4% as well as increased revenue from acquired operations of $11.9 million or 3.1% during the year ended December 31, 2021.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Home Health and Hospice Services</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home health and hospice revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home health services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,505&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98,267&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospice services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,612&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,075&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home care and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total home health and hospice revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,570&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,659&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,911&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home health services:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total home health admissions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,366&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,670&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Medicare home health admissions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,382&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average Medicare revenue per 60-day completed episode</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,290&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospice services:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total hospice admissions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,613&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">427&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average daily census</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,083&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hospice Medicare revenue per day</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of home health and hospice agencies at period end</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The year to date average for Medicare revenue per 60-day completed episode includes post period claim adjustments for prior periods.  </span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Home health and hospice revenue increased $55.9 million, or 22.0%. Revenue grew due to an increase in all key performance indicators including an increase in total home health admissions of 40.1%, an increase in Medicare home health admissions of 33.8%, an increase in average Medicare revenue per 60-day completed episode of 3.5%, an increase of 5.2% in total hospice admissions, and an increase of 10.0% in hospice average daily census. The improvement in these metrics resulted in organic revenue growth of $44.0 million for the year ended December 31, 2021. Growth was also driven by the acquisition of 11 home health, hospice and home care operations,</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> between December 31, 2020 and December 31, 2021, resulting in an increase in revenue of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$11.9&#160;million or 4.7% o</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">verall. Revenue attributable to sequestration suspension accounted for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$3.6 million in the current year</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Living Services</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue (in thousands)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Number of communities at period end</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Occupancy</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5.0)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Average monthly revenue per occupied unit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior living revenue decreased $7.2 million, or 5.2%, for the year ended December 31, 2021 when compared to the same period in the prior year primarily due to a 5.0% decrease in occupancy related to the COVID-19 pandemic between</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> December 31, 2020 and December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Services </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth total cost of services by each of our reportable segments for the periods indicated: </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Home Health and Hospice</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Living</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cost of services</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">353,093&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">296,874&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,219&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated and combined cost of services increased $56.2 million or 18.9% for the year ended December 31, 2021 when compared to the year ended December 31, 2020. Cost of services as a percentage of revenue increased by 4.4% from 75.9% to 80.3% over the same time period. The increase in cost of services was driven by the increase in revenue, new acquisitions in the current year, an increase in wages and benefits, and additional costs related to the impact of the COVID-19 pandemic.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Home Health and Hospice Services</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.584%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">257,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,094&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,157&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services as a percentage of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of services related to our home health and hospice services segment increased $51.2 million, or 24.8%, primarily due to increased volume of services provided. Cost of services as a percentage of revenue for the year ended December 31, 2021 increased 1.9% compared to the year ended December 31, 2020, primarily due to wage costs increased over the prior year in per hour wages, increase in overtime, and reduced staff availability due to the impact of COVID-19 on the staffing environment, resulting in higher overtime and per hour wages.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Living Services </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of service </span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,842&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,062&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services as a percentage of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of services related to our senior living services segment increased $5.1 million, or 5.6% for the year ended December 31, 2021 when compared to the year ended December 31, 2020. As a percentage of revenue, costs of service increased by 7.6% as a result of a decrease in occupancy while wage costs increased.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rent&#8212;Cost of Services</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Rent increased 4.3% from $39.2&#160;million to $40.9 million for the year ended December 31, 2021 compared to the year ended December 31, 2020, primarily as a result of acquisitions and CPI adjustments. Rent as a percentage of total revenue decreased from 10.1% to 9.3% in the year ended December 31, 2021, as the growth in revenue outpaced the increase in rent expense. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">General and Administrative Expense. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our general and administrative expense increased $5.0 million or 15.9% from $31.3 million to $36.3 million and as a percent of revenue from 8.0% to 8.2% for the year ended December 31, 2021 compared to the year ended December 31, 2020. The increase in general and administrative costs was primarily driven by an increase of $4.8 million in wages and benefits, of which stock-based compensation accounted for $0.7&#160;million, during the year ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Depreciation and Amortization.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expense decreased slightly as a percentage of total revenue. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Provision for Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our effective tax rate for the year ended December 31, 2021 was 21.3% of earnings before income taxes compared with an effective tax rate of 13.1% for the year ended December 31, 2020. The increase in the effective tax rate was due to an increase in non-deductible expenses. See</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note 14</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to the Consolidated and Combined Financial Statements included elsewhere in this report filed on Form 10-K for further discussion.</span></div><div style="text-align:justify"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1255"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of Prior Year Information</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For a comparison of our results of operations of the fiscal year ended December 31, 2020 as compared to the year ended December 31, 2019 refer to Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operation on Form 10-K filed with the SEC on February 24, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_88"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary sources of liquidity are cash generated through operating activities and borrowings under our revolving credit facility.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revolving Credit Facility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On February&#160;23, 2021, Pennant entered into an amendment to its existing credit agreement (as amended, the &#8220;Credit Agreement&#8221;), which provides for an increased revolving credit facility with a syndicate of banks with a borrowing capacity of  $150.0 million (the &#8220;Revolving Credit Facility&#8221;). The Revolving Credit Facility is not subject to interim amortization and the Company will not be required to repay any loans under the Revolving Credit Facility prior to maturity in 2026. The Company is permitted to prepay all or any portion of the loans under the Revolving Credit Facility prior to maturity without premium or penalty, subject to reimbursement of any LIBOR breakage costs of the lenders. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its independent operating subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments. Financial covenants require compliance with certain levels of leverage ratios that impact the amount of interest. As of December 31, 2021, we were in compliance with all covenants.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021 we had $5.2&#160;million of cash and $92.3&#160;million of available borrowing capacity on our Revolving Credit Facility. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our existing cash, cash generated through operations and our access to financing facilities, together with funding through third-party sources such as commercial banks, will be sufficient to fund our operating activities and growth needs, and provide adequate liquidity for the next twelve months. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents selected data from our combined statement of cash flows for the periods presented: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.946%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.013%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(In thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash (used in) provided by operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,223)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,120)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(41,616)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,490&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net change in cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,147&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(359)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash at beginning of year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">402&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash at end of year</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,190&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Year Ended December 31, 2021 Compared to the Year Ended December 31, 2020 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net cash from operating activities for the year ended December 31, 2021 decreased by $68.4 million when compared to the year ended December 31, 2020 . The decrease was primarily related to the repayment of $21.8 in the current year related to AAP from the CARES Act resulting in a change of $49.8 million in operating cash flow.  Exclusive of the repayment of AAP, our net cash flow from operations would have been $3.6 million positive for the year ended December 31, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021. Other factors that contributed to the net cash used in operating activities was a decrease in net income of $13.4 million when compared to the year ended December 31, 2021.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our net cash used in investing activities for the year ended December 31, 2021 decreased by $21.5 million compared to the year ended December 31, 2020. The decrease in funds used for investing activities was primarily due to a decrease of $19.6 million in cash paid for acquisitions during the year ended December 31, 2021.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Our net cash provided by financing activities increased by approximately $52.4 million for the year ended December 31, 2021 when compared to the year ended December 31, 2020 primarily due to an increase in borrowing on our revolving credit facility, partially offset by payments on our deferred financing costs related to the refinance of our credit facility in the first quarter 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:80%">  </span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_91"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Interest Rate Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We are exposed to risks associated with market changes in interest rates. Our Revolving Credit Facility exposes us to variability in interest payments due to changes in LIBOR. A 1.0% interest rate change would cause interest expense to change by approximately $0.5 million annually based upon our outstanding long-term debt as of December 31, 2021. We manage our exposure to this market risk by monitoring available financing alternatives. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LIBOR Phase-Out.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> LIBOR is in the process of being wound down. As of December 31, 2021 all CHF and EUR LIBOR settings, the 1 Week and 2 Months USD LIBOR settings, and the Overnight/Spot Next, 1 Week, 2 Months and 12 Months GBP and JPY LIBOR settings have ceased to be published. However, the Overnight and the 1-, 3-, 6- and 12-Months USD LIBOR settings will continue until June 2023. We are required to pay interest on borrowings under our Credit Facility at floating rates based on the 1-month LIBOR and thus, we do not expect to transition away from the LIBOR benchmark until June 2023.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Future debt that we may incur may also require that we pay interest based upon LIBOR, or a &#8220;synthetic&#8221; benchmark equivalent such as the Standard Overnight Financing Rate or (&#8220;SOFR&#8221;). We currently expect that the determination of interest under our credit agreement would be revised as provided under the agreement or amended as necessary to provide for an interest rate that approximates the existing interest rate as calculated in accordance with LIBOR for similar types of loans. Despite our current expectations, we cannot be sure that, if LIBOR is phased out or transitioned, the changes to the determination of interest under our agreement would approximate the current calculation in accordance with LIBOR. We do not know what standard, if any, will replace LIBOR if it is phased out or transitioned.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_94"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Statements and Supplementary Data</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated and combined financial statements and accompanying notes listed in Part IV, Item 15(a)(1) of this Annual Report on Form 10-K are included elsewhere in this report.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_97"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_100"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9A. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Controls and Procedures</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, we have evaluated the effectiveness of our disclosure controls and procedures (as such term is defined in Rules&#160;13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;)), as of the end of the period covered by this Annual Report. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that these disclosure controls and procedures were effective to provide reasonable assurance that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Management conducted an assessment of the effectiveness of our internal control over financial reporting as of December 31, 2021 based on the criteria set forth in &#8220;Internal Control-Integrated Framework&#8221; (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). Based on this assessment, management has concluded that our internal control over financial reporting was effective as of December 31, 2021 based on those criteria.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent registered public accounting firm, Deloitte &amp; Touche LLP, has audited the consolidated financial statements included in this Annual Report on Form 10-K and, as part of their audit, has issued an audit report, included herein, on the effectiveness of our internal control over financial reporting. Their report is set forth below.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal quarter ended December 31, 2021, there were no material changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1435"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Directors of The Pennant Group, Inc.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the internal control over financial reporting of The Pennant Group, Inc. and subsidiaries (the &#8220;Company&#8221;) as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO). In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2021, based on criteria established in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Internal Control &#8212; Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by COSO.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated financial statements as of and for the year ended December 31, 2021 of the Company and our report dated February 28, 2022 expressed an unqualified opinion on those financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management&#8217;s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition and Limitations of Internal Control over Financial Reporting</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> DELOITTE &amp; TOUCHE LLP</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boise, Idaho</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 28, 2022</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_103"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9B.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Information</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1483"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9C.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_106"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part III.</span></div><div style="text-align:center"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_109"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 10.&#160;&#160;&#160;&#160;  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Directors, Executive Officers and Corporate Governance</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is hereby incorporated by reference to our definitive proxy statement on Form 14A for the 2022 Annual Meeting of Stockholders.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_112"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 11. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Compensation</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is hereby incorporated by reference to our definitive proxy statement on Form 14A for the 2022 Annual Meeting of Stockholders.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_115"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 12. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security Ownership of Certain Beneficial Owners and Management and Related Stockholders</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is hereby incorporated by reference to our definitive proxy statement on Form 14A for the 2022 Annual Meeting of Stockholders.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_118"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 13.&#160;&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain Relationships and Related Transactions and Director Independence</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is hereby incorporated by reference to our definitive proxy statement on Form 14A for the 2022 Annual Meeting of Stockholders.</span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_121"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 14.&#160;&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Principal Accountant Fees and Services</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is hereby incorporated by reference to our definitive proxy statement on Form 14A for the 2022 Annual Meeting of Stockholders.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part IV.</span></div><div style="text-align:center"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_127"></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 15. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exhibits, Financial Statements and Schedules</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following documents are filed as a part of this report: </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(1) Financial Statements: </span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Consolidated and Combined Financial Statements of the Company are included in Part II, Item 8 of this Annual Report on Form 10-K.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Report of Independent Registered Public Accounting Firm </span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Consolidated Balance Sheets as of December 31, 2021 and 2020</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Consolidated and Combined Statements of Income for the Years Ended December 31, 2021, 2020 and 2019</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Consolidated and Combined Statements of Changes in Shareholders' Equity and Net Parent Investment for the Years Ended December 31, 2021, 2020 and 2019</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Consolidated and Combined Statements of Cash Flows for the Years Ended December 31, 2021, 2020 and 2019</span></div><div style="margin-bottom:6pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;padding-left:14.5pt">Notes to the Consolidated and Combined Financial Statements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)(2) Financial Statement Schedules: </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no financial schedules included in this Report as they are either not applicable or included in the financial statements.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a) (3)&#160;Exhibits:&#160;&#160;The following exhibits are filed with this Report or incorporated by reference:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibits</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Exhibit Description</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519260914/d812063dex21.htm">2.1#</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Master Separation Agreement, dated as of October 1, 2019, by and between The Ensign Group, Inc. and The Pennant Group, Inc. (incorporated by reference to Exhibit 2.1 to The Pennant Group, Inc.&#8217;s Current Report on Form 8-K (File No. 001-38900) filed with the SEC on October 3, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1766400/000176640022000027/pntg2ndarbylaws.htm">3.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Second Amended and Restated Certificate of Incorporation of The Pennant Group, Inc., effective as of February 21, 2022 (incorporated by reference to Exhibit 3.1 to The Pennant Group, Inc.&#8217;s Current Report on Form 8-K (File No. 001-38900) filed with the SEC February 22, 2022).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519260914/d812063dex32.htm">3.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Amended and Restated By-laws of The Pennant Group, Inc. (incorporated by reference to Exhibit 3.2 to The Pennant Group, Inc.&#8217;s Current Report on Form 8-K (File No. 001-38900) filed with the SEC on October 3, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="descriptionofsecuritiesq42.htm">4.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Description of Securities of The Pennant Group, Inc. (incorporated by reference to Exhibit 4.1 to The Pennant Group, Inc.&#8217;s Annual Report on Form 10-K (File No. 001-389000) filed with the SEC on March 4, 2020). </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519260914/d812063dex101.htm">10.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Transition Services Agreement, dated as of October 1, 2019, by and between The Ensign Group, Inc. and The Pennant Group, Inc. (incorporated by reference to Exhibit 10.1 to The Pennant Group, Inc.&#8217;s Current Report on Form 8-K (File No. 001-38900) filed with the SEC on October 3, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519260914/d812063dex101.htm">10.2</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Tax Matters Agreement, dated as of October 1, 2019, by and between The Ensign Group, Inc. and The Pennant Group, Inc. (incorporated by reference to Exhibit 10.2 to The Pennant Group, Inc.&#8217;s Current Report on Form 8-K (File No. 001-38900) filed with the SEC on October 3, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519260914/d812063dex103.htm">10.3</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Employee Matters Agreement, dated as of October 1, 2019, by and between The Ensign Group, Inc. and The Pennant Group, Inc. (incorporated by reference to Exhibit 10.3 to The Pennant Group, Inc.&#8217;s Current Report on Form 8-K (File No. 001-38900) filed with the SEC on October 3, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519224516/d693607dex104.htm">10.4</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form of Lease Agreement by and among subsidiaries of The Ensign Group, Inc. and subsidiaries of The Pennant Group, Inc. (incorporated by reference to Exhibit 10.4 to The Pennant Group, Inc.&#8217;s Amendment No. 2 to the Registration Statement on Form 10 (File No. 001-38900) filed with the SEC on August 19, 2019).</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519260914/d812063dex1012.htm">10.5+</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Pennant Group, Inc. 2019 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.12 to The Pennant Group, Inc.&#8217;s Current Report on Form 8-K (File No. 001-38900) filed with the SEC on October 3, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519224516/d693607dex106.htm">10.6+</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form of Options Granted Under The Pennant Group, Inc. 2019 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.6 to The Pennant Group, Inc.&#8217;s Amendment No. 2 to the Registration Statement on Form 10 (File No. 001-38900) filed with the SEC on August 19, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519224516/d693607dex107.htm">10.7+</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form of RSUs Granted Under The Pennant Group, Inc. 2019 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.7 to The Pennant Group, Inc.&#8217;s Amendment No. 2 to the Registration Statement on Form 10 (File No. 001-38900) filed with the SEC on August 19, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519224516/d693607dex108.htm">10.8+</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form of RS Granted Under The Pennant Group, Inc. 2019 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.8 to The Pennant Group, Inc.&#8217;s Amendment No. 2 to the Registration Statement on Form 10 (File No. 001-38900) filed with the SEC on August 19, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519260914/d812063dex1011.htm">10.9+</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Pennant Group, Inc. 2019 Long Term Incentive Plan (incorporated by reference to Exhibit 10.11 to The Pennant Group, Inc.&#8217;s Current Report on Form 8-K (File No. 001-38900) filed with the SEC on October 3, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519224516/d693607dex1010.htm">10.10+</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form of LTIP RS Granted Under The Pennant Group, Inc. 2019 Long Term Incentive Plan (incorporated by reference to Exhibit 10.10 to The Pennant Group, Inc.&#8217;s Amendment No. 2 to the Registration Statement on Form 10 (File No. 001-38900) filed with the SEC on August 19, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1766400/000119312519224516/d693607dex1011.htm">10.11</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form of Indemnification Agreement to be entered into between The Pennant Group, Inc. and each of its directors and executive officers (incorporated by reference to Exhibit 10.11 to The Pennant Group, Inc.&#8217;s Amendment No. 2 to the Registration Statement on Form 10 (File No. 001-38900) filed with the SEC on August 19, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1766400/000176640021000035/pntgconformedamendedcredit.htm">10.12</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Credit Agreement, dated February 23, 2021, by and among the Company and certain of its subsidiaries, the lenders named therein, and Truist Bank (successor by merger to SunTrust Bank), as administrative agent for the lenders (incorporated by reference to Exhibit 10.1 to The Pennant Group, Inc.&#8217;s Current Report on Form 8-K (File No. 001-38900) filed with the SEC on February 24, 2021).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1125376/000112537616000216/ex102cornerstoneomnibusinc.htm">10.13+</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cornerstone Healthcare, Inc. 2016 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.13 to The Pennant Group, Inc.&#8217;s Amendment No. 3 to the Registration Statement on Form 10 (File No. 001-38900) filed with the SEC on September 3, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="http://www.sec.gov/Archives/edgar/data/1125376/000112537617000035/a2016proxystatement.htm#s79c1f29a0e9c477ca771e6b5687c20a1">10.14+</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Ensign Group, Inc. 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.14 to The Pennant Group, Inc.&#8217;s Amendment No. 3 to the Registration Statement on Form 10 (File No. 001-38900) filed with the SEC on September 3, 2019).</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="listofsubsidiariesofpntgq4.htm">21.1*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Subsidiaries of The Pennant Group, Inc.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="deloitteconsentq421-ex231.htm">23.1*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Consent of Deloitte &amp; Touche LLP.</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ceocert-exhibit311q421.htm">31.1*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="cfocert-exhibit312q421.htm">31.2*</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="ceocert-exhibit321q421.htm">32.1**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline" href="cfocert-exhibit322q421.htm">32.2**</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Certification of Chief Financial Officer pursuant 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">101.INS*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">101.SCH*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">101.CAL*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">101.DEF*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">101.LAB*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">101.PRE*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:9.426%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.374%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">104*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Cover Page Interactive Data File &#8211; the cover page XBRL tags are embedded within the Inline XBRL document.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">* Filed with this report.<br/>** Furnished with this report.<br/>+ Exhibit constitutes a management contract or compensatory plan or agreement.<br/># Schedules omitted pursuant to Item 601(b)(2) of Regulation S-K. The Pennant Group Inc. agrees to furnish a supplemental copy of any omitted schedule to the SEC upon request.</span></td></tr></table></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_130"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 16.&#160;&#160;&#160;&#160;  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Form 10-K Summary</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.680%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.927%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:42.093%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Pennant Group, Inc.</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated: February&#160;28, 2022</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BY:&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ JENNIFER L. FREEMAN &#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer L. Freeman</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer (Principal Financial Officer, Principal Accounting Officer and Duly Authorized Officer)</span></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.744%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:31.746%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Signature</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date</span></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ DANIEL H WALKER</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman and Chief Executive Officer (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel H Walker</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ JENNIFER L. FREEMAN</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer (Principal Financial Officer, Principal Accounting Officer and Duly Authorized Officer)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer L. Freeman</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ CHRISTOPER R. CHRISTENSEN </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Christopher R. Christensen</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ JOHN G. NACKEL, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">John G. Nackel, Ph.D.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;/s/ STEPHEN M. R. COVEY</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stephen M. R. Covey</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ JOANNE STRINGFIELD </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JoAnne Stringfield</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ SCOTT E. LAMB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scott E. Lamb</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ GREGORY K. MORRIS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gregory K. Morris</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ BARRY M. SMITH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barry M. Smith</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX TO THE CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND FINANCIAL STATEMENT SCHEDULE</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.520%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_136">Report of Independent Registered Public Accounting Firm</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_136"> (PCA</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_136">OB</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_136"> ID No. </a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:AuditorFirmId" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzYvZnJhZzpmNDFmM2ZiODZhNDA0MWI2OWU0Zjc5NDlkZThhNGFiNS90YWJsZTo3YWJjZjY0NjRmMWI0M2JiYWEyYWIzNDJkZGUwNGRmMS90YWJsZXJhbmdlOjdhYmNmNjQ2NGYxYjQzYmJhYTJhYjM0MmRkZTA0ZGYxXzAtMC0xLTEtNzQ2NjkvdGV4dHJlZ2lvbjo4MDQ4ODhjN2FmZDg0ZTY2OTA3NmJjYjQwODAxZTdiY18zODQ4MjkwNjk3NDMw_c863acb8-1854-41aa-b44c-067e51b4862c">34</ix:nonNumeric></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_136">)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_139">53</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and Combined Financial Statements:</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_142">Consolidated Balance Sheets as of December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_142">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_142"> and 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_142">20</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_142">55</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_145">Consolidated and Combined Statements of Income for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_145">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_145">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_145">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_145"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_145">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_145">56</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_148">Consolidated and Combined Statements of Stockholders' Equity for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_148">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_148">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_148">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_148"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_148">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_148">57</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_151">Consolidated and Combined Statements of Cash Flows for the Years Ended December 31, 202</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_151">1</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_151">, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_151">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_151"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_151">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_151">58</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_154">Notes to the Consolidated and Combined Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_157">60</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the shareholders and the Board of Directors of The Pennant Group, Inc. </span></div><div style="text-align:justify;text-indent:18pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of The Pennant Group, Inc. and subsidiaries (the "Company") as of December 31, 2021 and 2020, the related consolidated and combined statements of income, stockholders' equity and net parent investment, and cash flows for each of the three years in the period ended December 31, 2021, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America .</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also audited in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal controls over financial reporting as of December 31, 2021, based on the criteria established in</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Internal Control - Integrated Framework (2013)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> issued by the Committee of Sponsoring Organizations of the Treadway Commissions and our report dated February 28, 2022 expressed an unqualified opinion on the Company's internal control over financial reporting.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Self-Insurance Reserves&#8212; Refer to Notes 2 to the financial statements</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is self-insured for general and professional liability and workers&#8217; compensation. The self-insurance liability is undiscounted and determined actuarially based on historical data of the Company&#8217;s claims experience. The Company has established retention amounts that limit the Company&#8217;s exposure. Self-insurance liabilities recorded as of December 31, 2021 were $6,906 thousand.  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the evaluation of the Company&#8217;s self-insurance liabilities as a critical audit matter because the projected settlement value of reported and unreported claims involves significant estimation by management. This required a high degree of auditor judgment and an increased extent of effort, including the need to involve our actuarial specialists when performing audit procedures to evaluate whether the self-insurance liabilities were appropriately recorded as of December 31, 2021</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the self-insurance liabilities included the following among others:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We tested the effectiveness of controls over the reserve for general and professional liability and workers&#8217; compensation, including those over the determination of the case reserves for known claims.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reading the Company&#8217;s insurance policies and comparing the coverage and terms by plan year to the assumptions used by management.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Testing the completeness and accuracy of the underlying data, including historical claims, used to determine the assumptions for loss development. </span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Involving actuarial specialists with specialized skill, industry knowledge, and relevant experience who assisted in:</span></div><div style="text-align:justify"><span><br/></span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Comparing prior-year expected development and ultimate loss to actuals incurred during the current year to identify potential bias in the determination of the self-insurance reserves.</span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Developing an independent range of estimates of the insurance reserves, utilizing paid and reported loss development factors from the Company&#8217;s historical data and industry loss development factors.  </span></div><div style="padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13pt">Evaluating qualifications of the Company&#8217;s actuaries by assessing the certifications and determining whether they meet the Qualification Standards of the American Academy of Actuaries to render the statements of actuarial opinion in their analyses.  </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:AuditorName" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzkvZnJhZzo5NmE1NzlmNGZmZTU0YTNlYTc0MDMzZTUxYmE0OGRjZS90ZXh0cmVnaW9uOjk2YTU3OWY0ZmZlNTRhM2VhNzQwMzNlNTFiYTQ4ZGNlXzI3NDg3NzkwNzIzMDg_f96660bf-9c67-49b3-b3aa-3dcdd3ad57c1">DELOITTE &amp; TOUCHE LLP</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="dei:AuditorLocation" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzkvZnJhZzo5NmE1NzlmNGZmZTU0YTNlYTc0MDMzZTUxYmE0OGRjZS90ZXh0cmVnaW9uOjk2YTU3OWY0ZmZlNTRhM2VhNzQwMzNlNTFiYTQ4ZGNlXzI3NDg3NzkwNzIzMDc_1d4f9e5c-2f80-4f5b-952f-ca931dc1df8d">Boise, Idaho</ix:nonNumeric>  </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 28, 2022  </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company's auditor since 2019.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_142"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">      THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except par value)</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.592%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:Cash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMtMS0xLTEtNDExMzI_fd4e47e7-fb82-42a0-bb8d-349c16a9ba93">5,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:Cash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMtMy0xLTEtNDExMzI_7211c857-54a5-4e17-b384-536ca59d86e2">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable&#8212;less allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzQtMC0xLTEtNDExMzIvdGV4dHJlZ2lvbjpkNjc1Mzk5MDQ4YjA0MzgwOTAwODQ4NGE2YTliNjIxNl82NA_582ec952-359d-4d67-bd6d-325f966c541c">902</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzQtMC0xLTEtNDExMzIvdGV4dHJlZ2lvbjpkNjc1Mzk5MDQ4YjA0MzgwOTAwODQ4NGE2YTliNjIxNl83MQ_d49fe8db-79dd-4029-a553-c673f397ae09">643</ix:nonFraction>, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzQtMS0xLTEtNDExMzI_07d8abcd-8999-4727-b183-290def2d0cc5">53,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzQtMy0xLTEtNDExMzI_dc9d0344-2b76-44e5-8fc3-0c2645465878">47,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzUtMS0xLTEtNDExMzI_e4c116f9-954d-401c-bf3f-3fd83151898c">16,711</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzUtMy0xLTEtNDExMzI_d05dc55a-221a-47e2-8ea1-0e02f158cd8b">12,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzYtMS0xLTEtNDExMzI_1d919777-5dd3-44ee-b6b0-894db75ca1ca">75,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzYtMy0xLTEtNDExMzI_f1906129-9e6a-4546-a9d0-4dc0fa0cbc5f">59,599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzctMS0xLTEtNDExMzI_527d1f8c-7d35-47f0-8b15-fb916a009ed4">16,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzctMy0xLTEtNDExMzI_bd5d8d01-e23d-4682-8064-f2c2b072d43a">17,884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzgtMS0xLTEtNDExMzI_b959531f-ced6-4b44-92e6-ab85ffcea9d3">300,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzgtMy0xLTEtNDExMzI_ca655e88-9a41-42fb-ac34-8c8eba328edf">308,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Escrow deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:EscrowDeposit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzktMS0xLTEtNDExMzI_bcb5de4d-7d9f-4a61-bc05-e1227f3db824">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:EscrowDeposit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzktMy0xLTEtNDExMzI_ff9f0120-08e5-4c7b-a30a-ed0a53971630">525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzEwLTEtMS0xLTQxMTMy_1c1b5dbd-08c0-4688-847e-9c8d69db3b2f">3,848</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzEwLTMtMS0xLTQxMTMy_bd5c0d43-a321-4c52-8997-2bb3006a58e2">2,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:OtherRestrictedAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzExLTEtMS0xLTQxMTMy_bc59da5b-a324-4db9-97a3-b7ec0e93ef24">4,828</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:OtherRestrictedAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzExLTMtMS0xLTQxMTMy_d6e6ef9b-4445-4c8c-a6ad-4155af6d41f9">4,289</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzEzLTEtMS0xLTQxMTMy_1d21dfd1-df21-4637-be44-5c693503cf05">74,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzEzLTMtMS0xLTQxMTMy_79798066-be31-4a78-a402-c5624121fa56">66,444</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other indefinite-lived intangibles</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE0LTEtMS0xLTQxMTMy_2459c5f3-185a-4123-ae8f-687b71246a37">53,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE0LTMtMS0xLTQxMTMy_7291261c-bc30-40fe-a74d-8dd82f6fb20a">47,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE1LTEtMS0xLTQxMTMy_f63fd5c8-c2ab-42dd-a855-218ff955d48c">530,297</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE1LTMtMS0xLTQxMTMy_562ab77d-c1ef-43ec-9c80-d0fe7a04b71a">506,976</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE4LTEtMS0xLTQxMTMy_deb4569f-e10c-4bdf-9dd9-6940fa5af6da">10,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE4LTMtMS0xLTQxMTMy_a82a8029-eda8-4f3c-89fb-6a6fb20f986f">9,761</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued wages and related liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE5LTEtMS0xLTQxMTMy_187800b0-ce81-4989-8a49-5f1178a98dfc">23,480</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE5LTMtMS0xLTQxMTMy_230b8d11-c7e6-4062-afc0-4920dd3ba918">26,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities&#8212;current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIwLTEtMS0xLTQxMTMy_202ed855-509a-48b6-8c79-9051a8d7a858">16,118</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIwLTMtMS0xLTQxMTMy_f17ca5fc-d719-4664-a5f9-fd7d23be1f22">14,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIxLTEtMS0xLTQxMTMy_491796ec-3e4d-4290-8cae-bbb8039f0205">21,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIxLTMtMS0xLTQxMTMy_f2e52fc6-2467-4361-bb75-b7df91521aba">38,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIyLTEtMS0xLTQxMTMy_980db25b-0e7d-4fb9-8f5b-6f2700375f12">71,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIyLTMtMS0xLTQxMTMy_b7865fdb-4a7d-47e0-975a-d911a75c1e46">89,015</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities&#8212;long-term </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIzLTEtMS0xLTQxMTMy_f6d5dce4-114b-4312-9bbb-d951ff3b9298">287,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIzLTMtMS0xLTQxMTMy_d4abe7de-af5c-4839-be76-c7da75714c82">296,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI0LTEtMS0xLTQxMTMy_f2ed25aa-4250-4494-b70c-77bb06e1b424">5,293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI0LTMtMS0xLTQxMTMy_6ab4d9e3-643f-418d-96e3-a809d0e2c2e5">11,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI1LTEtMS0xLTQxMTMy_fe57270a-0842-425e-ac73-0dc1f8eea85f">51,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI1LTMtMS0xLTQxMTMy_fa9a882d-4fb9-4161-abff-5e0a781bc32e">8,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI2LTEtMS0xLTQxMTMy_c4d93483-30f1-45d8-bd66-43508698bb59">416,053</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI2LTMtMS0xLTQxMTMy_6064dd0c-c3ac-4406-ae37-b8441158cd11">405,804</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI3LTEtMS0xLTQyMzIz_22e7a407-9f07-409a-8393-681b45b810ce"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI3LTMtMS0xLTQyMzI1_dca06b45-4874-4734-9a05-8b15a7aa3c83"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMTg_82acc9ca-1617-4cf5-9587-9bb34f4793ec"><ix:nonFraction unitRef="usdPerShare" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMTg_e2a1dd19-92b6-4e42-be17-f1f224f22707">0.001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMzI_0f0b9666-2d7a-4c8d-811d-4679b4a42614"><ix:nonFraction unitRef="shares" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMzI_2cf5a833-837a-4681-983e-18517ef85e83">100,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfNTQ_cc71e562-efc9-4d70-91ce-63930df92e12">28,826</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfNjE_fdcd00f4-2f9c-40d1-b014-058c2817a62f">28,499</ix:nonFraction> shares issued and outstanding at December&#160;31, 2021, respectively, and <ix:nonFraction unitRef="shares" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMTE5_f68df1d0-975b-4b84-aa75-0d9d7081def6">28,696</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMTI2_df93e0d5-6846-48ee-90e7-f6850df77011">28,243</ix:nonFraction> shares issued and outstanding at December 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTEtMS0xLTQxMTMy_949e94e7-3889-4397-8b0b-4ba4d5289433">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTMtMS0xLTQxMTMy_de25d36b-f99b-49e8-9bfd-17551bec43f9">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMwLTEtMS0xLTQxMTMy_937aeb3e-98e0-4d3e-9daf-c7ad24ca53f6">95,595</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMwLTMtMS0xLTQxMTMy_6584ea7c-8c4a-4045-9222-dfbbf1ed8837">84,671</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMxLTEtMS0xLTQxMTMy_ce9fb581-2d47-47e0-b9be-4bb3bc9fd26a">14,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMxLTMtMS0xLTQxMTMy_5c3fa6bb-b885-4bd3-bef5-bf0f60314021">11,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost, 3 shares at December 31, 2021 and 2020</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMyLTEtMS0xLTQxMTMy_6e9cac93-c3ed-4eb0-ab5b-28a16b6d1966">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMyLTMtMS0xLTQxMTMy_6631c04e-97e2-4269-ab82-411f82331ff4">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Pennant Group, Inc. stockholders' equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:NetParentInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMzLTEtMS0xLTQxMTMy_a698482b-9e22-4487-86df-7712861a45dd">110,199</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="pntg:NetParentInvestment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMzLTMtMS0xLTQxMTMy_4d060a1d-ebc5-4c65-92a4-58c536881003">96,579</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM0LTEtMS0xLTQxMTMy_468791d5-1d19-42af-90ff-6aeb97f1faf1">4,045</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:MinorityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM0LTMtMS0xLTQxMTMy_f4ec11ab-0f10-4e02-acb8-33f033a86482">4,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM1LTEtMS0xLTQxMTMy_58b9ad50-b74e-42b2-9895-d6ab399ee4cf">114,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM1LTMtMS0xLTQxMTMy_ad3fd9c8-b716-4b8a-97eb-95cdc76b86d5">101,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM2LTEtMS0xLTQxMTMy_a5e7f6c8-7b2e-438c-88f4-f2afe6fdfa52">530,297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM2LTMtMS0xLTQxMTMy_5120c4ef-9f9c-4504-b242-76ed2548d9f6">506,976</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated and combined financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED AND COMBINED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except for per-share amounts)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.991%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzMtMS0xLTEtNDExMzI_6576ee1e-8ab5-49f2-953e-c0c6f49844bb">439,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzMtMy0xLTEtNDExMzI_a14793f6-2b74-400f-b208-02c25543188f">390,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzMtNS0xLTEtNDExMzI_63f47a66-7341-4c9f-b9fd-54fd410833af">338,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expense:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzYtMS0xLTEtNDExMzI_baf409d3-347d-4b77-af3a-85f3cd3e3944">353,093</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzYtMy0xLTEtNDExMzI_87327812-765d-4675-be83-bb5ad7c5f56b">296,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzYtNS0xLTEtNDExMzI_0cde6ac6-acf9-473a-b0f0-8484f9106a42">258,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzctMS0xLTEtNDExMzI_fd0f82c4-0e0e-4b42-9cc8-910e8c0a2a73">40,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzctMy0xLTEtNDExMzI_d5165ec7-c99e-40f0-b52e-109b3148cd78">39,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzctNS0xLTEtNDExMzI_d6fdbc82-25fc-40b0-afaf-25f38997cc7f">34,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzgtMS0xLTEtNDExMzI_60a914df-ba1e-4e4c-8732-795a6b44b7f6">36,259</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzgtMy0xLTEtNDExMzI_8abbd718-79d1-48f3-ac66-87751c7dff1d">31,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzgtNS0xLTEtNDExMzI_3301ab0f-cb46-4dfd-a887-210f13f30557">35,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzktMS0xLTEtNDExMzI_46411cbf-f8bb-432a-a78d-7930ebc5fb1e">4,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzktMy0xLTEtNDExMzI_96f40dd3-e44b-46b6-8f09-f9494bb57d67">4,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzktNS0xLTEtNDExMzI_3b2ce5b0-e186-46ec-8137-47fa05948aba">3,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEwLTEtMS0xLTQxMTMy_dc1bd3c5-bda2-41f8-bda5-a040e48a94b9">434,999</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEwLTMtMS0xLTQxMTMy_169e0736-2bb2-4f9c-bf91-f0b2ee4a39b3">372,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:CostsAndExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEwLTUtMS0xLTQxMTMy_d22b3f24-e172-4e21-b425-24e0cb7f5593">332,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzExLTEtMS0xLTQxMTMy_2cb83f41-4e80-49a2-9f01-f24224cf5548">4,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzExLTMtMS0xLTQxMTMy_91e874e6-66a1-41ec-b775-3f1b76f7f372">18,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzExLTUtMS0xLTQxMTMy_0a5df602-25fd-4676-ade9-6c4b7bd6211f">5,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (expense) income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEzLTEtMS0xLTQxMTMy_0cce4854-ec52-40ad-a7be-c7d63f719303">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEzLTMtMS0xLTQxMTMy_5ff3a154-721c-4b14-b7fe-c5a2aeb86656">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEzLTUtMS0xLTQxMTMy_d5858b8e-6034-4179-94f5-c688c0875574">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE0LTEtMS0xLTQxMTMy_d7ae4234-fbd7-4cec-9dde-52c38edd2c41">1,941</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:InterestExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE0LTMtMS0xLTQxMTMy_c7f76df1-9b01-4f57-b7fb-ed8e4be4820b">1,239</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE0LTUtMS0xLTQxMTMy_403e6998-872d-487c-8eb2-a994702881ee">410</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE1LTEtMS0xLTQxMTMy_2594184b-c656-4e3b-9f13-9c859d0a001d">1,965</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE1LTMtMS0xLTQxMTMy_f84e49b9-9978-4869-8f43-db85a4d0dd6a">1,014</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE1LTUtMS0xLTQxMTMy_9064007f-fdc9-414d-8558-0b364d3e1bd7">410</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE2LTEtMS0xLTQxMTMy_fda681d1-a423-416d-9f66-abab9754590c">2,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE2LTMtMS0xLTQxMTMy_048e1706-8fef-4207-bfeb-c11b1d291406">17,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE2LTUtMS0xLTQxMTMy_5109bd39-3d05-4c9a-8f22-52ac5380f03c">5,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE3LTEtMS0xLTQxMTMy_a538f3a5-441e-4122-bb7f-0ae298a2d9b3">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE3LTMtMS0xLTQxMTMy_f15576b0-ff2e-4546-8f66-970cd79f3e61">2,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE3LTUtMS0xLTQxMTMy_941b705b-f298-416b-98bb-d0a264a2b801">2,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE4LTEtMS0xLTQxMTMy_c463069e-8115-4160-a5b2-1df01e695640">2,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE4LTMtMS0xLTQxMTMy_99cf0ea4-9a38-4eb5-91f7-579b3ca0551a">15,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE4LTUtMS0xLTQxMTMy_b300f0d6-bbdb-4c58-9c37-5bef9c64871a">3,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: net (loss)/ income  attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE5LTEtMS0xLTQxMTMy_5765d219-8c8e-4aa8-b536-ee13c2a81a3a">548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE5LTMtMS0xLTQxMTMy_ed513a97-3f4a-4d0e-89a0-3d0f0a650aa0">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE5LTUtMS0xLTQxMTMy_fb98612b-15ef-4752-a9b2-f9650ca67a2e">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income and other comprehensive income attributable to The Pennant Group, Inc. </span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIwLTEtMS0xLTQxMTMy_683453f0-2bf9-4f5e-96b7-ced8459acb93">2,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIwLTMtMS0xLTQxMTMy_f4e34dda-55f4-4dc9-90be-ed25f0ae0a22">15,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIwLTUtMS0xLTQxMTMy_ceb1be9e-c6e5-4a14-936f-fc9dfd9203e7">2,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Earnings per common share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Note 4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">:</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIyLTEtMS0xLTQxMTMy_f98d53e6-7e45-4666-a80a-714029cd97a4">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIyLTMtMS0xLTQxMTMy_8a5f4cbe-6676-4932-91c7-c8ce8380b4a5">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIyLTUtMS0xLTQxMTMy_1cb2039f-9fdd-4a42-8124-390dcd0e281c">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIzLTEtMS0xLTQxMTMy_24326b67-c281-428e-a5cd-aec1b3bdd877">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIzLTMtMS0xLTQxMTMy_835be445-d0fc-429a-afbb-e2562687e301">0.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIzLTUtMS0xLTQxMTMy_9ed37711-66f2-453a-ae01-31f03cee1e12">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI1LTEtMS0xLTQxMTMy_892f74ea-f8e7-4ca1-a8f3-1a82f8a6c0b3">28,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI1LTMtMS0xLTQxMTMy_a8e86190-b15f-42f0-b41f-d3866545c1fa">28,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI1LTUtMS0xLTQxMTMy_536076e0-b442-43b0-897c-1ba15bb3c3f6">27,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI2LTEtMS0xLTQxMTMy_51df11ca-9677-483b-b675-2ea6f757d8b9">30,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI2LTMtMS0xLTQxMTMy_19f6fc8b-47ab-4d6f-bfe3-7fb3cec0ee45">30,228</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI2LTUtMS0xLTQxMTMy_0c767d19-f1c1-4146-83cb-018c8d61c780">29,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated and combined financial statements.</span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="padding-left:18pt;padding-right:18pt;text-align:center;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS' EQUITY </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AND NET PARENT INVESTMENT</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.205%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.872%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.705%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.927%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.355%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.494%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.991%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Additional Paid-In Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Retained Earnings/ (Accumulated Deficit)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Controlling Interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Parent Investment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd91651521da4c609cd12f37af52ba44_I20181231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMS0xLTEtNDExMzI_0a9525d0-a07c-40a5-8d68-14f11fc9f975">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd91651521da4c609cd12f37af52ba44_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMy0xLTEtNDExMzI_9d128e9f-60a5-4cf8-9d68-a3468ead0dc9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb3f0aba2eec4f708396a60e99675481_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtNS0xLTEtNDExMzI_e79e819d-809a-4493-8a71-77efadaf8a7c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide2b3e36383446e7a915226ee5c83310_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtNy0xLTEtNDExMzI_21b14e05-4eea-43b6-850b-8e71fa8e1242">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9a8ca1010c9b475d92df11e16146a5d8_I20181231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtOS0xLTEtNDExMzI_bdfed4fd-6cde-479b-897c-5c992daadeff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9a8ca1010c9b475d92df11e16146a5d8_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMTEtMS0xLTQxMTMy_5364194c-95d6-4d1e-81ea-fa728d8c4252">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01fbcc736c2f4d88b3e0b648821e0ba8_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMTMtMS0xLTQxMTMy_f6c9161c-c3e5-446d-a9ab-3eb60d854cc4">55,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d956ca6cd1c408fae3c1c5b8a11d188_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMTUtMS0xLTQxMTMy_b564ddc1-c63d-4c65-ba06-a7d810106930">9,432</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i855d825b738d453698699f3f7321df6f_I20181231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMTctMS0xLTQxMTMy_6e864443-6053-400c-a390-b4b4dffde5c9">65,288</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interest attributable to subsidiary equity plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzQtMTMtMS0xLTQxMTMy_154d05a2-63ab-4e55-8511-7c25bfd73402">2,991</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia77015134f924c9fbf430ceacefda567_D20190101-20191231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzQtMTUtMS0xLTQxMTMy_ce737472-3b92-42bb-bfb3-8238ea5de176">3,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzQtMTctMS0xLTQxMTMy_1f9b0603-3ba7-4c80-9dd7-a9f7b79c563b">594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share repurchase related to subsidiary equity plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia77015134f924c9fbf430ceacefda567_D20190101-20191231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzUtMTUtMS0xLTQxMTMy_ffe9eaad-5a8f-4f0c-801e-3bacc67515bc">394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:MinorityInterestDecreaseFromRedemptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzUtMTctMS0xLTQxMTMy_10c54d3d-5a0d-4117-bbd2-1dee069d1b14">394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia77015134f924c9fbf430ceacefda567_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzYtMTUtMS0xLTQxMTMy_3366971d-a312-449e-b0bb-772bf109ea90">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzYtMTctMS0xLTQxMTMy_efd3d5bc-3ba9-4492-85cf-733d7db19b58">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net transfer from parent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231" decimals="-3" name="pntg:StockholdersEquityDistributionsFromParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzctMTMtMS0xLTQ2OTg3_c501e64b-1907-40cc-aa08-bd2dc24bdc1a">11,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:StockholdersEquityDistributionsFromParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzctMTctMS0xLTQ2OTg3_4e7a08ef-6cc8-434d-bc7a-cbc627be1ce8">11,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to The Pennant Group, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i690e1ad892ed46a8bc17a390e883382b_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtNy0xLTEtNDY5ODc_361f5746-a99d-4c05-a72a-854a13116432">3,799</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTMtMS0xLTQ2OTg3_4916b0c5-2287-466f-a8c3-9b0a49335f0b">6,345</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTctMS0xLTQ2OTg3_082996e0-724c-4b68-8621-787dbccf323d">2,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash Dividend to Parent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzktMTMtMS0xLTQ2OTg3_dbf666ae-1405-4fda-a51f-dcc7a0fa7219">11,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:DividendsCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzktMTctMS0xLTQ2OTg3_b743ca99-b7a9-445d-8818-1c3cfe2f9bb9">11,600</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of Invested Equity</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4557ca296245b787f54721e8fb4fc7_D20190101-20191231" decimals="-3" name="pntg:ReclassificationOfInvestedEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTUtMS0xLTQ2OTg3_4d56cafd-1aac-49ea-b9fc-7d779af88165">72,893</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231" decimals="-3" sign="-" name="pntg:ReclassificationOfInvestedEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTEzLTEtMS00Njk4Nw_00b3611e-4d7b-4030-a4d6-c79227db1b72">59,504</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia77015134f924c9fbf430ceacefda567_D20190101-20191231" decimals="-3" sign="-" name="pntg:ReclassificationOfInvestedEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTE1LTEtMS00Njk4Nw_49570fb0-1223-4b02-a642-fca78c7e0958">13,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:ReclassificationOfInvestedEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTE3LTEtMS00Njk4Nw_301b5919-e493-4013-b58e-80ddd3b0b834">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of Common Stock after spin-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a9a8de246d64eae8dd59832de0af5e7_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTEtMS0xLTQ2OTg3_56d56359-7c70-4634-8c14-1ae4a7005391">27,834</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4a9a8de246d64eae8dd59832de0af5e7_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTMtMS0xLTQ2OTg3_2700c85b-8524-45b6-8459-727a9efd47b7">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5c4557ca296245b787f54721e8fb4fc7_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTUtMS0xLTQ2OTg3_3c492b66-2b8d-4843-bbe4-249886160476">28</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTE3LTEtMS00Njk4Nw_6fec2ba0-8667-4d83-a31b-dfd9a436eb3b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based Compensation after spin-off</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4557ca296245b787f54721e8fb4fc7_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEyLTUtMS0xLTQ2OTg3_b8649ca4-5045-403d-9e38-4b7e5225e2e8">1,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEyLTE3LTEtMS00Njk4Nw_7eb2f060-7eef-49a1-8b85-8657b3b103ec">1,987</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exercise of Stock Options, issuance of other awards after spin-off</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a9a8de246d64eae8dd59832de0af5e7_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEzLTEtMS0xLTQ2OTg3_712e0969-127d-4c5d-8422-52e5a2fd77ac">601</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5c4557ca296245b787f54721e8fb4fc7_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEzLTUtMS0xLTQ2OTg3_a304411d-631a-4f44-b912-ff0ff4c35aa6">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEzLTE3LTEtMS00Njk4Nw_f2bfa53e-231b-49de-a81d-5e89ee6c3316">30</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5166a6bf5fa34ea4a777f2940c33fc70_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMS0xLTEtNDExMzI_0ae8549e-397e-4cd9-b7d8-05d1c2c9f34a">28,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5166a6bf5fa34ea4a777f2940c33fc70_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMy0xLTEtNDExMzI_fa1854b7-8361-40af-93e3-4ec168299572">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i53e93f7878814ac5ba917527e6bc6fdb_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtNS0xLTEtNDExMzI_43771e36-4cd3-46fe-b371-8d28bd6099a8">74,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5bfd4e9286bf4ca98e7e5f4e442a2026_I20191231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtNy0xLTEtNDExMzI_3fd4ddcb-6743-4e73-b945-40e355a10526">3,799</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5b80432f9127486d82bf8a5566b3b726_I20191231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtOS0xLTEtNDExMzI_2e563f43-039c-460e-808a-248290a58eef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5b80432f9127486d82bf8a5566b3b726_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTEtMS0xLTQxMTMy_6e8c5944-0234-4ada-bbd6-1b5a1c907f14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7504d19735f49cc9eea4e20bfed667a_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTMtMS0xLTQxMTMy_801bacba-d55d-4578-9235-559d4f7c3a85">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35bd8b5de02d40739ff3a3df8cfe4355_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTUtMS0xLTQxMTMy_2164ba6a-3a35-4c78-84f6-27120c5eb313">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTctMS0xLTQxMTMy_63a71b99-bb77-4de4-9214-0cf0293342de">71,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Noncontrolling interests assumed related to acquisitions</span></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90f6d4e5d3849e5bcb29a785a2ddaac_D20200101-20201231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzktMTUtMS0xLTQxMTMy_7153f649-d5ef-4899-abe0-8711a8057f47">4,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzktMTctMS0xLTQxMTMy_c29e8c96-c443-40dc-bc57-a946da9bc54f">4,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sale of noncontrolling interests, net of tax</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic350fc4ba36449e4872a8c4cc3fc52fb_D20200101-20201231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTUtMS0xLTQxMTMy_751811cf-90e4-42b5-9406-8a7ebbbf16b3">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie90f6d4e5d3849e5bcb29a785a2ddaac_D20200101-20201231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTE1LTEtMS00MTEzMg_93cc8530-36d6-41c8-adc6-b2d29245d2a0">138</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTE3LTEtMS00MTEzMg_bc375f4d-0d9a-4abd-8dc8-ce7132255aeb">451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Non-Controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie90f6d4e5d3849e5bcb29a785a2ddaac_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTE1LTEtMS00MTEzMg_9f8229f3-0fd2-46fd-aa8c-28ab66cbb66a">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTE3LTEtMS00MTEzMg_6bb1919f-f257-4938-9d93-e7a0eb201bd1">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income attributable to The Pennant Group, Inc.</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if33183982ee24195bfee778d16529013_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEyLTctMS0xLTQxMTMy_fe3e290a-36cc-485c-b728-c9544cab37c8">15,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEyLTE3LTEtMS00MTEzMg_535a18e2-4e3f-49c9-8d18-31ea2b2234ec">15,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic350fc4ba36449e4872a8c4cc3fc52fb_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEzLTUtMS0xLTQxMTMy_d886675a-1ea0-4b22-be03-bca7c9d5684a">8,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEzLTE3LTEtMS00MTEzMg_acca38f1-709b-46dc-8d24-6e0029565d1f">8,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from the exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2296c7a7384d4e56b1c183412b8e586e_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE0LTEtMS0xLTQxMTMy_992894f7-8c06-4827-8901-6428189d9d09">238</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic350fc4ba36449e4872a8c4cc3fc52fb_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE0LTUtMS0xLTQxMTMy_b350c899-e079-4005-91e8-6659b999c62a">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE0LTE3LTEtMS00MTEzMg_849c5ed1-73a3-4164-acb7-cbf994b688c8">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance/ (cancellation) of restricted stock</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2296c7a7384d4e56b1c183412b8e586e_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE1LTEtMS0xLTQxMTMy_41988215-14ad-4b7b-882d-b9561581218f">26</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shares of common stock withheld to satisfy tax withholding obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2296c7a7384d4e56b1c183412b8e586e_D20200101-20201231" decimals="-3" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE2LTEtMS0xLTQxMTMy_6521d1ef-d7da-48f2-aa2f-6004bd5a2846">3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i166349c580b648b886b6acee6a9a1cbb_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE2LTktMS0xLTQxMTMy_58a39c23-2adf-4cdb-9aab-ab59faf22a54">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i166349c580b648b886b6acee6a9a1cbb_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE2LTExLTEtMS00MTEzMg_74093493-08dd-412a-a186-c6c708efc11c">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE2LTE3LTEtMS00MTEzMg_91d73f68-55e8-40d9-9776-a551d80b2aa1">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99cc169c87d54cfbaeeb3b1336ab30eb_I20201231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTEtMS0xLTQxMTMy_dff51408-0d08-4e7a-998e-065c37980d07">28,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99cc169c87d54cfbaeeb3b1336ab30eb_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTMtMS0xLTQxMTMy_5febf22d-c422-422b-888b-ca7d3df9a9bd">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05bcdfdd5a524814835b5fe3930e4688_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTUtMS0xLTQxMTMy_c1b3822e-ef0e-4092-b21e-c10be425c4d7">84,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95ba983a79d7440dbbf23a35c1171deb_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTctMS0xLTQxMTMy_df8e66ad-d59a-4afc-8c1a-5b44e8838aa2">11,945</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic64854ee9b9849e0b09fa298cbfd3e99_I20201231" decimals="-3" sign="-" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTktMS0xLTQxMTMy_356b4c51-1f90-4a09-820a-7f0fbf803684">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic64854ee9b9849e0b09fa298cbfd3e99_I20201231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTExLTEtMS00MTEzMg_39150f7e-9c63-4f17-b9b9-7774bb8b08a0">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a5b873622de45afa65e19177ba49557_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTEzLTEtMS00MTEzMg_800f3911-ec1a-4205-a651-e1d4f69d42ff">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia44088af8f1e46d1b16f10b9327f6cf5_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTE1LTEtMS00MTEzMg_6e9d6141-26ed-4daa-8c31-81bfd19923e1">4,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTE3LTEtMS00MTEzMg_287a95d7-583d-4b0a-a53f-f31d779b5795">101,172</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income/ (loss) attributable to The Pennant Group, Inc.</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d456b9856964a9b93a6df6f1fa39ccf_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIwLTctMS0xLTQxMTMy_e08cd52e-7b52-4f3c-b05c-09af85691226">2,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIwLTE3LTEtMS00MTEzMg_addaa0a0-2270-4a50-a87d-40830321b931">2,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss attributable to Non-Controlling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iad9a8ecab0c04918aee8cdd00de80898_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIxLTE1LTEtMS00MTEzMg_526d3120-0b38-41a7-b2cb-61a2d91eaf38">548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIxLTE3LTEtMS00MTEzMg_633c75ec-fa51-4b95-a7c6-39671c0d6495">548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95eabde00ded4cf097fa61177f5f5a10_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIyLTUtMS0xLTQxMTMy_75e3bf0c-64de-43c2-8965-51cf195b6d10">10,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIyLTE3LTEtMS00MTEzMg_b7f49664-7be9-457b-9aee-8ac5dcc9094b">10,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock from the exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb984f908c724c4bbff50002d4aec555_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIzLTEtMS0xLTQxMTMy_840287f9-d124-4b3a-a134-84a4be9410ba">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95eabde00ded4cf097fa61177f5f5a10_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIzLTUtMS0xLTQxMTMy_038c92a4-f117-4e46-94db-5b4a4523fdf0">884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIzLTE3LTEtMS00MTEzMg_3c99ac21-798f-4b70-8536-8a2581623d81">884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net issuance of restricted stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icb984f908c724c4bbff50002d4aec555_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI0LTEtMS0xLTQxMTMy_e796f113-8c1a-478c-9515-d972875c9fe2">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9b5f6ca5bfb2481690e71d78cb6d8667_I20211231" decimals="-3" name="us-gaap:SharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTEtMS0xLTQxMTMy_c7027866-5060-41e4-887e-09a8b57d9a86">28,826</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b5f6ca5bfb2481690e71d78cb6d8667_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTMtMS0xLTQxMTMy_05158f8d-9051-4dee-a0f7-ddd62d1bf84d">28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i82251654ca3f4fc288f2fb5540302bd6_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTUtMS0xLTQxMTMy_76988381-bd88-4481-87f7-f8da2ec3b7c3">95,595</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7bd7edef27e34175800cc42062b7c736_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTctMS0xLTQxMTMy_248aa0df-91b3-4235-9747-62d020b5002c">14,641</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i15a951b1e5734b3997d7829d03437e38_I20211231" decimals="-3" sign="-" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTktMS0xLTQxMTMy_64226bcc-9902-47de-8513-0a49b676b5e9">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15a951b1e5734b3997d7829d03437e38_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTExLTEtMS00MTEzMg_790d4d91-d69e-4956-b67a-6cd8b1a50b9f">65</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i570ab8a66ef6484f8c4085965fb06999_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTEzLTEtMS00MTEzMg_8fe549fd-0263-4ba2-b696-e7bea99e47ec">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27c052df90b74bb0b3ea9126a1f86ca7_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTE1LTEtMS00MTEzMg_e8540a06-e672-480f-989d-054be63a8321">4,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTE3LTEtMS00MTEzMg_c73475fd-7d11-4ee1-a59f-b9c12268ae3d">114,244</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated and combined financial statements.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_151"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMtMS0xLTEtNDExMzI_2487b4be-f430-4095-9c2c-e5be96b7aabd">2,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMtMy0xLTEtNDExMzI_7fa6c6a8-1e8e-4858-9628-596d2ed75be8">15,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMtNS0xLTEtNDExMzI_8f6727c0-da7e-48ef-8eee-564a4d63e0ce">3,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzUtMS0xLTEtNDExMzI_9d4a6385-55cf-45ff-8970-660010bda38c">4,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzUtMy0xLTEtNDExMzI_b4221f29-c3c6-4b5c-a65e-ab478da512cf">4,675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzUtNS0xLTEtNDExMzI_a4aad377-576d-4c80-9c80-c2fd9296d13e">3,810</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Amortization of deferred financing fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzYtMS0xLTEtNDExMzI_be315652-d2c7-453a-bc94-83ab798c8b63">488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzYtMy0xLTEtNDExMzI_0bd88dd7-30be-40f3-8c42-aa3ad8a56afb">330</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzYtNS0xLTEtNDExMzI_c4e62913-cb58-40a7-ad12-63f4eb912153">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzctMS0xLTEtNDExMzI_a7c87888-f0d4-4085-b119-549e83fa8cb3">616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzctMy0xLTEtNDExMzI_d9d0f29f-dc58-4c12-b1e8-3836233d42eb">560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzctNS0xLTEtNDExMzI_78a05b57-2e36-414c-836a-b5076faeca91">858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzgtMS0xLTEtNDExMzI_dad76fd8-7e00-4992-a9a0-cafbd38e66af">10,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzgtMy0xLTEtNDExMzI_c85262bc-7469-4b62-864f-07e256993023">8,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzgtNS0xLTEtNDExMzI_2cb315c3-10f0-4214-b7cb-7f9ce6f09a11">3,382</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzktMS0xLTEtNDExMzI_92b7cf8d-3d2f-4eab-8de8-4f044b27da4d">1,752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzktMy0xLTEtNDExMzI_d75b7223-489e-4f8d-a8d8-cac9e05ed48f">2,201</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:DeferredIncomeTaxesAndTaxCredits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzktNS0xLTEtNDExMzI_cc469553-bbff-4901-95ff-2a15f3319107">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEwLTEtMS0xLTQxMTMy_f3079670-38f8-447b-b512-57dfeb5f87ae">2,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEwLTMtMS0xLTQxMTMy_201f5e92-451a-4567-9048-f199159b8a5a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEwLTUtMS0xLTQxMTMy_74c38bf5-043a-4e72-89f9-aa116859f2f1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEyLTEtMS0xLTQxMTMy_406d3570-8933-40fd-97a5-7ba9747b6a26">7,335</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEyLTMtMS0xLTQxMTMy_b47e1de7-5489-49fd-916f-6e94884e169e">15,712</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEyLTUtMS0xLTQxMTMy_e409b4b1-4c2e-430a-b285-3f9becce4566">8,571</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEzLTEtMS0xLTQxMTMy_f86be489-fbcc-469b-b2d2-f3ebf7156bdd">4,624</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEzLTMtMS0xLTQxMTMy_7212e6bc-1ae1-4f1a-9978-86cf369eebda">7,435</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEzLTUtMS0xLTQxMTMy_bda24793-ebad-4f9d-959d-a0ab8f54550b">2,746</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE0LTEtMS0xLTQxMTMy_b04eb67d-c4fe-4b9e-8691-95c3869ade4e">803</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE0LTMtMS0xLTQxMTMy_fb2f2271-6e88-4077-af45-56d99c37f2dd">2,068</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE0LTUtMS0xLTQxMTMy_dc5e1635-05e1-431b-9cec-567a56f85e91">1,861</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE1LTEtMS0xLTQxMTMy_50dfe5ad-7949-4893-99cf-8595ff19a4b8">562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE1LTMtMS0xLTQxMTMy_b9d7f9a6-75cf-476a-9d33-9d7c5bad110a">993</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE1LTUtMS0xLTQxMTMy_44cdf929-09f2-4978-8d75-ee6e5930194d">4,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued wages and related liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE2LTEtMS0xLTQxMTMy_ae9c8735-d385-47f9-8d88-573ed49bd9f6">3,864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE2LTMtMS0xLTQxMTMy_c37fb0f2-e84d-415c-bc60-111b77458bcf">10,538</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE2LTUtMS0xLTQxMTMy_30d1673f-fb98-4ed6-b30c-f0c25a12cbc7">3,376</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE3LTEtMS0xLTQxMTMy_d265ecff-ba12-4cee-a29f-33604a0ccb59">2,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE3LTMtMS0xLTQxMTMy_4f06560b-eee0-4da8-97ca-bb5be6f0a492">2,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE3LTUtMS0xLTQxMTMy_93bc6e4f-4eb2-47c9-8e2f-8a66ec8043e7">1,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Advance payments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE4LTEtMS0xLTQxMTMy_1d628997-de86-4a17-b73a-63566271647a">21,786</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE4LTMtMS0xLTQxMTMy_de48f714-172d-404e-9e7b-cca77ffee708">27,997</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInContractWithCustomerLiability" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE4LTUtMS0xLTQxMTMy_aa693868-a995-4310-8291-3fb6b9acad73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIwLTEtMS0xLTQxMTMy_deee0c7a-1faf-4ec5-8d59-7da9a11b3730">3,708</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIwLTMtMS0xLTQxMTMy_072697d9-c6ba-4cc4-af3f-ab29dad5147f">2,076</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIwLTUtMS0xLTQxMTMy_8b74d515-1eec-4e64-a6fc-830e17627c52">2,185</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash (used in) provided by operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIxLTEtMS0xLTQxMTMy_e663ef52-f51f-4b9a-b04a-8e725ecd1256">18,223</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIxLTMtMS0xLTQxMTMy_54fc15f0-0670-4da5-aa63-59f2102901e2">50,204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIxLTUtMS0xLTQxMTMy_81f42281-80f1-4c7e-8029-932d5354d8a1">9,554</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIzLTEtMS0xLTQxMTMy_1e6310fa-8164-4b47-989d-feaeafbc8f62">6,303</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIzLTMtMS0xLTQxMTMy_bdee4ba3-b37a-482f-bed5-acf5f46d5bd5">7,253</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIzLTUtMS0xLTQxMTMy_d6e8c0cb-a344-4db8-b195-5823539581a4">6,714</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash payments for business acquisitions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI0LTEtMS0xLTQxMTMy_a0f08f8f-7045-4020-bfda-0a014a10e5b1">13,550</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI0LTMtMS0xLTQxMTMy_4808cb1a-eea0-42b0-b06e-21261461e8f9">33,193</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToAcquireBusinessesGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI0LTUtMS0xLTQxMTMy_f3a05ddf-7789-4047-98f5-a63a6a34c3e9">18,760</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Escrow deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:PaymentsForDepositsOnAcquisition" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI4LTEtMS0xLTQxMTMy_347cb70e-593d-4aaa-8700-d68dfe7bfc87">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:PaymentsForDepositsOnAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI4LTMtMS0xLTQxMTMy_f3d6af3c-1092-4725-ad5a-7b2de0d948e7">525</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:PaymentsForDepositsOnAcquisition" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI4LTUtMS0xLTQxMTMy_1ca0c2ad-daa9-4c3e-8a0e-c36db8d011ac">1,400</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Restricted and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:PaymentsForProceedsFromPropertyReserveRequirements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI5LTEtMS0xLTQxMTMy_d0a3a990-c508-413f-95ce-f04cdf839c80">267</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:PaymentsForProceedsFromPropertyReserveRequirements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI5LTMtMS0xLTQxMTMy_554a4c48-fcc7-452c-b87b-06ba04a5733c">645</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" sign="-" name="pntg:PaymentsForProceedsFromPropertyReserveRequirements" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI5LTUtMS0xLTQxMTMy_299cda5d-062a-4c56-9735-72a8e76ee938">409</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMwLTEtMS0xLTQxMTMy_9105ebd9-f264-47c1-9ba4-c49c50f50a08">20,120</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMwLTMtMS0xLTQxMTMy_aa051ac2-8b19-4da2-8ec3-7d1d738ec69b">41,616</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMwLTUtMS0xLTQxMTMy_7838a7d4-1a54-4cf2-a093-bb5218f4219f">26,465</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from sale of subsidiary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:ProceedsFromSaleOfSubsidiaryShares" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMyLTEtMS0xLTQxMTMy_ea6e3c77-432d-4d32-9ad6-d26965512a72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:ProceedsFromSaleOfSubsidiaryShares" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMyLTMtMS0xLTQxMTMy_3f036f1c-a524-4b53-9825-89feee27ddd2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:ProceedsFromSaleOfSubsidiaryShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMyLTUtMS0xLTQxMTMy_2d562fea-bcc7-4309-87db-2254fd878b7e">2,293</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of subsidiary shares </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMzLTEtMS0xLTQxMTMy_c256a373-44ce-4481-9a90-a4db831900d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMzLTMtMS0xLTQxMTMy_559c1151-7f36-44c1-aaaa-003dcc831f5d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsToMinorityShareholders" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMzLTUtMS0xLTQxMTMy_14508522-8511-4d2f-9363-6749a5a312c2">2,687</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net investment from parent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:DistributionToFromParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM0LTEtMS0xLTQxMTMy_52c5c823-c056-4931-9d98-d48bdaaeb72e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:DistributionToFromParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM0LTMtMS0xLTQxMTMy_1d3aadb6-01bc-46ac-8798-869fbe9ad8f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:DistributionToFromParent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM0LTUtMS0xLTQxMTMy_99d39aa5-4ecc-4934-832c-22f0226ce10d">10,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash distribution to parent in connection with Spin-Off </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM1LTEtMS0xLTQxMTMy_2514da84-8897-4c33-8c86-faa239f379fc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM1LTMtMS0xLTQxMTMy_bb17a9dd-7260-47c4-9d81-6880751fcc4a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsOfDividends" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM1LTUtMS0xLTQxMTMy_60cd37fc-97a7-4840-862e-5bd4a1b42a4e">11,600</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sale of noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM2LTEtMS0xLTQxMTMy_60bf8ca1-ffcb-4bde-8526-74f9eeebfc29">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM2LTMtMS0xLTQxMTMy_ce87934e-c2f9-436d-97c6-166365ed1a0f">555</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromMinorityShareholders" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM2LTUtMS0xLTQxMTMy_6de89e9b-a13e-4af6-87fb-fbfb306d5fad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from revolver agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM3LTEtMS0xLTQxMTMy_26747c77-6a27-496c-88f2-7742f173455b">125,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM3LTMtMS0xLTQxMTMy_1bcf4ab0-0dc4-402e-afbe-39a14b567dd3">52,700</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM3LTUtMS0xLTQxMTMy_f44f3509-9467-4f5e-bccb-f16d18149adf">42,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments on revolver agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM4LTEtMS0xLTQxMTMy_1730beb3-7f93-40bc-9df4-4ba1b6cacebd">81,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM4LTMtMS0xLTQxMTMy_f1f6b66f-4ea6-448b-96f3-bbc6ef6eb5db">63,200</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:RepaymentsOfLongTermLinesOfCredit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM4LTUtMS0xLTQxMTMy_64f4cf41-d5a0-4548-ac18-45b9f13e4064">22,500</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repurchase of shares of common stock to satisfy tax withholding obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM5LTEtMS0xLTQxMTMy_9f35de7d-ae74-44af-a190-c9fca33e2de4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM5LTMtMS0xLTQxMTMy_50e5629a-8cf3-4e0d-b9de-4f1a1315435f">65</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM5LTUtMS0xLTQxMTMy_f21c8cc3-2618-492f-93c9-643a3a6eab57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Payments for deferred financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQwLTEtMS0xLTQxMTMy_9020a642-4fad-4e5a-918b-87dda7cfb4f5">1,394</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQwLTMtMS0xLTQxMTMy_fc596ed3-c9b0-4a5e-932b-9140341732d2">78</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:PaymentsOfFinancingCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQwLTUtMS0xLTQxMTMy_f629bd4a-00ec-43a7-a754-8c952213491a">1,552</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of common stock upon the exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQxLTEtMS0xLTQxMTMy_6bb53fb1-35a7-4104-be70-0866c6beb004">884</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQxLTMtMS0xLTQxMTMy_9eb68315-9a91-44be-a6fa-5e4e0a8b9b3c">1,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQxLTUtMS0xLTQxMTMy_a2a71e5a-b799-4748-9a73-26e696267735">30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQyLTEtMS0xLTQxMTMy_5aac9670-8457-4b2b-a6b6-3002ec766b79">43,490</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQyLTMtMS0xLTQxMTMy_31c65c78-29db-4a10-9c1b-9556a3c184c2">8,947</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQyLTUtMS0xLTQxMTMy_3c670ed8-a15d-43a0-ae36-eb49a8200470">17,272</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net increase (decrease) in cash </span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQzLTEtMS0xLTQxMTMy_32bfc112-76f8-4a07-8e9c-2a6ecdd51445">5,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQzLTMtMS0xLTQxMTMy_9e0ddf6c-c64c-41f2-b40f-d988f33a1802">359</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQzLTUtMS0xLTQxMTMy_4aab59df-efb6-4afb-b556-36bfd6ee537c">361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ0LTEtMS0xLTQxMTMy_7f6da96e-340c-472e-9c42-97d9ae0ae887">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ0LTMtMS0xLTQxMTMy_bc579cf5-d9d4-4bdb-9f29-b96cd765f629">402</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i855d825b738d453698699f3f7321df6f_I20181231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ0LTUtMS0xLTQxMTMy_4cee7181-1a87-48e3-a86d-0f8f90b013dc">41</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ1LTEtMS0xLTQxMTMy_7c787ced-4b18-45a8-9097-15187cfb0d73">5,190</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ1LTMtMS0xLTQxMTMy_d514ecfb-b101-486e-9d0d-647f149f2c76">43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ1LTUtMS0xLTQxMTMy_73a96cb6-e67e-4d8e-aca5-5c440af4eb84">402</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated and combined financial statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS - (Continued)</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In Thousands)</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.916%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash paid during the period for:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzQtMS0xLTEtNDExMzI_2c5b6e8c-992d-4e9d-843d-e8ed5a18b71d">1,448</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzQtMy0xLTEtNDExMzI_df2d8c6f-53bb-46af-9478-b4cf793c60b6">1,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzQtNS0xLTEtNDExMzI_138de62e-a930-4211-acb8-deaff422660b">156</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzUtMS0xLTEtNDExMzI_50c6577f-1bc3-4351-8cc0-dca00e3a024a">2,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaid" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzUtMy0xLTEtNDExMzI_e941da73-a125-4b21-a0f0-7b0001a36fd9">7,865</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzUtNS0xLTEtNDExMzI_6e298f58-8deb-466c-a437-f24ee3f4bf36">120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzYtMS0xLTEtNDExMzI_c2ad4fe2-19a2-4871-9abd-29222953ca2c">39,151</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzYtMy0xLTEtNDExMzI_df6bf801-d9d2-4c66-a6e2-e23ad083beff">35,853</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzYtNS0xLTEtNDExMzI_adbf164c-50b7-416c-b1d9-e962795331b8">37,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use assets obtained in exchange for new operating lease obligations</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzctMS0xLTEtNDExMzI_baddea6f-d4c5-4884-b7d7-ec32d49698dd">3,230</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzctMy0xLTEtNDExMzI_ce0261d3-49de-4d17-848f-d78fcc78ce00">5,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzctNS0xLTEtNDExMzI_e1e48aaf-f74d-420b-b41a-b105ef37d837">9,059</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net non-cash adjustment to right-of-use assets and lease liabilities from lease modifications</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzgtMS0xLTEtNDExMzI_89c8e65b-ce1b-4fa8-932c-f40a2e878d1f">4,674</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzgtMy0xLTEtNDExMzI_cd30ec4e-bf07-417c-84c3-beac29f40543">1,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzgtNS0xLTEtNDExMzI_6d8fcf3a-6968-44c1-866f-785db450c5a8">77,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash investing activity:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital expenditures in accounts payable</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzEwLTEtMS0xLTQxMTMy_ce771465-8ad2-4e17-a9e9-9febff972944">730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzEwLTMtMS0xLTQxMTMy_06744dc2-f8a5-44a3-833d-e8501e4de3b1">560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzEwLTUtMS0xLTQxMTMy_09ecff57-492c-426b-b574-c735dec41aba">946</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes to consolidated and combined financial statements.</span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_154"></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_157"></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span><br/></span></div><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP INC. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO THE CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS</span></div><div style="margin-bottom:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Dollars in thousands, except per share data and operational senior living units)</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">1. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:NatureOfOperations" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTcvZnJhZzpjYTViNzliMGIwOWU0NGQzYWVkYzgzZWIzNTEyMDc3Ny90ZXh0cmVnaW9uOmNhNWI3OWIwYjA5ZTQ0ZDNhZWRjODNlYjM1MTIwNzc3XzY1OTcwNjk3Njg3OTk_e709b170-0d74-44de-859e-271e50e6f343" continuedAt="i3c8e153efc6c4aceb435c1993e96a5fa" escape="true">DESCRIPTION OF BUSINESS</ix:nonNumeric></span></div><ix:continuation id="i3c8e153efc6c4aceb435c1993e96a5fa"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pennant Group, Inc. (herein referred to as &#8220;Pennant,&#8221; the &#8220;Company,&#8221; &#8220;it,&#8221; or &#8220;its&#8221;), is a holding company with no direct operating assets, employees or revenue. The Company, through its independent operating subsidiaries, provides healthcare services across the post-acute care continuum. As of December&#160;31, 2021, the Company&#8217;s subsidiaries operated <ix:nonFraction unitRef="agency" contextRef="ife1126ceed284fbdb9bf6b3dbab68da3_I20211231" decimals="INF" name="pntg:NumberOfServiceProviders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTcvZnJhZzpjYTViNzliMGIwOWU0NGQzYWVkYzgzZWIzNTEyMDc3Ny90ZXh0cmVnaW9uOmNhNWI3OWIwYjA5ZTQ0ZDNhZWRjODNlYjM1MTIwNzc3XzEwOTk1MTE2Mjk5MjI_601ff99b-7d5b-4095-bf9d-eab16d3843b7">88</ix:nonFraction> home health, hospice and home care agencies and <ix:nonFraction unitRef="agency" contextRef="icc510d566b5a497d8c3bf8da297c74be_I20211231" decimals="INF" name="pntg:NumberOfRealEstatePropertiesUnderLease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTcvZnJhZzpjYTViNzliMGIwOWU0NGQzYWVkYzgzZWIzNTEyMDc3Ny90ZXh0cmVnaW9uOmNhNWI3OWIwYjA5ZTQ0ZDNhZWRjODNlYjM1MTIwNzc3XzEwOTk1MTE2Mjk5MjY_b505169d-0edf-4364-965a-983f7df39456">54</ix:nonFraction> senior living communities located in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;1, 2019, The Ensign Group, Inc. (NASDAQ: ENSG) (&#8220;Ensign&#8221; or the &#8220;Parent&#8221;) completed the separation of Pennant from Ensign through a tax-free distribution of substantially all of Pennant&#8217;s issued and outstanding common stock to the stockholders of Ensign (the &#8220;Spin-Off&#8221;). To accomplish the Spin-Off, Ensign contributed the Company&#8217;s assets and liabilities into Pennant and each Ensign stockholder received a distribution of one share of Pennant common stock for every two shares of Ensign&#8217;s common stock, plus cash in lieu of fractional shares. Additionally, the noncontrolling interest was converted into shares of Pennant at the established conversion ratio. As a result of the Spin-Off on October&#160;1, 2019, Pennant began trading as an independent company on the NASDAQ under the symbol &#8220;PNTG.&#8221;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s subsidiaries, collectively referred to as the Service Center, provide accounting, payroll, human resources, information technology, legal, risk management, and other services to the operations through contractual relationships.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company&#8217;s affiliated operations are operated by separate, independent subsidiaries that have their own management, employees and assets. References herein to the consolidated &#8220;Company&#8221; and &#8220;its&#8221; assets and activities is not meant to imply, nor should it be construed as meaning, that Pennant has direct operating assets, employees or revenue, or that any of the subsidiaries, are operated by Pennant.</span></div></ix:continuation><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_163"></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">2. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzY1OTcwNjk3OTI2MTk_8d45be69-8ae1-425b-8c0c-13af9c666bd1" continuedAt="i9c889a6b3d6544ed8b9287caa5fc4b46" escape="true">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i9c889a6b3d6544ed8b9287caa5fc4b46" continuedAt="i38b82351d3394d9884d273ae71eeee60"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzY1OTcwNjk3OTI2MjE_bfce2fdd-8baf-4dae-b7ca-d29383e01733" continuedAt="i37e69315d8e1463d961ebbf97024e01f" escape="true">Basis of Presentation - </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i37e69315d8e1463d961ebbf97024e01f">The accompanying consolidated and combined financial statements of the Company (the &#8220;Financial Statements&#8221;) reflect the Company&#8217;s financial position for the years ended December 31, 2021 and 2020, and the Company&#8217;s results of operations and cash flows for the years ended December 31, 2021, 2020 and 2019 and have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and pursuant to the regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Prior to the Spin-Off, the combined financial statements were prepared on a stand-alone basis and derived from the consolidated financial statements and accounting records of Ensign. Management believes that the Financial Statements reflect, in all material respects, all adjustments which are of a normal and recurring nature necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows for the periods presented in conformity with GAAP applicable to the annual period.</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MDU_bd4b2f64-398c-4713-9975-3c91d66acdff" continuedAt="icb2cb18de2724e4199502ea79f800c41" escape="true">All intercompany transactions and balances between the various legal entities comprising the Company have been eliminated in consolidation. The consolidated and combined statements of income reflect income that is attributable to the Company and the noncontrolling interest. </ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="icb2cb18de2724e4199502ea79f800c41">The Company consists of various limited liability companies and corporations established to operate home health, hospice, home care, and senior living operations. The Financial Statements include the accounts of all entities controlled by the Company through its ownership of a majority voting interest. Revenue was derived from transactional information specific to the Company&#8217;s services provided. The costs in the consolidated and combined statements of income reflect direct costs and allocated costs prior to the Spin-Off.</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzY1OTcwNjk3OTI2MjM_eba6e6f8-091a-4df9-bfcb-9df6c554c562" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimates and Assumptions -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Financial Statements relate to self-insurance reserves, revenue, cost allocations from prior to the Spin-Off, intangible assets and goodwill, right-of-use assets and lease liabilities for leases greater than 12 months, and income taxes. Actual results could differ from those estimates.</span></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i38b82351d3394d9884d273ae71eeee60" continuedAt="i152fd9c16de0441791a55cca2fdfc674"><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYwNDczMTM5Nzg3Mzc_2c05185d-3897-4790-81af-f4dc3dfa6477" continuedAt="ib04d312a06334541a7a7540093a102ac" escape="true">Revenue Recognition -</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib04d312a06334541a7a7540093a102ac"> Revenues are recognized when services are provided to the patients at the amount that reflects the consideration to which the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rate, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration which is included in the transaction price may be constrained, and is included in the net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#8217;s estimates, the Company adjusts these estimates, which would effect net service revenue in the period such variances become known.</ix:continuation> </span></div><div style="text-align:justify;text-indent:40.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company&#8217;s contracts have an original duration of one year or less, the Company uses the practical expedient applicable to its contracts and does not consider the time value of money. Further, because of the short duration of these contracts, the Company has not disclosed the transaction price for the remaining performance obligations as of the end of each reporting period or when the Company expects to recognize this revenue. In addition, the Company has applied the practical expedient provided by ASC 340, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 340&#8221;), and all incremental customer contract acquisition costs are expensed as they are incurred because the amortization period would have been one year or less. See Note 5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Revenue and Accounts Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:40.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CARES Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the United States. During the second quarter of 2020 the Company applied for and received $<ix:nonFraction unitRef="usd" contextRef="ia2439a6130274330bd9bb469dbc05ee6_I20200630" decimals="-3" name="pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzQxOTA_1f345d88-f75e-4030-bb38-803a456dc7fa">27,997</ix:nonFraction> in funds under the Accelerated and Advance Payment (&#8220;AAP&#8221;) Program. For the year ended December 31, 2021, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NTQwMjI_635112fa-0aaf-42cd-a654-b88307ec0aea">21,786</ix:nonFraction> of the AAP funds, with the remaining balance of $<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE3NTkyMTg2MDgyMTMw_0662b208-4cfe-49f3-8ae3-eac63f7d02c3">6,211</ix:nonFraction> recorded in other accrued liabilities on the consolidated balance sheets. The CARES Act allowed for deferred payment of the employer-paid portion of social security taxes through the end of 2020, with approximately 50% due on December 31, 2021 and the remainder due on December 31, 2022. The Company deferred approximately $<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:AccruedPayrollTaxesEmployerPortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NjIyMTI_53d55eed-9795-4e1f-8eac-84cdd5361a2e">7,836</ix:nonFraction> of employer-paid portion of social security tax. In the fourth quarter of the current year, we repaid $<ix:nonFraction unitRef="usd" contextRef="i8a7e4cc4f1ef44e18318557df8f16b2c_I20211231" decimals="-3" name="pntg:AccruedPayrollTaxesEmployerPortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NjIzMTc_01bc3621-a922-4192-8d93-085720bbf45c">3,707</ix:nonFraction> and approximately $<ix:nonFraction unitRef="usd" contextRef="iae5c52d50c06400983c31c67aa43fc0a_I20211231" decimals="-3" name="pntg:AccruedPayrollTaxesEmployerPortion" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NjIzMzk_748f85a8-053b-4378-9b65-f3b79e07cf69">4,129</ix:nonFraction> of the balance remains deferred and is recorded in accrued wages and related liabilities. The CARES Act temporarily suspended the 2% sequestration payment adjustment on Medicare fee-for-service payment beginning May 1, 2020 and was extended through December 31, 2021. The Company recognized $<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:AmountToOffsetExpenseSequestrationRelief" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NTQ2MTE_1359af9d-2db3-4e53-9ca4-4ef48a840267">3,555</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:DirectMedicalSuppliesLaborAndOtherExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NTQ2MTk_707aed0d-742b-44a4-b65a-85ab1050c4bf">2,765</ix:nonFraction> in revenue related to the suspension of sequestration for the years ended December 31, 2021 and 2020, respectively, exclusive of our start-up operations. The Company will continue to assess the effect of the CARES Act and ongoing other government legislation related to the COVID-19 pandemic that may be issued.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MDY_c72fd71e-8cf1-4bb1-93b3-4340608474de" continuedAt="i440f644d3cd24d17aad3a578a1caab0c" escape="true">Cash </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i440f644d3cd24d17aad3a578a1caab0c">- Cash consists of petty cash and bank deposits and therefore approximates fair value. The Company places its cash with high credit quality financial institutions.</ix:continuation> </span></div><div style="text-align:justify;text-indent:40.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MDc_7899d13d-f07c-4f86-8b4e-2425b7107423" continuedAt="id41cdccd5deb47f39a52730da22bdab6" escape="true">Accounts Receivable and Allowance for Doubtful Accounts -</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id41cdccd5deb47f39a52730da22bdab6"> Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration. The allowance for doubtful accounts is the Company&#8217;s best estimate of current expected credit losses in the accounts receivable balance.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MDg_5d7c66f7-acf6-4019-b1f9-63a4c2a62ad8" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property and equipment are initially recorded at their historical cost. Repairs and maintenance are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYxNzc_c179bcbb-5edd-46f8-ac7b-9c974960a03d">three</span> to <ix:nonNumeric contextRef="i6001b46500b947f08cda938279f351a0_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYxODM_5638e00d-a0a6-4d43-ac06-f799ad493045">15</ix:nonNumeric> years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term.</span></ix:nonNumeric></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MDk_4f0a2994-401e-46dd-ab3c-c693f0d58629" continuedAt="i445a0b67c4aa46969a22ea5561cc8865" escape="true">Impairment of Long-Lived Assets -</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i445a0b67c4aa46969a22ea5561cc8865"> The Company reviews the carrying value of long-lived assets that are held and used in the independent operating subsidiaries for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is determined based upon expected undiscounted future net cash flows from the operating subsidiary to which the assets relate, utilizing management&#8217;s best estimate, appropriate assumptions, and projections at the time. If the carrying value is determined to be unrecoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair value of the asset. The Company estimates the fair value of assets based on the estimated future discounted cash flows of the asset. For the year ended December 31, 2021,</ix:continuation> management evaluated its long-lived assets and the Company identified $<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NTQ3NzQ_13712c5c-8ce4-4314-89b3-11e6ff0f9a9b">2,835</ix:nonFraction> in long-lived asset impairment related to <ix:nonFraction unitRef="community" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="INF" name="pntg:ImpairmentLongLivedAssetsNumberOfCommunities" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzI3NDg3NzkxMDg0MDE_9f6e8963-f3cc-4740-869d-32224c190a19">six</ix:nonFraction> senior living communities. Management did not identify any </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i152fd9c16de0441791a55cca2fdfc674" continuedAt="id9be76ff7b984dccba631538d4168b2e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">asset impairment during the years ended December 31, 2020 and 2019. See further discussion at Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment, Net.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTA_5cead5fd-198b-46dd-a552-69b317dfd8a5" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets and Goodwill -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s indefinite-lived intangible assets consist of trade names and Medicare and Medicaid licenses. The Company tests indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable. The Company did not identify any indefinite-lived intangible asset impairment during the years ended December 31, 2021, 2020 and 2019.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations.  Goodwill is subject to annual test for impairment as of the beginning of the fourth quarter or more frequently if events or changes indicate that the Company's goodwill might be impaired. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then it is required to perform a quantitative impairment test by comparing the fair value with the carrying amount of the reporting unit. If the carrying amount of a reporting unit exceeds its fair value, then the Company records an impairment of goodwill equal to the amount that the carrying amount of a reporting unit exceeds its fair value.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we evaluated potential triggering events that might be indicators that our goodwill and indefinite lived intangibles were impaired. As a result of our evaluation, <ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="INF" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzkyNDg_4c56f075-93c1-4a94-a194-334bf30c8eda"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="INF" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzkyNDg_d6c249f6-17c1-4e7b-8b3d-d1e413a6391d"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="INF" name="us-gaap:GoodwillAndIntangibleAssetImpairment" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzkyNDg_f2f9959f-94d0-4679-b36b-d8d6c4ff5109">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> goodwill or indefinite intangible asset impairments were recorded during the years ended December 31, 2021, 2020 and 2019. See further discussion at Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, Net.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Self-Insurance Reserve -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company retains risk for a substantial portion of potential claims for general and professional liability and workers&#8217; compensation. Beginning on January 1, 2022 the Company transitioned its employee health plans to a self insurance model.  Prior to that date the Company did not retain risk related to its employee health plans.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company recognizes obligations associated with these costs, up to specified deductible limits in the period in which a claim is incurred, including with respect to both reported claims and claims incurred but not reported. The Company evaluates the adequacy of the self insurance reserves in conjunction with an independent actuarial assessment.As of December 31, 2021 the general and professional liability insurance has a retention limit of $<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzk5Mjc_41c5c0b5-65ad-44f4-9639-237a217f0690">150</ix:nonFraction> per claim with a $<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:CorridorAsAnAdditionalOutOfPocketRetention" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzk5NDc_cf0eed6c-5c9c-4c78-a5f9-9929367588c5">500</ix:nonFraction> corridor as an additional out-of-pocket retention we must satisfy for claims within the policy year before the carrier will reimburse losses. The workers&#8217; compensation insurance has a retention limit of $<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:WorkersCompensationInsuranceRetentionLimitPerClaim" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwMTUz_e0c28152-90f7-41c9-a261-b1276bcd3a7d">250</ix:nonFraction> per claim, except for policies held in Texas and Washington which are subject to state insurance and possess their own limits. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These costs have generally been estimated based on historical data of our claims experience. Such estimates, and the resulting reserves, are reviewed and updated by us on a quarterly basis. Additionally, the Company has partially indemnified Ensign for general and professional liabilities incurred prior to the Spin-off but not reported until after that date and included that amount in its accrual below.     </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="pntg:SummaryOfInsuranceLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYwNDczMTM5Nzg3NDA_98c666e3-d92b-4673-ba22-666d785d5b8c" continuedAt="i35209a69bd104ff896ee8f967bc42fd0" escape="true">The following table presents details of the Company's insurance programs, including amounts accrued for the periods indicated in other accrued liabilities and other long-term liabilities in our accompanying balance sheets. The amounts accrued below represent the total estimated liability for individual claims that are less than our noted insurance coverage amounts, which includes outstanding claims and claims incurred but not reported. The amounts are reported gross of reinsurance receivable of $<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzExMTk5_5b9e00fc-e520-41a0-96c3-a2af8edb1628">927</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzExMjA2_f48947fd-f9c8-4e2c-bfd8-d7c770e7ce18">704</ix:nonFraction> included in restricted and other assets for the years ended December 31, 2021 and 2020, respectively.   </ix:nonNumeric></span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="id9be76ff7b984dccba631538d4168b2e" continuedAt="i647fb88f71ba44f08addb56a2314dfd0"><div style="text-align:center"><ix:continuation id="i35209a69bd104ff896ee8f967bc42fd0"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:62.710%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.625%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.538%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.627%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of Insurance</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and professional liability  </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:GeneralAndProfessionalInsuranceLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzMtMS0xLTEtNDExMzI_745f694c-ac2d-4a6d-b8d8-4db6ed1d3e8d">2,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="pntg:GeneralAndProfessionalInsuranceLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzMtMy0xLTEtNDExMzI_79c7f717-5797-4682-8304-a4f353d62c1e">1,063</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers&#8217; compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzQtMS0xLTEtNDExMzI_9dd7c196-d906-409a-a0a3-6bdc7ead7852">4,899</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzQtMy0xLTEtNDExMzI_4f8135c2-3dc0-4e90-9049-1bdcfec61213">2,783</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated liability</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:InsuranceProgramAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzUtMS0xLTEtNDExMzI_421a6fde-e73f-455b-8db7-0f8a9686d050">6,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="pntg:InsuranceProgramAccruedExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzUtMy0xLTEtNDExMzI_43f6bdfe-78b7-448d-89f5-2113cf8bb6fe">3,846</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: long-term portion, included in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:InsuranceProgramAccruedExpensesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzYtMS0xLTEtNDExMzI_c6ba15af-b9f2-4e25-96a1-4761aa07d2ee">5,293</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="pntg:InsuranceProgramAccruedExpensesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzYtMy0xLTEtNDExMzI_ccfd6c61-ed24-4126-8603-69edf27e995c">2,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of estimated liability, included in other accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:InsuranceProgramAccruedExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzctMS0xLTEtNDExMzI_35c9e9d8-d3bd-4de2-929e-d9351b5cd20c">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="pntg:InsuranceProgramAccruedExpensesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzctMy0xLTEtNDExMzI_0338fbb2-61f5-4346-9ef7-e5da840ebd50">1,354</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTE_6393c67f-18bb-4ebf-a17f-4bdab0afe68b" continuedAt="i0d3bb1cd9a8341c3b1d3d9034e065e1c" escape="true">Fair Value of Financial Instruments - </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i0d3bb1cd9a8341c3b1d3d9034e065e1c">The Company&#8217;s financial instruments consist principally of cash, accounts receivable, accounts payable, accrued liabilities, and debt. The Company believes all of the financial instruments&#8217; recorded values approximate fair values because of their nature or respective short durations. The Company determines fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted market prices in active markets; Level 2, defined as inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.</ix:continuation> </span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTI_ec83d95e-9ad7-4bb0-bb03-4cb261ba6ece" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Deferred tax assets and liabilities are established for temporary differences between the financial reporting basis and the tax basis of the Company&#8217;s assets and liabilities at tax rates in effect when such temporary differences are expected to reverse. The Company generally expects to fully utilize its deferred tax assets; however, when necessary, the Company records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the need for a valuation allowance or the need for and magnitude of liabilities for uncertain tax positions, the Company makes certain estimates and assumptions. These estimates and assumptions are based on, among other things, knowledge of operations, markets, historical trends and likely future changes and, when appropriate, the opinions of advisors with knowledge and expertise in certain fields. Due to certain risks associated with the Company&#8217;s estimates and assumptions, actual results could differ.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTM_33a84427-12ba-4f65-8037-a927705cc114" continuedAt="i2dbfdc3844084c0b83d22e8b470d9465" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The noncontrolling interest in a subsidiary is initially recognized at estimated fair value on the acquisition date and is presented within total equity in the Company's consolidated balance sheets. The Company presents the noncontrolling interest and the amount of consolidated net income/ (loss) attributable to The Pennant Group, Inc. in its consolidated and combined statements of income.  Net income per share is calculated based on net income/ (loss) attributable to The Pennant Group, Inc.'s stockholders. The carrying amount of the noncontrolling interest is adjusted based on an allocation of subsidiary earnings based on ownership interest.</span></ix:nonNumeric></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all share-based payment awards, including employee stock options and restricted stock, made to employees and Pennant&#8217;s directors based on estimated fair values, ratably over the requisite service period of the award. The Company accounts for forfeitures as they occur. Net income has been reduced as a result of the recognition of the fair value of all stock options and restricted stock awards issued, the amount of which is contingent upon the number of future grants and other variables. The total amount of share-based compensation was $<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NDYy_f598669c-9b49-4d86-8a99-f12e720f9d8d">10,040</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NDY2_4d7c7dfb-83f4-4435-bca1-8ad83a1e5c3e">8,335</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NDc0_a6ef13cd-bb4f-4439-9090-b7ad3bf6b0cc">3,382</ix:nonFraction> for the years ended December 31, 2021, 2020 and 2019, respectively, of which $<ix:nonFraction unitRef="usd" contextRef="i0e8f395592e742f3ba6c06ba1409606c_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NTEy_9df57335-0707-4d38-b922-74e496aabba9">7,964</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i743dd5e050c24c6f903e2cd1bc39b900_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NTE2_1c98b93d-445c-466f-b20b-10d402cb9046">7,222</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib4445accb5d94db3851353dbfa2ed4f3_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NTIz_a7c27176-0d7c-4505-8be3-9717e33dd7e9">2,769</ix:nonFraction>, respectively, was recorded in general and administrative expense, with the difference being recorded in cost of services. For further discussion see Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Options and Awards.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MzMwMzQ_beba2b37-682a-45a8-a6d0-26078198e0cd" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- In connection with the Spin-Off, shares of existing equity awards were replaced with shares under the new Pennant awards and are reflected in basic and diluted net income per share for the years ended December 31, 2021, 2020 and 2019, respectively. For further discussion see Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Computation of Net Income Per Common Share</span></ix:nonNumeric></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prior to Spin-Off</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Financial Statements include allocations of costs for certain shared services provided to the Company by Ensign subsidiaries prior to the Spin-Off on October&#160;1, 2019. Such allocations include, but are not limited to, executive management, accounting, human resources, information technology, compliance, legal, payroll, insurance, tax, </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i647fb88f71ba44f08addb56a2314dfd0" continuedAt="ic3559636d4164a0cbd9e7c21243684ba"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treasury, and other general and administrative items. These costs were allocated to the Company on a basis of revenue, location, employee count, or other measures. These cost allocations are reflected within general and administrative expense in the consolidated and combined statements of income for the year ended December 31, 2019, including for share-based compensation expenses disclosed in Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Options and Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amount of general and administrative costs allocated from January 1, 2019 to October&#160;1, 2019, the date of the Spin-Off, inclusive of share-based compensation expense, was $<ix:nonFraction unitRef="usd" contextRef="i8ffd18948f6c4a1e9cdee019c70baf5e_D20190101-20191001" decimals="-3" name="us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE1NTY0_905b13f0-5cc5-4ee5-997a-572bc4522e93">23,710</ix:nonFraction>. Management believes the basis on which the expenses were allocated to be a reasonable reflection of the services provided to the Company during the periods. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Prior to the Spin-Off Ensign was partially self-insured for healthcare, general and professional liability, and workers&#8217; compensation, and historically allocated premium expense to all subsidiaries of Ensign in its accounting records. To reflect all of the insurance costs, quarterly actuary determined adjustments were allocated to the Company based on the proportional historical premium expense. No self-insurance accruals were allocated to the Company as these accruals represent the obligations of Ensign. In connection with the Spin-Off, the Company purchased insurance through a third-party to replace the coverage provided by Ensign&#8217;s self-insured policies.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Ensign&#8217;s external debt and related interest expense were not allocated to the Company for any of the periods presented as no portion of the borrowings were assumed by the Company as part of the Spin-Off. All interest incurred by the Company was subsequent to the Spin-Off.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Prior to the date of the Spin-off, the Company&#8217;s operations have been included in Ensign&#8217;s U.S. federal and state income tax returns and all income taxes have been paid by subsidiaries of Ensign. Also prior to the date of the Spin-off, income tax expense and other income tax related information contained in these Financial Statements were presented using a separate tax return approach. Under this approach, the provision for income taxes represents income tax paid or payable for the current year plus the change in deferred taxes during the year calculated as if the Company was a stand-alone taxpayer filing hypothetical income tax returns. Management believes that the assumptions and estimates used to determine these tax amounts are reasonable. However, the Company&#8217;s Financial Statements may not necessarily reflect its income tax expense or tax payments in the future, or what tax amounts would have been if the Company had been a stand-alone company for the entire period presented.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="pntg:InvestedCapitalPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTQ_8b7a061c-2e0e-4a13-bce4-c2e5316f1ff1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Invested Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The net parent investment on the consolidated and combined statement of stockholders equity and statement of cash flows represents Ensign&#8217;s historical investment in the Company, the net effect of transactions with, and allocations from, Ensign and the Company&#8217;s accumulated earnings. Invested capital was reclassified into additional paid-in-capital at the date of the Spin-Off.</span></ix:nonNumeric></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="i2dbfdc3844084c0b83d22e8b470d9465" continuedAt="i54c233ac11fe4b2299ff8c0deacccec5"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Prior to the Spin-Off, the Company presented the noncontrolling interest and the amount of consolidated net income/ (loss) attributable to the Company in its Financial Statements. The carrying amount of the noncontrolling interest was adjusted by an allocation of subsidiary earnings based on ownership interest prior to the Spin-Off. The noncontrolling subsidiary interest included in the Financial Statements was converted into common shares of Pennant concurrent with the distribution to Ensign stockholders at the date of the Spin-Off and thus, does not receive an allocated portion of earnings</span></ix:continuation><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i54c233ac11fe4b2299ff8c0deacccec5">.</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYwNDczMTM5Nzg3NTM_eafed810-0a64-45dd-999f-af1ef34e989f" continuedAt="i35147954bac84e1a8b4fc3a0b05e8b20" escape="true">Share-based compensation</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i35147954bac84e1a8b4fc3a0b05e8b20"> - Prior to the Spin-Off, employees of the Company&#8217;s subsidiaries participated in Ensign&#8217;s equity-based incentive plans (the &#8220;Ensign Plans&#8221;) and the Cornerstone Subsidiary Equity plan (the &#8220;Subsidiary Equity Plan&#8221;). Share-based compensation includes the expense attributable to employees of the Company&#8217;s subsidiaries who participated in the Ensign Plans, as well as the allocated cost related to Ensign subsidiaries&#8217; employees that participated in the Ensign Plans. Share-based compensation related to Ensign subsidiaries&#8217; employees that participated in the Ensign Plans were allocated on the basis of revenue. All share-based compensation related to the Subsidiary Equity Plan was recognized in the Financial Statements and, therefore, no cost allocation was necessary.</ix:continuation> </span></div><div style="text-align:justify;text-indent:40.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Spin-Off, share-based compensation costs associated with the Subsidiary Equity Plan awards was initially measured at fair value at the grant date and was expensed as non-cash compensation over the vesting term.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, these awards were granted once per year. The fair value has been determined by an independent valuation of the subsidiary shares. The valuation incorporated a discounted cash flow analysis combined with a market-based approach to determine the fair value of the subsidiary equity. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTU_ce914135-e8b7-4360-b9f2-fd39a85f1abb" continuedAt="icee96aeeb35f4c9399b07df1cc7ba21d" escape="true">Recent Accounting Standards Adopted by the Company</ix:nonNumeric></span></div></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic3559636d4164a0cbd9e7c21243684ba" continuedAt="ie2d04d69001d4dd49962de5ed756e1a6"><ix:continuation id="icee96aeeb35f4c9399b07df1cc7ba21d" continuedAt="i203c0af42d194ee5850e5426db485b61">Except for rules and interpretive releases of the SEC under authority of federal securities laws and a limited number of grandfathered standards, the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. For any new pronouncements, the Company considers whether the new pronouncements could alter previous generally accepted accounting principles and determines whether any new or modified principles will have a material impact on the Company&#8217;s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company&#8217;s financial management and certain standards are under consideration.</ix:continuation></ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"><ix:continuation id="ie2d04d69001d4dd49962de5ed756e1a6" continuedAt="id7ce915d6f5649f39729ee200d76660c"><ix:continuation id="i203c0af42d194ee5850e5426db485b61" continuedAt="i989e378fe50945599934487174b343f4">FASB Accounting Standards Update, or ASU, ASU 2021-01 &#8220;Reference Rate Reform (Topic 848): Scope&#8221; or ASU 2020-4 - </ix:continuation></ix:continuation></span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id7ce915d6f5649f39729ee200d76660c"><ix:continuation id="i989e378fe50945599934487174b343f4">On January 7, 2021, the FASB issued ASU 2021-01 to amend the scope of  the guidance in ASU 2020-04 &#8220;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&#8221; or ASU 2020-4. Specifically, the amendments in ASU 2021-01 clarify that &#8220;certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition.&#8221;  The amendment in ASU 2021-1 is available to all entities: (i) on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 through the date that the final update to the standard was issued or (ii) on a prospective basis for new contract modifications through December 31, 2022.  The Company has adopted ASU 2021-01 on a prospective basis effective as of January 7, 2021.  There was no material impact to the Company&#8217;s Consolidated and Combined Financial Statements or related disclosures as a result of the adoption of ASU 2021-01.</ix:continuation></ix:continuation>    </span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_166"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">3. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzYwNDczMTM5NTUwMzE_65214932-54b1-4053-8050-ddfe6e272279" continuedAt="i2d4cbf10d01e4d70b01ec1e0a0a09ee9" escape="true">RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT</ix:nonNumeric></span></div><ix:continuation id="i2d4cbf10d01e4d70b01ec1e0a0a09ee9"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Spin-Off, our businesses were included as subsidiaries of Ensign. As a result, our transactions were considered related party transactions. On October&#160;1, 2019, in connection with the Spin-Off, Pennant entered into several agreements with Ensign that set forth the principal actions taken or to be taken in connection with the Spin-Off and govern the relationship of the parties following the Spin-Off. On October 1, 2021 the company concluded its Transition Services Agreement with Ensign.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred $<ix:nonFraction unitRef="usd" contextRef="ia1fcf346d3fa483083f350885e86c53f_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzEwOTk1MTE2MzExMjI_aa019e11-8765-42c6-a33f-668f0e9c4567">3,124</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i4727a9c1e3f3474da652ab9778b0c723_D20200101-20201231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzEwOTk1MTE2MzExMzA_043e6f02-7061-459c-914f-41156cfd017a">5,536</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i6798f615dd65498b96c25d713d9ea243_D20190101-20191231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzEwOTk1MTE2MzMxOTI_a8155aef-bace-4f7f-8058-9322fc6db4ca">2,982</ix:nonFraction> in costs related to the Transitions Services Agreement for the years ended December 31, 2021, 2020 and 2019, respectively. Additionally, the Company has recognized $<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzEwOTk1MTE2MzEyNTc_58726000-dcb3-4089-8630-9662df3b9814">208</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzEwOTk1MTE2MzEyNjU_93b4ddd4-a218-4954-a050-e62661f5f4ad">578</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:RelatedPartyTransactionAmountsOfTransaction" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzc2OTY1ODE0MDA1MTg_97aaa47a-7d37-40ea-8245-4b99aa73e7a7">291</ix:nonFraction> in tax benefits related to the Tax Matters Agreement for the years ended December 31, 2021, 2020 and 2019, respectively, and has recorded a payable to Ensign in connection with any unpaid portion of these amounts.  See &#8220;Certain Relationships and Related Party Transactions&#8212;Agreements with Ensign Related to the Spin-Off,&#8221; contained within the Information Statement as well as the Form 8-K filed with the SEC on October 3, 2019 for further discussion of the agreements entered into in connection with the Spin-Off.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases <ix:nonFraction unitRef="property" contextRef="i69f3d63932564edfa50a96879cf88c45_I20211231" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzI0Mw_b5902798-34f4-4cc2-868f-c1388c67b28f">32</ix:nonFraction> of its senior living communities from subsidiaries of Ensign, each of the leases have a term of between <ix:nonNumeric contextRef="i8539c32fc47d41f7855d6538692f738d_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzM1MA_b54d788a-0a57-492f-85d9-904fdebfa608">14</ix:nonNumeric> and <ix:nonNumeric contextRef="ice5e4b95ef8a477bb882b9b591fb511b_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzM1Nw_68f757fa-c9ca-4af9-9158-eb327701158e">20</ix:nonNumeric> years from the lease commencement date. The total amount of rent expense included in Rent - cost of services paid to subsidiaries of Ensign was $<ix:nonFraction unitRef="usd" contextRef="i9faefefa7c85403d9d9fba65201c913a_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzUwNA_c13ea755-5485-4e52-94b7-9e717caf0662">12,773</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i71dbacd7819b435d8e92bd5a906d4011_D20200101-20201231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzUwOA_73d1e33e-23f8-42f8-86a6-1bd568517f34">12,536</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i1429b5ff57464841a7fd199281d35777_D20190101-20191231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzUxNg_0aa80167-71e2-4872-b66f-0d3d0c600c0f">11,292</ix:nonFraction> for the years ended December 31, 2021, 2020 and 2019, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain related party activity occurred as the Company&#8217;s subsidiaries received services from Ensign&#8217;s subsidiaries. Services included in cost of services were $<ix:nonFraction unitRef="usd" contextRef="i815557615f93465196531049671aa210_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzcwNg_9276273b-7548-4f2a-9aeb-bc84fcbcd9ff">3,084</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i7fc9e1d6963b4b9eb991007f35b632c0_D20200101-20201231" decimals="-3" name="us-gaap:RelatedPartyCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzcxMA_097ce710-bde0-4b65-b057-ebf7b0f640f4">4,205</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i06cec63574054d8fb69e409cc0711e6f_D20190101-20191231" decimals="-3" name="us-gaap:RelatedPartyCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzcxOA_0f813273-f4bf-4a6c-ba0d-d0a9c8462f60">3,166</ix:nonFraction> for the years ended December 31, 2021, 2020 and 2019, respectively.</span></div></ix:continuation><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_169"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">4. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90ZXh0cmVnaW9uOmJlZTk4N2ZjZTgxYjQzYWRhMmU5YmNhNGMzNWJlOTQxXzYwNDczMTM5NTM2MDA_c049d785-116a-4e54-b855-b8b4ee83e84c" continuedAt="ia908207c48aa49788a18a776386e9966" escape="true">COMPUTATION OF NET INCOME PER COMMON SHARE</ix:nonNumeric></span></div><ix:continuation id="ia908207c48aa49788a18a776386e9966" continuedAt="ibc0f5d28190a45f0a9c5bca99d9c371f"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share is computed by dividing net income attributable to stockholders of the Company by the weighted average number of outstanding common shares for the period. The computation of diluted net income per share is similar to the computation of basic net income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prior to Spin-Off</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to the noncontrolling interest has been included in the numerator for the year ended December 31, 2019, as the non-controlling subsidiary interest that existed prior to the Spin-Off was converted into common shares of Pennant concurrent with the distribution to Ensign stockholders at the date of the Spin-Off</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.   </span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ibc0f5d28190a45f0a9c5bca99d9c371f"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90ZXh0cmVnaW9uOmJlZTk4N2ZjZTgxYjQzYWRhMmU5YmNhNGMzNWJlOTQxXzYwNDczMTM5NTM2MDE_bdff9498-0c71-4590-a6eb-742d1e2a0e2f" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods presented: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.402%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.699%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzMtMS0xLTEtNDI2NzY_7c1b9c50-ac2f-4f4a-b2a2-86947998a373">2,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzMtMy0xLTEtNDI2Nzg_03496fdc-a41e-4c6d-8c3c-f143f277cfb6">15,553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:ProfitLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzMtNS0xLTEtNDExMzI_4f2878c2-7f96-4edb-8253-9aa0476a0872">3,175</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: net (loss)/ income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzQtMS0xLTEtNDI2NzY_75463315-5e3f-4dc8-939e-7212f88d3842">548</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzQtMy0xLTEtNDI2Nzg_6e3097ae-1f88-4c83-bf83-1347f295d269">191</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzQtNS0xLTEtNDExMzI_ce94f3ee-7bf2-4622-aded-cf8d712240d1">629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to The Pennant Group, Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzUtMS0xLTEtNDI2NzY_72a727f0-1a13-40ca-b14a-1849c36bd05d">2,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzUtMy0xLTEtNDI2Nzg_2b45c221-f8a3-4968-a4dd-245ed36e6a39">15,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzUtNS0xLTEtNDExMzI_91267dc0-864b-47f8-a1d4-446d380a4e48">2,546</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic net income per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzgtMS0xLTEtNDExMzI_8e8fab6b-d7a8-4c1d-8064-ff4a62087a50">28,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzgtMy0xLTEtNDExMzI_c9dcac25-0b57-4799-b22c-c6589a4aa9aa">28,029</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzgtNS0xLTEtNDExMzI_49d7c347-2cc6-47af-9201-e3b08251d269">27,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: incremental shares from assumed conversion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzktMS0xLTEtNDExMzI_20550180-16d4-445f-acc9-7552c367c907">2,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzktMy0xLTEtNDExMzI_f1dbf461-cdbd-47ac-9ef0-d093cba159ef">2,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzktNS0xLTEtNDExMzI_ec453422-304c-4e8f-ba97-d1c458156cb7">1,748</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted weighted average common shares outstanding for diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEwLTEtMS0xLTQxMTMy_d304f6b4-2d06-4fb7-8c25-4dc094a42b05">30,642</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEwLTMtMS0xLTQxMTMy_a9103dd5-f789-44c2-8308-593bcf868729">30,228</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEwLTUtMS0xLTQxMTMy_b12af9da-c32d-42f8-bc9e-46dac64e163e">29,586</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings Per Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per common share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEzLTEtMS0xLTQxMTMy_40074294-5454-42f8-beac-c370abd37c6b">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEzLTMtMS0xLTQxMTMy_2a2e3d37-0b15-4ede-8489-5a4577c1c8ef">0.56</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEzLTUtMS0xLTQxMTMy_c181656a-358c-4c6a-a79b-c4cfec7dea5a">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per common share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzE0LTEtMS0xLTQxMTMy_c39a8b70-450e-4c30-b5db-7acc4bc316d5">0.09</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzE0LTMtMS0xLTQxMTMy_e04ca2ac-bf8a-4ce3-8058-278a7c6578fa">0.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzE0LTUtMS0xLTQxMTMy_4ea82028-963b-4b13-bd8b-b8053566bafc">0.11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The calculation of dilutive shares outstanding excludes out-of-the-money stock options (i.e., such options&#8217; exercise prices were greater than the average market price of our common shares for the period) because their inclusion would have been antidilutive. Options outstanding which are anti-dilutive and therefore not factored into the weighted average common shares amount above were <ix:nonFraction unitRef="shares" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZTo5NDQ3OTY1ZDE2NTE0OWY3YjYyYzMxMTE1YTY4YjYwMi90YWJsZXJhbmdlOjk0NDc5NjVkMTY1MTQ5ZjdiNjJjMzExMTVhNjhiNjAyXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjozOWNjNjliZDAzYzA0YzI3ODdiZThhNzk1MjY3YTgwMV8zOTE_fd2762c9-d862-4576-953c-1157351cdaeb">478</ix:nonFraction>, <ix:nonFraction unitRef="shares" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZTo5NDQ3OTY1ZDE2NTE0OWY3YjYyYzMxMTE1YTY4YjYwMi90YWJsZXJhbmdlOjk0NDc5NjVkMTY1MTQ5ZjdiNjJjMzExMTVhNjhiNjAyXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjozOWNjNjliZDAzYzA0YzI3ODdiZThhNzk1MjY3YTgwMV8zOTg_80b4be99-e824-4e5b-81c5-8d982ca46c8c">93</ix:nonFraction>, and <ix:nonFraction unitRef="shares" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZTo5NDQ3OTY1ZDE2NTE0OWY3YjYyYzMxMTE1YTY4YjYwMi90YWJsZXJhbmdlOjk0NDc5NjVkMTY1MTQ5ZjdiNjJjMzExMTVhNjhiNjAyXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjozOWNjNjliZDAzYzA0YzI3ODdiZThhNzk1MjY3YTgwMV8xMDk5NTExNjI4MjE0_d5505141-2bba-4fe3-813b-04b57cc6a305">15</ix:nonFraction> for the years ended December 31, 2021, 2020 and 2019, respectively.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the year ended December 31, 2019 basic and diluted earnings per share were calculated based on net income as the numerator, which included the conversion of the noncontrolling interest in connection with the Spin-Off. For the years ended December 31, 2021 and 2020, basic and diluted earnings per share were calculated based on net income attributable to The Pennant Group, Inc. as the numerator.</span></div></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_175"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">5.&#160;<ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="pntg:RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzYwNDczMTM5NjQ3MzI_e8993644-1e0d-4678-bdf3-ddf6740f28ec" continuedAt="i7f400296886647e98007b244472a412d" escape="true">REVENUE AND ACCOUNTS RECEIVABLE</ix:nonNumeric></span></div><ix:continuation id="i7f400296886647e98007b244472a412d" continuedAt="i86079e649a434e70a3408c4fb4e32192"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue is recognized when services are provided to the patients at the amount that reflects the consideration to which the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and managed care programs (Commercial, Medicare Advantage and Managed Medicaid plans), in exchange for providing patient care. The healthcare services in home health and hospice patient contracts include routine services in exchange for a contractual agreed-upon amount or rate. Routine services are treated as a single performance obligation satisfied over time as services are rendered. As such, patient care services represent a bundle of services that are not capable of being distinct within the context of the contract. Additionally, there may be ancillary services which are not included in the rates for routine services, but instead are treated as separate performance obligations satisfied at a point in time, if and when those services are rendered.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rate, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration which is included in the transaction price may be constrained, and is included in the net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#8217;s estimates, the Company adjusts these estimates, which would affect net service revenue in the period such variances become known. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from the Medicare and Medicaid programs accounted for <ix:nonFraction unitRef="number" contextRef="i663cd00e1ad6470dbb471e5fc87e9203_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzIxMTg_bda53759-a1d3-4be1-9367-bd363d79e094">62.6</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ifab97b7b0975436f83121c89244a55d3_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzE3NTkyMTg2MDU2NDIz_1981020c-9113-41ba-8783-48fbb5776733">60.1</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i1f1a78bb16f147c18572f1380b8c667f_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzIxMzA_c0a8f9f9-e6a6-454d-a0fa-d6ffe32a3848">55.6</ix:nonFraction>% of the Company&#8217;s revenue for the years ended December 31, 2021, 2020 and 2019, respectively. The Company records revenue from these governmental and managed care programs as services are performed at their expected net realizable amounts under these programs. The Company&#8217;s revenue from governmental and managed care programs is subject to audit and retroactive adjustment by governmental and third-party agencies. Consistent with healthcare industry accounting practices, any changes to these governmental revenue estimates are recorded in the period the change or adjustment becomes known based on final settlement. </span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i86079e649a434e70a3408c4fb4e32192" continuedAt="if310ae96b14c4e1fa5f091757fc23939"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates revenue from contracts with its patients or residents by reportable operating segments and payors. The Company has determined that disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. A reconciliation of disaggregated revenue to segment revenue as well as revenue by payor is provided in below. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s service specific revenue recognition policies are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Home Health Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Medicare episodes that began after January 1, 2020, net service revenue is recognized in accordance with the Patient Driven Groupings Model (&#8220;PDGM&#8221;). This new reimbursement structure involves case mix calculation methodology refinements, changes to low-utilization payment adjustment (&#8220;LUPA&#8221;) thresholds, the elimination of therapy thresholds, a change to the unit of payment from a 60-day episode to a 30-day payment period, and reduction of requests for anticipated payments (&#8220;RAPs&#8221;) to 20% of the estimated payment for a patient&#8217;s initial or subsequent period of care up-front (after the initial assessment is completed and upon initial billing). The RAPs were completely phased out effective January 1, 2021. Under PDGM, Medicare provides agencies with payments for each 30-day payment period provided to beneficiaries. If a beneficiary is still eligible for care after the end of the first 30-day payment period, a second 30-day payment period can begin. There are no limits to the number of periods of care a beneficiary who remains eligible for the home health benefit can receive. While payment for each 30-day payment period is adjusted to reflect the beneficiary&#8217;s health condition and needs, a special outlier provision exists to ensure appropriate payment for those beneficiaries that have the most expensive care needs. The payment under the Medicare program is also adjusted for certain variables including, but not limited to: (a) a LUPA if the number of visits is below an established threshold that varies based on the diagnosis of a beneficiary; (b) a partial payment if the patient transferred to another provider or the Company received a patient from another provider before completing the period of care; (c) adjustment to the admission source of claim if it is determined that the patient had a qualifying stay in a post-acute care setting within 14 days prior to the start of a 30-day payment period; (d) the timing of the 30-day payment period provided to a patient in relation to the admission date, regardless of whether the same home health provider provided care for the entire series of episodes; (e) changes to the acuity of the patient during the previous 30-day payment period; (f) changes in the base payments established by the Medicare program; (g) adjustments to the base payments for case mix and geographic wages; and (h) recoveries of overpayments. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all episodes that began prior to January 1, 2020, net service revenue was recorded under the Medicare prospective payment system based on a 60-day episode payment rate that is subject to adjustment based on certain variables including, but not limited to: (a) an outlier payment if the patient&#8217;s care was unusually costly; (b) a LUPA if the number of visits was fewer than five; (c) a partial payment if the patient transferred to another provider or transferred from another provider before completing the episode; (d) a payment adjustment based upon the level of covered therapy services; (e)&#160;the number of episodes of care provided to a patient, regardless of whether the same home health provider provided care for the entire series of episodes; (f)&#160;changes in the base episode payments established by the Medicare program; (g)&#160;adjustments to the base episode payments for case mix and geographic wages; and (h)&#160;recoveries of overpayments.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adjusts Medicare revenue on completed episodes to reflect differences between estimated and actual payment amounts, an inability to obtain appropriate billing documentation and other reasons unrelated to credit risk. Therefore, the Company believes that its reported net service revenue and patient accounts receivable will be the net amounts to be realized from Medicare for services rendered.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to revenue recognized on completed episodes and periods, the Company also recognizes a portion of revenue associated with episodes and periods in progress. Episodes in progress are 30-day payment periods, if the episode started after January 1, 2020, or 60-day episodes of care, if the episode started prior to January 1, 2020, that begin during the reporting period but were not completed as of the end of the period. As such, the Company estimates revenue and recognizes it on a daily basis. The primary factors underlying this estimate are the number of episodes in progress at the end of the reporting period, expected Medicare revenue per period of care or episode of care and the Company&#8217;s estimate of the average percentage complete based on the scheduled end of period and end of episode dates.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="if310ae96b14c4e1fa5f091757fc23939" continuedAt="ib167e78a57da4fa4a60774eaab6c6c6c"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Medicare Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Episodic Based Revenue -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company recognizes revenue in a similar manner as it recognizes Medicare revenue for episodic-based rates that are paid by other insurance carriers, including Medicare Advantage programs; however, these rates can vary based upon the negotiated terms.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-episodic Based Revenue -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is recognized on an accrual basis based upon the date of service at amounts equal to its established or estimated per visit rates, as applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hospice Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized on an accrual basis based upon the date of service at amounts equal to the estimated payment rates. The estimated payment rates are calculated as daily rates for each of the levels of care the Company delivers. Revenue is adjusted for an inability to obtain appropriate billing documentation or authorizations acceptable to Medicare and other reasons unrelated to credit risk. Additionally, as Medicare hospice revenue is subject to an inpatient cap and an overall payment cap, the Company monitors its provider numbers and estimates amounts due back to Medicare if a cap has been exceeded. The Company regularly evaluates and records these adjustments as a reduction to revenue and an increase to other accrued liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Living Revenue</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected the lessor practical expedient within ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 842&#8221;) and therefore recognizes, measures, presents, and discloses the revenue for services rendered under the Company&#8217;s senior living residency agreements based upon the predominant component, either the lease or non-lease component, of the contracts. The Company has determined that the services included under the Company&#8217;s senior living residency agreements each have the same timing and pattern of transfer. The Company recognizes revenue under ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for its senior residency agreements, for which it has determined that the non-lease components of such residency agreements are the predominant component of each such contract.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s senior living revenue consists of fees for basic housing and assisted living care. Accordingly, we record revenue when services are rendered on the date services are provided at amounts billable to individual residents. <ix:nonNumeric contextRef="idca163657edf4bc2aca2d8b382f0f7b2_D20210101-20211231" name="us-gaap:RevenuePerformanceObligationDescriptionOfPaymentTerms" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzEwMTcz_6d289274-96fe-4488-bead-a9d33bbbe73a">Residency agreements are generally for a term of 30 days, with resident fees billed monthly in advance. For residents under reimbursement arrangements with Medicaid, revenue is recorded based on contractually agreed-upon amounts or rates on a per resident, daily basis or as services are rendered.</ix:nonNumeric> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzYwNDczMTM5NjQ3MzM_29d8c8d7-14bc-4320-8a56-7d5d753f5766" continuedAt="ibe4e43f06ede40679af12195b0cff374" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by payor for the years ended December 31, 2021, 2020 and 2019, is summarized in the following tables:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:19.221%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.104%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hospice Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i431551b89e134941b82c51244240a244_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzMtMi0xLTEtNDExMzI_8684cbf1-691b-41e7-85f6-3b16580bcac1">80,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b3121c806bb417081699695640c414f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzMtNC0xLTEtNDExMzI_55e564d6-4b6c-45a7-a744-2e542d6cc9d1">135,939</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17b4bb1acf134933be5201416c719d6c_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzMtNi0xLTEtNDExMzI_8fcc84fb-de8a-4613-bb3c-29a0c80be953">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03057061bfb7409985a60619a19b48e6_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzMtOC0xLTEtNDExMzI_abbb93fe-7b5f-4d2b-979a-bdacb8e3b536">216,788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6ddd0deea9264c2889a8b36d67a563b0_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzMtMTAtMS0xLTQxMTMy_3b215a23-46bf-4327-a0ae-3e10a4d2f684">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i30d0fef362f9476098b2e5f91ab55f41_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzQtMi0xLTEtNDExMzI_ac3179dd-2bc0-49cb-b5ca-aebf89c99d9a">8,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d0123d2512e41bfbbd00432a081dabd_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzQtNC0xLTEtNDExMzI_22e5c150-8561-4570-932f-681937862fc4">12,103</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idac1833793374955a04bd068e4506c0e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzQtNi0xLTEtNDExMzI_f3b7f181-6788-4e87-b45a-eb98a60989cf">37,317</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iac9f214a0b30486f90920ce93092e539_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzQtOC0xLTEtNDExMzI_2a01d8fb-b91d-4c20-8a41-25a8424d3b8b">58,355</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i05e5b7442b2e4748b8bc9f050198888e_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzQtMTAtMS0xLTQxMTMy_a2807c20-79ea-4a65-9761-2d14a590b5df">13.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf54a7dfae6a484abdd050e8ddda248a_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzUtMi0xLTEtNDExMzI_2c596972-b93d-42c0-820a-e60b48bafd43">89,784</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3cad94c3015b470d965cbc5ee38f4770_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzUtNC0xLTEtNDExMzI_e2f0cc6e-e87e-4ae1-a43a-f31ad61c02e1">148,042</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id38b672538cd430abff250dfff0240b6_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzUtNi0xLTEtNDExMzI_81fa01fb-491c-4a06-95ad-3595d6b4657f">37,317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5365806816e44649649e52c6625abe4_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzUtOC0xLTEtNDExMzI_f879ad94-a09f-42c5-86d6-1c43de3bc920">275,143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i663cd00e1ad6470dbb471e5fc87e9203_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzUtMTAtMS0xLTQxMTMy_bda53759-a1d3-4be1-9367-bd363d79e094">62.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idf736e5de07e408db946428a0745839b_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzYtMi0xLTEtNDExMzI_0d0f336e-1f0c-4fc4-b76a-df657b1a8cf0">46,167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icea654d979af4e61816fbe050cb29db1_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzYtNC0xLTEtNDExMzI_28d94e60-b22d-481b-ac1d-deb816b841df">3,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8458a5a068c4090af7e21aad43775a0_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzYtNi0xLTEtNDExMzI_c08ebe0e-6b11-4098-ba9b-6a0cbeba1940">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8406e50463644fbdb227c6e79289ad64_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzYtOC0xLTEtNDExMzI_76a252f5-8c61-4689-828b-e0a618fff20d">49,363</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifdb705c6ba97400d913dd4a58f256b0e_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzYtMTAtMS0xLTQxMTMy_212e908e-41bc-473a-8ecd-ba1abe803dc3">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7de26af2c3974c3eb74c36971003d68f_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzctMi0xLTEtNDExMzI_aa053f1c-8405-4a51-b33d-1176aa5a6f71">22,007</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if26e6ee1ae2b4492b5956195b2492b91_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzctNC0xLTEtNDExMzI_ba39a975-40c7-4426-b1a1-ead8608a7eaf">374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d63dc45c0b146cfb92561c882177fea_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzctNi0xLTEtNDExMzI_f712333c-ea76-4683-b4d0-2983713d9569">92,807</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5f6f3d7d4c8a4c4caa054a915ffff62d_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzctOC0xLTEtNDExMzI_7c0765e1-ce1d-4992-b4f9-a9a070ddb445">115,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie381063adb71430c9c8b4f7607c9030f_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzctMTAtMS0xLTQxMTMy_3fda3333-fc91-4744-b058-9eb7d5d62ed0">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic242ef7737ea4e8d8f2e0629c8af8812_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzgtMi0xLTEtNDExMzI_e396b512-31c4-4676-b837-57d960a02a1e">157,958</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6cb3dbfbde247d28b978021dfabc07e_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzgtNC0xLTEtNDExMzI_755a43b2-4d0d-4670-b309-0207efa12fb8">151,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca163657edf4bc2aca2d8b382f0f7b2_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzgtNi0xLTEtNDExMzI_a6ae22e6-4836-4b32-b043-a66d314b99b1">130,124</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzgtOC0xLTEtNDExMzI_1b542b83-0272-4ec0-ab64-a5754655a85d">439,694</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i400c7c456591430da87c024511cdb9f8_D20210101-20211231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzgtMTAtMS0xLTQxMTMy_1380a1ba-c388-4d7c-827c-206622f63d53">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ib167e78a57da4fa4a60774eaab6c6c6c" continuedAt="i42afba10e0f74745aebad2e93f2651bf"><ix:continuation id="ibe4e43f06ede40679af12195b0cff374"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.870%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.176%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hospice Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9994a97da124177acf7e325874bdc4a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzMtMi0xLTEtNDExMzI_fbc5e955-c1a3-4ae6-961e-e82010934f28">58,399</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9422adb47dd144de9fd4fb328368c4e3_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzMtNC0xLTEtNDExMzI_0b0ad15d-3b6e-4e26-a4ca-570236f4f1f3">119,873</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8202cceeb8344c46a087879b40701124_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzMtNi0xLTEtNDExMzI_33061cae-2892-44f6-b58c-904c489b0aaf">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib8551d37adc147afa5952e88c48adde6_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzMtOC0xLTEtNDExMzI_a32c3ae5-ce46-4c0b-8f68-a4139b485aad">178,272</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8ca13a6f741345fea9329cb059f1ed4b_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzMtMTAtMS0xLTQxMTMy_6ffae2ba-9552-4ab4-99a8-54bced43890c">45.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2984f9f8dd8744ecbd977408c0e3b962_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzQtMi0xLTEtNDExMzI_8e7a9db7-4b4d-4e97-8771-2f1ae7b78be4">7,645</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i48f286f45fe449d6a5632e508d5c2057_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzQtNC0xLTEtNDExMzI_c00045a2-0e7b-4a64-a922-ba6d9beb9c33">12,462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0599a83f392c492c8ca20b93a86ccd91_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzQtNi0xLTEtNDExMzI_18536110-ea21-4d11-8f54-6a3dcfd80769">36,780</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36bae4b32d354f01bfa55606e2bf53ff_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzQtOC0xLTEtNDExMzI_a2aba5c1-ca0c-4305-bcc6-353c7d74a067">56,887</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iccdbd602cb6b43c1b386f036f6f9c78b_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzQtMTAtMS0xLTQxMTMy_f0afa848-b862-42da-a972-9de24ab3fff9">14.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29892b01245e41eb84f75876a0351a3a_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzUtMi0xLTEtNDExMzI_d85261bd-9aec-4cbb-ac67-26b6db9f5b6d">66,044</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8bd2b41188c847e0ba8e9c40a817df93_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzUtNC0xLTEtNDExMzI_787a2a4f-c8a6-4d4f-995e-f52afec386d4">132,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if4653a795c674a2a99639c0e0ca313f2_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzUtNi0xLTEtNDExMzI_bbc43fab-3ee3-4103-b96a-b807a7cde276">36,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2eee5c7b272f4114a364a863a01dd73b_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzUtOC0xLTEtNDExMzI_58ffb0ad-5bd5-4161-a953-e32d06273815">235,159</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ifab97b7b0975436f83121c89244a55d3_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzUtMTAtMS0xLTQxMTMy_1981020c-9113-41ba-8783-48fbb5776733">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4d7797f8df2244b09c017060c787f7c4_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzYtMi0xLTEtNDExMzI_df5f65b2-2000-4a0a-a71e-9dc83835194e">31,572</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07e05d97399f4e76ae18df53c721bcbc_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzYtNC0xLTEtNDExMzI_1aada0e1-418d-4a99-8725-0cd7ea330ab3">1,546</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i869ae7cc46294c22b376048f3f1d1a6d_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzYtNi0xLTEtNDExMzI_f860940c-4ea7-4533-ac1d-cce1ee45f9b8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if499ccd516774920992a7dec4b1cef2e_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzYtOC0xLTEtNDExMzI_d5f1500e-bdba-4ff9-9a19-060f00e3d1ea">33,118</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib32ab0952f954ffcac6e996208515105_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzYtMTAtMS0xLTQxMTMy_4fceb8fc-eaae-4bcb-9245-ba911a3046de">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e46c22d3f0f4b2d8bc8e8a60fc2ccc5_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzctMi0xLTEtNDExMzI_b99b6957-14d6-46fd-af40-e6df1a350ee6">21,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6b21bb23ad2d4d29ae1a573ce3633cf1_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzctNC0xLTEtNDExMzI_698bd3b1-9d8e-4b95-bf89-0e3d64f321e7">194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6adffdb90bb04f3ea1ba43662f341d52_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzctNi0xLTEtNDExMzI_41988f49-df6d-4317-9d88-926717b05787">100,514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idfddb8b08a444307a9d0127349167737_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzctOC0xLTEtNDExMzI_8ea46e23-878b-429c-a388-5259358ba0dc">122,676</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i762cb9691e2742e883abaa93d43be077_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzctMTAtMS0xLTQxMTMy_b407a285-7f85-4d9e-b356-4f9cf59bedd7">31.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6ee634dbd9cf40079a3e668ce24a98e3_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzgtMi0xLTEtNDExMzI_daa15e42-1724-4ad6-b51f-54637c232a4d">119,584</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4566419dadde4c98a7120368b872f3da_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzgtNC0xLTEtNDExMzI_293df5e1-cb4b-4275-adff-6acdc4aa36a7">134,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa4cbfc68844bf2ab83f3ee4d31a520_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzgtNi0xLTEtNDExMzI_280f3453-0657-4983-a352-dfb2023c86c3">137,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzgtOC0xLTEtNDExMzI_b30ffed2-0957-4d54-94da-041eaa8f236d">390,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5a2eb0a55f1548d09ebdd38af8a78640_D20200101-20201231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzgtMTAtMS0xLTQxMTMy_103f22dd-79a4-4ed9-9dee-846b33464845">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:80%"> </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:18.987%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.149%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.152%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hospice Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89476537bc774ebc87ef3b108c8f978e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzMtMi0xLTEtNDExMzI_3468d525-5961-41e8-8767-60188fecee1f">47,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i33675a436d3e40e985deb8177a576c9d_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzMtNC0xLTEtNDExMzI_945e20ce-9afa-42f5-b32c-ccd382603e5d">93,933</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab8c34ad3ce545459293744ddcb6827c_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzMtNi0xLTEtNDExMzI_d4b9f6de-7cfa-4aa2-84d9-24abb0ced63b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i900aa21d63db4875b0f5ce732299844e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzMtOC0xLTEtNDExMzI_768df2a9-a6a2-48dc-a81b-a250888a2065">141,752</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i49df9afbb9944bb4b9a18d9b551d87cc_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzMtMTAtMS0xLTQxMTMy_5fece732-b3df-419d-8e21-fec44d30f543">41.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a868a69cef4c5fa0fad890560c7186_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzQtMi0xLTEtNDExMzI_1f18587c-4dbe-42a5-94a9-d1fbafcf4269">6,575</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i150c3c3a7f2441dba86ec0345435079c_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzQtNC0xLTEtNDExMzI_60b9d11f-7a54-403c-ae46-45008b8d0718">10,061</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i264e682f589d40f8996079dbbb6714ee_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzQtNi0xLTEtNDExMzI_0ce72752-3720-4320-85b2-bfa0814d20a7">29,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i555f8697f79c4135bf985a88ac806168_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzQtOC0xLTEtNDExMzI_122eacbf-9c24-401e-9a77-91b4ca6954c4">46,455</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i4264f7ca59794b258dcd7d108f89c4bb_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzQtMTAtMS0xLTQxMTMy_cd1d16ca-4baa-49e9-9e59-5fb5b9534f8c">13.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib11f67911ae04e9e9474289103ab7ca0_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzUtMi0xLTEtNDExMzI_e369d7b3-ecab-458a-9829-7d8d9580e6d3">54,394</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i993ccc72246c43c6882a67446f7e3d04_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzUtNC0xLTEtNDExMzI_a9c77f93-74e0-4655-9687-db17eb7a4d03">103,994</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia66c44f3f144416dbe4fb6670ae3d912_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzUtNi0xLTEtNDExMzI_180317ff-d9b0-42cf-bfe8-1211cec7fd4f">29,819</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0b8618d03b954dd9b12ccc9dc2633994_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzUtOC0xLTEtNDExMzI_a7f036e7-8211-4bed-85aa-7d80dc6cad3f">188,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1f1a78bb16f147c18572f1380b8c667f_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzUtMTAtMS0xLTQxMTMy_c0a8f9f9-e6a6-454d-a0fa-d6ffe32a3848">55.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d5ca24424934279961a03e8619d1a55_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzYtMi0xLTEtNDExMzI_03725b94-0569-4bd8-be53-18899545586f">27,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18dd800368c0436f9fdaee03faceced1_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzYtNC0xLTEtNDExMzI_fda021e2-5938-49bc-8149-e44cb98436e5">1,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26c2df1bf2f84583ad5e170e30ac0da6_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzYtNi0xLTEtNDExMzI_70d19005-df0d-481f-a648-2fcc61d874ea">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i63ed1921de984ba2b86b439f98dd36dc_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzYtOC0xLTEtNDExMzI_3edb76a9-2d0d-48fb-b904-0c4955077f47">29,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8f79c51975d142fcb63efb2a71b34744_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzYtMTAtMS0xLTQxMTMy_0e1bf2c1-1c46-432b-b23a-3ac73b2b056a">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if165ef086e644209a29aa525477fce96_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzctMi0xLTEtNDExMzI_94ae7ea3-15dd-40dd-9c38-3172a9f19140">18,837</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ebf7bc335ba488f9cb8f70150a6bd1a_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzctNC0xLTEtNDExMzI_a92f459d-4d9a-45fa-a592-b70d59a43792">152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0325f33d9f364afd88fb10e9c56068e0_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzctNi0xLTEtNDExMzI_7dde6b9f-9448-4460-8cc1-f84e9f94c9ec">102,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22dbeb2253784b39851f81d479af22fd_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzctOC0xLTEtNDExMzI_bc50398c-fbff-40d0-884c-8ceabb6cf0e6">121,077</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i32ea97b6e981410cbc2b5ebf32b066a3_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzctMTAtMS0xLTQxMTMy_e1f76a2d-b5ca-46b0-aa81-0bae61c22e7a">35.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e919c640df94e919b7b44c94f671f8e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzgtMi0xLTEtNDExMzI_b600767c-6ba0-4bfa-9bd1-166348ea262c">100,942</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic5ffc58dbb624c40ac8f80c16398d43c_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzgtNC0xLTEtNDExMzI_449140c2-4d8b-486d-9a0a-e15408e88b97">105,682</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie112d35bfda34b3288ce4100b5cdf3cf_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzgtNi0xLTEtNDExMzI_7ed27726-fa6b-4316-9149-9a29f344e9b7">131,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzgtOC0xLTEtNDExMzI_3de4433f-7c81-47bf-a6b6-2f2aa1335ade">338,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5f2f4fea3b5747c3907908c54f286f3a_D20190101-20191231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzgtMTAtMS0xLTQxMTMy_73a3cf86-4a8a-401b-9ea0-f860e4852a63">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.</span></td></tr></table></div></ix:continuation><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Impact</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the Company&#8217;s consolidated balance sheets are contract assets, comprised of billed accounts receivable and unbilled receivables, which are the result of the timing of revenue recognition, billings and cash collections, as well as, contract liabilities, which primarily represent payments the Company receives in advance of services provided. As of December 31, 2021, the Company had contract liabilities in the amount of $<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzEwOTk1MTE2Mzk3NTQ_0662b208-4cfe-49f3-8ae3-eac63f7d02c3">6,211</ix:nonFraction> related to Advance Payments received in connection with the CARES Act. As further discussed in Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Accrued Liabilities,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the repayment terms for Medicare advance payments were modified through the passage of the Continuing Appropriations Act, 2021 and Other Extensions Act on October 1, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzYwNDczMTM5NjQ3MzQ_22928e7c-4b5e-4225-af03-3c9d5e2d7ee5" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of December 31, 2021 and December 31, 2020 is summarized in the following table: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.186%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.391%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.393%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia630ac63be744170818adf1a6996df94_I20211231" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzEtMS0xLTEtNDExMzI_7f068da9-0095-408f-8edc-24d9365ed30f">31,327</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib84e2fa7e66c4c8280ad68c7ca28d55c_I20201231" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzEtMy0xLTEtNDExMzI_58538df8-e19d-499f-aa65-79dbf44d3a87">28,569</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic852038e4be24f098e1d5554086d7e6b_I20211231" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzItMS0xLTEtNDExMzI_b8948e10-1501-4a37-a76c-55a390ac317a">11,793</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i23e0fe4823904639ac80d8fdad567676_I20201231" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzItMy0xLTEtNDExMzI_da27f2d1-54b1-41d4-8654-ef6b41ca48c9">7,669</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie0ea0e85a0e047b098694b3d6d36944a_I20211231" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzMtMS0xLTEtNDExMzI_0d40de54-80af-4eb3-bcea-cca7e3dc9b70">7,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i31bba7ec3d96407896690fde2506a953_I20201231" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzMtMy0xLTEtNDExMzI_3aed2e77-d4e1-4eca-9c28-da2bcd6b660c">7,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabbe1867eaad43e6b8ea27b135c22cfd_I20211231" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzQtMS0xLTEtNDExMzI_76cd4698-c315-47f2-bbb6-92f5d3182e49">3,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51de978558994d7d85f12eee1b08a961_I20201231" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzQtMy0xLTEtNDExMzI_1539da5e-da4a-4deb-a051-84191d60682d">4,036</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzUtMS0xLTEtNDExMzI_c1ab8c76-be42-4160-9b5e-2c79a6fb1f79">54,842</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AccountsReceivableGrossCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzUtMy0xLTEtNDExMzI_b1fe25ba-6c01-4280-a2ca-0c56ca265ea5">47,864</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzYtMS0xLTEtNDExMzI_582ec952-359d-4d67-bd6d-325f966c541c">902</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzYtMy0xLTEtNDExMzI_d49fe8db-79dd-4029-a553-c673f397ae09">643</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzctMS0xLTEtNDExMzI_b8781dc6-3c20-40fc-bd1a-b07c63f3f75c">53,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzctMy0xLTEtNDExMzI_1390de89-0c26-4a7b-bbed-04fb25329073">47,221</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i42afba10e0f74745aebad2e93f2651bf"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzYwNDczMTM5NjQ3MzU_6688f422-369d-4509-962b-dd8a818b7192" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for our allowance for doubtful accounts for the years ended December 31, 2021, 2020 and 2019:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzItMS0xLTEtNDExMzI_7544b13d-bb22-438f-a58f-dba9a3a6a2b2">643</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzItMy0xLTEtNDExMzI_cb4791bb-ab45-43bd-8d98-8b9aab0fb7e4">677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i855d825b738d453698699f3f7321df6f_I20181231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzItNS0xLTEtNDExMzI_936ac73d-cc81-4fdc-9aa6-c672c2990a55">616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to bad debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzQtMS0xLTEtNDExMzI_e7fce570-5bc7-4627-b180-78db87bc662a">616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzQtMy0xLTEtNDExMzI_1ad3f71c-0330-4701-8294-fbff3b05cf2b">560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzQtNS0xLTEtNDExMzI_6be7564d-f22b-44e7-aa9d-e42918f9b02d">858</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of uncollectible accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzUtMS0xLTEtNDExMzI_9eefc7ca-f59f-47fb-9cd9-7598a38fcd0f">357</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzUtMy0xLTEtNDExMzI_985e3b2e-52bc-4ee4-947e-ed0bacfa30ef">594</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzUtNS0xLTEtNDExMzI_47b8c2a3-7deb-484f-ac41-1025f47088f9">797</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzYtMS0xLTEtNDExMzI_22395016-181e-4fae-a246-92fbe555d03e">902</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzYtMy0xLTEtNDExMzI_a06c18a1-b273-4977-b12e-03f145e31458">643</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzYtNS0xLTEtNDExMzI_e2ec45c5-347e-4912-9223-ab14ffba5803">677</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_178"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">6. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90ZXh0cmVnaW9uOmYwMmRkNDYzODJlODQyN2NiMjk5ZDY1OTE5YzQzZDA1XzYwNDczMTM5NTU5ODQ_6c7b864e-115b-4191-a6d2-69ffc95f023f" continuedAt="i349ec6eca1c448a18a2aa2b36b6037fd" escape="true">BUSINESS SEGMENTS</ix:nonNumeric></span></div><ix:continuation id="i349ec6eca1c448a18a2aa2b36b6037fd" continuedAt="id00c41c357124ccd85df991ee73b7de3"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its operations into the following reportable operating segments: (1) home health and hospice services, which includes the Company&#8217;s home health, hospice and home care businesses; and (2) senior living services, which includes the operation of assisted living, independent living and memory care communities. The reporting segments are business units that offer different services and are managed separately to provide greater visibility into those operations. Our Chief Executive Officer and President, who is our Chief Operating Decision Maker &#8220;CODM&#8221;, reviews financial information at the operating segment level. We also report an &#8220;all other&#8221; category that includes general and administrative expense from our Service Center.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company provided services through <ix:nonFraction unitRef="agency" contextRef="ife1126ceed284fbdb9bf6b3dbab68da3_I20211231" decimals="INF" name="pntg:NumberOfServiceProviders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90ZXh0cmVnaW9uOmYwMmRkNDYzODJlODQyN2NiMjk5ZDY1OTE5YzQzZDA1XzIxOTkwMjMyNTg4OTM_601ff99b-7d5b-4095-bf9d-eab16d3843b7">88</ix:nonFraction> affiliated home health, hospice and home care agencies, and <ix:nonFraction unitRef="agency" contextRef="icc510d566b5a497d8c3bf8da297c74be_I20211231" decimals="INF" name="pntg:NumberOfRealEstatePropertiesUnderLease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90ZXh0cmVnaW9uOmYwMmRkNDYzODJlODQyN2NiMjk5ZDY1OTE5YzQzZDA1XzIxOTkwMjMyNTg4OTc_b505169d-0edf-4364-965a-983f7df39456">54</ix:nonFraction> affiliated senior living operations. The Company evaluates performance and allocates capital resources to each segment based on an operating model that is designed to maximize the quality of care provided and profitability. The Company&#8217;s Service Center provides various services to all lines of business. The Company does not review assets by segment and therefore assets by segment are not disclosed below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CODM uses Segment Adjusted EBITDAR from Operations as the primary measure of profit and loss for the Company's reportable segments and to compare the performance of its operations with those of its competitors. Segment Adjusted EBITDAR from Operations is net income/ (loss) attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, and, in order to view the operations performance on a comparable basis from period to period, certain adjustments including: (1) costs at start-up operations, (2) share-based compensation, (3) acquisition related costs, (4) Spin-Off transaction costs, (5) redundant and nonrecurring costs associated with the transition services agreement, (6) net income/ (loss) attributable to noncontrolling interest, (7) net COVID-19 related costs and (8) impairment of long-lived assets. General and administrative expenses are not allocated to the reportable segments, and are included as &#8220;All Other&#8221;, accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90ZXh0cmVnaW9uOmYwMmRkNDYzODJlODQyN2NiMjk5ZDY1OTE5YzQzZDA1XzYwNDczMTM5NTU5ODU_8999fcdb-80a9-4bbf-bd71-387e9cef9027" escape="true"><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain financial information regarding our reportable segments, general and administrative expenses are not allocated to the reportable segments and are included in &#8220;All Other&#8221;. </span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:42.174%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.502%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4e373408b54afd8e67604fcad521cc_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzItMi0xLTEtNDExMzI_5ec3277c-77a2-4126-bd83-791bd522b02e">309,570</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57cdf4fb339b4e68892dc8149e2518b9_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzItNC0xLTEtNDExMzI_2fe35494-9339-440b-b4a4-bbe5b467dc6b">130,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb6560107a1842b88eb0a7a57c2f2031_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzItNi0xLTEtNDExMzI_eb58651e-251d-4466-a432-f1f7b07d4e53">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzItOC0xLTEtNDExMzI_8845e56a-9800-48dc-815f-792aec7e9687">439,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc4e373408b54afd8e67604fcad521cc_D20210101-20211231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzMtMi0xLTEtNDExMzI_2ff552f3-afc5-4381-bfef-10d9b98cdd76">55,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57cdf4fb339b4e68892dc8149e2518b9_D20210101-20211231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzMtNC0xLTEtNDExMzI_a520fdd0-0bef-4c5d-ae48-b843aaa5a32f">37,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifb6560107a1842b88eb0a7a57c2f2031_D20210101-20211231" decimals="-3" sign="-" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzMtNi0xLTEtNDExMzI_51238a13-363e-4a3a-a88e-5e6e60fea10c">26,208</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzMtOC0xLTEtNDExMzI_1435fb7a-bee7-4f07-9faf-30d6e4abc411">66,874</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbb785491adf4226bb9a9857b10f52e9_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzUtMi0xLTEtNDExMzI_aaa745b3-e538-4aab-864d-cbea45536d0f">253,659</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b47eeb041d04c25b8cd00f6bf592f7f_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzUtNC0xLTEtNDExMzI_8923b38b-8399-43ac-9934-92602a3542c9">137,294</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffbc90dc71cb4be1a22f4af87b57ff85_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzUtNi0xLTEtNDExMzI_fbe3e3a8-b992-4771-a3a0-c45348c3e2e6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzUtOC0xLTEtNDExMzI_97bdc816-34d2-45ce-83de-f9bed6ecdf45">390,953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbb785491adf4226bb9a9857b10f52e9_D20200101-20201231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzYtMi0xLTEtNDExMzI_c570b10a-d9d6-4ae4-91d3-e02f5b88a605">49,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b47eeb041d04c25b8cd00f6bf592f7f_D20200101-20201231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzYtNC0xLTEtNDExMzI_1eccd838-6b76-49d4-b9cc-cd4b7464540f">48,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iffbc90dc71cb4be1a22f4af87b57ff85_D20200101-20201231" decimals="-3" sign="-" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzYtNi0xLTEtNDExMzI_d426e006-5303-41c3-b55b-ac86b7ee8421">22,762</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzYtOC0xLTEtNDExMzI_b32e2e56-7a3d-4b92-b3a8-1bd8b0a2e3db">75,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976083bf7720489d9ec3c392eb20769e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzgtMi0xLTEtNDExMzI_cbadf3b7-c8f3-4e92-91bc-8b68bfcca984">206,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df8a9f1fea242caaf3c3e4967630be6_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzgtNC0xLTEtNDExMzI_85255966-32f3-490c-90f1-f20234b7fbd1">131,907</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a59a4ea155b45bfb972b34701628d91_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzgtNi0xLTEtNDExMzI_7f08ba65-9f81-4232-8028-6bd6965e4025">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzgtOC0xLTEtNDExMzI_25772459-d0f4-4e47-bd15-85da340a1f62">338,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i976083bf7720489d9ec3c392eb20769e_D20190101-20191231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzktMi0xLTEtNDExMzI_5aebc205-5465-4c47-8b58-c4d00ef2e438">33,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2df8a9f1fea242caaf3c3e4967630be6_D20190101-20191231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzktNC0xLTEtNDExMzI_4837fe6d-c68e-4433-9daf-be1afbc57212">47,344</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8a59a4ea155b45bfb972b34701628d91_D20190101-20191231" decimals="-3" sign="-" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzktNi0xLTEtNDExMzI_64773f00-88c5-478d-b8b8-85d08fb9672c">18,591</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzktOC0xLTEtNDExMzI_4a788751-26f6-4b5b-b488-35bb1ae05e55">62,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><ix:continuation id="id00c41c357124ccd85df991ee73b7de3"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="pntg:ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90ZXh0cmVnaW9uOmYwMmRkNDYzODJlODQyN2NiMjk5ZDY1OTE5YzQzZDA1XzYwNDczMTM5NTU5ODY_ce95f4a0-98ca-43b5-a441-209529785fe3" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:66.103%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.385%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.445%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzItMS0xLTEtNDExMzI_d65401c7-14f1-4b12-8ea8-efe7023fe1b1">66,874</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzItMy0xLTEtNDExMzI_891d5473-b83f-42bb-98f6-03f684150cb5">75,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzItNS0xLTEtNDExMzI_142799a2-baa6-423d-b98a-d09da4fc8c0c">62,107</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzMtMS0xLTEtNDExMzI_7dc7b25a-a15a-4747-bf21-a7aefc7a1835">4,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzMtMy0xLTEtNDExMzI_dab1cfd9-284a-429c-85a7-72c3e41b28cf">4,675</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzMtNS0xLTEtNDExMzI_a2f15fb2-48e8-4eeb-bf4e-1a9d2df9cfb3">3,810</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzQtMS0xLTEtNDExMzI_9a96c40f-cb16-4ca4-8dc6-faaeaed19f7b">40,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzQtMy0xLTEtNDExMzI_0bf916b5-23bf-4af3-b6fd-416927b079ea">39,191</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzQtNS0xLTEtNDExMzI_8631c4a8-6178-41cc-b878-1014f54ecc1f">34,975</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzUtMS0xLTEtNDExMzI_6b1bd548-297e-4c5c-ad10-2c8a22a65d31">24</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzUtMy0xLTEtNDExMzI_2269de3c-d368-46cf-b377-2a78b451f317">225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzUtNS0xLTEtNDExMzI_16f7f267-b219-49b8-be80-f3630b7ed6fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Segment EBITDAR from Operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Costs at start-up operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:StartUpActivitiesCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzctMS0xLTEtNDExMzI_c4dc4c29-d1ed-44c5-a76a-09e50bb0ecba">1,045</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:StartUpActivitiesCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzctMy0xLTEtNDExMzI_2f29c120-cefd-454e-9a33-2dde8401d5b4">1,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:StartUpActivitiesCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzctNS0xLTEtNDExMzI_d13efc3c-863b-47a5-bce1-09fd4c3a2d9a">483</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzgtMS0xLTEtNDExMzI_6fe7a82f-9525-4058-9e9f-9fcf5ca653cb">10,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzgtMy0xLTEtNDExMzI_48b07d32-b839-4623-8fdd-ba0841e37401">8,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzgtNS0xLTEtNDExMzI_b79e7de6-6fe1-439e-ac22-75b29b1763a1">3,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzktMS0xLTEtNDExMzI_37aaea60-e1f9-4a36-bce8-96a2a2a32066">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzktMy0xLTEtNDExMzI_52bbbeef-b99f-43dc-ac7e-4406f5e682e1">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzktNS0xLTEtNDExMzI_0d5a78c4-6e69-4f5b-9e44-a5d189142f12">665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off related transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:SpinoffTransactionCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEwLTEtMS0xLTQxMTMy_ce02cf24-e287-4469-80c1-09ec0d7defd1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:SpinoffTransactionCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEwLTMtMS0xLTQxMTMy_6e2c4af1-054d-4667-a701-f21fb5728824">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:SpinoffTransactionCosts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEwLTUtMS0xLTQxMTMy_323a04e8-bc0f-4b48-b738-fb91b7f924b7">13,219</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition services costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:AcquisitionRelatedCostsNotCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzExLTEtMS0xLTQxMTMy_1d8ff545-2df8-43d7-a9a6-add9e4b0e168">2,008</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:AcquisitionRelatedCostsNotCapitalized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzExLTMtMS0xLTQxMTMy_7fa0b652-a345-40d9-befd-9f9dd9e6c022">1,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:AcquisitionRelatedCostsNotCapitalized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzExLTUtMS0xLTQxMTMy_5c457d20-f69c-4eaa-82fe-c1af45ed79f1">532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 Related costs and supplies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEyLTEtMS0xLTQxMTMy_6e029bc1-ca18-4b99-ade4-29c2b21afb68">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEyLTMtMS0xLTQxMTMy_56beee47-f4c0-4c91-8745-c4bb331bef4f">447</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEyLTUtMS0xLTQxMTMy_e8ecb28c-6d1a-4550-a2aa-252bdbe946f0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTEtMS0xLTYwMTgz_344a7480-eb05-430f-b058-3be7045c7573">2,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTMtMS0xLTYwMTgz_80ab4c99-1c44-49a4-8063-e61854fe029d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTUtMS0xLTYwMTgz_0d3fc104-370d-477f-9c62-1ffc0fd7ff82">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Net income/ (loss) attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTEtMS0xLTQxMTMy_3038f9cc-9362-4655-857f-66b82a8560d6">548</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTMtMS0xLTQxMTMy_879d9f73-c52d-4489-a467-266f82cf3aef">191</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:NetIncomeLossAttributableToNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTUtMS0xLTQxMTMy_1969f87e-aa7a-4557-b736-7b3126c09e11">629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and Combined Income from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzE0LTEtMS0xLTQxMTMy_9b90d989-5691-42fb-92e9-d70e34010d3a">4,695</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzE0LTMtMS0xLTQxMTMy_05aa5f9d-9c2f-4d00-87ca-a632064a7cfd">18,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzE0LTUtMS0xLTQxMTMy_ab7e35ed-113c-4e34-b540-d718432acca3">5,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents results related to start-up operations.  This amount excludes rent and depreciation and amortization expense related to such operations.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense incurred which is included in cost of services and general and administrative expense. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition related costs that are not capitalizable.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs incurred related to the Spin-Off are included in general and administrative expense.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A portion of the costs incurred under the Transition Services Agreement identified as redundant or nonrecurring that are included in general and administrative expense. Fees incurred under the Transition Services Agreement, net of the Company&#8217;s payroll reimbursement, were $<ix:nonFraction unitRef="usd" contextRef="ia1fcf346d3fa483083f350885e86c53f_D20210101-20211231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo5Y2RjZDgyYWUzYjI0OTMwOGMzYzAwMzQ1ZTFhNmU4ZS90YWJsZXJhbmdlOjljZGNkODJhZTNiMjQ5MzA4YzNjMDAzNDVlMWE2ZThlXzQtMi0xLTEtNDI3NTgvdGV4dHJlZ2lvbjo0MTMxZmM3OTNiMmE0YmJkYmUwM2ZlN2YyZjhiMDUwYV8yMTk5MDIzMjU2NjYy_aa019e11-8765-42c6-a33f-668f0e9c4567">3,124</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i4727a9c1e3f3474da652ab9778b0c723_D20200101-20201231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo5Y2RjZDgyYWUzYjI0OTMwOGMzYzAwMzQ1ZTFhNmU4ZS90YWJsZXJhbmdlOjljZGNkODJhZTNiMjQ5MzA4YzNjMDAzNDVlMWE2ZThlXzQtMi0xLTEtNDI3NTgvdGV4dHJlZ2lvbjo0MTMxZmM3OTNiMmE0YmJkYmUwM2ZlN2YyZjhiMDUwYV8yMTk5MDIzMjU2Njcz_043e6f02-7061-459c-914f-41156cfd017a">5,536</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="i6798f615dd65498b96c25d713d9ea243_D20190101-20191231" decimals="-3" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo5Y2RjZDgyYWUzYjI0OTMwOGMzYzAwMzQ1ZTFhNmU4ZS90YWJsZXJhbmdlOjljZGNkODJhZTNiMjQ5MzA4YzNjMDAzNDVlMWE2ZThlXzQtMi0xLTEtNDI3NTgvdGV4dHJlZ2lvbjo0MTMxZmM3OTNiMmE0YmJkYmUwM2ZlN2YyZjhiMDUwYV8yMTk5MDIzMjU2NjU5_a8155aef-bace-4f7f-8058-9322fc6db4ca">2,982</ix:nonFraction>, for the years ended December 31, 2021, 2020 and 2019, respectively. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning in the first quarter of fiscal year 2021, we updated our definition of Segment Adjusted EBITDAR to no longer include an adjustment for COVID-19 expenses offset by the amount of sequestration relief. COVID-19 expenses continue to be part of daily operations for which less specific identification is visible. Furthermore, the sequestration relief was extended through December 31, 2021. Sequestration relief was $<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:AmountToOffsetExpenseSequestrationRelief" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo5Y2RjZDgyYWUzYjI0OTMwOGMzYzAwMzQ1ZTFhNmU4ZS90YWJsZXJhbmdlOjljZGNkODJhZTNiMjQ5MzA4YzNjMDAzNDVlMWE2ZThlXzUtMi0xLTEtNTE0MzMvdGV4dHJlZ2lvbjpiOGQyZDgyMTA0ZmI0MzNhYWE2NjZlOTAxM2ZkODYwYV8yMTk5MDIzMjU2NTAy_1359af9d-2db3-4e53-9ca4-4ef48a840267">3,555</ix:nonFraction> for the year ended December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The 2020 amount represents incremental costs incurred as part of the Company's response to COVID-19 including direct medical supplies, labor, and other expenses, net of $<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:DirectMedicalSuppliesLaborAndOtherExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo5Y2RjZDgyYWUzYjI0OTMwOGMzYzAwMzQ1ZTFhNmU4ZS90YWJsZXJhbmdlOjljZGNkODJhZTNiMjQ5MzA4YzNjMDAzNDVlMWE2ZThlXzUtMi0xLTEtNTE0MzMvdGV4dHJlZ2lvbjpiOGQyZDgyMTA0ZmI0MzNhYWE2NjZlOTAxM2ZkODYwYV8yMTk5MDIzMjU2NzQ0_707aed0d-742b-44a4-b65a-85ab1050c4bf">2,765</ix:nonFraction> in increased revenue related to the 2% payment increase in Medicare reimbursements for sequestration relief for the year ended December 31, 2020.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">On January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements (collectively, the &#8220;Transfer Agreements&#8221;) with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#8220;Transaction&#8221;). The closing of the Transaction is anticipated to occur in the first half of 2022. The Company impaired certain leasehold improvements included in property and equipment primarily  related to the operations included in the transaction with Ensign.</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_181"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">7.&#160;<ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzYwNDczMTM5NjE3MDU_f0fd87fd-10f8-4bb2-8b60-dbf1ebf1dcf8" continuedAt="i9ec429c2194443e9aabdc4ca95a8292f" escape="true">ACQUISITIONS</ix:nonNumeric></span></div><ix:continuation id="i9ec429c2194443e9aabdc4ca95a8292f" continuedAt="iae55183ca8124a4cbf2581fefaeab3d8"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s acquisition focus is to purchase or lease operations that are complementary to the Company&#8217;s current businesses, accretive to the Company&#8217;s business or otherwise advance the Company&#8217;s strategy. The results of all the Company&#8217;s independent operating subsidiaries are included in the Financial Statements subsequent to the date of acquisition. Acquisitions are accounted for using the acquisition method of accounting. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Acquisitions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, the Company expanded its operations with the addition of <ix:nonFraction unitRef="agency" contextRef="ic8da0ae531824141a5fbf3f5f9b8abb5_D20210101-20211231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzU0NQ_9a82acc0-98be-473c-9f48-f7f75cedb06a">five</ix:nonFraction> home health agencies, <ix:nonFraction unitRef="agency" contextRef="i70e465de07bc4489a1d93b090ad882d3_D20210101-20211231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzU2OA_bf54472f-f38b-4965-9a31-d7ca976000a7">four</ix:nonFraction> hospice agencies, and <ix:nonFraction unitRef="agency" contextRef="i1b3df8b0ec1847a485fa591f8a59348b_D20210101-20211231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2MzY3NzM_f911ded6-bfe2-4012-ae48-3bbcd6d7a8e2">two</ix:nonFraction> home care agencies. The aggregate purchase price for these acquisitions was $<ix:nonFraction unitRef="usd" contextRef="ifb52edba0b344f30ae760f39f36a33ba_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzY3OQ_48ae4cfb-ca4f-4084-bc0f-eb4f4a8eb19d">14,135</ix:nonFraction>. A subsidiary of the Company entered into a separate operations transfer agreement with the prior operator of each acquired operation as part of each transaction.  The goodwill was primarily attributable to intangible assets that do not qualify for separate recognition  and  to synergies the Company expects to achieve related to the acquisition and was allocated to the  Company's  operating  segments  which  are  its  reporting  units.   The Company anticipates that the total goodwill recognized </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="iae55183ca8124a4cbf2581fefaeab3d8" continuedAt="ia3d7f167c1e84917bb1e6e60cb29d1ef"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will be fully deductible for tax purposes. Acquisition costs related to the business combinations of home health, hospice, and home care acquisitions of $<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:NonCapitalizableRelatedToTheBusinessCombinations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzE2NDkyNjc0NTY3NTg_b7ccc09d-03f3-4996-aa70-a6349a02c592">80</ix:nonFraction> were expensed related to the business combinations during the year ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="agency" contextRef="id3b8477112444416aa795ea6a1381886_D20210101-20211231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDEyNjA_7daa1dc7-a54f-4871-9bd7-3e7e4ea87097">Two</ix:nonFraction> of the hospice agencies were acquired Medicare licenses and are considered asset acquisitions. The fair value of assets for the hospice licenses acquired totaled $<ix:nonFraction unitRef="usd" contextRef="ie6f061c2888d4b629403b99a7a704501_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDEyNzE_696e6636-1daa-427e-af9d-52167b8dc737">585</ix:nonFraction> and was allocated to indefinite-lived intangible assets. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Acquisitions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the Company expanded its operations with the addition of <ix:nonFraction unitRef="agency" contextRef="i6ee634dbd9cf40079a3e668ce24a98e3_D20200101-20201231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2Mzk2NTY_2462b9f9-77aa-4f21-81db-8efdab06ae50">six</ix:nonFraction> home health agency, <ix:nonFraction unitRef="agency" contextRef="i4566419dadde4c98a7120368b872f3da_D20200101-20201231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2Mzk2NjA_c5fe88a2-fc28-4d0b-ad80-3ae04b3d138f">six</ix:nonFraction> hospice agencies, and <ix:nonFraction unitRef="agency" contextRef="i11b4722640e743ca9f00c59f8e177f35_D20200101-20201231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2Mzk2NjQ_9c490da1-f423-402d-8c06-fefb392c5925">two</ix:nonFraction> senior living communities. The aggregate purchase price for these acquisitions was $<ix:nonFraction unitRef="usd" contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2Mzk2Nzc_c2d7d25c-d21b-4d8a-8b4e-5ccb9503dd5e">39,239</ix:nonFraction>. In connection with the addition of the senior living communities, the Company entered into a new long-term &#8220;triple-net&#8221; lease with a subsidiary of Ensign.  The addition of these operations added a total of <ix:nonFraction unitRef="agency" contextRef="i16a5a490d6884205a5e9dd42dbbb3399_I20201231" decimals="INF" name="pntg:NumberOfUnitsInRealEstatePropertyAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2Mzk2ODE_e45fee9c-edb7-45b8-9603-45cdfb0dfbff">164</ix:nonFraction> operational senior living units to be operated by the Company&#8217;s independent operating subsidiaries. A subsidiary of the Company entered into a separate operations transfer agreement with the prior operator of each acquired operation as part of each transaction.  The goodwill was primarily attributable intangible assets that do not qualify for separate recognition and to synergies the Company expects to achieve related to the acquisition and was allocated to  the  Company's  operating  segments  which  are  its  reporting  units.   The Company anticipates that the total goodwill recognized will be fully deductible for tax purposes. Acquisition costs related to the business combinations of home health, hospice, and home care acquisitions of $<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:NonCapitalizableRelatedToTheBusinessCombinations" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2MzgzNTE_6fb536fc-1903-4c8e-ae65-22d01527ecbe">99</ix:nonFraction> were expensed related to the business combinations during the year ended December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company announced it closed on a home health joint venture and hospice joint venture with Scripps Health (&#8220;Scripps&#8221;), a leading nonprofit integrated health system based in San Diego, California. The closing was effective October 1, 2020. The resulting joint ventures, which combined certain assets and the operations of Scripps&#8217; home health business and the assets and operations of the local Pennant-affiliated home health and hospice agencies, are majority-owned and managed by an independent operating subsidiary of the Company and provide home health and hospice services to patients throughout San Diego County. The fair value of assets contributed by Scripps to the home health joint venture were included in the total value of assets acquired as described above and in the summary table below. The Company paid Scripps $<ix:nonFraction unitRef="usd" contextRef="ibc65670bbb7246fa8052cb8e64d56db2_D20201001-20201031" decimals="-3" name="us-gaap:PaymentsToAcquireInterestInJointVenture" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzI1NjI_d3cb6582-71da-4b20-ba63-d034eb644c89">6,200</ix:nonFraction> in cash and contributed assets from the local Pennant-affiliated home health agency with a net book value of $<ix:nonFraction unitRef="usd" contextRef="ibc65670bbb7246fa8052cb8e64d56db2_D20201001-20201031" decimals="-3" name="pntg:CashAndContributedAssetsNetBookValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzI2NzQ_21137d55-c15a-4070-af19-c709a2155b9e">614</ix:nonFraction>.  The Company acquired <ix:nonFraction unitRef="number" contextRef="i186dae40bd454249853b01c1eba9d848_I20201031" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzI3MDE_dba3311d-b099-4c7b-b0b6-c0a00dc4a6b1">60.0</ix:nonFraction>% ownership interest in the joint venture. The contributions of assets by Scripps to the joint venture, resulted in the Company recording a noncontrolling interest with a fair value of $<ix:nonFraction unitRef="usd" contextRef="i9ff49407f6be490cad905da779b4d980_D20201001-20201031" decimals="-3" name="us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzI4ODc_4655eebe-a14c-406b-8b15-8daf77aceeed">4,646</ix:nonFraction>.  The fair value of the noncontrolling interest was determined using discounted cash flow models.  As part of the transaction with Scripps, the Company contributed the assets of the local Pennant-affiliated hospice agency to another joint venture. The Company sold Scripps a noncontrolling interest in the hospice joint venture for $<ix:nonFraction unitRef="usd" contextRef="i9ff49407f6be490cad905da779b4d980_D20201001-20201031" decimals="-3" name="us-gaap:ProceedsFromDivestitureOfInterestInJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzMyMjI_a8a1d9ff-65f0-46b1-a7a1-36d112949b65">555</ix:nonFraction> in cash. The company retained an <ix:nonFraction unitRef="number" contextRef="i18a947ebb0914b1a81c869f2499ef9ee_I20201031" decimals="3" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzMyNTk_3e916ab4-aebd-44bf-956c-c488bc868107">80.0</ix:nonFraction>% ownership interest in the hospice joint venture. The transaction resulted in the Company recognizing a noncontrolling interest of $<ix:nonFraction unitRef="usd" contextRef="i9ff49407f6be490cad905da779b4d980_D20201001-20201031" decimals="-3" name="pntg:NoncontrollingInterestJointVenture" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzMzOTM_380f4d3d-996d-4a61-91b2-aa0befd40f4c">138</ix:nonFraction> and a contribution to additional paid in capital of $<ix:nonFraction unitRef="usd" contextRef="i1e1d06b38ad84064a8290b0beceb92d9_I20201031" decimals="-3" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzM0NDg_8cea6c74-eb1a-46c3-a6d0-bad786bed2d3">313</ix:nonFraction>, net of $<ix:nonFraction unitRef="usd" contextRef="i9ff49407f6be490cad905da779b4d980_D20201001-20201031" decimals="-3" name="pntg:AdditionalPaidInCapitalEffectOfIncomeTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzM0NTk_051bfbe0-4cc9-4d26-9fc8-1914c21db988">104</ix:nonFraction> of the income tax effect.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Acquisitions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the Company expanded its operations with the addition of <ix:nonFraction unitRef="agency" contextRef="i0e919c640df94e919b7b44c94f671f8e_D20190101-20191231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5NDQ_238bad79-5994-492f-ba38-9d25e4a6e72d">two</ix:nonFraction> home health agencies, <ix:nonFraction unitRef="agency" contextRef="ic5ffc58dbb624c40ac8f80c16398d43c_D20190101-20191231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5NTE_a50bd0fd-d5b7-408f-9f91-bc56831421f2">five</ix:nonFraction> hospice agencies, <ix:nonFraction unitRef="agency" contextRef="i1eedc1128d554ef1b5b1df73ddae1f03_D20190101-20191231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5NTc_817f7f66-4cf9-4be2-80e3-f8c2bb51c2a7">two</ix:nonFraction> home care agencies and <ix:nonFraction unitRef="agency" contextRef="ia34b018da1b745588a4443489d6fd7a5_D20190101-20191231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5NjM_1da2d89f-f952-4e8f-b748-4f3009e754ff">two</ix:nonFraction> senior living operations. In connection with the acquisition of <ix:nonFraction unitRef="agency" contextRef="i091dbe9239e9447a88678cb20a666033_D20190101-20191231" decimals="INF" name="pntg:NumberOfBusinessesAndAssetsAcquired" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzI3NDg3NzkwODczMTM_919145c0-6dfa-4396-803e-20fa2513f058">one</ix:nonFraction> of the senior living communities, the Company entered into a new long-term &#8220;triple-net&#8221; lease with a subsidiary of Ensign. The Company did not acquire any material assets or assume any liabilities. A subsidiary of the Company entered into a separate operations transfer agreement with the prior operator of each acquired operation as part of each transaction. The addition of these operations added a total of <ix:nonFraction unitRef="agency" contextRef="i727696b9c07044d1ae50621d44a2e115_I20191231" decimals="INF" name="pntg:NumberOfUnitsInRealEstatePropertyAcquired" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5ODU_eac6482c-e701-46d7-8eff-04d791c9569e">143</ix:nonFraction> operational senior living units to be operated by the Company&#8217;s independent operating subsidiaries. The aggregate purchase price for these acquisitions was $<ix:nonFraction unitRef="usd" contextRef="ie51d580ad1694816b75edef851ee768f_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5ODk_1b0ff303-1ded-4cc6-9d67-895b5d4d5c40">18,760</ix:nonFraction>. Acquisition costs related to the business combinations of home health, hospice, and home care was $<ix:nonFraction unitRef="usd" contextRef="ic9b4d5180d754f1991716345bb9bfd11_D20190101-20191231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionRelatedCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzYwNDczMTM5NjE3MjQ_6e90cbb4-389f-4ade-a328-230d09224e14">611</ix:nonFraction> during the year ended December 31, 2019.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of assets for home health and hospice acquisitions was mostly concentrated in goodwill and as such, these transactions were classified as business combinations in accordance with ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia3d7f167c1e84917bb1e6e60cb29d1ef"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">805&#8221;).  <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzYwNDczMTM5NjE3MDY_9b3cb4e7-41dd-435d-99ec-a14e98d3d223" continuedAt="i0093f65c1a2547a5be2dd49940eba982" escape="true">The table below presents the allocation of the purchase price for the operations acquired in acquisitions during the years ended December 31, 2021, 2020 and 2019 as noted above:</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:continuation id="i0093f65c1a2547a5be2dd49940eba982"><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.625%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture, and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231" decimals="-3" name="pntg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzItMS0xLTEtNDExMzI_124f3049-e29c-4772-ba37-4a70f10366f4">62</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231" decimals="-3" name="pntg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzItMy0xLTEtNDExMzI_b2f81a0b-2691-4c71-a70a-ce4eefb534d8">174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie51d580ad1694816b75edef851ee768f_I20191231" decimals="-3" name="pntg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzItNS0xLTEtNDExMzI_91c15510-c649-49dc-8c21-22de5a4a433c">91</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzMtMS0xLTEtNDExMzI_3e18434d-afc0-47f9-8dd9-9aad8c849351">7,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzMtMy0xLTEtNDExMzI_9e41dd23-ec34-4c96-b533-473631aa31ef">25,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie51d580ad1694816b75edef851ee768f_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzMtNS0xLTEtNDExMzI_1b8ef251-cad3-4c80-8ca6-f3d52ba1c607">10,341</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzQtMS0xLTEtNDExMzI_3c437e19-c0a6-4322-ba26-c1226df81300">6,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzQtMy0xLTEtNDExMzI_5438faf7-af25-4255-a86c-cd0b7ca0479a">14,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie51d580ad1694816b75edef851ee768f_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzQtNS0xLTEtNDExMzI_675ff21a-789a-46aa-855b-f11b48ff8c71">8,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzUtMS0xLTEtNDExMzI_c8308646-a2f3-4329-993b-33f5aef7e0ed">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzUtMy0xLTEtNDExMzI_fe763daa-43c5-431b-a72b-d3081bb0fca4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie51d580ad1694816b75edef851ee768f_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzUtNS0xLTEtNDExMzI_2565f5c4-eb36-45c7-ad51-6046751a6867">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzYtMS0xLTEtNDExMzI_54caad9c-a62f-4e22-afe2-fd8f9e53cb17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzYtMy0xLTEtNDExMzI_eea16f2f-b0dd-46e6-a8b8-eb6a1a627ab1">172</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie51d580ad1694816b75edef851ee768f_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzYtNS0xLTEtNDExMzI_0162bd8c-e26b-4c99-85aa-268eaa56482e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total acquisitions</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifb52edba0b344f30ae760f39f36a33ba_D20210101-20211231" decimals="-3" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzctMS0xLTEtNDExMzI_48ae4cfb-ca4f-4084-bc0f-eb4f4a8eb19d">14,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzctMy0xLTEtNDExMzI_c2d7d25c-d21b-4d8a-8b4e-5ccb9503dd5e">39,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie51d580ad1694816b75edef851ee768f_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzctNS0xLTEtNDExMzI_1b0ff303-1ded-4cc6-9d67-895b5d4d5c40">18,760</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: noncontrolling interest and additional paid in capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzgtMS0xLTEtNDExMzI_649ef022-5557-453c-9396-7fb106939cef">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzgtMy0xLTEtNDExMzI_b10a975a-42d1-45e3-a980-995f115be1ba">4,646</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie51d580ad1694816b75edef851ee768f_I20191231" decimals="-3" name="us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzgtNS0xLTEtNDExMzI_f68b7f4d-d999-4841-b9b0-de9005215bf9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash paid in prior year (held in escrow)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231" decimals="-3" name="pntg:BusinessCombinationCashPaidInPriorYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktMS0xLTEtNjIxOTk_41f0bf4e-d951-4227-baf6-9f0cd03a4c30">585</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231" decimals="-3" name="pntg:BusinessCombinationCashPaidInPriorYear" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktMy0xLTEtNjIxOTk_7b76f38c-4bc1-4ffc-a834-6c69dcd8848d">1,400</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie51d580ad1694816b75edef851ee768f_I20191231" decimals="-3" name="pntg:BusinessCombinationCashPaidInPriorYear" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktNS0xLTEtNjIxOTk_bdd253bc-c6f4-4f81-9f4e-a5321aa40b72">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for acquisitions</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktMS0xLTEtNDExMzI_a28cd868-5651-4854-8893-b92d27f1cb4d">13,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktMy0xLTEtNDExMzI_5efee020-6347-4af8-8dcb-903a56db4464">33,193</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie51d580ad1694816b75edef851ee768f_I20191231" decimals="-3" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktNS0xLTEtNDExMzI_7877dd74-3838-4c9d-9f67-aa635862f1e1">18,760</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consists of the of noncontrolling interest related to Scripps contribution of assets to the joint venture.  </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total cash paid for acquisitions for the year ended December 31, 2021 includes $<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="pntg:TotalAcquisitions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZToyOTJmMzc2Y2YwZDg0YzBjOWI0NWUyMDU5NzViN2JmNy90YWJsZXJhbmdlOjI5MmYzNzZjZjBkODRjMGM5YjQ1ZTIwNTk3NWI3YmY3XzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjo4NGExZGE2Y2ZjM2I0OTk2YTViZDg0NDljYWJkN2I2ZV81Nw_766353f8-4780-4ce4-8caa-a93dc962617a">585</ix:nonFraction> as an escrow deposit that was paid in the prior year. </span></div></td></tr></table></div></ix:continuation></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_184"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">8.&#160;<ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzYwNDczMTM5NTI5Mjc_359374dd-947b-4d78-ae0d-6a3f5b2ca214" continuedAt="i8671977c11c643f89f022a63222a7948" escape="true">PROPERTY AND EQUIPMENT&#8212;NET</ix:nonNumeric></span></div><ix:continuation id="i8671977c11c643f89f022a63222a7948"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzYwNDczMTM5NTI5Mjg_cd77b282-5408-4ea8-9df2-ab664e3d2ac5" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consist of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:63.081%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.443%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22ba094ecdd748caa523069cfe03b1bb_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzItMS0xLTEtNDExMzI_83b8458c-58cd-428c-ad63-894500417d6b">11,660</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic989f4d1015643d8b1f921fe889e7655_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzItMy0xLTEtNDExMzI_637b3d0c-4e40-42ea-bec5-0e586181e986">9,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic76aa9c6653849259b83d26fe4a1a6e7_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzMtMS0xLTEtNDExMzI_b22b1af0-9246-413b-a6ae-7909a86332d4">22,415</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i472b81765f954025a5079e55559a1cce_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzMtMy0xLTEtNDExMzI_75221416-a329-4a1f-b982-5e0bfe63ea61">22,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i489985632d6945938dec271036a4ca11_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzQtMS0xLTEtNDExMzI_e6ee71da-f50f-4f7d-885c-eff9cc12cf30">1,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b29edf2eac54eb981cacc738f038708_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzQtMy0xLTEtNDExMzI_596ee0c7-555f-46d5-96c4-2224dcc11914">1,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzUtMS0xLTEtNDExMzI_5fea0a8e-44b6-4a23-a419-3e9b3e165cd2">35,274</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzUtMy0xLTEtNDExMzI_c2feecb1-7be8-4bc4-aa2b-6253698e8690">33,590</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzYtMS0xLTEtNDExMzI_311dc0fd-8152-4147-b557-e11ac161ad53">18,486</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzYtMy0xLTEtNDExMzI_171b7927-5f1b-4fa8-8845-500b3e9e4a93">15,706</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzctMS0xLTEtNDExMzI_55f1f6b7-1461-458b-a8a6-eb88ebb03639">16,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzctMy0xLTEtNDExMzI_3ffb132a-8c3e-4e90-a23d-72ee7195f261">17,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzExNw_b86c3a62-2b4c-4198-ae7b-04b4c638337d">4,751</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzEyMQ_a93be9df-e86f-40a3-85b0-b7fe43dbecd5">4,661</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzEyOA_f8b41078-5da0-44ad-819e-5764ece77a20">3,757</ix:nonFraction> for the years ended December 31, 2021, 2020 and 2019, respectively. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Impairment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the carrying value of long-lived assets impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. On January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#8220;Transaction&#8221;). The closing of the Transaction is anticipated to occur in the first half of 2022. As of the year ended December 31, 2021, management determined that the long-lived assets for the impacted communities were not recoverable and the Company recognized a non-cash long-lived asset impairment charge of $<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzEwOTk1MTE2MzE1ODc_13712c5c-8ce4-4314-89b3-11e6ff0f9a9b">2,835</ix:nonFraction> in cost of services in the Consolidated and Combined Statements of Income.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_187"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">9. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzYwNDczMTM5NTQ3MzQ_6a1fe6e9-819e-48c7-8db4-50c35f144582" continuedAt="ibcace8af5224418e94f67aee5a0cff3a" escape="true">GOODWILL AND INTANGIBLE ASSETS&#8212;NET </ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="ibcace8af5224418e94f67aee5a0cff3a" continuedAt="ia54b29e2c15447cbb14a5a6635be5573"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill during the fourth quarter of each year and also if events or changes in circumstances indicate the occurrence of a triggering event which might indicate there may be impairment. The Company performs its goodwill impairment analysis for each reporting unit that constitutes a component for which (1) discrete financial information is available and (2) segment management regularly reviews the operating results of that component, in accordance with the provisions of ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 350&#8221;).</span></ix:continuation></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ia54b29e2c15447cbb14a5a6635be5573"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill for impairment by initially considering qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, as a basis for determining whether it is necessary to perform a quantitative analysis. If it is determined that it is more likely than not that the fair value of reporting unit is less than its carrying amount, a quantitative analysis is performed to identify goodwill impairment. If it is determined that it is not more likely than not that the fair value of the reporting unit is less than its carrying amount, it is unnecessary to perform a quantitative analysis. The Company may elect to bypass the qualitative assessment and proceed directly to performing a quantitative analysis. Impairment is the condition that exists when the carrying amount of goodwill exceeds its implied fair value. An impairment loss is recognized for the amount that the carrying amount of the reporting unit, including goodwill, exceeds its fair value, limited to the total amount of goodwill allocated to that reporting unit. The Company did <ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzE3NTM_3a6e0b9c-3377-469e-88fe-7e11a89c3000"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzE3NTM_ba4fa088-6841-40d4-b943-70aac5c386ca"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="INF" name="us-gaap:AssetImpairmentCharges" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzE3NTM_d7ae9818-d9c8-417c-9975-50b97aa5e870">no</ix:nonFraction></ix:nonFraction></ix:nonFraction>t identify any impairment charge during the years ended December 31, 2021, 2020 and 2019.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzYwNDczMTM5NTQ3MzU_c35b0b10-ebb3-4411-bf63-7b2d4bdd36f6" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents activity in goodwill by segment as of and for the year ended December 31, 2021:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.122%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.005%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.008%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9ad5091204ea402db4f786593e9c88e3_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzEtMS0xLTEtNDExMzI_2c09372e-d923-4224-be27-652ce9390039">37,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i646d026e30024a759d2d20651293e096_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzEtMy0xLTEtNDExMzI_779a8f71-d887-4095-9a0f-062473d82e1d">3,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzEtNS0xLTEtNDExMzI_43f931c8-bb20-4719-90d9-509f60d16eca">41,233</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8bee216f16649f4bd17307d4aca1e38_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzItMS0xLTEtNDExMzI_f1618c4d-0a75-481a-9d11-e68beea08d28">25,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaaa4cbfc68844bf2ab83f3ee4d31a520_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzItMy0xLTEtNDExMzI_98179cfe-d7e2-4eca-b2cb-f02fec0d05d0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzItNS0xLTEtNDExMzI_0a4c8864-7606-4cf5-8f11-15930a174d13">25,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i594abec2ef2e406b8dbe4ab6e7d5e8ee_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzQtMS0xLTEtNDExMzI_e43d1a8a-2699-49a3-82bc-35bb7b8966c9">62,802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7266ba82d91645fe8dc1b6eb5c7fc950_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzQtMy0xLTEtNDExMzI_cc1582bb-6347-4f3f-9abd-2281eba95124">3,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzQtNS0xLTEtNDExMzI_afc7b794-59bf-485c-a347-303f91d7baea">66,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35d93aabb6ad43d4a0807093b6ff3cdd_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzUtMS0xLTEtNDExMzI_827d2ef7-fc97-4d30-8473-11f9eeef4ac3">7,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idca163657edf4bc2aca2d8b382f0f7b2_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzUtMy0xLTEtNDExMzI_1b4d25d3-39b7-4185-93cb-ea28c993495c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:GoodwillAcquiredDuringPeriod" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzUtNS0xLTEtNDExMzI_5c3d94a5-026f-4332-b9bf-8067a9ff46f6">7,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife1126ceed284fbdb9bf6b3dbab68da3_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzctMS0xLTEtNDExMzI_7b4faa7c-3ff3-4ad1-b6bc-eee7eb63878c">70,623</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icc510d566b5a497d8c3bf8da297c74be_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzctMy0xLTEtNDExMzI_5bca0797-3c77-41d9-9e9a-d92030303ac3">3,642</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzctNS0xLTEtNDExMzI_2a017b51-3585-461d-95ce-1e4439d12f94">74,265</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzYwNDczMTM5NTQ3MzY_94ed95a3-93f4-4e5f-b47a-48a3f9b280f8" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other indefinite-lived intangible assets consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:60.011%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.053%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i85977dbd3e304b269d60b79b21d58dd3_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzItMS0xLTEtNDExMzI_2a58d458-5b61-48f0-8618-191baeee31a2">1,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i295733ffaf3446e09492cf5e0c2391e7_I20201231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzItMy0xLTEtNDExMzI_19e23182-20cd-443a-a919-b49aaf7bfe5d">1,355</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicaid licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib53ed044a9784155997f65bf19912e24_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzMtMS0xLTEtNDExMzI_ebcf55e0-577a-44df-aabc-d627e857898e">52,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3953707a65c34f67a229dcf123865af0_I20201231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzMtMy0xLTEtNDExMzI_6c068dcf-764b-49c5-a7f3-e43d8c4b5f10">46,133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzQtMS0xLTEtNDExMzI_303163cd-3509-46c7-bfc0-3b2ae30e1481">53,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzQtMy0xLTEtNDExMzI_94dcff77-e252-439d-825c-1a91c33be561">47,488</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_190"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">10.&#160;<ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:OtherLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90ZXh0cmVnaW9uOjM0MzNkYTQzYjUzNjQxN2ViMWVkZWYzODExZmFiZTE0XzYwNDczMTM5NTQ0NTE_a7723c33-1bff-4ca0-8776-99b09ba928ad" continuedAt="i6a9580a149a045af9a6720769618cff2" escape="true">OTHER ACCRUED LIABILITIES</ix:nonNumeric></span></div><ix:continuation id="i6a9580a149a045af9a6720769618cff2" continuedAt="ica9b3e72d83b4c36a221e59d01284659"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90ZXh0cmVnaW9uOjM0MzNkYTQzYjUzNjQxN2ViMWVkZWYzODExZmFiZTE0XzYwNDczMTM5NTQ0NTI_df11d9e4-1639-4de0-af1f-bb5d5694ec34" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.052%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.054%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refunds payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:CustomerRefundLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzItMi0xLTEtNDExMzI_81396711-76f5-4e45-8838-23fbee48da5e">3,095</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:CustomerRefundLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzItNC0xLTEtNDExMzI_e58fd7e7-e8a2-467e-8bb8-f8531bdb93a3">2,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzMtMi0xLTEtNDExMzI_59ffdc6d-4d59-4efd-9002-124d5f1367a9">1,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzMtNC0xLTEtNDExMzI_a0162c97-d22d-4cf7-9273-7070fa382710">1,271</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resident deposits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DepositLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzQtMi0xLTEtNDExMzI_4b371e10-3151-420f-bb62-77b21d415fe6">5,111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DepositLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzQtNC0xLTEtNDExMzI_7e4e69a6-365c-436f-adff-9807d0d8493f">5,647</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (CARES Act advance payments)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:ContractLiabilityAdvancePaymentsCARESAct" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzUtMi0xLTEtNDExMzI_1dc0861a-e439-4cdc-84b8-edf57f2610b7">6,211</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="pntg:ContractLiabilityAdvancePaymentsCARESAct" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzUtNC0xLTEtNDExMzI_040a8047-df5f-4f24-ae0e-c68819512fa8">22,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzYtMi0xLTEtNDExMzI_b9d0d43d-686f-4718-b05d-ef88d9a99a68">1,102</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzYtNC0xLTEtNDExMzI_c0c679f6-f525-4fb4-bf0f-fe0e5808d0f9">982</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance retention - current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:SelfInsuranceReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzctMi0xLTEtNDExMzI_2dc35608-da5c-4506-82e5-e00e2d39f1df">1,613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:SelfInsuranceReserveCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzctNC0xLTEtNDExMzI_6c8c51c7-7f43-4678-a313-c4c14691b9ee">1,354</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzgtMi0xLTEtNDExMzI_6b3c9242-6ac5-4814-be4b-edd2f03ce619">2,896</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzgtNC0xLTEtNDExMzI_d16ef7e9-0273-4059-aeb6-561712c79e8f">3,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzktMi0xLTEtNDExMzI_face03ba-bd3d-4130-b566-610e02b17ac5">21,484</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzktNC0xLTEtNDExMzI_844011ce-598d-4d1b-a615-48cc3f76b12c">38,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refunds payable includes payables related to overpayments, duplicate payments and credit balances from various payor sources. Deferred revenue occurs when the Company receives payments in advance of services provided. Resident deposits include refundable deposits to residents and a small portion consists of non-refundable deposits recognized into revenue over a period of time. The CARES Act also expanded the Centers for Medicare &amp; Medicaid Services&#8217; (&#8220;CMS&#8221;) ability to provide accelerated/advance payments intended to increase the cash flow of healthcare providers and suppliers impacted by COVID-19. During the second quarter of 2020, the Company applied for and received $<ix:nonFraction unitRef="usd" contextRef="ia2439a6130274330bd9bb469dbc05ee6_I20200630" decimals="-3" name="pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90ZXh0cmVnaW9uOjM0MzNkYTQzYjUzNjQxN2ViMWVkZWYzODExZmFiZTE0Xzc1OA_1f345d88-f75e-4030-bb38-803a456dc7fa">27,997</ix:nonFraction> in funds under the AAP Program. On October 1, 2020, the Continuing Appropriations Act, 2021 and Other Extensions Act (the &#8220;CA Act&#8221;) was signed into law. Among other things, the CA Act significantly changed the repayment terms for AAP. These funds are subject to </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ica9b3e72d83b4c36a221e59d01284659">automatic recoupment through offsets to new claims beginning one year after funds were issued beginning in April 2021, at which time, Medicare began to automatically recoup 25% of Medicare payments for 11 months. At the end of the 11 months and assuming full repayment has not occurred, recoupment will increase to 50% for another six months. Any balance outstanding after these two recoupment periods will be subject to repayment at a 4% interest rate. For the year ended December 31, 2021, the Company repaid $<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="pntg:RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90ZXh0cmVnaW9uOjM0MzNkYTQzYjUzNjQxN2ViMWVkZWYzODExZmFiZTE0XzEwOTk1MTE2Mjk1Mjk_635112fa-0aaf-42cd-a654-b88307ec0aea">21,786</ix:nonFraction> of the AAP funds. The Company reclassified $<ix:nonFraction unitRef="usd" contextRef="ifc995fe4fa2343f99750c39392d1ca31_I20201231" decimals="-3" name="us-gaap:LiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90ZXh0cmVnaW9uOjM0MzNkYTQzYjUzNjQxN2ViMWVkZWYzODExZmFiZTE0XzEwOTk1MTE2Mjk3NDY_bf937794-2d21-4d69-b4b1-fc57512ee432">5,226</ix:nonFraction> of AAP to other long-term liabilities for the year ended December 31, 2020. The Company anticipates completing repayment of the AAP within the allotted recoupment periods.</ix:continuation></span></div><div><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_193"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">11. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzYwNDczMTM5NTYzMTg_2c8977e1-c3e4-4bef-811a-fb8bf406b58a" continuedAt="i225fd435e6aa46cc945f609977aa58c3" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="i225fd435e6aa46cc945f609977aa58c3"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzYwNDczMTM5NTYzMjA_956a1c7a-1169-4b64-8322-984d988cd04a" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt, net consists of the following:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i87be8b1071da42259fd25653dc6e32b8_I20211231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzItMS0xLTEtNDExMzI_08d171c7-9dec-46fc-9d67-cefa36cefdf1">53,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2750bb749074a028d77edb545a82f0d_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzItMy0xLTEtNDExMzI_b91570d4-632e-40fb-9a10-8d590cbcd0f9">9,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzMtMS0xLTEtNDExMzI_ea3ee317-66dd-41cf-b511-f4eff85ea0d9">2,128</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzMtMy0xLTEtNDExMzI_777e7c1a-6ee4-4c72-801f-9804725c7a54">1,223</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzQtMS0xLTEtNDExMzI_f9883837-8ea8-4b88-8725-81c331e5027d">51,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzQtMy0xLTEtNDExMzI_5d7e4cbc-b6e1-44dd-ab17-e1b029011576">8,277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization expense for debt issuance costs was $<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphODM0ODQzYTY3ZDc0ZGE5YWMwNzFlZWEyMzI0MTk1OS90YWJsZXJhbmdlOmE4MzQ4NDNhNjdkNzRkYTlhYzA3MWVlYTIzMjQxOTU5XzAtMi0xLTEtNjE2MjMvdGV4dHJlZ2lvbjpkYzg3NjljMGVkN2I0MjEyOTFmYjg0NGE0ZDYyZDk4OF8xMDk5NTExNjI3OTk4_5c4b2629-1cab-49b8-b569-03a40c47f8cd">488</ix:nonFraction>, $<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphODM0ODQzYTY3ZDc0ZGE5YWMwNzFlZWEyMzI0MTk1OS90YWJsZXJhbmdlOmE4MzQ4NDNhNjdkNzRkYTlhYzA3MWVlYTIzMjQxOTU5XzAtMi0xLTEtNjE2MjMvdGV4dHJlZ2lvbjpkYzg3NjljMGVkN2I0MjEyOTFmYjg0NGE0ZDYyZDk4OF8xMDk5NTExNjI4MDA4_c92bc23e-f6c4-4c2d-bdb0-b07e9aadc8b8">330</ix:nonFraction>, and $<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:AmortizationOfFinancingCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphODM0ODQzYTY3ZDc0ZGE5YWMwNzFlZWEyMzI0MTk1OS90YWJsZXJhbmdlOmE4MzQ4NDNhNjdkNzRkYTlhYzA3MWVlYTIzMjQxOTU5XzAtMi0xLTEtNjE2MjMvdGV4dHJlZ2lvbjpkYzg3NjljMGVkN2I0MjEyOTFmYjg0NGE0ZDYyZDk4OF8xMDk5NTExNjI4MDE0_dfa3ae6c-d0f4-46ee-98ad-b17d0090c15d">78</ix:nonFraction> for the years ended December 31, 2021, 2020 and 2019, respectively, and is recorded in interest expense, net on the Consolidated and Combined Statements of Income.</span></div></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;23, 2021, Pennant entered into an amendment to its existing credit agreement (as amended, the &#8220;Credit Agreement&#8221;), which provides for an increased revolving credit facility with a syndicate of banks with a borrowing capacity of $<ix:nonFraction unitRef="usd" contextRef="i0ed5cb11e8c74a8cab4af56099f9fe37_I20210223" decimals="INF" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2MzczOTk_93b6499e-c80a-441e-8c47-2b4d4242e527">150,000</ix:nonFraction> (the &#8220;Revolving Credit Facility&#8221;). The interest rates applicable to loans under the Revolving Credit Facility are, at the Company&#8217;s election, either (i) Adjusted LIBOR (as defined in the Credit Agreement) plus a margin ranging from <ix:nonFraction unitRef="number" contextRef="if8303ce9e51d4a7a9f23b6cb4859d119_D20210223-20210223" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MDQ_baa2c1b4-ada5-4af3-95a8-bcc0709029d3">2.3</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i7bcff1b3b19a471fbb07b38194bdf040_D20210223-20210223" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MDg_7f014d7a-35fa-4bd8-bac1-f52e6b231235">3.3</ix:nonFraction>% per annum or (ii) Base Rate plus a margin ranging from <ix:nonFraction unitRef="number" contextRef="iff4b598798b347b1bad79e786d66d4ec_D20210223-20210223" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MTI_6c69150a-492e-49e8-b5c2-2d43863a7815">1.3</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="i15fbe4ddfaed4fb2ab68184822fc9b20_D20210223-20210223" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MTY_a3cd37c4-c25b-4ce3-9049-49055b9f49f1">2.3</ix:nonFraction>% per annum, in each case based on the ratio of Consolidated Total Net Debt to Consolidated EBITDA (each, as defined in the Credit Agreement). In addition, Pennant pays a commitment fee on the undrawn portion of the commitments under the Revolving Credit Facility which ranges from <ix:nonFraction unitRef="number" contextRef="id896243133374d5a85762f6aa03af650_D20210223-20210223" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MjA_b7c48e58-7fde-44b4-9024-29162d5fad32">0.35</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="ie9d1d1fbe9ca4de3972432630165dd25_D20210223-20210223" decimals="INF" name="us-gaap:LineOfCreditFacilityCommitmentFeePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MjQ_bbaa1a6e-ff3f-46e9-afac-6fcec0da2b40">0.50</ix:nonFraction>% per annum, depending on the Consolidated Total Net Debt to Consolidated EBITDA ratio of the Company and its subsidiaries. The Company is not required to repay any loans under the Credit Agreement prior to maturity in 2026, other than to the extent the outstanding borrowings exceed the aggregate commitments under the Credit Agreement. As of December 31, 2021, the Company&#8217;s weighted average interest rate on its outstanding debt was <ix:nonFraction unitRef="number" contextRef="i87be8b1071da42259fd25653dc6e32b8_I20211231" decimals="4" name="us-gaap:LongtermDebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0NDA_7e44916e-c249-4311-8d26-b2163213224c">2.64</ix:nonFraction>%. As of December 31, 2021, the Company had available borrowing on the Revolving Credit Facility of $<ix:nonFraction unitRef="usd" contextRef="i87be8b1071da42259fd25653dc6e32b8_I20211231" decimals="INF" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0NDQ_310dc3b8-2c34-4931-b7fe-105439d362ac">92,314</ix:nonFraction>, which is net of outstanding letters of credit of $<ix:nonFraction unitRef="usd" contextRef="ibe0c05707f51401b8343fc06afba6d47_I20211231" decimals="-3" name="us-gaap:LettersOfCreditOutstandingAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0NTE_9d7867c9-dc51-4513-ba04-a0c9d78792ca">4,186</ix:nonFraction>. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Revolving Credit Facility approximates carrying value, due to the short-term nature and variable interest rates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of this debt is categorized within Level 2 of the fair value hierarchy based on the observable market borrowing rates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement is guaranteed, jointly and severally, by certain of the Company&#8217;s independent operating subsidiaries, and is secured by a pledge of stock of the Company's material independent operating subsidiaries as well as a first lien on substantially all of each material operating subsidiary's personal property. The Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its independent operating subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments. Financial covenants require compliance with certain levels of leverage ratios that impact the amount of interest. As of December 31, 2021, the Company was compliant with all such financial covenants.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_196"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDI_76779b0c-c940-46e8-935e-2ef8b34668ed" continuedAt="i220bb3994e324bcaa06f3975dadeb154" escape="true">OPTIONS AND AWARDS</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i220bb3994e324bcaa06f3975dadeb154" continuedAt="idffb19630cd84a06831c0a4b8efad8bd">Share-based compensation expense consists of share-based payment awards made to employees and directors,  including employee stock options, restricted stock awards (&#8220;RSA&#8221;), and restricted stock units (&#8220;RSU&#8221; and together with RSA, &#8220;Restricted Stock&#8221;), based on estimated fair values, ratably over the requisite service period of the award. The Company accounts for forfeitures as they occur.</ix:continuation></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="idffb19630cd84a06831c0a4b8efad8bd" continuedAt="i09755e1f4c244f7798cc9e72c1fa3fa6"><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Spin-Off, the Company issued new options and restricted stock awards to Pennant and Ensign employees under the 2019 Omnibus Incentive Plan (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OIP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and Long-Term Incentive Plan (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LTIP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, together referred to as the &#8220;Pennant Plans&#8221;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prior to Spin-Off</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all periods prior to the Spin-Off, employees of the Company participated in Ensign's share-based compensation plans. The compensation expense recorded by the Company included the expense associated with these employees, as well as an allocation of share-based compensation of certain Ensign employees who provided general and administrative services on our behalf.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding options held by employees of the Company under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ensign stock plans (collectively the &#8220;Ensign Plans&#8221;) and outstanding options and restricted stock awards under the Company Subsidiary Equity Plan (together with the Ensign Plans the &#8220;Pre-Spin Plans&#8221;) </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were modified and replaced with Pennant awards under the Pennant Plans at the Spin-Off date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following disclosures represent share-based compensation expense relating to the Ensign and Pennant Plans, including awards to employees of the Company&#8217;s subsidiaries and an allocation of costs from employees in the Service Center prior to the Spin-Off, and total share-based compensation after the Spin-Off.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDM_d59a53e3-4d81-4a48-a867-d9695d7d716a" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense for all of the Plans for the years ended December 31, 2021, 2020 and 2019:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.332%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.938%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prior to the Spin-Off:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ffd18948f6c4a1e9cdee019c70baf5e_D20190101-20191001" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzMtNS0xLTEtNDExMzI_3ff5d4d8-4a74-44df-aa7f-59e784be077f">1,395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Following the Spin-Off:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense related to stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i009062db7a07451db770939cb218b995_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzYtMS0xLTEtNDExMzI_3a69ccd0-9cdc-4b19-8a55-b8252d99b414">3,093</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia395591b1bb04bc59721af3b9e0057ad_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzYtMy0xLTEtNDExMzI_5e9f3a09-a51c-431d-8c09-acb3a5d077e7">1,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i324266d2a6034a369becaa333073dedc_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzYtNS0xLTEtNDExMzI_5bb7f671-3d90-452c-95be-384e26595c1b">315</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense related to Restricted Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibca5874771a942ac8128f8834681ae6b_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzctMS0xLTEtNDExMzI_08b77aac-39aa-42e3-8754-fc2c316caa11">6,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95a5ddcc5c1c4f24a7b7984fb2f61366_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzctMy0xLTEtNDExMzI_03870e48-9ff7-4a6a-8ec6-7c029c747705">6,200</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7835b6571f414650b23c89f2da3e8e1d_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzctNS0xLTEtNDExMzI_3943d9a7-990a-4037-b0a9-e92b3f947c0b">1,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense related to Restricted Stock to non-employee directors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i820fe8df97df45148956430597a8021c_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzgtMS0xLTEtNDExMzI_f4d4eb5e-e7c8-4cc7-abb1-2aa1352d0ee1">806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic2d08a40a2ea4844850b407dc06a1380_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzgtMy0xLTEtNDExMzI_2a7cf496-e0e1-4a72-a6a8-4a7fa5782bd1">475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18d0ff58a4094edcab67e0572e47b712_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzgtNS0xLTEtNDExMzI_8abff8f6-c70c-4546-b355-52ad496cc4f9">83</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzktMS0xLTEtNDExMzI_f598669c-9b49-4d86-8a99-f12e720f9d8d">10,040</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzktMy0xLTEtNDExMzI_4d7c7dfb-83f4-4435-bca1-8ad83a1e5c3e">8,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzktNS0xLTEtNDExMzI_a6ef13cd-bb4f-4439-9090-b7ad3bf6b0cc">3,382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In future periods, the Company estimates it will recognize the following share-based compensation expense for unvested stock options and unvested Restricted Stock, which were unvested as of December 31, 2021: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.402%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.783%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.785%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Recognition Period (in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c42f8d3450a45bb97f418276e55401a_I20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTphNDM1MWZjODgyMzA0NDhhODFjNTEwYjI1YWVhZWY5NC90YWJsZXJhbmdlOmE0MzUxZmM4ODIzMDQ0OGE4MWM1MTBiMjVhZWFlZjk0XzEtMS0xLTEtNDExMzI_095d2527-e37d-4116-8a4d-b092056e67bd">12,620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i695c64b54bea4f3ea301a4f593b04c27_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTphNDM1MWZjODgyMzA0NDhhODFjNTEwYjI1YWVhZWY5NC90YWJsZXJhbmdlOmE0MzUxZmM4ODIzMDQ0OGE4MWM1MTBiMjVhZWFlZjk0XzEtMy0xLTEtNDExMzI_2054ec3e-ecac-4f85-a942-aa360dac5f2c">3.8</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested Restricted Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71a2785689d7485e88d7d7a0fd2e1588_I20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTphNDM1MWZjODgyMzA0NDhhODFjNTEwYjI1YWVhZWY5NC90YWJsZXJhbmdlOmE0MzUxZmM4ODIzMDQ0OGE4MWM1MTBiMjVhZWFlZjk0XzItMS0xLTEtNDExMzI_22bea62d-25ab-4546-a155-a95b2aa3ead2">4,780</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTphNDM1MWZjODgyMzA0NDhhODFjNTEwYjI1YWVhZWY5NC90YWJsZXJhbmdlOmE0MzUxZmM4ODIzMDQ0OGE4MWM1MTBiMjVhZWFlZjk0XzItMy0xLTEtNDExMzI_eebf216e-1e89-4195-aa3f-d357205a9ef4">0.9</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTphNDM1MWZjODgyMzA0NDhhODFjNTEwYjI1YWVhZWY5NC90YWJsZXJhbmdlOmE0MzUxZmM4ODIzMDQ0OGE4MWM1MTBiMjVhZWFlZjk0XzMtMS0xLTEtNDExMzI_99780f15-edb8-40b3-9998-962a6250b2a5">17,400</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Pennant Plans, options granted to employees of the subsidiaries of Pennant generally vest over <ix:nonNumeric contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzIwMDI_0d1fb474-2cb5-4b76-bd39-77b6b3763f85">five years</ix:nonNumeric> at <ix:nonFraction unitRef="number" contextRef="i695c64b54bea4f3ea301a4f593b04c27_D20210101-20211231" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzIwMDg_69170276-cda1-4fb6-afba-4ad98cedeb96">20</ix:nonFraction>% per year on the anniversary of the grant date. Options expire <ix:nonNumeric contextRef="i695c64b54bea4f3ea301a4f593b04c27_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzIwNzM_3acbc461-27db-4c26-9b5f-de1f8c64c73a">ten years</ix:nonNumeric> after the date of grant. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option-pricing model to recognize the value of share-based compensation expense for share-based payment awards under the Plans. Determining the appropriate fair-value model and calculating the fair value of share-based awards at the grant date requires considerable judgment, including estimating stock price volatility and </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i09755e1f4c244f7798cc9e72c1fa3fa6" continuedAt="i639b8ac5ebbf404a86b4b1791428f8db"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expected option life. The Company develops estimates based on historical data and market information, which can change significantly over time. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDU_23226234-4fe9-46ec-8024-fa63b8801fbf" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option is estimated on the grant date using a Black-Scholes option-pricing model with the following weighted average assumptions for stock options granted after the Spin-Off:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:24.338%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.607%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Year</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Granted</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Free Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dividend Yield</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Fair Value of Options</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fba7cde195142a3978c879c27cb0bab_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtMi0xLTEtNDExMzI_5f457402-dd1d-4e3b-a6cb-70d6b86ab9fb">454</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtNC0xLTEtNDExMzI_9db87ed0-5a91-4e96-9ee7-ea3b0a246015">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtNi0xLTEtNDExMzI_3d0c5904-2115-4114-9575-2d5ca17dad54">6.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtOC0xLTEtNDExMzI_46a6bf1a-eddc-4c46-827f-7574a0666158">38.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtMTAtMS0xLTQxMTMy_feaca482-5893-4f4c-88c7-aa2d8aa84c59">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2fba7cde195142a3978c879c27cb0bab_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtMTItMS0xLTQxMTMy_72e41af9-7e20-45ff-84c9-8e0ef0c9d3da">13.84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icc2e87893a0146e3bc467cb6aa1d0766_D20200101-20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItMi0xLTEtNDExMzI_0c0d8497-d472-46ce-96a8-7d4574d82341">693</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia6c286ff8cbc4714836982d56e9417c0_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItNC0xLTEtNDExMzI_e1abb53f-bae8-4c9f-9ded-9d1347a007f4">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia6c286ff8cbc4714836982d56e9417c0_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItNi0xLTEtNDExMzI_c3973274-4e90-45bb-84a3-7b179ea31bbe">6.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia6c286ff8cbc4714836982d56e9417c0_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItOC0xLTEtNDExMzI_313f859d-b431-47d5-b6c8-817e7a9e6b22">35.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia6c286ff8cbc4714836982d56e9417c0_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItMTAtMS0xLTQxMTMy_2f3b7158-5f97-4332-b273-f43153a8ce30">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icc2e87893a0146e3bc467cb6aa1d0766_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItMTItMS0xLTQxMTMy_616128f7-5181-434f-aabf-5812e72f57e0">11.05</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iddb04c9f35bb476b81dba3be31ee57a0_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtMi0xLTEtNjE0NzQ_40c4478a-aa53-45d0-aad9-8f3e46a3dd99">667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id19dc50301904b4ca1463fc976675c69_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtNC0xLTEtNjE0NzQ_187971bb-be4b-4951-b2a7-e3e0dbd6efaf">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="id19dc50301904b4ca1463fc976675c69_D20190101-20191231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtNi0xLTEtNjE0NzQ_06c337c8-ae07-495c-917c-18326460fd76">6.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id19dc50301904b4ca1463fc976675c69_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtOC0xLTEtNjE0NzQ_cc41a2eb-4b2a-4fc3-8dd8-71ae6bd0b319">34.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="id19dc50301904b4ca1463fc976675c69_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtMTAtMS0xLTYxNDc0_e413f584-0b4d-4fb2-ac20-5684574d45c1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iddb04c9f35bb476b81dba3be31ee57a0_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtMTItMS0xLTYxNDc0_86603725-b3de-4fb5-aaae-871a4d7537ab">5.70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Under the midpoint method, the expected option life is the midpoint between the contractual option life and the average vesting period for the options being granted. This resulted in an expected option life of <ix:nonNumeric contextRef="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo0YjZlNzc0YmNiMmQ0YWY0YTllNGNhMmYxMWFjNjI1NC90YWJsZXJhbmdlOjRiNmU3NzRiY2IyZDRhZjRhOWU0Y2EyZjExYWM2MjU0XzAtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjozMGY3YmNjYmVhNWM0ZjA3YjZlMGFiMTczMzBkMTEwM18yMTQ_3d0c5904-2115-4114-9575-2d5ca17dad54">6.5</ix:nonNumeric> years for the options granted.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Because the Company&#8217;s equity shares have been traded for a relatively short period of time, expected volatility assumption was based on the volatility of related industry stocks.</span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDY_c7b33298-9e9a-4c19-ba37-357e27bbe11e" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the employee stock option activity during the year ended December 31, 2021:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Outstanding</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Vested</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">of Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vested</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie191aaa5b8784c6cb75b59a0e2300e56_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzUtMS0xLTEtNDExMzI_7ecc5b57-d62c-475c-901c-ca59cda51abf">1,982</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie191aaa5b8784c6cb75b59a0e2300e56_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzUtMy0xLTEtNDExMzI_894a6295-5f65-4c11-a1c9-cea4659492bb">17.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie191aaa5b8784c6cb75b59a0e2300e56_I20201231" decimals="-3" name="pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzUtNS0xLTEtNDExMzI_4734b625-dd8c-497e-96e8-d9660d774754">615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ie191aaa5b8784c6cb75b59a0e2300e56_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzUtNy0xLTEtNDExMzI_c84306a0-32d1-427f-849b-6f54a07b6cdf">7.52</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzYtMS0xLTEtNDExMzI_321213db-5e2f-4d43-8569-3297f2f7b022">454</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzYtMy0xLTEtNDExMzI_3208c4da-3c7d-431f-a6ab-f1122f198af2">35.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzctMS0xLTEtNDExMzI_df60f7f1-bed9-448a-bbd6-958302b8369b">115</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzctMy0xLTEtNDExMzI_0d6e45cd-f6cf-4720-8109-37a68a6474b0">7.67</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/ Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzgtMS0xLTEtNDExMzI_0cdea695-97fd-4aba-9fd0-fdafeb2ed3de">79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzgtMy0xLTEtNDExMzI_df7d1a72-d268-49b0-a8a1-273a217861ab">21.81</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzEwLTEtMS0xLTQxMTMy_74253849-5dfa-4992-8be6-8f9a6d13c12b">2,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzEwLTMtMS0xLTQxMTMy_94b44ef0-0ebf-46d2-a298-acaaff97f1bb">21.38</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231" decimals="-3" name="pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzEwLTUtMS0xLTQxMTMy_919dc38d-4fdb-4206-8bba-fe4c376f4964">840</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzEwLTctMS0xLTQxMTMy_e3c93b9f-b93f-4951-a0de-3c491b6a9675">12.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDc_8d4bcc8d-4517-4e47-81b8-6ed1b8d22a81" escape="true"><div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options outstanding, vested, unvested and exercised as of and for the period ended December 31, 2021 is as follows:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.356%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.444%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo1ODIyYmUzZDc2MDM0ODZjODhmODdmMTk4NzhjMTFjNC90YWJsZXJhbmdlOjU4MjJiZTNkNzYwMzQ4NmM4OGY4N2YxOTg3OGMxMWM0XzEtMS0xLTEtNDExMzI_b2cc6a9a-1efb-47ca-bb19-8832424e3769">14,749</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231" decimals="-3" name="pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo1ODIyYmUzZDc2MDM0ODZjODhmODdmMTk4NzhjMTFjNC90YWJsZXJhbmdlOjU4MjJiZTNkNzYwMzQ4NmM4OGY4N2YxOTg3OGMxMWM0XzItMS0xLTEtNDExMzI_eda7bcde-3725-4efe-8609-3ea68d739f7e">10,221</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231" decimals="-3" name="pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo1ODIyYmUzZDc2MDM0ODZjODhmODdmMTk4NzhjMTFjNC90YWJsZXJhbmdlOjU4MjJiZTNkNzYwMzQ4NmM4OGY4N2YxOTg3OGMxMWM0XzMtMS0xLTEtNDExMzI_1f68c68a-3b4a-4831-acce-9a0ef89d6c49">4,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo1ODIyYmUzZDc2MDM0ODZjODhmODdmMTk4NzhjMTFjNC90YWJsZXJhbmdlOjU4MjJiZTNkNzYwMzQ4NmM4OGY4N2YxOTg3OGMxMWM0XzQtMS0xLTEtNDExMzI_b56e6e3d-6c95-46ee-b530-67d04311d8a6">3,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value is calculated as the difference between the market value of the underlying common stock and the exercise price of the options. There were <ix:nonFraction unitRef="shares" contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzMxODg_40e68488-cd62-455a-94f7-627576fc6792">1,402</ix:nonFraction> unvested and outstanding options at December 31, 2021. The weighted average contractual life for options outstanding, vested and expected to vest at December 31, 2021 was&#160;<ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzMzMzI_37b14680-ea9a-48a9-96bc-b55662ff7615">7.39</ix:nonNumeric> years.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i639b8ac5ebbf404a86b4b1791428f8db"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Pennant Plans, the Company granted Restricted Stock to Pennant employees, Ensign employees, and to non-employee directors. All awards generally vest between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzM1Mjk_ccbd4d6d-4bc1-4f64-a712-9a0de31e9ccd">three</span> to <ix:nonNumeric contextRef="i55dd760f997d474083702aac3bd35021_D20210101-20211231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzM1MzU_ffa3cad7-62ac-4cd9-8635-971cff0f9918">five years</ix:nonNumeric>. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDg_33b8bad3-6726-4893-8176-9c8addf4881b" continuedAt="if5099f14a96b4b3b9165f09d50370a01" escape="true">A summary of the status of Pennant&#8217;s non-vested Restricted Stock, and changes during the period ended December 31, 2021, is presented below: </ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><ix:continuation id="if5099f14a96b4b3b9165f09d50370a01"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.783%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.668%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Vested Restricted Awards</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdcc7ffbdc094bad9d2c2e68f1561ed9_I20201231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzEtMS0xLTEtNDExMzI_57a4fa46-f40c-4b27-aa2e-c8c15aaf4da2">1,635</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icdcc7ffbdc094bad9d2c2e68f1561ed9_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzEtMy0xLTEtNDExMzI_8b865ae8-be39-4e60-b6ac-b7be70119419">14.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzItMS0xLTEtNDExMzI_293efb5e-b8f9-47ee-bc82-fe8b3c098893">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzItMy0xLTEtNDExMzI_ea790946-fe07-4b98-b972-caee97917852">39.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzMtMS0xLTEtNDExMzI_8a495bd6-421c-4bcf-8c86-4c408cee75a9">157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzMtMy0xLTEtNDExMzI_f11aa232-ad72-469c-a1d8-66cbb6d7f922">16.20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzQtMS0xLTEtNDExMzI_e8851f9a-69ed-4778-9126-475f81a303a4">5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzQtMy0xLTEtNDExMzI_6dbd53a8-2d61-4a9b-949d-47ee2b820c42">14.13</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i71a2785689d7485e88d7d7a0fd2e1588_I20211231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzUtMS0xLTEtNDExMzI_ac885050-1ceb-4573-a517-753ccc262f37">1,493</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i71a2785689d7485e88d7d7a0fd2e1588_I20211231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzUtMy0xLTEtNDExMzI_53a75850-6f92-4d1e-ad90-5755b89c992b">15.00</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div></ix:continuation><div style="padding-left:13.5pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_199"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">13. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzYwNDczMTM5NTU2Njc_cc8275f9-4dfe-401d-aa97-2133b1f4a4b2" continuedAt="i3211d3a7039f4cb392c55c9102d11a5d" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="i3211d3a7039f4cb392c55c9102d11a5d" continuedAt="ifd72bfe34a1a43899105678087e32e47"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s independent operating subsidiaries lease <ix:nonFraction unitRef="facility" contextRef="icc510d566b5a497d8c3bf8da297c74be_I20211231" decimals="INF" name="pntg:NumberOfRealEstatePropertiesUnderLease" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzcx_85a39232-d244-4a56-8dc2-b69d7294136d">54</ix:nonFraction> senior living communities and its administrative offices under non-cancelable operating leases, most of which have initial lease terms ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzIyMg_b91d98ae-34f8-4760-a680-7806138f8865">five</span> to <ix:nonNumeric contextRef="i4ca3f78db99945b69974d02c724d9240_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzIyOA_668b41a2-39c3-4d86-a17b-d3ae7a022373">21</ix:nonNumeric> years. The Company&#8217;s independent operating subsidiaries also lease the administrative offices of <ix:nonFraction unitRef="agency" contextRef="ife1126ceed284fbdb9bf6b3dbab68da3_I20211231" decimals="INF" name="pntg:NumberOfServiceProviders" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzEwOTk1MTE2MzA4Mjk_601ff99b-7d5b-4095-bf9d-eab16d3843b7">88</ix:nonFraction> home health and hospice agencies which generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzEwOTk1MTE2MzA5MjU_3cc0a8cb-6980-4caa-9f55-af4c4d207bb0">one</span> to <ix:nonNumeric contextRef="i8fb2a9d080dd42e58f04fb43fed99eb9_I20201231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzEwOTk1MTE2MzA5MzM_40eacfbe-48d4-4706-b79d-24a9bd2d7b2c">seven years</ix:nonNumeric>. Most of these leases contain renewal options, most involve rent increases and none contain purchase options. The lease term excludes lease renewals because the renewal rents are not at a bargain, there are no economic penalties for the Company to renew the lease, and it is not reasonably certain that the Company will exercise the extension options. As of December 31, 2021, the Company&#8217;s independent operating subsidiaries leased <ix:nonFraction unitRef="property" contextRef="i69f3d63932564edfa50a96879cf88c45_I20211231" decimals="INF" name="us-gaap:NumberOfRealEstateProperties" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzY0OQ_b5902798-34f4-4cc2-868f-c1388c67b28f">32</ix:nonFraction> communities from subsidiaries of Ensign (&#8220;Ensign Leases&#8221;) under a master lease arrangement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The existing leases with subsidiaries of Ensign are for initial terms of between <ix:nonNumeric contextRef="i8539c32fc47d41f7855d6538692f738d_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzgyNQ_b54d788a-0a57-492f-85d9-904fdebfa608">14</ix:nonNumeric> to <ix:nonNumeric contextRef="ice5e4b95ef8a477bb882b9b591fb511b_I20211231" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzgzMQ_68f757fa-c9ca-4af9-9158-eb327701158e">20</ix:nonNumeric> years. In addition to rent, each of the operating companies are required to pay the following: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all community maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="facility" contextRef="i69f3d63932564edfa50a96879cf88c45_I20211231" decimals="INF" name="pntg:NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzE1MzU_ffa08c9f-f6bc-4ce6-ae59-50c99c93b53c">Fifteen</ix:nonFraction> of the Company&#8217;s affiliated senior living communities, excluding the communities that are operated under the Ensign Leases (as defined herein), are operated under <ix:nonFraction unitRef="arrangement" contextRef="i69f3d63932564edfa50a96879cf88c45_I20211231" decimals="INF" name="pntg:NumberOfSeparateMasterLeaseArrangements" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzE3MDE_8537a64a-60a5-4f81-9086-400efffd241e">two</ix:nonFraction> separate master lease arrangements. Under these master leases, a breach at a single community could subject one or more of the other communities covered by the same master lease to the same default risk. Failure to comply with Medicare and Medicaid provider requirements is a default under several of the Company&#8217;s leases and master leases. With an indivisible lease, it is difficult to restructure the composition of the portfolio or economic terms of the master lease without the consent of the landlord.</span></div><div><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzYwNDczMTM5NTU2NjU_37f12042-e5b0-4e6a-9d83-d9ee1553ec17" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease cost, are as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs:</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility rent&#8212;cost of services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibaa9096cc2bd4e858996c09298dd6eb0_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzMtMS0xLTEtNDExMzI_f1f10a45-f06f-4fcd-86fd-250236dcbaef">35,958</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1309a04126c24144b850a38c0baa4831_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzMtMy0xLTEtNDExMzI_2a58b975-58f4-4481-bef5-2f193a8f0cf7">35,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id61049412f5d48e69963ed0bcb95677c_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzMtNS0xLTEtNDExMzI_9509cccf-be82-43ff-a4dd-d8749134aff3">32,011</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59c4cea8cd4b414fbbbcfe383d2f2015_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzQtMS0xLTEtNDExMzI_c0d4c048-502f-498d-a8bb-10a8a0c098ce">4,905</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7385e6d9e8844d5b9ae1f8bed5241579_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzQtMy0xLTEtNDExMzI_fe62ee1b-c3c4-42b9-9d47-eb0d43ffe8d5">3,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if5ac6849e7e74533af722a23640f12d7_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzQtNS0xLTEtNDExMzI_c8cc0fb2-2e8f-4bb2-91a2-0e1e1f34ef2a">2,964</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzUtMS0xLTEtNDExMzI_f9a2a355-74ff-4020-badb-2c59181ec522">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzUtMy0xLTEtNDExMzI_33d2f365-76aa-47b8-acf1-6d55dde3b4e4">143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzUtNS0xLTEtNDExMzI_01cf4670-5487-4643-8399-4f7ac2dd6de4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0ee98e79dbdf4459bb64dd4764f5f04c_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzYtMS0xLTEtNDExMzI_b4eccbbd-9b50-474b-9d74-5e4c56a33de9">40,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief8be8ba89d54b41b5b925a9afe0bfd6_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzYtMy0xLTEtNDExMzI_5c8bb2a0-756d-4e60-bd72-d32d4e14d41a">39,191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i828be32df55549349516ec453fb5f7fa_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzYtNS0xLTEtNDExMzI_2d8c05ed-a2bd-4a2f-a614-8fdb052cf1e8">34,975</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e8f395592e742f3ba6c06ba1409606c_D20210101-20211231" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzgtMS0xLTEtNDExMzI_4e4ba5ab-f9d4-4cb5-af5f-6631ed74c53e">276</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i743dd5e050c24c6f903e2cd1bc39b900_D20200101-20201231" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzgtMy0xLTEtNDExMzI_9bfadd5a-4250-4126-b13d-dd6b0895b7cd">295</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib4445accb5d94db3851353dbfa2ed4f3_D20190101-20191231" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzgtNS0xLTEtNDExMzI_6ae480b9-24a6-42d8-8359-21540edcb4b5">162</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzktMS0xLTEtNDExMzI_6e098bd5-c98c-45b5-8164-28f75452cdb6">6,248</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzktMy0xLTEtNDExMzI_06561a5f-7cdb-4f67-8c86-d7e5c73e0710">5,330</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzktNS0xLTEtNDExMzI_5f72d5ed-e9ca-4d76-93e9-3a768ae14ca8">4,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents variable lease cost for operating leases, which costs include property taxes and insurance, common area maintenance, and consumer price index increases, incurred as part of our triple net lease, and which is included in cost of services for the years ended December 31, 2021, 2020 and 2019.</span></div></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="ifd72bfe34a1a43899105678087e32e47"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzYwNDczMTM5NTU2NjY_06a8f05e-4af0-4acc-9f72-a444dc55717e" escape="true"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the lease maturity analysis for all leases as of December 31, 2021:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.303%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.497%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzEtMS0xLTEtNDExMzI_ef052efc-addf-4a13-a2b7-eb4d938499d1">38,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzItMS0xLTEtNDExMzI_b615da92-d262-454d-8db0-1cba505d90c7">37,978</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzMtMS0xLTEtNDExMzI_77d1c28d-6241-4e9b-86c6-7c8acdc22693">36,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzQtMS0xLTEtNDExMzI_e3c337d1-4011-4ca6-9530-5ba25866d48e">35,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzUtMS0xLTEtNDExMzI_57667449-d0ef-4969-9b01-1f586127f048">35,078</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzYtMS0xLTEtNDExMzI_22f324be-7e4f-435e-b507-98a8fd7ac3e1">320,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzctMS0xLTEtNDExMzI_16df98ee-df06-4d12-ae15-2cd4c1a6b399">505,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzgtMS0xLTEtNDExMzI_ec9994a8-707b-4be2-b85d-68d2e583df51">201,462</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of total lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzktMS0xLTEtNDExMzI_9ef0affa-1932-40a4-9518-30b18bf44db5">303,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzEwLTEtMS0xLTQxMTMy_91046012-7478-4a8d-a53f-a46213817228">16,118</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzExLTEtMS0xLTQxMTMy_4b860369-58e3-4960-b704-0474df4cf2b4">287,753</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used its incremental borrowing rate based on the information available at each lease&#8217;s commencement date to determine each lease's operating lease liability. As of December 31, 2021, the weighted average remaining lease term is <ix:nonNumeric contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzI4NDA_64893e4f-8919-4b02-aca6-de364d8d4543">14.1</ix:nonNumeric> years and the weighted average discount rate is <ix:nonFraction unitRef="number" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzI4ODU_260ee93b-8a2c-42e4-ba2c-c126b22f60af">7.9</ix:nonFraction>%.</span></div></ix:continuation><div style="text-indent:22.5pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_202"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">14. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzYwNDczMTM5NTYyMDA_bda817fe-295f-4e2c-ac71-69dccd5b9587" continuedAt="i9aa2d091b61e423d86fb2fdf7143ccaa" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i9aa2d091b61e423d86fb2fdf7143ccaa" continuedAt="i7ce277018b674e78bef2e78a879855b2"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzYwNDczMTM5NTYyMDE_d98af7a9-bffb-4bb3-8bc3-95aedd179cd8" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income tax expense for the years ended December 31, 2021, 2020 and 2019 is summarized as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.915%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzMtMS0xLTEtNDExMzI_89fff5fc-bd49-4653-9371-1bae4dd8f604">1,768</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzMtMy0xLTEtNDExMzI_2f2be580-08f7-4d98-9155-f2a0c0c25489">5,058</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzMtNS0xLTEtNDExMzI_afb1ed38-b622-4d9a-bae1-c9235a8aa85b">562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzQtMS0xLTEtNDExMzI_98b32687-7685-4ae8-80fd-1508c88c7b4b">566</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzQtMy0xLTEtNDExMzI_a59df459-116a-4332-8fe0-683ded874d29">1,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzQtNS0xLTEtNDExMzI_48e4d164-67d6-4acf-8985-3e712ac6ddbe">278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzUtMS0xLTEtNDExMzI_19254e07-63d4-405b-b030-b1cf7ebc05b9">2,334</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzUtMy0xLTEtNDExMzI_d07126f0-1f20-49d8-89d6-94d1f8794e0d">6,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzUtNS0xLTEtNDExMzI_4bb3a102-28e4-4954-92ce-42cde35d0623">840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzctMS0xLTEtNDExMzI_086d997b-7ba9-4c2b-ad5a-cd8fd4dbfadd">1,360</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzctMy0xLTEtNDExMzI_d7873147-8c0d-452a-a853-e645019affa6">3,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzctNS0xLTEtNDExMzI_19b69cc0-fbf3-4543-a1a5-e096f44b6b60">1,070</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzgtMS0xLTEtNDExMzI_7cf8749e-3430-4b5f-87d2-b378955753e1">392</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzgtMy0xLTEtNDExMzI_2eba57d1-d011-43cf-aeab-a9d673bb98ee">838</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzgtNS0xLTEtNDExMzI_a5db438b-8f3e-4324-8a6f-44c5ad0ac2b1">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzktMS0xLTEtNDExMzI_60432ead-4d1a-4272-b9f7-4eeecb07e3eb">1,752</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzktMy0xLTEtNDExMzI_7c0a3bd4-1eac-40c4-9483-cfc941f1151a">4,186</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzktNS0xLTEtNDExMzI_2e69b112-d60c-47db-b9b4-3787453f2f50">1,245</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzExLTEtMS0xLTQxMTMy_870c7763-18b7-487a-859f-b92666e8b6c4">582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzExLTMtMS0xLTQxMTMy_84aca38b-3cd5-45b1-936a-26108e891298">2,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzExLTUtMS0xLTQxMTMy_0a392cc5-b8d4-4e7c-89b6-61d8cf3d5fd0">2,085</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i7ce277018b674e78bef2e78a879855b2" continuedAt="i8efc57c0bcfc4af2acb01ff9c51c9a91"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzYwNDczMTM5NTYyMDI_09c488e1-dd31-47d1-96ad-906a74691bd2" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory rate to the effective tax rate for income from continuing operations for the years ended December 31, 2021, 2020 and 2019, respectively, is comprised as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.841%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.769%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzItMS0xLTEtNDExMzI_3dc58203-be18-4b34-8931-06ae85df4129">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzItMy0xLTEtNDExMzI_486c0b62-0469-4312-8deb-9dc6f5272571">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzItNS0xLTEtNDExMzI_6a59cf3e-2da1-4a88-8fd5-663b9ec3d972">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes - net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzMtMS0xLTEtNDExMzI_b0bd1a37-3378-4e21-9ccc-f558f973635d">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzMtMy0xLTEtNDExMzI_06a2d72b-d769-4509-913a-66269860ad50">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzMtNS0xLTEtNDExMzI_b1b370c4-3457-407a-bb91-31cc5c932b17">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtMS0xLTEtNTkyNDc_999c8518-8e33-424a-871d-8dfb6fb05806">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtMy0xLTEtNTkyNDc_70d04542-bc84-4f26-ad58-bc06eee6ccb8">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtNS0xLTEtNTkyNDc_524e8000-92ed-4abe-ade2-d21d7599b459">1.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible equity compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtMS0xLTEtNTkyNDc_91a5221a-de18-4df0-8905-ef7c6bb32539">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtMy0xLTEtNTkyNDc_55c91bcf-081a-4a6e-91ac-39a0058fe3c6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtNS0xLTEtNTkyNDc_16fe4d4a-80dd-4bb4-bee7-da1b367d8537">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 162(m) limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" name="pntg:EffectiveIncomeTaxRateReconciliationSection162mLimitation" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtMS0xLTEtNTkyNDc_22094b78-b0a0-441a-804e-202862930e44">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" name="pntg:EffectiveIncomeTaxRateReconciliationSection162mLimitation" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtMy0xLTEtNTkyNDc_5aca3f35-0d61-404b-ba14-e5e5e2221f98">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" name="pntg:EffectiveIncomeTaxRateReconciliationSection162mLimitation" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtNS0xLTEtNTkyNDc_c398f2a6-b335-4531-b43a-05aa9cb7c444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" name="pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctMS0xLTEtNTkyNDc_370d9e56-a51a-4528-88e6-145dd42330f9">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" name="pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctMy0xLTEtNTkyNDc_2662ad1e-caea-4600-a79b-648e03aad3af">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" name="pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctNS0xLTEtNTkyNDc_0b05dd14-8c5b-45d7-abea-9e67b361a6ba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtMS0xLTEtNDExMzI_5fbcfeb9-89b4-4e87-af12-8bba8746bc5c">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtMy0xLTEtNDExMzI_8e17248c-c1a2-48b4-9f35-7f07272eae98">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtNS0xLTEtNDExMzI_3e70c9ef-70e1-4a27-95a0-f85364888f09">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" name="pntg:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtMS0xLTEtNDExMzI_189f7885-6627-4536-9309-6ed9729ac8e5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" name="pntg:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtMy0xLTEtNDExMzI_6b514d99-b3d7-4a02-9e06-41ff0b625912">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" name="pntg:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtNS0xLTEtNDExMzI_f15c4c35-e8d1-455f-a0ca-93aaa4a736a3">41.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtMS0xLTEtNDExMzI_e1760c77-4283-48e1-94ec-d11c03f1edac">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtMy0xLTEtNDExMzI_6bb73166-a251-454e-95b8-e2b7b6121bdb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtNS0xLTEtNDExMzI_ba2d9661-97ac-4f39-9792-5d43a5043605">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductible equity compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" sign="-" name="pntg:EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctMS0xLTEtNDExMzI_1cc0d585-f7c3-4edc-9aae-bdde882f168a">34.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" sign="-" name="pntg:EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctMy0xLTEtNDExMzI_dab7d936-7082-47f1-b818-e1e3f3b19bc7">10.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" sign="-" name="pntg:EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctNS0xLTEtNDExMzI_a9471493-297e-48a1-aef6-bfd4439f453b">30.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzgtMS0xLTEtNDExMzI_7dd48be9-49e1-4a7c-9454-2d522ecfc621">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzgtMy0xLTEtNDExMzI_3f1d2bc8-0c31-41b3-89bb-00726d4236cb">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzgtNS0xLTEtNDExMzI_c2a27f8c-2b11-4ff8-b711-0cc20b410f17">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzktMS0xLTEtNDExMzI_fb13b39f-7ea1-4dbb-9bd9-cd86d800ae47">1.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzktMy0xLTEtNDExMzI_f3160eb7-fcba-4d1e-8684-75f6284fbb5f">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzktNS0xLTEtNDExMzI_5e32ffb3-2f54-47f8-8445-9e6e781d7432">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzEwLTEtMS0xLTQxMTMy_d7a6a51a-36c2-4f94-b301-eea9e3c6b0e8">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzEwLTMtMS0xLTQxMTMy_5f69b4b9-02ee-4d43-a355-5db6b8026c4c">13.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzEwLTUtMS0xLTQxMTMy_bb9dcb17-351a-4e39-af8f-4c743ca5f460">39.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.723%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.247%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's completion of the Spin-Off  in the year ended December 31, 2019 resulted in the Company not being able to deduct approximately $<ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzAtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjowNzQ5Njk0NWU5ZTE0MmM3OWU3ODE1MWI5YWY2ZjRlZl8xMjA_f991cdee-a4df-4fda-8f31-88aa16bb5fa4">10,300</ix:nonFraction> of the related transaction costs, which increased the effective tax rate significantly and affected all items that were impacted by this exclusion.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">During the year ended December 31, 2021, employees exercised stock options representing approximately <ix:nonFraction unitRef="shares" contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjoyN2QxZDQ2NzU0YzY0YmNmYTgzNDY1NmY3YjFjM2I5OF84MQ_df60f7f1-bed9-448a-bbd6-958302b8369b">115</ix:nonFraction> shares. During the year ended December 31, 2020, employees exercised stock options representing approximately <ix:nonFraction unitRef="shares" contextRef="i39dc640518df47b9a65a3d3dbeec9bd5_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjoyN2QxZDQ2NzU0YzY0YmNmYTgzNDY1NmY3YjFjM2I5OF8yNzQ4Nzc5MDY5OTI5_5182938c-4a4c-4021-836e-0eeb6727a99a">239</ix:nonFraction> shares. During the year ended December 31, 2019, employees exercised stock options representing approximately <ix:nonFraction unitRef="shares" contextRef="i3a5ce69e0ffd47a7befd0d6c5941a09f_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjoyN2QxZDQ2NzU0YzY0YmNmYTgzNDY1NmY3YjFjM2I5OF8yNzQ4Nzc5MDY5OTM1_8121e54d-b8b9-49dd-b343-6094da14aa10">100</ix:nonFraction> shares and had restricted stock awards vest representing <ix:nonFraction unitRef="shares" contextRef="i0169fb92128e49f58280fc837cf38434_D20190101-20191231" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjoyN2QxZDQ2NzU0YzY0YmNmYTgzNDY1NmY3YjFjM2I5OF8yNzQ4Nzc5MDY5OTQx_aa1f25a2-4502-453c-a8be-b6fbde5355de">960</ix:nonFraction> shares. These exercises and vestings resulted in tax benefits that reduced the Company's effective tax rate significantly in all three years. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">During the year ended December 31, 2021, approximately $<ix:nonFraction unitRef="usd" contextRef="ibca5874771a942ac8128f8834681ae6b_D20210101-20211231" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzItMi0xLTEtNTkyNzcvdGV4dHJlZ2lvbjo4YWIxOTkxYmRlY2E0NDUzODBlMWRlZGE1ZTNhODJkY18xMDk5NTExNjI4MDI3_5330f550-5a35-4abc-b7d6-16189aae7c4d">2,528</ix:nonFraction> of the share-based compensation expense related to restricted stock did not result in a deferred tax asset because it will be subject to future limitation under IRC Section 162(m).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certain items in the prior year have been reclassified to conform with the current year presentation.  </span></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the date of the Spin-Off, the Company's operations were included in Ensign&#8217;s U.S. federal and state income tax returns and all income taxes were paid by subsidiaries of Ensign. Additionally, prior to the date of the Spin-Off, income tax expense and other income tax related information contained in these Consolidated and Combined Financial Statements for the year ended 2019 were presented on a separate tax return approach. Under this approach, the provision for income taxes represents income tax paid or payable for the current year plus the change in deferred taxes during the year calculated as if the Company were a stand-alone taxpayer filing hypothetical income tax returns. Management believes that the assumptions and estimates used to determine these tax amounts were reasonable. However, the Company's Consolidated and Combined Financial Statements or the year ended 2019 may not necessarily reflect the Company&#8217;s income tax expense or tax payments in the future, or what its tax amounts would have been if the Company had been a stand-alone company during the periods presented.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i8efc57c0bcfc4af2acb01ff9c51c9a91" continuedAt="i57fc32edae5042a29fe32d6cf33447ce"><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzYwNDczMTM5NTYyMDM_b701d49f-6bef-4103-a196-0b70260c0fd9" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s deferred tax assets and liabilities for the years ended December 31, 2021 and 2020 are summarized below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.976%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.498%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzMtMS0xLTEtNDExMzI_a7dd7805-eff2-49c5-8ffe-55b135875fa6">9,829</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzMtMy0xLTEtNDExMzI_1f71d458-b47f-418f-8b59-87f22074ccc2">8,181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzQtMS0xLTEtNDExMzI_83fd79a1-bb26-4362-9151-5aebcd30d39b">1,728</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzQtMy0xLTEtNDExMzI_eac3362f-6298-4bc6-a5c1-8e2fe23b7c94">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsStateTaxes" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzUtMS0xLTEtNDExMzI_b28b471f-9eeb-4827-88b6-fcb5b7cc5442">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsStateTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzUtMy0xLTEtNDExMzI_5b22fb49-91bf-46b4-9d1b-4727481f5944">147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:DeferredTaxAssetsLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzYtMS0xLTEtNDExMzI_90a0c4ba-4636-4708-80b3-7c5c7bda6df5">79,575</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="pntg:DeferredTaxAssetsLeaseLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzYtMy0xLTEtNDExMzI_fedd6040-7955-49b3-bc0e-2a46069ac6df">80,979</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzctMS0xLTEtNDExMzI_90d22e96-265a-48f0-aadb-7cd86bdec53c">953</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzctMy0xLTEtNDExMzI_d92ea397-b3ab-4b98-ab2f-de32ae36c7cd">277</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzgtMS0xLTEtNDExMzI_9c3bb976-9b18-4029-ab08-307fba667bf7">92,085</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzgtMy0xLTEtNDExMzI_1b1ced40-3668-4f8e-b116-4815cc2ca0c0">90,459</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzktMS0xLTEtNDExMzI_b8fa3423-9243-47a2-acbf-2382240fa5aa">25</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzktMy0xLTEtNDExMzI_b7f8cf70-b0a2-4c8c-8d6b-e26f1eb8c596">15</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEwLTEtMS0xLTQxMTMy_17739915-6914-41b9-a401-5b6e8612b8f5">92,060</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEwLTMtMS0xLTQxMTMy_86a7386f-7824-400d-8c3d-452c578bed4b">90,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:DeferredTaxLiabilitiesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzExLTEtMS0xLTQxMTMy_faa10b11-aba5-4a6c-9f19-eb556662d212">8,432</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="pntg:DeferredTaxLiabilitiesDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzExLTMtMS0xLTQxMTMy_d49ff8d9-6d23-4955-bc29-07229ef1f99e">7,512</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEyLTEtMS0xLTQxMTMy_96fee3a8-52c0-4a7e-8228-e871638a4f79">907</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPrepaidExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEyLTMtMS0xLTQxMTMy_51017c0c-f402-491d-afa4-604ef15cef81">780</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEzLTEtMS0xLTQxMTMy_93ba0df7-abea-4318-a489-a45541366bda">78,656</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEzLTMtMS0xLTQxMTMy_f34bcbbe-f1dd-4005-b73d-78ddad11cd82">80,055</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:DeferredTaxLiabilitiesStateTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE0LTEtMS0xLTQxMTMy_eecf17f4-e0e8-4cd7-ba1e-fb15fe09462a">217</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="pntg:DeferredTaxLiabilitiesStateTaxes" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE0LTMtMS0xLTQxMTMy_8a4fae1a-a2aa-429c-88d3-ca67baa24dd5">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE1LTEtMS0xLTQxMTMy_7aa125e6-8b74-4e0d-8e05-5b4b0be89919">88,212</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE1LTMtMS0xLTQxMTMy_10926fcc-959b-4665-9ff3-ce34a8ad78e4">88,347</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE2LTEtMS0xLTQxMTMy_47f29026-0e24-4668-8242-08bc2f6ead14">3,848</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE2LTMtMS0xLTQxMTMy_9a167bbf-2cf5-49cd-8489-9508773bda5e">2,097</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the Company utilized all of its net operating loss ("NOL") carryforwards for federal income tax purposes. As of December 31, 2021, the Company has $<ix:nonFraction unitRef="usd" contextRef="i930d5c4fd9b84161879c0000c0e816d2_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzIyNTU_72ae0295-fe8c-45b5-97ae-8b5ab0446fab">614</ix:nonFraction> of NOL carryforwards in various states, which are available to reduce future state taxable income, if any. The state NOL carryforwards, if not utilized, will expire in years ending between December 31, 2030 and December 31, 2040. The Company believes that it is more likely than not that the benefit from the state NOL carryforwards in jurisdictions where we do not file a consolidated return will not be realized. In recognition of this risk, as of December 31, 2021, the Company has provided a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="i930d5c4fd9b84161879c0000c0e816d2_I20211231" decimals="-3" name="us-gaap:OperatingLossCarryforwardsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzE0MjkzNjUxMTY1Mzg2_663a39d4-0733-4153-bb9f-283dbb40ee01">25</ix:nonFraction> on the deferred tax assets related to these states for the tax effect of the NOL carryforwards that will not be realized.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal statutes of limitations on the Company&#8217;s 2017, 2016, and 2015 income tax years lapsed during the third quarter of 2021, 2020, and 2019, respectively. During the fourth quarter of each year, various state statutes of limitations also lapsed. The lapses for the years ended December 31, 2021 and 2020 had no impact on the Company&#8217;s unrecognized tax benefits. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzYwNDczMTM5NTc4MjQ_bc732f27-777c-477c-8e58-4a1d0e973fde" escape="true"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.648%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.496%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.500%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzItMS0xLTEtNjMwNzc_34eecbd0-af37-4b26-a8bf-1ed69e6f2744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzItMy0xLTEtNjMwNzk_fed62462-c256-47da-ae5e-4ddf934173c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i855d825b738d453698699f3f7321df6f_I20181231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzItNS0xLTEtNzY1ODk_216b86fb-ff6a-46bc-83a8-9fb99e06d52f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzMtMS0xLTEtNjMwNzc_2d709ed7-2476-4a63-af31-dd4c9239f007">188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzMtMy0xLTEtNjMwNzk_cdd4b677-d2c1-40ca-a524-55ab9d28227d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzMtNS0xLTEtNzY1ODk_4787c605-4363-471a-b498-5fc1b5357d7d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions related to the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzQtMS0xLTEtNjMwNzc_a9312cdb-aeed-4760-8563-5a2f971896bb">123</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzQtMy0xLTEtNjMwNzk_04ce0d6e-30b2-462e-9431-7ece5dc5c9bc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzQtNS0xLTEtNzY1ODk_305a7abd-02ca-40ca-a264-08328e806ceb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzUtMS0xLTEtNjMwNzc_ce0e2558-d546-4d77-922e-1216424824e1">65</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzUtMy0xLTEtNjMwODU_c7943f7f-238a-44cb-8d44-10bc8b44cdd3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzUtNS0xLTEtNzY1ODk_6f7731d0-6658-462a-896a-e323f1467e9c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i57fc32edae5042a29fe32d6cf33447ce">None of unrecognized tax benefits net of their state benefits would affect the Company&#8217;s effective tax rate for the years ended December 31, 2021 and 2020.  The Company classifies interest and/or penalties on income tax liabilities or refunds as additional income tax expense or income. Such amounts are not material.</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_205"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%"> 15. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzYwNDczMTM5NjI1OTQ_f98b2c03-8a4d-48fe-b6dc-d6c2eccabcaa" continuedAt="if1375004288f419b91d03111080e5bde" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><ix:continuation id="if1375004288f419b91d03111080e5bde" continuedAt="i222ea2416e0545d4805191e7b660585f"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Matters - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides services in complex and highly regulated industries. The Company&#8217;s compliance with applicable federal, state and local laws and regulations governing these industries may be subject to </span></ix:continuation></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i222ea2416e0545d4805191e7b660585f" continuedAt="i64cc630d51774f4f8b97c0f5ba72d4c1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">governmental review and adverse findings may result in significant regulatory action, which could include sanctions, damages, fines, penalties (many of which may not be covered by insurance), and even exclusion from government programs.&#160;The Company is a party to various regulatory and other governmental audits and investigations in the ordinary course of business and cannot predict the ultimate outcome of any federal or state regulatory survey, audit or investigation. While governmental audits and investigations are the subject of administrative appeals, the appeals process, even if successful, may take several years to resolve. The Department of Justice, CMS, or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company's businesses. The Company believes that it is presently in compliance in all material respects with all applicable laws and regulations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost-Containment Measures - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government and third party payors have instituted cost-containment measures designed to limit payments made to providers of healthcare services, and there can be no assurance that future measures designed to limit payments made to providers will not adversely affect the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnities - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into certain types of contracts that contingently require the Company to indemnify parties against third-party claims. These contracts primarily include (i)&#160;certain real estate leases, under which the Company may be required to indemnify property owners or prior operators for post-transfer environmental or other liabilities and other claims arising from the Company&#8217;s use of the applicable premises, (ii)&#160;operations transfer agreements, in which the Company agrees to indemnify past operators of agencies and communities the Company acquires against certain liabilities arising from the transfer of the operation and/or the operation thereof after the transfer, (iii)&#160;certain Ensign lending agreements, and (iv)&#160;certain agreements with management, directors and employees, under which the subsidiaries of the Company may be required to indemnify such persons for liabilities arising out of their employment relationships. The terms of such obligations vary by contract and, in most instances, a specific or maximum dollar amount is not explicitly stated therein. Generally, amounts under these contracts cannot be reasonably estimated until a specific claim is asserted. Consequently, because no claims have been asserted, no liabilities have been recorded for these obligations on the Company&#8217;s combined balance sheets for any of the periods presented.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s businesses involve a significant risk of liability given the age and health of the patients and residents served by its independent operating subsidiaries. The Company, its operating companies, and others in the industry may be subject to a number of claims and lawsuits, including professional liability claims, alleging that services provided have resulted in personal injury, elder abuse, wrongful death or other related claims. Healthcare litigation (including class action litigation) is common and is filed based upon a wide variety of claims and theories, and the Company is routinely subjected to these claims in the ordinary course of business, including potential claims related to patient care and treatment, professional negligence and class actions, as well as employment related claims. If there were a significant increase in the number of these claims or an increase in amounts owing should plaintiffs be successful in their prosecution of these claims, this could materially adversely affect the Company&#8217;s business, financial condition, results of operations and cash flows. In addition, the defense of these lawsuits may result in significant legal costs, regardless of the outcome, and can result in large settlement amounts or damage awards.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the potential lawsuits and claims described above, the Company is also subject to potential lawsuits under the False Claims Act (the &#8220;FCA&#8221;) and comparable state laws alleging submission of fraudulent claims for services to any healthcare program (such as Medicare) or payor. A violation may provide the basis for exclusion from federally funded healthcare programs. Such exclusions could have a correlative negative impact on the Company&#8217;s financial performance. Some states, including California, Arizona and Texas, have enacted similar whistleblower and false claims laws and regulations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, Congress passed the Fraud Enforcement and Recovery Act ("FERA") which made significant changes to the FCA, expanding the types of activities subject to prosecution and whistleblower liability. Following changes by FERA, healthcare providers face significant penalties for the knowing retention of government overpayments, even if no false claim was involved. Providers can now be liable for knowingly and improperly avoiding or decreasing an obligation to pay money or property to the government, including the retention of any government overpayment. The Patient Protection and Affordable Care Act of 2010 (the &#8220;ACA&#8221;) supplemented FERA by imposing an affirmative obligation on healthcare providers to return an overpayment to CMS within 60 days of &#8220;identification&#8221; or the date any corresponding cost report is due, whichever is later. Retention of any overpayment beyond this period may create liability under the FCA. In addition, FERA extended protections against retaliation for whistleblowers, including protections not only for employees, but also contractors and agents. Thus, there is generally no need for an employment relationship in order to qualify for protection against retaliation for whistleblowing.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict or provide any assurance as to the possible outcome of any litigation. If any litigation were to proceed, and the Company and its operating companies are subjected to, alleged to be liable for, or agree to a settlement </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:57.6pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i878c6ec7c06b4a14a7fbd056397eb9d2_10">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE PENNANT GROUP, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED AND COMBINED FINANCIAL STATEMENTS - (Continued)</span></div><div><span><br/></span></div></div><ix:continuation id="i64cc630d51774f4f8b97c0f5ba72d4c1"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of, claims or obligations under federal Medicare statutes, the FCA, or similar state and federal statutes and related regulations, the Company&#8217;s business, financial condition and results of operations and cash flows could be materially and adversely affected. Among other things, any settlement or litigation could involve the payment of substantial sums to settle any alleged civil violations, and may also include the assumption of specific procedural and financial obligations by the Company or its independent operating subsidiaries going forward under a corporate integrity agreement and/or other arrangement with the government. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Revenue Recoupments - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to probe reviews relating to Medicare services, billings and potential overpayments by Unified Program Integrity Contractors (UPIC), Recovery Audit Contractors (RAC), Zone Program Integrity Contractors (ZPIC), Program Safeguard Contractors (PSC), Supplemental Medical Review Contractors (SMRC) and Medicaid Integrity Contributors (MIC) programs, each of the foregoing collectively referred to as &#8220;Reviews.&#8221;  As of December 31, 2021, <ix:nonFraction unitRef="review" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="INF" name="pntg:NumberOfOperatingSubsidiariesWithReviewsScheduled" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzgxMjQ_f3e59f91-d995-4109-b476-1514f9acfd1c">eight</ix:nonFraction> of the Company&#8217;s independent operating subsidiaries had Reviews scheduled, on appeal or in dispute resolution process, both pre- and post-payment. The Company anticipates that these probe reviews will increase in frequency in the future. If an operation fails an initial or subsequent Review, the operation could then be subject to extended Review, suspension of payment, or extrapolation of the identified error rate to all billing in the same time period. As of December 31, 2021, and through the filing of this Annual Report on Form 10-K, the Company&#8217;s independent operating subsidiaries have responded to the Reviews that are currently ongoing, on appeal or in dispute resolution process and the Company has no probable or estimable contingencies. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One hospice provider number is subject to a Medicare payment suspension imposed by a Uniform Program Integrity Contractor (UPIC). As of December 31, 2021 the UPIC requested for review <ix:nonFraction unitRef="record" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="INF" name="pntg:UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzEwOTk1MTE2NDAyMDk_1c088053-cec0-4cd6-8517-70933ecddce9">42</ix:nonFraction> patient records covering a <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="pntg:UniformProgramIntegrityContractorPeriodOfReview" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzYwNDczMTM5NjUxMTA_61df0491-757f-48fa-aac5-da1abb1cdb06">4-month</ix:nonNumeric> period to determine whether, in its view, a Medicare overpayment was made. Subsequent to December 31, 2021 the UPIC expanded upon its initial request to cover an additional <ix:nonFraction unitRef="record" contextRef="ie92494cf696341a4b8eb690958419fa7_I20220228" decimals="INF" name="pntg:UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzEwOTk1MTE2NDEzODM_3034eac3-54e1-40ef-80ce-356f80465db2">60</ix:nonFraction> patient records over an additional <ix:nonNumeric contextRef="ie6d715a9ac734e11ac6ce730afc95baa_D20220101-20220228" name="pntg:UniformProgramIntegrityContractorPeriodOfReview" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzgyNDYzMzcyMjE5NjA_948e2c52-ef1f-425a-b702-d5eab471bc68">6-month</ix:nonNumeric> period. Medicare payments to that provider number are suspended pending the conclusion of the UPIC&#8217;s review. The payments suspended as of December 31, 2021 total $<ix:nonFraction unitRef="usd" contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231" decimals="-3" name="pntg:UniformProgramIntegrityContractorSuspendedPayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzE2NDkyNjc0NTM5NTM_f7e41a9b-9713-4e42-a758-70dcd243b1cb">3,700</ix:nonFraction>. The suspended amounts represent all Medicare payments due to the provider number since the start of the suspension and are not an overpayment finding. If the UPIC concludes that an overpayment exists, it will recover the overpayment from the suspended funds and release the excess funds, if any, to the provider. The UPIC has not specified when the payment suspension will end or when it will reach an over-payment determination. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has significant accounts receivable balances, the collectability of which is dependent on the availability of funds from certain governmental programs, primarily Medicare and Medicaid. These receivables represent the only significant concentration of credit risk for the Company. The Company does not believe there are significant credit risks associated with these governmental programs. The Company believes that an appropriate allowance has been recorded for the possibility of these receivables proving uncollectible, and continually monitors and adjusts these allowances as necessary. The Company&#8217;s gross receivables from the Medicare and Medicaid programs accounted for approximately <ix:nonFraction unitRef="number" contextRef="idcd019ebb6aa4404ad2ce8284c512582_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzk1OTg_d9953b57-846e-4b8f-812a-968b29868d50">78.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i84a5a381cc15426491a05ab72627a087_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzk2MDU_9717268b-9590-44db-8d0b-48222dd4defc">75.7</ix:nonFraction>% of its total gross accounts receivable as of December 31, 2021 and December 31, 2020, respectively. Revenue from reimbursement under the Medicare and Medicaid programs accounted for <ix:nonFraction unitRef="number" contextRef="i663cd00e1ad6470dbb471e5fc87e9203_D20210101-20211231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzk3NjA_bda53759-a1d3-4be1-9367-bd363d79e094">62.6</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="ifab97b7b0975436f83121c89244a55d3_D20200101-20201231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzk3NjQ_d158dcba-6b2f-44f4-81ce-193abf4da0bb">60.1</ix:nonFraction>%, and <ix:nonFraction unitRef="number" contextRef="i1f1a78bb16f147c18572f1380b8c667f_D20190101-20191231" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzk3NzI_c0a8f9f9-e6a6-454d-a0fa-d6ffe32a3848">55.6</ix:nonFraction>% of the Company's revenue for the years ended December 31, 2021, 2020 and 2019, respectively.</span></div></ix:continuation><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div id="i878c6ec7c06b4a14a7fbd056397eb9d2_1391"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:174%">16. <ix:nonNumeric contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzkxL2ZyYWc6OTNhNzgxMmZmY2Y2NDA4NTkxZGEyZmRlNmY4OTc4ZDMvdGV4dHJlZ2lvbjo5M2E3ODEyZmZjZjY0MDg1OTFkYTJmZGU2Zjg5NzhkM182MDQ3MzEzOTU0NjQ0_d9c60ec0-ee5a-41ab-84ce-5d407dc99e64" continuedAt="ie324c628709545b297a8dd478961aa9d" escape="true">SUBSEQUENT EVENT</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie324c628709545b297a8dd478961aa9d">On January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements (collectively, the &#8220;Transfer Agreements&#8221;) with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#8220;Transaction&#8221;). The Transfer Agreements require one of the transferors to place in escrow $<ix:nonFraction unitRef="usd" contextRef="ib75d5bc9e37c446180e5fa26fafb6083_I20220127" decimals="-3" name="us-gaap:EscrowDeposit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzkxL2ZyYWc6OTNhNzgxMmZmY2Y2NDA4NTkxZGEyZmRlNmY4OTc4ZDMvdGV4dHJlZ2lvbjo5M2E3ODEyZmZjZjY0MDg1OTFkYTJmZGU2Zjg5NzhkM183MTQ2ODI1NTgyNDIy_2b05528e-ebc2-47b9-8f19-f69db4b018b8">6,500</ix:nonFraction> to cover post-closing capital expenditures and operating losses related to one of the communities. The closing of the Transaction is anticipated to occur in the first half of 2022, subject to receipt of applicable regulatory approvals and satisfaction of other customary closing conditions set forth in the Transfer Agreements. As such, management determined that the long-lived assets for the impacted communities were impaired and the Company recognized a non-cash charge of $<ix:nonFraction unitRef="usd" contextRef="i941ffd2f6e49432b85465ef637f2d33d_D20210101-20211231" decimals="-3" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzkxL2ZyYWc6OTNhNzgxMmZmY2Y2NDA4NTkxZGEyZmRlNmY4OTc4ZDMvdGV4dHJlZ2lvbjo5M2E3ODEyZmZjZjY0MDg1OTFkYTJmZGU2Zjg5NzhkM18xMDk5NTExNjMwMDY2_fd12cc23-aff7-416e-9396-a19211ace2f3">2,613</ix:nonFraction> in its operating results for the year ended December 31, 2021, included in the transaction.</ix:continuation> </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>2
<FILENAME>descriptionofsecuritiesq42.htm
<DESCRIPTION>EX-4.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ifc3b1ad860f540e5bbacbdf689dd263f_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 4.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DESCRIPTION OF SECURITIES</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, The Pennant Group, Inc. has registered one class of securities under Section 12 of the Securities Exchange Act of 1934, as amended (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Common Stock</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description of our Common Stock (as defined below) is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference to our Amended and Restated Certificate of Incorporation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Certificate of Incorporation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and our Amended and Restated By-laws (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Bylaws</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), each of which are incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this Exhibit is a part. We encourage you to read our Certificate of Incorporation, our Bylaws and the applicable provisions of the Delaware General Corporate Law (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DGCL</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), for additional information.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Authorized Capital Shares</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our authorized capital shares consist of 100,000,000 shares of common stock, $0.001 par value per share (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Common Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and 1,000,000 shares of preferred stock, $0.001 par value per share (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Preferred Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have outstanding shares of Common Stock. The outstanding shares of our Common Stock are fully paid and non-assessable. This means the full purchase price for the outstanding shares of Common Stock has been paid and the holders of such shares will not be assessed any additional amounts for such shares. Any additional shares of Common Stock that the Company may issue in the future will also be fully paid and non-assessable.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each share of Common Stock is entitled to one vote on all matters submitted to a vote of the stockholders, including the election of directors. Our Common Stock does not have cumulative voting rights. This means a holder of a single share of Common Stock cannot cast more than one vote for each position to be filled on the Board of Directors. It also means the holders of a majority of the shares of Common Stock entitled to vote in the election of directors can elect all directors standing for election and the holders of the remaining shares will not be able to elect any directors.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Rights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the rights of holders of outstanding shares of Preferred Stock, if any, the holders of Common Stock are entitled to receive dividends, if any, as may be declared from time to time by the Board of Directors in its discretion out of funds legally available for the payment of dividends. Delaware law allows a corporation to pay dividends only out of surplus, as determined under the DGCL.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidation Rights</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the liquidation, dissolution or winding up of the Company, the holders of Common Stock are entitled to receive ratably the net assets of the Company legally available for distribution after we have paid or provided for all of our liabilities and all of the preferential amounts to which any holders of Preferred Stock, if any, may be entitled.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Rights and Preferences</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Common Stock has no sinking fund or redemption provisions or pre-emptive, conversion or exchange rights. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholder Action by Written Consent</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate of Incorporation and Bylaws prohibit stockholder action by written consent except when the action to be taken has previously been approved by our Board of Directors.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exclusive Jurisdiction of Certain Actions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Certificate of Incorporation provides that, unless the Company consents in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware shall, to the fullest extent permitted by law, be the sole and exclusive forum for any (1) derivative action or proceeding brought on behalf of the Company, (2) action asserting a claim of breach of a fiduciary duty owed by any director, officer, employee or agent of the Company to the Company or our stockholders, or any claim for aiding and abetting any such alleged breach, (3) action asserting a claim against the Company or any director or officer of the Company arising pursuant to any provision of the DGCL or the Certificate of Incorporation or our Bylaws, or (4) action asserting a claim against us or any director or officer of the Company governed by the internal affairs doctrine except for, as to each of (1) through (4) above, any claim (A) as to which the Court of Chancery determines that there is an indispensable party not subject to the jurisdiction of the Court of Chancery (and the indispensable party does not consent to the personal jurisdiction of the Court of Chancery within ten days following such determination), (B) which is vested in the exclusive jurisdiction of a court or forum other than the Court of Chancery, or (C) arising under the federal securities laws, including the Securities Act of 1933, as amended, as to which the Court of Chancery and the federal district court for the District of Delaware shall concurrently be the sole and exclusive forums. Notwithstanding the foregoing, the provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America shall be the sole and exclusive forum. The foregoing may have the effect of discouraging lawsuits against the Company&#8217;s directors and officers. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Listing</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Common Stock is traded on The Nasdaq Global Select Market under the trading symbol &#8220;PNTG.&#8221;</font></div><div style="margin-top:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>3
<FILENAME>listofsubsidiariesofpntgq4.htm
<DESCRIPTION>EX-21.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic30cfffa56e44333ab96d8cf532da458_1"></div><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">List of Subsidiaries of The Pennant Group, Inc.</font></div><div><font><br></font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The following is a list of subsidiaries of The Pennant Group, Inc. as of December 31, 2021&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.275%"><tr><td style="width:1.0%"></td><td style="width:64.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.344%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Jurisdiction</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2410 Stillhouse Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Alpowa Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arches Home Care, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Autumn Ridge Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beach City Senior Living LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bear River Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Black Mountain Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brenwood Park Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brookhollow Senior Living LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brown Road Senior Housing LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bruce Neenah Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cactus Heights Healthcare LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Canyon Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Care Continuum Solutions LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitol Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CCS Holding LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cedar Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clark Fork Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clear Creek Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connected Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Copper Basin Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cornerstone Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cornerstone Service Center, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Crown Point Healthcare LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Custom Care Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">De Soto Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denmark Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eagle Pass Senior Living LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elkhorn Healthcare LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emblem Healthcare, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerald Healthcare, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eureka Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exemplar Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finding Home Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Glacier Peak Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Go Assisted, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granite Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.275%"><tr><td style="width:1.0%"></td><td style="width:64.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.344%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granite Hills Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Great Lakes Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Great Plains Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Green Bay Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Heartland Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hummingbird Healthcare LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">iCare Private Duty, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indigo Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Iron Bridge Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jameson Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jentilly Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joshua Tree Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kenosha Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Keystone Hospice Care, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lake Pointe Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lemon Senior Living LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lowes Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madison Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Manitowoc Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">McFarland Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mesa Grande Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mesa Springs Senior Living LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mission Inn Senior Living LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mohave Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monument Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moss Bay Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mountain Peak Home Care, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mountain Vista Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oceano Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Oceanside Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orange Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orangewood Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Orchard Prairie Healthcare LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Painted Sky Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Paragon Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Park Point Healthcare LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Peaceful Heart Healthcare LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pearl Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pecan Bayou Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pennant Services, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pinnacle Senior Living LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pinnacle Service Center LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pleasant Run Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.275%"><tr><td style="width:1.0%"></td><td style="width:64.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.344%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prairie View Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Primrose Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prospect Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Racine Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rancho Bernardo Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Red Rock Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riverview Village Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rock Garden Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rockbrook Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rogue River Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rolling Hills Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rosenburg Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sacramento River Healthcare LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Saguaro Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Gabriel Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sand Lily Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandstone Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sentinel Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sheboygan Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Silver Lake Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Somers Kenosha Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Bay Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">South Plains Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Southern Pines Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spanish Meadows Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spokane Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spring Valley Assisted Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Star Valley Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stevens Point Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stoughton Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Summerlin Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sun Peak Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sycamore Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Symbol Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terrace Court Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teton Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Pennant Group, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas Road Senior Housing, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thousand Peaks Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Healtcare Services LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Triumph Healthcare LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Twin Falls Senior Living LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Two Rivers Senior Living, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:54pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.275%"><tr><td style="width:1.0%"></td><td style="width:64.633%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.623%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.344%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vesper Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Victoria Ventura Assisted Living Community, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Virgin River Healthcare, Inc.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whitewater Healthcare LLC</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Whitetank Mountain Healthcare LLC</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Willow Creek Senior Living, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Wisconsin Rapids Senior Living, Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nevada</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>deloitteconsentq421-ex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic5c92a5115c646d386e49f12772a7af8_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 23.1 </font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in Registration Statement No. 333-233937 on Form </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-8</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of our reports dated February&#160;28, 2022, relating to the financial statements of The Pennant Group, Inc. and the effectiveness of the Pennant Group, Inc.&#8217;s internal control over financial reporting appearing in this Annual Report on Form 10-K for the year ended December 31, 2021. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">DELOITTE &#38; TOUCHE LLP</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Boise, Idaho</font></div><div><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;28, 2022</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>5
<FILENAME>ceocert-exhibit311q421.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i22dc2fc116814160943895c47cc81a69_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.1 </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Daniel H Walker, certify that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of The Pennant Group, Inc&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2022</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.753%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.084%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.665%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.365%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DANIEL H WALKER</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel H Walker</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman and Chief Executive Officer (Principal Executive Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>6
<FILENAME>cfocert-exhibit312q421.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="i1f7c5b2d114b4554a089cabb62009b92_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 31.2</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jennifer L. Freeman, certify that&#58; </font></div><div style="text-align:justify"><font><br></font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this annual report on Form 10-K of The Pennant Group, Inc.&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e) and 15d-15(e)) for the registrant and have&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:9pt;padding-left:54pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></div><div><font><br></font></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;28, 2022</font><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:2.408%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.788%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.771%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:28.578%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.332%"></td><td style="width:0.1%"></td></tr><tr><td colspan="18" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JENNIFER L. FREEMAN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer L. Freeman</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer (Principal Financial Officer, Principal Accounting Officer and Duly Authorized Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>7
<FILENAME>ceocert-exhibit321q421.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="if44df81ff1a641d584a8fb195f458c55_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.1</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. &#167;1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of The Pennant Group, Inc. (the Company) on Form 10-K for the period ended December 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Daniel H Walker, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;  </font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.443%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; DANIEL H WALKER</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Daniel H Walker</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman and Chief Executive Officer (Principal Executive Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A signed original of this written statement required by 18 U.S.C. Section&#160;1350 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>8
<FILENAME>cfocert-exhibit322q421.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2022 Workiva -->
<title>Document</title></head><body><div id="ic6edd2505a7649c9acd608a93bbb2865_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 32.2 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18 U.S.C. &#167;1350, </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 </font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of The Pennant Group, Inc. (the Company) on Form 10-K for the period ended December 31, 2021, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Jennifer L. Freeman, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. &#167; 1350, as adopted pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58; </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.577%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.736%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.063%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.747%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.917%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JENNIFER L. FREEMAN</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;&#160;</font></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer L. Freeman&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;&#160;&#160;</font></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer (Principal Financial Officer, Principal Accounting Officer and Duly Authorized Officer)</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="24" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 28, 2022</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">A signed original of this written statement required by 18 U.S.C. Section&#160;1350 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>pntg-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6a149289-91af-40b5-8f3e-f8666bbd5c45,g:56c4c52a-4e81-467a-86f6-87d568a87628-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:pntg="http://pennantgroup.com/20211231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://pennantgroup.com/20211231">
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pntg-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pntg-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pntg-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="pntg-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="COVERPAGE" roleURI="http://pennantgroup.com/role/COVERPAGE">
        <link:definition>0001001 - Document - COVER PAGE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AUDITINFORMATION" roleURI="http://pennantgroup.com/role/AUDITINFORMATION">
        <link:definition>0002002 - Document - AUDIT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1001003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME" roleURI="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME">
        <link:definition>1003005 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT" roleURI="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT">
        <link:definition>1004006 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS' EQUITY AND NET PARENT INVESTMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" roleURI="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS">
        <link:definition>1005007 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESS" roleURI="http://pennantgroup.com/role/DESCRIPTIONOFBUSINESS">
        <link:definition>2101101 - Disclosure - DESCRIPTION OF BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DESCRIPTIONOFBUSINESSDetails" roleURI="http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails">
        <link:definition>2402401 - Disclosure - DESCRIPTION OF BUSINESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
        <link:definition>2406402 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails" roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails">
        <link:definition>2407403 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - SUMMARY OF INSURANCE LIABILITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails_1" roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails_1">
        <link:definition>2407403 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - SUMMARY OF INSURANCE LIABILITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENT" roleURI="http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENT">
        <link:definition>2108103 - Disclosure - RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails" roleURI="http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails">
        <link:definition>2409404 - Disclosure - RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPUTATIONOFNETINCOMEPERCOMMONSHARE" roleURI="http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE">
        <link:definition>2110104 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPUTATIONOFNETINCOMEPERCOMMONSHARETables" roleURI="http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables">
        <link:definition>2311302 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails" roleURI="http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails">
        <link:definition>2412405 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE - RECONCILIATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDACCOUNTSRECEIVABLE" roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLE">
        <link:definition>2113105 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDACCOUNTSRECEIVABLETables" roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLETables">
        <link:definition>2314303 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails" roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails">
        <link:definition>2415406 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - NARRATIVE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails" roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails">
        <link:definition>2416407 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - REVENUE BY MAJOR PAYOR (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails" roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails">
        <link:definition>2417408 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - ACCOUNTS RECEIVABLE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="REVENUEANDACCOUNTSRECEIVABLEALLOWANCEFORDOUBTFULACCOUNTSDetails" roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEALLOWANCEFORDOUBTFULACCOUNTSDetails">
        <link:definition>2418409 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTS" roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTS">
        <link:definition>2119106 - Disclosure - BUSINESS SEGMENTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTSTables" roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTSTables">
        <link:definition>2320304 - Disclosure - BUSINESS SEGMENTS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTSNARRATIVEDetails" roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails">
        <link:definition>2421410 - Disclosure - BUSINESS SEGMENTS - NARRATIVE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTSFINANCIALDATADetails" roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails">
        <link:definition>2422411 - Disclosure - BUSINESS SEGMENTS - FINANCIAL DATA (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails" roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails">
        <link:definition>2423412 - Disclosure - BUSINESS SEGMENTS - INCOME FROM OPERATIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONS" roleURI="http://pennantgroup.com/role/ACQUISITIONS">
        <link:definition>2124107 - Disclosure - ACQUISITIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSTables" roleURI="http://pennantgroup.com/role/ACQUISITIONSTables">
        <link:definition>2325305 - Disclosure - ACQUISITIONS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSNARRATIVEDetails" roleURI="http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails">
        <link:definition>2426413 - Disclosure - ACQUISITIONS - NARRATIVE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails" roleURI="http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails">
        <link:definition>2427414 - Disclosure - ACQUISITIONS - SCHEDULE OF OPERATIONS ACQUIRED IN BUSINESS COMBINATIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNET" roleURI="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNET">
        <link:definition>2128108 - Disclosure - PROPERTY AND EQUIPMENT&#8212;NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNETTables" roleURI="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETTables">
        <link:definition>2329306 - Disclosure - PROPERTY AND EQUIPMENT&#8212;NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYANDEQUIPMENTNETDetails" roleURI="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails">
        <link:definition>2430415 - Disclosure - PROPERTY AND EQUIPMENT&#8212;NET (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSNET" roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNET">
        <link:definition>2131109 - Disclosure - GOODWILL AND INTANGIBLE ASSETS&#8212;NET</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSNETTables" roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETTables">
        <link:definition>2332307 - Disclosure - GOODWILL AND INTANGIBLE ASSETS&#8212;NET (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSNETNARRATIVEDetails" roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETNARRATIVEDetails">
        <link:definition>2433416 - Disclosure - GOODWILL AND INTANGIBLE ASSETS&#8212;NET - NARRATIVE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails" roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails">
        <link:definition>2434417 - Disclosure - GOODWILL AND INTANGIBLE ASSETS&#8212;NET - ACTIVITY IN GOODWILL (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails" roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails">
        <link:definition>2435418 - Disclosure - GOODWILL AND INTANGIBLE ASSETS&#8212;NET - INDEFINITE-LIVED INTANGIBLE ASSETS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERACCRUEDLIABILITIES" roleURI="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIES">
        <link:definition>2136110 - Disclosure - OTHER ACCRUED LIABILITIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERACCRUEDLIABILITIESTables" roleURI="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESTables">
        <link:definition>2337308 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERACCRUEDLIABILITIESDetails" roleURI="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails">
        <link:definition>2438419 - Disclosure - OTHER ACCRUED LIABILITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OTHERACCRUEDLIABILITIESNARRATIVEDetails" roleURI="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails">
        <link:definition>2439420 - Disclosure - OTHER ACCRUED LIABILITIES - NARRATIVE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://pennantgroup.com/role/DEBT">
        <link:definition>2140111 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://pennantgroup.com/role/DEBTTables">
        <link:definition>2341309 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTSCHEDULEOFLONGTERMDEBTDetails" roleURI="http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails">
        <link:definition>2442421 - Disclosure - DEBT - SCHEDULE OF LONG-TERM DEBT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNARRATIVEDetails" roleURI="http://pennantgroup.com/role/DEBTNARRATIVEDetails">
        <link:definition>2443422 - Disclosure - DEBT - NARRATIVE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDS" roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDS">
        <link:definition>2144112 - Disclosure - OPTIONS AND AWARDS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSTables" roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSTables">
        <link:definition>2345310 - Disclosure - OPTIONS AND AWARDS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails" roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails">
        <link:definition>2446423 - Disclosure - OPTIONS AND AWARDS - SHARE-BASED COMPENSATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails" roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails">
        <link:definition>2447424 - Disclosure - OPTIONS AND AWARDS - SHARE-BASED COMPENSATION EXPENSE AND NARRATIVE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSOPTIONSGRANTEDDetails" roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails">
        <link:definition>2448425 - Disclosure - OPTIONS AND AWARDS - OPTIONS GRANTED (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails" roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails">
        <link:definition>2449426 - Disclosure - OPTIONS AND AWARDS - EMPLOYEE STOCK OPTION ACTIVITY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails" roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails">
        <link:definition>2450427 - Disclosure - OPTIONS AND AWARDS - AGGREGATE INTRINSIC VALUE OF OPTIONS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OPTIONSANDAWARDSRESTRICTEDSTOCKDetails" roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails">
        <link:definition>2451428 - Disclosure - OPTIONS AND AWARDS - RESTRICTED STOCK (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://pennantgroup.com/role/LEASES">
        <link:definition>2152113 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://pennantgroup.com/role/LEASESTables">
        <link:definition>2353311 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNARRATIVEDetails" roleURI="http://pennantgroup.com/role/LEASESNARRATIVEDetails">
        <link:definition>2454429 - Disclosure - LEASES - NARRATIVE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESIMPACTOFNEWLEASESGUIDANCEDetails" roleURI="http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails">
        <link:definition>2455430 - Disclosure - LEASES - IMPACT OF NEW LEASES GUIDANCE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESFUTUREMINIMUMLEASEPAYMENTSDetails" roleURI="http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails">
        <link:definition>2456431 - Disclosure - LEASES - FUTURE MINIMUM LEASE PAYMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1" roleURI="http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1">
        <link:definition>2456431 - Disclosure - LEASES - FUTURE MINIMUM LEASE PAYMENTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://pennantgroup.com/role/INCOMETAXES">
        <link:definition>2157114 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://pennantgroup.com/role/INCOMETAXESTables">
        <link:definition>2358312 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESPROVISIONFORINCOMETAXESDetails" roleURI="http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails">
        <link:definition>2459432 - Disclosure - INCOME TAXES - PROVISION FOR INCOME TAXES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTAXRATERECONCILIATIONDetails" roleURI="http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails">
        <link:definition>2460433 - Disclosure - INCOME TAXES - TAX RATE RECONCILIATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails" roleURI="http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails">
        <link:definition>2461434 - Disclosure - INCOME TAXES - DEFERRED TAX ASSETS AND LIABILITIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNARRATIVEDetails" roleURI="http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails">
        <link:definition>2462435 - Disclosure - INCOME TAXES - NARRATIVE (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails" roleURI="http://pennantgroup.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails">
        <link:definition>2463436 - Disclosure - INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2164115 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESDetails" roleURI="http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails">
        <link:definition>2465437 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENT" roleURI="http://pennantgroup.com/role/SUBSEQUENTEVENT">
        <link:definition>2166116 - Disclosure - SUBSEQUENT EVENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTDetails" roleURI="http://pennantgroup.com/role/SUBSEQUENTEVENTDetails">
        <link:definition>2467438 - Disclosure - SUBSEQUENT EVENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="pntg_OperatingLeaseRentExpenseMember" abstract="true" name="OperatingLeaseRentExpenseMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="pntg_HomeHealthAndHospiceServicesSegmentMember" abstract="true" name="HomeHealthAndHospiceServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_HospiceSubsegmentMember" abstract="true" name="HospiceSubsegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_HomeHealthJointVentureMember" abstract="true" name="HomeHealthJointVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_CorridorAsAnAdditionalOutOfPocketRetention" abstract="false" name="CorridorAsAnAdditionalOutOfPocketRetention" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_GrantYear2019Member" abstract="true" name="GrantYear2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement" abstract="false" name="NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pntg_TheEnsignPlansMember" abstract="true" name="TheEnsignPlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview" abstract="false" name="UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pntg_InsuranceProgramAccruedExpensesNoncurrent" abstract="false" name="InsuranceProgramAccruedExpensesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_AccruedPayrollTaxesEmployerPortion" abstract="false" name="AccruedPayrollTaxesEmployerPortion" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_SpinoffTransactionCosts" abstract="false" name="SpinoffTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_NumberOfRealEstatePropertiesUnderLease" abstract="false" name="NumberOfRealEstatePropertiesUnderLease" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pntg_DistributionToFromParent" abstract="false" name="DistributionToFromParent" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_DirectMedicalSuppliesLaborAndOtherExpenses" abstract="false" name="DirectMedicalSuppliesLaborAndOtherExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_ManagedCareMember" abstract="true" name="ManagedCareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_GrantYear2021Member" abstract="true" name="GrantYear2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock" abstract="false" name="ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pntg_AmountToOffsetExpenseSequestrationRelief" abstract="false" name="AmountToOffsetExpenseSequestrationRelief" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_AssetAcquisitions2019Member" abstract="true" name="AssetAcquisitions2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_PaymentsForDepositsOnAcquisition" abstract="false" name="PaymentsForDepositsOnAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_InsuranceProgramAccruedExpenses" abstract="false" name="InsuranceProgramAccruedExpenses" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation" abstract="false" name="EffectiveIncomeTaxRateReconciliationSection162mLimitation" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim" abstract="false" name="GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_WorkersCompensationInsuranceRetentionLimitPerClaim" abstract="false" name="WorkersCompensationInsuranceRetentionLimitPerClaim" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_ScrippsHealthMember" abstract="true" name="ScrippsHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_StockholdersEquityDistributionsFromParent" abstract="false" name="StockholdersEquityDistributionsFromParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_ImpairmentLongLivedAssetsNumberOfCommunities" abstract="false" name="ImpairmentLongLivedAssetsNumberOfCommunities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pntg_TransitionServicesAgreementMember" abstract="true" name="TransitionServicesAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_AccruedWagesAndRelatedLiabilitiesMember" abstract="true" name="AccruedWagesAndRelatedLiabilitiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_NumberOfSeparateMasterLeaseArrangements" abstract="false" name="NumberOfSeparateMasterLeaseArrangements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds" abstract="false" name="RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_SummaryOfInsuranceLiabilityTableTextBlock" abstract="false" name="SummaryOfInsuranceLiabilityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses" abstract="false" name="IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_HomeHealthSubsegmentMember" abstract="true" name="HomeHealthSubsegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_SpinOffTransactionDistributionRatio" abstract="false" name="SpinOffTransactionDistributionRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pntg_BusinessAcquisitions2019Member" abstract="true" name="BusinessAcquisitions2019Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_DeferredTaxLiabilitiesStateTaxes" abstract="false" name="DeferredTaxLiabilitiesStateTaxes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_NonCapitalizableRelatedToTheBusinessCombinations" abstract="false" name="NonCapitalizableRelatedToTheBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_PaymentsForProceedsFromPropertyReserveRequirements" abstract="false" name="PaymentsForProceedsFromPropertyReserveRequirements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent" abstract="false" name="EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pntg_EnsignSubsidiaryMember" abstract="true" name="EnsignSubsidiaryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_NoncontrollingInterestJointVenture" abstract="false" name="NoncontrollingInterestJointVenture" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_NumberOfServiceProviders" abstract="false" name="NumberOfServiceProviders" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pntg_MedicareMember" abstract="true" name="MedicareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_ContractLiabilityAdvancePaymentsCARESAct" abstract="false" name="ContractLiabilityAdvancePaymentsCARESAct" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_BusinessCombinationCashPaidInPriorYear" abstract="false" name="BusinessCombinationCashPaidInPriorYear" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_GrantYear2020Member" abstract="true" name="GrantYear2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability" abstract="false" name="AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled" abstract="false" name="NumberOfOperatingSubsidiariesWithReviewsScheduled" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" abstract="false" name="TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" abstract="false" name="IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_PrivateAndOtherMember" abstract="true" name="PrivateAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_InvestedCapitalPolicyTextBlock" abstract="false" name="InvestedCapitalPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pntg_AssetAcquisitions2021Member" abstract="true" name="AssetAcquisitions2021Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_SeniorLivingServicesSegmentMember" abstract="true" name="SeniorLivingServicesSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_UniformProgramIntegrityContractorSuspendedPayments" abstract="false" name="UniformProgramIntegrityContractorSuspendedPayments" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_AffiliatesOfEnsignMember" abstract="true" name="AffiliatesOfEnsignMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_GeneralAndProfessionalInsuranceLiability" abstract="false" name="GeneralAndProfessionalInsuranceLiability" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_AdditionalPaidInCapitalEffectOfIncomeTax" abstract="false" name="AdditionalPaidInCapitalEffectOfIncomeTax" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_ReclassificationOfInvestedEquity" abstract="false" name="ReclassificationOfInvestedEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_UniformProgramIntegrityContractorPeriodOfReview" abstract="false" name="UniformProgramIntegrityContractorPeriodOfReview" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="pntg_MedicareAndMedicaidMember" abstract="true" name="MedicareAndMedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_MedicaidMember" abstract="true" name="MedicaidMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_DeferredTaxLiabilitiesDepreciationAndAmortization" abstract="false" name="DeferredTaxLiabilitiesDepreciationAndAmortization" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_InsuranceProgramAccruedExpensesCurrent" abstract="false" name="InsuranceProgramAccruedExpensesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_NumberOfUnitsInRealEstatePropertyAcquired" abstract="false" name="NumberOfUnitsInRealEstatePropertyAcquired" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock" abstract="false" name="RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="pntg_AcquisitionRelatedCostsNotCapitalized" abstract="false" name="AcquisitionRelatedCostsNotCapitalized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_NetParentInvestment" abstract="false" name="NetParentInvestment" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus" abstract="false" name="EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="pntg_HospiceJoinVentureMember" abstract="true" name="HospiceJoinVentureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_NumberOfBusinessesAndAssetsAcquired" abstract="false" name="NumberOfBusinessesAndAssetsAcquired" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="pntg_ProceedsFromSaleOfSubsidiaryShares" abstract="false" name="ProceedsFromSaleOfSubsidiaryShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_FacilityMember" abstract="true" name="FacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_DeferredTaxAssetsLeaseLiabilities" abstract="false" name="DeferredTaxAssetsLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_CashAndContributedAssetsNetBookValue" abstract="false" name="CashAndContributedAssetsNetBookValue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_TotalAcquisitions" abstract="false" name="TotalAcquisitions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_StartUpActivitiesCosts" abstract="false" name="StartUpActivitiesCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="pntg_HomeCareAgenciesMember" abstract="true" name="HomeCareAgenciesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="pntg_AssetAcquisitions2020Member" abstract="true" name="AssetAcquisitions2020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>10
<FILENAME>pntg-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6a149289-91af-40b5-8f3e-f8666bbd5c45,g:56c4c52a-4e81-467a-86f6-87d568a87628-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="pntg-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_360e8f3e-3602-40f1-a5d7-abfaa72bb97f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_b5853b06-7e93-41dd-a7e5-cec4165ae743" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_360e8f3e-3602-40f1-a5d7-abfaa72bb97f" xlink:to="loc_us-gaap_Cash_b5853b06-7e93-41dd-a7e5-cec4165ae743" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6faff59a-3fb8-4f4c-9c22-c90c0e1f3076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_360e8f3e-3602-40f1-a5d7-abfaa72bb97f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6faff59a-3fb8-4f4c-9c22-c90c0e1f3076" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bb6d2dde-9673-49b8-814a-7d37d87881d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_360e8f3e-3602-40f1-a5d7-abfaa72bb97f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bb6d2dde-9673-49b8-814a-7d37d87881d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3afb0660-c1d9-4aaa-b0d7-16d509518200" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7a4232c4-6034-4c32-bcb7-85d669fb1b10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3afb0660-c1d9-4aaa-b0d7-16d509518200" xlink:to="loc_us-gaap_LiabilitiesCurrent_7a4232c4-6034-4c32-bcb7-85d669fb1b10" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_da24ff7e-8bc5-4a5e-aa18-35342eb71948" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3afb0660-c1d9-4aaa-b0d7-16d509518200" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_da24ff7e-8bc5-4a5e-aa18-35342eb71948" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_8b0440b2-7eb2-4e68-9648-3df6e0c6093e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3afb0660-c1d9-4aaa-b0d7-16d509518200" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_8b0440b2-7eb2-4e68-9648-3df6e0c6093e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_06d9a303-c9b2-416e-849c-335489ff47d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_3afb0660-c1d9-4aaa-b0d7-16d509518200" xlink:to="loc_us-gaap_LongTermDebt_06d9a303-c9b2-416e-849c-335489ff47d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1e4b5b40-abe7-4d0a-bc90-0f1a85be42c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NetParentInvestment_ee6fdc65-eb10-4702-abd0-fe0f5724d2d0" xlink:href="pntg-20211231.xsd#pntg_NetParentInvestment"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1e4b5b40-abe7-4d0a-bc90-0f1a85be42c1" xlink:to="loc_pntg_NetParentInvestment_ee6fdc65-eb10-4702-abd0-fe0f5724d2d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_f655be1c-817e-49bf-bc10-2ca4702ae091" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1e4b5b40-abe7-4d0a-bc90-0f1a85be42c1" xlink:to="loc_us-gaap_MinorityInterest_f655be1c-817e-49bf-bc10-2ca4702ae091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_1b393f45-03db-43bd-8cae-3cb532be7180" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_5cd61c67-09f8-4699-83b2-cd52a6fb662b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1b393f45-03db-43bd-8cae-3cb532be7180" xlink:to="loc_us-gaap_Liabilities_5cd61c67-09f8-4699-83b2-cd52a6fb662b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_52e4c89a-4565-4ac8-8169-95db3f1be5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1b393f45-03db-43bd-8cae-3cb532be7180" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_52e4c89a-4565-4ac8-8169-95db3f1be5e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_d4901d2a-6d23-445b-b538-7a019d359120" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_1b393f45-03db-43bd-8cae-3cb532be7180" xlink:to="loc_us-gaap_CommitmentsAndContingencies_d4901d2a-6d23-445b-b538-7a019d359120" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_0b9c0aba-9978-4b2f-b070-0125420f6e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_3deed146-a581-4448-a6f5-a5da7a46821c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0b9c0aba-9978-4b2f-b070-0125420f6e5d" xlink:to="loc_us-gaap_AccountsPayableCurrent_3deed146-a581-4448-a6f5-a5da7a46821c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f8966da1-7692-4fe9-885d-ef6cc199ff98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0b9c0aba-9978-4b2f-b070-0125420f6e5d" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_f8966da1-7692-4fe9-885d-ef6cc199ff98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_0d8d0973-8cf4-453a-ac36-c77dd3f8ed76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0b9c0aba-9978-4b2f-b070-0125420f6e5d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_0d8d0973-8cf4-453a-ac36-c77dd3f8ed76" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_82bc6ef9-450f-4174-ae92-85919998e09a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_0b9c0aba-9978-4b2f-b070-0125420f6e5d" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_82bc6ef9-450f-4174-ae92-85919998e09a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_dc0e741c-9477-409b-82a3-21f907e10c60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_882d35b2-ea99-4b0a-beb6-b8452dacb87e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dc0e741c-9477-409b-82a3-21f907e10c60" xlink:to="loc_us-gaap_AssetsCurrent_882d35b2-ea99-4b0a-beb6-b8452dacb87e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_82b0161b-cd3f-49a1-ba67-9b54d6e9fa3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dc0e741c-9477-409b-82a3-21f907e10c60" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_82b0161b-cd3f-49a1-ba67-9b54d6e9fa3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_9898c5ee-ae41-4fa5-bd1d-860a860ce41d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dc0e741c-9477-409b-82a3-21f907e10c60" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_9898c5ee-ae41-4fa5-bd1d-860a860ce41d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestrictedAssetsNoncurrent_8e2d360f-2360-42d7-9f0a-a9dda44051dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestrictedAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dc0e741c-9477-409b-82a3-21f907e10c60" xlink:to="loc_us-gaap_OtherRestrictedAssetsNoncurrent_8e2d360f-2360-42d7-9f0a-a9dda44051dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_15ae2bc3-d936-4bb9-b82f-c8d899f08a15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dc0e741c-9477-409b-82a3-21f907e10c60" xlink:to="loc_us-gaap_Goodwill_15ae2bc3-d936-4bb9-b82f-c8d899f08a15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_26ae9b92-e25e-4b9a-be44-9ab17ee7fce4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dc0e741c-9477-409b-82a3-21f907e10c60" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_26ae9b92-e25e-4b9a-be44-9ab17ee7fce4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_d5e895ce-c0a0-42bd-b0e0-da5e2b2e6d3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EscrowDeposit"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dc0e741c-9477-409b-82a3-21f907e10c60" xlink:to="loc_us-gaap_EscrowDeposit_d5e895ce-c0a0-42bd-b0e0-da5e2b2e6d3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_e5f755b2-263b-4985-8a8f-adaf7718d2ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_dc0e741c-9477-409b-82a3-21f907e10c60" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_e5f755b2-263b-4985-8a8f-adaf7718d2ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NetParentInvestment_50cc3381-2b0c-44ac-9100-2774877769a1" xlink:href="pntg-20211231.xsd#pntg_NetParentInvestment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_74c43c2b-e7f3-4f90-8cd4-c6bb01b5bf88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pntg_NetParentInvestment_50cc3381-2b0c-44ac-9100-2774877769a1" xlink:to="loc_us-gaap_AdditionalPaidInCapital_74c43c2b-e7f3-4f90-8cd4-c6bb01b5bf88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2f77ca5a-5c29-426f-b60b-977aad50da2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pntg_NetParentInvestment_50cc3381-2b0c-44ac-9100-2774877769a1" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_2f77ca5a-5c29-426f-b60b-977aad50da2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_933d1239-35fa-46e6-898e-b8c7f1b9025d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pntg_NetParentInvestment_50cc3381-2b0c-44ac-9100-2774877769a1" xlink:to="loc_us-gaap_TreasuryStockValue_933d1239-35fa-46e6-898e-b8c7f1b9025d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_7c8f38ee-0dd1-4530-80d3-bbd6267834fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pntg_NetParentInvestment_50cc3381-2b0c-44ac-9100-2774877769a1" xlink:to="loc_us-gaap_CommonStockValue_7c8f38ee-0dd1-4530-80d3-bbd6267834fb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="pntg-20211231.xsd#CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_34106c1a-97b4-422b-8d6f-64109a3a896d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6edcce5d-31fd-4175-b4e2-21a0a943fb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_34106c1a-97b4-422b-8d6f-64109a3a896d" xlink:to="loc_us-gaap_OperatingIncomeLoss_6edcce5d-31fd-4175-b4e2-21a0a943fb3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_36d67dff-8749-425e-a00c-3461e6b3bbeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_34106c1a-97b4-422b-8d6f-64109a3a896d" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_36d67dff-8749-425e-a00c-3461e6b3bbeb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_6b4729ab-36ef-4164-865a-6205c49b0040" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9eafe868-ed42-43ab-8d26-375430400ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6b4729ab-36ef-4164-865a-6205c49b0040" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9eafe868-ed42-43ab-8d26-375430400ba1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_ab38cab0-8c5e-43aa-863a-f4333b91ead6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_6b4729ab-36ef-4164-865a-6205c49b0040" xlink:to="loc_us-gaap_CostsAndExpenses_ab38cab0-8c5e-43aa-863a-f4333b91ead6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_15fc0c1e-4e64-43fa-8562-bcee49ed99f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_0dd0254f-bed0-4577-9f49-f6239747f2c0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_15fc0c1e-4e64-43fa-8562-bcee49ed99f7" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_0dd0254f-bed0-4577-9f49-f6239747f2c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_2b4cb654-05ca-431f-9065-369d6e128dad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_15fc0c1e-4e64-43fa-8562-bcee49ed99f7" xlink:to="loc_us-gaap_DepreciationAndAmortization_2b4cb654-05ca-431f-9065-369d6e128dad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_c77c171e-6bfe-4b4e-b027-691f6ce0ded1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_15fc0c1e-4e64-43fa-8562-bcee49ed99f7" xlink:to="loc_us-gaap_OperatingLeaseExpense_c77c171e-6bfe-4b4e-b027-691f6ce0ded1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_6858d553-8c3b-497b-a0a1-b85001b25c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CostsAndExpenses_15fc0c1e-4e64-43fa-8562-bcee49ed99f7" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_6858d553-8c3b-497b-a0a1-b85001b25c01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_5b35668c-619a-4bfa-9020-0a6aebf9aece" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_49c098a1-b972-4714-8f23-dd334ad674c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_5b35668c-619a-4bfa-9020-0a6aebf9aece" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_49c098a1-b972-4714-8f23-dd334ad674c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_71efedfd-246d-4af9-b280-a53e8dc09faa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_5b35668c-619a-4bfa-9020-0a6aebf9aece" xlink:to="loc_us-gaap_InterestExpense_71efedfd-246d-4af9-b280-a53e8dc09faa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_1fb2bc87-72d4-442b-995a-137a46b0c632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a307697c-dac7-4052-aa72-f67e0090cfdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1fb2bc87-72d4-442b-995a-137a46b0c632" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a307697c-dac7-4052-aa72-f67e0090cfdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_8765cba6-aded-4312-a48d-6db5708ea660" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ProfitLoss_1fb2bc87-72d4-442b-995a-137a46b0c632" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_8765cba6-aded-4312-a48d-6db5708ea660" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="pntg-20211231.xsd#CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d43b9b-f6a2-4adb-bf5e-33195c5d8b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_PaymentsForDepositsOnAcquisition_c28438e1-9e6f-4955-8e15-762038b37c70" xlink:href="pntg-20211231.xsd#pntg_PaymentsForDepositsOnAcquisition"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d43b9b-f6a2-4adb-bf5e-33195c5d8b2c" xlink:to="loc_pntg_PaymentsForDepositsOnAcquisition_c28438e1-9e6f-4955-8e15-762038b37c70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_58460e52-d41f-4783-8812-224097614494" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d43b9b-f6a2-4adb-bf5e-33195c5d8b2c" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_58460e52-d41f-4783-8812-224097614494" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_PaymentsForProceedsFromPropertyReserveRequirements_128073a3-c2d9-42b2-bc9a-4f9843f3cfc0" xlink:href="pntg-20211231.xsd#pntg_PaymentsForProceedsFromPropertyReserveRequirements"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d43b9b-f6a2-4adb-bf5e-33195c5d8b2c" xlink:to="loc_pntg_PaymentsForProceedsFromPropertyReserveRequirements_128073a3-c2d9-42b2-bc9a-4f9843f3cfc0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a41499c4-6812-4654-9488-217f1c407d9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d43b9b-f6a2-4adb-bf5e-33195c5d8b2c" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a41499c4-6812-4654-9488-217f1c407d9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4e593211-9a93-4186-a867-8b77c7680fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_4e593211-9a93-4186-a867-8b77c7680fb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_536b347b-969a-4986-baf3-c4e61c28384a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_536b347b-969a-4986-baf3-c4e61c28384a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b25ce4ef-0314-4163-94fe-f33b24ae69f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b25ce4ef-0314-4163-94fe-f33b24ae69f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_73f5f7f0-f2ca-44f8-8c5d-9040bf73c881" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_73f5f7f0-f2ca-44f8-8c5d-9040bf73c881" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1ff19d82-59e6-4223-bc25-42002f4ff653" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1ff19d82-59e6-4223-bc25-42002f4ff653" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_33f3876f-557d-4d72-ab53-80596b3157e5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_ProfitLoss_33f3876f-557d-4d72-ab53-80596b3157e5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_ecb1d5a6-6774-4111-a70d-f957fd59c839" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_ecb1d5a6-6774-4111-a70d-f957fd59c839" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_16e227f8-5b63-4cfe-a289-962fefb009ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_ShareBasedCompensation_16e227f8-5b63-4cfe-a289-962fefb009ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1233ebb1-e11a-4ba3-a27f-14fe0e4d6744" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_1233ebb1-e11a-4ba3-a27f-14fe0e4d6744" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_912d0b73-69e6-4d2d-9d35-bafbf9ea0c3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_912d0b73-69e6-4d2d-9d35-bafbf9ea0c3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_44d0570e-cd09-4207-80aa-77a18404a8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_44d0570e-cd09-4207-80aa-77a18404a8f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_8ccf67b0-07d5-430d-9b6a-7c0b201bb886" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_8ccf67b0-07d5-430d-9b6a-7c0b201bb886" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_22e9ad69-7b9e-4f09-94d7-c121e07ea96e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_22e9ad69-7b9e-4f09-94d7-c121e07ea96e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_4970ed80-4114-4345-b3c7-2f26d2e0ddb4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="14" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_4970ed80-4114-4345-b3c7-2f26d2e0ddb4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_df9a8a12-2884-4ae2-af34-83117a1dd868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_072a52f4-9923-4170-84ea-6fbfaa2b0b15" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_df9a8a12-2884-4ae2-af34-83117a1dd868" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc0d238-9dd8-431f-802e-5b4400d4af7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_fd175acc-e7d3-4f18-92d1-bdf6d823eba0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc0d238-9dd8-431f-802e-5b4400d4af7d" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_fd175acc-e7d3-4f18-92d1-bdf6d823eba0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_5840c7da-55fc-4409-8212-6fb84e49959e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc0d238-9dd8-431f-802e-5b4400d4af7d" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_5840c7da-55fc-4409-8212-6fb84e49959e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ProceedsFromSaleOfSubsidiaryShares_324f5729-53dd-436c-91c6-5849073739fe" xlink:href="pntg-20211231.xsd#pntg_ProceedsFromSaleOfSubsidiaryShares"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc0d238-9dd8-431f-802e-5b4400d4af7d" xlink:to="loc_pntg_ProceedsFromSaleOfSubsidiaryShares_324f5729-53dd-436c-91c6-5849073739fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_b52113d6-8f56-47a6-b1d9-a7f8168430b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc0d238-9dd8-431f-802e-5b4400d4af7d" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_b52113d6-8f56-47a6-b1d9-a7f8168430b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_47c8c5f5-5136-428c-8f57-6df67db638ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc0d238-9dd8-431f-802e-5b4400d4af7d" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_47c8c5f5-5136-428c-8f57-6df67db638ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_60824214-1fc0-4915-a45e-72c35a2b82e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc0d238-9dd8-431f-802e-5b4400d4af7d" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_60824214-1fc0-4915-a45e-72c35a2b82e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_8c6c1ea5-e331-45ab-9d9a-4fd2e52a7bb0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc0d238-9dd8-431f-802e-5b4400d4af7d" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_8c6c1ea5-e331-45ab-9d9a-4fd2e52a7bb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_4b83262a-133a-4b48-8889-c51da5bdae05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc0d238-9dd8-431f-802e-5b4400d4af7d" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_4b83262a-133a-4b48-8889-c51da5bdae05" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_7ca34526-fcba-409d-b8be-ee29f8ec8191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc0d238-9dd8-431f-802e-5b4400d4af7d" xlink:to="loc_us-gaap_PaymentsOfDividends_7ca34526-fcba-409d-b8be-ee29f8ec8191" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DistributionToFromParent_002ca2ec-449d-499b-b10f-7d5d9ac6cacb" xlink:href="pntg-20211231.xsd#pntg_DistributionToFromParent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4fc0d238-9dd8-431f-802e-5b4400d4af7d" xlink:to="loc_pntg_DistributionToFromParent_002ca2ec-449d-499b-b10f-7d5d9ac6cacb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d1e3f069-bf4d-48b6-aec5-5db09c37448e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b708939-920a-44ae-a3e7-5a5e93fc98f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d1e3f069-bf4d-48b6-aec5-5db09c37448e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_8b708939-920a-44ae-a3e7-5a5e93fc98f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5488b248-95c8-4d95-b610-25dc779be2f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d1e3f069-bf4d-48b6-aec5-5db09c37448e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5488b248-95c8-4d95-b610-25dc779be2f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6246d6ba-b6d8-4ac8-afb4-ed3492393ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d1e3f069-bf4d-48b6-aec5-5db09c37448e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6246d6ba-b6d8-4ac8-afb4-ed3492393ba1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InsuranceProgramAccruedExpenses_eb98c152-287a-4160-bfad-e0064a6e31a9" xlink:href="pntg-20211231.xsd#pntg_InsuranceProgramAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GeneralAndProfessionalInsuranceLiability_9e14f809-4ee0-4951-9842-7490caa60ba6" xlink:href="pntg-20211231.xsd#pntg_GeneralAndProfessionalInsuranceLiability"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pntg_InsuranceProgramAccruedExpenses_eb98c152-287a-4160-bfad-e0064a6e31a9" xlink:to="loc_pntg_GeneralAndProfessionalInsuranceLiability_9e14f809-4ee0-4951-9842-7490caa60ba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_e57e7018-29eb-4282-9081-8e502f2d7b9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pntg_InsuranceProgramAccruedExpenses_eb98c152-287a-4160-bfad-e0064a6e31a9" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_e57e7018-29eb-4282-9081-8e502f2d7b9d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails_1" xlink:type="simple" xlink:href="pntg-20211231.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails_1"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InsuranceProgramAccruedExpenses_c97bf839-33f0-43ca-b1ef-b07b648bf48c" xlink:href="pntg-20211231.xsd#pntg_InsuranceProgramAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InsuranceProgramAccruedExpensesNoncurrent_0f1f0c4d-40ad-433d-9613-3c95dda08ba4" xlink:href="pntg-20211231.xsd#pntg_InsuranceProgramAccruedExpensesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pntg_InsuranceProgramAccruedExpenses_c97bf839-33f0-43ca-b1ef-b07b648bf48c" xlink:to="loc_pntg_InsuranceProgramAccruedExpensesNoncurrent_0f1f0c4d-40ad-433d-9613-3c95dda08ba4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InsuranceProgramAccruedExpensesCurrent_23e2347e-3df3-40f6-b71b-ae13e74c1266" xlink:href="pntg-20211231.xsd#pntg_InsuranceProgramAccruedExpensesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_pntg_InsuranceProgramAccruedExpenses_c97bf839-33f0-43ca-b1ef-b07b648bf48c" xlink:to="loc_pntg_InsuranceProgramAccruedExpensesCurrent_23e2347e-3df3-40f6-b71b-ae13e74c1266" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6d205c6a-62ba-4368-84a2-eaf38dfcaee6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf498c6b-2881-4543-a34a-dd61faaed543" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6d205c6a-62ba-4368-84a2-eaf38dfcaee6" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_cf498c6b-2881-4543-a34a-dd61faaed543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ebd58042-910e-4496-8595-ff2c44fe3e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_6d205c6a-62ba-4368-84a2-eaf38dfcaee6" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_ebd58042-910e-4496-8595-ff2c44fe3e5d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7a5657a7-ff01-42fa-873a-f003a74508ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_216169ea-3586-4a16-9bae-70976abbe477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7a5657a7-ff01-42fa-873a-f003a74508ca" xlink:to="loc_us-gaap_ProfitLoss_216169ea-3586-4a16-9bae-70976abbe477" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0ba7a61b-dda2-4ebd-b51c-547f54c63533" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_7a5657a7-ff01-42fa-873a-f003a74508ca" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_0ba7a61b-dda2-4ebd-b51c-547f54c63533" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_cbd9d135-51ba-42f7-9418-33a8add9a01d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_4dcbaeec-3101-4f13-a005-12cceb59694d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_cbd9d135-51ba-42f7-9418-33a8add9a01d" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_4dcbaeec-3101-4f13-a005-12cceb59694d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3c14a965-cd20-4af1-b686-aaddf30e0230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent_cbd9d135-51ba-42f7-9418-33a8add9a01d" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_3c14a965-cd20-4af1-b686-aaddf30e0230" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c2cd8804-0899-4742-9551-83844ba58ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_66bb9ce6-8e2f-4580-b630-c0766c89fb48" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c2cd8804-0899-4742-9551-83844ba58ea9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_66bb9ce6-8e2f-4580-b630-c0766c89fb48" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_17a98e03-64ae-4e16-bf4c-a9481f6539e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c2cd8804-0899-4742-9551-83844ba58ea9" xlink:to="loc_us-gaap_Goodwill_17a98e03-64ae-4e16-bf4c-a9481f6539e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_e7970289-4e43-4f76-bb69-14b3dc6c0e52" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c2cd8804-0899-4742-9551-83844ba58ea9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_e7970289-4e43-4f76-bb69-14b3dc6c0e52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures_22f3da69-fcd1-4c35-8693-9c7ba7c66960" xlink:href="pntg-20211231.xsd#pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c2cd8804-0899-4742-9551-83844ba58ea9" xlink:to="loc_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures_22f3da69-fcd1-4c35-8693-9c7ba7c66960" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b5a97084-0cfd-46bf-b65b-77e90b09954e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_c2cd8804-0899-4742-9551-83844ba58ea9" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_b5a97084-0cfd-46bf-b65b-77e90b09954e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_82313f98-c027-4ae3-b88d-390b58f270cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_888f8c40-f589-41ea-8fd9-4c32576164b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_82313f98-c027-4ae3-b88d-390b58f270cf" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_888f8c40-f589-41ea-8fd9-4c32576164b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_508eadf1-3589-4623-895c-900eb50acb62" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_82313f98-c027-4ae3-b88d-390b58f270cf" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_508eadf1-3589-4623-895c-900eb50acb62" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_BusinessCombinationCashPaidInPriorYear_745f8566-05f0-4fa2-b935-5d8e41647b25" xlink:href="pntg-20211231.xsd#pntg_BusinessCombinationCashPaidInPriorYear"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_82313f98-c027-4ae3-b88d-390b58f270cf" xlink:to="loc_pntg_BusinessCombinationCashPaidInPriorYear_745f8566-05f0-4fa2-b935-5d8e41647b25" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#PROPERTYANDEQUIPMENTNETDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_451900f4-20e1-4ad6-9fe0-c48b29a2b7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e0ac737a-0d1a-46f1-a378-fce82e8313e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_451900f4-20e1-4ad6-9fe0-c48b29a2b7f2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e0ac737a-0d1a-46f1-a378-fce82e8313e8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_be06d49a-34e7-48bf-aee9-3837d1215a36" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_451900f4-20e1-4ad6-9fe0-c48b29a2b7f2" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_be06d49a-34e7-48bf-aee9-3837d1215a36" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OTHERACCRUEDLIABILITIESDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a54b1e73-c6b0-4323-8799-c5e17ff22916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent_715e85b4-9ded-4c1d-b3db-d7f4a135cfa3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a54b1e73-c6b0-4323-8799-c5e17ff22916" xlink:to="loc_us-gaap_CustomerRefundLiabilityCurrent_715e85b4-9ded-4c1d-b3db-d7f4a135cfa3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f347de88-9c16-4ee0-b600-f37bf03f3c0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a54b1e73-c6b0-4323-8799-c5e17ff22916" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_f347de88-9c16-4ee0-b600-f37bf03f3c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositLiabilityCurrent_8a8a77ae-f409-4075-830c-97d881c2f7d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a54b1e73-c6b0-4323-8799-c5e17ff22916" xlink:to="loc_us-gaap_DepositLiabilityCurrent_8a8a77ae-f409-4075-830c-97d881c2f7d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_6d55db61-3254-4905-b9a7-4c209dd3ab13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a54b1e73-c6b0-4323-8799-c5e17ff22916" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_6d55db61-3254-4905-b9a7-4c209dd3ab13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_35bc28e2-59ec-4547-a48d-d0e01335b443" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a54b1e73-c6b0-4323-8799-c5e17ff22916" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_35bc28e2-59ec-4547-a48d-d0e01335b443" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent_bb632e9a-cd23-460d-81ae-29e824c662eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a54b1e73-c6b0-4323-8799-c5e17ff22916" xlink:to="loc_us-gaap_SelfInsuranceReserveCurrent_bb632e9a-cd23-460d-81ae-29e824c662eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ContractLiabilityAdvancePaymentsCARESAct_805f7245-15b2-4934-8d98-7a1d4c4e9a8c" xlink:href="pntg-20211231.xsd#pntg_ContractLiabilityAdvancePaymentsCARESAct"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a54b1e73-c6b0-4323-8799-c5e17ff22916" xlink:to="loc_pntg_ContractLiabilityAdvancePaymentsCARESAct_805f7245-15b2-4934-8d98-7a1d4c4e9a8c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#DEBTSCHEDULEOFLONGTERMDEBTDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_f22a4895-d441-48b9-8667-95b850d3f5fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_9fd55560-22e1-47fc-b41b-b14c5233e103" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f22a4895-d441-48b9-8667-95b850d3f5fa" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_9fd55560-22e1-47fc-b41b-b14c5233e103" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_fecc46f1-8d56-4f86-a6e7-36bf196afe60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_f22a4895-d441-48b9-8667-95b850d3f5fa" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_fecc46f1-8d56-4f86-a6e7-36bf196afe60" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_27ae4435-95af-4704-87ba-bc441b8fc3d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_2a7208f6-76a6-42bd-926c-4862469050a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_27ae4435-95af-4704-87ba-bc441b8fc3d8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_2a7208f6-76a6-42bd-926c-4862469050a4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_013a8c3d-da8f-490e-9fdd-6b49cef7230b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_27ae4435-95af-4704-87ba-bc441b8fc3d8" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_013a8c3d-da8f-490e-9fdd-6b49cef7230b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_577ba6b7-874f-46fc-bea2-b1573c94b58b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_91aae64e-d0c6-4aee-b5e6-117b0bdc1361" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_577ba6b7-874f-46fc-bea2-b1573c94b58b" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_91aae64e-d0c6-4aee-b5e6-117b0bdc1361" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_d04c7377-e21c-4953-8964-710c772f170e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_577ba6b7-874f-46fc-bea2-b1573c94b58b" xlink:to="loc_us-gaap_OperatingLeaseLiability_d04c7377-e21c-4953-8964-710c772f170e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ed9aa9da-bf7b-40e9-93a2-c6806b035ab5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a32b0329-2167-4f83-be33-601cf26965a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_ed9aa9da-bf7b-40e9-93a2-c6806b035ab5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a32b0329-2167-4f83-be33-601cf26965a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_491fbde8-7f78-43bc-bb12-fbe42fbdf74e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_ed9aa9da-bf7b-40e9-93a2-c6806b035ab5" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_491fbde8-7f78-43bc-bb12-fbe42fbdf74e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1" xlink:type="simple" xlink:href="pntg-20211231.xsd#LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecce4754-ac29-4d8f-b453-50341e7f4651" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2a874d75-1e47-4357-8621-ba090958f12f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecce4754-ac29-4d8f-b453-50341e7f4651" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2a874d75-1e47-4357-8621-ba090958f12f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8ced9533-e59a-4fe8-973e-65b646fefd2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecce4754-ac29-4d8f-b453-50341e7f4651" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_8ced9533-e59a-4fe8-973e-65b646fefd2d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1cda688d-42a7-4484-b61c-ad6434452a78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecce4754-ac29-4d8f-b453-50341e7f4651" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_1cda688d-42a7-4484-b61c-ad6434452a78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_919a5fb4-5540-479c-86cc-beb344428b2c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecce4754-ac29-4d8f-b453-50341e7f4651" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_919a5fb4-5540-479c-86cc-beb344428b2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_715fb6d3-f493-4078-a417-75d4c6bd87a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecce4754-ac29-4d8f-b453-50341e7f4651" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_715fb6d3-f493-4078-a417-75d4c6bd87a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5787961c-de8f-45f8-b499-34445df9e2fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_ecce4754-ac29-4d8f-b453-50341e7f4651" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_5787961c-de8f-45f8-b499-34445df9e2fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXESPROVISIONFORINCOMETAXESDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_63a1578f-482e-4ea2-889d-701ed7c60831" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f70f4049-40e4-4c9c-b23c-931e83863ecd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_63a1578f-482e-4ea2-889d-701ed7c60831" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f70f4049-40e4-4c9c-b23c-931e83863ecd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cf1f2bb4-55d4-4b21-bee8-9bca6470bd1d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_63a1578f-482e-4ea2-889d-701ed7c60831" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_cf1f2bb4-55d4-4b21-bee8-9bca6470bd1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_35f4a036-cf19-4c09-a402-c3b6b7315f13" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_9561e6a6-a065-4b50-8889-ac837baccaa6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_35f4a036-cf19-4c09-a402-c3b6b7315f13" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_9561e6a6-a065-4b50-8889-ac837baccaa6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_df05de52-b1a8-41b7-b06a-f4f4d5ec7abe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_35f4a036-cf19-4c09-a402-c3b6b7315f13" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_df05de52-b1a8-41b7-b06a-f4f4d5ec7abe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ba9d4198-adb3-4e57-945c-5ff7ef5e1536" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_ed7cd373-1b51-4b8e-8a4a-91b391271bcf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ba9d4198-adb3-4e57-945c-5ff7ef5e1536" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_ed7cd373-1b51-4b8e-8a4a-91b391271bcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_abb56ca5-36ed-4dbb-96c3-6614997f06db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ba9d4198-adb3-4e57-945c-5ff7ef5e1536" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_abb56ca5-36ed-4dbb-96c3-6614997f06db" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXESTAXRATERECONCILIATIONDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus_7fa062c7-e077-49a1-9f0c-4503742d17b1" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus_7fa062c7-e077-49a1-9f0c-4503742d17b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_18c6e101-7f67-449d-886c-f058e7cb9a37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_18c6e101-7f67-449d-886c-f058e7cb9a37" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_4bbc1586-40df-4bda-8de7-ce53102c63bd" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_4bbc1586-40df-4bda-8de7-ce53102c63bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent_5cfc35fa-1461-47d8-a097-43925e5a718e" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent_5cfc35fa-1461-47d8-a097-43925e5a718e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_cc266135-403d-4dfa-9522-4241db87e861" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_cc266135-403d-4dfa-9522-4241db87e861" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2cf4e6f5-f6de-4eb3-a33b-6244f8162e69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_2cf4e6f5-f6de-4eb3-a33b-6244f8162e69" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_81f35f8b-3d41-4bea-98f4-0dafbea5b4b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_81f35f8b-3d41-4bea-98f4-0dafbea5b4b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_035ecbf7-744c-44da-89f8-de656c61a6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_035ecbf7-744c-44da-89f8-de656c61a6f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_67404f86-6af1-4a4f-933a-d5a809d7877d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_67404f86-6af1-4a4f-933a-d5a809d7877d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation_dc0eb627-460a-45a4-a35c-f7d755011efd" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation_dc0eb627-460a-45a4-a35c-f7d755011efd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_7a7dea29-fbb0-4e97-aa68-fca3ca9e56f5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_7a7dea29-fbb0-4e97-aa68-fca3ca9e56f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_45dde2a3-b505-4f32-b03d-3201bbac2de9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_6a382185-d61b-4702-b07e-a735b31f0885" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_45dde2a3-b505-4f32-b03d-3201bbac2de9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"/>
  <link:calculationLink xlink:role="http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_ecbdc03b-7469-48a0-9e26-9f87dc8fa1af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_546a7031-a5be-4680-b2b4-5bf1bdf4a1be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ecbdc03b-7469-48a0-9e26-9f87dc8fa1af" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_546a7031-a5be-4680-b2b4-5bf1bdf4a1be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_22c911ed-f0ed-42d0-bf46-df7596c16398" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ecbdc03b-7469-48a0-9e26-9f87dc8fa1af" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_22c911ed-f0ed-42d0-bf46-df7596c16398" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DeferredTaxAssetsLeaseLiabilities_2adba2b8-4837-4942-b2ec-fe91a4d17ede" xlink:href="pntg-20211231.xsd#pntg_DeferredTaxAssetsLeaseLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ecbdc03b-7469-48a0-9e26-9f87dc8fa1af" xlink:to="loc_pntg_DeferredTaxAssetsLeaseLiabilities_2adba2b8-4837-4942-b2ec-fe91a4d17ede" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_d81fc3cd-bccd-4549-8739-d8417dacf721" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ecbdc03b-7469-48a0-9e26-9f87dc8fa1af" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_d81fc3cd-bccd-4549-8739-d8417dacf721" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_d88f0f30-0950-4dad-a4b7-f8c9aa3ea745" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_ecbdc03b-7469-48a0-9e26-9f87dc8fa1af" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_d88f0f30-0950-4dad-a4b7-f8c9aa3ea745" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_ebd9cc56-628f-48fe-9ca8-c23b2cf7593a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2835ec34-6f96-45ca-94dc-9f8988df8d27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_ebd9cc56-628f-48fe-9ca8-c23b2cf7593a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_2835ec34-6f96-45ca-94dc-9f8988df8d27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_ba912576-039c-4626-aa67-2beb79d0ca7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_ebd9cc56-628f-48fe-9ca8-c23b2cf7593a" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_ba912576-039c-4626-aa67-2beb79d0ca7a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization_45f73742-5de1-4ad0-8cb6-aca1ce1f193c" xlink:href="pntg-20211231.xsd#pntg_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_ebd9cc56-628f-48fe-9ca8-c23b2cf7593a" xlink:to="loc_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization_45f73742-5de1-4ad0-8cb6-aca1ce1f193c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DeferredTaxLiabilitiesStateTaxes_8a317f71-1394-4e48-aa2d-a1c444e0b7d3" xlink:href="pntg-20211231.xsd#pntg_DeferredTaxLiabilitiesStateTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_ebd9cc56-628f-48fe-9ca8-c23b2cf7593a" xlink:to="loc_pntg_DeferredTaxLiabilitiesStateTaxes_8a317f71-1394-4e48-aa2d-a1c444e0b7d3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_49486706-4586-4124-afa0-2ad1cc07e5f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1f5e8ae9-e12f-4e98-a871-e1d3d814b19e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_49486706-4586-4124-afa0-2ad1cc07e5f1" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1f5e8ae9-e12f-4e98-a871-e1d3d814b19e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_478a2022-0666-4ca4-8656-95ccb17633be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_49486706-4586-4124-afa0-2ad1cc07e5f1" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_478a2022-0666-4ca4-8656-95ccb17633be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_e83c07cd-c204-497e-a10d-6ee706e15cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_69391530-9285-4453-a8db-0feead4b7c66" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e83c07cd-c204-497e-a10d-6ee706e15cc9" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_69391530-9285-4453-a8db-0feead4b7c66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_57522d5c-1596-4a5f-be06-a88d58b2c460" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_e83c07cd-c204-497e-a10d-6ee706e15cc9" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_57522d5c-1596-4a5f-be06-a88d58b2c460" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>11
<FILENAME>pntg-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6a149289-91af-40b5-8f3e-f8666bbd5c45,g:56c4c52a-4e81-467a-86f6-87d568a87628-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT" xlink:type="simple" xlink:href="pntg-20211231.xsd#CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT" xlink:type="extended" id="ifce015c70a294d17a902342756c13a11_CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_45e4d13c-5966-4056-9bb5-1b5b2ff51fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_45e4d13c-5966-4056-9bb5-1b5b2ff51fac" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_599161a3-49a9-4961-9033-006df2c27d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_SharesOutstanding_599161a3-49a9-4961-9033-006df2c27d7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5a8deb46-2b4c-495f-8e0b-1f696470b7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5a8deb46-2b4c-495f-8e0b-1f696470b7ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dc614bc6-edc5-43ce-8d82-0ae081ba8659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dc614bc6-edc5-43ce-8d82-0ae081ba8659" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_7c591974-3c24-4717-ac0a-7df11f138dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_7c591974-3c24-4717-ac0a-7df11f138dc7" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9eedff0e-0cbe-497d-9eca-97a5f5854919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9eedff0e-0cbe-497d-9eca-97a5f5854919" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_StockholdersEquityDistributionsFromParent_7e32f6af-19f6-4725-9805-bcaaa6f85436" xlink:href="pntg-20211231.xsd#pntg_StockholdersEquityDistributionsFromParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_pntg_StockholdersEquityDistributionsFromParent_7e32f6af-19f6-4725-9805-bcaaa6f85436" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e51070c6-1c53-4211-b6e5-f7878062abca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_NetIncomeLoss_e51070c6-1c53-4211-b6e5-f7878062abca" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_05277f47-8386-4c00-a633-560bb27f2a26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_DividendsCash_05277f47-8386-4c00-a633-560bb27f2a26" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ReclassificationOfInvestedEquity_d154668f-d230-4589-827e-dfcc87c083c7" xlink:href="pntg-20211231.xsd#pntg_ReclassificationOfInvestedEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_pntg_ReclassificationOfInvestedEquity_d154668f-d230-4589-827e-dfcc87c083c7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_9131e3f9-b9d3-4615-9f7f-1d816a345c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_9131e3f9-b9d3-4615-9f7f-1d816a345c21" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_381b3f55-3662-4b07-9e96-d2b7425bea28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_381b3f55-3662-4b07-9e96-d2b7425bea28" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3caaf3a6-587b-433e-8129-7ca404de5be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3caaf3a6-587b-433e-8129-7ca404de5be0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e2063f8f-d99e-4546-b54e-68c73a8f3191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e2063f8f-d99e-4546-b54e-68c73a8f3191" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3ff28796-bd12-45d4-ae32-31c0b35ac107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3ff28796-bd12-45d4-ae32-31c0b35ac107" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8afd6d3e-a047-48e7-b1cb-63d5a0cf5b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8afd6d3e-a047-48e7-b1cb-63d5a0cf5b65" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_296d7bf1-48c6-4a75-9a2e-3d0a35f63fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_296d7bf1-48c6-4a75-9a2e-3d0a35f63fd0" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ee5c3141-73f5-41a3-b016-4190d1b39152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ee5c3141-73f5-41a3-b016-4190d1b39152" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_9b1f69c0-0225-4a0c-8632-3bdc1c6489f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_9b1f69c0-0225-4a0c-8632-3bdc1c6489f1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_11f67f61-c49f-4ea3-8adb-0847ebb54916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_11f67f61-c49f-4ea3-8adb-0847ebb54916" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1ab1ddb8-4fc6-4321-9554-d2d88411f534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1ab1ddb8-4fc6-4321-9554-d2d88411f534" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_fa2e7275-7058-4188-b7ac-a040ef3a6d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5dde59a-b1b5-427f-8a1f-60e9b1803928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_690805f0-1a24-42e2-a5c6-4469681e4ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_45e4d13c-5966-4056-9bb5-1b5b2ff51fac" xlink:to="loc_us-gaap_StatementTable_690805f0-1a24-42e2-a5c6-4469681e4ed6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ebe699b8-905d-485a-8841-a4ba18611e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_690805f0-1a24-42e2-a5c6-4469681e4ed6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ebe699b8-905d-485a-8841-a4ba18611e1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ebe699b8-905d-485a-8841-a4ba18611e1e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ebe699b8-905d-485a-8841-a4ba18611e1e" xlink:to="loc_us-gaap_EquityComponentDomain_ebe699b8-905d-485a-8841-a4ba18611e1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ebe699b8-905d-485a-8841-a4ba18611e1e" xlink:to="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_936160f0-6045-418c-a095-ef5daf1faf26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_CommonStockMember_936160f0-6045-418c-a095-ef5daf1faf26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4d33ca3a-2db3-49e8-987c-7c6ae09b3954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4d33ca3a-2db3-49e8-987c-7c6ae09b3954" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_dc169f05-b2d5-47d2-9651-c2322c48285c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_RetainedEarningsMember_dc169f05-b2d5-47d2-9651-c2322c48285c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_91c41806-a754-4cca-bd25-fcac29ec9df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_TreasuryStockMember_91c41806-a754-4cca-bd25-fcac29ec9df1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_ea6c3654-4db2-49ca-8fe5-7bfedbcf6323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_ParentMember_ea6c3654-4db2-49ca-8fe5-7bfedbcf6323" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_549e979d-b9af-41df-95f0-d44021dcf4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_NoncontrollingInterestMember_549e979d-b9af-41df-95f0-d44021dcf4d9" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended" id="i9f24ade9940347259a6e8bef66cbccd0_DESCRIPTIONOFBUSINESSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_96960494-3469-4e94-acfc-8fc32a417497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfServiceProviders_42af40d8-fa2d-4cee-8dbc-ee7b0cb51cb5" xlink:href="pntg-20211231.xsd#pntg_NumberOfServiceProviders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96960494-3469-4e94-acfc-8fc32a417497" xlink:to="loc_pntg_NumberOfServiceProviders_42af40d8-fa2d-4cee-8dbc-ee7b0cb51cb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfRealEstatePropertiesUnderLease_44e037fa-0904-464b-ae08-9feb25113322" xlink:href="pntg-20211231.xsd#pntg_NumberOfRealEstatePropertiesUnderLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96960494-3469-4e94-acfc-8fc32a417497" xlink:to="loc_pntg_NumberOfRealEstatePropertiesUnderLease_44e037fa-0904-464b-ae08-9feb25113322" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SpinOffTransactionDistributionRatio_0d13e22d-4c94-47f5-8a12-6eaf07ebd462" xlink:href="pntg-20211231.xsd#pntg_SpinOffTransactionDistributionRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96960494-3469-4e94-acfc-8fc32a417497" xlink:to="loc_pntg_SpinOffTransactionDistributionRatio_0d13e22d-4c94-47f5-8a12-6eaf07ebd462" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d44d17a2-826f-47c1-9a30-4194c2de0ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96960494-3469-4e94-acfc-8fc32a417497" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d44d17a2-826f-47c1-9a30-4194c2de0ad9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_77a7abfe-aee5-49aa-9127-e1e33d0ef340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d44d17a2-826f-47c1-9a30-4194c2de0ad9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_77a7abfe-aee5-49aa-9127-e1e33d0ef340" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_77a7abfe-aee5-49aa-9127-e1e33d0ef340_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_77a7abfe-aee5-49aa-9127-e1e33d0ef340" xlink:to="loc_us-gaap_SegmentDomain_77a7abfe-aee5-49aa-9127-e1e33d0ef340_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e2ec8c75-42ff-433c-a650-ac6167544212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_77a7abfe-aee5-49aa-9127-e1e33d0ef340" xlink:to="loc_us-gaap_SegmentDomain_e2ec8c75-42ff-433c-a650-ac6167544212" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_d11bea18-2735-4c91-b89a-6a2fa54a9336" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e2ec8c75-42ff-433c-a650-ac6167544212" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_d11bea18-2735-4c91-b89a-6a2fa54a9336" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_9576ff89-e3fc-4c80-8e29-3164041adf96" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e2ec8c75-42ff-433c-a650-ac6167544212" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_9576ff89-e3fc-4c80-8e29-3164041adf96" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended" id="i2fe62a7c84b7448f879f2432f5012516_BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_d8fb9bf6-7a2c-4c58-8bed-b91cc8443bc4" xlink:href="pntg-20211231.xsd#pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_d8fb9bf6-7a2c-4c58-8bed-b91cc8443bc4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds_7b69fa96-1ee9-4815-a56a-d9282407b3f4" xlink:href="pntg-20211231.xsd#pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds_7b69fa96-1ee9-4815-a56a-d9282407b3f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AccruedPayrollTaxesEmployerPortion_298448a8-d2ac-4d12-bd7d-da2930f2fc05" xlink:href="pntg-20211231.xsd#pntg_AccruedPayrollTaxesEmployerPortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_AccruedPayrollTaxesEmployerPortion_298448a8-d2ac-4d12-bd7d-da2930f2fc05" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DirectMedicalSuppliesLaborAndOtherExpenses_0b9435f5-88d0-4d65-a27c-9970b8d11b51" xlink:href="pntg-20211231.xsd#pntg_DirectMedicalSuppliesLaborAndOtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_DirectMedicalSuppliesLaborAndOtherExpenses_0b9435f5-88d0-4d65-a27c-9970b8d11b51" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f36f8ceb-2248-4c0a-a0f5-a8ba51cc3581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f36f8ceb-2248-4c0a-a0f5-a8ba51cc3581" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_399eff36-e803-40b2-a7cb-952b833cb25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_399eff36-e803-40b2-a7cb-952b833cb25b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ImpairmentLongLivedAssetsNumberOfCommunities_5e30dd47-6e19-4a4a-8615-85065a04d755" xlink:href="pntg-20211231.xsd#pntg_ImpairmentLongLivedAssetsNumberOfCommunities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_ImpairmentLongLivedAssetsNumberOfCommunities_5e30dd47-6e19-4a4a-8615-85065a04d755" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_86f158f8-ab82-4b23-8d84-72f612ce93ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_86f158f8-ab82-4b23-8d84-72f612ce93ba" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim_7bb02e8b-8c45-48c4-8b9e-7af22c27a594" xlink:href="pntg-20211231.xsd#pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim_7bb02e8b-8c45-48c4-8b9e-7af22c27a594" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_CorridorAsAnAdditionalOutOfPocketRetention_6d1c874a-6d83-46b9-8a9d-22b5060f5992" xlink:href="pntg-20211231.xsd#pntg_CorridorAsAnAdditionalOutOfPocketRetention"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_CorridorAsAnAdditionalOutOfPocketRetention_6d1c874a-6d83-46b9-8a9d-22b5060f5992" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim_4864bad4-23fb-4e26-a2bb-c0a7e178290f" xlink:href="pntg-20211231.xsd#pntg_WorkersCompensationInsuranceRetentionLimitPerClaim"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim_4864bad4-23fb-4e26-a2bb-c0a7e178290f" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_ca10a894-e44f-44b4-ba35-ebefe9dcdfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_ca10a894-e44f-44b4-ba35-ebefe9dcdfe5" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_24f59945-0b3a-4067-a6a2-a4f27ad466e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_24f59945-0b3a-4067-a6a2-a4f27ad466e3" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_3537d0d2-7439-408f-97d8-753f912313a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_3537d0d2-7439-408f-97d8-753f912313a3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_137cd687-7677-4ab2-aed4-6230bf488186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_137cd687-7677-4ab2-aed4-6230bf488186" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd54dce3-9ac3-4bdd-888e-dd8b01141837" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_137cd687-7677-4ab2-aed4-6230bf488186" xlink:to="loc_srt_RangeAxis_dd54dce3-9ac3-4bdd-888e-dd8b01141837" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dd54dce3-9ac3-4bdd-888e-dd8b01141837_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_dd54dce3-9ac3-4bdd-888e-dd8b01141837" xlink:to="loc_srt_RangeMember_dd54dce3-9ac3-4bdd-888e-dd8b01141837_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e54dbba8-3f7e-4656-a4ad-b744c3b8dafd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_dd54dce3-9ac3-4bdd-888e-dd8b01141837" xlink:to="loc_srt_RangeMember_e54dbba8-3f7e-4656-a4ad-b744c3b8dafd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_85260071-a296-4c65-ae2f-ea33fba401a3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e54dbba8-3f7e-4656-a4ad-b744c3b8dafd" xlink:to="loc_srt_MinimumMember_85260071-a296-4c65-ae2f-ea33fba401a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8f185283-b94c-4ee7-8743-c6ee80f866b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e54dbba8-3f7e-4656-a4ad-b744c3b8dafd" xlink:to="loc_srt_MaximumMember_8f185283-b94c-4ee7-8743-c6ee80f866b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_eb84aa43-0e03-4a14-b3b1-5490479607c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_137cd687-7677-4ab2-aed4-6230bf488186" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_eb84aa43-0e03-4a14-b3b1-5490479607c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_eb84aa43-0e03-4a14-b3b1-5490479607c4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_eb84aa43-0e03-4a14-b3b1-5490479607c4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_eb84aa43-0e03-4a14-b3b1-5490479607c4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_17bcdea7-2c4a-4bac-b046-6cd043b942be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_eb84aa43-0e03-4a14-b3b1-5490479607c4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_17bcdea7-2c4a-4bac-b046-6cd043b942be" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1abbb325-2fbb-45be-9818-e5e06b73810a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_17bcdea7-2c4a-4bac-b046-6cd043b942be" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1abbb325-2fbb-45be-9818-e5e06b73810a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e0146df1-6e57-4a65-ab86-bfc28474b02e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_137cd687-7677-4ab2-aed4-6230bf488186" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e0146df1-6e57-4a65-ab86-bfc28474b02e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_e0146df1-6e57-4a65-ab86-bfc28474b02e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e0146df1-6e57-4a65-ab86-bfc28474b02e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_e0146df1-6e57-4a65-ab86-bfc28474b02e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d3aed26d-a44b-4fa8-b749-94085b0137ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e0146df1-6e57-4a65-ab86-bfc28474b02e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d3aed26d-a44b-4fa8-b749-94085b0137ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bbfa92f3-f1c5-4730-8542-2fe581686267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d3aed26d-a44b-4fa8-b749-94085b0137ea" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bbfa92f3-f1c5-4730-8542-2fe581686267" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AccruedWagesAndRelatedLiabilitiesMember_b8ccba43-70d4-40ad-8505-0edea5153fbc" xlink:href="pntg-20211231.xsd#pntg_AccruedWagesAndRelatedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d3aed26d-a44b-4fa8-b749-94085b0137ea" xlink:to="loc_pntg_AccruedWagesAndRelatedLiabilitiesMember_b8ccba43-70d4-40ad-8505-0edea5153fbc" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails" xlink:type="extended" id="i6d461a7aa3e34385ad95789294efc68a_RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b9af2788-ad73-4acc-99c2-ad678825b4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b9af2788-ad73-4acc-99c2-ad678825b4a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_74decc6a-d838-48c1-b52f-1c8de64e2bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_74decc6a-d838-48c1-b52f-1c8de64e2bb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_21e4aa07-d622-4852-8bdd-8385fae7109b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_21e4aa07-d622-4852-8bdd-8385fae7109b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d11cf4f2-bdc2-425b-9138-335c1da7ab0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d11cf4f2-bdc2-425b-9138-335c1da7ab0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyCosts_dbb87f41-d871-4cc5-a755-2cce937794b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:to="loc_us-gaap_RelatedPartyCosts_dbb87f41-d871-4cc5-a755-2cce937794b2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_3fb61b64-efa3-4dc3-ac25-111d9599a2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_3fb61b64-efa3-4dc3-ac25-111d9599a2d6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_3fb61b64-efa3-4dc3-ac25-111d9599a2d6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_3fb61b64-efa3-4dc3-ac25-111d9599a2d6" xlink:to="loc_us-gaap_RelatedPartyDomain_3fb61b64-efa3-4dc3-ac25-111d9599a2d6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_57f6125c-c85a-4c71-bc69-0139d56bee41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_3fb61b64-efa3-4dc3-ac25-111d9599a2d6" xlink:to="loc_us-gaap_RelatedPartyDomain_57f6125c-c85a-4c71-bc69-0139d56bee41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_0f64dab4-426a-4c13-8a08-ae18fbda96cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_57f6125c-c85a-4c71-bc69-0139d56bee41" xlink:to="loc_srt_AffiliatedEntityMember_0f64dab4-426a-4c13-8a08-ae18fbda96cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b19bc361-2c81-4565-97d7-6b2c9edde025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b19bc361-2c81-4565-97d7-6b2c9edde025" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_b19bc361-2c81-4565-97d7-6b2c9edde025_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b19bc361-2c81-4565-97d7-6b2c9edde025" xlink:to="loc_us-gaap_SegmentDomain_b19bc361-2c81-4565-97d7-6b2c9edde025_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1d0f593d-083e-4df3-a8a1-6894714c7c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b19bc361-2c81-4565-97d7-6b2c9edde025" xlink:to="loc_us-gaap_SegmentDomain_1d0f593d-083e-4df3-a8a1-6894714c7c87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_8a8ca264-4e1b-4949-b666-402a09fcc0a2" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_1d0f593d-083e-4df3-a8a1-6894714c7c87" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_8a8ca264-4e1b-4949-b666-402a09fcc0a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3261f220-4789-4e1c-88e2-03e5a7e11fcc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:to="loc_srt_RangeAxis_3261f220-4789-4e1c-88e2-03e5a7e11fcc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3261f220-4789-4e1c-88e2-03e5a7e11fcc_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_3261f220-4789-4e1c-88e2-03e5a7e11fcc" xlink:to="loc_srt_RangeMember_3261f220-4789-4e1c-88e2-03e5a7e11fcc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_70eabc35-e4d6-4e06-956b-3d7afdcb26bc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_3261f220-4789-4e1c-88e2-03e5a7e11fcc" xlink:to="loc_srt_RangeMember_70eabc35-e4d6-4e06-956b-3d7afdcb26bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b2bc2775-f62c-42dd-a92a-39e3a25db7e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_70eabc35-e4d6-4e06-956b-3d7afdcb26bc" xlink:to="loc_srt_MinimumMember_b2bc2775-f62c-42dd-a92a-39e3a25db7e0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_63a02b26-6e4d-4160-835e-0b207bc79ee8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_70eabc35-e4d6-4e06-956b-3d7afdcb26bc" xlink:to="loc_srt_MaximumMember_63a02b26-6e4d-4160-835e-0b207bc79ee8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_b354d765-16ec-49d4-b5b2-525cc1406eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_b354d765-16ec-49d4-b5b2-525cc1406eb2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_b354d765-16ec-49d4-b5b2-525cc1406eb2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b354d765-16ec-49d4-b5b2-525cc1406eb2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_b354d765-16ec-49d4-b5b2-525cc1406eb2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_b52ae50d-9f50-4bab-ac74-6e28e0f4d75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b354d765-16ec-49d4-b5b2-525cc1406eb2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_b52ae50d-9f50-4bab-ac74-6e28e0f4d75c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_OperatingLeaseRentExpenseMember_5c7a3fca-baa0-453b-bc07-7153221c0bb9" xlink:href="pntg-20211231.xsd#pntg_OperatingLeaseRentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_b52ae50d-9f50-4bab-ac74-6e28e0f4d75c" xlink:to="loc_pntg_OperatingLeaseRentExpenseMember_5c7a3fca-baa0-453b-bc07-7153221c0bb9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TransitionServicesAgreementMember_b8609e86-841b-433b-b6a8-77a6f04558a0" xlink:href="pntg-20211231.xsd#pntg_TransitionServicesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_b52ae50d-9f50-4bab-ac74-6e28e0f4d75c" xlink:to="loc_pntg_TransitionServicesAgreementMember_b8609e86-841b-433b-b6a8-77a6f04558a0" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails" xlink:type="extended" id="idffa5eb5c1574eb8bf14cc1f32f56fa6_REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9f3700ca-9aa0-41cd-8145-cf1b60ce2c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_00b96574-ba28-402b-9b3e-f3135d586c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9f3700ca-9aa0-41cd-8145-cf1b60ce2c99" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_00b96574-ba28-402b-9b3e-f3135d586c68" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_163791f1-f5a7-4c56-9dbe-06a12a00ca20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9f3700ca-9aa0-41cd-8145-cf1b60ce2c99" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_163791f1-f5a7-4c56-9dbe-06a12a00ca20" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_99e2b44f-2827-49c3-816a-4341d3983b7a" xlink:href="pntg-20211231.xsd#pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9f3700ca-9aa0-41cd-8145-cf1b60ce2c99" xlink:to="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_99e2b44f-2827-49c3-816a-4341d3983b7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9f3700ca-9aa0-41cd-8145-cf1b60ce2c99" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_9e28df97-7cdb-4324-b106-4739db3a64f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_9e28df97-7cdb-4324-b106-4739db3a64f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9e28df97-7cdb-4324-b106-4739db3a64f4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_9e28df97-7cdb-4324-b106-4739db3a64f4" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9e28df97-7cdb-4324-b106-4739db3a64f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9b66f2b1-1ef1-457c-9c84-e47d9b9aaa7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_9e28df97-7cdb-4324-b106-4739db3a64f4" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9b66f2b1-1ef1-457c-9c84-e47d9b9aaa7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_8b8e2b4b-d075-4d12-8650-8eab3a071330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9b66f2b1-1ef1-457c-9c84-e47d9b9aaa7f" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_8b8e2b4b-d075-4d12-8650-8eab3a071330" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9047c7b4-a1ee-4eca-b73f-378b8ab8ba0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9047c7b4-a1ee-4eca-b73f-378b8ab8ba0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9047c7b4-a1ee-4eca-b73f-378b8ab8ba0a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9047c7b4-a1ee-4eca-b73f-378b8ab8ba0a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_9047c7b4-a1ee-4eca-b73f-378b8ab8ba0a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_febe183e-7119-4b67-b1af-a70fb1001e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9047c7b4-a1ee-4eca-b73f-378b8ab8ba0a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_febe183e-7119-4b67-b1af-a70fb1001e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_02b96247-5ca2-46ed-89aa-936283b1994a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_febe183e-7119-4b67-b1af-a70fb1001e5e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_02b96247-5ca2-46ed-89aa-936283b1994a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_381bb360-8bc7-43b4-a5a4-3e0ebaf4054c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:to="loc_srt_MajorCustomersAxis_381bb360-8bc7-43b4-a5a4-3e0ebaf4054c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_381bb360-8bc7-43b4-a5a4-3e0ebaf4054c_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_381bb360-8bc7-43b4-a5a4-3e0ebaf4054c" xlink:to="loc_srt_NameOfMajorCustomerDomain_381bb360-8bc7-43b4-a5a4-3e0ebaf4054c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ded37ce7-8d5c-4f7e-a436-459d1e4d3992" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_381bb360-8bc7-43b4-a5a4-3e0ebaf4054c" xlink:to="loc_srt_NameOfMajorCustomerDomain_ded37ce7-8d5c-4f7e-a436-459d1e4d3992" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareAndMedicaidMember_019eb1c0-c799-4d1f-bf56-470f5542e893" xlink:href="pntg-20211231.xsd#pntg_MedicareAndMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ded37ce7-8d5c-4f7e-a436-459d1e4d3992" xlink:to="loc_pntg_MedicareAndMedicaidMember_019eb1c0-c799-4d1f-bf56-470f5542e893" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1e9284e9-b9bd-40f8-87d6-85630ca9b8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1e9284e9-b9bd-40f8-87d6-85630ca9b8e0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1e9284e9-b9bd-40f8-87d6-85630ca9b8e0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1e9284e9-b9bd-40f8-87d6-85630ca9b8e0" xlink:to="loc_us-gaap_SegmentDomain_1e9284e9-b9bd-40f8-87d6-85630ca9b8e0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_782ca052-e57a-4b50-8e09-ff8b969a95a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1e9284e9-b9bd-40f8-87d6-85630ca9b8e0" xlink:to="loc_us-gaap_SegmentDomain_782ca052-e57a-4b50-8e09-ff8b969a95a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_5c1917a2-4ff2-42f3-992d-bc033ca0bd9e" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_782ca052-e57a-4b50-8e09-ff8b969a95a6" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_5c1917a2-4ff2-42f3-992d-bc033ca0bd9e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails" xlink:type="extended" id="i6ce692c3b4064f148cc4d80399887b3d_REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2fc6c5dc-d0e6-4d9f-a0af-03a134c7e29d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d1c312d0-60af-4d8a-a9e4-9ed083fdb7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2fc6c5dc-d0e6-4d9f-a0af-03a134c7e29d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d1c312d0-60af-4d8a-a9e4-9ed083fdb7ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0c030ef7-49c2-4700-9b3d-30438b06c349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2fc6c5dc-d0e6-4d9f-a0af-03a134c7e29d" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0c030ef7-49c2-4700-9b3d-30438b06c349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2fc6c5dc-d0e6-4d9f-a0af-03a134c7e29d" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ed5d5021-8904-450b-b9de-b2670dee40b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ed5d5021-8904-450b-b9de-b2670dee40b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_ed5d5021-8904-450b-b9de-b2670dee40b1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ed5d5021-8904-450b-b9de-b2670dee40b1" xlink:to="loc_us-gaap_SegmentDomain_ed5d5021-8904-450b-b9de-b2670dee40b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9987fb64-0ab8-4fce-b875-3f249e8ddaef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ed5d5021-8904-450b-b9de-b2670dee40b1" xlink:to="loc_us-gaap_SegmentDomain_9987fb64-0ab8-4fce-b875-3f249e8ddaef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_99fe2c94-7823-4939-9220-da93081e13d3" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9987fb64-0ab8-4fce-b875-3f249e8ddaef" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_99fe2c94-7823-4939-9220-da93081e13d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_b87c3e08-9794-47d9-b094-578c46961846" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9987fb64-0ab8-4fce-b875-3f249e8ddaef" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_b87c3e08-9794-47d9-b094-578c46961846" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_f59150ef-82f6-4f47-a908-949d8e9f640b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:to="loc_us-gaap_SubsegmentsAxis_f59150ef-82f6-4f47-a908-949d8e9f640b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_f59150ef-82f6-4f47-a908-949d8e9f640b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_f59150ef-82f6-4f47-a908-949d8e9f640b" xlink:to="loc_us-gaap_SubsegmentsDomain_f59150ef-82f6-4f47-a908-949d8e9f640b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_cca8e2ff-3c65-4a3e-8193-4f1dbba8641a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_f59150ef-82f6-4f47-a908-949d8e9f640b" xlink:to="loc_us-gaap_SubsegmentsDomain_cca8e2ff-3c65-4a3e-8193-4f1dbba8641a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthSubsegmentMember_afde9bd4-8256-4e66-be47-d9321bf79bbf" xlink:href="pntg-20211231.xsd#pntg_HomeHealthSubsegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_cca8e2ff-3c65-4a3e-8193-4f1dbba8641a" xlink:to="loc_pntg_HomeHealthSubsegmentMember_afde9bd4-8256-4e66-be47-d9321bf79bbf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HospiceSubsegmentMember_95d6c70f-8c77-4fda-b45f-fd1c86374790" xlink:href="pntg-20211231.xsd#pntg_HospiceSubsegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_cca8e2ff-3c65-4a3e-8193-4f1dbba8641a" xlink:to="loc_pntg_HospiceSubsegmentMember_95d6c70f-8c77-4fda-b45f-fd1c86374790" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_eae62ef3-5024-402f-bcfe-324777a5bb0b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:to="loc_srt_MajorCustomersAxis_eae62ef3-5024-402f-bcfe-324777a5bb0b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_eae62ef3-5024-402f-bcfe-324777a5bb0b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_eae62ef3-5024-402f-bcfe-324777a5bb0b" xlink:to="loc_srt_NameOfMajorCustomerDomain_eae62ef3-5024-402f-bcfe-324777a5bb0b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_eae62ef3-5024-402f-bcfe-324777a5bb0b" xlink:to="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareMember_1c2c0788-75fd-4cd1-a70f-5ad13d09b73d" xlink:href="pntg-20211231.xsd#pntg_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:to="loc_pntg_MedicareMember_1c2c0788-75fd-4cd1-a70f-5ad13d09b73d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicaidMember_2dba5d95-7227-4a04-86a6-5ae3547500bd" xlink:href="pntg-20211231.xsd#pntg_MedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:to="loc_pntg_MedicaidMember_2dba5d95-7227-4a04-86a6-5ae3547500bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareAndMedicaidMember_1f5076db-c3eb-4f5f-9163-2ad4a84ef552" xlink:href="pntg-20211231.xsd#pntg_MedicareAndMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:to="loc_pntg_MedicareAndMedicaidMember_1f5076db-c3eb-4f5f-9163-2ad4a84ef552" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ManagedCareMember_04b2d970-e999-468e-887b-ff522505a720" xlink:href="pntg-20211231.xsd#pntg_ManagedCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:to="loc_pntg_ManagedCareMember_04b2d970-e999-468e-887b-ff522505a720" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_PrivateAndOtherMember_091f1014-8fe2-4b06-97aa-ec62e983c5bf" xlink:href="pntg-20211231.xsd#pntg_PrivateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:to="loc_pntg_PrivateAndOtherMember_091f1014-8fe2-4b06-97aa-ec62e983c5bf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_02f550e6-9213-4349-b895-d3568743ed63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_02f550e6-9213-4349-b895-d3568743ed63" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_02f550e6-9213-4349-b895-d3568743ed63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_02f550e6-9213-4349-b895-d3568743ed63" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_02f550e6-9213-4349-b895-d3568743ed63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f64b22cd-b2b6-409d-9253-d7c6dfb4a0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_02f550e6-9213-4349-b895-d3568743ed63" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f64b22cd-b2b6-409d-9253-d7c6dfb4a0f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_6cbf99e2-3f85-4f13-b228-c3b302adb0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f64b22cd-b2b6-409d-9253-d7c6dfb4a0f4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_6cbf99e2-3f85-4f13-b228-c3b302adb0f2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e512dc39-9533-4196-9d94-0f328150628b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e512dc39-9533-4196-9d94-0f328150628b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_e512dc39-9533-4196-9d94-0f328150628b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e512dc39-9533-4196-9d94-0f328150628b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_e512dc39-9533-4196-9d94-0f328150628b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_fe16335e-6066-47d0-a51b-f11c36cc43e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e512dc39-9533-4196-9d94-0f328150628b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_fe16335e-6066-47d0-a51b-f11c36cc43e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_27cf6d72-0783-41c2-a0c7-1bed39a64edf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_fe16335e-6066-47d0-a51b-f11c36cc43e0" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_27cf6d72-0783-41c2-a0c7-1bed39a64edf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails" xlink:type="extended" id="iceca3358b24848d88dbd993d5df79d94_REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c1ca54de-ca43-484b-b54d-6d057e620684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrentAbstract_587a7c29-6be0-4f31-a105-0d6eea31efe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c1ca54de-ca43-484b-b54d-6d057e620684" xlink:to="loc_us-gaap_AccountsReceivableNetCurrentAbstract_587a7c29-6be0-4f31-a105-0d6eea31efe6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_6bd40432-f34b-4376-85de-ca6bb72f64ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsReceivableNetCurrentAbstract_587a7c29-6be0-4f31-a105-0d6eea31efe6" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_6bd40432-f34b-4376-85de-ca6bb72f64ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_34fbb3e3-eea8-4fa9-ae73-4fe924de915a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsReceivableNetCurrentAbstract_587a7c29-6be0-4f31-a105-0d6eea31efe6" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_34fbb3e3-eea8-4fa9-ae73-4fe924de915a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b7d6ccbb-56dd-4cbc-aa69-a4f8e0e07d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccountsReceivableNetCurrentAbstract_587a7c29-6be0-4f31-a105-0d6eea31efe6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b7d6ccbb-56dd-4cbc-aa69-a4f8e0e07d50" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_43363d20-239b-45e4-96e2-5c01d9029123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c1ca54de-ca43-484b-b54d-6d057e620684" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_43363d20-239b-45e4-96e2-5c01d9029123" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_a9f0abf7-7a40-4ce0-8cec-fdefe679aa62" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_43363d20-239b-45e4-96e2-5c01d9029123" xlink:to="loc_srt_MajorCustomersAxis_a9f0abf7-7a40-4ce0-8cec-fdefe679aa62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_a9f0abf7-7a40-4ce0-8cec-fdefe679aa62_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_a9f0abf7-7a40-4ce0-8cec-fdefe679aa62" xlink:to="loc_srt_NameOfMajorCustomerDomain_a9f0abf7-7a40-4ce0-8cec-fdefe679aa62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_a9f0abf7-7a40-4ce0-8cec-fdefe679aa62" xlink:to="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareMember_1ef90ce7-d4e6-4df2-a733-b82e02e8a40e" xlink:href="pntg-20211231.xsd#pntg_MedicareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:to="loc_pntg_MedicareMember_1ef90ce7-d4e6-4df2-a733-b82e02e8a40e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicaidMember_2edc3670-1597-4408-81db-112a50e17108" xlink:href="pntg-20211231.xsd#pntg_MedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:to="loc_pntg_MedicaidMember_2edc3670-1597-4408-81db-112a50e17108" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ManagedCareMember_1d79005b-854f-4195-8c94-2fe600f775a7" xlink:href="pntg-20211231.xsd#pntg_ManagedCareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:to="loc_pntg_ManagedCareMember_1d79005b-854f-4195-8c94-2fe600f775a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_PrivateAndOtherMember_5a0b01fa-097e-457c-b07b-6fe87be98de7" xlink:href="pntg-20211231.xsd#pntg_PrivateAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:to="loc_pntg_PrivateAndOtherMember_5a0b01fa-097e-457c-b07b-6fe87be98de7" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#BUSINESSSEGMENTSNARRATIVEDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails" xlink:type="extended" id="i5f62945c4547405b94cc581afbaf26d2_BUSINESSSEGMENTSNARRATIVEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_776f3b18-87a3-4984-adad-3914ff12b7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfServiceProviders_45197321-fe68-4420-a6ea-a3ff3abfd591" xlink:href="pntg-20211231.xsd#pntg_NumberOfServiceProviders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_776f3b18-87a3-4984-adad-3914ff12b7d4" xlink:to="loc_pntg_NumberOfServiceProviders_45197321-fe68-4420-a6ea-a3ff3abfd591" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfRealEstatePropertiesUnderLease_1951abdf-7dd5-4346-8b08-788bb5cdd9f6" xlink:href="pntg-20211231.xsd#pntg_NumberOfRealEstatePropertiesUnderLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_776f3b18-87a3-4984-adad-3914ff12b7d4" xlink:to="loc_pntg_NumberOfRealEstatePropertiesUnderLease_1951abdf-7dd5-4346-8b08-788bb5cdd9f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8dedcf2a-da97-4452-8eb0-2d0574aa0444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_776f3b18-87a3-4984-adad-3914ff12b7d4" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8dedcf2a-da97-4452-8eb0-2d0574aa0444" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9f8dd7b1-dc5e-45e8-bdeb-1b6e1c0b0736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8dedcf2a-da97-4452-8eb0-2d0574aa0444" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9f8dd7b1-dc5e-45e8-bdeb-1b6e1c0b0736" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9f8dd7b1-dc5e-45e8-bdeb-1b6e1c0b0736_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9f8dd7b1-dc5e-45e8-bdeb-1b6e1c0b0736" xlink:to="loc_us-gaap_SegmentDomain_9f8dd7b1-dc5e-45e8-bdeb-1b6e1c0b0736_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_13a15c9c-ecd4-4dec-b7d6-26aa8e857c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9f8dd7b1-dc5e-45e8-bdeb-1b6e1c0b0736" xlink:to="loc_us-gaap_SegmentDomain_13a15c9c-ecd4-4dec-b7d6-26aa8e857c21" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_50c19402-21ef-4b6a-babd-a80ec940d087" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_13a15c9c-ecd4-4dec-b7d6-26aa8e857c21" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_50c19402-21ef-4b6a-babd-a80ec940d087" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_01551a52-dd39-4976-bf4d-e19ca52780e7" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_13a15c9c-ecd4-4dec-b7d6-26aa8e857c21" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_01551a52-dd39-4976-bf4d-e19ca52780e7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#BUSINESSSEGMENTSFINANCIALDATADetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails" xlink:type="extended" id="i0276488bff0549b092b318fd7c83fed4_BUSINESSSEGMENTSFINANCIALDATADetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_846c70b5-6014-4e90-a288-43bf4c84abb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28879a69-83c6-4e25-8520-71699219a359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_846c70b5-6014-4e90-a288-43bf4c84abb6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28879a69-83c6-4e25-8520-71699219a359" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_8446799a-7f48-4126-bdfa-ab05d6d81b75" xlink:href="pntg-20211231.xsd#pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_846c70b5-6014-4e90-a288-43bf4c84abb6" xlink:to="loc_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_8446799a-7f48-4126-bdfa-ab05d6d81b75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3fc3fd61-8f9f-4a60-8f46-f695172b1777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_846c70b5-6014-4e90-a288-43bf4c84abb6" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3fc3fd61-8f9f-4a60-8f46-f695172b1777" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_451062be-b954-4206-9881-7813ff726a6a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3fc3fd61-8f9f-4a60-8f46-f695172b1777" xlink:to="loc_srt_ConsolidationItemsAxis_451062be-b954-4206-9881-7813ff726a6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_451062be-b954-4206-9881-7813ff726a6a_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_451062be-b954-4206-9881-7813ff726a6a" xlink:to="loc_srt_ConsolidationItemsDomain_451062be-b954-4206-9881-7813ff726a6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b75d3535-5f33-4de3-8e60-f1bf5542992d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_451062be-b954-4206-9881-7813ff726a6a" xlink:to="loc_srt_ConsolidationItemsDomain_b75d3535-5f33-4de3-8e60-f1bf5542992d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b2f57af1-b8c2-4f4a-943e-5282e69cff92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b75d3535-5f33-4de3-8e60-f1bf5542992d" xlink:to="loc_us-gaap_OperatingSegmentsMember_b2f57af1-b8c2-4f4a-943e-5282e69cff92" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_404fc2d0-852f-4a4c-a0a5-69901a311d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_b75d3535-5f33-4de3-8e60-f1bf5542992d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_404fc2d0-852f-4a4c-a0a5-69901a311d82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_27195e34-6768-4f49-848f-dc34c0c8b753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3fc3fd61-8f9f-4a60-8f46-f695172b1777" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_27195e34-6768-4f49-848f-dc34c0c8b753" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_27195e34-6768-4f49-848f-dc34c0c8b753_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_27195e34-6768-4f49-848f-dc34c0c8b753" xlink:to="loc_us-gaap_SegmentDomain_27195e34-6768-4f49-848f-dc34c0c8b753_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a4a3fa43-5147-4032-bd49-51125a88350e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_27195e34-6768-4f49-848f-dc34c0c8b753" xlink:to="loc_us-gaap_SegmentDomain_a4a3fa43-5147-4032-bd49-51125a88350e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_a1d1a581-c8bd-4ffa-a522-95e5fe1148c3" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4a3fa43-5147-4032-bd49-51125a88350e" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_a1d1a581-c8bd-4ffa-a522-95e5fe1148c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_07852981-6283-46e4-8c41-9fea6c5044a2" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a4a3fa43-5147-4032-bd49-51125a88350e" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_07852981-6283-46e4-8c41-9fea6c5044a2" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails" xlink:type="extended" id="i62b504ef6b534f5090713039a9a199f4_BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_10795433-b9d5-4c35-8bf0-d08dcf45ce65" xlink:href="pntg-20211231.xsd#pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_10795433-b9d5-4c35-8bf0-d08dcf45ce65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c451e9ed-92b1-4b79-84e9-c813f4592339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_DepreciationAndAmortization_c451e9ed-92b1-4b79-84e9-c813f4592339" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_7a604fa1-d29d-47b6-9e00-8f01635ffd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_OperatingLeaseExpense_7a604fa1-d29d-47b6-9e00-8f01635ffd2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ef21d03e-74dc-43f8-89e5-9dfa99440c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ef21d03e-74dc-43f8-89e5-9dfa99440c41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_StartUpActivitiesCosts_2181ee21-30f5-411e-ad22-979c82201499" xlink:href="pntg-20211231.xsd#pntg_StartUpActivitiesCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_StartUpActivitiesCosts_2181ee21-30f5-411e-ad22-979c82201499" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7cd78ac9-76a2-471c-bd66-823495b23e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7cd78ac9-76a2-471c-bd66-823495b23e14" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e95b220c-f20f-4736-9e8b-df445adda076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e95b220c-f20f-4736-9e8b-df445adda076" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SpinoffTransactionCosts_6cf6fe60-963f-49d8-99c1-12caf6d34a7b" xlink:href="pntg-20211231.xsd#pntg_SpinoffTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_SpinoffTransactionCosts_6cf6fe60-963f-49d8-99c1-12caf6d34a7b" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AcquisitionRelatedCostsNotCapitalized_363711e0-b81a-4efb-8232-be825cf8ffc6" xlink:href="pntg-20211231.xsd#pntg_AcquisitionRelatedCostsNotCapitalized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_AcquisitionRelatedCostsNotCapitalized_363711e0-b81a-4efb-8232-be825cf8ffc6" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses_11d18d56-ecd3-4a36-88f5-b574d43ee01f" xlink:href="pntg-20211231.xsd#pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses_11d18d56-ecd3-4a36-88f5-b574d43ee01f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_d16cb316-a50b-420b-9efd-e03dbad74695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_d16cb316-a50b-420b-9efd-e03dbad74695" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c087f46d-7a45-49c8-96b6-7b66f2cc02cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c087f46d-7a45-49c8-96b6-7b66f2cc02cd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0f1312f4-8d5c-40ba-aad0-7a8629a345e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_OperatingIncomeLoss_0f1312f4-8d5c-40ba-aad0-7a8629a345e9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b754d162-60f8-4981-a96e-0c26721181e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b754d162-60f8-4981-a96e-0c26721181e6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AmountToOffsetExpenseSequestrationRelief_f349cafb-1246-4ac5-85c7-6265048544b4" xlink:href="pntg-20211231.xsd#pntg_AmountToOffsetExpenseSequestrationRelief"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_AmountToOffsetExpenseSequestrationRelief_f349cafb-1246-4ac5-85c7-6265048544b4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DirectMedicalSuppliesLaborAndOtherExpenses_ed5c2392-1d8f-4b0f-bcd2-b874643dc1b8" xlink:href="pntg-20211231.xsd#pntg_DirectMedicalSuppliesLaborAndOtherExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_DirectMedicalSuppliesLaborAndOtherExpenses_ed5c2392-1d8f-4b0f-bcd2-b874643dc1b8" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_288cf020-8e90-4df6-8137-fda3f9b62b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_288cf020-8e90-4df6-8137-fda3f9b62b23" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_b848d8d0-9df7-42ea-b683-ddc7985bc4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_288cf020-8e90-4df6-8137-fda3f9b62b23" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_b848d8d0-9df7-42ea-b683-ddc7985bc4e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_b848d8d0-9df7-42ea-b683-ddc7985bc4e4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b848d8d0-9df7-42ea-b683-ddc7985bc4e4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_b848d8d0-9df7-42ea-b683-ddc7985bc4e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_536b0680-50f5-4609-952a-df65a5d84b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b848d8d0-9df7-42ea-b683-ddc7985bc4e4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_536b0680-50f5-4609-952a-df65a5d84b2e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TransitionServicesAgreementMember_32c76a72-1fae-43f5-ba35-ab23970f6775" xlink:href="pntg-20211231.xsd#pntg_TransitionServicesAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_536b0680-50f5-4609-952a-df65a5d84b2e" xlink:to="loc_pntg_TransitionServicesAgreementMember_32c76a72-1fae-43f5-ba35-ab23970f6775" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4b2f9d17-4c40-4a79-b74e-407662e17a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_288cf020-8e90-4df6-8137-fda3f9b62b23" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4b2f9d17-4c40-4a79-b74e-407662e17a3c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_4b2f9d17-4c40-4a79-b74e-407662e17a3c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4b2f9d17-4c40-4a79-b74e-407662e17a3c" xlink:to="loc_us-gaap_RelatedPartyDomain_4b2f9d17-4c40-4a79-b74e-407662e17a3c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c05e470c-84c9-4504-99ec-3e450efc4b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4b2f9d17-4c40-4a79-b74e-407662e17a3c" xlink:to="loc_us-gaap_RelatedPartyDomain_c05e470c-84c9-4504-99ec-3e450efc4b5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_e9c7539b-a525-4a54-8aa4-a701ababd2f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_c05e470c-84c9-4504-99ec-3e450efc4b5b" xlink:to="loc_srt_AffiliatedEntityMember_e9c7539b-a525-4a54-8aa4-a701ababd2f6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#ACQUISITIONSNARRATIVEDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails" xlink:type="extended" id="i86a420babcdd4663b0e5c5b5f4e7cd1f_ACQUISITIONSNARRATIVEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfBusinessesAndAssetsAcquired_da3ec30d-a5c6-4b2d-b599-6f5b94af3cfc" xlink:href="pntg-20211231.xsd#pntg_NumberOfBusinessesAndAssetsAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_NumberOfBusinessesAndAssetsAcquired_da3ec30d-a5c6-4b2d-b599-6f5b94af3cfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b699fecb-6c71-4d32-a449-b22c0d9498e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b699fecb-6c71-4d32-a449-b22c0d9498e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NonCapitalizableRelatedToTheBusinessCombinations_c7d7d7b9-9d5d-4bb7-a3be-e8a1054c10ac" xlink:href="pntg-20211231.xsd#pntg_NonCapitalizableRelatedToTheBusinessCombinations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_NonCapitalizableRelatedToTheBusinessCombinations_c7d7d7b9-9d5d-4bb7-a3be-e8a1054c10ac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_4020a3e5-701a-4984-9190-babb91e84999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_4020a3e5-701a-4984-9190-babb91e84999" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_31117ab8-6ad3-44f3-b563-1848098252d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_31117ab8-6ad3-44f3-b563-1848098252d8" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfUnitsInRealEstatePropertyAcquired_e14c9bd7-0938-4a90-a976-b561b5857327" xlink:href="pntg-20211231.xsd#pntg_NumberOfUnitsInRealEstatePropertyAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_NumberOfUnitsInRealEstatePropertyAcquired_e14c9bd7-0938-4a90-a976-b561b5857327" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_6667277c-e7cb-427c-ba46-794dc33c3ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_6667277c-e7cb-427c-ba46-794dc33c3ea5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_CashAndContributedAssetsNetBookValue_242aa653-93fa-443c-9b13-cf804188bd8e" xlink:href="pntg-20211231.xsd#pntg_CashAndContributedAssetsNetBookValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_CashAndContributedAssetsNetBookValue_242aa653-93fa-443c-9b13-cf804188bd8e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8b5d41ca-3cb2-47fb-82c0-87b8b6b32498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8b5d41ca-3cb2-47fb-82c0-87b8b6b32498" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_68f172e2-af0a-4d1b-a6f6-e39268acc5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_68f172e2-af0a-4d1b-a6f6-e39268acc5ea" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_68c50042-8859-47f4-afe1-2251d8365441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_68c50042-8859-47f4-afe1-2251d8365441" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NoncontrollingInterestJointVenture_27b3206e-08d6-4137-acba-2dd7a09cb4d9" xlink:href="pntg-20211231.xsd#pntg_NoncontrollingInterestJointVenture"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_NoncontrollingInterestJointVenture_27b3206e-08d6-4137-acba-2dd7a09cb4d9" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_bb9d64ff-f77b-4349-b068-e81a36d4920c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_bb9d64ff-f77b-4349-b068-e81a36d4920c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AdditionalPaidInCapitalEffectOfIncomeTax_5576524a-7ae0-493b-bb7e-084d380b284a" xlink:href="pntg-20211231.xsd#pntg_AdditionalPaidInCapitalEffectOfIncomeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_AdditionalPaidInCapitalEffectOfIncomeTax_5576524a-7ae0-493b-bb7e-084d380b284a" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_675436fb-e645-4c35-a4bf-753c4590b1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_675436fb-e645-4c35-a4bf-753c4590b1fa" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d8a05b06-cb45-487f-87fe-6f1ae1da3b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d8a05b06-cb45-487f-87fe-6f1ae1da3b4f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d8a05b06-cb45-487f-87fe-6f1ae1da3b4f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d8a05b06-cb45-487f-87fe-6f1ae1da3b4f" xlink:to="loc_us-gaap_SegmentDomain_d8a05b06-cb45-487f-87fe-6f1ae1da3b4f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a3161238-568e-4bc9-996d-d0303aff281a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d8a05b06-cb45-487f-87fe-6f1ae1da3b4f" xlink:to="loc_us-gaap_SegmentDomain_a3161238-568e-4bc9-996d-d0303aff281a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_3a21a7af-f781-4481-8b1e-370f78ae74dc" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a3161238-568e-4bc9-996d-d0303aff281a" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_3a21a7af-f781-4481-8b1e-370f78ae74dc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_9410c289-164a-4a23-ac67-2f1de9d59411" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_a3161238-568e-4bc9-996d-d0303aff281a" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_9410c289-164a-4a23-ac67-2f1de9d59411" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_26cf765c-3dfb-4069-8ca8-1508b9e63f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_us-gaap_SubsegmentsAxis_26cf765c-3dfb-4069-8ca8-1508b9e63f02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_26cf765c-3dfb-4069-8ca8-1508b9e63f02_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsegmentsAxis_26cf765c-3dfb-4069-8ca8-1508b9e63f02" xlink:to="loc_us-gaap_SubsegmentsDomain_26cf765c-3dfb-4069-8ca8-1508b9e63f02_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_cf42a6fa-0215-4c8c-99e4-6d78ac12e632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsegmentsAxis_26cf765c-3dfb-4069-8ca8-1508b9e63f02" xlink:to="loc_us-gaap_SubsegmentsDomain_cf42a6fa-0215-4c8c-99e4-6d78ac12e632" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthSubsegmentMember_a58acd97-0dd1-4dfb-a90f-0deefe557bb2" xlink:href="pntg-20211231.xsd#pntg_HomeHealthSubsegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_cf42a6fa-0215-4c8c-99e4-6d78ac12e632" xlink:to="loc_pntg_HomeHealthSubsegmentMember_a58acd97-0dd1-4dfb-a90f-0deefe557bb2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HospiceSubsegmentMember_a076b383-b5ce-4fc3-babf-cd5df8b97f9c" xlink:href="pntg-20211231.xsd#pntg_HospiceSubsegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_cf42a6fa-0215-4c8c-99e4-6d78ac12e632" xlink:to="loc_pntg_HospiceSubsegmentMember_a076b383-b5ce-4fc3-babf-cd5df8b97f9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeCareAgenciesMember_bd1a14c5-50fd-4792-beb4-a01bbf5750bb" xlink:href="pntg-20211231.xsd#pntg_HomeCareAgenciesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsegmentsDomain_cf42a6fa-0215-4c8c-99e4-6d78ac12e632" xlink:to="loc_pntg_HomeCareAgenciesMember_bd1a14c5-50fd-4792-beb4-a01bbf5750bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d674c522-60c7-4df5-8e06-bdbc5d72115f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d674c522-60c7-4df5-8e06-bdbc5d72115f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d674c522-60c7-4df5-8e06-bdbc5d72115f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d674c522-60c7-4df5-8e06-bdbc5d72115f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_d674c522-60c7-4df5-8e06-bdbc5d72115f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35b15c1-86de-42f1-bcea-d2a013f25b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d674c522-60c7-4df5-8e06-bdbc5d72115f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35b15c1-86de-42f1-bcea-d2a013f25b93" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_133efa97-d932-4390-869c-8625e6017e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35b15c1-86de-42f1-bcea-d2a013f25b93" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_133efa97-d932-4390-869c-8625e6017e4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_BusinessAcquisitions2019Member_da7a7307-a25c-4e0e-947d-3f00dd59f2ae" xlink:href="pntg-20211231.xsd#pntg_BusinessAcquisitions2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35b15c1-86de-42f1-bcea-d2a013f25b93" xlink:to="loc_pntg_BusinessAcquisitions2019Member_da7a7307-a25c-4e0e-947d-3f00dd59f2ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_0c9c152c-aac2-4373-92b9-60e0ba0fa3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_us-gaap_AssetAcquisitionAxis_0c9c152c-aac2-4373-92b9-60e0ba0fa3f2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_0c9c152c-aac2-4373-92b9-60e0ba0fa3f2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AssetAcquisitionAxis_0c9c152c-aac2-4373-92b9-60e0ba0fa3f2" xlink:to="loc_us-gaap_AssetAcquisitionDomain_0c9c152c-aac2-4373-92b9-60e0ba0fa3f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_ae4581bf-f398-42b1-9397-28007f61fe5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AssetAcquisitionAxis_0c9c152c-aac2-4373-92b9-60e0ba0fa3f2" xlink:to="loc_us-gaap_AssetAcquisitionDomain_ae4581bf-f398-42b1-9397-28007f61fe5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AssetAcquisitions2021Member_d069da2a-fff4-475f-b991-145590b0ecdf" xlink:href="pntg-20211231.xsd#pntg_AssetAcquisitions2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_ae4581bf-f398-42b1-9397-28007f61fe5e" xlink:to="loc_pntg_AssetAcquisitions2021Member_d069da2a-fff4-475f-b991-145590b0ecdf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AssetAcquisitions2020Member_f757b2d4-d2dc-4b47-ba22-085ad5524838" xlink:href="pntg-20211231.xsd#pntg_AssetAcquisitions2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_ae4581bf-f398-42b1-9397-28007f61fe5e" xlink:to="loc_pntg_AssetAcquisitions2020Member_f757b2d4-d2dc-4b47-ba22-085ad5524838" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AssetAcquisitions2019Member_b774fe07-4030-4e0a-975f-d2c1b9c10e86" xlink:href="pntg-20211231.xsd#pntg_AssetAcquisitions2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetAcquisitionDomain_ae4581bf-f398-42b1-9397-28007f61fe5e" xlink:to="loc_pntg_AssetAcquisitions2019Member_b774fe07-4030-4e0a-975f-d2c1b9c10e86" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e34b9cec-4969-4b16-ab94-82c10fb12445" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_srt_CounterpartyNameAxis_e34b9cec-4969-4b16-ab94-82c10fb12445" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e34b9cec-4969-4b16-ab94-82c10fb12445_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_e34b9cec-4969-4b16-ab94-82c10fb12445" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_e34b9cec-4969-4b16-ab94-82c10fb12445_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8cd9af0-2028-42b6-9375-2fca0cef7c73" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_e34b9cec-4969-4b16-ab94-82c10fb12445" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8cd9af0-2028-42b6-9375-2fca0cef7c73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ScrippsHealthMember_089b98ab-015e-45d3-9ee4-9a13a13b4d79" xlink:href="pntg-20211231.xsd#pntg_ScrippsHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8cd9af0-2028-42b6-9375-2fca0cef7c73" xlink:to="loc_pntg_ScrippsHealthMember_089b98ab-015e-45d3-9ee4-9a13a13b4d79" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EnsignSubsidiaryMember_dca0f915-daf0-4c34-a840-a1c3c85fa351" xlink:href="pntg-20211231.xsd#pntg_EnsignSubsidiaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8cd9af0-2028-42b6-9375-2fca0cef7c73" xlink:to="loc_pntg_EnsignSubsidiaryMember_dca0f915-daf0-4c34-a840-a1c3c85fa351" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_1663986f-e556-4f23-8ac4-7703a5799886" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_srt_OwnershipAxis_1663986f-e556-4f23-8ac4-7703a5799886" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_1663986f-e556-4f23-8ac4-7703a5799886_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_1663986f-e556-4f23-8ac4-7703a5799886" xlink:to="loc_srt_OwnershipDomain_1663986f-e556-4f23-8ac4-7703a5799886_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b8ed40e5-5ee7-4b0c-801c-e4e8ac22452a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_1663986f-e556-4f23-8ac4-7703a5799886" xlink:to="loc_srt_OwnershipDomain_b8ed40e5-5ee7-4b0c-801c-e4e8ac22452a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthJointVentureMember_fdd86326-e4d2-471f-b8f4-fb1d936870ea" xlink:href="pntg-20211231.xsd#pntg_HomeHealthJointVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b8ed40e5-5ee7-4b0c-801c-e4e8ac22452a" xlink:to="loc_pntg_HomeHealthJointVentureMember_fdd86326-e4d2-471f-b8f4-fb1d936870ea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HospiceJoinVentureMember_81c20200-49fa-46cc-ad60-7967934d401e" xlink:href="pntg-20211231.xsd#pntg_HospiceJoinVentureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_b8ed40e5-5ee7-4b0c-801c-e4e8ac22452a" xlink:to="loc_pntg_HospiceJoinVentureMember_81c20200-49fa-46cc-ad60-7967934d401e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails" xlink:type="extended" id="i24b7431630c24100b3ee6bc9a972c225_ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures_7ac2ab6c-b72b-4faa-af04-624aea04a1df" xlink:href="pntg-20211231.xsd#pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures_7ac2ab6c-b72b-4faa-af04-624aea04a1df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c43b2d44-0c41-4994-8c7d-919b108d56f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_Goodwill_c43b2d44-0c41-4994-8c7d-919b108d56f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cfe591a1-063e-4823-8522-4de5a96b4bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cfe591a1-063e-4823-8522-4de5a96b4bb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d366a1d7-a97b-48be-8e0a-337591bc514c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d366a1d7-a97b-48be-8e0a-337591bc514c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3c680e93-bd95-461d-97fa-92d6f89bdd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3c680e93-bd95-461d-97fa-92d6f89bdd1b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d9b5d09b-bfa7-45ff-b98c-89497d5ba338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d9b5d09b-bfa7-45ff-b98c-89497d5ba338" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_e76b01b1-144e-4d96-8aec-92ac3f18f699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_e76b01b1-144e-4d96-8aec-92ac3f18f699" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_BusinessCombinationCashPaidInPriorYear_d809a25a-c72d-4886-a16a-92447c2378e3" xlink:href="pntg-20211231.xsd#pntg_BusinessCombinationCashPaidInPriorYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_pntg_BusinessCombinationCashPaidInPriorYear_d809a25a-c72d-4886-a16a-92447c2378e3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_b00268b3-f151-405c-b400-b84c52c2a5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_b00268b3-f151-405c-b400-b84c52c2a5f0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TotalAcquisitions_1b8dd72c-19d2-4f21-92e5-0cba90328886" xlink:href="pntg-20211231.xsd#pntg_TotalAcquisitions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_pntg_TotalAcquisitions_1b8dd72c-19d2-4f21-92e5-0cba90328886" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb706dfc-4d36-4919-9871-d054b46b75fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb706dfc-4d36-4919-9871-d054b46b75fa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9f5046fc-4cc3-47df-92b7-17ea7f36ff1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb706dfc-4d36-4919-9871-d054b46b75fa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9f5046fc-4cc3-47df-92b7-17ea7f36ff1c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f5046fc-4cc3-47df-92b7-17ea7f36ff1c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f5046fc-4cc3-47df-92b7-17ea7f36ff1c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_9f5046fc-4cc3-47df-92b7-17ea7f36ff1c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17518184-edc6-4fa6-8d29-ff89d6466608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f5046fc-4cc3-47df-92b7-17ea7f36ff1c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17518184-edc6-4fa6-8d29-ff89d6466608" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_7ac1b427-1e64-48dd-8dd8-bef1f0b75016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17518184-edc6-4fa6-8d29-ff89d6466608" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_7ac1b427-1e64-48dd-8dd8-bef1f0b75016" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#PROPERTYANDEQUIPMENTNETDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails" xlink:type="extended" id="i0a60012c26b24df7bb9a5d78552c7f96_PROPERTYANDEQUIPMENTNETDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4d517a49-565a-44d5-9217-ce067505db10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4d517a49-565a-44d5-9217-ce067505db10" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a04de6cc-5805-4351-9045-1b20135518ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a04de6cc-5805-4351-9045-1b20135518ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6997ea80-3c18-4791-8ecb-8aae38e05f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6997ea80-3c18-4791-8ecb-8aae38e05f4a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7a5c9fdb-3747-48af-9ae1-fada8836abed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:to="loc_us-gaap_Depreciation_7a5c9fdb-3747-48af-9ae1-fada8836abed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_4dcd7a8b-e576-40dd-bb0b-48f5660cbbea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_4dcd7a8b-e576-40dd-bb0b-48f5660cbbea" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33a2e728-df55-47f0-a69e-86ef9fe3b5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33a2e728-df55-47f0-a69e-86ef9fe3b5a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1b1ba07-2dbb-4190-b6eb-a7a714783380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33a2e728-df55-47f0-a69e-86ef9fe3b5a2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1b1ba07-2dbb-4190-b6eb-a7a714783380" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1b1ba07-2dbb-4190-b6eb-a7a714783380_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1b1ba07-2dbb-4190-b6eb-a7a714783380" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d1b1ba07-2dbb-4190-b6eb-a7a714783380_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2b6451ab-ca2d-4831-af3c-cfdf221158bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1b1ba07-2dbb-4190-b6eb-a7a714783380" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2b6451ab-ca2d-4831-af3c-cfdf221158bc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_8b2d343f-1130-43a7-ab00-d2f06bf02716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2b6451ab-ca2d-4831-af3c-cfdf221158bc" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_8b2d343f-1130-43a7-ab00-d2f06bf02716" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_abe580e7-b328-45f8-b8c4-3e8796cae668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2b6451ab-ca2d-4831-af3c-cfdf221158bc" xlink:to="loc_us-gaap_EquipmentMember_abe580e7-b328-45f8-b8c4-3e8796cae668" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_08273e09-b5a6-4087-93af-68e7180ef1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2b6451ab-ca2d-4831-af3c-cfdf221158bc" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_08273e09-b5a6-4087-93af-68e7180ef1cd" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails" xlink:type="extended" id="i43bee9afec134c09a1977e1c1a92334c_GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_228ffa2c-faf8-446c-abcd-41d31c343a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_d90b291f-a560-4af7-8b82-dbc9b4f9f686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillLineItems_228ffa2c-faf8-446c-abcd-41d31c343a74" xlink:to="loc_us-gaap_GoodwillRollForward_d90b291f-a560-4af7-8b82-dbc9b4f9f686" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_af50bfa3-289f-41e5-8c36-88706c480ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_d90b291f-a560-4af7-8b82-dbc9b4f9f686" xlink:to="loc_us-gaap_Goodwill_af50bfa3-289f-41e5-8c36-88706c480ef5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_338b0b42-ad9f-451e-8c52-70a5207d064d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GoodwillRollForward_d90b291f-a560-4af7-8b82-dbc9b4f9f686" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_338b0b42-ad9f-451e-8c52-70a5207d064d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1a103445-3630-48e6-8a38-ce520c17e2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e39eec20-2687-48b4-919d-1ba4faf1400a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_GoodwillLineItems_228ffa2c-faf8-446c-abcd-41d31c343a74" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e39eec20-2687-48b4-919d-1ba4faf1400a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9ffc8557-05e6-412f-85c0-b1c364590bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e39eec20-2687-48b4-919d-1ba4faf1400a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9ffc8557-05e6-412f-85c0-b1c364590bb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9ffc8557-05e6-412f-85c0-b1c364590bb6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9ffc8557-05e6-412f-85c0-b1c364590bb6" xlink:to="loc_us-gaap_SegmentDomain_9ffc8557-05e6-412f-85c0-b1c364590bb6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_21a512ed-44e4-439d-87c2-1d8bb3aa0537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9ffc8557-05e6-412f-85c0-b1c364590bb6" xlink:to="loc_us-gaap_SegmentDomain_21a512ed-44e4-439d-87c2-1d8bb3aa0537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_7b87d92f-417e-4529-934c-165989b40f3a" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_21a512ed-44e4-439d-87c2-1d8bb3aa0537" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_7b87d92f-417e-4529-934c-165989b40f3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_de91f064-7980-40df-b8d2-d63d9b65caa1" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_21a512ed-44e4-439d-87c2-1d8bb3aa0537" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_de91f064-7980-40df-b8d2-d63d9b65caa1" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails" xlink:type="extended" id="i13abcb18045d4be3bdd8d56392955832_GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_bf353f1d-e0b9-4d9b-9ca1-927aa70c54d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0a824d86-17eb-4143-bdf2-c5a2a7ea89a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_bf353f1d-e0b9-4d9b-9ca1-927aa70c54d4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0a824d86-17eb-4143-bdf2-c5a2a7ea89a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_ea193d70-a070-4141-833a-f11c5b3f1f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_bf353f1d-e0b9-4d9b-9ca1-927aa70c54d4" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_ea193d70-a070-4141-833a-f11c5b3f1f98" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae11015f-9401-499f-9914-45afcd7a2835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_ea193d70-a070-4141-833a-f11c5b3f1f98" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae11015f-9401-499f-9914-45afcd7a2835" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae11015f-9401-499f-9914-45afcd7a2835_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae11015f-9401-499f-9914-45afcd7a2835" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_ae11015f-9401-499f-9914-45afcd7a2835_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d78b619-1e36-40ab-b253-2079104cffbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae11015f-9401-499f-9914-45afcd7a2835" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d78b619-1e36-40ab-b253-2079104cffbe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c9e38f1e-c61e-452b-b967-3ccd774548ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d78b619-1e36-40ab-b253-2079104cffbe" xlink:to="loc_us-gaap_TradeNamesMember_c9e38f1e-c61e-452b-b967-3ccd774548ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_79f310a3-98b4-4131-825f-217b9b17e939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d78b619-1e36-40ab-b253-2079104cffbe" xlink:to="loc_us-gaap_LicensingAgreementsMember_79f310a3-98b4-4131-825f-217b9b17e939" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OTHERACCRUEDLIABILITIESNARRATIVEDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails" xlink:type="extended" id="i931ff87393e34411a84f0d3c05a3d283_OTHERACCRUEDLIABILITIESNARRATIVEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_3b6cfeba-1072-4304-803f-1448c1d2e430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_6bca2acc-3a28-4597-9bf4-b9f550d70338" xlink:href="pntg-20211231.xsd#pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_3b6cfeba-1072-4304-803f-1448c1d2e430" xlink:to="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_6bca2acc-3a28-4597-9bf4-b9f550d70338" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds_24ba088c-a2af-4b47-b3cc-028ded40f7e0" xlink:href="pntg-20211231.xsd#pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_3b6cfeba-1072-4304-803f-1448c1d2e430" xlink:to="loc_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds_24ba088c-a2af-4b47-b3cc-028ded40f7e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_9517b8cf-0786-4c42-b69d-9937450d8a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_3b6cfeba-1072-4304-803f-1448c1d2e430" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_9517b8cf-0786-4c42-b69d-9937450d8a67" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_62c59f56-d7f0-4645-bd11-3f2dc543b292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_3b6cfeba-1072-4304-803f-1448c1d2e430" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_62c59f56-d7f0-4645-bd11-3f2dc543b292" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_10d64638-e9f3-4e49-a2df-9608cdf24c9b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_62c59f56-d7f0-4645-bd11-3f2dc543b292" xlink:to="loc_srt_RestatementAxis_10d64638-e9f3-4e49-a2df-9608cdf24c9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_10d64638-e9f3-4e49-a2df-9608cdf24c9b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_10d64638-e9f3-4e49-a2df-9608cdf24c9b" xlink:to="loc_srt_RestatementDomain_10d64638-e9f3-4e49-a2df-9608cdf24c9b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7c9b4033-237a-47cd-b288-26e1ff085ff1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_10d64638-e9f3-4e49-a2df-9608cdf24c9b" xlink:to="loc_srt_RestatementDomain_7c9b4033-237a-47cd-b288-26e1ff085ff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_ae8dd25d-68f0-4272-951f-3186e008c314" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_7c9b4033-237a-47cd-b288-26e1ff085ff1" xlink:to="loc_srt_RestatementAdjustmentMember_ae8dd25d-68f0-4272-951f-3186e008c314" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#DEBTSCHEDULEOFLONGTERMDEBTDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails" xlink:type="extended" id="ic0f3f72935b140f197a39be228889695_DEBTSCHEDULEOFLONGTERMDEBTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4da90d1d-3124-4f77-86c5-d4fd0622d0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4da90d1d-3124-4f77-86c5-d4fd0622d0ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_4427ea94-a455-4600-b036-071bf2681709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_4427ea94-a455-4600-b036-071bf2681709" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7110170b-eec1-4df8-96b6-c89291df33ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:to="loc_us-gaap_LongTermDebt_7110170b-eec1-4df8-96b6-c89291df33ff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_bf944644-897c-482f-8b9c-97e53f89276b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_bf944644-897c-482f-8b9c-97e53f89276b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_daf36174-72cd-49fb-b212-01c730a1d2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:to="loc_us-gaap_DebtInstrumentTable_daf36174-72cd-49fb-b212-01c730a1d2c1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_38530285-bb7d-4e39-be3c-de51ee46681d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_daf36174-72cd-49fb-b212-01c730a1d2c1" xlink:to="loc_us-gaap_CreditFacilityAxis_38530285-bb7d-4e39-be3c-de51ee46681d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_38530285-bb7d-4e39-be3c-de51ee46681d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_38530285-bb7d-4e39-be3c-de51ee46681d" xlink:to="loc_us-gaap_CreditFacilityDomain_38530285-bb7d-4e39-be3c-de51ee46681d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6d41da50-cfcd-4de5-8509-ed95ecbe9205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_38530285-bb7d-4e39-be3c-de51ee46681d" xlink:to="loc_us-gaap_CreditFacilityDomain_6d41da50-cfcd-4de5-8509-ed95ecbe9205" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b01157ad-f0bc-4524-821c-76d460a36759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_6d41da50-cfcd-4de5-8509-ed95ecbe9205" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b01157ad-f0bc-4524-821c-76d460a36759" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0ecd65d5-52ec-4942-a474-efd0dc7ca9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_daf36174-72cd-49fb-b212-01c730a1d2c1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0ecd65d5-52ec-4942-a474-efd0dc7ca9ae" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0ecd65d5-52ec-4942-a474-efd0dc7ca9ae_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0ecd65d5-52ec-4942-a474-efd0dc7ca9ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0ecd65d5-52ec-4942-a474-efd0dc7ca9ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4ecafcb8-8b2a-4b22-ba62-7aa71dfb2b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0ecd65d5-52ec-4942-a474-efd0dc7ca9ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4ecafcb8-8b2a-4b22-ba62-7aa71dfb2b75" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7d79a9a8-6c6c-44ed-b507-3e44cd7c8e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4ecafcb8-8b2a-4b22-ba62-7aa71dfb2b75" xlink:to="loc_us-gaap_LineOfCreditMember_7d79a9a8-6c6c-44ed-b507-3e44cd7c8e9b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/DEBTNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#DEBTNARRATIVEDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/DEBTNARRATIVEDetails" xlink:type="extended" id="i7ceb211bb8964d09b0f5865f27e06916_DEBTNARRATIVEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3931fbb9-552d-4dbb-b1a9-3e12a10fc000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3931fbb9-552d-4dbb-b1a9-3e12a10fc000" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_dc1833b0-256c-4ffc-b7be-556a057ecd71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_dc1833b0-256c-4ffc-b7be-556a057ecd71" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c0bbcd73-9e0a-4604-ac0d-f75a787c6736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c0bbcd73-9e0a-4604-ac0d-f75a787c6736" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_61c3ece7-6988-4ca7-b20c-3dc126371e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_61c3ece7-6988-4ca7-b20c-3dc126371e5f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_bef211d9-fb6f-442d-9a4e-c89e32417e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_bef211d9-fb6f-442d-9a4e-c89e32417e27" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_0347df8b-c70a-47f0-86eb-6ba2f1c46eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_0347df8b-c70a-47f0-86eb-6ba2f1c46eff" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5a0d73b8-1534-457f-a686-d642da7a33c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:to="loc_us-gaap_CreditFacilityAxis_5a0d73b8-1534-457f-a686-d642da7a33c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5a0d73b8-1534-457f-a686-d642da7a33c9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_5a0d73b8-1534-457f-a686-d642da7a33c9" xlink:to="loc_us-gaap_CreditFacilityDomain_5a0d73b8-1534-457f-a686-d642da7a33c9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9f69c377-30ec-434d-b01b-1f5c80b85de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_5a0d73b8-1534-457f-a686-d642da7a33c9" xlink:to="loc_us-gaap_CreditFacilityDomain_9f69c377-30ec-434d-b01b-1f5c80b85de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_54fc53cd-026c-4b06-94c9-5ad07537e0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9f69c377-30ec-434d-b01b-1f5c80b85de1" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_54fc53cd-026c-4b06-94c9-5ad07537e0f3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_b39e926f-e9cb-4fee-aee1-f75c1ab36d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_9f69c377-30ec-434d-b01b-1f5c80b85de1" xlink:to="loc_us-gaap_LetterOfCreditMember_b39e926f-e9cb-4fee-aee1-f75c1ab36d2d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2d09df55-7e17-4f60-a9c0-1c51d7a704c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:to="loc_srt_RangeAxis_2d09df55-7e17-4f60-a9c0-1c51d7a704c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2d09df55-7e17-4f60-a9c0-1c51d7a704c8_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_2d09df55-7e17-4f60-a9c0-1c51d7a704c8" xlink:to="loc_srt_RangeMember_2d09df55-7e17-4f60-a9c0-1c51d7a704c8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f67b33a1-e48c-4576-a6ca-b9ec8abef58c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_2d09df55-7e17-4f60-a9c0-1c51d7a704c8" xlink:to="loc_srt_RangeMember_f67b33a1-e48c-4576-a6ca-b9ec8abef58c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c5546d8a-c8d9-4528-9473-6be4763afab1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f67b33a1-e48c-4576-a6ca-b9ec8abef58c" xlink:to="loc_srt_MinimumMember_c5546d8a-c8d9-4528-9473-6be4763afab1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b234e15c-04b4-4bca-af18-a2a682aec5af" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_f67b33a1-e48c-4576-a6ca-b9ec8abef58c" xlink:to="loc_srt_MaximumMember_b234e15c-04b4-4bca-af18-a2a682aec5af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_847d1248-8f95-4683-a995-92022184c206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:to="loc_us-gaap_VariableRateAxis_847d1248-8f95-4683-a995-92022184c206" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_847d1248-8f95-4683-a995-92022184c206_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_847d1248-8f95-4683-a995-92022184c206" xlink:to="loc_us-gaap_VariableRateDomain_847d1248-8f95-4683-a995-92022184c206_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0f3ab491-0874-4688-8d4d-69ec680eac24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_847d1248-8f95-4683-a995-92022184c206" xlink:to="loc_us-gaap_VariableRateDomain_0f3ab491-0874-4688-8d4d-69ec680eac24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a2cb0897-40d2-42da-9b27-fee14c0e1682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_0f3ab491-0874-4688-8d4d-69ec680eac24" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a2cb0897-40d2-42da-9b27-fee14c0e1682" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_98d62371-f0b1-432d-888f-0d66fa76872e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_0f3ab491-0874-4688-8d4d-69ec680eac24" xlink:to="loc_us-gaap_BaseRateMember_98d62371-f0b1-432d-888f-0d66fa76872e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_10668adc-d510-43f5-bd39-6f8ead60e855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_10668adc-d510-43f5-bd39-6f8ead60e855" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_10668adc-d510-43f5-bd39-6f8ead60e855_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_10668adc-d510-43f5-bd39-6f8ead60e855" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_10668adc-d510-43f5-bd39-6f8ead60e855_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d3f1e240-8bc1-4b6d-a7dd-443a73fc6735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_10668adc-d510-43f5-bd39-6f8ead60e855" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d3f1e240-8bc1-4b6d-a7dd-443a73fc6735" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_26b0845e-6b39-4d78-8759-30960e351fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d3f1e240-8bc1-4b6d-a7dd-443a73fc6735" xlink:to="loc_us-gaap_LineOfCreditMember_26b0845e-6b39-4d78-8759-30960e351fb8" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails" xlink:type="extended" id="ia761fe9d34b9400c8096f57a48e258ca_OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2740981d-5eae-4c54-bf3f-8b5272328d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_63e54aaf-0ebf-4015-99fd-3880db51d92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2740981d-5eae-4c54-bf3f-8b5272328d9d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_63e54aaf-0ebf-4015-99fd-3880db51d92e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_275fb6c9-cdab-4928-a6a9-d59351fbfb49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2740981d-5eae-4c54-bf3f-8b5272328d9d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_275fb6c9-cdab-4928-a6a9-d59351fbfb49" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0fbc972d-7722-415c-9c93-9463ff59efca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_275fb6c9-cdab-4928-a6a9-d59351fbfb49" xlink:to="loc_us-gaap_AwardTypeAxis_0fbc972d-7722-415c-9c93-9463ff59efca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fbc972d-7722-415c-9c93-9463ff59efca_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0fbc972d-7722-415c-9c93-9463ff59efca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0fbc972d-7722-415c-9c93-9463ff59efca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b61009b2-3e20-429c-866d-4af17c49c627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0fbc972d-7722-415c-9c93-9463ff59efca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b61009b2-3e20-429c-866d-4af17c49c627" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4a224987-80f8-46d0-a08f-b5aac8cf984b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b61009b2-3e20-429c-866d-4af17c49c627" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4a224987-80f8-46d0-a08f-b5aac8cf984b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_994dce4b-ffc1-457e-92b0-3ca62b558287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b61009b2-3e20-429c-866d-4af17c49c627" xlink:to="loc_us-gaap_RestrictedStockMember_994dce4b-ffc1-457e-92b0-3ca62b558287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_aa78ed5c-66db-4d13-b272-c9d04120eaaf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_275fb6c9-cdab-4928-a6a9-d59351fbfb49" xlink:to="loc_srt_TitleOfIndividualAxis_aa78ed5c-66db-4d13-b272-c9d04120eaaf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aa78ed5c-66db-4d13-b272-c9d04120eaaf_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_aa78ed5c-66db-4d13-b272-c9d04120eaaf" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_aa78ed5c-66db-4d13-b272-c9d04120eaaf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d333065d-70ed-421a-be67-c8f8f89a179d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_aa78ed5c-66db-4d13-b272-c9d04120eaaf" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d333065d-70ed-421a-be67-c8f8f89a179d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_679e4b54-e313-45c7-bf6e-16e22c598c3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d333065d-70ed-421a-be67-c8f8f89a179d" xlink:to="loc_srt_DirectorMember_679e4b54-e313-45c7-bf6e-16e22c598c3e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails" xlink:type="extended" id="i2b417babab6f4a74b5f3156d821dd244_OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8a9009b2-1282-4f9d-858f-675fa802da2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8a9009b2-1282-4f9d-858f-675fa802da2e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a5feed41-d4d9-4e6a-8fd1-f81851e3644f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a5feed41-d4d9-4e6a-8fd1-f81851e3644f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3c59ad83-31d7-4a27-b7ea-b9cd323df009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3c59ad83-31d7-4a27-b7ea-b9cd323df009" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0eef6e47-8a11-48e7-a07b-3ac3788a9ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0eef6e47-8a11-48e7-a07b-3ac3788a9ae8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f5ed23f8-dc91-4511-9ae7-710122784b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f5ed23f8-dc91-4511-9ae7-710122784b16" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_09d613d8-7cdd-45c7-9eba-2c4b97b4de56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_09d613d8-7cdd-45c7-9eba-2c4b97b4de56" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0f9c889f-b35c-4fde-9b32-9468e476c47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0f9c889f-b35c-4fde-9b32-9468e476c47c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_ae18df1b-c237-40be-832b-df5c70f46ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_ae18df1b-c237-40be-832b-df5c70f46ad3" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_52cfd397-18ee-495b-bfdd-934db26d1317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_52cfd397-18ee-495b-bfdd-934db26d1317" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e2b93d06-fc64-4c58-a241-e5335cea2d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e2b93d06-fc64-4c58-a241-e5335cea2d7f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6c33853c-aff5-4294-ad37-40eae7435119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e2b93d06-fc64-4c58-a241-e5335cea2d7f" xlink:to="loc_us-gaap_PlanNameAxis_6c33853c-aff5-4294-ad37-40eae7435119" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6c33853c-aff5-4294-ad37-40eae7435119_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_6c33853c-aff5-4294-ad37-40eae7435119" xlink:to="loc_us-gaap_PlanNameDomain_6c33853c-aff5-4294-ad37-40eae7435119_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d77e1c75-361c-42f8-9e85-0f8460d14599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_6c33853c-aff5-4294-ad37-40eae7435119" xlink:to="loc_us-gaap_PlanNameDomain_d77e1c75-361c-42f8-9e85-0f8460d14599" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_d46fd445-b6c7-4201-8e37-f584bd5825d5" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_d77e1c75-361c-42f8-9e85-0f8460d14599" xlink:to="loc_pntg_TheEnsignPlansMember_d46fd445-b6c7-4201-8e37-f584bd5825d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8ab13ad6-3aff-490f-84c0-8c9703435d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e2b93d06-fc64-4c58-a241-e5335cea2d7f" xlink:to="loc_us-gaap_AwardTypeAxis_8ab13ad6-3aff-490f-84c0-8c9703435d10" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ab13ad6-3aff-490f-84c0-8c9703435d10_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8ab13ad6-3aff-490f-84c0-8c9703435d10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ab13ad6-3aff-490f-84c0-8c9703435d10_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_382e10af-a2b3-4fdc-a07d-16f55ac0aef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8ab13ad6-3aff-490f-84c0-8c9703435d10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_382e10af-a2b3-4fdc-a07d-16f55ac0aef1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_cb881516-af9f-4622-8500-bb107448b5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_382e10af-a2b3-4fdc-a07d-16f55ac0aef1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_cb881516-af9f-4622-8500-bb107448b5d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_882dff83-baf7-4b21-abb1-493835200711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_382e10af-a2b3-4fdc-a07d-16f55ac0aef1" xlink:to="loc_us-gaap_RestrictedStockMember_882dff83-baf7-4b21-abb1-493835200711" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4751beab-bf50-4c77-afea-df02e1b6d951" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e2b93d06-fc64-4c58-a241-e5335cea2d7f" xlink:to="loc_srt_RangeAxis_4751beab-bf50-4c77-afea-df02e1b6d951" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4751beab-bf50-4c77-afea-df02e1b6d951_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4751beab-bf50-4c77-afea-df02e1b6d951" xlink:to="loc_srt_RangeMember_4751beab-bf50-4c77-afea-df02e1b6d951_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_223bb228-35af-4a4c-a816-7d888bced1d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4751beab-bf50-4c77-afea-df02e1b6d951" xlink:to="loc_srt_RangeMember_223bb228-35af-4a4c-a816-7d888bced1d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ed3d4a89-0ef7-4701-aab8-a1ae4eba2647" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_223bb228-35af-4a4c-a816-7d888bced1d8" xlink:to="loc_srt_MaximumMember_ed3d4a89-0ef7-4701-aab8-a1ae4eba2647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_117bbbec-bee7-4dcc-ace1-118b14abe2d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_223bb228-35af-4a4c-a816-7d888bced1d8" xlink:to="loc_srt_MinimumMember_117bbbec-bee7-4dcc-ace1-118b14abe2d9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSOPTIONSGRANTEDDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails" xlink:type="extended" id="i758ef1f2646d47d6add4f8e0a6d55cfd_OPTIONSANDAWARDSOPTIONSGRANTEDDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_45fe3167-5c3f-43df-b1b9-71071b848936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_45fe3167-5c3f-43df-b1b9-71071b848936" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8b90bdf1-21d3-47bf-8675-4766e8541309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8b90bdf1-21d3-47bf-8675-4766e8541309" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8feae370-6272-4b4f-835b-0717bc712450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8feae370-6272-4b4f-835b-0717bc712450" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_d1b1901f-ad36-4ea8-8d67-d917e8352c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_d1b1901f-ad36-4ea8-8d67-d917e8352c41" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_994996bf-a07a-4575-a892-29d4ccaf740b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_994996bf-a07a-4575-a892-29d4ccaf740b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fadf8028-1b9d-4af4-b4af-cd99bd0ad9be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fadf8028-1b9d-4af4-b4af-cd99bd0ad9be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da4d4633-6f24-4556-9c9a-294fc731d607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da4d4633-6f24-4556-9c9a-294fc731d607" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_38c06e33-79a8-4fb8-a53c-48e45c985349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da4d4633-6f24-4556-9c9a-294fc731d607" xlink:to="loc_us-gaap_PlanNameAxis_38c06e33-79a8-4fb8-a53c-48e45c985349" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_38c06e33-79a8-4fb8-a53c-48e45c985349_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_38c06e33-79a8-4fb8-a53c-48e45c985349" xlink:to="loc_us-gaap_PlanNameDomain_38c06e33-79a8-4fb8-a53c-48e45c985349_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8aa02584-8305-4f73-b4a3-bb61ea0849d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_38c06e33-79a8-4fb8-a53c-48e45c985349" xlink:to="loc_us-gaap_PlanNameDomain_8aa02584-8305-4f73-b4a3-bb61ea0849d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_1d3c9ca3-f058-4746-b21e-51c273d55ff5" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8aa02584-8305-4f73-b4a3-bb61ea0849d1" xlink:to="loc_pntg_TheEnsignPlansMember_1d3c9ca3-f058-4746-b21e-51c273d55ff5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_23341988-d21b-4bd9-9d27-a40e4d4ebc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da4d4633-6f24-4556-9c9a-294fc731d607" xlink:to="loc_us-gaap_AwardDateAxis_23341988-d21b-4bd9-9d27-a40e4d4ebc0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_23341988-d21b-4bd9-9d27-a40e4d4ebc0d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardDateAxis_23341988-d21b-4bd9-9d27-a40e4d4ebc0d" xlink:to="loc_us-gaap_AwardDateDomain_23341988-d21b-4bd9-9d27-a40e4d4ebc0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_1aa81e21-7645-443f-9b7b-9c34ce7823e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardDateAxis_23341988-d21b-4bd9-9d27-a40e4d4ebc0d" xlink:to="loc_us-gaap_AwardDateDomain_1aa81e21-7645-443f-9b7b-9c34ce7823e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GrantYear2021Member_ac6809ca-abba-42f2-a5aa-515a54430680" xlink:href="pntg-20211231.xsd#pntg_GrantYear2021Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1aa81e21-7645-443f-9b7b-9c34ce7823e3" xlink:to="loc_pntg_GrantYear2021Member_ac6809ca-abba-42f2-a5aa-515a54430680" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GrantYear2020Member_35b8219f-a09f-4658-aa8b-99a739771a8a" xlink:href="pntg-20211231.xsd#pntg_GrantYear2020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1aa81e21-7645-443f-9b7b-9c34ce7823e3" xlink:to="loc_pntg_GrantYear2020Member_35b8219f-a09f-4658-aa8b-99a739771a8a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GrantYear2019Member_760c4b66-5cb9-4855-8dbb-554bbef57758" xlink:href="pntg-20211231.xsd#pntg_GrantYear2019Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AwardDateDomain_1aa81e21-7645-443f-9b7b-9c34ce7823e3" xlink:to="loc_pntg_GrantYear2019Member_760c4b66-5cb9-4855-8dbb-554bbef57758" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0788b886-b65a-4407-bff2-446534d2f304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da4d4633-6f24-4556-9c9a-294fc731d607" xlink:to="loc_us-gaap_AwardTypeAxis_0788b886-b65a-4407-bff2-446534d2f304" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0788b886-b65a-4407-bff2-446534d2f304_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_0788b886-b65a-4407-bff2-446534d2f304" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_0788b886-b65a-4407-bff2-446534d2f304_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bea2a57b-0254-4f19-babb-ab5ef67a575e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_0788b886-b65a-4407-bff2-446534d2f304" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bea2a57b-0254-4f19-babb-ab5ef67a575e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8497d90a-b91f-4620-a413-5e0ae6003c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bea2a57b-0254-4f19-babb-ab5ef67a575e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8497d90a-b91f-4620-a413-5e0ae6003c5a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails" xlink:type="extended" id="ia9e38855c3a3428893628f0c573677b5_OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6c339e1e-8f45-43d0-bde4-e0ec429162b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6c339e1e-8f45-43d0-bde4-e0ec429162b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1ff6f698-c9fc-4345-8cd4-564c45a84c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1ff6f698-c9fc-4345-8cd4-564c45a84c37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8c56cd60-e7a8-4fe3-891b-a221dc00b9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8c56cd60-e7a8-4fe3-891b-a221dc00b9ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_dd634938-99fc-4492-bfcd-ca3fde3dfde2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_dd634938-99fc-4492-bfcd-ca3fde3dfde2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2ed09c92-90ae-494b-bf64-a5ca82bdc280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4190c95b-bead-4c6e-ba4f-d84d9d0cedb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4190c95b-bead-4c6e-ba4f-d84d9d0cedb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4b6e6fa8-6c09-45ab-a35c-79e9048cb7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4b6e6fa8-6c09-45ab-a35c-79e9048cb7f4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9b431e28-066c-445e-8bde-fb1442fccd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9b431e28-066c-445e-8bde-fb1442fccd1c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_04185ec2-b60a-42e6-8037-7ddf0c6cb85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_04185ec2-b60a-42e6-8037-7ddf0c6cb85c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4b0917d4-c931-433a-9688-92ae896edcda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber_4d464c63-f89a-47f9-ab63-364a2ee52e22" xlink:href="pntg-20211231.xsd#pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:to="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber_4d464c63-f89a-47f9-ab63-364a2ee52e22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1d923e04-1236-4f6b-9138-ed7dced63178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1d923e04-1236-4f6b-9138-ed7dced63178" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac4fc48c-7da8-4d9e-98a8-8e6725efa496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac4fc48c-7da8-4d9e-98a8-8e6725efa496" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7c2bb8e1-fc14-428a-8418-6ccdfb70f498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac4fc48c-7da8-4d9e-98a8-8e6725efa496" xlink:to="loc_us-gaap_PlanNameAxis_7c2bb8e1-fc14-428a-8418-6ccdfb70f498" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7c2bb8e1-fc14-428a-8418-6ccdfb70f498_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_7c2bb8e1-fc14-428a-8418-6ccdfb70f498" xlink:to="loc_us-gaap_PlanNameDomain_7c2bb8e1-fc14-428a-8418-6ccdfb70f498_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fc73b41d-50eb-4299-8d95-8ae7dde85759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_7c2bb8e1-fc14-428a-8418-6ccdfb70f498" xlink:to="loc_us-gaap_PlanNameDomain_fc73b41d-50eb-4299-8d95-8ae7dde85759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_74a0e2c0-311a-4db1-a8f6-2a9edc78503f" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_fc73b41d-50eb-4299-8d95-8ae7dde85759" xlink:to="loc_pntg_TheEnsignPlansMember_74a0e2c0-311a-4db1-a8f6-2a9edc78503f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails" xlink:type="extended" id="i3145b9d1845c4fa98790026a1eac0818_OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_787fed45-5a26-4145-85f4-89edff53b7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_787fed45-5a26-4145-85f4-89edff53b7d0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue_b587503c-3089-48f2-82cb-2f45bd4902a6" xlink:href="pntg-20211231.xsd#pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:to="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue_b587503c-3089-48f2-82cb-2f45bd4902a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_0bfa433f-5a04-4398-9f7a-7a27fc8174c9" xlink:href="pntg-20211231.xsd#pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:to="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_0bfa433f-5a04-4398-9f7a-7a27fc8174c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_7958ced4-bfe8-4ace-896b-2029afe5e8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_7958ced4-bfe8-4ace-896b-2029afe5e8cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3e3f6df-0e67-475d-a65e-b3147276a470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3e3f6df-0e67-475d-a65e-b3147276a470" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5d225865-df53-484e-bbd5-7413076d686b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3e3f6df-0e67-475d-a65e-b3147276a470" xlink:to="loc_us-gaap_PlanNameAxis_5d225865-df53-484e-bbd5-7413076d686b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5d225865-df53-484e-bbd5-7413076d686b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5d225865-df53-484e-bbd5-7413076d686b" xlink:to="loc_us-gaap_PlanNameDomain_5d225865-df53-484e-bbd5-7413076d686b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9033fdb9-e1be-4717-a728-d9e74087b426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5d225865-df53-484e-bbd5-7413076d686b" xlink:to="loc_us-gaap_PlanNameDomain_9033fdb9-e1be-4717-a728-d9e74087b426" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_9eddfb05-e0ba-4c25-8546-5b6bb38ea2cf" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_9033fdb9-e1be-4717-a728-d9e74087b426" xlink:to="loc_pntg_TheEnsignPlansMember_9eddfb05-e0ba-4c25-8546-5b6bb38ea2cf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails" xlink:type="extended" id="i46dc0ee28ca34d50902e2c73a7091057_OPTIONSANDAWARDSRESTRICTEDSTOCKDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_76a6be18-1dca-4253-9fa2-ba5b2592102e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_76a6be18-1dca-4253-9fa2-ba5b2592102e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_852ea4f2-34f6-41ea-b78c-5b4019cd6def" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_852ea4f2-34f6-41ea-b78c-5b4019cd6def" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_15273592-e06d-4b51-a299-d259ff87d1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_15273592-e06d-4b51-a299-d259ff87d1b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b7dd8e33-2075-4fd9-8ff7-78c1cd43c2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b7dd8e33-2075-4fd9-8ff7-78c1cd43c2ef" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8345dd40-cf6f-404b-bb86-103329ca83e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8345dd40-cf6f-404b-bb86-103329ca83e2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12543398-df13-4de3-8968-f344350408b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_76a6be18-1dca-4253-9fa2-ba5b2592102e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_099878d8-3b23-4767-a566-e835a4b3da4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_099878d8-3b23-4767-a566-e835a4b3da4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_66ed17f9-7267-41f0-8481-c48be4df64ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_66ed17f9-7267-41f0-8481-c48be4df64ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_94fa35da-a61d-4c08-b1a5-b5154329ff7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_94fa35da-a61d-4c08-b1a5-b5154329ff7c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8fb1e47f-58ed-4baa-aab1-14690f189d08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8fb1e47f-58ed-4baa-aab1-14690f189d08" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_02dc37ce-ba6c-4083-81b7-62a1193e5f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a957fda-6ebd-446e-ba12-5e986d377640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_76a6be18-1dca-4253-9fa2-ba5b2592102e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a957fda-6ebd-446e-ba12-5e986d377640" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_608625c6-e846-4747-b93c-ef7ae0866829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a957fda-6ebd-446e-ba12-5e986d377640" xlink:to="loc_us-gaap_PlanNameAxis_608625c6-e846-4747-b93c-ef7ae0866829" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_608625c6-e846-4747-b93c-ef7ae0866829_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_608625c6-e846-4747-b93c-ef7ae0866829" xlink:to="loc_us-gaap_PlanNameDomain_608625c6-e846-4747-b93c-ef7ae0866829_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_64c6d412-1ad3-4c67-bfb0-2b40c9fc8c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_608625c6-e846-4747-b93c-ef7ae0866829" xlink:to="loc_us-gaap_PlanNameDomain_64c6d412-1ad3-4c67-bfb0-2b40c9fc8c78" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_7a2e5c7e-01ac-4b61-aae1-23e1af182627" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_64c6d412-1ad3-4c67-bfb0-2b40c9fc8c78" xlink:to="loc_pntg_TheEnsignPlansMember_7a2e5c7e-01ac-4b61-aae1-23e1af182627" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_059b4b57-9d8c-475b-a866-727a8966f673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a957fda-6ebd-446e-ba12-5e986d377640" xlink:to="loc_us-gaap_AwardTypeAxis_059b4b57-9d8c-475b-a866-727a8966f673" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_059b4b57-9d8c-475b-a866-727a8966f673_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_059b4b57-9d8c-475b-a866-727a8966f673" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_059b4b57-9d8c-475b-a866-727a8966f673_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719d9648-faed-40f7-afa3-ac3f3a19a00d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_059b4b57-9d8c-475b-a866-727a8966f673" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719d9648-faed-40f7-afa3-ac3f3a19a00d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_8feee1d1-3e0a-403f-ba83-75a696cd4be9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719d9648-faed-40f7-afa3-ac3f3a19a00d" xlink:to="loc_us-gaap_RestrictedStockMember_8feee1d1-3e0a-403f-ba83-75a696cd4be9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/LEASESNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#LEASESNARRATIVEDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/LEASESNARRATIVEDetails" xlink:type="extended" id="i3c6ba18076ab4ee7b5dcdb9594a1cc81_LEASESNARRATIVEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfRealEstatePropertiesUnderLease_3b32d0ec-d2b0-4819-b658-66a59032f2fe" xlink:href="pntg-20211231.xsd#pntg_NumberOfRealEstatePropertiesUnderLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_pntg_NumberOfRealEstatePropertiesUnderLease_3b32d0ec-d2b0-4819-b658-66a59032f2fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0db14d21-ce87-4b4d-a0e8-4f279d0c0850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0db14d21-ce87-4b4d-a0e8-4f279d0c0850" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfServiceProviders_bf8c6771-3cb9-4412-a629-a06d08ca336d" xlink:href="pntg-20211231.xsd#pntg_NumberOfServiceProviders"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_pntg_NumberOfServiceProviders_bf8c6771-3cb9-4412-a629-a06d08ca336d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_f3669f22-5535-4cf9-804c-e8307249a7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_f3669f22-5535-4cf9-804c-e8307249a7c9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement_d2521923-fe79-49f9-89e7-6daa47b424e4" xlink:href="pntg-20211231.xsd#pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement_d2521923-fe79-49f9-89e7-6daa47b424e4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfSeparateMasterLeaseArrangements_24b9385b-c228-4676-ae86-1efe85bc25f3" xlink:href="pntg-20211231.xsd#pntg_NumberOfSeparateMasterLeaseArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_pntg_NumberOfSeparateMasterLeaseArrangements_24b9385b-c228-4676-ae86-1efe85bc25f3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fb0ee800-0deb-4938-b53a-fb8e5f781148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fb0ee800-0deb-4938-b53a-fb8e5f781148" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e1a80f0e-4899-491a-888a-f6cbdf6f76ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e1a80f0e-4899-491a-888a-f6cbdf6f76ae" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f6e6b39e-10fd-49d4-b69e-004e394bb970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f6e6b39e-10fd-49d4-b69e-004e394bb970" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d6e63f3a-1f67-48d6-a48f-197f26a5f7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f6e6b39e-10fd-49d4-b69e-004e394bb970" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d6e63f3a-1f67-48d6-a48f-197f26a5f7b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d6e63f3a-1f67-48d6-a48f-197f26a5f7b9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d6e63f3a-1f67-48d6-a48f-197f26a5f7b9" xlink:to="loc_us-gaap_SegmentDomain_d6e63f3a-1f67-48d6-a48f-197f26a5f7b9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_82f4a84a-beb6-40cb-a815-4f9da1e930aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d6e63f3a-1f67-48d6-a48f-197f26a5f7b9" xlink:to="loc_us-gaap_SegmentDomain_82f4a84a-beb6-40cb-a815-4f9da1e930aa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_413041a7-aed0-4069-a967-dce5c32b9422" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_82f4a84a-beb6-40cb-a815-4f9da1e930aa" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_413041a7-aed0-4069-a967-dce5c32b9422" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_bfcb7480-42c5-47c9-920a-291ba90e46f7" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_82f4a84a-beb6-40cb-a815-4f9da1e930aa" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_bfcb7480-42c5-47c9-920a-291ba90e46f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4db3b35f-7ed2-45a2-be3c-ecf18aaac23b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f6e6b39e-10fd-49d4-b69e-004e394bb970" xlink:to="loc_srt_RangeAxis_4db3b35f-7ed2-45a2-be3c-ecf18aaac23b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_4db3b35f-7ed2-45a2-be3c-ecf18aaac23b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_4db3b35f-7ed2-45a2-be3c-ecf18aaac23b" xlink:to="loc_srt_RangeMember_4db3b35f-7ed2-45a2-be3c-ecf18aaac23b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e76a2526-096f-4c54-8a82-0b9123ef60a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_4db3b35f-7ed2-45a2-be3c-ecf18aaac23b" xlink:to="loc_srt_RangeMember_e76a2526-096f-4c54-8a82-0b9123ef60a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0259535e-35d5-4585-bb67-00333c0fa1a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e76a2526-096f-4c54-8a82-0b9123ef60a1" xlink:to="loc_srt_MinimumMember_0259535e-35d5-4585-bb67-00333c0fa1a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bb3c9134-101d-4b38-98d0-058747d5aabd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_e76a2526-096f-4c54-8a82-0b9123ef60a1" xlink:to="loc_srt_MaximumMember_bb3c9134-101d-4b38-98d0-058747d5aabd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6409c5bd-2c11-4c3f-b0cd-2889edd2dac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f6e6b39e-10fd-49d4-b69e-004e394bb970" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6409c5bd-2c11-4c3f-b0cd-2889edd2dac8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_6409c5bd-2c11-4c3f-b0cd-2889edd2dac8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6409c5bd-2c11-4c3f-b0cd-2889edd2dac8" xlink:to="loc_us-gaap_RelatedPartyDomain_6409c5bd-2c11-4c3f-b0cd-2889edd2dac8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9e85c2e0-5f61-4108-bb9c-c3593192093e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6409c5bd-2c11-4c3f-b0cd-2889edd2dac8" xlink:to="loc_us-gaap_RelatedPartyDomain_9e85c2e0-5f61-4108-bb9c-c3593192093e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_b691f58b-835c-44ca-8a01-c9ea24021474" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_9e85c2e0-5f61-4108-bb9c-c3593192093e" xlink:to="loc_srt_AffiliatedEntityMember_b691f58b-835c-44ca-8a01-c9ea24021474" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#LEASESIMPACTOFNEWLEASESGUIDANCEDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails" xlink:type="extended" id="i0f492e44b7e54e1cb0cc3ccc605da75a_LEASESIMPACTOFNEWLEASESGUIDANCEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b4e4df3-ae82-4abc-80e3-105b123457c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_9b002992-4ef6-4ded-aa7a-19f71758eea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b4e4df3-ae82-4abc-80e3-105b123457c1" xlink:to="loc_us-gaap_LeaseCostAbstract_9b002992-4ef6-4ded-aa7a-19f71758eea5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_6d47215f-961f-46f6-86a5-65e51bed44b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseCostAbstract_9b002992-4ef6-4ded-aa7a-19f71758eea5" xlink:to="loc_us-gaap_OperatingLeaseCost_6d47215f-961f-46f6-86a5-65e51bed44b3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_4f5a7261-66f3-43c4-89aa-c353c99c316b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseCostAbstract_9b002992-4ef6-4ded-aa7a-19f71758eea5" xlink:to="loc_us-gaap_SubleaseIncome_4f5a7261-66f3-43c4-89aa-c353c99c316b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_94c93cb0-c15e-4ff0-992e-43e8650927a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LeaseCostAbstract_9b002992-4ef6-4ded-aa7a-19f71758eea5" xlink:to="loc_us-gaap_VariableLeaseCost_94c93cb0-c15e-4ff0-992e-43e8650927a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d3644de9-b749-4bf9-839f-a96fffe9edd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b4e4df3-ae82-4abc-80e3-105b123457c1" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d3644de9-b749-4bf9-839f-a96fffe9edd9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_135952c7-95e7-4a7a-8183-e948734505a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d3644de9-b749-4bf9-839f-a96fffe9edd9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_135952c7-95e7-4a7a-8183-e948734505a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_135952c7-95e7-4a7a-8183-e948734505a7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_135952c7-95e7-4a7a-8183-e948734505a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_135952c7-95e7-4a7a-8183-e948734505a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0519f511-639e-4a70-8b2d-cb7c111b03fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_135952c7-95e7-4a7a-8183-e948734505a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0519f511-639e-4a70-8b2d-cb7c111b03fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_783feadf-9649-4b84-9e5a-fe14701c57c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0519f511-639e-4a70-8b2d-cb7c111b03fd" xlink:to="loc_us-gaap_CostOfSalesMember_783feadf-9649-4b84-9e5a-fe14701c57c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c9705b31-dbbd-40d8-a94f-37cb8ea81f57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0519f511-639e-4a70-8b2d-cb7c111b03fd" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c9705b31-dbbd-40d8-a94f-37cb8ea81f57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_05b1b937-72c5-4e32-9054-4e5813a94a70" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d3644de9-b749-4bf9-839f-a96fffe9edd9" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_05b1b937-72c5-4e32-9054-4e5813a94a70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_05b1b937-72c5-4e32-9054-4e5813a94a70_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_05b1b937-72c5-4e32-9054-4e5813a94a70" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_05b1b937-72c5-4e32-9054-4e5813a94a70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e0157c6-c565-4d72-b514-f648419091f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_05b1b937-72c5-4e32-9054-4e5813a94a70" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e0157c6-c565-4d72-b514-f648419091f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_FacilityMember_09c3d3b8-5d56-420e-b175-d6f935c50a28" xlink:href="pntg-20211231.xsd#pntg_FacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e0157c6-c565-4d72-b514-f648419091f1" xlink:to="loc_pntg_FacilityMember_09c3d3b8-5d56-420e-b175-d6f935c50a28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_69cab48d-82ad-4745-8630-b261a5a2df69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficeBuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e0157c6-c565-4d72-b514-f648419091f1" xlink:to="loc_srt_OfficeBuildingMember_69cab48d-82ad-4745-8630-b261a5a2df69" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXESTAXRATERECONCILIATIONDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails" xlink:type="extended" id="i992d4fca065c4bf798b3f8f713a76ccd_INCOMETAXESTAXRATERECONCILIATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d5c0b532-698a-4479-9549-5441fb5fa0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d5c0b532-698a-4479-9549-5441fb5fa0ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_55a23024-f618-4f62-826a-bc14db523043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_55a23024-f618-4f62-826a-bc14db523043" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_294c7855-496e-4bbd-a96d-927870d0e207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_294c7855-496e-4bbd-a96d-927870d0e207" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_cb61a861-d0ca-474c-99b1-ed933e957758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_cb61a861-d0ca-474c-99b1-ed933e957758" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation_ce63e76e-3197-4a75-8301-6b5a3c25b26b" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation_ce63e76e-3197-4a75-8301-6b5a3c25b26b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus_45f94a52-8ada-4372-bab7-12f839b0bb42" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus_45f94a52-8ada-4372-bab7-12f839b0bb42" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_e9641b1c-2806-42cd-b53b-0cefe259bb03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_e9641b1c-2806-42cd-b53b-0cefe259bb03" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_ed48b7ca-7184-4b6f-87ed-9c73b078b13f" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_ed48b7ca-7184-4b6f-87ed-9c73b078b13f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_e41a6b63-7830-4432-95b5-1c12086bffa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_e41a6b63-7830-4432-95b5-1c12086bffa5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent_06fa54bc-06e8-4863-bdd2-4549a9d8f906" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent_06fa54bc-06e8-4863-bdd2-4549a9d8f906" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_a0aa0e1c-b6a1-4fa9-a95a-8458b2472e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_a0aa0e1c-b6a1-4fa9-a95a-8458b2472e33" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ab49acdd-98d3-4850-a0f2-01727dda75cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ab49acdd-98d3-4850-a0f2-01727dda75cd" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bb254157-05c8-453c-b118-b3be2cfa58ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bb254157-05c8-453c-b118-b3be2cfa58ce" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount_4300d6bd-ac63-440d-bb7e-c3fa9d05ae3d" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount_4300d6bd-ac63-440d-bb7e-c3fa9d05ae3d" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1fd57062-ecf5-41d5-a5cb-95120304091d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1fd57062-ecf5-41d5-a5cb-95120304091d" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e4281b50-28b9-4042-882e-90e6f2e84beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e4281b50-28b9-4042-882e-90e6f2e84beb" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4c9baf06-6f11-4607-8151-47ee910b47f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_ShareBasedCompensation_4c9baf06-6f11-4607-8151-47ee910b47f1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_f626fbe9-2702-4469-8106-13600d7feb78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_f626fbe9-2702-4469-8106-13600d7feb78" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4f23cf13-0667-4aa3-a7cd-68efa134f039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f626fbe9-2702-4469-8106-13600d7feb78" xlink:to="loc_us-gaap_PlanNameAxis_4f23cf13-0667-4aa3-a7cd-68efa134f039" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_4f23cf13-0667-4aa3-a7cd-68efa134f039_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_4f23cf13-0667-4aa3-a7cd-68efa134f039" xlink:to="loc_us-gaap_PlanNameDomain_4f23cf13-0667-4aa3-a7cd-68efa134f039_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8259fd4c-2a5f-4079-9488-28eeee847309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_4f23cf13-0667-4aa3-a7cd-68efa134f039" xlink:to="loc_us-gaap_PlanNameDomain_8259fd4c-2a5f-4079-9488-28eeee847309" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_86c25948-1f66-4ba6-a69c-34058615b4b0" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8259fd4c-2a5f-4079-9488-28eeee847309" xlink:to="loc_pntg_TheEnsignPlansMember_86c25948-1f66-4ba6-a69c-34058615b4b0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8910e3c8-f883-43c9-8c0c-f6587344259f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f626fbe9-2702-4469-8106-13600d7feb78" xlink:to="loc_us-gaap_AwardTypeAxis_8910e3c8-f883-43c9-8c0c-f6587344259f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8910e3c8-f883-43c9-8c0c-f6587344259f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_8910e3c8-f883-43c9-8c0c-f6587344259f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8910e3c8-f883-43c9-8c0c-f6587344259f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7f6dca8-cc31-44ba-8d48-fa5312796d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_8910e3c8-f883-43c9-8c0c-f6587344259f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7f6dca8-cc31-44ba-8d48-fa5312796d87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9a8c3162-1307-4404-afb5-f29e9ba868f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7f6dca8-cc31-44ba-8d48-fa5312796d87" xlink:to="loc_us-gaap_RestrictedStockMember_9a8c3162-1307-4404-afb5-f29e9ba868f7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXESNARRATIVEDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails" xlink:type="extended" id="idbcce10aae3349eab84ac59b65f83825_INCOMETAXESNARRATIVEDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2dcf69bf-718e-4de2-b8f6-72d19dfda4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_5621be4d-4b74-465e-86c5-b98b4ae180b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2dcf69bf-718e-4de2-b8f6-72d19dfda4eb" xlink:to="loc_us-gaap_OperatingLossCarryforwards_5621be4d-4b74-465e-86c5-b98b4ae180b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_77ff12a6-d5f1-474d-94d3-18fba5bdd75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2dcf69bf-718e-4de2-b8f6-72d19dfda4eb" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_77ff12a6-d5f1-474d-94d3-18fba5bdd75b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_a391aee3-b3bb-4f2b-9c1c-90c2a1aff409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2dcf69bf-718e-4de2-b8f6-72d19dfda4eb" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_a391aee3-b3bb-4f2b-9c1c-90c2a1aff409" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_c0d5f30f-195e-4035-a3ca-1d4b2d5350c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_a391aee3-b3bb-4f2b-9c1c-90c2a1aff409" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_c0d5f30f-195e-4035-a3ca-1d4b2d5350c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_c0d5f30f-195e-4035-a3ca-1d4b2d5350c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c0d5f30f-195e-4035-a3ca-1d4b2d5350c5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_c0d5f30f-195e-4035-a3ca-1d4b2d5350c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_cfe9192a-20f0-45ec-95a8-a5b37fcb39ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c0d5f30f-195e-4035-a3ca-1d4b2d5350c5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_cfe9192a-20f0-45ec-95a8-a5b37fcb39ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_e96e8b59-9ec9-4ee3-8fe5-643561cfb425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cfe9192a-20f0-45ec-95a8-a5b37fcb39ec" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_e96e8b59-9ec9-4ee3-8fe5-643561cfb425" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended" id="i3d62d8e093054f8984a0fcab357d67a5_COMMITMENTSANDCONTINGENCIESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled_54c5b6a0-ba58-4b2f-bb99-dc5b6cd76102" xlink:href="pntg-20211231.xsd#pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:to="loc_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled_54c5b6a0-ba58-4b2f-bb99-dc5b6cd76102" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview_02bc16bc-25fc-4dc9-8190-84961770f342" xlink:href="pntg-20211231.xsd#pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:to="loc_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview_02bc16bc-25fc-4dc9-8190-84961770f342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_UniformProgramIntegrityContractorPeriodOfReview_05f7d37e-6579-4282-9c60-6248c3f6a717" xlink:href="pntg-20211231.xsd#pntg_UniformProgramIntegrityContractorPeriodOfReview"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:to="loc_pntg_UniformProgramIntegrityContractorPeriodOfReview_05f7d37e-6579-4282-9c60-6248c3f6a717" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_UniformProgramIntegrityContractorSuspendedPayments_617f2714-eb35-4e66-bf72-67b9c6b02114" xlink:href="pntg-20211231.xsd#pntg_UniformProgramIntegrityContractorSuspendedPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:to="loc_pntg_UniformProgramIntegrityContractorSuspendedPayments_617f2714-eb35-4e66-bf72-67b9c6b02114" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_58244e17-1eab-42e7-b43f-1479dbf8324b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_58244e17-1eab-42e7-b43f-1479dbf8324b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:to="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_82c7cb59-91a1-4618-abcc-3be04200b38b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:to="loc_srt_MajorCustomersAxis_82c7cb59-91a1-4618-abcc-3be04200b38b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_82c7cb59-91a1-4618-abcc-3be04200b38b_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_82c7cb59-91a1-4618-abcc-3be04200b38b" xlink:to="loc_srt_NameOfMajorCustomerDomain_82c7cb59-91a1-4618-abcc-3be04200b38b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_fe3228cf-d63a-442b-b016-a55204a72371" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_82c7cb59-91a1-4618-abcc-3be04200b38b" xlink:to="loc_srt_NameOfMajorCustomerDomain_fe3228cf-d63a-442b-b016-a55204a72371" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareAndMedicaidMember_3d5223ad-b1b1-43b0-8e9d-43edc5eb7c3a" xlink:href="pntg-20211231.xsd#pntg_MedicareAndMedicaidMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_fe3228cf-d63a-442b-b016-a55204a72371" xlink:to="loc_pntg_MedicareAndMedicaidMember_3d5223ad-b1b1-43b0-8e9d-43edc5eb7c3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7b18095c-0b89-488e-be5f-5682054eabdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7b18095c-0b89-488e-be5f-5682054eabdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7b18095c-0b89-488e-be5f-5682054eabdc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7b18095c-0b89-488e-be5f-5682054eabdc" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_7b18095c-0b89-488e-be5f-5682054eabdc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_106ddc19-faa8-4a3c-89eb-fd7e6777bbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7b18095c-0b89-488e-be5f-5682054eabdc" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_106ddc19-faa8-4a3c-89eb-fd7e6777bbdd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_723f8938-f5c7-4aad-aca8-9354992177ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_106ddc19-faa8-4a3c-89eb-fd7e6777bbdd" xlink:to="loc_us-gaap_AccountsReceivableMember_723f8938-f5c7-4aad-aca8-9354992177ad" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_e86e67cd-974a-49a5-a793-e81bc2cebc31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_106ddc19-faa8-4a3c-89eb-fd7e6777bbdd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_e86e67cd-974a-49a5-a793-e81bc2cebc31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7c905cac-8a45-4991-b10c-8a490bf6d01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7c905cac-8a45-4991-b10c-8a490bf6d01f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7c905cac-8a45-4991-b10c-8a490bf6d01f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7c905cac-8a45-4991-b10c-8a490bf6d01f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7c905cac-8a45-4991-b10c-8a490bf6d01f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4ebc5590-0253-4e16-a659-a24bc8fd9d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7c905cac-8a45-4991-b10c-8a490bf6d01f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4ebc5590-0253-4e16-a659-a24bc8fd9d6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c7e50ffd-270e-4bd0-92ab-a19e2cb1b8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_4ebc5590-0253-4e16-a659-a24bc8fd9d6a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c7e50ffd-270e-4bd0-92ab-a19e2cb1b8d1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_69968e5e-829d-4186-9c73-115b5ab7427c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_69968e5e-829d-4186-9c73-115b5ab7427c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_69968e5e-829d-4186-9c73-115b5ab7427c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_69968e5e-829d-4186-9c73-115b5ab7427c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_69968e5e-829d-4186-9c73-115b5ab7427c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_07c8b662-d60d-4d26-9e33-92f73d6af253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_69968e5e-829d-4186-9c73-115b5ab7427c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_07c8b662-d60d-4d26-9e33-92f73d6af253" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2ec3a9c7-ac75-4592-ac55-1d4a412f00a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_07c8b662-d60d-4d26-9e33-92f73d6af253" xlink:to="loc_us-gaap_SubsequentEventMember_2ec3a9c7-ac75-4592-ac55-1d4a412f00a9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/SUBSEQUENTEVENTDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#SUBSEQUENTEVENTDetails"/>
  <link:definitionLink xlink:role="http://pennantgroup.com/role/SUBSEQUENTEVENTDetails" xlink:type="extended" id="ib57c68d0e756431a9d661b169667571b_SUBSEQUENTEVENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_9aabc951-ad54-4526-b563-a19cb6543fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_a1bc3e3a-6ae8-41b1-b723-bcaaf969bd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EscrowDeposit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_9aabc951-ad54-4526-b563-a19cb6543fe0" xlink:to="loc_us-gaap_EscrowDeposit_a1bc3e3a-6ae8-41b1-b723-bcaaf969bd63" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_57de0cc6-b93e-4d0e-879d-10535586c554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_9aabc951-ad54-4526-b563-a19cb6543fe0" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_57de0cc6-b93e-4d0e-879d-10535586c554" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_c161f511-17e1-468c-ae67-f928ac732bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_9aabc951-ad54-4526-b563-a19cb6543fe0" xlink:to="loc_us-gaap_SubsequentEventTable_c161f511-17e1-468c-ae67-f928ac732bec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c257f520-1484-4b55-8e52-6d07fdbabd39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_c161f511-17e1-468c-ae67-f928ac732bec" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c257f520-1484-4b55-8e52-6d07fdbabd39" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_c257f520-1484-4b55-8e52-6d07fdbabd39_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c257f520-1484-4b55-8e52-6d07fdbabd39" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_c257f520-1484-4b55-8e52-6d07fdbabd39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f2d1b390-29d7-44f6-9262-ce71da93bb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c257f520-1484-4b55-8e52-6d07fdbabd39" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f2d1b390-29d7-44f6-9262-ce71da93bb8e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_113b007f-6e8b-4533-9dc1-6da885db0f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f2d1b390-29d7-44f6-9262-ce71da93bb8e" xlink:to="loc_us-gaap_SubsequentEventMember_113b007f-6e8b-4533-9dc1-6da885db0f23" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_46392be1-cea3-438f-ac46-1688b60e80aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_c161f511-17e1-468c-ae67-f928ac732bec" xlink:to="loc_srt_CounterpartyNameAxis_46392be1-cea3-438f-ac46-1688b60e80aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46392be1-cea3-438f-ac46-1688b60e80aa_default" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_46392be1-cea3-438f-ac46-1688b60e80aa" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_46392be1-cea3-438f-ac46-1688b60e80aa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a71cf777-0593-42e4-aa90-ce0186b3fc08" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_46392be1-cea3-438f-ac46-1688b60e80aa" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a71cf777-0593-42e4-aa90-ce0186b3fc08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AffiliatesOfEnsignMember_ba181dc9-fb46-4c1a-9781-dbe2f5eacc31" xlink:href="pntg-20211231.xsd#pntg_AffiliatesOfEnsignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a71cf777-0593-42e4-aa90-ce0186b3fc08" xlink:to="loc_pntg_AffiliatesOfEnsignMember_ba181dc9-fb46-4c1a-9781-dbe2f5eacc31" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7753b787-4aa5-405d-90fb-7a76f6a87491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_c161f511-17e1-468c-ae67-f928ac732bec" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7753b787-4aa5-405d-90fb-7a76f6a87491" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7753b787-4aa5-405d-90fb-7a76f6a87491_default" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7753b787-4aa5-405d-90fb-7a76f6a87491" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7753b787-4aa5-405d-90fb-7a76f6a87491_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6a371841-77c6-4da0-bb1d-56e93330b89b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7753b787-4aa5-405d-90fb-7a76f6a87491" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6a371841-77c6-4da0-bb1d-56e93330b89b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_e6789575-cf8b-4f93-a023-2804f459a390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6a371841-77c6-4da0-bb1d-56e93330b89b" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_e6789575-cf8b-4f93-a023-2804f459a390" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>12
<FILENAME>pntg-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6a149289-91af-40b5-8f3e-f8666bbd5c45,g:56c4c52a-4e81-467a-86f6-87d568a87628-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_767d1011-618f-403b-9432-168d7e957565_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid during the period for:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_36a61adf-eb86-4f1f-904f-ee6cf5c8487b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionAxis" xlink:to="lab_us-gaap_AssetAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_9c8d5bc7-febe-492e-9447-05f9aabf8401_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_TotalAcquisitions_c87fa941-d20e-4735-b46a-09dc729ed4c6_terseLabel_en-US" xlink:label="lab_pntg_TotalAcquisitions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquisitions</link:label>
    <link:label id="lab_pntg_TotalAcquisitions_label_en-US" xlink:label="lab_pntg_TotalAcquisitions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Acquisitions</link:label>
    <link:label id="lab_pntg_TotalAcquisitions_documentation_en-US" xlink:label="lab_pntg_TotalAcquisitions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Acquisitions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TotalAcquisitions" xlink:href="pntg-20211231.xsd#pntg_TotalAcquisitions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_TotalAcquisitions" xlink:to="lab_pntg_TotalAcquisitions" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability_a1e124a2-f1d4-4874-b8c8-a6527c17b38a_terseLabel_en-US" xlink:label="lab_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net non-cash adjustment to right-of-use assets and lease liabilities from lease modifications</link:label>
    <link:label id="lab_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability_label_en-US" xlink:label="lab_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment Operating Lease Right-of-Use Asset And Operating Lease Liability</link:label>
    <link:label id="lab_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability_documentation_en-US" xlink:label="lab_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment Operating Lease Right-of-Use Asset And Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability" xlink:href="pntg-20211231.xsd#pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability" xlink:to="lab_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_60237392-b35f-4da7-bd8d-3d36c94e48e5_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense at statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_fef5feb6-0794-4b2a-a4f6-c3cfbe715834_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_efda0f32-cb17-423a-8112-df8af7127a46_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_31bf3864-ffa8-443f-8507-55c4af135bf8_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e3b02c68-324c-4097-ac47-4e840e59f963_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_3d8b8a3b-4e3c-4b6e-bd4e-4203ebc69867_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_e2d521a3-8600-405f-826d-3783aba9d2e5_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_25fdcabf-f545-4b6a-a8bf-abaf1042c92f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income and other comprehensive income attributable to The Pennant Group, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_4cb121de-004b-4c7d-a028-0c4c7c073463_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income/ (loss) attributable to The Pennant Group, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ead3abd4-6dc4-4f8c-aa43-151a12a8e98e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to The Pennant Group, Inc.</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_SummaryOfInsuranceLiabilityTableTextBlock_5ed72a95-0b8e-47ea-a6fb-4b69d42324ec_terseLabel_en-US" xlink:label="lab_pntg_SummaryOfInsuranceLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of insurance liability</link:label>
    <link:label id="lab_pntg_SummaryOfInsuranceLiabilityTableTextBlock_label_en-US" xlink:label="lab_pntg_SummaryOfInsuranceLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Insurance Liability [Table Text Block]</link:label>
    <link:label id="lab_pntg_SummaryOfInsuranceLiabilityTableTextBlock_documentation_en-US" xlink:label="lab_pntg_SummaryOfInsuranceLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Insurance Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SummaryOfInsuranceLiabilityTableTextBlock" xlink:href="pntg-20211231.xsd#pntg_SummaryOfInsuranceLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_SummaryOfInsuranceLiabilityTableTextBlock" xlink:to="lab_pntg_SummaryOfInsuranceLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_9c70a518-b31c-4963-9c77-062980fb1e1a_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_30880971-eca6-478c-ba42-2505ad046af1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued wages and related liabilities</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_MedicaidMember_8b59caad-ffd7-4e7b-9f90-112f3b7badb8_terseLabel_en-US" xlink:label="lab_pntg_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid</link:label>
    <link:label id="lab_pntg_MedicaidMember_label_en-US" xlink:label="lab_pntg_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:label id="lab_pntg_MedicaidMember_documentation_en-US" xlink:label="lab_pntg_MedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicaid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicaidMember" xlink:href="pntg-20211231.xsd#pntg_MedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_MedicaidMember" xlink:to="lab_pntg_MedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_0f9a1706-d5fb-4b60-9680-48fd04c12c7b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_785f6a5e-92d0-47d2-b343-d06f79daf56c_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition related costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_c4555caf-216d-4d12-9656-261b3448c59a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, acquisition costs</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition Related Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionRelatedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_1c806df3-ea06-4d12-a8ce-64fe0ffed849_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization_2ebdcfba-fa54-4554-901a-5788a99aa08b_negatedTerseLabel_en-US" xlink:label="lab_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization_label_en-US" xlink:label="lab_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Depreciation And Amortization</link:label>
    <link:label id="lab_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization_documentation_en-US" xlink:label="lab_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Depreciation And Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:href="pntg-20211231.xsd#pntg_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="lab_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_af8fd19b-2437-43ec-b630-58433f07ba75_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_8514f0fd-e831-4741-b182-fe55492a6e28_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_c8023037-cde3-474f-b908-699b081d3382_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_6561e605-e457-4f3e-930d-8374ca8bf599_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited &amp; Expired (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_a2c130d7-2b5b-41b4-9770-516967d8e9e1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_69401340-5d60-4963-bf7f-598d48b0ea93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_7e7e5cc7-30b0-4849-b5fd-97a6384e8eb1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_a74a02b9-925a-4d28-ae97-cde3aa7ccd19_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMinorityShareholders" xlink:to="lab_us-gaap_ProceedsFromMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_InsuranceProgramAccruedExpensesCurrent_d2f18473-7fb1-45e8-8b9f-26466ec7c35a_terseLabel_en-US" xlink:label="lab_pntg_InsuranceProgramAccruedExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of estimated liability, included in other accrued liabilities</link:label>
    <link:label id="lab_pntg_InsuranceProgramAccruedExpensesCurrent_label_en-US" xlink:label="lab_pntg_InsuranceProgramAccruedExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Program Accrued Expenses, Current</link:label>
    <link:label id="lab_pntg_InsuranceProgramAccruedExpensesCurrent_documentation_en-US" xlink:label="lab_pntg_InsuranceProgramAccruedExpensesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Program Accrued Expenses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InsuranceProgramAccruedExpensesCurrent" xlink:href="pntg-20211231.xsd#pntg_InsuranceProgramAccruedExpensesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_InsuranceProgramAccruedExpensesCurrent" xlink:to="lab_pntg_InsuranceProgramAccruedExpensesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_6d540783-8c9f-4297-90fd-f8e5a681c9e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_b47e2303-f9e6-4434-b441-a32efcfef527_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase (decrease) in cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositLiabilityCurrent_55016b60-49f6-48ed-88b8-86328f257e4f_terseLabel_en-US" xlink:label="lab_us-gaap_DepositLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Resident deposits</link:label>
    <link:label id="lab_us-gaap_DepositLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_DepositLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deposit Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositLiabilityCurrent" xlink:to="lab_us-gaap_DepositLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_1a9f4338-1e08-42b5-8fe1-0fbb69e454ed_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_9bfa619e-58fe-45d2-9a45-c99e427d04cd_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation after spin-off</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_2afc03ca-2be7-4ab6-9859-cfaa3c8d37b0_verboseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expenses from transactions with related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_1e0d6136-9ee2-449e-b4ef-58d60cdb089e_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fees incurred</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_ScrippsHealthMember_851cf871-8e30-416a-bae7-b50b2ae15056_terseLabel_en-US" xlink:label="lab_pntg_ScrippsHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scripps Health</link:label>
    <link:label id="lab_pntg_ScrippsHealthMember_label_en-US" xlink:label="lab_pntg_ScrippsHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scripps Health [Member]</link:label>
    <link:label id="lab_pntg_ScrippsHealthMember_documentation_en-US" xlink:label="lab_pntg_ScrippsHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Scripps Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ScrippsHealthMember" xlink:href="pntg-20211231.xsd#pntg_ScrippsHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_ScrippsHealthMember" xlink:to="lab_pntg_ScrippsHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_PaymentsForProceedsFromPropertyReserveRequirements_ddd55943-d59c-4fb4-a55c-f5a251259f8e_negatedTerseLabel_en-US" xlink:label="lab_pntg_PaymentsForProceedsFromPropertyReserveRequirements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted and other assets</link:label>
    <link:label id="lab_pntg_PaymentsForProceedsFromPropertyReserveRequirements_label_en-US" xlink:label="lab_pntg_PaymentsForProceedsFromPropertyReserveRequirements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Property Reserve Requirements</link:label>
    <link:label id="lab_pntg_PaymentsForProceedsFromPropertyReserveRequirements_documentation_en-US" xlink:label="lab_pntg_PaymentsForProceedsFromPropertyReserveRequirements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For (Proceeds From) Property Reserve Requirements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_PaymentsForProceedsFromPropertyReserveRequirements" xlink:href="pntg-20211231.xsd#pntg_PaymentsForProceedsFromPropertyReserveRequirements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_PaymentsForProceedsFromPropertyReserveRequirements" xlink:to="lab_pntg_PaymentsForProceedsFromPropertyReserveRequirements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_fd09a5b4-a68d-45bd-99a3-af458b4cf839_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_7673c810-d3e7-4f65-aa55-0452247a78f7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d6169f8-30cb-4d76-a07f-539b3d8b27f1_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_NumberOfUnitsInRealEstatePropertyAcquired_637dad26-e35e-4151-8093-dc3f0000b304_terseLabel_en-US" xlink:label="lab_pntg_NumberOfUnitsInRealEstatePropertyAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of units (in units)</link:label>
    <link:label id="lab_pntg_NumberOfUnitsInRealEstatePropertyAcquired_label_en-US" xlink:label="lab_pntg_NumberOfUnitsInRealEstatePropertyAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Units In Real Estate Property Acquired</link:label>
    <link:label id="lab_pntg_NumberOfUnitsInRealEstatePropertyAcquired_documentation_en-US" xlink:label="lab_pntg_NumberOfUnitsInRealEstatePropertyAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Units In Real Estate Property Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfUnitsInRealEstatePropertyAcquired" xlink:href="pntg-20211231.xsd#pntg_NumberOfUnitsInRealEstatePropertyAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_NumberOfUnitsInRealEstatePropertyAcquired" xlink:to="lab_pntg_NumberOfUnitsInRealEstatePropertyAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_837a4b39-f15e-49b2-8e37-9fe97d4ae706_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers, by Reporting Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:to="lab_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_f6460318-b29e-487e-ad1c-88fc1a1b73c8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for deferred financing costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Financing Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfFinancingCosts" xlink:to="lab_us-gaap_PaymentsOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_7a5dde58-c714-4fbd-933c-210615b1e61c_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_b0d5cf6b-d780-4c6e-a210-e347a96a722f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_1fcd1366-9491-43ae-b478-80cc15ef30b6_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets (liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_deb46470-5a40-4d01-8030-5845b4af4b0f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d75349fe-49d0-4b5e-a86e-fcbf924cea9e_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options which are anti-dilutive and not factored into the weighted average common shares amount (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_12bddfb1-c97d-4ef5-9363-7ba13fb69a04_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_GeneralAndProfessionalInsuranceLiability_2c23e543-298b-48f3-a03f-a0d2b13ab010_terseLabel_en-US" xlink:label="lab_pntg_GeneralAndProfessionalInsuranceLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and professional liability</link:label>
    <link:label id="lab_pntg_GeneralAndProfessionalInsuranceLiability_label_en-US" xlink:label="lab_pntg_GeneralAndProfessionalInsuranceLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General And Professional Insurance Liability</link:label>
    <link:label id="lab_pntg_GeneralAndProfessionalInsuranceLiability_documentation_en-US" xlink:label="lab_pntg_GeneralAndProfessionalInsuranceLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General And Professional Insurance Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GeneralAndProfessionalInsuranceLiability" xlink:href="pntg-20211231.xsd#pntg_GeneralAndProfessionalInsuranceLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_GeneralAndProfessionalInsuranceLiability" xlink:to="lab_pntg_GeneralAndProfessionalInsuranceLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_993a7d11-fd87-4864-9687-7dbcbbdec8dc_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination and Asset Acquisition [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:to="lab_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c513736a-be87-42b9-9a31-90826e0cb17c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_855102cb-8376-4817-b4f0-b5168d29587d_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitment fee percentage</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_9c6dffd6-05c5-4ee4-88c0-f93f315989fd_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_67a0320c-9ba9-4dfc-a73f-2972f1d88808_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_UniformProgramIntegrityContractorPeriodOfReview_1c88cc57-c26f-4634-9726-eb56cf63687c_terseLabel_en-US" xlink:label="lab_pntg_UniformProgramIntegrityContractorPeriodOfReview" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of review</link:label>
    <link:label id="lab_pntg_UniformProgramIntegrityContractorPeriodOfReview_label_en-US" xlink:label="lab_pntg_UniformProgramIntegrityContractorPeriodOfReview" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform Program Integrity Contractor, Period Of Review</link:label>
    <link:label id="lab_pntg_UniformProgramIntegrityContractorPeriodOfReview_documentation_en-US" xlink:label="lab_pntg_UniformProgramIntegrityContractorPeriodOfReview" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform Program Integrity Contractor, Period Of Review</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_UniformProgramIntegrityContractorPeriodOfReview" xlink:href="pntg-20211231.xsd#pntg_UniformProgramIntegrityContractorPeriodOfReview"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_UniformProgramIntegrityContractorPeriodOfReview" xlink:to="lab_pntg_UniformProgramIntegrityContractorPeriodOfReview" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_712990e0-4dc1-4431-90da-2b742fce869e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_926e3e05-8646-4a48-9881-17fca1090fdb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_bceb9779-d694-4c42-93ec-cf80ca745d1a_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_8e15f72f-b309-4537-ac8c-d7214b12b343_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_ac6eaf0e-122a-4600-9cea-0a7fad64d25f_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsAxis_28cdd3c6-f696-48e7-9da8-201e7d51283d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsAxis_label_en-US" xlink:label="lab_us-gaap_SubsegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsAxis" xlink:to="lab_us-gaap_SubsegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_d9769b6b-4c66-44da-8932-f2566d26292f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_ddfb0bc4-d69d-4f19-b3c9-1c37444e22af_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible asset impairments</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_4057db96-3add-4489-bb7f-c79e0b975c44_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of options vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_cd4ac77b-d0d5-4ac7-8a1a-aab914018433_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_0833d196-3de2-482c-a55e-823d5e29f73f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled_20da8390-df44-46a5-981b-03cf2249a258_terseLabel_en-US" xlink:label="lab_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating subsidiaries with reviews scheduled</link:label>
    <link:label id="lab_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled_label_en-US" xlink:label="lab_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Operating Subsidiaries With Reviews Scheduled</link:label>
    <link:label id="lab_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled_documentation_en-US" xlink:label="lab_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Operating Subsidiaries With Reviews Scheduled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled" xlink:href="pntg-20211231.xsd#pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled" xlink:to="lab_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_8438eeee-cda1-41bc-b2fa-c353aff427ed_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_a63bf947-e718-42f4-8a64-8ff272e835da_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GOODWILL AND INTANGIBLE ASSETS&#8212;NET</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_f6f1187f-0cb9-44bc-a677-a1e68f6fcff0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue %</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_fa45fcd1-dedd-41c1-8825-be3750ce352f_verboseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk, percent</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_7e889bab-9aab-434f-9d7b-fbf22c0e47ab_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DividendsCash_3edce9b7-2bb0-4357-8d07-356b4d15c235_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Dividend to Parent</link:label>
    <link:label id="lab_us-gaap_DividendsCash_label_en-US" xlink:label="lab_us-gaap_DividendsCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividends, Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DividendsCash" xlink:to="lab_us-gaap_DividendsCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_1732ed13-6fee-4c7f-a0ad-59a67b691dce_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_8e771e3b-f8ce-4221-897d-620a02076c15_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_54b2b841-e69f-4070-89ad-56b9385a5442_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade name</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_236a77c3-e1dd-4f7f-b223-7f741d6f8e00_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings/ (Accumulated Deficit)</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b31cf5d7-a708-470a-9024-5ef11b59998b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_62bb8fb0-c357-4c74-b67c-0b7a5b287614_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right of use asset</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_1050cfc5-caf3-4f8b-bf65-b320240405bc_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_1c58d02a-a171-4fe3-831b-218802ebc18c_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_d45c0aa0-2e8d-400d-a853-2179c0770a6d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_70a548bb-b233-4961-8491-32d02e495a6b_terseLabel_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions</link:label>
    <link:label id="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_label_en-US" xlink:label="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Series of Individually Immaterial Business Acquisitions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:to="lab_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_BusinessCombinationCashPaidInPriorYear_7a33e306-92be-427f-989d-2770c5259197_negatedTerseLabel_en-US" xlink:label="lab_pntg_BusinessCombinationCashPaidInPriorYear" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: cash paid in prior year (held in escrow)</link:label>
    <link:label id="lab_pntg_BusinessCombinationCashPaidInPriorYear_label_en-US" xlink:label="lab_pntg_BusinessCombinationCashPaidInPriorYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Cash Paid In Prior Year</link:label>
    <link:label id="lab_pntg_BusinessCombinationCashPaidInPriorYear_documentation_en-US" xlink:label="lab_pntg_BusinessCombinationCashPaidInPriorYear" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Cash Paid In Prior Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_BusinessCombinationCashPaidInPriorYear" xlink:href="pntg-20211231.xsd#pntg_BusinessCombinationCashPaidInPriorYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_BusinessCombinationCashPaidInPriorYear" xlink:to="lab_pntg_BusinessCombinationCashPaidInPriorYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_f09d4786-0af3-40f3-9785-5bf6e64aeb1d_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_a1196e33-2ac5-4632-bb9f-fa9bea859f30_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_88c78467-5102-4031-9c87-703899f6a85d_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures in accounts payable</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_12ffc880-6fc0-4d7d-92c9-f754575d9481_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets obtained in exchange for new operating lease obligations</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_14a462ea-05b3-468b-ad30-01cc5962dbaa_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets and liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_302d3673-56c6-48ee-88db-8464991b7d1a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_ManagedCareMember_dc2a3bd3-b98e-49bc-8c8d-c550ae1118de_terseLabel_en-US" xlink:label="lab_pntg_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed care</link:label>
    <link:label id="lab_pntg_ManagedCareMember_label_en-US" xlink:label="lab_pntg_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care [Member]</link:label>
    <link:label id="lab_pntg_ManagedCareMember_documentation_en-US" xlink:label="lab_pntg_ManagedCareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Managed Care [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ManagedCareMember" xlink:href="pntg-20211231.xsd#pntg_ManagedCareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_ManagedCareMember" xlink:to="lab_pntg_ManagedCareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_9f953c25-3e56-41ca-8aab-b17f145ba113_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_23704844-78cc-4a89-a55b-9366a38b43a4_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, vesting percent per year</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_9e17b9e7-ef1c-481e-a97d-f9f891fc63d4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock withheld to satisfy tax withholding obligations (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_UniformProgramIntegrityContractorSuspendedPayments_e1294ed8-d0af-4d60-9e6b-58a5c549fbde_terseLabel_en-US" xlink:label="lab_pntg_UniformProgramIntegrityContractorSuspendedPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Suspended payments</link:label>
    <link:label id="lab_pntg_UniformProgramIntegrityContractorSuspendedPayments_label_en-US" xlink:label="lab_pntg_UniformProgramIntegrityContractorSuspendedPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform Program Integrity Contractor, Suspended Payments</link:label>
    <link:label id="lab_pntg_UniformProgramIntegrityContractorSuspendedPayments_documentation_en-US" xlink:label="lab_pntg_UniformProgramIntegrityContractorSuspendedPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform Program Integrity Contractor, Suspended Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_UniformProgramIntegrityContractorSuspendedPayments" xlink:href="pntg-20211231.xsd#pntg_UniformProgramIntegrityContractorSuspendedPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_UniformProgramIntegrityContractorSuspendedPayments" xlink:to="lab_pntg_UniformProgramIntegrityContractorSuspendedPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0cda630e-e725-467c-bbaa-f4033dc9cef9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd6ba72f-e3bc-4705-9342-e30e8d391d4e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent_62878133-5018-414c-80a8-2ec0ca75bedf_terseLabel_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deductible equity compensation</link:label>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent_label_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent_documentation_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Deductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent" xlink:to="lab_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_ac8bbaa4-445a-473b-8ffe-4a3c5a14973f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing availability</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_f1d42d2f-38ac-4bee-8c65-fa13b26a3b8f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_dcc80290-ba37-4498-a229-b60eb3b78e03_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_d2454755-2355-409d-9376-62314d06db6e_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_ab025e6a-c98a-427e-98a2-00bb7bb39940_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent&#8212;cost of services</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_8b41b66e-6f01-4160-b2fb-ab229f752880_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rent&#8212;cost of services</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseExpense" xlink:to="lab_us-gaap_OperatingLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_05fab98e-d8d9-4c5a-a930-57a7fcf174cf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_BusinessAcquisitions2019Member_0778115e-0d77-4b88-bcf0-d0a78e951190_terseLabel_en-US" xlink:label="lab_pntg_BusinessAcquisitions2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business acquisitions 2019</link:label>
    <link:label id="lab_pntg_BusinessAcquisitions2019Member_label_en-US" xlink:label="lab_pntg_BusinessAcquisitions2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions 2019 [Member]</link:label>
    <link:label id="lab_pntg_BusinessAcquisitions2019Member_documentation_en-US" xlink:label="lab_pntg_BusinessAcquisitions2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisitions 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_BusinessAcquisitions2019Member" xlink:href="pntg-20211231.xsd#pntg_BusinessAcquisitions2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_BusinessAcquisitions2019Member" xlink:to="lab_pntg_BusinessAcquisitions2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_d01edfc9-b794-4dc0-a962-5be18b3cfb44_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_064224c1-8152-4c76-8129-4197e7da40a7_terseLabel_en-US" xlink:label="lab_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The coronavirus aid, relief, and economic security act, advance payments received</link:label>
    <link:label id="lab_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_label_en-US" xlink:label="lab_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Coronavirus Aid, Relief, and Economic Security Act, Advance Payments Received</link:label>
    <link:label id="lab_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_documentation_en-US" xlink:label="lab_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Coronavirus Aid, Relief, and Economic Security Act, Advance Payments Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" xlink:href="pntg-20211231.xsd#pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" xlink:to="lab_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_39a60578-ba99-4fa6-a0a1-e3a5b69c22ff_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d549fa8e-e066-4218-8fe3-671a87442a5c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_d8e14eed-4220-455b-b7bd-916eabc6ca6a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Vested Restricted Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_fe5ccfe2-1b2b-4c1f-bb01-c346d177dc2f_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of non-vested restricted stock awards</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_GrantYear2021Member_2c4d2f74-871b-4bcc-8fe0-e72b1d2e3785_terseLabel_en-US" xlink:label="lab_pntg_GrantYear2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_pntg_GrantYear2021Member_label_en-US" xlink:label="lab_pntg_GrantYear2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Year 2021 [Member]</link:label>
    <link:label id="lab_pntg_GrantYear2021Member_documentation_en-US" xlink:label="lab_pntg_GrantYear2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Year 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GrantYear2021Member" xlink:href="pntg-20211231.xsd#pntg_GrantYear2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_GrantYear2021Member" xlink:to="lab_pntg_GrantYear2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_d94706cb-9f6b-4368-9a7c-b5c98697e8ac_negatedLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares of common stock withheld to satisfy tax withholding obligations</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_f99fe62b-9abb-4258-a7d0-8b53c402f1c5_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_1112f0b8-2795-426f-9cbc-939a4cee4a38_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Self Insurance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EscrowDeposit_8c4014e6-2043-4d78-906e-d81d720b568b_terseLabel_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow deposits</link:label>
    <link:label id="lab_us-gaap_EscrowDeposit_label_en-US" xlink:label="lab_us-gaap_EscrowDeposit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow Deposit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EscrowDeposit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EscrowDeposit" xlink:to="lab_us-gaap_EscrowDeposit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_01f793e6-106b-4b5e-a366-5dadef825575_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business combination, purchase price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_582466b3-52fd-4257-a43a-b20635ca9818_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_ReclassificationOfInvestedEquity_9bc77bee-b27b-4717-9197-580ac6ef531f_terseLabel_en-US" xlink:label="lab_pntg_ReclassificationOfInvestedEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification of Invested Equity</link:label>
    <link:label id="lab_pntg_ReclassificationOfInvestedEquity_label_en-US" xlink:label="lab_pntg_ReclassificationOfInvestedEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Of Invested Equity</link:label>
    <link:label id="lab_pntg_ReclassificationOfInvestedEquity_documentation_en-US" xlink:label="lab_pntg_ReclassificationOfInvestedEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification Of Invested Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ReclassificationOfInvestedEquity" xlink:href="pntg-20211231.xsd#pntg_ReclassificationOfInvestedEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_ReclassificationOfInvestedEquity" xlink:to="lab_pntg_ReclassificationOfInvestedEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_c414200e-9630-4da9-90e3-25f13df9640c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_17ca3f28-7a87-48d1-a942-4f90e70b9e6d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_MedicareAndMedicaidMember_7273671b-8c9a-4618-ab90-da31b75bc35e_verboseLabel_en-US" xlink:label="lab_pntg_MedicareAndMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare And Medicaid</link:label>
    <link:label id="lab_pntg_MedicareAndMedicaidMember_label_en-US" xlink:label="lab_pntg_MedicareAndMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare And Medicaid [Member]</link:label>
    <link:label id="lab_pntg_MedicareAndMedicaidMember_documentation_en-US" xlink:label="lab_pntg_MedicareAndMedicaidMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare And Medicaid [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareAndMedicaidMember" xlink:href="pntg-20211231.xsd#pntg_MedicareAndMedicaidMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_MedicareAndMedicaidMember" xlink:to="lab_pntg_MedicareAndMedicaidMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_deb95a59-c7f3-447d-8d62-03c1d559a1cb_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_a54dd52e-bab2-4b39-9fd8-3ff9ab96a343_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds_5f9a8eb2-2bc5-4773-b042-931327188260_terseLabel_en-US" xlink:label="lab_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of the coronavirus aid, relief, and economic security act</link:label>
    <link:label id="lab_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds_label_en-US" xlink:label="lab_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of The Coronavirus Aid, Relief, and Economic Security Act Funds</link:label>
    <link:label id="lab_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds_documentation_en-US" xlink:label="lab_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment Of The Coronavirus Aid, Relief, and Economic Security Act Funds</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds" xlink:href="pntg-20211231.xsd#pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds" xlink:to="lab_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_a105019e-370f-4a35-befb-1851229371ac_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_824fb706-3176-4041-96c4-b0fd07679ca4_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_SeniorLivingServicesSegmentMember_0be71233-8db8-4d79-9aca-f2a67dfa0f36_terseLabel_en-US" xlink:label="lab_pntg_SeniorLivingServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Living Services</link:label>
    <link:label id="lab_pntg_SeniorLivingServicesSegmentMember_label_en-US" xlink:label="lab_pntg_SeniorLivingServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Living Services Segment [Member]</link:label>
    <link:label id="lab_pntg_SeniorLivingServicesSegmentMember_documentation_en-US" xlink:label="lab_pntg_SeniorLivingServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Living Services Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_SeniorLivingServicesSegmentMember" xlink:to="lab_pntg_SeniorLivingServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_StartUpActivitiesCosts_8f84bb21-4ed2-41f8-a013-e34da3968128_terseLabel_en-US" xlink:label="lab_pntg_StartUpActivitiesCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Costs at start-up operations</link:label>
    <link:label id="lab_pntg_StartUpActivitiesCosts_label_en-US" xlink:label="lab_pntg_StartUpActivitiesCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Start-Up Activities, Costs</link:label>
    <link:label id="lab_pntg_StartUpActivitiesCosts_documentation_en-US" xlink:label="lab_pntg_StartUpActivitiesCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Start-Up Activities, Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_StartUpActivitiesCosts" xlink:href="pntg-20211231.xsd#pntg_StartUpActivitiesCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_StartUpActivitiesCosts" xlink:to="lab_pntg_StartUpActivitiesCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_c7ac454d-8b16-409d-90b0-59c442ac2cbe_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_08dff02f-0fce-4e6a-9140-041564e4aebe_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_4dd1baf5-62e5-41ac-ab1a-b09a26d7dc14_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_35683730-5959-499c-9f79-42886716b656_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_8f4de92f-60c1-4065-8d56-40c5d7253b6d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Under Adoption of ASC 842 [Abstract]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_9fd4738d-d1e6-461a-b3b2-dc0bce1f8f63_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_01ad2ff1-3d31-429d-9cb3-94525d212f95_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_0da8d022-b6c1-4440-aa3e-1c7dbdea9e61_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_f19b3e24-abf8-4c2c-abf5-6a9d48ce74ad_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_444c27cf-ca9e-4e81-9c5c-305b369b1014_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_label_en-US" xlink:label="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:to="lab_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_1a6b4193-6c36-4b43-b180-5098540e6e5c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_8a49da03-5142-418e-bf90-563e2dd76880_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_ad6d0558-c405-4358-a131-ab2fdc0efb84_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7c80682f-3efe-4510-997c-62af418e96e3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber_7d1bb963-4220-46fa-9da5-6f378477e1b6_terseLabel_en-US" xlink:label="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options vested (in shares)</link:label>
    <link:label id="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber_label_en-US" xlink:label="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding, Number</link:label>
    <link:label id="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber_documentation_en-US" xlink:label="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber" xlink:href="pntg-20211231.xsd#pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber" xlink:to="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0ce9119a-0a9d-4110-9b8e-044f9d313e01_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_59db060e-3f04-47ef-bea3-2d5fc9ce276c_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_8fb40741-4e48-4407-9bc6-bbe51f144e36_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_MedicareMember_ed783e1d-fecb-4d4a-8ed5-a6df49a0fb6f_terseLabel_en-US" xlink:label="lab_pntg_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare</link:label>
    <link:label id="lab_pntg_MedicareMember_label_en-US" xlink:label="lab_pntg_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:label id="lab_pntg_MedicareMember_documentation_en-US" xlink:label="lab_pntg_MedicareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareMember" xlink:href="pntg-20211231.xsd#pntg_MedicareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_MedicareMember" xlink:to="lab_pntg_MedicareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_518c2dac-a120-41c4-9b36-8a3417b93ae4_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5bd25eb0-8829-44b0-b7b9-1e2c80e4c0a1_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_0b937f37-0e17-4685-bae9-de84336c71c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus_af32c547-ba4c-4a9b-adfc-1cbbb337a8d8_terseLabel_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible accrued bonus</link:label>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus_label_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Accrued Bonus</link:label>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus_documentation_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Accrued Bonus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus" xlink:to="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_DistributionToFromParent_2beb9fc0-7b8d-480b-9b4d-5f6ad9e2dd81_terseLabel_en-US" xlink:label="lab_pntg_DistributionToFromParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net investment from parent</link:label>
    <link:label id="lab_pntg_DistributionToFromParent_label_en-US" xlink:label="lab_pntg_DistributionToFromParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution (To) From Parent</link:label>
    <link:label id="lab_pntg_DistributionToFromParent_documentation_en-US" xlink:label="lab_pntg_DistributionToFromParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Distribution (To) From Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DistributionToFromParent" xlink:href="pntg-20211231.xsd#pntg_DistributionToFromParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_DistributionToFromParent" xlink:to="lab_pntg_DistributionToFromParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_61aa0cfb-6c6a-4cf6-86c9-159d50f0f533_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of basic and diluted net income per share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_d6057dbf-1e61-479c-821c-02b05bd831d1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_a504f182-132e-4073-b25c-b18073d3a79f_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMPUTATION OF NET INCOME PER COMMON SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_c2137e51-76fb-4bb7-a16d-fedb2e1e5504_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_5d65fc82-11c2-46a4-a7f6-9da393132c04_terseLabel_en-US" xlink:label="lab_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Adjusted EBITDAR from Operations</link:label>
    <link:label id="lab_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_ebdc3f1b-0977-48b8-8689-d8102dd19cfe_verboseLabel_en-US" xlink:label="lab_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Adjusted EBITDAR from Operations</link:label>
    <link:label id="lab_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_label_en-US" xlink:label="lab_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) From Continuing Operations Before Interest, Taxes, Depreciation And Amortization, Rent Costs, Acquisition Costs And Stock-based Compensation</link:label>
    <link:label id="lab_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_documentation_en-US" xlink:label="lab_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) From Continuing Operations Before Interest, Taxes, Depreciation And Amortization, Rent Costs, Acquisition Costs And Stock-based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" xlink:href="pntg-20211231.xsd#pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" xlink:to="lab_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_HomeHealthAndHospiceServicesSegmentMember_5f0b2217-805b-489d-9df0-091871308212_terseLabel_en-US" xlink:label="lab_pntg_HomeHealthAndHospiceServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Health and Hospice Services</link:label>
    <link:label id="lab_pntg_HomeHealthAndHospiceServicesSegmentMember_label_en-US" xlink:label="lab_pntg_HomeHealthAndHospiceServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Health And Hospice Services Segment [Member]</link:label>
    <link:label id="lab_pntg_HomeHealthAndHospiceServicesSegmentMember_documentation_en-US" xlink:label="lab_pntg_HomeHealthAndHospiceServicesSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Health And Hospice Services Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_HomeHealthAndHospiceServicesSegmentMember" xlink:to="lab_pntg_HomeHealthAndHospiceServicesSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_626b5823-c5a1-4eda-959a-93adf854073d_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State taxes</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsStateTaxes_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, State Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsStateTaxes" xlink:to="lab_us-gaap_DeferredTaxAssetsStateTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6b6fea44-a104-4b9e-b9e7-3e342b057e58_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from the exercise of stock options / issuance of other awards after spin-off</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_f61f8387-4968-4bf6-97c4-95968e4e1858_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_AssetAcquisitions2021Member_db80a551-a532-4d68-aa0c-d2e3f7ddef11_terseLabel_en-US" xlink:label="lab_pntg_AssetAcquisitions2021Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisitions 2021</link:label>
    <link:label id="lab_pntg_AssetAcquisitions2021Member_label_en-US" xlink:label="lab_pntg_AssetAcquisitions2021Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisitions 2021 [Member]</link:label>
    <link:label id="lab_pntg_AssetAcquisitions2021Member_documentation_en-US" xlink:label="lab_pntg_AssetAcquisitions2021Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisitions 2021</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AssetAcquisitions2021Member" xlink:href="pntg-20211231.xsd#pntg_AssetAcquisitions2021Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_AssetAcquisitions2021Member" xlink:to="lab_pntg_AssetAcquisitions2021Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AffiliatedEntityMember_054ee27f-c248-4fc1-a099-03a2783cc04f_terseLabel_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related party</link:label>
    <link:label id="lab_srt_AffiliatedEntityMember_label_en-US" xlink:label="lab_srt_AffiliatedEntityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliated Entity [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AffiliatedEntityMember" xlink:to="lab_srt_AffiliatedEntityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6a0e80ad-160f-4047-b7bd-8c3421d72ce8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_0323dba1-42cd-4135-8a01-25d9ad1afa83_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_913a47ce-7531-4ca6-a567-6fb5cca69c38_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_981f8c85-e4d5-4e6b-af7d-1e153fc0dbd5_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_4a4cf67f-701d-448e-9f71-331d4d46e326_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible meals and entertainment</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_c7784063-288e-4051-a99c-595da38e8a53_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at January 1</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_efd89a37-428f-40fb-892c-ffd8e9d9f798_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at December 31</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_NonCapitalizableRelatedToTheBusinessCombinations_bfb46486-f9fb-4a21-b66d-68fe4fd6d344_terseLabel_en-US" xlink:label="lab_pntg_NonCapitalizableRelatedToTheBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-capitalizable</link:label>
    <link:label id="lab_pntg_NonCapitalizableRelatedToTheBusinessCombinations_label_en-US" xlink:label="lab_pntg_NonCapitalizableRelatedToTheBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-capitalizable Related to the Business Combinations</link:label>
    <link:label id="lab_pntg_NonCapitalizableRelatedToTheBusinessCombinations_documentation_en-US" xlink:label="lab_pntg_NonCapitalizableRelatedToTheBusinessCombinations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-capitalizable Related to the Business Combinations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NonCapitalizableRelatedToTheBusinessCombinations" xlink:href="pntg-20211231.xsd#pntg_NonCapitalizableRelatedToTheBusinessCombinations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_NonCapitalizableRelatedToTheBusinessCombinations" xlink:to="lab_pntg_NonCapitalizableRelatedToTheBusinessCombinations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_eba77918-25de-42ce-83a7-078935c0c91d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_99ea54e6-df25-4ffa-91ae-5f1eb67c34bd_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_be8ae686-5319-49f3-a456-e38244429260_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_94ddf819-00a1-45b3-8947-ea8cc8c86352_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_70f89bfc-9560-40c7-8de8-00b2bdad28c5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_a264497c-e5c8-45cf-be7b-a735f32489d7_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of noncontrolling interests, net of tax</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Sale of Parent Equity Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_44c43257-aaf3-4e5a-9316-f1ffffe95315_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_22117f30-c88e-458a-82b6-9dd84c2d0ccb_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_AuditInformationAbstract_label_en-US" xlink:label="lab_pntg_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_pntg_AuditInformationAbstract_documentation_en-US" xlink:label="lab_pntg_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AuditInformationAbstract" xlink:href="pntg-20211231.xsd#pntg_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_AuditInformationAbstract" xlink:to="lab_pntg_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_InsuranceProgramAccruedExpenses_cdb03980-30fd-47a3-8133-d8f0f82488fd_totalLabel_en-US" xlink:label="lab_pntg_InsuranceProgramAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total estimated liability</link:label>
    <link:label id="lab_pntg_InsuranceProgramAccruedExpenses_label_en-US" xlink:label="lab_pntg_InsuranceProgramAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Program Accrued Expenses</link:label>
    <link:label id="lab_pntg_InsuranceProgramAccruedExpenses_documentation_en-US" xlink:label="lab_pntg_InsuranceProgramAccruedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Program Accrued Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InsuranceProgramAccruedExpenses" xlink:href="pntg-20211231.xsd#pntg_InsuranceProgramAccruedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_InsuranceProgramAccruedExpenses" xlink:to="lab_pntg_InsuranceProgramAccruedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_9317d24e-8984-48ee-bdec-8a2e10c0adad_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Common Stock after spin-off</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_2882a56b-b823-4ab8-98a5-c75a695fd751_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards, valuation allowance</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:to="lab_us-gaap_OperatingLossCarryforwardsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0d1a17e2-fa71-4512-8582-3684c166f7a3_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease obligations</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_cef69801-34e2-4382-9ff7-f701b16390fd_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_a693e2de-6da1-4a74-9ea2-a6ab6cdb85c7_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_c13d00fc-a89a-443c-89dd-35aab4de77a0_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_ee919d3a-d703-4b59-bb61-6a717be64a2f_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_1671ca55-eca3-4075-85ce-ebb04bac0e9f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes on continuing operations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_667530d4-488a-4d30-be10-5cf69cc78d80_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_4c9b3b11-ff8c-40da-9f39-acba8fdfe0f8_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPTIONS AND AWARDS</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_f6463986-36bd-4cb5-848f-2a490cf24159_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: noncontrolling interest and additional paid in capital</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:to="lab_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_3ef08b0b-ccd5-403b-b9f2-8c0c0694d318_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_d8f34b62-3e95-4fa2-95b5-9af2ebf5c6f3_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expense</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_95234523-27e6-492e-b856-f40a4345af25_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock after spin-off (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_396fbc89-1004-4ed5-ba1a-25f61d4acc3a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_e5649d38-2c8e-4b6d-a327-ddb8c3c52ea5_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3bf2a611-094f-4ae0-859a-8eaff0cdb796_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_b787bdca-e57d-4898-9692-dba6c2a910a1_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of credit outstanding</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_6ed91918-2f85-455a-a192-e34648bad9c3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_06502a20-73b9-49aa-b7ff-24f9e6523840_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.001 par value; 100,000 shares authorized; 28,826 and 28,499 shares issued and outstanding at December&#160;31, 2021, respectively, and 28,696 and 28,243 shares issued and outstanding at December 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_b5caaa44-8f57-40b5-bd3b-8e346083295c_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_AssetAcquisitions2019Member_1eb27762-a932-42d6-986c-518c548a1b08_terseLabel_en-US" xlink:label="lab_pntg_AssetAcquisitions2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset acquisitions 2019</link:label>
    <link:label id="lab_pntg_AssetAcquisitions2019Member_label_en-US" xlink:label="lab_pntg_AssetAcquisitions2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisitions 2019 [Member]</link:label>
    <link:label id="lab_pntg_AssetAcquisitions2019Member_documentation_en-US" xlink:label="lab_pntg_AssetAcquisitions2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisitions 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AssetAcquisitions2019Member" xlink:href="pntg-20211231.xsd#pntg_AssetAcquisitions2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_AssetAcquisitions2019Member" xlink:to="lab_pntg_AssetAcquisitions2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_56c81711-f850-4311-acdf-09a311b82e35_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested options and stock awards, cost net yet recognized, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_64bb201e-7012-48fa-82ff-c0d5af9fe865_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_304901bb-33b5-4d14-906f-901799ad2363_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_1a55f1f6-9a78-4b0f-bb55-106b837a07f0_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_7c144116-047d-4003-9c35-ff0b78cd43a3_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0723c0f2-f4c8-408b-b411-19e7a963ba74_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_bba724ed-9367-4bdc-96f9-a72337606114_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_AffiliatesOfEnsignMember_153258b6-4090-47d0-b737-43827976a31f_terseLabel_en-US" xlink:label="lab_pntg_AffiliatesOfEnsignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliates Of Ensign</link:label>
    <link:label id="lab_pntg_AffiliatesOfEnsignMember_label_en-US" xlink:label="lab_pntg_AffiliatesOfEnsignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliates Of Ensign [Member]</link:label>
    <link:label id="lab_pntg_AffiliatesOfEnsignMember_documentation_en-US" xlink:label="lab_pntg_AffiliatesOfEnsignMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Affiliates Of Ensign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AffiliatesOfEnsignMember" xlink:href="pntg-20211231.xsd#pntg_AffiliatesOfEnsignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_AffiliatesOfEnsignMember" xlink:to="lab_pntg_AffiliatesOfEnsignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_967bad08-6a1b-4598-9d51-7e3d3fd398e0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_f57f7887-ada8-4578-ad31-e6c3dcb7358a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_07ca42a7-1d1b-498f-b5d0-f5567be9d377_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_eeb19662-949d-4cdb-8313-fa7d76de5382_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ee5e7099-9487-493e-8d76-ff0562d9f5bf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_fbcef8a5-aa3e-4425-a7fb-a0ecd3a0df0b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACQUISITIONS</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_888794da-90fd-4a1e-aea4-3704e6cc46d1_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock_7523273a-714e-4db8-be1d-630d11b5b866_terseLabel_en-US" xlink:label="lab_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of total combined adjusted EBITDAR from operations for our reportable segments to combined income from operations</link:label>
    <link:label id="lab_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock_label_en-US" xlink:label="lab_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Adjusted EBITDAR to Income from Operations [Table Text Block]</link:label>
    <link:label id="lab_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock_documentation_en-US" xlink:label="lab_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Adjusted EBITDAR to Income from Operations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock" xlink:href="pntg-20211231.xsd#pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock" xlink:to="lab_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_3eefaa3b-bb85-4e6f-ac1f-ec4930d2f5d6_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_845b00b4-45f6-4e5e-a419-9e9ce9075e3b_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate, Type of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:to="lab_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_1f4e3306-1e49-4318-a009-d46fd7087712_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options granted fair value assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_d7d5e98f-12b5-4b73-9933-873618d77d6d_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest attributable to subsidiary equity plan</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Subsidiary Equity Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_1a30b983-961a-48a9-abee-4dedc4b95e4d_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_a6dda378-e736-453c-ac6a-04215271fdcc_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillLineItems_c71ce75b-f69c-4d2d-a640-7c4d405f26ba_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:label id="lab_us-gaap_GoodwillLineItems_label_en-US" xlink:label="lab_us-gaap_GoodwillLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillLineItems" xlink:to="lab_us-gaap_GoodwillLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpenses_a6f2ed71-34f6-4aaa-ab9a-8e78c67d9448_totalLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total expenses</link:label>
    <link:label id="lab_us-gaap_CostsAndExpenses_label_en-US" xlink:label="lab_us-gaap_CostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpenses" xlink:to="lab_us-gaap_CostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_d71ac601-1f8a-466e-abea-8d2ade0ccf2c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_DeferredTaxLiabilitiesStateTaxes_85f9363d-f5b5-4d5c-b29c-5e8c39ff7a86_negatedTerseLabel_en-US" xlink:label="lab_pntg_DeferredTaxLiabilitiesStateTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State taxes</link:label>
    <link:label id="lab_pntg_DeferredTaxLiabilitiesStateTaxes_label_en-US" xlink:label="lab_pntg_DeferredTaxLiabilitiesStateTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, State Taxes</link:label>
    <link:label id="lab_pntg_DeferredTaxLiabilitiesStateTaxes_documentation_en-US" xlink:label="lab_pntg_DeferredTaxLiabilitiesStateTaxes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, State Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DeferredTaxLiabilitiesStateTaxes" xlink:href="pntg-20211231.xsd#pntg_DeferredTaxLiabilitiesStateTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_DeferredTaxLiabilitiesStateTaxes" xlink:to="lab_pntg_DeferredTaxLiabilitiesStateTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_9ab4e245-9322-455d-8708-d168366225b8_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_3d4102c9-6280-424f-8e53-e5591a61638b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_fb6fd43a-96ef-4daf-8952-8301c2e0c5dd_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview_22fa6dd7-2ee6-4ef2-be72-d9af70247332_terseLabel_en-US" xlink:label="lab_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of patient records under review</link:label>
    <link:label id="lab_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview_label_en-US" xlink:label="lab_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform Program Integrity Contractor, Number Of Patient Records Under Review</link:label>
    <link:label id="lab_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview_documentation_en-US" xlink:label="lab_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Uniform Program Integrity Contractor, Number Of Patient Records Under Review</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview" xlink:href="pntg-20211231.xsd#pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview" xlink:to="lab_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0f2f45af-da9c-4494-80aa-189718ef5c34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: present value adjustments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_8a177dc6-ff57-41d4-b527-d19a9eab2c8e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_71dc4eaa-3d8c-4e9a-a7a6-2c6c7fe8cb70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_3f13291f-1613-4256-8c64-d19f2c8e4abd_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_e1bb48f3-7df6-4fcf-8544-f215a0cad96f_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures_61c022d5-805b-494d-85c5-330bb314a38a_terseLabel_en-US" xlink:label="lab_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment, furniture, and fixtures</link:label>
    <link:label id="lab_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures_label_en-US" xlink:label="lab_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment, Furniture and Fixtures</link:label>
    <link:label id="lab_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures_documentation_en-US" xlink:label="lab_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment, Furniture and Fixtures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures" xlink:href="pntg-20211231.xsd#pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures" xlink:to="lab_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_InvestedCapitalPolicyTextBlock_692dcc5d-880a-4b05-9322-4159fc0e0944_terseLabel_en-US" xlink:label="lab_pntg_InvestedCapitalPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invested Capital</link:label>
    <link:label id="lab_pntg_InvestedCapitalPolicyTextBlock_label_en-US" xlink:label="lab_pntg_InvestedCapitalPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invested Capital [Policy Text Block]</link:label>
    <link:label id="lab_pntg_InvestedCapitalPolicyTextBlock_documentation_en-US" xlink:label="lab_pntg_InvestedCapitalPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Invested Capital [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InvestedCapitalPolicyTextBlock" xlink:href="pntg-20211231.xsd#pntg_InvestedCapitalPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_InvestedCapitalPolicyTextBlock" xlink:to="lab_pntg_InvestedCapitalPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_af14cbbb-0c6b-4168-b608-faa8be0952bd_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_AcquisitionRelatedCostsNotCapitalized_414966a9-b751-4790-8c40-02630390e868_terseLabel_en-US" xlink:label="lab_pntg_AcquisitionRelatedCostsNotCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction services costs</link:label>
    <link:label id="lab_pntg_AcquisitionRelatedCostsNotCapitalized_label_en-US" xlink:label="lab_pntg_AcquisitionRelatedCostsNotCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-Related Costs, Not Capitalized</link:label>
    <link:label id="lab_pntg_AcquisitionRelatedCostsNotCapitalized_documentation_en-US" xlink:label="lab_pntg_AcquisitionRelatedCostsNotCapitalized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition-Related Costs, Not Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AcquisitionRelatedCostsNotCapitalized" xlink:href="pntg-20211231.xsd#pntg_AcquisitionRelatedCostsNotCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_AcquisitionRelatedCostsNotCapitalized" xlink:to="lab_pntg_AcquisitionRelatedCostsNotCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_OperatingLeaseRentExpenseMember_e4f3f345-63f0-4995-9d26-3503d8e513c1_terseLabel_en-US" xlink:label="lab_pntg_OperatingLeaseRentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, rent expense</link:label>
    <link:label id="lab_pntg_OperatingLeaseRentExpenseMember_label_en-US" xlink:label="lab_pntg_OperatingLeaseRentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Rent Expense [Member]</link:label>
    <link:label id="lab_pntg_OperatingLeaseRentExpenseMember_documentation_en-US" xlink:label="lab_pntg_OperatingLeaseRentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Rent Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_OperatingLeaseRentExpenseMember" xlink:href="pntg-20211231.xsd#pntg_OperatingLeaseRentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_OperatingLeaseRentExpenseMember" xlink:to="lab_pntg_OperatingLeaseRentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfDividends_49b5541f-be12-498b-b4db-2bf3e8d2a574_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash distribution to parent in connection with Spin-Off</link:label>
    <link:label id="lab_us-gaap_PaymentsOfDividends_label_en-US" xlink:label="lab_us-gaap_PaymentsOfDividends" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Dividends</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfDividends" xlink:to="lab_us-gaap_PaymentsOfDividends" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_HomeCareAgenciesMember_6d2a272e-0ae8-4245-bef5-d3ea7a784fe1_terseLabel_en-US" xlink:label="lab_pntg_HomeCareAgenciesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Care Agencies</link:label>
    <link:label id="lab_pntg_HomeCareAgenciesMember_label_en-US" xlink:label="lab_pntg_HomeCareAgenciesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Care Agencies [Member]</link:label>
    <link:label id="lab_pntg_HomeCareAgenciesMember_documentation_en-US" xlink:label="lab_pntg_HomeCareAgenciesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Care Agencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeCareAgenciesMember" xlink:href="pntg-20211231.xsd#pntg_HomeCareAgenciesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_HomeCareAgenciesMember" xlink:to="lab_pntg_HomeCareAgenciesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_98a1abd2-6f6b-4925-9ddd-2dea37f93290_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_f99dc2f9-4cb3-4121-bce4-8d9f972a9c04_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_988ff449-f808-4249-8cec-86a377f0d0e3_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquire interest in joint venture</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:to="lab_us-gaap_PaymentsToAcquireInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_01c18eb9-dc7f-42eb-b8db-c7f00cbdbcd3_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_f142f939-3779-4c20-bd22-81798051d5f5_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity:</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_e2bd9636-a369-4242-a3e2-c025a40e916b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_5538756c-d6e8-4cd6-84e5-8aa1c057a970_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash paid for acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_09968516-c8c6-41bd-bc01-23860c29d540_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_a404422f-5427-415c-91c8-be0d90dd97eb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_HomeHealthSubsegmentMember_1100e118-86b8-49db-b476-94a0d087654e_terseLabel_en-US" xlink:label="lab_pntg_HomeHealthSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Health Services</link:label>
    <link:label id="lab_pntg_HomeHealthSubsegmentMember_label_en-US" xlink:label="lab_pntg_HomeHealthSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Health Subsegment [Member]</link:label>
    <link:label id="lab_pntg_HomeHealthSubsegmentMember_documentation_en-US" xlink:label="lab_pntg_HomeHealthSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Health Subsegment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthSubsegmentMember" xlink:href="pntg-20211231.xsd#pntg_HomeHealthSubsegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_HomeHealthSubsegmentMember" xlink:to="lab_pntg_HomeHealthSubsegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_07184dd0-47f7-417c-87de-ecb0b5884168_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BUSINESS SEGMENTS</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_f9443b15-11c1-4eb9-a904-6754149c2352_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share repurchase related to subsidiary equity plan</link:label>
    <link:label id="lab_us-gaap_MinorityInterestDecreaseFromRedemptions_label_en-US" xlink:label="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:to="lab_us-gaap_MinorityInterestDecreaseFromRedemptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_7fdc5f0a-4e27-4b06-8b3f-be8fcc8c8bf8_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_46d6f502-f20b-440c-9af3-35b169016075_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_287d24bc-ea74-40a9-b9b5-cfbd886a2bb7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities&#8212;current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_c0a27f38-e58c-4589-9cae-03a500f69226_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: current lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d17994db-5a42-4d47-aa5b-38c5ba92221a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_0ffddca9-d4a9-4a2b-9425-fa567b44c6fd_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_d8eaafc3-2cee-43ea-8d7b-1d2670b9a54f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_784e1c13-1a7e-4179-a3ea-ae87d88d4955_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_bb1d8706-5dd8-4d46-aa3f-c27e0b29e87f_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_d758df74-d123-423e-a545-7a6ffc38837b_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_3549ec44-d671-46cb-b3ce-3a965ea1e674_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_3315da02-ef55-40d6-af83-febaba555265_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amounts of related party transaction</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Amounts of Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:to="lab_us-gaap_RelatedPartyTransactionAmountsOfTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_1215245c-d4ac-4e46-b9b6-625f55fe6d54_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_NumberOfRealEstatePropertiesUnderLease_d141c63d-6bda-4d83-bf04-aa1e3a05d005_terseLabel_en-US" xlink:label="lab_pntg_NumberOfRealEstatePropertiesUnderLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties under lease</link:label>
    <link:label id="lab_pntg_NumberOfRealEstatePropertiesUnderLease_label_en-US" xlink:label="lab_pntg_NumberOfRealEstatePropertiesUnderLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Real Estate Properties Under Lease</link:label>
    <link:label id="lab_pntg_NumberOfRealEstatePropertiesUnderLease_documentation_en-US" xlink:label="lab_pntg_NumberOfRealEstatePropertiesUnderLease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Real Estate Properties Under Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfRealEstatePropertiesUnderLease" xlink:href="pntg-20211231.xsd#pntg_NumberOfRealEstatePropertiesUnderLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_NumberOfRealEstatePropertiesUnderLease" xlink:to="lab_pntg_NumberOfRealEstatePropertiesUnderLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_82073de7-9c3c-418f-b95d-b929fe280470_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OfficeBuildingMember_cf95d807-6fe9-4701-88e5-158042efeacd_terseLabel_en-US" xlink:label="lab_srt_OfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office</link:label>
    <link:label id="lab_srt_OfficeBuildingMember_label_en-US" xlink:label="lab_srt_OfficeBuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficeBuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OfficeBuildingMember" xlink:to="lab_srt_OfficeBuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_PaymentsForDepositsOnAcquisition_d97582db-7b32-4dd6-b54d-acfca1de9ca4_negatedTerseLabel_en-US" xlink:label="lab_pntg_PaymentsForDepositsOnAcquisition" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Escrow deposits</link:label>
    <link:label id="lab_pntg_PaymentsForDepositsOnAcquisition_label_en-US" xlink:label="lab_pntg_PaymentsForDepositsOnAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Deposits On Acquisition</link:label>
    <link:label id="lab_pntg_PaymentsForDepositsOnAcquisition_documentation_en-US" xlink:label="lab_pntg_PaymentsForDepositsOnAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments For Deposits On Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_PaymentsForDepositsOnAcquisition" xlink:href="pntg-20211231.xsd#pntg_PaymentsForDepositsOnAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_PaymentsForDepositsOnAcquisition" xlink:to="lab_pntg_PaymentsForDepositsOnAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_89e71bad-cd72-4ff1-b449-480f70c7697a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_5bfcb13e-db73-44c2-975c-5876e1f640c6_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_3756d580-ffb6-4574-92ec-6d1141be6331_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other (expense) income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_5ab96362-81d6-48eb-a97f-514537ca9def_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim_7a857ac3-d4b5-45f4-8f56-d8ad2ad235ee_terseLabel_en-US" xlink:label="lab_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and professional liability, retention limit</link:label>
    <link:label id="lab_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim_label_en-US" xlink:label="lab_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General And Professional Liability Insurance, Retention Limit, Per Claim</link:label>
    <link:label id="lab_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim_documentation_en-US" xlink:label="lab_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General And Professional Liability Insurance, Retention Limit, Per Claim</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim" xlink:href="pntg-20211231.xsd#pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim" xlink:to="lab_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_a447b2e7-7aed-4fb3-a0bb-ae1c568c6b34_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_AdditionalPaidInCapitalEffectOfIncomeTax_82b8018d-bdc4-4988-b702-f0ccb497cd4f_terseLabel_en-US" xlink:label="lab_pntg_AdditionalPaidInCapitalEffectOfIncomeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax effect</link:label>
    <link:label id="lab_pntg_AdditionalPaidInCapitalEffectOfIncomeTax_label_en-US" xlink:label="lab_pntg_AdditionalPaidInCapitalEffectOfIncomeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Effect of Income Tax</link:label>
    <link:label id="lab_pntg_AdditionalPaidInCapitalEffectOfIncomeTax_documentation_en-US" xlink:label="lab_pntg_AdditionalPaidInCapitalEffectOfIncomeTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital, Effect of Income Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AdditionalPaidInCapitalEffectOfIncomeTax" xlink:href="pntg-20211231.xsd#pntg_AdditionalPaidInCapitalEffectOfIncomeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_AdditionalPaidInCapitalEffectOfIncomeTax" xlink:to="lab_pntg_AdditionalPaidInCapitalEffectOfIncomeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_f6678e62-72ae-4335-96b1-af170c1082fa_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OTHER ACCRUED LIABILITIES</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_OtherLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_ad7d6fe0-76c9-47e6-ab5d-8e70483e5ed2_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3cdda03d-b49f-4ac2-954b-9df37d64e9cf_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_HospiceJoinVentureMember_44de40fb-f381-4d9b-a468-f9f0bba8a3da_terseLabel_en-US" xlink:label="lab_pntg_HospiceJoinVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospice Join Venture</link:label>
    <link:label id="lab_pntg_HospiceJoinVentureMember_label_en-US" xlink:label="lab_pntg_HospiceJoinVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospice Join Venture [Member]</link:label>
    <link:label id="lab_pntg_HospiceJoinVentureMember_documentation_en-US" xlink:label="lab_pntg_HospiceJoinVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospice Join Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HospiceJoinVentureMember" xlink:href="pntg-20211231.xsd#pntg_HospiceJoinVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_HospiceJoinVentureMember" xlink:to="lab_pntg_HospiceJoinVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_a9141086-e64e-49c1-bc37-432b4b1583b2_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_92d0f455-19a2-40b5-b060-b012d637547b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_e0f420bd-faf0-4a6f-a858-f46ddc9f843a_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_016e8d5a-cef9-441a-89ac-6283e9711519_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_bdd97ac8-c627-45eb-8a78-1079d04a25d2_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_313aea4e-2654-47c6-8911-fdf701468e0d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_4b0e2fb8-9a17-4a96-be75-b3a92d23e595_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_93b3badd-4e90-4753-8381-880fd771e503_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_f66609c0-28b2-4e28-af19-5c85795e2cd4_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue by major payor source</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_e228421a-ce2a-48d0-918b-1aed0f252b62_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_601e8240-9111-49d6-af3d-55f399db3212_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_ProceedsFromSaleOfSubsidiaryShares_171515b8-6a97-43a0-a4c4-38b17b48e00a_terseLabel_en-US" xlink:label="lab_pntg_ProceedsFromSaleOfSubsidiaryShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from sale of subsidiary shares</link:label>
    <link:label id="lab_pntg_ProceedsFromSaleOfSubsidiaryShares_label_en-US" xlink:label="lab_pntg_ProceedsFromSaleOfSubsidiaryShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Subsidiary Shares</link:label>
    <link:label id="lab_pntg_ProceedsFromSaleOfSubsidiaryShares_documentation_en-US" xlink:label="lab_pntg_ProceedsFromSaleOfSubsidiaryShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds From Sale Of Subsidiary Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ProceedsFromSaleOfSubsidiaryShares" xlink:href="pntg-20211231.xsd#pntg_ProceedsFromSaleOfSubsidiaryShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_ProceedsFromSaleOfSubsidiaryShares" xlink:to="lab_pntg_ProceedsFromSaleOfSubsidiaryShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_ecf8ad81-7617-47b0-ae9c-5ab0016a30d7_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_AssetAcquisitions2020Member_3b371919-37c4-4324-b370-546dd60370f6_terseLabel_en-US" xlink:label="lab_pntg_AssetAcquisitions2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisitions 2020</link:label>
    <link:label id="lab_pntg_AssetAcquisitions2020Member_label_en-US" xlink:label="lab_pntg_AssetAcquisitions2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisitions 2020 [Member]</link:label>
    <link:label id="lab_pntg_AssetAcquisitions2020Member_documentation_en-US" xlink:label="lab_pntg_AssetAcquisitions2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisitions 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AssetAcquisitions2020Member" xlink:href="pntg-20211231.xsd#pntg_AssetAcquisitions2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_AssetAcquisitions2020Member" xlink:to="lab_pntg_AssetAcquisitions2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_5bc41cd8-6885-4589-a6fa-c08d7bfc8b31_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment terms</link:label>
    <link:label id="lab_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_label_en-US" xlink:label="lab_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Performance Obligation, Description of Payment Terms</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms" xlink:to="lab_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_f2e7a976-965c-4f00-927d-d7262d586d19_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_aca4fd15-a188-4623-82d6-bece046125d7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other indefinite-lived intangible assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue_cb377593-129b-4026-9b51-8fbbb5a98255_terseLabel_en-US" xlink:label="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested</link:label>
    <link:label id="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue" xlink:href="pntg-20211231.xsd#pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue" xlink:to="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_213547c7-0a1e-4995-8d4c-71e0338edb20_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ff0f96ee-613d-46ff-8ba8-719386de64b9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_c93de475-ef48-42b2-aec6-7372f8c5e85c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_SpinoffTransactionCosts_5bd908e2-5bcb-4d86-9112-4bc51883b1c6_terseLabel_en-US" xlink:label="lab_pntg_SpinoffTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin-off related transaction costs</link:label>
    <link:label id="lab_pntg_SpinoffTransactionCosts_label_en-US" xlink:label="lab_pntg_SpinoffTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spinoff, Transaction Costs</link:label>
    <link:label id="lab_pntg_SpinoffTransactionCosts_documentation_en-US" xlink:label="lab_pntg_SpinoffTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spinoff, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SpinoffTransactionCosts" xlink:href="pntg-20211231.xsd#pntg_SpinoffTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_SpinoffTransactionCosts" xlink:to="lab_pntg_SpinoffTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_fe792e99-9daf-4e31-b73e-dd87ebbe95a5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of shares of common stock to satisfy tax withholding obligations</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_4fca52e5-f68a-4942-83db-505d434fec16_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_d5d218d9-ede6-48a3-a020-29511c858018_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash investing activity:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_f93b2e9e-9c88-41ab-9f6a-20709c95edeb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_f34f389d-2f34-40c1-b0fa-9bb9b3230e4b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_d65ad17c-7899-47a6-aa8c-778946228337_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_DirectMedicalSuppliesLaborAndOtherExpenses_768fb69d-c2cc-4ec8-b2a6-cf3a34943adc_terseLabel_en-US" xlink:label="lab_pntg_DirectMedicalSuppliesLaborAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct medical supplies, labor, and other expenses</link:label>
    <link:label id="lab_pntg_DirectMedicalSuppliesLaborAndOtherExpenses_label_en-US" xlink:label="lab_pntg_DirectMedicalSuppliesLaborAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Medical Supplies, Labor, and Other Expenses</link:label>
    <link:label id="lab_pntg_DirectMedicalSuppliesLaborAndOtherExpenses_documentation_en-US" xlink:label="lab_pntg_DirectMedicalSuppliesLaborAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Direct Medical Supplies, Labor, and Other Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DirectMedicalSuppliesLaborAndOtherExpenses" xlink:href="pntg-20211231.xsd#pntg_DirectMedicalSuppliesLaborAndOtherExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_DirectMedicalSuppliesLaborAndOtherExpenses" xlink:to="lab_pntg_DirectMedicalSuppliesLaborAndOtherExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_SpinOffTransactionDistributionRatio_74c940f7-0750-4f06-84a2-aea14320a695_terseLabel_en-US" xlink:label="lab_pntg_SpinOffTransactionDistributionRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin-off transaction, distribution ratio</link:label>
    <link:label id="lab_pntg_SpinOffTransactionDistributionRatio_label_en-US" xlink:label="lab_pntg_SpinOffTransactionDistributionRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin Off Transaction, Distribution Ratio</link:label>
    <link:label id="lab_pntg_SpinOffTransactionDistributionRatio_documentation_en-US" xlink:label="lab_pntg_SpinOffTransactionDistributionRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Spin Off Transaction, Distribution Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SpinOffTransactionDistributionRatio" xlink:href="pntg-20211231.xsd#pntg_SpinOffTransactionDistributionRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_SpinOffTransactionDistributionRatio" xlink:to="lab_pntg_SpinOffTransactionDistributionRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_d4e8c2ff-85aa-45b4-a28b-e79a882fc0ec_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities&#8212;long-term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_3658b883-d6e6-41e3-b7da-dd49958e2b83_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_993bf246-ad41-4590-be33-da0cc8620454_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_e8500178-57cf-48d4-9eb0-c41f9f7cd4a7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense, net</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_6312838c-435b-404a-a39c-1938fd4cd550_terseLabel_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Medicare and Medicaid licenses</link:label>
    <link:label id="lab_us-gaap_LicensingAgreementsMember_label_en-US" xlink:label="lab_us-gaap_LicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LicensingAgreementsMember" xlink:to="lab_us-gaap_LicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_ca692a5e-b70a-4b32-967b-b853607fa119_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued wages and related liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_2bf99d39-fdd0-4c91-a839-232720e1b0b4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_AmountToOffsetExpenseSequestrationRelief_4f5e6bdf-d430-4dbc-9695-b04b0edc7e65_terseLabel_en-US" xlink:label="lab_pntg_AmountToOffsetExpenseSequestrationRelief" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sequestration relief</link:label>
    <link:label id="lab_pntg_AmountToOffsetExpenseSequestrationRelief_label_en-US" xlink:label="lab_pntg_AmountToOffsetExpenseSequestrationRelief" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount to Offset Expense, Sequestration Relief</link:label>
    <link:label id="lab_pntg_AmountToOffsetExpenseSequestrationRelief_documentation_en-US" xlink:label="lab_pntg_AmountToOffsetExpenseSequestrationRelief" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount to Offset Expense, Sequestration Relief</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AmountToOffsetExpenseSequestrationRelief" xlink:href="pntg-20211231.xsd#pntg_AmountToOffsetExpenseSequestrationRelief"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_AmountToOffsetExpenseSequestrationRelief" xlink:to="lab_pntg_AmountToOffsetExpenseSequestrationRelief" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_HomeHealthJointVentureMember_6b68a0b7-58b7-42d3-b618-716e6142e78b_terseLabel_en-US" xlink:label="lab_pntg_HomeHealthJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Health Joint Venture</link:label>
    <link:label id="lab_pntg_HomeHealthJointVentureMember_label_en-US" xlink:label="lab_pntg_HomeHealthJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Health Joint Venture [Member]</link:label>
    <link:label id="lab_pntg_HomeHealthJointVentureMember_documentation_en-US" xlink:label="lab_pntg_HomeHealthJointVentureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Home Health Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthJointVentureMember" xlink:href="pntg-20211231.xsd#pntg_HomeHealthJointVentureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_HomeHealthJointVentureMember" xlink:to="lab_pntg_HomeHealthJointVentureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_04b6b494-7cb9-4dc4-8bbc-f76193675822_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_30246253-6fa9-49ee-b55f-9f3f4d0a0917_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquisitions</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_3800f790-0c5b-433a-809a-7df38219e104_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_e57b76e1-aafe-4f6f-bac7-37aebf32842a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating segments</link:label>
    <link:label id="lab_us-gaap_OperatingSegmentsMember_label_en-US" xlink:label="lab_us-gaap_OperatingSegmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Segments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingSegmentsMember" xlink:to="lab_us-gaap_OperatingSegmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_05d5c764-f649-4be3-a2ff-8c66b17c20c8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_3c1d7d55-ed24-4bd1-9fcd-ae2487e0e240_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_15590690-fb50-4ece-98a9-5d215cb15aed_terseLabel_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property taxes</link:label>
    <link:label id="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrual for Taxes Other than Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SelfInsuranceReserveCurrent_0709e59e-cb22-4df6-b811-5d56a300c874_terseLabel_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued insurance retention - current portion</link:label>
    <link:label id="lab_us-gaap_SelfInsuranceReserveCurrent_label_en-US" xlink:label="lab_us-gaap_SelfInsuranceReserveCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Self Insurance Reserve, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SelfInsuranceReserveCurrent" xlink:to="lab_us-gaap_SelfInsuranceReserveCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_688ecadb-4200-4776-82c1-b830f8466f5f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_1ce24e79-41bb-48ee-97e5-f63faf1d312c_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_2c3c98c1-cd2b-4704-bbda-7eec2a8c3e6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of operations acquired in business combinations</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_5d05c278-5918-4629-8cc2-307ae2b17027_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_6d53706b-bbeb-4c29-9852-77bcead3a503_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_FacilityMember_f920e947-7e23-4d78-a32c-97a73f8d5a15_terseLabel_en-US" xlink:label="lab_pntg_FacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility</link:label>
    <link:label id="lab_pntg_FacilityMember_label_en-US" xlink:label="lab_pntg_FacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility [Member]</link:label>
    <link:label id="lab_pntg_FacilityMember_documentation_en-US" xlink:label="lab_pntg_FacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_FacilityMember" xlink:href="pntg-20211231.xsd#pntg_FacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_FacilityMember" xlink:to="lab_pntg_FacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_3bcfbac0-8bc9-4340-9c32-5307ab7cbe98_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_34c84f4a-53c9-4848-ba2a-7d42e780f7e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-Free Interest Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_13d77300-3471-4a23-9bd4-c8d38600a136_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_9461efe0-976b-4dea-aa82-ba2e3d74ba45_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_22a67b83-fa55-4418-b76b-ce105a4ec6a3_terseLabel_en-US" xlink:label="lab_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance receivables</link:label>
    <link:label id="lab_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_label_en-US" xlink:label="lab_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reinsurance Recoverables, Incurred but Not Reported Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims" xlink:to="lab_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_97fea97c-4398-4fa0-853f-8c1c51705389_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_2983c30b-a434-42b0-90fb-054ff4bfb472_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock upon the exercise of options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_38a61f25-09e1-44aa-bb6d-4bf37a1f545d_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other indefinite-lived intangibles</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_a93f2891-7a41-4cf1-8ebe-7472d55fbb21_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_a4105275-ef79-4c27-91b0-16463d2bd830_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_a90b3591-3058-4211-bd2a-94605bf60387_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited &amp; Expired (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_36c35815-e5a0-4cd3-a6c7-37e0a1560a70_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_7db0ec89-f93b-44c8-8309-f3c6b559f150_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_ba54fc27-e69f-4d01-a983-097c72316ffb_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_a39c5f19-06a1-434e-b00c-5d55317c8fba_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_89ae54fb-b983-451e-b2be-1d028ed2f018_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity, ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_3a5b81bb-e812-493a-89c6-2ac264624cf1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable&#8212;less allowance for doubtful accounts of $902 and $643, respectively</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_b3cd87a1-0415-43bc-a2a7-2820de6d6da8_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f6715eda-1fd5-4637-b80e-533b8e88291f_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_4db3c266-0369-48c6-b4e3-1ec6f9db1be3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_99e72048-5d75-4c1c-8726-12f530f74391_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options, unvested and outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_7f67f4a2-a849-427a-8f1c-ed0b1a89a4ff_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_089f3125-ff4d-4af7-b2a3-d17dca5067ce_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_067d08dc-0db5-466d-bd01-d8eb4b108b80_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_363def61-2712-47e7-8cbf-febf26050b57_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_9684e62f-a1d4-4a56-b27a-c68d9dc2ee6a_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_1527fce9-edf1-44a9-92bc-2c6bf7d1c6dd_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_ef0f2f7b-1cfe-473b-85ab-61de12e43cc8_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_1ea201bc-effe-4354-b227-db578e2ca5ae_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_12ce91ef-9770-4185-a3f0-3121b36c2889_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_bf8db8c8-5dd2-4c58-bd25-7a051b5160d2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial data combined by business segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ca3a7107-6859-4aa3-87ea-8da580505eec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_8237f2cf-fc9b-4c71-9383-84356cf425f3_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_69c60e9d-8ad0-49ac-930e-69ee68366e27_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_eae05f3a-d2dd-4ea7-9af0-756b7dccf472_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_f17b85ff-5511-42c4-811f-def3f3d6bfe5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_ef44741e-dd70-46b6-8392-80feba387233_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interests assumed related to acquisitions</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Increase from Business Combination</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:to="lab_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_fc7d2846-70c6-42c9-9be3-ff1afd1b0a4d_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_011d06ab-c5f1-4174-98da-55dd94fe810a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_a36dd290-1a68-4b60-90e4-aa0638a5faa2_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_c8177c61-3ba3-45c6-9472-d4ce4c6ccceb_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_306a1356-eb81-4de8-b6c0-292a98ee63d4_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible equity compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_f7cb5be0-d798-445e-9ae4-1f47ff39d209_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_44df4829-918a-4ea0-a94a-fa844c1722e4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested Restricted Stock</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_3a34cc03-13fa-442b-b28e-c0de5e154a00_terseLabel_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers&#8217; compensation</link:label>
    <link:label id="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:to="lab_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a74a1cbc-1706-4261-afd0-0d3b570eae46_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value of options (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_fcab2ca7-d3df-4bef-8bc1-944ac85d2060_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_4a0e9a71-29ff-4655-8fe7-5829a294580f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reductions for tax positions related to the current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_7ade0ae4-96aa-4552-be0d-6544abc31137_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Prepaid Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_71bfddd3-e836-42f8-ad7c-165e432c04c9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net issuance of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherRestrictedAssetsNoncurrent_b0f4cc35-79af-4af3-89ff-2edcec43b37d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherRestrictedAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted and other assets</link:label>
    <link:label id="lab_us-gaap_OtherRestrictedAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherRestrictedAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Restricted Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestrictedAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestrictedAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherRestrictedAssetsNoncurrent" xlink:to="lab_us-gaap_OtherRestrictedAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_7eb6e476-bf5e-47e6-b0d5-79db6f9f67b6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_7110294b-6a23-4f58-bfa6-00b6d5f78b03_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_GrantYear2019Member_3445ece7-9fc2-48fa-8404-29d75ba6a18b_terseLabel_en-US" xlink:label="lab_pntg_GrantYear2019Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2019</link:label>
    <link:label id="lab_pntg_GrantYear2019Member_label_en-US" xlink:label="lab_pntg_GrantYear2019Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Year 2019 [Member]</link:label>
    <link:label id="lab_pntg_GrantYear2019Member_documentation_en-US" xlink:label="lab_pntg_GrantYear2019Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Year 2019 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GrantYear2019Member" xlink:href="pntg-20211231.xsd#pntg_GrantYear2019Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_GrantYear2019Member" xlink:to="lab_pntg_GrantYear2019Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_39b74d3f-7324-45ca-92fb-b45812f7579c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_c0386095-6033-4956-9b70-73c668f570d1_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advance payments</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_9bf55615-873e-4282-966e-1149e61cfda3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_cb0d1c60-ddcc-4787-8f57-cf8407f04327_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_HospiceSubsegmentMember_1d80d920-a5e6-4b36-b1ca-8ff686decdac_terseLabel_en-US" xlink:label="lab_pntg_HospiceSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospice Services</link:label>
    <link:label id="lab_pntg_HospiceSubsegmentMember_label_en-US" xlink:label="lab_pntg_HospiceSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospice Subsegment [Member]</link:label>
    <link:label id="lab_pntg_HospiceSubsegmentMember_documentation_en-US" xlink:label="lab_pntg_HospiceSubsegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hospice Subsegment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HospiceSubsegmentMember" xlink:href="pntg-20211231.xsd#pntg_HospiceSubsegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_HospiceSubsegmentMember" xlink:to="lab_pntg_HospiceSubsegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_c84d95d3-4c87-4c80-8b8b-e96a94977743_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_88c722e3-97fb-4428-9e86-c0a21a9dfa68_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_1ddcac40-a270-4977-8675-e25de7be220d_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_7a357173-9ae7-45b9-a99e-5d099371e681_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_90f3c90a-8950-41bc-bd01-32c9b11d2f50_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_5e11a322-fee5-4ae3-b5dc-b72e64d42b05_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_ImpairmentLongLivedAssetsNumberOfCommunities_75c29b99-ad47-4169-8a88-0737c67233f8_terseLabel_en-US" xlink:label="lab_pntg_ImpairmentLongLivedAssetsNumberOfCommunities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of communities impaired</link:label>
    <link:label id="lab_pntg_ImpairmentLongLivedAssetsNumberOfCommunities_label_en-US" xlink:label="lab_pntg_ImpairmentLongLivedAssetsNumberOfCommunities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Assets, Number Of Communities</link:label>
    <link:label id="lab_pntg_ImpairmentLongLivedAssetsNumberOfCommunities_documentation_en-US" xlink:label="lab_pntg_ImpairmentLongLivedAssetsNumberOfCommunities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Assets, Number Of Communities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ImpairmentLongLivedAssetsNumberOfCommunities" xlink:href="pntg-20211231.xsd#pntg_ImpairmentLongLivedAssetsNumberOfCommunities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_ImpairmentLongLivedAssetsNumberOfCommunities" xlink:to="lab_pntg_ImpairmentLongLivedAssetsNumberOfCommunities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_1e09545c-77cb-4f3a-9aba-62f777ef52ae_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_EnsignSubsidiaryMember_7d2c5e76-b0d3-4288-9228-5991ccaeb9a1_terseLabel_en-US" xlink:label="lab_pntg_EnsignSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ensign Subsidiary</link:label>
    <link:label id="lab_pntg_EnsignSubsidiaryMember_label_en-US" xlink:label="lab_pntg_EnsignSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ensign Subsidiary [Member]</link:label>
    <link:label id="lab_pntg_EnsignSubsidiaryMember_documentation_en-US" xlink:label="lab_pntg_EnsignSubsidiaryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ensign Subsidiary</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EnsignSubsidiaryMember" xlink:href="pntg-20211231.xsd#pntg_EnsignSubsidiaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_EnsignSubsidiaryMember" xlink:to="lab_pntg_EnsignSubsidiaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_15aa3f8e-d6ce-4779-a839-b0785b2b5cfc_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other</link:label>
    <link:label id="lab_us-gaap_CorporateNonSegmentMember_label_en-US" xlink:label="lab_us-gaap_CorporateNonSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate, Non-Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateNonSegmentMember" xlink:to="lab_us-gaap_CorporateNonSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_47c33bed-602c-4526-b0a3-c0cc78737fb0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_3cd25c3e-8b5a-4e73-9ff5-64bf75f40c9f_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_8b864ad4-393f-412a-a624-80a76a8de3ae_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimates and Assumptions</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c40a2987-30cf-47c4-a6de-3360a1018365_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_36755ff4-9b2d-4568-a985-0d4b37e394c8_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_1aab1272-dc9e-4e40-b537-b75af100f664_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_653a2263-7561-4808-a951-51dfe9a17164_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_bd987bac-3392-4541-a554-8a122bbaccef_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_DeferredTaxAssetsLeaseLiabilities_76bbb373-415c-4d46-8470-62c6a9d346fe_terseLabel_en-US" xlink:label="lab_pntg_DeferredTaxAssetsLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities</link:label>
    <link:label id="lab_pntg_DeferredTaxAssetsLeaseLiabilities_label_en-US" xlink:label="lab_pntg_DeferredTaxAssetsLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease Liabilities</link:label>
    <link:label id="lab_pntg_DeferredTaxAssetsLeaseLiabilities_documentation_en-US" xlink:label="lab_pntg_DeferredTaxAssetsLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DeferredTaxAssetsLeaseLiabilities" xlink:href="pntg-20211231.xsd#pntg_DeferredTaxAssetsLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_DeferredTaxAssetsLeaseLiabilities" xlink:to="lab_pntg_DeferredTaxAssetsLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_f387d128-56c1-4bd2-a340-82d468af76ac_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_7bf7cfe2-9037-412c-a6a8-ac124a8894c8_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restatement Adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_b07d629e-6c89-4c58-8e5f-38c84fe34650_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:to="lab_us-gaap_DeferredIncomeTaxesAndTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_408e5a99-cb06-498a-b148-24fdf6dc3012_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_DirectorMember_65e8feb3-caf4-4279-8a1c-ffc82d98b56a_terseLabel_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-employee director</link:label>
    <link:label id="lab_srt_DirectorMember_label_en-US" xlink:label="lab_srt_DirectorMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Director [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_DirectorMember" xlink:to="lab_srt_DirectorMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_d400fa73-5031-43a1-abb5-3d23e5575a8c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of subsidiary shares</link:label>
    <link:label id="lab_us-gaap_PaymentsToMinorityShareholders_label_en-US" xlink:label="lab_us-gaap_PaymentsToMinorityShareholders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Noncontrolling Interests</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToMinorityShareholders" xlink:to="lab_us-gaap_PaymentsToMinorityShareholders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_21638aea-a22f-4dc6-a51f-81a52136a8fc_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_ca5a5c3f-a17b-45c5-807f-097b06e75118_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_3fba6f27-f5c9-4149-af31-9b33799adaf2_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_b5e1c5aa-0aeb-4590-8958-f4a18b6307b7_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_3a69ee91-7bd3-4451-9b2f-dffda6b85523_terseLabel_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Controlling Interest</link:label>
    <link:label id="lab_us-gaap_NoncontrollingInterestMember_label_en-US" xlink:label="lab_us-gaap_NoncontrollingInterestMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncontrollingInterestMember" xlink:to="lab_us-gaap_NoncontrollingInterestMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_TransitionServicesAgreementMember_fd6f8411-5e4a-459e-a4d2-d6d0cbb0f0a0_terseLabel_en-US" xlink:label="lab_pntg_TransitionServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement</link:label>
    <link:label id="lab_pntg_TransitionServicesAgreementMember_label_en-US" xlink:label="lab_pntg_TransitionServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement [Member]</link:label>
    <link:label id="lab_pntg_TransitionServicesAgreementMember_documentation_en-US" xlink:label="lab_pntg_TransitionServicesAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transition Services Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TransitionServicesAgreementMember" xlink:href="pntg-20211231.xsd#pntg_TransitionServicesAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_TransitionServicesAgreementMember" xlink:to="lab_pntg_TransitionServicesAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_35bef2ff-94fa-4178-9a07-8b334a1b6cbc_verboseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_59b57f08-87ef-4025-91c0-cb3440530b9a_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_549e9a50-7e6f-4931-adb3-c4cf4ae33438_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accounts receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_8b54f896-7255-47da-b9f7-3ecaeca2b24a_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: net (loss)/ income attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_e020e992-6363-49a5-8581-fd602b3eb177_netLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_355abfea-57c3-4a9c-ac79-7166a9672214_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Add: Net income/ (loss) attributable to noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_52c78fb2-78e6-4a88-9ab9-030c852d42a3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AAP amount reclassified</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrent" xlink:to="lab_us-gaap_LiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_51cb40d1-0da9-4b6c-bc73-999fb8edac66_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_5c6500ea-0f9d-44b1-ab25-691279f9f204_terseLabel_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility</link:label>
    <link:label id="lab_us-gaap_RevolvingCreditFacilityMember_label_en-US" xlink:label="lab_us-gaap_RevolvingCreditFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving Credit Facility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevolvingCreditFacilityMember" xlink:to="lab_us-gaap_RevolvingCreditFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_ddac7beb-8e52-47d0-a0ac-86ba8f325851_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash (used in) provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_336828fc-8fcf-4384-b72c-5a512d9327da_terseLabel_en-US" xlink:label="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested</link:label>
    <link:label id="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_label_en-US" xlink:label="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:label id="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_documentation_en-US" xlink:label="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:href="pntg-20211231.xsd#pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:to="lab_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_CashAndContributedAssetsNetBookValue_c0c407dd-3b92-4c8c-8352-51c864317783_terseLabel_en-US" xlink:label="lab_pntg_CashAndContributedAssetsNetBookValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net book value</link:label>
    <link:label id="lab_pntg_CashAndContributedAssetsNetBookValue_label_en-US" xlink:label="lab_pntg_CashAndContributedAssetsNetBookValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Contributed Assets Net Book Value</link:label>
    <link:label id="lab_pntg_CashAndContributedAssetsNetBookValue_documentation_en-US" xlink:label="lab_pntg_CashAndContributedAssetsNetBookValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash And Contributed Assets Net Book Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_CashAndContributedAssetsNetBookValue" xlink:href="pntg-20211231.xsd#pntg_CashAndContributedAssetsNetBookValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_CashAndContributedAssetsNetBookValue" xlink:to="lab_pntg_CashAndContributedAssetsNetBookValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_08995c06-07ff-4041-b0ad-f4b01d87594d_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems_label_en-US" xlink:label="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts, Notes, Loans and Financing Receivable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:to="lab_us-gaap_AccountsNotesAndLoansReceivableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_c2b9df34-4e99-4ba9-a804-d956f93e49d9_terseLabel_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:label id="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_label_en-US" xlink:label="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Real Estate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:to="lab_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement_e3ceceb8-b267-4413-8a17-d8cfac59127f_terseLabel_en-US" xlink:label="lab_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of properties under lease, master lease agreement</link:label>
    <link:label id="lab_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement_label_en-US" xlink:label="lab_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Real Estate Properties Under Lease, Master Lease Agreement</link:label>
    <link:label id="lab_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement_documentation_en-US" xlink:label="lab_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Real Estate Properties Under Lease, Master Lease Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement" xlink:href="pntg-20211231.xsd#pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement" xlink:to="lab_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_4a2f6fed-9b40-480e-9db3-14c053f46bfb_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_39631678-b9c9-46a3-9a26-23ccc211cc97_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Components of operating lease cot</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_0bf1cd04-7e9f-4a7d-92aa-85cdd68eb3d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_TheEnsignPlansMember_5e9a3ac1-7998-44ec-93d4-8efd3b1c6dbc_terseLabel_en-US" xlink:label="lab_pntg_TheEnsignPlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Ensign Plans</link:label>
    <link:label id="lab_pntg_TheEnsignPlansMember_label_en-US" xlink:label="lab_pntg_TheEnsignPlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Ensign Plans [Member]</link:label>
    <link:label id="lab_pntg_TheEnsignPlansMember_documentation_en-US" xlink:label="lab_pntg_TheEnsignPlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The Ensign Plans [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_TheEnsignPlansMember" xlink:to="lab_pntg_TheEnsignPlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_99b5bd29-dd21-4279-bf46-713b4b8249f5_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_13cff130-fc57-4e5f-9183-b73ddf7f74f6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c4bd0803-1c93-4f6c-9ab0-7cef652fee14_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5261b6bb-a2a3-4442-aea7-8863ef752e2e_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average shares outstanding for basic net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_18fd3f0e-8796-4b8f-be9b-28f740f68438_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_e6177491-2d63-4a80-b393-eb0fc2d80081_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted net income per common share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_ba499ca7-b1be-4d45-aede-1834ee038e91_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_3128fe7c-37a7-4e61-b9a0-268fba6ac5ed_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_ada42071-8677-4f4d-a915-1d95c2b98995_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments on revolver agreement</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:to="lab_us-gaap_RepaymentsOfLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_633485cb-4110-4faa-92b3-8cf20fa9190a_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plus: incremental shares from assumed conversion (in share)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number Diluted Shares Outstanding Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:to="lab_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_InsuranceProgramAccruedExpensesNoncurrent_5e4dc32c-a81d-4169-b375-8f6691df4673_negatedTerseLabel_en-US" xlink:label="lab_pntg_InsuranceProgramAccruedExpensesNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: long-term portion, included in other long-term liabilities</link:label>
    <link:label id="lab_pntg_InsuranceProgramAccruedExpensesNoncurrent_label_en-US" xlink:label="lab_pntg_InsuranceProgramAccruedExpensesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Program Accrued Expenses, Noncurrent</link:label>
    <link:label id="lab_pntg_InsuranceProgramAccruedExpensesNoncurrent_documentation_en-US" xlink:label="lab_pntg_InsuranceProgramAccruedExpensesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance Program Accrued Expenses, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InsuranceProgramAccruedExpensesNoncurrent" xlink:href="pntg-20211231.xsd#pntg_InsuranceProgramAccruedExpensesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_InsuranceProgramAccruedExpensesNoncurrent" xlink:to="lab_pntg_InsuranceProgramAccruedExpensesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_55eac3e2-6d29-43d0-b4bf-d01f6fe3b4e6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LongtermDebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Weighted Average Interest Rate, at Point in Time</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_LongtermDebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyCosts_196cbfc7-a431-4cbb-8a4f-575a9cd84701_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_RelatedPartyCosts_label_en-US" xlink:label="lab_us-gaap_RelatedPartyCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyCosts" xlink:to="lab_us-gaap_RelatedPartyCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_a71f52eb-9dae-4ce2-a179-d153960efa5f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENT</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_NumberOfServiceProviders_5a143704-bd1f-40f0-a87e-2a6fbb8c6d9b_terseLabel_en-US" xlink:label="lab_pntg_NumberOfServiceProviders" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of service providers</link:label>
    <link:label id="lab_pntg_NumberOfServiceProviders_label_en-US" xlink:label="lab_pntg_NumberOfServiceProviders" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Service Providers</link:label>
    <link:label id="lab_pntg_NumberOfServiceProviders_documentation_en-US" xlink:label="lab_pntg_NumberOfServiceProviders" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Service Providers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfServiceProviders" xlink:href="pntg-20211231.xsd#pntg_NumberOfServiceProviders"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_NumberOfServiceProviders" xlink:to="lab_pntg_NumberOfServiceProviders" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostAbstract_e98006bd-a0df-4725-9374-6929773f0e38_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeaseCostAbstract_label_en-US" xlink:label="lab_us-gaap_LeaseCostAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostAbstract" xlink:to="lab_us-gaap_LeaseCostAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount_0dd89f3e-780a-458d-886d-6436b0c3701e_terseLabel_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nondeductible transaction costs</link:label>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount_label_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Transaction Costs, Amount</link:label>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount_documentation_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Transaction Costs, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount" xlink:to="lab_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_bf78d2df-3393-4630-b49f-0446fe44417b_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_d9893db2-9772-4625-81cf-52d89e7d2a1a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost, 3 shares at December 31, 2021 and 2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c7702cb0-b153-40a1-8169-b44e290ea44f_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1084cd07-c8d9-456c-a110-bb2169639a0e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_3cc6a2d5-45d6-4836-9742-60826f93ed06_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_780ed393-3340-4e35-b3a1-c69643b9934a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_GrantYear2020Member_d0610c78-b4f9-4807-9e9f-70a088e2ad04_terseLabel_en-US" xlink:label="lab_pntg_GrantYear2020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2020</link:label>
    <link:label id="lab_pntg_GrantYear2020Member_label_en-US" xlink:label="lab_pntg_GrantYear2020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Year 2020 [Member]</link:label>
    <link:label id="lab_pntg_GrantYear2020Member_documentation_en-US" xlink:label="lab_pntg_GrantYear2020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant Year 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GrantYear2020Member" xlink:href="pntg-20211231.xsd#pntg_GrantYear2020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_GrantYear2020Member" xlink:to="lab_pntg_GrantYear2020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_99cc382c-bada-47d3-adda-3f941c4ce4f0_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9722c06c-bc00-4816-9f74-118442e7d568_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of federal statutory rate to effective tax rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsegmentsDomain_cac9a012-f8f8-4239-88ec-3c7f4fc8b7aa_terseLabel_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsegmentsDomain_label_en-US" xlink:label="lab_us-gaap_SubsegmentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsegments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsegmentsDomain" xlink:to="lab_us-gaap_SubsegmentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_c345b572-9345-45a6-bff3-d0c0bf49e7df_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_f4a842a6-346d-4ae4-b0a2-d25663b59f5d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_2fe0f5fd-0fea-4cc9-9ac5-274247282233_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_16da72d2-06bb-4cee-ab4e-12b839d01d07_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of long-lived assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_5c4dc525-39df-448c-ae62-ebf31168a600_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ParentMember_2f600485-e0b6-4cc2-bcd9-215aa1e4998c_terseLabel_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment</link:label>
    <link:label id="lab_us-gaap_ParentMember_label_en-US" xlink:label="lab_us-gaap_ParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ParentMember" xlink:to="lab_us-gaap_ParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_64b7fe47-43f4-4022-9cde-86eec8e19025_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options outstanding, vested, expected to vest and exercisable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_b5bab483-43e4-40f4-9ae6-401ecbcb49a2_terseLabel_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:label id="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems_label_en-US" xlink:label="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Major Customer [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:to="lab_us-gaap_EntityWideRevenueMajorCustomerLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_23f0a5e1-453f-44dc-8c57-08499da100ec_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from revolver agreement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLongTermLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Long-term Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLongTermLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_NoncontrollingInterestJointVenture_3343f2ad-94b7-4971-9206-40f4036d47b1_terseLabel_en-US" xlink:label="lab_pntg_NoncontrollingInterestJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest to scripps</link:label>
    <link:label id="lab_pntg_NoncontrollingInterestJointVenture_label_en-US" xlink:label="lab_pntg_NoncontrollingInterestJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Joint Venture</link:label>
    <link:label id="lab_pntg_NoncontrollingInterestJointVenture_documentation_en-US" xlink:label="lab_pntg_NoncontrollingInterestJointVenture" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NoncontrollingInterestJointVenture" xlink:href="pntg-20211231.xsd#pntg_NoncontrollingInterestJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_NoncontrollingInterestJointVenture" xlink:to="lab_pntg_NoncontrollingInterestJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation_6ff1b431-e304-4f7b-8003-fafd66fddd83_terseLabel_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Section 162(m) limitation</link:label>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation_label_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Section 162(m) Limitation</link:label>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation_documentation_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Section 162(m) Limitation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation" xlink:to="lab_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e8e98015-73cb-40b1-975d-57363e6ca087_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_6707afcc-ccf6-4e53-8518-19a10a1d4c1b_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_59c6ef4d-1ea5-4989-8d0b-dd81ea91f34a_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance/ (cancellation) of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrentAbstract_69b52e39-e204-4e4e-b8bb-c84478708533_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrentAbstract" xlink:to="lab_us-gaap_AccountsReceivableNetCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_56a35156-1e04-4eba-81b3-c407df77dae1_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_e2cb113d-ead5-4005-9a58-936591d1e87d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_NumberOfSeparateMasterLeaseArrangements_ae5b1b50-7b53-4404-8dd3-93e14f92880e_terseLabel_en-US" xlink:label="lab_pntg_NumberOfSeparateMasterLeaseArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of separate master lease arrangements</link:label>
    <link:label id="lab_pntg_NumberOfSeparateMasterLeaseArrangements_label_en-US" xlink:label="lab_pntg_NumberOfSeparateMasterLeaseArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Separate Master Lease Arrangements</link:label>
    <link:label id="lab_pntg_NumberOfSeparateMasterLeaseArrangements_documentation_en-US" xlink:label="lab_pntg_NumberOfSeparateMasterLeaseArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Separate Master Lease Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfSeparateMasterLeaseArrangements" xlink:href="pntg-20211231.xsd#pntg_NumberOfSeparateMasterLeaseArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_NumberOfSeparateMasterLeaseArrangements" xlink:to="lab_pntg_NumberOfSeparateMasterLeaseArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_70f453b0-d13f-4298-895e-f90a672eb4c2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_4760166c-c70a-40ad-a5d0-8cac377b6785_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State income taxes - net of federal benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_75c623a1-b056-4639-8662-a73bc684878b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateDomain_d1afc0bd-dcde-40cf-aa91-9223cba1794f_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:label id="lab_us-gaap_AwardDateDomain_label_en-US" xlink:label="lab_us-gaap_AwardDateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateDomain" xlink:to="lab_us-gaap_AwardDateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_a0087758-0f63-4973-a0bd-a362b55f1ac5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_378329a2-8446-422f-a0fc-1bc9235fca21_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_fd2a8ea8-2aaa-454b-aede-30a1bbc0084e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a52373eb-ce90-4b90-a689-a03f367bccf2_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_38704570-8410-41fb-a29e-aae364b9f3af_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-deductible expenses</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_3ef7a885-2fbe-438f-8099-39ecca161209_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY AND EQUIPMENT&#8212;NET</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_AccruedPayrollTaxesEmployerPortion_cc773be9-e460-4034-a8b6-623546d5c405_terseLabel_en-US" xlink:label="lab_pntg_AccruedPayrollTaxesEmployerPortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll taxes employer portion</link:label>
    <link:label id="lab_pntg_AccruedPayrollTaxesEmployerPortion_label_en-US" xlink:label="lab_pntg_AccruedPayrollTaxesEmployerPortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Payroll Taxes, Employer Portion</link:label>
    <link:label id="lab_pntg_AccruedPayrollTaxesEmployerPortion_documentation_en-US" xlink:label="lab_pntg_AccruedPayrollTaxesEmployerPortion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Payroll Taxes, Employer Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AccruedPayrollTaxesEmployerPortion" xlink:href="pntg-20211231.xsd#pntg_AccruedPayrollTaxesEmployerPortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_AccruedPayrollTaxesEmployerPortion" xlink:to="lab_pntg_AccruedPayrollTaxesEmployerPortion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_75b89182-fffc-426a-9f2b-6e5e4f43799f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_f9e704ba-d304-4a13-b6ea-a5e358e71692_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of long-term debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_8a8b8a77-2e73-485d-a15e-4fd513278b6e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_5b447d66-2152-46a1-bd47-a95a0a73b821_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_c4db94b8-4570-43d9-ba24-9f8c526801a7_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings per common share (Note 4):</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_ContractLiabilityAdvancePaymentsCARESAct_a4627984-a478-4407-91c2-9d756678c1cb_terseLabel_en-US" xlink:label="lab_pntg_ContractLiabilityAdvancePaymentsCARESAct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liabilities (CARES Act advance payments)</link:label>
    <link:label id="lab_pntg_ContractLiabilityAdvancePaymentsCARESAct_label_en-US" xlink:label="lab_pntg_ContractLiabilityAdvancePaymentsCARESAct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liability, Advance Payments, CARES Act</link:label>
    <link:label id="lab_pntg_ContractLiabilityAdvancePaymentsCARESAct_documentation_en-US" xlink:label="lab_pntg_ContractLiabilityAdvancePaymentsCARESAct" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract Liability, Advance Payments, CARES Act</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ContractLiabilityAdvancePaymentsCARESAct" xlink:href="pntg-20211231.xsd#pntg_ContractLiabilityAdvancePaymentsCARESAct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_ContractLiabilityAdvancePaymentsCARESAct" xlink:to="lab_pntg_ContractLiabilityAdvancePaymentsCARESAct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_d3a94d74-9f0d-4889-8ac6-f9966bb1db07_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_14d5b6f3-1c59-4b98-be12-d5acf4518077_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_4b5ee959-ce62-41c9-a0a1-b16e32dc6d88_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_aab2fa97-7544-49d7-89c4-d6a9fb5e080d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerMember_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerMember" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_d0323f4d-6923-475b-b899-8f5ebd548772_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_CorridorAsAnAdditionalOutOfPocketRetention_11f77abf-0b46-4cfa-b311-00e14a7105e1_terseLabel_en-US" xlink:label="lab_pntg_CorridorAsAnAdditionalOutOfPocketRetention" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Out-of-pocket retention</link:label>
    <link:label id="lab_pntg_CorridorAsAnAdditionalOutOfPocketRetention_label_en-US" xlink:label="lab_pntg_CorridorAsAnAdditionalOutOfPocketRetention" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corridor as an Additional Out-of-Pocket Retention</link:label>
    <link:label id="lab_pntg_CorridorAsAnAdditionalOutOfPocketRetention_documentation_en-US" xlink:label="lab_pntg_CorridorAsAnAdditionalOutOfPocketRetention" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corridor as an Additional Out-of-Pocket Retention</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_CorridorAsAnAdditionalOutOfPocketRetention" xlink:href="pntg-20211231.xsd#pntg_CorridorAsAnAdditionalOutOfPocketRetention"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_CorridorAsAnAdditionalOutOfPocketRetention" xlink:to="lab_pntg_CorridorAsAnAdditionalOutOfPocketRetention" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_f13d9ffa-7a00-4f6a-9a85-390f5c95aba2_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_StockholdersEquityDistributionsFromParent_164a2963-9420-4faf-a1ea-ef7da8cfe530_terseLabel_en-US" xlink:label="lab_pntg_StockholdersEquityDistributionsFromParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net transfer from parent</link:label>
    <link:label id="lab_pntg_StockholdersEquityDistributionsFromParent_label_en-US" xlink:label="lab_pntg_StockholdersEquityDistributionsFromParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Distributions From Parent</link:label>
    <link:label id="lab_pntg_StockholdersEquityDistributionsFromParent_documentation_en-US" xlink:label="lab_pntg_StockholdersEquityDistributionsFromParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Distributions From Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_StockholdersEquityDistributionsFromParent" xlink:href="pntg-20211231.xsd#pntg_StockholdersEquityDistributionsFromParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_StockholdersEquityDistributionsFromParent" xlink:to="lab_pntg_StockholdersEquityDistributionsFromParent" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses_b5ee2c8a-5935-47cd-81e0-68dc1573ac59_terseLabel_en-US" xlink:label="lab_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COVID-19 Related costs and supplies</link:label>
    <link:label id="lab_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses_label_en-US" xlink:label="lab_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Costs, Direct Medical Supplies, Labor, and Other Expenses</link:label>
    <link:label id="lab_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses_documentation_en-US" xlink:label="lab_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Costs, Direct Medical Supplies, Labor, and Other Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses" xlink:href="pntg-20211231.xsd#pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses" xlink:to="lab_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_da020931-a1cb-4f6c-9ea7-4ec1ea612baa_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash from sale of noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Divestiture of Interest in Joint Venture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:to="lab_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ebca6135-0edb-4191-a198-a579b61e5ca3_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning of period, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_155bf6f6-c011-4b25-9fa4-4040bf71bbb9_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">End of period, weighted average exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_0e0fc09b-27db-4b99-93dd-408dbf527a56_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_1b16f7be-78b8-45e9-bc6f-ecb21783f7de_terseLabel_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expense:</link:label>
    <link:label id="lab_us-gaap_CostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_CostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostsAndExpensesAbstract" xlink:to="lab_us-gaap_CostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_a42f440e-c43c-4bca-8672-16c275c168cd_terseLabel_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:label id="lab_us-gaap_AssetAcquisitionDomain_label_en-US" xlink:label="lab_us-gaap_AssetAcquisitionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Acquisition [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetAcquisitionDomain" xlink:to="lab_us-gaap_AssetAcquisitionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_ab905042-e971-4e7c-b97b-8dd71e826c3d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable" xlink:to="lab_us-gaap_ScheduleOfGoodwillTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_0f948a0c-f903-4299-af96-9b6b3be37ae3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_17aa5c12-e7fc-4c6a-8983-8ae9d9d7e2ae_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_b77afa5e-4058-44da-bfb9-110209bed1d6_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemTable_bbe2d4b3-a24e-493b-818c-e2e74c326099_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Table]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemTable_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable" xlink:to="lab_us-gaap_UnusualOrInfrequentItemTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_6cd0098e-2cba-4b72-8be0-a88e1e8d517c_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_6023a30b-b20a-4203-a8d8-dc3577cefaaa_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_ac854a8f-5c48-4752-8b13-50272340d4ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_8a2257f5-355d-4bf1-91f6-27e8aef4396e_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total income tax provision(d)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_NumberOfBusinessesAndAssetsAcquired_3c38c663-b99f-4729-8e39-013ac45e77b3_terseLabel_en-US" xlink:label="lab_pntg_NumberOfBusinessesAndAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of businesses acquired and assets acquisitions</link:label>
    <link:label id="lab_pntg_NumberOfBusinessesAndAssetsAcquired_label_en-US" xlink:label="lab_pntg_NumberOfBusinessesAndAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses And Assets Acquired</link:label>
    <link:label id="lab_pntg_NumberOfBusinessesAndAssetsAcquired_documentation_en-US" xlink:label="lab_pntg_NumberOfBusinessesAndAssetsAcquired" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Businesses And Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfBusinessesAndAssetsAcquired" xlink:href="pntg-20211231.xsd#pntg_NumberOfBusinessesAndAssetsAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_NumberOfBusinessesAndAssetsAcquired" xlink:to="lab_pntg_NumberOfBusinessesAndAssetsAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfitLoss_15ee6123-8cda-488c-84b7-537037967e3d_totalLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_2df42013-c706-4d48-b536-601851766878_verboseLabel_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_ProfitLoss_label_en-US" xlink:label="lab_us-gaap_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfitLoss" xlink:to="lab_us-gaap_ProfitLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_bab10667-8f7e-434b-adaa-220f18043672_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, gross</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGrossCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGrossCurrent" xlink:to="lab_us-gaap_AccountsReceivableGrossCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_52578002-9719-4c02-af59-ce8fd72e0bef_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred financing fees</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_d734a8ee-ce6d-4ccd-b536-e8b474124bdd_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_5ce92edb-ae75-4c8a-a8bb-684e0de28bd8_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_5107a146-5994-4cee-996a-984f92e92961_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities assumed</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5fe24996-f65d-4704-b95f-8908de6187a6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_8429957a-695c-4d6c-8998-cf3fa4437d95_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_54ef667a-2846-42d4-bd01-6ebe9ca8849a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_d593a56f-d9d8-4e38-87f7-6b7041636ab5_terseLabel_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_label_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transaction Costs, Percent</link:label>
    <link:label id="lab_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_documentation_en-US" xlink:label="lab_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Transaction Costs, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xlink:to="lab_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_9a6f9f7c-7c9b-44a6-a1f8-914095c35ad2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_606af586-2d9d-4cc2-84e1-f49c482769e9_totalLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_009a3a89-526d-458b-ac96-7b83c63a0665_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardDateAxis_ad47a567-6c52-429d-9ec7-f318e4a2d0c0_terseLabel_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardDateAxis_label_en-US" xlink:label="lab_us-gaap_AwardDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardDateAxis" xlink:to="lab_us-gaap_AwardDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_6f1f1472-0021-47f9-b760-25160ed14ff1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_9ade3e53-d193-42fa-9d8e-2849c04878cc_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIBOR</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_dba432d7-349e-4692-a7aa-670c956bfdea_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRefundLiabilityCurrent_8f6eee1c-624e-4bad-8d5a-751faa9901a9_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Refunds payable</link:label>
    <link:label id="lab_us-gaap_CustomerRefundLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Refund Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRefundLiabilityCurrent" xlink:to="lab_us-gaap_CustomerRefundLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_22a73dfb-326a-402d-884f-cc58268c0232_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_03ddae87-2eda-4fdd-9299-45f298086a12_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from the exercise of stock options / issuance of other awards after spin-off (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_e21c3cb3-8d05-4e44-aa8b-0cd6b7811040_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_fde21bd4-5a38-4058-8ebd-74ed7ed8c933_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_974bc5a3-9ccd-4207-b885-31d5785e2fdf_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_7adfcc74-04a5-4629-80e9-6fc154fb0b92_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjusted weighted average common shares outstanding for diluted income per share (in share)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_a9db10f8-3337-4fae-a65d-7699ca8a2eb6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_e9deb621-1d74-459a-998c-fdf8aa1563cc_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_4cebae17-bdae-4db7-b941-4781347a1805_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_25a84a79-d0f4-4609-a351-7920db99759f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock option activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_b603ae46-7748-4125-b3c4-044dc050f3d4_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Margin</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_NetParentInvestment_c189d2f2-8aa0-42eb-82f0-a1f5317ad7ed_totalLabel_en-US" xlink:label="lab_pntg_NetParentInvestment" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Pennant Group, Inc. stockholders' equity</link:label>
    <link:label id="lab_pntg_NetParentInvestment_label_en-US" xlink:label="lab_pntg_NetParentInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment</link:label>
    <link:label id="lab_pntg_NetParentInvestment_documentation_en-US" xlink:label="lab_pntg_NetParentInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Parent Investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NetParentInvestment" xlink:href="pntg-20211231.xsd#pntg_NetParentInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_NetParentInvestment" xlink:to="lab_pntg_NetParentInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemLineItems_7ebcbb26-decc-49bd-b802-29adc1c529d2_terseLabel_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Line Items]</link:label>
    <link:label id="lab_us-gaap_UnusualOrInfrequentItemLineItems_label_en-US" xlink:label="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unusual or Infrequent Item, or Both [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems" xlink:to="lab_us-gaap_UnusualOrInfrequentItemLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_c99f9726-7ac9-4b80-add4-882061e057f2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs of uncollectible accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_a5590f87-8bed-4d47-ac75-91b2289d6362_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_cdfeb8c3-dba6-4fd9-984a-439366b4d39f_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense):</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpenseAbstract_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:to="lab_us-gaap_NonoperatingIncomeExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_ecc19772-6d1f-48a4-872d-41523a71d5d0_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_58848a1b-8101-4c13-8eab-e6cbc0793bb2_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_d7707f33-f6b5-49e3-a228-ab36dba28779_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_2dbd81d9-531b-439f-93b3-6759d49102e5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_35c58454-6759-4988-824c-459da150aaa9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_6187e3b8-516f-476e-9d9e-ae97372ced92_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_60d9c23e-6e9a-41ab-bb07-b00520b7307a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_2199ca04-edd3-4cde-8893-4abfec0319b5_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_9f158366-a431-4c29-bd02-d05ca57d92b1_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_aba4e649-4c6d-4fc9-997f-85281cf42205_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_b51e9ae4-9547-4bb1-98ab-61315ac0ad29_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative expense</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_9a4186c7-a20f-424a-a44b-e86d4bae2073_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_2fcefe4f-2ccb-4d8c-aaa7-98df3d3c5a20_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_2f220a80-ab7a-454a-abc9-e8c4d5f2966d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_2dae78dc-5acb-4b1f-9e14-0ff723501741_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_b02976c5-76b5-41fa-b3f3-dbd88e1a9149_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payments for business acquisitions</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesGross_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesGross" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_AccruedWagesAndRelatedLiabilitiesMember_c0f45441-dd14-406a-bb4c-981c604c937c_terseLabel_en-US" xlink:label="lab_pntg_AccruedWagesAndRelatedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Wages and Related Liabilities</link:label>
    <link:label id="lab_pntg_AccruedWagesAndRelatedLiabilitiesMember_label_en-US" xlink:label="lab_pntg_AccruedWagesAndRelatedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Wages and Related Liabilities [Member]</link:label>
    <link:label id="lab_pntg_AccruedWagesAndRelatedLiabilitiesMember_documentation_en-US" xlink:label="lab_pntg_AccruedWagesAndRelatedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Wages and Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AccruedWagesAndRelatedLiabilitiesMember" xlink:href="pntg-20211231.xsd#pntg_AccruedWagesAndRelatedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_AccruedWagesAndRelatedLiabilitiesMember" xlink:to="lab_pntg_AccruedWagesAndRelatedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_f265df0e-e02f-416e-ab37-7136d3965686_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_7f09cbc5-62b4-4807-95fb-937a037c22c8_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_55606c1c-2252-40e0-9e7f-851e7ca26fa6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_5efcb50f-3088-4631-9ad2-c4e484f7ea98_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_931da45f-6a41-4bb6-a7c9-4de94d9a350c_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_1ad82b95-601c-4ecc-adda-74ab08c18ac2_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Standards Adopted by the Company</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_cc6a257b-8073-4c2a-b8c3-6830235686dc_totalLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total unrecognized share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_27cf286f-2ab9-46f6-bd34-ab1d3121caed_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_8b13206c-d332-46fd-a0af-4b62e06b0aa5_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_03256aee-844d-452e-8db8-c133165481ef_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_c8ceac97-be98-4c2f-aa5c-267b299f5abc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_da68b5aa-f296-487f-9549-c7856aecc7ba_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_d5cef1b0-9ccb-453a-a8a8-243d267d585b_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, beginning balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_df46db32-0ac0-414f-9ca8-c1aac957131f_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, ending balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock_0e7bb626-0ac0-4d30-a1c8-6399b05a1c7d_terseLabel_en-US" xlink:label="lab_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">REVENUE AND ACCOUNTS RECEIVABLE</link:label>
    <link:label id="lab_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer And Accounts Receivables Disclosure [Text Block]</link:label>
    <link:label id="lab_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock_documentation_en-US" xlink:label="lab_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer And Accounts Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock" xlink:href="pntg-20211231.xsd#pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock" xlink:to="lab_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim_81f07445-60cd-4c89-ae05-d11ae020eb8b_terseLabel_en-US" xlink:label="lab_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' compensation, retention limit</link:label>
    <link:label id="lab_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim_label_en-US" xlink:label="lab_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Insurance, Retention Limit, Per Claim</link:label>
    <link:label id="lab_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim_documentation_en-US" xlink:label="lab_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Workers' Compensation Insurance, Retention Limit, Per Claim</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim" xlink:href="pntg-20211231.xsd#pntg_WorkersCompensationInsuranceRetentionLimitPerClaim"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim" xlink:to="lab_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterest_466fa98e-e79d-4bd0-9ebb-26215e91a83c_verboseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling interest</link:label>
    <link:label id="lab_us-gaap_MinorityInterest_label_en-US" xlink:label="lab_us-gaap_MinorityInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterest" xlink:to="lab_us-gaap_MinorityInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_ac45a2c8-71b1-470e-b488-0e93f6c53816_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating facilities</link:label>
    <link:label id="lab_us-gaap_NumberOfRealEstateProperties_label_en-US" xlink:label="lab_us-gaap_NumberOfRealEstateProperties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Real Estate Properties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfRealEstateProperties" xlink:to="lab_us-gaap_NumberOfRealEstateProperties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_b9f8d41a-b9db-4e9b-ba76-7bfd2bae589b_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of services</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_pntg_PrivateAndOtherMember_aec0dced-db56-40bb-83f0-8f3790c0dc5e_terseLabel_en-US" xlink:label="lab_pntg_PrivateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private and other</link:label>
    <link:label id="lab_pntg_PrivateAndOtherMember_label_en-US" xlink:label="lab_pntg_PrivateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private And Other [Member]</link:label>
    <link:label id="lab_pntg_PrivateAndOtherMember_documentation_en-US" xlink:label="lab_pntg_PrivateAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private And Other [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_PrivateAndOtherMember" xlink:href="pntg-20211231.xsd#pntg_PrivateAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_pntg_PrivateAndOtherMember" xlink:to="lab_pntg_PrivateAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_25d14808-9680-4348-a73d-0e4c6a52f888_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Activity in goodwill by segment</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NatureOfOperations_90b03930-e6d3-4a79-ae52-bcfd39a68d28_terseLabel_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DESCRIPTION OF BUSINESS</link:label>
    <link:label id="lab_us-gaap_NatureOfOperations_label_en-US" xlink:label="lab_us-gaap_NatureOfOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NatureOfOperations" xlink:to="lab_us-gaap_NatureOfOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_71b283e5-dc7a-4a10-968d-8a1dad695a38_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash (used in) provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_3750b12e-d025-4b7e-a423-b39e9f77607d_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_23496a49-af77-4156-8a04-05dbf25e5210_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease costs</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_2b852e83-99c4-4efe-9b14-2238d26cdc18_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_62e3cb72-7c9f-4821-88ab-d72096f6e973_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_cf9bcc11-597e-43c4-a2c9-68a52e2ef037_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_76b6add2-50bf-4d4c-b520-b1b8ca1e698d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_e9a87c41-1adf-40dd-84d0-9673c59448ab_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average contractual life for options outstanding, vested and expected to vest</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>13
<FILENAME>pntg-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2022 Workiva-->
<!--r:6a149289-91af-40b5-8f3e-f8666bbd5c45,g:56c4c52a-4e81-467a-86f6-87d568a87628-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://pennantgroup.com/role/COVERPAGE" xlink:type="simple" xlink:href="pntg-20211231.xsd#COVERPAGE"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/COVERPAGE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c5168b89-faa0-4882-8333-7ac0999cf1cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_DocumentType_c5168b89-faa0-4882-8333-7ac0999cf1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_b509e048-69c2-4330-badf-2273c8699053" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_DocumentAnnualReport_b509e048-69c2-4330-badf-2273c8699053" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_a13cb734-7752-4a15-af81-106997e298ba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_DocumentPeriodEndDate_a13cb734-7752-4a15-af81-106997e298ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_cfa305de-1e02-43dd-b67c-f350f049abe4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_CurrentFiscalYearEndDate_cfa305de-1e02-43dd-b67c-f350f049abe4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5971212b-e20a-44b0-a6e3-eadc7856c79a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_DocumentTransitionReport_5971212b-e20a-44b0-a6e3-eadc7856c79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bc885105-4667-4b71-877f-0901f328b212" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityFileNumber_bc885105-4667-4b71-877f-0901f328b212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_803c5c6c-d7a1-4784-893c-ac7305b828ae" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityRegistrantName_803c5c6c-d7a1-4784-893c-ac7305b828ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_2ce2fe6c-d575-4060-a500-a122bb2af447" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityIncorporationStateCountryCode_2ce2fe6c-d575-4060-a500-a122bb2af447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_38e489bf-2ea0-44d6-8fe7-6724e74f730f" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityTaxIdentificationNumber_38e489bf-2ea0-44d6-8fe7-6724e74f730f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b4214b1a-d6a4-4e44-a80c-ed835198c176" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityAddressAddressLine1_b4214b1a-d6a4-4e44-a80c-ed835198c176" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_bef3cdb8-29bb-448f-a426-2d2a07c11117" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityAddressAddressLine2_bef3cdb8-29bb-448f-a426-2d2a07c11117" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_97d6eb9b-f76b-4588-9b34-bc4fe7a2f568" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityAddressCityOrTown_97d6eb9b-f76b-4588-9b34-bc4fe7a2f568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_2d51a76a-5813-42a7-9057-01d58338d499" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityAddressStateOrProvince_2d51a76a-5813-42a7-9057-01d58338d499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_e0f5d498-ed67-461d-922e-15aa024a17c0" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityAddressPostalZipCode_e0f5d498-ed67-461d-922e-15aa024a17c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a19d4e4b-20f1-40ec-acf2-1670614ec9e8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_CityAreaCode_a19d4e4b-20f1-40ec-acf2-1670614ec9e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_915b0389-8e94-4339-aae3-66913e7cad48" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_LocalPhoneNumber_915b0389-8e94-4339-aae3-66913e7cad48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_e47b1aec-c912-424b-a806-9bdfa060fcce" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_Security12bTitle_e47b1aec-c912-424b-a806-9bdfa060fcce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_4bf78d4b-b8a7-4d70-8fdb-72de70e6f2c6" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_TradingSymbol_4bf78d4b-b8a7-4d70-8fdb-72de70e6f2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_99b7fc98-e651-40df-89f3-2a1e1d2476ab" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_SecurityExchangeName_99b7fc98-e651-40df-89f3-2a1e1d2476ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_8e1c9f4f-649a-49d1-9208-c70f9bff5eba" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_8e1c9f4f-649a-49d1-9208-c70f9bff5eba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_7fb6b771-5525-4ee2-bd88-1dfec271a456" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityVoluntaryFilers_7fb6b771-5525-4ee2-bd88-1dfec271a456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_af460751-a1c7-4ad4-b689-128473183d2b" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityCurrentReportingStatus_af460751-a1c7-4ad4-b689-128473183d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_da0c6677-656a-4303-9fea-30ce6b819af7" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityInteractiveDataCurrent_da0c6677-656a-4303-9fea-30ce6b819af7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_24f1e663-2d71-4f22-bef9-9b4429d0dcb8" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityFilerCategory_24f1e663-2d71-4f22-bef9-9b4429d0dcb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_a3e01691-09e4-4e4a-9b7d-3022cf244654" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntitySmallBusiness_a3e01691-09e4-4e4a-9b7d-3022cf244654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b884abcc-98fe-437f-83e9-cbc530a8cea9" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityEmergingGrowthCompany_b884abcc-98fe-437f-83e9-cbc530a8cea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_a6c331f8-2ff0-4582-9f7a-9fac424261cd" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_IcfrAuditorAttestationFlag_a6c331f8-2ff0-4582-9f7a-9fac424261cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_9c33250c-3552-471c-86b9-7beaaea5a47d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityShellCompany_9c33250c-3552-471c-86b9-7beaaea5a47d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_f0120be8-de27-4d91-8957-fec58bdcf120" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_f0120be8-de27-4d91-8957-fec58bdcf120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_e3d20cd3-fc40-4fce-8d67-70764b0290a4" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityPublicFloat_e3d20cd3-fc40-4fce-8d67-70764b0290a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_3c31fbeb-d2c1-49fb-bcd7-f69e0a2037a1" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_3c31fbeb-d2c1-49fb-bcd7-f69e0a2037a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_41366d40-f535-4760-a3d0-8fccac85479d" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_EntityCentralIndexKey_41366d40-f535-4760-a3d0-8fccac85479d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_f7e2bf1c-53c6-4f68-a434-cf03817e6472" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_DocumentFiscalYearFocus_f7e2bf1c-53c6-4f68-a434-cf03817e6472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_2c9fba34-574c-421c-9c42-c476d043b341" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_DocumentFiscalPeriodFocus_2c9fba34-574c-421c-9c42-c476d043b341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_d2c6c3e4-2a98-405d-b174-dd9103c2bdcf" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_ff17e75f-3dd8-4d44-878f-c680f75cc439" xlink:to="loc_dei_AmendmentFlag_d2c6c3e4-2a98-405d-b174-dd9103c2bdcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/AUDITINFORMATION" xlink:type="simple" xlink:href="pntg-20211231.xsd#AUDITINFORMATION"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/AUDITINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AuditInformationAbstract_63c19b38-959d-48e4-b4f9-56a1338e2451" xlink:href="pntg-20211231.xsd#pntg_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_40c2fa1a-a419-40c2-9c64-df1564cda664" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pntg_AuditInformationAbstract_63c19b38-959d-48e4-b4f9-56a1338e2451" xlink:to="loc_dei_AuditorFirmId_40c2fa1a-a419-40c2-9c64-df1564cda664" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_0629f3f9-a26b-449c-b919-47694cd80c2a" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pntg_AuditInformationAbstract_63c19b38-959d-48e4-b4f9-56a1338e2451" xlink:to="loc_dei_AuditorName_0629f3f9-a26b-449c-b919-47694cd80c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_edac9db8-9093-4ed4-b3f7-000ebedfd689" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_pntg_AuditInformationAbstract_63c19b38-959d-48e4-b4f9-56a1338e2451" xlink:to="loc_dei_AuditorLocation_edac9db8-9093-4ed4-b3f7-000ebedfd689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="pntg-20211231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_695eca23-7a82-43c1-bc96-26c03f6a93bf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_87bb98bb-22ff-4139-9234-1a587170d47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_695eca23-7a82-43c1-bc96-26c03f6a93bf" xlink:to="loc_us-gaap_AssetsAbstract_87bb98bb-22ff-4139-9234-1a587170d47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_360d72cb-5504-413a-9c00-12bb4d38d074" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87bb98bb-22ff-4139-9234-1a587170d47c" xlink:to="loc_us-gaap_AssetsCurrentAbstract_360d72cb-5504-413a-9c00-12bb4d38d074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_d77b745b-9774-48b2-ac30-9001e642ace0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_360d72cb-5504-413a-9c00-12bb4d38d074" xlink:to="loc_us-gaap_Cash_d77b745b-9774-48b2-ac30-9001e642ace0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_9ab56477-2a4f-46ab-b49f-8069d462ef3e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_360d72cb-5504-413a-9c00-12bb4d38d074" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_9ab56477-2a4f-46ab-b49f-8069d462ef3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_61b23487-3760-44ae-8d64-39c766b00dee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_360d72cb-5504-413a-9c00-12bb4d38d074" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_61b23487-3760-44ae-8d64-39c766b00dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_390c3ba4-33a8-403a-ac84-f5757ea23a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_360d72cb-5504-413a-9c00-12bb4d38d074" xlink:to="loc_us-gaap_AssetsCurrent_390c3ba4-33a8-403a-ac84-f5757ea23a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f25e0844-2725-4067-b44f-de9b65d19b07" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87bb98bb-22ff-4139-9234-1a587170d47c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f25e0844-2725-4067-b44f-de9b65d19b07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_46713605-8f9f-4cb9-a570-f4157c1c8afc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87bb98bb-22ff-4139-9234-1a587170d47c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_46713605-8f9f-4cb9-a570-f4157c1c8afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_a16729df-a8e7-4ede-a2f9-793d299bd211" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EscrowDeposit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87bb98bb-22ff-4139-9234-1a587170d47c" xlink:to="loc_us-gaap_EscrowDeposit_a16729df-a8e7-4ede-a2f9-793d299bd211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_4a870cb2-10e9-46f9-8fbb-4a51c95837f8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87bb98bb-22ff-4139-9234-1a587170d47c" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_4a870cb2-10e9-46f9-8fbb-4a51c95837f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherRestrictedAssetsNoncurrent_6c8a40f5-3444-4d2d-8381-ed6134348bf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherRestrictedAssetsNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87bb98bb-22ff-4139-9234-1a587170d47c" xlink:to="loc_us-gaap_OtherRestrictedAssetsNoncurrent_6c8a40f5-3444-4d2d-8381-ed6134348bf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b18f8562-88d7-4d80-8277-da7d79ac65ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87bb98bb-22ff-4139-9234-1a587170d47c" xlink:to="loc_us-gaap_Goodwill_b18f8562-88d7-4d80-8277-da7d79ac65ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_429cd7e3-2228-48e4-aec4-99ea3f541354" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87bb98bb-22ff-4139-9234-1a587170d47c" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_429cd7e3-2228-48e4-aec4-99ea3f541354" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6366fccb-fc6f-4950-b928-cc56446731a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_87bb98bb-22ff-4139-9234-1a587170d47c" xlink:to="loc_us-gaap_Assets_6366fccb-fc6f-4950-b928-cc56446731a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bd0d3cd5-be22-49c2-a7cd-4af33eb040e8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_695eca23-7a82-43c1-bc96-26c03f6a93bf" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bd0d3cd5-be22-49c2-a7cd-4af33eb040e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_e7994c9b-c382-46d4-aae7-36794ef33b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bd0d3cd5-be22-49c2-a7cd-4af33eb040e8" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_e7994c9b-c382-46d4-aae7-36794ef33b4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_7800bdf9-0557-4fc1-8247-4d483869a41b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7994c9b-c382-46d4-aae7-36794ef33b4c" xlink:to="loc_us-gaap_AccountsPayableCurrent_7800bdf9-0557-4fc1-8247-4d483869a41b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c1ea9cd6-283e-4157-b3ee-61584d4d4933" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7994c9b-c382-46d4-aae7-36794ef33b4c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c1ea9cd6-283e-4157-b3ee-61584d4d4933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3631cc9a-4497-4333-9891-893ff14e18a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7994c9b-c382-46d4-aae7-36794ef33b4c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3631cc9a-4497-4333-9891-893ff14e18a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_dd78b803-7360-421a-8ac1-90797a801072" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7994c9b-c382-46d4-aae7-36794ef33b4c" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_dd78b803-7360-421a-8ac1-90797a801072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_bcfb1163-847a-47c8-aa1d-5afc2562329c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_e7994c9b-c382-46d4-aae7-36794ef33b4c" xlink:to="loc_us-gaap_LiabilitiesCurrent_bcfb1163-847a-47c8-aa1d-5afc2562329c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ce3e68bf-7a3c-4a99-a421-50bc86ed363b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bd0d3cd5-be22-49c2-a7cd-4af33eb040e8" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_ce3e68bf-7a3c-4a99-a421-50bc86ed363b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_469ff65a-8849-4a39-bb84-bf477bde1c01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bd0d3cd5-be22-49c2-a7cd-4af33eb040e8" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_469ff65a-8849-4a39-bb84-bf477bde1c01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_6dde893b-de31-42dc-8669-8ea425308caa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bd0d3cd5-be22-49c2-a7cd-4af33eb040e8" xlink:to="loc_us-gaap_LongTermDebt_6dde893b-de31-42dc-8669-8ea425308caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_3a777a03-4058-4c0f-aea7-94c7d26fdd06" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bd0d3cd5-be22-49c2-a7cd-4af33eb040e8" xlink:to="loc_us-gaap_Liabilities_3a777a03-4058-4c0f-aea7-94c7d26fdd06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_cf331220-0ca6-4939-be94-bdcef111093b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bd0d3cd5-be22-49c2-a7cd-4af33eb040e8" xlink:to="loc_us-gaap_CommitmentsAndContingencies_cf331220-0ca6-4939-be94-bdcef111093b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_51f852db-f900-47b0-af46-be6c2fe634ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bd0d3cd5-be22-49c2-a7cd-4af33eb040e8" xlink:to="loc_us-gaap_EquityAbstract_51f852db-f900-47b0-af46-be6c2fe634ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_11670929-e520-46be-a99c-34efa87d4855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_51f852db-f900-47b0-af46-be6c2fe634ec" xlink:to="loc_us-gaap_CommonStockValue_11670929-e520-46be-a99c-34efa87d4855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_912866cc-cfab-4be3-b79c-e49bc8913aac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_51f852db-f900-47b0-af46-be6c2fe634ec" xlink:to="loc_us-gaap_AdditionalPaidInCapital_912866cc-cfab-4be3-b79c-e49bc8913aac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6f60ffe9-f764-4baa-97bd-e9ca00cc7e55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_51f852db-f900-47b0-af46-be6c2fe634ec" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6f60ffe9-f764-4baa-97bd-e9ca00cc7e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_7b3f5aa1-ebbe-47fc-874b-1c5b8c1d1754" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_51f852db-f900-47b0-af46-be6c2fe634ec" xlink:to="loc_us-gaap_TreasuryStockValue_7b3f5aa1-ebbe-47fc-874b-1c5b8c1d1754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NetParentInvestment_4c77d50b-e32c-452d-be51-4860a1110631" xlink:href="pntg-20211231.xsd#pntg_NetParentInvestment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_51f852db-f900-47b0-af46-be6c2fe634ec" xlink:to="loc_pntg_NetParentInvestment_4c77d50b-e32c-452d-be51-4860a1110631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterest_c69ac04e-3b53-4ebe-9479-4584e95a86c7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_51f852db-f900-47b0-af46-be6c2fe634ec" xlink:to="loc_us-gaap_MinorityInterest_c69ac04e-3b53-4ebe-9479-4584e95a86c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1b2ab3f1-8d48-4b1e-afaa-4f12e778c4b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_51f852db-f900-47b0-af46-be6c2fe634ec" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_1b2ab3f1-8d48-4b1e-afaa-4f12e778c4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_7f037ec5-3191-4e01-96b3-1ea8ea044336" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_bd0d3cd5-be22-49c2-a7cd-4af33eb040e8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_7f037ec5-3191-4e01-96b3-1ea8ea044336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="pntg-20211231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0b683727-5bec-4d00-aced-417668edf163" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ab2deb27-8d67-4d99-aabc-a851f6f325fc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b683727-5bec-4d00-aced-417668edf163" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ab2deb27-8d67-4d99-aabc-a851f6f325fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_c985dad1-2397-4f77-ad60-a97463554569" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b683727-5bec-4d00-aced-417668edf163" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_c985dad1-2397-4f77-ad60-a97463554569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_e1eef205-ecc7-40be-a72b-cbeb9312da27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b683727-5bec-4d00-aced-417668edf163" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_e1eef205-ecc7-40be-a72b-cbeb9312da27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_eb9c7611-261b-46ea-ac2e-42740e156eeb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b683727-5bec-4d00-aced-417668edf163" xlink:to="loc_us-gaap_CommonStockSharesIssued_eb9c7611-261b-46ea-ac2e-42740e156eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f1366c71-50e4-4c19-b011-a230301b99f9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0b683727-5bec-4d00-aced-417668edf163" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f1366c71-50e4-4c19-b011-a230301b99f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME" xlink:type="simple" xlink:href="pntg-20211231.xsd#CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7f0396e3-9429-4b0d-8607-a47bf58b7ead" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_7f0396e3-9429-4b0d-8607-a47bf58b7ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpensesAbstract_c49cd194-f3d3-48e0-b280-a85edf2ecae6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpensesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:to="loc_us-gaap_CostsAndExpensesAbstract_c49cd194-f3d3-48e0-b280-a85edf2ecae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_d9d100bd-2236-464a-aadf-df17db40a727" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c49cd194-f3d3-48e0-b280-a85edf2ecae6" xlink:to="loc_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_d9d100bd-2236-464a-aadf-df17db40a727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_b8450a61-5b12-4caa-9236-b231f5a9851d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c49cd194-f3d3-48e0-b280-a85edf2ecae6" xlink:to="loc_us-gaap_OperatingLeaseExpense_b8450a61-5b12-4caa-9236-b231f5a9851d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_86e3fc3b-d735-467a-a9be-165366f46320" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c49cd194-f3d3-48e0-b280-a85edf2ecae6" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_86e3fc3b-d735-467a-a9be-165366f46320" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_72def609-7913-45f5-b727-3022d4ef8025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c49cd194-f3d3-48e0-b280-a85edf2ecae6" xlink:to="loc_us-gaap_DepreciationAndAmortization_72def609-7913-45f5-b727-3022d4ef8025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostsAndExpenses_5646f1dc-99a8-483a-9fa0-ca5b0f5918e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostsAndExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostsAndExpensesAbstract_c49cd194-f3d3-48e0-b280-a85edf2ecae6" xlink:to="loc_us-gaap_CostsAndExpenses_5646f1dc-99a8-483a-9fa0-ca5b0f5918e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_c7c994b6-820e-4576-94ba-130127f783db" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:to="loc_us-gaap_OperatingIncomeLoss_c7c994b6-820e-4576-94ba-130127f783db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpenseAbstract_617595f9-7bb8-435e-9871-1b708f90f4cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpenseAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:to="loc_us-gaap_NonoperatingIncomeExpenseAbstract_617595f9-7bb8-435e-9871-1b708f90f4cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_8db9fbcb-9af5-4ff0-ac82-fb46307b6824" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_617595f9-7bb8-435e-9871-1b708f90f4cd" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_8db9fbcb-9af5-4ff0-ac82-fb46307b6824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_d0db7b1c-f035-4c26-a270-f993884e4d8f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_617595f9-7bb8-435e-9871-1b708f90f4cd" xlink:to="loc_us-gaap_InterestExpense_d0db7b1c-f035-4c26-a270-f993884e4d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_ad264b02-a23b-454b-9ba6-0104b9301a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NonoperatingIncomeExpenseAbstract_617595f9-7bb8-435e-9871-1b708f90f4cd" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_ad264b02-a23b-454b-9ba6-0104b9301a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_02a33e85-f544-4219-aff8-42cb2709ae41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_02a33e85-f544-4219-aff8-42cb2709ae41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_0e382f1d-a4e3-453d-a637-e56975a13c77" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_0e382f1d-a4e3-453d-a637-e56975a13c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_5a287487-0ef4-46e8-9734-fbc5bd196e64" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:to="loc_us-gaap_ProfitLoss_5a287487-0ef4-46e8-9734-fbc5bd196e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bb8f8464-e34f-49ee-817e-cd576358b976" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_bb8f8464-e34f-49ee-817e-cd576358b976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_67b60417-bf4f-465c-8105-cb10e9c204cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:to="loc_us-gaap_NetIncomeLoss_67b60417-bf4f-465c-8105-cb10e9c204cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_b30c849e-bda2-4edb-865e-7c1ca29513cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:to="loc_us-gaap_EarningsPerShareAbstract_b30c849e-bda2-4edb-865e-7c1ca29513cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_b9752adb-59f4-4752-a48c-38c87c8fbed4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b30c849e-bda2-4edb-865e-7c1ca29513cd" xlink:to="loc_us-gaap_EarningsPerShareBasic_b9752adb-59f4-4752-a48c-38c87c8fbed4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_f98129c2-acff-4fc7-a014-91224a98fd9f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_b30c849e-bda2-4edb-865e-7c1ca29513cd" xlink:to="loc_us-gaap_EarningsPerShareDiluted_f98129c2-acff-4fc7-a014-91224a98fd9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c75787fe-ed96-4b29-aa91-751c3d67eb60" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_7d36c7fa-9bf4-46ad-abb6-0439a7655377" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c75787fe-ed96-4b29-aa91-751c3d67eb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d0056e99-528e-4854-ab58-6d8e71a969ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c75787fe-ed96-4b29-aa91-751c3d67eb60" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_d0056e99-528e-4854-ab58-6d8e71a969ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_44919c67-df58-4fcf-84ea-f5f2306eb571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_c75787fe-ed96-4b29-aa91-751c3d67eb60" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_44919c67-df58-4fcf-84ea-f5f2306eb571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT" xlink:type="simple" xlink:href="pntg-20211231.xsd#CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_6aa146c2-6623-4a06-99f5-02412dffb780" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_690805f0-1a24-42e2-a5c6-4469681e4ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_6aa146c2-6623-4a06-99f5-02412dffb780" xlink:to="loc_us-gaap_StatementTable_690805f0-1a24-42e2-a5c6-4469681e4ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ebe699b8-905d-485a-8841-a4ba18611e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_690805f0-1a24-42e2-a5c6-4469681e4ed6" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ebe699b8-905d-485a-8841-a4ba18611e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ebe699b8-905d-485a-8841-a4ba18611e1e" xlink:to="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_936160f0-6045-418c-a095-ef5daf1faf26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_CommonStockMember_936160f0-6045-418c-a095-ef5daf1faf26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_4d33ca3a-2db3-49e8-987c-7c6ae09b3954" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_4d33ca3a-2db3-49e8-987c-7c6ae09b3954" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_dc169f05-b2d5-47d2-9651-c2322c48285c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_RetainedEarningsMember_dc169f05-b2d5-47d2-9651-c2322c48285c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_91c41806-a754-4cca-bd25-fcac29ec9df1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_TreasuryStockMember_91c41806-a754-4cca-bd25-fcac29ec9df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ParentMember_ea6c3654-4db2-49ca-8fe5-7bfedbcf6323" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ParentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_ParentMember_ea6c3654-4db2-49ca-8fe5-7bfedbcf6323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestMember_549e979d-b9af-41df-95f0-d44021dcf4d9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_40e6bbda-4185-408d-98a2-883fba22fac8" xlink:to="loc_us-gaap_NoncontrollingInterestMember_549e979d-b9af-41df-95f0-d44021dcf4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_45e4d13c-5966-4056-9bb5-1b5b2ff51fac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_690805f0-1a24-42e2-a5c6-4469681e4ed6" xlink:to="loc_us-gaap_StatementLineItems_45e4d13c-5966-4056-9bb5-1b5b2ff51fac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_45e4d13c-5966-4056-9bb5-1b5b2ff51fac" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_599161a3-49a9-4961-9033-006df2c27d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_SharesOutstanding_599161a3-49a9-4961-9033-006df2c27d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5a8deb46-2b4c-495f-8e0b-1f696470b7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_5a8deb46-2b4c-495f-8e0b-1f696470b7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dc614bc6-edc5-43ce-8d82-0ae081ba8659" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance_dc614bc6-edc5-43ce-8d82-0ae081ba8659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_7c591974-3c24-4717-ac0a-7df11f138dc7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestDecreaseFromRedemptions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_MinorityInterestDecreaseFromRedemptions_7c591974-3c24-4717-ac0a-7df11f138dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9eedff0e-0cbe-497d-9eca-97a5f5854919" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_9eedff0e-0cbe-497d-9eca-97a5f5854919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_StockholdersEquityDistributionsFromParent_7e32f6af-19f6-4725-9805-bcaaa6f85436" xlink:href="pntg-20211231.xsd#pntg_StockholdersEquityDistributionsFromParent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_pntg_StockholdersEquityDistributionsFromParent_7e32f6af-19f6-4725-9805-bcaaa6f85436" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e51070c6-1c53-4211-b6e5-f7878062abca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_NetIncomeLoss_e51070c6-1c53-4211-b6e5-f7878062abca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DividendsCash_05277f47-8386-4c00-a633-560bb27f2a26" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCash"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_DividendsCash_05277f47-8386-4c00-a633-560bb27f2a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ReclassificationOfInvestedEquity_d154668f-d230-4589-827e-dfcc87c083c7" xlink:href="pntg-20211231.xsd#pntg_ReclassificationOfInvestedEquity"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_pntg_ReclassificationOfInvestedEquity_d154668f-d230-4589-827e-dfcc87c083c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_9131e3f9-b9d3-4615-9f7f-1d816a345c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_9131e3f9-b9d3-4615-9f7f-1d816a345c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_381b3f55-3662-4b07-9e96-d2b7425bea28" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_381b3f55-3662-4b07-9e96-d2b7425bea28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3caaf3a6-587b-433e-8129-7ca404de5be0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3caaf3a6-587b-433e-8129-7ca404de5be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e2063f8f-d99e-4546-b54e-68c73a8f3191" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_e2063f8f-d99e-4546-b54e-68c73a8f3191" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3ff28796-bd12-45d4-ae32-31c0b35ac107" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_3ff28796-bd12-45d4-ae32-31c0b35ac107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8afd6d3e-a047-48e7-b1cb-63d5a0cf5b65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination_8afd6d3e-a047-48e7-b1cb-63d5a0cf5b65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_296d7bf1-48c6-4a75-9a2e-3d0a35f63fd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_296d7bf1-48c6-4a75-9a2e-3d0a35f63fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ee5c3141-73f5-41a3-b016-4190d1b39152" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures_ee5c3141-73f5-41a3-b016-4190d1b39152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_9b1f69c0-0225-4a0c-8632-3bdc1c6489f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_9b1f69c0-0225-4a0c-8632-3bdc1c6489f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_11f67f61-c49f-4ea3-8adb-0847ebb54916" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_11f67f61-c49f-4ea3-8adb-0847ebb54916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1ab1ddb8-4fc6-4321-9554-d2d88411f534" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_1ab1ddb8-4fc6-4321-9554-d2d88411f534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_fa2e7275-7058-4188-b7ac-a040ef3a6d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_SharesOutstanding_fa2e7275-7058-4188-b7ac-a040ef3a6d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5dde59a-b1b5-427f-8a1f-60e9b1803928" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_cc2116b7-565a-4ab6-9373-2630c3ef234d" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f5dde59a-b1b5-427f-8a1f-60e9b1803928" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="pntg-20211231.xsd#CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_ccef66a2-31c4-412e-a514-e15b60a2aa01" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8dab348c-52f3-444c-a730-97429cb7baae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ccef66a2-31c4-412e-a514-e15b60a2aa01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8dab348c-52f3-444c-a730-97429cb7baae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_818b0bec-0c84-4d3e-96e0-4b130f11b5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8dab348c-52f3-444c-a730-97429cb7baae" xlink:to="loc_us-gaap_ProfitLoss_818b0bec-0c84-4d3e-96e0-4b130f11b5e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3af01e7-e4ec-4e97-abe4-337007131076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8dab348c-52f3-444c-a730-97429cb7baae" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3af01e7-e4ec-4e97-abe4-337007131076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_3efb6acb-4abc-4031-a75f-ce65f965c70b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3af01e7-e4ec-4e97-abe4-337007131076" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_3efb6acb-4abc-4031-a75f-ce65f965c70b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_1977f39b-5596-433d-b07c-7c2080c55148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3af01e7-e4ec-4e97-abe4-337007131076" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_1977f39b-5596-433d-b07c-7c2080c55148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_2c253fcf-0e3a-457d-8a71-f8e0bada3d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3af01e7-e4ec-4e97-abe4-337007131076" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_2c253fcf-0e3a-457d-8a71-f8e0bada3d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_432fe45b-1ac7-429a-a3c9-7354c586971b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3af01e7-e4ec-4e97-abe4-337007131076" xlink:to="loc_us-gaap_ShareBasedCompensation_432fe45b-1ac7-429a-a3c9-7354c586971b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_5fc0ce57-a42a-4c7c-9178-4898e69f817d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxesAndTaxCredits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3af01e7-e4ec-4e97-abe4-337007131076" xlink:to="loc_us-gaap_DeferredIncomeTaxesAndTaxCredits_5fc0ce57-a42a-4c7c-9178-4898e69f817d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_176d6e97-e742-459c-8542-8530e8191de5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3af01e7-e4ec-4e97-abe4-337007131076" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_176d6e97-e742-459c-8542-8530e8191de5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b499b1a3-0c8f-4d52-ae5d-311df44ab4f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_f3af01e7-e4ec-4e97-abe4-337007131076" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b499b1a3-0c8f-4d52-ae5d-311df44ab4f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2b7ddb33-7b59-4bc6-ad33-6b92633be514" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b499b1a3-0c8f-4d52-ae5d-311df44ab4f7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_2b7ddb33-7b59-4bc6-ad33-6b92633be514" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b3eb8c36-c575-4978-b9d2-da65ca2aa1a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b499b1a3-0c8f-4d52-ae5d-311df44ab4f7" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b3eb8c36-c575-4978-b9d2-da65ca2aa1a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0ff42174-7fcf-4477-a181-3a400a15ee71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b499b1a3-0c8f-4d52-ae5d-311df44ab4f7" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0ff42174-7fcf-4477-a181-3a400a15ee71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_58859e06-a6dc-468a-809d-54a640ab02e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b499b1a3-0c8f-4d52-ae5d-311df44ab4f7" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_58859e06-a6dc-468a-809d-54a640ab02e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_4428b98b-1109-49f1-a654-c34dfe9a6c5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b499b1a3-0c8f-4d52-ae5d-311df44ab4f7" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_4428b98b-1109-49f1-a654-c34dfe9a6c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_ee9b88ea-39de-4743-b247-e969b69d7e9c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b499b1a3-0c8f-4d52-ae5d-311df44ab4f7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_ee9b88ea-39de-4743-b247-e969b69d7e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_f2398b58-c924-44f1-b87e-b7b8f36d2803" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInContractWithCustomerLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b499b1a3-0c8f-4d52-ae5d-311df44ab4f7" xlink:to="loc_us-gaap_IncreaseDecreaseInContractWithCustomerLiability_f2398b58-c924-44f1-b87e-b7b8f36d2803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_77ff90ab-5d34-47e8-8b21-a9ae119ff493" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_b499b1a3-0c8f-4d52-ae5d-311df44ab4f7" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities_77ff90ab-5d34-47e8-8b21-a9ae119ff493" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_09e8e090-b6e7-4ac2-bd37-6e78ed22d631" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_8dab348c-52f3-444c-a730-97429cb7baae" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_09e8e090-b6e7-4ac2-bd37-6e78ed22d631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_48113d95-72fb-4378-b7a5-56457927b7bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ccef66a2-31c4-412e-a514-e15b60a2aa01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_48113d95-72fb-4378-b7a5-56457927b7bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d2199760-af8c-4fbf-b318-0f1c3d96f382" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_48113d95-72fb-4378-b7a5-56457927b7bd" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d2199760-af8c-4fbf-b318-0f1c3d96f382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesGross_04823766-ed7f-4f1c-8a02-9e3fc9825513" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_48113d95-72fb-4378-b7a5-56457927b7bd" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesGross_04823766-ed7f-4f1c-8a02-9e3fc9825513" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_PaymentsForDepositsOnAcquisition_37676ae7-9044-4011-8a92-259ce5b35be0" xlink:href="pntg-20211231.xsd#pntg_PaymentsForDepositsOnAcquisition"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_48113d95-72fb-4378-b7a5-56457927b7bd" xlink:to="loc_pntg_PaymentsForDepositsOnAcquisition_37676ae7-9044-4011-8a92-259ce5b35be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_PaymentsForProceedsFromPropertyReserveRequirements_3d3865ac-370c-4d6c-9fad-f54b84f43b14" xlink:href="pntg-20211231.xsd#pntg_PaymentsForProceedsFromPropertyReserveRequirements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_48113d95-72fb-4378-b7a5-56457927b7bd" xlink:to="loc_pntg_PaymentsForProceedsFromPropertyReserveRequirements_3d3865ac-370c-4d6c-9fad-f54b84f43b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1d67a5da-603a-4a33-8843-209d68d5b018" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_48113d95-72fb-4378-b7a5-56457927b7bd" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1d67a5da-603a-4a33-8843-209d68d5b018" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ccef66a2-31c4-412e-a514-e15b60a2aa01" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ProceedsFromSaleOfSubsidiaryShares_7fa4410b-3f43-441a-9293-c7e6bb7b391f" xlink:href="pntg-20211231.xsd#pntg_ProceedsFromSaleOfSubsidiaryShares"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:to="loc_pntg_ProceedsFromSaleOfSubsidiaryShares_7fa4410b-3f43-441a-9293-c7e6bb7b391f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToMinorityShareholders_b407fdc4-d7df-453e-a544-c9d13cb3f5b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToMinorityShareholders"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:to="loc_us-gaap_PaymentsToMinorityShareholders_b407fdc4-d7df-453e-a544-c9d13cb3f5b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DistributionToFromParent_a3eaf158-417a-4fe9-a44d-4f2bfa50ae0b" xlink:href="pntg-20211231.xsd#pntg_DistributionToFromParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:to="loc_pntg_DistributionToFromParent_a3eaf158-417a-4fe9-a44d-4f2bfa50ae0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDividends_8eb13495-5da1-48c5-867b-2a7a9e904ea2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividends"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:to="loc_us-gaap_PaymentsOfDividends_8eb13495-5da1-48c5-867b-2a7a9e904ea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMinorityShareholders_2cc3f342-3ab7-4964-a613-9a2fb942d362" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromMinorityShareholders"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:to="loc_us-gaap_ProceedsFromMinorityShareholders_2cc3f342-3ab7-4964-a613-9a2fb942d362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_939769af-4f54-4aae-ae18-b11575a228a0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromLongTermLinesOfCredit"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:to="loc_us-gaap_ProceedsFromLongTermLinesOfCredit_939769af-4f54-4aae-ae18-b11575a228a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_3eca9d2b-9b9f-4cb6-80fb-c82a8617d7cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RepaymentsOfLongTermLinesOfCredit"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:to="loc_us-gaap_RepaymentsOfLongTermLinesOfCredit_3eca9d2b-9b9f-4cb6-80fb-c82a8617d7cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0a7535bb-55e1-4d04-a47a-5f9a9ad97893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_0a7535bb-55e1-4d04-a47a-5f9a9ad97893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfFinancingCosts_91d81a5f-5418-4485-98d5-ea8cfea6d584" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfFinancingCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:to="loc_us-gaap_PaymentsOfFinancingCosts_91d81a5f-5418-4485-98d5-ea8cfea6d584" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_af3ecd5d-1ebb-4a15-8c81-fe4392043f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_af3ecd5d-1ebb-4a15-8c81-fe4392043f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_84d5da1c-81b9-471f-a4ed-3f93be8ee7aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_f9cd546b-8fb1-4f5f-b230-215cf02b4e08" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_84d5da1c-81b9-471f-a4ed-3f93be8ee7aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ad0609e6-a05a-4eab-8938-add50fbb182e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ccef66a2-31c4-412e-a514-e15b60a2aa01" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_ad0609e6-a05a-4eab-8938-add50fbb182e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c5b7a4d0-c236-47db-9945-852ebc253379" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ccef66a2-31c4-412e-a514-e15b60a2aa01" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c5b7a4d0-c236-47db-9945-852ebc253379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_255a4d40-5bdd-47cf-9afd-90df96d2ddf2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ccef66a2-31c4-412e-a514-e15b60a2aa01" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_255a4d40-5bdd-47cf-9afd-90df96d2ddf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_5c0d2659-8bfb-42e5-8a4c-3bdd783b5e21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_ccef66a2-31c4-412e-a514-e15b60a2aa01" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_5c0d2659-8bfb-42e5-8a4c-3bdd783b5e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_118b3baf-e2ee-4544-945d-1387bc9c60e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_5c0d2659-8bfb-42e5-8a4c-3bdd783b5e21" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_118b3baf-e2ee-4544-945d-1387bc9c60e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_08f3bd4b-c6e3-42ed-ad0b-1ea868219a85" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_118b3baf-e2ee-4544-945d-1387bc9c60e7" xlink:to="loc_us-gaap_InterestPaidNet_08f3bd4b-c6e3-42ed-ad0b-1ea868219a85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_597bea92-bfb3-4e32-b90e-6c685d1af2a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_118b3baf-e2ee-4544-945d-1387bc9c60e7" xlink:to="loc_us-gaap_IncomeTaxesPaid_597bea92-bfb3-4e32-b90e-6c685d1af2a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_cb7a689c-01d7-4bca-ae35-9cbfe089698c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_118b3baf-e2ee-4544-945d-1387bc9c60e7" xlink:to="loc_us-gaap_OperatingLeasePayments_cb7a689c-01d7-4bca-ae35-9cbfe089698c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a3fa3aba-62cd-415c-82b8-307b9db5e27a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_5c0d2659-8bfb-42e5-8a4c-3bdd783b5e21" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a3fa3aba-62cd-415c-82b8-307b9db5e27a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability_cd92b3c6-3c31-4cdc-a328-b893d8132f4f" xlink:href="pntg-20211231.xsd#pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_5c0d2659-8bfb-42e5-8a4c-3bdd783b5e21" xlink:to="loc_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability_cd92b3c6-3c31-4cdc-a328-b893d8132f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_3fee5a38-36ec-410e-bfbf-6fd23c342c90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_5c0d2659-8bfb-42e5-8a4c-3bdd783b5e21" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_3fee5a38-36ec-410e-bfbf-6fd23c342c90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_df2a2731-98a9-4a66-ba18-6bf33d9c848e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_3fee5a38-36ec-410e-bfbf-6fd23c342c90" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_df2a2731-98a9-4a66-ba18-6bf33d9c848e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/DESCRIPTIONOFBUSINESS" xlink:type="simple" xlink:href="pntg-20211231.xsd#DESCRIPTIONOFBUSINESS"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/DESCRIPTIONOFBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_33302409-7d1e-4dde-a318-35c09ba7e27c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NatureOfOperations_0e080945-787b-4b3f-acbd-829dfee7b94f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_33302409-7d1e-4dde-a318-35c09ba7e27c" xlink:to="loc_us-gaap_NatureOfOperations_0e080945-787b-4b3f-acbd-829dfee7b94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#DESCRIPTIONOFBUSINESSDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebe88701-7fa3-4cb3-b9c0-e9beb9e1a1bd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d44d17a2-826f-47c1-9a30-4194c2de0ad9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ebe88701-7fa3-4cb3-b9c0-e9beb9e1a1bd" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d44d17a2-826f-47c1-9a30-4194c2de0ad9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_77a7abfe-aee5-49aa-9127-e1e33d0ef340" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d44d17a2-826f-47c1-9a30-4194c2de0ad9" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_77a7abfe-aee5-49aa-9127-e1e33d0ef340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e2ec8c75-42ff-433c-a650-ac6167544212" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_77a7abfe-aee5-49aa-9127-e1e33d0ef340" xlink:to="loc_us-gaap_SegmentDomain_e2ec8c75-42ff-433c-a650-ac6167544212" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_d11bea18-2735-4c91-b89a-6a2fa54a9336" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e2ec8c75-42ff-433c-a650-ac6167544212" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_d11bea18-2735-4c91-b89a-6a2fa54a9336" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_9576ff89-e3fc-4c80-8e29-3164041adf96" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e2ec8c75-42ff-433c-a650-ac6167544212" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_9576ff89-e3fc-4c80-8e29-3164041adf96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_96960494-3469-4e94-acfc-8fc32a417497" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_d44d17a2-826f-47c1-9a30-4194c2de0ad9" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_96960494-3469-4e94-acfc-8fc32a417497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfServiceProviders_42af40d8-fa2d-4cee-8dbc-ee7b0cb51cb5" xlink:href="pntg-20211231.xsd#pntg_NumberOfServiceProviders"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96960494-3469-4e94-acfc-8fc32a417497" xlink:to="loc_pntg_NumberOfServiceProviders_42af40d8-fa2d-4cee-8dbc-ee7b0cb51cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfRealEstatePropertiesUnderLease_44e037fa-0904-464b-ae08-9feb25113322" xlink:href="pntg-20211231.xsd#pntg_NumberOfRealEstatePropertiesUnderLease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96960494-3469-4e94-acfc-8fc32a417497" xlink:to="loc_pntg_NumberOfRealEstatePropertiesUnderLease_44e037fa-0904-464b-ae08-9feb25113322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SpinOffTransactionDistributionRatio_0d13e22d-4c94-47f5-8a12-6eaf07ebd462" xlink:href="pntg-20211231.xsd#pntg_SpinOffTransactionDistributionRatio"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_96960494-3469-4e94-acfc-8fc32a417497" xlink:to="loc_pntg_SpinOffTransactionDistributionRatio_0d13e22d-4c94-47f5-8a12-6eaf07ebd462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="pntg-20211231.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_6123a0e5-9342-4922-865b-6ef457295b84" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_a448343a-4c57-457c-ba80-30eba3ef9868" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_6123a0e5-9342-4922-865b-6ef457295b84" xlink:to="loc_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock_a448343a-4c57-457c-ba80-30eba3ef9868" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="pntg-20211231.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7c1b9a5c-22e7-4c7a-997a-c2f6f96aa505" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_7c1b9a5c-22e7-4c7a-997a-c2f6f96aa505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_6bb99ddc-6331-4865-a3d3-a8023fd8953a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_6bb99ddc-6331-4865-a3d3-a8023fd8953a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_53cf7fc9-84f9-49f7-8a5a-0528428ea13f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_UseOfEstimates_53cf7fc9-84f9-49f7-8a5a-0528428ea13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_640c875e-132e-45c7-9eb0-8fba3b9188cf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_640c875e-132e-45c7-9eb0-8fba3b9188cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_eb843a83-ecf8-4309-8a6a-24cf0dd77b59" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_eb843a83-ecf8-4309-8a6a-24cf0dd77b59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_e6b28c42-d1d9-4465-9044-4a7974ba4c7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_e6b28c42-d1d9-4465-9044-4a7974ba4c7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_73bb193f-f4c0-4d27-9dbd-e5478ed62215" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_73bb193f-f4c0-4d27-9dbd-e5478ed62215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_dac67f13-2a4f-4bf2-82af-7a2d9b00a684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock_dac67f13-2a4f-4bf2-82af-7a2d9b00a684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_bf1b38c6-ec39-458d-b030-5a2e79d817ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_bf1b38c6-ec39-458d-b030-5a2e79d817ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9dfa4518-1913-449e-b98a-ba23e56d183e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_9dfa4518-1913-449e-b98a-ba23e56d183e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_fdde9cce-c03b-4302-ae0d-79e28025a657" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_fdde9cce-c03b-4302-ae0d-79e28025a657" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InvestedCapitalPolicyTextBlock_d00dfb4a-0fc8-423e-b3d2-f3587ee126b2" xlink:href="pntg-20211231.xsd#pntg_InvestedCapitalPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_pntg_InvestedCapitalPolicyTextBlock_d00dfb4a-0fc8-423e-b3d2-f3587ee126b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_e81c25fb-f561-4372-9ab9-6b2f735b47b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy_e81c25fb-f561-4372-9ab9-6b2f735b47b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_a95a6074-dc81-492f-adb1-11cbc199960f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_a95a6074-dc81-492f-adb1-11cbc199960f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ac1d911d-ca5d-454b-ba9e-1f97c53fefdf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_ac1d911d-ca5d-454b-ba9e-1f97c53fefdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f3870ec4-3208-4085-9d45-ad158fa9fa67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f3af8a88-20d3-4d07-8a24-8fcd90e54686" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_f3870ec4-3208-4085-9d45-ad158fa9fa67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="pntg-20211231.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b166e024-a692-46bc-9f00-91a24472f26a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SummaryOfInsuranceLiabilityTableTextBlock_e524f0d5-35e2-47e3-81c1-407fb56d9fbf" xlink:href="pntg-20211231.xsd#pntg_SummaryOfInsuranceLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b166e024-a692-46bc-9f00-91a24472f26a" xlink:to="loc_pntg_SummaryOfInsuranceLiabilityTableTextBlock_e524f0d5-35e2-47e3-81c1-407fb56d9fbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_c13d3aa5-da4b-4173-8dd8-33cd2208d451" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_137cd687-7677-4ab2-aed4-6230bf488186" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_c13d3aa5-da4b-4173-8dd8-33cd2208d451" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_137cd687-7677-4ab2-aed4-6230bf488186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_dd54dce3-9ac3-4bdd-888e-dd8b01141837" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_137cd687-7677-4ab2-aed4-6230bf488186" xlink:to="loc_srt_RangeAxis_dd54dce3-9ac3-4bdd-888e-dd8b01141837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e54dbba8-3f7e-4656-a4ad-b744c3b8dafd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_dd54dce3-9ac3-4bdd-888e-dd8b01141837" xlink:to="loc_srt_RangeMember_e54dbba8-3f7e-4656-a4ad-b744c3b8dafd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_85260071-a296-4c65-ae2f-ea33fba401a3" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e54dbba8-3f7e-4656-a4ad-b744c3b8dafd" xlink:to="loc_srt_MinimumMember_85260071-a296-4c65-ae2f-ea33fba401a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8f185283-b94c-4ee7-8743-c6ee80f866b7" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e54dbba8-3f7e-4656-a4ad-b744c3b8dafd" xlink:to="loc_srt_MaximumMember_8f185283-b94c-4ee7-8743-c6ee80f866b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_eb84aa43-0e03-4a14-b3b1-5490479607c4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_137cd687-7677-4ab2-aed4-6230bf488186" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_eb84aa43-0e03-4a14-b3b1-5490479607c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_17bcdea7-2c4a-4bac-b046-6cd043b942be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_eb84aa43-0e03-4a14-b3b1-5490479607c4" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_17bcdea7-2c4a-4bac-b046-6cd043b942be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1abbb325-2fbb-45be-9818-e5e06b73810a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_17bcdea7-2c4a-4bac-b046-6cd043b942be" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_1abbb325-2fbb-45be-9818-e5e06b73810a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_e0146df1-6e57-4a65-ab86-bfc28474b02e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_137cd687-7677-4ab2-aed4-6230bf488186" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_e0146df1-6e57-4a65-ab86-bfc28474b02e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d3aed26d-a44b-4fa8-b749-94085b0137ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_e0146df1-6e57-4a65-ab86-bfc28474b02e" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d3aed26d-a44b-4fa8-b749-94085b0137ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bbfa92f3-f1c5-4730-8542-2fe581686267" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d3aed26d-a44b-4fa8-b749-94085b0137ea" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_bbfa92f3-f1c5-4730-8542-2fe581686267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AccruedWagesAndRelatedLiabilitiesMember_b8ccba43-70d4-40ad-8505-0edea5153fbc" xlink:href="pntg-20211231.xsd#pntg_AccruedWagesAndRelatedLiabilitiesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d3aed26d-a44b-4fa8-b749-94085b0137ea" xlink:to="loc_pntg_AccruedWagesAndRelatedLiabilitiesMember_b8ccba43-70d4-40ad-8505-0edea5153fbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_137cd687-7677-4ab2-aed4-6230bf488186" xlink:to="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_d8fb9bf6-7a2c-4c58-8bed-b91cc8443bc4" xlink:href="pntg-20211231.xsd#pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_d8fb9bf6-7a2c-4c58-8bed-b91cc8443bc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds_7b69fa96-1ee9-4815-a56a-d9282407b3f4" xlink:href="pntg-20211231.xsd#pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds_7b69fa96-1ee9-4815-a56a-d9282407b3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AccruedPayrollTaxesEmployerPortion_298448a8-d2ac-4d12-bd7d-da2930f2fc05" xlink:href="pntg-20211231.xsd#pntg_AccruedPayrollTaxesEmployerPortion"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_AccruedPayrollTaxesEmployerPortion_298448a8-d2ac-4d12-bd7d-da2930f2fc05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DirectMedicalSuppliesLaborAndOtherExpenses_0b9435f5-88d0-4d65-a27c-9970b8d11b51" xlink:href="pntg-20211231.xsd#pntg_DirectMedicalSuppliesLaborAndOtherExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_DirectMedicalSuppliesLaborAndOtherExpenses_0b9435f5-88d0-4d65-a27c-9970b8d11b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f36f8ceb-2248-4c0a-a0f5-a8ba51cc3581" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_f36f8ceb-2248-4c0a-a0f5-a8ba51cc3581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_399eff36-e803-40b2-a7cb-952b833cb25b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_399eff36-e803-40b2-a7cb-952b833cb25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ImpairmentLongLivedAssetsNumberOfCommunities_5e30dd47-6e19-4a4a-8615-85065a04d755" xlink:href="pntg-20211231.xsd#pntg_ImpairmentLongLivedAssetsNumberOfCommunities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_ImpairmentLongLivedAssetsNumberOfCommunities_5e30dd47-6e19-4a4a-8615-85065a04d755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_86f158f8-ab82-4b23-8d84-72f612ce93ba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_86f158f8-ab82-4b23-8d84-72f612ce93ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim_7bb02e8b-8c45-48c4-8b9e-7af22c27a594" xlink:href="pntg-20211231.xsd#pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim_7bb02e8b-8c45-48c4-8b9e-7af22c27a594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_CorridorAsAnAdditionalOutOfPocketRetention_6d1c874a-6d83-46b9-8a9d-22b5060f5992" xlink:href="pntg-20211231.xsd#pntg_CorridorAsAnAdditionalOutOfPocketRetention"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_CorridorAsAnAdditionalOutOfPocketRetention_6d1c874a-6d83-46b9-8a9d-22b5060f5992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim_4864bad4-23fb-4e26-a2bb-c0a7e178290f" xlink:href="pntg-20211231.xsd#pntg_WorkersCompensationInsuranceRetentionLimitPerClaim"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim_4864bad4-23fb-4e26-a2bb-c0a7e178290f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_ca10a894-e44f-44b4-ba35-ebefe9dcdfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims_ca10a894-e44f-44b4-ba35-ebefe9dcdfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_24f59945-0b3a-4067-a6a2-a4f27ad466e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_24f59945-0b3a-4067-a6a2-a4f27ad466e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_3537d0d2-7439-408f-97d8-753f912313a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_8f2c1d10-4b4a-4b03-88a1-8af26270b81b" xlink:to="loc_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty_3537d0d2-7439-408f-97d8-753f912313a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1796a387-07f8-46b1-855c-df24289abde1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GeneralAndProfessionalInsuranceLiability_9d370f7f-7d4e-46c5-927c-d029fd8318b3" xlink:href="pntg-20211231.xsd#pntg_GeneralAndProfessionalInsuranceLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1796a387-07f8-46b1-855c-df24289abde1" xlink:to="loc_pntg_GeneralAndProfessionalInsuranceLiability_9d370f7f-7d4e-46c5-927c-d029fd8318b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_2814f3ca-f192-4208-8f63-9419a7bdd2dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1796a387-07f8-46b1-855c-df24289abde1" xlink:to="loc_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent_2814f3ca-f192-4208-8f63-9419a7bdd2dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InsuranceProgramAccruedExpenses_2dd36fa1-690c-4d03-83aa-0770042da10d" xlink:href="pntg-20211231.xsd#pntg_InsuranceProgramAccruedExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1796a387-07f8-46b1-855c-df24289abde1" xlink:to="loc_pntg_InsuranceProgramAccruedExpenses_2dd36fa1-690c-4d03-83aa-0770042da10d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InsuranceProgramAccruedExpensesNoncurrent_f7a8412c-90e9-49bf-9953-7d286fa10f8a" xlink:href="pntg-20211231.xsd#pntg_InsuranceProgramAccruedExpensesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1796a387-07f8-46b1-855c-df24289abde1" xlink:to="loc_pntg_InsuranceProgramAccruedExpensesNoncurrent_f7a8412c-90e9-49bf-9953-7d286fa10f8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_InsuranceProgramAccruedExpensesCurrent_1f604680-e41c-4261-9fc8-19bab0abaf4b" xlink:href="pntg-20211231.xsd#pntg_InsuranceProgramAccruedExpensesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1796a387-07f8-46b1-855c-df24289abde1" xlink:to="loc_pntg_InsuranceProgramAccruedExpensesCurrent_1f604680-e41c-4261-9fc8-19bab0abaf4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails_1" xlink:type="simple" xlink:href="pntg-20211231.xsd#BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails_1"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENT" xlink:type="simple" xlink:href="pntg-20211231.xsd#RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENT"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_107739b2-5222-430e-8a95-b54b3b9cee5d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_d20da617-7223-4cdf-bec6-719fd4234598" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_107739b2-5222-430e-8a95-b54b3b9cee5d" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_d20da617-7223-4cdf-bec6-719fd4234598" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_1b3a1cdd-455d-4800-ab0c-ef1a1ab01f58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_1b3a1cdd-455d-4800-ab0c-ef1a1ab01f58" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_3fb61b64-efa3-4dc3-ac25-111d9599a2d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_3fb61b64-efa3-4dc3-ac25-111d9599a2d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_57f6125c-c85a-4c71-bc69-0139d56bee41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_3fb61b64-efa3-4dc3-ac25-111d9599a2d6" xlink:to="loc_us-gaap_RelatedPartyDomain_57f6125c-c85a-4c71-bc69-0139d56bee41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_0f64dab4-426a-4c13-8a08-ae18fbda96cc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_57f6125c-c85a-4c71-bc69-0139d56bee41" xlink:to="loc_srt_AffiliatedEntityMember_0f64dab4-426a-4c13-8a08-ae18fbda96cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_b19bc361-2c81-4565-97d7-6b2c9edde025" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_b19bc361-2c81-4565-97d7-6b2c9edde025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_1d0f593d-083e-4df3-a8a1-6894714c7c87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_b19bc361-2c81-4565-97d7-6b2c9edde025" xlink:to="loc_us-gaap_SegmentDomain_1d0f593d-083e-4df3-a8a1-6894714c7c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_8a8ca264-4e1b-4949-b666-402a09fcc0a2" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_1d0f593d-083e-4df3-a8a1-6894714c7c87" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_8a8ca264-4e1b-4949-b666-402a09fcc0a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_3261f220-4789-4e1c-88e2-03e5a7e11fcc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:to="loc_srt_RangeAxis_3261f220-4789-4e1c-88e2-03e5a7e11fcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_70eabc35-e4d6-4e06-956b-3d7afdcb26bc" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_3261f220-4789-4e1c-88e2-03e5a7e11fcc" xlink:to="loc_srt_RangeMember_70eabc35-e4d6-4e06-956b-3d7afdcb26bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b2bc2775-f62c-42dd-a92a-39e3a25db7e0" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_70eabc35-e4d6-4e06-956b-3d7afdcb26bc" xlink:to="loc_srt_MinimumMember_b2bc2775-f62c-42dd-a92a-39e3a25db7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_63a02b26-6e4d-4160-835e-0b207bc79ee8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_70eabc35-e4d6-4e06-956b-3d7afdcb26bc" xlink:to="loc_srt_MaximumMember_63a02b26-6e4d-4160-835e-0b207bc79ee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_b354d765-16ec-49d4-b5b2-525cc1406eb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_b354d765-16ec-49d4-b5b2-525cc1406eb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_b52ae50d-9f50-4bab-ac74-6e28e0f4d75c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b354d765-16ec-49d4-b5b2-525cc1406eb2" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_b52ae50d-9f50-4bab-ac74-6e28e0f4d75c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_OperatingLeaseRentExpenseMember_5c7a3fca-baa0-453b-bc07-7153221c0bb9" xlink:href="pntg-20211231.xsd#pntg_OperatingLeaseRentExpenseMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_b52ae50d-9f50-4bab-ac74-6e28e0f4d75c" xlink:to="loc_pntg_OperatingLeaseRentExpenseMember_5c7a3fca-baa0-453b-bc07-7153221c0bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TransitionServicesAgreementMember_b8609e86-841b-433b-b6a8-77a6f04558a0" xlink:href="pntg-20211231.xsd#pntg_TransitionServicesAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_b52ae50d-9f50-4bab-ac74-6e28e0f4d75c" xlink:to="loc_pntg_TransitionServicesAgreementMember_b8609e86-841b-433b-b6a8-77a6f04558a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_564ebc7b-a042-4c93-8580-9466be0e2cf8" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b9af2788-ad73-4acc-99c2-ad678825b4a1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b9af2788-ad73-4acc-99c2-ad678825b4a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_74decc6a-d838-48c1-b52f-1c8de64e2bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAmountsOfTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:to="loc_us-gaap_RelatedPartyTransactionAmountsOfTransaction_74decc6a-d838-48c1-b52f-1c8de64e2bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_21e4aa07-d622-4852-8bdd-8385fae7109b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_21e4aa07-d622-4852-8bdd-8385fae7109b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d11cf4f2-bdc2-425b-9138-335c1da7ab0b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_d11cf4f2-bdc2-425b-9138-335c1da7ab0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyCosts_dbb87f41-d871-4cc5-a755-2cce937794b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_c7b514d3-850f-4826-8438-b856977ef7b6" xlink:to="loc_us-gaap_RelatedPartyCosts_dbb87f41-d871-4cc5-a755-2cce937794b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE" xlink:type="simple" xlink:href="pntg-20211231.xsd#COMPUTATIONOFNETINCOMEPERCOMMONSHARE"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_4edf3f03-a967-4f6c-b850-1d2472be1909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_4c127360-8180-402a-b8b4-bf9ba4f929fb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_4edf3f03-a967-4f6c-b850-1d2472be1909" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_4c127360-8180-402a-b8b4-bf9ba4f929fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables" xlink:type="simple" xlink:href="pntg-20211231.xsd#COMPUTATIONOFNETINCOMEPERCOMMONSHARETables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_2d6c4427-b534-4753-a77f-d4ce7311b0ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_e1e45391-a85b-434c-8b87-90433abba0be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_2d6c4427-b534-4753-a77f-d4ce7311b0ca" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock_e1e45391-a85b-434c-8b87-90433abba0be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d8876ca7-fdea-4112-b0bf-00841d75e734" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_32b8155a-ad3c-4665-b1b2-8ff347b4691a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d8876ca7-fdea-4112-b0bf-00841d75e734" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_32b8155a-ad3c-4665-b1b2-8ff347b4691a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfitLoss_4cf15e3c-1166-4602-8fa2-9ab95dc9e477" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_32b8155a-ad3c-4665-b1b2-8ff347b4691a" xlink:to="loc_us-gaap_ProfitLoss_4cf15e3c-1166-4602-8fa2-9ab95dc9e477" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a86a174b-a5cb-4244-90b6-721a7cbc4a55" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_32b8155a-ad3c-4665-b1b2-8ff347b4691a" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_a86a174b-a5cb-4244-90b6-721a7cbc4a55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e0bc0ae5-4581-4d35-99f1-bad31a2b1867" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract_32b8155a-ad3c-4665-b1b2-8ff347b4691a" xlink:to="loc_us-gaap_NetIncomeLoss_e0bc0ae5-4581-4d35-99f1-bad31a2b1867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_57232475-6f8a-419e-a813-883a36fe3a05" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d8876ca7-fdea-4112-b0bf-00841d75e734" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_57232475-6f8a-419e-a813-883a36fe3a05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c8488336-e8b7-4e9c-adc5-e264f1953acf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_57232475-6f8a-419e-a813-883a36fe3a05" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_c8488336-e8b7-4e9c-adc5-e264f1953acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_0f9a2af6-30fa-4cd8-8756-b8a81fd8086d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_57232475-6f8a-419e-a813-883a36fe3a05" xlink:to="loc_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment_0f9a2af6-30fa-4cd8-8756-b8a81fd8086d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_da240ae3-c247-46d5-9680-e9887f1db937" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract_57232475-6f8a-419e-a813-883a36fe3a05" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_da240ae3-c247-46d5-9680-e9887f1db937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_677e9918-072b-41a4-98eb-47093e73b46e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d8876ca7-fdea-4112-b0bf-00841d75e734" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_677e9918-072b-41a4-98eb-47093e73b46e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_861f9c1f-dbf8-4f40-babb-d41fe3bb3334" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_677e9918-072b-41a4-98eb-47093e73b46e" xlink:to="loc_us-gaap_EarningsPerShareBasic_861f9c1f-dbf8-4f40-babb-d41fe3bb3334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_8184939c-f5f6-42df-a2d4-27dcd5f3b6a8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_677e9918-072b-41a4-98eb-47093e73b46e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_8184939c-f5f6-42df-a2d4-27dcd5f3b6a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f275f804-f265-4d6e-a6d2-49718bdcec3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d8876ca7-fdea-4112-b0bf-00841d75e734" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f275f804-f265-4d6e-a6d2-49718bdcec3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLE" xlink:type="simple" xlink:href="pntg-20211231.xsd#REVENUEANDACCOUNTSRECEIVABLE"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_53de95f9-832b-488e-b555-7bc05baacbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock_c7c551cf-5793-4a02-abe8-d39ca7fa5038" xlink:href="pntg-20211231.xsd#pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_53de95f9-832b-488e-b555-7bc05baacbf0" xlink:to="loc_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock_c7c551cf-5793-4a02-abe8-d39ca7fa5038" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLETables" xlink:type="simple" xlink:href="pntg-20211231.xsd#REVENUEANDACCOUNTSRECEIVABLETables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7575c18-dd77-4a0e-af08-c9576ce8002e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_67dd6aa0-5f7f-4274-95bd-b4dbb8b43a87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7575c18-dd77-4a0e-af08-c9576ce8002e" xlink:to="loc_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock_67dd6aa0-5f7f-4274-95bd-b4dbb8b43a87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_eb69c7ea-7de2-4d87-95bd-c9785d79cb3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7575c18-dd77-4a0e-af08-c9576ce8002e" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_eb69c7ea-7de2-4d87-95bd-c9785d79cb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_09f39e7c-32ef-42d8-bad4-20ad2d5462c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_b7575c18-dd77-4a0e-af08-c9576ce8002e" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_09f39e7c-32ef-42d8-bad4-20ad2d5462c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_71033c47-c36e-4a5d-b6d0-b02b054c2dcb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_71033c47-c36e-4a5d-b6d0-b02b054c2dcb" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_9e28df97-7cdb-4324-b106-4739db3a64f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_9e28df97-7cdb-4324-b106-4739db3a64f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_9b66f2b1-1ef1-457c-9c84-e47d9b9aaa7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_9e28df97-7cdb-4324-b106-4739db3a64f4" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_9b66f2b1-1ef1-457c-9c84-e47d9b9aaa7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_8b8e2b4b-d075-4d12-8650-8eab3a071330" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_9b66f2b1-1ef1-457c-9c84-e47d9b9aaa7f" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_8b8e2b4b-d075-4d12-8650-8eab3a071330" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9047c7b4-a1ee-4eca-b73f-378b8ab8ba0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9047c7b4-a1ee-4eca-b73f-378b8ab8ba0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_febe183e-7119-4b67-b1af-a70fb1001e5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_9047c7b4-a1ee-4eca-b73f-378b8ab8ba0a" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_febe183e-7119-4b67-b1af-a70fb1001e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_02b96247-5ca2-46ed-89aa-936283b1994a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_febe183e-7119-4b67-b1af-a70fb1001e5e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_02b96247-5ca2-46ed-89aa-936283b1994a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_381bb360-8bc7-43b4-a5a4-3e0ebaf4054c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:to="loc_srt_MajorCustomersAxis_381bb360-8bc7-43b4-a5a4-3e0ebaf4054c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ded37ce7-8d5c-4f7e-a436-459d1e4d3992" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_381bb360-8bc7-43b4-a5a4-3e0ebaf4054c" xlink:to="loc_srt_NameOfMajorCustomerDomain_ded37ce7-8d5c-4f7e-a436-459d1e4d3992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareAndMedicaidMember_019eb1c0-c799-4d1f-bf56-470f5542e893" xlink:href="pntg-20211231.xsd#pntg_MedicareAndMedicaidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ded37ce7-8d5c-4f7e-a436-459d1e4d3992" xlink:to="loc_pntg_MedicareAndMedicaidMember_019eb1c0-c799-4d1f-bf56-470f5542e893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_1e9284e9-b9bd-40f8-87d6-85630ca9b8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_1e9284e9-b9bd-40f8-87d6-85630ca9b8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_782ca052-e57a-4b50-8e09-ff8b969a95a6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_1e9284e9-b9bd-40f8-87d6-85630ca9b8e0" xlink:to="loc_us-gaap_SegmentDomain_782ca052-e57a-4b50-8e09-ff8b969a95a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_5c1917a2-4ff2-42f3-992d-bc033ca0bd9e" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_782ca052-e57a-4b50-8e09-ff8b969a95a6" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_5c1917a2-4ff2-42f3-992d-bc033ca0bd9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9f3700ca-9aa0-41cd-8145-cf1b60ce2c99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_981b5baf-5db9-4001-8353-86ddf901a209" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_9f3700ca-9aa0-41cd-8145-cf1b60ce2c99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_00b96574-ba28-402b-9b3e-f3135d586c68" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9f3700ca-9aa0-41cd-8145-cf1b60ce2c99" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_00b96574-ba28-402b-9b3e-f3135d586c68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_163791f1-f5a7-4c56-9dbe-06a12a00ca20" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9f3700ca-9aa0-41cd-8145-cf1b60ce2c99" xlink:to="loc_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms_163791f1-f5a7-4c56-9dbe-06a12a00ca20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_99e2b44f-2827-49c3-816a-4341d3983b7a" xlink:href="pntg-20211231.xsd#pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9f3700ca-9aa0-41cd-8145-cf1b60ce2c99" xlink:to="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_99e2b44f-2827-49c3-816a-4341d3983b7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e7bb3540-64bd-42d3-8ad5-d296a0271c27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e7bb3540-64bd-42d3-8ad5-d296a0271c27" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_ed5d5021-8904-450b-b9de-b2670dee40b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_ed5d5021-8904-450b-b9de-b2670dee40b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9987fb64-0ab8-4fce-b875-3f249e8ddaef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_ed5d5021-8904-450b-b9de-b2670dee40b1" xlink:to="loc_us-gaap_SegmentDomain_9987fb64-0ab8-4fce-b875-3f249e8ddaef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_99fe2c94-7823-4939-9220-da93081e13d3" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9987fb64-0ab8-4fce-b875-3f249e8ddaef" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_99fe2c94-7823-4939-9220-da93081e13d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_b87c3e08-9794-47d9-b094-578c46961846" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9987fb64-0ab8-4fce-b875-3f249e8ddaef" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_b87c3e08-9794-47d9-b094-578c46961846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_f59150ef-82f6-4f47-a908-949d8e9f640b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:to="loc_us-gaap_SubsegmentsAxis_f59150ef-82f6-4f47-a908-949d8e9f640b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_cca8e2ff-3c65-4a3e-8193-4f1dbba8641a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_f59150ef-82f6-4f47-a908-949d8e9f640b" xlink:to="loc_us-gaap_SubsegmentsDomain_cca8e2ff-3c65-4a3e-8193-4f1dbba8641a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthSubsegmentMember_afde9bd4-8256-4e66-be47-d9321bf79bbf" xlink:href="pntg-20211231.xsd#pntg_HomeHealthSubsegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_cca8e2ff-3c65-4a3e-8193-4f1dbba8641a" xlink:to="loc_pntg_HomeHealthSubsegmentMember_afde9bd4-8256-4e66-be47-d9321bf79bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HospiceSubsegmentMember_95d6c70f-8c77-4fda-b45f-fd1c86374790" xlink:href="pntg-20211231.xsd#pntg_HospiceSubsegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_cca8e2ff-3c65-4a3e-8193-4f1dbba8641a" xlink:to="loc_pntg_HospiceSubsegmentMember_95d6c70f-8c77-4fda-b45f-fd1c86374790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_eae62ef3-5024-402f-bcfe-324777a5bb0b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:to="loc_srt_MajorCustomersAxis_eae62ef3-5024-402f-bcfe-324777a5bb0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_eae62ef3-5024-402f-bcfe-324777a5bb0b" xlink:to="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareMember_1c2c0788-75fd-4cd1-a70f-5ad13d09b73d" xlink:href="pntg-20211231.xsd#pntg_MedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:to="loc_pntg_MedicareMember_1c2c0788-75fd-4cd1-a70f-5ad13d09b73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicaidMember_2dba5d95-7227-4a04-86a6-5ae3547500bd" xlink:href="pntg-20211231.xsd#pntg_MedicaidMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:to="loc_pntg_MedicaidMember_2dba5d95-7227-4a04-86a6-5ae3547500bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareAndMedicaidMember_1f5076db-c3eb-4f5f-9163-2ad4a84ef552" xlink:href="pntg-20211231.xsd#pntg_MedicareAndMedicaidMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:to="loc_pntg_MedicareAndMedicaidMember_1f5076db-c3eb-4f5f-9163-2ad4a84ef552" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ManagedCareMember_04b2d970-e999-468e-887b-ff522505a720" xlink:href="pntg-20211231.xsd#pntg_ManagedCareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:to="loc_pntg_ManagedCareMember_04b2d970-e999-468e-887b-ff522505a720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_PrivateAndOtherMember_091f1014-8fe2-4b06-97aa-ec62e983c5bf" xlink:href="pntg-20211231.xsd#pntg_PrivateAndOtherMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_26c15e6a-7f0b-40f8-91ec-033cee9c9f15" xlink:to="loc_pntg_PrivateAndOtherMember_091f1014-8fe2-4b06-97aa-ec62e983c5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_02f550e6-9213-4349-b895-d3568743ed63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_02f550e6-9213-4349-b895-d3568743ed63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f64b22cd-b2b6-409d-9253-d7c6dfb4a0f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_02f550e6-9213-4349-b895-d3568743ed63" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f64b22cd-b2b6-409d-9253-d7c6dfb4a0f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_6cbf99e2-3f85-4f13-b228-c3b302adb0f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f64b22cd-b2b6-409d-9253-d7c6dfb4a0f4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_6cbf99e2-3f85-4f13-b228-c3b302adb0f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_e512dc39-9533-4196-9d94-0f328150628b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_e512dc39-9533-4196-9d94-0f328150628b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_fe16335e-6066-47d0-a51b-f11c36cc43e0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_e512dc39-9533-4196-9d94-0f328150628b" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_fe16335e-6066-47d0-a51b-f11c36cc43e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_27cf6d72-0783-41c2-a0c7-1bed39a64edf" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_fe16335e-6066-47d0-a51b-f11c36cc43e0" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_27cf6d72-0783-41c2-a0c7-1bed39a64edf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2fc6c5dc-d0e6-4d9f-a0af-03a134c7e29d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_fada2de2-e3a7-447a-9779-76732e12f165" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_2fc6c5dc-d0e6-4d9f-a0af-03a134c7e29d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d1c312d0-60af-4d8a-a9e4-9ed083fdb7ee" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2fc6c5dc-d0e6-4d9f-a0af-03a134c7e29d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d1c312d0-60af-4d8a-a9e4-9ed083fdb7ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_0c030ef7-49c2-4700-9b3d-30438b06c349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2fc6c5dc-d0e6-4d9f-a0af-03a134c7e29d" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_0c030ef7-49c2-4700-9b3d-30438b06c349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_387162fd-47f7-4c1b-974d-188c991efcd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_43363d20-239b-45e4-96e2-5c01d9029123" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_387162fd-47f7-4c1b-974d-188c991efcd9" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_43363d20-239b-45e4-96e2-5c01d9029123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_a9f0abf7-7a40-4ce0-8cec-fdefe679aa62" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_43363d20-239b-45e4-96e2-5c01d9029123" xlink:to="loc_srt_MajorCustomersAxis_a9f0abf7-7a40-4ce0-8cec-fdefe679aa62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_a9f0abf7-7a40-4ce0-8cec-fdefe679aa62" xlink:to="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareMember_1ef90ce7-d4e6-4df2-a733-b82e02e8a40e" xlink:href="pntg-20211231.xsd#pntg_MedicareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:to="loc_pntg_MedicareMember_1ef90ce7-d4e6-4df2-a733-b82e02e8a40e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicaidMember_2edc3670-1597-4408-81db-112a50e17108" xlink:href="pntg-20211231.xsd#pntg_MedicaidMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:to="loc_pntg_MedicaidMember_2edc3670-1597-4408-81db-112a50e17108" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ManagedCareMember_1d79005b-854f-4195-8c94-2fe600f775a7" xlink:href="pntg-20211231.xsd#pntg_ManagedCareMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:to="loc_pntg_ManagedCareMember_1d79005b-854f-4195-8c94-2fe600f775a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_PrivateAndOtherMember_5a0b01fa-097e-457c-b07b-6fe87be98de7" xlink:href="pntg-20211231.xsd#pntg_PrivateAndOtherMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_ee40b1ae-4a69-443f-8e88-dc2fe1b903cf" xlink:to="loc_pntg_PrivateAndOtherMember_5a0b01fa-097e-457c-b07b-6fe87be98de7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c1ca54de-ca43-484b-b54d-6d057e620684" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsNotesAndLoansReceivableLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable_43363d20-239b-45e4-96e2-5c01d9029123" xlink:to="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c1ca54de-ca43-484b-b54d-6d057e620684" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrentAbstract_587a7c29-6be0-4f31-a105-0d6eea31efe6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsNotesAndLoansReceivableLineItems_c1ca54de-ca43-484b-b54d-6d057e620684" xlink:to="loc_us-gaap_AccountsReceivableNetCurrentAbstract_587a7c29-6be0-4f31-a105-0d6eea31efe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGrossCurrent_6bd40432-f34b-4376-85de-ca6bb72f64ed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableGrossCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetCurrentAbstract_587a7c29-6be0-4f31-a105-0d6eea31efe6" xlink:to="loc_us-gaap_AccountsReceivableGrossCurrent_6bd40432-f34b-4376-85de-ca6bb72f64ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_34fbb3e3-eea8-4fa9-ae73-4fe924de915a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetCurrentAbstract_587a7c29-6be0-4f31-a105-0d6eea31efe6" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_34fbb3e3-eea8-4fa9-ae73-4fe924de915a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_b7d6ccbb-56dd-4cbc-aa69-a4f8e0e07d50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountsReceivableNetCurrentAbstract_587a7c29-6be0-4f31-a105-0d6eea31efe6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_b7d6ccbb-56dd-4cbc-aa69-a4f8e0e07d50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEALLOWANCEFORDOUBTFULACCOUNTSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#REVENUEANDACCOUNTSRECEIVABLEALLOWANCEFORDOUBTFULACCOUNTSDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEALLOWANCEFORDOUBTFULACCOUNTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6e215506-ed1b-423b-a984-a95263bcc4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f43f9283-f26b-428d-a12b-5d96937387ca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_6e215506-ed1b-423b-a984-a95263bcc4e9" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f43f9283-f26b-428d-a12b-5d96937387ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_d9799776-30f3-4cdd-8048-c517cd77bbb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f43f9283-f26b-428d-a12b-5d96937387ca" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_d9799776-30f3-4cdd-8048-c517cd77bbb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_0fbb9179-5ecc-4bc4-bfec-170324c7bfe9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f43f9283-f26b-428d-a12b-5d96937387ca" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_0fbb9179-5ecc-4bc4-bfec-170324c7bfe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_d60fa83b-e4f7-4c66-bf51-72fa8766e1dc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f43f9283-f26b-428d-a12b-5d96937387ca" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_d60fa83b-e4f7-4c66-bf51-72fa8766e1dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_5c2c6b8c-9551-402f-a5a9-918eb4b8d946" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_f43f9283-f26b-428d-a12b-5d96937387ca" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_5c2c6b8c-9551-402f-a5a9-918eb4b8d946" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTS" xlink:type="simple" xlink:href="pntg-20211231.xsd#BUSINESSSEGMENTS"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/BUSINESSSEGMENTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5896d2d0-6617-450e-862a-d6fc01ad5585" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_236f46dd-e5ac-4f8f-bdf6-b539c398a5c3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5896d2d0-6617-450e-862a-d6fc01ad5585" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_236f46dd-e5ac-4f8f-bdf6-b539c398a5c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTSTables" xlink:type="simple" xlink:href="pntg-20211231.xsd#BUSINESSSEGMENTSTables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/BUSINESSSEGMENTSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c7a66c7f-488d-455a-90c7-d5011e512e90" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_28c16b55-d32c-4817-8af8-536066ff7c76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c7a66c7f-488d-455a-90c7-d5011e512e90" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_28c16b55-d32c-4817-8af8-536066ff7c76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock_4244611b-ab5b-4bac-a22b-14f6744f76be" xlink:href="pntg-20211231.xsd#pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c7a66c7f-488d-455a-90c7-d5011e512e90" xlink:to="loc_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock_4244611b-ab5b-4bac-a22b-14f6744f76be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#BUSINESSSEGMENTSNARRATIVEDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_cf2cc39d-fa78-48ed-9837-5dc241a8ebc0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8dedcf2a-da97-4452-8eb0-2d0574aa0444" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_cf2cc39d-fa78-48ed-9837-5dc241a8ebc0" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8dedcf2a-da97-4452-8eb0-2d0574aa0444" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9f8dd7b1-dc5e-45e8-bdeb-1b6e1c0b0736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8dedcf2a-da97-4452-8eb0-2d0574aa0444" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9f8dd7b1-dc5e-45e8-bdeb-1b6e1c0b0736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_13a15c9c-ecd4-4dec-b7d6-26aa8e857c21" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9f8dd7b1-dc5e-45e8-bdeb-1b6e1c0b0736" xlink:to="loc_us-gaap_SegmentDomain_13a15c9c-ecd4-4dec-b7d6-26aa8e857c21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_50c19402-21ef-4b6a-babd-a80ec940d087" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_13a15c9c-ecd4-4dec-b7d6-26aa8e857c21" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_50c19402-21ef-4b6a-babd-a80ec940d087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_01551a52-dd39-4976-bf4d-e19ca52780e7" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_13a15c9c-ecd4-4dec-b7d6-26aa8e857c21" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_01551a52-dd39-4976-bf4d-e19ca52780e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_776f3b18-87a3-4984-adad-3914ff12b7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8dedcf2a-da97-4452-8eb0-2d0574aa0444" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_776f3b18-87a3-4984-adad-3914ff12b7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfServiceProviders_45197321-fe68-4420-a6ea-a3ff3abfd591" xlink:href="pntg-20211231.xsd#pntg_NumberOfServiceProviders"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_776f3b18-87a3-4984-adad-3914ff12b7d4" xlink:to="loc_pntg_NumberOfServiceProviders_45197321-fe68-4420-a6ea-a3ff3abfd591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfRealEstatePropertiesUnderLease_1951abdf-7dd5-4346-8b08-788bb5cdd9f6" xlink:href="pntg-20211231.xsd#pntg_NumberOfRealEstatePropertiesUnderLease"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_776f3b18-87a3-4984-adad-3914ff12b7d4" xlink:to="loc_pntg_NumberOfRealEstatePropertiesUnderLease_1951abdf-7dd5-4346-8b08-788bb5cdd9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#BUSINESSSEGMENTSFINANCIALDATADetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_f25f3115-1a74-417e-8e64-31ff511df461" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3fc3fd61-8f9f-4a60-8f46-f695172b1777" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_f25f3115-1a74-417e-8e64-31ff511df461" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3fc3fd61-8f9f-4a60-8f46-f695172b1777" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_451062be-b954-4206-9881-7813ff726a6a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3fc3fd61-8f9f-4a60-8f46-f695172b1777" xlink:to="loc_srt_ConsolidationItemsAxis_451062be-b954-4206-9881-7813ff726a6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_b75d3535-5f33-4de3-8e60-f1bf5542992d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_451062be-b954-4206-9881-7813ff726a6a" xlink:to="loc_srt_ConsolidationItemsDomain_b75d3535-5f33-4de3-8e60-f1bf5542992d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingSegmentsMember_b2f57af1-b8c2-4f4a-943e-5282e69cff92" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingSegmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b75d3535-5f33-4de3-8e60-f1bf5542992d" xlink:to="loc_us-gaap_OperatingSegmentsMember_b2f57af1-b8c2-4f4a-943e-5282e69cff92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateNonSegmentMember_404fc2d0-852f-4a4c-a0a5-69901a311d82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateNonSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_b75d3535-5f33-4de3-8e60-f1bf5542992d" xlink:to="loc_us-gaap_CorporateNonSegmentMember_404fc2d0-852f-4a4c-a0a5-69901a311d82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_27195e34-6768-4f49-848f-dc34c0c8b753" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3fc3fd61-8f9f-4a60-8f46-f695172b1777" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_27195e34-6768-4f49-848f-dc34c0c8b753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a4a3fa43-5147-4032-bd49-51125a88350e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_27195e34-6768-4f49-848f-dc34c0c8b753" xlink:to="loc_us-gaap_SegmentDomain_a4a3fa43-5147-4032-bd49-51125a88350e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_a1d1a581-c8bd-4ffa-a522-95e5fe1148c3" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4a3fa43-5147-4032-bd49-51125a88350e" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_a1d1a581-c8bd-4ffa-a522-95e5fe1148c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_07852981-6283-46e4-8c41-9fea6c5044a2" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a4a3fa43-5147-4032-bd49-51125a88350e" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_07852981-6283-46e4-8c41-9fea6c5044a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_846c70b5-6014-4e90-a288-43bf4c84abb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_3fc3fd61-8f9f-4a60-8f46-f695172b1777" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_846c70b5-6014-4e90-a288-43bf4c84abb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28879a69-83c6-4e25-8520-71699219a359" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_846c70b5-6014-4e90-a288-43bf4c84abb6" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28879a69-83c6-4e25-8520-71699219a359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_8446799a-7f48-4126-bdfa-ab05d6d81b75" xlink:href="pntg-20211231.xsd#pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_846c70b5-6014-4e90-a288-43bf4c84abb6" xlink:to="loc_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_8446799a-7f48-4126-bdfa-ab05d6d81b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a4262fdd-5713-4310-949f-121fb04a8fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_288cf020-8e90-4df6-8137-fda3f9b62b23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a4262fdd-5713-4310-949f-121fb04a8fb9" xlink:to="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_288cf020-8e90-4df6-8137-fda3f9b62b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_b848d8d0-9df7-42ea-b683-ddc7985bc4e4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_288cf020-8e90-4df6-8137-fda3f9b62b23" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_b848d8d0-9df7-42ea-b683-ddc7985bc4e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_536b0680-50f5-4609-952a-df65a5d84b2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_b848d8d0-9df7-42ea-b683-ddc7985bc4e4" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_536b0680-50f5-4609-952a-df65a5d84b2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TransitionServicesAgreementMember_32c76a72-1fae-43f5-ba35-ab23970f6775" xlink:href="pntg-20211231.xsd#pntg_TransitionServicesAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_536b0680-50f5-4609-952a-df65a5d84b2e" xlink:to="loc_pntg_TransitionServicesAgreementMember_32c76a72-1fae-43f5-ba35-ab23970f6775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4b2f9d17-4c40-4a79-b74e-407662e17a3c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_288cf020-8e90-4df6-8137-fda3f9b62b23" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4b2f9d17-4c40-4a79-b74e-407662e17a3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c05e470c-84c9-4504-99ec-3e450efc4b5b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_4b2f9d17-4c40-4a79-b74e-407662e17a3c" xlink:to="loc_us-gaap_RelatedPartyDomain_c05e470c-84c9-4504-99ec-3e450efc4b5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_e9c7539b-a525-4a54-8aa4-a701ababd2f6" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_c05e470c-84c9-4504-99ec-3e450efc4b5b" xlink:to="loc_srt_AffiliatedEntityMember_e9c7539b-a525-4a54-8aa4-a701ababd2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EntityWideRevenueMajorCustomerLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable_288cf020-8e90-4df6-8137-fda3f9b62b23" xlink:to="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_10795433-b9d5-4c35-8bf0-d08dcf45ce65" xlink:href="pntg-20211231.xsd#pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation_10795433-b9d5-4c35-8bf0-d08dcf45ce65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_c451e9ed-92b1-4b79-84e9-c813f4592339" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_DepreciationAndAmortization_c451e9ed-92b1-4b79-84e9-c813f4592339" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseExpense_7a604fa1-d29d-47b6-9e00-8f01635ffd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_OperatingLeaseExpense_7a604fa1-d29d-47b6-9e00-8f01635ffd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ef21d03e-74dc-43f8-89e5-9dfa99440c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ef21d03e-74dc-43f8-89e5-9dfa99440c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_StartUpActivitiesCosts_2181ee21-30f5-411e-ad22-979c82201499" xlink:href="pntg-20211231.xsd#pntg_StartUpActivitiesCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_StartUpActivitiesCosts_2181ee21-30f5-411e-ad22-979c82201499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_7cd78ac9-76a2-471c-bd66-823495b23e14" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_7cd78ac9-76a2-471c-bd66-823495b23e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e95b220c-f20f-4736-9e8b-df445adda076" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_e95b220c-f20f-4736-9e8b-df445adda076" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SpinoffTransactionCosts_6cf6fe60-963f-49d8-99c1-12caf6d34a7b" xlink:href="pntg-20211231.xsd#pntg_SpinoffTransactionCosts"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_SpinoffTransactionCosts_6cf6fe60-963f-49d8-99c1-12caf6d34a7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AcquisitionRelatedCostsNotCapitalized_363711e0-b81a-4efb-8232-be825cf8ffc6" xlink:href="pntg-20211231.xsd#pntg_AcquisitionRelatedCostsNotCapitalized"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_AcquisitionRelatedCostsNotCapitalized_363711e0-b81a-4efb-8232-be825cf8ffc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses_11d18d56-ecd3-4a36-88f5-b574d43ee01f" xlink:href="pntg-20211231.xsd#pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses_11d18d56-ecd3-4a36-88f5-b574d43ee01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_d16cb316-a50b-420b-9efd-e03dbad74695" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_d16cb316-a50b-420b-9efd-e03dbad74695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c087f46d-7a45-49c8-96b6-7b66f2cc02cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest_c087f46d-7a45-49c8-96b6-7b66f2cc02cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_0f1312f4-8d5c-40ba-aad0-7a8629a345e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_OperatingIncomeLoss_0f1312f4-8d5c-40ba-aad0-7a8629a345e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b754d162-60f8-4981-a96e-0c26721181e6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_b754d162-60f8-4981-a96e-0c26721181e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AmountToOffsetExpenseSequestrationRelief_f349cafb-1246-4ac5-85c7-6265048544b4" xlink:href="pntg-20211231.xsd#pntg_AmountToOffsetExpenseSequestrationRelief"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_AmountToOffsetExpenseSequestrationRelief_f349cafb-1246-4ac5-85c7-6265048544b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DirectMedicalSuppliesLaborAndOtherExpenses_ed5c2392-1d8f-4b0f-bcd2-b874643dc1b8" xlink:href="pntg-20211231.xsd#pntg_DirectMedicalSuppliesLaborAndOtherExpenses"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EntityWideRevenueMajorCustomerLineItems_826af124-cf1a-4ca0-bdbb-5bae2dafac76" xlink:to="loc_pntg_DirectMedicalSuppliesLaborAndOtherExpenses_ed5c2392-1d8f-4b0f-bcd2-b874643dc1b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/ACQUISITIONS" xlink:type="simple" xlink:href="pntg-20211231.xsd#ACQUISITIONS"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/ACQUISITIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f9c75e28-def3-4e5c-8708-24319d044974" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_21fa2fdb-443b-44b7-9fc1-9106e63538f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_f9c75e28-def3-4e5c-8708-24319d044974" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_21fa2fdb-443b-44b7-9fc1-9106e63538f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/ACQUISITIONSTables" xlink:type="simple" xlink:href="pntg-20211231.xsd#ACQUISITIONSTables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/ACQUISITIONSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_eb8e564d-8b72-406c-b127-4388e73bd028" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_385a9235-e1e0-40b1-bc80-75c78c491f46" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_eb8e564d-8b72-406c-b127-4388e73bd028" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_385a9235-e1e0-40b1-bc80-75c78c491f46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#ACQUISITIONSNARRATIVEDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3cb42a59-cb6f-44e7-b1d3-2a4bcc152d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_3cb42a59-cb6f-44e7-b1d3-2a4bcc152d87" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d8a05b06-cb45-487f-87fe-6f1ae1da3b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d8a05b06-cb45-487f-87fe-6f1ae1da3b4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_a3161238-568e-4bc9-996d-d0303aff281a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d8a05b06-cb45-487f-87fe-6f1ae1da3b4f" xlink:to="loc_us-gaap_SegmentDomain_a3161238-568e-4bc9-996d-d0303aff281a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_3a21a7af-f781-4481-8b1e-370f78ae74dc" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a3161238-568e-4bc9-996d-d0303aff281a" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_3a21a7af-f781-4481-8b1e-370f78ae74dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_9410c289-164a-4a23-ac67-2f1de9d59411" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_a3161238-568e-4bc9-996d-d0303aff281a" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_9410c289-164a-4a23-ac67-2f1de9d59411" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsAxis_26cf765c-3dfb-4069-8ca8-1508b9e63f02" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_us-gaap_SubsegmentsAxis_26cf765c-3dfb-4069-8ca8-1508b9e63f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsegmentsDomain_cf42a6fa-0215-4c8c-99e4-6d78ac12e632" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsegmentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsAxis_26cf765c-3dfb-4069-8ca8-1508b9e63f02" xlink:to="loc_us-gaap_SubsegmentsDomain_cf42a6fa-0215-4c8c-99e4-6d78ac12e632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthSubsegmentMember_a58acd97-0dd1-4dfb-a90f-0deefe557bb2" xlink:href="pntg-20211231.xsd#pntg_HomeHealthSubsegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_cf42a6fa-0215-4c8c-99e4-6d78ac12e632" xlink:to="loc_pntg_HomeHealthSubsegmentMember_a58acd97-0dd1-4dfb-a90f-0deefe557bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HospiceSubsegmentMember_a076b383-b5ce-4fc3-babf-cd5df8b97f9c" xlink:href="pntg-20211231.xsd#pntg_HospiceSubsegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_cf42a6fa-0215-4c8c-99e4-6d78ac12e632" xlink:to="loc_pntg_HospiceSubsegmentMember_a076b383-b5ce-4fc3-babf-cd5df8b97f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeCareAgenciesMember_bd1a14c5-50fd-4792-beb4-a01bbf5750bb" xlink:href="pntg-20211231.xsd#pntg_HomeCareAgenciesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsegmentsDomain_cf42a6fa-0215-4c8c-99e4-6d78ac12e632" xlink:to="loc_pntg_HomeCareAgenciesMember_bd1a14c5-50fd-4792-beb4-a01bbf5750bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_d674c522-60c7-4df5-8e06-bdbc5d72115f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_d674c522-60c7-4df5-8e06-bdbc5d72115f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35b15c1-86de-42f1-bcea-d2a013f25b93" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_d674c522-60c7-4df5-8e06-bdbc5d72115f" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35b15c1-86de-42f1-bcea-d2a013f25b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_133efa97-d932-4390-869c-8625e6017e4c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35b15c1-86de-42f1-bcea-d2a013f25b93" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_133efa97-d932-4390-869c-8625e6017e4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_BusinessAcquisitions2019Member_da7a7307-a25c-4e0e-947d-3f00dd59f2ae" xlink:href="pntg-20211231.xsd#pntg_BusinessAcquisitions2019Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_f35b15c1-86de-42f1-bcea-d2a013f25b93" xlink:to="loc_pntg_BusinessAcquisitions2019Member_da7a7307-a25c-4e0e-947d-3f00dd59f2ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionAxis_0c9c152c-aac2-4373-92b9-60e0ba0fa3f2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_us-gaap_AssetAcquisitionAxis_0c9c152c-aac2-4373-92b9-60e0ba0fa3f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetAcquisitionDomain_ae4581bf-f398-42b1-9397-28007f61fe5e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetAcquisitionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionAxis_0c9c152c-aac2-4373-92b9-60e0ba0fa3f2" xlink:to="loc_us-gaap_AssetAcquisitionDomain_ae4581bf-f398-42b1-9397-28007f61fe5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AssetAcquisitions2021Member_d069da2a-fff4-475f-b991-145590b0ecdf" xlink:href="pntg-20211231.xsd#pntg_AssetAcquisitions2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_ae4581bf-f398-42b1-9397-28007f61fe5e" xlink:to="loc_pntg_AssetAcquisitions2021Member_d069da2a-fff4-475f-b991-145590b0ecdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AssetAcquisitions2020Member_f757b2d4-d2dc-4b47-ba22-085ad5524838" xlink:href="pntg-20211231.xsd#pntg_AssetAcquisitions2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_ae4581bf-f398-42b1-9397-28007f61fe5e" xlink:to="loc_pntg_AssetAcquisitions2020Member_f757b2d4-d2dc-4b47-ba22-085ad5524838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AssetAcquisitions2019Member_b774fe07-4030-4e0a-975f-d2c1b9c10e86" xlink:href="pntg-20211231.xsd#pntg_AssetAcquisitions2019Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetAcquisitionDomain_ae4581bf-f398-42b1-9397-28007f61fe5e" xlink:to="loc_pntg_AssetAcquisitions2019Member_b774fe07-4030-4e0a-975f-d2c1b9c10e86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_e34b9cec-4969-4b16-ab94-82c10fb12445" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_srt_CounterpartyNameAxis_e34b9cec-4969-4b16-ab94-82c10fb12445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8cd9af0-2028-42b6-9375-2fca0cef7c73" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_e34b9cec-4969-4b16-ab94-82c10fb12445" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8cd9af0-2028-42b6-9375-2fca0cef7c73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ScrippsHealthMember_089b98ab-015e-45d3-9ee4-9a13a13b4d79" xlink:href="pntg-20211231.xsd#pntg_ScrippsHealthMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8cd9af0-2028-42b6-9375-2fca0cef7c73" xlink:to="loc_pntg_ScrippsHealthMember_089b98ab-015e-45d3-9ee4-9a13a13b4d79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EnsignSubsidiaryMember_dca0f915-daf0-4c34-a840-a1c3c85fa351" xlink:href="pntg-20211231.xsd#pntg_EnsignSubsidiaryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_b8cd9af0-2028-42b6-9375-2fca0cef7c73" xlink:to="loc_pntg_EnsignSubsidiaryMember_dca0f915-daf0-4c34-a840-a1c3c85fa351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_1663986f-e556-4f23-8ac4-7703a5799886" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_srt_OwnershipAxis_1663986f-e556-4f23-8ac4-7703a5799886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_b8ed40e5-5ee7-4b0c-801c-e4e8ac22452a" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_1663986f-e556-4f23-8ac4-7703a5799886" xlink:to="loc_srt_OwnershipDomain_b8ed40e5-5ee7-4b0c-801c-e4e8ac22452a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthJointVentureMember_fdd86326-e4d2-471f-b8f4-fb1d936870ea" xlink:href="pntg-20211231.xsd#pntg_HomeHealthJointVentureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b8ed40e5-5ee7-4b0c-801c-e4e8ac22452a" xlink:to="loc_pntg_HomeHealthJointVentureMember_fdd86326-e4d2-471f-b8f4-fb1d936870ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HospiceJoinVentureMember_81c20200-49fa-46cc-ad60-7967934d401e" xlink:href="pntg-20211231.xsd#pntg_HospiceJoinVentureMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_b8ed40e5-5ee7-4b0c-801c-e4e8ac22452a" xlink:to="loc_pntg_HospiceJoinVentureMember_81c20200-49fa-46cc-ad60-7967934d401e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_16d1d41c-4213-4b79-bb94-5094be64c704" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfBusinessesAndAssetsAcquired_da3ec30d-a5c6-4b2d-b599-6f5b94af3cfc" xlink:href="pntg-20211231.xsd#pntg_NumberOfBusinessesAndAssetsAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_NumberOfBusinessesAndAssetsAcquired_da3ec30d-a5c6-4b2d-b599-6f5b94af3cfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b699fecb-6c71-4d32-a449-b22c0d9498e7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_b699fecb-6c71-4d32-a449-b22c0d9498e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NonCapitalizableRelatedToTheBusinessCombinations_c7d7d7b9-9d5d-4bb7-a3be-e8a1054c10ac" xlink:href="pntg-20211231.xsd#pntg_NonCapitalizableRelatedToTheBusinessCombinations"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_NonCapitalizableRelatedToTheBusinessCombinations_c7d7d7b9-9d5d-4bb7-a3be-e8a1054c10ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_4020a3e5-701a-4984-9190-babb91e84999" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_4020a3e5-701a-4984-9190-babb91e84999" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_31117ab8-6ad3-44f3-b563-1848098252d8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_31117ab8-6ad3-44f3-b563-1848098252d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfUnitsInRealEstatePropertyAcquired_e14c9bd7-0938-4a90-a976-b561b5857327" xlink:href="pntg-20211231.xsd#pntg_NumberOfUnitsInRealEstatePropertyAcquired"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_NumberOfUnitsInRealEstatePropertyAcquired_e14c9bd7-0938-4a90-a976-b561b5857327" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_6667277c-e7cb-427c-ba46-794dc33c3ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInterestInJointVenture"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_PaymentsToAcquireInterestInJointVenture_6667277c-e7cb-427c-ba46-794dc33c3ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_CashAndContributedAssetsNetBookValue_242aa653-93fa-443c-9b13-cf804188bd8e" xlink:href="pntg-20211231.xsd#pntg_CashAndContributedAssetsNetBookValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_CashAndContributedAssetsNetBookValue_242aa653-93fa-443c-9b13-cf804188bd8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8b5d41ca-3cb2-47fb-82c0-87b8b6b32498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_8b5d41ca-3cb2-47fb-82c0-87b8b6b32498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_68f172e2-af0a-4d1b-a6f6-e39268acc5ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest_68f172e2-af0a-4d1b-a6f6-e39268acc5ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_68c50042-8859-47f4-afe1-2251d8365441" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromDivestitureOfInterestInJointVenture"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture_68c50042-8859-47f4-afe1-2251d8365441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NoncontrollingInterestJointVenture_27b3206e-08d6-4137-acba-2dd7a09cb4d9" xlink:href="pntg-20211231.xsd#pntg_NoncontrollingInterestJointVenture"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_NoncontrollingInterestJointVenture_27b3206e-08d6-4137-acba-2dd7a09cb4d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_bb9d64ff-f77b-4349-b068-e81a36d4920c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_bb9d64ff-f77b-4349-b068-e81a36d4920c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AdditionalPaidInCapitalEffectOfIncomeTax_5576524a-7ae0-493b-bb7e-084d380b284a" xlink:href="pntg-20211231.xsd#pntg_AdditionalPaidInCapitalEffectOfIncomeTax"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_pntg_AdditionalPaidInCapitalEffectOfIncomeTax_5576524a-7ae0-493b-bb7e-084d380b284a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_675436fb-e645-4c35-a4bf-753c4590b1fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionRelatedCosts"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_207962c8-09b1-4a04-8666-3c635d20d36f" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionRelatedCosts_675436fb-e645-4c35-a4bf-753c4590b1fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4f2d2013-4245-4366-b342-703b422f4d09" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAndAssetAcquisitionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb706dfc-4d36-4919-9871-d054b46b75fa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract_4f2d2013-4245-4366-b342-703b422f4d09" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb706dfc-4d36-4919-9871-d054b46b75fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_9f5046fc-4cc3-47df-92b7-17ea7f36ff1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb706dfc-4d36-4919-9871-d054b46b75fa" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_9f5046fc-4cc3-47df-92b7-17ea7f36ff1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17518184-edc6-4fa6-8d29-ff89d6466608" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_9f5046fc-4cc3-47df-92b7-17ea7f36ff1c" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17518184-edc6-4fa6-8d29-ff89d6466608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_7ac1b427-1e64-48dd-8dd8-bef1f0b75016" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_17518184-edc6-4fa6-8d29-ff89d6466608" xlink:to="loc_us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember_7ac1b427-1e64-48dd-8dd8-bef1f0b75016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_fb706dfc-4d36-4919-9871-d054b46b75fa" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures_7ac2ab6c-b72b-4faa-af04-624aea04a1df" xlink:href="pntg-20211231.xsd#pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures_7ac2ab6c-b72b-4faa-af04-624aea04a1df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c43b2d44-0c41-4994-8c7d-919b108d56f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_Goodwill_c43b2d44-0c41-4994-8c7d-919b108d56f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cfe591a1-063e-4823-8522-4de5a96b4bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets_cfe591a1-063e-4823-8522-4de5a96b4bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d366a1d7-a97b-48be-8e0a-337591bc514c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_d366a1d7-a97b-48be-8e0a-337591bc514c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3c680e93-bd95-461d-97fa-92d6f89bdd1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities_3c680e93-bd95-461d-97fa-92d6f89bdd1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d9b5d09b-bfa7-45ff-b98c-89497d5ba338" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d9b5d09b-bfa7-45ff-b98c-89497d5ba338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_e76b01b1-144e-4d96-8aec-92ac3f18f699" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue_e76b01b1-144e-4d96-8aec-92ac3f18f699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_BusinessCombinationCashPaidInPriorYear_d809a25a-c72d-4886-a16a-92447c2378e3" xlink:href="pntg-20211231.xsd#pntg_BusinessCombinationCashPaidInPriorYear"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_pntg_BusinessCombinationCashPaidInPriorYear_d809a25a-c72d-4886-a16a-92447c2378e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_b00268b3-f151-405c-b400-b84c52c2a5f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest_b00268b3-f151-405c-b400-b84c52c2a5f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TotalAcquisitions_1b8dd72c-19d2-4f21-92e5-0cba90328886" xlink:href="pntg-20211231.xsd#pntg_TotalAcquisitions"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_b0b9e32a-94f7-43b8-8979-265b1f41853d" xlink:to="loc_pntg_TotalAcquisitions_1b8dd72c-19d2-4f21-92e5-0cba90328886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNET" xlink:type="simple" xlink:href="pntg-20211231.xsd#PROPERTYANDEQUIPMENTNET"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6a5c41ee-4cea-42cf-b24b-d5ed854ff2a5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_208b780e-0782-4c7c-9912-d408457c7dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_6a5c41ee-4cea-42cf-b24b-d5ed854ff2a5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_208b780e-0782-4c7c-9912-d408457c7dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETTables" xlink:type="simple" xlink:href="pntg-20211231.xsd#PROPERTYANDEQUIPMENTNETTables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b5baedcb-0f87-420a-89c2-f9a883500e58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7cad0e0b-762c-418d-9762-fb892611a967" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_b5baedcb-0f87-420a-89c2-f9a883500e58" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7cad0e0b-762c-418d-9762-fb892611a967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#PROPERTYANDEQUIPMENTNETDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a37721f9-bdd1-426c-8b0a-6324e44b9fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33a2e728-df55-47f0-a69e-86ef9fe3b5a2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_a37721f9-bdd1-426c-8b0a-6324e44b9fcd" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33a2e728-df55-47f0-a69e-86ef9fe3b5a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1b1ba07-2dbb-4190-b6eb-a7a714783380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33a2e728-df55-47f0-a69e-86ef9fe3b5a2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1b1ba07-2dbb-4190-b6eb-a7a714783380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2b6451ab-ca2d-4831-af3c-cfdf221158bc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d1b1ba07-2dbb-4190-b6eb-a7a714783380" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2b6451ab-ca2d-4831-af3c-cfdf221158bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_8b2d343f-1130-43a7-ab00-d2f06bf02716" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2b6451ab-ca2d-4831-af3c-cfdf221158bc" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_8b2d343f-1130-43a7-ab00-d2f06bf02716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_abe580e7-b328-45f8-b8c4-3e8796cae668" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2b6451ab-ca2d-4831-af3c-cfdf221158bc" xlink:to="loc_us-gaap_EquipmentMember_abe580e7-b328-45f8-b8c4-3e8796cae668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_08273e09-b5a6-4087-93af-68e7180ef1cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2b6451ab-ca2d-4831-af3c-cfdf221158bc" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_08273e09-b5a6-4087-93af-68e7180ef1cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_33a2e728-df55-47f0-a69e-86ef9fe3b5a2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_4d517a49-565a-44d5-9217-ce067505db10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_4d517a49-565a-44d5-9217-ce067505db10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a04de6cc-5805-4351-9045-1b20135518ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a04de6cc-5805-4351-9045-1b20135518ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_6997ea80-3c18-4791-8ecb-8aae38e05f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_6997ea80-3c18-4791-8ecb-8aae38e05f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_7a5c9fdb-3747-48af-9ae1-fada8836abed" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:to="loc_us-gaap_Depreciation_7a5c9fdb-3747-48af-9ae1-fada8836abed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_4dcd7a8b-e576-40dd-bb0b-48f5660cbbea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64cf4eb5-20da-41fb-8b53-80c65f72cd4f" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_4dcd7a8b-e576-40dd-bb0b-48f5660cbbea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNET" xlink:type="simple" xlink:href="pntg-20211231.xsd#GOODWILLANDINTANGIBLEASSETSNET"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNET" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_989197de-fc64-4025-8f13-fc08b424858b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_65d3ffa6-e58a-463a-bc7f-d7e8f8bbec5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_989197de-fc64-4025-8f13-fc08b424858b" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_65d3ffa6-e58a-463a-bc7f-d7e8f8bbec5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETTables" xlink:type="simple" xlink:href="pntg-20211231.xsd#GOODWILLANDINTANGIBLEASSETSNETTables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1b562fea-15e1-4c92-860e-6871bb605893" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_dcd96e72-218f-41cb-bf4b-75ea6e21321f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1b562fea-15e1-4c92-860e-6871bb605893" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_dcd96e72-218f-41cb-bf4b-75ea6e21321f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_0aabc9b4-9ba6-45d4-8831-73a1fc85c609" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_1b562fea-15e1-4c92-860e-6871bb605893" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_0aabc9b4-9ba6-45d4-8831-73a1fc85c609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#GOODWILLANDINTANGIBLEASSETSNETNARRATIVEDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETNARRATIVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f5fb112c-e2c0-42ed-aa3e-f89f006eb894" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_b77307fb-3a04-4c6e-ac18-8c4f23d66ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_f5fb112c-e2c0-42ed-aa3e-f89f006eb894" xlink:to="loc_us-gaap_AssetImpairmentCharges_b77307fb-3a04-4c6e-ac18-8c4f23d66ad4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9db13248-0cd6-44ef-88da-6d5d6935a47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTable_e39eec20-2687-48b4-919d-1ba4faf1400a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfGoodwillTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_9db13248-0cd6-44ef-88da-6d5d6935a47c" xlink:to="loc_us-gaap_ScheduleOfGoodwillTable_e39eec20-2687-48b4-919d-1ba4faf1400a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_9ffc8557-05e6-412f-85c0-b1c364590bb6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e39eec20-2687-48b4-919d-1ba4faf1400a" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_9ffc8557-05e6-412f-85c0-b1c364590bb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_21a512ed-44e4-439d-87c2-1d8bb3aa0537" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_9ffc8557-05e6-412f-85c0-b1c364590bb6" xlink:to="loc_us-gaap_SegmentDomain_21a512ed-44e4-439d-87c2-1d8bb3aa0537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_7b87d92f-417e-4529-934c-165989b40f3a" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_21a512ed-44e4-439d-87c2-1d8bb3aa0537" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_7b87d92f-417e-4529-934c-165989b40f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_de91f064-7980-40df-b8d2-d63d9b65caa1" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_21a512ed-44e4-439d-87c2-1d8bb3aa0537" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_de91f064-7980-40df-b8d2-d63d9b65caa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillLineItems_228ffa2c-faf8-446c-abcd-41d31c343a74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfGoodwillTable_e39eec20-2687-48b4-919d-1ba4faf1400a" xlink:to="loc_us-gaap_GoodwillLineItems_228ffa2c-faf8-446c-abcd-41d31c343a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_d90b291f-a560-4af7-8b82-dbc9b4f9f686" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillLineItems_228ffa2c-faf8-446c-abcd-41d31c343a74" xlink:to="loc_us-gaap_GoodwillRollForward_d90b291f-a560-4af7-8b82-dbc9b4f9f686" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_af50bfa3-289f-41e5-8c36-88706c480ef5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d90b291f-a560-4af7-8b82-dbc9b4f9f686" xlink:to="loc_us-gaap_Goodwill_af50bfa3-289f-41e5-8c36-88706c480ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_338b0b42-ad9f-451e-8c52-70a5207d064d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d90b291f-a560-4af7-8b82-dbc9b4f9f686" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_338b0b42-ad9f-451e-8c52-70a5207d064d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_1a103445-3630-48e6-8a38-ce520c17e2ea" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_d90b291f-a560-4af7-8b82-dbc9b4f9f686" xlink:to="loc_us-gaap_Goodwill_1a103445-3630-48e6-8a38-ce520c17e2ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed2620c5-49f4-489f-adbe-fa5ddfce0380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_ea193d70-a070-4141-833a-f11c5b3f1f98" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_ed2620c5-49f4-489f-adbe-fa5ddfce0380" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_ea193d70-a070-4141-833a-f11c5b3f1f98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae11015f-9401-499f-9914-45afcd7a2835" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_ea193d70-a070-4141-833a-f11c5b3f1f98" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae11015f-9401-499f-9914-45afcd7a2835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d78b619-1e36-40ab-b253-2079104cffbe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis_ae11015f-9401-499f-9914-45afcd7a2835" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d78b619-1e36-40ab-b253-2079104cffbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_c9e38f1e-c61e-452b-b967-3ccd774548ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d78b619-1e36-40ab-b253-2079104cffbe" xlink:to="loc_us-gaap_TradeNamesMember_c9e38f1e-c61e-452b-b967-3ccd774548ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LicensingAgreementsMember_79f310a3-98b4-4131-825f-217b9b17e939" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicensingAgreementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain_7d78b619-1e36-40ab-b253-2079104cffbe" xlink:to="loc_us-gaap_LicensingAgreementsMember_79f310a3-98b4-4131-825f-217b9b17e939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_bf353f1d-e0b9-4d9b-9ca1-927aa70c54d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable_ea193d70-a070-4141-833a-f11c5b3f1f98" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_bf353f1d-e0b9-4d9b-9ca1-927aa70c54d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0a824d86-17eb-4143-bdf2-c5a2a7ea89a4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems_bf353f1d-e0b9-4d9b-9ca1-927aa70c54d4" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_0a824d86-17eb-4143-bdf2-c5a2a7ea89a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIES" xlink:type="simple" xlink:href="pntg-20211231.xsd#OTHERACCRUEDLIABILITIES"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_64409ffe-dcb3-4af1-8356-42e6405f3282" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_d36c719c-bdc8-4a9f-b47e-eedb3351746f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_64409ffe-dcb3-4af1-8356-42e6405f3282" xlink:to="loc_us-gaap_OtherLiabilitiesDisclosureTextBlock_d36c719c-bdc8-4a9f-b47e-eedb3351746f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESTables" xlink:type="simple" xlink:href="pntg-20211231.xsd#OTHERACCRUEDLIABILITIESTables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_8d847a9c-4e1d-4239-b14e-afd30c7de4e9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_4cb239e1-5a34-44a5-a455-eef69415b711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_8d847a9c-4e1d-4239-b14e-afd30c7de4e9" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_4cb239e1-5a34-44a5-a455-eef69415b711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OTHERACCRUEDLIABILITIESDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_25326f80-8902-40d5-8b29-63cb6ea0ca1a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_93411162-b412-4b87-8e4d-9709bf2edeaa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_25326f80-8902-40d5-8b29-63cb6ea0ca1a" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_93411162-b412-4b87-8e4d-9709bf2edeaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRefundLiabilityCurrent_2d819295-1028-4214-ab2e-3c0523f27e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerRefundLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_93411162-b412-4b87-8e4d-9709bf2edeaa" xlink:to="loc_us-gaap_CustomerRefundLiabilityCurrent_2d819295-1028-4214-ab2e-3c0523f27e7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d08c6a50-4728-4d7c-b2e0-80c95621bf58" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_93411162-b412-4b87-8e4d-9709bf2edeaa" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_d08c6a50-4728-4d7c-b2e0-80c95621bf58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositLiabilityCurrent_a4ecce55-60b7-47de-b138-5fa774c1775d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DepositLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_93411162-b412-4b87-8e4d-9709bf2edeaa" xlink:to="loc_us-gaap_DepositLiabilityCurrent_a4ecce55-60b7-47de-b138-5fa774c1775d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_ContractLiabilityAdvancePaymentsCARESAct_59cd3723-970a-4746-b803-392b52f88173" xlink:href="pntg-20211231.xsd#pntg_ContractLiabilityAdvancePaymentsCARESAct"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_93411162-b412-4b87-8e4d-9709bf2edeaa" xlink:to="loc_pntg_ContractLiabilityAdvancePaymentsCARESAct_59cd3723-970a-4746-b803-392b52f88173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_0578a76e-f1e7-40b1-a5c9-5abc1241ee1b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_93411162-b412-4b87-8e4d-9709bf2edeaa" xlink:to="loc_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent_0578a76e-f1e7-40b1-a5c9-5abc1241ee1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SelfInsuranceReserveCurrent_593e14bb-8722-4c75-a82b-99b9e464ca7a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SelfInsuranceReserveCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_93411162-b412-4b87-8e4d-9709bf2edeaa" xlink:to="loc_us-gaap_SelfInsuranceReserveCurrent_593e14bb-8722-4c75-a82b-99b9e464ca7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesCurrent_c31d8c77-0a50-46ca-9263-545427f3fe88" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherSundryLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_93411162-b412-4b87-8e4d-9709bf2edeaa" xlink:to="loc_us-gaap_OtherSundryLiabilitiesCurrent_c31d8c77-0a50-46ca-9263-545427f3fe88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1fbcb105-6fe2-45de-9669-5f4fd965e88d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrentAbstract_93411162-b412-4b87-8e4d-9709bf2edeaa" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_1fbcb105-6fe2-45de-9669-5f4fd965e88d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OTHERACCRUEDLIABILITIESNARRATIVEDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_40c86474-d00b-42e5-b10d-d4afbbacd825" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemTable_62c59f56-d7f0-4645-bd11-3f2dc543b292" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_40c86474-d00b-42e5-b10d-d4afbbacd825" xlink:to="loc_us-gaap_UnusualOrInfrequentItemTable_62c59f56-d7f0-4645-bd11-3f2dc543b292" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_10d64638-e9f3-4e49-a2df-9608cdf24c9b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_62c59f56-d7f0-4645-bd11-3f2dc543b292" xlink:to="loc_srt_RestatementAxis_10d64638-e9f3-4e49-a2df-9608cdf24c9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7c9b4033-237a-47cd-b288-26e1ff085ff1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_10d64638-e9f3-4e49-a2df-9608cdf24c9b" xlink:to="loc_srt_RestatementDomain_7c9b4033-237a-47cd-b288-26e1ff085ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_ae8dd25d-68f0-4272-951f-3186e008c314" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_7c9b4033-237a-47cd-b288-26e1ff085ff1" xlink:to="loc_srt_RestatementAdjustmentMember_ae8dd25d-68f0-4272-951f-3186e008c314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnusualOrInfrequentItemLineItems_3b6cfeba-1072-4304-803f-1448c1d2e430" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnusualOrInfrequentItemLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemTable_62c59f56-d7f0-4645-bd11-3f2dc543b292" xlink:to="loc_us-gaap_UnusualOrInfrequentItemLineItems_3b6cfeba-1072-4304-803f-1448c1d2e430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_6bca2acc-3a28-4597-9bf4-b9f550d70338" xlink:href="pntg-20211231.xsd#pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_3b6cfeba-1072-4304-803f-1448c1d2e430" xlink:to="loc_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived_6bca2acc-3a28-4597-9bf4-b9f550d70338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds_24ba088c-a2af-4b47-b3cc-028ded40f7e0" xlink:href="pntg-20211231.xsd#pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_3b6cfeba-1072-4304-803f-1448c1d2e430" xlink:to="loc_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds_24ba088c-a2af-4b47-b3cc-028ded40f7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrent_9517b8cf-0786-4c42-b69d-9937450d8a67" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_UnusualOrInfrequentItemLineItems_3b6cfeba-1072-4304-803f-1448c1d2e430" xlink:to="loc_us-gaap_LiabilitiesNoncurrent_9517b8cf-0786-4c42-b69d-9937450d8a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/DEBT" xlink:type="simple" xlink:href="pntg-20211231.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e8cfc6e9-527f-42fd-b287-64bd56d2bdba" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_d3dd4aba-5a95-4839-8ed1-03e5af187909" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e8cfc6e9-527f-42fd-b287-64bd56d2bdba" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_d3dd4aba-5a95-4839-8ed1-03e5af187909" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/DEBTTables" xlink:type="simple" xlink:href="pntg-20211231.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_6010e249-c0b2-47f7-941c-a01629fdb7d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0e771b4a-67f7-45c3-ab2b-1c5dff7a5d78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_6010e249-c0b2-47f7-941c-a01629fdb7d1" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_0e771b4a-67f7-45c3-ab2b-1c5dff7a5d78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#DEBTSCHEDULEOFLONGTERMDEBTDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_8313f06f-cddd-41c5-96dd-b9138934eac2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_daf36174-72cd-49fb-b212-01c730a1d2c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_8313f06f-cddd-41c5-96dd-b9138934eac2" xlink:to="loc_us-gaap_DebtInstrumentTable_daf36174-72cd-49fb-b212-01c730a1d2c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_38530285-bb7d-4e39-be3c-de51ee46681d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_daf36174-72cd-49fb-b212-01c730a1d2c1" xlink:to="loc_us-gaap_CreditFacilityAxis_38530285-bb7d-4e39-be3c-de51ee46681d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_6d41da50-cfcd-4de5-8509-ed95ecbe9205" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_38530285-bb7d-4e39-be3c-de51ee46681d" xlink:to="loc_us-gaap_CreditFacilityDomain_6d41da50-cfcd-4de5-8509-ed95ecbe9205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_b01157ad-f0bc-4524-821c-76d460a36759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_6d41da50-cfcd-4de5-8509-ed95ecbe9205" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_b01157ad-f0bc-4524-821c-76d460a36759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_0ecd65d5-52ec-4942-a474-efd0dc7ca9ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_daf36174-72cd-49fb-b212-01c730a1d2c1" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_0ecd65d5-52ec-4942-a474-efd0dc7ca9ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4ecafcb8-8b2a-4b22-ba62-7aa71dfb2b75" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_0ecd65d5-52ec-4942-a474-efd0dc7ca9ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4ecafcb8-8b2a-4b22-ba62-7aa71dfb2b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_7d79a9a8-6c6c-44ed-b507-3e44cd7c8e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_4ecafcb8-8b2a-4b22-ba62-7aa71dfb2b75" xlink:to="loc_us-gaap_LineOfCreditMember_7d79a9a8-6c6c-44ed-b507-3e44cd7c8e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_daf36174-72cd-49fb-b212-01c730a1d2c1" xlink:to="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4da90d1d-3124-4f77-86c5-d4fd0622d0ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4da90d1d-3124-4f77-86c5-d4fd0622d0ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_4427ea94-a455-4600-b036-071bf2681709" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_4427ea94-a455-4600-b036-071bf2681709" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_7110170b-eec1-4df8-96b6-c89291df33ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:to="loc_us-gaap_LongTermDebt_7110170b-eec1-4df8-96b6-c89291df33ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_bf944644-897c-482f-8b9c-97e53f89276b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_481eea05-eeba-4a69-873d-50c7e4bbef6b" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_bf944644-897c-482f-8b9c-97e53f89276b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/DEBTNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#DEBTNARRATIVEDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/DEBTNARRATIVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2edbe309-0f84-4f71-8f76-8a94f9b074f0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2edbe309-0f84-4f71-8f76-8a94f9b074f0" xlink:to="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_5a0d73b8-1534-457f-a686-d642da7a33c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:to="loc_us-gaap_CreditFacilityAxis_5a0d73b8-1534-457f-a686-d642da7a33c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_9f69c377-30ec-434d-b01b-1f5c80b85de1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_5a0d73b8-1534-457f-a686-d642da7a33c9" xlink:to="loc_us-gaap_CreditFacilityDomain_9f69c377-30ec-434d-b01b-1f5c80b85de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevolvingCreditFacilityMember_54fc53cd-026c-4b06-94c9-5ad07537e0f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevolvingCreditFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9f69c377-30ec-434d-b01b-1f5c80b85de1" xlink:to="loc_us-gaap_RevolvingCreditFacilityMember_54fc53cd-026c-4b06-94c9-5ad07537e0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_b39e926f-e9cb-4fee-aee1-f75c1ab36d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_9f69c377-30ec-434d-b01b-1f5c80b85de1" xlink:to="loc_us-gaap_LetterOfCreditMember_b39e926f-e9cb-4fee-aee1-f75c1ab36d2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_2d09df55-7e17-4f60-a9c0-1c51d7a704c8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:to="loc_srt_RangeAxis_2d09df55-7e17-4f60-a9c0-1c51d7a704c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_f67b33a1-e48c-4576-a6ca-b9ec8abef58c" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_2d09df55-7e17-4f60-a9c0-1c51d7a704c8" xlink:to="loc_srt_RangeMember_f67b33a1-e48c-4576-a6ca-b9ec8abef58c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_c5546d8a-c8d9-4528-9473-6be4763afab1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f67b33a1-e48c-4576-a6ca-b9ec8abef58c" xlink:to="loc_srt_MinimumMember_c5546d8a-c8d9-4528-9473-6be4763afab1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b234e15c-04b4-4bca-af18-a2a682aec5af" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_f67b33a1-e48c-4576-a6ca-b9ec8abef58c" xlink:to="loc_srt_MaximumMember_b234e15c-04b4-4bca-af18-a2a682aec5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_847d1248-8f95-4683-a995-92022184c206" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:to="loc_us-gaap_VariableRateAxis_847d1248-8f95-4683-a995-92022184c206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_0f3ab491-0874-4688-8d4d-69ec680eac24" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_847d1248-8f95-4683-a995-92022184c206" xlink:to="loc_us-gaap_VariableRateDomain_0f3ab491-0874-4688-8d4d-69ec680eac24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a2cb0897-40d2-42da-9b27-fee14c0e1682" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_0f3ab491-0874-4688-8d4d-69ec680eac24" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_a2cb0897-40d2-42da-9b27-fee14c0e1682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_98d62371-f0b1-432d-888f-0d66fa76872e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_0f3ab491-0874-4688-8d4d-69ec680eac24" xlink:to="loc_us-gaap_BaseRateMember_98d62371-f0b1-432d-888f-0d66fa76872e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_10668adc-d510-43f5-bd39-6f8ead60e855" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_10668adc-d510-43f5-bd39-6f8ead60e855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d3f1e240-8bc1-4b6d-a7dd-443a73fc6735" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_10668adc-d510-43f5-bd39-6f8ead60e855" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d3f1e240-8bc1-4b6d-a7dd-443a73fc6735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_26b0845e-6b39-4d78-8759-30960e351fb8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_d3f1e240-8bc1-4b6d-a7dd-443a73fc6735" xlink:to="loc_us-gaap_LineOfCreditMember_26b0845e-6b39-4d78-8759-30960e351fb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_76222d3a-6cd1-49b0-81f2-887481dce299" xlink:to="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3931fbb9-552d-4dbb-b1a9-3e12a10fc000" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_3931fbb9-552d-4dbb-b1a9-3e12a10fc000" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_dc1833b0-256c-4ffc-b7be-556a057ecd71" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_dc1833b0-256c-4ffc-b7be-556a057ecd71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c0bbcd73-9e0a-4604-ac0d-f75a787c6736" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityCommitmentFeePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_LineOfCreditFacilityCommitmentFeePercentage_c0bbcd73-9e0a-4604-ac0d-f75a787c6736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_61c3ece7-6988-4ca7-b20c-3dc126371e5f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LongtermDebtWeightedAverageInterestRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_LongtermDebtWeightedAverageInterestRate_61c3ece7-6988-4ca7-b20c-3dc126371e5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_bef211d9-fb6f-442d-9a4e-c89e32417e27" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_bef211d9-fb6f-442d-9a4e-c89e32417e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_0347df8b-c70a-47f0-86eb-6ba2f1c46eff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_567bc6b0-6da9-414d-80e0-cc01f637d314" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_0347df8b-c70a-47f0-86eb-6ba2f1c46eff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDS" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDS"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c32529a-35b5-4b3b-8caf-00dc6c52d1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_82920d6b-681c-4d3b-a7ce-20f4f342162c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5c32529a-35b5-4b3b-8caf-00dc6c52d1cc" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_82920d6b-681c-4d3b-a7ce-20f4f342162c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSTables" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSTables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_26117e1a-d1c1-4d20-bd12-b2f4898fb4b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_5ac142ef-d338-467b-ba47-ce28792bfef4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_26117e1a-d1c1-4d20-bd12-b2f4898fb4b0" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_5ac142ef-d338-467b-ba47-ce28792bfef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7bf86d49-1714-4943-b494-73e354a03571" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_26117e1a-d1c1-4d20-bd12-b2f4898fb4b0" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_7bf86d49-1714-4943-b494-73e354a03571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_baa08f83-2cf5-4931-bb8a-99936b84ad9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_26117e1a-d1c1-4d20-bd12-b2f4898fb4b0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_baa08f83-2cf5-4931-bb8a-99936b84ad9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_114fd017-c96e-45cb-90c5-67484c1384ac" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_26117e1a-d1c1-4d20-bd12-b2f4898fb4b0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock_114fd017-c96e-45cb-90c5-67484c1384ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_ce58607d-babd-439b-bb79-b3f707619c6f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_26117e1a-d1c1-4d20-bd12-b2f4898fb4b0" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_ce58607d-babd-439b-bb79-b3f707619c6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6477f672-aea9-4c51-a8ac-7cdb20cd90ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_275fb6c9-cdab-4928-a6a9-d59351fbfb49" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_6477f672-aea9-4c51-a8ac-7cdb20cd90ff" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_275fb6c9-cdab-4928-a6a9-d59351fbfb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0fbc972d-7722-415c-9c93-9463ff59efca" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_275fb6c9-cdab-4928-a6a9-d59351fbfb49" xlink:to="loc_us-gaap_AwardTypeAxis_0fbc972d-7722-415c-9c93-9463ff59efca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b61009b2-3e20-429c-866d-4af17c49c627" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0fbc972d-7722-415c-9c93-9463ff59efca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b61009b2-3e20-429c-866d-4af17c49c627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_4a224987-80f8-46d0-a08f-b5aac8cf984b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b61009b2-3e20-429c-866d-4af17c49c627" xlink:to="loc_us-gaap_EmployeeStockOptionMember_4a224987-80f8-46d0-a08f-b5aac8cf984b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_994dce4b-ffc1-457e-92b0-3ca62b558287" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b61009b2-3e20-429c-866d-4af17c49c627" xlink:to="loc_us-gaap_RestrictedStockMember_994dce4b-ffc1-457e-92b0-3ca62b558287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_aa78ed5c-66db-4d13-b272-c9d04120eaaf" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_275fb6c9-cdab-4928-a6a9-d59351fbfb49" xlink:to="loc_srt_TitleOfIndividualAxis_aa78ed5c-66db-4d13-b272-c9d04120eaaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d333065d-70ed-421a-be67-c8f8f89a179d" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_aa78ed5c-66db-4d13-b272-c9d04120eaaf" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d333065d-70ed-421a-be67-c8f8f89a179d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_DirectorMember_679e4b54-e313-45c7-bf6e-16e22c598c3e" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_DirectorMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_d333065d-70ed-421a-be67-c8f8f89a179d" xlink:to="loc_srt_DirectorMember_679e4b54-e313-45c7-bf6e-16e22c598c3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2740981d-5eae-4c54-bf3f-8b5272328d9d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_275fb6c9-cdab-4928-a6a9-d59351fbfb49" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2740981d-5eae-4c54-bf3f-8b5272328d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_63e54aaf-0ebf-4015-99fd-3880db51d92e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2740981d-5eae-4c54-bf3f-8b5272328d9d" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_63e54aaf-0ebf-4015-99fd-3880db51d92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bdc7cb13-4840-4574-8432-4ad981a9a422" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e2b93d06-fc64-4c58-a241-e5335cea2d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bdc7cb13-4840-4574-8432-4ad981a9a422" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e2b93d06-fc64-4c58-a241-e5335cea2d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6c33853c-aff5-4294-ad37-40eae7435119" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e2b93d06-fc64-4c58-a241-e5335cea2d7f" xlink:to="loc_us-gaap_PlanNameAxis_6c33853c-aff5-4294-ad37-40eae7435119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_d77e1c75-361c-42f8-9e85-0f8460d14599" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_6c33853c-aff5-4294-ad37-40eae7435119" xlink:to="loc_us-gaap_PlanNameDomain_d77e1c75-361c-42f8-9e85-0f8460d14599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_d46fd445-b6c7-4201-8e37-f584bd5825d5" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_d77e1c75-361c-42f8-9e85-0f8460d14599" xlink:to="loc_pntg_TheEnsignPlansMember_d46fd445-b6c7-4201-8e37-f584bd5825d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8ab13ad6-3aff-490f-84c0-8c9703435d10" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e2b93d06-fc64-4c58-a241-e5335cea2d7f" xlink:to="loc_us-gaap_AwardTypeAxis_8ab13ad6-3aff-490f-84c0-8c9703435d10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_382e10af-a2b3-4fdc-a07d-16f55ac0aef1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8ab13ad6-3aff-490f-84c0-8c9703435d10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_382e10af-a2b3-4fdc-a07d-16f55ac0aef1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_cb881516-af9f-4622-8500-bb107448b5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_382e10af-a2b3-4fdc-a07d-16f55ac0aef1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_cb881516-af9f-4622-8500-bb107448b5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_882dff83-baf7-4b21-abb1-493835200711" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_382e10af-a2b3-4fdc-a07d-16f55ac0aef1" xlink:to="loc_us-gaap_RestrictedStockMember_882dff83-baf7-4b21-abb1-493835200711" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4751beab-bf50-4c77-afea-df02e1b6d951" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e2b93d06-fc64-4c58-a241-e5335cea2d7f" xlink:to="loc_srt_RangeAxis_4751beab-bf50-4c77-afea-df02e1b6d951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_223bb228-35af-4a4c-a816-7d888bced1d8" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4751beab-bf50-4c77-afea-df02e1b6d951" xlink:to="loc_srt_RangeMember_223bb228-35af-4a4c-a816-7d888bced1d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ed3d4a89-0ef7-4701-aab8-a1ae4eba2647" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_223bb228-35af-4a4c-a816-7d888bced1d8" xlink:to="loc_srt_MaximumMember_ed3d4a89-0ef7-4701-aab8-a1ae4eba2647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_117bbbec-bee7-4dcc-ace1-118b14abe2d9" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_223bb228-35af-4a4c-a816-7d888bced1d8" xlink:to="loc_srt_MinimumMember_117bbbec-bee7-4dcc-ace1-118b14abe2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_e2b93d06-fc64-4c58-a241-e5335cea2d7f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8a9009b2-1282-4f9d-858f-675fa802da2e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_8a9009b2-1282-4f9d-858f-675fa802da2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a5feed41-d4d9-4e6a-8fd1-f81851e3644f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a5feed41-d4d9-4e6a-8fd1-f81851e3644f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3c59ad83-31d7-4a27-b7ea-b9cd323df009" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3c59ad83-31d7-4a27-b7ea-b9cd323df009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0eef6e47-8a11-48e7-a07b-3ac3788a9ae8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_0eef6e47-8a11-48e7-a07b-3ac3788a9ae8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f5ed23f8-dc91-4511-9ae7-710122784b16" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f5ed23f8-dc91-4511-9ae7-710122784b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_09d613d8-7cdd-45c7-9eba-2c4b97b4de56" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_09d613d8-7cdd-45c7-9eba-2c4b97b4de56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0f9c889f-b35c-4fde-9b32-9468e476c47c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_0f9c889f-b35c-4fde-9b32-9468e476c47c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_ae18df1b-c237-40be-832b-df5c70f46ad3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_ae18df1b-c237-40be-832b-df5c70f46ad3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_52cfd397-18ee-495b-bfdd-934db26d1317" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_5ce1b51b-fccd-4f7f-897c-bb7984352e73" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_52cfd397-18ee-495b-bfdd-934db26d1317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSOPTIONSGRANTEDDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7b0ca141-2f34-49ff-8e03-81227ac59f63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da4d4633-6f24-4556-9c9a-294fc731d607" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7b0ca141-2f34-49ff-8e03-81227ac59f63" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da4d4633-6f24-4556-9c9a-294fc731d607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_38c06e33-79a8-4fb8-a53c-48e45c985349" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da4d4633-6f24-4556-9c9a-294fc731d607" xlink:to="loc_us-gaap_PlanNameAxis_38c06e33-79a8-4fb8-a53c-48e45c985349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8aa02584-8305-4f73-b4a3-bb61ea0849d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_38c06e33-79a8-4fb8-a53c-48e45c985349" xlink:to="loc_us-gaap_PlanNameDomain_8aa02584-8305-4f73-b4a3-bb61ea0849d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_1d3c9ca3-f058-4746-b21e-51c273d55ff5" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8aa02584-8305-4f73-b4a3-bb61ea0849d1" xlink:to="loc_pntg_TheEnsignPlansMember_1d3c9ca3-f058-4746-b21e-51c273d55ff5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateAxis_23341988-d21b-4bd9-9d27-a40e4d4ebc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da4d4633-6f24-4556-9c9a-294fc731d607" xlink:to="loc_us-gaap_AwardDateAxis_23341988-d21b-4bd9-9d27-a40e4d4ebc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardDateDomain_1aa81e21-7645-443f-9b7b-9c34ce7823e3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardDateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateAxis_23341988-d21b-4bd9-9d27-a40e4d4ebc0d" xlink:to="loc_us-gaap_AwardDateDomain_1aa81e21-7645-443f-9b7b-9c34ce7823e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GrantYear2021Member_ac6809ca-abba-42f2-a5aa-515a54430680" xlink:href="pntg-20211231.xsd#pntg_GrantYear2021Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1aa81e21-7645-443f-9b7b-9c34ce7823e3" xlink:to="loc_pntg_GrantYear2021Member_ac6809ca-abba-42f2-a5aa-515a54430680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GrantYear2020Member_35b8219f-a09f-4658-aa8b-99a739771a8a" xlink:href="pntg-20211231.xsd#pntg_GrantYear2020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1aa81e21-7645-443f-9b7b-9c34ce7823e3" xlink:to="loc_pntg_GrantYear2020Member_35b8219f-a09f-4658-aa8b-99a739771a8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_GrantYear2019Member_760c4b66-5cb9-4855-8dbb-554bbef57758" xlink:href="pntg-20211231.xsd#pntg_GrantYear2019Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardDateDomain_1aa81e21-7645-443f-9b7b-9c34ce7823e3" xlink:to="loc_pntg_GrantYear2019Member_760c4b66-5cb9-4855-8dbb-554bbef57758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_0788b886-b65a-4407-bff2-446534d2f304" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da4d4633-6f24-4556-9c9a-294fc731d607" xlink:to="loc_us-gaap_AwardTypeAxis_0788b886-b65a-4407-bff2-446534d2f304" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bea2a57b-0254-4f19-babb-ab5ef67a575e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_0788b886-b65a-4407-bff2-446534d2f304" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bea2a57b-0254-4f19-babb-ab5ef67a575e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_8497d90a-b91f-4620-a413-5e0ae6003c5a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bea2a57b-0254-4f19-babb-ab5ef67a575e" xlink:to="loc_us-gaap_EmployeeStockOptionMember_8497d90a-b91f-4620-a413-5e0ae6003c5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_da4d4633-6f24-4556-9c9a-294fc731d607" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_45fe3167-5c3f-43df-b1b9-71071b848936" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_45fe3167-5c3f-43df-b1b9-71071b848936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8b90bdf1-21d3-47bf-8675-4766e8541309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_8b90bdf1-21d3-47bf-8675-4766e8541309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8feae370-6272-4b4f-835b-0717bc712450" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_8feae370-6272-4b4f-835b-0717bc712450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_d1b1901f-ad36-4ea8-8d67-d917e8352c41" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_d1b1901f-ad36-4ea8-8d67-d917e8352c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_994996bf-a07a-4575-a892-29d4ccaf740b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_994996bf-a07a-4575-a892-29d4ccaf740b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fadf8028-1b9d-4af4-b4af-cd99bd0ad9be" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_82d1685d-1c35-4bd2-93a3-ed1b482502f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_fadf8028-1b9d-4af4-b4af-cd99bd0ad9be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5a5cde01-96ef-4da1-a800-90492e8c4dfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac4fc48c-7da8-4d9e-98a8-8e6725efa496" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_5a5cde01-96ef-4da1-a800-90492e8c4dfa" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac4fc48c-7da8-4d9e-98a8-8e6725efa496" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_7c2bb8e1-fc14-428a-8418-6ccdfb70f498" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac4fc48c-7da8-4d9e-98a8-8e6725efa496" xlink:to="loc_us-gaap_PlanNameAxis_7c2bb8e1-fc14-428a-8418-6ccdfb70f498" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_fc73b41d-50eb-4299-8d95-8ae7dde85759" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_7c2bb8e1-fc14-428a-8418-6ccdfb70f498" xlink:to="loc_us-gaap_PlanNameDomain_fc73b41d-50eb-4299-8d95-8ae7dde85759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_74a0e2c0-311a-4db1-a8f6-2a9edc78503f" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_fc73b41d-50eb-4299-8d95-8ae7dde85759" xlink:to="loc_pntg_TheEnsignPlansMember_74a0e2c0-311a-4db1-a8f6-2a9edc78503f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_ac4fc48c-7da8-4d9e-98a8-8e6725efa496" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6c339e1e-8f45-43d0-bde4-e0ec429162b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_6c339e1e-8f45-43d0-bde4-e0ec429162b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1ff6f698-c9fc-4345-8cd4-564c45a84c37" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1ff6f698-c9fc-4345-8cd4-564c45a84c37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8c56cd60-e7a8-4fe3-891b-a221dc00b9ff" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8c56cd60-e7a8-4fe3-891b-a221dc00b9ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_dd634938-99fc-4492-bfcd-ca3fde3dfde2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_dd634938-99fc-4492-bfcd-ca3fde3dfde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2ed09c92-90ae-494b-bf64-a5ca82bdc280" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1b935d8a-e80a-47c9-85f6-7638188f037e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_2ed09c92-90ae-494b-bf64-a5ca82bdc280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4190c95b-bead-4c6e-ba4f-d84d9d0cedb5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4190c95b-bead-4c6e-ba4f-d84d9d0cedb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4b6e6fa8-6c09-45ab-a35c-79e9048cb7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_4b6e6fa8-6c09-45ab-a35c-79e9048cb7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9b431e28-066c-445e-8bde-fb1442fccd1c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_9b431e28-066c-445e-8bde-fb1442fccd1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_04185ec2-b60a-42e6-8037-7ddf0c6cb85c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_04185ec2-b60a-42e6-8037-7ddf0c6cb85c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4b0917d4-c931-433a-9688-92ae896edcda" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_aa10afa3-42f3-4289-8f60-914fabb41f7b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_4b0917d4-c931-433a-9688-92ae896edcda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber_4d464c63-f89a-47f9-ab63-364a2ee52e22" xlink:href="pntg-20211231.xsd#pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:to="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber_4d464c63-f89a-47f9-ab63-364a2ee52e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1d923e04-1236-4f6b-9138-ed7dced63178" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_453a2e67-b0fe-49e0-ba62-fad35649cd65" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_1d923e04-1236-4f6b-9138-ed7dced63178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2fba2aee-9acb-496f-b675-49adebcaa7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3e3f6df-0e67-475d-a65e-b3147276a470" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_2fba2aee-9acb-496f-b675-49adebcaa7cb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3e3f6df-0e67-475d-a65e-b3147276a470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5d225865-df53-484e-bbd5-7413076d686b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3e3f6df-0e67-475d-a65e-b3147276a470" xlink:to="loc_us-gaap_PlanNameAxis_5d225865-df53-484e-bbd5-7413076d686b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9033fdb9-e1be-4717-a728-d9e74087b426" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5d225865-df53-484e-bbd5-7413076d686b" xlink:to="loc_us-gaap_PlanNameDomain_9033fdb9-e1be-4717-a728-d9e74087b426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_9eddfb05-e0ba-4c25-8546-5b6bb38ea2cf" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_9033fdb9-e1be-4717-a728-d9e74087b426" xlink:to="loc_pntg_TheEnsignPlansMember_9eddfb05-e0ba-4c25-8546-5b6bb38ea2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c3e3f6df-0e67-475d-a65e-b3147276a470" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_787fed45-5a26-4145-85f4-89edff53b7d0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_787fed45-5a26-4145-85f4-89edff53b7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue_b587503c-3089-48f2-82cb-2f45bd4902a6" xlink:href="pntg-20211231.xsd#pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:to="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue_b587503c-3089-48f2-82cb-2f45bd4902a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_0bfa433f-5a04-4398-9f7a-7a27fc8174c9" xlink:href="pntg-20211231.xsd#pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:to="loc_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue_0bfa433f-5a04-4398-9f7a-7a27fc8174c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_7958ced4-bfe8-4ace-896b-2029afe5e8cc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_606a1289-bc1a-4e1c-a49a-b00d7d3b3535" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_7958ced4-bfe8-4ace-896b-2029afe5e8cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3e516973-d6d2-42a8-93c4-cefd8077df5c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a957fda-6ebd-446e-ba12-5e986d377640" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_3e516973-d6d2-42a8-93c4-cefd8077df5c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a957fda-6ebd-446e-ba12-5e986d377640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_608625c6-e846-4747-b93c-ef7ae0866829" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a957fda-6ebd-446e-ba12-5e986d377640" xlink:to="loc_us-gaap_PlanNameAxis_608625c6-e846-4747-b93c-ef7ae0866829" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_64c6d412-1ad3-4c67-bfb0-2b40c9fc8c78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_608625c6-e846-4747-b93c-ef7ae0866829" xlink:to="loc_us-gaap_PlanNameDomain_64c6d412-1ad3-4c67-bfb0-2b40c9fc8c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_7a2e5c7e-01ac-4b61-aae1-23e1af182627" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_64c6d412-1ad3-4c67-bfb0-2b40c9fc8c78" xlink:to="loc_pntg_TheEnsignPlansMember_7a2e5c7e-01ac-4b61-aae1-23e1af182627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_059b4b57-9d8c-475b-a866-727a8966f673" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a957fda-6ebd-446e-ba12-5e986d377640" xlink:to="loc_us-gaap_AwardTypeAxis_059b4b57-9d8c-475b-a866-727a8966f673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719d9648-faed-40f7-afa3-ac3f3a19a00d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_059b4b57-9d8c-475b-a866-727a8966f673" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719d9648-faed-40f7-afa3-ac3f3a19a00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_8feee1d1-3e0a-403f-ba83-75a696cd4be9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_719d9648-faed-40f7-afa3-ac3f3a19a00d" xlink:to="loc_us-gaap_RestrictedStockMember_8feee1d1-3e0a-403f-ba83-75a696cd4be9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_76a6be18-1dca-4253-9fa2-ba5b2592102e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2a957fda-6ebd-446e-ba12-5e986d377640" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_76a6be18-1dca-4253-9fa2-ba5b2592102e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_76a6be18-1dca-4253-9fa2-ba5b2592102e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_852ea4f2-34f6-41ea-b78c-5b4019cd6def" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_852ea4f2-34f6-41ea-b78c-5b4019cd6def" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_15273592-e06d-4b51-a299-d259ff87d1b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_15273592-e06d-4b51-a299-d259ff87d1b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b7dd8e33-2075-4fd9-8ff7-78c1cd43c2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_b7dd8e33-2075-4fd9-8ff7-78c1cd43c2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8345dd40-cf6f-404b-bb86-103329ca83e2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8345dd40-cf6f-404b-bb86-103329ca83e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12543398-df13-4de3-8968-f344350408b1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_f76f6456-0728-47e3-b606-dcd8e7ea5c9a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_12543398-df13-4de3-8968-f344350408b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_76a6be18-1dca-4253-9fa2-ba5b2592102e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_099878d8-3b23-4767-a566-e835a4b3da4e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_099878d8-3b23-4767-a566-e835a4b3da4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_66ed17f9-7267-41f0-8481-c48be4df64ab" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_66ed17f9-7267-41f0-8481-c48be4df64ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_94fa35da-a61d-4c08-b1a5-b5154329ff7c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_94fa35da-a61d-4c08-b1a5-b5154329ff7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8fb1e47f-58ed-4baa-aab1-14690f189d08" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_8fb1e47f-58ed-4baa-aab1-14690f189d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_02dc37ce-ba6c-4083-81b7-62a1193e5f50" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_22fadb92-6ea8-4b21-a42b-fad3fb7cad43" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_02dc37ce-ba6c-4083-81b7-62a1193e5f50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/LEASES" xlink:type="simple" xlink:href="pntg-20211231.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_21949646-1a07-4640-aefb-e480a44168d3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_4fbf06ca-fac4-431d-b87c-f3ca657ff29a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_21949646-1a07-4640-aefb-e480a44168d3" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_4fbf06ca-fac4-431d-b87c-f3ca657ff29a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/LEASESTables" xlink:type="simple" xlink:href="pntg-20211231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_7d16532a-1049-43e6-8691-026e0e2a2230" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_7c42f06b-80db-4093-915c-3cd37bd12d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7d16532a-1049-43e6-8691-026e0e2a2230" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_7c42f06b-80db-4093-915c-3cd37bd12d0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_da343f04-0b95-4772-b459-ab9def03ce4d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_7d16532a-1049-43e6-8691-026e0e2a2230" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_da343f04-0b95-4772-b459-ab9def03ce4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/LEASESNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#LEASESNARRATIVEDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/LEASESNARRATIVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5a200b47-0f21-445b-97e8-611b135a006a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_f6e6b39e-10fd-49d4-b69e-004e394bb970" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5a200b47-0f21-445b-97e8-611b135a006a" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_f6e6b39e-10fd-49d4-b69e-004e394bb970" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_d6e63f3a-1f67-48d6-a48f-197f26a5f7b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f6e6b39e-10fd-49d4-b69e-004e394bb970" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_d6e63f3a-1f67-48d6-a48f-197f26a5f7b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_82f4a84a-beb6-40cb-a815-4f9da1e930aa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_d6e63f3a-1f67-48d6-a48f-197f26a5f7b9" xlink:to="loc_us-gaap_SegmentDomain_82f4a84a-beb6-40cb-a815-4f9da1e930aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_SeniorLivingServicesSegmentMember_413041a7-aed0-4069-a967-dce5c32b9422" xlink:href="pntg-20211231.xsd#pntg_SeniorLivingServicesSegmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_82f4a84a-beb6-40cb-a815-4f9da1e930aa" xlink:to="loc_pntg_SeniorLivingServicesSegmentMember_413041a7-aed0-4069-a967-dce5c32b9422" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_bfcb7480-42c5-47c9-920a-291ba90e46f7" xlink:href="pntg-20211231.xsd#pntg_HomeHealthAndHospiceServicesSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_82f4a84a-beb6-40cb-a815-4f9da1e930aa" xlink:to="loc_pntg_HomeHealthAndHospiceServicesSegmentMember_bfcb7480-42c5-47c9-920a-291ba90e46f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_4db3b35f-7ed2-45a2-be3c-ecf18aaac23b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f6e6b39e-10fd-49d4-b69e-004e394bb970" xlink:to="loc_srt_RangeAxis_4db3b35f-7ed2-45a2-be3c-ecf18aaac23b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_e76a2526-096f-4c54-8a82-0b9123ef60a1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_4db3b35f-7ed2-45a2-be3c-ecf18aaac23b" xlink:to="loc_srt_RangeMember_e76a2526-096f-4c54-8a82-0b9123ef60a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0259535e-35d5-4585-bb67-00333c0fa1a4" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e76a2526-096f-4c54-8a82-0b9123ef60a1" xlink:to="loc_srt_MinimumMember_0259535e-35d5-4585-bb67-00333c0fa1a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_bb3c9134-101d-4b38-98d0-058747d5aabd" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_e76a2526-096f-4c54-8a82-0b9123ef60a1" xlink:to="loc_srt_MaximumMember_bb3c9134-101d-4b38-98d0-058747d5aabd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6409c5bd-2c11-4c3f-b0cd-2889edd2dac8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f6e6b39e-10fd-49d4-b69e-004e394bb970" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6409c5bd-2c11-4c3f-b0cd-2889edd2dac8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_9e85c2e0-5f61-4108-bb9c-c3593192093e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_6409c5bd-2c11-4c3f-b0cd-2889edd2dac8" xlink:to="loc_us-gaap_RelatedPartyDomain_9e85c2e0-5f61-4108-bb9c-c3593192093e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AffiliatedEntityMember_b691f58b-835c-44ca-8a01-c9ea24021474" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_AffiliatedEntityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_9e85c2e0-5f61-4108-bb9c-c3593192093e" xlink:to="loc_srt_AffiliatedEntityMember_b691f58b-835c-44ca-8a01-c9ea24021474" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_f6e6b39e-10fd-49d4-b69e-004e394bb970" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfRealEstatePropertiesUnderLease_3b32d0ec-d2b0-4819-b658-66a59032f2fe" xlink:href="pntg-20211231.xsd#pntg_NumberOfRealEstatePropertiesUnderLease"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_pntg_NumberOfRealEstatePropertiesUnderLease_3b32d0ec-d2b0-4819-b658-66a59032f2fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0db14d21-ce87-4b4d-a0e8-4f279d0c0850" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_0db14d21-ce87-4b4d-a0e8-4f279d0c0850" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfServiceProviders_bf8c6771-3cb9-4412-a629-a06d08ca336d" xlink:href="pntg-20211231.xsd#pntg_NumberOfServiceProviders"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_pntg_NumberOfServiceProviders_bf8c6771-3cb9-4412-a629-a06d08ca336d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfRealEstateProperties_f3669f22-5535-4cf9-804c-e8307249a7c9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfRealEstateProperties"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_us-gaap_NumberOfRealEstateProperties_f3669f22-5535-4cf9-804c-e8307249a7c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement_d2521923-fe79-49f9-89e7-6daa47b424e4" xlink:href="pntg-20211231.xsd#pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement_d2521923-fe79-49f9-89e7-6daa47b424e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfSeparateMasterLeaseArrangements_24b9385b-c228-4676-ae86-1efe85bc25f3" xlink:href="pntg-20211231.xsd#pntg_NumberOfSeparateMasterLeaseArrangements"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_pntg_NumberOfSeparateMasterLeaseArrangements_24b9385b-c228-4676-ae86-1efe85bc25f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fb0ee800-0deb-4938-b53a-fb8e5f781148" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_fb0ee800-0deb-4938-b53a-fb8e5f781148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e1a80f0e-4899-491a-888a-f6cbdf6f76ae" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7402d8c6-1111-47cb-a246-c1a6d9c864b9" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e1a80f0e-4899-491a-888a-f6cbdf6f76ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#LEASESIMPACTOFNEWLEASESGUIDANCEDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d4ee9b76-c936-4ad6-a412-741640accfe7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_d3644de9-b749-4bf9-839f-a96fffe9edd9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d4ee9b76-c936-4ad6-a412-741640accfe7" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_d3644de9-b749-4bf9-839f-a96fffe9edd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_135952c7-95e7-4a7a-8183-e948734505a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d3644de9-b749-4bf9-839f-a96fffe9edd9" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_135952c7-95e7-4a7a-8183-e948734505a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_0519f511-639e-4a70-8b2d-cb7c111b03fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_135952c7-95e7-4a7a-8183-e948734505a7" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_0519f511-639e-4a70-8b2d-cb7c111b03fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_783feadf-9649-4b84-9e5a-fe14701c57c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0519f511-639e-4a70-8b2d-cb7c111b03fd" xlink:to="loc_us-gaap_CostOfSalesMember_783feadf-9649-4b84-9e5a-fe14701c57c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c9705b31-dbbd-40d8-a94f-37cb8ea81f57" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_0519f511-639e-4a70-8b2d-cb7c111b03fd" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_c9705b31-dbbd-40d8-a94f-37cb8ea81f57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_05b1b937-72c5-4e32-9054-4e5813a94a70" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d3644de9-b749-4bf9-839f-a96fffe9edd9" xlink:to="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_05b1b937-72c5-4e32-9054-4e5813a94a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e0157c6-c565-4d72-b514-f648419091f1" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MortgageLoansOnRealEstateNamePropertyTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis_05b1b937-72c5-4e32-9054-4e5813a94a70" xlink:to="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e0157c6-c565-4d72-b514-f648419091f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_FacilityMember_09c3d3b8-5d56-420e-b175-d6f935c50a28" xlink:href="pntg-20211231.xsd#pntg_FacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e0157c6-c565-4d72-b514-f648419091f1" xlink:to="loc_pntg_FacilityMember_09c3d3b8-5d56-420e-b175-d6f935c50a28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OfficeBuildingMember_69cab48d-82ad-4745-8630-b261a5a2df69" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_OfficeBuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MortgageLoansOnRealEstateNamePropertyTypeDomain_7e0157c6-c565-4d72-b514-f648419091f1" xlink:to="loc_srt_OfficeBuildingMember_69cab48d-82ad-4745-8630-b261a5a2df69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b4e4df3-ae82-4abc-80e3-105b123457c1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_d3644de9-b749-4bf9-839f-a96fffe9edd9" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b4e4df3-ae82-4abc-80e3-105b123457c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostAbstract_9b002992-4ef6-4ded-aa7a-19f71758eea5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_7b4e4df3-ae82-4abc-80e3-105b123457c1" xlink:to="loc_us-gaap_LeaseCostAbstract_9b002992-4ef6-4ded-aa7a-19f71758eea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_6d47215f-961f-46f6-86a5-65e51bed44b3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_9b002992-4ef6-4ded-aa7a-19f71758eea5" xlink:to="loc_us-gaap_OperatingLeaseCost_6d47215f-961f-46f6-86a5-65e51bed44b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_4f5a7261-66f3-43c4-89aa-c353c99c316b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_9b002992-4ef6-4ded-aa7a-19f71758eea5" xlink:to="loc_us-gaap_SubleaseIncome_4f5a7261-66f3-43c4-89aa-c353c99c316b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_94c93cb0-c15e-4ff0-992e-43e8650927a3" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeaseCostAbstract_9b002992-4ef6-4ded-aa7a-19f71758eea5" xlink:to="loc_us-gaap_VariableLeaseCost_94c93cb0-c15e-4ff0-992e-43e8650927a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a01f8ec6-058a-4648-95e9-cbc19ae51b86" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a01f8ec6-058a-4648-95e9-cbc19ae51b86" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_da2b2c4e-e6a6-4fb0-bc67-3fde7237838e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_da2b2c4e-e6a6-4fb0-bc67-3fde7237838e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a0694493-9c6d-41f8-a2ec-9fce0fc3d8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a0694493-9c6d-41f8-a2ec-9fce0fc3d8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6f11fbc8-5572-4df9-846a-0c016f11a150" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_6f11fbc8-5572-4df9-846a-0c016f11a150" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7add7bfc-6650-4164-91df-2b58e29d4e54" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_7add7bfc-6650-4164-91df-2b58e29d4e54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e4b53001-90b3-47f0-bcd2-9029c14cf639" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_e4b53001-90b3-47f0-bcd2-9029c14cf639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2b352ea6-d728-4b51-9b5e-3f9eb6dc8845" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_2b352ea6-d728-4b51-9b5e-3f9eb6dc8845" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0e9155f-0870-4c74-a575-c13078b767a7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0e9155f-0870-4c74-a575-c13078b767a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3ba885c7-2772-418c-b09c-686d98c71a23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_3ba885c7-2772-418c-b09c-686d98c71a23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_b16091ed-d68c-4a38-960c-fe0706a7ab99" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:to="loc_us-gaap_OperatingLeaseLiability_b16091ed-d68c-4a38-960c-fe0706a7ab99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_2def1a4f-e81d-4771-bd13-2e051e30c12d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_2def1a4f-e81d-4771-bd13-2e051e30c12d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7afc52e4-eb14-4996-a9f5-26c4f5a617ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_6fc857b3-8110-426d-833a-f9ebc9f54a63" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_7afc52e4-eb14-4996-a9f5-26c4f5a617ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1" xlink:type="simple" xlink:href="pntg-20211231.xsd#LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXES" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1b8404e0-8d73-4214-8876-f9aea3c3f3d4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_389b8c01-5738-4569-bc1f-6102b5e9a966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1b8404e0-8d73-4214-8876-f9aea3c3f3d4" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_389b8c01-5738-4569-bc1f-6102b5e9a966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_02f9e586-773e-4976-b8cb-444549a71de0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ab5ab001-1680-4357-b443-39521159ee3a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_02f9e586-773e-4976-b8cb-444549a71de0" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ab5ab001-1680-4357-b443-39521159ee3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_e19066c9-b44a-45c4-b1bc-7541f1e708cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_02f9e586-773e-4976-b8cb-444549a71de0" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_e19066c9-b44a-45c4-b1bc-7541f1e708cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4bc91d41-2e10-48d7-9106-823a1560a1b7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_02f9e586-773e-4976-b8cb-444549a71de0" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4bc91d41-2e10-48d7-9106-823a1560a1b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_8891d7cd-0cda-4358-9bcd-170545a25039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_02f9e586-773e-4976-b8cb-444549a71de0" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_8891d7cd-0cda-4358-9bcd-170545a25039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXESPROVISIONFORINCOMETAXESDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_ae4eed5a-9f2f-4e46-a283-699e191ae04b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ee26750b-f106-4f62-8e25-7c7af8dd14af" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ae4eed5a-9f2f-4e46-a283-699e191ae04b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ee26750b-f106-4f62-8e25-7c7af8dd14af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1a7368a7-a2ff-4a7c-864f-dde9aa038a83" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ee26750b-f106-4f62-8e25-7c7af8dd14af" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_1a7368a7-a2ff-4a7c-864f-dde9aa038a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9e30aa13-4f16-4d30-b5dc-aa5915fe6966" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ee26750b-f106-4f62-8e25-7c7af8dd14af" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_9e30aa13-4f16-4d30-b5dc-aa5915fe6966" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_acbc2030-56ea-4a69-9c45-29f0e636285b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_ee26750b-f106-4f62-8e25-7c7af8dd14af" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_acbc2030-56ea-4a69-9c45-29f0e636285b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3fa0bfdb-5a15-48d2-a589-6e30902c080d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ae4eed5a-9f2f-4e46-a283-699e191ae04b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3fa0bfdb-5a15-48d2-a589-6e30902c080d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_baba4e05-1da4-48a7-bd15-cefcd80565fd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3fa0bfdb-5a15-48d2-a589-6e30902c080d" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_baba4e05-1da4-48a7-bd15-cefcd80565fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5bbe90ee-42a5-475b-b282-d3f0a2f7e3fe" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3fa0bfdb-5a15-48d2-a589-6e30902c080d" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5bbe90ee-42a5-475b-b282-d3f0a2f7e3fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_875c5666-5716-4514-8f28-152d4fe0b1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_3fa0bfdb-5a15-48d2-a589-6e30902c080d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_875c5666-5716-4514-8f28-152d4fe0b1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_2b9c8867-ee58-4be9-98fa-7f409bf51871" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_ae4eed5a-9f2f-4e46-a283-699e191ae04b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_2b9c8867-ee58-4be9-98fa-7f409bf51871" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXESTAXRATERECONCILIATIONDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_459fd54a-5ba2-4fb0-9846-6cc2519c342b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_f626fbe9-2702-4469-8106-13600d7feb78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_459fd54a-5ba2-4fb0-9846-6cc2519c342b" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_f626fbe9-2702-4469-8106-13600d7feb78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_4f23cf13-0667-4aa3-a7cd-68efa134f039" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f626fbe9-2702-4469-8106-13600d7feb78" xlink:to="loc_us-gaap_PlanNameAxis_4f23cf13-0667-4aa3-a7cd-68efa134f039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8259fd4c-2a5f-4079-9488-28eeee847309" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_4f23cf13-0667-4aa3-a7cd-68efa134f039" xlink:to="loc_us-gaap_PlanNameDomain_8259fd4c-2a5f-4079-9488-28eeee847309" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_TheEnsignPlansMember_86c25948-1f66-4ba6-a69c-34058615b4b0" xlink:href="pntg-20211231.xsd#pntg_TheEnsignPlansMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8259fd4c-2a5f-4079-9488-28eeee847309" xlink:to="loc_pntg_TheEnsignPlansMember_86c25948-1f66-4ba6-a69c-34058615b4b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_8910e3c8-f883-43c9-8c0c-f6587344259f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f626fbe9-2702-4469-8106-13600d7feb78" xlink:to="loc_us-gaap_AwardTypeAxis_8910e3c8-f883-43c9-8c0c-f6587344259f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7f6dca8-cc31-44ba-8d48-fa5312796d87" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_8910e3c8-f883-43c9-8c0c-f6587344259f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7f6dca8-cc31-44ba-8d48-fa5312796d87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_9a8c3162-1307-4404-afb5-f29e9ba868f7" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b7f6dca8-cc31-44ba-8d48-fa5312796d87" xlink:to="loc_us-gaap_RestrictedStockMember_9a8c3162-1307-4404-afb5-f29e9ba868f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_f626fbe9-2702-4469-8106-13600d7feb78" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d5c0b532-698a-4479-9549-5441fb5fa0ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_d5c0b532-698a-4479-9549-5441fb5fa0ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_55a23024-f618-4f62-826a-bc14db523043" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_55a23024-f618-4f62-826a-bc14db523043" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_294c7855-496e-4bbd-a96d-927870d0e207" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment_294c7855-496e-4bbd-a96d-927870d0e207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_cb61a861-d0ca-474c-99b1-ed933e957758" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_cb61a861-d0ca-474c-99b1-ed933e957758" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation_ce63e76e-3197-4a75-8301-6b5a3c25b26b" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation_ce63e76e-3197-4a75-8301-6b5a3c25b26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus_45f94a52-8ada-4372-bab7-12f839b0bb42" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus_45f94a52-8ada-4372-bab7-12f839b0bb42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_e9641b1c-2806-42cd-b53b-0cefe259bb03" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_e9641b1c-2806-42cd-b53b-0cefe259bb03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_ed48b7ca-7184-4b6f-87ed-9c73b078b13f" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent_ed48b7ca-7184-4b6f-87ed-9c73b078b13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_e41a6b63-7830-4432-95b5-1c12086bffa5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits_e41a6b63-7830-4432-95b5-1c12086bffa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent_06fa54bc-06e8-4863-bdd2-4549a9d8f906" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent_06fa54bc-06e8-4863-bdd2-4549a9d8f906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_a0aa0e1c-b6a1-4fa9-a95a-8458b2472e33" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense_a0aa0e1c-b6a1-4fa9-a95a-8458b2472e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ab49acdd-98d3-4850-a0f2-01727dda75cd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_ab49acdd-98d3-4850-a0f2-01727dda75cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bb254157-05c8-453c-b118-b3be2cfa58ce" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_bb254157-05c8-453c-b118-b3be2cfa58ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount_4300d6bd-ac63-440d-bb7e-c3fa9d05ae3d" xlink:href="pntg-20211231.xsd#pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount_4300d6bd-ac63-440d-bb7e-c3fa9d05ae3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1fd57062-ecf5-41d5-a5cb-95120304091d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_1fd57062-ecf5-41d5-a5cb-95120304091d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e4281b50-28b9-4042-882e-90e6f2e84beb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_e4281b50-28b9-4042-882e-90e6f2e84beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4c9baf06-6f11-4607-8151-47ee910b47f1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_84f5e800-d371-41fa-be9a-6c51059a8ed9" xlink:to="loc_us-gaap_ShareBasedCompensation_4c9baf06-6f11-4607-8151-47ee910b47f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_b46ff2ed-36fb-4cd1-a783-64824d1d3a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_b46ff2ed-36fb-4cd1-a783-64824d1d3a0a" xlink:to="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_186a1784-dafe-4881-a20c-a19495237b78" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_186a1784-dafe-4881-a20c-a19495237b78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_41fedc24-2c2b-4452-93fe-ee675b7590bb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_41fedc24-2c2b-4452-93fe-ee675b7590bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsStateTaxes_eae30149-49c0-4d13-9e50-29859931c9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsStateTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_us-gaap_DeferredTaxAssetsStateTaxes_eae30149-49c0-4d13-9e50-29859931c9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DeferredTaxAssetsLeaseLiabilities_2eb0d7b3-8831-48f3-ad71-13eb61e492f8" xlink:href="pntg-20211231.xsd#pntg_DeferredTaxAssetsLeaseLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_pntg_DeferredTaxAssetsLeaseLiabilities_2eb0d7b3-8831-48f3-ad71-13eb61e492f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_d3fb4146-3308-4fa9-98ba-96d972987f74" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance_d3fb4146-3308-4fa9-98ba-96d972987f74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_07f1b0e1-26ff-4551-829a-d30305b49380" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_07f1b0e1-26ff-4551-829a-d30305b49380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dab8268a-dd46-4004-a797-5454a0cc3c82" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_dab8268a-dd46-4004-a797-5454a0cc3c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_9ef9d0ed-5727-44ab-be47-413fe780d72f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_9ef9d0ed-5727-44ab-be47-413fe780d72f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization_a328de4e-72ce-4d98-9bdf-29c4b9a70528" xlink:href="pntg-20211231.xsd#pntg_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization_a328de4e-72ce-4d98-9bdf-29c4b9a70528" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_4c873cb3-175f-49fe-8717-cd5b9c1b2963" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPrepaidExpenses"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses_4c873cb3-175f-49fe-8717-cd5b9c1b2963" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_75f1c007-8358-4536-83c2-fe526589fc6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_75f1c007-8358-4536-83c2-fe526589fc6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_DeferredTaxLiabilitiesStateTaxes_a1eda617-b1f3-4970-861f-8e4af8f1985c" xlink:href="pntg-20211231.xsd#pntg_DeferredTaxLiabilitiesStateTaxes"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_pntg_DeferredTaxLiabilitiesStateTaxes_a1eda617-b1f3-4970-861f-8e4af8f1985c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_bf83efe6-cb71-41f6-a24a-907613bd1d63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_bf83efe6-cb71-41f6-a24a-907613bd1d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c723d2e0-54ae-4a0a-86a9-f0e9128e6a18" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsNetAbstract_273be9fc-1681-4202-91de-cdce32633da6" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_c723d2e0-54ae-4a0a-86a9-f0e9128e6a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXESNARRATIVEDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9325285c-8cfc-41bf-afac-193f3124fe72" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_a391aee3-b3bb-4f2b-9c1c-90c2a1aff409" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9325285c-8cfc-41bf-afac-193f3124fe72" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_a391aee3-b3bb-4f2b-9c1c-90c2a1aff409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_c0d5f30f-195e-4035-a3ca-1d4b2d5350c5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_a391aee3-b3bb-4f2b-9c1c-90c2a1aff409" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_c0d5f30f-195e-4035-a3ca-1d4b2d5350c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_cfe9192a-20f0-45ec-95a8-a5b37fcb39ec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_c0d5f30f-195e-4035-a3ca-1d4b2d5350c5" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_cfe9192a-20f0-45ec-95a8-a5b37fcb39ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_e96e8b59-9ec9-4ee3-8fe5-643561cfb425" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_cfe9192a-20f0-45ec-95a8-a5b37fcb39ec" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_e96e8b59-9ec9-4ee3-8fe5-643561cfb425" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_2dcf69bf-718e-4de2-b8f6-72d19dfda4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_a391aee3-b3bb-4f2b-9c1c-90c2a1aff409" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_2dcf69bf-718e-4de2-b8f6-72d19dfda4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_5621be4d-4b74-465e-86c5-b98b4ae180b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2dcf69bf-718e-4de2-b8f6-72d19dfda4eb" xlink:to="loc_us-gaap_OperatingLossCarryforwards_5621be4d-4b74-465e-86c5-b98b4ae180b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_77ff12a6-d5f1-474d-94d3-18fba5bdd75b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsValuationAllowance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_2dcf69bf-718e-4de2-b8f6-72d19dfda4eb" xlink:to="loc_us-gaap_OperatingLossCarryforwardsValuationAllowance_77ff12a6-d5f1-474d-94d3-18fba5bdd75b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#INCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5052ed43-a7c8-4eb6-a39d-426f8339992b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f1fe19b4-2d01-4639-b0b8-156060ca9802" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5052ed43-a7c8-4eb6-a39d-426f8339992b" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f1fe19b4-2d01-4639-b0b8-156060ca9802" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_1ad81772-429c-40f6-bbf5-525763a6e91d" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f1fe19b4-2d01-4639-b0b8-156060ca9802" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_1ad81772-429c-40f6-bbf5-525763a6e91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_ae6ad15c-327d-44f4-811a-d3b0d75e1ec4" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f1fe19b4-2d01-4639-b0b8-156060ca9802" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_ae6ad15c-327d-44f4-811a-d3b0d75e1ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_d508f2fe-718b-44c5-b94a-b60c80f67906" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f1fe19b4-2d01-4639-b0b8-156060ca9802" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions_d508f2fe-718b-44c5-b94a-b60c80f67906" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_d1de9794-4dff-4c42-a9fd-7e07896b9ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_f1fe19b4-2d01-4639-b0b8-156060ca9802" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_d1de9794-4dff-4c42-a9fd-7e07896b9ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="pntg-20211231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_338a3192-9031-4f50-b92d-319658580575" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a946f53c-0c1b-42eb-a907-6977913d8160" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_338a3192-9031-4f50-b92d-319658580575" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a946f53c-0c1b-42eb-a907-6977913d8160" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#COMMITMENTSANDCONTINGENCIESDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9a131e21-887a-4afb-9880-c718dd718455" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9a131e21-887a-4afb-9880-c718dd718455" xlink:to="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_82c7cb59-91a1-4618-abcc-3be04200b38b" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:to="loc_srt_MajorCustomersAxis_82c7cb59-91a1-4618-abcc-3be04200b38b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_fe3228cf-d63a-442b-b016-a55204a72371" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_82c7cb59-91a1-4618-abcc-3be04200b38b" xlink:to="loc_srt_NameOfMajorCustomerDomain_fe3228cf-d63a-442b-b016-a55204a72371" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_MedicareAndMedicaidMember_3d5223ad-b1b1-43b0-8e9d-43edc5eb7c3a" xlink:href="pntg-20211231.xsd#pntg_MedicareAndMedicaidMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_fe3228cf-d63a-442b-b016-a55204a72371" xlink:to="loc_pntg_MedicareAndMedicaidMember_3d5223ad-b1b1-43b0-8e9d-43edc5eb7c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7b18095c-0b89-488e-be5f-5682054eabdc" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7b18095c-0b89-488e-be5f-5682054eabdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_106ddc19-faa8-4a3c-89eb-fd7e6777bbdd" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_7b18095c-0b89-488e-be5f-5682054eabdc" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_106ddc19-faa8-4a3c-89eb-fd7e6777bbdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_723f8938-f5c7-4aad-aca8-9354992177ad" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_106ddc19-faa8-4a3c-89eb-fd7e6777bbdd" xlink:to="loc_us-gaap_AccountsReceivableMember_723f8938-f5c7-4aad-aca8-9354992177ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerMember_e86e67cd-974a-49a5-a793-e81bc2cebc31" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RevenueFromContractWithCustomerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_106ddc19-faa8-4a3c-89eb-fd7e6777bbdd" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerMember_e86e67cd-974a-49a5-a793-e81bc2cebc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7c905cac-8a45-4991-b10c-8a490bf6d01f" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7c905cac-8a45-4991-b10c-8a490bf6d01f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4ebc5590-0253-4e16-a659-a24bc8fd9d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7c905cac-8a45-4991-b10c-8a490bf6d01f" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4ebc5590-0253-4e16-a659-a24bc8fd9d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c7e50ffd-270e-4bd0-92ab-a19e2cb1b8d1" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_4ebc5590-0253-4e16-a659-a24bc8fd9d6a" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c7e50ffd-270e-4bd0-92ab-a19e2cb1b8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_69968e5e-829d-4186-9c73-115b5ab7427c" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_69968e5e-829d-4186-9c73-115b5ab7427c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_07c8b662-d60d-4d26-9e33-92f73d6af253" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_69968e5e-829d-4186-9c73-115b5ab7427c" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_07c8b662-d60d-4d26-9e33-92f73d6af253" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_2ec3a9c7-ac75-4592-ac55-1d4a412f00a9" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_07c8b662-d60d-4d26-9e33-92f73d6af253" xlink:to="loc_us-gaap_SubsequentEventMember_2ec3a9c7-ac75-4592-ac55-1d4a412f00a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_d6260baf-679d-443c-8047-4bbd39c584b8" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled_54c5b6a0-ba58-4b2f-bb99-dc5b6cd76102" xlink:href="pntg-20211231.xsd#pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:to="loc_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled_54c5b6a0-ba58-4b2f-bb99-dc5b6cd76102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview_02bc16bc-25fc-4dc9-8190-84961770f342" xlink:href="pntg-20211231.xsd#pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:to="loc_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview_02bc16bc-25fc-4dc9-8190-84961770f342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_UniformProgramIntegrityContractorPeriodOfReview_05f7d37e-6579-4282-9c60-6248c3f6a717" xlink:href="pntg-20211231.xsd#pntg_UniformProgramIntegrityContractorPeriodOfReview"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:to="loc_pntg_UniformProgramIntegrityContractorPeriodOfReview_05f7d37e-6579-4282-9c60-6248c3f6a717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_UniformProgramIntegrityContractorSuspendedPayments_617f2714-eb35-4e66-bf72-67b9c6b02114" xlink:href="pntg-20211231.xsd#pntg_UniformProgramIntegrityContractorSuspendedPayments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:to="loc_pntg_UniformProgramIntegrityContractorSuspendedPayments_617f2714-eb35-4e66-bf72-67b9c6b02114" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_58244e17-1eab-42e7-b43f-1479dbf8324b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_cb7422c2-9b84-4862-b021-f30c6449aca0" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_58244e17-1eab-42e7-b43f-1479dbf8324b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/SUBSEQUENTEVENT" xlink:type="simple" xlink:href="pntg-20211231.xsd#SUBSEQUENTEVENT"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/SUBSEQUENTEVENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_ff9e230a-5316-4445-b506-bbcc5434905e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_58fed746-fbe7-43a2-afd2-5a3fbf8edbfa" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_ff9e230a-5316-4445-b506-bbcc5434905e" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_58fed746-fbe7-43a2-afd2-5a3fbf8edbfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://pennantgroup.com/role/SUBSEQUENTEVENTDetails" xlink:type="simple" xlink:href="pntg-20211231.xsd#SUBSEQUENTEVENTDetails"/>
  <link:presentationLink xlink:role="http://pennantgroup.com/role/SUBSEQUENTEVENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_60eca70c-d3d1-480a-9fdd-1eb5183a5f69" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_c161f511-17e1-468c-ae67-f928ac732bec" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_60eca70c-d3d1-480a-9fdd-1eb5183a5f69" xlink:to="loc_us-gaap_SubsequentEventTable_c161f511-17e1-468c-ae67-f928ac732bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_c257f520-1484-4b55-8e52-6d07fdbabd39" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c161f511-17e1-468c-ae67-f928ac732bec" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_c257f520-1484-4b55-8e52-6d07fdbabd39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_f2d1b390-29d7-44f6-9262-ce71da93bb8e" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_c257f520-1484-4b55-8e52-6d07fdbabd39" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_f2d1b390-29d7-44f6-9262-ce71da93bb8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_113b007f-6e8b-4533-9dc1-6da885db0f23" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_f2d1b390-29d7-44f6-9262-ce71da93bb8e" xlink:to="loc_us-gaap_SubsequentEventMember_113b007f-6e8b-4533-9dc1-6da885db0f23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_46392be1-cea3-438f-ac46-1688b60e80aa" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c161f511-17e1-468c-ae67-f928ac732bec" xlink:to="loc_srt_CounterpartyNameAxis_46392be1-cea3-438f-ac46-1688b60e80aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a71cf777-0593-42e4-aa90-ce0186b3fc08" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_46392be1-cea3-438f-ac46-1688b60e80aa" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a71cf777-0593-42e4-aa90-ce0186b3fc08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_pntg_AffiliatesOfEnsignMember_ba181dc9-fb46-4c1a-9781-dbe2f5eacc31" xlink:href="pntg-20211231.xsd#pntg_AffiliatesOfEnsignMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_a71cf777-0593-42e4-aa90-ce0186b3fc08" xlink:to="loc_pntg_AffiliatesOfEnsignMember_ba181dc9-fb46-4c1a-9781-dbe2f5eacc31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7753b787-4aa5-405d-90fb-7a76f6a87491" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c161f511-17e1-468c-ae67-f928ac732bec" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7753b787-4aa5-405d-90fb-7a76f6a87491" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6a371841-77c6-4da0-bb1d-56e93330b89b" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_7753b787-4aa5-405d-90fb-7a76f6a87491" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6a371841-77c6-4da0-bb1d-56e93330b89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_e6789575-cf8b-4f93-a023-2804f459a390" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_6a371841-77c6-4da0-bb1d-56e93330b89b" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_e6789575-cf8b-4f93-a023-2804f459a390" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_9aabc951-ad54-4526-b563-a19cb6543fe0" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c161f511-17e1-468c-ae67-f928ac732bec" xlink:to="loc_us-gaap_SubsequentEventLineItems_9aabc951-ad54-4526-b563-a19cb6543fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EscrowDeposit_a1bc3e3a-6ae8-41b1-b723-bcaaf969bd63" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EscrowDeposit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_9aabc951-ad54-4526-b563-a19cb6543fe0" xlink:to="loc_us-gaap_EscrowDeposit_a1bc3e3a-6ae8-41b1-b723-bcaaf969bd63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_57de0cc6-b93e-4d0e-879d-10535586c554" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_9aabc951-ad54-4526-b563-a19cb6543fe0" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_57de0cc6-b93e-4d0e-879d-10535586c554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>pntg-20211231_g1.jpg
<TEXT>
begin 644 pntg-20211231_g1.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX))  0L3 'V+17Y__P#!+K_@M_XG_P""B_[5WQ4_9 \7_LB0?"WQ9\)K:?\
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MI>*&:SN9#"TMNZWRVI:-)-DB',#%&C/# @GR_P#9?_X.-;W]J?\ X)N_&?\
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MHE@BDF1H(9'_ '<,@WHI>5@LG]#] &#\2?BC\.O@]X6D\;?%'QIIVA:7'/'
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MP"I<"OA+X>*J_P#![CX[*J!GP/"3@=3_ ,(=IU 'ZW_!/]NC]CK]I'XB:O\
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MS22*NX&)A\V]V;H/A5_P<)?'KXZ?M*_'3]CKX1?\$R[K7/B!\$QJZ7HL?BO
M-+NVTZ\:UFD>ZN+&%H8V9?W0$<DLC.BF-%\R2, _4&N-^-_[0WP1_9J\'O\
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M<<@@'ZC4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M5E5U*.H((P01P15/0?#7ASPK8G3/"^@66FVS2M*;>PM4A0NQRS;4 &3W/4T
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MWO\ P3(\<>#;3Q!92:OI_P :=0N;W2TNE-Q!!-I>EK%*\>=RH[12A6(PQB<
MDJ<?L#10!\M_\%)OV]9?V!O%/P0\7:]HVK7W@_Q?\29] \<)HFCR7UQ:6+Z3
M>SK>B*)'D,<$T,4LFP9$2R'#$ '\P?\ @X1_X)[_ /!*_P#::^">D_M!_P#!
M.Z\\&:A\?_%_BBPMO"7ACX/:K;71\<?:)U6X:2QM'9$,4;27#W@5,&,B9SO7
M'[OR6MM--'<2V\;20DF)V0$H2,'![9'%9VE>"/!>@ZS=^(]#\(:79:A?_P#'
M]?VFGQQS7'.?WCJH9^>>2: /P"_X./M>'PT_:&_X)Y?#CXS?%72M0\8^ ;6T
M/Q'O9-41W@F6XT-9;V<DY1)7M[AP[X#!&/8UT_\ P78^,OPC/_!QS^Q3XC7X
MG^'VT[0I_"USK>H)K$)@T^&77WGCEGD#;8D:%TE#,0#&ZOG:0:_>JB@#\'/@
ME\4_AK<?\'J_Q*UB#Q_HSV>H:"-&L;I=2B,=QJ$?AG38'M$;=AIEFAEC,8^8
M/&RXR"*X_P#X)Z?M6:#_ ,$(_P#@M;^TW\"O^"B4NH^%O!WQFUR?5M"\<76E
M7%S:WFR_N[FPN3Y2.SQ30W]PCN@?RYAL?&'*_P!"=4M6\-^'=>GM;G7-!LKV
M2QF\VRDN[5)&MY/[Z%@=C>XP: /Q(_X.E?"_C7]I#]A_X#_MV?LT?"GQ(W@/
MX8>-+ZZO+&XT*?39!IMQ]G^RZH;;"SVUHS6>U7=8G5;F-]JA@:^I_P#@F]\2
M/^"-?[;7QV\#?M3_ +%GPEUGQ/\ $_1] E;5?$^K7.MW5UX#MI;2>-[.[NM0
ME:'>[W$L"01M(7\V69 8T>0?HY)&DJ-%*@96!#*PR"/0U3T'PYX>\+6']E^&
M-!LM.M?,:3[-86J0Q[V.6;:@ R3U/>@#D_VE?VC_ (/?LC? OQ+^T=\?/&$&
MA>$_">FM>ZMJ$W)V@A4BC7K)+(Y6-(Q\SNZJ.2*_ 3X0_P#!TS^Q]H?[47C/
M]NOXW_LG>/O%WQ1U>TFT/P)$M]8QZ=X0\.1R,UOIUH6=G$L['SKJZV;G>0HB
MK&@5OZ-** /Q>_X+J_LW?%VR_;"_88_X*P?$'PS#;Z7X$\7>%+'XXWFGQ.+3
MPRB:M:7WVI]Q9HK19);Y#(YPA$09B7%6_@#^SO-^VC_P=8>.OV]/A;>6^O?"
MSX0^%[2V/C72YEN-+O\ 6YO#\5B+&WN$)2>2,74TC["1&8 &P64']D[BW@NX
M'M;J!)8I4*21R*&5U(P00>"".U0Z1HVC^'M-BT?0-*MK&T@7$%K9P+%'&,YP
MJJ !R>U 'X#_ /!X'\<?@[J_[5O[*6@:-\3M"OK[P9KNMW'BRSL=4BFETB-K
MW1PIN41B823;7 PP!_=/Z&OUE_;H_P""M_[(7[ /P,\)?M*_%+5=9\3>!?&'
MBF'1+/Q/\.[*+6+.T9TD?[3/+'*$$"B)@?++R,>$C<@@?3E5]4TK2]<T^72-
M:TVWO+2X39/:W4*R1R+Z,K @CV- 'XY_\%9/V:/V4_\ @LE^U+^S!\4?^"=_
MC?PMXQ\<0^-[:\^(/C;P->17"Z3X2@\N=KC5)8?]1/')&L=M#.4E9Y98U'RM
ML_92J6@>'/#WA734T;POH-EIMG&28[2PM4AB4^RH !^57: /QL_X-[O >M?L
M]_\ !9G_ (*!_ 3QS"\&KW7C*UUO3TG&'N-.DU+4[B&X /9X=0M7_P"V@KY8
M_P"#D'XZ?!BY_P"#A3]FKQC9?%7P_<Z3X+T[P@/%VI6NKPRP:.T'BF]GF2Y=
M&(A:.%ED96P55@2 "*_:CX]_L+7M[^U_X:_X*(_LS:AI>C_%31-!E\-^*-/U
M=Y(M,\;>'Y'60V%Y+$CR6\T,J1RP72I(5,81XY$*A/I*@#\7O^#B+X]'_@K3
M\)_ /_!./_@EE%'\;-<UKQU;ZYXM\3> 9UU#0-"L[>&:*)+O5(B;2(O+<!SF
M7*"W(8 R(&\I_P""]G_!)SXF?LJ_\$H_V4-)^%VGWGBO0OV:;N[C^)#:/:O)
MN.HO;7-UJ@C W"W6[@F&3RBW2;N S#]]Z" P*L,@]0: /Q"_X*3:!:_\%._^
M#@W]D3_AB[QCIWC;1/AOI.C>,?&WBSPK?)>6.BZ?%K+7Z^?<1$I%+)%;J(XV
M(8M/%QAA7*_#OXO?"E_^#UCQEXC3XDZ$=.O- CTBTU :M#Y$VH+X4L8&M%DW
M;6F$T;Q&,'=YB,F-P(K]V=!\,>&O"MM)9>%_#UCIL,LK2RQ6%HD*O(>KD( "
MQ[GK5Z@#\$O^"+'QF^&4G_!S5^V/XDT?QMI6I0:_IOB?_A&?L&I0R?VW)'K=
ME*8K,[MMPY2-V 0G*HS=%)'R_P#&G]N2Y_X*-_\ !.#]KO5_&/PT\2^%/%.C
M>*M+OO"WP;^&W@:[L/#/ANP75[*2_P!7U>:SA2&[U$K')%)+?L74KNAC0%_*
M_J-J-+.TC22-+6-5F8M*H0 .3P2?4F@#\!?VI/C-\,M<_P"#,GP9X=L_%L$=
M\UOH&BVUK>QO;/>7UMK4,T\5N)57[3LC5F9XMZC8XSE& _3W_@@5XB\$^(/^
M"/?P#C\#Z]IM]'I_@&TM-273;I)1;7RC=/#)L)V2AV)9&PP+<CFOK^&&&WB6
MWMXE2-%"HB+@*!T  Z"G4 ?S(_M@_ _X7?!SXI^#?^"KG_!#W]H\>%?BCXH^
M(T6C>(OV<+755EUBPUVYF?S[6UM1MDN;"26-MT$D7DM$ZR(PC*QQ_P!,^F2:
MA+IMO+JT$<5TT"&YBB?<B2;1N"GN <@&J\?A7PO%J=OK<7ANP6]M+;[/:W:V
M:"6&'_GFCXRJ?[(.*OT ?@O_ ,$[_C!\*+O_ (.]_P!H7Q);?$O09-.USPSJ
MFG:+?IJT)AO[M!I&Z"%]VV20>1-\JDG]T_\ =-<U_P $;OCM\%='_P""WO\
MP4&\<:M\6O#EMHNK6GC2_P!*U:?6H$MKVUCUV25YX92VV6,1?O-RDC9\W3FO
MZ#:* /Q'_P"#(_Q5X9D_9'^,?@A/$%D=9B^(T%])I0NE^T+;/801K,8\[O++
MHR[L8RI&<U^B_P#P68^,_P )_@Q_P36^+]]\5?B)H^@)JO@34;'2EU2_2)[Z
MZDA,<<$*,=TLA9U&U 3SZ5]0T4 ?C7_P= _L.G_@H'^SM\(OV\?V%M6LO%_B
MKPMXML-"L=7\':C'<C4=/U.\BAM'CG@9@Q@U!X-NT_(+N9B1MK*_X.;O#'PY
M_9<_X(:>$/V2]7^+&EZEXU3QKH][J*W-_$NHZ_?RF]N=2U8P9#D3WCW,[N%"
MAY2..!7[4T4 ?B%JGQX^"5__ ,&;TGAVR^+OAJ74;7X7V>BW.G1ZY ;B'46U
M;Y;1HP^Y9F$4K",C<5C9@,*2/G7XO?%OX67'_!E_\./A_!\1]#?7O^$VDLSH
MBZK$;L7">)[^Y>(P[MX80.DQ&,^6ZM]U@3_2/10!_-M_P6O^+?PL\5_\&U'[
M$G@[PQ\1]#U'5X?^$?\ .TNRU6*6XC^R>'[JWNMT:L67RIG2)\CY78*<$XKJ
MO^#E_P"-_P &_%^D_P#!/;4?"?Q4\/:I!IUE<:GJ$NG:Q#.+:S<^'U2>38QV
M1L;><!C@$P2 <HV/Z'Z* /Q1_;!^'5U^SK_P=-_L_P#_  4<^(WB"S3X+_$;
MPZ]AI/Q"DO$_LBSOW\.ZAI\5J]UGRH_-:6WEC8L%D%P2I.Q]K_\ @E-\+]?^
M-'_!Q/\ M6_\%+?"FHP_\*7T*UU+0H/':W"C2]6O!]AC=8+@GRYHHELIY9)4
M8JF(B3B137[1ZMI&DZ]ITNCZ[I=O>VDZ[9[6[@62.09SAE8$$?6G:?IVGZ18
MQ:9I5C#:VT"!(;>WB")&HZ!5& !["@#^;'_@B;\9OA)X?^"7_!4^[U[XF:#9
M1ZYX"O;O1GN]5BC%_ 8_$<*R0[F'F@RWEI&-N<O<Q*.9%!];_P""'GCC]C^X
M_P"#:WXJ^"?VN-&C\3^!1\88=-^(.A:=>'[=I=GJ=]HUI!J(2(-*K0/)]KC*
MJ2[6;!,D$#]^:9/;6]T@BN8$D4.KA9%! 96#*>>X8 @]B : /P;_ ."*/P%^
M+/\ P3W_ ."US?L@?L5_M@6/QM_9L\8?#^Z\6>([_0=5BOK/18'CG2Q:[\AF
M@@U#[1#!%NC*F>"8,44 )'ZG^W=X%UOX[?\ !W7^S1H/@F%YE\!?""'6O$]S
M$,BQ@AN-<F_>8Z!C+;1CWN5]:_7]M#M?#&DZE<^ _"FEI?W"RW"6PQ:17ET5
M)7SI(XW*[FP&DV.0#G:V,'PO]C[]A&V^!GQF^(G[8OQCU^S\3?&;XLW$'_"4
M:]96[)9Z1IMNBQVFBZ<K_.MK"B)ND;#W$B^:ZK\D<8!]$T444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!^8WQH_X+)_&SXX_
M&GXX? S]B;Q=X%\&CX#?$KP=X0US5/&&A2ZQJ>O7NI>)[31[U[:S2ZMD@L[9
MWDB>1FE>7("&V9TE7Z]_8O\ CG^U;X]\9_$CX)_M@_"GPUHGB7X?:M91Z=XD
M\&W5P=+\4Z;=P-+#?007.Z6U(*21/$TLNV2-P'( )_*S_@O_ /\ !#B;1_&N
MJ?\ !73_ ()S?%)]&\=OX[TC_A(O!UG,CQ:KK\^MVEC#<6<N=D=P-2>!IH)L
MQF1'<LC*4?K_ -D'_@YH^)VL?\$T_C)\1_VM_AC'HWQH^!VLZ3X:UZ8Z1)%:
MS76I7,ME!?W5FNV2)[>6"X:YMH\;C"!'Y9E"Q@'M/_!:3_@N+XC_ &+OVFO@
MY^Q-^S MI<^,O&7Q#TJU\=:[>6 N+71].DN+8/8)N^0WLL5U#*026AADB<K_
M *1&P^K?V\_&7_!1JXTJ'X5_\$V/AWX%'BJYL&O=4\=_%:\N8=$TJ'<R1V\$
M=M'))=WLA5R!@10JBM*?WL:G^=O_ (*D_P#!2?\ X)[?&KXK?LF:I^ROXS\7
MZ_9?"CQK?^(/BIXH\4^'FMM1UN_N]1TJ[N=2D&?WT\S6L[%5PL8$<:!45%7^
ME]O&?B/]J[]DK3/B=^RC\6%\'77Q!\'6.M>"O%NK>%UU V$%Y!'<0326,DD:
MNWE2#*,X )YSC! /@[_@@E_P5M_;=_;,^/'QL_8H_P""@/PST.Q\>?!J[*7_
M (A\-VGD0>8EW):SVEPJN\1<21EHY(R%D17X^7<W#^ O^"TG[:G[=O[/7[5/
M[;'[%>L>$/#/@W]GB9IO!'AC6_"[ZC)XOLK2&6[O)[^;SXWA\VVBW11VX0H6
MVL\F-U>4?\$%O$?[:O[#W_!8WXY?\$H_VO8='\5S>-+34/'&M>-K738UNM5O
M7,4JZBUTJ+)-!<17+@Q2D^3,2J;#YH?F=$_8?_;C_P"#?W]E3]L_P7J'PW\*
M^/O@%\0? ]ZGA_QY+XZATZYTAY;>YL+99[.2)Y)IY!>PQM&@VM+$@60*Y90#
M]8/^"2O_  4<\'?\%3?V)_#O[5GAGPZ-$U&XN)]+\5^'Q/YHTS5;?;YT2O@;
MHV5XYD)Y\N9-V&R*ZW]OO]O+]G__ ()O?LT:S^U#^T;KLUOHVF,EO8:=8HKW
MFKWT@;R;*V1B \K[6/)"JJ.[%51B/B?_ (-%_P!G/QU\!/\ @D=:^)_'>G3V
M;?$SQ]J/BS2+:X0JXL'M[2QADVGH)!8M*I_B25&'!%?,/_!W+J6M?$C]M7]C
M_P#9C\5:A=6O@C6_$$DVH&%@JRS7&I6-I(_S JSQ0$[=P(7SVXPQ! /U$_8;
M\<?M\_M.>$=%_:9_:7C\/_"SP[XAMH]2\-_"3P_IIO-5@L95#P_VMJ5R2IF=
M&#-!;V\)CX#2%MRK]-5^+7B3]HS]K?\ X)A?\''GPX_8DTW]J'XB_$CX/_&_
M0K"Z;PQ\2/$\VM2Z2]V]Y:A[:>?+P^5=61EPN%,4C(P.%9?VEH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#X _:2_X)X?\%!-,\/^
M/O#'[.'[2OA'Q3X.\=_&W0_'=IX(\:^#I4N_#$\?B;3]4NA:7\6H1I-:AK>2
M=X)(@[8D6-U>3)]E_P""?_\ P31\!_L2WWQ/^)?B'Q>OC?XC_&KQE)XF^)?B
MN714L;:[N3),\5M:V8>7[-;0F>8HC22R9E8M(W 7Z:HH ^%_^"J'_!%+1_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !117@'Q2_X*B_L*_!;X@:I\+?B9\<O[,U[1;CR
M-3L?^$9U.;R9-H;&^*V9&X8'*L1S6M*A6KRM3BY/R3?Y&-;$4,/'FJS45YM+
M\SW^BOF'_A\K_P $V_\ HX[_ ,L_6/\ Y#H_X?*_\$V_^CCO_+/UC_Y#K?\
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M$VO7&H1I91V@3S#<-.6V"+9\V\G;MYSB@#4HKR#X+_M^?L8?M$>/1\+O@O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M23_HX[_RS]'_ /D.C_A\K_P4D_Z.._\ +/T?_P"0Z/\ 5?,/YH_>_P#Y$/\
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M"/\ T1%7T_"W^^3_ ,/ZH^3XP_W&G_B_1G@-%%%?<GYX%%%% !1110 4444
M%%%% !1110 5]K?\$$_^3Z)O^Q'U#_T;;U\4U]K?\$$_^3Z)O^Q'U#_T;;UY
M^:_\BVK_ (6>GDW_ "-:/^)'[14445^7GZZ%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MY([\./\ L9KS_P!)UKU<D_Y&M+U?Y,\;B#_D3U?1?FC\G:***_2S\H"BBB@
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MM/Z1CF6)I8O'3K4[VD[Z[_FPK[6_X()_\GT3?]B/J'_HVWKXIK[6_P"""?\
MR?1-_P!B/J'_ *-MZSS7_D6U?\+-<F_Y&M'_ !(_:*BBBOR\_70HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ME6N@Z#IEO96-E;I;V5E:0K'%;Q(H5(T10 BJH "@    58HH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?"O_ "+&F_\ 7A#_ .@"K]4/"O\ R+&F_P#7A#_Z *OU^0/<_;H_"@K\!?\
M@J3_ ,I ?BA_V,(_]$15^_5?@+_P5)_Y2 _%#_L81_Z(BKZ;A;_?)_X?U1\I
MQA_N-/\ Q?HSP&BBBON3\\"BBB@ HHHH **** "BBB@ HHHH *^UO^""?_)]
M$W_8CZA_Z-MZ^*:^UO\ @@G_ ,GT3?\ 8CZA_P"C;>O/S7_D6U?\+/3R;_D:
MT?\ $C]HJ***_+S]="BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KC?VB_P#DWSQW_P!B;JG_ *22UV5<;^T7_P F^>._^Q-U3_TD
MEK2C_%CZHRK?P9>C/YN:***_7#\4"BBB@ HHHH **** "BBB@ HHHH ****
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MKA%!R::DKIIW04445TG(?TT^%?\ D6--_P"O"'_T 5?JAX5_Y%C3?^O"'_T
M5?K\@>Y^W1^%!7X"_P#!4G_E(#\4/^QA'_HB*OWZK\!?^"I/_*0'XH?]C"/_
M $1%7TW"W^^3_P /ZH^4XP_W&G_B_1G@-%%%?<GYX%%%% !1110 4444 %%%
M% !1110 5]K?\$$_^3Z)O^Q'U#_T;;U\4U]K?\$$_P#D^B;_ +$?4/\ T;;U
MY^:_\BVK_A9Z>3?\C6C_ (D?M%1117Y>?KH4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCIOKO:_2]_O/H*&,H?V9.A7DI*WNK7FC*SVTVO;K:WW'T#_P1 _Y-C_:(_[
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M'_!.>Q_8,\&?M.P?VB/A<?!>L_$3QCX2FU>ZO8WL/L<EVL*7]OMEPSLN^24
M[0V_!+>8?\$5_P#@DI\2/^"/OP<U_P#9]3]JK1_B)X4USQ7-XAVO\-Y=)OK>
M\EM;:V<"<:I<(T6VTA.TQ9SN^;D8^VZ* "BBB@ HHHH *XW]HO\ Y-\\=_\
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M/^OG_MLCQBBBBO#/Y^"BBB@ HHHH **** "BBB@ HHHH *^L/^"-7_)W\O\
MV*-[_P"C(*^3Z^L/^"-7_)W\O_8HWO\ Z,@KHPG^\P]3Z3@[_DJ,'_U\B?JQ
M1117U!_6@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5^>G_!SO\(?VL_C+_P2MUK0
MOV2M'U'5[O3/%FG:KXU\.Z5$TL^L:! LS3VXA7YIU$YM9GB&2T<#\'H?T+KP
M_P#;M_;8\&?L&>!?"'QC^*D)B\&:E\0++0?&&M?9Y)%T2SNH+D)?/L!V11W"
M6XD=@0L;N>N* /RG_P""9?[9/_!/_P#X+AQ_%;X&_M!Z7X<^''Q2\7?$#P]X
MK^'OA>6-6DTR\TG0-&L?/TF9UC#8FTN4FU5EE-M(4.Y0S#]'OVN_^"0W[ '[
M9'BWQ?\ &7]L_P"'7_"87^IZ"FGV>K:WJ\T0\*:9!!S'8&-U2VQ*9[II2"[/
M,P9BBHB_BQ_P5Q_9._9]_:L_;/\ %WQM_P""9_Q!TC5OCQJW[1_AVS\ Z5\+
MM7M[B'4-+D\)Z3>SZWBS++ EOJ1>22_R$WS2^8S, 5^S_P#@X;_X+B_L]_LZ
M:OIW_!-K5=:\1:PVOV\?_"^+KP!-#'?V6BR1AFTB"25U2"XO5(61R2T-M(<*
M7E0H <9_P:*>%/'O[-/_  3_ /C[^U%XZFUJ;X87?B274?!EH;5S)?0Z7:3_
M &Z]MX0,N9AY,/RYW2693JE?G]\-OVY?^"/7CWXU7NK?\%B_^"0?CE?''C#Q
M%>ZOXR^)EO\ $[7X[BXGO+N6;S6TA9K-(8(ED6-5A9B(XAA78?-^Q'_!(_\
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M_P#!*SX:?!+XL:+)IOB^Z@N]=\3Z;,,265U?7#SK;N/X9(H6AB<=GC:OLN@
MHHHH **** /PY_X+:_\ *0[Q7_V"]*_](8:^3:^LO^"VO_*0[Q7_ -@O2O\
MTAAKY-K]3RW_ )%U'_"OR/Q_-O\ D9UO\4OS"BBBNT\\**** "BBB@ HHHH
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M^DZU62?\C6EZO\F1Q!_R)ZOHOS1^3M%%%?I9^4!1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5_X*2?\ 1QW_ )9^C_\ R'1_P^5_X*2?]''?^6?H_P#\AUV?ZKYA_-'[W_\
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M3_LX^+-?\>_L]> _'/BR_P#M>JZUX,TN_P!3NO*2/SKB:TBDD?:@"KEF)PH
M&<  5Y^893B<MC&55IW[7_5(]/+<ZPN:SE&E&2Y==4OT;.SHHHKRSUS\.?\
M@MK_ ,I#O%?_ &"]*_\ 2&&ODVOK+_@MK_RD.\5_]@O2O_2&&ODVOU/+?^1=
M1_PK\C\?S;_D9UO\4OS"BBBNT\\**** "BBB@ HHHH **** "BBB@#ZA_P""
M,W_*2'X=_P"YJ_\ Z:+ROW7K\*/^",W_ "DA^'?^YJ__ *:+ROW7KX/BC_D8
M1_PK\Y'Z-PA_R+9_XW_Z3$*XW]HO_DWSQW_V)NJ?^DDM=E7&_M%_\F^>._\
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M_BJ]4HH_U\SC_GW3^Z7_ ,D'^MF8_P D/N?_ ,D>5_\ "M_&G_0&_P#)B/\
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M* "BBB@ HHHH *^L/^"-7_)W\O\ V*-[_P"C(*^3Z^L/^"-7_)W\O_8HWO\
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M_8FZI_Z22U\_1_BQ]4?2UOX,O1G\W-%%%?KA^*!1110 4444 %%%% !1110
M4444 %%%% '["_\ !O5_R:!XK_[*3<_^F^PK[SKX,_X-ZO\ DT#Q7_V4FY_]
M-]A7WG7YEG'_ ",ZOJ?K61_\BFCZ!7PU_P %QO\ DEW@7_L/W/\ Z(%?<M?#
M7_!<;_DEW@7_ +#]S_Z(%>#CO]UE_74\7C[_ ))'%>B_]*B?FY1117S1_*X4
M444 %%%% !1110 4444 %%%% !1110!^_GAS_D7K#_KRB_\ 0!5RJ?AS_D7K
M#_KRB_\ 0!5ROKUL?VK3^!>@5^+W_!0[_D]/XA?]AL?^B8Z_:&OQ>_X*'?\
M)Z?Q"_[#8_\ 1,=>9FO\&/J?E?BY_P B.A_U\_\ ;9'C%%%%>&?S\%%%% !1
M110 4444 %%%% !1110 5]8?\$:O^3OY?^Q1O?\ T9!7R?7UA_P1J_Y._E_[
M%&]_]&05T83_ 'F'J?2<'?\ )48/_KY$_5BBBBOJ#^M HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "OS$D_X..MCLG_  QOG!(S_P +#_\ O?7Z=U_,3/\
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M%?>=?!G_  ;U?\F@>*_^RDW/_IOL*^\Z_,LX_P"1G5]3]:R/_D4T?0*^&O\
M@N-_R2[P+_V'[G_T0*^Y:^&O^"XW_)+O O\ V'[G_P!$"O!QW^ZR_KJ>+Q]_
MR2.*]%_Z5$_-RBBBOFC^5PHHHH **** "BBB@ HHHH **** "BBB@#]_/#G_
M "+UA_UY1?\ H JY5/PY_P B]8?]>47_ * *N5]>MC^U:?P+T"OQ>_X*'?\
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MI11117YP?J1\._\ !P!_R9+I'_91+'_TDO:_&FOV6_X. /\ DR72/^RB6/\
MZ27M?C37Z#PW_P BWYL_,^*O^1L_\*"BBOM/_@GW^QE#\</V//B?\:OAAX6T
M3Q/\4M'U6+3_  QH>OV\-S;VL 6&6686\X,,LTJ/,D?G*R!H3@ DD>OB<33P
MM+GGM=+[W;7LNYXF$PM7&5?9PWLW]ROIW?9'Q917U;^W?\4/AIJ_C[XP?"GQ
MW\'M!T[Q?HGCV1_!WB;1]$6PN)+7[2RS6UTMN$CGS&R.DLBESM;+L66O;/\
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M,KJ.,*_HT_9"_P"33?A?_P!D[T3_ -((:_G+K^C3]D+_ )--^%__ &3O1/\
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M./\ H(J?^!R_S#^TLQ_Y_3_\"?\ F8?_  K?P7_T!O\ R8D_^*H_X5OX+_Z
MW_DQ)_\ %5N44?VSG'_014_\#E_F']I9C_S^G_X$_P#,P_\ A6_@O_H#?^3$
MG_Q5'_"M_!?_ $!O_)B3_P"*K<HH_MG./^@BI_X'+_,/[2S'_G]/_P "?^9A
M_P#"M_!?_0&_\F)/_BJ/^%;^"_\ H#?^3$G_ ,56Y11_;.<?]!%3_P #E_F'
M]I9C_P _I_\ @3_S/TU_X(8Z'I>@_LM>)K32;7RHV\?W#LN]FRWV&R&?F)]!
M7VG7QO\ \$2?^38O$G_8^7'_ *16=?9%>Q0JU:U&,ZDG*3W;=V_F?U)P9.=7
MA;"RFVVX[O5[L*^&O^"XW_)+O O_ &'[G_T0*^Y:^&O^"XW_ "2[P+_V'[G_
M -$"LL=_NLOZZG-Q]_R2.*]%_P"E1/S<HHHKYH_E<**** "BBB@ HHHH ***
M* "BBB@ HHHH _?SPY_R+UA_UY1?^@"KE4_#G_(O6'_7E%_Z *N5]>MC^U:?
MP+T"OQ>_X*'?\GI_$+_L-C_T3'7[0U^+W_!0[_D]/XA?]AL?^B8Z\S-?X,?4
M_*_%S_D1T/\ KY_[;(\8HHHKPS^?@HHHH **** "BBB@ HHHH **** "OK#_
M ((U?\G?R_\ 8HWO_HR"OD^OK#_@C5_R=_+_ -BC>_\ HR"NC"?[S#U/I.#O
M^2HP?_7R)^K%%%%?4']:!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!^57_!:3_@J7<_LE_\ !3SX ?LI_M ?$+Q7\/\ ]GOQ
M/X=N=:\?^+?!E[<V-YJ-VTEU;6]JU[:%;J"V@EBMI9OLKI*4N@22 %/??\$?
M?V?_ (\^&O@W^S'^T7\(/VG/&.M_#/Q7\'88OB?X"\3>*WUBR@U$V$;VM_I[
MWK2368$ZRQ2VT$@C!=-L:!'KZ!_;G_9:_85_X*62ZE^P1^U9X,BU?6+#PO!X
MHTF6-UM]1TR"XGGM!>V%P,NCI);[9!@QD20K(KJ^VOQD_P"#?K_AMG_@G'_P
M4E^!W[(Y^),WB?X0_M+_  E_X3I-!CD=X-*233;JY6Y\IB1;7,5Q9F!W4A)X
MY$)!;8L8![7_ ,')?Q^_;L^ /[;_ .SC\,M&_;*UR#X?_$GQ=')>>"/#&G+I
M%O&MMJMD@CGFBD:>\1X[A R2R&/=&S!%#;5_3G_@K5^U]IG[#7_!/?XE?M!W
M/BN+1=0M=$_LSPYJ4L;O]FU2^=;2UG\M 7D$4DRSLJ L4A?'2ORT_P"#M)E'
M[?G[$N6 QXFNR>>@_M72*_6O]O?X<_L$?%#X+6?AO_@HPW@4> _^$CMGLE^(
M>O1:?8/JA26.!5DEEC5IBKRA4R2?F('&0 ?C!_P3<_X)]_##]M/XQZ!=_!'_
M (.E/B%\3HM&U6VU+7_AP^E:YH>J:K80RH]Q L=[K0F5&0&-IDAE5-X)!X!^
MD?BC^UCXU_;/_P"#FS_AV=\4/$NJQ?!WX<>!YY6\%6&K3V5MXBU:71H;TW-Y
MY#H]QY:W8$<;$HAM@ZJ&9B?&O^"Q_P#P0-^#7[%*?#G_ (*!?\$C#JG@GQUI
MWQ0T"QTSP?I^M3W=IJ%U>W:0VLUDTSO*C^<\8>+>T3PN^%0(0_V__P %$?\
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M>BZC!?Z=/)\1/$<RQSPR+)&QCDU%D<!E!VLI4XP002*^[J** "BBB@ HHHH
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MZA_X(S?\I(?AW_N:O_Z:+ROW7K\*/^",W_*2'X=_[FK_ /IHO*_=>O@^*/\
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M(?\ ][Z]#^P,V_Y]_C'_ #/,_P!9,E_Y^_\ DLO\C]/**_,/_B(]_P"K-O\
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M  < ?\F2Z1_V42Q_])+VOQIK]EO^#@#_ ),ETC_LHEC_ .DE[7XTU^@\-_\
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MP/\ [NI_^FRZK]A*][*_]W?K^B/Z'\)?^2<J_P#7V7_I%,*Y;XY_\D2\8_\
M8JZA_P"DTE=37+?'/_DB7C'_ +%74/\ TFDKT)?"S](QG^Z5/\+_ "/P@HHH
MKY$_C **** "BBB@ HHHH **** "BBB@ HHHH _4#_@B3_R;%XD_['RX_P#2
M*SK[(KXW_P"")/\ R;%XD_['RX_](K.OLBOI\'_NL/0_J[@C_DE,)_@_5A7P
MU_P7&_Y)=X%_[#]S_P"B!7W+7PU_P7&_Y)=X%_[#]S_Z(%3CO]UE_74QX^_Y
M)'%>B_\ 2HGYN4445\T?RN%%%% !1110 4444 %%%% !1110 4444 ?OYX<_
MY%ZP_P"O*+_T 5<JGX<_Y%ZP_P"O*+_T 5<KZ];']JT_@7H%?B]_P4._Y/3^
M(7_8;'_HF.OVAK\7O^"AW_)Z?Q"_[#8_]$QUYF:_P8^I^5^+G_(CH?\ 7S_V
MV1XQ1117AG\_!17T_P""_P!C+P1X%\$^!O'?QOTC7=:/C[PSK.L6-KHU^EG:
MV$%MI<MY LDQBE,DTBJKJH"*N,GS K(?,?'7PJ^"KW?@_7OAM\3KNVT#Q/!.
MVJ_\)' C7&@R0-B:.0PX%P=F'3:J%]R  %L#:5"<5=_UM_F>S7R+'X:BIU+)
MZ>ZW:2346GK9;3CLVU?6UG;RZBOM?X3_ +(_["'[3OP+\6ZA\"_%'C33O$O@
M_33<75_XH:&-9&\N1TD>*,LGD.8G'RL'3&3VW>.?LC_LKZ1\8O!'C[XW_$&6
M['ACX?:#->RV5C*(I=4NEADE2W$A#>6F$^=@"<.H'7(IX:HG&UG?]-SIJ<,9
ME&K0A!QFJRE*,HRO&T+\]WTY;:Z>EV>%T5[[\9/V7/#B_LG>$/VQ/A;:75EI
MVM7DMAX@\/W%R;@6%PD\T*2Q2$!C$YAY5LE6=>2#QZ%K_P"Q3\$_@/\ $3X4
M_!'XV6>L:GK7Q%0)KFJ6.J"V71YYG2&&.W3RV#[97P[2;@P&0%Z4EAJE_N_'
M84.&,SE-IV4;4Y<S;Y6JK2A;2_O>FEG>UCY HKTS]KC]F_6?V5?C=J/PGU/4
M?MUO'&EUI.HF/8;JTDSL<KV8$,C#IN1L<8H_93^%OPZ^)OQ*EE^-&OW>D^"=
M"TR74?%.IV4;M+# "L,00(CL6:>6%<!2<%CCBH]G/VG(]SSO[,Q<<R>!FE&H
MI<KNTDFMVWLDMV]K:['F=%?3G[1/A#_@F!X=^$^HW_[._P 4O%.O^+2\2:99
M7D5S%"N9!YDCF6SC!"INP V2Q7MFOF.BI3]G*UT_1W#,LNEEM=4G5A4NKWIR
M4UUTNM+Z;>@5]8?\$:O^3OY?^Q1O?_1D%?)]?6'_  1J_P"3OY?^Q1O?_1D%
M:83_ 'F'J>IP=_R5&#_Z^1/U8HHHKZ@_K0**** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ K\;O^#@C_D]70?^R;6/_I=?U^R-?C=_P<$?\GJZ
M#_V3:Q_]+K^O?X;_ .1FO1GS?%7_ "*7_B1\,4445^@GYF%%%% !1110 444
M4 %%%% !1110 5[9_P $X/\ D^[X5?\ 8Y6G_H5>)U[9_P $X/\ D^[X5?\
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M$?0?'_[7DNEZ#<QS#PQX?MM(O)8SD&X62:=USZKYX0CLRL.H-<C^Q9^V]?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7L8?_"M_!?\ T!O_ "8D_P#BJ/\ A6_@O_H#?^3$G_Q5;E%<O]LYQ_T$5/\
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M+?'/_DB7C'_L5=0_])I*]"7PL_2,9_NE3_"_R/P@HHHKY$_C **** "BBB@
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M %%%% !7UA_P1J_Y._E_[%&]_P#1D%?)]?6'_!&K_D[^7_L4;W_T9!71A/\
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M^"8?_!2KP9^T?>&Z^(>J:'JWB#Q@-9&+PW7]F:E(L[J_S9AO8';_ &&QTR*
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MO'-[X1_:O\0?#GPS\&/A#I.@>/M:E;2/$>GZ!:M;6-_>-.JVUTD0)BMPR/\
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MW"1P,^5?#CX _$_QA\)9/C?\'+75-0U/P_XC-OJ%GHFYKRSC\J*2"[C2+]X
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M'_014_\  Y?YA_:68_\ /Z?_ ($_\S#_ .%;^"_^@-_Y,2?_ !5'_"M_!?\
MT!O_ "8D_P#BJW**/[9SC_H(J?\ @<O\P_M+,?\ G]/_ ,"?^9A_\*W\%_\
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MO)3/=W#RN0 7D<L< 8 R?88IE%!-V37>HZA?K$M]?33""(10"64MY:#HJYZ
M>@XJ&BB@;;;NPHHHH$?OYX<_Y%ZP_P"O*+_T 5<JGX<_Y%ZP_P"O*+_T 5<K
MZ];']JT_@7H%?B]_P4._Y/3^(7_8;'_HF.OVAK\7O^"AW_)Z?Q"_[#8_]$QU
MYF:_P8^I^5^+G_(CH?\ 7S_VV1XQ1117AG\_!1110 4444 %%%% !1110 44
M44 %?6'_  1J_P"3OY?^Q1O?_1D%?)]?6'_!&K_D[^7_ +%&]_\ 1D%=&$_W
MF'J?2<'?\E1@_P#KY$_5BBBBOJ#^M HHHH **** "BBB@ HHHH *\[_:H_:K
M^!7[%OP2U;]H/]HOQM'H7AG2#&DL_D//-<SRN$AMH(8PSSS2.0JQH"3R> "1
MZ)7QG_P7>_X)I^-_^"IW[!=W\ OA7XVM]#\8:#XFM/$_A.2^E:.UN[VVAN(1
M;3.H)C5X[F7:X!VR"-B, T 1)_P6D\ ^#_'OB+0/VAOV1/B[\.?#F@^-])\+
M3^--6TRPU&SLK[4=/L+RUCU"+3;NXGL&D_M"!%)1X\NBO)'*7AC^B_VJ?VM?
MV=OV)O@WJ'Q\_:?^*.G^$_"^G,L;WU\69[B9@2EO!"@:2XF;!VQ1JS$*3C )
M'X8?\$S_ /@L=KW[.G[2?Q-_X)L_\%Z/A;J5MXG^(_BO2HO$GC+6Q&JV]Y#I
M6G:?9B_2' \J2"SLYEU"%R-SB8_*QF7KO^"F/Q!^-G[>G_!T5\+?V%_!]YX=
MDTOX*6L&JZ#HGC..XFT675QI']NO>7,,#*\QQ]DCV!E#"W"[E#N: /V0_9D_
M:(^(W[2.BI\0;W]F/Q1\/_"M[:B;19?']U;VNL7RM@I(=.@:8VT;+DXN)(YA
MQNA7)QQWQ]_X*6? WX._M Z=^Q[X!\.>(OBA\8]3L_MJ_#?X?VT,]UIMGA?]
M,U&XN)8K73K?YT.Z>5682)L1]R@_&7['/_!P-\9O%NN_M4?LV?MI_!+PMH7Q
M>_9H\$>)?$\DG@J:Y_L;7[31PZS^7'<N\L1WFW93YC>9'/G$90AOS_\ ^"3/
M[3O_  4+_92_X)T?M ?\%MOAEX:^&7Q"U/6_BPD?Q6E\>0ZC)KM_:)]F9WM)
M;>:.*!%FU/>RL'RH)V@0HK ']('@G4O%^K^&+74O'?A>UT75)DW7.EV>J?;4
MM^>%\[RXPS8QG"X!R 6 #'YS_P""K/\ P5<^ 7_!(_X&Z+\;OCKX;UW74\0^
M)$T;2="\-"!KR>0PRS/+B:2-1$BQ89L\-)&,?-7<?\$[_P!M;P1_P41_8R\"
M?MB^ -#GTJQ\9:9))/I%U,))-/O()Y+:ZMRX WA)X955]J[U"MM7=@?#/_!:
M[X&?\%Z_&/[9'A#]HW_@E1;Z)::/X!\ 76EVAGU'1Y+V^NKZYCGOPEOJB-"J
MLEG81ALJ_P"Z<!L.00#U'_@E/_P<%_ 7_@K?\<=:^"?P(_9Q^(FAGP]X<?6-
M8U[Q*EBMG;Q^='#'$3#<.QED:0[5QR(Y#_":^_J_+#_@AA_P6_\ VG/VMOVA
M/%?_  3F_P""D7P0'@KXV>#M)DU""ZCTF33_ .TX(FB6:*XM7)\JX"S1RJ\9
M\J6-F950*#)^I] !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %?C=_P<$?\GJZ#_P!DVL?_ $NOZ_9&OQN_X."/^3U=!_[)
MM8_^EU_7O\-_\C->C/F^*O\ D4O_ !(^&****_03\S"BBB@ HHHH **** "B
MBB@ HHHH *]L_P""<'_)]WPJ_P"QRM/_ $*O$Z]L_P""<'_)]WPJ_P"QRM/_
M $*N?%_[I4_PO\CIP7^^4_\ %'\T?T&4445^3G[.%?S\S?ZUO]XU_0-7\_,W
M^M;_ 'C7CYM]CY_H?B?C%_S _P#<7_W&-HHHKQS\3"BBB@ HHHH **** "BB
MB@ HHHH *_17_@AC_P BI\1O^PCIO_HNXK\ZJ_17_@AC_P BI\1O^PCIO_HN
MXKMR_P#WN/S_ "/N?#?_ )+##^D__2)'WG1117T9_3Y\B_\ !:7_ )-+TS_L
M>+/_ -)KNORQK]3O^"TO_)I>F?\ 8\6?_I-=U^6-?/9E_O/R1_-GBC_R53_P
M1_4****X#\Z"BBB@ HHHH **** "BBB@ HHHH *_=#]F3_DVWX>_]B/I/_I'
M%7X7U^Z'[,G_ ";;\/?^Q'TG_P!(XJ]7*OCEZ'[!X0?[_BO\,?S9W%%%%>V?
MO!^17_!6?_D][Q)_V#M._P#22*OFROI/_@K/_P GO>)/^P=IW_I)%7S97RV*
M_P!XGZL_D7BK_DI<9_U]G_Z4PHHHK \$**** "BBB@ HHHH **** "BBB@#Z
M$_X)7_\ )]W@?_=U/_TV75?L)7X]_P#!*_\ Y/N\#_[NI_\ ILNJ_82O>RO_
M '=^OZ(_H?PE_P"2<J_]?9?^D4PKEOCG_P D2\8_]BKJ'_I-)74URWQS_P"2
M)>,?^Q5U#_TFDKT)?"S](QG^Z5/\+_(_""BBBOD3^,#VC]@O]IG0_P!E7X^0
M_$#Q7HDE]H]_IDVEZNL"!I88)7C?S44\,5:),KD94L.IKZG_ &F_V,]/^(_P
MT\,?M+?L#>*K:72_#>DW;:;HUB6)DA>[N;B;[.SY.]9)ID-NX' *#D;#\4_
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M8#Z?9]3/]:U?@G\#?!-S_P %._C-\5+S3XIE\'VVG7%C$4!$5Y?V2RR3#_;
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M]''?^6?H_P#\AT?\/E?^"DG_ $<=_P"6?H__ ,AU\PT4?V=E_P#SYC_X"O\
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MO^?\_P#P*7^9]/?\/E?^"DG_ $<=_P"6?H__ ,AT?\/E?^"DG_1QW_EGZ/\
M_(=?,-%']G9?_P ^8_\ @*_R#^T\R_Y_S_\  I?YG]#W["/Q-\<?&;]D/P%\
M4?B3K?\ :6NZUH:W&IWWV:*'SI-[C=LB547@#A5 KUJO!_\ @F%_R8)\+?\
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M)/\ XJC_ (5OX+_Z W_DQ)_\56Y11_;.<?\ 014_\#E_F']I9C_S^G_X$_\
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M .3[O _^[J?_ *;+JOV$KWLK_P!W?K^B/Z'\)?\ DG*O_7V7_I%,*Y;XY_\
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MNGN;^^O)C)+<3.Q9Y'9N68DDDGJ35.BBNE))61RMMN["BBB@1_0!_P $PO\
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M '6'H?U=P1_R2F$_P?JPKX:_X+C?\DN\"_\ 8?N?_1 K[EKX:_X+C?\ )+O
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MRO>]]3AHYJJ%Y1HPY^?GC+WKQ?9>]9JZNE)/7J?0/PHU+]D'XC_#;XH_$/\
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MOA9^D8S_ '2I_A?Y'X04445\B?Q@%%%% !1110 4444 %%%% !1110 4444
M?J!_P1)_Y-B\2?\ 8^7'_I%9U]D5\;_\$2?^38O$G_8^7'_I%9U]D5]/@_\
M=8>A_5W!'_)*83_!^K"OAK_@N-_R2[P+_P!A^Y_]$"ON6OAK_@N-_P DN\"_
M]A^Y_P#1 J<=_NLOZZF/'W_)(XKT7_I43\W****^:/Y7"BBB@ HHHH ****
M"BBB@ HHHH **** /W\\.?\ (O6'_7E%_P"@"KE4_#G_ "+UA_UY1?\ H JY
M7UZV/[5I_ O0*_%[_@H=_P GI_$+_L-C_P!$QU^T-?B]_P %#O\ D]/XA?\
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M!R_S.;^TLQ_Y_3_\"?\ F8?_  K?P7_T!O\ R8D_^*H_X5OX+_Z W_DQ)_\
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M^Z;_ .EL-?1U?./_  5A_P"3'/%/_7[IO_I;#58G_=Y^C_(]KBC_ ))K&?\
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M.37-UA6E&=1RBK(\+.,5AL;F=6OAX*$).Z2T2[V71-W:71:!11169YI^TO\
MP3[_ .3,/AY_V %_]&/7L=>.?\$^_P#DS#X>?]@!?_1CU['7U='^#'T1_8>1
M_P#(DPO_ %[A_P"DH*_+7_@M9_R=?HW_ &(=I_Z5WE?J57Y:_P#!:S_DZ_1O
M^Q#M/_2N\KES+_=7ZH^/\4?^25E_CC^I\@T445\\?S8%%%% !1110 4444 %
M%%% !1110 5ZS^PG_P GA_#G_L:K;_T*O)J]9_83_P"3P_AS_P!C5;?^A5I1
M_C1]4>EDO_(XPW_7R'_I2/VOHHHKZP_L8*_GYF_UK?[QK^@:OY^9O]:W^\:\
M?-OL?/\ 0_$_&+_F!_[B_P#N,;1117CGXF%%%% !1110 4444 %%%% !1110
M 5^BO_!#'_D5/B-_V$=-_P#1=Q7YU5^BO_!#'_D5/B-_V$=-_P#1=Q7;E_\
MO<?G^1]SX;_\EAA_2?\ Z1(^\Z***^C/Z?/D7_@M+_R:7IG_ &/%G_Z37=?E
MC7ZG?\%I?^32],_['BS_ /2:[K\L:^>S+_>?DC^;/%'_ )*I_P""/ZA1117
M?G04444 %%%% !1110 4444 %%%% !7[H?LR?\FV_#W_ +$?2?\ TCBK\+Z_
M=#]F3_DVWX>_]B/I/_I'%7JY5\<O0_8/"#_?\5_AC^;.XHHHKVS]X/R*_P""
ML_\ R>]XD_[!VG?^DD5?-E?2?_!6?_D][Q)_V#M._P#22*OFROEL5_O$_5G\
MB\5?\E+C/^OL_P#TIA1116!X(4444 %%%% !1110 4444 %%%% 'T)_P2O\
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M>O8Z\<_X)]_\F8?#S_L +_Z,>O8Z^KH_P8^B/[#R/_D287_KW#_TE!7Y:_\
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M4_PO\C\(****^1/XP"BBB@ HHHH **** "BBB@ HHHH **** /U _P"")/\
MR;%XD_['RX_](K.OLBOC?_@B3_R;%XD_['RX_P#2*SK[(KZ?!_[K#T/ZNX(_
MY)3"?X/U85\-?\%QO^27>!?^P_<_^B!7W+7PU_P7&_Y)=X%_[#]S_P"B!4X[
M_=9?UU,>/O\ DD<5Z+_TJ)^;E%%%?-'\KA1110 4444 %%%% !1110 4444
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M /X:^3_XQ7Z-T4 ?C;X@_P""'/\ P62\4Z]>^)M=_:[_ &?Y[[4;N2ZO)_\
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M4?5\/_(ON0?ZM<.?] 5+_P %P_R/QB_X<.?\%??^CL?V?_\ PEM8_P#BZ/\
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MX(^?\%8]:^-VM_!.#]J+X&+?Z+HUMJ$]P_A75/(=)F(55Q)NW#'.1CTKLO\
MAPY_P5]_Z.Q_9_\ _"6UC_XNOT^\&^!?%UA^VGXT^(%YH,\>BZAX/TZULM18
M#RY9HW8N@YZ@&O7Z/J^'_D7W(/\ 5KAS_H"I?^"X?Y'XQ?\ #AS_ (*^_P#1
MV/[/_P#X2VL?_%T?\.'/^"OO_1V/[/\ _P"$MK'_ ,77[.T4?5\/_(ON0?ZM
M<.?] 5+_ ,%P_P C\8O^'#G_  5]_P"CL?V?_P#PEM8_^+H_X<.?\%??^CL?
MV?\ _P );6/_ (NOV=HH^KX?^1?<@_U:X<_Z J7_ (+A_D?C%_PX<_X*^_\
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M:Q_\71_PX<_X*^_]'8_L_P#_ (2VL?\ Q=?L[11]7P_\B^Y!_JUPY_T!4O\
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M_@K[_P!'8_L__P#A+:Q_\77[.T4?5\/_ "+[D'^K7#G_ $!4O_!</\C\8O\
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MZ<&VWNVVKMGXQ?\ #AS_ (*^_P#1V/[/_P#X2VL?_%T?\.'/^"OO_1V/[/\
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M&/[9_P"S_IFN::)?L5[_ ,(9J<WE^9$\3_)+N0Y1V'*G&<CD U[#_P ,T_\
M!S;_ -))OV?_ /PU\G_QBOT;HK2$(4U:*MZ'HX3 X++Z;IX6E&G%N]HQ45?:
M]DEKHM?(_.3_ (9I_P"#FW_I)-^S_P#^&OD_^,54UW]D[_@Y:\2Z)>>'-;_X
M*._L_P ]EJ%K);7</_"LI5\R)U*NN5A!&02,@@^E?I-15'3**DFFKIGXQ?\
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M";XFV%]\/#XQTJPE\16VDQ'3OL(O5::63>RN8CPD<<AW*5)7@T ?0=%?!?\
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MX41W\O3K=PQRLFY))95&48-"1C(!^HE%4_#M[/J/A^PU"Z8&6>SBDD(& 69
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M;^%FA>-OC?X_UR?^P?#_ (BNK>&UCTBRA$FH7;-<75M'\C2V<(!E&6NEP"<
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MP@\+0ZUXG64:%K7A2Q$)M)?LDEW!*KQ2/%=6DL<3(" )(W/SGY'0 '[*45\
M?\%Z_P#@K)^T]_P2H_9V@^+GP3_9;TKQ!::CKL&B1>,/%'B!%L[*\G@EFC(L
M(&^T7*XAD4EG@ =?XE()^KOV'_BMXO\ CO\ L6?"#XX?$&>"77O&7PN\/Z[K
M<MK (HGO+O38+B8H@X13)(V%'0<4 >HT444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% 'S_ /\ !2C]IC5_V=?V9]4TOX8^')_$GQ0\>QR^&?A-X.L
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MF3X!:1<6^@Z&DCO=W\PEO-2NY7,D]Y<R #S)I9&+,0 HX555%51ZI0 4444
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MXH?$OQ19Z)X>\/:9-J&MZOJ$H2"SM84+R2NQZ*JJ3^%;-?'7_!8;_@F?\?\
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MCQ_P41_X)L+\1?VDM9;5_%?@[QQ?>%+OQ%+"J2ZQ%!;6=U%<2A %,@2\6)F
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M^\3?'/5M;\+KH6C-XDT.XM3HUNUS'<7'EM/J-V6$KPV^0-F/)!.[C'/>)?\
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MHT7X=^%+#Q/;:[(5^&TNK7\]Q!;SPHAF.J6\:Q_Z0[$"+=E4&[ .[WK]B+X
M_$G]EC]F'P3^SA\1?BOH_C,^!/"NG>']*US2O"<NCF>TLK9+:)IHGO;H-*4C
M0LRLJDY(49P #UBBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "L_P 6^*M!\"^%=3\;>*K_ .RZ7H^GS7VI77E._DV\4;22/M0%FPJDX4$G
M' )K0KS[]K3_ )-5^)G_ &3[6O\ TAFJ9MQBV<^,K2P^$J58[QBVODKGGW_#
MTW]@_P#Z+K_Y;&J?_(U'_#TW]@__ *+K_P"6QJG_ ,C5^/-%>'_:F([+\?\
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M:;+!:3S!)KTRSJRE85.XICG/+(H9U]1H **** "BBB@ HHHH **** "BBB@
MHHHH *^;->_X*\_\$[_#.N7OAO7/VA?(O=/NY+:\A_X1/5V\N6-BKKE;0@X8
M$9!(/8U])U_-E\=_^2X>,_\ L:]1_P#2F2O<R3+*&93FJK:Y;;6Z^J9\]G^;
M8G*H4W22?->][]+=FC]K_P#A\K_P3;_Z.._\L_6/_D.C_A\K_P $V_\ HX[_
M ,L_6/\ Y#K\):*^@_U7R_\ FE]Z_P#D3YK_ %OS+^2'W2_^2/Z1O@3^T#\(
MOVE_ 2?$_P""7BW^V]#DNY+9+[[!<6V98\;UV7$:/QD<[<'L:[*OC;_@A-_R
M839_]C7J7_H25]DU\;C:$,-BYTH[1;6I]W@*\\5@J=:>\DF[;:A1117*=844
M5\VZU_P4 \0^-/CIXT^ G[(O[-.L_%*^^&MS#9_$'7D\166D:5IFHRQ"9=,B
MGN6+75XL3*\B(GEQ;T5Y58[0 ?25%>&?L>?MR:+^U[XH^(7@>+X'^-O .N?#
M+5[/2?%.A^.[2VANHKV>W^T;4^S3312P^48F2=)&242!E^7!/N= !1110 45
MY=^SQ\:?C?\ %?QA\2= ^+G[+NI_#S3_  AXUFTCP?K%_K\%ZGB_3D0,FJ1)
M$JFV1\_ZM]Q' +;@ZIZC0 4444 %%?*O_!2;_@J+I?\ P32B\&:MX_\ V:O%
M_B_2O'OBZV\+^'K_ ,)ZAI^Y]6N$=X;:2.YGB*;Q')A^5^0Y*\9^E/!.L^)=
M?\-6VK>+O!TF@7\RDSZ3+?17+0<\ R1$HQQ_=)'N: -:BO+OC_\ &CXW_"WX
M@?#3PK\*/V7=3\?Z3XQ\6_V7XR\06&OP6<?@ZQ\LO_:,L<JEKE,@CRT*G@_-
MN*(_J- !117EW[*WQH^-_P ;?#WBO5?CG^R[J?PKN]#\=ZEHNAZ=J>OP:@VM
MZ9;E!!JR-"JB))]SXB.XKY9.YU*L0#U&BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ KS[]K3_ )-5^)G_ &3[6O\ TAFKT&O/OVM/^35?
MB9_V3[6O_2&:HJ?PWZ'#F?\ R+:W^"7Y,_#BBBBODC^-0K]Q_P!DO_DU7X9_
M]D^T7_TAAK\.*_<?]DO_ )-5^&?_ &3[1?\ TAAKU<J_B2]#]>\(?^1EBO\
M OS/0:***]L_>@HHJEXBU2^T31+G5=-\-WNL3P1[HM,TZ2!9[@_W4,\D<8/^
M^ZCCK0!^1?\ P1 ^,7QM^&_QP_;=TWX7?LD>)?B):W'[7OBF6YU'1/$NC6*6
MLGVF0>4RW]W [' #94%<'&<Y%:OQ(^(WQ.^)'_!SO^R[J7Q1_9[UOX=W5O\
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M3-"=/MTD$4DUP998XV>9;:$>7*PD(\O> >$_\$[X/B)_PY4_;&U;X5_%W6/
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
H@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>pntg-20211231_g2.jpg
<TEXT>
begin 644 pntg-20211231_g2.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JFNZWI?AK1[G7
M];NO(M+.%I;B;8S;$').%!)_ 5;HH \"\$_\%3_^"<WQ*\?)\*OAW^V=\/\
M7?$\D\D*>'=(\01W-\9$SO7R(R7RN#N&/EP<XQ4WQ;_X*??\$\_@)XYF^&7Q
MO_;&\ ^$?$-O_K=$\1^((K.Z W,@81RE6*EE8!@"#@X)K\,O^"8_Q\^"/[-/
M_!TK^U'\1/CM\0-,\+Z(WB+X@6L6I:FQ6/[3)K\3*@(!^8A7/X&JW_!QI^TM
M^SY^U-_P5X_9?\4_ 'XFZ3XLTZQ@T:RU&[TQBR1R_P!OL_EMN YVN#C_ &J
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M3P;X0T9D6[US5)K-3%;1LWRQ(%1V>0@A%4X#,41@#ZXHKY$^$7_!3GQ-;_\
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M/[;7[(_[(TEA'^T_^T1X4\!?VHI.FOXIU>.S2YQG(1I"%8_*> <\9KP73?\
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M;/R;!Q?V=\-/99T?[?&Z*T4>8P2Q20&*OGCQ-_P<@?'K1?V"O!?_  4\M?\
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M'_\ 9U\)_'G_ ()^ZKX.^'/[1UG8OX4\7WOCNVN-0MVN6M4\Z2PBA.R%)+N
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MB"X9!T4R8W$>V<4[5O#^@:_:S6.NZ'9WL%S#Y5Q#=VR2)+'G.Q@P(9<\X/%
M'X"_ WQ_^V%XM_X-8OVH_"7[47C*?Q7HW@S6I?#_ ,-/&,]V]RNK:5;7MC&Y
MMKEP&N[))A(L,QSE2T8.V)57@/$G[97[.=Q_P:#^&?V*;+XAV-Q\6/$6I6^F
M:/\ #\!AJ]TW_"9R:@+B"V(\R>W,,+H+B,-%YN8MWF H/V@_X+'?LV?&+]J[
M_@FM\1?V4?V;O ]KJ7B3QGIEKI>E07&HP6-I91I<PS-+*\A&U%2$J%168LR#
M 7<RX/\ P1*_9!^*_P"QY_P3K^&O[,/[3_PLTVQ\:?#C^TXDU*WO+6_@E6ZU
M*[NUDM9D)=/W<Z(X94.X$#<,&@#\A/\ @NG\*-:_90_X-T_V/OV2_B_JEO8_
M$#2_$=KJ6J>%[JZ07UJDFGZE+,K19W8@DNXX'8#:'P,\BNX_X+?:S\0O@#^T
M7^PY_P %GOACI<OC7X5>"?"/A^PUF_\ #DJW-O ]M=&XDC:524C-S#<2PHY.
M/,MRI(( /] U17MC9:E9RZ?J-G%<6\\92:">,.DBD8*LIX(([&@#X2^*O[4?
M[/?_  64_P""?WQS^&7_  3OO]4\4:CXN^$.J6A\4)X7N=.LO[2>V9+729[F
M[CB\RY<NZE(_,6% QD:/S(A+^8__  1&^+/_  2G\<?L6?\ #NK_ (*-_!?Q
M5J?Q>\%^+[^TTSX4:@NOSR^(I9+F6XABMM/BE%O%=)-+-"ZR+%LVB5V"F1U_
MHBTK2=*T+3HM(T33+>SM(%VP6MK"L<<:^BJH  ^E0Q^&/#4.OR>*HO#UBNJ2
MPB&74EM$%P\8QA#)C<5X'&<<4 0^#='T_P +>"]*\/V&C1Z7:Z=I<%O#IZS^
M8MG''&JB(.?O! -N[OC-?!V@?&[X4_\ !3S_ (*)^);3]G'_ (* #PP/@#I0
MT+PXO@6;0=1N-8U344\[5KU(]2M+M)(888;2TCGA0%7^WKOVN0WZ"T4 ?S0_
M\%9K"Z_X(A?\%X/AG^W?X%_:$N/B'=^([A=9^(MO=-I<&J,Q(M=3MI[738+>
M&$7%E-&\;M"N^5I'.XH6/VG_ ,%[OB/_ ,$[_C!XY_8W_:ZT']J+2/#OCFX\
M<KK'PD^)K8O/#"Z?87%I?7#ZMY9#B))Q;(BH5D$L[J^U1(T?[%U\*_\ !7+_
M ()R_$?]NOXQ_!WQ-KWPG\'_ !6^$O@6XU.?QC\)M;U=M%U&_O)X1';WEIJ4
M<;/B(\O:F6".78N\O\H0 \@_8.\*_P#!/O\ :5_X*X:Y_P %&]:_X*/?"GXE
M_&?5/#PT?P-\// .I);6VBV4=F()I8H[B=[F_G:$2EG"HB":7Y#\K)\ _L/Z
MO^RK_P $W?\ @J?^U'^QY_P6'TW7= T#XC:]/J/A;Q-<ZGK%KIVJ6YN[UD,J
MZ?(OVB&\MKP$-(KJK0O$VUF9:^[_  7_ ,&_/P#U#]K7X-_M#? W]B"Q_9TM
M/A;XZMO$VMZ@OQ(N-5U3Q +7,D&FI9Q33VL4+S!&DN#,)-B&,1L)"4_4K5?#
M'AO7;NTO]<\/6-[/82^;8S7=HDCVS_WXRP)1O<8- 'X7_P#!R-H'[*_P<_X(
M0?#?X6_LS_"U/AMX8UGXUP:IX,\$ZEYMM>W5E]FU1I+\6ERQN(DD\V.8I( \
M8N8A(L;L8QXM_P %K/C3\(==M_\ @EUJ>B?$_0+RWT3P9I%]K,UKJT,BV%MO
MT%/-F*L?*4/:W*DMC#6\HZHP'](]% 'X.?\ !:#QOX[_ ."<'_!P+\"?^"O_
M (E\/:CKOP;U/P_::7>>(='B-S!:QO;7EC=P*R_*7^S78NXE) F)8(248C[B
M_;/_ ."@W['/[57_  2+_:A^*'[/'BPW?A&[^#&OVB^.[W0IM)TW6-6NM*NH
M(K&WDO$ADN[H$1(0B, 98X]V_*+]\:OH^D>(--FT;7M+MKVSN%VSVMW LD<@
MSG#*P((^M2VEG::?:QV-A:QP00H$AAA0*B*!@* .  .PH _F?^!_P2\;_M<?
M\&CNO?#S]GX_\)%XG^'7QFF\2^(_"NC2">_^PH[!MT"9?B*8W !'S+;N5R1B
MOLS_ ()(_&G_ ((Y_MZ_"?\ 9]M?^%.ZUXT_:'^'\6DJ_AK4+_7;V;PMJ-FU
ML+G6DEGF:TM+,&VCN@P8!ML, 5IMD1_9BJ.D>&/#7A^XN[O0?#UC8RW\WG7T
MMG:)$UQ)_?D*@%V]SDT ?SE?\%?/V>?V:H_BO\1/^"IO_!-7]J$?"G]H/X>_
M&;4=%\;?""'6Q'JVLZM'KDFFC4](B&V69KLC[1)"J2PRK).I*O%*C_T(_LZ:
MS\5/$?[/G@3Q#\=-%CTWQO?^#=+N/&.G1)M2UU5[2)KN)0.@68R*!VQ71S>%
M?"]QJ%MJUQX;L'NK)Y'L[E[-#) TA)D9&(RI8DDD8R3S5^@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV_''X%:/J7@[06MW\-:58!]/.AO;IL@>QEM&CDLVC3Y5,3+A?EY4D5F_"_\
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M4_IXHK^8>BC_ %3_ .GW_DO_ -L'^N?_ $X_\F_^U/Z>**_F'HH_U3_Z??\
MDO\ ]L'^N?\ TX_\F_\ M3^GBBOYAZ*/]4_^GW_DO_VP?ZY_]./_ ";_ .U/
MZ>**_F'HH_U3_P"GW_DO_P!L'^N?_3C_ ,F_^U/Z>**_F'HH_P!4_P#I]_Y+
M_P#;!_KG_P!./_)O_M3^GBBOYAZ*/]4_^GW_ )+_ /;!_KG_ -./_)O_ +4_
MIXHK^8>BC_5/_I]_Y+_]L'^N?_3C_P F_P#M3^GBBOYAZ*/]4_\ I]_Y+_\
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MWE;]6>_DV;_VM3G+DY>5VWO^B"BBBO)/9"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#^<;]K#_DZ;XE_
M]E UG_TNFK@*[_\ :P_Y.F^)?_90-9_]+IJX"OUNA_ CZ+\C\4Q'\>?J_P P
MHHHK4R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH [_]D_\ Y.F^&G_90-&_]+H:_HYK^<;]D_\ Y.F^
M&G_90-&_]+H:_HYKXOBK^-2]&??<'?[O5]5^04445\F?9!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!_
M.-^UA_R=-\2_^R@:S_Z735P%=_\ M8?\G3?$O_LH&L_^ETU<!7ZW0_@1]%^1
M^*8C^//U?YA1116ID%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!W_[)_P#R=-\-/^R@:-_Z70U_1S7\
MXW[)_P#R=-\-/^R@:-_Z70U_1S7Q?%7\:EZ,^^X._P!WJ^J_(****^3/L@HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH _G&_:P_Y.F^)?_90-9_\ 2Z:N KO_ -K#_DZ;XE_]E UG_P!+
MIJX"OUNA_ CZ+\C\4Q'\>?J_S"BBBM3(**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#O_P!D_P#Y.F^&
MG_90-&_]+H:_HYK^<;]D_P#Y.F^&G_90-&_]+H:_HYKXOBK^-2]&??<'?[O5
M]5^04445\F?9!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110!_.-^UA_P G3?$O_LH&L_\ I=-7 5W_ .UA
M_P G3?$O_LH&L_\ I=-7 5^MT/X$?1?D?BF(_CS]7^84445J9!1110 4444
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M"BBBM3(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@1]%^1^*8C^//U?YA1116ID%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!W_ .R?_P G3?#3_LH&C?\
MI=#7]'-?SC?LG_\ )TWPT_[*!HW_ *70U_1S7Q?%7\:EZ,^^X._W>KZK\@HH
MHKY,^R"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#^<;]K#_DZ;XE_P#90-9_]+IJX"N__:P_Y.F^)?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#6?_ $NFK@*_6Z'\"/HOR/Q3$?QY^K_,****U,@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .__ &3_
M /DZ;X:?]E T;_TNAK^CFOYQOV3_ /DZ;X:?]E T;_TNAK^CFOB^*OXU+T9]
M]P=_N]7U7Y!1117R9]D%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% '\XW[6'_ "=-\2_^R@:S_P"ETU<!
M7?\ [6'_ "=-\2_^R@:S_P"ETU<!7ZW0_@1]%^1^*8C^//U?YA1116ID%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?SC?M8?\G3?$O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJ/[0VH:)!K?BC4[Y-&\!>'+B4K'?ZG(CN&F*G<((HXWED(P2$"!E:12/-O\
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M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#O_V3_P#DZ;X:?]E T;_TNAK^CFOYQOV3_P#DZ;X:?]E
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MZO\ ,****U,@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH **** /YQOVL/\ DZ;XE_\ 90-9_P#2Z:N KO\ ]K#_ ).F^)?_ &4#6?\
MTNFK@*_6Z'\"/HOR/Q3$?QY^K_,****U,@HHHH **** "BBB@ HHHH ****
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M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#O_V3_P#DZ;X:?]E T;_TNAK^CFOYQOV3_P#DZ;X:?]E
MT;_TNAK^CFOB^*OXU+T9]]P=_N]7U7Y!1117R9]D%%%% !1110 4444 >1_M
M:?MX_LA_L)Z'H_B3]KCXZ:1X&L?$%W+;:-<:LDS"ZEC4,ZJ(D<Y"L"<XZUX=
M_P 1#/\ P1=_Z2 ^#?\ P'O?_C%?57Q$^#_PD^+]I;:?\6?A=X<\46]G(TEG
M!XBT2WO4@<C!9%F1@I(X)&,URG_#$_[&?_1H_P ,?_""T[_XS0!X!_Q$,_\
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M$_[&?_1H_P ,?_""T[_XS1_K1F'\L?N?_P D'^J&6_SS^^/_ ,B?S2_\-"?
M'_HN?@W_ ,*BT_\ CE'_  T)\ ?^BY^#?_"HM/\ XY7]+7_#$_[&?_1H_P ,
M?_""T[_XS1_PQ/\ L9_]&C_#'_P@M._^,T?ZT9A_+'[G_P#)!_JAEO\ //[X
M_P#R)_-+_P -"? '_HN?@W_PJ+3_ ..4?\-"? '_ *+GX-_\*BT_^.5_2U_P
MQ/\ L9_]&C_#'_P@M._^,T?\,3_L9_\ 1H_PQ_\ ""T[_P",T?ZT9A_+'[G_
M /)!_JAEO\\_OC_\B?S2_P##0GP!_P"BY^#?_"HM/_CE'_#0GP!_Z+GX-_\
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M@M._^,T?\,3_ +&?_1H_PQ_\(+3O_C-'^M&8?RQ^Y_\ R0?ZH9;_ #S^^/\
M\B?S2_\ #0GP!_Z+GX-_\*BT_P#CE'_#0GP!_P"BY^#?_"HM/_CE?TM?\,3_
M +&?_1H_PQ_\(+3O_C-'_#$_[&?_ $:/\,?_  @M._\ C-'^M&8?RQ^Y_P#R
M0?ZH9;_//[X__(G\TO\ PT)\ ?\ HN?@W_PJ+3_XY1_PT)\ ?^BY^#?_  J+
M3_XY7]+7_#$_[&?_ $:/\,?_  @M._\ C-'_  Q/^QG_ -&C_#'_ ,(+3O\
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M_A!:=_\ &:K_ %HS#^6/W/\ ^2)_U0RW^>?WQ_\ D3^:7_AH3X _]%S\&_\
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M /D@_P!4,M_GG]\?_D3^:7_AH3X _P#1<_!O_A46G_QRC_AH3X _]%S\&_\
MA46G_P <K^EK_AB?]C/_ *-'^&/_ (06G?\ QFC_ (8G_8S_ .C1_AC_ .$%
MIW_QFC_6C,/Y8_<__D@_U0RW^>?WQ_\ D3^:7_AH3X _]%S\&_\ A46G_P <
MH_X:$^ /_1<_!O\ X5%I_P#'*_I:_P"&)_V,_P#HT?X8_P#A!:=_\9H_X8G_
M &,_^C1_AC_X06G?_&:/]:,P_EC]S_\ D@_U0RW^>?WQ_P#D3^:7_AH3X _]
M%S\&_P#A46G_ ,<H_P"&A/@#_P!%S\&_^%1:?_'*_I:_X8G_ &,_^C1_AC_X
M06G?_&:/^&)_V,_^C1_AC_X06G?_ !FC_6C,/Y8_<_\ Y(/]4,M_GG]\?_D3
M^:7_ (:$^ /_ $7/P;_X5%I_\<H_X:$^ /\ T7/P;_X5%I_\<K^EK_AB?]C/
M_HT?X8_^$%IW_P 9H_X8G_8S_P"C1_AC_P"$%IW_ ,9H_P!:,P_EC]S_ /D@
M_P!4,M_GG]\?_D3^:7_AH3X _P#1<_!O_A46G_QRC_AH3X _]%S\&_\ A46G
M_P <K^EK_AB?]C/_ *-'^&/_ (06G?\ QFC_ (8G_8S_ .C1_AC_ .$%IW_Q
MFC_6C,/Y8_<__D@_U0RW^>?WQ_\ D3^:7_AH3X _]%S\&_\ A46G_P <H_X:
M$^ /_1<_!O\ X5%I_P#'*_I:_P"&)_V,_P#HT?X8_P#A!:=_\9H_X8G_ &,_
M^C1_AC_X06G?_&:/]:,P_EC]S_\ D@_U0RW^>?WQ_P#D3^:7_AH3X _]%S\&
M_P#A46G_ ,<H_P"&A/@#_P!%S\&_^%1:?_'*_I:_X8G_ &,_^C1_AC_X06G?
M_&:/^&)_V,_^C1_AC_X06G?_ !FC_6C,/Y8_<_\ Y(/]4,M_GG]\?_D3^=7]
MGO\ :M_9D\#?'WP/XU\4_M ^#;73-'\8:9?:C<_\)';/Y,$5U')(^U'+-A5)
MPH).. 37[5_\1#/_  1=_P"D@/@W_P ![W_XQ7O_ /PQ/^QG_P!&C_#'_P (
M+3O_ (S1_P ,3_L9_P#1H_PQ_P#""T[_ .,UY>89E7S*4954E;M?]6SU\MRK
M#Y5"4:3;YM=;?HD> ?\ $0S_ ,$7?^D@/@W_ ,![W_XQ1_Q$,_\ !%W_ *2
M^#?_  'O?_C%>_\ _#$_[&?_ $:/\,?_  @M._\ C-'_  Q/^QG_ -&C_#'_
M ,(+3O\ XS7GGIG+_LF_\%-/V#_VZ/%&J^"_V2OVE-"\;ZIHE@M[JMEI4<ZO
M;V[.(Q(?-C08W$#C/6O=JY/X=_ 3X%_"&^N-4^$WP7\)^%[F[B$5W<>'?#EK
M9231@Y".T,:EE!YP>,UUE !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 445P_P"T'^TO^S]^RA\.Y?BS^TI\8_#W@CPY#.L!U;Q'
MJ<=M%),P)6*/<<R2$!B$0%B%) X- '<45YY^S9^UG^S1^V'X%?XE?LN_''PW
MXZT2&Y-M<WWAW4TN!;3 9\J90=T+X(;:X4D$'&"#61\:/V[_ -CK]G;QB?A_
M\;?VC/"_AS68K*.]OK#4-1 ?3[2201QW-V5R+.!G(59IRB$Y 8X- 'K5%16%
M_8ZK8PZII=[#<VUS"LMO<6\@>.6-@"KJPX92"""."#7'>%/VD?@#X\^+NM_
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MEC5F4E=K. ?JG1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M'_!(7X(Z'X'\>:/JU]X>\$P6>O6.G:E%-/IMP)IU\J>-6+0L2CX#@$[21D4
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
H !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>pntg-20211231_g3.jpg
<TEXT>
begin 644 pntg-20211231_g3.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2V^Q2:=J>EC4GDN[^*3:\$\D%[&K[T4,+02AG$A:O%M3_P"#A:*Y_9A\2?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?^$_@1>:Y#;:?X6UD#4-6MK>4DV_]KM#<![6>91TBPD+E8GR^-_UQ_P:]?\
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M%4>DV)/*)XN\2#S9Y$;H2NF1+$X'*LPR1G% 'W[1110 4444 %%%% !1110
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M-C]BG3/V,4_:4\/>-++PO;ZD/!^NR?#B;3Y;66[NY[S==1C5)A=(D]Q)\B&
ME,+O!&ZO@7QO_P &KW[:?C_XH^*OC)K'_!>;QS;:_P"--;DU;Q'=:1\.;JR2
M[NF 7<8X->5 %14C10,)'&B* J@#]H** /'OV _V3(?V&?V0?!/[*Z_$&X\6
MS^%+"=-0\47EH8)=7O+BYFNKF[>-I92K23SR.09'.6Y8GFN6_P""<O[$&O\
M[%_A'XBZA\1_'UGXJ\;_ !5^*VL^-_%VOV5D\$32WDBB"UC5V9A%!!'&BKG
M.[  -?15% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% 'Y0?&S_@I9^VQX1^,WB[PGX>^-/V?3]+\3W]I8V_\ PCFFOY4,=Q(B
M+N:V+-A5 R22<<DUS'_#TW]O#_HNO_EL:7_\C5YC^TA_R<1X]_['35/_ $KE
MKBZ^7GB*ZF_??WL_DO&\2<10QE2,<9524G_R\GW?F?07_#TW]O#_ *+K_P"6
MQI?_ ,C4?\/3?V\/^BZ_^6QI?_R-7S[14_6,1_._O9S?ZR\1_P#0;5_\&3_S
M/H+_ (>F_MX?]%U_\MC2_P#Y&H_X>F_MX?\ 1=?_ "V-+_\ D:OGVBCZQB/Y
MW][#_67B/_H-J_\ @R?^9]!?\/3?V\/^BZ_^6QI?_P C4?\ #TW]O#_HNO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@#\*_VD/\ DXCQ[_V.FJ?^E<M<77:?M(?\G$>/?^QTU3_T
MKEKBZ^1J?&_4_C''_P"_5?\ %+\V%%%%2<H4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ':?LW_\G$>
MO^QTTO\ ]*XJ_=2OPK_9O_Y.(\!?]CII?_I7%7[J5[65?!+U/W?P@_W'%?XH
M_DPHHHKUC]A"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@#\*_VD/^3B/'O_8Z:I_Z5RUQ==I^TA_R<1X]
M_P"QTU3_ -*Y:XNOD:GQOU/XQQ_^_5?\4OS84445)RA1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =I^
MS?\ \G$> O\ L=-+_P#2N*OW4K\*_P!F_P#Y.(\!?]CII?\ Z5Q5^ZE>UE7P
M2]3]W\(/]QQ7^*/Y,****]8_80HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _"O\ :0_Y.(\>_P#8Z:I_
MZ5RUQ==I^TA_R<1X]_['35/_ $KEKBZ^1J?&_4_C''_[]5_Q2_-A1114G*%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!VG[-_\ R<1X"_['32__ $KBK]U*_"O]F_\ Y.(\!?\ 8Z:7
M_P"E<5?NI7M95\$O4_=_"#_<<5_BC^3"BBBO6/V$**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBBB@ HHHH **** /PK_:0_Y.(\>_]CIJG_I7+7%UVG[2'_)Q'CW_ +'35/\
MTKEKBZ^1J?&_4_C''_[]5_Q2_-A1114G*%%%% !1110 4444 %%%% !1110
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MCII?_I7%7[J5[65?!+U/W?P@_P!QQ7^*/Y,****]8_80HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _"O
M]I#_ ).(\>_]CIJG_I7+7%UVG[2'_)Q'CW_L=-4_]*Y:XNOD:GQOU/XQQ_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% ':?LW_ /)Q'@+_ +'32_\
MTKBK]U*_"O\ 9O\ ^3B/ 7_8Z:7_ .E<5?NI7M95\$O4_=_"#_<<5_BC^3"B
MBBO6/V$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%UVG[2'_ "<1X]_['35/_2N6N+KY&I\;]3^,<?\ []5_Q2_-A1114G*%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!VG[-__ "<1X"_['32__2N*OW4K\*_V;_\ DXCP%_V.FE_^E<5?
MNI7M95\$O4_=_"#_ ''%?XH_DPHHHKUC]A"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#\*_VD/\ DXCQ
M[_V.FJ?^E<M<77:?M(?\G$>/?^QTU3_TKEKBZ^1J?&_4_C''_P"_5?\ %+\V
M%%%%2<H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M****DY0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** .T_9O\ ^3B/ 7_8Z:7_ .E<5?NI7X5_LW_\G$>
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M5?!+U/W?P@_W'%?XH_DPHHHKUC]A"BBB@ HHHH **** "BBB@ HHHH _"O\
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M'35/_2N6N+KY&I\;]3^,<?\ []5_Q2_-A1114G*%%%% !1110 4444 %%%%
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M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!VG[-_\
MR<1X"_['32__ $KBK]U*_"O]F_\ Y.(\!?\ 8Z:7_P"E<5?NI7M95\$O4_=_
M"#_<<5_BC^3"BBBO6/V$**** "BBB@#\*_VD/^3B/'O_ &.FJ?\ I7+7%UVG
M[2'_ "<1X]_['35/_2N6N+KY&I\;]3^,<?\ []5_Q2_-A1114G*%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!VG[-__ "<1X"_['32__2N*OW4K\*_V;_\ DXCP%_V.FE_^E<5?NI7M
M95\$O4_=_"#_ ''%?XH_DPHHHKUC]A"BBB@ HHHH **** "BBB@ HHHH _"O
M]I#_ ).(\>_]CIJG_I7+7%UVG[2'_)Q'CW_L=-4_]*Y:XNOD:GQOU/XQQ_\
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MP]J_X)T_]'2:)_X!W?\ \9H_X>U?\$Z?^CI-$_\  .[_ /C->I_\,R?LV_\
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M (.[;_XNOW9_X9D_9M_Z-[\#_P#A)V?_ ,;H_P"&9/V;?^C>_ __ (2=G_\
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M_@[MO_BZ/[=\-?\ 0WZ)_P"#NV_^+K]V?^&9/V;?^C>_ _\ X2=G_P#&Z/\
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M  D[/_XW1_PS)^S;_P!&]^!__"3L_P#XW0!Y9_P]J_X)T_\ 1TFB?^ =W_\
M&:/^'M7_  3I_P"CI-$_\ [O_P",UZG_ ,,R?LV_]&]^!_\ PD[/_P"-T?\
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M_@[MO_BZ/[=\-?\ 0WZ)_P"#NV_^+K]V?^&9/V;?^C>_ _\ X2=G_P#&Z/\
MAF3]FW_HWOP/_P"$G9__ !NC^R\/W?X?Y!_Q"7AS_G[5_P# H?\ RL_";^W?
M#7_0WZ)_X.[;_P"+H_MWPU_T-^B?^#NV_P#BZ_=G_AF3]FW_ *-[\#_^$G9_
M_&Z/^&9/V;?^C>_ _P#X2=G_ /&Z/[+P_=_A_D'_ !"7AS_G[5_\"A_\K/PF
M_MWPU_T-^B?^#NV_^+H_MWPU_P!#?HG_ (.[;_XNOW9_X9D_9M_Z-[\#_P#A
M)V?_ ,;H_P"&9/V;?^C>_ __ (2=G_\ &Z/[+P_=_A_D'_$)>'/^?M7_ ,"A
M_P#*S\)O[=\-?]#?HG_@[MO_ (NC^W?#7_0WZ)_X.[;_ .+K]V?^&9/V;?\
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MUDLDHAMIN1+&K,I*[6< _5.BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(Z_9>%-2U+P#<2?"J'6+E8'\8:=/8ZW:V4FG!R#=,S7%G&4CW,DLWEMAE8
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MMFBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *IZEX>T#6+NT
MU#5]#L[J>PE,MC/<VR.]LY_BC+ E#[C!JY10 4444 9>L^!_!7B/5+;7/$/@
M_2[^]LO^/.\O-/CEE@YS\CLI*\^A%:E%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %4]2\/:!K%W::AJ^AV=U/82F6QGN;9'>V<_Q1E@2A]Q@U<HH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>pntg-20211231_g4.jpg
<TEXT>
begin 644 pntg-20211231_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\
MH-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\ H-0?]]4?\)CX
M8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC_H-0?]]4?\)C
MX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]
M4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H I_\ "8^&/^@U
M!_WU1_PF/AC_ *#4'_?57/[.T_\ Y\8?^_0H_L[3_P#GQA_[]"@"G_PF/AC_
M *#4'_?5'_"8^&/^@U!_WU5S^SM/_P"?&'_OT*/[.T__ )\8?^_0H I_\)CX
M8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
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M\)CX8_Z#4'_?5'_"8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT*
M*?\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\ ^?&'
M_OT* *?_  F/AC_H-0?]]4?\)CX8_P"@U!_WU5S^SM/_ .?&'_OT*/[.T_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH V**Q_P#A)=7_ .A0O?\
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MHK'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\
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M_P"^EH_X275_^A0O?^^EH V**Q_^$EU?_H4+W_OI:/\ A)=7_P"A0O?^^EH
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M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK
M_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2ZO_T*%[_WTM'_  DNK_\
M0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\ ]"A>_P#?2T ;%%8__"2Z
MO_T*%[_WTM'_  DNK_\ 0H7O_?2T ;%%8_\ PDNK_P#0H7O_ 'TM'_"2ZO\
M]"A>_P#?2T ;%%9=GKVI7-TD$WAFZA5FPTKLN%]S6I0 4444 %%%% !7$?%W
MPY\?]8U30]2^"'Q0\/Z%#932_P!N:=XB\,/J$6I1L%";7CN(7A9,.1@D,7&>
M%P>WHH \[\(_ [5_#'_"9>,F\=(WCKQK:QQ7WBBVTA4AL_(@>*T6"U=Y!Y4)
M=Y DCN7>20LQ# +C>#O@?\;/$5EHEE^U#\8M#\6Q>']2@U"VM] \)-I:W]Y
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MLSVXRC.*E%W04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 6'[1OPSD\7C1O[*U?2=:O-#\4Z+Y_F_V;JEI*8KB /@;UR ZM@$HZD@$D
M]$HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MY117CU\16Q-5U*LKMGN8;#4,)25*C&T4%%%%8FX4444 %%%% !1110 4444
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M\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%%
M&/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\
MC1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-
M;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P
M&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8
M_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&
M[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;L
MO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+Q
MO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?8O&_
M_0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!C_
M &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_ (T?
M8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\ C6Q1
M0!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_\!C_
M (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P&/\
MC6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_
M\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P
M&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]
M!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&
M[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B
M\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+Q
MO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8
M_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-
M'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL
M44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8
M_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_
M (TGQ!^(G@;X4>#K[X@?$CQ59:+HNFPF6^U'4)Q''$O;D]23@!1DL2  20*_
M,G]HG_@H/^T[_P %(_B%/^RM^P!X7U33_#<^8]7U_)@N+RW)VM+/+TLK4_W<
M^9(/E/+>57=@\!6QC;6D5O)[+^NQY^.S*A@4E+WIO:*W?]=SU7]N[_@KW_PI
MG69O@9^S%J-CXR\=S3?8Y;VPLC<6FFSL=HC0+G[5<;C@1KE5;AB2#'7'_LB_
M\$A?B?\ %?Q:/VHO^"@FNRZOKNIS+>1^%-6G::1VX*M?$'  &,6R_*H 5L &
M,?0W[ 7_  2T^#G[%FG0>+]76#Q/X_EAQ=>([F#]W9%AAHK-&_U:XR#(?WCC
M/*J=@^I*[*N/HX.FZ.!TOO/J_3LCAHY=B,;46(S#6WPP7PQ]>[_ P=/T+Q1I
M-A!I6E7NFVUK;1+%;6UO8[(XHU&%15'"J   !P *F^Q>-_\ H-V7_@,?\:V*
M*\7<][8Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@
M,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_
M !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@
M,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_
M !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@
M,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_
M !K8HH Q_L7C?_H-V7_@,?\ &C[%XW_Z#=E_X#'_ !K8HH Q_L7C?_H-V7_@
M,?\ &C[%XW_Z#=E_X#'_ !K8HH ^>?V]/V'9_P!N#X,?\*\USQ39:?JVF7?V
M[P[JOV1B+>X"E2C@')B=3M8#D$*V"5 /YD_\.._^"@?_  E__"-?\('H7V+S
MMG_"0_\ "3VWV3;G[^W=]HV_]LL^U?MY17JX'.<9@*3IT[->?3TV/&S#(L!F
M595:MU+R=K^NC/AKX2_\$,?V;/#GPBLO!_Q:TR'Q'XDRTVH>([>^N[5A*P'[
MN)8Y57RU P-ZDDY8XS@<CX[_ .#>7X-ZN7F^'GQOU_1'?D1ZA;17T2?0 1-C
MZN3[U^B=%1'.,SC-R55Z_-?<]#26293*FH.BK+Y/[UJ?EY'_ ,$D?^"F/P''
MF_LW_MG)):P?ZNQA\1ZAIID Z#R,20GZ,V*23XO?\%_OV>AM\5?#>?QG9P?<
MQH5EJOF*/?3BLY_X%\U?J)16W]LU:G\>G"?K'7[T8?V%1I_[O5G3\E+3[G<_
M+C3_ /@O)\?OA[J*:%^T-^RJ=.NLXE-NT]A(N.N(+F-B?IO%>M_#O_@NO^RG
MXO*0^+=;\0>%)#Q))JWAGSXE/L;225B/^  ^U?<6LZ%HGB/3WTGQ#H]K?VLG
M^LMKVW66-OJK @UXW\1?^";O["WQ2\QO%?[,7A:.27)DGT:S.FR,3W+VAB)/
MN31]9R>K_$H./^&5_P &'U7/*/\ #Q$9^4HV_&.I#\.OVY_V:?BMY<?@C]K+
MP'<32X\JTN[]+2X?Z17!1S_WS7K%HOBV_MDO+'Q)I\T,B[HY8H=RN/4$'!%?
M&OQ%_P"" G['GB?S+CP)XL\8^&)CGRXH=1BN[=?JDT9D/_?P5Y/=?\$-?VL/
M@]<OJ/[+O[:PM) V^,227VBOGT+VLDV3[X&?:CZKE%7^'7<?*4?U6@?7,ZH_
MQ<.I+O&7Z/4_2;[%XW_Z#=E_X#'_ !H^Q>-_^@W9?^ Q_P :_-7^R?\ @X&_
M9V_X]-2F\;:;!]X^?IVJ^9C_ *Z!;L_ABG1_\%K/VW_@C(MK^U)^Q.L*QD*\
MIL+_ $1G]\W"S*2?4  ]J?\ 8F(G_!G"?I)7_&P?V]AJ?\>G.G_BB[?>KGZ4
M?8O&_P#T&[+_ ,!C_C1]B\;_ /0;LO\ P&/^-?$OP[_X.!_V4/$7EVWQ"^'7
MC'PW,WWY8[:"]MT^K)(LA_".O>?AW_P4\_8)^)_EIX>_::\.VLDF (M?DDTQ
M@?[O^EK&"?H3GMFN2KEN84?CI/[K_BCLHYMEN(^"K'[[/[G8]A^Q>-_^@W9?
M^ Q_QH^Q>-_^@W9?^ Q_QJSX<\5^%_&.G+K'A'Q)8:K:-]VZTV\2>,_1D)%7
MZXFFG9G>FFKHQ_L7C?\ Z#=E_P" Q_QH^Q>-_P#H-V7_ (#'_&JWQ/\ BQ\-
M/@KX1G\>?%CQQIOA_1[=@LE_JETL2%SG"+GEW.#A5RQQP#7FGP?_ ."C7[$W
MQX\71^ _A?\ M!:3>ZQ/)Y=K87=O<63W+]DB^U1QB5CV5,DUI"A7J0<XP;2W
M:3M]YE/$X>G45.<TI/9-J[^1ZI]B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-
M;%%9&QC_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]!NR_
M\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&[+_P
M&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B\;_]
M!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+QO_T&
M[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8_P!B
M\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-'V+Q
MO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL44 8
M_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8_P"-
M'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_ (UL
M44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;LO_ 8
M_P"-'V+QO_T&[+_P&/\ C6Q10!C_ &+QO_T&[+_P&/\ C1]B\;_]!NR_\!C_
M (UL44 8_P!B\;_]!NR_\!C_ (T?8O&__0;LO_ 8_P"-;%% &/\ 8O&__0;L
MO_ 8_P"-'V+QO_T&[+_P&/\ C6Q10!EV=IXM2Z1[[5K5X@W[Q$MR"1[&M2BB
M@ HHHH **** "BBJ'B?Q7X7\$Z'/XG\9^)+#2--M5#7.H:I>);P0@G +22$*
MHR0.30!?HK.\*^+O"?CK0X?$_@CQ/IVLZ;<@FWU#2KV.X@EP<';)&2K<^AK.
MUGXO?";PYX@_X1+Q#\4/#MAJI9%&F7NMP17&Y\%!Y;.&RV1CCG(Q0!T5%9'C
M#Q_X$^'EA%JGC_QKI&AVLTPAAN=8U**VCDD()"*TC %L \#GBM6&:*XB6XMY
M5>-U#(Z-D,#R"".HH =1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M04444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M^)G[.>L_#^RL/$VFZUXA;Q%JEA<,9+"YCNDM[,VD\K2;Y8D1I9%A B9]H+$
M '.? W7KCXQ?\%*/CE<>*HUN;3X:>'M \.^&;>==R6\=_!)=WKA3P&D=(U9N
MK)&@/ Q4_P#P3(\6ZC/X,^)_P:N+AY-/^&7QEU[PUX;#L3Y.EQ2K);P9/:,2
MM&H_A144< "MQ?A3XV^!'[7WC7]H;P5X#U#Q-H7Q-\.Z;%K]AHTULMW9ZMIR
MO#!)MN)8D:&6"386#91XP6&UMR[7[%'[/NO_  "^&NN3>.7MSXH\<^-=4\6^
M*8[27S(K>\OI=_D(^!O$<:Q(6Z%E8C@B@#V*BBB@ JE?>(M$TV?[+?ZE'%(
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M^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\
M0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\
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M#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\
M0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'P
MQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ% %/\ X3'PQ_T&H/\
MOJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T
M&H/^^J/^$Q\,?]!J#_OJKG]G:?\ \^,/_?H4?V=I_P#SXP_]^A0!3_X3'PQ_
MT&H/^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']G:?_ ,^,/_?H4 4_^$Q\
M,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\ WZ%
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M_P!^A1_9VG_\^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\
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M8^&/^@U!_P!]5<_L[3_^?&'_ +]"C^SM/_Y\8?\ OT* *?\ PF/AC_H-0?\
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M'_OT* *?_"8^&/\ H-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\
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MZ% %/_A,?#'_ $&H/^^J/^$Q\,?]!J#_ +ZJY_9VG_\ /C#_ -^A1_9VG_\
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M@KQK/X;^$7P6U3QCIUK.8I-<N-873HI\'!>%##*[H>Q<1D^@KZ4_8F_X* _
M_P#;E\-7E]\.7NM-UO2E4ZQX:U7:+FW5N!*A4E98B<C>O(. RJ2 ?Y^J^I?^
M"-'CR'P'_P % ?",NH^*[72=/U2TU#3[^2]NEACN!):R&&#+$ LUPD&U>I8
M#G%?9X_A_ T\#*5)-2BKWNW>W=>?E8^$R[B7,*N80A6:<9-*UDK7[/?3SN?N
MG1117PY^@A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !117$_'G]HSX+?L
MS>"I/'_QM\?66AZ>N1 +A]TUVX&?+AB7+RO[*#@<G R:J$)U)*,5=LF<X4X.
M4W9+JSMJ^9?VUO\ @JC^SE^QS#<^&)-1'BOQI&I$?A71KA<V[]OM4W*VX_V<
M-)R"$P<U\E?%7_@HW^VK_P %&/&ES\"/V /AYJWA[0&/EZAKJ.([TPL2/,N+
MH'R[!".BHQD." [9V5[O^Q3_ ,$6O@K\ IK;XB?'Z>W\?^,@PFV741;2[&7K
MF.)^;AP<_O)1CH0B$9KV8Y?AL#'GQTM>D%N_5]$>%+,L7F$G3R^.G6I+9?X5
MU9\Y>'_@E_P47_X+$Z];>./C5XAD\"_"[SQ-I]L;9XK1X^S6MJ6#W;X/$\K;
M>6VOQLK]!OV4/V&OV=OV-O#G]D_!_P &H-2FA":EXDU';-J%[Z[Y<#:N0#Y:
M!4R,[<Y->O*JHH1%  &  . *6N7%YE6Q,/9Q7)36T5M\^YUX+*J&%G[6;<ZC
MWE+5_+LO0****\X]0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M47=/J@HHHJ2@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ K@?CGXJ^.FEP:?X5_9Y\%:)J.OZG
MYTC:GXJNIH=+TR"+9N>8P*TDDC-(BI$NW=\[%@(SGOJQ_'7CGP_\._#DOB7Q
M%-)Y:NL5O;6T9DGNYW.V."&,<R2NQ"JHZD^F30!XK^S3^UYX\\3:O\3/A?\
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M^ Q_QH^Q>-_^@W9?^ Q_QH V**Q_L7C?_H-V7_@,?\:/L7C?_H-V7_@,?\:
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M16/]B\;_ /0;LO\ P&/^-'V+QO\ ]!NR_P# 8_XT ;%%8_V+QO\ ]!NR_P#
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MDMOGV?D=6!S.CC&Z<ER5%O%[_+NO,[NBBBO//3"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BD=TC0R2.%51EF8X
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MD] D_P""A7[%7@TZ_P",_&1/ACXU:+*NI0G6))VDM+2<RQK+;% $B@8@ ")
M%PK,H!]P>,/'_@3X>6$6J>/_ !KI&AVLTPAAN=8U**VCDD()"*TC %L \#GB
MM6&:*XB6XMY5>-U#(Z-D,#R"".HKYB^!NO7'QB_X*4?'*X\51K<VGPT\/:!X
M=\,V\Z[DMX[^"2[O7"G@-(Z1JS=62- >!BI_^"9'BW49_!GQ/^#5Q</)I_PR
M^,NO>&O#8=B?)TN*59+>#)[1B5HU'\**BC@ 4 ?3%%%% !115*^\1:)IL_V6
M_P!2CBD !V,><4 7:*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJ@#2HK-_P"$
MQ\,?]!J#_OJC_A,?#'_0:@_[ZH TJ*S?^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\
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M)OVHO^">?BW5K_1+?,FI^'4S/=VMOG<T4D72_MA]/,3@X)4RC].?^$Q\,?\
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MPQ_T&H/^^J -*BLW_A,?#'_0:@_[ZILGC;PG"ADFUZW11U9GP!0!J45R]_\
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M7<<1>"O+QU_XEL(S_P!]-7T!_P )CX8_Z#4'_?5'_"8^&/\ H-0?]]4 >9?
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MA?$WP[IL6OV&C36RW=GJVG*\,$FVXEB1H98)-A8-E'C!8;6W+M?L4?L^Z_\
M +X:ZY-XY>W/BCQSXUU3Q;XICM)?,BM[R^EW^0CX&\1QK$A;H65B."*]BHH
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M_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:?_SXP_\
M?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_ 'Z%']G:
M?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9VG_\^,/_
M 'Z%']G:?_SXP_\ ?H5-10!#_9VG_P#/C#_WZ%']G:?_ ,^,/_?H5-10!#_9
MVG_\^,/_ 'Z%>;?M-_L?? 7]K?P&_@3XP^"X;A4#'3M6M%6*]TZ0C_602@$K
MT&5.4; W*V*]/HJZ=2=*:G!V:ZD5*5.M!PFKI[IGY'Z[X%_;B_X(I^/)/%/A
M.0>._A'?7H-RLL+&S<,0,3(-QL+DC $JY1SM!WXV#]!OV/?VV/V=OVU/!_\
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M=I__ #XP_P#?H4?V=I__ #XP_P#?H5-17,=9#_9VG_\ /C#_ -^A1_9VG_\
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MSVC5?+A*<JK\E9?-L^V_CK_P4!_8F_9U\ZT^(_QFT$ZC#D-HVCXO[P-_<:*
M,8S_ -=-H]Z^0OB9_P %WM4\;:T? _[&W[*M[K>I3DK97.O6S3S2'I\MC9[F
M;_OZ/<5Z;\"O^""_[)/PY\G4OBWK6M^/;^/!>*ZF-A8DCN(8&\SKV:5@?3KG
MZ]^&?P<^$_P8T4>'?A+\-]$\-V6!NM]%TR.W$A'=]@!=O=LD^M/VF387X8RJ
MOS]V/W;_ 'B]GGN+^.4:,>R]Z7WO3[C\TE_9C_X+1?MRMY_QC\>M\/?#EURV
MGW5VNF(8CU0VEF#+)C^[<8^M/^+'_!O-XET;X7PW_P '?CC'KWB^"0M>V>LV
M(LK.[C(^["RF1HW!SRY*MGJF.?U*N;JVLX6N;RXCBC7[TDKA5'U)KRCX]?M3
M>%/ASH;:?X+U>RU77+A2L"6TZRQVO;?(5)&1V3J>_%"SW&PDO9*,(KHDK?/J
M#X>P%2+]LY3D_M2D[_+I^!^6OP8_X(5?MH^-O&L&F?%G2-+\%Z&DP^W:I/K%
MM>RM%GYO)BMI'W/CH'*#U/:OU_\ A5\(_ OP:^&^B?"KP/HR0Z3H&FQ65BDJ
MAG*(H&YVQ\SL<LS=V)/>OEWX$_M3^*?A]XIF_P"$VU*YU/2=3N3+?^:Y>2"1
MCS,G]5Z$#C!%?5/B/XBZ'HGPZN?B7IS#4M/@L3=1FTD'[Y/]DGC\_2N?'YIB
MLQM[6UET6WZG3EV48/*[NC=M[MZOTZ&S_9VG_P#/C#_WZ%']G:?_ ,^,/_?H
M5\]7G_!0/3@=NF?"V>4GA?.U8)^@C:M/X<?M:>.O'_CG3/#I^%9M+&]NECGN
MPTLGE*<_-G8 .>YKSCU#W+^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0J:O&_C9J/[
M6">.I+#X.V6[23;1F.;R;3B0@[ANG]_YT >O?V=I_P#SXP_]^A1_9VG_ //C
M#_WZ%?.?_"&_MY:U_P ?WBK[)GK_ *=;1X_[\@U[+\%/#_Q"\,^!(M)^)VMC
M4-56XD9[D73390G*@LP!X]* .G_L[3_^?&'_ +]"JU[<^%]-S_:-Q86^.OG.
MB?SJC\3/!C?$+P)J?@Q-1^R-J%OY:W/E[_+.X$'&1GIZBO$[+_@GWH\>/[1^
M)]S+Z^3I:Q_SD:@#VRT\8_#*_P!2BT:Q\4Z%->3$B&TAOH6ED(!)"J#D\ G@
M=JU_[.T__GQA_P"_0KR3X<?LB_#;P#XRM/$^F^,=4NM0TR3S4@:>$+R"OSJ$
MW8Y/<5Z5X>^(/@+Q;J%SI/A7QOI&IW5F ;RVT_4HII( 3@%U1B5Y&.:5T0ZE
M-22;5WMYG*^/OV@/@M\-M>E\,>*;XQW\"*TEO%ICO@,H8?,%VG@CO7*7O[;'
MP(M<BWT+5KGT\G38@#_WW(*UM-B_9)_:'\<ZG/HFK:#XHUO3HT75%L=3:4P*
M"44.J/M'*D=.U9GP9\2_L2?&+Q%JOA3X1:9X>UC4-" .J0-H,G[C+%!\T\0#
M?,I'RDXQ2YX::[G.L?@92@E5C>=U'WE[S6Z6NMNMMNIZ%\+_ !MX8^*W@ZW\
M:Z'HS06]Q)(BQ74*!U*.5.=I(YQGKWKY9_:B^-6O>._%=SX,ATF72=*TNY,?
MV&6+RY9I%./,E'_H*] #GDFO=?V=?VI/V?OC=KVM_#SX*>;'+X:P=0MO[(-I
M$A9V3Y00,_,ISQZ5^57[=GQ6\._&W]K#QA\2/"EG>V]C>7-M!'#J,2I,K6]I
M#;/D*S #?"Q'/0C.#P.7$8R%&FIQUN^Y\KQ)QK@<BRVEC*"5=3DXI*5MD^9W
MM+9I)KS/LCX-?&SXH^ =_A/P-IT&J?;Y!]GT^ZLFN"DG<Q*I!!/<<COCO7MW
MPGU+]JW7?B#IUS\0/"45KX?W2?VA$;*UBP#&P4X)\SA]IP/3GC-?GA_P2R_Y
M/P\"?]Q3_P!-=W7Z"?L;_M?_ !'_ &DO'7B_PMXX^$!\-6_AXHMC<J9G6Z;S
M9(Y!O=%4XVJ0!ZFC#XR->*;5FVUWV5Q<-<:X7/Z$)5*;I3G.4(QNY7Y8QDVY
M<J2TEU^1[Y_9VG_\^,/_ 'Z%>,?%3]CM?BA\1+WQG)X].GVMUY6RQCT_S-A6
M-4."9 !DKGIWK*_8S^,?[7?Q-\9^+M/_ &E?A4/#^GV!C'AZXBT2:S2X(DD6
M3!F=B^5\L@],?6C]BZ#]NJ'Q7XND_:\F$VFR&$>%WW:>-H624/A+/D;E,9^?
MGY?7-;1K*7+9/6_3:W<]O#9Y2Q?L'3HU+57)7<+*'+_/K[JE]G>YH:5^P5\,
M+;#:OXHUNZ8=1')%$I_#83^M>K>"/A[X7^'_ (8MO"6@61-I:;_*^TD2/\SE
MSEB.>6->,_L5? _]K/X1^)/%NI?M'_&#_A)['5C -"@EU^ZO)+3RWER=LJ*D
M6Y77.PG)09Z"C]B7]C3QI^RKKOBS6O%/Q</B1?$WV;RX&MY ;;R6F*DR22,6
MXF(Z#I1&I4ER^[O>_E_PX8;,\PQ/L&\)**FY\_,TG3Y?A;7VN?I;;J>S6=_\
M-?'$5WI6GWNAZPEML-];0R0W BR24WJ,[<E"1G^Z<=*Q/A7\5?@!\4AJ-K\'
M/%?A_6ET@1?VB-#,<BP>9OV9*#!W>6^,9^Z:X7]CW]ASPE^QYJ'B34/"OCC4
M=5_X24P?:(+NWCCCA$+2E-H7G_EJPY-;7[-/[&WP=_91NM:O/A6=6\S7_*_M
M ZE?"4'RC(4"A54+CS'[=Z(RKOENDM[_ *!AL1GU7ZO*M1A!/G]HN;F<;?!R
MM:._VK[%KX#_ +3_ .S[^TPVM?\ "E==_MA= \C^T&.DRV^/.\SR]HF1"V?*
M?MVK$_9:_;'^#O[7B^(_^%6^%-6MF\-BV^U)K=E!"9C.)=FSRY)./W+ DXQD
M<5UGP7_9E^!G[/,NI3?!SP##HKZOY?\ :3QWD\QGV%RF3+(V,%WQC'WJV_ G
MPD^%?PN%S_PK7X;:%H!O2IO6T;28;9K@KDJ9#&H+XW-C=G&3ZT15?W>9KK>W
MX6##4^(']7EB9TTUS^U44[2O\'(Y:JWVK[GCO[%O[:^@_MF+XL31?A4- E\,
MBTV1W=^LYN?/$^,@1+LP8<'EOO=N\/[$/[2OQ=_:<T[Q9<?$WX(P^$9-)^RC
M16?3+B-+KS1-N^:8 /L,:9VXP'&>HKZ#L=.T_3(/LVFV,-O&.D<$01?R%341
MA57+S2O:]]-_^&#"Y?FT/J\L1BW-PY^>T%%5.;X;I?#R=+;[L^=OV)/&?[77
MQ,T?Q9)^U+\.H_#EQ&+8>&F_L9+8'>LPE(4EB=I6(_-_>[\T?L4>!_VRK3P_
MXMM_VP]0CDN[_P"SCP_+'<6CO;@I,)L?90%3!,1'Z=*^B:*(T;<MY-VO\[]_
MT##9+*C]7=3$5)NES[RTGS_SI+7E^SM;S/G;]BO]F']H3X0>&/%NC?M+_%:#
MQ;-KX@%A,NKW=\UJH2591ON44KG>A 7^Z?:OR K^@BBN:O@8UHQBI6M?SW/E
MN(/#ZAG.$PV'HUW3C1Y]9)S;YVGJW*.S3[[^1^=W_!$C2!K>B_%W3$=(Y9[7
M2(HIWBW^4S+J #8XS@X.,CI7T7^QS^Q+XD_95\%>+?#&H?$^+Q'<:]Y9TZZD
MLGA%H4CD5?E9WQRX/RGM7T-16U'#0I0BGJXWU]3VLDX5P>4X+#4JDO:3H*:C
M+6/\1MOW>9K9VUOM=6/G?]CG]F#X_P#P"\"^+M&^+GQ7B\5ZEJ@0^'YGU6ZN
M4M-L4@QFX4&/+N"=N<[03TI/V.OA)^UO\-/ 7BZR_:-\81>(M8GV'PRYU$7(
M3;%(,;W5=NYRGWO2OHFBKC0C'ELWI?KW._#Y#A,)[!4IS2I*22YFT^??FO\
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M&=5\8?"GQ1#J.GZ(<:K/+I,]N+<["_(FC7=\H)RN:V/!?P#^#?PX\-ZKX0\
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M,QS.K['GPCCSQDY>]%\C6T7WYNZVZGOG]G:?_P ^,/\ WZ%']G:?_P ^,/\
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MH?$W_"3?;O\ F+BR^S?9_L__ $PEW[O/]L;>^>/GW_A^/I__ $:7#_X68_\
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M-.^)/P\UE;_2-4B+VT_ELC JQ1XW1@&CD1U9&1@&5E92 0: -^BBB@ HHHH
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M=?39/VEQQ^[4^6,8)D!VC]";"PL=*L8=,TRRBMK:WB6*WMX(PB1(HPJJHX4
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MM?B*\CBMQYL\IC<O"S2?*HSMR  "*W/V</VR_B'\;OVI?&?P0U7X:6UEX?\
M#JZB^E^(H#,1?)!>QP1$%AL(='+Y4\XR.*%7@[>;L%+B#+ZOL_B7M)N$;Q:]
MZ._31=F]&5?V[?\ @F-\#?VV-+E\07%NGAOQQ%#ML?%=A;@M-@86.ZC&!<)T
M )(=<#:V,J?C?X/?ME_MC?\ !)OQ[:?LZ_MF>$[_ ,1^ ]WEZ-J<,IF>&W4@
M>987#X$T2@C-O(59,J!Y?1OMOX ?MN:S\:_VJ/&O[-]W\*/[+@\)?VB8M>.I
M,_VM;:]CME_=&)0N\2;\[SC'?.1SVC_'[X,_MZ?%_P >_L0_%3X"17NE^'/[
M0^TWU]?B5)FM+Q+021!45X)"9-ZNK;EY />O5P><TE25#$+GIMV2ZI_W7T_(
M\BMC<GQ56GB,%6Y*LY.$7RRM.4=XR5OQV\V>\?!CXW?"O]H3P%:?$SX.^-+/
M7-&O!\ES:O\ -$^ 3'(APT4@R,HX##(XYKJZ_$6TC^.7["_[4?CS4_V$-;\2
M:II'@V_NQXBT?4;,7$<EC:W1@=KF.)L3PJS+^]"HZ"0D;,,U?7VO_P#!8O3O
MBK^RWK6H_#FPO_!7Q'M=#LK^![E+2YLV9K^TBEBMS,29G,,SMM:'*JKG/R;J
MRQU/"T*2KT*G/3=TN]TKM-=_/85+C;*H82=3$RM*/-HOM.";DH7LF]-FUZGW
MY17X\_\ #TW]O#_HNO\ Y;&E_P#R-7W!_P $X/V[H/VE?#5I\*?'>H:IJ/C_
M $S2;O4=>U2;3;:WM9XA>[(PGDE?F$<T (\M1\K9)/)\BCCZ%>?*KI^9ADGB
M%D.>X]82DIPDUISJ*3>FBM*6O7;9/4^IJ*\,^#_[>/PX^+WQY\8_ B#PW?Z/
M<^"XKY]3U359X4MV%K=);2$$,=HW.#EL<#FO&_$/_!;CX%^!/&WB/0/'?P]U
M)=+T>[N+72M6\/ZA'J!UB:.;8GE)MC14= T@<RE< #G<*ZZ4E7G&-/5R=EYO
ML>Z^)<CC&$G75IR<5H]91W6VEO.R/M>F7%Q!:0/=74Z1Q1H6DDD8*JJ!DDD]
M *_-WX@_\%8_VSOB;=7/AG]G/X(:'X?FR^^X\1J\MS:1AMNX[W2(2 E04VR8
M.>N,U\Z>)_"?[67[7_C&;PY^T?\ M">+TM8"S7;W%JTFF;UD"L(;:,PP9R20
MP'(7H>W50AA:G*ZM513;6S;5M[I=/S.)\5X6LX+"4IU'.3BGRN,;K>[EMZVL
M?I/\=?\ @JK^PY\ O.L]>^-%IKNI0Y!TCPBO]HS%AU4O&?)1ATP\BFOE'QE_
MP7#_ &B?CEKDO@7]B#]E.[N[I_ECO-0M9M3N@IZ/]FM@$A(]6>1>.:/V%/\
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M>4JM(2N"2 &'*YST%=7??##X<ZCX.O/A[=>!]*_L+4%9;W28[%$MY@QRVY%
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M^$5U\!_#O@&*'PE>^9]KT>2\GE67>06R\DC/R0/XJM>'?V?/@OX3^&5S\&M
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M(J4W"'-=1<F]82BK7@EN^^QZ#1117KG[*%%%% !1110 4444 %%%% !1110
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M)6_![]G7XB?\+8U[Q-=>*=:M;AI=$BFM!;6.F'! >.'?([R $X:61P#AE56
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M%"]_[Z6C_A)=7_Z%"]_[Z6MBB@#'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
MOI:V** .4\16FF^+OLO_  DWPR>^^PW*W%I]H5&\J0=&'^'0UI_\)+J__0H7
MO_?2UL44 8__  DNK_\ 0H7O_?2T?\)+J_\ T*%[_P!]+6Q10!C_ /"2ZO\
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M@#'_ .$EU?\ Z%"]_P"^EH_X275_^A0O?^^EK8HH Q_^$EU?_H4+W_OI:/\
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M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\
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M^$EU?_H4+W_OI:V** ,?_A)=7_Z%"]_[Z6C_ (275_\ H4+W_OI:V** ,?\
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M%"]_[Z6MBB@#'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6MBB@#'_ .$EU?\
MZ%"]_P"^EH_X275_^A0O?^^EK8HH R[/7M2N;I()O#-U"K-AI79<+[FM2BB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &SS);
MPO<2YVHI9MJDG &>@Y/T%?"_P.^,7AO]J_\ :<EC\1?M@_%KX?\ BM=::]M?
M@WJ%F='M;G3K>4^5%&LT.^7S((E>8*X?<\I4*JY'VYXF\1Z/X/\ #FH>+?$5
MV8-/TNQEO+Z=8GD,<,2%W;:@+-A5)PH)/0 FOF?XY^(_V>_VY]/^'-_^SMX[
MT;Q3XHT7Q]H^N:1K6@SK+/H5G#=1RWDER5^>U1[=)(_*EV>9*8UVDC@ W+'Q
M]K?[27[:OQ ^ P\5:SI7A/X5>'M*6_AT#5IK";4-7U)'G21[B!ED\N&",*(@
MP4N[%P^%"[G["/QS\6?&/X=>)_#'Q$U$7WB3X<?$#5O!VMZIY2QG4GLI0([L
MHH"JTD+QEMH WAR !@#BO %OH_[,G_!07XQ^*?B?KEEHOA_XJZ!H>M>']:U2
MZ2WM3-IT$MK>6IED(7S5#QS;,Y\MBPR%;&M_P39^'/B+PWX"^(/Q:\3:5<6+
M?%+XL:YXLTNSO(6CFBTZXE5;7>C %2\<?F 'G;(N<'B@#Z-HHHH ***SM2\,
MZ?JMT;NXGN58J!B*X*CCV% &C16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U
M &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _-[_X
M%M1_P@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%
M%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\
M(/I'_/S>_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\
M\(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D
M?\_-[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^
MD?\ /S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>
M_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S
M>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%
MM0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\ /S>_
M^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U &
MQ16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'
M_"#Z1_S\WO\ X%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M0!L45C_
M /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\ /S>_^!;4?\(/
MI'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U &Q16/_P (
M/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\
MWO\ X%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M0!L45C_ /"#Z1_S
M\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^
M!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U &Q16/_P (/I'_ #\W
MO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0
M!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_ (%M
M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;4 ;%%8
M_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U &Q16/_P (/I'_ #\WO_@6U'_"
M#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\ X%M0!L45C_\
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M[_X%M0!L45C_ /"#Z1_S\WO_ (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\
M/S>_^!;4?\(/I'_/S>_^!;4 ;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@
M6U &Q16/_P (/I'_ #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\
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M #\WO_@6U'_"#Z1_S\WO_@6U &Q16/\ \(/I'_/S>_\ @6U'_"#Z1_S\WO\
MX%M0!L45C_\ "#Z1_P _-[_X%M1_P@^D?\_-[_X%M0!L45C_ /"#Z1_S\WO_
M (%M1_P@^D?\_-[_ .!;4 ;%%8__  @^D?\ /S>_^!;4?\(/I'_/S>_^!;4
M;%%8_P#P@^D?\_-[_P"!;4?\(/I'_/S>_P#@6U &Q1679^$M-L;I+N&XNBT;
M94/<L1^(K4H **** "BBB@ HHHH *ALK"PTV(P:=90P(7+%(8PH+'J<#N?6I
MJ* ([FTM;Q!%=VT<JJX95D0, P.0>>X/>I*** "BBB@ HHHH **** "BJFE:
M_H6NO=QZ)K=I>-87;6M\MK<K(;>=55C%)M)V.%=25." P..15'5_B)\/_#_B
M6R\&:]XZT:RUC4AG3M*N]3BBN;KG'[N)F#/R"/E!Z4 ;-%0:GJ>GZ+IMQK&K
MWL5M:6D#S75S.X5(HU!9G8G@  $DGH!5:\\5^&-.T^SU;4O$-E:VVH3P06,]
MU<K&MQ+,0L,:%B-SNS *HY8D  F@#0HHKF=<^-/P?\+^&K7QEXI^*?AW2](O
M9C%9ZGJ>LP6\$[ABI5))&56.01@'M0!TU%16-]9:I90ZEIMY%<6]Q$LD%Q!(
M'21&&0RL.""#D$=:R_"GQ%^'WCN:\MO _CK1M9DTZ7RM0CTK4XKAK63D;)!&
MQV-P>#@\'TH V:*J:AK^A:3?V6EZIK=I;76I3-%IUM<7*I)=2*C.R1J3EV"*
MS$+D@*3T%,\1^)_#7@[1YO$7B[Q#8Z5I]N ;B^U*[2"&+) &YW(5<D@<GJ:
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MEM.%ROGB'=M\WR\[MF[C=C&>*MT %%%% !1110 4444 %%%% !1110 4444
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MYXQ0!\J?&#XS_""S_P"".?@+XI?#+QKI5OX[\%0^'[[0 EZG]HQ>(H[NWBU
M,A/F/)(9+LR@C+K(S-D&OT9M9)9K:.:>$QNR O&3G:2.1^%?._CC]F0?M)_%
MS1=:\3_"BQ\(^!M UV+7=3M9+2V34_&&J0DFV^T>06V6<3'S"LK&25\!HT"
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M!7 .R-> #7.?\$Q?#^A^%;?X]^'?#6DV]A86?[1_B*.TLK2$1Q01BWL<(B*
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MIY-7N[NWGN9Y'^](9DNYXGR?F20J<CBO>OA'9_%OXL^"=:_9]^*W[',GPO\
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M33L/ ,G[!?P_\/\ @WX@Q>,-)BT.2WFU!D?:7:60RVI24!PL+,T 5P#LC7@
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MJ/AFRU&V@DN-4O)FN)+87$[K$J1O+Y0=FXCA&T-A5(!XM\<OV4/A'X2_:C^
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M'%(OFQD\ [\<9KVBPT+3_C#\;/&E_K'FOI/A_14\)6ODSM$QFN4CO-1*.A#
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MV%!RY0 Y;]O#]CW]G(?LI>/-2N?A9I^I^.=9$DVA>(S91MK5[XBN)0MD([D
M2\W#Q1K&K!%B&P (N!Z7\=/AZVH?L)>(?!/Q?AM?$.H6'PPN4U6XO81,L]]#
MISAK@;A][S 7#=0<$8->=:[\4/VUK_XP77C;5O\ @G5KVMZ?HES)'X(MF^(^
M@6Z6R%"CWLB&Y;-U(I90V3Y43%$Y>5I/6OB8/BYXX_9*URQU/X8.?&/B'P9=
MV\GA;2M3MG^R7=S;.JV_VB:6.)_+9PC2A@K%2RC! H I_L#?\F._"#_LFFB?
M^D,->MUYA^Q=X5\;^ /V4_A_\.?B-X-NM"UOPUX2T_2=2L+JZMICYUO;1Q.Z
MO;2R(R%E.#N!QU KT^@ HHHH ;+%'/$T$R!D=2KJ>A!ZBOF#_@GUX:\/^$/C
M=^TAX?\ "VBVNG6$'Q81H+.R@6**/?I]N[;54 +EF8\=S7U [%4+*A8@9"C&
M3[<U\^_L>> ?BYX*^-OQK\2?$/X2:GH.F^,_'":OX?OKO4M/F6>W6TA@PRVU
MS*Z.6C+890,$<YXH P_VWOV2/V9)/V8_B9XH\8?"W3M7\4:S9WEU8^(9[!)=
M8GUF8E-/AM[C;YH(G>"WAB4[0NU,$%L]EXBTWXA>%/V/_"/P5\7>(9KGQIXB
MT32/".H:DDY:9[N:W2*_ND?^)XX$N[G/?R<UQ'C3XE_MG:C\:;CQ)>?\$]==
M\0:%X>O&'@J'_A8F@VR;]I1M0EC:Y8F=@S+&#_JD9OXG8CT[P3IWQ;^(_C_P
MEXY^,'P^B\.'0?#-Q?2:1%J,=W';ZK>R-$L(E0XDEM;2.6-Y% 1S?$ID#@ X
MO]N;P1^S+\/_ ( ^+_'GQ-^ W_"4O+X9?3K1+;PK+J4MI%' 4AC1TC?[!!&3
MYADRBJQ9P2Y&>P_8RTKX?ZG^QG\/_#OAKQS!XX\/KX.M+*/6IX28]12.,1.&
MCD&54,K(8G&5"[&Y!K1\1?&;XJZ-\2-5\"6O[*WBK5M-AMXGT?Q-INJZ7]BO
MRT8+K(L]U');[')7E&+!20#E0:_[)WP+E_9:_9PTGX5QVT=Y=Z>;V]N;32B!
M$+BZNIKI[>W,I0>6C3&-"VS*HI.W)P >:?\ !*+2-+\/_L\^)]!T2PBM;*Q^
M+/B>WL[6! J0Q)J#JB*!P %   Z 5W4/@+1?VAO&_P 0[_Q/).VA@VOA*V2W
MF*"YMK9Q<ZBH8<A)YIFLY0""19D#'6N4_87\&_&CX(_ [QQIWQ$^"VJ:=JS^
M-?$&OZ1IDFIV$[:C%<W#W$$2-;W$BI(<A"'V@$]2.:[VST[XH? +]F*"R\!_
M#B7QSXTLM-,TVD6FI6UFNIZM<.9KJ9IKF1$CC:XEEE8Y+8)VAC@$ \?\9_LQ
M_#+P9_P4"^#VN?LU^ -)\)ZAI.C:Q<^/E\,:?'9V\NBF 06T=S'$JH[/=$"+
M(W$0RL,^2-KOV-;;3?VF_'G[2OC/XHZ;'J4=Y\2M0\ );W2!A'HVGP)$MN@/
MW$=KB61@.KN6/-:7P&\<_ME:9XCM=,\5_L+7VEWOB/5X)?&GCW6OB!H\Z*@P
M'9;>UF>78D8,<,"Y"94LS$R.U_P/\,OBS^RQ\1_BY+\,_AE=^*-(^(VO/XI\
M--8WMK$MEK,\ CNX+OSY4*1-)'',LJ!_D9U(WJH< Y;_ ()[:%H/[7_[%GPX
MU_\ :+TZ+Q=-X1FU+319ZY"MS:7D]M<O;07DT4@(EF2"/:K/G!ED;[Q!&S^Q
M1\%M!^%_[4?QVU;X.Z5%H_PXO-6TNTTW1[!-E@-9@MF_M)[:,?+&JM)%$^P;
M?,1TX\K:,_1?A7^TA^Q;^R%X%_9I_9Q^#FI>.]4CAD'BWQ%I/B#3M/-F\LK3
MW4D!OI4+2O)*ZQ,498U =@2HC;T?]F#Q9\=KRY7P+XQ_8\/PM\*:-I&VP>\\
M8V.J37=P9%PBK:2.5 7S'>24EG9U/)W&@#@OAMX5\->%_P#@K9X^?PYH-I8G
M4O@QI=YJ!M+=8_M%PVI3HTK[1\SE40%CR=HKZCKYZ\,> OB[;?\ !2#Q'\:+
M[X1:I!X0U'X:V?A^TU]]2TXHUU!>S3LQB6Z,XC*2#!,><@Y45]"T %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 45Q?
M_#2'[.__ $7KP7_X5-I_\<KIO#WB?PUXNTU=9\*>(;'4[-R0MUIUVD\9/H&0
MD4 7J*S='\8^$?$.J7^AZ!XJTV^O=*D$>IV=G?1RRV;G.%E123&3M;A@/NGT
MI_B7Q5X7\&:4VN^,/$EAI-BCJKWFI7B01*S' !=R "3P.>: +]%<[XI^+_PE
M\#:F-%\:_%'P[H]X8A(+35-;@MY2A) ;;(X.#@\XQP:S?^&D/V=_^B]>"_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV2?'UM\*M.\)V'Q*EL;];YKN]032>3"63'E1["/J3T)H ]_HKYN_X8T^+_\
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M^&R^/H=5^%MQJL5W\-=*NKZ:>^T9'0FXMW+IM$6\@(%=ON%SAI&K=^-_PM^
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M07L7E:EJNA:U=Z=)?I@#;/\ 9I467@ ;F!;  S@5[G10!R?P=^!?PB_9_P#
M$'PN^#G@'3] T& LRZ?9QDB1V #/(SDM*Y  +N68@ $\"O(]$_X)3?L&>'?B
M$/B1I7P'MDN$U 7\>EMJEVVFI<@Y$HLFE,''92FP=E&!7T110!\6?\%+OV6-
M&^'O_!,B]_9X_9<^%&J36%CKUC+IOAW1H[O4IU#ZA]HF8;C+*XW.[G)(4'L
M /4=$_X);?L,:!\0X/B18? Z!KFSOS>V&EW&J74NF6EP6W&2*R>4P)SR%";0
M>@&!CZ"HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
E** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024820012392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COVER PAGE - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Feb. 22, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">THE PENNANT GROUP, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">83-3349931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1675 East Riverside Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Eagle<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">ID<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">83616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(208)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">506-6100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">PNTG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,529,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,143,039<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Part&#160;III of this Form&#160;10-K incorporates information by reference from the Registrant's definitive proxy statement on Schedule 14A for the Registrant's 2022 Annual Meeting of Stockholders to be filed within 120&#160;days after the close of the fiscal year covered by this annual report.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001766400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024819925640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>AUDIT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">DELOITTE & TOUCHE LLP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boise, Idaho<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024818272408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 5,190<span></span>
</td>
<td class="nump">$ 43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable&#8212;less allowance for doubtful accounts of $902 and $643, respectively</a></td>
<td class="nump">53,940<span></span>
</td>
<td class="nump">47,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">16,711<span></span>
</td>
<td class="nump">12,335<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">75,841<span></span>
</td>
<td class="nump">59,599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">16,788<span></span>
</td>
<td class="nump">17,884<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">300,997<span></span>
</td>
<td class="nump">308,650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow deposits</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">3,848<span></span>
</td>
<td class="nump">2,097<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherRestrictedAssetsNoncurrent', window );">Restricted and other assets</a></td>
<td class="nump">4,828<span></span>
</td>
<td class="nump">4,289<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">74,265<span></span>
</td>
<td class="nump">66,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Other indefinite-lived intangibles</a></td>
<td class="nump">53,730<span></span>
</td>
<td class="nump">47,488<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">530,297<span></span>
</td>
<td class="nump">506,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">10,553<span></span>
</td>
<td class="nump">9,761<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued wages and related liabilities</a></td>
<td class="nump">23,480<span></span>
</td>
<td class="nump">26,873<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities&#8212;current</a></td>
<td class="nump">16,118<span></span>
</td>
<td class="nump">14,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">21,484<span></span>
</td>
<td class="nump">38,275<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">71,635<span></span>
</td>
<td class="nump">89,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities&#8212;long-term</a></td>
<td class="nump">287,753<span></span>
</td>
<td class="nump">296,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">5,293<span></span>
</td>
<td class="nump">11,897<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="nump">51,372<span></span>
</td>
<td class="nump">8,277<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">416,053<span></span>
</td>
<td class="nump">405,804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.001 par value; 100,000 shares authorized; 28,826 and 28,499 shares issued and outstanding at December&#160;31, 2021, respectively, and 28,696 and 28,243 shares issued and outstanding at December 31, 2020, respectively</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">95,595<span></span>
</td>
<td class="nump">84,671<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">14,641<span></span>
</td>
<td class="nump">11,945<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost, 3 shares at December 31, 2021 and 2020</a></td>
<td class="num">(65)<span></span>
</td>
<td class="num">(65)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NetParentInvestment', window );">Total Pennant Group, Inc. stockholders' equity</a></td>
<td class="nump">110,199<span></span>
</td>
<td class="nump">96,579<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterest', window );">Noncontrolling interest</a></td>
<td class="nump">4,045<span></span>
</td>
<td class="nump">4,593<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total equity</a></td>
<td class="nump">114,244<span></span>
</td>
<td class="nump">101,172<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and equity</a></td>
<td class="nump">$ 530,297<span></span>
</td>
<td class="nump">$ 506,976<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NetParentInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net Parent Investment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NetParentInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherRestrictedAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets that are pledged or subject to withdrawal restrictions, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherRestrictedAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024819937016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 902<span></span>
</td>
<td class="nump">$ 643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in shares)</a></td>
<td class="nump">100,000,000<span></span>
</td>
<td class="nump">100,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">28,826,000<span></span>
</td>
<td class="nump">28,696,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">28,499,000<span></span>
</td>
<td class="nump">28,243,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024818163928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED AND COMBINED STATEMENTS OF INCOME - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 439,694<span></span>
</td>
<td class="nump">$ 390,953<span></span>
</td>
<td class="nump">$ 338,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpensesAbstract', window );"><strong>Expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization', window );">Cost of services</a></td>
<td class="nump">353,093<span></span>
</td>
<td class="nump">296,874<span></span>
</td>
<td class="nump">258,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rent&#8212;cost of services</a></td>
<td class="nump">40,863<span></span>
</td>
<td class="nump">39,191<span></span>
</td>
<td class="nump">34,975<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty', window );">General and administrative expense</a></td>
<td class="nump">36,259<span></span>
</td>
<td class="nump">31,296<span></span>
</td>
<td class="nump">35,135<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,784<span></span>
</td>
<td class="nump">4,675<span></span>
</td>
<td class="nump">3,810<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostsAndExpenses', window );">Total expenses</a></td>
<td class="nump">434,999<span></span>
</td>
<td class="nump">372,036<span></span>
</td>
<td class="nump">332,861<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">4,695<span></span>
</td>
<td class="nump">18,917<span></span>
</td>
<td class="nump">5,670<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpenseAbstract', window );"><strong>Other income (expense):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other (expense) income</a></td>
<td class="num">(24)<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense, net</a></td>
<td class="num">(1,941)<span></span>
</td>
<td class="num">(1,239)<span></span>
</td>
<td class="num">(410)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Other income (expense), net</a></td>
<td class="num">(1,965)<span></span>
</td>
<td class="num">(1,014)<span></span>
</td>
<td class="num">(410)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before provision for income taxes</a></td>
<td class="nump">2,730<span></span>
</td>
<td class="nump">17,903<span></span>
</td>
<td class="nump">5,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">582<span></span>
</td>
<td class="nump">2,350<span></span>
</td>
<td class="nump">2,085<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">2,148<span></span>
</td>
<td class="nump">15,553<span></span>
</td>
<td class="nump">3,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Less: net (loss)/ income attributable to noncontrolling interest</a></td>
<td class="num">(548)<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income and other comprehensive income attributable to The Pennant Group, Inc.</a></td>
<td class="nump">$ 2,696<span></span>
</td>
<td class="nump">$ 15,744<span></span>
</td>
<td class="nump">$ 2,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings per common share (Note 4):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in dollars per share)</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in dollars per share)</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">28,406<span></span>
</td>
<td class="nump">28,029<span></span>
</td>
<td class="nump">27,838<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">30,642<span></span>
</td>
<td class="nump">30,228<span></span>
</td>
<td class="nump">29,586<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total costs of sales and operating expenses for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123384075&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024819823624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS' EQUITY AND NET PARENT INVESTMENT - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Retained Earnings/ (Accumulated Deficit)</div></th>
<th class="th"><div>Treasury Stock</div></th>
<th class="th"><div>Net Parent Investment</div></th>
<th class="th"><div>Non-Controlling Interest</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, beginning balance at Dec. 31, 2018</a></td>
<td class="nump">$ 65,288<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 55,856<span></span>
</td>
<td class="nump">$ 9,432<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance', window );">Noncontrolling interest attributable to subsidiary equity plan</a></td>
<td class="nump">594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,991)<span></span>
</td>
<td class="nump">3,585<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestDecreaseFromRedemptions', window );">Share repurchase related to subsidiary equity plan</a></td>
<td class="num">(394)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(394)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interest</a></td>
<td class="nump">629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_StockholdersEquityDistributionsFromParent', window );">Net transfer from parent</a></td>
<td class="nump">11,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income/ (loss) attributable to The Pennant Group, Inc.</a></td>
<td class="nump">2,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,799)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,345<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCash', window );">Cash Dividend to Parent</a></td>
<td class="num">(11,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,600)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_ReclassificationOfInvestedEquity', window );">Reclassification of Invested Equity</a></td>
<td class="nump">137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,893<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59,504)<span></span>
</td>
<td class="num">(13,252)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Common Stock after spin-off</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="num">(28)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock after spin-off (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27,834<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based Compensation after spin-off</a></td>
<td class="nump">1,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,987<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options / issuance of other awards after spin-off</a></td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options / issuance of other awards after spin-off (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">601<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Dec. 31, 2019</a></td>
<td class="nump">71,111<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">74,882<span></span>
</td>
<td class="num">(3,799)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interest</a></td>
<td class="num">(191)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(191)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income/ (loss) attributable to The Pennant Group, Inc.</a></td>
<td class="nump">15,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,744<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based Compensation after spin-off</a></td>
<td class="nump">8,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options / issuance of other awards after spin-off</a></td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options / issuance of other awards after spin-off (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">238<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination', window );">Noncontrolling interests assumed related to acquisitions</a></td>
<td class="nump">4,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,646<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of noncontrolling interests, net of tax</a></td>
<td class="nump">451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">138<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures', window );">Issuance/ (cancellation) of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares of common stock withheld to satisfy tax withholding obligations</a></td>
<td class="num">(65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (65)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares of common stock withheld to satisfy tax withholding obligations (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Dec. 31, 2020</a></td>
<td class="nump">101,172<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">84,671<span></span>
</td>
<td class="nump">11,945<span></span>
</td>
<td class="num">$ (65)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4,593<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Net income attributable to noncontrolling interest</a></td>
<td class="num">(548)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(548)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income/ (loss) attributable to The Pennant Group, Inc.</a></td>
<td class="nump">2,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,696<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based Compensation after spin-off</a></td>
<td class="nump">10,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,040<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options / issuance of other awards after spin-off</a></td>
<td class="nump">884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from the exercise of stock options / issuance of other awards after spin-off (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Net issuance of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Equity, ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28,826<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Equity, ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 114,244<span></span>
</td>
<td class="nump">$ 28<span></span>
</td>
<td class="nump">$ 95,595<span></span>
</td>
<td class="nump">$ 14,641<span></span>
</td>
<td class="num">$ (65)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,045<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_ReclassificationOfInvestedEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reclassification Of Invested Equity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_ReclassificationOfInvestedEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_StockholdersEquityDistributionsFromParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stockholders' Equity, Distributions From Parent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_StockholdersEquityDistributionsFromParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestDecreaseFromRedemptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4616395-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestDecreaseFromRedemptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 24: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4568447-111683<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024817274696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 2,148<span></span>
</td>
<td class="nump">$ 15,553<span></span>
</td>
<td class="nump">$ 3,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash (used in) provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">4,784<span></span>
</td>
<td class="nump">4,675<span></span>
</td>
<td class="nump">3,810<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing fees</a></td>
<td class="nump">488<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="nump">858<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">10,040<span></span>
</td>
<td class="nump">8,335<span></span>
</td>
<td class="nump">3,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAndTaxCredits', window );">Deferred income taxes</a></td>
<td class="num">(1,752)<span></span>
</td>
<td class="num">(2,201)<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">2,835<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(7,335)<span></span>
</td>
<td class="num">(15,712)<span></span>
</td>
<td class="num">(8,571)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(4,624)<span></span>
</td>
<td class="num">(7,435)<span></span>
</td>
<td class="num">(2,746)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease obligations</a></td>
<td class="nump">803<span></span>
</td>
<td class="nump">2,068<span></span>
</td>
<td class="num">(1,861)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">562<span></span>
</td>
<td class="nump">993<span></span>
</td>
<td class="nump">4,069<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued wages and related liabilities</a></td>
<td class="num">(3,864)<span></span>
</td>
<td class="nump">10,538<span></span>
</td>
<td class="nump">3,376<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities', window );">Other accrued liabilities</a></td>
<td class="nump">2,570<span></span>
</td>
<td class="nump">2,427<span></span>
</td>
<td class="nump">1,720<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability', window );">Advance payments</a></td>
<td class="num">(21,786)<span></span>
</td>
<td class="nump">27,997<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities', window );">Other long-term liabilities</a></td>
<td class="num">(3,708)<span></span>
</td>
<td class="nump">2,076<span></span>
</td>
<td class="nump">2,185<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash (used in) provided by operating activities</a></td>
<td class="num">(18,223)<span></span>
</td>
<td class="nump">50,204<span></span>
</td>
<td class="nump">9,554<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property and equipment</a></td>
<td class="num">(6,303)<span></span>
</td>
<td class="num">(7,253)<span></span>
</td>
<td class="num">(6,714)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesGross', window );">Cash payments for business acquisitions</a></td>
<td class="num">(13,550)<span></span>
</td>
<td class="num">(33,193)<span></span>
</td>
<td class="num">(18,760)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_PaymentsForDepositsOnAcquisition', window );">Escrow deposits</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(525)<span></span>
</td>
<td class="num">(1,400)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_PaymentsForProceedsFromPropertyReserveRequirements', window );">Restricted and other assets</a></td>
<td class="num">(267)<span></span>
</td>
<td class="num">(645)<span></span>
</td>
<td class="nump">409<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(20,120)<span></span>
</td>
<td class="num">(41,616)<span></span>
</td>
<td class="num">(26,465)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_ProceedsFromSaleOfSubsidiaryShares', window );">Proceeds from sale of subsidiary shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,293<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToMinorityShareholders', window );">Repurchase of subsidiary shares</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(2,687)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_DistributionToFromParent', window );">Net investment from parent</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">10,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividends', window );">Cash distribution to parent in connection with Spin-Off</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(11,600)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromMinorityShareholders', window );">Sale of noncontrolling interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">555<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLongTermLinesOfCredit', window );">Proceeds from revolver agreement</a></td>
<td class="nump">125,500<span></span>
</td>
<td class="nump">52,700<span></span>
</td>
<td class="nump">42,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermLinesOfCredit', window );">Payments on revolver agreement</a></td>
<td class="num">(81,500)<span></span>
</td>
<td class="num">(63,200)<span></span>
</td>
<td class="num">(22,500)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of shares of common stock to satisfy tax withholding obligations</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(65)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfFinancingCosts', window );">Payments for deferred financing costs</a></td>
<td class="num">(1,394)<span></span>
</td>
<td class="num">(78)<span></span>
</td>
<td class="num">(1,552)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Issuance of common stock upon the exercise of options</a></td>
<td class="nump">884<span></span>
</td>
<td class="nump">1,141<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="nump">43,490<span></span>
</td>
<td class="num">(8,947)<span></span>
</td>
<td class="nump">17,272<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash</a></td>
<td class="nump">5,147<span></span>
</td>
<td class="num">(359)<span></span>
</td>
<td class="nump">361<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash beginning of period</a></td>
<td class="nump">43<span></span>
</td>
<td class="nump">402<span></span>
</td>
<td class="nump">41<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash end of period</a></td>
<td class="nump">5,190<span></span>
</td>
<td class="nump">43<span></span>
</td>
<td class="nump">402<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Cash paid during the period for:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest</a></td>
<td class="nump">1,448<span></span>
</td>
<td class="nump">1,116<span></span>
</td>
<td class="nump">156<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes</a></td>
<td class="nump">2,616<span></span>
</td>
<td class="nump">7,865<span></span>
</td>
<td class="nump">120<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease liabilities</a></td>
<td class="nump">39,151<span></span>
</td>
<td class="nump">35,853<span></span>
</td>
<td class="nump">37,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for new operating lease obligations</a></td>
<td class="nump">3,230<span></span>
</td>
<td class="nump">5,451<span></span>
</td>
<td class="nump">9,059<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability', window );">Net non-cash adjustment to right-of-use assets and lease liabilities from lease modifications</a></td>
<td class="nump">4,674<span></span>
</td>
<td class="nump">1,939<span></span>
</td>
<td class="nump">77,462<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Non-cash investing activity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Capital expenditures in accounts payable</a></td>
<td class="nump">$ 730<span></span>
</td>
<td class="nump">$ 560<span></span>
</td>
<td class="nump">$ 946<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment Operating Lease Right-of-Use Asset And Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_DistributionToFromParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Distribution (To) From Parent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_DistributionToFromParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_PaymentsForDepositsOnAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For Deposits On Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_PaymentsForDepositsOnAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_PaymentsForProceedsFromPropertyReserveRequirements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments For (Proceeds From) Property Reserve Requirements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_PaymentsForProceedsFromPropertyReserveRequirements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_ProceedsFromSaleOfSubsidiaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Proceeds From Sale Of Subsidiary Shares</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_ProceedsFromSaleOfSubsidiaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAndTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) and income tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAndTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 310<br> -Section 45<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123371682&amp;loc=d3e55415-109406<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in other expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for loan and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMinorityShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMinorityShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821563432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">DESCRIPTION OF BUSINESS</a></td>
<td class="text">DESCRIPTION OF BUSINESS<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Pennant Group, Inc. (herein referred to as &#8220;Pennant,&#8221; the &#8220;Company,&#8221; &#8220;it,&#8221; or &#8220;its&#8221;), is a holding company with no direct operating assets, employees or revenue. The Company, through its independent operating subsidiaries, provides healthcare services across the post-acute care continuum. As of December&#160;31, 2021, the Company&#8217;s subsidiaries operated 88 home health, hospice and home care agencies and 54 senior living communities located in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;1, 2019, The Ensign Group, Inc. (NASDAQ: ENSG) (&#8220;Ensign&#8221; or the &#8220;Parent&#8221;) completed the separation of Pennant from Ensign through a tax-free distribution of substantially all of Pennant&#8217;s issued and outstanding common stock to the stockholders of Ensign (the &#8220;Spin-Off&#8221;). To accomplish the Spin-Off, Ensign contributed the Company&#8217;s assets and liabilities into Pennant and each Ensign stockholder received a distribution of one share of Pennant common stock for every two shares of Ensign&#8217;s common stock, plus cash in lieu of fractional shares. Additionally, the noncontrolling interest was converted into shares of Pennant at the established conversion ratio. As a result of the Spin-Off on October&#160;1, 2019, Pennant began trading as an independent company on the NASDAQ under the symbol &#8220;PNTG.&#8221;</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s subsidiaries, collectively referred to as the Service Center, provide accounting, payroll, human resources, information technology, legal, risk management, and other services to the operations through contractual relationships.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of the Company&#8217;s affiliated operations are operated by separate, independent subsidiaries that have their own management, employees and assets. References herein to the consolidated &#8220;Company&#8221; and &#8220;its&#8221; assets and activities is not meant to imply, nor should it be construed as meaning, that Pennant has direct operating assets, employees or revenue, or that any of the subsidiaries, are operated by Pennant.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024823832152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock', window );">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Basis of Presentation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated and combined financial statements of the Company (the &#8220;Financial Statements&#8221;) reflect the Company&#8217;s financial position for the years ended December 31, 2021 and 2020, and the Company&#8217;s results of operations and cash flows for the years ended December 31, 2021, 2020 and 2019 and have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and pursuant to the regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Prior to the Spin-Off, the combined financial statements were prepared on a stand-alone basis and derived from the consolidated financial statements and accounting records of Ensign. Management believes that the Financial Statements reflect, in all material respects, all adjustments which are of a normal and recurring nature necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows for the periods presented in conformity with GAAP applicable to the annual period. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intercompany transactions and balances between the various legal entities comprising the Company have been eliminated in consolidation. The consolidated and combined statements of income reflect income that is attributable to the Company and the noncontrolling interest. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company consists of various limited liability companies and corporations established to operate home health, hospice, home care, and senior living operations. The Financial Statements include the accounts of all entities controlled by the Company through its ownership of a majority voting interest. Revenue was derived from transactional information specific to the Company&#8217;s services provided. The costs in the consolidated and combined statements of income reflect direct costs and allocated costs prior to the Spin-Off. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimates and Assumptions -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Financial Statements relate to self-insurance reserves, revenue, cost allocations from prior to the Spin-Off, intangible assets and goodwill, right-of-use assets and lease liabilities for leases greater than 12 months, and income taxes. Actual results could differ from those estimates.</span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue Recognition -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenues are recognized when services are provided to the patients at the amount that reflects the consideration to which the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rate, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration which is included in the transaction price may be constrained, and is included in the net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#8217;s estimates, the Company adjusts these estimates, which would effect net service revenue in the period such variances become known. </span></div><div style="text-align:justify;text-indent:40.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the Company&#8217;s contracts have an original duration of one year or less, the Company uses the practical expedient applicable to its contracts and does not consider the time value of money. Further, because of the short duration of these contracts, the Company has not disclosed the transaction price for the remaining performance obligations as of the end of each reporting period or when the Company expects to recognize this revenue. In addition, the Company has applied the practical expedient provided by ASC 340, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Assets and Deferred Costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 340&#8221;), and all incremental customer contract acquisition costs are expensed as they are incurred because the amortization period would have been one year or less. See Note 5</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, Revenue and Accounts Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="text-align:justify;text-indent:40.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CARES Act</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: The Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) was enacted on March 27, 2020 in the United States. During the second quarter of 2020 the Company applied for and received $27,997 in funds under the Accelerated and Advance Payment (&#8220;AAP&#8221;) Program. For the year ended December 31, 2021, the Company repaid $21,786 of the AAP funds, with the remaining balance of $6,211 recorded in other accrued liabilities on the consolidated balance sheets. The CARES Act allowed for deferred payment of the employer-paid portion of social security taxes through the end of 2020, with approximately 50% due on December 31, 2021 and the remainder due on December 31, 2022. The Company deferred approximately $7,836 of employer-paid portion of social security tax. In the fourth quarter of the current year, we repaid $3,707 and approximately $4,129 of the balance remains deferred and is recorded in accrued wages and related liabilities. The CARES Act temporarily suspended the 2% sequestration payment adjustment on Medicare fee-for-service payment beginning May 1, 2020 and was extended through December 31, 2021. The Company recognized $3,555 and $2,765 in revenue related to the suspension of sequestration for the years ended December 31, 2021 and 2020, respectively, exclusive of our start-up operations. The Company will continue to assess the effect of the CARES Act and ongoing other government legislation related to the COVID-19 pandemic that may be issued.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Cash consists of petty cash and bank deposits and therefore approximates fair value. The Company places its cash with high credit quality financial institutions. </span></div><div style="text-align:justify;text-indent:40.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration. The allowance for doubtful accounts is the Company&#8217;s best estimate of current expected credit losses in the accounts receivable balance. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property and equipment are initially recorded at their historical cost. Repairs and maintenance are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYxNzc_c179bcbb-5edd-46f8-ac7b-9c974960a03d">three</span> to 15 years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Impairment of Long-Lived Assets -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company reviews the carrying value of long-lived assets that are held and used in the independent operating subsidiaries for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is determined based upon expected undiscounted future net cash flows from the operating subsidiary to which the assets relate, utilizing management&#8217;s best estimate, appropriate assumptions, and projections at the time. If the carrying value is determined to be unrecoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair value of the asset. The Company estimates the fair value of assets based on the estimated future discounted cash flows of the asset. For the year ended December 31, 2021, management evaluated its long-lived assets and the Company identified $2,835 in long-lived asset impairment related to six senior living communities. Management did not identify any </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">asset impairment during the years ended December 31, 2020 and 2019. See further discussion at Note 8, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment, Net.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets and Goodwill -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s indefinite-lived intangible assets consist of trade names and Medicare and Medicaid licenses. The Company tests indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable. The Company did not identify any indefinite-lived intangible asset impairment during the years ended December 31, 2021, 2020 and 2019.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations.  Goodwill is subject to annual test for impairment as of the beginning of the fourth quarter or more frequently if events or changes indicate that the Company's goodwill might be impaired. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then it is required to perform a quantitative impairment test by comparing the fair value with the carrying amount of the reporting unit. If the carrying amount of a reporting unit exceeds its fair value, then the Company records an impairment of goodwill equal to the amount that the carrying amount of a reporting unit exceeds its fair value.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we evaluated potential triggering events that might be indicators that our goodwill and indefinite lived intangibles were impaired. As a result of our evaluation, no goodwill or indefinite intangible asset impairments were recorded during the years ended December 31, 2021, 2020 and 2019. See further discussion at Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, Net.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Self-Insurance Reserve -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company retains risk for a substantial portion of potential claims for general and professional liability and workers&#8217; compensation. Beginning on January 1, 2022 the Company transitioned its employee health plans to a self insurance model.  Prior to that date the Company did not retain risk related to its employee health plans.   </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company recognizes obligations associated with these costs, up to specified deductible limits in the period in which a claim is incurred, including with respect to both reported claims and claims incurred but not reported. The Company evaluates the adequacy of the self insurance reserves in conjunction with an independent actuarial assessment.As of December 31, 2021 the general and professional liability insurance has a retention limit of $150 per claim with a $500 corridor as an additional out-of-pocket retention we must satisfy for claims within the policy year before the carrier will reimburse losses. The workers&#8217; compensation insurance has a retention limit of $250 per claim, except for policies held in Texas and Washington which are subject to state insurance and possess their own limits. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These costs have generally been estimated based on historical data of our claims experience. Such estimates, and the resulting reserves, are reviewed and updated by us on a quarterly basis. Additionally, the Company has partially indemnified Ensign for general and professional liabilities incurred prior to the Spin-off but not reported until after that date and included that amount in its accrual below.     </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents details of the Company's insurance programs, including amounts accrued for the periods indicated in other accrued liabilities and other long-term liabilities in our accompanying balance sheets. The amounts accrued below represent the total estimated liability for individual claims that are less than our noted insurance coverage amounts, which includes outstanding claims and claims incurred but not reported. The amounts are reported gross of reinsurance receivable of $927 and $704 included in restricted and other assets for the years ended December 31, 2021 and 2020, respectively.   </span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:62.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.627%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of Insurance</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and professional liability  </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers&#8217; compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated liability</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,906&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,846&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: long-term portion, included in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,492)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of estimated liability, included in other accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value of Financial Instruments - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments consist principally of cash, accounts receivable, accounts payable, accrued liabilities, and debt. The Company believes all of the financial instruments&#8217; recorded values approximate fair values because of their nature or respective short durations. The Company determines fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted market prices in active markets; Level 2, defined as inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Deferred tax assets and liabilities are established for temporary differences between the financial reporting basis and the tax basis of the Company&#8217;s assets and liabilities at tax rates in effect when such temporary differences are expected to reverse. The Company generally expects to fully utilize its deferred tax assets; however, when necessary, the Company records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the need for a valuation allowance or the need for and magnitude of liabilities for uncertain tax positions, the Company makes certain estimates and assumptions. These estimates and assumptions are based on, among other things, knowledge of operations, markets, historical trends and likely future changes and, when appropriate, the opinions of advisors with knowledge and expertise in certain fields. Due to certain risks associated with the Company&#8217;s estimates and assumptions, actual results could differ.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The noncontrolling interest in a subsidiary is initially recognized at estimated fair value on the acquisition date and is presented within total equity in the Company's consolidated balance sheets. The Company presents the noncontrolling interest and the amount of consolidated net income/ (loss) attributable to The Pennant Group, Inc. in its consolidated and combined statements of income.  Net income per share is calculated based on net income/ (loss) attributable to The Pennant Group, Inc.'s stockholders. The carrying amount of the noncontrolling interest is adjusted based on an allocation of subsidiary earnings based on ownership interest.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-Based Compensation -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all share-based payment awards, including employee stock options and restricted stock, made to employees and Pennant&#8217;s directors based on estimated fair values, ratably over the requisite service period of the award. The Company accounts for forfeitures as they occur. Net income has been reduced as a result of the recognition of the fair value of all stock options and restricted stock awards issued, the amount of which is contingent upon the number of future grants and other variables. The total amount of share-based compensation was $10,040, $8,335, and $3,382 for the years ended December 31, 2021, 2020 and 2019, respectively, of which $7,964, $7,222 and $2,769, respectively, was recorded in general and administrative expense, with the difference being recorded in cost of services. For further discussion see Note 12, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Options and Awards.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- In connection with the Spin-Off, shares of existing equity awards were replaced with shares under the new Pennant awards and are reflected in basic and diluted net income per share for the years ended December 31, 2021, 2020 and 2019, respectively. For further discussion see Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Computation of Net Income Per Common Share</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prior to Spin-Off</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost Allocation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The Financial Statements include allocations of costs for certain shared services provided to the Company by Ensign subsidiaries prior to the Spin-Off on October&#160;1, 2019. Such allocations include, but are not limited to, executive management, accounting, human resources, information technology, compliance, legal, payroll, insurance, tax, </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">treasury, and other general and administrative items. These costs were allocated to the Company on a basis of revenue, location, employee count, or other measures. These cost allocations are reflected within general and administrative expense in the consolidated and combined statements of income for the year ended December 31, 2019, including for share-based compensation expenses disclosed in Note 12</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Options and Awards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The amount of general and administrative costs allocated from January 1, 2019 to October&#160;1, 2019, the date of the Spin-Off, inclusive of share-based compensation expense, was $23,710. Management believes the basis on which the expenses were allocated to be a reasonable reflection of the services provided to the Company during the periods. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Insurance</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Prior to the Spin-Off Ensign was partially self-insured for healthcare, general and professional liability, and workers&#8217; compensation, and historically allocated premium expense to all subsidiaries of Ensign in its accounting records. To reflect all of the insurance costs, quarterly actuary determined adjustments were allocated to the Company based on the proportional historical premium expense. No self-insurance accruals were allocated to the Company as these accruals represent the obligations of Ensign. In connection with the Spin-Off, the Company purchased insurance through a third-party to replace the coverage provided by Ensign&#8217;s self-insured policies.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Ensign&#8217;s external debt and related interest expense were not allocated to the Company for any of the periods presented as no portion of the borrowings were assumed by the Company as part of the Spin-Off. All interest incurred by the Company was subsequent to the Spin-Off.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Prior to the date of the Spin-off, the Company&#8217;s operations have been included in Ensign&#8217;s U.S. federal and state income tax returns and all income taxes have been paid by subsidiaries of Ensign. Also prior to the date of the Spin-off, income tax expense and other income tax related information contained in these Financial Statements were presented using a separate tax return approach. Under this approach, the provision for income taxes represents income tax paid or payable for the current year plus the change in deferred taxes during the year calculated as if the Company was a stand-alone taxpayer filing hypothetical income tax returns. Management believes that the assumptions and estimates used to determine these tax amounts are reasonable. However, the Company&#8217;s Financial Statements may not necessarily reflect its income tax expense or tax payments in the future, or what tax amounts would have been if the Company had been a stand-alone company for the entire period presented.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Invested Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The net parent investment on the consolidated and combined statement of stockholders equity and statement of cash flows represents Ensign&#8217;s historical investment in the Company, the net effect of transactions with, and allocations from, Ensign and the Company&#8217;s accumulated earnings. Invested capital was reclassified into additional paid-in-capital at the date of the Spin-Off.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Prior to the Spin-Off, the Company presented the noncontrolling interest and the amount of consolidated net income/ (loss) attributable to the Company in its Financial Statements. The carrying amount of the noncontrolling interest was adjusted by an allocation of subsidiary earnings based on ownership interest prior to the Spin-Off. The noncontrolling subsidiary interest included in the Financial Statements was converted into common shares of Pennant concurrent with the distribution to Ensign stockholders at the date of the Spin-Off and thus, does not receive an allocated portion of earnings</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share-based compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Prior to the Spin-Off, employees of the Company&#8217;s subsidiaries participated in Ensign&#8217;s equity-based incentive plans (the &#8220;Ensign Plans&#8221;) and the Cornerstone Subsidiary Equity plan (the &#8220;Subsidiary Equity Plan&#8221;). Share-based compensation includes the expense attributable to employees of the Company&#8217;s subsidiaries who participated in the Ensign Plans, as well as the allocated cost related to Ensign subsidiaries&#8217; employees that participated in the Ensign Plans. Share-based compensation related to Ensign subsidiaries&#8217; employees that participated in the Ensign Plans were allocated on the basis of revenue. All share-based compensation related to the Subsidiary Equity Plan was recognized in the Financial Statements and, therefore, no cost allocation was necessary. </span></div><div style="text-align:justify;text-indent:40.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:40.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Spin-Off, share-based compensation costs associated with the Subsidiary Equity Plan awards was initially measured at fair value at the grant date and was expensed as non-cash compensation over the vesting term.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, these awards were granted once per year. The fair value has been determined by an independent valuation of the subsidiary shares. The valuation incorporated a discounted cash flow analysis combined with a market-based approach to determine the fair value of the subsidiary equity. </span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Standards Adopted by the Company</span></div>Except for rules and interpretive releases of the SEC under authority of federal securities laws and a limited number of grandfathered standards, the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. For any new pronouncements, the Company considers whether the new pronouncements could alter previous generally accepted accounting principles and determines whether any new or modified principles will have a material impact on the Company&#8217;s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company&#8217;s financial management and certain standards are under consideration.FASB Accounting Standards Update, or ASU, ASU 2021-01 &#8220;Reference Rate Reform (Topic 848): Scope&#8221; or ASU 2020-4 - On January 7, 2021, the FASB issued ASU 2021-01 to amend the scope of  the guidance in ASU 2020-04 &#8220;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&#8221; or ASU 2020-4. Specifically, the amendments in ASU 2021-01 clarify that &#8220;certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition.&#8221;  The amendment in ASU 2021-1 is available to all entities: (i) on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 through the date that the final update to the standard was issued or (ii) on a prospective basis for new contract modifications through December 31, 2022.  The Company has adopted ASU 2021-01 on a prospective basis effective as of January 7, 2021.  There was no material impact to the Company&#8217;s Consolidated and Combined Financial Statements or related disclosures as a result of the adoption of ASU 2021-01.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821589960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT</a></td>
<td class="text">RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Spin-Off, our businesses were included as subsidiaries of Ensign. As a result, our transactions were considered related party transactions. On October&#160;1, 2019, in connection with the Spin-Off, Pennant entered into several agreements with Ensign that set forth the principal actions taken or to be taken in connection with the Spin-Off and govern the relationship of the parties following the Spin-Off. On October 1, 2021 the company concluded its Transition Services Agreement with Ensign.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has incurred $3,124, $5,536, and $2,982 in costs related to the Transitions Services Agreement for the years ended December 31, 2021, 2020 and 2019, respectively. Additionally, the Company has recognized $208, $578, and $291 in tax benefits related to the Tax Matters Agreement for the years ended December 31, 2021, 2020 and 2019, respectively, and has recorded a payable to Ensign in connection with any unpaid portion of these amounts.  See &#8220;Certain Relationships and Related Party Transactions&#8212;Agreements with Ensign Related to the Spin-Off,&#8221; contained within the Information Statement as well as the Form 8-K filed with the SEC on October 3, 2019 for further discussion of the agreements entered into in connection with the Spin-Off.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company leases 32 of its senior living communities from subsidiaries of Ensign, each of the leases have a term of between 14 and 20 years from the lease commencement date. The total amount of rent expense included in Rent - cost of services paid to subsidiaries of Ensign was $12,773, $12,536, and $11,292 for the years ended December 31, 2021, 2020 and 2019, respectively. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain related party activity occurred as the Company&#8217;s subsidiaries received services from Ensign&#8217;s subsidiaries. Services included in cost of services were $3,084, $4,205, and $3,166 for the years ended December 31, 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821518600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPUTATION OF NET INCOME PER COMMON SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">COMPUTATION OF NET INCOME PER COMMON SHARE</a></td>
<td class="text">COMPUTATION OF NET INCOME PER COMMON SHARE<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share is computed by dividing net income attributable to stockholders of the Company by the weighted average number of outstanding common shares for the period. The computation of diluted net income per share is similar to the computation of basic net income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prior to Spin-Off</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income attributable to the noncontrolling interest has been included in the numerator for the year ended December 31, 2019, as the non-controlling subsidiary interest that existed prior to the Spin-Off was converted into common shares of Pennant concurrent with the distribution to Ensign stockholders at the date of the Spin-Off</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.   </span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods presented: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: net (loss)/ income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(548)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to The Pennant Group, Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,744&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,546&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic net income per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: incremental shares from assumed conversion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted weighted average common shares outstanding for diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings Per Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per common share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per common share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The calculation of dilutive shares outstanding excludes out-of-the-money stock options (i.e., such options&#8217; exercise prices were greater than the average market price of our common shares for the period) because their inclusion would have been antidilutive. Options outstanding which are anti-dilutive and therefore not factored into the weighted average common shares amount above were 478, 93, and 15 for the years ended December 31, 2021, 2020 and 2019, respectively.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the year ended December 31, 2019 basic and diluted earnings per share were calculated based on net income as the numerator, which included the conversion of the noncontrolling interest in connection with the Spin-Off. For the years ended December 31, 2021 and 2020, basic and diluted earnings per share were calculated based on net income attributable to The Pennant Group, Inc. as the numerator.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821475608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND ACCOUNTS RECEIVABLE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock', window );">REVENUE AND ACCOUNTS RECEIVABLE</a></td>
<td class="text">REVENUE AND ACCOUNTS RECEIVABLE<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue is recognized when services are provided to the patients at the amount that reflects the consideration to which the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and managed care programs (Commercial, Medicare Advantage and Managed Medicaid plans), in exchange for providing patient care. The healthcare services in home health and hospice patient contracts include routine services in exchange for a contractual agreed-upon amount or rate. Routine services are treated as a single performance obligation satisfied over time as services are rendered. As such, patient care services represent a bundle of services that are not capable of being distinct within the context of the contract. Additionally, there may be ancillary services which are not included in the rates for routine services, but instead are treated as separate performance obligations satisfied at a point in time, if and when those services are rendered.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rate, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration which is included in the transaction price may be constrained, and is included in the net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#8217;s estimates, the Company adjusts these estimates, which would affect net service revenue in the period such variances become known. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from the Medicare and Medicaid programs accounted for 62.6%, 60.1%, and 55.6% of the Company&#8217;s revenue for the years ended December 31, 2021, 2020 and 2019, respectively. The Company records revenue from these governmental and managed care programs as services are performed at their expected net realizable amounts under these programs. The Company&#8217;s revenue from governmental and managed care programs is subject to audit and retroactive adjustment by governmental and third-party agencies. Consistent with healthcare industry accounting practices, any changes to these governmental revenue estimates are recorded in the period the change or adjustment becomes known based on final settlement. </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company disaggregates revenue from contracts with its patients or residents by reportable operating segments and payors. The Company has determined that disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. A reconciliation of disaggregated revenue to segment revenue as well as revenue by payor is provided in below. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s service specific revenue recognition policies are as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Home Health Revenue</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Medicare Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For Medicare episodes that began after January 1, 2020, net service revenue is recognized in accordance with the Patient Driven Groupings Model (&#8220;PDGM&#8221;). This new reimbursement structure involves case mix calculation methodology refinements, changes to low-utilization payment adjustment (&#8220;LUPA&#8221;) thresholds, the elimination of therapy thresholds, a change to the unit of payment from a 60-day episode to a 30-day payment period, and reduction of requests for anticipated payments (&#8220;RAPs&#8221;) to 20% of the estimated payment for a patient&#8217;s initial or subsequent period of care up-front (after the initial assessment is completed and upon initial billing). The RAPs were completely phased out effective January 1, 2021. Under PDGM, Medicare provides agencies with payments for each 30-day payment period provided to beneficiaries. If a beneficiary is still eligible for care after the end of the first 30-day payment period, a second 30-day payment period can begin. There are no limits to the number of periods of care a beneficiary who remains eligible for the home health benefit can receive. While payment for each 30-day payment period is adjusted to reflect the beneficiary&#8217;s health condition and needs, a special outlier provision exists to ensure appropriate payment for those beneficiaries that have the most expensive care needs. The payment under the Medicare program is also adjusted for certain variables including, but not limited to: (a) a LUPA if the number of visits is below an established threshold that varies based on the diagnosis of a beneficiary; (b) a partial payment if the patient transferred to another provider or the Company received a patient from another provider before completing the period of care; (c) adjustment to the admission source of claim if it is determined that the patient had a qualifying stay in a post-acute care setting within 14 days prior to the start of a 30-day payment period; (d) the timing of the 30-day payment period provided to a patient in relation to the admission date, regardless of whether the same home health provider provided care for the entire series of episodes; (e) changes to the acuity of the patient during the previous 30-day payment period; (f) changes in the base payments established by the Medicare program; (g) adjustments to the base payments for case mix and geographic wages; and (h) recoveries of overpayments. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all episodes that began prior to January 1, 2020, net service revenue was recorded under the Medicare prospective payment system based on a 60-day episode payment rate that is subject to adjustment based on certain variables including, but not limited to: (a) an outlier payment if the patient&#8217;s care was unusually costly; (b) a LUPA if the number of visits was fewer than five; (c) a partial payment if the patient transferred to another provider or transferred from another provider before completing the episode; (d) a payment adjustment based upon the level of covered therapy services; (e)&#160;the number of episodes of care provided to a patient, regardless of whether the same home health provider provided care for the entire series of episodes; (f)&#160;changes in the base episode payments established by the Medicare program; (g)&#160;adjustments to the base episode payments for case mix and geographic wages; and (h)&#160;recoveries of overpayments.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company adjusts Medicare revenue on completed episodes to reflect differences between estimated and actual payment amounts, an inability to obtain appropriate billing documentation and other reasons unrelated to credit risk. Therefore, the Company believes that its reported net service revenue and patient accounts receivable will be the net amounts to be realized from Medicare for services rendered.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to revenue recognized on completed episodes and periods, the Company also recognizes a portion of revenue associated with episodes and periods in progress. Episodes in progress are 30-day payment periods, if the episode started after January 1, 2020, or 60-day episodes of care, if the episode started prior to January 1, 2020, that begin during the reporting period but were not completed as of the end of the period. As such, the Company estimates revenue and recognizes it on a daily basis. The primary factors underlying this estimate are the number of episodes in progress at the end of the reporting period, expected Medicare revenue per period of care or episode of care and the Company&#8217;s estimate of the average percentage complete based on the scheduled end of period and end of episode dates.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Medicare Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Episodic Based Revenue -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company recognizes revenue in a similar manner as it recognizes Medicare revenue for episodic-based rates that are paid by other insurance carriers, including Medicare Advantage programs; however, these rates can vary based upon the negotiated terms.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-episodic Based Revenue -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Revenue is recognized on an accrual basis based upon the date of service at amounts equal to its established or estimated per visit rates, as applicable.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hospice Revenue</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized on an accrual basis based upon the date of service at amounts equal to the estimated payment rates. The estimated payment rates are calculated as daily rates for each of the levels of care the Company delivers. Revenue is adjusted for an inability to obtain appropriate billing documentation or authorizations acceptable to Medicare and other reasons unrelated to credit risk. Additionally, as Medicare hospice revenue is subject to an inpatient cap and an overall payment cap, the Company monitors its provider numbers and estimates amounts due back to Medicare if a cap has been exceeded. The Company regularly evaluates and records these adjustments as a reduction to revenue and an increase to other accrued liabilities.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Senior Living Revenue</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has elected the lessor practical expedient within ASC Topic 842, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC 842&#8221;) and therefore recognizes, measures, presents, and discloses the revenue for services rendered under the Company&#8217;s senior living residency agreements based upon the predominant component, either the lease or non-lease component, of the contracts. The Company has determined that the services included under the Company&#8217;s senior living residency agreements each have the same timing and pattern of transfer. The Company recognizes revenue under ASC Topic 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customers</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for its senior residency agreements, for which it has determined that the non-lease components of such residency agreements are the predominant component of each such contract.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s senior living revenue consists of fees for basic housing and assisted living care. Accordingly, we record revenue when services are rendered on the date services are provided at amounts billable to individual residents. Residency agreements are generally for a term of 30 days, with resident fees billed monthly in advance. For residents under reimbursement arrangements with Medicaid, revenue is recorded based on contractually agreed-upon amounts or rates on a per resident, daily basis or as services are rendered. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by payor for the years ended December 31, 2021, 2020 and 2019, is summarized in the following tables:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hospice Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,849&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,784&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,042&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,958&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,612&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.176%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hospice Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,399&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,044&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,335&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:80%"> </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.149%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.149%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.149%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.149%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hospice Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,819&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,933&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,752&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,819&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,942&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,682&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,531&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Balance Sheet Impact</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Included in the Company&#8217;s consolidated balance sheets are contract assets, comprised of billed accounts receivable and unbilled receivables, which are the result of the timing of revenue recognition, billings and cash collections, as well as, contract liabilities, which primarily represent payments the Company receives in advance of services provided. As of December 31, 2021, the Company had contract liabilities in the amount of $6,211 related to Advance Payments received in connection with the CARES Act. As further discussed in Note 10, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Accrued Liabilities,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the repayment terms for Medicare advance payments were modified through the passage of the Continuing Appropriations Act, 2021 and Other Extensions Act on October 1, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of December 31, 2021 and December 31, 2020 is summarized in the following table: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(643)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,940&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for our allowance for doubtful accounts for the years ended December 31, 2021, 2020 and 2019:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to bad debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of uncollectible accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(594)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(797)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue from Contract with Customer And Accounts Receivables Disclosure [Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821396168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">BUSINESS SEGMENTS</a></td>
<td class="text">BUSINESS SEGMENTS<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies its operations into the following reportable operating segments: (1) home health and hospice services, which includes the Company&#8217;s home health, hospice and home care businesses; and (2) senior living services, which includes the operation of assisted living, independent living and memory care communities. The reporting segments are business units that offer different services and are managed separately to provide greater visibility into those operations. Our Chief Executive Officer and President, who is our Chief Operating Decision Maker &#8220;CODM&#8221;, reviews financial information at the operating segment level. We also report an &#8220;all other&#8221; category that includes general and administrative expense from our Service Center.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, the Company provided services through 88 affiliated home health, hospice and home care agencies, and 54 affiliated senior living operations. The Company evaluates performance and allocates capital resources to each segment based on an operating model that is designed to maximize the quality of care provided and profitability. The Company&#8217;s Service Center provides various services to all lines of business. The Company does not review assets by segment and therefore assets by segment are not disclosed below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CODM uses Segment Adjusted EBITDAR from Operations as the primary measure of profit and loss for the Company's reportable segments and to compare the performance of its operations with those of its competitors. Segment Adjusted EBITDAR from Operations is net income/ (loss) attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, and, in order to view the operations performance on a comparable basis from period to period, certain adjustments including: (1) costs at start-up operations, (2) share-based compensation, (3) acquisition related costs, (4) Spin-Off transaction costs, (5) redundant and nonrecurring costs associated with the transition services agreement, (6) net income/ (loss) attributable to noncontrolling interest, (7) net COVID-19 related costs and (8) impairment of long-lived assets. General and administrative expenses are not allocated to the reportable segments, and are included as &#8220;All Other&#8221;, accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain financial information regarding our reportable segments, general and administrative expenses are not allocated to the reportable segments and are included in &#8220;All Other&#8221;. </span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,762)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,591)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.103%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,048&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,107&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Segment EBITDAR from Operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Costs at start-up operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off related transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition services costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 Related costs and supplies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Net income/ (loss) attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(548)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and Combined Income from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,917&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents results related to start-up operations.  This amount excludes rent and depreciation and amortization expense related to such operations.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense incurred which is included in cost of services and general and administrative expense. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition related costs that are not capitalizable.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs incurred related to the Spin-Off are included in general and administrative expense.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A portion of the costs incurred under the Transition Services Agreement identified as redundant or nonrecurring that are included in general and administrative expense. Fees incurred under the Transition Services Agreement, net of the Company&#8217;s payroll reimbursement, were $3,124, $5,536, and $2,982, for the years ended December 31, 2021, 2020 and 2019, respectively. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning in the first quarter of fiscal year 2021, we updated our definition of Segment Adjusted EBITDAR to no longer include an adjustment for COVID-19 expenses offset by the amount of sequestration relief. COVID-19 expenses continue to be part of daily operations for which less specific identification is visible. Furthermore, the sequestration relief was extended through December 31, 2021. Sequestration relief was $3,555 for the year ended December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The 2020 amount represents incremental costs incurred as part of the Company's response to COVID-19 including direct medical supplies, labor, and other expenses, net of $2,765 in increased revenue related to the 2% payment increase in Medicare reimbursements for sequestration relief for the year ended December 31, 2020.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">On January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements (collectively, the &#8220;Transfer Agreements&#8221;) with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#8220;Transaction&#8221;). The closing of the Transaction is anticipated to occur in the first half of 2022. The Company impaired certain leasehold improvements included in property and equipment primarily  related to the operations included in the transaction with Ensign.</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821461480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">ACQUISITIONS</a></td>
<td class="text">ACQUISITIONS<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s acquisition focus is to purchase or lease operations that are complementary to the Company&#8217;s current businesses, accretive to the Company&#8217;s business or otherwise advance the Company&#8217;s strategy. The results of all the Company&#8217;s independent operating subsidiaries are included in the Financial Statements subsequent to the date of acquisition. Acquisitions are accounted for using the acquisition method of accounting. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Acquisitions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2021, the Company expanded its operations with the addition of five home health agencies, four hospice agencies, and two home care agencies. The aggregate purchase price for these acquisitions was $14,135. A subsidiary of the Company entered into a separate operations transfer agreement with the prior operator of each acquired operation as part of each transaction.  The goodwill was primarily attributable to intangible assets that do not qualify for separate recognition  and  to synergies the Company expects to achieve related to the acquisition and was allocated to the  Company's  operating  segments  which  are  its  reporting  units.   The Company anticipates that the total goodwill recognized </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">will be fully deductible for tax purposes. Acquisition costs related to the business combinations of home health, hospice, and home care acquisitions of $80 were expensed related to the business combinations during the year ended December 31, 2021.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Two of the hospice agencies were acquired Medicare licenses and are considered asset acquisitions. The fair value of assets for the hospice licenses acquired totaled $585 and was allocated to indefinite-lived intangible assets. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2020 Acquisitions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the Company expanded its operations with the addition of six home health agency, six hospice agencies, and two senior living communities. The aggregate purchase price for these acquisitions was $39,239. In connection with the addition of the senior living communities, the Company entered into a new long-term &#8220;triple-net&#8221; lease with a subsidiary of Ensign.  The addition of these operations added a total of 164 operational senior living units to be operated by the Company&#8217;s independent operating subsidiaries. A subsidiary of the Company entered into a separate operations transfer agreement with the prior operator of each acquired operation as part of each transaction.  The goodwill was primarily attributable intangible assets that do not qualify for separate recognition and to synergies the Company expects to achieve related to the acquisition and was allocated to  the  Company's  operating  segments  which  are  its  reporting  units.   The Company anticipates that the total goodwill recognized will be fully deductible for tax purposes. Acquisition costs related to the business combinations of home health, hospice, and home care acquisitions of $99 were expensed related to the business combinations during the year ended December 31, 2020.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company announced it closed on a home health joint venture and hospice joint venture with Scripps Health (&#8220;Scripps&#8221;), a leading nonprofit integrated health system based in San Diego, California. The closing was effective October 1, 2020. The resulting joint ventures, which combined certain assets and the operations of Scripps&#8217; home health business and the assets and operations of the local Pennant-affiliated home health and hospice agencies, are majority-owned and managed by an independent operating subsidiary of the Company and provide home health and hospice services to patients throughout San Diego County. The fair value of assets contributed by Scripps to the home health joint venture were included in the total value of assets acquired as described above and in the summary table below. The Company paid Scripps $6,200 in cash and contributed assets from the local Pennant-affiliated home health agency with a net book value of $614.  The Company acquired 60.0% ownership interest in the joint venture. The contributions of assets by Scripps to the joint venture, resulted in the Company recording a noncontrolling interest with a fair value of $4,646.  The fair value of the noncontrolling interest was determined using discounted cash flow models.  As part of the transaction with Scripps, the Company contributed the assets of the local Pennant-affiliated hospice agency to another joint venture. The Company sold Scripps a noncontrolling interest in the hospice joint venture for $555 in cash. The company retained an 80.0% ownership interest in the hospice joint venture. The transaction resulted in the Company recognizing a noncontrolling interest of $138 and a contribution to additional paid in capital of $313, net of $104 of the income tax effect.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2019 Acquisitions</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2019, the Company expanded its operations with the addition of two home health agencies, five hospice agencies, two home care agencies and two senior living operations. In connection with the acquisition of one of the senior living communities, the Company entered into a new long-term &#8220;triple-net&#8221; lease with a subsidiary of Ensign. The Company did not acquire any material assets or assume any liabilities. A subsidiary of the Company entered into a separate operations transfer agreement with the prior operator of each acquired operation as part of each transaction. The addition of these operations added a total of 143 operational senior living units to be operated by the Company&#8217;s independent operating subsidiaries. The aggregate purchase price for these acquisitions was $18,760. Acquisition costs related to the business combinations of home health, hospice, and home care was $611 during the year ended December 31, 2019.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of assets for home health and hospice acquisitions was mostly concentrated in goodwill and as such, these transactions were classified as business combinations in accordance with ASC Topic 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (&#8220;ASC </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">805&#8221;).  The table below presents the allocation of the purchase price for the operations acquired in acquisitions during the years ended December 31, 2021, 2020 and 2019 as noted above:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture, and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total acquisitions</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,239&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,760&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: noncontrolling interest and additional paid in capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash paid in prior year (held in escrow)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for acquisitions</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,550&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,193&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consists of the of noncontrolling interest related to Scripps contribution of assets to the joint venture.  </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total cash paid for acquisitions for the year ended December 31, 2021 includes $585 as an escrow deposit that was paid in the prior year. </span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI http://asc.fasb.org/topic&amp;trid=2303972<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821505240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT&#8212;NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY AND EQUIPMENT&#8212;NET</a></td>
<td class="text">PROPERTY AND EQUIPMENT&#8212;NET<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consist of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,984&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,590&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,486)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,706)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,788&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,884&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense was $4,751, $4,661 and $3,757 for the years ended December 31, 2021, 2020 and 2019, respectively. </span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Asset Impairment</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews the carrying value of long-lived assets impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. On January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#8220;Transaction&#8221;). The closing of the Transaction is anticipated to occur in the first half of 2022. As of the year ended December 31, 2021, management determined that the long-lived assets for the impacted communities were not recoverable and the Company recognized a non-cash long-lived asset impairment charge of $2,835 in cost of services in the Consolidated and Combined Statements of Income.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821484840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS&#8212;NET<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">GOODWILL AND INTANGIBLE ASSETS&#8212;NET</a></td>
<td class="text">GOODWILL AND INTANGIBLE ASSETS&#8212;NET <span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company tests goodwill during the fourth quarter of each year and also if events or changes in circumstances indicate the occurrence of a triggering event which might indicate there may be impairment. The Company performs its goodwill impairment analysis for each reporting unit that constitutes a component for which (1) discrete financial information is available and (2) segment management regularly reviews the operating results of that component, in accordance with the provisions of ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles-Goodwill and Other </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(&#8220;ASC 350&#8221;).</span><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews goodwill for impairment by initially considering qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, as a basis for determining whether it is necessary to perform a quantitative analysis. If it is determined that it is more likely than not that the fair value of reporting unit is less than its carrying amount, a quantitative analysis is performed to identify goodwill impairment. If it is determined that it is not more likely than not that the fair value of the reporting unit is less than its carrying amount, it is unnecessary to perform a quantitative analysis. The Company may elect to bypass the qualitative assessment and proceed directly to performing a quantitative analysis. Impairment is the condition that exists when the carrying amount of goodwill exceeds its implied fair value. An impairment loss is recognized for the amount that the carrying amount of the reporting unit, including goodwill, exceeds its fair value, limited to the total amount of goodwill allocated to that reporting unit. The Company did not identify any impairment charge during the years ended December 31, 2021, 2020 and 2019.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents activity in goodwill by segment as of and for the year ended December 31, 2021:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.008%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,233&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,623&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other indefinite-lived intangible assets consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicaid licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,488&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821465368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCRUED LIABILITIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesDisclosureTextBlock', window );">OTHER ACCRUED LIABILITIES</a></td>
<td class="text">OTHER ACCRUED LIABILITIES<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refunds payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,095&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,664&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resident deposits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (CARES Act advance payments)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance retention - current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,275&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refunds payable includes payables related to overpayments, duplicate payments and credit balances from various payor sources. Deferred revenue occurs when the Company receives payments in advance of services provided. Resident deposits include refundable deposits to residents and a small portion consists of non-refundable deposits recognized into revenue over a period of time. The CARES Act also expanded the Centers for Medicare &amp; Medicaid Services&#8217; (&#8220;CMS&#8221;) ability to provide accelerated/advance payments intended to increase the cash flow of healthcare providers and suppliers impacted by COVID-19. During the second quarter of 2020, the Company applied for and received $27,997 in funds under the AAP Program. On October 1, 2020, the Continuing Appropriations Act, 2021 and Other Extensions Act (the &#8220;CA Act&#8221;) was signed into law. Among other things, the CA Act significantly changed the repayment terms for AAP. These funds are subject to </span></div>automatic recoupment through offsets to new claims beginning one year after funds were issued beginning in April 2021, at which time, Medicare began to automatically recoup 25% of Medicare payments for 11 months. At the end of the 11 months and assuming full repayment has not occurred, recoupment will increase to 50% for another six months. Any balance outstanding after these two recoupment periods will be subject to repayment at a 4% interest rate. For the year ended December 31, 2021, the Company repaid $21,786 of the AAP funds. The Company reclassified $5,226 of AAP to other long-term liabilities for the year ended December 31, 2020. The Company anticipates completing repayment of the AAP within the allotted recoupment periods.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for other liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20,24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821558248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt, net consists of the following:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,277&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization expense for debt issuance costs was $488, $330, and $78 for the years ended December 31, 2021, 2020 and 2019, respectively, and is recorded in interest expense, net on the Consolidated and Combined Statements of Income.</span></div></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February&#160;23, 2021, Pennant entered into an amendment to its existing credit agreement (as amended, the &#8220;Credit Agreement&#8221;), which provides for an increased revolving credit facility with a syndicate of banks with a borrowing capacity of $150,000 (the &#8220;Revolving Credit Facility&#8221;). The interest rates applicable to loans under the Revolving Credit Facility are, at the Company&#8217;s election, either (i) Adjusted LIBOR (as defined in the Credit Agreement) plus a margin ranging from 2.3% to 3.3% per annum or (ii) Base Rate plus a margin ranging from 1.3% to 2.3% per annum, in each case based on the ratio of Consolidated Total Net Debt to Consolidated EBITDA (each, as defined in the Credit Agreement). In addition, Pennant pays a commitment fee on the undrawn portion of the commitments under the Revolving Credit Facility which ranges from 0.35% to 0.50% per annum, depending on the Consolidated Total Net Debt to Consolidated EBITDA ratio of the Company and its subsidiaries. The Company is not required to repay any loans under the Credit Agreement prior to maturity in 2026, other than to the extent the outstanding borrowings exceed the aggregate commitments under the Credit Agreement. As of December 31, 2021, the Company&#8217;s weighted average interest rate on its outstanding debt was 2.64%. As of December 31, 2021, the Company had available borrowing on the Revolving Credit Facility of $92,314, which is net of outstanding letters of credit of $4,186. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the Revolving Credit Facility approximates carrying value, due to the short-term nature and variable interest rates. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of this debt is categorized within Level 2 of the fair value hierarchy based on the observable market borrowing rates.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Credit Agreement is guaranteed, jointly and severally, by certain of the Company&#8217;s independent operating subsidiaries, and is secured by a pledge of stock of the Company's material independent operating subsidiaries as well as a first lien on substantially all of each material operating subsidiary's personal property. The Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its independent operating subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments. Financial covenants require compliance with certain levels of leverage ratios that impact the amount of interest. As of December 31, 2021, the Company was compliant with all such financial covenants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821414232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">OPTIONS AND AWARDS</a></td>
<td class="text">OPTIONS AND AWARDSShare-based compensation expense consists of share-based payment awards made to employees and directors,  including employee stock options, restricted stock awards (&#8220;RSA&#8221;), and restricted stock units (&#8220;RSU&#8221; and together with RSA, &#8220;Restricted Stock&#8221;), based on estimated fair values, ratably over the requisite service period of the award. The Company accounts for forfeitures as they occur.<div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Spin-Off, the Company issued new options and restricted stock awards to Pennant and Ensign employees under the 2019 Omnibus Incentive Plan (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">OIP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) and Long-Term Incentive Plan (the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">LTIP</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, together referred to as the &#8220;Pennant Plans&#8221;</span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prior to Spin-Off</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For all periods prior to the Spin-Off, employees of the Company participated in Ensign's share-based compensation plans. The compensation expense recorded by the Company included the expense associated with these employees, as well as an allocation of share-based compensation of certain Ensign employees who provided general and administrative services on our behalf.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding options held by employees of the Company under the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ensign stock plans (collectively the &#8220;Ensign Plans&#8221;) and outstanding options and restricted stock awards under the Company Subsidiary Equity Plan (together with the Ensign Plans the &#8220;Pre-Spin Plans&#8221;) </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">were modified and replaced with Pennant awards under the Pennant Plans at the Spin-Off date.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following disclosures represent share-based compensation expense relating to the Ensign and Pennant Plans, including awards to employees of the Company&#8217;s subsidiaries and an allocation of costs from employees in the Service Center prior to the Spin-Off, and total share-based compensation after the Spin-Off.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense for all of the Plans for the years ended December 31, 2021, 2020 and 2019:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prior to the Spin-Off:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Following the Spin-Off:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense related to stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense related to Restricted Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense related to Restricted Stock to non-employee directors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,040&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,382&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In future periods, the Company estimates it will recognize the following share-based compensation expense for unvested stock options and unvested Restricted Stock, which were unvested as of December 31, 2021: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Recognition Period (in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested Restricted Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Options</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Pennant Plans, options granted to employees of the subsidiaries of Pennant generally vest over five years at 20% per year on the anniversary of the grant date. Options expire ten years after the date of grant. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option-pricing model to recognize the value of share-based compensation expense for share-based payment awards under the Plans. Determining the appropriate fair-value model and calculating the fair value of share-based awards at the grant date requires considerable judgment, including estimating stock price volatility and </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expected option life. The Company develops estimates based on historical data and market information, which can change significantly over time. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option is estimated on the grant date using a Black-Scholes option-pricing model with the following weighted average assumptions for stock options granted after the Spin-Off:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.338%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.607%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Free Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dividend Yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Fair Value of Options</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Under the midpoint method, the expected option life is the midpoint between the contractual option life and the average vesting period for the options being granted. This resulted in an expected option life of 6.5 years for the options granted.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Because the Company&#8217;s equity shares have been traded for a relatively short period of time, expected volatility assumption was based on the volatility of related industry stocks.</span></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the employee stock option activity during the year ended December 31, 2021:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Outstanding</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Vested</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">of Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vested</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/ Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,242&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options outstanding, vested, unvested and exercised as of and for the period ended December 31, 2021 is as follows:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The intrinsic value is calculated as the difference between the market value of the underlying common stock and the exercise price of the options. There were 1,402 unvested and outstanding options at December 31, 2021. The weighted average contractual life for options outstanding, vested and expected to vest at December 31, 2021 was&#160;7.39 years.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Pennant Plans, the Company granted Restricted Stock to Pennant employees, Ensign employees, and to non-employee directors. All awards generally vest between <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzM1Mjk_ccbd4d6d-4bc1-4f64-a712-9a0de31e9ccd">three</span> to five years. A summary of the status of Pennant&#8217;s non-vested Restricted Stock, and changes during the period ended December 31, 2021, is presented below: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.668%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Vested Restricted Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821534696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s independent operating subsidiaries lease 54 senior living communities and its administrative offices under non-cancelable operating leases, most of which have initial lease terms ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzIyMg_b91d98ae-34f8-4760-a680-7806138f8865">five</span> to 21 years. The Company&#8217;s independent operating subsidiaries also lease the administrative offices of 88 home health and hospice agencies which generally range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzEwOTk1MTE2MzA5MjU_3cc0a8cb-6980-4caa-9f55-af4c4d207bb0">one</span> to seven years. Most of these leases contain renewal options, most involve rent increases and none contain purchase options. The lease term excludes lease renewals because the renewal rents are not at a bargain, there are no economic penalties for the Company to renew the lease, and it is not reasonably certain that the Company will exercise the extension options. As of December 31, 2021, the Company&#8217;s independent operating subsidiaries leased 32 communities from subsidiaries of Ensign (&#8220;Ensign Leases&#8221;) under a master lease arrangement</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The existing leases with subsidiaries of Ensign are for initial terms of between 14 to 20 years. In addition to rent, each of the operating companies are required to pay the following: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all community maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties.  </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fifteen of the Company&#8217;s affiliated senior living communities, excluding the communities that are operated under the Ensign Leases (as defined herein), are operated under two separate master lease arrangements. Under these master leases, a breach at a single community could subject one or more of the other communities covered by the same master lease to the same default risk. Failure to comply with Medicare and Medicaid provider requirements is a default under several of the Company&#8217;s leases and master leases. With an indivisible lease, it is difficult to restructure the composition of the portfolio or economic terms of the master lease without the consent of the landlord.</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease cost, are as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs:</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility rent&#8212;cost of services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents variable lease cost for operating leases, which costs include property taxes and insurance, common area maintenance, and consumer price index increases, incurred as part of our triple net lease, and which is included in cost of services for the years ended December 31, 2021, 2020 and 2019.</span></div></td></tr></table></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the lease maturity analysis for all leases as of December 31, 2021:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,929&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201,462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of total lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,118)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used its incremental borrowing rate based on the information available at each lease&#8217;s commencement date to determine each lease's operating lease liability. As of December 31, 2021, the weighted average remaining lease term is 14.1 years and the weighted average discount rate is 7.9%.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821436504">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income tax expense for the years ended December 31, 2021, 2020 and 2019 is summarized as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.915%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,752)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,186)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,085&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory rate to the effective tax rate for income from continuing operations for the years ended December 31, 2021, 2020 and 2019, respectively, is comprised as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes - net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible equity compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 162(m) limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductible equity compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's completion of the Spin-Off  in the year ended December 31, 2019 resulted in the Company not being able to deduct approximately $10,300 of the related transaction costs, which increased the effective tax rate significantly and affected all items that were impacted by this exclusion.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">During the year ended December 31, 2021, employees exercised stock options representing approximately 115 shares. During the year ended December 31, 2020, employees exercised stock options representing approximately 239 shares. During the year ended December 31, 2019, employees exercised stock options representing approximately 100 shares and had restricted stock awards vest representing 960 shares. These exercises and vestings resulted in tax benefits that reduced the Company's effective tax rate significantly in all three years. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">During the year ended December 31, 2021, approximately $2,528 of the share-based compensation expense related to restricted stock did not result in a deferred tax asset because it will be subject to future limitation under IRC Section 162(m).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certain items in the prior year have been reclassified to conform with the current year presentation.  </span></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the date of the Spin-Off, the Company's operations were included in Ensign&#8217;s U.S. federal and state income tax returns and all income taxes were paid by subsidiaries of Ensign. Additionally, prior to the date of the Spin-Off, income tax expense and other income tax related information contained in these Consolidated and Combined Financial Statements for the year ended 2019 were presented on a separate tax return approach. Under this approach, the provision for income taxes represents income tax paid or payable for the current year plus the change in deferred taxes during the year calculated as if the Company were a stand-alone taxpayer filing hypothetical income tax returns. Management believes that the assumptions and estimates used to determine these tax amounts were reasonable. However, the Company's Consolidated and Combined Financial Statements or the year ended 2019 may not necessarily reflect the Company&#8217;s income tax expense or tax payments in the future, or what its tax amounts would have been if the Company had been a stand-alone company during the periods presented.</span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s deferred tax assets and liabilities for the years ended December 31, 2021 and 2020 are summarized below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,085&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,459&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,060&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,432)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,656)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,212)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, the Company utilized all of its net operating loss ("NOL") carryforwards for federal income tax purposes. As of December 31, 2021, the Company has $614 of NOL carryforwards in various states, which are available to reduce future state taxable income, if any. The state NOL carryforwards, if not utilized, will expire in years ending between December 31, 2030 and December 31, 2040. The Company believes that it is more likely than not that the benefit from the state NOL carryforwards in jurisdictions where we do not file a consolidated return will not be realized. In recognition of this risk, as of December 31, 2021, the Company has provided a valuation allowance of $25 on the deferred tax assets related to these states for the tax effect of the NOL carryforwards that will not be realized.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The federal statutes of limitations on the Company&#8217;s 2017, 2016, and 2015 income tax years lapsed during the third quarter of 2021, 2020, and 2019, respectively. During the fourth quarter of each year, various state statutes of limitations also lapsed. The lapses for the years ended December 31, 2021 and 2020 had no impact on the Company&#8217;s unrecognized tax benefits. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions related to the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>None of unrecognized tax benefits net of their state benefits would affect the Company&#8217;s effective tax rate for the years ended December 31, 2021 and 2020.  The Company classifies interest and/or penalties on income tax liabilities or refunds as additional income tax expense or income. Such amounts are not material.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821594104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIES<span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Regulatory Matters - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company provides services in complex and highly regulated industries. The Company&#8217;s compliance with applicable federal, state and local laws and regulations governing these industries may be subject to </span><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">governmental review and adverse findings may result in significant regulatory action, which could include sanctions, damages, fines, penalties (many of which may not be covered by insurance), and even exclusion from government programs.&#160;The Company is a party to various regulatory and other governmental audits and investigations in the ordinary course of business and cannot predict the ultimate outcome of any federal or state regulatory survey, audit or investigation. While governmental audits and investigations are the subject of administrative appeals, the appeals process, even if successful, may take several years to resolve. The Department of Justice, CMS, or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company's businesses. The Company believes that it is presently in compliance in all material respects with all applicable laws and regulations.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost-Containment Measures - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government and third party payors have instituted cost-containment measures designed to limit payments made to providers of healthcare services, and there can be no assurance that future measures designed to limit payments made to providers will not adversely affect the Company.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Indemnities - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, the Company enters into certain types of contracts that contingently require the Company to indemnify parties against third-party claims. These contracts primarily include (i)&#160;certain real estate leases, under which the Company may be required to indemnify property owners or prior operators for post-transfer environmental or other liabilities and other claims arising from the Company&#8217;s use of the applicable premises, (ii)&#160;operations transfer agreements, in which the Company agrees to indemnify past operators of agencies and communities the Company acquires against certain liabilities arising from the transfer of the operation and/or the operation thereof after the transfer, (iii)&#160;certain Ensign lending agreements, and (iv)&#160;certain agreements with management, directors and employees, under which the subsidiaries of the Company may be required to indemnify such persons for liabilities arising out of their employment relationships. The terms of such obligations vary by contract and, in most instances, a specific or maximum dollar amount is not explicitly stated therein. Generally, amounts under these contracts cannot be reasonably estimated until a specific claim is asserted. Consequently, because no claims have been asserted, no liabilities have been recorded for these obligations on the Company&#8217;s combined balance sheets for any of the periods presented.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s businesses involve a significant risk of liability given the age and health of the patients and residents served by its independent operating subsidiaries. The Company, its operating companies, and others in the industry may be subject to a number of claims and lawsuits, including professional liability claims, alleging that services provided have resulted in personal injury, elder abuse, wrongful death or other related claims. Healthcare litigation (including class action litigation) is common and is filed based upon a wide variety of claims and theories, and the Company is routinely subjected to these claims in the ordinary course of business, including potential claims related to patient care and treatment, professional negligence and class actions, as well as employment related claims. If there were a significant increase in the number of these claims or an increase in amounts owing should plaintiffs be successful in their prosecution of these claims, this could materially adversely affect the Company&#8217;s business, financial condition, results of operations and cash flows. In addition, the defense of these lawsuits may result in significant legal costs, regardless of the outcome, and can result in large settlement amounts or damage awards.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the potential lawsuits and claims described above, the Company is also subject to potential lawsuits under the False Claims Act (the &#8220;FCA&#8221;) and comparable state laws alleging submission of fraudulent claims for services to any healthcare program (such as Medicare) or payor. A violation may provide the basis for exclusion from federally funded healthcare programs. Such exclusions could have a correlative negative impact on the Company&#8217;s financial performance. Some states, including California, Arizona and Texas, have enacted similar whistleblower and false claims laws and regulations. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2009, Congress passed the Fraud Enforcement and Recovery Act ("FERA") which made significant changes to the FCA, expanding the types of activities subject to prosecution and whistleblower liability. Following changes by FERA, healthcare providers face significant penalties for the knowing retention of government overpayments, even if no false claim was involved. Providers can now be liable for knowingly and improperly avoiding or decreasing an obligation to pay money or property to the government, including the retention of any government overpayment. The Patient Protection and Affordable Care Act of 2010 (the &#8220;ACA&#8221;) supplemented FERA by imposing an affirmative obligation on healthcare providers to return an overpayment to CMS within 60 days of &#8220;identification&#8221; or the date any corresponding cost report is due, whichever is later. Retention of any overpayment beyond this period may create liability under the FCA. In addition, FERA extended protections against retaliation for whistleblowers, including protections not only for employees, but also contractors and agents. Thus, there is generally no need for an employment relationship in order to qualify for protection against retaliation for whistleblowing.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company cannot predict or provide any assurance as to the possible outcome of any litigation. If any litigation were to proceed, and the Company and its operating companies are subjected to, alleged to be liable for, or agree to a settlement </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of, claims or obligations under federal Medicare statutes, the FCA, or similar state and federal statutes and related regulations, the Company&#8217;s business, financial condition and results of operations and cash flows could be materially and adversely affected. Among other things, any settlement or litigation could involve the payment of substantial sums to settle any alleged civil violations, and may also include the assumption of specific procedural and financial obligations by the Company or its independent operating subsidiaries going forward under a corporate integrity agreement and/or other arrangement with the government. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicare Revenue Recoupments - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to probe reviews relating to Medicare services, billings and potential overpayments by Unified Program Integrity Contractors (UPIC), Recovery Audit Contractors (RAC), Zone Program Integrity Contractors (ZPIC), Program Safeguard Contractors (PSC), Supplemental Medical Review Contractors (SMRC) and Medicaid Integrity Contributors (MIC) programs, each of the foregoing collectively referred to as &#8220;Reviews.&#8221;  As of December 31, 2021, eight of the Company&#8217;s independent operating subsidiaries had Reviews scheduled, on appeal or in dispute resolution process, both pre- and post-payment. The Company anticipates that these probe reviews will increase in frequency in the future. If an operation fails an initial or subsequent Review, the operation could then be subject to extended Review, suspension of payment, or extrapolation of the identified error rate to all billing in the same time period. As of December 31, 2021, and through the filing of this Annual Report on Form 10-K, the Company&#8217;s independent operating subsidiaries have responded to the Reviews that are currently ongoing, on appeal or in dispute resolution process and the Company has no probable or estimable contingencies. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One hospice provider number is subject to a Medicare payment suspension imposed by a Uniform Program Integrity Contractor (UPIC). As of December 31, 2021 the UPIC requested for review 42 patient records covering a 4-month period to determine whether, in its view, a Medicare overpayment was made. Subsequent to December 31, 2021 the UPIC expanded upon its initial request to cover an additional 60 patient records over an additional 6-month period. Medicare payments to that provider number are suspended pending the conclusion of the UPIC&#8217;s review. The payments suspended as of December 31, 2021 total $3,700. The suspended amounts represent all Medicare payments due to the provider number since the start of the suspension and are not an overpayment finding. If the UPIC concludes that an overpayment exists, it will recover the overpayment from the suspended funds and release the excess funds, if any, to the provider. The UPIC has not specified when the payment suspension will end or when it will reach an over-payment determination. </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Credit Risk - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has significant accounts receivable balances, the collectability of which is dependent on the availability of funds from certain governmental programs, primarily Medicare and Medicaid. These receivables represent the only significant concentration of credit risk for the Company. The Company does not believe there are significant credit risks associated with these governmental programs. The Company believes that an appropriate allowance has been recorded for the possibility of these receivables proving uncollectible, and continually monitors and adjusts these allowances as necessary. The Company&#8217;s gross receivables from the Medicare and Medicaid programs accounted for approximately 78.6% and 75.7% of its total gross accounts receivable as of December 31, 2021 and December 31, 2020, respectively. Revenue from reimbursement under the Medicare and Medicaid programs accounted for 62.6%, 60.1%, and 55.6% of the Company's revenue for the years ended December 31, 2021, 2020 and 2019, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821589400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENT</a></td>
<td class="text">SUBSEQUENT EVENTOn January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements (collectively, the &#8220;Transfer Agreements&#8221;) with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#8220;Transaction&#8221;). The Transfer Agreements require one of the transferors to place in escrow $6,500 to cover post-closing capital expenditures and operating losses related to one of the communities. The closing of the Transaction is anticipated to occur in the first half of 2022, subject to receipt of applicable regulatory approvals and satisfaction of other customary closing conditions set forth in the Transfer Agreements. As such, management determined that the long-lived assets for the impacted communities were impaired and the Company recognized a non-cash charge of $2,613 in its operating results for the year ended December 31, 2021, included in the transaction.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024817125752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation - The accompanying consolidated and combined financial statements of the Company (the &#8220;Financial Statements&#8221;) reflect the Company&#8217;s financial position for the years ended December 31, 2021 and 2020, and the Company&#8217;s results of operations and cash flows for the years ended December 31, 2021, 2020 and 2019 and have been prepared in accordance with accounting principles generally accepted in the United States (&#8220;GAAP&#8221;) and pursuant to the regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Prior to the Spin-Off, the combined financial statements were prepared on a stand-alone basis and derived from the consolidated financial statements and accounting records of Ensign. Management believes that the Financial Statements reflect, in all material respects, all adjustments which are of a normal and recurring nature necessary to present fairly the Company&#8217;s financial position, results of operations, and cash flows for the periods presented in conformity with GAAP applicable to the annual period.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">All intercompany transactions and balances between the various legal entities comprising the Company have been eliminated in consolidation. The consolidated and combined statements of income reflect income that is attributable to the Company and the noncontrolling interest. The Company consists of various limited liability companies and corporations established to operate home health, hospice, home care, and senior living operations. The Financial Statements include the accounts of all entities controlled by the Company through its ownership of a majority voting interest. Revenue was derived from transactional information specific to the Company&#8217;s services provided. The costs in the consolidated and combined statements of income reflect direct costs and allocated costs prior to the Spin-Off.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Estimates and Assumptions</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimates and Assumptions -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Financial Statements relate to self-insurance reserves, revenue, cost allocations from prior to the Spin-Off, intangible assets and goodwill, right-of-use assets and lease liabilities for leases greater than 12 months, and income taxes. Actual results could differ from those estimates.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text">Revenue Recognition - Revenues are recognized when services are provided to the patients at the amount that reflects the consideration to which the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rate, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration which is included in the transaction price may be constrained, and is included in the net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#8217;s estimates, the Company adjusts these estimates, which would effect net service revenue in the period such variances become known.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash</a></td>
<td class="text">Cash - Cash consists of petty cash and bank deposits and therefore approximates fair value. The Company places its cash with high credit quality financial institutions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text">Accounts Receivable and Allowance for Doubtful Accounts - Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration. The allowance for doubtful accounts is the Company&#8217;s best estimate of current expected credit losses in the accounts receivable balance.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Property and Equipment -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Property and equipment are initially recorded at their historical cost. Repairs and maintenance are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYxNzc_c179bcbb-5edd-46f8-ac7b-9c974960a03d">three</span> to 15 years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text">Impairment of Long-Lived Assets - The Company reviews the carrying value of long-lived assets that are held and used in the independent operating subsidiaries for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is determined based upon expected undiscounted future net cash flows from the operating subsidiary to which the assets relate, utilizing management&#8217;s best estimate, appropriate assumptions, and projections at the time. If the carrying value is determined to be unrecoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair value of the asset. The Company estimates the fair value of assets based on the estimated future discounted cash flows of the asset. For the year ended December 31, 2021,<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangible Assets and Goodwill -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company&#8217;s indefinite-lived intangible assets consist of trade names and Medicare and Medicaid licenses. The Company tests indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable. The Company did not identify any indefinite-lived intangible asset impairment during the years ended December 31, 2021, 2020 and 2019.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations.  Goodwill is subject to annual test for impairment as of the beginning of the fourth quarter or more frequently if events or changes indicate that the Company's goodwill might be impaired. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then it is required to perform a quantitative impairment test by comparing the fair value with the carrying amount of the reporting unit. If the carrying amount of a reporting unit exceeds its fair value, then the Company records an impairment of goodwill equal to the amount that the carrying amount of a reporting unit exceeds its fair value.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, we evaluated potential triggering events that might be indicators that our goodwill and indefinite lived intangibles were impaired. As a result of our evaluation, no goodwill or indefinite intangible asset impairments were recorded during the years ended December 31, 2021, 2020 and 2019. See further discussion at Note 9, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Goodwill and Intangible Assets, Net.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value of Financial Instruments</a></td>
<td class="text">Fair Value of Financial Instruments - The Company&#8217;s financial instruments consist principally of cash, accounts receivable, accounts payable, accrued liabilities, and debt. The Company believes all of the financial instruments&#8217; recorded values approximate fair values because of their nature or respective short durations. The Company determines fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted market prices in active markets; Level 2, defined as inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Deferred tax assets and liabilities are established for temporary differences between the financial reporting basis and the tax basis of the Company&#8217;s assets and liabilities at tax rates in effect when such temporary differences are expected to reverse. The Company generally expects to fully utilize its deferred tax assets; however, when necessary, the Company records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining the need for a valuation allowance or the need for and magnitude of liabilities for uncertain tax positions, the Company makes certain estimates and assumptions. These estimates and assumptions are based on, among other things, knowledge of operations, markets, historical trends and likely future changes and, when appropriate, the opinions of advisors with knowledge and expertise in certain fields. Due to certain risks associated with the Company&#8217;s estimates and assumptions, actual results could differ.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_InvestedCapitalPolicyTextBlock', window );">Invested Capital</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Invested Capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The net parent investment on the consolidated and combined statement of stockholders equity and statement of cash flows represents Ensign&#8217;s historical investment in the Company, the net effect of transactions with, and allocations from, Ensign and the Company&#8217;s accumulated earnings. Invested capital was reclassified into additional paid-in-capital at the date of the Spin-Off.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy', window );">Noncontrolling Interest</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- The noncontrolling interest in a subsidiary is initially recognized at estimated fair value on the acquisition date and is presented within total equity in the Company's consolidated balance sheets. The Company presents the noncontrolling interest and the amount of consolidated net income/ (loss) attributable to The Pennant Group, Inc. in its consolidated and combined statements of income.  Net income per share is calculated based on net income/ (loss) attributable to The Pennant Group, Inc.'s stockholders. The carrying amount of the noncontrolling interest is adjusted based on an allocation of subsidiary earnings based on ownership interest.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Noncontrolling Interest </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- Prior to the Spin-Off, the Company presented the noncontrolling interest and the amount of consolidated net income/ (loss) attributable to the Company in its Financial Statements. The carrying amount of the noncontrolling interest was adjusted by an allocation of subsidiary earnings based on ownership interest prior to the Spin-Off. The noncontrolling subsidiary interest included in the Financial Statements was converted into common shares of Pennant concurrent with the distribution to Ensign stockholders at the date of the Spin-Off and thus, does not receive an allocated portion of earnings</span>.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Earnings Per Share</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Earnings Per Share </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">- In connection with the Spin-Off, shares of existing equity awards were replaced with shares under the new Pennant awards and are reflected in basic and diluted net income per share for the years ended December 31, 2021, 2020 and 2019, respectively. For further discussion see Note 4, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Computation of Net Income Per Common Share</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text">Share-based compensation - Prior to the Spin-Off, employees of the Company&#8217;s subsidiaries participated in Ensign&#8217;s equity-based incentive plans (the &#8220;Ensign Plans&#8221;) and the Cornerstone Subsidiary Equity plan (the &#8220;Subsidiary Equity Plan&#8221;). Share-based compensation includes the expense attributable to employees of the Company&#8217;s subsidiaries who participated in the Ensign Plans, as well as the allocated cost related to Ensign subsidiaries&#8217; employees that participated in the Ensign Plans. Share-based compensation related to Ensign subsidiaries&#8217; employees that participated in the Ensign Plans were allocated on the basis of revenue. All share-based compensation related to the Subsidiary Equity Plan was recognized in the Financial Statements and, therefore, no cost allocation was necessary.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards Adopted by the Company</a></td>
<td class="text">Recent Accounting Standards Adopted by the CompanyExcept for rules and interpretive releases of the SEC under authority of federal securities laws and a limited number of grandfathered standards, the Financial Accounting Standards Board (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. For any new pronouncements, the Company considers whether the new pronouncements could alter previous generally accepted accounting principles and determines whether any new or modified principles will have a material impact on the Company&#8217;s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company&#8217;s financial management and certain standards are under consideration.FASB Accounting Standards Update, or ASU, ASU 2021-01 &#8220;Reference Rate Reform (Topic 848): Scope&#8221; or ASU 2020-4 - On January 7, 2021, the FASB issued ASU 2021-01 to amend the scope of  the guidance in ASU 2020-04 &#8220;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&#8221; or ASU 2020-4. Specifically, the amendments in ASU 2021-01 clarify that &#8220;certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition.&#8221;  The amendment in ASU 2021-1 is available to all entities: (i) on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 through the date that the final update to the standard was issued or (ii) on a prospective basis for new contract modifications through December 31, 2022.  The Company has adopted ASU 2021-01 on a prospective basis effective as of January 7, 2021.  There was no material impact to the Company&#8217;s Consolidated and Combined Financial Statements or related disclosures as a result of the adoption of ASU 2021-01.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_InvestedCapitalPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Invested Capital [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_InvestedCapitalPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e4975-111524<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5212-111524<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=SL6953423-111524<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5093-111524<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5033-111524<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821558248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_SummaryOfInsuranceLiabilityTableTextBlock', window );">Summary of insurance liability</a></td>
<td class="text">The following table presents details of the Company's insurance programs, including amounts accrued for the periods indicated in other accrued liabilities and other long-term liabilities in our accompanying balance sheets. The amounts accrued below represent the total estimated liability for individual claims that are less than our noted insurance coverage amounts, which includes outstanding claims and claims incurred but not reported. The amounts are reported gross of reinsurance receivable of $927 and $704 included in restricted and other assets for the years ended December 31, 2021 and 2020, respectively.   <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:62.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.625%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.538%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.627%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Type of Insurance</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and professional liability  </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,063&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Workers&#8217; compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,899&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,783&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total estimated liability</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,906&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,846&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: long-term portion, included in other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,293)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,492)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of estimated liability, included in other accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_SummaryOfInsuranceLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Summary Of Insurance Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_SummaryOfInsuranceLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821582296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock', window );">Computation of basic and diluted net income per share</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods presented: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.402%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.699%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,148&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,553&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: net (loss)/ income attributable to noncontrolling interests</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(548)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income attributable to The Pennant Group, Inc.</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,696&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,744&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,546&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average shares outstanding for basic net income per share</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,029&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,838&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plus: incremental shares from assumed conversion</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,748&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted weighted average common shares outstanding for diluted income per share</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,642&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,228&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,586&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Earnings Per Share:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic net income per common share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted net income per common share</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.11&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The calculation of dilutive shares outstanding excludes out-of-the-money stock options (i.e., such options&#8217; exercise prices were greater than the average market price of our common shares for the period) because their inclusion would have been antidilutive. Options outstanding which are anti-dilutive and therefore not factored into the weighted average common shares amount above were 478, 93, and 15 for the years ended December 31, 2021, 2020 and 2019, respectively.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">For the year ended December 31, 2019 basic and diluted earnings per share were calculated based on net income as the numerator, which included the conversion of the noncontrolling interest in connection with the Spin-Off. For the years ended December 31, 2021 and 2020, basic and diluted earnings per share were calculated based on net income attributable to The Pennant Group, Inc. as the numerator.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1278-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024903438712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND ACCOUNTS RECEIVABLE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock', window );">Revenue by major payor source</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by payor for the years ended December 31, 2021, 2020 and 2019, is summarized in the following tables:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:19.221%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.104%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hospice Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,849&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,939&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216,788&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,935&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,317&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,355&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,784&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">148,042&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,317&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">275,143&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,196&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,007&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,807&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157,958&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151,612&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,124&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,694&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.</span></td></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.870%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.176%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hospice Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58,399&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,873&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,272&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,645&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,780&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,887&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,044&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,335&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,780&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235,159&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,572&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,546&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,118&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,514&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,676&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119,584&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,294&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,953&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:80%"> </span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:18.987%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.149%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.149%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.149%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.149%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.152%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health Services</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Hospice Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Revenue %</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,819&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,933&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141,752&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,575&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,061&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,455&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subtotal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,394&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">103,994&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,819&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188,207&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27,711&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,536&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,837&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">121,077&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100,942&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,682&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,531&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of accounts receivable</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of December 31, 2021 and December 31, 2020 is summarized in the following table: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.186%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.391%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.393%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,327&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicaid</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,793&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Managed care</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,590&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,036&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, gross</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54,842&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,864&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(902)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(643)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,940&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,221&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Allowance for doubtful accounts</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity for our allowance for doubtful accounts for the years ended December 31, 2021, 2020 and 2019:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to bad debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">616&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Write-offs of uncollectible accounts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(357)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(594)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(797)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">902&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">643&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024819802280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENTS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Financial data combined by business segment</a></td>
<td class="text"><div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents certain financial information regarding our reportable segments, general and administrative expenses are not allocated to the reportable segments and are included in &#8220;All Other&#8221;. </span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:42.174%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.502%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">All Other</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">309,570&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,124&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439,694&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,208)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,874&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,659&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137,294&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390,953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,309&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,762)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31, 2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">131,907&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,344&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,591)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,107&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock', window );">Reconciliation of total combined adjusted EBITDAR from operations for our reportable segments to combined income from operations</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:66.103%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.445%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Segment Adjusted EBITDAR from Operations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,874&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,048&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,107&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,675&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,863&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,191&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,975&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to Segment EBITDAR from Operations:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Costs at start-up operations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,787&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">483&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,040&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,382&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquisition related costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">665&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Spin-off related transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,219&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transition services costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(e)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">COVID-19 Related costs and supplies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(f)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">447&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:24pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Impairment of long-lived assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(g)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,835&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Add: Net income/ (loss) attributable to noncontrolling interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(548)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(191)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">629&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consolidated and Combined Income from operations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,695&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,917&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,670&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents results related to start-up operations.  This amount excludes rent and depreciation and amortization expense related to such operations.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation expense incurred which is included in cost of services and general and administrative expense. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition related costs that are not capitalizable.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Costs incurred related to the Spin-Off are included in general and administrative expense.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">A portion of the costs incurred under the Transition Services Agreement identified as redundant or nonrecurring that are included in general and administrative expense. Fees incurred under the Transition Services Agreement, net of the Company&#8217;s payroll reimbursement, were $3,124, $5,536, and $2,982, for the years ended December 31, 2021, 2020 and 2019, respectively. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Beginning in the first quarter of fiscal year 2021, we updated our definition of Segment Adjusted EBITDAR to no longer include an adjustment for COVID-19 expenses offset by the amount of sequestration relief. COVID-19 expenses continue to be part of daily operations for which less specific identification is visible. Furthermore, the sequestration relief was extended through December 31, 2021. Sequestration relief was $3,555 for the year ended December 31, 2021.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The 2020 amount represents incremental costs incurred as part of the Company's response to COVID-19 including direct medical supplies, labor, and other expenses, net of $2,765 in increased revenue related to the 2% payment increase in Medicare reimbursements for sequestration relief for the year ended December 31, 2020.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(g)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">On January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements (collectively, the &#8220;Transfer Agreements&#8221;) with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#8220;Transaction&#8221;). The closing of the Transaction is anticipated to occur in the first half of 2022. The Company impaired certain leasehold improvements included in property and equipment primarily  related to the operations included in the transaction with Ensign.</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Reconciliation of Adjusted EBITDAR to Income from Operations [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821536424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract', window );"><strong>Business Combination and Asset Acquisition [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of operations acquired in business combinations</a></td>
<td class="text">The table below presents the allocation of the purchase price for the operations acquired in acquisitions during the years ended December 31, 2021, 2020 and 2019 as noted above:<div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.625%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment, furniture, and fixtures</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">91&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,821&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,341&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other indefinite-lived intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,026&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities assumed</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total acquisitions</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,135&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,239&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,760&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: noncontrolling interest and additional paid in capital</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,646)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: cash paid in prior year (held in escrow)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(585)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,400)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash paid for acquisitions</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,550&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,193&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,760&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Consists of the of noncontrolling interest related to Scripps contribution of assets to the joint venture.  </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total cash paid for acquisitions for the year ended December 31, 2021 includes $585 as an escrow deposit that was paid in the prior year. </span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAndAssetAcquisitionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAndAssetAcquisitionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024903500744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT&#8212;NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of property and equipment, net</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consist of the following:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.081%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.443%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,660&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,984&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,415&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,274&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,590&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18,486)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,706)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,788&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,884&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024818227640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS&#8212;NET (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Activity in goodwill by segment</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents activity in goodwill by segment as of and for the year ended December 31, 2021:</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.122%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.008%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Home Health and Hospice Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Living Services</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2019</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,591&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,233&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,802&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,821&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2021</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,623&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,642&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,265&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Other indefinite-lived intangible assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other indefinite-lived intangible assets consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:60.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.053%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade name</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,355&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicare and Medicaid licenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,133&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,730&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,488&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821567400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCRUED LIABILITIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Schedule of other accrued liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities consist of the following:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.052%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.054%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Refunds payable</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,095&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,664&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Resident deposits</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,647&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contract liabilities (CARES Act advance payments)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,211&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,102&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">982&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued insurance retention - current portion</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,354&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,896&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,586&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,484&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,275&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024821583128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of long-term debt</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term debt, net consists of the following:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revolving credit facility</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: unamortized debt issuance costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,128)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,223)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51,372&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,277&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization expense for debt issuance costs was $488, $330, and $78 for the years ended December 31, 2021, 2020 and 2019, respectively, and is recorded in interest expense, net on the Consolidated and Combined Statements of Income.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28541-108399<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69E<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495743-112612<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21521-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21538-112644<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123599511&amp;loc=d3e64711-112823<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024819736376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Total share-based compensation expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense for all of the Plans for the years ended December 31, 2021, 2020 and 2019:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.938%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Prior to the Spin-Off:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Following the Spin-Off:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense related to stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,093&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,660&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">315&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense related to Restricted Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,200&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,589&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense related to Restricted Stock to non-employee directors</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,040&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,335&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,382&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In future periods, the Company estimates it will recognize the following share-based compensation expense for unvested stock options and unvested Restricted Stock, which were unvested as of December 31, 2021: </span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.402%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.785%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Unrecognized Compensation Expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Recognition Period (in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested stock options</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,620&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.8</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested Restricted Stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,780&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total unrecognized share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,400&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Stock options granted fair value assumptions</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of each option is estimated on the grant date using a Black-Scholes option-pricing model with the following weighted average assumptions for stock options granted after the Spin-Off:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:24.338%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.607%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Grant Year</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options Granted</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Risk-Free Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Life</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expected Volatility</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Dividend Yield</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weighted Average Fair Value of Options</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.84&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">693&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.05&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2019</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">667&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Under the midpoint method, the expected option life is the midpoint between the contractual option life and the average vesting period for the options being granted. This resulted in an expected option life of 6.5 years for the options granted.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Because the Company&#8217;s equity shares have been traded for a relatively short period of time, expected volatility assumption was based on the volatility of related industry stocks.</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Employee stock option activity</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the employee stock option activity during the year ended December 31, 2021:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.438%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Outstanding</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Price</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Options Vested</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Average</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Exercise Price</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">of Options</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Vested</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.48&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">454&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(115)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.67&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/ Expired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(79)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.81&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,242&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.38&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock', window );">Aggregate intrinsic value of options outstanding, vested, expected to vest and exercisable</a></td>
<td class="text"><div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate intrinsic value of options outstanding, vested, unvested and exercised as of and for the period ended December 31, 2021 is as follows:</span></div><div style="margin-bottom:7pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.356%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.444%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Options</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,749&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,221&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Summary of non-vested restricted stock awards</a></td>
<td class="text">A summary of the status of Pennant&#8217;s non-vested Restricted Stock, and changes during the period ended December 31, 2021, is presented below: <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.668%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Vested Restricted Awards</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average Grant Date Fair Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,635&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.82&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.13&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,493&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.00&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024823805448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Components of operating lease cot</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease cost, are as follows:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease costs:</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facility rent&#8212;cost of services</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,958&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,011&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office rent&#8212;cost of services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,905&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,964&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rent&#8212;cost of services</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,863&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39,191&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,975&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">276&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,248&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Represents variable lease cost for operating leases, which costs include property taxes and insurance, common area maintenance, and consumer price index increases, incurred as part of our triple net lease, and which is included in cost of services for the years ended December 31, 2021, 2020 and 2019.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Future minimum lease payments</a></td>
<td class="text"><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table shows the lease maturity analysis for all leases as of December 31, 2021:</span></div><div style="text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.303%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.497%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,929&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,978&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,906&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,778&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,078&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">320,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease payments</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505,333&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: present value adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(201,462)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of total lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">303,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: current lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,118)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term operating lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">287,753&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024820033000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Provision for income taxes on continuing operations</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income tax expense for the years ended December 31, 2021, 2020 and 2019 is summarized as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.915%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,768&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,058&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">566&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,478&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,334&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,536&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">840&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,360)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,070&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(392)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(838)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,752)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,186)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">582&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,085&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Reconciliation of federal statutory rate to effective tax rate</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the federal statutory rate to the effective tax rate for income from continuing operations for the years ended December 31, 2021, 2020 and 2019, respectively, is comprised as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.841%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.769%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax expense at statutory rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State income taxes - net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible meals and entertainment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible equity compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(c)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Section 162(m) limitation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible accrued bonus</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other non-deductible expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Transaction costs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(a)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax credits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deductible equity compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(b)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(30.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Noncontrolling interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other adjustments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total income tax provision</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(d)</span></div></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.723%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.247%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The Company's completion of the Spin-Off  in the year ended December 31, 2019 resulted in the Company not being able to deduct approximately $10,300 of the related transaction costs, which increased the effective tax rate significantly and affected all items that were impacted by this exclusion.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(b)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">During the year ended December 31, 2021, employees exercised stock options representing approximately 115 shares. During the year ended December 31, 2020, employees exercised stock options representing approximately 239 shares. During the year ended December 31, 2019, employees exercised stock options representing approximately 100 shares and had restricted stock awards vest representing 960 shares. These exercises and vestings resulted in tax benefits that reduced the Company's effective tax rate significantly in all three years. </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(c)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">During the year ended December 31, 2021, approximately $2,528 of the share-based compensation expense related to restricted stock did not result in a deferred tax asset because it will be subject to future limitation under IRC Section 162(m).</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(d)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Certain items in the prior year have been reclassified to conform with the current year presentation.  </span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Deferred tax assets and liabilities</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s deferred tax assets and liabilities for the years ended December 31, 2021 and 2020 are summarized below.</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.976%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.498%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets (liabilities):</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,829&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,181&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,728&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79,575&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,979&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">953&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">277&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,085&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,459&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,060&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,444&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,432)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,512)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(907)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(780)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78,656)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80,055)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(217)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,212)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,347)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,848&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,097&#160;</span></td><td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of unrecognized tax benefits</a></td>
<td class="text"><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:</span></div><div style="text-align:justify;text-indent:36pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.648%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.500%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at January 1</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions related to the current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(123)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=124434304&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024818308616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DESCRIPTION OF BUSINESS (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>agency</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>facility</div>
</th>
<th class="th"><div>Oct. 01, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_SpinOffTransactionDistributionRatio', window );">Spin-off transaction, distribution ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfServiceProviders', window );">Number of service providers</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfRealEstatePropertiesUnderLease', window );">Number of properties under lease</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NumberOfRealEstatePropertiesUnderLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Real Estate Properties Under Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NumberOfRealEstatePropertiesUnderLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NumberOfServiceProviders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Service Providers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NumberOfServiceProviders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_SpinOffTransactionDistributionRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Spin Off Transaction, Distribution Ratio</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_SpinOffTransactionDistributionRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814536024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Oct. 01, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>community</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived', window );">The coronavirus aid, relief, and economic security act, advance payments received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,211,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,997,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds', window );">Repayment of the coronavirus aid, relief, and economic security act</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,786,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_AccruedPayrollTaxesEmployerPortion', window );">Accrued payroll taxes employer portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,836,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_DirectMedicalSuppliesLaborAndOtherExpenses', window );">Direct medical supplies, labor, and other expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,765,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,835,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_ImpairmentLongLivedAssetsNumberOfCommunities', window );">Number of communities impaired | community</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Intangible asset impairments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim', window );">General and professional liability, retention limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_CorridorAsAnAdditionalOutOfPocketRetention', window );">Out-of-pocket retention</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim', window );">Workers' compensation, retention limit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">250,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims', window );">Reinsurance receivables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">927,000<span></span>
</td>
<td class="nump">704,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">$ 1,395,000<span></span>
</td>
<td class="nump">10,040,000<span></span>
</td>
<td class="nump">8,335,000<span></span>
</td>
<td class="nump">3,382,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty', window );">General and administrative expense</a></td>
<td class="nump">$ 23,710,000<span></span>
</td>
<td class="nump">36,259,000<span></span>
</td>
<td class="nump">31,296,000<span></span>
</td>
<td class="nump">35,135,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember', window );">Other long-term liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_AccruedPayrollTaxesEmployerPortion', window );">Accrued payroll taxes employer portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,707,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=pntg_AccruedWagesAndRelatedLiabilitiesMember', window );">Accrued Wages and Related Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_AccruedPayrollTaxesEmployerPortion', window );">Accrued payroll taxes employer portion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,129,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,964,000<span></span>
</td>
<td class="nump">$ 7,222,000<span></span>
</td>
<td class="nump">$ 2,769,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment estimated useful lives</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_AccruedPayrollTaxesEmployerPortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Payroll Taxes, Employer Portion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_AccruedPayrollTaxesEmployerPortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_CorridorAsAnAdditionalOutOfPocketRetention">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Corridor as an Additional Out-of-Pocket Retention</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_CorridorAsAnAdditionalOutOfPocketRetention</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_DirectMedicalSuppliesLaborAndOtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Direct Medical Supplies, Labor, and Other Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_DirectMedicalSuppliesLaborAndOtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General And Professional Liability Insurance, Retention Limit, Per Claim</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_ImpairmentLongLivedAssetsNumberOfCommunities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairment, Long-Lived Assets, Number Of Communities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_ImpairmentLongLivedAssetsNumberOfCommunities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment Of The Coronavirus Aid, Relief, and Economic Security Act Funds</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Coronavirus Aid, Relief, and Economic Security Act, Advance Payments Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_WorkersCompensationInsuranceRetentionLimitPerClaim">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Workers' Compensation Insurance, Retention Limit, Per Claim</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_WorkersCompensationInsuranceRetentionLimitPerClaim</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Estimated amount after valuation allowance of reinsurance recoverables, due from reinsurers for incurred claims not yet reported, and claims settlement expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21409-158489<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 310<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=99404803&amp;loc=d3e21412-158489<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=pntg_AccruedWagesAndRelatedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=pntg_AccruedWagesAndRelatedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814935672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - SUMMARY OF INSURANCE LIABILITY (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_GeneralAndProfessionalInsuranceLiability', window );">General and professional liability</a></td>
<td class="nump">$ 2,007<span></span>
</td>
<td class="nump">$ 1,063<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent', window );">Workers&#8217; compensation</a></td>
<td class="nump">4,899<span></span>
</td>
<td class="nump">2,783<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_InsuranceProgramAccruedExpenses', window );">Total estimated liability</a></td>
<td class="nump">6,906<span></span>
</td>
<td class="nump">3,846<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_InsuranceProgramAccruedExpensesNoncurrent', window );">Less: long-term portion, included in other long-term liabilities</a></td>
<td class="num">(5,293)<span></span>
</td>
<td class="num">(2,492)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_InsuranceProgramAccruedExpensesCurrent', window );">Current portion of estimated liability, included in other accrued liabilities</a></td>
<td class="nump">$ 1,613<span></span>
</td>
<td class="nump">$ 1,354<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_GeneralAndProfessionalInsuranceLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>General And Professional Insurance Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_GeneralAndProfessionalInsuranceLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_InsuranceProgramAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Insurance Program Accrued Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_InsuranceProgramAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_InsuranceProgramAccruedExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Insurance Program Accrued Expenses, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_InsuranceProgramAccruedExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_InsuranceProgramAccruedExpensesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Insurance Program Accrued Expenses, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_InsuranceProgramAccruedExpensesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814505224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction', window );">Amounts of related party transaction</a></td>
<td class="nump">$ 208<span></span>
</td>
<td class="nump">$ 578<span></span>
</td>
<td class="nump">$ 291<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyCosts', window );">Cost of services</a></td>
<td class="nump">$ 3,084<span></span>
</td>
<td class="nump">4,205<span></span>
</td>
<td class="nump">3,166<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Related party | Operating lease, rent expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses from transactions with related party</a></td>
<td class="nump">12,773<span></span>
</td>
<td class="nump">12,536<span></span>
</td>
<td class="nump">11,292<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Related party | Transition Services Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Expenses from transactions with related party</a></td>
<td class="nump">$ 3,124<span></span>
</td>
<td class="nump">$ 5,536<span></span>
</td>
<td class="nump">$ 2,982<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Related party | Senior Living Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of operating facilities | property</a></td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Related party | Senior Living Services | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember', window );">Related party | Senior Living Services | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(C))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAmountsOfTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transactions with related party during the financial reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAmountsOfTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=pntg_OperatingLeaseRentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=pntg_OperatingLeaseRentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=pntg_TransitionServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=pntg_TransitionServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024817199032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMPUTATION OF NET INCOME PER COMMON SHARE - RECONCILIATION (Details) - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net income</a></td>
<td class="nump">$ 2,148<span></span>
</td>
<td class="nump">$ 15,553<span></span>
</td>
<td class="nump">$ 3,175<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Add: Net income/ (loss) attributable to noncontrolling interest</a></td>
<td class="num">(548)<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income attributable to The Pennant Group, Inc.</a></td>
<td class="nump">$ 2,696<span></span>
</td>
<td class="nump">$ 15,744<span></span>
</td>
<td class="nump">$ 2,546<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted average shares outstanding for basic net income per share (in shares)</a></td>
<td class="nump">28,406<span></span>
</td>
<td class="nump">28,029<span></span>
</td>
<td class="nump">27,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment', window );">Plus: incremental shares from assumed conversion (in share)</a></td>
<td class="nump">2,236<span></span>
</td>
<td class="nump">2,199<span></span>
</td>
<td class="nump">1,748<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Adjusted weighted average common shares outstanding for diluted income per share (in share)</a></td>
<td class="nump">30,642<span></span>
</td>
<td class="nump">30,228<span></span>
</td>
<td class="nump">29,586<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Earnings Per Share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per common share (in dollars per share)</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.56<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per common share (in dollars per share)</a></td>
<td class="nump">$ 0.09<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="nump">$ 0.11<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Options which are anti-dilutive and not factored into the weighted average common shares amount (in shares)</a></td>
<td class="nump">478<span></span>
</td>
<td class="nump">93<span></span>
</td>
<td class="nump">15<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=125512782&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024818146728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND ACCOUNTS RECEIVABLE - NARRATIVE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived', window );">The coronavirus aid, relief, and economic security act, advance payments received</a></td>
<td class="nump">$ 6,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,997<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms', window );">Payment terms</a></td>
<td class="text">Residency agreements are generally for a term of 30 days, with resident fees billed monthly in advance. For residents under reimbursement arrangements with Medicaid, revenue is recorded based on contractually agreed-upon amounts or rates on a per resident, daily basis or as services are rendered.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer concentration risk | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Customer concentration risk | Revenue | Medicare And Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">62.60%<span></span>
</td>
<td class="nump">60.10%<span></span>
</td>
<td class="nump">55.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Coronavirus Aid, Relief, and Economic Security Act, Advance Payments Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of payment terms in contract with customer. Includes, but is not limited to, timing of payment, existence of financing component, variability of consideration and constraint on variable consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pntg_MedicareAndMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pntg_MedicareAndMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814142856">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND ACCOUNTS RECEIVABLE - REVENUE BY MAJOR PAYOR (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 439,694<span></span>
</td>
<td class="nump">$ 390,953<span></span>
</td>
<td class="nump">$ 338,531<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_MedicareMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 216,788<span></span>
</td>
<td class="nump">$ 178,272<span></span>
</td>
<td class="nump">$ 141,752<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_MedicareMember', window );">Medicare | Revenue | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">49.30%<span></span>
</td>
<td class="nump">45.60%<span></span>
</td>
<td class="nump">41.90%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_MedicaidMember', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 58,355<span></span>
</td>
<td class="nump">$ 56,887<span></span>
</td>
<td class="nump">$ 46,455<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_MedicaidMember', window );">Medicaid | Revenue | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">13.30%<span></span>
</td>
<td class="nump">14.50%<span></span>
</td>
<td class="nump">13.70%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_MedicareAndMedicaidMember', window );">Medicare And Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 275,143<span></span>
</td>
<td class="nump">$ 235,159<span></span>
</td>
<td class="nump">$ 188,207<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_MedicareAndMedicaidMember', window );">Medicare And Medicaid | Revenue | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">62.60%<span></span>
</td>
<td class="nump">60.10%<span></span>
</td>
<td class="nump">55.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_ManagedCareMember', window );">Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 49,363<span></span>
</td>
<td class="nump">$ 33,118<span></span>
</td>
<td class="nump">$ 29,247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_ManagedCareMember', window );">Managed care | Revenue | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">11.20%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">8.60%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_PrivateAndOtherMember', window );">Private and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 115,188<span></span>
</td>
<td class="nump">$ 122,676<span></span>
</td>
<td class="nump">$ 121,077<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_PrivateAndOtherMember', window );">Private and other | Revenue | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Revenue %</a></td>
<td class="nump">26.20%<span></span>
</td>
<td class="nump">31.40%<span></span>
</td>
<td class="nump">35.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Home Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 157,958<span></span>
</td>
<td class="nump">$ 119,584<span></span>
</td>
<td class="nump">$ 100,942<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Home Health Services | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">80,849<span></span>
</td>
<td class="nump">58,399<span></span>
</td>
<td class="nump">47,819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Home Health Services | Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">8,935<span></span>
</td>
<td class="nump">7,645<span></span>
</td>
<td class="nump">6,575<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Home Health Services | Medicare And Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">89,784<span></span>
</td>
<td class="nump">66,044<span></span>
</td>
<td class="nump">54,394<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Home Health Services | Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">46,167<span></span>
</td>
<td class="nump">31,572<span></span>
</td>
<td class="nump">27,711<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Home Health Services | Private and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">22,007<span></span>
</td>
<td class="nump">21,968<span></span>
</td>
<td class="nump">18,837<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Hospice Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">151,612<span></span>
</td>
<td class="nump">134,075<span></span>
</td>
<td class="nump">105,682<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Hospice Services | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">135,939<span></span>
</td>
<td class="nump">119,873<span></span>
</td>
<td class="nump">93,933<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Hospice Services | Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">12,103<span></span>
</td>
<td class="nump">12,462<span></span>
</td>
<td class="nump">10,061<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Hospice Services | Medicare And Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">148,042<span></span>
</td>
<td class="nump">132,335<span></span>
</td>
<td class="nump">103,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Hospice Services | Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">3,196<span></span>
</td>
<td class="nump">1,546<span></span>
</td>
<td class="nump">1,536<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Hospice Services | Private and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">374<span></span>
</td>
<td class="nump">194<span></span>
</td>
<td class="nump">152<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">130,124<span></span>
</td>
<td class="nump">137,294<span></span>
</td>
<td class="nump">131,907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">37,317<span></span>
</td>
<td class="nump">36,780<span></span>
</td>
<td class="nump">29,819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Medicare And Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">37,317<span></span>
</td>
<td class="nump">36,780<span></span>
</td>
<td class="nump">29,819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Private and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 92,807<span></span>
</td>
<td class="nump">$ 100,514<span></span>
</td>
<td class="nump">$ 102,088<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pntg_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pntg_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pntg_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pntg_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pntg_MedicareAndMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pntg_MedicareAndMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pntg_ManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pntg_ManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pntg_PrivateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pntg_PrivateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=pntg_HomeHealthSubsegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=pntg_HomeHealthSubsegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=pntg_HospiceSubsegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=pntg_HospiceSubsegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024817211848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>REVENUE AND ACCOUNTS RECEIVABLE - ACCOUNTS RECEIVABLE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrentAbstract', window );"><strong>Accounts Receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable, gross</a></td>
<td class="nump">$ 54,842<span></span>
</td>
<td class="nump">$ 47,864<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Less: allowance for doubtful accounts</a></td>
<td class="num">(902)<span></span>
</td>
<td class="num">(643)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">53,940<span></span>
</td>
<td class="nump">47,221<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_MedicareMember', window );">Medicare</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrentAbstract', window );"><strong>Accounts Receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable, gross</a></td>
<td class="nump">31,327<span></span>
</td>
<td class="nump">28,569<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_MedicaidMember', window );">Medicaid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrentAbstract', window );"><strong>Accounts Receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable, gross</a></td>
<td class="nump">11,793<span></span>
</td>
<td class="nump">7,669<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_ManagedCareMember', window );">Managed care</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrentAbstract', window );"><strong>Accounts Receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable, gross</a></td>
<td class="nump">7,901<span></span>
</td>
<td class="nump">7,590<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_PrivateAndOtherMember', window );">Private and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrentAbstract', window );"><strong>Accounts Receivable [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableGrossCurrent', window );">Accounts receivable, gross</a></td>
<td class="nump">$ 3,821<span></span>
</td>
<td class="nump">$ 4,036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGrossCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGrossCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pntg_MedicareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pntg_MedicareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pntg_MedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pntg_MedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pntg_ManagedCareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pntg_ManagedCareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pntg_PrivateAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pntg_PrivateAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024914826632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>REVENUE AND ACCOUNTS RECEIVABLE - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at beginning of period</a></td>
<td class="nump">$ 643<span></span>
</td>
<td class="nump">$ 677<span></span>
</td>
<td class="nump">$ 616<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">616<span></span>
</td>
<td class="nump">560<span></span>
</td>
<td class="nump">858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs of uncollectible accounts</a></td>
<td class="num">(357)<span></span>
</td>
<td class="num">(594)<span></span>
</td>
<td class="num">(797)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Balance at end of period</a></td>
<td class="nump">$ 902<span></span>
</td>
<td class="nump">$ 643<span></span>
</td>
<td class="nump">$ 677<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024824226856">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>BUSINESS SEGMENTS - NARRATIVE (Details) - Dec. 31, 2021<br></strong></div></th>
<th class="th"><div>agency</div></th>
<th class="th"><div>facility</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfServiceProviders', window );">Number of service providers</a></td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfRealEstatePropertiesUnderLease', window );">Number of properties under lease</a></td>
<td class="nump">54<span></span>
</td>
<td class="nump">54<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NumberOfRealEstatePropertiesUnderLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Real Estate Properties Under Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NumberOfRealEstatePropertiesUnderLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NumberOfServiceProviders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Service Providers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NumberOfServiceProviders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024914857192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENTS - FINANCIAL DATA (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 439,694<span></span>
</td>
<td class="nump">$ 390,953<span></span>
</td>
<td class="nump">$ 338,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation', window );">Segment Adjusted EBITDAR from Operations</a></td>
<td class="nump">66,874<span></span>
</td>
<td class="nump">75,048<span></span>
</td>
<td class="nump">62,107<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">130,124<span></span>
</td>
<td class="nump">137,294<span></span>
</td>
<td class="nump">131,907<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Home Health and Hospice Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">309,570<span></span>
</td>
<td class="nump">253,659<span></span>
</td>
<td class="nump">206,624<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation', window );">Segment Adjusted EBITDAR from Operations</a></td>
<td class="nump">55,565<span></span>
</td>
<td class="nump">49,501<span></span>
</td>
<td class="nump">33,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember', window );">Operating segments | Senior Living Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">130,124<span></span>
</td>
<td class="nump">137,294<span></span>
</td>
<td class="nump">131,907<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation', window );">Segment Adjusted EBITDAR from Operations</a></td>
<td class="nump">37,517<span></span>
</td>
<td class="nump">48,309<span></span>
</td>
<td class="nump">47,344<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember', window );">All Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation', window );">Segment Adjusted EBITDAR from Operations</a></td>
<td class="num">$ (26,208)<span></span>
</td>
<td class="num">$ (22,762)<span></span>
</td>
<td class="num">$ (18,591)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) From Continuing Operations Before Interest, Taxes, Depreciation And Amortization, Rent Costs, Acquisition Costs And Stock-based Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_CorporateNonSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814986984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>BUSINESS SEGMENTS - INCOME FROM OPERATIONS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation', window );">Segment Adjusted EBITDAR from Operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 66,874<span></span>
</td>
<td class="nump">$ 75,048<span></span>
</td>
<td class="nump">$ 62,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Less: Depreciation and amortization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,784<span></span>
</td>
<td class="nump">4,675<span></span>
</td>
<td class="nump">3,810<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Rent&#8212;cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,863<span></span>
</td>
<td class="nump">39,191<span></span>
</td>
<td class="nump">34,975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24)<span></span>
</td>
<td class="nump">225<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_StartUpActivitiesCosts', window );">Less: Costs at start-up operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,045<span></span>
</td>
<td class="nump">1,787<span></span>
</td>
<td class="nump">483<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 1,395<span></span>
</td>
<td class="nump">10,040<span></span>
</td>
<td class="nump">8,335<span></span>
</td>
<td class="nump">3,382<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Acquisition related costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">665<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_SpinoffTransactionCosts', window );">Spin-off related transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">13,219<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_AcquisitionRelatedCostsNotCapitalized', window );">Transaction services costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,008<span></span>
</td>
<td class="nump">1,181<span></span>
</td>
<td class="nump">532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses', window );">COVID-19 Related costs and supplies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">447<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,835<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest', window );">Add: Net income/ (loss) attributable to noncontrolling interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(548)<span></span>
</td>
<td class="num">(191)<span></span>
</td>
<td class="nump">629<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,695<span></span>
</td>
<td class="nump">18,917<span></span>
</td>
<td class="nump">5,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_AmountToOffsetExpenseSequestrationRelief', window );">Sequestration relief</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_DirectMedicalSuppliesLaborAndOtherExpenses', window );">Direct medical supplies, labor, and other expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=pntg_TransitionServicesAgreementMember', window );">Transition Services Agreement | Related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EntityWideRevenueMajorCustomerLineItems', window );"><strong>Revenue, Major Customer [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Fees incurred</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,124<span></span>
</td>
<td class="nump">$ 5,536<span></span>
</td>
<td class="nump">$ 2,982<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_AcquisitionRelatedCostsNotCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Acquisition-Related Costs, Not Capitalized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_AcquisitionRelatedCostsNotCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_AmountToOffsetExpenseSequestrationRelief">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount to Offset Expense, Sequestration Relief</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_AmountToOffsetExpenseSequestrationRelief</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_DirectMedicalSuppliesLaborAndOtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Direct Medical Supplies, Labor, and Other Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_DirectMedicalSuppliesLaborAndOtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Income (Loss) From Continuing Operations Before Interest, Taxes, Depreciation And Amortization, Rent Costs, Acquisition Costs And Stock-based Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Incremental Costs, Direct Medical Supplies, Labor, and Other Expenses</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_SpinoffTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Spinoff, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_SpinoffTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_StartUpActivitiesCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Start-Up Activities, Costs</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_StartUpActivitiesCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EntityWideRevenueMajorCustomerLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EntityWideRevenueMajorCustomerLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of Net Income (Loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=pntg_TransitionServicesAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=pntg_TransitionServicesAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024819558024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS - NARRATIVE (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Oct. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>agency</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>agency</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>agency</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NonCapitalizableRelatedToTheBusinessCombinations', window );">Non-capitalizable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 80<span></span>
</td>
<td class="nump">$ 99<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInterestInJointVenture', window );">Acquire interest in joint venture</a></td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_CashAndContributedAssetsNetBookValue', window );">Net book value</a></td>
<td class="nump">614<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of noncontrolling interests, net of tax</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">451<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,595<span></span>
</td>
<td class="nump">84,671<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business combination, acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80<span></span>
</td>
<td class="nump">99<span></span>
</td>
<td class="nump">$ 665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pntg_ScrippsHealthMember', window );">Scripps Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest', window );">Sale of noncontrolling interests, net of tax</a></td>
<td class="nump">4,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture', window );">Cash from sale of noncontrolling interest</a></td>
<td class="nump">555<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NoncontrollingInterestJointVenture', window );">Noncontrolling interest to scripps</a></td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_AdditionalPaidInCapitalEffectOfIncomeTax', window );">Income tax effect</a></td>
<td class="nump">$ 104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pntg_ScrippsHealthMember', window );">Scripps Health | Home Health Joint Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership interest</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CounterpartyNameAxis=pntg_ScrippsHealthMember', window );">Scripps Health | Hospice Join Venture</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership interest</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of Individually Immaterial Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Other indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,242<span></span>
</td>
<td class="nump">14,026<span></span>
</td>
<td class="nump">8,326<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 39,239<span></span>
</td>
<td class="nump">$ 18,760<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of Individually Immaterial Business Acquisitions | Asset Acquisitions 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Business combination, purchase price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,135<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of Individually Immaterial Business Acquisitions | Asset Acquisitions 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfUnitsInRealEstatePropertyAcquired', window );">Number of units (in units) | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="nump">143<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=pntg_BusinessAcquisitions2019Member', window );">Business acquisitions 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts', window );">Business combination, acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 611<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=pntg_HospiceSubsegmentMember', window );">Hospice Services | Series of Individually Immaterial Business Acquisitions | Asset Acquisitions 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Other indefinite-lived intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=pntg_HospiceSubsegmentMember', window );">Hospice Services | Series of Individually Immaterial Business Acquisitions | Asset Acquisitions 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfBusinessesAndAssetsAcquired', window );">Number of businesses acquired and assets acquisitions | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsegmentsAxis=pntg_HomeCareAgenciesMember', window );">Home Care Agencies | Series of Individually Immaterial Business Acquisitions | Asset acquisitions 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfBusinessesAndAssetsAcquired', window );">Number of businesses acquired and assets acquisitions | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Home Health Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfBusinessesAndAssetsAcquired', window );">Number of businesses acquired and assets acquisitions | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Home Health Services | Asset Acquisitions 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfBusinessesAndAssetsAcquired', window );">Number of businesses acquired and assets acquisitions | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Hospice Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfBusinessesAndAssetsAcquired', window );">Number of businesses acquired and assets acquisitions | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Hospice Services | Asset Acquisitions 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfBusinessesAndAssetsAcquired', window );">Number of businesses acquired and assets acquisitions | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Hospice Services | Series of Individually Immaterial Business Acquisitions | Asset Acquisitions 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfBusinessesAndAssetsAcquired', window );">Number of businesses acquired and assets acquisitions | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Home Care Agencies | Asset Acquisitions 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfBusinessesAndAssetsAcquired', window );">Number of businesses acquired and assets acquisitions | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Asset acquisitions 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfBusinessesAndAssetsAcquired', window );">Number of businesses acquired and assets acquisitions | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Asset acquisitions 2019 | Ensign Subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfBusinessesAndAssetsAcquired', window );">Number of businesses acquired and assets acquisitions | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_AdditionalPaidInCapitalEffectOfIncomeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional Paid in Capital, Effect of Income Tax</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_AdditionalPaidInCapitalEffectOfIncomeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_CashAndContributedAssetsNetBookValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash And Contributed Assets Net Book Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_CashAndContributedAssetsNetBookValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NonCapitalizableRelatedToTheBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-capitalizable Related to the Business Combinations</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NonCapitalizableRelatedToTheBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NoncontrollingInterestJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncontrolling Interest Joint Venture</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NoncontrollingInterestJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NumberOfBusinessesAndAssetsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Businesses And Assets Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NumberOfBusinessesAndAssetsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NumberOfUnitsInRealEstatePropertyAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Units In Real Estate Property Acquired</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NumberOfUnitsInRealEstatePropertyAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionRelatedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 25<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123586518&amp;loc=d3e1043-128460<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionRelatedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=116859721&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569655-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDivestitureOfInterestInJointVenture">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDivestitureOfInterestInJointVenture</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pntg_ScrippsHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pntg_ScrippsHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=pntg_HomeHealthJointVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=pntg_HomeHealthJointVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=pntg_HospiceJoinVentureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=pntg_HospiceJoinVentureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=pntg_AssetAcquisitions2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=pntg_AssetAcquisitions2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=pntg_AssetAcquisitions2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=pntg_AssetAcquisitions2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=pntg_BusinessAcquisitions2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=pntg_BusinessAcquisitions2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=pntg_HospiceSubsegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=pntg_HospiceSubsegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=pntg_HomeCareAgenciesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=pntg_HomeCareAgenciesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetAcquisitionAxis=pntg_AssetAcquisitions2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetAcquisitionAxis=pntg_AssetAcquisitions2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsegmentsAxis=pntg_HomeHealthSubsegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsegmentsAxis=pntg_HomeHealthSubsegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pntg_EnsignSubsidiaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pntg_EnsignSubsidiaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814461560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACQUISITIONS - SCHEDULE OF OPERATIONS ACQUIRED IN BUSINESS COMBINATIONS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 66,444<span></span>
</td>
<td class="nump">$ 74,265<span></span>
</td>
<td class="nump">$ 41,233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_TotalAcquisitions', window );">Total acquisitions</a></td>
<td class="nump">585<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember', window );">Series of Individually Immaterial Business Acquisitions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures', window );">Equipment, furniture, and fixtures</a></td>
<td class="nump">174<span></span>
</td>
<td class="nump">62<span></span>
</td>
<td class="nump">91<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">25,211<span></span>
</td>
<td class="nump">7,821<span></span>
</td>
<td class="nump">10,341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets', window );">Other indefinite-lived intangible assets</a></td>
<td class="nump">14,026<span></span>
</td>
<td class="nump">6,242<span></span>
</td>
<td class="nump">8,326<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities', window );">Liabilities assumed</a></td>
<td class="num">(172)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Total acquisitions</a></td>
<td class="nump">39,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue', window );">Less: noncontrolling interest and additional paid in capital</a></td>
<td class="num">(4,646)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_BusinessCombinationCashPaidInPriorYear', window );">Less: cash paid in prior year (held in escrow)</a></td>
<td class="num">(1,400)<span></span>
</td>
<td class="num">(585)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest', window );">Total cash paid for acquisitions</a></td>
<td class="nump">$ 33,193<span></span>
</td>
<td class="nump">$ 13,550<span></span>
</td>
<td class="nump">$ 18,760<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_BusinessCombinationCashPaidInPriorYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Cash Paid In Prior Year</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_BusinessCombinationCashPaidInPriorYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment, Furniture and Fixtures</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_TotalAcquisitions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total Acquisitions</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_TotalAcquisitions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123413009&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814093208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY AND EQUIPMENT&#8212;NET (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 35,274<span></span>
</td>
<td class="nump">$ 33,590<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(18,486)<span></span>
</td>
<td class="num">(15,706)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">16,788<span></span>
</td>
<td class="nump">17,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">4,751<span></span>
</td>
<td class="nump">4,661<span></span>
</td>
<td class="nump">$ 3,757<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">2,835<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">11,660<span></span>
</td>
<td class="nump">9,984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">2,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">22,415<span></span>
</td>
<td class="nump">22,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 1,199<span></span>
</td>
<td class="nump">$ 1,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024903473592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS&#8212;NET - NARRATIVE (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024818308600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS&#8212;NET - ACTIVITY IN GOODWILL (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">$ 66,444<span></span>
</td>
<td class="nump">$ 41,233<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">7,821<span></span>
</td>
<td class="nump">25,211<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">74,265<span></span>
</td>
<td class="nump">66,444<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">62,802<span></span>
</td>
<td class="nump">37,591<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">7,821<span></span>
</td>
<td class="nump">25,211<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">70,623<span></span>
</td>
<td class="nump">62,802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, beginning balance</a></td>
<td class="nump">3,642<span></span>
</td>
<td class="nump">3,642<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill, ending balance</a></td>
<td class="nump">$ 3,642<span></span>
</td>
<td class="nump">$ 3,642<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024824114664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>GOODWILL AND INTANGIBLE ASSETS&#8212;NET - INDEFINITE-LIVED INTANGIBLE ASSETS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Other indefinite-lived intangibles</a></td>
<td class="nump">$ 53,730<span></span>
</td>
<td class="nump">$ 47,488<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Other indefinite-lived intangibles</a></td>
<td class="nump">1,355<span></span>
</td>
<td class="nump">1,355<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember', window );">Medicare and Medicaid licenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems', window );"><strong>Indefinite-lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Other indefinite-lived intangibles</a></td>
<td class="nump">$ 52,375<span></span>
</td>
<td class="nump">$ 46,133<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_LicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024819623736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OTHER ACCRUED LIABILITIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrentAbstract', window );"><strong>Other Accrued Liabilities, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CustomerRefundLiabilityCurrent', window );">Refunds payable</a></td>
<td class="nump">$ 3,095<span></span>
</td>
<td class="nump">$ 2,664<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">1,456<span></span>
</td>
<td class="nump">1,271<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepositLiabilityCurrent', window );">Resident deposits</a></td>
<td class="nump">5,111<span></span>
</td>
<td class="nump">5,647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_ContractLiabilityAdvancePaymentsCARESAct', window );">Contract liabilities (CARES Act advance payments)</a></td>
<td class="nump">6,211<span></span>
</td>
<td class="nump">22,771<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent', window );">Property taxes</a></td>
<td class="nump">1,102<span></span>
</td>
<td class="nump">982<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SelfInsuranceReserveCurrent', window );">Accrued insurance retention - current portion</a></td>
<td class="nump">1,613<span></span>
</td>
<td class="nump">1,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">2,896<span></span>
</td>
<td class="nump">3,586<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">$ 21,484<span></span>
</td>
<td class="nump">$ 38,275<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_ContractLiabilityAdvancePaymentsCARESAct">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contract Liability, Advance Payments, CARES Act</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_ContractLiabilityAdvancePaymentsCARESAct</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6419918&amp;loc=d3e35281-107843<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123360276&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123351226&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current portion, due within one year or one operating cycle, if longer, of deposits held other than customer deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99376301&amp;loc=d3e1243-112600<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SelfInsuranceReserveCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid within one year (or the normal operating cycle, if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SelfInsuranceReserveCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024818201096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OTHER ACCRUED LIABILITIES - NARRATIVE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived', window );">The coronavirus aid, relief, and economic security act, advance payments received</a></td>
<td class="nump">$ 6,211<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 27,997<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds', window );">Repayment of the coronavirus aid, relief, and economic security act</a></td>
<td class="nump">$ 21,786<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RestatementAxis=srt_RestatementAdjustmentMember', window );">Restatement Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnusualOrInfrequentItemLineItems', window );"><strong>Unusual or Infrequent Item, or Both [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrent', window );">AAP amount reclassified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,226<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Repayment Of The Coronavirus Aid, Relief, and Economic Security Act Funds</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Coronavirus Aid, Relief, and Economic Security Act, Advance Payments Received</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 201.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnusualOrInfrequentItemLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnusualOrInfrequentItemLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RestatementAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RestatementAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024914813880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - SCHEDULE OF LONG-TERM DEBT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Less: unamortized debt issuance costs</a></td>
<td class="num">$ (2,128)<span></span>
</td>
<td class="num">$ (1,223)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Long-term debt, net</a></td>
<td class="nump">51,372<span></span>
</td>
<td class="nump">8,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of deferred financing fees</a></td>
<td class="nump">488<span></span>
</td>
<td class="nump">330<span></span>
</td>
<td class="nump">$ 78<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Revolving credit facility</a></td>
<td class="nump">$ 53,500<span></span>
</td>
<td class="nump">$ 9,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495355-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI http://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814959304">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - NARRATIVE (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Feb. 23, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Borrowing capacity</a></td>
<td class="nump">$ 150,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.64%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Borrowing availability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,314,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.35%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Minimum | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage', window );">Commitment fee percentage</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Maximum | LIBOR</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin</a></td>
<td class="nump">3.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember', window );">Revolving credit facility | Maximum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Margin</a></td>
<td class="nump">2.30%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember', window );">Letters of credit | Line of credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Letters of credit outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,186,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of long-term debt outstanding calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_RevolvingCreditFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024817129208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - SHARE-BASED COMPENSATION (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 01, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="nump">$ 1,395<span></span>
</td>
<td class="nump">$ 10,040<span></span>
</td>
<td class="nump">$ 8,335<span></span>
</td>
<td class="nump">$ 3,382<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,093<span></span>
</td>
<td class="nump">1,660<span></span>
</td>
<td class="nump">315<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,141<span></span>
</td>
<td class="nump">6,200<span></span>
</td>
<td class="nump">1,589<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards | Non-employee director</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 806<span></span>
</td>
<td class="nump">$ 475<span></span>
</td>
<td class="nump">$ 83<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_DirectorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_DirectorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814284264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - SHARE-BASED COMPENSATION EXPENSE AND NARRATIVE (Details)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1', window );">Weighted average contractual life for options outstanding, vested and expected to vest</a></td>
<td class="text">7 years 4 months 20 days<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember', window );">The Ensign Plans</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Total unrecognized share-based compensation expense</a></td>
<td class="nump">$ 17,400<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Options, unvested and outstanding (in shares) | shares</a></td>
<td class="nump">1,402<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember', window );">The Ensign Plans | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unvested stock options</a></td>
<td class="nump">$ 12,620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unvested options and stock awards, cost net yet recognized, period for recognition</a></td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Options, vesting percent per year</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Options, expiration period</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember', window );">The Ensign Plans | Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unvested Restricted Stock</a></td>
<td class="nump">$ 4,780<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unvested options and stock awards, cost net yet recognized, period for recognition</a></td>
<td class="text">10 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814218296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - OPTIONS GRANTED (Details) - The Ensign Plans - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember', window );">2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="nump">454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options (in dollars per share)</a></td>
<td class="nump">$ 13.84<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember', window );">2021 | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-Free Interest Rate</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">38.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend Yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember', window );">2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">693<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.05<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember', window );">2020 | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend Yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember', window );">2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Options granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">667<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.70<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember', window );">2019 | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-Free Interest Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 6 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend Yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=pntg_GrantYear2021Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=pntg_GrantYear2021Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=pntg_GrantYear2020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=pntg_GrantYear2020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardDateAxis=pntg_GrantYear2019Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardDateAxis=pntg_GrantYear2019Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024818137800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - EMPLOYEE STOCK OPTION ACTIVITY (Details) - The Ensign Plans - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Beginning balance, outstanding (in shares)</a></td>
<td class="nump">1,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="nump">454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="num">(115)<span></span>
</td>
<td class="num">(239)<span></span>
</td>
<td class="num">(100)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited &amp; Expired (in shares)</a></td>
<td class="num">(79)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Ending balance, outstanding (in shares)</a></td>
<td class="nump">2,242<span></span>
</td>
<td class="nump">1,982<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Beginning of period, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 17.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="nump">35.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="nump">7.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited &amp; Expired (in dollars per share)</a></td>
<td class="nump">21.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">End of period, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 21.38<span></span>
</td>
<td class="nump">$ 17.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber', window );">Number of options vested (in shares)</a></td>
<td class="nump">840<span></span>
</td>
<td class="nump">615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice', window );">Weighted average exercise price of options vested (in dollars per share)</a></td>
<td class="nump">$ 12.28<span></span>
</td>
<td class="nump">$ 7.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding, Number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024819990072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - AGGREGATE INTRINSIC VALUE OF OPTIONS (Details) - The Ensign Plans<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding</a></td>
<td class="nump">$ 14,749<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue', window );">Vested</a></td>
<td class="nump">10,221<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue', window );">Unvested</a></td>
<td class="nump">4,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Exercised</a></td>
<td class="nump">$ 3,248<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding, Aggregate Intrinsic Value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814420984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>OPTIONS AND AWARDS - RESTRICTED STOCK (Details) - The Ensign Plans - Restricted stock awards - $ / shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Non-Vested Restricted Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Beginning balance, outstanding (in shares)</a></td>
<td class="nump">1,635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(157)<span></span>
</td>
<td class="num">(960)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Ending balance, outstanding (in shares)</a></td>
<td class="nump">1,493<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Beginning of period, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 14.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share)</a></td>
<td class="nump">39.82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share)</a></td>
<td class="nump">16.20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in dollars per share)</a></td>
<td class="nump">14.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">End of period, weighted average exercise price (in dollars per share)</a></td>
<td class="nump">$ 15.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814785832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - NARRATIVE (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>agency</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>facility</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>property</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>arrangement</div>
</th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">14 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfRealEstatePropertiesUnderLease', window );">Number of properties under lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="nump">54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfRealEstateProperties', window );">Number of operating facilities | property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement', window );">Number of properties under lease, master lease agreement | facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfSeparateMasterLeaseArrangements', window );">Number of separate master lease arrangements | arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Minimum | Related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">21 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember', window );">Senior Living Services | Maximum | Related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfServiceProviders', window );">Number of service providers | agency</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember', window );">Home Health and Hospice Services | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NumberOfRealEstatePropertiesUnderLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Real Estate Properties Under Lease</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NumberOfRealEstatePropertiesUnderLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Real Estate Properties Under Lease, Master Lease Agreement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NumberOfSeparateMasterLeaseArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Separate Master Lease Arrangements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NumberOfSeparateMasterLeaseArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NumberOfServiceProviders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Service Providers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NumberOfServiceProviders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfRealEstateProperties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of real estate properties owned as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfRealEstateProperties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_SeniorLivingServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=srt_AffiliatedEntityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=pntg_HomeHealthAndHospiceServicesSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024819848344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - IMPACT OF NEW LEASES GUIDANCE (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (143)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">6,248<span></span>
</td>
<td class="nump">5,330<span></span>
</td>
<td class="nump">4,608<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">40,863<span></span>
</td>
<td class="nump">39,191<span></span>
</td>
<td class="nump">34,975<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of services | Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">35,958<span></span>
</td>
<td class="nump">35,562<span></span>
</td>
<td class="nump">32,011<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of services | Office</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">4,905<span></span>
</td>
<td class="nump">3,772<span></span>
</td>
<td class="nump">2,964<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostAbstract', window );"><strong>Lease, Cost [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease costs</a></td>
<td class="nump">$ 276<span></span>
</td>
<td class="nump">$ 295<span></span>
</td>
<td class="nump">$ 162<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=pntg_FacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=pntg_FacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OfficeBuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis=srt_OfficeBuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814421784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - FUTURE MINIMUM LEASE PAYMENTS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Leases, Under Adoption of ASC 842 [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 38,929<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">37,978<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">36,906<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">35,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">35,078<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">320,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">505,333<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: present value adjustments</a></td>
<td class="num">(201,462)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of total lease liabilities</a></td>
<td class="nump">303,871<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: current lease liabilities</a></td>
<td class="num">(16,118)<span></span>
</td>
<td class="num">$ (14,106)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">$ 287,753<span></span>
</td>
<td class="nump">$ 296,615<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024819443880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - PROVISION FOR INCOME TAXES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 1,768<span></span>
</td>
<td class="nump">$ 5,058<span></span>
</td>
<td class="nump">$ 562<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">566<span></span>
</td>
<td class="nump">1,478<span></span>
</td>
<td class="nump">278<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current</a></td>
<td class="nump">2,334<span></span>
</td>
<td class="nump">6,536<span></span>
</td>
<td class="nump">840<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(1,360)<span></span>
</td>
<td class="num">(3,348)<span></span>
</td>
<td class="nump">1,070<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(392)<span></span>
</td>
<td class="num">(838)<span></span>
</td>
<td class="nump">175<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred</a></td>
<td class="num">(1,752)<span></span>
</td>
<td class="num">(4,186)<span></span>
</td>
<td class="nump">1,245<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total income tax expense</a></td>
<td class="nump">$ 582<span></span>
</td>
<td class="nump">$ 2,350<span></span>
</td>
<td class="nump">$ 2,085<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024819573976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - TAX RATE RECONCILIATION (Details) - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax expense at statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income taxes - net of federal benefit</a></td>
<td class="nump">3.90%<span></span>
</td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">6.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment', window );">Non-deductible meals and entertainment</a></td>
<td class="nump">1.80%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">1.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Non-deductible equity compensation</a></td>
<td class="nump">19.40%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation', window );">Section 162(m) limitation</a></td>
<td class="nump">2.10%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus', window );">Non-deductible accrued bonus</a></td>
<td class="nump">2.70%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Other non-deductible expenses</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.10%<span></span>
</td>
<td class="nump">0.80%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent', window );">Transaction costs</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">41.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits', window );">Tax credits</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(1.60%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent', window );">Deductible equity compensation</a></td>
<td class="num">(34.10%)<span></span>
</td>
<td class="num">(10.80%)<span></span>
</td>
<td class="num">(30.00%)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense', window );">Noncontrolling interest</a></td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">0.30%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other adjustments</a></td>
<td class="num">(1.20%)<span></span>
</td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(0.40%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Total income tax provision(d)</a></td>
<td class="nump">21.30%<span></span>
</td>
<td class="nump">13.10%<span></span>
</td>
<td class="nump">39.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount', window );">Nondeductible transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,300<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 10,040<span></span>
</td>
<td class="nump">$ 8,335<span></span>
</td>
<td class="nump">$ 3,382<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">$ 2,528<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember', window );">The Ensign Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">239<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember', window );">The Ensign Plans | Restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="nump">157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">960<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Deductible Expense, Share-based Payment Arrangement, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Accrued Bonus</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Nondeductible Expense, Transaction Costs, Amount</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Section 162(m) Limitation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Transaction Costs, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=pntg_TheEnsignPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024818174184">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNetAbstract', window );"><strong>Deferred Tax Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">$ 9,829<span></span>
</td>
<td class="nump">$ 8,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="nump">1,728<span></span>
</td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsStateTaxes', window );">State taxes</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">147<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_DeferredTaxAssetsLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">79,575<span></span>
</td>
<td class="nump">80,979<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance', window );">Insurance</a></td>
<td class="nump">953<span></span>
</td>
<td class="nump">277<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">92,085<span></span>
</td>
<td class="nump">90,459<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(25)<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net deferred tax assets</a></td>
<td class="nump">92,060<span></span>
</td>
<td class="nump">90,444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(8,432)<span></span>
</td>
<td class="num">(7,512)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="num">(907)<span></span>
</td>
<td class="num">(780)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Right of use asset</a></td>
<td class="num">(78,656)<span></span>
</td>
<td class="num">(80,055)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_DeferredTaxLiabilitiesStateTaxes', window );">State taxes</a></td>
<td class="num">(217)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(88,212)<span></span>
</td>
<td class="num">(88,347)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets (liabilities)</a></td>
<td class="nump">$ 3,848<span></span>
</td>
<td class="nump">$ 2,097<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_DeferredTaxAssetsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_DeferredTaxAssetsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Depreciation And Amortization</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_DeferredTaxLiabilitiesStateTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, State Taxes</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_DeferredTaxLiabilitiesStateTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsStateTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsStateTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated losses under self insurance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024824263544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - NARRATIVE (Details) - State and Local Jurisdiction<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 614<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsValuationAllowance', window );">Operating loss carryforwards, valuation allowance</a></td>
<td class="nump">$ 25<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024820009144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at January 1</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Additions for tax positions of prior years</a></td>
<td class="nump">188<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions', window );">Reductions for tax positions related to the current year</a></td>
<td class="num">(123)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at December 31</a></td>
<td class="nump">$ 65<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024813981976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">2 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 28, 2022 </div>
<div>record</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>record </div>
<div>review</div>
</th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled', window );">Number of operating subsidiaries with reviews scheduled | review</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview', window );">Number of patient records under review</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_UniformProgramIntegrityContractorPeriodOfReview', window );">Period of review</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_UniformProgramIntegrityContractorSuspendedPayments', window );">Suspended payments | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview', window );">Number of patient records under review</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_pntg_UniformProgramIntegrityContractorPeriodOfReview', window );">Period of review</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember', window );">Revenue | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_MedicareAndMedicaidMember', window );">Medicare And Medicaid | Receivables | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">78.60%<span></span>
</td>
<td class="nump">75.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=pntg_MedicareAndMedicaidMember', window );">Medicare And Medicaid | Revenue | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62.60%<span></span>
</td>
<td class="nump">60.10%<span></span>
</td>
<td class="nump">55.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Operating Subsidiaries With Reviews Scheduled</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Uniform Program Integrity Contractor, Number Of Patient Records Under Review</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_UniformProgramIntegrityContractorPeriodOfReview">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Uniform Program Integrity Contractor, Period Of Review</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_UniformProgramIntegrityContractorPeriodOfReview</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_pntg_UniformProgramIntegrityContractorSuspendedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Uniform Program Integrity Contractor, Suspended Payments</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">pntg_UniformProgramIntegrityContractorSuspendedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>pntg_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_RevenueFromContractWithCustomerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=pntg_MedicareAndMedicaidMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=pntg_MedicareAndMedicaidMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140024814346008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jan. 27, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow deposits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">2,835<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment of long-lived assets</a></td>
<td class="nump">$ 2,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent event | Affiliates Of Ensign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EscrowDeposit', window );">Escrow deposits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EscrowDeposit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EscrowDeposit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109226691&amp;loc=d3e2921-110230<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123351718&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=pntg_AffiliatesOfEnsignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=pntg_AffiliatesOfEnsignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>pntg-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:pntg="http://pennantgroup.com/20211231"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="pntg-20211231.xsd" xlink:type="simple"/>
    <context id="i207edde9314a4bd687eb41d894c01add_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6abd4a4310074b4097aa0589993a20d0_I20220222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <instant>2022-02-22</instant>
        </period>
    </context>
    <context id="i6fe0ba45acf1463a9efa0125b5bbd460_I20210630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="if28ce3a43e8b460b988657b9a4224a4e_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idd91651521da4c609cd12f37af52ba44_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ifb3f0aba2eec4f708396a60e99675481_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ide2b3e36383446e7a915226ee5c83310_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i9a8ca1010c9b475d92df11e16146a5d8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i01fbcc736c2f4d88b3e0b648821e0ba8_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7d956ca6cd1c408fae3c1c5b8a11d188_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i855d825b738d453698699f3f7321df6f_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia77015134f924c9fbf430ceacefda567_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i690e1ad892ed46a8bc17a390e883382b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5c4557ca296245b787f54721e8fb4fc7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4a9a8de246d64eae8dd59832de0af5e7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5166a6bf5fa34ea4a777f2940c33fc70_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i53e93f7878814ac5ba917527e6bc6fdb_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5bfd4e9286bf4ca98e7e5f4e442a2026_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5b80432f9127486d82bf8a5566b3b726_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie7504d19735f49cc9eea4e20bfed667a_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i35bd8b5de02d40739ff3a3df8cfe4355_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7a6863ed0a604be89046cf3ba27d50b9_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie90f6d4e5d3849e5bcb29a785a2ddaac_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic350fc4ba36449e4872a8c4cc3fc52fb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if33183982ee24195bfee778d16529013_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2296c7a7384d4e56b1c183412b8e586e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i166349c580b648b886b6acee6a9a1cbb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i99cc169c87d54cfbaeeb3b1336ab30eb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i05bcdfdd5a524814835b5fe3930e4688_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i95ba983a79d7440dbbf23a35c1171deb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic64854ee9b9849e0b09fa298cbfd3e99_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1a5b873622de45afa65e19177ba49557_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia44088af8f1e46d1b16f10b9327f6cf5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9d456b9856964a9b93a6df6f1fa39ccf_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iad9a8ecab0c04918aee8cdd00de80898_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i95eabde00ded4cf097fa61177f5f5a10_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icb984f908c724c4bbff50002d4aec555_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9b5f6ca5bfb2481690e71d78cb6d8667_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i82251654ca3f4fc288f2fb5540302bd6_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7bd7edef27e34175800cc42062b7c736_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i15a951b1e5734b3997d7829d03437e38_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i570ab8a66ef6484f8c4085965fb06999_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:ParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i27c052df90b74bb0b3ea9126a1f86ca7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:NoncontrollingInterestMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ife1126ceed284fbdb9bf6b3dbab68da3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="icc510d566b5a497d8c3bf8da297c74be_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7e5a5757ae4345638434593287f327d1_I20191001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <instant>2019-10-01</instant>
        </period>
    </context>
    <context id="ia2439a6130274330bd9bb469dbc05ee6_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i8a7e4cc4f1ef44e18318557df8f16b2c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="iae5c52d50c06400983c31c67aa43fc0a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">pntg:AccruedWagesAndRelatedLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2652a0d3863d49cfa54d2dbb7a690e3c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6001b46500b947f08cda938279f351a0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i0e8f395592e742f3ba6c06ba1409606c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i743dd5e050c24c6f903e2cd1bc39b900_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib4445accb5d94db3851353dbfa2ed4f3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8ffd18948f6c4a1e9cdee019c70baf5e_D20190101-20191001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-10-01</endDate>
        </period>
    </context>
    <context id="ia1fcf346d3fa483083f350885e86c53f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:TransitionServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4727a9c1e3f3474da652ab9778b0c723_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:TransitionServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6798f615dd65498b96c25d713d9ea243_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:TransitionServicesAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i69f3d63932564edfa50a96879cf88c45_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8539c32fc47d41f7855d6538692f738d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ice5e4b95ef8a477bb882b9b591fb511b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i9faefefa7c85403d9d9fba65201c913a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:OperatingLeaseRentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i71dbacd7819b435d8e92bd5a906d4011_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:OperatingLeaseRentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1429b5ff57464841a7fd199281d35777_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">pntg:OperatingLeaseRentExpenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i815557615f93465196531049671aa210_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7fc9e1d6963b4b9eb991007f35b632c0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i06cec63574054d8fb69e409cc0711e6f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">srt:AffiliatedEntityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i663cd00e1ad6470dbb471e5fc87e9203_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifab97b7b0975436f83121c89244a55d3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i1f1a78bb16f147c18572f1380b8c667f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idca163657edf4bc2aca2d8b382f0f7b2_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i431551b89e134941b82c51244240a244_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i9b3121c806bb417081699695640c414f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i17b4bb1acf134933be5201416c719d6c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i03057061bfb7409985a60619a19b48e6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i6ddd0deea9264c2889a8b36d67a563b0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i30d0fef362f9476098b2e5f91ab55f41_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i2d0123d2512e41bfbbd00432a081dabd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idac1833793374955a04bd068e4506c0e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="iac9f214a0b30486f90920ce93092e539_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i05e5b7442b2e4748b8bc9f050198888e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibf54a7dfae6a484abdd050e8ddda248a_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i3cad94c3015b470d965cbc5ee38f4770_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id38b672538cd430abff250dfff0240b6_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ib5365806816e44649649e52c6625abe4_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="idf736e5de07e408db946428a0745839b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icea654d979af4e61816fbe050cb29db1_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if8458a5a068c4090af7e21aad43775a0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i8406e50463644fbdb227c6e79289ad64_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifdb705c6ba97400d913dd4a58f256b0e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7de26af2c3974c3eb74c36971003d68f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="if26e6ee1ae2b4492b5956195b2492b91_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5d63dc45c0b146cfb92561c882177fea_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i5f6f3d7d4c8a4c4caa054a915ffff62d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie381063adb71430c9c8b4f7607c9030f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic242ef7737ea4e8d8f2e0629c8af8812_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic6cb3dbfbde247d28b978021dfabc07e_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i400c7c456591430da87c024511cdb9f8_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia9994a97da124177acf7e325874bdc4a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9422adb47dd144de9fd4fb328368c4e3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8202cceeb8344c46a087879b40701124_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib8551d37adc147afa5952e88c48adde6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8ca13a6f741345fea9329cb059f1ed4b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2984f9f8dd8744ecbd977408c0e3b962_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i48f286f45fe449d6a5632e508d5c2057_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i0599a83f392c492c8ca20b93a86ccd91_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i36bae4b32d354f01bfa55606e2bf53ff_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iccdbd602cb6b43c1b386f036f6f9c78b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i29892b01245e41eb84f75876a0351a3a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i8bd2b41188c847e0ba8e9c40a817df93_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if4653a795c674a2a99639c0e0ca313f2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2eee5c7b272f4114a364a863a01dd73b_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4d7797f8df2244b09c017060c787f7c4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i07e05d97399f4e76ae18df53c721bcbc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i869ae7cc46294c22b376048f3f1d1a6d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if499ccd516774920992a7dec4b1cef2e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib32ab0952f954ffcac6e996208515105_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3e46c22d3f0f4b2d8bc8e8a60fc2ccc5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6b21bb23ad2d4d29ae1a573ce3633cf1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6adffdb90bb04f3ea1ba43662f341d52_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="idfddb8b08a444307a9d0127349167737_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i762cb9691e2742e883abaa93d43be077_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6ee634dbd9cf40079a3e668ce24a98e3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4566419dadde4c98a7120368b872f3da_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iaaa4cbfc68844bf2ab83f3ee4d31a520_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5a2eb0a55f1548d09ebdd38af8a78640_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i89476537bc774ebc87ef3b108c8f978e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i33675a436d3e40e985deb8177a576c9d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iab8c34ad3ce545459293744ddcb6827c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i900aa21d63db4875b0f5ce732299844e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i49df9afbb9944bb4b9a18d9b551d87cc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i78a868a69cef4c5fa0fad890560c7186_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i150c3c3a7f2441dba86ec0345435079c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i264e682f589d40f8996079dbbb6714ee_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i555f8697f79c4135bf985a88ac806168_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i4264f7ca59794b258dcd7d108f89c4bb_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib11f67911ae04e9e9474289103ab7ca0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i993ccc72246c43c6882a67446f7e3d04_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia66c44f3f144416dbe4fb6670ae3d912_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0b8618d03b954dd9b12ccc9dc2633994_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1d5ca24424934279961a03e8619d1a55_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i18dd800368c0436f9fdaee03faceced1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i26c2df1bf2f84583ad5e170e30ac0da6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i63ed1921de984ba2b86b439f98dd36dc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8f79c51975d142fcb63efb2a71b34744_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if165ef086e644209a29aa525477fce96_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i1ebf7bc335ba488f9cb8f70150a6bd1a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0325f33d9f364afd88fb10e9c56068e0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i22dbeb2253784b39851f81d479af22fd_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i32ea97b6e981410cbc2b5ebf32b066a3_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0e919c640df94e919b7b44c94f671f8e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic5ffc58dbb624c40ac8f80c16398d43c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie112d35bfda34b3288ce4100b5cdf3cf_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5f2f4fea3b5747c3907908c54f286f3a_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:RevenueFromContractWithCustomerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia630ac63be744170818adf1a6996df94_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib84e2fa7e66c4c8280ad68c7ca28d55c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic852038e4be24f098e1d5554086d7e6b_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i23e0fe4823904639ac80d8fdad567676_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicaidMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie0ea0e85a0e047b098694b3d6d36944a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i31bba7ec3d96407896690fde2506a953_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:ManagedCareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iabbe1867eaad43e6b8ea27b135c22cfd_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i51de978558994d7d85f12eee1b08a961_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:PrivateAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icc4e373408b54afd8e67604fcad521cc_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i57cdf4fb339b4e68892dc8149e2518b9_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifb6560107a1842b88eb0a7a57c2f2031_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icbb785491adf4226bb9a9857b10f52e9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4b47eeb041d04c25b8cd00f6bf592f7f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iffbc90dc71cb4be1a22f4af87b57ff85_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i976083bf7720489d9ec3c392eb20769e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2df8a9f1fea242caaf3c3e4967630be6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8a59a4ea155b45bfb972b34701628d91_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:CorporateNonSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic8da0ae531824141a5fbf3f5f9b8abb5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeHealthSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i70e465de07bc4489a1d93b090ad882d3_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1b3df8b0ec1847a485fa591f8a59348b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeCareAgenciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ifb52edba0b344f30ae760f39f36a33ba_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="id3b8477112444416aa795ea6a1381886_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ie6f061c2888d4b629403b99a7a704501_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i11b4722640e743ca9f00c59f8e177f35_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HospiceSubsegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i960a0c21f35a47e1abe131c0263a41ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i16a5a490d6884205a5e9dd42dbbb3399_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc65670bbb7246fa8052cb8e64d56db2_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i186dae40bd454249853b01c1eba9d848_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:ScrippsHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">pntg:HomeHealthJointVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i9ff49407f6be490cad905da779b4d980_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:ScrippsHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="i18a947ebb0914b1a81c869f2499ef9ee_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:ScrippsHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">pntg:HospiceJoinVentureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i1e1d06b38ad84064a8290b0beceb92d9_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:ScrippsHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i1eedc1128d554ef1b5b1df73ddae1f03_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsegmentsAxis">pntg:HomeCareAgenciesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ia34b018da1b745588a4443489d6fd7a5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i091dbe9239e9447a88678cb20a666033_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:EnsignSubsidiaryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i727696b9c07044d1ae50621d44a2e115_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AssetAcquisitionAxis">pntg:AssetAcquisitions2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie51d580ad1694816b75edef851ee768f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic9b4d5180d754f1991716345bb9bfd11_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">pntg:BusinessAcquisitions2019Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i22ba094ecdd748caa523069cfe03b1bb_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ic989f4d1015643d8b1f921fe889e7655_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic76aa9c6653849259b83d26fe4a1a6e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i472b81765f954025a5079e55559a1cce_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i489985632d6945938dec271036a4ca11_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7b29edf2eac54eb981cacc738f038708_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i9ad5091204ea402db4f786593e9c88e3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i646d026e30024a759d2d20651293e096_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id8bee216f16649f4bd17307d4aca1e38_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i594abec2ef2e406b8dbe4ab6e7d5e8ee_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i7266ba82d91645fe8dc1b6eb5c7fc950_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35d93aabb6ad43d4a0807093b6ff3cdd_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i85977dbd3e304b269d60b79b21d58dd3_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i295733ffaf3446e09492cf5e0c2391e7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib53ed044a9784155997f65bf19912e24_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3953707a65c34f67a229dcf123865af0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IndefiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:LicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifc995fe4fa2343f99750c39392d1ca31_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i87be8b1071da42259fd25653dc6e32b8_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ib2750bb749074a028d77edb545a82f0d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0ed5cb11e8c74a8cab4af56099f9fe37_I20210223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-23</instant>
        </period>
    </context>
    <context id="if8303ce9e51d4a7a9f23b6cb4859d119_D20210223-20210223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-23</startDate>
            <endDate>2021-02-23</endDate>
        </period>
    </context>
    <context id="i7bcff1b3b19a471fbb07b38194bdf040_D20210223-20210223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-23</startDate>
            <endDate>2021-02-23</endDate>
        </period>
    </context>
    <context id="iff4b598798b347b1bad79e786d66d4ec_D20210223-20210223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-23</startDate>
            <endDate>2021-02-23</endDate>
        </period>
    </context>
    <context id="i15fbe4ddfaed4fb2ab68184822fc9b20_D20210223-20210223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-23</startDate>
            <endDate>2021-02-23</endDate>
        </period>
    </context>
    <context id="id896243133374d5a85762f6aa03af650_D20210223-20210223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-23</startDate>
            <endDate>2021-02-23</endDate>
        </period>
    </context>
    <context id="ie9d1d1fbe9ca4de3972432630165dd25_D20210223-20210223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:RevolvingCreditFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-23</startDate>
            <endDate>2021-02-23</endDate>
        </period>
    </context>
    <context id="ibe0c05707f51401b8343fc06afba6d47_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i009062db7a07451db770939cb218b995_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ia395591b1bb04bc59721af3b9e0057ad_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i324266d2a6034a369becaa333073dedc_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibca5874771a942ac8128f8834681ae6b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i95a5ddcc5c1c4f24a7b7984fb2f61366_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7835b6571f414650b23c89f2da3e8e1d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i820fe8df97df45148956430597a8021c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ic2d08a40a2ea4844850b407dc06a1380_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18d0ff58a4094edcab67e0572e47b712_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:DirectorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i3c42f8d3450a45bb97f418276e55401a_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i695c64b54bea4f3ea301a4f593b04c27_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i71a2785689d7485e88d7d7a0fd2e1588_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4e98f7de032448e1bdb5e3acc586323d_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i2fba7cde195142a3978c879c27cb0bab_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2021Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icc2e87893a0146e3bc467cb6aa1d0766_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ia6c286ff8cbc4714836982d56e9417c0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2020Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iddb04c9f35bb476b81dba3be31ee57a0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id19dc50301904b4ca1463fc976675c69_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardDateAxis">pntg:GrantYear2019Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ie191aaa5b8784c6cb75b59a0e2300e56_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i4cd15a2a6a27445183cb22f7b6c7b21b_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i55dd760f997d474083702aac3bd35021_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="icdcc7ffbdc094bad9d2c2e68f1561ed9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i91b3a92c7481472dbec77f9233ecabdc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4ca3f78db99945b69974d02c724d9240_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:SeniorLivingServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i41995e14a074437c84df40537f2238d0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i8fb2a9d080dd42e58f04fb43fed99eb9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">pntg:HomeHealthAndHospiceServicesSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibaa9096cc2bd4e858996c09298dd6eb0_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">pntg:FacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i1309a04126c24144b850a38c0baa4831_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">pntg:FacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id61049412f5d48e69963ed0bcb95677c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">pntg:FacilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i59c4cea8cd4b414fbbbcfe383d2f2015_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i7385e6d9e8844d5b9ae1f8bed5241579_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if5ac6849e7e74533af722a23640f12d7_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis">srt:OfficeBuildingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0ee98e79dbdf4459bb64dd4764f5f04c_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="ief8be8ba89d54b41b5b925a9afe0bfd6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i828be32df55549349516ec453fb5f7fa_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i39dc640518df47b9a65a3d3dbeec9bd5_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3a5ce69e0ffd47a7befd0d6c5941a09f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i0169fb92128e49f58280fc837cf38434_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">pntg:TheEnsignPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i930d5c4fd9b84161879c0000c0e816d2_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ie92494cf696341a4b8eb690958419fa7_I20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-28</instant>
        </period>
    </context>
    <context id="ie6d715a9ac734e11ac6ce730afc95baa_D20220101-20220228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-02-28</endDate>
        </period>
    </context>
    <context id="idcd019ebb6aa4404ad2ce8284c512582_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="i84a5a381cc15426491a05ab72627a087_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">pntg:MedicareAndMedicaidMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib75d5bc9e37c446180e5fa26fafb6083_I20220127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">pntg:AffiliatesOfEnsignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-27</instant>
        </period>
    </context>
    <context id="i941ffd2f6e49432b85465ef637f2d33d_D20210101-20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001766400</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="agency">
        <measure>pntg:agency</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="community">
        <measure>pntg:community</measure>
    </unit>
    <unit id="property">
        <measure>pntg:property</measure>
    </unit>
    <unit id="facility">
        <measure>pntg:facility</measure>
    </unit>
    <unit id="arrangement">
        <measure>pntg:arrangement</measure>
    </unit>
    <unit id="review">
        <measure>pntg:review</measure>
    </unit>
    <unit id="record">
        <measure>pntg:record</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl80L2ZyYWc6NjA1OGI2NDcwMTVjNGZmMmI4YjVmYWRiOTM3OTlhZWMvdGFibGU6MmI0ZGEzYzRiYjdlNDJmYzljOThmZWE1MTQ3MmZkNDMvdGFibGVyYW5nZToyYjRkYTNjNGJiN2U0MmZjOWM5OGZlYTUxNDcyZmQ0M18wLTEtMS0xLTQyOTM0_768ce92a-b021-4d16-b854-1bdc9bbc05eb">0001766400</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl80L2ZyYWc6NjA1OGI2NDcwMTVjNGZmMmI4YjVmYWRiOTM3OTlhZWMvdGFibGU6MmI0ZGEzYzRiYjdlNDJmYzljOThmZWE1MTQ3MmZkNDMvdGFibGVyYW5nZToyYjRkYTNjNGJiN2U0MmZjOWM5OGZlYTUxNDcyZmQ0M18yLTEtMS0xLTQyOTM0_3d37fd38-fa52-48f1-9bdd-660d2429d71e">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl80L2ZyYWc6NjA1OGI2NDcwMTVjNGZmMmI4YjVmYWRiOTM3OTlhZWMvdGFibGU6MmI0ZGEzYzRiYjdlNDJmYzljOThmZWE1MTQ3MmZkNDMvdGFibGVyYW5nZToyYjRkYTNjNGJiN2U0MmZjOWM5OGZlYTUxNDcyZmQ0M18zLTEtMS0xLTQyOTM0_59a69e00-ed22-4f75-a8be-37c7dd700d4a">FY</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl80L2ZyYWc6NjA1OGI2NDcwMTVjNGZmMmI4YjVmYWRiOTM3OTlhZWMvdGFibGU6MmI0ZGEzYzRiYjdlNDJmYzljOThmZWE1MTQ3MmZkNDMvdGFibGVyYW5nZToyYjRkYTNjNGJiN2U0MmZjOWM5OGZlYTUxNDcyZmQ0M180LTEtMS0xLTQyOTM0_b3fc6ec1-3c41-433e-a3d5-729dced6169b">false</dei:AmendmentFlag>
    <pntg:SpinOffTransactionDistributionRatio
      contextRef="i7e5a5757ae4345638434593287f327d1_I20191001"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjAvZnJhZzpjOTA4NjA4MTRhYjY0MDg4YjhhMzY2YzZlZDMyYzRjMC90ZXh0cmVnaW9uOmM5MDg2MDgxNGFiNjQwODhiOGEzNjZjNmVkMzJjNGMwXzMxNA_db239c2b-609c-406d-a630-5f0a3523c90a"
      unitRef="number">0.50</pntg:SpinOffTransactionDistributionRatio>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i2652a0d3863d49cfa54d2dbb7a690e3c_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYxNzc_c179bcbb-5edd-46f8-ac7b-9c974960a03d">P3Y0M0D</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i4cd15a2a6a27445183cb22f7b6c7b21b_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzM1Mjk_ccbd4d6d-4bc1-4f64-a712-9a0de31e9ccd">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i91b3a92c7481472dbec77f9233ecabdc_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzIyMg_b91d98ae-34f8-4760-a680-7806138f8865">P5Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i41995e14a074437c84df40537f2238d0_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzEwOTk1MTE2MzA5MjU_3cc0a8cb-6980-4caa-9f55-af4c4d207bb0">P1Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <dei:DocumentType
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18yMTQ_700f82f4-6e4c-48cd-b12d-d3457ad6fcf7">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6NGQ5MTY5MjBiOWZkNDA0OTlmYWU0MTNkMTUwNDdhZGUvdGFibGVyYW5nZTo0ZDkxNjkyMGI5ZmQ0MDQ5OWZhZTQxM2QxNTA0N2FkZV8wLTAtMS0xLTQyMzAx_56464375-ee47-4bad-9f17-6cb71d0a9c08">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18yNDU_43cbbf99-5585-4734-9f86-a684f0aa2c42">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18yNDU_f85118b5-832a-46f2-a6e8-f111431d84f0">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6MjEyMTMxMDgzOGYzNDM2MmFmY2Q1N2FkMGRjN2NlODAvdGFibGVyYW5nZToyMTIxMzEwODM4ZjM0MzYyYWZjZDU3YWQwZGM3Y2U4MF8wLTAtMS0xLTQyMzA0_1a67c166-5cbf-4cd8-a33c-451f2ed8f437">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18zNTI_0cf8fa51-5368-4f4e-a8bb-aa6ceaa259e0">001-38900</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM182NTk3MDY5NzcwMTA5_cf2c5287-54a0-4c65-9c98-b8d36de794e0">THE PENNANT GROUP, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6Y2ExOGJkMzQwMzE4NGE5YWIwZDdkZGFiNDFkYmFiZmUvdGFibGVyYW5nZTpjYTE4YmQzNDAzMTg0YTlhYjBkN2RkYWI0MWRiYWJmZV8wLTAtMS0xLTQyMzA3_28a03cb6-08c6-42fb-ada1-d758d903f8fb">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6Y2ExOGJkMzQwMzE4NGE5YWIwZDdkZGFiNDFkYmFiZmUvdGFibGVyYW5nZTpjYTE4YmQzNDAzMTg0YTlhYjBkN2RkYWI0MWRiYWJmZV8wLTEtMS0xLTQyMzEw_18faa445-6ace-4a57-bafd-d77d8d79faf1">83-3349931</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM180OTU_d3bbd7fd-0833-4c7e-84a9-3918e187ebf6">1675 East Riverside Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM180OTk_a3bf4d03-2410-4ba3-9746-8e7c61607c8c">Suite 150</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM181MDM_5ba4b833-f4a5-45c5-b188-6d8cc52c8f78">Eagle</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM181MDc_1954858a-54a3-4b99-afdd-152ffc0a2fa6">ID</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM181MDk_b983a147-aad2-4df7-8056-e6508dcdbee6">83616</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM181Njc_8bf76b3e-cd75-4484-92ed-c8cff15b4de7">(208)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM181NzA_0b8d9a0e-1193-4462-98f4-dac791a720e7">506-6100</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6MjFkNDIzNWI4ZTU3NGQ1ZjgwYzRlNGFlNjAyNzEyMTMvdGFibGVyYW5nZToyMWQ0MjM1YjhlNTc0ZDVmODBjNGU0YWU2MDI3MTIxM18xLTAtMS0xLTQyMzEy_b37d85b1-ce2f-4bb1-86c7-67f48a02dc6b">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6MjFkNDIzNWI4ZTU3NGQ1ZjgwYzRlNGFlNjAyNzEyMTMvdGFibGVyYW5nZToyMWQ0MjM1YjhlNTc0ZDVmODBjNGU0YWU2MDI3MTIxM18xLTEtMS0xLTQyMzE1_76e51642-05a2-442e-9a44-56c2a6a33f0d">PNTG</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6MjFkNDIzNWI4ZTU3NGQ1ZjgwYzRlNGFlNjAyNzEyMTMvdGFibGVyYW5nZToyMWQ0MjM1YjhlNTc0ZDVmODBjNGU0YWU2MDI3MTIxM18xLTItMS0xLTQyMzE3_7dfb0f9e-4459-41c7-8614-d95a53ec2d44">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18xMDIz_4aa62db7-43a0-4df7-afe8-0c7ae852d83f">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18xMTYx_a3ba37ae-3d3a-49b2-8827-6315e0690eb3">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18xNTEy_bdfed933-eaab-4721-81ef-aa991fc0ed96">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18xODMy_a6925514-c778-4ee1-bada-472a672411cd">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6NzUyYzkyYzY1OWU3NGM3N2E4MmJhOTc1MDRiNjExMDEvdGFibGVyYW5nZTo3NTJjOTJjNjU5ZTc0Yzc3YTgyYmE5NzUwNGI2MTEwMV8wLTAtMS0xLTU0MTg1_029b27ee-2dd2-4970-b13e-608aebb7bdfe">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6NzUyYzkyYzY1OWU3NGM3N2E4MmJhOTc1MDRiNjExMDEvdGFibGVyYW5nZTo3NTJjOTJjNjU5ZTc0Yzc3YTgyYmE5NzUwNGI2MTEwMV8wLTctMS0xLTQyMzgx_4af1e7f0-7808-4000-a7bc-4c9cd1473510">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGFibGU6NzUyYzkyYzY1OWU3NGM3N2E4MmJhOTc1MDRiNjExMDEvdGFibGVyYW5nZTo3NTJjOTJjNjU5ZTc0Yzc3YTgyYmE5NzUwNGI2MTEwMV8wLTktMS0xLTQyMzgz_44993306-4e2c-4f11-9dce-80eab3fe3877">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18zNDUx_301ef13d-fd72-47ef-a30b-a855b3753c5b">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18yOTAw_503a1fcb-ff12-4f12-8445-7ff269275cf8">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i6abd4a4310074b4097aa0589993a20d0_I20220222"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18yOTIz_177cbd36-ff2e-43b7-8f8d-3598bd777f56"
      unitRef="shares">28529556</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityPublicFloat
      contextRef="i6fe0ba45acf1463a9efa0125b5bbd460_I20210630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xL2ZyYWc6NDY0YTIxOTliNzQ4NDdjNmFjMjIwNzcxZTE3NjhhYjMvdGV4dHJlZ2lvbjo0NjRhMjE5OWI3NDg0N2M2YWMyMjA3NzFlMTc2OGFiM18zMjA3_d167ed3a-eb55-43f5-b654-ed9a28786051"
      unitRef="usd">1143039000</dei:EntityPublicFloat>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl83L2ZyYWc6NGQwMjYzZDE5ZDZlNDkwYTkzZGE5ZDQyYTI0OTBiOGIvdGV4dHJlZ2lvbjo0ZDAyNjNkMTlkNmU0OTBhOTNkYTlkNDJhMjQ5MGI4Yl83Njk2NTgxMzk0NzUy_87c92653-3978-4bcd-a268-399e40d75994">Part&#160;III of this Form&#160;10-K incorporates information by reference from the Registrant's definitive proxy statement on Schedule 14A for the Registrant's 2022 Annual Meeting of Stockholders to be filed within 120&#160;days after the close of the fiscal year covered by this annual report.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <dei:AuditorFirmId
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzYvZnJhZzpmNDFmM2ZiODZhNDA0MWI2OWU0Zjc5NDlkZThhNGFiNS90YWJsZTo3YWJjZjY0NjRmMWI0M2JiYWEyYWIzNDJkZGUwNGRmMS90YWJsZXJhbmdlOjdhYmNmNjQ2NGYxYjQzYmJhYTJhYjM0MmRkZTA0ZGYxXzAtMC0xLTEtNzQ2NjkvdGV4dHJlZ2lvbjo4MDQ4ODhjN2FmZDg0ZTY2OTA3NmJjYjQwODAxZTdiY18zODQ4MjkwNjk3NDMw_c863acb8-1854-41aa-b44c-067e51b4862c">34</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzkvZnJhZzo5NmE1NzlmNGZmZTU0YTNlYTc0MDMzZTUxYmE0OGRjZS90ZXh0cmVnaW9uOjk2YTU3OWY0ZmZlNTRhM2VhNzQwMzNlNTFiYTQ4ZGNlXzI3NDg3NzkwNzIzMDg_f96660bf-9c67-49b3-b3aa-3dcdd3ad57c1">DELOITTE &amp; TOUCHE LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzkvZnJhZzo5NmE1NzlmNGZmZTU0YTNlYTc0MDMzZTUxYmE0OGRjZS90ZXh0cmVnaW9uOjk2YTU3OWY0ZmZlNTRhM2VhNzQwMzNlNTFiYTQ4ZGNlXzI3NDg3NzkwNzIzMDc_1d4f9e5c-2f80-4f5b-952f-ca931dc1df8d">Boise, Idaho</dei:AuditorLocation>
    <us-gaap:Cash
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMtMS0xLTEtNDExMzI_fd4e47e7-fb82-42a0-bb8d-349c16a9ba93"
      unitRef="usd">5190000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMtMy0xLTEtNDExMzI_7211c857-54a5-4e17-b384-536ca59d86e2"
      unitRef="usd">43000</us-gaap:Cash>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzQtMC0xLTEtNDExMzIvdGV4dHJlZ2lvbjpkNjc1Mzk5MDQ4YjA0MzgwOTAwODQ4NGE2YTliNjIxNl82NA_582ec952-359d-4d67-bd6d-325f966c541c"
      unitRef="usd">902000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzQtMC0xLTEtNDExMzIvdGV4dHJlZ2lvbjpkNjc1Mzk5MDQ4YjA0MzgwOTAwODQ4NGE2YTliNjIxNl83MQ_d49fe8db-79dd-4029-a553-c673f397ae09"
      unitRef="usd">643000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzQtMS0xLTEtNDExMzI_07d8abcd-8999-4727-b183-290def2d0cc5"
      unitRef="usd">53940000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzQtMy0xLTEtNDExMzI_dc9d0344-2b76-44e5-8fc3-0c2645465878"
      unitRef="usd">47221000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzUtMS0xLTEtNDExMzI_e4c116f9-954d-401c-bf3f-3fd83151898c"
      unitRef="usd">16711000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzUtMy0xLTEtNDExMzI_d05dc55a-221a-47e2-8ea1-0e02f158cd8b"
      unitRef="usd">12335000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzYtMS0xLTEtNDExMzI_1d919777-5dd3-44ee-b6b0-894db75ca1ca"
      unitRef="usd">75841000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzYtMy0xLTEtNDExMzI_f1906129-9e6a-4546-a9d0-4dc0fa0cbc5f"
      unitRef="usd">59599000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzctMS0xLTEtNDExMzI_527d1f8c-7d35-47f0-8b15-fb916a009ed4"
      unitRef="usd">16788000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzctMy0xLTEtNDExMzI_bd5d8d01-e23d-4682-8064-f2c2b072d43a"
      unitRef="usd">17884000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzgtMS0xLTEtNDExMzI_b959531f-ced6-4b44-92e6-ab85ffcea9d3"
      unitRef="usd">300997000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzgtMy0xLTEtNDExMzI_ca655e88-9a41-42fb-ac34-8c8eba328edf"
      unitRef="usd">308650000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:EscrowDeposit
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzktMS0xLTEtNDExMzI_bcb5de4d-7d9f-4a61-bc05-e1227f3db824"
      unitRef="usd">0</us-gaap:EscrowDeposit>
    <us-gaap:EscrowDeposit
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzktMy0xLTEtNDExMzI_ff9f0120-08e5-4c7b-a30a-ed0a53971630"
      unitRef="usd">525000</us-gaap:EscrowDeposit>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzEwLTEtMS0xLTQxMTMy_1c1b5dbd-08c0-4688-847e-9c8d69db3b2f"
      unitRef="usd">3848000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzEwLTMtMS0xLTQxMTMy_bd5c0d43-a321-4c52-8997-2bb3006a58e2"
      unitRef="usd">2097000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherRestrictedAssetsNoncurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzExLTEtMS0xLTQxMTMy_bc59da5b-a324-4db9-97a3-b7ec0e93ef24"
      unitRef="usd">4828000</us-gaap:OtherRestrictedAssetsNoncurrent>
    <us-gaap:OtherRestrictedAssetsNoncurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzExLTMtMS0xLTQxMTMy_d6e6ef9b-4445-4c8c-a6ad-4155af6d41f9"
      unitRef="usd">4289000</us-gaap:OtherRestrictedAssetsNoncurrent>
    <us-gaap:Goodwill
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzEzLTEtMS0xLTQxMTMy_1d21dfd1-df21-4637-be44-5c693503cf05"
      unitRef="usd">74265000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzEzLTMtMS0xLTQxMTMy_79798066-be31-4a78-a402-c5624121fa56"
      unitRef="usd">66444000</us-gaap:Goodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE0LTEtMS0xLTQxMTMy_2459c5f3-185a-4123-ae8f-687b71246a37"
      unitRef="usd">53730000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE0LTMtMS0xLTQxMTMy_7291261c-bc30-40fe-a74d-8dd82f6fb20a"
      unitRef="usd">47488000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:Assets
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE1LTEtMS0xLTQxMTMy_f63fd5c8-c2ab-42dd-a855-218ff955d48c"
      unitRef="usd">530297000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE1LTMtMS0xLTQxMTMy_562ab77d-c1ef-43ec-9c80-d0fe7a04b71a"
      unitRef="usd">506976000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE4LTEtMS0xLTQxMTMy_deb4569f-e10c-4bdf-9dd9-6940fa5af6da"
      unitRef="usd">10553000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE4LTMtMS0xLTQxMTMy_a82a8029-eda8-4f3c-89fb-6a6fb20f986f"
      unitRef="usd">9761000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE5LTEtMS0xLTQxMTMy_187800b0-ce81-4989-8a49-5f1178a98dfc"
      unitRef="usd">23480000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzE5LTMtMS0xLTQxMTMy_230b8d11-c7e6-4062-afc0-4920dd3ba918"
      unitRef="usd">26873000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIwLTEtMS0xLTQxMTMy_202ed855-509a-48b6-8c79-9051a8d7a858"
      unitRef="usd">16118000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIwLTMtMS0xLTQxMTMy_f17ca5fc-d719-4664-a5f9-fd7d23be1f22"
      unitRef="usd">14106000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIxLTEtMS0xLTQxMTMy_491796ec-3e4d-4290-8cae-bbb8039f0205"
      unitRef="usd">21484000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIxLTMtMS0xLTQxMTMy_f2e52fc6-2467-4361-bb75-b7df91521aba"
      unitRef="usd">38275000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIyLTEtMS0xLTQxMTMy_980db25b-0e7d-4fb9-8f5b-6f2700375f12"
      unitRef="usd">71635000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIyLTMtMS0xLTQxMTMy_b7865fdb-4a7d-47e0-975a-d911a75c1e46"
      unitRef="usd">89015000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIzLTEtMS0xLTQxMTMy_f6d5dce4-114b-4312-9bbb-d951ff3b9298"
      unitRef="usd">287753000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzIzLTMtMS0xLTQxMTMy_d4abe7de-af5c-4839-be76-c7da75714c82"
      unitRef="usd">296615000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI0LTEtMS0xLTQxMTMy_f2ed25aa-4250-4494-b70c-77bb06e1b424"
      unitRef="usd">5293000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI0LTMtMS0xLTQxMTMy_6ab4d9e3-643f-418d-96e3-a809d0e2c2e5"
      unitRef="usd">11897000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI1LTEtMS0xLTQxMTMy_fe57270a-0842-425e-ac73-0dc1f8eea85f"
      unitRef="usd">51372000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI1LTMtMS0xLTQxMTMy_fa9a882d-4fb9-4161-abff-5e0a781bc32e"
      unitRef="usd">8277000</us-gaap:LongTermDebt>
    <us-gaap:Liabilities
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI2LTEtMS0xLTQxMTMy_c4d93483-30f1-45d8-bd66-43508698bb59"
      unitRef="usd">416053000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI2LTMtMS0xLTQxMTMy_6064dd0c-c3ac-4406-ae37-b8441158cd11"
      unitRef="usd">405804000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI3LTEtMS0xLTQyMzIz_22e7a407-9f07-409a-8393-681b45b810ce"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI3LTMtMS0xLTQyMzI1_dca06b45-4874-4734-9a05-8b15a7aa3c83"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMTg_82acc9ca-1617-4cf5-9587-9bb34f4793ec"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMTg_e2a1dd19-92b6-4e42-be17-f1f224f22707"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMzI_0f0b9666-2d7a-4c8d-811d-4679b4a42614"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMzI_2cf5a833-837a-4681-983e-18517ef85e83"
      unitRef="shares">100000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfNTQ_cc71e562-efc9-4d70-91ce-63930df92e12"
      unitRef="shares">28826000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfNjE_fdcd00f4-2f9c-40d1-b014-058c2817a62f"
      unitRef="shares">28499000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMTE5_f68df1d0-975b-4b84-aa75-0d9d7081def6"
      unitRef="shares">28696000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTAtMS0xLTQxMTMyL3RleHRyZWdpb246MjZiNDQzMDg1MzA3NDIxOGEyNDZiMzE3ZTkzNTQwZjVfMTI2_df93e0d5-6846-48ee-90e7-f6850df77011"
      unitRef="shares">28243000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTEtMS0xLTQxMTMy_949e94e7-3889-4397-8b0b-4ba4d5289433"
      unitRef="usd">28000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzI5LTMtMS0xLTQxMTMy_de25d36b-f99b-49e8-9bfd-17551bec43f9"
      unitRef="usd">28000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMwLTEtMS0xLTQxMTMy_937aeb3e-98e0-4d3e-9daf-c7ad24ca53f6"
      unitRef="usd">95595000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMwLTMtMS0xLTQxMTMy_6584ea7c-8c4a-4045-9222-dfbbf1ed8837"
      unitRef="usd">84671000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMxLTEtMS0xLTQxMTMy_ce9fb581-2d47-47e0-b9be-4bb3bc9fd26a"
      unitRef="usd">14641000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMxLTMtMS0xLTQxMTMy_5c3fa6bb-b885-4bd3-bef5-bf0f60314021"
      unitRef="usd">11945000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockValue
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMyLTEtMS0xLTQxMTMy_6e9cac93-c3ed-4eb0-ab5b-28a16b6d1966"
      unitRef="usd">65000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMyLTMtMS0xLTQxMTMy_6631c04e-97e2-4269-ab82-411f82331ff4"
      unitRef="usd">65000</us-gaap:TreasuryStockValue>
    <pntg:NetParentInvestment
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMzLTEtMS0xLTQxMTMy_a698482b-9e22-4487-86df-7712861a45dd"
      unitRef="usd">110199000</pntg:NetParentInvestment>
    <pntg:NetParentInvestment
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzMzLTMtMS0xLTQxMTMy_4d060a1d-ebc5-4c65-92a4-58c536881003"
      unitRef="usd">96579000</pntg:NetParentInvestment>
    <us-gaap:MinorityInterest
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM0LTEtMS0xLTQxMTMy_468791d5-1d19-42af-90ff-6aeb97f1faf1"
      unitRef="usd">4045000</us-gaap:MinorityInterest>
    <us-gaap:MinorityInterest
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM0LTMtMS0xLTQxMTMy_f4ec11ab-0f10-4e02-acb8-33f033a86482"
      unitRef="usd">4593000</us-gaap:MinorityInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM1LTEtMS0xLTQxMTMy_58b9ad50-b74e-42b2-9895-d6ab399ee4cf"
      unitRef="usd">114244000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM1LTMtMS0xLTQxMTMy_ad3fd9c8-b716-4b8a-97eb-95cdc76b86d5"
      unitRef="usd">101172000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM2LTEtMS0xLTQxMTMy_a5e7f6c8-7b2e-438c-88f4-f2afe6fdfa52"
      unitRef="usd">530297000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDIvZnJhZzozZTg0Mjc0NzQ1OGM0NzI4YjA3N2ZmY2RiYjE4YTc0ZS90YWJsZToxNDMwMTk4OGZlOTE0Y2Y4OThiZGIzZWY2MWNkMTdiOS90YWJsZXJhbmdlOjE0MzAxOTg4ZmU5MTRjZjg5OGJkYjNlZjYxY2QxN2I5XzM2LTMtMS0xLTQxMTMy_5120c4ef-9f9c-4504-b242-76ed2548d9f6"
      unitRef="usd">506976000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzMtMS0xLTEtNDExMzI_6576ee1e-8ab5-49f2-953e-c0c6f49844bb"
      unitRef="usd">439694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzMtMy0xLTEtNDExMzI_a14793f6-2b74-400f-b208-02c25543188f"
      unitRef="usd">390953000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzMtNS0xLTEtNDExMzI_63f47a66-7341-4c9f-b9fd-54fd410833af"
      unitRef="usd">338531000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzYtMS0xLTEtNDExMzI_baf409d3-347d-4b77-af3a-85f3cd3e3944"
      unitRef="usd">353093000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzYtMy0xLTEtNDExMzI_87327812-765d-4675-be83-bb5ad7c5f56b"
      unitRef="usd">296874000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzYtNS0xLTEtNDExMzI_0cde6ac6-acf9-473a-b0f0-8484f9106a42"
      unitRef="usd">258941000</us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization>
    <us-gaap:OperatingLeaseExpense
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzctMS0xLTEtNDExMzI_fd0f82c4-0e0e-4b42-9cc8-910e8c0a2a73"
      unitRef="usd">40863000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzctMy0xLTEtNDExMzI_d5165ec7-c99e-40f0-b52e-109b3148cd78"
      unitRef="usd">39191000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzctNS0xLTEtNDExMzI_d6fdbc82-25fc-40b0-afaf-25f38997cc7f"
      unitRef="usd">34975000</us-gaap:OperatingLeaseExpense>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzgtMS0xLTEtNDExMzI_60a914df-ba1e-4e4c-8732-795a6b44b7f6"
      unitRef="usd">36259000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzgtMy0xLTEtNDExMzI_8abbd718-79d1-48f3-ac66-87751c7dff1d"
      unitRef="usd">31296000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzgtNS0xLTEtNDExMzI_3301ab0f-cb46-4dfd-a887-210f13f30557"
      unitRef="usd">35135000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <us-gaap:DepreciationAndAmortization
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzktMS0xLTEtNDExMzI_46411cbf-f8bb-432a-a78d-7930ebc5fb1e"
      unitRef="usd">4784000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzktMy0xLTEtNDExMzI_96f40dd3-e44b-46b6-8f09-f9494bb57d67"
      unitRef="usd">4675000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzktNS0xLTEtNDExMzI_3b2ce5b0-e186-46ec-8137-47fa05948aba"
      unitRef="usd">3810000</us-gaap:DepreciationAndAmortization>
    <us-gaap:CostsAndExpenses
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEwLTEtMS0xLTQxMTMy_dc1bd3c5-bda2-41f8-bda5-a040e48a94b9"
      unitRef="usd">434999000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEwLTMtMS0xLTQxMTMy_169e0736-2bb2-4f9c-bf91-f0b2ee4a39b3"
      unitRef="usd">372036000</us-gaap:CostsAndExpenses>
    <us-gaap:CostsAndExpenses
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEwLTUtMS0xLTQxMTMy_d22b3f24-e172-4e21-b425-24e0cb7f5593"
      unitRef="usd">332861000</us-gaap:CostsAndExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzExLTEtMS0xLTQxMTMy_2cb83f41-4e80-49a2-9f01-f24224cf5548"
      unitRef="usd">4695000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzExLTMtMS0xLTQxMTMy_91e874e6-66a1-41ec-b775-3f1b76f7f372"
      unitRef="usd">18917000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzExLTUtMS0xLTQxMTMy_0a5df602-25fd-4676-ade9-6c4b7bd6211f"
      unitRef="usd">5670000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEzLTEtMS0xLTQxMTMy_0cce4854-ec52-40ad-a7be-c7d63f719303"
      unitRef="usd">-24000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEzLTMtMS0xLTQxMTMy_5ff3a154-721c-4b14-b7fe-c5a2aeb86656"
      unitRef="usd">225000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzEzLTUtMS0xLTQxMTMy_d5858b8e-6034-4179-94f5-c688c0875574"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:InterestExpense
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE0LTEtMS0xLTQxMTMy_d7ae4234-fbd7-4cec-9dde-52c38edd2c41"
      unitRef="usd">1941000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE0LTMtMS0xLTQxMTMy_c7f76df1-9b01-4f57-b7fb-ed8e4be4820b"
      unitRef="usd">1239000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE0LTUtMS0xLTQxMTMy_403e6998-872d-487c-8eb2-a994702881ee"
      unitRef="usd">410000</us-gaap:InterestExpense>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE1LTEtMS0xLTQxMTMy_2594184b-c656-4e3b-9f13-9c859d0a001d"
      unitRef="usd">-1965000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE1LTMtMS0xLTQxMTMy_f84e49b9-9978-4869-8f43-db85a4d0dd6a"
      unitRef="usd">-1014000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE1LTUtMS0xLTQxMTMy_9064007f-fdc9-414d-8558-0b364d3e1bd7"
      unitRef="usd">-410000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE2LTEtMS0xLTQxMTMy_fda681d1-a423-416d-9f66-abab9754590c"
      unitRef="usd">2730000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE2LTMtMS0xLTQxMTMy_048e1706-8fef-4207-bfeb-c11b1d291406"
      unitRef="usd">17903000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE2LTUtMS0xLTQxMTMy_5109bd39-3d05-4c9a-8f22-52ac5380f03c"
      unitRef="usd">5260000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE3LTEtMS0xLTQxMTMy_a538f3a5-441e-4122-bb7f-0ae298a2d9b3"
      unitRef="usd">582000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE3LTMtMS0xLTQxMTMy_f15576b0-ff2e-4546-8f66-970cd79f3e61"
      unitRef="usd">2350000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE3LTUtMS0xLTQxMTMy_941b705b-f298-416b-98bb-d0a264a2b801"
      unitRef="usd">2085000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ProfitLoss
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE4LTEtMS0xLTQxMTMy_c463069e-8115-4160-a5b2-1df01e695640"
      unitRef="usd">2148000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE4LTMtMS0xLTQxMTMy_99cf0ea4-9a38-4eb5-91f7-579b3ca0551a"
      unitRef="usd">15553000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE4LTUtMS0xLTQxMTMy_b300f0d6-bbdb-4c58-9c37-5bef9c64871a"
      unitRef="usd">3175000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE5LTEtMS0xLTQxMTMy_5765d219-8c8e-4aa8-b536-ee13c2a81a3a"
      unitRef="usd">-548000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE5LTMtMS0xLTQxMTMy_ed513a97-3f4a-4d0e-89a0-3d0f0a650aa0"
      unitRef="usd">-191000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzE5LTUtMS0xLTQxMTMy_fb98612b-15ef-4752-a9b2-f9650ca67a2e"
      unitRef="usd">629000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIwLTEtMS0xLTQxMTMy_683453f0-2bf9-4f5e-96b7-ced8459acb93"
      unitRef="usd">2696000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIwLTMtMS0xLTQxMTMy_f4e34dda-55f4-4dc9-90be-ed25f0ae0a22"
      unitRef="usd">15744000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIwLTUtMS0xLTQxMTMy_ceb1be9e-c6e5-4a14-936f-fc9dfd9203e7"
      unitRef="usd">2546000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIyLTEtMS0xLTQxMTMy_f98d53e6-7e45-4666-a80a-714029cd97a4"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIyLTMtMS0xLTQxMTMy_8a5f4cbe-6676-4932-91c7-c8ce8380b4a5"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIyLTUtMS0xLTQxMTMy_1cb2039f-9fdd-4a42-8124-390dcd0e281c"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIzLTEtMS0xLTQxMTMy_24326b67-c281-428e-a5cd-aec1b3bdd877"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIzLTMtMS0xLTQxMTMy_835be445-d0fc-429a-afbb-e2562687e301"
      unitRef="usdPerShare">0.52</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzIzLTUtMS0xLTQxMTMy_9ed37711-66f2-453a-ae01-31f03cee1e12"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI1LTEtMS0xLTQxMTMy_892f74ea-f8e7-4ca1-a8f3-1a82f8a6c0b3"
      unitRef="shares">28406000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI1LTMtMS0xLTQxMTMy_a8e86190-b15f-42f0-b41f-d3866545c1fa"
      unitRef="shares">28029000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI1LTUtMS0xLTQxMTMy_536076e0-b442-43b0-897c-1ba15bb3c3f6"
      unitRef="shares">27838000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI2LTEtMS0xLTQxMTMy_51df11ca-9677-483b-b675-2ea6f757d8b9"
      unitRef="shares">30642000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI2LTMtMS0xLTQxMTMy_19f6fc8b-47ab-4d6f-bfe3-7fb3cec0ee45"
      unitRef="shares">30228000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDUvZnJhZzphNTIzNTA4ZWQyMzc0NzE4ODIyNGUzY2EzOWFkZTk0ZS90YWJsZTpiOWJlYWU4ZTkwMDc0YjI5YWQ3Mjk5OTkwZjAyNGIzNS90YWJsZXJhbmdlOmI5YmVhZThlOTAwNzRiMjlhZDcyOTk5OTBmMDI0YjM1XzI2LTUtMS0xLTQxMTMy_0c767d19-f1c1-4146-83cb-018c8d61c780"
      unitRef="shares">29586000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:SharesOutstanding
      contextRef="idd91651521da4c609cd12f37af52ba44_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMS0xLTEtNDExMzI_0a9525d0-a07c-40a5-8d68-14f11fc9f975"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="idd91651521da4c609cd12f37af52ba44_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMy0xLTEtNDExMzI_9d128e9f-60a5-4cf8-9d68-a3468ead0dc9"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ifb3f0aba2eec4f708396a60e99675481_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtNS0xLTEtNDExMzI_e79e819d-809a-4493-8a71-77efadaf8a7c"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ide2b3e36383446e7a915226ee5c83310_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtNy0xLTEtNDExMzI_21b14e05-4eea-43b6-850b-8e71fa8e1242"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i9a8ca1010c9b475d92df11e16146a5d8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtOS0xLTEtNDExMzI_bdfed4fd-6cde-479b-897c-5c992daadeff"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9a8ca1010c9b475d92df11e16146a5d8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMTEtMS0xLTQxMTMy_5364194c-95d6-4d1e-81ea-fa728d8c4252"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i01fbcc736c2f4d88b3e0b648821e0ba8_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMTMtMS0xLTQxMTMy_f6c9161c-c3e5-446d-a9ab-3eb60d854cc4"
      unitRef="usd">55856000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7d956ca6cd1c408fae3c1c5b8a11d188_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMTUtMS0xLTQxMTMy_b564ddc1-c63d-4c65-ba06-a7d810106930"
      unitRef="usd">9432000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i855d825b738d453698699f3f7321df6f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzMtMTctMS0xLTQxMTMy_6e864443-6053-400c-a390-b4b4dffde5c9"
      unitRef="usd">65288000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzQtMTMtMS0xLTQxMTMy_154d05a2-63ab-4e55-8511-7c25bfd73402"
      unitRef="usd">-2991000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="ia77015134f924c9fbf430ceacefda567_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzQtMTUtMS0xLTQxMTMy_ce737472-3b92-42bb-bfb3-8238ea5de176"
      unitRef="usd">3585000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzQtMTctMS0xLTQxMTMy_1f9b0603-3ba7-4c80-9dd7-a9f7b79c563b"
      unitRef="usd">594000</us-gaap:NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ia77015134f924c9fbf430ceacefda567_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzUtMTUtMS0xLTQxMTMy_ffe9eaad-5a8f-4f0c-801e-3bacc67515bc"
      unitRef="usd">394000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:MinorityInterestDecreaseFromRedemptions
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzUtMTctMS0xLTQxMTMy_10c54d3d-5a0d-4117-bbd2-1dee069d1b14"
      unitRef="usd">394000</us-gaap:MinorityInterestDecreaseFromRedemptions>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ia77015134f924c9fbf430ceacefda567_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzYtMTUtMS0xLTQxMTMy_3366971d-a312-449e-b0bb-772bf109ea90"
      unitRef="usd">629000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzYtMTctMS0xLTQxMTMy_efd3d5bc-3ba9-4492-85cf-733d7db19b58"
      unitRef="usd">629000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <pntg:StockholdersEquityDistributionsFromParent
      contextRef="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzctMTMtMS0xLTQ2OTg3_c501e64b-1907-40cc-aa08-bd2dc24bdc1a"
      unitRef="usd">11894000</pntg:StockholdersEquityDistributionsFromParent>
    <pntg:StockholdersEquityDistributionsFromParent
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzctMTctMS0xLTQ2OTg3_4e7a08ef-6cc8-434d-bc7a-cbc627be1ce8"
      unitRef="usd">11894000</pntg:StockholdersEquityDistributionsFromParent>
    <us-gaap:NetIncomeLoss
      contextRef="i690e1ad892ed46a8bc17a390e883382b_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtNy0xLTEtNDY5ODc_361f5746-a99d-4c05-a72a-854a13116432"
      unitRef="usd">-3799000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTMtMS0xLTQ2OTg3_4916b0c5-2287-466f-a8c3-9b0a49335f0b"
      unitRef="usd">6345000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTctMS0xLTQ2OTg3_082996e0-724c-4b68-8621-787dbccf323d"
      unitRef="usd">2546000</us-gaap:NetIncomeLoss>
    <us-gaap:DividendsCash
      contextRef="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzktMTMtMS0xLTQ2OTg3_dbf666ae-1405-4fda-a51f-dcc7a0fa7219"
      unitRef="usd">11600000</us-gaap:DividendsCash>
    <us-gaap:DividendsCash
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzktMTctMS0xLTQ2OTg3_b743ca99-b7a9-445d-8818-1c3cfe2f9bb9"
      unitRef="usd">11600000</us-gaap:DividendsCash>
    <pntg:ReclassificationOfInvestedEquity
      contextRef="i5c4557ca296245b787f54721e8fb4fc7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTUtMS0xLTQ2OTg3_4d56cafd-1aac-49ea-b9fc-7d779af88165"
      unitRef="usd">72893000</pntg:ReclassificationOfInvestedEquity>
    <pntg:ReclassificationOfInvestedEquity
      contextRef="i07fe49b2137b43dfac203c221fbb121f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTEzLTEtMS00Njk4Nw_00b3611e-4d7b-4030-a4d6-c79227db1b72"
      unitRef="usd">-59504000</pntg:ReclassificationOfInvestedEquity>
    <pntg:ReclassificationOfInvestedEquity
      contextRef="ia77015134f924c9fbf430ceacefda567_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTE1LTEtMS00Njk4Nw_49570fb0-1223-4b02-a642-fca78c7e0958"
      unitRef="usd">-13252000</pntg:ReclassificationOfInvestedEquity>
    <pntg:ReclassificationOfInvestedEquity
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTE3LTEtMS00Njk4Nw_301b5919-e493-4013-b58e-80ddd3b0b834"
      unitRef="usd">137000</pntg:ReclassificationOfInvestedEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i4a9a8de246d64eae8dd59832de0af5e7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTEtMS0xLTQ2OTg3_56d56359-7c70-4634-8c14-1ae4a7005391"
      unitRef="shares">27834000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i4a9a8de246d64eae8dd59832de0af5e7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTMtMS0xLTQ2OTg3_2700c85b-8524-45b6-8459-727a9efd47b7"
      unitRef="usd">28000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i5c4557ca296245b787f54721e8fb4fc7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTUtMS0xLTQ2OTg3_3c492b66-2b8d-4843-bbe4-249886160476"
      unitRef="usd">-28000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTE3LTEtMS00Njk4Nw_6fec2ba0-8667-4d83-a31b-dfd9a436eb3b"
      unitRef="usd">0</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i5c4557ca296245b787f54721e8fb4fc7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEyLTUtMS0xLTQ2OTg3_b8649ca4-5045-403d-9e38-4b7e5225e2e8"
      unitRef="usd">1987000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEyLTE3LTEtMS00Njk4Nw_7eb2f060-7eef-49a1-8b85-8657b3b103ec"
      unitRef="usd">1987000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4a9a8de246d64eae8dd59832de0af5e7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEzLTEtMS0xLTQ2OTg3_712e0969-127d-4c5d-8422-52e5a2fd77ac"
      unitRef="shares">601000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i5c4557ca296245b787f54721e8fb4fc7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEzLTUtMS0xLTQ2OTg3_a304411d-631a-4f44-b912-ff0ff4c35aa6"
      unitRef="usd">30000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEzLTE3LTEtMS00Njk4Nw_f2bfa53e-231b-49de-a81d-5e89ee6c3316"
      unitRef="usd">30000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SharesOutstanding
      contextRef="i5166a6bf5fa34ea4a777f2940c33fc70_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMS0xLTEtNDExMzI_0ae8549e-397e-4cd9-b7d8-05d1c2c9f34a"
      unitRef="shares">28435000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5166a6bf5fa34ea4a777f2940c33fc70_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMy0xLTEtNDExMzI_fa1854b7-8361-40af-93e3-4ec168299572"
      unitRef="usd">28000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i53e93f7878814ac5ba917527e6bc6fdb_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtNS0xLTEtNDExMzI_43771e36-4cd3-46fe-b371-8d28bd6099a8"
      unitRef="usd">74882000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5bfd4e9286bf4ca98e7e5f4e442a2026_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtNy0xLTEtNDExMzI_3fd4ddcb-6743-4e73-b945-40e355a10526"
      unitRef="usd">-3799000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i5b80432f9127486d82bf8a5566b3b726_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtOS0xLTEtNDExMzI_2e563f43-039c-460e-808a-248290a58eef"
      unitRef="shares">0</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i5b80432f9127486d82bf8a5566b3b726_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTEtMS0xLTQxMTMy_6e8c5944-0234-4ada-bbd6-1b5a1c907f14"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ie7504d19735f49cc9eea4e20bfed667a_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTMtMS0xLTQxMTMy_801bacba-d55d-4578-9235-559d4f7c3a85"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i35bd8b5de02d40739ff3a3df8cfe4355_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTUtMS0xLTQxMTMy_2164ba6a-3a35-4c78-84f6-27120c5eb313"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzgtMTctMS0xLTQxMTMy_63a71b99-bb77-4de4-9214-0cf0293342de"
      unitRef="usd">71111000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="ie90f6d4e5d3849e5bcb29a785a2ddaac_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzktMTUtMS0xLTQxMTMy_7153f649-d5ef-4899-abe0-8711a8057f47"
      unitRef="usd">4646000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzktMTctMS0xLTQxMTMy_c29e8c96-c443-40dc-bc57-a946da9bc54f"
      unitRef="usd">4646000</us-gaap:NoncontrollingInterestIncreaseFromBusinessCombination>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ic350fc4ba36449e4872a8c4cc3fc52fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTUtMS0xLTQxMTMy_751811cf-90e4-42b5-9406-8a7ebbbf16b3"
      unitRef="usd">313000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="ie90f6d4e5d3849e5bcb29a785a2ddaac_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTE1LTEtMS00MTEzMg_93cc8530-36d6-41c8-adc6-b2d29245d2a0"
      unitRef="usd">138000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEwLTE3LTEtMS00MTEzMg_bc375f4d-0d9a-4abd-8dc8-ce7132255aeb"
      unitRef="usd">451000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie90f6d4e5d3849e5bcb29a785a2ddaac_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTE1LTEtMS00MTEzMg_9f8229f3-0fd2-46fd-aa8c-28ab66cbb66a"
      unitRef="usd">-191000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzExLTE3LTEtMS00MTEzMg_6bb1919f-f257-4938-9d93-e7a0eb201bd1"
      unitRef="usd">-191000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="if33183982ee24195bfee778d16529013_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEyLTctMS0xLTQxMTMy_fe3e290a-36cc-485c-b728-c9544cab37c8"
      unitRef="usd">15744000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEyLTE3LTEtMS00MTEzMg_535a18e2-4e3f-49c9-8d18-31ea2b2234ec"
      unitRef="usd">15744000</us-gaap:NetIncomeLoss>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic350fc4ba36449e4872a8c4cc3fc52fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEzLTUtMS0xLTQxMTMy_d886675a-1ea0-4b22-be03-bca7c9d5684a"
      unitRef="usd">8335000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzEzLTE3LTEtMS00MTEzMg_acca38f1-709b-46dc-8d24-6e0029565d1f"
      unitRef="usd">8335000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i2296c7a7384d4e56b1c183412b8e586e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE0LTEtMS0xLTQxMTMy_992894f7-8c06-4827-8901-6428189d9d09"
      unitRef="shares">238000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic350fc4ba36449e4872a8c4cc3fc52fb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE0LTUtMS0xLTQxMTMy_b350c899-e079-4005-91e8-6659b999c62a"
      unitRef="usd">1141000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE0LTE3LTEtMS00MTEzMg_849c5ed1-73a3-4164-acb7-cbf994b688c8"
      unitRef="usd">1141000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
      contextRef="i2296c7a7384d4e56b1c183412b8e586e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE1LTEtMS0xLTQxMTMy_41988215-14ad-4b7b-882d-b9561581218f"
      unitRef="shares">26000</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i2296c7a7384d4e56b1c183412b8e586e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE2LTEtMS0xLTQxMTMy_6521d1ef-d7da-48f2-aa2f-6004bd5a2846"
      unitRef="shares">3000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i166349c580b648b886b6acee6a9a1cbb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE2LTktMS0xLTQxMTMy_58a39c23-2adf-4cdb-9aab-ab59faf22a54"
      unitRef="shares">-3000</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i166349c580b648b886b6acee6a9a1cbb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE2LTExLTEtMS00MTEzMg_74093493-08dd-412a-a186-c6c708efc11c"
      unitRef="usd">65000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE2LTE3LTEtMS00MTEzMg_91d73f68-55e8-40d9-9776-a551d80b2aa1"
      unitRef="usd">65000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="i99cc169c87d54cfbaeeb3b1336ab30eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTEtMS0xLTQxMTMy_dff51408-0d08-4e7a-998e-065c37980d07"
      unitRef="shares">28696000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i99cc169c87d54cfbaeeb3b1336ab30eb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTMtMS0xLTQxMTMy_5febf22d-c422-422b-888b-ca7d3df9a9bd"
      unitRef="usd">28000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i05bcdfdd5a524814835b5fe3930e4688_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTUtMS0xLTQxMTMy_c1b3822e-ef0e-4092-b21e-c10be425c4d7"
      unitRef="usd">84671000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i95ba983a79d7440dbbf23a35c1171deb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTctMS0xLTQxMTMy_df8e66ad-d59a-4afc-8c1a-5b44e8838aa2"
      unitRef="usd">11945000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="ic64854ee9b9849e0b09fa298cbfd3e99_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTktMS0xLTQxMTMy_356b4c51-1f90-4a09-820a-7f0fbf803684"
      unitRef="shares">-3000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ic64854ee9b9849e0b09fa298cbfd3e99_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTExLTEtMS00MTEzMg_39150f7e-9c63-4f17-b9b9-7774bb8b08a0"
      unitRef="usd">-65000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i1a5b873622de45afa65e19177ba49557_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTEzLTEtMS00MTEzMg_800f3911-ec1a-4205-a651-e1d4f69d42ff"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="ia44088af8f1e46d1b16f10b9327f6cf5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTE1LTEtMS00MTEzMg_6e9d6141-26ed-4daa-8c31-81bfd19923e1"
      unitRef="usd">4593000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzE5LTE3LTEtMS00MTEzMg_287a95d7-583d-4b0a-a53f-f31d779b5795"
      unitRef="usd">101172000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i9d456b9856964a9b93a6df6f1fa39ccf_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIwLTctMS0xLTQxMTMy_e08cd52e-7b52-4f3c-b05c-09af85691226"
      unitRef="usd">2696000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIwLTE3LTEtMS00MTEzMg_addaa0a0-2270-4a50-a87d-40830321b931"
      unitRef="usd">2696000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="iad9a8ecab0c04918aee8cdd00de80898_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIxLTE1LTEtMS00MTEzMg_526d3120-0b38-41a7-b2cb-61a2d91eaf38"
      unitRef="usd">-548000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIxLTE3LTEtMS00MTEzMg_633c75ec-fa51-4b95-a7c6-39671c0d6495"
      unitRef="usd">-548000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i95eabde00ded4cf097fa61177f5f5a10_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIyLTUtMS0xLTQxMTMy_75e3bf0c-64de-43c2-8965-51cf195b6d10"
      unitRef="usd">10040000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIyLTE3LTEtMS00MTEzMg_b7f49664-7be9-457b-9aee-8ac5dcc9094b"
      unitRef="usd">10040000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="icb984f908c724c4bbff50002d4aec555_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIzLTEtMS0xLTQxMTMy_840287f9-d124-4b3a-a134-84a4be9410ba"
      unitRef="shares">115000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i95eabde00ded4cf097fa61177f5f5a10_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIzLTUtMS0xLTQxMTMy_038c92a4-f117-4e46-94db-5b4a4523fdf0"
      unitRef="usd">884000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzIzLTE3LTEtMS00MTEzMg_3c99ac21-798f-4b70-8536-8a2581623d81"
      unitRef="usd">884000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="icb984f908c724c4bbff50002d4aec555_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI0LTEtMS0xLTQxMTMy_e796f113-8c1a-478c-9515-d972875c9fe2"
      unitRef="shares">15000</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:SharesOutstanding
      contextRef="i9b5f6ca5bfb2481690e71d78cb6d8667_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTEtMS0xLTQxMTMy_c7027866-5060-41e4-887e-09a8b57d9a86"
      unitRef="shares">28826000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i9b5f6ca5bfb2481690e71d78cb6d8667_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTMtMS0xLTQxMTMy_05158f8d-9051-4dee-a0f7-ddd62d1bf84d"
      unitRef="usd">28000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i82251654ca3f4fc288f2fb5540302bd6_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTUtMS0xLTQxMTMy_76988381-bd88-4481-87f7-f8da2ec3b7c3"
      unitRef="usd">95595000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i7bd7edef27e34175800cc42062b7c736_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTctMS0xLTQxMTMy_248aa0df-91b3-4235-9747-62d020b5002c"
      unitRef="usd">14641000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:SharesOutstanding
      contextRef="i15a951b1e5734b3997d7829d03437e38_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTktMS0xLTQxMTMy_64226bcc-9902-47de-8513-0a49b676b5e9"
      unitRef="shares">-3000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i15a951b1e5734b3997d7829d03437e38_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTExLTEtMS00MTEzMg_790d4d91-d69e-4956-b67a-6cd8b1a50b9f"
      unitRef="usd">-65000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i570ab8a66ef6484f8c4085965fb06999_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTEzLTEtMS00MTEzMg_8fe549fd-0263-4ba2-b696-e7bea99e47ec"
      unitRef="usd">0</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27c052df90b74bb0b3ea9126a1f86ca7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTE1LTEtMS00MTEzMg_e8540a06-e672-480f-989d-054be63a8321"
      unitRef="usd">4045000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNDgvZnJhZzoyZmNlZGNhZDMxYzE0ODgxOGI4NWE1ODBkZjY1ZDNhMi90YWJsZTo4ZWI4ZjVlYzExYzg0MWVjYjUyM2ZlYjczMGY1ZTM5Ni90YWJsZXJhbmdlOjhlYjhmNWVjMTFjODQxZWNiNTIzZmViNzMwZjVlMzk2XzI4LTE3LTEtMS00MTEzMg_c73475fd-7d11-4ee1-a59f-b9c12268ae3d"
      unitRef="usd">114244000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:ProfitLoss
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMtMS0xLTEtNDExMzI_2487b4be-f430-4095-9c2c-e5be96b7aabd"
      unitRef="usd">2148000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMtMy0xLTEtNDExMzI_7fa6c6a8-1e8e-4858-9628-596d2ed75be8"
      unitRef="usd">15553000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMtNS0xLTEtNDExMzI_8f6727c0-da7e-48ef-8eee-564a4d63e0ce"
      unitRef="usd">3175000</us-gaap:ProfitLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzUtMS0xLTEtNDExMzI_9d4a6385-55cf-45ff-8970-660010bda38c"
      unitRef="usd">4784000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzUtMy0xLTEtNDExMzI_b4221f29-c3c6-4b5c-a65e-ab478da512cf"
      unitRef="usd">4675000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzUtNS0xLTEtNDExMzI_a4aad377-576d-4c80-9c80-c2fd9296d13e"
      unitRef="usd">3810000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzYtMS0xLTEtNDExMzI_be315652-d2c7-453a-bc94-83ab798c8b63"
      unitRef="usd">488000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzYtMy0xLTEtNDExMzI_0bd88dd7-30be-40f3-8c42-aa3ad8a56afb"
      unitRef="usd">330000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzYtNS0xLTEtNDExMzI_c4e62913-cb58-40a7-ad12-63f4eb912153"
      unitRef="usd">78000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzctMS0xLTEtNDExMzI_a7c87888-f0d4-4085-b119-549e83fa8cb3"
      unitRef="usd">616000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzctMy0xLTEtNDExMzI_d9d0f29f-dc58-4c12-b1e8-3836233d42eb"
      unitRef="usd">560000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzctNS0xLTEtNDExMzI_78a05b57-2e36-414c-836a-b5076faeca91"
      unitRef="usd">858000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ShareBasedCompensation
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzgtMS0xLTEtNDExMzI_dad76fd8-7e00-4992-a9a0-cafbd38e66af"
      unitRef="usd">10040000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzgtMy0xLTEtNDExMzI_c85262bc-7469-4b62-864f-07e256993023"
      unitRef="usd">8335000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzgtNS0xLTEtNDExMzI_2cb315c3-10f0-4214-b7cb-7f9ce6f09a11"
      unitRef="usd">3382000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzktMS0xLTEtNDExMzI_92b7cf8d-3d2f-4eab-8de8-4f044b27da4d"
      unitRef="usd">-1752000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzktMy0xLTEtNDExMzI_d75b7223-489e-4f8d-a8d8-cac9e05ed48f"
      unitRef="usd">-2201000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:DeferredIncomeTaxesAndTaxCredits
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzktNS0xLTEtNDExMzI_cc469553-bbff-4901-95ff-2a15f3319107"
      unitRef="usd">79000</us-gaap:DeferredIncomeTaxesAndTaxCredits>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEwLTEtMS0xLTQxMTMy_f3079670-38f8-447b-b512-57dfeb5f87ae"
      unitRef="usd">2835000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEwLTMtMS0xLTQxMTMy_201f5e92-451a-4567-9048-f199159b8a5a"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEwLTUtMS0xLTQxMTMy_74c38bf5-043a-4e72-89f9-aa116859f2f1"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEyLTEtMS0xLTQxMTMy_406d3570-8933-40fd-97a5-7ba9747b6a26"
      unitRef="usd">7335000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEyLTMtMS0xLTQxMTMy_b47e1de7-5489-49fd-916f-6e94884e169e"
      unitRef="usd">15712000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEyLTUtMS0xLTQxMTMy_e409b4b1-4c2e-430a-b285-3f9becce4566"
      unitRef="usd">8571000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEzLTEtMS0xLTQxMTMy_f86be489-fbcc-469b-b2d2-f3ebf7156bdd"
      unitRef="usd">4624000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEzLTMtMS0xLTQxMTMy_7212e6bc-1ae1-4f1a-9978-86cf369eebda"
      unitRef="usd">7435000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzEzLTUtMS0xLTQxMTMy_bda24793-ebad-4f9d-959d-a0ab8f54550b"
      unitRef="usd">2746000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE0LTEtMS0xLTQxMTMy_b04eb67d-c4fe-4b9e-8691-95c3869ade4e"
      unitRef="usd">803000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE0LTMtMS0xLTQxMTMy_fb2f2271-6e88-4077-af45-56d99c37f2dd"
      unitRef="usd">2068000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE0LTUtMS0xLTQxMTMy_dc5e1635-05e1-431b-9cec-567a56f85e91"
      unitRef="usd">-1861000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE1LTEtMS0xLTQxMTMy_50dfe5ad-7949-4893-99cf-8595ff19a4b8"
      unitRef="usd">562000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE1LTMtMS0xLTQxMTMy_b9d7f9a6-75cf-476a-9d33-9d7c5bad110a"
      unitRef="usd">993000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE1LTUtMS0xLTQxMTMy_44cdf929-09f2-4978-8d75-ee6e5930194d"
      unitRef="usd">4069000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE2LTEtMS0xLTQxMTMy_ae9c8735-d385-47f9-8d88-573ed49bd9f6"
      unitRef="usd">-3864000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE2LTMtMS0xLTQxMTMy_c37fb0f2-e84d-415c-bc60-111b77458bcf"
      unitRef="usd">10538000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE2LTUtMS0xLTQxMTMy_30d1673f-fb98-4ed6-b30c-f0c25a12cbc7"
      unitRef="usd">3376000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE3LTEtMS0xLTQxMTMy_d265ecff-ba12-4cee-a29f-33604a0ccb59"
      unitRef="usd">2570000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE3LTMtMS0xLTQxMTMy_4f06560b-eee0-4da8-97ca-bb5be6f0a492"
      unitRef="usd">2427000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE3LTUtMS0xLTQxMTMy_93bc6e4f-4eb2-47c9-8e2f-8a66ec8043e7"
      unitRef="usd">1720000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE4LTEtMS0xLTQxMTMy_1d628997-de86-4a17-b73a-63566271647a"
      unitRef="usd">-21786000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE4LTMtMS0xLTQxMTMy_de48f714-172d-404e-9e7b-cca77ffee708"
      unitRef="usd">27997000</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInContractWithCustomerLiability
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzE4LTUtMS0xLTQxMTMy_aa693868-a995-4310-8291-3fb6b9acad73"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInContractWithCustomerLiability>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIwLTEtMS0xLTQxMTMy_deee0c7a-1faf-4ec5-8d59-7da9a11b3730"
      unitRef="usd">-3708000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIwLTMtMS0xLTQxMTMy_072697d9-c6ba-4cc4-af3f-ab29dad5147f"
      unitRef="usd">2076000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIwLTUtMS0xLTQxMTMy_8b74d515-1eec-4e64-a6fc-830e17627c52"
      unitRef="usd">2185000</us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIxLTEtMS0xLTQxMTMy_e663ef52-f51f-4b9a-b04a-8e725ecd1256"
      unitRef="usd">-18223000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIxLTMtMS0xLTQxMTMy_54fc15f0-0670-4da5-aa63-59f2102901e2"
      unitRef="usd">50204000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIxLTUtMS0xLTQxMTMy_81f42281-80f1-4c7e-8029-932d5354d8a1"
      unitRef="usd">9554000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIzLTEtMS0xLTQxMTMy_1e6310fa-8164-4b47-989d-feaeafbc8f62"
      unitRef="usd">6303000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIzLTMtMS0xLTQxMTMy_bdee4ba3-b37a-482f-bed5-acf5f46d5bd5"
      unitRef="usd">7253000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzIzLTUtMS0xLTQxMTMy_d6e8c0cb-a344-4db8-b195-5823539581a4"
      unitRef="usd">6714000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI0LTEtMS0xLTQxMTMy_a0f08f8f-7045-4020-bfda-0a014a10e5b1"
      unitRef="usd">13550000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI0LTMtMS0xLTQxMTMy_4808cb1a-eea0-42b0-b06e-21261461e8f9"
      unitRef="usd">33193000</us-gaap:PaymentsToAcquireBusinessesGross>
    <us-gaap:PaymentsToAcquireBusinessesGross
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI0LTUtMS0xLTQxMTMy_f3a05ddf-7789-4047-98f5-a63a6a34c3e9"
      unitRef="usd">18760000</us-gaap:PaymentsToAcquireBusinessesGross>
    <pntg:PaymentsForDepositsOnAcquisition
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI4LTEtMS0xLTQxMTMy_347cb70e-593d-4aaa-8700-d68dfe7bfc87"
      unitRef="usd">0</pntg:PaymentsForDepositsOnAcquisition>
    <pntg:PaymentsForDepositsOnAcquisition
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI4LTMtMS0xLTQxMTMy_f3d6af3c-1092-4725-ad5a-7b2de0d948e7"
      unitRef="usd">525000</pntg:PaymentsForDepositsOnAcquisition>
    <pntg:PaymentsForDepositsOnAcquisition
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI4LTUtMS0xLTQxMTMy_1ca0c2ad-daa9-4c3e-8a0e-c36db8d011ac"
      unitRef="usd">1400000</pntg:PaymentsForDepositsOnAcquisition>
    <pntg:PaymentsForProceedsFromPropertyReserveRequirements
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI5LTEtMS0xLTQxMTMy_d0a3a990-c508-413f-95ce-f04cdf839c80"
      unitRef="usd">267000</pntg:PaymentsForProceedsFromPropertyReserveRequirements>
    <pntg:PaymentsForProceedsFromPropertyReserveRequirements
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI5LTMtMS0xLTQxMTMy_554a4c48-fcc7-452c-b87b-06ba04a5733c"
      unitRef="usd">645000</pntg:PaymentsForProceedsFromPropertyReserveRequirements>
    <pntg:PaymentsForProceedsFromPropertyReserveRequirements
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzI5LTUtMS0xLTQxMTMy_299cda5d-062a-4c56-9735-72a8e76ee938"
      unitRef="usd">-409000</pntg:PaymentsForProceedsFromPropertyReserveRequirements>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMwLTEtMS0xLTQxMTMy_9105ebd9-f264-47c1-9ba4-c49c50f50a08"
      unitRef="usd">-20120000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMwLTMtMS0xLTQxMTMy_aa051ac2-8b19-4da2-8ec3-7d1d738ec69b"
      unitRef="usd">-41616000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMwLTUtMS0xLTQxMTMy_7838a7d4-1a54-4cf2-a093-bb5218f4219f"
      unitRef="usd">-26465000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <pntg:ProceedsFromSaleOfSubsidiaryShares
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMyLTEtMS0xLTQxMTMy_ea6e3c77-432d-4d32-9ad6-d26965512a72"
      unitRef="usd">0</pntg:ProceedsFromSaleOfSubsidiaryShares>
    <pntg:ProceedsFromSaleOfSubsidiaryShares
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMyLTMtMS0xLTQxMTMy_3f036f1c-a524-4b53-9825-89feee27ddd2"
      unitRef="usd">0</pntg:ProceedsFromSaleOfSubsidiaryShares>
    <pntg:ProceedsFromSaleOfSubsidiaryShares
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMyLTUtMS0xLTQxMTMy_2d562fea-bcc7-4309-87db-2254fd878b7e"
      unitRef="usd">2293000</pntg:ProceedsFromSaleOfSubsidiaryShares>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMzLTEtMS0xLTQxMTMy_c256a373-44ce-4481-9a90-a4db831900d1"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMzLTMtMS0xLTQxMTMy_559c1151-7f36-44c1-aaaa-003dcc831f5d"
      unitRef="usd">0</us-gaap:PaymentsToMinorityShareholders>
    <us-gaap:PaymentsToMinorityShareholders
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzMzLTUtMS0xLTQxMTMy_14508522-8511-4d2f-9363-6749a5a312c2"
      unitRef="usd">2687000</us-gaap:PaymentsToMinorityShareholders>
    <pntg:DistributionToFromParent
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM0LTEtMS0xLTQxMTMy_52c5c823-c056-4931-9d98-d48bdaaeb72e"
      unitRef="usd">0</pntg:DistributionToFromParent>
    <pntg:DistributionToFromParent
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM0LTMtMS0xLTQxMTMy_1d3aadb6-01bc-46ac-8798-869fbe9ad8f8"
      unitRef="usd">0</pntg:DistributionToFromParent>
    <pntg:DistributionToFromParent
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM0LTUtMS0xLTQxMTMy_99d39aa5-4ecc-4934-832c-22f0226ce10d"
      unitRef="usd">10788000</pntg:DistributionToFromParent>
    <us-gaap:PaymentsOfDividends
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM1LTEtMS0xLTQxMTMy_2514da84-8897-4c33-8c86-faa239f379fc"
      unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM1LTMtMS0xLTQxMTMy_bb17a9dd-7260-47c4-9d81-6880751fcc4a"
      unitRef="usd">0</us-gaap:PaymentsOfDividends>
    <us-gaap:PaymentsOfDividends
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM1LTUtMS0xLTQxMTMy_60cd37fc-97a7-4840-862e-5bd4a1b42a4e"
      unitRef="usd">11600000</us-gaap:PaymentsOfDividends>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM2LTEtMS0xLTQxMTMy_60bf8ca1-ffcb-4bde-8526-74f9eeebfc29"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM2LTMtMS0xLTQxMTMy_ce87934e-c2f9-436d-97c6-166365ed1a0f"
      unitRef="usd">555000</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromMinorityShareholders
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM2LTUtMS0xLTQxMTMy_6de89e9b-a13e-4af6-87fb-fbfb306d5fad"
      unitRef="usd">0</us-gaap:ProceedsFromMinorityShareholders>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM3LTEtMS0xLTQxMTMy_26747c77-6a27-496c-88f2-7742f173455b"
      unitRef="usd">125500000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM3LTMtMS0xLTQxMTMy_1bcf4ab0-0dc4-402e-afbe-39a14b567dd3"
      unitRef="usd">52700000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:ProceedsFromLongTermLinesOfCredit
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM3LTUtMS0xLTQxMTMy_f44f3509-9467-4f5e-bccb-f16d18149adf"
      unitRef="usd">42500000</us-gaap:ProceedsFromLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM4LTEtMS0xLTQxMTMy_1730beb3-7f93-40bc-9df4-4ba1b6cacebd"
      unitRef="usd">81500000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM4LTMtMS0xLTQxMTMy_f1f6b66f-4ea6-448b-96f3-bbc6ef6eb5db"
      unitRef="usd">63200000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:RepaymentsOfLongTermLinesOfCredit
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM4LTUtMS0xLTQxMTMy_64f4cf41-d5a0-4548-ac18-45b9f13e4064"
      unitRef="usd">22500000</us-gaap:RepaymentsOfLongTermLinesOfCredit>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM5LTEtMS0xLTQxMTMy_9f35de7d-ae74-44af-a190-c9fca33e2de4"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM5LTMtMS0xLTQxMTMy_50e5629a-8cf3-4e0d-b9de-4f1a1315435f"
      unitRef="usd">65000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzM5LTUtMS0xLTQxMTMy_f21c8cc3-2618-492f-93c9-643a3a6eab57"
      unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQwLTEtMS0xLTQxMTMy_9020a642-4fad-4e5a-918b-87dda7cfb4f5"
      unitRef="usd">1394000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQwLTMtMS0xLTQxMTMy_fc596ed3-c9b0-4a5e-932b-9140341732d2"
      unitRef="usd">78000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:PaymentsOfFinancingCosts
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQwLTUtMS0xLTQxMTMy_f629bd4a-00ec-43a7-a754-8c952213491a"
      unitRef="usd">1552000</us-gaap:PaymentsOfFinancingCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQxLTEtMS0xLTQxMTMy_6bb53fb1-35a7-4104-be70-0866c6beb004"
      unitRef="usd">884000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQxLTMtMS0xLTQxMTMy_9eb68315-9a91-44be-a6fa-5e4e0a8b9b3c"
      unitRef="usd">1141000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQxLTUtMS0xLTQxMTMy_a2a71e5a-b799-4748-9a73-26e696267735"
      unitRef="usd">30000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQyLTEtMS0xLTQxMTMy_5aac9670-8457-4b2b-a6b6-3002ec766b79"
      unitRef="usd">43490000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQyLTMtMS0xLTQxMTMy_31c65c78-29db-4a10-9c1b-9556a3c184c2"
      unitRef="usd">-8947000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQyLTUtMS0xLTQxMTMy_3c670ed8-a15d-43a0-ae36-eb49a8200470"
      unitRef="usd">17272000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQzLTEtMS0xLTQxMTMy_32bfc112-76f8-4a07-8e9c-2a6ecdd51445"
      unitRef="usd">5147000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQzLTMtMS0xLTQxMTMy_9e0ddf6c-c64c-41f2-b40f-d988f33a1802"
      unitRef="usd">-359000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQzLTUtMS0xLTQxMTMy_4aab59df-efb6-4afb-b556-36bfd6ee537c"
      unitRef="usd">361000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ0LTEtMS0xLTQxMTMy_7f6da96e-340c-472e-9c42-97d9ae0ae887"
      unitRef="usd">43000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ0LTMtMS0xLTQxMTMy_bc579cf5-d9d4-4bdb-9f29-b96cd765f629"
      unitRef="usd">402000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i855d825b738d453698699f3f7321df6f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ0LTUtMS0xLTQxMTMy_4cee7181-1a87-48e3-a86d-0f8f90b013dc"
      unitRef="usd">41000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ1LTEtMS0xLTQxMTMy_7c787ced-4b18-45a8-9097-15187cfb0d73"
      unitRef="usd">5190000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ1LTMtMS0xLTQxMTMy_d514ecfb-b101-486e-9d0d-647f149f2c76"
      unitRef="usd">43000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTowNjFkZjU3MDY3MmM0OTM5OWI5MmZmZDY1OTA3Y2FkMC90YWJsZXJhbmdlOjA2MWRmNTcwNjcyYzQ5Mzk5YjkyZmZkNjU5MDdjYWQwXzQ1LTUtMS0xLTQxMTMy_73a96cb6-e67e-4d8e-aca5-5c440af4eb84"
      unitRef="usd">402000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzQtMS0xLTEtNDExMzI_2c5b6e8c-992d-4e9d-843d-e8ed5a18b71d"
      unitRef="usd">1448000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzQtMy0xLTEtNDExMzI_df2d8c6f-53bb-46af-9478-b4cf793c60b6"
      unitRef="usd">1116000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzQtNS0xLTEtNDExMzI_138de62e-a930-4211-acb8-deaff422660b"
      unitRef="usd">156000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzUtMS0xLTEtNDExMzI_50c6577f-1bc3-4351-8cc0-dca00e3a024a"
      unitRef="usd">2616000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzUtMy0xLTEtNDExMzI_e941da73-a125-4b21-a0f0-7b0001a36fd9"
      unitRef="usd">7865000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzUtNS0xLTEtNDExMzI_6e298f58-8deb-466c-a437-f24ee3f4bf36"
      unitRef="usd">120000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OperatingLeasePayments
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzYtMS0xLTEtNDExMzI_c2ad4fe2-19a2-4871-9abd-29222953ca2c"
      unitRef="usd">39151000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzYtMy0xLTEtNDExMzI_df6bf801-d9d2-4c66-a6e2-e23ad083beff"
      unitRef="usd">35853000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzYtNS0xLTEtNDExMzI_adbf164c-50b7-416c-b1d9-e962795331b8"
      unitRef="usd">37088000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzctMS0xLTEtNDExMzI_baddea6f-d4c5-4884-b7d7-ec32d49698dd"
      unitRef="usd">3230000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzctMy0xLTEtNDExMzI_ce0261d3-49de-4d17-848f-d78fcc78ce00"
      unitRef="usd">5451000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzctNS0xLTEtNDExMzI_e1e48aaf-f74d-420b-b41a-b105ef37d837"
      unitRef="usd">9059000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <pntg:AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzgtMS0xLTEtNDExMzI_89c8e65b-ce1b-4fa8-932c-f40a2e878d1f"
      unitRef="usd">4674000</pntg:AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability>
    <pntg:AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzgtMy0xLTEtNDExMzI_cd30ec4e-bf07-417c-84c3-beac29f40543"
      unitRef="usd">1939000</pntg:AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability>
    <pntg:AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzgtNS0xLTEtNDExMzI_6d8fcf3a-6968-44c1-866f-785db450c5a8"
      unitRef="usd">77462000</pntg:AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzEwLTEtMS0xLTQxMTMy_ce771465-8ad2-4e17-a9e9-9febff972944"
      unitRef="usd">730000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzEwLTMtMS0xLTQxMTMy_06744dc2-f8a5-44a3-833d-e8501e4de3b1"
      unitRef="usd">560000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTEvZnJhZzpmOTdlNDZlNTFiYzI0NDU2ODczOWViMTY4ZTc3NjIxOS90YWJsZTo2ZmZiN2VmNTQ5ZDk0NmM3ODIwNGQ3YzAwMjgyNDA3Yy90YWJsZXJhbmdlOjZmZmI3ZWY1NDlkOTQ2Yzc4MjA0ZDdjMDAyODI0MDdjXzEwLTUtMS0xLTQxMTMy_09ecff57-492c-426b-b574-c735dec41aba"
      unitRef="usd">946000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:NatureOfOperations
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTcvZnJhZzpjYTViNzliMGIwOWU0NGQzYWVkYzgzZWIzNTEyMDc3Ny90ZXh0cmVnaW9uOmNhNWI3OWIwYjA5ZTQ0ZDNhZWRjODNlYjM1MTIwNzc3XzY1OTcwNjk3Njg3OTk_e709b170-0d74-44de-859e-271e50e6f343">DESCRIPTION OF BUSINESS&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Pennant Group, Inc. (herein referred to as &#x201c;Pennant,&#x201d; the &#x201c;Company,&#x201d; &#x201c;it,&#x201d; or &#x201c;its&#x201d;), is a holding company with no direct operating assets, employees or revenue. The Company, through its independent operating subsidiaries, provides healthcare services across the post-acute care continuum. As of December&#160;31, 2021, the Company&#x2019;s subsidiaries operated 88 home health, hospice and home care agencies and 54 senior living communities located in Arizona, California, Colorado, Idaho, Iowa, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin and Wyoming.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;1, 2019, The Ensign Group, Inc. (NASDAQ: ENSG) (&#x201c;Ensign&#x201d; or the &#x201c;Parent&#x201d;) completed the separation of Pennant from Ensign through a tax-free distribution of substantially all of Pennant&#x2019;s issued and outstanding common stock to the stockholders of Ensign (the &#x201c;Spin-Off&#x201d;). To accomplish the Spin-Off, Ensign contributed the Company&#x2019;s assets and liabilities into Pennant and each Ensign stockholder received a distribution of one share of Pennant common stock for every two shares of Ensign&#x2019;s common stock, plus cash in lieu of fractional shares. Additionally, the noncontrolling interest was converted into shares of Pennant at the established conversion ratio. As a result of the Spin-Off on October&#160;1, 2019, Pennant began trading as an independent company on the NASDAQ under the symbol &#x201c;PNTG.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain of the Company&#x2019;s subsidiaries, collectively referred to as the Service Center, provide accounting, payroll, human resources, information technology, legal, risk management, and other services to the operations through contractual relationships.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each of the Company&#x2019;s affiliated operations are operated by separate, independent subsidiaries that have their own management, employees and assets. References herein to the consolidated &#x201c;Company&#x201d; and &#x201c;its&#x201d; assets and activities is not meant to imply, nor should it be construed as meaning, that Pennant has direct operating assets, employees or revenue, or that any of the subsidiaries, are operated by Pennant.&lt;/span&gt;&lt;/div&gt;</us-gaap:NatureOfOperations>
    <pntg:NumberOfServiceProviders
      contextRef="ife1126ceed284fbdb9bf6b3dbab68da3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTcvZnJhZzpjYTViNzliMGIwOWU0NGQzYWVkYzgzZWIzNTEyMDc3Ny90ZXh0cmVnaW9uOmNhNWI3OWIwYjA5ZTQ0ZDNhZWRjODNlYjM1MTIwNzc3XzEwOTk1MTE2Mjk5MjI_601ff99b-7d5b-4095-bf9d-eab16d3843b7"
      unitRef="agency">88</pntg:NumberOfServiceProviders>
    <pntg:NumberOfRealEstatePropertiesUnderLease
      contextRef="icc510d566b5a497d8c3bf8da297c74be_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNTcvZnJhZzpjYTViNzliMGIwOWU0NGQzYWVkYzgzZWIzNTEyMDc3Ny90ZXh0cmVnaW9uOmNhNWI3OWIwYjA5ZTQ0ZDNhZWRjODNlYjM1MTIwNzc3XzEwOTk1MTE2Mjk5MjY_b505169d-0edf-4364-965a-983f7df39456"
      unitRef="agency">54</pntg:NumberOfRealEstatePropertiesUnderLease>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzY1OTcwNjk3OTI2MTk_8d45be69-8ae1-425b-8c0c-13af9c666bd1">BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Basis of Presentation - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated and combined financial statements of the Company (the &#x201c;Financial Statements&#x201d;) reflect the Company&#x2019;s financial position for the years ended December 31, 2021 and 2020, and the Company&#x2019;s results of operations and cash flows for the years ended December 31, 2021, 2020 and 2019 and have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) and pursuant to the regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Prior to the Spin-Off, the combined financial statements were prepared on a stand-alone basis and derived from the consolidated financial statements and accounting records of Ensign. Management believes that the Financial Statements reflect, in all material respects, all adjustments which are of a normal and recurring nature necessary to present fairly the Company&#x2019;s financial position, results of operations, and cash flows for the periods presented in conformity with GAAP applicable to the annual period. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intercompany transactions and balances between the various legal entities comprising the Company have been eliminated in consolidation. The consolidated and combined statements of income reflect income that is attributable to the Company and the noncontrolling interest. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company consists of various limited liability companies and corporations established to operate home health, hospice, home care, and senior living operations. The Financial Statements include the accounts of all entities controlled by the Company through its ownership of a majority voting interest. Revenue was derived from transactional information specific to the Company&#x2019;s services provided. The costs in the consolidated and combined statements of income reflect direct costs and allocated costs prior to the Spin-Off. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Estimates and Assumptions -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The preparation of the Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Financial Statements relate to self-insurance reserves, revenue, cost allocations from prior to the Spin-Off, intangible assets and goodwill, right-of-use assets and lease liabilities for leases greater than 12 months, and income taxes. Actual results could differ from those estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue Recognition -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenues are recognized when services are provided to the patients at the amount that reflects the consideration to which the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rate, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration which is included in the transaction price may be constrained, and is included in the net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#x2019;s estimates, the Company adjusts these estimates, which would effect net service revenue in the period such variances become known. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:40.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the Company&#x2019;s contracts have an original duration of one year or less, the Company uses the practical expedient applicable to its contracts and does not consider the time value of money. Further, because of the short duration of these contracts, the Company has not disclosed the transaction price for the remaining performance obligations as of the end of each reporting period or when the Company expects to recognize this revenue. In addition, the Company has applied the practical expedient provided by ASC 340, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Assets and Deferred Costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 340&#x201d;), and all incremental customer contract acquisition costs are expensed as they are incurred because the amortization period would have been one year or less. See Note 5&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;, Revenue and Accounts Receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:40.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CARES Act&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;: The Coronavirus Aid, Relief, and Economic Security Act (the &#x201c;CARES Act&#x201d;) was enacted on March 27, 2020 in the United States. During the second quarter of 2020 the Company applied for and received $27,997 in funds under the Accelerated and Advance Payment (&#x201c;AAP&#x201d;) Program. For the year ended December 31, 2021, the Company repaid $21,786 of the AAP funds, with the remaining balance of $6,211 recorded in other accrued liabilities on the consolidated balance sheets. The CARES Act allowed for deferred payment of the employer-paid portion of social security taxes through the end of 2020, with approximately 50% due on December 31, 2021 and the remainder due on December 31, 2022. The Company deferred approximately $7,836 of employer-paid portion of social security tax. In the fourth quarter of the current year, we repaid $3,707 and approximately $4,129 of the balance remains deferred and is recorded in accrued wages and related liabilities. The CARES Act temporarily suspended the 2% sequestration payment adjustment on Medicare fee-for-service payment beginning May 1, 2020 and was extended through December 31, 2021. The Company recognized $3,555 and $2,765 in revenue related to the suspension of sequestration for the years ended December 31, 2021 and 2020, respectively, exclusive of our start-up operations. The Company will continue to assess the effect of the CARES Act and ongoing other government legislation related to the COVID-19 pandemic that may be issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cash &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- Cash consists of petty cash and bank deposits and therefore approximates fair value. The Company places its cash with high credit quality financial institutions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:40.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable and Allowance for Doubtful Accounts -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration. The allowance for doubtful accounts is the Company&#x2019;s best estimate of current expected credit losses in the accounts receivable balance. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property and Equipment -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Property and equipment are initially recorded at their historical cost. Repairs and maintenance are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYxNzc_c179bcbb-5edd-46f8-ac7b-9c974960a03d"&gt;three&lt;/span&gt; to 15 years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Impairment of Long-Lived Assets -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company reviews the carrying value of long-lived assets that are held and used in the independent operating subsidiaries for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is determined based upon expected undiscounted future net cash flows from the operating subsidiary to which the assets relate, utilizing management&#x2019;s best estimate, appropriate assumptions, and projections at the time. If the carrying value is determined to be unrecoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair value of the asset. The Company estimates the fair value of assets based on the estimated future discounted cash flows of the asset. For the year ended December 31, 2021, management evaluated its long-lived assets and the Company identified $2,835 in long-lived asset impairment related to six senior living communities. Management did not identify any &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;asset impairment during the years ended December 31, 2020 and 2019. See further discussion at Note 8, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property and Equipment, Net.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets and Goodwill -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company&#x2019;s indefinite-lived intangible assets consist of trade names and Medicare and Medicaid licenses. The Company tests indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable. The Company did not identify any indefinite-lived intangible asset impairment during the years ended December 31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations.  Goodwill is subject to annual test for impairment as of the beginning of the fourth quarter or more frequently if events or changes indicate that the Company's goodwill might be impaired. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then it is required to perform a quantitative impairment test by comparing the fair value with the carrying amount of the reporting unit. If the carrying amount of a reporting unit exceeds its fair value, then the Company records an impairment of goodwill equal to the amount that the carrying amount of a reporting unit exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, we evaluated potential triggering events that might be indicators that our goodwill and indefinite lived intangibles were impaired. As a result of our evaluation, no goodwill or indefinite intangible asset impairments were recorded during the years ended December 31, 2021, 2020 and 2019. See further discussion at Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Intangible Assets, Net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Self-Insurance Reserve -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company retains risk for a substantial portion of potential claims for general and professional liability and workers&#x2019; compensation. Beginning on January 1, 2022 the Company transitioned its employee health plans to a self insurance model.  Prior to that date the Company did not retain risk related to its employee health plans.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company recognizes obligations associated with these costs, up to specified deductible limits in the period in which a claim is incurred, including with respect to both reported claims and claims incurred but not reported. The Company evaluates the adequacy of the self insurance reserves in conjunction with an independent actuarial assessment.As of December 31, 2021 the general and professional liability insurance has a retention limit of $150 per claim with a $500 corridor as an additional out-of-pocket retention we must satisfy for claims within the policy year before the carrier will reimburse losses. The workers&#x2019; compensation insurance has a retention limit of $250 per claim, except for policies held in Texas and Washington which are subject to state insurance and possess their own limits. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These costs have generally been estimated based on historical data of our claims experience. Such estimates, and the resulting reserves, are reviewed and updated by us on a quarterly basis. Additionally, the Company has partially indemnified Ensign for general and professional liabilities incurred prior to the Spin-off but not reported until after that date and included that amount in its accrual below.     &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents details of the Company's insurance programs, including amounts accrued for the periods indicated in other accrued liabilities and other long-term liabilities in our accompanying balance sheets. The amounts accrued below represent the total estimated liability for individual claims that are less than our noted insurance coverage amounts, which includes outstanding claims and claims incurred but not reported. The amounts are reported gross of reinsurance receivable of $927 and $704 included in restricted and other assets for the years ended December 31, 2021 and 2020, respectively.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Type of Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and professional liability  &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers&#x2019; compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: long-term portion, included in other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of estimated liability, included in other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value of Financial Instruments - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments consist principally of cash, accounts receivable, accounts payable, accrued liabilities, and debt. The Company believes all of the financial instruments&#x2019; recorded values approximate fair values because of their nature or respective short durations. The Company determines fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted market prices in active markets; Level 2, defined as inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Deferred tax assets and liabilities are established for temporary differences between the financial reporting basis and the tax basis of the Company&#x2019;s assets and liabilities at tax rates in effect when such temporary differences are expected to reverse. The Company generally expects to fully utilize its deferred tax assets; however, when necessary, the Company records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the need for a valuation allowance or the need for and magnitude of liabilities for uncertain tax positions, the Company makes certain estimates and assumptions. These estimates and assumptions are based on, among other things, knowledge of operations, markets, historical trends and likely future changes and, when appropriate, the opinions of advisors with knowledge and expertise in certain fields. Due to certain risks associated with the Company&#x2019;s estimates and assumptions, actual results could differ.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- The noncontrolling interest in a subsidiary is initially recognized at estimated fair value on the acquisition date and is presented within total equity in the Company's consolidated balance sheets. The Company presents the noncontrolling interest and the amount of consolidated net income/ (loss) attributable to The Pennant Group, Inc. in its consolidated and combined statements of income.  Net income per share is calculated based on net income/ (loss) attributable to The Pennant Group, Inc.'s stockholders. The carrying amount of the noncontrolling interest is adjusted based on an allocation of subsidiary earnings based on ownership interest.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-Based Compensation -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures and recognizes compensation expense for all share-based payment awards, including employee stock options and restricted stock, made to employees and Pennant&#x2019;s directors based on estimated fair values, ratably over the requisite service period of the award. The Company accounts for forfeitures as they occur. Net income has been reduced as a result of the recognition of the fair value of all stock options and restricted stock awards issued, the amount of which is contingent upon the number of future grants and other variables. The total amount of share-based compensation was $10,040, $8,335, and $3,382 for the years ended December 31, 2021, 2020 and 2019, respectively, of which $7,964, $7,222 and $2,769, respectively, was recorded in general and administrative expense, with the difference being recorded in cost of services. For further discussion see Note 12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Options and Awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- In connection with the Spin-Off, shares of existing equity awards were replaced with shares under the new Pennant awards and are reflected in basic and diluted net income per share for the years ended December 31, 2021, 2020 and 2019, respectively. For further discussion see Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Computation of Net Income Per Common Share&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prior to Spin-Off&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost Allocation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The Financial Statements include allocations of costs for certain shared services provided to the Company by Ensign subsidiaries prior to the Spin-Off on October&#160;1, 2019. Such allocations include, but are not limited to, executive management, accounting, human resources, information technology, compliance, legal, payroll, insurance, tax, &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;treasury, and other general and administrative items. These costs were allocated to the Company on a basis of revenue, location, employee count, or other measures. These cost allocations are reflected within general and administrative expense in the consolidated and combined statements of income for the year ended December 31, 2019, including for share-based compensation expenses disclosed in Note 12&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Options and Awards&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The amount of general and administrative costs allocated from January 1, 2019 to October&#160;1, 2019, the date of the Spin-Off, inclusive of share-based compensation expense, was $23,710. Management believes the basis on which the expenses were allocated to be a reasonable reflection of the services provided to the Company during the periods. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Insurance&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Prior to the Spin-Off Ensign was partially self-insured for healthcare, general and professional liability, and workers&#x2019; compensation, and historically allocated premium expense to all subsidiaries of Ensign in its accounting records. To reflect all of the insurance costs, quarterly actuary determined adjustments were allocated to the Company based on the proportional historical premium expense. No self-insurance accruals were allocated to the Company as these accruals represent the obligations of Ensign. In connection with the Spin-Off, the Company purchased insurance through a third-party to replace the coverage provided by Ensign&#x2019;s self-insured policies.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Ensign&#x2019;s external debt and related interest expense were not allocated to the Company for any of the periods presented as no portion of the borrowings were assumed by the Company as part of the Spin-Off. All interest incurred by the Company was subsequent to the Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Prior to the date of the Spin-off, the Company&#x2019;s operations have been included in Ensign&#x2019;s U.S. federal and state income tax returns and all income taxes have been paid by subsidiaries of Ensign. Also prior to the date of the Spin-off, income tax expense and other income tax related information contained in these Financial Statements were presented using a separate tax return approach. Under this approach, the provision for income taxes represents income tax paid or payable for the current year plus the change in deferred taxes during the year calculated as if the Company was a stand-alone taxpayer filing hypothetical income tax returns. Management believes that the assumptions and estimates used to determine these tax amounts are reasonable. However, the Company&#x2019;s Financial Statements may not necessarily reflect its income tax expense or tax payments in the future, or what tax amounts would have been if the Company had been a stand-alone company for the entire period presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Invested Capital&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The net parent investment on the consolidated and combined statement of stockholders equity and statement of cash flows represents Ensign&#x2019;s historical investment in the Company, the net effect of transactions with, and allocations from, Ensign and the Company&#x2019;s accumulated earnings. Invested capital was reclassified into additional paid-in-capital at the date of the Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- Prior to the Spin-Off, the Company presented the noncontrolling interest and the amount of consolidated net income/ (loss) attributable to the Company in its Financial Statements. The carrying amount of the noncontrolling interest was adjusted by an allocation of subsidiary earnings based on ownership interest prior to the Spin-Off. The noncontrolling subsidiary interest included in the Financial Statements was converted into common shares of Pennant concurrent with the distribution to Ensign stockholders at the date of the Spin-Off and thus, does not receive an allocated portion of earnings&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Prior to the Spin-Off, employees of the Company&#x2019;s subsidiaries participated in Ensign&#x2019;s equity-based incentive plans (the &#x201c;Ensign Plans&#x201d;) and the Cornerstone Subsidiary Equity plan (the &#x201c;Subsidiary Equity Plan&#x201d;). Share-based compensation includes the expense attributable to employees of the Company&#x2019;s subsidiaries who participated in the Ensign Plans, as well as the allocated cost related to Ensign subsidiaries&#x2019; employees that participated in the Ensign Plans. Share-based compensation related to Ensign subsidiaries&#x2019; employees that participated in the Ensign Plans were allocated on the basis of revenue. All share-based compensation related to the Subsidiary Equity Plan was recognized in the Financial Statements and, therefore, no cost allocation was necessary. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:40.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:40.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Spin-Off, share-based compensation costs associated with the Subsidiary Equity Plan awards was initially measured at fair value at the grant date and was expensed as non-cash compensation over the vesting term.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Historically, these awards were granted once per year. The fair value has been determined by an independent valuation of the subsidiary shares. The valuation incorporated a discounted cash flow analysis combined with a market-based approach to determine the fair value of the subsidiary equity. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recent Accounting Standards Adopted by the Company&lt;/span&gt;&lt;/div&gt;Except for rules and interpretive releases of the SEC under authority of federal securities laws and a limited number of grandfathered standards, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. For any new pronouncements, the Company considers whether the new pronouncements could alter previous generally accepted accounting principles and determines whether any new or modified principles will have a material impact on the Company&#x2019;s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company&#x2019;s financial management and certain standards are under consideration.FASB Accounting Standards Update, or ASU, ASU 2021-01 &#x201c;Reference Rate Reform (Topic 848): Scope&#x201d; or ASU 2020-4 - On January 7, 2021, the FASB issued ASU 2021-01 to amend the scope of  the guidance in ASU 2020-04 &#x201c;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&#x201d; or ASU 2020-4. Specifically, the amendments in ASU 2021-01 clarify that &#x201c;certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition.&#x201d;  The amendment in ASU 2021-1 is available to all entities: (i) on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 through the date that the final update to the standard was issued or (ii) on a prospective basis for new contract modifications through December 31, 2022.  The Company has adopted ASU 2021-01 on a prospective basis effective as of January 7, 2021.  There was no material impact to the Company&#x2019;s Consolidated and Combined Financial Statements or related disclosures as a result of the adoption of ASU 2021-01.</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzY1OTcwNjk3OTI2MjE_bfce2fdd-8baf-4dae-b7ca-d29383e01733">Basis of Presentation - The accompanying consolidated and combined financial statements of the Company (the &#x201c;Financial Statements&#x201d;) reflect the Company&#x2019;s financial position for the years ended December 31, 2021 and 2020, and the Company&#x2019;s results of operations and cash flows for the years ended December 31, 2021, 2020 and 2019 and have been prepared in accordance with accounting principles generally accepted in the United States (&#x201c;GAAP&#x201d;) and pursuant to the regulations of the Securities and Exchange Commission (&#x201c;SEC&#x201d;). Prior to the Spin-Off, the combined financial statements were prepared on a stand-alone basis and derived from the consolidated financial statements and accounting records of Ensign. Management believes that the Financial Statements reflect, in all material respects, all adjustments which are of a normal and recurring nature necessary to present fairly the Company&#x2019;s financial position, results of operations, and cash flows for the periods presented in conformity with GAAP applicable to the annual period.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MDU_bd4b2f64-398c-4713-9975-3c91d66acdff">All intercompany transactions and balances between the various legal entities comprising the Company have been eliminated in consolidation. The consolidated and combined statements of income reflect income that is attributable to the Company and the noncontrolling interest. The Company consists of various limited liability companies and corporations established to operate home health, hospice, home care, and senior living operations. The Financial Statements include the accounts of all entities controlled by the Company through its ownership of a majority voting interest. Revenue was derived from transactional information specific to the Company&#x2019;s services provided. The costs in the consolidated and combined statements of income reflect direct costs and allocated costs prior to the Spin-Off.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzY1OTcwNjk3OTI2MjM_eba6e6f8-091a-4df9-bfcb-9df6c554c562">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Estimates and Assumptions -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The preparation of the Financial Statements in conformity with GAAP requires management to make certain estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Financial Statements relate to self-insurance reserves, revenue, cost allocations from prior to the Spin-Off, intangible assets and goodwill, right-of-use assets and lease liabilities for leases greater than 12 months, and income taxes. Actual results could differ from those estimates.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYwNDczMTM5Nzg3Mzc_2c05185d-3897-4790-81af-f4dc3dfa6477">Revenue Recognition - Revenues are recognized when services are provided to the patients at the amount that reflects the consideration to which the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and insurers (private and Medicare replacement plans), in exchange for providing patient care. Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rate, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration which is included in the transaction price may be constrained, and is included in the net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#x2019;s estimates, the Company adjusts these estimates, which would effect net service revenue in the period such variances become known.</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived
      contextRef="ia2439a6130274330bd9bb469dbc05ee6_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzQxOTA_1f345d88-f75e-4030-bb38-803a456dc7fa"
      unitRef="usd">27997000</pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived>
    <pntg:RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NTQwMjI_635112fa-0aaf-42cd-a654-b88307ec0aea"
      unitRef="usd">21786000</pntg:RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds>
    <pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE3NTkyMTg2MDgyMTMw_0662b208-4cfe-49f3-8ae3-eac63f7d02c3"
      unitRef="usd">6211000</pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived>
    <pntg:AccruedPayrollTaxesEmployerPortion
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NjIyMTI_53d55eed-9795-4e1f-8eac-84cdd5361a2e"
      unitRef="usd">7836000</pntg:AccruedPayrollTaxesEmployerPortion>
    <pntg:AccruedPayrollTaxesEmployerPortion
      contextRef="i8a7e4cc4f1ef44e18318557df8f16b2c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NjIzMTc_01bc3621-a922-4192-8d93-085720bbf45c"
      unitRef="usd">3707000</pntg:AccruedPayrollTaxesEmployerPortion>
    <pntg:AccruedPayrollTaxesEmployerPortion
      contextRef="iae5c52d50c06400983c31c67aa43fc0a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NjIzMzk_748f85a8-053b-4378-9b65-f3b79e07cf69"
      unitRef="usd">4129000</pntg:AccruedPayrollTaxesEmployerPortion>
    <pntg:AmountToOffsetExpenseSequestrationRelief
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NTQ2MTE_1359af9d-2db3-4e53-9ca4-4ef48a840267"
      unitRef="usd">3555000</pntg:AmountToOffsetExpenseSequestrationRelief>
    <pntg:DirectMedicalSuppliesLaborAndOtherExpenses
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NTQ2MTk_707aed0d-742b-44a4-b65a-85ab1050c4bf"
      unitRef="usd">2765000</pntg:DirectMedicalSuppliesLaborAndOtherExpenses>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MDY_c72fd71e-8cf1-4bb1-93b3-4340608474de">Cash - Cash consists of petty cash and bank deposits and therefore approximates fair value. The Company places its cash with high credit quality financial institutions.</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MDc_7899d13d-f07c-4f86-8b4e-2425b7107423">Accounts Receivable and Allowance for Doubtful Accounts - Accounts receivable consist primarily of amounts due from Medicare and Medicaid programs, other government programs, managed care health plans and private payor sources, net of estimates for variable consideration. The allowance for doubtful accounts is the Company&#x2019;s best estimate of current expected credit losses in the accounts receivable balance.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MDg_5d7c66f7-acf6-4019-b1f9-63a4c2a62ad8">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Property and Equipment -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Property and equipment are initially recorded at their historical cost. Repairs and maintenance are expensed as incurred. Depreciation is computed using the straight-line method over the estimated useful lives of the depreciable assets (ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYxNzc_c179bcbb-5edd-46f8-ac7b-9c974960a03d"&gt;three&lt;/span&gt; to 15 years). Leasehold improvements are amortized on a straight-line basis over the shorter of their estimated useful lives or the remaining lease term.&lt;/span&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i6001b46500b947f08cda938279f351a0_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYxODM_5638e00d-a0a6-4d43-ac06-f799ad493045">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MDk_4f0a2994-401e-46dd-ab3c-c693f0d58629">Impairment of Long-Lived Assets - The Company reviews the carrying value of long-lived assets that are held and used in the independent operating subsidiaries for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of these assets is determined based upon expected undiscounted future net cash flows from the operating subsidiary to which the assets relate, utilizing management&#x2019;s best estimate, appropriate assumptions, and projections at the time. If the carrying value is determined to be unrecoverable from future operating cash flows, the asset is deemed impaired and an impairment loss would be recognized to the extent the carrying value exceeded the estimated fair value of the asset. The Company estimates the fair value of assets based on the estimated future discounted cash flows of the asset. For the year ended December 31, 2021,</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwOTk1MTE2NTQ3NzQ_13712c5c-8ce4-4314-89b3-11e6ff0f9a9b"
      unitRef="usd">2835000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <pntg:ImpairmentLongLivedAssetsNumberOfCommunities
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzI3NDg3NzkxMDg0MDE_9f6e8963-f3cc-4740-869d-32224c190a19"
      unitRef="community">6</pntg:ImpairmentLongLivedAssetsNumberOfCommunities>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTA_5cead5fd-198b-46dd-a552-69b317dfd8a5">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangible Assets and Goodwill -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company&#x2019;s indefinite-lived intangible assets consist of trade names and Medicare and Medicaid licenses. The Company tests indefinite-lived intangible assets for impairment on an annual basis or more frequently if events or changes in circumstances indicate that the carrying amount of the intangible asset may not be recoverable. The Company did not identify any indefinite-lived intangible asset impairment during the years ended December 31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations.  Goodwill is subject to annual test for impairment as of the beginning of the fourth quarter or more frequently if events or changes indicate that the Company's goodwill might be impaired. The Company assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If the Company determines it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then it is required to perform a quantitative impairment test by comparing the fair value with the carrying amount of the reporting unit. If the carrying amount of a reporting unit exceeds its fair value, then the Company records an impairment of goodwill equal to the amount that the carrying amount of a reporting unit exceeds its fair value.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, we evaluated potential triggering events that might be indicators that our goodwill and indefinite lived intangibles were impaired. As a result of our evaluation, no goodwill or indefinite intangible asset impairments were recorded during the years ended December 31, 2021, 2020 and 2019. See further discussion at Note 9, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Goodwill and Intangible Assets, Net.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzkyNDg_4c56f075-93c1-4a94-a194-334bf30c8eda"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzkyNDg_d6c249f6-17c1-4e7b-8b3d-d1e413a6391d"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzkyNDg_f2f9959f-94d0-4679-b36b-d8d6c4ff5109"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <pntg:GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzk5Mjc_41c5c0b5-65ad-44f4-9639-237a217f0690"
      unitRef="usd">150000</pntg:GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim>
    <pntg:CorridorAsAnAdditionalOutOfPocketRetention
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzk5NDc_cf0eed6c-5c9c-4c78-a5f9-9929367588c5"
      unitRef="usd">500000</pntg:CorridorAsAnAdditionalOutOfPocketRetention>
    <pntg:WorkersCompensationInsuranceRetentionLimitPerClaim
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzEwMTUz_e0c28152-90f7-41c9-a261-b1276bcd3a7d"
      unitRef="usd">250000</pntg:WorkersCompensationInsuranceRetentionLimitPerClaim>
    <pntg:SummaryOfInsuranceLiabilityTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYwNDczMTM5Nzg3NDA_98c666e3-d92b-4673-ba22-666d785d5b8c">The following table presents details of the Company's insurance programs, including amounts accrued for the periods indicated in other accrued liabilities and other long-term liabilities in our accompanying balance sheets. The amounts accrued below represent the total estimated liability for individual claims that are less than our noted insurance coverage amounts, which includes outstanding claims and claims incurred but not reported. The amounts are reported gross of reinsurance receivable of $927 and $704 included in restricted and other assets for the years ended December 31, 2021 and 2020, respectively.   &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.710%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.538%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.627%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Type of Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and professional liability  &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,063&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Workers&#x2019; compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,899&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,783&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total estimated liability&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,846&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: long-term portion, included in other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,293)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,492)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current portion of estimated liability, included in other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</pntg:SummaryOfInsuranceLiabilityTableTextBlock>
    <us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzExMTk5_5b9e00fc-e520-41a0-96c3-a2af8edb1628"
      unitRef="usd">927000</us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims>
    <us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzExMjA2_f48947fd-f9c8-4e2c-bfd8-d7c770e7ce18"
      unitRef="usd">704000</us-gaap:ReinsuranceReceivablesIncurredButNotReportedClaims>
    <pntg:GeneralAndProfessionalInsuranceLiability
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzMtMS0xLTEtNDExMzI_745f694c-ac2d-4a6d-b8d8-4db6ed1d3e8d"
      unitRef="usd">2007000</pntg:GeneralAndProfessionalInsuranceLiability>
    <pntg:GeneralAndProfessionalInsuranceLiability
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzMtMy0xLTEtNDExMzI_79c7f717-5797-4682-8304-a4f353d62c1e"
      unitRef="usd">1063000</pntg:GeneralAndProfessionalInsuranceLiability>
    <us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzQtMS0xLTEtNDExMzI_9dd7c196-d906-409a-a0a3-6bdc7ead7852"
      unitRef="usd">4899000</us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent>
    <us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzQtMy0xLTEtNDExMzI_4f8135c2-3dc0-4e90-9049-1bdcfec61213"
      unitRef="usd">2783000</us-gaap:WorkersCompensationLiabilityCurrentAndNoncurrent>
    <pntg:InsuranceProgramAccruedExpenses
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzUtMS0xLTEtNDExMzI_421a6fde-e73f-455b-8db7-0f8a9686d050"
      unitRef="usd">6906000</pntg:InsuranceProgramAccruedExpenses>
    <pntg:InsuranceProgramAccruedExpenses
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzUtMy0xLTEtNDExMzI_43f6bdfe-78b7-448d-89f5-2113cf8bb6fe"
      unitRef="usd">3846000</pntg:InsuranceProgramAccruedExpenses>
    <pntg:InsuranceProgramAccruedExpensesNoncurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzYtMS0xLTEtNDExMzI_c6ba15af-b9f2-4e25-96a1-4761aa07d2ee"
      unitRef="usd">5293000</pntg:InsuranceProgramAccruedExpensesNoncurrent>
    <pntg:InsuranceProgramAccruedExpensesNoncurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzYtMy0xLTEtNDExMzI_ccfd6c61-ed24-4126-8603-69edf27e995c"
      unitRef="usd">2492000</pntg:InsuranceProgramAccruedExpensesNoncurrent>
    <pntg:InsuranceProgramAccruedExpensesCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzctMS0xLTEtNDExMzI_35c9e9d8-d3bd-4de2-929e-d9351b5cd20c"
      unitRef="usd">1613000</pntg:InsuranceProgramAccruedExpensesCurrent>
    <pntg:InsuranceProgramAccruedExpensesCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90YWJsZTplZmY1Mzk2MWRkYzI0ZmViOWI1YzJkYjM1NzdlYWFkMi90YWJsZXJhbmdlOmVmZjUzOTYxZGRjMjRmZWI5YjVjMmRiMzU3N2VhYWQyXzctMy0xLTEtNDExMzI_0338fbb2-61f5-4346-9ef7-e5da840ebd50"
      unitRef="usd">1354000</pntg:InsuranceProgramAccruedExpensesCurrent>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTE_6393c67f-18bb-4ebf-a17f-4bdab0afe68b">Fair Value of Financial Instruments - The Company&#x2019;s financial instruments consist principally of cash, accounts receivable, accounts payable, accrued liabilities, and debt. The Company believes all of the financial instruments&#x2019; recorded values approximate fair values because of their nature or respective short durations. The Company determines fair value measurements are based on a three-tier hierarchy that prioritizes the inputs used to measure fair value. These tiers include: Level 1, defined as observable inputs such as quoted market prices in active markets; Level 2, defined as inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly; and Level 3, defined as unobservable inputs for which little or no market data exists, therefore requiring an entity to develop its own assumptions.</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTI_ec83d95e-9ad7-4bb0-bb03-4cb261ba6ece">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - Deferred tax assets and liabilities are established for temporary differences between the financial reporting basis and the tax basis of the Company&#x2019;s assets and liabilities at tax rates in effect when such temporary differences are expected to reverse. The Company generally expects to fully utilize its deferred tax assets; however, when necessary, the Company records a valuation allowance to reduce its net deferred tax assets to the amount that is more likely than not to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining the need for a valuation allowance or the need for and magnitude of liabilities for uncertain tax positions, the Company makes certain estimates and assumptions. These estimates and assumptions are based on, among other things, knowledge of operations, markets, historical trends and likely future changes and, when appropriate, the opinions of advisors with knowledge and expertise in certain fields. Due to certain risks associated with the Company&#x2019;s estimates and assumptions, actual results could differ.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTM_33a84427-12ba-4f65-8037-a927705cc114">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- The noncontrolling interest in a subsidiary is initially recognized at estimated fair value on the acquisition date and is presented within total equity in the Company's consolidated balance sheets. The Company presents the noncontrolling interest and the amount of consolidated net income/ (loss) attributable to The Pennant Group, Inc. in its consolidated and combined statements of income.  Net income per share is calculated based on net income/ (loss) attributable to The Pennant Group, Inc.'s stockholders. The carrying amount of the noncontrolling interest is adjusted based on an allocation of subsidiary earnings based on ownership interest.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Noncontrolling Interest &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- Prior to the Spin-Off, the Company presented the noncontrolling interest and the amount of consolidated net income/ (loss) attributable to the Company in its Financial Statements. The carrying amount of the noncontrolling interest was adjusted by an allocation of subsidiary earnings based on ownership interest prior to the Spin-Off. The noncontrolling subsidiary interest included in the Financial Statements was converted into common shares of Pennant concurrent with the distribution to Ensign stockholders at the date of the Spin-Off and thus, does not receive an allocated portion of earnings&lt;/span&gt;.</us-gaap:ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NDYy_f598669c-9b49-4d86-8a99-f12e720f9d8d"
      unitRef="usd">10040000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NDY2_4d7c7dfb-83f4-4435-bca1-8ad83a1e5c3e"
      unitRef="usd">8335000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NDc0_a6ef13cd-bb4f-4439-9090-b7ad3bf6b0cc"
      unitRef="usd">3382000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i0e8f395592e742f3ba6c06ba1409606c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NTEy_9df57335-0707-4d38-b922-74e496aabba9"
      unitRef="usd">7964000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i743dd5e050c24c6f903e2cd1bc39b900_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NTE2_1c98b93d-445c-466f-b20b-10d402cb9046"
      unitRef="usd">7222000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib4445accb5d94db3851353dbfa2ed4f3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE0NTIz_a7c27176-0d7c-4505-8be3-9717e33dd7e9"
      unitRef="usd">2769000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MzMwMzQ_beba2b37-682a-45a8-a6d0-26078198e0cd">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Earnings Per Share &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;- In connection with the Spin-Off, shares of existing equity awards were replaced with shares under the new Pennant awards and are reflected in basic and diluted net income per share for the years ended December 31, 2021, 2020 and 2019, respectively. For further discussion see Note 4, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Computation of Net Income Per Common Share&lt;/span&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
      contextRef="i8ffd18948f6c4a1e9cdee019c70baf5e_D20190101-20191001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzE1NTY0_905b13f0-5cc5-4ee5-997a-572bc4522e93"
      unitRef="usd">23710000</us-gaap:RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty>
    <pntg:InvestedCapitalPolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTQ_8b7a061c-2e0e-4a13-bce4-c2e5316f1ff1">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Invested Capital&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The net parent investment on the consolidated and combined statement of stockholders equity and statement of cash flows represents Ensign&#x2019;s historical investment in the Company, the net effect of transactions with, and allocations from, Ensign and the Company&#x2019;s accumulated earnings. Invested capital was reclassified into additional paid-in-capital at the date of the Spin-Off.&lt;/span&gt;</pntg:InvestedCapitalPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzYwNDczMTM5Nzg3NTM_eafed810-0a64-45dd-999f-af1ef34e989f">Share-based compensation - Prior to the Spin-Off, employees of the Company&#x2019;s subsidiaries participated in Ensign&#x2019;s equity-based incentive plans (the &#x201c;Ensign Plans&#x201d;) and the Cornerstone Subsidiary Equity plan (the &#x201c;Subsidiary Equity Plan&#x201d;). Share-based compensation includes the expense attributable to employees of the Company&#x2019;s subsidiaries who participated in the Ensign Plans, as well as the allocated cost related to Ensign subsidiaries&#x2019; employees that participated in the Ensign Plans. Share-based compensation related to Ensign subsidiaries&#x2019; employees that participated in the Ensign Plans were allocated on the basis of revenue. All share-based compensation related to the Subsidiary Equity Plan was recognized in the Financial Statements and, therefore, no cost allocation was necessary.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjMvZnJhZzozMTJlOWEwZmQzMWE0ZjU5ODVhNGY1NzYwZDgyZGJlYy90ZXh0cmVnaW9uOjMxMmU5YTBmZDMxYTRmNTk4NWE0ZjU3NjBkODJkYmVjXzc2OTY1ODE0MjA0MTU_ce914135-e8b7-4360-b9f2-fd39a85f1abb">Recent Accounting Standards Adopted by the CompanyExcept for rules and interpretive releases of the SEC under authority of federal securities laws and a limited number of grandfathered standards, the Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) is the sole source of authoritative GAAP literature recognized by the FASB and applicable to the Company. For any new pronouncements, the Company considers whether the new pronouncements could alter previous generally accepted accounting principles and determines whether any new or modified principles will have a material impact on the Company&#x2019;s reported financial position or operations in the near term. The applicability of any standard is subject to the formal review of the Company&#x2019;s financial management and certain standards are under consideration.FASB Accounting Standards Update, or ASU, ASU 2021-01 &#x201c;Reference Rate Reform (Topic 848): Scope&#x201d; or ASU 2020-4 - On January 7, 2021, the FASB issued ASU 2021-01 to amend the scope of  the guidance in ASU 2020-04 &#x201c;Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting&#x201d; or ASU 2020-4. Specifically, the amendments in ASU 2021-01 clarify that &#x201c;certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition.&#x201d;  The amendment in ASU 2021-1 is available to all entities: (i) on a full retrospective basis as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020 through the date that the final update to the standard was issued or (ii) on a prospective basis for new contract modifications through December 31, 2022.  The Company has adopted ASU 2021-01 on a prospective basis effective as of January 7, 2021.  There was no material impact to the Company&#x2019;s Consolidated and Combined Financial Statements or related disclosures as a result of the adoption of ASU 2021-01.</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzYwNDczMTM5NTUwMzE_65214932-54b1-4053-8050-ddfe6e272279">RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Spin-Off, our businesses were included as subsidiaries of Ensign. As a result, our transactions were considered related party transactions. On October&#160;1, 2019, in connection with the Spin-Off, Pennant entered into several agreements with Ensign that set forth the principal actions taken or to be taken in connection with the Spin-Off and govern the relationship of the parties following the Spin-Off. On October 1, 2021 the company concluded its Transition Services Agreement with Ensign.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has incurred $3,124, $5,536, and $2,982 in costs related to the Transitions Services Agreement for the years ended December 31, 2021, 2020 and 2019, respectively. Additionally, the Company has recognized $208, $578, and $291 in tax benefits related to the Tax Matters Agreement for the years ended December 31, 2021, 2020 and 2019, respectively, and has recorded a payable to Ensign in connection with any unpaid portion of these amounts.  See &#x201c;Certain Relationships and Related Party Transactions&#x2014;Agreements with Ensign Related to the Spin-Off,&#x201d; contained within the Information Statement as well as the Form 8-K filed with the SEC on October 3, 2019 for further discussion of the agreements entered into in connection with the Spin-Off.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company leases 32 of its senior living communities from subsidiaries of Ensign, each of the leases have a term of between 14 and 20 years from the lease commencement date. The total amount of rent expense included in Rent - cost of services paid to subsidiaries of Ensign was $12,773, $12,536, and $11,292 for the years ended December 31, 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain related party activity occurred as the Company&#x2019;s subsidiaries received services from Ensign&#x2019;s subsidiaries. Services included in cost of services were $3,084, $4,205, and $3,166 for the years ended December 31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ia1fcf346d3fa483083f350885e86c53f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzEwOTk1MTE2MzExMjI_aa019e11-8765-42c6-a33f-668f0e9c4567"
      unitRef="usd">3124000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i4727a9c1e3f3474da652ab9778b0c723_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzEwOTk1MTE2MzExMzA_043e6f02-7061-459c-914f-41156cfd017a"
      unitRef="usd">5536000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i6798f615dd65498b96c25d713d9ea243_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzEwOTk1MTE2MzMxOTI_a8155aef-bace-4f7f-8058-9322fc6db4ca"
      unitRef="usd">2982000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzEwOTk1MTE2MzEyNTc_58726000-dcb3-4089-8630-9662df3b9814"
      unitRef="usd">208000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzEwOTk1MTE2MzEyNjU_93b4ddd4-a218-4954-a050-e62661f5f4ad"
      unitRef="usd">578000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzc2OTY1ODE0MDA1MTg_97aaa47a-7d37-40ea-8245-4b99aa73e7a7"
      unitRef="usd">291000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i69f3d63932564edfa50a96879cf88c45_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzI0Mw_b5902798-34f4-4cc2-868f-c1388c67b28f"
      unitRef="property">32</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i8539c32fc47d41f7855d6538692f738d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzM1MA_b54d788a-0a57-492f-85d9-904fdebfa608">P14Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ice5e4b95ef8a477bb882b9b591fb511b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzM1Nw_68f757fa-c9ca-4af9-9158-eb327701158e">P20Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i9faefefa7c85403d9d9fba65201c913a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzUwNA_c13ea755-5485-4e52-94b7-9e717caf0662"
      unitRef="usd">12773000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i71dbacd7819b435d8e92bd5a906d4011_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzUwOA_73d1e33e-23f8-42f8-86a6-1bd568517f34"
      unitRef="usd">12536000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i1429b5ff57464841a7fd199281d35777_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzUxNg_0aa80167-71e2-4872-b66f-0d3d0c600c0f"
      unitRef="usd">11292000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyCosts
      contextRef="i815557615f93465196531049671aa210_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzcwNg_9276273b-7548-4f2a-9aeb-bc84fcbcd9ff"
      unitRef="usd">3084000</us-gaap:RelatedPartyCosts>
    <us-gaap:RelatedPartyCosts
      contextRef="i7fc9e1d6963b4b9eb991007f35b632c0_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzcxMA_097ce710-bde0-4b65-b057-ebf7b0f640f4"
      unitRef="usd">4205000</us-gaap:RelatedPartyCosts>
    <us-gaap:RelatedPartyCosts
      contextRef="i06cec63574054d8fb69e409cc0711e6f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjYvZnJhZzplYjY1YTM0NDIyNDM0ZDE5YWU2Yzc1NjRiZTg5MGZkYy90ZXh0cmVnaW9uOmViNjVhMzQ0MjI0MzRkMTlhZTZjNzU2NGJlODkwZmRjXzcxOA_0f813273-f4bf-4a6c-ba0d-d0a9c8462f60"
      unitRef="usd">3166000</us-gaap:RelatedPartyCosts>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90ZXh0cmVnaW9uOmJlZTk4N2ZjZTgxYjQzYWRhMmU5YmNhNGMzNWJlOTQxXzYwNDczMTM5NTM2MDA_c049d785-116a-4e54-b855-b8b4ee83e84c">COMPUTATION OF NET INCOME PER COMMON SHARE&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share is computed by dividing net income attributable to stockholders of the Company by the weighted average number of outstanding common shares for the period. The computation of diluted net income per share is similar to the computation of basic net income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the dilutive potential common shares had been issued.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prior to Spin-Off&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income attributable to the noncontrolling interest has been included in the numerator for the year ended December 31, 2019, as the non-controlling subsidiary interest that existed prior to the Spin-Off was converted into common shares of Pennant concurrent with the distribution to Ensign stockholders at the date of the Spin-Off&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.   &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per share for the periods presented: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: net (loss)/ income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(548)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to The Pennant Group, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for basic net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: incremental shares from assumed conversion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted weighted average common shares outstanding for diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings Per Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per common share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per common share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;The calculation of dilutive shares outstanding excludes out-of-the-money stock options (i.e., such options&#x2019; exercise prices were greater than the average market price of our common shares for the period) because their inclusion would have been antidilutive. Options outstanding which are anti-dilutive and therefore not factored into the weighted average common shares amount above were 478, 93, and 15 for the years ended December 31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;For the year ended December 31, 2019 basic and diluted earnings per share were calculated based on net income as the numerator, which included the conversion of the noncontrolling interest in connection with the Spin-Off. For the years ended December 31, 2021 and 2020, basic and diluted earnings per share were calculated based on net income attributable to The Pennant Group, Inc. as the numerator.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90ZXh0cmVnaW9uOmJlZTk4N2ZjZTgxYjQzYWRhMmU5YmNhNGMzNWJlOTQxXzYwNDczMTM5NTM2MDE_bdff9498-0c71-4590-a6eb-742d1e2a0e2f">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per share for the periods presented: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.344%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.695%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.699%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,553&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: net (loss)/ income attributable to noncontrolling interests&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(548)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net income attributable to The Pennant Group, Inc.&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average shares outstanding for basic net income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,029&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,838&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Plus: incremental shares from assumed conversion&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,748&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjusted weighted average common shares outstanding for diluted income per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,228&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Earnings Per Share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic net income per common share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted net income per common share&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;The calculation of dilutive shares outstanding excludes out-of-the-money stock options (i.e., such options&#x2019; exercise prices were greater than the average market price of our common shares for the period) because their inclusion would have been antidilutive. Options outstanding which are anti-dilutive and therefore not factored into the weighted average common shares amount above were 478, 93, and 15 for the years ended December 31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;For the year ended December 31, 2019 basic and diluted earnings per share were calculated based on net income as the numerator, which included the conversion of the noncontrolling interest in connection with the Spin-Off. For the years ended December 31, 2021 and 2020, basic and diluted earnings per share were calculated based on net income attributable to The Pennant Group, Inc. as the numerator.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock>
    <us-gaap:ProfitLoss
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzMtMS0xLTEtNDI2NzY_7c1b9c50-ac2f-4f4a-b2a2-86947998a373"
      unitRef="usd">2148000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzMtMy0xLTEtNDI2Nzg_03496fdc-a41e-4c6d-8c3c-f143f277cfb6"
      unitRef="usd">15553000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzMtNS0xLTEtNDExMzI_4f2878c2-7f96-4edb-8253-9aa0476a0872"
      unitRef="usd">3175000</us-gaap:ProfitLoss>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzQtMS0xLTEtNDI2NzY_75463315-5e3f-4dc8-939e-7212f88d3842"
      unitRef="usd">-548000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzQtMy0xLTEtNDI2Nzg_6e3097ae-1f88-4c83-bf83-1347f295d269"
      unitRef="usd">-191000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzQtNS0xLTEtNDExMzI_ce94f3ee-7bf2-4622-aded-cf8d712240d1"
      unitRef="usd">629000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzUtMS0xLTEtNDI2NzY_72a727f0-1a13-40ca-b14a-1849c36bd05d"
      unitRef="usd">2696000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzUtMy0xLTEtNDI2Nzg_2b45c221-f8a3-4968-a4dd-245ed36e6a39"
      unitRef="usd">15744000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzUtNS0xLTEtNDExMzI_91267dc0-864b-47f8-a1d4-446d380a4e48"
      unitRef="usd">2546000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzgtMS0xLTEtNDExMzI_8e8fab6b-d7a8-4c1d-8064-ff4a62087a50"
      unitRef="shares">28406000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzgtMy0xLTEtNDExMzI_c9dcac25-0b57-4799-b22c-c6589a4aa9aa"
      unitRef="shares">28029000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzgtNS0xLTEtNDExMzI_49d7c347-2cc6-47af-9201-e3b08251d269"
      unitRef="shares">27838000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzktMS0xLTEtNDExMzI_20550180-16d4-445f-acc9-7552c367c907"
      unitRef="shares">2236000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzktMy0xLTEtNDExMzI_f1dbf461-cdbd-47ac-9ef0-d093cba159ef"
      unitRef="shares">2199000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzktNS0xLTEtNDExMzI_ec453422-304c-4e8f-ba97-d1c458156cb7"
      unitRef="shares">1748000</us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEwLTEtMS0xLTQxMTMy_d304f6b4-2d06-4fb7-8c25-4dc094a42b05"
      unitRef="shares">30642000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEwLTMtMS0xLTQxMTMy_a9103dd5-f789-44c2-8308-593bcf868729"
      unitRef="shares">30228000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEwLTUtMS0xLTQxMTMy_b12af9da-c32d-42f8-bc9e-46dac64e163e"
      unitRef="shares">29586000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEzLTEtMS0xLTQxMTMy_40074294-5454-42f8-beac-c370abd37c6b"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEzLTMtMS0xLTQxMTMy_2a2e3d37-0b15-4ede-8489-5a4577c1c8ef"
      unitRef="usdPerShare">0.56</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzEzLTUtMS0xLTQxMTMy_c181656a-358c-4c6a-a79b-c4cfec7dea5a"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzE0LTEtMS0xLTQxMTMy_c39a8b70-450e-4c30-b5db-7acc4bc316d5"
      unitRef="usdPerShare">0.09</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzE0LTMtMS0xLTQxMTMy_e04ca2ac-bf8a-4ce3-8058-278a7c6578fa"
      unitRef="usdPerShare">0.52</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZToyYjVlYmI3NGVhYjA0N2Q2YjEyNGEwOTBmNWMxMmQ3Yy90YWJsZXJhbmdlOjJiNWViYjc0ZWFiMDQ3ZDZiMTI0YTA5MGY1YzEyZDdjXzE0LTUtMS0xLTQxMTMy_4ea82028-963b-4b13-bd8b-b8053566bafc"
      unitRef="usdPerShare">0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZTo5NDQ3OTY1ZDE2NTE0OWY3YjYyYzMxMTE1YTY4YjYwMi90YWJsZXJhbmdlOjk0NDc5NjVkMTY1MTQ5ZjdiNjJjMzExMTVhNjhiNjAyXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjozOWNjNjliZDAzYzA0YzI3ODdiZThhNzk1MjY3YTgwMV8zOTE_fd2762c9-d862-4576-953c-1157351cdaeb"
      unitRef="shares">478000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZTo5NDQ3OTY1ZDE2NTE0OWY3YjYyYzMxMTE1YTY4YjYwMi90YWJsZXJhbmdlOjk0NDc5NjVkMTY1MTQ5ZjdiNjJjMzExMTVhNjhiNjAyXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjozOWNjNjliZDAzYzA0YzI3ODdiZThhNzk1MjY3YTgwMV8zOTg_80b4be99-e824-4e5b-81c5-8d982ca46c8c"
      unitRef="shares">93000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNjkvZnJhZzpiZWU5ODdmY2U4MWI0M2FkYTJlOWJjYTRjMzViZTk0MS90YWJsZTo5NDQ3OTY1ZDE2NTE0OWY3YjYyYzMxMTE1YTY4YjYwMi90YWJsZXJhbmdlOjk0NDc5NjVkMTY1MTQ5ZjdiNjJjMzExMTVhNjhiNjAyXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjozOWNjNjliZDAzYzA0YzI3ODdiZThhNzk1MjY3YTgwMV8xMDk5NTExNjI4MjE0_d5505141-2bba-4fe3-813b-04b57cc6a305"
      unitRef="shares">15000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <pntg:RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzYwNDczMTM5NjQ3MzI_e8993644-1e0d-4678-bdf3-ddf6740f28ec">REVENUE AND ACCOUNTS RECEIVABLE&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Revenue is recognized when services are provided to the patients at the amount that reflects the consideration to which the Company expects to be entitled from patients and third-party payors, including Medicaid, Medicare and managed care programs (Commercial, Medicare Advantage and Managed Medicaid plans), in exchange for providing patient care. The healthcare services in home health and hospice patient contracts include routine services in exchange for a contractual agreed-upon amount or rate. Routine services are treated as a single performance obligation satisfied over time as services are rendered. As such, patient care services represent a bundle of services that are not capable of being distinct within the context of the contract. Additionally, there may be ancillary services which are not included in the rates for routine services, but instead are treated as separate performance obligations satisfied at a point in time, if and when those services are rendered.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue recognized from healthcare services are adjusted for estimates of variable consideration to arrive at the transaction price. The Company determines the transaction price based on contractually agreed-upon amounts or rate, adjusted for estimates of variable consideration. The Company uses the expected value method in determining the variable component that should be used to arrive at the transaction price, using contractual agreements and historical reimbursement experience within each payor type. The amount of variable consideration which is included in the transaction price may be constrained, and is included in the net revenue only to the extent that it is probable that a significant reversal in the amount of the cumulative revenue recognized will not occur in a future period. If actual amounts of consideration ultimately received differ from the Company&#x2019;s estimates, the Company adjusts these estimates, which would affect net service revenue in the period such variances become known. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from the Medicare and Medicaid programs accounted for 62.6%, 60.1%, and 55.6% of the Company&#x2019;s revenue for the years ended December 31, 2021, 2020 and 2019, respectively. The Company records revenue from these governmental and managed care programs as services are performed at their expected net realizable amounts under these programs. The Company&#x2019;s revenue from governmental and managed care programs is subject to audit and retroactive adjustment by governmental and third-party agencies. Consistent with healthcare industry accounting practices, any changes to these governmental revenue estimates are recorded in the period the change or adjustment becomes known based on final settlement. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company disaggregates revenue from contracts with its patients or residents by reportable operating segments and payors. The Company has determined that disaggregating revenue into these categories achieves the disclosure objectives to depict how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors. A reconciliation of disaggregated revenue to segment revenue as well as revenue by payor is provided in below. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s service specific revenue recognition policies are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Home Health Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Medicare Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For Medicare episodes that began after January 1, 2020, net service revenue is recognized in accordance with the Patient Driven Groupings Model (&#x201c;PDGM&#x201d;). This new reimbursement structure involves case mix calculation methodology refinements, changes to low-utilization payment adjustment (&#x201c;LUPA&#x201d;) thresholds, the elimination of therapy thresholds, a change to the unit of payment from a 60-day episode to a 30-day payment period, and reduction of requests for anticipated payments (&#x201c;RAPs&#x201d;) to 20% of the estimated payment for a patient&#x2019;s initial or subsequent period of care up-front (after the initial assessment is completed and upon initial billing). The RAPs were completely phased out effective January 1, 2021. Under PDGM, Medicare provides agencies with payments for each 30-day payment period provided to beneficiaries. If a beneficiary is still eligible for care after the end of the first 30-day payment period, a second 30-day payment period can begin. There are no limits to the number of periods of care a beneficiary who remains eligible for the home health benefit can receive. While payment for each 30-day payment period is adjusted to reflect the beneficiary&#x2019;s health condition and needs, a special outlier provision exists to ensure appropriate payment for those beneficiaries that have the most expensive care needs. The payment under the Medicare program is also adjusted for certain variables including, but not limited to: (a) a LUPA if the number of visits is below an established threshold that varies based on the diagnosis of a beneficiary; (b) a partial payment if the patient transferred to another provider or the Company received a patient from another provider before completing the period of care; (c) adjustment to the admission source of claim if it is determined that the patient had a qualifying stay in a post-acute care setting within 14 days prior to the start of a 30-day payment period; (d) the timing of the 30-day payment period provided to a patient in relation to the admission date, regardless of whether the same home health provider provided care for the entire series of episodes; (e) changes to the acuity of the patient during the previous 30-day payment period; (f) changes in the base payments established by the Medicare program; (g) adjustments to the base payments for case mix and geographic wages; and (h) recoveries of overpayments. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For all episodes that began prior to January 1, 2020, net service revenue was recorded under the Medicare prospective payment system based on a 60-day episode payment rate that is subject to adjustment based on certain variables including, but not limited to: (a) an outlier payment if the patient&#x2019;s care was unusually costly; (b) a LUPA if the number of visits was fewer than five; (c) a partial payment if the patient transferred to another provider or transferred from another provider before completing the episode; (d) a payment adjustment based upon the level of covered therapy services; (e)&#160;the number of episodes of care provided to a patient, regardless of whether the same home health provider provided care for the entire series of episodes; (f)&#160;changes in the base episode payments established by the Medicare program; (g)&#160;adjustments to the base episode payments for case mix and geographic wages; and (h)&#160;recoveries of overpayments.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company adjusts Medicare revenue on completed episodes to reflect differences between estimated and actual payment amounts, an inability to obtain appropriate billing documentation and other reasons unrelated to credit risk. Therefore, the Company believes that its reported net service revenue and patient accounts receivable will be the net amounts to be realized from Medicare for services rendered.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to revenue recognized on completed episodes and periods, the Company also recognizes a portion of revenue associated with episodes and periods in progress. Episodes in progress are 30-day payment periods, if the episode started after January 1, 2020, or 60-day episodes of care, if the episode started prior to January 1, 2020, that begin during the reporting period but were not completed as of the end of the period. As such, the Company estimates revenue and recognizes it on a daily basis. The primary factors underlying this estimate are the number of episodes in progress at the end of the reporting period, expected Medicare revenue per period of care or episode of care and the Company&#x2019;s estimate of the average percentage complete based on the scheduled end of period and end of episode dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-Medicare Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Episodic Based Revenue -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company recognizes revenue in a similar manner as it recognizes Medicare revenue for episodic-based rates that are paid by other insurance carriers, including Medicare Advantage programs; however, these rates can vary based upon the negotiated terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-episodic Based Revenue -&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Revenue is recognized on an accrual basis based upon the date of service at amounts equal to its established or estimated per visit rates, as applicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Hospice Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized on an accrual basis based upon the date of service at amounts equal to the estimated payment rates. The estimated payment rates are calculated as daily rates for each of the levels of care the Company delivers. Revenue is adjusted for an inability to obtain appropriate billing documentation or authorizations acceptable to Medicare and other reasons unrelated to credit risk. Additionally, as Medicare hospice revenue is subject to an inpatient cap and an overall payment cap, the Company monitors its provider numbers and estimates amounts due back to Medicare if a cap has been exceeded. The Company regularly evaluates and records these adjustments as a reduction to revenue and an increase to other accrued liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Senior Living Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has elected the lessor practical expedient within ASC Topic 842, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC 842&#x201d;) and therefore recognizes, measures, presents, and discloses the revenue for services rendered under the Company&#x2019;s senior living residency agreements based upon the predominant component, either the lease or non-lease component, of the contracts. The Company has determined that the services included under the Company&#x2019;s senior living residency agreements each have the same timing and pattern of transfer. The Company recognizes revenue under ASC Topic 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; for its senior residency agreements, for which it has determined that the non-lease components of such residency agreements are the predominant component of each such contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s senior living revenue consists of fees for basic housing and assisted living care. Accordingly, we record revenue when services are rendered on the date services are provided at amounts billable to individual residents. Residency agreements are generally for a term of 30 days, with resident fees billed monthly in advance. For residents under reimbursement arrangements with Medicaid, revenue is recorded based on contractually agreed-upon amounts or rates on a per resident, daily basis or as services are rendered. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue by payor for the years ended December 31, 2021, 2020 and 2019, is summarized in the following tables:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health and Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Living Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.176%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health and Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Living Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:80%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health and Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Living Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Balance Sheet Impact&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Included in the Company&#x2019;s consolidated balance sheets are contract assets, comprised of billed accounts receivable and unbilled receivables, which are the result of the timing of revenue recognition, billings and cash collections, as well as, contract liabilities, which primarily represent payments the Company receives in advance of services provided. As of December 31, 2021, the Company had contract liabilities in the amount of $6,211 related to Advance Payments received in connection with the CARES Act. As further discussed in Note 10, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Accrued Liabilities,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the repayment terms for Medicare advance payments were modified through the passage of the Continuing Appropriations Act, 2021 and Other Extensions Act on October 1, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable as of December 31, 2021 and December 31, 2020 is summarized in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity for our allowance for doubtful accounts for the years ended December 31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to bad debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs of uncollectible accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(594)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pntg:RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i663cd00e1ad6470dbb471e5fc87e9203_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzIxMTg_bda53759-a1d3-4be1-9367-bd363d79e094"
      unitRef="number">0.626</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifab97b7b0975436f83121c89244a55d3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzE3NTkyMTg2MDU2NDIz_1981020c-9113-41ba-8783-48fbb5776733"
      unitRef="number">0.601</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1f1a78bb16f147c18572f1380b8c667f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzIxMzA_c0a8f9f9-e6a6-454d-a0fa-d6ffe32a3848"
      unitRef="number">0.556</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenuePerformanceObligationDescriptionOfPaymentTerms
      contextRef="idca163657edf4bc2aca2d8b382f0f7b2_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzEwMTcz_6d289274-96fe-4488-bead-a9d33bbbe73a">Residency agreements are generally for a term of 30 days, with resident fees billed monthly in advance. For residents under reimbursement arrangements with Medicaid, revenue is recorded based on contractually agreed-upon amounts or rates on a per resident, daily basis or as services are rendered.</us-gaap:RevenuePerformanceObligationDescriptionOfPaymentTerms>
    <us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzYwNDczMTM5NjQ3MzM_29d8c8d7-14bc-4320-8a56-7d5d753f5766">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue by payor for the years ended December 31, 2021, 2020 and 2019, is summarized in the following tables:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:19.221%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.104%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health and Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Living Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;135,939&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,935&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,103&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;148,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;275,143&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,363&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,007&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,807&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;157,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151,612&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.870%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.171%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.176%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health and Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Living Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58,399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;178,272&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;45.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,645&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,044&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;235,159&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,572&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,546&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,118&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,514&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;122,676&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119,584&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:80%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.987%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.149%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.152%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health and Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Living Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Revenue %&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141,752&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,061&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,455&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Subtotal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;103,994&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,837&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;121,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,682&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Private and other payors in our home health and hospice services segment includes revenue from all payors generated in our home care operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i431551b89e134941b82c51244240a244_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzMtMi0xLTEtNDExMzI_8684cbf1-691b-41e7-85f6-3b16580bcac1"
      unitRef="usd">80849000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9b3121c806bb417081699695640c414f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzMtNC0xLTEtNDExMzI_55e564d6-4b6c-45a7-a744-2e542d6cc9d1"
      unitRef="usd">135939000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i17b4bb1acf134933be5201416c719d6c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzMtNi0xLTEtNDExMzI_8fcc84fb-de8a-4613-bb3c-29a0c80be953"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i03057061bfb7409985a60619a19b48e6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzMtOC0xLTEtNDExMzI_abbb93fe-7b5f-4d2b-979a-bdacb8e3b536"
      unitRef="usd">216788000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i6ddd0deea9264c2889a8b36d67a563b0_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzMtMTAtMS0xLTQxMTMy_3b215a23-46bf-4327-a0ae-3e10a4d2f684"
      unitRef="number">0.493</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i30d0fef362f9476098b2e5f91ab55f41_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzQtMi0xLTEtNDExMzI_ac3179dd-2bc0-49cb-b5ca-aebf89c99d9a"
      unitRef="usd">8935000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2d0123d2512e41bfbbd00432a081dabd_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzQtNC0xLTEtNDExMzI_22e5c150-8561-4570-932f-681937862fc4"
      unitRef="usd">12103000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idac1833793374955a04bd068e4506c0e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzQtNi0xLTEtNDExMzI_f3b7f181-6788-4e87-b45a-eb98a60989cf"
      unitRef="usd">37317000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iac9f214a0b30486f90920ce93092e539_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzQtOC0xLTEtNDExMzI_2a01d8fb-b91d-4c20-8a41-25a8424d3b8b"
      unitRef="usd">58355000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i05e5b7442b2e4748b8bc9f050198888e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzQtMTAtMS0xLTQxMTMy_a2807c20-79ea-4a65-9761-2d14a590b5df"
      unitRef="number">0.133</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ibf54a7dfae6a484abdd050e8ddda248a_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzUtMi0xLTEtNDExMzI_2c596972-b93d-42c0-820a-e60b48bafd43"
      unitRef="usd">89784000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3cad94c3015b470d965cbc5ee38f4770_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzUtNC0xLTEtNDExMzI_e2f0cc6e-e87e-4ae1-a43a-f31ad61c02e1"
      unitRef="usd">148042000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id38b672538cd430abff250dfff0240b6_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzUtNi0xLTEtNDExMzI_81fa01fb-491c-4a06-95ad-3595d6b4657f"
      unitRef="usd">37317000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib5365806816e44649649e52c6625abe4_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzUtOC0xLTEtNDExMzI_f879ad94-a09f-42c5-86d6-1c43de3bc920"
      unitRef="usd">275143000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i663cd00e1ad6470dbb471e5fc87e9203_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzUtMTAtMS0xLTQxMTMy_bda53759-a1d3-4be1-9367-bd363d79e094"
      unitRef="number">0.626</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idf736e5de07e408db946428a0745839b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzYtMi0xLTEtNDExMzI_0d0f336e-1f0c-4fc4-b76a-df657b1a8cf0"
      unitRef="usd">46167000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icea654d979af4e61816fbe050cb29db1_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzYtNC0xLTEtNDExMzI_28d94e60-b22d-481b-ac1d-deb816b841df"
      unitRef="usd">3196000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8458a5a068c4090af7e21aad43775a0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzYtNi0xLTEtNDExMzI_c08ebe0e-6b11-4098-ba9b-6a0cbeba1940"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8406e50463644fbdb227c6e79289ad64_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzYtOC0xLTEtNDExMzI_76a252f5-8c61-4689-828b-e0a618fff20d"
      unitRef="usd">49363000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifdb705c6ba97400d913dd4a58f256b0e_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzYtMTAtMS0xLTQxMTMy_212e908e-41bc-473a-8ecd-ba1abe803dc3"
      unitRef="number">0.112</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i7de26af2c3974c3eb74c36971003d68f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzctMi0xLTEtNDExMzI_aa053f1c-8405-4a51-b33d-1176aa5a6f71"
      unitRef="usd">22007000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if26e6ee1ae2b4492b5956195b2492b91_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzctNC0xLTEtNDExMzI_ba39a975-40c7-4426-b1a1-ead8608a7eaf"
      unitRef="usd">374000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5d63dc45c0b146cfb92561c882177fea_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzctNi0xLTEtNDExMzI_f712333c-ea76-4683-b4d0-2983713d9569"
      unitRef="usd">92807000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i5f6f3d7d4c8a4c4caa054a915ffff62d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzctOC0xLTEtNDExMzI_7c0765e1-ce1d-4992-b4f9-a9a070ddb445"
      unitRef="usd">115188000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie381063adb71430c9c8b4f7607c9030f_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzctMTAtMS0xLTQxMTMy_3fda3333-fc91-4744-b058-9eb7d5d62ed0"
      unitRef="number">0.262</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic242ef7737ea4e8d8f2e0629c8af8812_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzgtMi0xLTEtNDExMzI_e396b512-31c4-4676-b837-57d960a02a1e"
      unitRef="usd">157958000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic6cb3dbfbde247d28b978021dfabc07e_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzgtNC0xLTEtNDExMzI_755a43b2-4d0d-4670-b309-0207efa12fb8"
      unitRef="usd">151612000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idca163657edf4bc2aca2d8b382f0f7b2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzgtNi0xLTEtNDExMzI_a6ae22e6-4836-4b32-b043-a66d314b99b1"
      unitRef="usd">130124000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzgtOC0xLTEtNDExMzI_1b542b83-0272-4ec0-ab64-a5754655a85d"
      unitRef="usd">439694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i400c7c456591430da87c024511cdb9f8_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpmZWZlOTViNDRiMjI0Mzc4YWYwMDkzOTA0ZDg3NzM3YS90YWJsZXJhbmdlOmZlZmU5NWI0NGIyMjQzNzhhZjAwOTM5MDRkODc3MzdhXzgtMTAtMS0xLTQxMTMy_1380a1ba-c388-4d7c-827c-206622f63d53"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia9994a97da124177acf7e325874bdc4a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzMtMi0xLTEtNDExMzI_fbc5e955-c1a3-4ae6-961e-e82010934f28"
      unitRef="usd">58399000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9422adb47dd144de9fd4fb328368c4e3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzMtNC0xLTEtNDExMzI_0b0ad15d-3b6e-4e26-a4ca-570236f4f1f3"
      unitRef="usd">119873000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8202cceeb8344c46a087879b40701124_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzMtNi0xLTEtNDExMzI_33061cae-2892-44f6-b58c-904c489b0aaf"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib8551d37adc147afa5952e88c48adde6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzMtOC0xLTEtNDExMzI_a32c3ae5-ce46-4c0b-8f68-a4139b485aad"
      unitRef="usd">178272000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8ca13a6f741345fea9329cb059f1ed4b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzMtMTAtMS0xLTQxMTMy_6ffae2ba-9552-4ab4-99a8-54bced43890c"
      unitRef="number">0.456</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2984f9f8dd8744ecbd977408c0e3b962_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzQtMi0xLTEtNDExMzI_8e7a9db7-4b4d-4e97-8771-2f1ae7b78be4"
      unitRef="usd">7645000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i48f286f45fe449d6a5632e508d5c2057_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzQtNC0xLTEtNDExMzI_c00045a2-0e7b-4a64-a922-ba6d9beb9c33"
      unitRef="usd">12462000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0599a83f392c492c8ca20b93a86ccd91_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzQtNi0xLTEtNDExMzI_18536110-ea21-4d11-8f54-6a3dcfd80769"
      unitRef="usd">36780000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i36bae4b32d354f01bfa55606e2bf53ff_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzQtOC0xLTEtNDExMzI_a2aba5c1-ca0c-4305-bcc6-353c7d74a067"
      unitRef="usd">56887000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iccdbd602cb6b43c1b386f036f6f9c78b_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzQtMTAtMS0xLTQxMTMy_f0afa848-b862-42da-a972-9de24ab3fff9"
      unitRef="number">0.145</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i29892b01245e41eb84f75876a0351a3a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzUtMi0xLTEtNDExMzI_d85261bd-9aec-4cbb-ac67-26b6db9f5b6d"
      unitRef="usd">66044000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8bd2b41188c847e0ba8e9c40a817df93_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzUtNC0xLTEtNDExMzI_787a2a4f-c8a6-4d4f-995e-f52afec386d4"
      unitRef="usd">132335000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if4653a795c674a2a99639c0e0ca313f2_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzUtNi0xLTEtNDExMzI_bbc43fab-3ee3-4103-b96a-b807a7cde276"
      unitRef="usd">36780000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2eee5c7b272f4114a364a863a01dd73b_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzUtOC0xLTEtNDExMzI_58ffb0ad-5bd5-4161-a953-e32d06273815"
      unitRef="usd">235159000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifab97b7b0975436f83121c89244a55d3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzUtMTAtMS0xLTQxMTMy_1981020c-9113-41ba-8783-48fbb5776733"
      unitRef="number">0.601</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4d7797f8df2244b09c017060c787f7c4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzYtMi0xLTEtNDExMzI_df5f65b2-2000-4a0a-a71e-9dc83835194e"
      unitRef="usd">31572000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i07e05d97399f4e76ae18df53c721bcbc_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzYtNC0xLTEtNDExMzI_1aada0e1-418d-4a99-8725-0cd7ea330ab3"
      unitRef="usd">1546000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i869ae7cc46294c22b376048f3f1d1a6d_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzYtNi0xLTEtNDExMzI_f860940c-4ea7-4533-ac1d-cce1ee45f9b8"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if499ccd516774920992a7dec4b1cef2e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzYtOC0xLTEtNDExMzI_d5f1500e-bdba-4ff9-9a19-060f00e3d1ea"
      unitRef="usd">33118000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib32ab0952f954ffcac6e996208515105_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzYtMTAtMS0xLTQxMTMy_4fceb8fc-eaae-4bcb-9245-ba911a3046de"
      unitRef="number">0.085</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i3e46c22d3f0f4b2d8bc8e8a60fc2ccc5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzctMi0xLTEtNDExMzI_b99b6957-14d6-46fd-af40-e6df1a350ee6"
      unitRef="usd">21968000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6b21bb23ad2d4d29ae1a573ce3633cf1_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzctNC0xLTEtNDExMzI_698bd3b1-9d8e-4b95-bf89-0e3d64f321e7"
      unitRef="usd">194000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6adffdb90bb04f3ea1ba43662f341d52_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzctNi0xLTEtNDExMzI_41988f49-df6d-4317-9d88-926717b05787"
      unitRef="usd">100514000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="idfddb8b08a444307a9d0127349167737_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzctOC0xLTEtNDExMzI_8ea46e23-878b-429c-a388-5259358ba0dc"
      unitRef="usd">122676000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i762cb9691e2742e883abaa93d43be077_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzctMTAtMS0xLTQxMTMy_b407a285-7f85-4d9e-b356-4f9cf59bedd7"
      unitRef="number">0.314</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i6ee634dbd9cf40079a3e668ce24a98e3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzgtMi0xLTEtNDExMzI_daa15e42-1724-4ad6-b51f-54637c232a4d"
      unitRef="usd">119584000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4566419dadde4c98a7120368b872f3da_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzgtNC0xLTEtNDExMzI_293df5e1-cb4b-4275-adff-6acdc4aa36a7"
      unitRef="usd">134075000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iaaa4cbfc68844bf2ab83f3ee4d31a520_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzgtNi0xLTEtNDExMzI_280f3453-0657-4983-a352-dfb2023c86c3"
      unitRef="usd">137294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzgtOC0xLTEtNDExMzI_b30ffed2-0957-4d54-94da-041eaa8f236d"
      unitRef="usd">390953000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5a2eb0a55f1548d09ebdd38af8a78640_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo3YWVhN2JmODRjN2I0OGQ5OTE5Y2JjM2IxNTMyNzA4ZS90YWJsZXJhbmdlOjdhZWE3YmY4NGM3YjQ4ZDk5MTljYmMzYjE1MzI3MDhlXzgtMTAtMS0xLTQxMTMy_103f22dd-79a4-4ed9-9dee-846b33464845"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i89476537bc774ebc87ef3b108c8f978e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzMtMi0xLTEtNDExMzI_3468d525-5961-41e8-8767-60188fecee1f"
      unitRef="usd">47819000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i33675a436d3e40e985deb8177a576c9d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzMtNC0xLTEtNDExMzI_945e20ce-9afa-42f5-b32c-ccd382603e5d"
      unitRef="usd">93933000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iab8c34ad3ce545459293744ddcb6827c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzMtNi0xLTEtNDExMzI_d4b9f6de-7cfa-4aa2-84d9-24abb0ced63b"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i900aa21d63db4875b0f5ce732299844e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzMtOC0xLTEtNDExMzI_768df2a9-a6a2-48dc-a81b-a250888a2065"
      unitRef="usd">141752000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i49df9afbb9944bb4b9a18d9b551d87cc_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzMtMTAtMS0xLTQxMTMy_5fece732-b3df-419d-8e21-fec44d30f543"
      unitRef="number">0.419</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i78a868a69cef4c5fa0fad890560c7186_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzQtMi0xLTEtNDExMzI_1f18587c-4dbe-42a5-94a9-d1fbafcf4269"
      unitRef="usd">6575000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i150c3c3a7f2441dba86ec0345435079c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzQtNC0xLTEtNDExMzI_60b9d11f-7a54-403c-ae46-45008b8d0718"
      unitRef="usd">10061000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i264e682f589d40f8996079dbbb6714ee_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzQtNi0xLTEtNDExMzI_0ce72752-3720-4320-85b2-bfa0814d20a7"
      unitRef="usd">29819000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i555f8697f79c4135bf985a88ac806168_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzQtOC0xLTEtNDExMzI_122eacbf-9c24-401e-9a77-91b4ca6954c4"
      unitRef="usd">46455000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i4264f7ca59794b258dcd7d108f89c4bb_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzQtMTAtMS0xLTQxMTMy_cd1d16ca-4baa-49e9-9e59-5fb5b9534f8c"
      unitRef="number">0.137</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib11f67911ae04e9e9474289103ab7ca0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzUtMi0xLTEtNDExMzI_e369d7b3-ecab-458a-9829-7d8d9580e6d3"
      unitRef="usd">54394000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i993ccc72246c43c6882a67446f7e3d04_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzUtNC0xLTEtNDExMzI_a9c77f93-74e0-4655-9687-db17eb7a4d03"
      unitRef="usd">103994000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia66c44f3f144416dbe4fb6670ae3d912_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzUtNi0xLTEtNDExMzI_180317ff-d9b0-42cf-bfe8-1211cec7fd4f"
      unitRef="usd">29819000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0b8618d03b954dd9b12ccc9dc2633994_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzUtOC0xLTEtNDExMzI_a7f036e7-8211-4bed-85aa-7d80dc6cad3f"
      unitRef="usd">188207000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1f1a78bb16f147c18572f1380b8c667f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzUtMTAtMS0xLTQxMTMy_c0a8f9f9-e6a6-454d-a0fa-d6ffe32a3848"
      unitRef="number">0.556</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1d5ca24424934279961a03e8619d1a55_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzYtMi0xLTEtNDExMzI_03725b94-0569-4bd8-be53-18899545586f"
      unitRef="usd">27711000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i18dd800368c0436f9fdaee03faceced1_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzYtNC0xLTEtNDExMzI_fda021e2-5938-49bc-8149-e44cb98436e5"
      unitRef="usd">1536000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i26c2df1bf2f84583ad5e170e30ac0da6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzYtNi0xLTEtNDExMzI_70d19005-df0d-481f-a648-2fcc61d874ea"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i63ed1921de984ba2b86b439f98dd36dc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzYtOC0xLTEtNDExMzI_3edb76a9-2d0d-48fb-b904-0c4955077f47"
      unitRef="usd">29247000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8f79c51975d142fcb63efb2a71b34744_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzYtMTAtMS0xLTQxMTMy_0e1bf2c1-1c46-432b-b23a-3ac73b2b056a"
      unitRef="number">0.086</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if165ef086e644209a29aa525477fce96_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzctMi0xLTEtNDExMzI_94ae7ea3-15dd-40dd-9c38-3172a9f19140"
      unitRef="usd">18837000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i1ebf7bc335ba488f9cb8f70150a6bd1a_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzctNC0xLTEtNDExMzI_a92f459d-4d9a-45fa-a592-b70d59a43792"
      unitRef="usd">152000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0325f33d9f364afd88fb10e9c56068e0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzctNi0xLTEtNDExMzI_7dde6b9f-9448-4460-8cc1-f84e9f94c9ec"
      unitRef="usd">102088000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i22dbeb2253784b39851f81d479af22fd_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzctOC0xLTEtNDExMzI_bc50398c-fbff-40d0-884c-8ceabb6cf0e6"
      unitRef="usd">121077000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i32ea97b6e981410cbc2b5ebf32b066a3_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzctMTAtMS0xLTQxMTMy_e1f76a2d-b5ca-46b0-aa81-0bae61c22e7a"
      unitRef="number">0.358</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0e919c640df94e919b7b44c94f671f8e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzgtMi0xLTEtNDExMzI_b600767c-6ba0-4bfa-9bd1-166348ea262c"
      unitRef="usd">100942000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic5ffc58dbb624c40ac8f80c16398d43c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzgtNC0xLTEtNDExMzI_449140c2-4d8b-486d-9a0a-e15408e88b97"
      unitRef="usd">105682000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie112d35bfda34b3288ce4100b5cdf3cf_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzgtNi0xLTEtNDExMzI_7ed27726-fa6b-4316-9149-9a29f344e9b7"
      unitRef="usd">131907000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzgtOC0xLTEtNDExMzI_3de4433f-7c81-47bf-a6b6-2f2aa1335ade"
      unitRef="usd">338531000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5f2f4fea3b5747c3907908c54f286f3a_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTpkMDYyODljODU4NjY0OWFhYWZiMTI0NjQ2Y2RiOGExOS90YWJsZXJhbmdlOmQwNjI4OWM4NTg2NjQ5YWFhZmIxMjQ2NDZjZGI4YTE5XzgtMTAtMS0xLTQxMTMy_73a3cf86-4a8a-401b-9ea0-f860e4852a63"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzEwOTk1MTE2Mzk3NTQ_0662b208-4cfe-49f3-8ae3-eac63f7d02c3"
      unitRef="usd">6211000</pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzYwNDczMTM5NjQ3MzQ_22928e7c-4b5e-4225-af03-3c9d5e2d7ee5">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable as of December 31, 2021 and December 31, 2020 is summarized in the following table: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.391%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:20.393%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,327&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicaid&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,793&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,669&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Managed care&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,036&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;54,842&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,864&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(902)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(643)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,940&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="ia630ac63be744170818adf1a6996df94_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzEtMS0xLTEtNDExMzI_7f068da9-0095-408f-8edc-24d9365ed30f"
      unitRef="usd">31327000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="ib84e2fa7e66c4c8280ad68c7ca28d55c_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzEtMy0xLTEtNDExMzI_58538df8-e19d-499f-aa65-79dbf44d3a87"
      unitRef="usd">28569000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="ic852038e4be24f098e1d5554086d7e6b_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzItMS0xLTEtNDExMzI_b8948e10-1501-4a37-a76c-55a390ac317a"
      unitRef="usd">11793000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i23e0fe4823904639ac80d8fdad567676_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzItMy0xLTEtNDExMzI_da27f2d1-54b1-41d4-8654-ef6b41ca48c9"
      unitRef="usd">7669000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="ie0ea0e85a0e047b098694b3d6d36944a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzMtMS0xLTEtNDExMzI_0d40de54-80af-4eb3-bcea-cca7e3dc9b70"
      unitRef="usd">7901000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i31bba7ec3d96407896690fde2506a953_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzMtMy0xLTEtNDExMzI_3aed2e77-d4e1-4eca-9c28-da2bcd6b660c"
      unitRef="usd">7590000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="iabbe1867eaad43e6b8ea27b135c22cfd_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzQtMS0xLTEtNDExMzI_76cd4698-c315-47f2-bbb6-92f5d3182e49"
      unitRef="usd">3821000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i51de978558994d7d85f12eee1b08a961_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzQtMy0xLTEtNDExMzI_1539da5e-da4a-4deb-a051-84191d60682d"
      unitRef="usd">4036000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzUtMS0xLTEtNDExMzI_c1ab8c76-be42-4160-9b5e-2c79a6fb1f79"
      unitRef="usd">54842000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AccountsReceivableGrossCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzUtMy0xLTEtNDExMzI_b1fe25ba-6c01-4280-a2ca-0c56ca265ea5"
      unitRef="usd">47864000</us-gaap:AccountsReceivableGrossCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzYtMS0xLTEtNDExMzI_582ec952-359d-4d67-bd6d-325f966c541c"
      unitRef="usd">902000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzYtMy0xLTEtNDExMzI_d49fe8db-79dd-4029-a553-c673f397ae09"
      unitRef="usd">643000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzctMS0xLTEtNDExMzI_b8781dc6-3c20-40fc-bd1a-b07c63f3f75c"
      unitRef="usd">53940000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZTo4NGJkNGVjNjYxMzI0OWJmYjcyOWRhYTFmODM5MzQwZC90YWJsZXJhbmdlOjg0YmQ0ZWM2NjEzMjQ5YmZiNzI5ZGFhMWY4MzkzNDBkXzctMy0xLTEtNDExMzI_1390de89-0c26-4a7b-bbed-04fb25329073"
      unitRef="usd">47221000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90ZXh0cmVnaW9uOjk4NzRhNWNiNDEyNTQxNmE4N2Y3MGU5ZTI1OThmYTlkXzYwNDczMTM5NjQ3MzU_6688f422-369d-4509-962b-dd8a818b7192">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity for our allowance for doubtful accounts for the years ended December 31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.350%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.600%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to bad debt expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;858&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Write-offs of uncollectible accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(357)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(594)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(797)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;902&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;643&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzItMS0xLTEtNDExMzI_7544b13d-bb22-438f-a58f-dba9a3a6a2b2"
      unitRef="usd">643000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzItMy0xLTEtNDExMzI_cb4791bb-ab45-43bd-8d98-8b9aab0fb7e4"
      unitRef="usd">677000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i855d825b738d453698699f3f7321df6f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzItNS0xLTEtNDExMzI_936ac73d-cc81-4fdc-9aa6-c672c2990a55"
      unitRef="usd">616000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzQtMS0xLTEtNDExMzI_e7fce570-5bc7-4627-b180-78db87bc662a"
      unitRef="usd">616000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzQtMy0xLTEtNDExMzI_1ad3f71c-0330-4701-8294-fbff3b05cf2b"
      unitRef="usd">560000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzQtNS0xLTEtNDExMzI_6be7564d-f22b-44e7-aa9d-e42918f9b02d"
      unitRef="usd">858000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzUtMS0xLTEtNDExMzI_9eefc7ca-f59f-47fb-9cd9-7598a38fcd0f"
      unitRef="usd">357000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzUtMy0xLTEtNDExMzI_985e3b2e-52bc-4ee4-947e-ed0bacfa30ef"
      unitRef="usd">594000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzUtNS0xLTEtNDExMzI_47b8c2a3-7deb-484f-ac41-1025f47088f9"
      unitRef="usd">797000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzYtMS0xLTEtNDExMzI_22395016-181e-4fae-a246-92fbe555d03e"
      unitRef="usd">902000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzYtMy0xLTEtNDExMzI_a06c18a1-b273-4977-b12e-03f145e31458"
      unitRef="usd">643000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzUvZnJhZzo5ODc0YTVjYjQxMjU0MTZhODdmNzBlOWUyNTk4ZmE5ZC90YWJsZToxMmM5ZmIxZDFjZGI0NGYzYTBkNGQ4OGE1YzliMWMxZS90YWJsZXJhbmdlOjEyYzlmYjFkMWNkYjQ0ZjNhMGQ0ZDg4YTVjOWIxYzFlXzYtNS0xLTEtNDExMzI_e2ec45c5-347e-4912-9223-ab14ffba5803"
      unitRef="usd">677000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90ZXh0cmVnaW9uOmYwMmRkNDYzODJlODQyN2NiMjk5ZDY1OTE5YzQzZDA1XzYwNDczMTM5NTU5ODQ_6c7b864e-115b-4191-a6d2-69ffc95f023f">BUSINESS SEGMENTS&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies its operations into the following reportable operating segments: (1) home health and hospice services, which includes the Company&#x2019;s home health, hospice and home care businesses; and (2) senior living services, which includes the operation of assisted living, independent living and memory care communities. The reporting segments are business units that offer different services and are managed separately to provide greater visibility into those operations. Our Chief Executive Officer and President, who is our Chief Operating Decision Maker &#x201c;CODM&#x201d;, reviews financial information at the operating segment level. We also report an &#x201c;all other&#x201d; category that includes general and administrative expense from our Service Center.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, the Company provided services through 88 affiliated home health, hospice and home care agencies, and 54 affiliated senior living operations. The Company evaluates performance and allocates capital resources to each segment based on an operating model that is designed to maximize the quality of care provided and profitability. The Company&#x2019;s Service Center provides various services to all lines of business. The Company does not review assets by segment and therefore assets by segment are not disclosed below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The CODM uses Segment Adjusted EBITDAR from Operations as the primary measure of profit and loss for the Company's reportable segments and to compare the performance of its operations with those of its competitors. Segment Adjusted EBITDAR from Operations is net income/ (loss) attributable to the Company's reportable segments excluding interest expense, provision for income taxes, depreciation and amortization expense, rent, and, in order to view the operations performance on a comparable basis from period to period, certain adjustments including: (1) costs at start-up operations, (2) share-based compensation, (3) acquisition related costs, (4) Spin-Off transaction costs, (5) redundant and nonrecurring costs associated with the transition services agreement, (6) net income/ (loss) attributable to noncontrolling interest, (7) net COVID-19 related costs and (8) impairment of long-lived assets. General and administrative expenses are not allocated to the reportable segments, and are included as &#x201c;All Other&#x201d;, accordingly the segment earnings measure reported is before allocation of corporate general and administrative expenses. The Company's segment measures may be different from the calculation methods used by other companies and, therefore, comparability may be limited.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents certain financial information regarding our reportable segments, general and administrative expenses are not allocated to the reportable segments and are included in &#x201c;All Other&#x201d;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health and Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Living Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDAR from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDAR from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDAR from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.103%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDAR from Operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rent&#x2014;cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to Segment EBITDAR from Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Costs at start-up operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition related costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spin-off related transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transition services costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 Related costs and supplies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(f)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(g)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Net income/ (loss) attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(548)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated and Combined Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Represents results related to start-up operations.  This amount excludes rent and depreciation and amortization expense related to such operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense incurred which is included in cost of services and general and administrative expense. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquisition related costs that are not capitalizable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Costs incurred related to the Spin-Off are included in general and administrative expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;A portion of the costs incurred under the Transition Services Agreement identified as redundant or nonrecurring that are included in general and administrative expense. Fees incurred under the Transition Services Agreement, net of the Company&#x2019;s payroll reimbursement, were $3,124, $5,536, and $2,982, for the years ended December 31, 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning in the first quarter of fiscal year 2021, we updated our definition of Segment Adjusted EBITDAR to no longer include an adjustment for COVID-19 expenses offset by the amount of sequestration relief. COVID-19 expenses continue to be part of daily operations for which less specific identification is visible. Furthermore, the sequestration relief was extended through December 31, 2021. Sequestration relief was $3,555 for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;The 2020 amount represents incremental costs incurred as part of the Company's response to COVID-19 including direct medical supplies, labor, and other expenses, net of $2,765 in increased revenue related to the 2% payment increase in Medicare reimbursements for sequestration relief for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(g)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;On January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements (collectively, the &#x201c;Transfer Agreements&#x201d;) with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#x201c;Transaction&#x201d;). The closing of the Transaction is anticipated to occur in the first half of 2022. The Company impaired certain leasehold improvements included in property and equipment primarily  related to the operations included in the transaction with Ensign.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <pntg:NumberOfServiceProviders
      contextRef="ife1126ceed284fbdb9bf6b3dbab68da3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90ZXh0cmVnaW9uOmYwMmRkNDYzODJlODQyN2NiMjk5ZDY1OTE5YzQzZDA1XzIxOTkwMjMyNTg4OTM_601ff99b-7d5b-4095-bf9d-eab16d3843b7"
      unitRef="agency">88</pntg:NumberOfServiceProviders>
    <pntg:NumberOfRealEstatePropertiesUnderLease
      contextRef="icc510d566b5a497d8c3bf8da297c74be_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90ZXh0cmVnaW9uOmYwMmRkNDYzODJlODQyN2NiMjk5ZDY1OTE5YzQzZDA1XzIxOTkwMjMyNTg4OTc_b505169d-0edf-4364-965a-983f7df39456"
      unitRef="agency">54</pntg:NumberOfRealEstatePropertiesUnderLease>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90ZXh0cmVnaW9uOmYwMmRkNDYzODJlODQyN2NiMjk5ZDY1OTE5YzQzZDA1XzYwNDczMTM5NTU5ODU_8999fcdb-80a9-4bbf-bd71-387e9cef9027">&lt;div style="margin-bottom:10pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents certain financial information regarding our reportable segments, general and administrative expenses are not allocated to the reportable segments and are included in &#x201c;All Other&#x201d;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:42.174%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.502%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health and Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Living Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;All Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;309,570&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,124&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439,694&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDAR from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,517&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(26,208)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,659&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137,294&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;390,953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDAR from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;131,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;338,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDAR from Operations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,344&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icc4e373408b54afd8e67604fcad521cc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzItMi0xLTEtNDExMzI_5ec3277c-77a2-4126-bd83-791bd522b02e"
      unitRef="usd">309570000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i57cdf4fb339b4e68892dc8149e2518b9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzItNC0xLTEtNDExMzI_2fe35494-9339-440b-b4a4-bbe5b467dc6b"
      unitRef="usd">130124000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ifb6560107a1842b88eb0a7a57c2f2031_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzItNi0xLTEtNDExMzI_eb58651e-251d-4466-a432-f1f7b07d4e53"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzItOC0xLTEtNDExMzI_8845e56a-9800-48dc-815f-792aec7e9687"
      unitRef="usd">439694000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="icc4e373408b54afd8e67604fcad521cc_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzMtMi0xLTEtNDExMzI_2ff552f3-afc5-4381-bfef-10d9b98cdd76"
      unitRef="usd">55565000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="i57cdf4fb339b4e68892dc8149e2518b9_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzMtNC0xLTEtNDExMzI_a520fdd0-0bef-4c5d-ae48-b843aaa5a32f"
      unitRef="usd">37517000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="ifb6560107a1842b88eb0a7a57c2f2031_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzMtNi0xLTEtNDExMzI_51238a13-363e-4a3a-a88e-5e6e60fea10c"
      unitRef="usd">-26208000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzMtOC0xLTEtNDExMzI_1435fb7a-bee7-4f07-9faf-30d6e4abc411"
      unitRef="usd">66874000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icbb785491adf4226bb9a9857b10f52e9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzUtMi0xLTEtNDExMzI_aaa745b3-e538-4aab-864d-cbea45536d0f"
      unitRef="usd">253659000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4b47eeb041d04c25b8cd00f6bf592f7f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzUtNC0xLTEtNDExMzI_8923b38b-8399-43ac-9934-92602a3542c9"
      unitRef="usd">137294000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="iffbc90dc71cb4be1a22f4af87b57ff85_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzUtNi0xLTEtNDExMzI_fbe3e3a8-b992-4771-a3a0-c45348c3e2e6"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzUtOC0xLTEtNDExMzI_97bdc816-34d2-45ce-83de-f9bed6ecdf45"
      unitRef="usd">390953000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="icbb785491adf4226bb9a9857b10f52e9_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzYtMi0xLTEtNDExMzI_c570b10a-d9d6-4ae4-91d3-e02f5b88a605"
      unitRef="usd">49501000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="i4b47eeb041d04c25b8cd00f6bf592f7f_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzYtNC0xLTEtNDExMzI_1eccd838-6b76-49d4-b9cc-cd4b7464540f"
      unitRef="usd">48309000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="iffbc90dc71cb4be1a22f4af87b57ff85_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzYtNi0xLTEtNDExMzI_d426e006-5303-41c3-b55b-ac86b7ee8421"
      unitRef="usd">-22762000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzYtOC0xLTEtNDExMzI_b32e2e56-7a3d-4b92-b3a8-1bd8b0a2e3db"
      unitRef="usd">75048000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i976083bf7720489d9ec3c392eb20769e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzgtMi0xLTEtNDExMzI_cbadf3b7-c8f3-4e92-91bc-8b68bfcca984"
      unitRef="usd">206624000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2df8a9f1fea242caaf3c3e4967630be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzgtNC0xLTEtNDExMzI_85255966-32f3-490c-90f1-f20234b7fbd1"
      unitRef="usd">131907000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8a59a4ea155b45bfb972b34701628d91_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzgtNi0xLTEtNDExMzI_7f08ba65-9f81-4232-8028-6bd6965e4025"
      unitRef="usd">0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzgtOC0xLTEtNDExMzI_25772459-d0f4-4e47-bd15-85da340a1f62"
      unitRef="usd">338531000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="i976083bf7720489d9ec3c392eb20769e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzktMi0xLTEtNDExMzI_5aebc205-5465-4c47-8b58-c4d00ef2e438"
      unitRef="usd">33354000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="i2df8a9f1fea242caaf3c3e4967630be6_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzktNC0xLTEtNDExMzI_4837fe6d-c68e-4433-9daf-be1afbc57212"
      unitRef="usd">47344000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="i8a59a4ea155b45bfb972b34701628d91_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzktNi0xLTEtNDExMzI_64773f00-88c5-478d-b8b8-85d08fb9672c"
      unitRef="usd">-18591000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo0OTY2MDUyNGMzMTM0NjQxYTY3YjhhZDBlOTQzOTQ1MC90YWJsZXJhbmdlOjQ5NjYwNTI0YzMxMzQ2NDFhNjdiOGFkMGU5NDM5NDUwXzktOC0xLTEtNDExMzI_4a788751-26f6-4b5b-b488-35bb1ae05e55"
      unitRef="usd">62107000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90ZXh0cmVnaW9uOmYwMmRkNDYzODJlODQyN2NiMjk5ZDY1OTE5YzQzZDA1XzYwNDczMTM5NTU5ODY_ce95f4a0-98ca-43b5-a441-209529785fe3">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below provides a reconciliation of Segment Adjusted EBITDAR from Operations above to income from operations:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:66.103%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.441%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.385%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Segment Adjusted EBITDAR from Operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,874&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,048&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,675&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,810&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rent&#x2014;cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Adjustments to Segment EBITDAR from Operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Costs at start-up operations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,045&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;483&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquisition related costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;99&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24.75pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Spin-off related transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,219&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transition services costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(e)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,008&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;COVID-19 Related costs and supplies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(f)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;447&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:24pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Impairment of long-lived assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(g)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Add: Net income/ (loss) attributable to noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(548)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(191)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;629&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Consolidated and Combined Income from operations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,695&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,917&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,670&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-align:justify;text-indent:-18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Represents results related to start-up operations.  This amount excludes rent and depreciation and amortization expense related to such operations.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense incurred which is included in cost of services and general and administrative expense. &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Acquisition related costs that are not capitalizable.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Costs incurred related to the Spin-Off are included in general and administrative expense.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;A portion of the costs incurred under the Transition Services Agreement identified as redundant or nonrecurring that are included in general and administrative expense. Fees incurred under the Transition Services Agreement, net of the Company&#x2019;s payroll reimbursement, were $3,124, $5,536, and $2,982, for the years ended December 31, 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Beginning in the first quarter of fiscal year 2021, we updated our definition of Segment Adjusted EBITDAR to no longer include an adjustment for COVID-19 expenses offset by the amount of sequestration relief. COVID-19 expenses continue to be part of daily operations for which less specific identification is visible. Furthermore, the sequestration relief was extended through December 31, 2021. Sequestration relief was $3,555 for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;The 2020 amount represents incremental costs incurred as part of the Company's response to COVID-19 including direct medical supplies, labor, and other expenses, net of $2,765 in increased revenue related to the 2% payment increase in Medicare reimbursements for sequestration relief for the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(g)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;On January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements (collectively, the &#x201c;Transfer Agreements&#x201d;) with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#x201c;Transaction&#x201d;). The closing of the Transaction is anticipated to occur in the first half of 2022. The Company impaired certain leasehold improvements included in property and equipment primarily  related to the operations included in the transaction with Ensign.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</pntg:ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzItMS0xLTEtNDExMzI_d65401c7-14f1-4b12-8ea8-efe7023fe1b1"
      unitRef="usd">66874000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzItMy0xLTEtNDExMzI_891d5473-b83f-42bb-98f6-03f684150cb5"
      unitRef="usd">75048000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzItNS0xLTEtNDExMzI_142799a2-baa6-423d-b98a-d09da4fc8c0c"
      unitRef="usd">62107000</pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation>
    <us-gaap:DepreciationAndAmortization
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzMtMS0xLTEtNDExMzI_7dc7b25a-a15a-4747-bf21-a7aefc7a1835"
      unitRef="usd">4784000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzMtMy0xLTEtNDExMzI_dab1cfd9-284a-429c-85a7-72c3e41b28cf"
      unitRef="usd">4675000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzMtNS0xLTEtNDExMzI_a2f15fb2-48e8-4eeb-bf4e-1a9d2df9cfb3"
      unitRef="usd">3810000</us-gaap:DepreciationAndAmortization>
    <us-gaap:OperatingLeaseExpense
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzQtMS0xLTEtNDExMzI_9a96c40f-cb16-4ca4-8dc6-faaeaed19f7b"
      unitRef="usd">40863000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzQtMy0xLTEtNDExMzI_0bf916b5-23bf-4af3-b6fd-416927b079ea"
      unitRef="usd">39191000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzQtNS0xLTEtNDExMzI_8631c4a8-6178-41cc-b878-1014f54ecc1f"
      unitRef="usd">34975000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzUtMS0xLTEtNDExMzI_6b1bd548-297e-4c5c-ad10-2c8a22a65d31"
      unitRef="usd">-24000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzUtMy0xLTEtNDExMzI_2269de3c-d368-46cf-b377-2a78b451f317"
      unitRef="usd">225000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzUtNS0xLTEtNDExMzI_16f7f267-b219-49b8-be80-f3630b7ed6fb"
      unitRef="usd">0</us-gaap:OtherNonoperatingIncomeExpense>
    <pntg:StartUpActivitiesCosts
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzctMS0xLTEtNDExMzI_c4dc4c29-d1ed-44c5-a76a-09e50bb0ecba"
      unitRef="usd">1045000</pntg:StartUpActivitiesCosts>
    <pntg:StartUpActivitiesCosts
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzctMy0xLTEtNDExMzI_2f29c120-cefd-454e-9a33-2dde8401d5b4"
      unitRef="usd">1787000</pntg:StartUpActivitiesCosts>
    <pntg:StartUpActivitiesCosts
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzctNS0xLTEtNDExMzI_d13efc3c-863b-47a5-bce1-09fd4c3a2d9a"
      unitRef="usd">483000</pntg:StartUpActivitiesCosts>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzgtMS0xLTEtNDExMzI_6fe7a82f-9525-4058-9e9f-9fcf5ca653cb"
      unitRef="usd">10040000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzgtMy0xLTEtNDExMzI_48b07d32-b839-4623-8fdd-ba0841e37401"
      unitRef="usd">8335000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzgtNS0xLTEtNDExMzI_b79e7de6-6fe1-439e-ac22-75b29b1763a1"
      unitRef="usd">3382000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzktMS0xLTEtNDExMzI_37aaea60-e1f9-4a36-bce8-96a2a2a32066"
      unitRef="usd">80000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzktMy0xLTEtNDExMzI_52bbbeef-b99f-43dc-ac7e-4406f5e682e1"
      unitRef="usd">99000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzktNS0xLTEtNDExMzI_0d5a78c4-6e69-4f5b-9e44-a5d189142f12"
      unitRef="usd">665000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <pntg:SpinoffTransactionCosts
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEwLTEtMS0xLTQxMTMy_ce02cf24-e287-4469-80c1-09ec0d7defd1"
      unitRef="usd">0</pntg:SpinoffTransactionCosts>
    <pntg:SpinoffTransactionCosts
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEwLTMtMS0xLTQxMTMy_6e2c4af1-054d-4667-a701-f21fb5728824"
      unitRef="usd">0</pntg:SpinoffTransactionCosts>
    <pntg:SpinoffTransactionCosts
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEwLTUtMS0xLTQxMTMy_323a04e8-bc0f-4b48-b738-fb91b7f924b7"
      unitRef="usd">13219000</pntg:SpinoffTransactionCosts>
    <pntg:AcquisitionRelatedCostsNotCapitalized
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzExLTEtMS0xLTQxMTMy_1d8ff545-2df8-43d7-a9a6-add9e4b0e168"
      unitRef="usd">2008000</pntg:AcquisitionRelatedCostsNotCapitalized>
    <pntg:AcquisitionRelatedCostsNotCapitalized
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzExLTMtMS0xLTQxMTMy_7fa0b652-a345-40d9-befd-9f9dd9e6c022"
      unitRef="usd">1181000</pntg:AcquisitionRelatedCostsNotCapitalized>
    <pntg:AcquisitionRelatedCostsNotCapitalized
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzExLTUtMS0xLTQxMTMy_5c457d20-f69c-4eaa-82fe-c1af45ed79f1"
      unitRef="usd">532000</pntg:AcquisitionRelatedCostsNotCapitalized>
    <pntg:IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEyLTEtMS0xLTQxMTMy_6e029bc1-ca18-4b99-ade4-29c2b21afb68"
      unitRef="usd">0</pntg:IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses>
    <pntg:IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEyLTMtMS0xLTQxMTMy_56beee47-f4c0-4c91-8745-c4bb331bef4f"
      unitRef="usd">447000</pntg:IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses>
    <pntg:IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEyLTUtMS0xLTQxMTMy_e8ecb28c-6d1a-4550-a2aa-252bdbe946f0"
      unitRef="usd">0</pntg:IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTEtMS0xLTYwMTgz_344a7480-eb05-430f-b058-3be7045c7573"
      unitRef="usd">2835000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTMtMS0xLTYwMTgz_80ab4c99-1c44-49a4-8063-e61854fe029d"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTUtMS0xLTYwMTgz_0d3fc104-370d-477f-9c62-1ffc0fd7ff82"
      unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTEtMS0xLTQxMTMy_3038f9cc-9362-4655-857f-66b82a8560d6"
      unitRef="usd">-548000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTMtMS0xLTQxMTMy_879d9f73-c52d-4489-a467-266f82cf3aef"
      unitRef="usd">-191000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLossAttributableToNoncontrollingInterest
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzEzLTUtMS0xLTQxMTMy_1969f87e-aa7a-4557-b736-7b3126c09e11"
      unitRef="usd">629000</us-gaap:NetIncomeLossAttributableToNoncontrollingInterest>
    <us-gaap:OperatingIncomeLoss
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzE0LTEtMS0xLTQxMTMy_9b90d989-5691-42fb-92e9-d70e34010d3a"
      unitRef="usd">4695000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzE0LTMtMS0xLTQxMTMy_05aa5f9d-9c2f-4d00-87ca-a632064a7cfd"
      unitRef="usd">18917000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTplYzE0YjViZTBhNzg0NTZmYWRkZTM2M2E4MTg4ZjA4Ny90YWJsZXJhbmdlOmVjMTRiNWJlMGE3ODQ1NmZhZGRlMzYzYTgxODhmMDg3XzE0LTUtMS0xLTQxMTMy_ab7e35ed-113c-4e34-b540-d718432acca3"
      unitRef="usd">5670000</us-gaap:OperatingIncomeLoss>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="ia1fcf346d3fa483083f350885e86c53f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo5Y2RjZDgyYWUzYjI0OTMwOGMzYzAwMzQ1ZTFhNmU4ZS90YWJsZXJhbmdlOjljZGNkODJhZTNiMjQ5MzA4YzNjMDAzNDVlMWE2ZThlXzQtMi0xLTEtNDI3NTgvdGV4dHJlZ2lvbjo0MTMxZmM3OTNiMmE0YmJkYmUwM2ZlN2YyZjhiMDUwYV8yMTk5MDIzMjU2NjYy_aa019e11-8765-42c6-a33f-668f0e9c4567"
      unitRef="usd">3124000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i4727a9c1e3f3474da652ab9778b0c723_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo5Y2RjZDgyYWUzYjI0OTMwOGMzYzAwMzQ1ZTFhNmU4ZS90YWJsZXJhbmdlOjljZGNkODJhZTNiMjQ5MzA4YzNjMDAzNDVlMWE2ZThlXzQtMi0xLTEtNDI3NTgvdGV4dHJlZ2lvbjo0MTMxZmM3OTNiMmE0YmJkYmUwM2ZlN2YyZjhiMDUwYV8yMTk5MDIzMjU2Njcz_043e6f02-7061-459c-914f-41156cfd017a"
      unitRef="usd">5536000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i6798f615dd65498b96c25d713d9ea243_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo5Y2RjZDgyYWUzYjI0OTMwOGMzYzAwMzQ1ZTFhNmU4ZS90YWJsZXJhbmdlOjljZGNkODJhZTNiMjQ5MzA4YzNjMDAzNDVlMWE2ZThlXzQtMi0xLTEtNDI3NTgvdGV4dHJlZ2lvbjo0MTMxZmM3OTNiMmE0YmJkYmUwM2ZlN2YyZjhiMDUwYV8yMTk5MDIzMjU2NjU5_a8155aef-bace-4f7f-8058-9322fc6db4ca"
      unitRef="usd">2982000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <pntg:AmountToOffsetExpenseSequestrationRelief
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo5Y2RjZDgyYWUzYjI0OTMwOGMzYzAwMzQ1ZTFhNmU4ZS90YWJsZXJhbmdlOjljZGNkODJhZTNiMjQ5MzA4YzNjMDAzNDVlMWE2ZThlXzUtMi0xLTEtNTE0MzMvdGV4dHJlZ2lvbjpiOGQyZDgyMTA0ZmI0MzNhYWE2NjZlOTAxM2ZkODYwYV8yMTk5MDIzMjU2NTAy_1359af9d-2db3-4e53-9ca4-4ef48a840267"
      unitRef="usd">3555000</pntg:AmountToOffsetExpenseSequestrationRelief>
    <pntg:DirectMedicalSuppliesLaborAndOtherExpenses
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xNzgvZnJhZzpmMDJkZDQ2MzgyZTg0MjdjYjI5OWQ2NTkxOWM0M2QwNS90YWJsZTo5Y2RjZDgyYWUzYjI0OTMwOGMzYzAwMzQ1ZTFhNmU4ZS90YWJsZXJhbmdlOjljZGNkODJhZTNiMjQ5MzA4YzNjMDAzNDVlMWE2ZThlXzUtMi0xLTEtNTE0MzMvdGV4dHJlZ2lvbjpiOGQyZDgyMTA0ZmI0MzNhYWE2NjZlOTAxM2ZkODYwYV8yMTk5MDIzMjU2NzQ0_707aed0d-742b-44a4-b65a-85ab1050c4bf"
      unitRef="usd">2765000</pntg:DirectMedicalSuppliesLaborAndOtherExpenses>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzYwNDczMTM5NjE3MDU_f0fd87fd-10f8-4bb2-8b60-dbf1ebf1dcf8">ACQUISITIONS&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s acquisition focus is to purchase or lease operations that are complementary to the Company&#x2019;s current businesses, accretive to the Company&#x2019;s business or otherwise advance the Company&#x2019;s strategy. The results of all the Company&#x2019;s independent operating subsidiaries are included in the Financial Statements subsequent to the date of acquisition. Acquisitions are accounted for using the acquisition method of accounting. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2021, the Company expanded its operations with the addition of five home health agencies, four hospice agencies, and two home care agencies. The aggregate purchase price for these acquisitions was $14,135. A subsidiary of the Company entered into a separate operations transfer agreement with the prior operator of each acquired operation as part of each transaction.  The goodwill was primarily attributable to intangible assets that do not qualify for separate recognition  and  to synergies the Company expects to achieve related to the acquisition and was allocated to the  Company's  operating  segments  which  are  its  reporting  units.   The Company anticipates that the total goodwill recognized &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;will be fully deductible for tax purposes. Acquisition costs related to the business combinations of home health, hospice, and home care acquisitions of $80 were expensed related to the business combinations during the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Two of the hospice agencies were acquired Medicare licenses and are considered asset acquisitions. The fair value of assets for the hospice licenses acquired totaled $585 and was allocated to indefinite-lived intangible assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2020 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2020, the Company expanded its operations with the addition of six home health agency, six hospice agencies, and two senior living communities. The aggregate purchase price for these acquisitions was $39,239. In connection with the addition of the senior living communities, the Company entered into a new long-term &#x201c;triple-net&#x201d; lease with a subsidiary of Ensign.  The addition of these operations added a total of 164 operational senior living units to be operated by the Company&#x2019;s independent operating subsidiaries. A subsidiary of the Company entered into a separate operations transfer agreement with the prior operator of each acquired operation as part of each transaction.  The goodwill was primarily attributable intangible assets that do not qualify for separate recognition and to synergies the Company expects to achieve related to the acquisition and was allocated to  the  Company's  operating  segments  which  are  its  reporting  units.   The Company anticipates that the total goodwill recognized will be fully deductible for tax purposes. Acquisition costs related to the business combinations of home health, hospice, and home care acquisitions of $99 were expensed related to the business combinations during the year ended December 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company announced it closed on a home health joint venture and hospice joint venture with Scripps Health (&#x201c;Scripps&#x201d;), a leading nonprofit integrated health system based in San Diego, California. The closing was effective October 1, 2020. The resulting joint ventures, which combined certain assets and the operations of Scripps&#x2019; home health business and the assets and operations of the local Pennant-affiliated home health and hospice agencies, are majority-owned and managed by an independent operating subsidiary of the Company and provide home health and hospice services to patients throughout San Diego County. The fair value of assets contributed by Scripps to the home health joint venture were included in the total value of assets acquired as described above and in the summary table below. The Company paid Scripps $6,200 in cash and contributed assets from the local Pennant-affiliated home health agency with a net book value of $614.  The Company acquired 60.0% ownership interest in the joint venture. The contributions of assets by Scripps to the joint venture, resulted in the Company recording a noncontrolling interest with a fair value of $4,646.  The fair value of the noncontrolling interest was determined using discounted cash flow models.  As part of the transaction with Scripps, the Company contributed the assets of the local Pennant-affiliated hospice agency to another joint venture. The Company sold Scripps a noncontrolling interest in the hospice joint venture for $555 in cash. The company retained an 80.0% ownership interest in the hospice joint venture. The transaction resulted in the Company recognizing a noncontrolling interest of $138 and a contribution to additional paid in capital of $313, net of $104 of the income tax effect.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2019 Acquisitions&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2019, the Company expanded its operations with the addition of two home health agencies, five hospice agencies, two home care agencies and two senior living operations. In connection with the acquisition of one of the senior living communities, the Company entered into a new long-term &#x201c;triple-net&#x201d; lease with a subsidiary of Ensign. The Company did not acquire any material assets or assume any liabilities. A subsidiary of the Company entered into a separate operations transfer agreement with the prior operator of each acquired operation as part of each transaction. The addition of these operations added a total of 143 operational senior living units to be operated by the Company&#x2019;s independent operating subsidiaries. The aggregate purchase price for these acquisitions was $18,760. Acquisition costs related to the business combinations of home health, hospice, and home care was $611 during the year ended December 31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of assets for home health and hospice acquisitions was mostly concentrated in goodwill and as such, these transactions were classified as business combinations in accordance with ASC Topic 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (&#x201c;ASC &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;805&#x201d;).  The table below presents the allocation of the purchase price for the operations acquired in acquisitions during the years ended December 31, 2021, 2020 and 2019 as noted above:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture, and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: noncontrolling interest and additional paid in capital&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: cash paid in prior year (held in escrow)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Consists of the of noncontrolling interest related to Scripps contribution of assets to the joint venture.  &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total cash paid for acquisitions for the year ended December 31, 2021 includes $585 as an escrow deposit that was paid in the prior year. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="ic8da0ae531824141a5fbf3f5f9b8abb5_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzU0NQ_9a82acc0-98be-473c-9f48-f7f75cedb06a"
      unitRef="agency">5</pntg:NumberOfBusinessesAndAssetsAcquired>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="i70e465de07bc4489a1d93b090ad882d3_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzU2OA_bf54472f-f38b-4965-9a31-d7ca976000a7"
      unitRef="agency">4</pntg:NumberOfBusinessesAndAssetsAcquired>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="i1b3df8b0ec1847a485fa591f8a59348b_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2MzY3NzM_f911ded6-bfe2-4012-ae48-3bbcd6d7a8e2"
      unitRef="agency">2</pntg:NumberOfBusinessesAndAssetsAcquired>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ifb52edba0b344f30ae760f39f36a33ba_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzY3OQ_48ae4cfb-ca4f-4084-bc0f-eb4f4a8eb19d"
      unitRef="usd">14135000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <pntg:NonCapitalizableRelatedToTheBusinessCombinations
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzE2NDkyNjc0NTY3NTg_b7ccc09d-03f3-4996-aa70-a6349a02c592"
      unitRef="usd">80000</pntg:NonCapitalizableRelatedToTheBusinessCombinations>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="id3b8477112444416aa795ea6a1381886_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDEyNjA_7daa1dc7-a54f-4871-9bd7-3e7e4ea87097"
      unitRef="agency">2</pntg:NumberOfBusinessesAndAssetsAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="ie6f061c2888d4b629403b99a7a704501_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDEyNzE_696e6636-1daa-427e-af9d-52167b8dc737"
      unitRef="usd">585000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="i6ee634dbd9cf40079a3e668ce24a98e3_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2Mzk2NTY_2462b9f9-77aa-4f21-81db-8efdab06ae50"
      unitRef="agency">6</pntg:NumberOfBusinessesAndAssetsAcquired>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="i4566419dadde4c98a7120368b872f3da_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2Mzk2NjA_c5fe88a2-fc28-4d0b-ad80-3ae04b3d138f"
      unitRef="agency">6</pntg:NumberOfBusinessesAndAssetsAcquired>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="i11b4722640e743ca9f00c59f8e177f35_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2Mzk2NjQ_9c490da1-f423-402d-8c06-fefb392c5925"
      unitRef="agency">2</pntg:NumberOfBusinessesAndAssetsAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2Mzk2Nzc_c2d7d25c-d21b-4d8a-8b4e-5ccb9503dd5e"
      unitRef="usd">39239000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <pntg:NumberOfUnitsInRealEstatePropertyAcquired
      contextRef="i16a5a490d6884205a5e9dd42dbbb3399_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2Mzk2ODE_e45fee9c-edb7-45b8-9603-45cdfb0dfbff"
      unitRef="agency">164</pntg:NumberOfUnitsInRealEstatePropertyAcquired>
    <pntg:NonCapitalizableRelatedToTheBusinessCombinations
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2MzgzNTE_6fb536fc-1903-4c8e-ae65-22d01527ecbe"
      unitRef="usd">99000</pntg:NonCapitalizableRelatedToTheBusinessCombinations>
    <us-gaap:PaymentsToAcquireInterestInJointVenture
      contextRef="ibc65670bbb7246fa8052cb8e64d56db2_D20201001-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzI1NjI_d3cb6582-71da-4b20-ba63-d034eb644c89"
      unitRef="usd">6200000</us-gaap:PaymentsToAcquireInterestInJointVenture>
    <pntg:CashAndContributedAssetsNetBookValue
      contextRef="ibc65670bbb7246fa8052cb8e64d56db2_D20201001-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzI2NzQ_21137d55-c15a-4070-af19-c709a2155b9e"
      unitRef="usd">614000</pntg:CashAndContributedAssetsNetBookValue>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i186dae40bd454249853b01c1eba9d848_I20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzI3MDE_dba3311d-b099-4c7b-b0b6-c0a00dc4a6b1"
      unitRef="number">0.600</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
      contextRef="i9ff49407f6be490cad905da779b4d980_D20201001-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzI4ODc_4655eebe-a14c-406b-8b15-8daf77aceeed"
      unitRef="usd">4646000</us-gaap:NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest>
    <us-gaap:ProceedsFromDivestitureOfInterestInJointVenture
      contextRef="i9ff49407f6be490cad905da779b4d980_D20201001-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzMyMjI_a8a1d9ff-65f0-46b1-a7a1-36d112949b65"
      unitRef="usd">555000</us-gaap:ProceedsFromDivestitureOfInterestInJointVenture>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="i18a947ebb0914b1a81c869f2499ef9ee_I20201031"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzMyNTk_3e916ab4-aebd-44bf-956c-c488bc868107"
      unitRef="number">0.800</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <pntg:NoncontrollingInterestJointVenture
      contextRef="i9ff49407f6be490cad905da779b4d980_D20201001-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzMzOTM_380f4d3d-996d-4a61-91b2-aa0befd40f4c"
      unitRef="usd">138000</pntg:NoncontrollingInterestJointVenture>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i1e1d06b38ad84064a8290b0beceb92d9_I20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzM0NDg_8cea6c74-eb1a-46c3-a6d0-bad786bed2d3"
      unitRef="usd">313000</us-gaap:AdditionalPaidInCapital>
    <pntg:AdditionalPaidInCapitalEffectOfIncomeTax
      contextRef="i9ff49407f6be490cad905da779b4d980_D20201001-20201031"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzM0NTk_051bfbe0-4cc9-4d26-9fc8-1914c21db988"
      unitRef="usd">104000</pntg:AdditionalPaidInCapitalEffectOfIncomeTax>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="i0e919c640df94e919b7b44c94f671f8e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5NDQ_238bad79-5994-492f-ba38-9d25e4a6e72d"
      unitRef="agency">2</pntg:NumberOfBusinessesAndAssetsAcquired>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="ic5ffc58dbb624c40ac8f80c16398d43c_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5NTE_a50bd0fd-d5b7-408f-9f91-bc56831421f2"
      unitRef="agency">5</pntg:NumberOfBusinessesAndAssetsAcquired>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="i1eedc1128d554ef1b5b1df73ddae1f03_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5NTc_817f7f66-4cf9-4be2-80e3-f8c2bb51c2a7"
      unitRef="agency">2</pntg:NumberOfBusinessesAndAssetsAcquired>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="ia34b018da1b745588a4443489d6fd7a5_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5NjM_1da2d89f-f952-4e8f-b748-4f3009e754ff"
      unitRef="agency">2</pntg:NumberOfBusinessesAndAssetsAcquired>
    <pntg:NumberOfBusinessesAndAssetsAcquired
      contextRef="i091dbe9239e9447a88678cb20a666033_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzI3NDg3NzkwODczMTM_919145c0-6dfa-4396-803e-20fa2513f058"
      unitRef="agency">1</pntg:NumberOfBusinessesAndAssetsAcquired>
    <pntg:NumberOfUnitsInRealEstatePropertyAcquired
      contextRef="i727696b9c07044d1ae50621d44a2e115_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5ODU_eac6482c-e701-46d7-8eff-04d791c9569e"
      unitRef="agency">143</pntg:NumberOfUnitsInRealEstatePropertyAcquired>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ie51d580ad1694816b75edef851ee768f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzEwOTk1MTE2NDA5ODk_1b0ff303-1ded-4cc6-9d67-895b5d4d5c40"
      unitRef="usd">18760000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionRelatedCosts
      contextRef="ic9b4d5180d754f1991716345bb9bfd11_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzYwNDczMTM5NjE3MjQ_6e90cbb4-389f-4ade-a328-230d09224e14"
      unitRef="usd">611000</us-gaap:BusinessCombinationAcquisitionRelatedCosts>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90ZXh0cmVnaW9uOmNiMWI4YTNhMzY0YzQ5NGFhMmU4MDk2ZTUwYmI4OTFmXzYwNDczMTM5NjE3MDY_9b3cb4e7-41dd-435d-99ec-a14e98d3d223">The table below presents the allocation of the purchase price for the operations acquired in acquisitions during the years ended December 31, 2021, 2020 and 2019 as noted above:&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.625%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.937%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment, furniture, and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,341&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other indefinite-lived intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,026&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities assumed&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,135&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: noncontrolling interest and additional paid in capital&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,646)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: cash paid in prior year (held in escrow)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(585)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,400)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash paid for acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,760&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Consists of the of noncontrolling interest related to Scripps contribution of assets to the joint venture.  &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Total cash paid for acquisitions for the year ended December 31, 2021 includes $585 as an escrow deposit that was paid in the prior year. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <pntg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures
      contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzItMS0xLTEtNDExMzI_124f3049-e29c-4772-ba37-4a70f10366f4"
      unitRef="usd">62000</pntg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures>
    <pntg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures
      contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzItMy0xLTEtNDExMzI_b2f81a0b-2691-4c71-a70a-ce4eefb534d8"
      unitRef="usd">174000</pntg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures>
    <pntg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures
      contextRef="ie51d580ad1694816b75edef851ee768f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzItNS0xLTEtNDExMzI_91c15510-c649-49dc-8c21-22de5a4a433c"
      unitRef="usd">91000</pntg:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures>
    <us-gaap:Goodwill
      contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzMtMS0xLTEtNDExMzI_3e18434d-afc0-47f9-8dd9-9aad8c849351"
      unitRef="usd">7821000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzMtMy0xLTEtNDExMzI_9e41dd23-ec34-4c96-b533-473631aa31ef"
      unitRef="usd">25211000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ie51d580ad1694816b75edef851ee768f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzMtNS0xLTEtNDExMzI_1b8ef251-cad3-4c80-8ca6-f3d52ba1c607"
      unitRef="usd">10341000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzQtMS0xLTEtNDExMzI_3c437e19-c0a6-4322-ba26-c1226df81300"
      unitRef="usd">6242000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzQtMy0xLTEtNDExMzI_5438faf7-af25-4255-a86c-cd0b7ca0479a"
      unitRef="usd">14026000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets
      contextRef="ie51d580ad1694816b75edef851ee768f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzQtNS0xLTEtNDExMzI_675ff21a-789a-46aa-855b-f11b48ff8c71"
      unitRef="usd">8326000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzUtMS0xLTEtNDExMzI_c8308646-a2f3-4329-993b-33f5aef7e0ed"
      unitRef="usd">10000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzUtMy0xLTEtNDExMzI_fe763daa-43c5-431b-a72b-d3081bb0fca4"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="ie51d580ad1694816b75edef851ee768f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzUtNS0xLTEtNDExMzI_2565f5c4-eb36-45c7-ad51-6046751a6867"
      unitRef="usd">2000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzYtMS0xLTEtNDExMzI_54caad9c-a62f-4e22-afe2-fd8f9e53cb17"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzYtMy0xLTEtNDExMzI_eea16f2f-b0dd-46e6-a8b8-eb6a1a627ab1"
      unitRef="usd">172000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
      contextRef="ie51d580ad1694816b75edef851ee768f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzYtNS0xLTEtNDExMzI_0162bd8c-e26b-4c99-85aa-268eaa56482e"
      unitRef="usd">0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="ifb52edba0b344f30ae760f39f36a33ba_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzctMS0xLTEtNDExMzI_48ae4cfb-ca4f-4084-bc0f-eb4f4a8eb19d"
      unitRef="usd">14135000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzctMy0xLTEtNDExMzI_c2d7d25c-d21b-4d8a-8b4e-5ccb9503dd5e"
      unitRef="usd">39239000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="ie51d580ad1694816b75edef851ee768f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzctNS0xLTEtNDExMzI_1b0ff303-1ded-4cc6-9d67-895b5d4d5c40"
      unitRef="usd">18760000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzgtMS0xLTEtNDExMzI_649ef022-5557-453c-9396-7fb106939cef"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzgtMy0xLTEtNDExMzI_b10a975a-42d1-45e3-a980-995f115be1ba"
      unitRef="usd">4646000</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue
      contextRef="ie51d580ad1694816b75edef851ee768f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzgtNS0xLTEtNDExMzI_f68b7f4d-d999-4841-b9b0-de9005215bf9"
      unitRef="usd">0</us-gaap:BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue>
    <pntg:BusinessCombinationCashPaidInPriorYear
      contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktMS0xLTEtNjIxOTk_41f0bf4e-d951-4227-baf6-9f0cd03a4c30"
      unitRef="usd">585000</pntg:BusinessCombinationCashPaidInPriorYear>
    <pntg:BusinessCombinationCashPaidInPriorYear
      contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktMy0xLTEtNjIxOTk_7b76f38c-4bc1-4ffc-a834-6c69dcd8848d"
      unitRef="usd">1400000</pntg:BusinessCombinationCashPaidInPriorYear>
    <pntg:BusinessCombinationCashPaidInPriorYear
      contextRef="ie51d580ad1694816b75edef851ee768f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktNS0xLTEtNjIxOTk_bdd253bc-c6f4-4f81-9f4e-a5321aa40b72"
      unitRef="usd">0</pntg:BusinessCombinationCashPaidInPriorYear>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
      contextRef="i51b705b73ebc4e52b08a7ba4bf19b3fc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktMS0xLTEtNDExMzI_a28cd868-5651-4854-8893-b92d27f1cb4d"
      unitRef="usd">13550000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
      contextRef="i960a0c21f35a47e1abe131c0263a41ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktMy0xLTEtNDExMzI_5efee020-6347-4af8-8dcb-903a56db4464"
      unitRef="usd">33193000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
      contextRef="ie51d580ad1694816b75edef851ee768f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZTo5ZGZmYzllYzJiMjE0YTljOTYyMDA4NWZlMzY2NmRmMC90YWJsZXJhbmdlOjlkZmZjOWVjMmIyMTRhOWM5NjIwMDg1ZmUzNjY2ZGYwXzktNS0xLTEtNDExMzI_7877dd74-3838-4c9d-9f67-aa635862f1e1"
      unitRef="usd">18760000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest>
    <pntg:TotalAcquisitions
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODEvZnJhZzpjYjFiOGEzYTM2NGM0OTRhYTJlODA5NmU1MGJiODkxZi90YWJsZToyOTJmMzc2Y2YwZDg0YzBjOWI0NWUyMDU5NzViN2JmNy90YWJsZXJhbmdlOjI5MmYzNzZjZjBkODRjMGM5YjQ1ZTIwNTk3NWI3YmY3XzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjo4NGExZGE2Y2ZjM2I0OTk2YTViZDg0NDljYWJkN2I2ZV81Nw_766353f8-4780-4ce4-8caa-a93dc962617a"
      unitRef="usd">585000</pntg:TotalAcquisitions>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzYwNDczMTM5NTI5Mjc_359374dd-947b-4d78-ae0d-6a3f5b2ca214">PROPERTY AND EQUIPMENT&#x2014;NET&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense was $4,751, $4,661 and $3,757 for the years ended December 31, 2021, 2020 and 2019, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Asset Impairment&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews the carrying value of long-lived assets impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. On January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#x201c;Transaction&#x201d;). The closing of the Transaction is anticipated to occur in the first half of 2022. As of the year ended December 31, 2021, management determined that the long-lived assets for the impacted communities were not recoverable and the Company recognized a non-cash long-lived asset impairment charge of $2,835 in cost of services in the Consolidated and Combined Statements of Income.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzYwNDczMTM5NTI5Mjg_cd77b282-5408-4ea8-9df2-ab664e3d2ac5">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.081%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.443%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.446%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,984&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,199&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,274&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,590&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(18,486)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,884&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i22ba094ecdd748caa523069cfe03b1bb_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzItMS0xLTEtNDExMzI_83b8458c-58cd-428c-ad63-894500417d6b"
      unitRef="usd">11660000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic989f4d1015643d8b1f921fe889e7655_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzItMy0xLTEtNDExMzI_637b3d0c-4e40-42ea-bec5-0e586181e986"
      unitRef="usd">9984000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic76aa9c6653849259b83d26fe4a1a6e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzMtMS0xLTEtNDExMzI_b22b1af0-9246-413b-a6ae-7909a86332d4"
      unitRef="usd">22415000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i472b81765f954025a5079e55559a1cce_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzMtMy0xLTEtNDExMzI_75221416-a329-4a1f-b982-5e0bfe63ea61"
      unitRef="usd">22420000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i489985632d6945938dec271036a4ca11_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzQtMS0xLTEtNDExMzI_e6ee71da-f50f-4f7d-885c-eff9cc12cf30"
      unitRef="usd">1199000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i7b29edf2eac54eb981cacc738f038708_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzQtMy0xLTEtNDExMzI_596ee0c7-555f-46d5-96c4-2224dcc11914"
      unitRef="usd">1186000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzUtMS0xLTEtNDExMzI_5fea0a8e-44b6-4a23-a419-3e9b3e165cd2"
      unitRef="usd">35274000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzUtMy0xLTEtNDExMzI_c2feecb1-7be8-4bc4-aa2b-6253698e8690"
      unitRef="usd">33590000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzYtMS0xLTEtNDExMzI_311dc0fd-8152-4147-b557-e11ac161ad53"
      unitRef="usd">18486000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzYtMy0xLTEtNDExMzI_171b7927-5f1b-4fa8-8845-500b3e9e4a93"
      unitRef="usd">15706000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzctMS0xLTEtNDExMzI_55f1f6b7-1461-458b-a8a6-eb88ebb03639"
      unitRef="usd">16788000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90YWJsZTo3MWYzNDdiZDVkZTQ0MWE4OTI5ZGNmN2Q0NDZhMDdkOC90YWJsZXJhbmdlOjcxZjM0N2JkNWRlNDQxYTg5MjlkY2Y3ZDQ0NmEwN2Q4XzctMy0xLTEtNDExMzI_3ffb132a-8c3e-4e90-a23d-72ee7195f261"
      unitRef="usd">17884000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzExNw_b86c3a62-2b4c-4198-ae7b-04b4c638337d"
      unitRef="usd">4751000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzEyMQ_a93be9df-e86f-40a3-85b0-b7fe43dbecd5"
      unitRef="usd">4661000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzEyOA_f8b41078-5da0-44ad-819e-5764ece77a20"
      unitRef="usd">3757000</us-gaap:Depreciation>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODQvZnJhZzphNjJiNWMxMjAxMzA0NTFmOWM1ZTkyNjBmYTcwMWE3YS90ZXh0cmVnaW9uOmE2MmI1YzEyMDEzMDQ1MWY5YzVlOTI2MGZhNzAxYTdhXzEwOTk1MTE2MzE1ODc_13712c5c-8ce4-4314-89b3-11e6ff0f9a9b"
      unitRef="usd">2835000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzYwNDczMTM5NTQ3MzQ_6a1fe6e9-819e-48c7-8db4-50c35f144582">GOODWILL AND INTANGIBLE ASSETS&#x2014;NET &lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company tests goodwill during the fourth quarter of each year and also if events or changes in circumstances indicate the occurrence of a triggering event which might indicate there may be impairment. The Company performs its goodwill impairment analysis for each reporting unit that constitutes a component for which (1) discrete financial information is available and (2) segment management regularly reviews the operating results of that component, in accordance with the provisions of ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles-Goodwill and Other &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(&#x201c;ASC 350&#x201d;).&lt;/span&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews goodwill for impairment by initially considering qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill, as a basis for determining whether it is necessary to perform a quantitative analysis. If it is determined that it is more likely than not that the fair value of reporting unit is less than its carrying amount, a quantitative analysis is performed to identify goodwill impairment. If it is determined that it is not more likely than not that the fair value of the reporting unit is less than its carrying amount, it is unnecessary to perform a quantitative analysis. The Company may elect to bypass the qualitative assessment and proceed directly to performing a quantitative analysis. Impairment is the condition that exists when the carrying amount of goodwill exceeds its implied fair value. An impairment loss is recognized for the amount that the carrying amount of the reporting unit, including goodwill, exceeds its fair value, limited to the total amount of goodwill allocated to that reporting unit. The Company did not identify any impairment charge during the years ended December 31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents activity in goodwill by segment as of and for the year ended December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health and Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Living Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other indefinite-lived intangible assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicaid licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:AssetImpairmentCharges
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzE3NTM_3a6e0b9c-3377-469e-88fe-7e11a89c3000"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzE3NTM_ba4fa088-6841-40d4-b943-70aac5c386ca"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzE3NTM_d7ae9818-d9c8-417c-9975-50b97aa5e870"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzYwNDczMTM5NTQ3MzU_c35b0b10-ebb3-4411-bf63-7b2d4bdd36f6">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents activity in goodwill by segment as of and for the year ended December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:46.122%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.005%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.008%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Home Health and Hospice Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Senior Living Services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,591&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;66,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,821&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,623&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,642&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="i9ad5091204ea402db4f786593e9c88e3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzEtMS0xLTEtNDExMzI_2c09372e-d923-4224-be27-652ce9390039"
      unitRef="usd">37591000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i646d026e30024a759d2d20651293e096_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzEtMy0xLTEtNDExMzI_779a8f71-d887-4095-9a0f-062473d82e1d"
      unitRef="usd">3642000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzEtNS0xLTEtNDExMzI_43f931c8-bb20-4719-90d9-509f60d16eca"
      unitRef="usd">41233000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="id8bee216f16649f4bd17307d4aca1e38_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzItMS0xLTEtNDExMzI_f1618c4d-0a75-481a-9d11-e68beea08d28"
      unitRef="usd">25211000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="iaaa4cbfc68844bf2ab83f3ee4d31a520_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzItMy0xLTEtNDExMzI_98179cfe-d7e2-4eca-b2cb-f02fec0d05d0"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzItNS0xLTEtNDExMzI_0a4c8864-7606-4cf5-8f11-15930a174d13"
      unitRef="usd">25211000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="i594abec2ef2e406b8dbe4ab6e7d5e8ee_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzQtMS0xLTEtNDExMzI_e43d1a8a-2699-49a3-82bc-35bb7b8966c9"
      unitRef="usd">62802000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i7266ba82d91645fe8dc1b6eb5c7fc950_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzQtMy0xLTEtNDExMzI_cc1582bb-6347-4f3f-9abd-2281eba95124"
      unitRef="usd">3642000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzQtNS0xLTEtNDExMzI_afc7b794-59bf-485c-a347-303f91d7baea"
      unitRef="usd">66444000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i35d93aabb6ad43d4a0807093b6ff3cdd_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzUtMS0xLTEtNDExMzI_827d2ef7-fc97-4d30-8473-11f9eeef4ac3"
      unitRef="usd">7821000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="idca163657edf4bc2aca2d8b382f0f7b2_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzUtMy0xLTEtNDExMzI_1b4d25d3-39b7-4185-93cb-ea28c993495c"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzUtNS0xLTEtNDExMzI_5c3d94a5-026f-4332-b9bf-8067a9ff46f6"
      unitRef="usd">7821000</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:Goodwill
      contextRef="ife1126ceed284fbdb9bf6b3dbab68da3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzctMS0xLTEtNDExMzI_7b4faa7c-3ff3-4ad1-b6bc-eee7eb63878c"
      unitRef="usd">70623000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="icc510d566b5a497d8c3bf8da297c74be_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzctMy0xLTEtNDExMzI_5bca0797-3c77-41d9-9e9a-d92030303ac3"
      unitRef="usd">3642000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTpiYjBhNDYyOTUzOTY0ZGU3YjY2OWMyMmJiYWE4MWNiYy90YWJsZXJhbmdlOmJiMGE0NjI5NTM5NjRkZTdiNjY5YzIyYmJhYTgxY2JjXzctNS0xLTEtNDExMzI_2a017b51-3585-461d-95ce-1e4439d12f94"
      unitRef="usd">74265000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90ZXh0cmVnaW9uOjY1NmRmMGQ2M2NlMTRmMmZiNzlhZDBiODRkZjlkMjQ0XzYwNDczMTM5NTQ3MzY_94ed95a3-93f4-4e5f-b47a-48a3f9b280f8">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other indefinite-lived intangible assets consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.053%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade name&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,355&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Medicare and Medicaid licenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i85977dbd3e304b269d60b79b21d58dd3_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzItMS0xLTEtNDExMzI_2a58d458-5b61-48f0-8618-191baeee31a2"
      unitRef="usd">1355000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i295733ffaf3446e09492cf5e0c2391e7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzItMy0xLTEtNDExMzI_19e23182-20cd-443a-a919-b49aaf7bfe5d"
      unitRef="usd">1355000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib53ed044a9784155997f65bf19912e24_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzMtMS0xLTEtNDExMzI_ebcf55e0-577a-44df-aabc-d627e857898e"
      unitRef="usd">52375000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i3953707a65c34f67a229dcf123865af0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzMtMy0xLTEtNDExMzI_6c068dcf-764b-49c5-a7f3-e43d8c4b5f10"
      unitRef="usd">46133000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzQtMS0xLTEtNDExMzI_303163cd-3509-46c7-bfc0-3b2ae30e1481"
      unitRef="usd">53730000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xODcvZnJhZzo2NTZkZjBkNjNjZTE0ZjJmYjc5YWQwYjg0ZGY5ZDI0NC90YWJsZTphMTE0NTg5OTA3ODU0ZTc2ODk2YTliNDU4YjkxZWQyMS90YWJsZXJhbmdlOmExMTQ1ODk5MDc4NTRlNzY4OTZhOWI0NThiOTFlZDIxXzQtMy0xLTEtNDExMzI_94dcff77-e252-439d-825c-1a91c33be561"
      unitRef="usd">47488000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:OtherLiabilitiesDisclosureTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90ZXh0cmVnaW9uOjM0MzNkYTQzYjUzNjQxN2ViMWVkZWYzODExZmFiZTE0XzYwNDczMTM5NTQ0NTE_a7723c33-1bff-4ca0-8776-99b09ba928ad">OTHER ACCRUED LIABILITIES&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Refunds payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Resident deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (CARES Act advance payments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued insurance retention - current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refunds payable includes payables related to overpayments, duplicate payments and credit balances from various payor sources. Deferred revenue occurs when the Company receives payments in advance of services provided. Resident deposits include refundable deposits to residents and a small portion consists of non-refundable deposits recognized into revenue over a period of time. The CARES Act also expanded the Centers for Medicare &amp;amp; Medicaid Services&#x2019; (&#x201c;CMS&#x201d;) ability to provide accelerated/advance payments intended to increase the cash flow of healthcare providers and suppliers impacted by COVID-19. During the second quarter of 2020, the Company applied for and received $27,997 in funds under the AAP Program. On October 1, 2020, the Continuing Appropriations Act, 2021 and Other Extensions Act (the &#x201c;CA Act&#x201d;) was signed into law. Among other things, the CA Act significantly changed the repayment terms for AAP. These funds are subject to &lt;/span&gt;&lt;/div&gt;automatic recoupment through offsets to new claims beginning one year after funds were issued beginning in April 2021, at which time, Medicare began to automatically recoup 25% of Medicare payments for 11 months. At the end of the 11 months and assuming full repayment has not occurred, recoupment will increase to 50% for another six months. Any balance outstanding after these two recoupment periods will be subject to repayment at a 4% interest rate. For the year ended December 31, 2021, the Company repaid $21,786 of the AAP funds. The Company reclassified $5,226 of AAP to other long-term liabilities for the year ended December 31, 2020. The Company anticipates completing repayment of the AAP within the allotted recoupment periods.</us-gaap:OtherLiabilitiesDisclosureTextBlock>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90ZXh0cmVnaW9uOjM0MzNkYTQzYjUzNjQxN2ViMWVkZWYzODExZmFiZTE0XzYwNDczMTM5NTQ0NTI_df11d9e4-1639-4de0-af1f-bb5d5694ec34">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities consist of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.052%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.054%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Refunds payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,095&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,271&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Resident deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contract liabilities (CARES Act advance payments)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,211&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued insurance retention - current portion&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,613&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,354&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,484&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:CustomerRefundLiabilityCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzItMi0xLTEtNDExMzI_81396711-76f5-4e45-8838-23fbee48da5e"
      unitRef="usd">3095000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:CustomerRefundLiabilityCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzItNC0xLTEtNDExMzI_e58fd7e7-e8a2-467e-8bb8-f8531bdb93a3"
      unitRef="usd">2664000</us-gaap:CustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzMtMi0xLTEtNDExMzI_59ffdc6d-4d59-4efd-9002-124d5f1367a9"
      unitRef="usd">1456000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzMtNC0xLTEtNDExMzI_a0162c97-d22d-4cf7-9273-7070fa382710"
      unitRef="usd">1271000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:DepositLiabilityCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzQtMi0xLTEtNDExMzI_4b371e10-3151-420f-bb62-77b21d415fe6"
      unitRef="usd">5111000</us-gaap:DepositLiabilityCurrent>
    <us-gaap:DepositLiabilityCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzQtNC0xLTEtNDExMzI_7e4e69a6-365c-436f-adff-9807d0d8493f"
      unitRef="usd">5647000</us-gaap:DepositLiabilityCurrent>
    <pntg:ContractLiabilityAdvancePaymentsCARESAct
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzUtMi0xLTEtNDExMzI_1dc0861a-e439-4cdc-84b8-edf57f2610b7"
      unitRef="usd">6211000</pntg:ContractLiabilityAdvancePaymentsCARESAct>
    <pntg:ContractLiabilityAdvancePaymentsCARESAct
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzUtNC0xLTEtNDExMzI_040a8047-df5f-4f24-ae0e-c68819512fa8"
      unitRef="usd">22771000</pntg:ContractLiabilityAdvancePaymentsCARESAct>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzYtMi0xLTEtNDExMzI_b9d0d43d-686f-4718-b05d-ef88d9a99a68"
      unitRef="usd">1102000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzYtNC0xLTEtNDExMzI_c0c679f6-f525-4fb4-bf0f-fe0e5808d0f9"
      unitRef="usd">982000</us-gaap:AccrualForTaxesOtherThanIncomeTaxesCurrent>
    <us-gaap:SelfInsuranceReserveCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzctMi0xLTEtNDExMzI_2dc35608-da5c-4506-82e5-e00e2d39f1df"
      unitRef="usd">1613000</us-gaap:SelfInsuranceReserveCurrent>
    <us-gaap:SelfInsuranceReserveCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzctNC0xLTEtNDExMzI_6c8c51c7-7f43-4678-a313-c4c14691b9ee"
      unitRef="usd">1354000</us-gaap:SelfInsuranceReserveCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzgtMi0xLTEtNDExMzI_6b3c9242-6ac5-4814-be4b-edd2f03ce619"
      unitRef="usd">2896000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherSundryLiabilitiesCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzgtNC0xLTEtNDExMzI_d16ef7e9-0273-4059-aeb6-561712c79e8f"
      unitRef="usd">3586000</us-gaap:OtherSundryLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzktMi0xLTEtNDExMzI_face03ba-bd3d-4130-b566-610e02b17ac5"
      unitRef="usd">21484000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90YWJsZTpkMDljYjM2MDE1NTg0YTYzYTNhYWFiMjU1ZGRlZmYyMy90YWJsZXJhbmdlOmQwOWNiMzYwMTU1ODRhNjNhM2FhYWIyNTVkZGVmZjIzXzktNC0xLTEtNDExMzI_844011ce-598d-4d1b-a615-48cc3f76b12c"
      unitRef="usd">38275000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived
      contextRef="ia2439a6130274330bd9bb469dbc05ee6_I20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90ZXh0cmVnaW9uOjM0MzNkYTQzYjUzNjQxN2ViMWVkZWYzODExZmFiZTE0Xzc1OA_1f345d88-f75e-4030-bb38-803a456dc7fa"
      unitRef="usd">27997000</pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived>
    <pntg:RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90ZXh0cmVnaW9uOjM0MzNkYTQzYjUzNjQxN2ViMWVkZWYzODExZmFiZTE0XzEwOTk1MTE2Mjk1Mjk_635112fa-0aaf-42cd-a654-b88307ec0aea"
      unitRef="usd">21786000</pntg:RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds>
    <us-gaap:LiabilitiesNoncurrent
      contextRef="ifc995fe4fa2343f99750c39392d1ca31_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTAvZnJhZzozNDMzZGE0M2I1MzY0MTdlYjFlZGVmMzgxMWZhYmUxNC90ZXh0cmVnaW9uOjM0MzNkYTQzYjUzNjQxN2ViMWVkZWYzODExZmFiZTE0XzEwOTk1MTE2Mjk3NDY_bf937794-2d21-4d69-b4b1-fc57512ee432"
      unitRef="usd">5226000</us-gaap:LiabilitiesNoncurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzYwNDczMTM5NTYzMTg_2c8977e1-c3e4-4bef-811a-fb8bf406b58a">DEBT&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt, net consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving credit facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization expense for debt issuance costs was $488, $330, and $78 for the years ended December 31, 2021, 2020 and 2019, respectively, and is recorded in interest expense, net on the Consolidated and Combined Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On February&#160;23, 2021, Pennant entered into an amendment to its existing credit agreement (as amended, the &#x201c;Credit Agreement&#x201d;), which provides for an increased revolving credit facility with a syndicate of banks with a borrowing capacity of $150,000 (the &#x201c;Revolving Credit Facility&#x201d;). The interest rates applicable to loans under the Revolving Credit Facility are, at the Company&#x2019;s election, either (i) Adjusted LIBOR (as defined in the Credit Agreement) plus a margin ranging from 2.3% to 3.3% per annum or (ii) Base Rate plus a margin ranging from 1.3% to 2.3% per annum, in each case based on the ratio of Consolidated Total Net Debt to Consolidated EBITDA (each, as defined in the Credit Agreement). In addition, Pennant pays a commitment fee on the undrawn portion of the commitments under the Revolving Credit Facility which ranges from 0.35% to 0.50% per annum, depending on the Consolidated Total Net Debt to Consolidated EBITDA ratio of the Company and its subsidiaries. The Company is not required to repay any loans under the Credit Agreement prior to maturity in 2026, other than to the extent the outstanding borrowings exceed the aggregate commitments under the Credit Agreement. As of December 31, 2021, the Company&#x2019;s weighted average interest rate on its outstanding debt was 2.64%. As of December 31, 2021, the Company had available borrowing on the Revolving Credit Facility of $92,314, which is net of outstanding letters of credit of $4,186. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the Revolving Credit Facility approximates carrying value, due to the short-term nature and variable interest rates. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of this debt is categorized within Level 2 of the fair value hierarchy based on the observable market borrowing rates.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Credit Agreement is guaranteed, jointly and severally, by certain of the Company&#x2019;s independent operating subsidiaries, and is secured by a pledge of stock of the Company's material independent operating subsidiaries as well as a first lien on substantially all of each material operating subsidiary's personal property. The Credit Agreement contains customary covenants that, among other things, restrict, subject to certain exceptions, the ability of the Company and its independent operating subsidiaries to grant liens on their assets, incur indebtedness, sell assets, make investments, engage in acquisitions, mergers or consolidations, amend certain material agreements and pay certain dividends and other restricted payments. Financial covenants require compliance with certain levels of leverage ratios that impact the amount of interest. As of December 31, 2021, the Company was compliant with all such financial covenants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzYwNDczMTM5NTYzMjA_956a1c7a-1169-4b64-8322-984d988cd04a">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term debt, net consists of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revolving credit facility&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: unamortized debt issuance costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,128)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,223)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;51,372&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:36pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Amortization expense for debt issuance costs was $488, $330, and $78 for the years ended December 31, 2021, 2020 and 2019, respectively, and is recorded in interest expense, net on the Consolidated and Combined Statements of Income.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i87be8b1071da42259fd25653dc6e32b8_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzItMS0xLTEtNDExMzI_08d171c7-9dec-46fc-9d67-cefa36cefdf1"
      unitRef="usd">53500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="ib2750bb749074a028d77edb545a82f0d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzItMy0xLTEtNDExMzI_b91570d4-632e-40fb-9a10-8d590cbcd0f9"
      unitRef="usd">9500000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzMtMS0xLTEtNDExMzI_ea3ee317-66dd-41cf-b511-f4eff85ea0d9"
      unitRef="usd">2128000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzMtMy0xLTEtNDExMzI_777e7c1a-6ee4-4c72-801f-9804725c7a54"
      unitRef="usd">1223000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzQtMS0xLTEtNDExMzI_f9883837-8ea8-4b88-8725-81c331e5027d"
      unitRef="usd">51372000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphMTk5MGE3NDQ0YTY0NTUzYjdmYmUxYzBjYWEyMWQ3OS90YWJsZXJhbmdlOmExOTkwYTc0NDRhNjQ1NTNiN2ZiZTFjMGNhYTIxZDc5XzQtMy0xLTEtNDExMzI_5d7e4cbc-b6e1-44dd-ab17-e1b029011576"
      unitRef="usd">8277000</us-gaap:LongTermDebt>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphODM0ODQzYTY3ZDc0ZGE5YWMwNzFlZWEyMzI0MTk1OS90YWJsZXJhbmdlOmE4MzQ4NDNhNjdkNzRkYTlhYzA3MWVlYTIzMjQxOTU5XzAtMi0xLTEtNjE2MjMvdGV4dHJlZ2lvbjpkYzg3NjljMGVkN2I0MjEyOTFmYjg0NGE0ZDYyZDk4OF8xMDk5NTExNjI3OTk4_5c4b2629-1cab-49b8-b569-03a40c47f8cd"
      unitRef="usd">488000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphODM0ODQzYTY3ZDc0ZGE5YWMwNzFlZWEyMzI0MTk1OS90YWJsZXJhbmdlOmE4MzQ4NDNhNjdkNzRkYTlhYzA3MWVlYTIzMjQxOTU5XzAtMi0xLTEtNjE2MjMvdGV4dHJlZ2lvbjpkYzg3NjljMGVkN2I0MjEyOTFmYjg0NGE0ZDYyZDk4OF8xMDk5NTExNjI4MDA4_c92bc23e-f6c4-4c2d-bdb0-b07e9aadc8b8"
      unitRef="usd">330000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90YWJsZTphODM0ODQzYTY3ZDc0ZGE5YWMwNzFlZWEyMzI0MTk1OS90YWJsZXJhbmdlOmE4MzQ4NDNhNjdkNzRkYTlhYzA3MWVlYTIzMjQxOTU5XzAtMi0xLTEtNjE2MjMvdGV4dHJlZ2lvbjpkYzg3NjljMGVkN2I0MjEyOTFmYjg0NGE0ZDYyZDk4OF8xMDk5NTExNjI4MDE0_dfa3ae6c-d0f4-46ee-98ad-b17d0090c15d"
      unitRef="usd">78000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i0ed5cb11e8c74a8cab4af56099f9fe37_I20210223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2MzczOTk_93b6499e-c80a-441e-8c47-2b4d4242e527"
      unitRef="usd">150000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if8303ce9e51d4a7a9f23b6cb4859d119_D20210223-20210223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MDQ_baa2c1b4-ada5-4af3-95a8-bcc0709029d3"
      unitRef="number">0.023</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i7bcff1b3b19a471fbb07b38194bdf040_D20210223-20210223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MDg_7f014d7a-35fa-4bd8-bac1-f52e6b231235"
      unitRef="number">0.033</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="iff4b598798b347b1bad79e786d66d4ec_D20210223-20210223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MTI_6c69150a-492e-49e8-b5c2-2d43863a7815"
      unitRef="number">0.013</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="i15fbe4ddfaed4fb2ab68184822fc9b20_D20210223-20210223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MTY_a3cd37c4-c25b-4ce3-9049-49055b9f49f1"
      unitRef="number">0.023</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="id896243133374d5a85762f6aa03af650_D20210223-20210223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MjA_b7c48e58-7fde-44b4-9024-29162d5fad32"
      unitRef="number">0.0035</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LineOfCreditFacilityCommitmentFeePercentage
      contextRef="ie9d1d1fbe9ca4de3972432630165dd25_D20210223-20210223"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0MjQ_bbaa1a6e-ff3f-46e9-afac-6fcec0da2b40"
      unitRef="number">0.0050</us-gaap:LineOfCreditFacilityCommitmentFeePercentage>
    <us-gaap:LongtermDebtWeightedAverageInterestRate
      contextRef="i87be8b1071da42259fd25653dc6e32b8_I20211231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0NDA_7e44916e-c249-4311-8d26-b2163213224c"
      unitRef="number">0.0264</us-gaap:LongtermDebtWeightedAverageInterestRate>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity
      contextRef="i87be8b1071da42259fd25653dc6e32b8_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0NDQ_310dc3b8-2c34-4931-b7fe-105439d362ac"
      unitRef="usd">92314000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:LettersOfCreditOutstandingAmount
      contextRef="ibe0c05707f51401b8343fc06afba6d47_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTMvZnJhZzplMDU2YmMwYWZlM2E0MWFlOTU4ZDRlNmNiYzJjNDZiZS90ZXh0cmVnaW9uOmUwNTZiYzBhZmUzYTQxYWU5NThkNGU2Y2JjMmM0NmJlXzEwOTk1MTE2Mzc0NTE_9d7867c9-dc51-4513-ba04-a0c9d78792ca"
      unitRef="usd">4186000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDI_76779b0c-c940-46e8-935e-2ef8b34668ed">OPTIONS AND AWARDSShare-based compensation expense consists of share-based payment awards made to employees and directors,  including employee stock options, restricted stock awards (&#x201c;RSA&#x201d;), and restricted stock units (&#x201c;RSU&#x201d; and together with RSA, &#x201c;Restricted Stock&#x201d;), based on estimated fair values, ratably over the requisite service period of the award. The Company accounts for forfeitures as they occur.&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Spin-Off, the Company issued new options and restricted stock awards to Pennant and Ensign employees under the 2019 Omnibus Incentive Plan (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;OIP&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;) and Long-Term Incentive Plan (the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201c;&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;LTIP&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;, together referred to as the &#x201c;Pennant Plans&#x201d;&lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;).&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prior to Spin-Off&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For all periods prior to the Spin-Off, employees of the Company participated in Ensign's share-based compensation plans. The compensation expense recorded by the Company included the expense associated with these employees, as well as an allocation of share-based compensation of certain Ensign employees who provided general and administrative services on our behalf.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding options held by employees of the Company under the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ensign stock plans (collectively the &#x201c;Ensign Plans&#x201d;) and outstanding options and restricted stock awards under the Company Subsidiary Equity Plan (together with the Ensign Plans the &#x201c;Pre-Spin Plans&#x201d;) &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;were modified and replaced with Pennant awards under the Pennant Plans at the Spin-Off date.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following disclosures represent share-based compensation expense relating to the Ensign and Pennant Plans, including awards to employees of the Company&#x2019;s subsidiaries and an allocation of costs from employees in the Service Center prior to the Spin-Off, and total share-based compensation after the Spin-Off.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total share-based compensation expense for all of the Plans for the years ended December 31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prior to the Spin-Off:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Following the Spin-Off:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to Restricted Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to Restricted Stock to non-employee directors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In future periods, the Company estimates it will recognize the following share-based compensation expense for unvested stock options and unvested Restricted Stock, which were unvested as of December 31, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Recognition Period (in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested Restricted Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unrecognized share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Pennant Plans, options granted to employees of the subsidiaries of Pennant generally vest over five years at 20% per year on the anniversary of the grant date. Options expire ten years after the date of grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Black-Scholes option-pricing model to recognize the value of share-based compensation expense for share-based payment awards under the Plans. Determining the appropriate fair-value model and calculating the fair value of share-based awards at the grant date requires considerable judgment, including estimating stock price volatility and &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;expected option life. The Company develops estimates based on historical data and market information, which can change significantly over time. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each option is estimated on the grant date using a Black-Scholes option-pricing model with the following weighted average assumptions for stock options granted after the Spin-Off:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Life&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dividend Yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Fair Value of Options&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Under the midpoint method, the expected option life is the midpoint between the contractual option life and the average vesting period for the options being granted. This resulted in an expected option life of 6.5 years for the options granted.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Because the Company&#x2019;s equity shares have been traded for a relatively short period of time, expected volatility assumption was based on the volatility of related industry stocks.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the employee stock option activity during the year ended December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;of Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/ Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options outstanding, vested, unvested and exercised as of and for the period ended December 31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The intrinsic value is calculated as the difference between the market value of the underlying common stock and the exercise price of the options. There were 1,402 unvested and outstanding options at December 31, 2021. The weighted average contractual life for options outstanding, vested and expected to vest at December 31, 2021 was&#160;7.39 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Pennant Plans, the Company granted Restricted Stock to Pennant employees, Ensign employees, and to non-employee directors. All awards generally vest between &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzM1Mjk_ccbd4d6d-4bc1-4f64-a712-9a0de31e9ccd"&gt;three&lt;/span&gt; to five years. A summary of the status of Pennant&#x2019;s non-vested Restricted Stock, and changes during the period ended December 31, 2021, is presented below: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-Vested Restricted Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDM_d59a53e3-4d81-4a48-a867-d9695d7d716a">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total share-based compensation expense for all of the Plans for the years ended December 31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:55.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.938%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Prior to the Spin-Off:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Following the Spin-Off:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,093&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,660&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;315&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to Restricted Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,200&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,589&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation expense related to Restricted Stock to non-employee directors&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;83&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,382&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In future periods, the Company estimates it will recognize the following share-based compensation expense for unvested stock options and unvested Restricted Stock, which were unvested as of December 31, 2021: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:18.785%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Unrecognized Compensation Expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Recognition Period (in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested stock options&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.8&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested Restricted Stock&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,780&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total unrecognized share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,400&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i8ffd18948f6c4a1e9cdee019c70baf5e_D20190101-20191001"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzMtNS0xLTEtNDExMzI_3ff5d4d8-4a74-44df-aa7f-59e784be077f"
      unitRef="usd">1395000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i009062db7a07451db770939cb218b995_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzYtMS0xLTEtNDExMzI_3a69ccd0-9cdc-4b19-8a55-b8252d99b414"
      unitRef="usd">3093000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia395591b1bb04bc59721af3b9e0057ad_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzYtMy0xLTEtNDExMzI_5e9f3a09-a51c-431d-8c09-acb3a5d077e7"
      unitRef="usd">1660000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i324266d2a6034a369becaa333073dedc_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzYtNS0xLTEtNDExMzI_5bb7f671-3d90-452c-95be-384e26595c1b"
      unitRef="usd">315000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ibca5874771a942ac8128f8834681ae6b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzctMS0xLTEtNDExMzI_08b77aac-39aa-42e3-8754-fc2c316caa11"
      unitRef="usd">6141000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i95a5ddcc5c1c4f24a7b7984fb2f61366_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzctMy0xLTEtNDExMzI_03870e48-9ff7-4a6a-8ec6-7c029c747705"
      unitRef="usd">6200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7835b6571f414650b23c89f2da3e8e1d_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzctNS0xLTEtNDExMzI_3943d9a7-990a-4037-b0a9-e92b3f947c0b"
      unitRef="usd">1589000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i820fe8df97df45148956430597a8021c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzgtMS0xLTEtNDExMzI_f4d4eb5e-e7c8-4cc7-abb1-2aa1352d0ee1"
      unitRef="usd">806000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ic2d08a40a2ea4844850b407dc06a1380_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzgtMy0xLTEtNDExMzI_2a7cf496-e0e1-4a72-a6a8-4a7fa5782bd1"
      unitRef="usd">475000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i18d0ff58a4094edcab67e0572e47b712_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzgtNS0xLTEtNDExMzI_8abff8f6-c70c-4546-b355-52ad496cc4f9"
      unitRef="usd">83000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzktMS0xLTEtNDExMzI_f598669c-9b49-4d86-8a99-f12e720f9d8d"
      unitRef="usd">10040000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzktMy0xLTEtNDExMzI_4d7c7dfb-83f4-4435-bca1-8ad83a1e5c3e"
      unitRef="usd">8335000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo3ZTgyZDE4ZTU0MTc0MjI1ODk5ZDQxOWIwYTE3MzBhOC90YWJsZXJhbmdlOjdlODJkMThlNTQxNzQyMjU4OTlkNDE5YjBhMTczMGE4XzktNS0xLTEtNDExMzI_a6ef13cd-bb4f-4439-9090-b7ad3bf6b0cc"
      unitRef="usd">3382000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i3c42f8d3450a45bb97f418276e55401a_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTphNDM1MWZjODgyMzA0NDhhODFjNTEwYjI1YWVhZWY5NC90YWJsZXJhbmdlOmE0MzUxZmM4ODIzMDQ0OGE4MWM1MTBiMjVhZWFlZjk0XzEtMS0xLTEtNDExMzI_095d2527-e37d-4116-8a4d-b092056e67bd"
      unitRef="usd">12620000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i695c64b54bea4f3ea301a4f593b04c27_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTphNDM1MWZjODgyMzA0NDhhODFjNTEwYjI1YWVhZWY5NC90YWJsZXJhbmdlOmE0MzUxZmM4ODIzMDQ0OGE4MWM1MTBiMjVhZWFlZjk0XzEtMy0xLTEtNDExMzI_2054ec3e-ecac-4f85-a942-aa360dac5f2c">P3Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i71a2785689d7485e88d7d7a0fd2e1588_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTphNDM1MWZjODgyMzA0NDhhODFjNTEwYjI1YWVhZWY5NC90YWJsZXJhbmdlOmE0MzUxZmM4ODIzMDQ0OGE4MWM1MTBiMjVhZWFlZjk0XzItMS0xLTEtNDExMzI_22bea62d-25ab-4546-a155-a95b2aa3ead2"
      unitRef="usd">4780000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTphNDM1MWZjODgyMzA0NDhhODFjNTEwYjI1YWVhZWY5NC90YWJsZXJhbmdlOmE0MzUxZmM4ODIzMDQ0OGE4MWM1MTBiMjVhZWFlZjk0XzItMy0xLTEtNDExMzI_eebf216e-1e89-4195-aa3f-d357205a9ef4">P0Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTphNDM1MWZjODgyMzA0NDhhODFjNTEwYjI1YWVhZWY5NC90YWJsZXJhbmdlOmE0MzUxZmM4ODIzMDQ0OGE4MWM1MTBiMjVhZWFlZjk0XzMtMS0xLTEtNDExMzI_99780f15-edb8-40b3-9998-962a6250b2a5"
      unitRef="usd">17400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzIwMDI_0d1fb474-2cb5-4b76-bd39-77b6b3763f85">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="i695c64b54bea4f3ea301a4f593b04c27_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzIwMDg_69170276-cda1-4fb6-afba-4ad98cedeb96"
      unitRef="number">0.20</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i695c64b54bea4f3ea301a4f593b04c27_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzIwNzM_3acbc461-27db-4c26-9b5f-de1f8c64c73a">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDU_23226234-4fe9-46ec-8024-fa63b8801fbf">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of each option is estimated on the grant date using a Black-Scholes option-pricing model with the following weighted average assumptions for stock options granted after the Spin-Off:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:24.338%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.595%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.607%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Grant Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Life&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Expected Volatility&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:700;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Dividend Yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Weighted Average Fair Value of Options&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.05&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;667&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Under the midpoint method, the expected option life is the midpoint between the contractual option life and the average vesting period for the options being granted. This resulted in an expected option life of 6.5 years for the options granted.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Because the Company&#x2019;s equity shares have been traded for a relatively short period of time, expected volatility assumption was based on the volatility of related industry stocks.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i2fba7cde195142a3978c879c27cb0bab_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtMi0xLTEtNDExMzI_5f457402-dd1d-4e3b-a6cb-70d6b86ab9fb"
      unitRef="shares">454000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtNC0xLTEtNDExMzI_9db87ed0-5a91-4e96-9ee7-ea3b0a246015"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtNi0xLTEtNDExMzI_3d0c5904-2115-4114-9575-2d5ca17dad54">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtOC0xLTEtNDExMzI_46a6bf1a-eddc-4c46-827f-7574a0666158"
      unitRef="number">0.384</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtMTAtMS0xLTQxMTMy_feaca482-5893-4f4c-88c7-aa2d8aa84c59"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2fba7cde195142a3978c879c27cb0bab_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzEtMTItMS0xLTQxMTMy_72e41af9-7e20-45ff-84c9-8e0ef0c9d3da"
      unitRef="usdPerShare">13.84</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="icc2e87893a0146e3bc467cb6aa1d0766_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItMi0xLTEtNDExMzI_0c0d8497-d472-46ce-96a8-7d4574d82341"
      unitRef="shares">693000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia6c286ff8cbc4714836982d56e9417c0_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItNC0xLTEtNDExMzI_e1abb53f-bae8-4c9f-9ded-9d1347a007f4"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia6c286ff8cbc4714836982d56e9417c0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItNi0xLTEtNDExMzI_c3973274-4e90-45bb-84a3-7b179ea31bbe">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ia6c286ff8cbc4714836982d56e9417c0_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItOC0xLTEtNDExMzI_313f859d-b431-47d5-b6c8-817e7a9e6b22"
      unitRef="number">0.359</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia6c286ff8cbc4714836982d56e9417c0_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItMTAtMS0xLTQxMTMy_2f3b7158-5f97-4332-b273-f43153a8ce30"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="icc2e87893a0146e3bc467cb6aa1d0766_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzItMTItMS0xLTQxMTMy_616128f7-5181-434f-aabf-5812e72f57e0"
      unitRef="usdPerShare">11.05</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="iddb04c9f35bb476b81dba3be31ee57a0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtMi0xLTEtNjE0NzQ_40c4478a-aa53-45d0-aad9-8f3e46a3dd99"
      unitRef="shares">667000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="id19dc50301904b4ca1463fc976675c69_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtNC0xLTEtNjE0NzQ_187971bb-be4b-4951-b2a7-e3e0dbd6efaf"
      unitRef="number">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="id19dc50301904b4ca1463fc976675c69_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtNi0xLTEtNjE0NzQ_06c337c8-ae07-495c-917c-18326460fd76">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="id19dc50301904b4ca1463fc976675c69_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtOC0xLTEtNjE0NzQ_cc41a2eb-4b2a-4fc3-8dd8-71ae6bd0b319"
      unitRef="number">0.346</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="id19dc50301904b4ca1463fc976675c69_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtMTAtMS0xLTYxNDc0_e413f584-0b4d-4fb2-ac20-5684574d45c1"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iddb04c9f35bb476b81dba3be31ee57a0_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpjMjVlYzJiMjg4MGU0NGMyYWIzODU3Mjg1ODYzNmM4ZC90YWJsZXJhbmdlOmMyNWVjMmIyODgwZTQ0YzJhYjM4NTcyODU4NjM2YzhkXzMtMTItMS0xLTYxNDc0_86603725-b3de-4fb5-aaae-871a4d7537ab"
      unitRef="usdPerShare">5.70</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ibed7f92eb540419982c328d7fd4095f5_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo0YjZlNzc0YmNiMmQ0YWY0YTllNGNhMmYxMWFjNjI1NC90YWJsZXJhbmdlOjRiNmU3NzRiY2IyZDRhZjRhOWU0Y2EyZjExYWM2MjU0XzAtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjozMGY3YmNjYmVhNWM0ZjA3YjZlMGFiMTczMzBkMTEwM18yMTQ_3d0c5904-2115-4114-9575-2d5ca17dad54">P6Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDY_c7b33298-9e9a-4c19-ba37-357e27bbe11e">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the employee stock option activity during the year ended December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:47.438%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.326%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.384%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.332%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Outstanding&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Options Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Average&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Exercise Price&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;of Options&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,982&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.52&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;454&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(115)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.67&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/ Expired&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ie191aaa5b8784c6cb75b59a0e2300e56_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzUtMS0xLTEtNDExMzI_7ecc5b57-d62c-475c-901c-ca59cda51abf"
      unitRef="shares">1982000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ie191aaa5b8784c6cb75b59a0e2300e56_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzUtMy0xLTEtNDExMzI_894a6295-5f65-4c11-a1c9-cea4659492bb"
      unitRef="usdPerShare">17.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber
      contextRef="ie191aaa5b8784c6cb75b59a0e2300e56_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzUtNS0xLTEtNDExMzI_4734b625-dd8c-497e-96e8-d9660d774754"
      unitRef="shares">615000</pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="ie191aaa5b8784c6cb75b59a0e2300e56_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzUtNy0xLTEtNDExMzI_c84306a0-32d1-427f-849b-6f54a07b6cdf"
      unitRef="usdPerShare">7.52</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzYtMS0xLTEtNDExMzI_321213db-5e2f-4d43-8569-3297f2f7b022"
      unitRef="shares">454000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzYtMy0xLTEtNDExMzI_3208c4da-3c7d-431f-a6ab-f1122f198af2"
      unitRef="usdPerShare">35.01</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzctMS0xLTEtNDExMzI_df60f7f1-bed9-448a-bbd6-958302b8369b"
      unitRef="shares">115000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzctMy0xLTEtNDExMzI_0d6e45cd-f6cf-4720-8109-37a68a6474b0"
      unitRef="usdPerShare">7.67</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzgtMS0xLTEtNDExMzI_0cdea695-97fd-4aba-9fd0-fdafeb2ed3de"
      unitRef="shares">79000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzgtMy0xLTEtNDExMzI_df7d1a72-d268-49b0-a8a1-273a217861ab"
      unitRef="usdPerShare">21.81</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzEwLTEtMS0xLTQxMTMy_74253849-5dfa-4992-8be6-8f9a6d13c12b"
      unitRef="shares">2242000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzEwLTMtMS0xLTQxMTMy_94b44ef0-0ebf-46d2-a298-acaaff97f1bb"
      unitRef="usdPerShare">21.38</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber
      contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzEwLTUtMS0xLTQxMTMy_919dc38d-4fdb-4206-8bba-fe4c376f4964"
      unitRef="shares">840000</pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
      contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTowMDc2ZjkyZjI3OTE0ZmE0ODAyYmZlMjA5MTUzMDI3OC90YWJsZXJhbmdlOjAwNzZmOTJmMjc5MTRmYTQ4MDJiZmUyMDkxNTMwMjc4XzEwLTctMS0xLTQxMTMy_e3c93b9f-b93f-4951-a0de-3c491b6a9675"
      unitRef="usdPerShare">12.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDc_8d4bcc8d-4517-4e47-81b8-6ed1b8d22a81">&lt;div style="margin-bottom:7pt;text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The aggregate intrinsic value of options outstanding, vested, unvested and exercised as of and for the period ended December 31, 2021 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.444%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,749&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,221&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo1ODIyYmUzZDc2MDM0ODZjODhmODdmMTk4NzhjMTFjNC90YWJsZXJhbmdlOjU4MjJiZTNkNzYwMzQ4NmM4OGY4N2YxOTg3OGMxMWM0XzEtMS0xLTEtNDExMzI_b2cc6a9a-1efb-47ca-bb19-8832424e3769"
      unitRef="usd">14749000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue
      contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo1ODIyYmUzZDc2MDM0ODZjODhmODdmMTk4NzhjMTFjNC90YWJsZXJhbmdlOjU4MjJiZTNkNzYwMzQ4NmM4OGY4N2YxOTg3OGMxMWM0XzItMS0xLTEtNDExMzI_eda7bcde-3725-4efe-8609-3ea68d739f7e"
      unitRef="usd">10221000</pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue>
    <pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue
      contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo1ODIyYmUzZDc2MDM0ODZjODhmODdmMTk4NzhjMTFjNC90YWJsZXJhbmdlOjU4MjJiZTNkNzYwMzQ4NmM4OGY4N2YxOTg3OGMxMWM0XzMtMS0xLTEtNDExMzI_1f68c68a-3b4a-4831-acce-9a0ef89d6c49"
      unitRef="usd">4528000</pntg:SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTo1ODIyYmUzZDc2MDM0ODZjODhmODdmMTk4NzhjMTFjNC90YWJsZXJhbmdlOjU4MjJiZTNkNzYwMzQ4NmM4OGY4N2YxOTg3OGMxMWM0XzQtMS0xLTEtNDExMzI_b56e6e3d-6c95-46ee-b530-67d04311d8a6"
      unitRef="usd">3248000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i4e98f7de032448e1bdb5e3acc586323d_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzMxODg_40e68488-cd62-455a-94f7-627576fc6792"
      unitRef="shares">1402000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzMzMzI_37b14680-ea9a-48a9-96bc-b55662ff7615">P7Y4M20D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i55dd760f997d474083702aac3bd35021_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzM1MzU_ffa3cad7-62ac-4cd9-8635-971cff0f9918">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90ZXh0cmVnaW9uOjNiODRjY2ZiOTNiODQzZTdiNzliMTU5OTEwNzQ2MDgzXzYwNDczMTM5NTY0NDg_33b8bad3-6726-4893-8176-9c8addf4881b">A summary of the status of Pennant&#x2019;s non-vested Restricted Stock, and changes during the period ended December 31, 2021, is presented below: &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.783%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Non-Vested Restricted Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average Grant Date Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,493&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.00&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="icdcc7ffbdc094bad9d2c2e68f1561ed9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzEtMS0xLTEtNDExMzI_57a4fa46-f40c-4b27-aa2e-c8c15aaf4da2"
      unitRef="shares">1635000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="icdcc7ffbdc094bad9d2c2e68f1561ed9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzEtMy0xLTEtNDExMzI_8b865ae8-be39-4e60-b6ac-b7be70119419"
      unitRef="usdPerShare">14.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzItMS0xLTEtNDExMzI_293efb5e-b8f9-47ee-bc82-fe8b3c098893"
      unitRef="shares">20000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzItMy0xLTEtNDExMzI_ea790946-fe07-4b98-b972-caee97917852"
      unitRef="usdPerShare">39.82</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzMtMS0xLTEtNDExMzI_8a495bd6-421c-4bcf-8c86-4c408cee75a9"
      unitRef="shares">157000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzMtMy0xLTEtNDExMzI_f11aa232-ad72-469c-a1d8-66cbb6d7f922"
      unitRef="usdPerShare">16.20</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzQtMS0xLTEtNDExMzI_e8851f9a-69ed-4778-9126-475f81a303a4"
      unitRef="shares">5000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i702d1fe46eaf4abcaa5d1e314df7293f_D20210101-20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzQtMy0xLTEtNDExMzI_6dbd53a8-2d61-4a9b-949d-47ee2b820c42"
      unitRef="usdPerShare">14.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i71a2785689d7485e88d7d7a0fd2e1588_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzUtMS0xLTEtNDExMzI_ac885050-1ceb-4573-a517-753ccc262f37"
      unitRef="shares">1493000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i71a2785689d7485e88d7d7a0fd2e1588_I20211231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTYvZnJhZzozYjg0Y2NmYjkzYjg0M2U3Yjc5YjE1OTkxMDc0NjA4My90YWJsZTpkNWVjODdmNjU3YTc0Zjk1OThlNjQzY2NjYWJjNDU4Mi90YWJsZXJhbmdlOmQ1ZWM4N2Y2NTdhNzRmOTU5OGU2NDNjY2NhYmM0NTgyXzUtMy0xLTEtNDExMzI_53a75850-6f92-4d1e-ad90-5755b89c992b"
      unitRef="usdPerShare">15.00</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzYwNDczMTM5NTU2Njc_cc8275f9-4dfe-401d-aa97-2133b1f4a4b2">LEASES&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s independent operating subsidiaries lease 54 senior living communities and its administrative offices under non-cancelable operating leases, most of which have initial lease terms ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzIyMg_b91d98ae-34f8-4760-a680-7806138f8865"&gt;five&lt;/span&gt; to 21 years. The Company&#x2019;s independent operating subsidiaries also lease the administrative offices of 88 home health and hospice agencies which generally range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzEwOTk1MTE2MzA5MjU_3cc0a8cb-6980-4caa-9f55-af4c4d207bb0"&gt;one&lt;/span&gt; to seven years. Most of these leases contain renewal options, most involve rent increases and none contain purchase options. The lease term excludes lease renewals because the renewal rents are not at a bargain, there are no economic penalties for the Company to renew the lease, and it is not reasonably certain that the Company will exercise the extension options. As of December 31, 2021, the Company&#x2019;s independent operating subsidiaries leased 32 communities from subsidiaries of Ensign (&#x201c;Ensign Leases&#x201d;) under a master lease arrangement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;span style="color:#ff0000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The existing leases with subsidiaries of Ensign are for initial terms of between 14 to 20 years. In addition to rent, each of the operating companies are required to pay the following: (1) all impositions and taxes levied on or with respect to the leased properties (other than taxes on the income of the lessor); (2) all utilities and other services necessary or appropriate for the leased properties and the business conducted on the leased properties; (3) all insurance required in connection with the leased properties and the business conducted on the leased properties; (4) all community maintenance and repair costs; and (5) all fees in connection with any licenses or authorizations necessary or appropriate for the leased properties and the business conducted on the leased properties.  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fifteen of the Company&#x2019;s affiliated senior living communities, excluding the communities that are operated under the Ensign Leases (as defined herein), are operated under two separate master lease arrangements. Under these master leases, a breach at a single community could subject one or more of the other communities covered by the same master lease to the same default risk. Failure to comply with Medicare and Medicaid provider requirements is a default under several of the Company&#x2019;s leases and master leases. With an indivisible lease, it is difficult to restructure the composition of the portfolio or economic terms of the master lease without the consent of the landlord.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of operating lease cost, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility rent&#x2014;cost of services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office rent&#x2014;cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rent&#x2014;cost of services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Represents variable lease cost for operating leases, which costs include property taxes and insurance, common area maintenance, and consumer price index increases, incurred as part of our triple net lease, and which is included in cost of services for the years ended December 31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the lease maturity analysis for all leases as of December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: present value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease liabilities are based on the net present value of the remaining lease payments over the remaining lease term. In determining the present value of lease payments, the Company used its incremental borrowing rate based on the information available at each lease&#x2019;s commencement date to determine each lease's operating lease liability. As of December 31, 2021, the weighted average remaining lease term is 14.1 years and the weighted average discount rate is 7.9%.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <pntg:NumberOfRealEstatePropertiesUnderLease
      contextRef="icc510d566b5a497d8c3bf8da297c74be_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzcx_85a39232-d244-4a56-8dc2-b69d7294136d"
      unitRef="facility">54</pntg:NumberOfRealEstatePropertiesUnderLease>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i4ca3f78db99945b69974d02c724d9240_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzIyOA_668b41a2-39c3-4d86-a17b-d3ae7a022373">P21Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <pntg:NumberOfServiceProviders
      contextRef="ife1126ceed284fbdb9bf6b3dbab68da3_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzEwOTk1MTE2MzA4Mjk_601ff99b-7d5b-4095-bf9d-eab16d3843b7"
      unitRef="agency">88</pntg:NumberOfServiceProviders>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i8fb2a9d080dd42e58f04fb43fed99eb9_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzEwOTk1MTE2MzA5MzM_40eacfbe-48d4-4706-b79d-24a9bd2d7b2c">P7Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:NumberOfRealEstateProperties
      contextRef="i69f3d63932564edfa50a96879cf88c45_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzY0OQ_b5902798-34f4-4cc2-868f-c1388c67b28f"
      unitRef="property">32</us-gaap:NumberOfRealEstateProperties>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i8539c32fc47d41f7855d6538692f738d_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzgyNQ_b54d788a-0a57-492f-85d9-904fdebfa608">P14Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="ice5e4b95ef8a477bb882b9b591fb511b_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzgzMQ_68f757fa-c9ca-4af9-9158-eb327701158e">P20Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <pntg:NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement
      contextRef="i69f3d63932564edfa50a96879cf88c45_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzE1MzU_ffa08c9f-f6bc-4ce6-ae59-50c99c93b53c"
      unitRef="facility">15</pntg:NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement>
    <pntg:NumberOfSeparateMasterLeaseArrangements
      contextRef="i69f3d63932564edfa50a96879cf88c45_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzE3MDE_8537a64a-60a5-4f81-9086-400efffd241e"
      unitRef="arrangement">2</pntg:NumberOfSeparateMasterLeaseArrangements>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzYwNDczMTM5NTU2NjU_37f12042-e5b0-4e6a-9d83-d9ee1553ec17">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of operating lease cost, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:59.280%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.622%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Facility rent&#x2014;cost of services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,958&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,011&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office rent&#x2014;cost of services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,905&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,964&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rent&#x2014;cost of services&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40,863&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39,191&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,975&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,248&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,330&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Represents variable lease cost for operating leases, which costs include property taxes and insurance, common area maintenance, and consumer price index increases, incurred as part of our triple net lease, and which is included in cost of services for the years ended December 31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="ibaa9096cc2bd4e858996c09298dd6eb0_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzMtMS0xLTEtNDExMzI_f1f10a45-f06f-4fcd-86fd-250236dcbaef"
      unitRef="usd">35958000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i1309a04126c24144b850a38c0baa4831_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzMtMy0xLTEtNDExMzI_2a58b975-58f4-4481-bef5-2f193a8f0cf7"
      unitRef="usd">35562000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="id61049412f5d48e69963ed0bcb95677c_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzMtNS0xLTEtNDExMzI_9509cccf-be82-43ff-a4dd-d8749134aff3"
      unitRef="usd">32011000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i59c4cea8cd4b414fbbbcfe383d2f2015_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzQtMS0xLTEtNDExMzI_c0d4c048-502f-498d-a8bb-10a8a0c098ce"
      unitRef="usd">4905000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i7385e6d9e8844d5b9ae1f8bed5241579_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzQtMy0xLTEtNDExMzI_fe62ee1b-c3c4-42b9-9d47-eb0d43ffe8d5"
      unitRef="usd">3772000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="if5ac6849e7e74533af722a23640f12d7_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzQtNS0xLTEtNDExMzI_c8cc0fb2-2e8f-4bb2-91a2-0e1e1f34ef2a"
      unitRef="usd">2964000</us-gaap:OperatingLeaseCost>
    <us-gaap:SubleaseIncome
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzUtMS0xLTEtNDExMzI_f9a2a355-74ff-4020-badb-2c59181ec522"
      unitRef="usd">0</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzUtMy0xLTEtNDExMzI_33d2f365-76aa-47b8-acf1-6d55dde3b4e4"
      unitRef="usd">143000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzUtNS0xLTEtNDExMzI_01cf4670-5487-4643-8399-4f7ac2dd6de4"
      unitRef="usd">0</us-gaap:SubleaseIncome>
    <us-gaap:OperatingLeaseCost
      contextRef="i0ee98e79dbdf4459bb64dd4764f5f04c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzYtMS0xLTEtNDExMzI_b4eccbbd-9b50-474b-9d74-5e4c56a33de9"
      unitRef="usd">40863000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ief8be8ba89d54b41b5b925a9afe0bfd6_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzYtMy0xLTEtNDExMzI_5c8bb2a0-756d-4e60-bd72-d32d4e14d41a"
      unitRef="usd">39191000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i828be32df55549349516ec453fb5f7fa_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzYtNS0xLTEtNDExMzI_2d8c05ed-a2bd-4a2f-a614-8fdb052cf1e8"
      unitRef="usd">34975000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i0e8f395592e742f3ba6c06ba1409606c_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzgtMS0xLTEtNDExMzI_4e4ba5ab-f9d4-4cb5-af5f-6631ed74c53e"
      unitRef="usd">276000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i743dd5e050c24c6f903e2cd1bc39b900_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzgtMy0xLTEtNDExMzI_9bfadd5a-4250-4126-b13d-dd6b0895b7cd"
      unitRef="usd">295000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="ib4445accb5d94db3851353dbfa2ed4f3_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzgtNS0xLTEtNDExMzI_6ae480b9-24a6-42d8-8359-21540edcb4b5"
      unitRef="usd">162000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzktMS0xLTEtNDExMzI_6e098bd5-c98c-45b5-8164-28f75452cdb6"
      unitRef="usd">6248000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzktMy0xLTEtNDExMzI_06561a5f-7cdb-4f67-8c86-d7e5c73e0710"
      unitRef="usd">5330000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpjNzc2NWNhODhjMWU0ZTA1YjJjMTIxM2Y1NzJlZTAxZC90YWJsZXJhbmdlOmM3NzY1Y2E4OGMxZTRlMDViMmMxMjEzZjU3MmVlMDFkXzktNS0xLTEtNDExMzI_5f72d5ed-e9ca-4d76-93e9-3a768ae14ca8"
      unitRef="usd">4608000</us-gaap:VariableLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzYwNDczMTM5NTU2NjY_06a8f05e-4af0-4acc-9f72-a444dc55717e">&lt;div style="text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table shows the lease maturity analysis for all leases as of December 31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.303%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,978&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,078&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;320,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;505,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: present value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(201,462)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;303,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: current lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(16,118)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;287,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzEtMS0xLTEtNDExMzI_ef052efc-addf-4a13-a2b7-eb4d938499d1"
      unitRef="usd">38929000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzItMS0xLTEtNDExMzI_b615da92-d262-454d-8db0-1cba505d90c7"
      unitRef="usd">37978000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzMtMS0xLTEtNDExMzI_77d1c28d-6241-4e9b-86c6-7c8acdc22693"
      unitRef="usd">36906000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzQtMS0xLTEtNDExMzI_e3c337d1-4011-4ca6-9530-5ba25866d48e"
      unitRef="usd">35778000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzUtMS0xLTEtNDExMzI_57667449-d0ef-4969-9b01-1f586127f048"
      unitRef="usd">35078000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzYtMS0xLTEtNDExMzI_22f324be-7e4f-435e-b507-98a8fd7ac3e1"
      unitRef="usd">320664000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzctMS0xLTEtNDExMzI_16df98ee-df06-4d12-ae15-2cd4c1a6b399"
      unitRef="usd">505333000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzgtMS0xLTEtNDExMzI_ec9994a8-707b-4be2-b85d-68d2e583df51"
      unitRef="usd">201462000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzktMS0xLTEtNDExMzI_9ef0affa-1932-40a4-9518-30b18bf44db5"
      unitRef="usd">303871000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzEwLTEtMS0xLTQxMTMy_91046012-7478-4a8d-a53f-a46213817228"
      unitRef="usd">16118000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90YWJsZTpkMTE0ODM5MWJhYmY0MTU2YmQxMGI0YmMwZWNlYzU1NC90YWJsZXJhbmdlOmQxMTQ4MzkxYmFiZjQxNTZiZDEwYjRiYzBlY2VjNTU0XzExLTEtMS0xLTQxMTMy_4b860369-58e3-4960-b704-0474df4cf2b4"
      unitRef="usd">287753000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzI4NDA_64893e4f-8919-4b02-aca6-de364d8d4543">P14Y1M6D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xOTkvZnJhZzpmMjg4OTU5YmI2Y2U0YzQyYjg3NzEzNmU0NmRlZjZmMC90ZXh0cmVnaW9uOmYyODg5NTliYjZjZTRjNDJiODc3MTM2ZTQ2ZGVmNmYwXzI4ODU_260ee93b-8a2c-42e4-ba2c-c126b22f60af"
      unitRef="number">0.079</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzYwNDczMTM5NTYyMDA_bda817fe-295f-4e2c-ac71-69dccd5b9587">INCOME TAXES&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income tax expense for the years ended December 31, 2021, 2020 and 2019 is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the federal statutory rate to the effective tax rate for income from continuing operations for the years ended December 31, 2021, 2020 and 2019, respectively, is comprised as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes - net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible equity compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 162(m) limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductible equity compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax provision&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;The Company's completion of the Spin-Off  in the year ended December 31, 2019 resulted in the Company not being able to deduct approximately $10,300 of the related transaction costs, which increased the effective tax rate significantly and affected all items that were impacted by this exclusion.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;During the year ended December 31, 2021, employees exercised stock options representing approximately 115 shares. During the year ended December 31, 2020, employees exercised stock options representing approximately 239 shares. During the year ended December 31, 2019, employees exercised stock options representing approximately 100 shares and had restricted stock awards vest representing 960 shares. These exercises and vestings resulted in tax benefits that reduced the Company's effective tax rate significantly in all three years. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;During the year ended December 31, 2021, approximately $2,528 of the share-based compensation expense related to restricted stock did not result in a deferred tax asset because it will be subject to future limitation under IRC Section 162(m).&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Certain items in the prior year have been reclassified to conform with the current year presentation.  &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the date of the Spin-Off, the Company's operations were included in Ensign&#x2019;s U.S. federal and state income tax returns and all income taxes were paid by subsidiaries of Ensign. Additionally, prior to the date of the Spin-Off, income tax expense and other income tax related information contained in these Consolidated and Combined Financial Statements for the year ended 2019 were presented on a separate tax return approach. Under this approach, the provision for income taxes represents income tax paid or payable for the current year plus the change in deferred taxes during the year calculated as if the Company were a stand-alone taxpayer filing hypothetical income tax returns. Management believes that the assumptions and estimates used to determine these tax amounts were reasonable. However, the Company's Consolidated and Combined Financial Statements or the year ended 2019 may not necessarily reflect the Company&#x2019;s income tax expense or tax payments in the future, or what its tax amounts would have been if the Company had been a stand-alone company during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s deferred tax assets and liabilities for the years ended December 31, 2021 and 2020 are summarized below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,432)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78,656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December 31, 2020, the Company utilized all of its net operating loss ("NOL") carryforwards for federal income tax purposes. As of December 31, 2021, the Company has $614 of NOL carryforwards in various states, which are available to reduce future state taxable income, if any. The state NOL carryforwards, if not utilized, will expire in years ending between December 31, 2030 and December 31, 2040. The Company believes that it is more likely than not that the benefit from the state NOL carryforwards in jurisdictions where we do not file a consolidated return will not be realized. In recognition of this risk, as of December 31, 2021, the Company has provided a valuation allowance of $25 on the deferred tax assets related to these states for the tax effect of the NOL carryforwards that will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The federal statutes of limitations on the Company&#x2019;s 2017, 2016, and 2015 income tax years lapsed during the third quarter of 2021, 2020, and 2019, respectively. During the fourth quarter of each year, various state statutes of limitations also lapsed. The lapses for the years ended December 31, 2021 and 2020 had no impact on the Company&#x2019;s unrecognized tax benefits. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;None of unrecognized tax benefits net of their state benefits would affect the Company&#x2019;s effective tax rate for the years ended December 31, 2021 and 2020.  The Company classifies interest and/or penalties on income tax liabilities or refunds as additional income tax expense or income. Such amounts are not material.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzYwNDczMTM5NTYyMDE_d98af7a9-bffb-4bb3-8bc3-95aedd179cd8">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income tax expense for the years ended December 31, 2021, 2020 and 2019 is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.915%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,768&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,058&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;566&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,478&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,536&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,360)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(838)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,752)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,186)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,350&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzMtMS0xLTEtNDExMzI_89fff5fc-bd49-4653-9371-1bae4dd8f604"
      unitRef="usd">1768000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzMtMy0xLTEtNDExMzI_2f2be580-08f7-4d98-9155-f2a0c0c25489"
      unitRef="usd">5058000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzMtNS0xLTEtNDExMzI_afb1ed38-b622-4d9a-bae1-c9235a8aa85b"
      unitRef="usd">562000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzQtMS0xLTEtNDExMzI_98b32687-7685-4ae8-80fd-1508c88c7b4b"
      unitRef="usd">566000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzQtMy0xLTEtNDExMzI_a59df459-116a-4332-8fe0-683ded874d29"
      unitRef="usd">1478000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzQtNS0xLTEtNDExMzI_48e4d164-67d6-4acf-8985-3e712ac6ddbe"
      unitRef="usd">278000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzUtMS0xLTEtNDExMzI_19254e07-63d4-405b-b030-b1cf7ebc05b9"
      unitRef="usd">2334000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzUtMy0xLTEtNDExMzI_d07126f0-1f20-49d8-89d6-94d1f8794e0d"
      unitRef="usd">6536000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzUtNS0xLTEtNDExMzI_4bb3a102-28e4-4954-92ce-42cde35d0623"
      unitRef="usd">840000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzctMS0xLTEtNDExMzI_086d997b-7ba9-4c2b-ad5a-cd8fd4dbfadd"
      unitRef="usd">-1360000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzctMy0xLTEtNDExMzI_d7873147-8c0d-452a-a853-e645019affa6"
      unitRef="usd">-3348000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzctNS0xLTEtNDExMzI_19b69cc0-fbf3-4543-a1a5-e096f44b6b60"
      unitRef="usd">1070000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzgtMS0xLTEtNDExMzI_7cf8749e-3430-4b5f-87d2-b378955753e1"
      unitRef="usd">-392000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzgtMy0xLTEtNDExMzI_2eba57d1-d011-43cf-aeab-a9d673bb98ee"
      unitRef="usd">-838000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzgtNS0xLTEtNDExMzI_a5db438b-8f3e-4324-8a6f-44c5ad0ac2b1"
      unitRef="usd">175000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzktMS0xLTEtNDExMzI_60432ead-4d1a-4272-b9f7-4eeecb07e3eb"
      unitRef="usd">-1752000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzktMy0xLTEtNDExMzI_7c0a3bd4-1eac-40c4-9483-cfc941f1151a"
      unitRef="usd">-4186000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzktNS0xLTEtNDExMzI_2e69b112-d60c-47db-b9b4-3787453f2f50"
      unitRef="usd">1245000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzExLTEtMS0xLTQxMTMy_870c7763-18b7-487a-859f-b92666e8b6c4"
      unitRef="usd">582000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzExLTMtMS0xLTQxMTMy_84aca38b-3cd5-45b1-936a-26108e891298"
      unitRef="usd">2350000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTphYzE1ZWZjZWY0ZDM0MzY1YjRmYWNjM2FhMmQ0ZDkxNS90YWJsZXJhbmdlOmFjMTVlZmNlZjRkMzQzNjViNGZhY2MzYWEyZDRkOTE1XzExLTUtMS0xLTQxMTMy_0a392cc5-b8d4-4e7c-89b6-61d8cf3d5fd0"
      unitRef="usd">2085000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzYwNDczMTM5NTYyMDI_09c488e1-dd31-47d1-96ad-906a74691bd2">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the federal statutory rate to the effective tax rate for income from continuing operations for the years ended December 31, 2021, 2020 and 2019, respectively, is comprised as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.841%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.769%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax expense at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State income taxes - net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible meals and entertainment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible equity compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(c)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Section 162(m) limitation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible accrued bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other non-deductible expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Transaction costs&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(a)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deductible equity compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(b)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(34.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(30.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Noncontrolling interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total income tax provision&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(d)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:2.723%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:95.247%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;The Company's completion of the Spin-Off  in the year ended December 31, 2019 resulted in the Company not being able to deduct approximately $10,300 of the related transaction costs, which increased the effective tax rate significantly and affected all items that were impacted by this exclusion.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;During the year ended December 31, 2021, employees exercised stock options representing approximately 115 shares. During the year ended December 31, 2020, employees exercised stock options representing approximately 239 shares. During the year ended December 31, 2019, employees exercised stock options representing approximately 100 shares and had restricted stock awards vest representing 960 shares. These exercises and vestings resulted in tax benefits that reduced the Company's effective tax rate significantly in all three years. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;During the year ended December 31, 2021, approximately $2,528 of the share-based compensation expense related to restricted stock did not result in a deferred tax asset because it will be subject to future limitation under IRC Section 162(m).&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;Certain items in the prior year have been reclassified to conform with the current year presentation.  &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzItMS0xLTEtNDExMzI_3dc58203-be18-4b34-8931-06ae85df4129"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzItMy0xLTEtNDExMzI_486c0b62-0469-4312-8deb-9dc6f5272571"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzItNS0xLTEtNDExMzI_6a59cf3e-2da1-4a88-8fd5-663b9ec3d972"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzMtMS0xLTEtNDExMzI_b0bd1a37-3378-4e21-9ccc-f558f973635d"
      unitRef="number">0.039</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzMtMy0xLTEtNDExMzI_06a2d72b-d769-4509-913a-66269860ad50"
      unitRef="number">0.027</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzMtNS0xLTEtNDExMzI_b1b370c4-3457-407a-bb91-31cc5c932b17"
      unitRef="number">0.068</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtMS0xLTEtNTkyNDc_999c8518-8e33-424a-871d-8dfb6fb05806"
      unitRef="number">0.018</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtMy0xLTEtNTkyNDc_70d04542-bc84-4f26-ad58-bc06eee6ccb8"
      unitRef="number">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtNS0xLTEtNTkyNDc_524e8000-92ed-4abe-ade2-d21d7599b459"
      unitRef="number">0.018</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtMS0xLTEtNTkyNDc_91a5221a-de18-4df0-8905-ef7c6bb32539"
      unitRef="number">0.194</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtMy0xLTEtNTkyNDc_55c91bcf-081a-4a6e-91ac-39a0058fe3c6"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtNS0xLTEtNTkyNDc_16fe4d4a-80dd-4bb4-bee7-da1b367d8537"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <pntg:EffectiveIncomeTaxRateReconciliationSection162mLimitation
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtMS0xLTEtNTkyNDc_22094b78-b0a0-441a-804e-202862930e44"
      unitRef="number">0.021</pntg:EffectiveIncomeTaxRateReconciliationSection162mLimitation>
    <pntg:EffectiveIncomeTaxRateReconciliationSection162mLimitation
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtMy0xLTEtNTkyNDc_5aca3f35-0d61-404b-ba14-e5e5e2221f98"
      unitRef="number">0</pntg:EffectiveIncomeTaxRateReconciliationSection162mLimitation>
    <pntg:EffectiveIncomeTaxRateReconciliationSection162mLimitation
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtNS0xLTEtNTkyNDc_c398f2a6-b335-4531-b43a-05aa9cb7c444"
      unitRef="number">0</pntg:EffectiveIncomeTaxRateReconciliationSection162mLimitation>
    <pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctMS0xLTEtNTkyNDc_370d9e56-a51a-4528-88e6-145dd42330f9"
      unitRef="number">0.027</pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus>
    <pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctMy0xLTEtNTkyNDc_2662ad1e-caea-4600-a79b-648e03aad3af"
      unitRef="number">0</pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus>
    <pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctNS0xLTEtNTkyNDc_0b05dd14-8c5b-45d7-abea-9e67b361a6ba"
      unitRef="number">0</pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtMS0xLTEtNDExMzI_5fbcfeb9-89b4-4e87-af12-8bba8746bc5c"
      unitRef="number">0.007</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtMy0xLTEtNDExMzI_8e17248c-c1a2-48b4-9f35-7f07272eae98"
      unitRef="number">0.001</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzQtNS0xLTEtNDExMzI_3e70c9ef-70e1-4a27-95a0-f85364888f09"
      unitRef="number">0.008</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <pntg:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtMS0xLTEtNDExMzI_189f7885-6627-4536-9309-6ed9729ac8e5"
      unitRef="number">0</pntg:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent>
    <pntg:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtMy0xLTEtNDExMzI_6b514d99-b3d7-4a02-9e06-41ff0b625912"
      unitRef="number">0</pntg:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent>
    <pntg:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzUtNS0xLTEtNDExMzI_f15c4c35-e8d1-455f-a0ca-93aaa4a736a3"
      unitRef="number">0.412</pntg:EffectiveIncomeTaxRateReconciliationTransactionCostsPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtMS0xLTEtNDExMzI_e1760c77-4283-48e1-94ec-d11c03f1edac"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtMy0xLTEtNDExMzI_6bb73166-a251-454e-95b8-e2b7b6121bdb"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzYtNS0xLTEtNDExMzI_ba2d9661-97ac-4f39-9792-5d43a5043605"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits>
    <pntg:EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctMS0xLTEtNDExMzI_1cc0d585-f7c3-4edc-9aae-bdde882f168a"
      unitRef="number">-0.341</pntg:EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent>
    <pntg:EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctMy0xLTEtNDExMzI_dab7d936-7082-47f1-b818-e1e3f3b19bc7"
      unitRef="number">-0.108</pntg:EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent>
    <pntg:EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzctNS0xLTEtNDExMzI_a9471493-297e-48a1-aef6-bfd4439f453b"
      unitRef="number">-0.300</pntg:EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzgtMS0xLTEtNDExMzI_7dd48be9-49e1-4a7c-9454-2d522ecfc621"
      unitRef="number">-0.050</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzgtMy0xLTEtNDExMzI_3f1d2bc8-0c31-41b3-89bb-00726d4236cb"
      unitRef="number">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzgtNS0xLTEtNDExMzI_c2a27f8c-2b11-4ff8-b711-0cc20b410f17"
      unitRef="number">0</us-gaap:EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzktMS0xLTEtNDExMzI_fb13b39f-7ea1-4dbb-9bd9-cd86d800ae47"
      unitRef="number">-0.012</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzktMy0xLTEtNDExMzI_f3160eb7-fcba-4d1e-8684-75f6284fbb5f"
      unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzktNS0xLTEtNDExMzI_5e32ffb3-2f54-47f8-8445-9e6e781d7432"
      unitRef="number">-0.004</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzEwLTEtMS0xLTQxMTMy_d7a6a51a-36c2-4f94-b301-eea9e3c6b0e8"
      unitRef="number">0.213</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzEwLTMtMS0xLTQxMTMy_5f69b4b9-02ee-4d43-a355-5db6b8026c4c"
      unitRef="number">0.131</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpkMTFkMDhhZjIyYTA0OTc2YjM4MDQyOTk5YTFhOGM1OC90YWJsZXJhbmdlOmQxMWQwOGFmMjJhMDQ5NzZiMzgwNDI5OTlhMWE4YzU4XzEwLTUtMS0xLTQxMTMy_bb9dcb17-351a-4e39-af8f-4c743ca5f460"
      unitRef="number">0.396</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzAtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjowNzQ5Njk0NWU5ZTE0MmM3OWU3ODE1MWI5YWY2ZjRlZl8xMjA_f991cdee-a4df-4fda-8f31-88aa16bb5fa4"
      unitRef="usd">10300000</pntg:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i561174c829a140b08b1d95c1f8f01962_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjoyN2QxZDQ2NzU0YzY0YmNmYTgzNDY1NmY3YjFjM2I5OF84MQ_df60f7f1-bed9-448a-bbd6-958302b8369b"
      unitRef="shares">115000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i39dc640518df47b9a65a3d3dbeec9bd5_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjoyN2QxZDQ2NzU0YzY0YmNmYTgzNDY1NmY3YjFjM2I5OF8yNzQ4Nzc5MDY5OTI5_5182938c-4a4c-4021-836e-0eeb6727a99a"
      unitRef="shares">239000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i3a5ce69e0ffd47a7befd0d6c5941a09f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjoyN2QxZDQ2NzU0YzY0YmNmYTgzNDY1NmY3YjFjM2I5OF8yNzQ4Nzc5MDY5OTM1_8121e54d-b8b9-49dd-b343-6094da14aa10"
      unitRef="shares">100000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i0169fb92128e49f58280fc837cf38434_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzEtMi0xLTEtNDExMzIvdGV4dHJlZ2lvbjoyN2QxZDQ2NzU0YzY0YmNmYTgzNDY1NmY3YjFjM2I5OF8yNzQ4Nzc5MDY5OTQx_aa1f25a2-4502-453c-a8be-b6fbde5355de"
      unitRef="shares">960000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensation
      contextRef="ibca5874771a942ac8128f8834681ae6b_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTpiYmEzZDRmMzEyOTA0ZGY0OWVjMTQ1NTM3ZDhjYTEwMS90YWJsZXJhbmdlOmJiYTNkNGYzMTI5MDRkZjQ5ZWMxNDU1MzdkOGNhMTAxXzItMi0xLTEtNTkyNzcvdGV4dHJlZ2lvbjo4YWIxOTkxYmRlY2E0NDUzODBlMWRlZGE1ZTNhODJkY18xMDk5NTExNjI4MDI3_5330f550-5a35-4abc-b7d6-16189aae7c4d"
      unitRef="usd">2528000</us-gaap:ShareBasedCompensation>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzYwNDczMTM5NTYyMDM_b701d49f-6bef-4103-a196-0b70260c0fd9">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s deferred tax assets and liabilities for the years ended December 31, 2021 and 2020 are summarized below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.976%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.498%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets (liabilities):&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,829&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,181&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,728&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;79,575&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,979&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;953&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;277&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,085&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,459&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(25)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,060&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,432)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,512)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(907)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(780)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(78,656)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80,055)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(217)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,212)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,848&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,097&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzMtMS0xLTEtNDExMzI_a7dd7805-eff2-49c5-8ffe-55b135875fa6"
      unitRef="usd">9829000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzMtMy0xLTEtNDExMzI_1f71d458-b47f-418f-8b59-87f22074ccc2"
      unitRef="usd">8181000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzQtMS0xLTEtNDExMzI_83fd79a1-bb26-4362-9151-5aebcd30d39b"
      unitRef="usd">1728000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzQtMy0xLTEtNDExMzI_eac3362f-6298-4bc6-a5c1-8e2fe23b7c94"
      unitRef="usd">875000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsStateTaxes
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzUtMS0xLTEtNDExMzI_b28b471f-9eeb-4827-88b6-fcb5b7cc5442"
      unitRef="usd">0</us-gaap:DeferredTaxAssetsStateTaxes>
    <us-gaap:DeferredTaxAssetsStateTaxes
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzUtMy0xLTEtNDExMzI_5b22fb49-91bf-46b4-9d1b-4727481f5944"
      unitRef="usd">147000</us-gaap:DeferredTaxAssetsStateTaxes>
    <pntg:DeferredTaxAssetsLeaseLiabilities
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzYtMS0xLTEtNDExMzI_90a0c4ba-4636-4708-80b3-7c5c7bda6df5"
      unitRef="usd">79575000</pntg:DeferredTaxAssetsLeaseLiabilities>
    <pntg:DeferredTaxAssetsLeaseLiabilities
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzYtMy0xLTEtNDExMzI_fedd6040-7955-49b3-bc0e-2a46069ac6df"
      unitRef="usd">80979000</pntg:DeferredTaxAssetsLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzctMS0xLTEtNDExMzI_90d22e96-265a-48f0-aadb-7cd86bdec53c"
      unitRef="usd">953000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzctMy0xLTEtNDExMzI_d92ea397-b3ab-4b98-ab2f-de32ae36c7cd"
      unitRef="usd">277000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzgtMS0xLTEtNDExMzI_9c3bb976-9b18-4029-ab08-307fba667bf7"
      unitRef="usd">92085000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzgtMy0xLTEtNDExMzI_1b1ced40-3668-4f8e-b116-4815cc2ca0c0"
      unitRef="usd">90459000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzktMS0xLTEtNDExMzI_b8fa3423-9243-47a2-acbf-2382240fa5aa"
      unitRef="usd">25000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzktMy0xLTEtNDExMzI_b7f8cf70-b0a2-4c8c-8d6b-e26f1eb8c596"
      unitRef="usd">15000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEwLTEtMS0xLTQxMTMy_17739915-6914-41b9-a401-5b6e8612b8f5"
      unitRef="usd">92060000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEwLTMtMS0xLTQxMTMy_86a7386f-7824-400d-8c3d-452c578bed4b"
      unitRef="usd">90444000</us-gaap:DeferredTaxAssetsNet>
    <pntg:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzExLTEtMS0xLTQxMTMy_faa10b11-aba5-4a6c-9f19-eb556662d212"
      unitRef="usd">8432000</pntg:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <pntg:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzExLTMtMS0xLTQxMTMy_d49ff8d9-6d23-4955-bc29-07229ef1f99e"
      unitRef="usd">7512000</pntg:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEyLTEtMS0xLTQxMTMy_96fee3a8-52c0-4a7e-8228-e871638a4f79"
      unitRef="usd">907000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesPrepaidExpenses
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEyLTMtMS0xLTQxMTMy_51017c0c-f402-491d-afa4-604ef15cef81"
      unitRef="usd">780000</us-gaap:DeferredTaxLiabilitiesPrepaidExpenses>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEzLTEtMS0xLTQxMTMy_93ba0df7-abea-4318-a489-a45541366bda"
      unitRef="usd">78656000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzEzLTMtMS0xLTQxMTMy_f34bcbbe-f1dd-4005-b73d-78ddad11cd82"
      unitRef="usd">80055000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <pntg:DeferredTaxLiabilitiesStateTaxes
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE0LTEtMS0xLTQxMTMy_eecf17f4-e0e8-4cd7-ba1e-fb15fe09462a"
      unitRef="usd">217000</pntg:DeferredTaxLiabilitiesStateTaxes>
    <pntg:DeferredTaxLiabilitiesStateTaxes
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE0LTMtMS0xLTQxMTMy_8a4fae1a-a2aa-429c-88d3-ca67baa24dd5"
      unitRef="usd">0</pntg:DeferredTaxLiabilitiesStateTaxes>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE1LTEtMS0xLTQxMTMy_7aa125e6-8b74-4e0d-8e05-5b4b0be89919"
      unitRef="usd">88212000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE1LTMtMS0xLTQxMTMy_10926fcc-959b-4665-9ff3-ce34a8ad78e4"
      unitRef="usd">88347000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE2LTEtMS0xLTQxMTMy_47f29026-0e24-4668-8242-08bc2f6ead14"
      unitRef="usd">3848000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZToxNTU3ZjQ0NGEzZTI0ZDhkYmYyOGM3YzJkYjZlMzY3Ni90YWJsZXJhbmdlOjE1NTdmNDQ0YTNlMjRkOGRiZjI4YzdjMmRiNmUzNjc2XzE2LTMtMS0xLTQxMTMy_9a167bbf-2cf5-49cd-8489-9508773bda5e"
      unitRef="usd">2097000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i930d5c4fd9b84161879c0000c0e816d2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzIyNTU_72ae0295-fe8c-45b5-97ae-8b5ab0446fab"
      unitRef="usd">614000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwardsValuationAllowance
      contextRef="i930d5c4fd9b84161879c0000c0e816d2_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzE0MjkzNjUxMTY1Mzg2_663a39d4-0733-4153-bb9f-283dbb40ee01"
      unitRef="usd">25000</us-gaap:OperatingLossCarryforwardsValuationAllowance>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90ZXh0cmVnaW9uOjdjODhmNzAxNWNhODQxMjA4YjdjNmU4YTdlYzkwZDA0XzYwNDczMTM5NTc4MjQ_bc732f27-777c-477c-8e58-4a1d0e973fde">&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.648%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.496%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.500%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="15" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at January 1&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions related to the current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(123)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzItMS0xLTEtNjMwNzc_34eecbd0-af37-4b26-a8bf-1ed69e6f2744"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzItMy0xLTEtNjMwNzk_fed62462-c256-47da-ae5e-4ddf934173c4"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i855d825b738d453698699f3f7321df6f_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzItNS0xLTEtNzY1ODk_216b86fb-ff6a-46bc-83a8-9fb99e06d52f"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzMtMS0xLTEtNjMwNzc_2d709ed7-2476-4a63-af31-dd4c9239f007"
      unitRef="usd">188000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzMtMy0xLTEtNjMwNzk_cdd4b677-d2c1-40ca-a524-55ab9d28227d"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzMtNS0xLTEtNzY1ODk_4787c605-4363-471a-b498-5fc1b5357d7d"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzQtMS0xLTEtNjMwNzc_a9312cdb-aeed-4760-8563-5a2f971896bb"
      unitRef="usd">123000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzQtMy0xLTEtNjMwNzk_04ce0d6e-30b2-462e-9431-7ece5dc5c9bc"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ie594b7d103bb43e2835adda0fde12a6e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzQtNS0xLTEtNzY1ODk_305a7abd-02ca-40ca-a264-08328e806ceb"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzUtMS0xLTEtNjMwNzc_ce0e2558-d546-4d77-922e-1216424824e1"
      unitRef="usd">65000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzUtMy0xLTEtNjMwODU_c7943f7f-238a-44cb-8d44-10bc8b44cdd3"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i7a6863ed0a604be89046cf3ba27d50b9_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDIvZnJhZzo3Yzg4ZjcwMTVjYTg0MTIwOGI3YzZlOGE3ZWM5MGQwNC90YWJsZTplOGY5ZDFkMjQxNmE0NjY4YTUwNjViODM0ZWU4MjAxNC90YWJsZXJhbmdlOmU4ZjlkMWQyNDE2YTQ2NjhhNTA2NWI4MzRlZTgyMDE0XzUtNS0xLTEtNzY1ODk_6f7731d0-6658-462a-896a-e323f1467e9c"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzYwNDczMTM5NjI1OTQ_f98b2c03-8a4d-48fe-b6dc-d6c2eccabcaa">COMMITMENTS AND CONTINGENCIES&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Regulatory Matters - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company provides services in complex and highly regulated industries. The Company&#x2019;s compliance with applicable federal, state and local laws and regulations governing these industries may be subject to &lt;/span&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;governmental review and adverse findings may result in significant regulatory action, which could include sanctions, damages, fines, penalties (many of which may not be covered by insurance), and even exclusion from government programs.&#160;The Company is a party to various regulatory and other governmental audits and investigations in the ordinary course of business and cannot predict the ultimate outcome of any federal or state regulatory survey, audit or investigation. While governmental audits and investigations are the subject of administrative appeals, the appeals process, even if successful, may take several years to resolve. The Department of Justice, CMS, or other federal and state enforcement and regulatory agencies may conduct additional investigations related to the Company's businesses. The Company believes that it is presently in compliance in all material respects with all applicable laws and regulations.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost-Containment Measures - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Government and third party payors have instituted cost-containment measures designed to limit payments made to providers of healthcare services, and there can be no assurance that future measures designed to limit payments made to providers will not adversely affect the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Indemnities - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;From time to time, the Company enters into certain types of contracts that contingently require the Company to indemnify parties against third-party claims. These contracts primarily include (i)&#160;certain real estate leases, under which the Company may be required to indemnify property owners or prior operators for post-transfer environmental or other liabilities and other claims arising from the Company&#x2019;s use of the applicable premises, (ii)&#160;operations transfer agreements, in which the Company agrees to indemnify past operators of agencies and communities the Company acquires against certain liabilities arising from the transfer of the operation and/or the operation thereof after the transfer, (iii)&#160;certain Ensign lending agreements, and (iv)&#160;certain agreements with management, directors and employees, under which the subsidiaries of the Company may be required to indemnify such persons for liabilities arising out of their employment relationships. The terms of such obligations vary by contract and, in most instances, a specific or maximum dollar amount is not explicitly stated therein. Generally, amounts under these contracts cannot be reasonably estimated until a specific claim is asserted. Consequently, because no claims have been asserted, no liabilities have been recorded for these obligations on the Company&#x2019;s combined balance sheets for any of the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s businesses involve a significant risk of liability given the age and health of the patients and residents served by its independent operating subsidiaries. The Company, its operating companies, and others in the industry may be subject to a number of claims and lawsuits, including professional liability claims, alleging that services provided have resulted in personal injury, elder abuse, wrongful death or other related claims. Healthcare litigation (including class action litigation) is common and is filed based upon a wide variety of claims and theories, and the Company is routinely subjected to these claims in the ordinary course of business, including potential claims related to patient care and treatment, professional negligence and class actions, as well as employment related claims. If there were a significant increase in the number of these claims or an increase in amounts owing should plaintiffs be successful in their prosecution of these claims, this could materially adversely affect the Company&#x2019;s business, financial condition, results of operations and cash flows. In addition, the defense of these lawsuits may result in significant legal costs, regardless of the outcome, and can result in large settlement amounts or damage awards.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the potential lawsuits and claims described above, the Company is also subject to potential lawsuits under the False Claims Act (the &#x201c;FCA&#x201d;) and comparable state laws alleging submission of fraudulent claims for services to any healthcare program (such as Medicare) or payor. A violation may provide the basis for exclusion from federally funded healthcare programs. Such exclusions could have a correlative negative impact on the Company&#x2019;s financial performance. Some states, including California, Arizona and Texas, have enacted similar whistleblower and false claims laws and regulations. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2009, Congress passed the Fraud Enforcement and Recovery Act ("FERA") which made significant changes to the FCA, expanding the types of activities subject to prosecution and whistleblower liability. Following changes by FERA, healthcare providers face significant penalties for the knowing retention of government overpayments, even if no false claim was involved. Providers can now be liable for knowingly and improperly avoiding or decreasing an obligation to pay money or property to the government, including the retention of any government overpayment. The Patient Protection and Affordable Care Act of 2010 (the &#x201c;ACA&#x201d;) supplemented FERA by imposing an affirmative obligation on healthcare providers to return an overpayment to CMS within 60 days of &#x201c;identification&#x201d; or the date any corresponding cost report is due, whichever is later. Retention of any overpayment beyond this period may create liability under the FCA. In addition, FERA extended protections against retaliation for whistleblowers, including protections not only for employees, but also contractors and agents. Thus, there is generally no need for an employment relationship in order to qualify for protection against retaliation for whistleblowing.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company cannot predict or provide any assurance as to the possible outcome of any litigation. If any litigation were to proceed, and the Company and its operating companies are subjected to, alleged to be liable for, or agree to a settlement &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of, claims or obligations under federal Medicare statutes, the FCA, or similar state and federal statutes and related regulations, the Company&#x2019;s business, financial condition and results of operations and cash flows could be materially and adversely affected. Among other things, any settlement or litigation could involve the payment of substantial sums to settle any alleged civil violations, and may also include the assumption of specific procedural and financial obligations by the Company or its independent operating subsidiaries going forward under a corporate integrity agreement and/or other arrangement with the government. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Medicare Revenue Recoupments - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to probe reviews relating to Medicare services, billings and potential overpayments by Unified Program Integrity Contractors (UPIC), Recovery Audit Contractors (RAC), Zone Program Integrity Contractors (ZPIC), Program Safeguard Contractors (PSC), Supplemental Medical Review Contractors (SMRC) and Medicaid Integrity Contributors (MIC) programs, each of the foregoing collectively referred to as &#x201c;Reviews.&#x201d;  As of December 31, 2021, eight of the Company&#x2019;s independent operating subsidiaries had Reviews scheduled, on appeal or in dispute resolution process, both pre- and post-payment. The Company anticipates that these probe reviews will increase in frequency in the future. If an operation fails an initial or subsequent Review, the operation could then be subject to extended Review, suspension of payment, or extrapolation of the identified error rate to all billing in the same time period. As of December 31, 2021, and through the filing of this Annual Report on Form 10-K, the Company&#x2019;s independent operating subsidiaries have responded to the Reviews that are currently ongoing, on appeal or in dispute resolution process and the Company has no probable or estimable contingencies. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;One hospice provider number is subject to a Medicare payment suspension imposed by a Uniform Program Integrity Contractor (UPIC). As of December 31, 2021 the UPIC requested for review 42 patient records covering a 4-month period to determine whether, in its view, a Medicare overpayment was made. Subsequent to December 31, 2021 the UPIC expanded upon its initial request to cover an additional 60 patient records over an additional 6-month period. Medicare payments to that provider number are suspended pending the conclusion of the UPIC&#x2019;s review. The payments suspended as of December 31, 2021 total $3,700. The suspended amounts represent all Medicare payments due to the provider number since the start of the suspension and are not an overpayment finding. If the UPIC concludes that an overpayment exists, it will recover the overpayment from the suspended funds and release the excess funds, if any, to the provider. The UPIC has not specified when the payment suspension will end or when it will reach an over-payment determination. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentrations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Credit Risk - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has significant accounts receivable balances, the collectability of which is dependent on the availability of funds from certain governmental programs, primarily Medicare and Medicaid. These receivables represent the only significant concentration of credit risk for the Company. The Company does not believe there are significant credit risks associated with these governmental programs. The Company believes that an appropriate allowance has been recorded for the possibility of these receivables proving uncollectible, and continually monitors and adjusts these allowances as necessary. The Company&#x2019;s gross receivables from the Medicare and Medicaid programs accounted for approximately 78.6% and 75.7% of its total gross accounts receivable as of December 31, 2021 and December 31, 2020, respectively. Revenue from reimbursement under the Medicare and Medicaid programs accounted for 62.6%, 60.1%, and 55.6% of the Company's revenue for the years ended December 31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <pntg:NumberOfOperatingSubsidiariesWithReviewsScheduled
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzgxMjQ_f3e59f91-d995-4109-b476-1514f9acfd1c"
      unitRef="review">8</pntg:NumberOfOperatingSubsidiariesWithReviewsScheduled>
    <pntg:UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzEwOTk1MTE2NDAyMDk_1c088053-cec0-4cd6-8517-70933ecddce9"
      unitRef="record">42</pntg:UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview>
    <pntg:UniformProgramIntegrityContractorPeriodOfReview
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzYwNDczMTM5NjUxMTA_61df0491-757f-48fa-aac5-da1abb1cdb06">P4M</pntg:UniformProgramIntegrityContractorPeriodOfReview>
    <pntg:UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview
      contextRef="ie92494cf696341a4b8eb690958419fa7_I20220228"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzEwOTk1MTE2NDEzODM_3034eac3-54e1-40ef-80ce-356f80465db2"
      unitRef="record">60</pntg:UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview>
    <pntg:UniformProgramIntegrityContractorPeriodOfReview
      contextRef="ie6d715a9ac734e11ac6ce730afc95baa_D20220101-20220228"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzgyNDYzMzcyMjE5NjA_948e2c52-ef1f-425a-b702-d5eab471bc68">P6M</pntg:UniformProgramIntegrityContractorPeriodOfReview>
    <pntg:UniformProgramIntegrityContractorSuspendedPayments
      contextRef="if28ce3a43e8b460b988657b9a4224a4e_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzE2NDkyNjc0NTM5NTM_f7e41a9b-9713-4e42-a758-70dcd243b1cb"
      unitRef="usd">3700000</pntg:UniformProgramIntegrityContractorSuspendedPayments>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="idcd019ebb6aa4404ad2ce8284c512582_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzk1OTg_d9953b57-846e-4b8f-812a-968b29868d50"
      unitRef="number">0.786</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i84a5a381cc15426491a05ab72627a087_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzk2MDU_9717268b-9590-44db-8d0b-48222dd4defc"
      unitRef="number">0.757</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i663cd00e1ad6470dbb471e5fc87e9203_D20210101-20211231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzk3NjA_bda53759-a1d3-4be1-9367-bd363d79e094"
      unitRef="number">0.626</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifab97b7b0975436f83121c89244a55d3_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzk3NjQ_d158dcba-6b2f-44f4-81ce-193abf4da0bb"
      unitRef="number">0.601</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1f1a78bb16f147c18572f1380b8c667f_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8yMDUvZnJhZzo2NDg0ZDQwOWRkY2U0NjAzOGIwNThhMWI1ZTM0MGMwZC90ZXh0cmVnaW9uOjY0ODRkNDA5ZGRjZTQ2MDM4YjA1OGExYjVlMzQwYzBkXzk3NzI_c0a8f9f9-e6a6-454d-a0fa-d6ffe32a3848"
      unitRef="number">0.556</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="i207edde9314a4bd687eb41d894c01add_D20210101-20211231"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzkxL2ZyYWc6OTNhNzgxMmZmY2Y2NDA4NTkxZGEyZmRlNmY4OTc4ZDMvdGV4dHJlZ2lvbjo5M2E3ODEyZmZjZjY0MDg1OTFkYTJmZGU2Zjg5NzhkM182MDQ3MzEzOTU0NjQ0_d9c60ec0-ee5a-41ab-84ce-5d407dc99e64">SUBSEQUENT EVENTOn January 27, 2022, affiliates of the Company, entered into certain operations transfer agreements (collectively, the &#x201c;Transfer Agreements&#x201d;) with affiliates of Ensign, providing for the transfer of the operations of certain senior living communities (the &#x201c;Transaction&#x201d;). The Transfer Agreements require one of the transferors to place in escrow $6,500 to cover post-closing capital expenditures and operating losses related to one of the communities. The closing of the Transaction is anticipated to occur in the first half of 2022, subject to receipt of applicable regulatory approvals and satisfaction of other customary closing conditions set forth in the Transfer Agreements. As such, management determined that the long-lived assets for the impacted communities were impaired and the Company recognized a non-cash charge of $2,613 in its operating results for the year ended December 31, 2021, included in the transaction.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:EscrowDeposit
      contextRef="ib75d5bc9e37c446180e5fa26fafb6083_I20220127"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzkxL2ZyYWc6OTNhNzgxMmZmY2Y2NDA4NTkxZGEyZmRlNmY4OTc4ZDMvdGV4dHJlZ2lvbjo5M2E3ODEyZmZjZjY0MDg1OTFkYTJmZGU2Zjg5NzhkM183MTQ2ODI1NTgyNDIy_2b05528e-ebc2-47b9-8f19-f69db4b018b8"
      unitRef="usd">6500000</us-gaap:EscrowDeposit>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse
      contextRef="i941ffd2f6e49432b85465ef637f2d33d_D20210101-20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjg3OGM2ZWM3YzA2YjRhMTRhN2ZiZDA1NjM5N2ViOWQyL3NlYzo4NzhjNmVjN2MwNmI0YTE0YTdmYmQwNTYzOTdlYjlkMl8xMzkxL2ZyYWc6OTNhNzgxMmZmY2Y2NDA4NTkxZGEyZmRlNmY4OTc4ZDMvdGV4dHJlZ2lvbjo5M2E3ODEyZmZjZjY0MDg1OTFkYTJmZGU2Zjg5NzhkM18xMDk5NTExNjMwMDY2_fd12cc23-aff7-416e-9396-a19211ace2f3"
      unitRef="usd">2613000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>93
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MM?TFL!!:B\1>AIS!:C(OP.]+(?3^QC1P^ YU\P]02P,$%     @ KX!<5&@
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M]^MO[:01%.@'#\1V=F9G-O:ZNY;J66>4&GC)N= ]+S-F>>'[.LEH3G1#+JG
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MT*#11@Y5]OQR8N32M<V9--B$W3##:Y(J&X#OYU*:UXGMQ/7%V_\/4$L#!!0
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MR='SEN\ES5?R#'UZUQX-%8RP^,YP68_FIAH-Z1D-)NB>YVHKT6V^8JOW#H9
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M=C05OZRS?$NX.,R?1VR74[(JC+;)"#F./]J2.!U<G!7?/>079]F>)W%*'W+
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MSG^7OEWS7&GB>](Q; OU#,>)20E Q=2B!(F^0_/QJ/G8K_E#K.I#%;A^06J
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MXM:1)Q/2@EV*C\I(DRFIQ1R+!"8&+WX_7?C@P*4_7K#HH+/H(%IT\/^#_Y^
MQ'U!XI8,_ CBRMFZ&HIK@ZB^*LB1BE5%SE$N@A72BQ]_.)Q.]SXT)X;Q<_)!
M!* T6^>VK*39=EO-LGH6MNYYT3>+KX=">2%%876NS$ID"054#X4P5N3*H4@%
M.HU#]"$@O:?@AX+*2MLMD6=81VLR-8VB5ZTA, Y^K0H!;4*!>>A6.3+5 _/U
MPJM<2:<(D)6S:Y4#L2"I0Y%)1\*36ZL,:S)SUOOH<&5]>".S.I"(,AG(K4Q=
MER-QZID>H">5"W(=18?Q7&,8>SYY]\'O:&^,0KP/#Q&,DAHCAOCP%2R(/(P;
M42>Z(@C(=F'Y[0'L- J!T&K=1+&LC0HLH&T6<9'34Z>^6"/!<*D5NK91_&ZU
M=3*WR'\N"W[8#9:Y8B7+WM!:YGC.'C6V2WYSM.(ZN:<GB;!]#A)F/DA?0'7@
MC0?E$1.O4O$\;"VZTVHD9D;,LF Y,#$NDY^',6&7$%V971;>G,XO3G]]+RYO
MYE>OQ:N&-TFRQZ<>_VX1%A-:6D4B:6+'6<93)5U7OBWOE\Z6K?:6+%($^?1F
MZ8C /=2S6M3M,<X78A)0]WHK\-/#ZI*JO*^AE!W'1<?R+:]+H*!I9X]<4M$H
M_F#BDXNT:2QYU7-J7BGS9K9<MFZ!X2C'+#JG?!%A6IEA"\!\C'8WSG_-NU1"
MT42MY$+I1!1E8%<;&MXDF14M9L]65%M&N"_AY#<AL@9N%4S07IAW? ?M!*K5
M;478V"3;<[ZSL7\&E:EK+(%AS&*MJ.832^ZUT(LNG&!0?GFNTI+>IIHSUL1P
M6*TY#? 1[<T'L9&LP\"05!NA;TL7A! Q("\7'&Y(IC-I[F ^Q9*7"(G'7<]G
M^QE!.+YE? N^(-PY A=&GMH:0K[3I=I.:$W$3 4A:L,9B.S9E@O,!"W[;^ZO
M1FUAG,,K#%VM.2_UG2'TZ#@'K0FD_JKK1V=2!P0HQZ[KDI&%-3>^%=;DEB.,
M9E67DN\.;VN7,;HR:3KD@ 7*"H-NLT)N-+R'O%/^$3.+03OC2W28Z@9JW7/G
M;:JEZ=KH*UVMQLR"!#4HX$BGW4)58,(E<_<[_LOE$IR/3;$'&DG;-N'%MFT9
M--S)RD[/#@484L@UL1KEA-V8'6>>[RAV*Y7=2-QQC-&]XT43[]K&PZR;.V#!
M[JW:9I9QOKE#^P4=1]FFGCW8'T1)S#:H4+ &D3<H0%_86H/VS,*H-KC8M'R4
MCBF-OK5<+;#SKV[B86K.DAO)MLW#+N^^CG>C:_1WP].X-\66Y%9Q5N<"!@'3
M0-NM=G\'3M,4_"R>_DM\DFZED&Y-2QS=&[U[.P +XWR>/H*MXDR\L $3=GS%
M58RJ8P'L+ZT-[0<KZ/XDG?P%4$L#!!0    ( *^ 7%2X*((\[1P  /=;   8
M    >&PO=V]R:W-H965T<R]S:&5E=#DN>&ULO3QK<]-(MG]%Q<W>9:J4EY,0
M,C!4A1#8; V0(C!3MV[=#VVK;?<@2Z);2O#\^GM>_9 L)\#L[@=(8DO=Y_WN
M?GY7V\]NJ76;?5V5E?OET;)MFY_W]]ULJ5?*[=6-KN";>6U7JH4_[6+?-5:K
M@EY:E?N3@X,G^RMEJD<OGM-GU_;%\[IK2U/I:YNY;K52=OU2E_7=+X\.'_D/
M/IC%LL4/]E\\;]1"W^CV4W-MX:_]L$IA5KIRIJXRJ^>_/#H__/GE,3Y/#_QF
M])U+?L\0DVE=?\8_KHI?'AT@0+K4LQ974/#C5E_HLL2% (POLN:CL"6^F/[N
M5W]-N ,N4^7T15W^;HIV^<NCIX^R0L]55[8?ZKM_:,'G!->;U:6C_[,[?O;)
MV:-LUKFV7LG+ ,'*5/Q3?14Z)"\\/=CRPD1>F!#<O!%!^4JUZL5S6]]E%I^&
MU? 70I7>!N!,A4RY:2U\:^"]]L7+\YNKF^S]Z^SZP^7-Y;N/YQ^OWK_+SM^]
MRFX^O7U[_N%_\+N;JS?OKEY?79R_^YB=7UR\__3NX]6[-]GU^U^O+JXN;Y[O
MMP )KK<_DUU?\JZ3+;L>3K*W==4N7799%;KH+[ /* 0\)AZ/EY-[5WRE9WO9
MT6&>30XFA_>L=Q3H<D3K'6U9[WPVJ[NJ-=4BNZY+,S/:9?][/G6M!3GZOWLV
M. X;'-,&Q_]APO_[=\U>*F=<5L^S:ZN=KEI%^K6;?5QJT+)9O6I4M4;*S>K*
M ?$*U>HB4U4!'ZRF %&1S4VEJIE19>;@=0U:WM**+2QQP0MDC_&/__ZOIY/)
MP;/7X?F;\#Q]=?CL)[0-J.3IR_C=X>DSEVS4U,X0H&#)Z-&U5M9E&@4P _'1
MJZFV080(7/CE(*??QI8&Y$'U"6RPD9:HX!A-Y9;9'.R=^[;-Z/\#V?+PC'Y9
MJEN=3;6N,C"VC;+PGJF(O+8 C#38B79)?XN8-M8 HDT)@KK0%<!3EFO\7C<M
MOXM@?*H,_D5$=-ECH>Z;\_/K0$W<O.FLZU0%)*WI-:L772D("I=N]*RS0%#-
M*%]^G2U5M2 JK8PCF^V7O[F\\*OO@<P8) FO>].8:O?]?)[37_=+QYVV.M("
M#3I^6Q6[JJPKC:;9,"B%MF#H815;KV3=1 Q'U\;7$E):C50F5"_!_2RJO>RM
MJL!'X=/ E-+H6\"[72H6NC'I]%*9$]O*$HQV"X#!,R W#7SA<OI8%7^ E1<4
MEV8&/ 4\86>55>AV2@+.(K4MPE:IMH,'*I AY\"-(BD;UL-LKHP%IG^;'N3C
M IQODV!XPM1 %-F,90I(BX&!:=<LCRA)F6H:L)AJ6FK/9U55'6Y-2^QEYX"W
M@26LV(H,K&KEU"QJT%25*.0.B-W>H1+@*K<*7N]<5NH%+ 8PL/CA(M8X)$YJ
M/J(" ;_ <ZH(LD@#[+9'1FN[G>I;)U"P>J6#O9$_20Q0]MK6FFG7IHA[8+P-
MJ6IXIVIM798(+Q%!NY;!\ \C.,;QE@%G0 &A*XV:FA+IS;3S^@<"V]3>!L&*
M (2!J*! 0)BY.ELBM$NMRG:9PQ^N,3.=\Z<S$#KF// 6%;0TMPA@E L&<532
M@0YE5VCF-&L1P8[BG7")T0:0ICT1A=]MW2V6F<&W[L!RN:5I6 -6ZH_:(K*W
M==NGUP?0P*H#*ZC<0.&C*"F4,HY;T1RAUIFYF0UX$U3$:7MK4.8:6]\:,-1>
M.!SAN&E*OEU2"F/Q!R]%QJ8LZQDMPI\U8U9Q+[MTK5F1J<:7SAV$S@VSF+TM
MFT-&3^SR%@Z-:ZK57SH S0&A@WD#(%;J,Z"J;0M!/0I3 H-*8"#!5_.Y][T
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MD@M\^N3W8H54)VZLP^TIE"Y3UIKSV5\I;7LXAV=:!T1>JH(_[U-ZEA@GBA7
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M2Q/+XP-VN9'U*P X [KAG&L^N_7L $>*MBZXC_=:U3!=JS59W4MFC,H=UO@
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M,H.4CF>G :5T?)KNP502IKAD*X=&^'6@#(#N]%&D#@3LVMRI4DFKR,7F[25
M+-J@A>GW5O&8P[HEX"/XX],F?HHO)E4QP1DTA6\MIXU*@#_>)L*$?O4KS"^^
MLS8]^$ ;N,5FRGD94QX&DZFD((X!$G())TMNN\/ /PUE+*X"J1T@UT.#M0F;
M&^;'-5GLU?:'F<O L.V&&5B?:3X;OSWYY77NQ$JR!ZFJ0 N/%-25^?GN86IZ
MER6SZ4E/BEPHYOC%7E05><0=0ND8D35/DNG\;:SS0BHKUK)JJ>^-%YBH ?,^
MJ#K062&MW;)44$:/MM07TJTP&G$-U5QW"GVV1G>%-/=Y\7 8RO7+J&"V7AH;
M%G'F:G30%\+*)[)A^_"HO%(HERU6VWTV,;DCNP[>04_WP.D1ZYTH?NI?N%]B
MW0,G$*]1/PQBK^+8..+.J'@!SK>B(.MQ('@R7T,[*1U'F&WB>,&S",^[4S<L
MXXZ*E@<-1B4HE<IE@ 3[XN+^B?F_.)XK JS5*SPP'VYP&."K% ME48%*D6:,
M6 XMXQ4G)/##G@(S#PX.&.4 \-89C>]H#=S[[3-(8LO' +ENB\][B<*LB>G6
M,0M@IX6]&K=^QPL\\&&GXZTJ\!5>?V"QXQ[KP68Z:)B#79PJF0_#<8CD7@$1
MC"^YV@$8UW4/FDLZ1][Q>H7B!$,YR$%CDXG (J91H);WW.!KA!T8"0NS7D;^
MP'D,'.I4%W!-=ADFTX;M<*3K^"GLB88LAPH,&R<74F(2[F5*Q1LB7<8O$<(>
M.@JB06\L/BD@7K"U1_0[;F<BQ0XE;%K#GJ@W7O&T!0JIJ&/#L)C$N@D%E(M(
MVZA@JP/%]#/^2AYDWNS=^VY'!E1=BPY<_!SR^-"19K)S)@S@\LF7S2*D>#P<
MW@Z'ZZMXIGP4CR?S7\,6QB'?!533\=GI2-AXVHT/WC3AA)D;CV8.MRN26'M8
M -\7QOC^@1T,_W*X_!]02P,$%     @ KX!<5',Q(W@*"@  5!L  !D   !X
M;"]W;W)K<VAE971S+W-H965T,3DN>&ULI5EK;]LX%OTKA'>ZFP".8OD5)TT+
M)$TZ6Z#3!$D?&"SV R/1-K>2Z"&IN-E?O^?R(4NVD\YB/B26J'LO[_L>2N=K
MI;^;I1"6_2B+RKSI+:U=G1T?FVPI2FX2M1(5GLR5+KG%K5X<FY46/'=,97$\
M' RFQR675>_MN5N[U6_/56T+68E;S4Q=EEP_78I"K=_TTEY<N).+I:6%X[?G
M*[X0]\)^6=UJW!TW4G)9BLI(53$MYF]Z%^G9Y9CH'<%7*=:F=<W(D@>EOM/-
MA_Q-;T *B4)DEB1P_#R*=Z(H2!#4^"/([#5;$F/[.DI_[VR'+0_<B'>J^"9S
MNWS3F_58+N:\+NR=6O]3!'LF)"]3A7'_V=K3CD<]EM7&JC(P0X-25OZ7_PA^
M:#',!L\P# /#T.GM-W):7G'+WYYKM6::J"&-+IRICAO*R8J"<F\UGDKPV;<W
MMY\_W'RZ9Q>?KMC%MXN[J_OS8PNY]/0X"S(NO8SA,S+2(?M-579IV'65B[PK
MX!@*-5H-HU:7PQ<E7HDL8:.TSX:#8?J"O%%CY<C)&STC[W[)M3BBZ.7LEC\A
MJ2R[T)I7"^&N_W7Q8*Q&AOS[A<W&S69CM]GX+[GT11E4BF=FQ3/QIH=:,T(_
MBMX>P6V[,E6B4@UWR2Y^T+7 (LK'6,/4G)D6\2HX@:^YS@T2*A?,*B;*5:&>
MA#",5SG+I4;M*&WZ3%994>>R6C0D#*F9?6=J1?N! EI:+3,+X?Y)$'WP][_-
MAL/!Z[O["W>5OC[L.^D[#'4E;9O^2Z!WU%8MA%T*C?*P2P9A?18)-W+N2<YF
M%V\J><-8B0+&S9Q+S1YY40M2&07S4#PQ]0BY$ Z5_JBED1;&P>,R$VPEM%0Y
M>8^>.Y,2]AF7[^!M7CVAJV2JKJ W^B/]S86TM28'&F*!\"RK=<(^5!2+*O0B
M9P1)O%_)ZNAF/N^[NRA4&E-#V0H]+?AWO\>"BQ&X6U%5G.()LFN$?%&U8EFC
M*KV!PT%ZRF[*2C[4!BIE2 'T1'9;\(H=$$'P*;OY<,NB^P^=U(^J6AQ]%KI\
MD>_CYPUC?Q,T=%JAM: P!L=$CJ@XB3+-C@F[A=\UD4</,31AQHLBA,2P5:3H
M^G%C=@A:=.J*:RLSN7)Y(*O@IG^83EUTBFA%.OEP[RTN5(?2:'CLX:D;/E<L
M9"T6(S$W1F72;1ZCC]5&VS[Y98WA1+_P*BQ5F=]NJW0[JN!9)K3EC3TM^]=+
M!2>I1TFJ+$0E-"]<*'F.02*IX;DHAEPW5"FJQI 32U[,$W936V-!3U4?TW I
M"F?NLU[>Y%K0QV>J<R4[P+1RX_A1%$_M+ BT[23P6:?VZ/!2*6RVCPK=UP]&
MYA* @UVCNNU3S-I.0VDI[)3HI"A<3_FUI=Y::,%*E<NYA!9>*9B9Q0 W);FM
M62?E&;>=!&8Y4B1AOK%?NH"_:P><DG$.+ZHUN227)BN4<0T'N].D@.!GLV63
MN 46P!^J)UA.-G24:_?]3:]Y+O;DF?3D-0HJNER&0;*3SYFBF337JFQ)@X>=
M)T+K?0=3X+%GRMS/!(N,?M9:/K?!XY$-M?PR2W30//2:8*"/%"W2W9/@VC!!
M4(<!J(CR =M$L.+^#YQZU&S/V.^@]KAHE]C3NJ9\N\_,LY_I^XO+T73XNG.5
M]D>G$_3+F"5=D3_%#"X[?*_NS'@VZ@].1Y ^G0Y@PN3_DK0]I=FTGXY3_,?I
M 2(GL]._)@YKE:J.&G328!<V&TS9^&3"9J.?>S,=] ?C 2YF_=%H@M]1?S0;
MTO">US36X_#ICNL(+Y#"%K6/O*')L*CD?X6CV]3KGTJ\NGJ$Q*:SM=M>\VC;
M_CZZO<R6OBDU5-R5Z$[:G;$O5:/A5G^Y#HI\<\<9/+T .,+I##LZ!D=TZU'1
M 2K6%<,A!.[5&1X=]J?(\5$RV]#L!&_</YD-V" Y#1&JV^K]U&?8Y*0_1AIY
M83=A[R_[&VZ_46X!_!_2::>E=5H8UJ*(,$8QO<@6CQSG-$1]4T S'PY>49:X
M!9JH#C=6%6BTH2$4-G";AV8?-89!R%IF117%-1V,"(G5L741:&V$'U>7&#[?
MC^ZSI2I(:2?T".TSH\S#H!(%F=I-30>%7T08[<Q\X031&F\>-5T)Z$XX(S0@
MO@(6@39D"*'P([^UUXMR.^-%5L>YM!0MJ+ZM7]@R3,Z-)SU^IUGHCCU0"/!>
ML/_4^8)4[9QB?,FZFO0 1=/,>52D0$$H@50BVUV:>F>R0LY%U_FY )11*]/J
M <VI8PF(I2 6"0WMN)-8<OU=6"CB7Z= :*S<#$,R6]*)E-$P!JK BFU.)[(,
M.W?=(CA8@W;2M XZ(?-:SJF-&^-_)DT:2+3I7.O8#WCH!\"S=1D2U^5&I_!C
M;>W.X#/VJ]/)S<68^;\&\CMIOA^]U^C?'VCX4XG=D>[7,1 ?$0%VP \W*U\W
M(3MX.&17DO N//V[)*BZT\;>D_N^1O?%_=TP'D_&+$U2]HI-DPD;S9(Q+N-4
M?45M!EUL[&?V%(-P *I .T'KVJ)-D\'$C_;I] 1RIY%V["[;M)/D9.",VK2L
M4N8K)>&F$B!5Y?WF*+&=CA3U#L.#L&LA?/11!NZM1HT4;/,X\$0U&9Q"O8R"
M'$Z[$>C$8#X(>AA"2EDH"6V:N@@G*5[M5PT.)HM]+]L6VHBCJ%V*C*./[463
MPJ-VUP!P ('.4(@,U)Q E8-J =&Z8X59*FW;!W>43G^C8+O$FQ1F:]XJ7-<8
M-V20$9&'K/(:L^O)9WLX&VZ*Q+I^TP!Q'YF]+TS\VTB2GM<Z=CPW,I[!E6?L
M4^T66EG;/J#M)/KU#Z$S"9_>NLZVR_W5#^.?,>YR;.M&^.T4*(GF<#*>L6E*
MR.DDF0R;NJ;2^H7*9) V\H$?TG1RZ$A1(>_]NQ.1'U-M2WI9<'!R2H^':3)+
M]X'G_G \],]',S9SN"T=)L.9BPI?++184/- 5<#%1F:;MAF3L'6\[#./3OHM
M^.1&0-36@RE:BZD<<NR9B%%E<A.RPYPU7MPE;,<1)@ -C4^CLX%(<=S<8*=Q
M?P(#-SX<P0G>X&TSL7T<J5Y[AR/D?(Z^6F6BTRC"6&K\0VMNHA=/I!0 0:GB
M43XVC^B9,#H#5_"LJPQ@&8='4Z"S8=>M>\_U=M<WOL)VAD^[L;E60R%Y(:C=
M:0X4Y-#;O@U=)SA)1J>^;26[8/597-D^$L3YM^^<$ME:[WZVW]W$\^TS9YJ$
M7="+(@^#MB#I)JPT1C^!_^L.ZK[PG#NE[R?S%15-:T[NJ_>I.QVEXP2X/18Y
MP?S3!(T@;'B03DX.63I-\*"I;G: D@=?.MKC>R0*YBKDHE$,V+Y7\<>M+QVE
MT OW/8?P7EU9_]&C66T^&5WX+R4;<O^]Z3>N%Z@75H@Y6 ?)R:3'M/^&XV^L
M6KGO)@_*6E6ZRZ7 S-%$@.=SI6R\H0V:#VEO_P=02P,$%     @ KX!<5/*'
M\W(1!P  'Q$  !D   !X;"]W;W)K<VAE971S+W-H965T,C N>&ULO5AK;^.V
M$OTKA.\K 53;DOS<30)DM[MM@2ZZV&Q;7!3]0$NTS:Y$JB05Q_WU/3.4%2=Q
M@EN@N%\<29PWSYPA<[&S[HO?*A7$75T9?SG8AM"\&HU\L56U]$/;*(.5M76U
M#'AUFY%OG)(E*]75*!N/9Z-::C.XNN!O']W5A6U#I8WZZ(1OZUJZ_1M5V=WE
M(!T</GS2FVV@#Z.KBT9NU(T*/S8?'=Y&O952U\IX;8UP:GTYN$Y?O9F0/ O\
MI-7.'ST+RF1E[1=Z^:Z\'(PI(%6I(I %B3^WZJVJ*C*$,'[O; YZEZ1X_'RP
M_IYS1RXKZ=5;6_VLR["]'"P&HE1KV5;AD]U]J[I\IF2OL)7G7[&+LBF$B]8'
M6W?*B*#6)OZ5=UT=CA06XV<4LDXAX[BC(X[R:QGDU86S.^%(&M;H@5-E;02G
M#6W*37!8U= +5]^_N[YY=W,Q"K!%7T9%I_<FZF7/Z*69^&!-V'KQSI2J?&A@
MA"#Z2+)#)&^R%RU^K8JAR--$9.,L?<%>WF>6L[W\N<P4-LN+7ZY7/CAL_J\O
MV)ST-B=L<_*7J_6_Z(G/6R7>VKJ19O_O?RRR=/[:"XWRH<-*98) JSD9M-F@
M1U9>EUHZC10JRD1,)\(KHZT3E;XEF<+6=6MT(!%I2J$#_I; B*:$">S"KM>Z
MP'(+^TX8:[XJI"E4)5>5.O+&#GPB:NL1Q%KLMKK8BJV$!4T.9-7%$)2KO7#2
M;$AM[6PMUNS'*#'D]-0=O-_;!)K#]F$VL/\./;U!1SHE0"N]CV@=ZRL5=DH9
MD4Y$L,"#V"OI_%!\!YVRU-S.6'"H62*41*Q0"MOCE HN,Y<&7ISZO=5.E:35
MR#W+KFT%1H+L*W&6G@M954+7C?5L/E8TR#LN_ZV&*GPB5L['*=^ 5<@:6>)4
M2]$X<L_;<6;QW6%1FLX(1;RE<B(P=0BW4MY;=_Y:G&4Q@#;HZGY#HQ&OW"UO
MHE'X]6!.BD,VY,YI&6(-3\?!26!EU7H@TGN4Q91M$6(Z)W403-Y5P_C6$5SN
MRZ<-63 =HW(M_D['D^CX .R]H*D2E.$@R*13C=0. CY GKZ<3:/.6BE_*CRT
M&OJEP!2A34#=VK"U3O\AXR[_?VHZ%._U.A"BNXU_3 (2?5J1W_+Y'@?2[XJJ
M+>DSV3AN?P M,-!C \!,['B2ZYJMH\,SZ6EH(?)2 %U*F_/DI.;.(I1&TC=L
M@T=O=AP@'?6_PF#&:4#\>/#C'XHA7"E6CIN38A,HUJ921WM;V+8JB1I^HU8B
M!D':M75]=T3X'Z=9V%M%,%S%#O:R?A1;UY"\T(UFX;3_@@V0NFH=2Q U5/L(
MCP^JU 6E3[L:7S3OW*VFO#K@<ZY"8Y]ZJ[%*7B$@,-<SV]IQ(-E^4)NA^#EB
MD]@?&^TU\3&O):!Q\E1JHF[RQ$0'1@?$.(&X]0>B.KANK M@-&VIB@J0M+4N
M[AF51!Y4BK+'&:TSA^XPH6<EQ%M95T9"9U^&"X#U1S.#.S'B![B*C.I?B?^"
MKN.Y0&"JJWH%MX?)3C]C_*1+\<,)8]!^+PMBP3WS.]<R>UUTDZDGPW^*?)HL
MIXOX,)UE]) EXS05/_#0>U%[DBS'4Y$G\WDFLF0YFXB;=A6#Z!BZT\1HF( .
M#V^?7HQH,DX6LYP"62;I,J4'.)I/Q3?*,$P("(\FM+IKB)L@F\UG]+N<BA39
M_(1A*7M4<&G0N^>0F"79A-*>)GD^1B:S\8)7/BF<RCUOU.T)92*TIQ,_3GHN
M/&4.>E$'WMIWDXN/%H=1D' _6I[=\IB>$Y8C)+4U=ALL6B@^V]R17=>YPV/K
MJ(.!%G +%]"VX ^G&X1K< GINH"LQ>!T'UDW?Q[5_<#4?$80ZC3JD@@[LDK0
MB]#N3P#(E*KEMT#O/8,C/70< 5$:6>V]CKYHVAP:FWOBB;.N :YKVZ*K\(7!
MN4B6V9+><I'/ 8L%/4]$/@,69_0\)23/X_<9/8_Q_)E(6JZI<?-LG,P U<\V
M] <R'&8B.4W'A(<<-._10AT2 (2J16N6O^$B$>7.D'XRF>&\\?&!#/7^D5T,
MH]7A*)*/\V0Q3SO3O($FG) [2V=)FB[.Q??6;+XBZGE"%\?BP/IBGLRG^1,>
M.)8B:EGQ..V&*V&D>1+ZEOJ=X'AOI2\-#8V3$A0B'RI+18]QB<GTL?V'%I-C
MLA<M!:=C_\11@2JNK',16CQ 'V2@3;Q+\Z7T%G.)P8<AR<.27?43A+I-H;W(
MK"C)%,;!(5QUI/$?_VRQ]T-Q?1JH,9$=WURI*6F8;4[7B=HPG0S3KLT.AZ G
MNJ7V!<.>\X;2?+C\U_#4U6MT=&D%96SX:DX90SO>7_NO_>W_.EYZ[\7COPX^
M2(<+"<W;-53'P_ET@+'/U_'X$FS#5^"5#;A0\^-624QP$L#ZVMIP>"$'_?]$
MKOX$4$L#!!0    ( *^ 7%0?UAV>,@H  #L;   9    >&PO=V]R:W-H965T
M<R]S:&5E=#(Q+GAM;*59:7/;.!+]*RAM9E>N8F@>.JA,DBK'3G:R-3DJ3O:H
MK?T D9"%"44J &C%^?7[ND%1E"SEF@\2)1R-/E]W@X\WM?EHETHY\7E55O;)
M8.G<^M'YN<V7:B5M6*]5A9E%;5;2X:^Y.;=KHV3!FU;E>1)%D_.5U-7@Z6,>
M>VN>/JX;5^I*O37"-JN5-'?/5%EOG@SBP7;@G;Y9.AHX?_IX+6_4M7(?UF\-
M_IUW5 J]4I75=26,6CP97,2/GHUH/2_XIU8;V_LM2))Y77^D/R^+)X.(&%*E
MRAU1D'C<JDM5ED0(;'QJ:0ZZ(VEC__>6^@N6';+,I567=?DO7;CEDT$V$(5:
MR*9T[^K-;ZJ59TST\KJT_"TV?FV:#D3>6%>OVLW@8*4K_Y2?6SWT-F31B0U)
MNR%AOOU!S.65=/+I8U-OA*'5H$8_6%3>#>9T14:Y=@:S&OO<TY>O+]^\>B[>
M7_S[^?7C<P>*-'Z>M[N?^=W)B=UQ(E[5E5M:\;PJ5+%/X!RL=/PD6WZ>)5^E
M>*7R4*1Q()(HB;]"+^WD2YE>>DJ^*J]72KR7G\65MGE9V\8H\=^+N74&'O&_
MKQPQZHX8\1&CGU3A5W=3T#VR:YFK)P-$E57F5@WV2(KW2R76IK[5' B(0Z&]
M4 Y"J<\(3ZMXV&'AG9+&"D76$-"E6LV5Z?3)WY&058$?\4QHVP:C_H+ETH)*
MB2BUC\1_0,;;]#X53X0)7#;&J,H]$B]4H8PLQ0,1!]-)AN<XB,;\G"3BVDFG
M\&N"V=$T$PD^[VN'];DG()(@34=B$HS3B<A&$0Y=*,P4.\K#.$@GT9D8ID$Z
MRLY *9I&+>5A.DLPDZ4T/AVWM(N6!FV=CFG!*(BS"6U-1MM%1U0)GK,$W^!I
M'/$SRL;B A"4UU6N2RT93^H%*WS1\F?!2>-J<R<,L>1JGE6+A6+<X1-XIF?
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M$8R-,.KJO1%_O#3D!'843OTS(A79-%-7U[<STDH\$ U!HHLE3(MJ6AA^+DL
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M;.RH>(@LI"2/UPQ7Z/2IEJGVS=5K\#3!K'@FRCD)-SMR<.@8*UU,11V'38$
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MWE@=E\M[O]?:;2P@IS85'EW,GSXY0TKPN[3RH>]V_/XJB'/?-?SGUJ!$.UJ
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M%"!3H!-V5EF#T: BY"QRVR)NC>H'>*$!'7(.PANRLF,[S-;*6!#ZM]E!/JW
M^3X-AC=,"TR1S5BG@+48L$U_S_J(FI2IK@/OI5:5]G)633/@U@3B:,:3_10\
MV4^S+N@LB'2/!YM?O@3&&Z#!BK/*P,4V3A71A%>J0BMS(.W^#JT0R;A5@/_@
MLDK? #7 !-9_!&*-0^FD_BM:,"@,1%05>19Q/R*ON=]1CMTC6'A;Z^#PY"OI
M(2I_WUNS&OJ4\QX9[\2:%M8TO6VK"O$E)FC7,QK^943'.-XRT PD(':542M3
MH<"9=]X!@,5TK7>" !&0,) ME(@(:Y?.-HCM1JNJW^3PQ76FT#D_+4#K6?5
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MV#V8<J?N6^MRB0>HMV]U"2IJREP^62T"1$.#A/P!J-0M:B4^#:^ WE>J8 <
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M4+DBF7]VL<X\TV,8&G,'G"AI$U  L#4E5F-ONILY!0W,QTDO:2FI6NJ <Y'
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MY/#H%*=/L".T=98\-'YN %'VDU=;IQ0X7^"^/F#@O=G^"834D^;($LSSQ?<
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MQH,OP._K%FHR^8(;A+_=\O+_ %!+ P04    " "O@%Q4=,>W6NT#  !F"
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M2KCMH=N4PP>RO3 8)+%[Q?&(XG'0'PWHX_Z9T-DNP=M!Z6#61D[#3CCVK_[
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ML-\B75^XZ@^KEOZ2,U,65R8_S'%'Y=H9X/]<*=M\N ";6^_)WU!+ P04
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MK1F>=,[XT;GV\D'@?6D>[<:8O"?]IOGH/UX7)YW(&V0J,W >(<?KP5R8JO)
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M(OS5<',@[%%R8T-/)F\M&1]V0M#,I ]/EH$+SXCRNL" 9XQ*N]B2Y=^0+^L
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M1:VYSLE,-1IGE!%GWR(T 5N+2FB8\2IG/ ?[).6*9,3$/=J"$89Q+5BE+.,
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M#QCTA3W! (4B1QGKA-@*8:,$&9/+[13H>K%>H^ZON/_$\ GIZ5=*E,!KTO^
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M"+E3+AMN<:'E-U&YW20:15!AS3OIUGK_$0_Y##U?J:4-*^Q[WP$YEYUUNCF
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MIA>7PPA,/W#ZB]-M:/*-=C0RPG%',QJ-=Z#OM=;N>/$!3E-_^AM02P,$%
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M+W=O<FMS:&5E=',O<VAE970S-"YX;6RE6&UOXS82_BL#7WM( $669-F6TR2
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M:8S,[3+EV"\5$>#Y6DK3?)" ]GGJZB]02P,$%     @ KX!<5(+>R10H!
M4 D  !D   !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL?5;;;N,V$/V5@;HH
M$D"-[K*<V@:2;-(6R&*#)-VB*/I 2[3%KD2J)!4G?]\92E&]&\<OTI"<.9S+
M&9*+G=)?3<VYA>>VD6;IU=9VYT%@RIJWS)RICDM<V2C=,HM#O0U,ISFKG%';
M!'$8YD'+A/16"S=WIU<+U=M&2'ZGP?1MR_3+)6_4;NE%WNO$O=C6EB:"U:)C
M6_[ [>_=G<91,*%4HN72""5!\\W2NXC.+S/2=PI?!-^9/1DHDK527VGP6[7T
M0G*(-[RTA,#P]\2O>-,0$+KQ[XCI35N2X;[\BG[C8L=8ULSP*]7\(2I;+[W"
M@XIO6-_8>[7[E8_Q. =+U1CWA=V@FZ0>E+VQJAV-T8-6R.'/GL<\[!D4X3L&
M\6@0.[^'C9R7'YEEJX56.]"DC6@DN%"=-3HG)!7EP6I<%6AG5[?7%P_7#W#R
MR-8--Z>+P"(H+07E"' Y ,3O $0Q?%+2U@:N9<6K;P$"]&9R*7YUZ3(^BOB1
MEV>01#[$81P=P4NF$!.'E[P7(L>J&?CK8FVL1A;\?00SG3!3AYF^@WFEVDY)
M+JT!M0%L$<VLD%MH:"\HE3V4R..0CS49'H<UU@>F.3 #&]5@0YES^),S/>0>
M,'.\77,]98\^(7ZB.7P^ (;6-ZP4C; OV&#2_OA#$4?QS[1$^QNNGT2)J?L
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M'JY) =<W2MG7 6TP/:)6_P%02P,$%     @ KX!<5"57X-F#!P  910  !D
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M+<#\O&G,^H48##>+%_\'4$L#!!0    ( *^ 7%0+NX54K (  (@'   9
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M<$R1RA9:<[8 H2M)#5""9X02^5&5PVU,-X^I*_JMI^J[V3'?RIDZ!M4LURE
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MLL3;1$[9_G=2)!1JO 5+A/D%^]RVJ8P76R%96CBK$:0TR__Q6T'$@0-J7W!
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MN#90[Y>,R8\'':"\RNG]"U!+ P04    " "O@%Q41H(RR&,$  !A#@  &0
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MT9RNE'9!X.>=3FF>:T\0QS^UTT'S36W8?MY[_V[( YDW(NF4YS^S1*4W@]$
M)71-REP]\=T/6A,*M;\5SZ7YCW8UUAV@52D5+VICB*#(6/5+?M="M QP=,+
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M"NX+YC&%.R 5&@#OUYRK_4!_H+E53OX#4$L#!!0    ( *^ 7%1Q.$6Q]0,
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M6 19<':2Q$\HV:/SUO9OBL$LV'GWPVBO^VV6Y-^&.2\[N[G\=/GAXR4Z_[!
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MAD*8DW4LQG3[ _*$'.4OH#'/?M$VMS4T%*RYH$D.E@R2*-U]R4LN1 F [2,
M,P>8'P58.<#*$MTQR](:$$&Z;4:WB"EKZ4T-,FTRM,PF2M7?.!%,[D82)[KC
MX=/P83I$O8<!ZO7[/Z</CQ,T'O:'MT^]F[LANJQ=/1N (%',S^7^=#) 9]_.
MT3<4I>AQ2=><I"%OZT*R4S'T(&=RLV-B'F$R@. *6?@"F8:):^#]C\.-MW!=
M:E((8Q;"F)D_ZXB_7A#0=2HX&D, T8;,8D"_>S,NF#QY?QH"6$4 *PM@OQ>
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M/A8K>KPF)2$CT[>F,<]_P;' 6E !ZST7-"F%I0=)E!;__O<R$ T!9%X0P*4
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MO"1'"-;=&;Y^EE#C,$ _FZ=2LAE:36YQ"[82U8/#AF8:3BM3?3AHFHW$GW/
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M9<F@LV+:*Q:"[O+YYXD*.4WECZ&<D G+ /+[AE)Q6F0&JIE[\C]02P,$%
M  @ KX!<5)Z*)*->!0  /1,  !D   !X;"]W;W)K<VAE971S+W-H965T-#@N
M>&ULM5A=;]LV%/TKA%<,'1!'(O6=.08<R]T,-'%@I]W#L =&HFVUDNB2=-(.
M^_&C*$5V)(K+RUYL?9Q[R<-[>>\1)\^4?>5[0@3X7N0EOQ[MA3A<619/]J3
M_)(>2"G?;"DKL)"W;&?Q R,X549%;B';]JT"9^5H.E'/[MET0H\BSTIRSP _
M%@5F/VY(3I^O1W#T\F"=[?:B>F!-)P>\(QLB/AWNF;RS6B]I5I"29[0$C&RO
M1S-XM4#*0"$^9^29GUV#BLHCI5^KFV5Z/;*K&9&<)*)R@>7?$YF3/*\\R7E\
M:YR.VC$KP_/K%^\?%'E)YA%S,J?Y'UDJ]M>C< 12LL7'7*SI\^^D(>15_A*:
M<_4+GFML(,')D0M:-,9R!D56UO_X>[,09P;2C]X -0:H:^ /&#B-@=,U< <,
MW,; ?:N!UQ@HZE;-72U<C 6>3AA]!JQ"2V_5A5I]92W7*RNK1-D()M]FTDY,
M;SYMEG>+S09L%K_=+NX>-F ,EG?SU>T"?%BO;L'J?K&>/2Q7=QOP/B8"9SG_
M14(^;6+P_MTOX!W(2O"PIT>.RY1/+"&G5#FVDF;XFWIX-#!\!&YI*?8<+,J4
MI!K[N=D>(H,#2ZY%NR#H94%ND-'C*A&7P(87 -DPTDW(;!Z3Y!(XRAQ!C7G\
M=G-;8[YXLWEW\J\6PVFSPU'^G %_:_)$RB.Y +?X"V5@KO*1,/#G1PD$2T$*
M_I=A&+<=QE7#N /#;,A.UAX!9ND7.0))P>)F^1#/UF#+: %6!\)P555T^36O
M/?O*<U45GZ:^'P;NQ'HZ7_4^*O!L-WR-6FA\(6@'+>H5.:\EYQG)?22<7X&8
MR#J>9+BNCF4*<$&9R/Y6#W2\:J?>V5S<(.S2TH#\P.NPZH.<$-IZ4GY+RC>2
M6LMP_?Q3B"#Z-:%< +H%G+"G+"':(/G]>=JA[W38]%%.!"/8H:-!N=$9Z5=\
M@I9/8.2S$GN9UEF9R/36$0AZ@XY1-QA]#$+=6/0Q X$(VXF';\BNN8P!!U@
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M"0<  +4H   9    >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;+V:7W/:.!#
MOXJ&Z<VT,TVP)%M )\D,(=R4FS;IA;3W<',/PA:@J_]0223MS7WXDXUC&6P+
MPN&^)-A(NZM=[4\KH8NG1'R52\84^!Z%L;SL+)5:O>MVI;]D$97GR8K%^IMY
M(B*J]*-8=.5*,!IDG:*PBQR'="/*X\[51?;ND[BZ2-8JY#'[)(!<1Q$5/ZY9
MF#Q==F#G^<4]7RQ5^J)[=;&B"S9EZO/JD]!/W4)*P",62Y[$0+#Y96<(WXU)
M/^V0M?C"V9,L?0;I4&9)\C5]F 27'2>UB(7,5ZD(JO\]LA$+PU22MN-;+K13
MZ$P[EC\_2_\U&[P>S(Q*-DK"/WB@EI>=?@<$;$[7H;I/GMZS?$!>*L]/0IG]
M!4]Y6Z<#_+54291WUA9$/-[\I]]S1Y0Z(-C0 >4=T&Z'7D,'G'? AW9P\P[N
MH1V\O$,V].YF[)GC;JBB5Q<B>0(B;:VEI1\R[V>]M;]XG$Z4J1+Z6Z[[J:OA
MZ/?/D^GD87)W.P5GX'9X?S]\F'P9@]<W3%$>RC?@%> Q>%@F:TGC0%YTE5:;
M=N[ZN8KKC0K4H *"CTFLEA*,XX %-?U'>_HCBX"N'F\Q:/0\Z&MDE7CGJW.
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M(S9WY#8/*EEEE\!FB5))E'U<,AHPD3;0W\^31#T_I J*FXI7_P%02P,$%
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M*?>%JO;MGWJ0;90690,V&924URMY;NJP PCZ>P!A PA? GI[ -T&T'TKH-<
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M&G:.";.B3K%V*Z(.7RE*&-P*)%=YCL6?"Z!\W;5<ZW7ACBPR91;LJ+/$"YB
MNE_>"CVS:Y:4Y, DX0P)F'>MGGO>;YOX(N"!P%INC)&I9,;YDYG$:==RC""@
MD"C#@/7K&?I J2'2,GY7G%:=T@ WQZ_LET7MNI89EM#G])&D*NM:+0NE,,<K
MJN[X^@=4]82&+^%4%D^TKF(="R4KJ7A>@;6"G+#RC5\J'S8 ;K 'X%4 [Z,
MOP+X1:&ELJ*L 58XZ@B^1L)$:S8S*+PIT+H:PDP7)TKH7:)Q*KJZN1D\QJ,1
MZHT'*!Y/>^.K^&(T1+W)9#B=?/W2\ESO^W@X1:=Z=S"\C,?Q='@ZBA^&[X2C
MXP$H3*@\T>'WDP$Z/CI!1X@P-,WX2F*6RHZMM&J3VTXJA1>E0F^/P@$D9\AW
MOR'/\=QWX/V/PYUMN*V]J@WS:L.\@L_?PQ<S_9$01A2<4OT!IBAF"K,%F5%
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M02X9SY& 63>XPF\'I&T =L0=@XW<:B.3RH3S!],93;M!9"*"%!)E**C^6<,
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M6L_*W"8QKN^M<KN*H'URE3^RG&6KS),GCIS71.<H,-XR,^Q-9,"SC"G+/0-
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M$=;(LT:J<(2[8;[9'&.#[-IV"H2YH;,ZPG9(]@"LF#+R4^7W=8(8)JYGBPW
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ME%V WZ=2FNW &BA_W>C]!5!+ P04    " "O@%Q4')/R'T$$  !;%0  &0
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MGI_DY0^2K;*SK2<F)4NRVR4E(>6Z@WH_9TSN'_0 Y7GJX#M02P,$%     @
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M!@36=R5D70Z((E$H^ Z$R=9L9F!+M6AMCC)S*#,E]"K5.!6]3.:CE_$,XO$
MXK=X.IC!-<1/3]/A4SP?PF@\GX[&LU$?7N/GQ1!>'F&/N!R@(K205QHPSQ&&
M^J R!I.", D70)F>Y1M)6"I#5VFK1M!-:EL/E:W@A*T!)C?0\K]!X 7^8C:
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MF@=XOQ9"'S9&037"COX%4$L#!!0    ( *^ 7%2&#^+)3 0  !T5   9
M>&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;+5876_B.!3]*Q;22KM2MXD=OCH"
MI$YIETK,J(*=F8?1/KC)!:Q)8M8VT$K[X]=.0IPRQ(&I>($X\3F^/KXYU_%@
MQ\4/N0)0Z"6)4SELK91:?_ \&:X@H?*:KR'53Q9<)%3IIEAZ<BV 1ADHB3WB
M^UTOH2QMC0;9O2<Q&O"-BED*3P+)39)0\?H18KX;MG!K?V/&EBME;GBCP9HN
M80[JR_I)Z)97LD0L@50RGB(!BV'K%G^8!($!9#V^,MC)RC4R4WGF_(=I/$;#
MEF\B@AA"92BH_MO"'<2Q8=)Q_%N0MLHQ#;!ZO6=_R":O)_-,)=SQ^!N+U&K8
MZK=0! NZB=6,[R903*AC^$(>R^P7[?*^7=TYW$C%DP*L(TA8FO_3ET*("H"T
M:P"D )!#@%\#" I < @@-8!V 6B?"N@4@,XAH%,#Z!: [@$ UTVZ5P!ZIP+Z
M!:"?K6Z^'-E:CJFBHX'@.R1,;\UF+K*$R-!Z"5EJ<G>NA'[*-$Z-IO>W\_LY
M^A-]OIW-;O]^_'J/?A^#HBR6?PP\I4<P_;RP8/N8LY$:MC&$URC 5XCX!!^!
MWYT!UV].&KX>(1F?0;*@(8N9.D9S?P;-6FBS$$=I'LZ9DA T78)^]=41IK_>
MI^WD=+C_%N[IG"D3AY2)0S*^H"YQ0$J *S0%[1Q7: PR%&R=^='WJ>Z+'A4D
M\A_'2$$Y4I"-U*X9Z5OF/Q AN@6ALT);IC%EEBY1; 9'"D1R+%?=M+B-7H$*
MB3!*>*I6J(LB^BH= ;?+@-OG!1PQ&?)-JI"@"HZMO)NO=WWC_^:(JU/&U7'R
MS"%E7* IVQKMYB"V+ 37A+LE<??"N= K1^HYI_!YDSR#0'R!BE>2@42;--+W
MLEPXYCDY8R=C-*5\.^JT!]ZVZBC.+F\"[9>!]G]!:_0?FD%,36ZLZ4]^\F:@
MFW*@FPMKCWU;*_P3U3?:4V6F5C@LRR;G\,G[@KLJ<D".BXPKU0N_*Q^N=*V4
M:M]"="D@LU\=JZ,TC(M1J['B3DVLUC Q.3%6"7KU=18<!&>K@]'272P>BL&J
M(=:I:8T6NRVQ-FD_:;M--HDKB:PYXO:E$]8:'G8[WM19'QK G;P^N *Q!HF[
M[U+V#&/ UBMQ[])*6[O#;K]K4-H-WI=B5R36#_'-+TI-7QJ2F%@G)/Z%I276
MXXC;X]S2-H );I265+9\;@=KDO:,+";6E$AP::FM-Q'W3JM!:C>8^,U26^<B
M;O.9\ 30!&BL-Z8TC="$R[46^Y1=&[&N1"Z];R/6C,BI.S>93\%4["W3E3HK
M=G4?>W?DY[U9OW^\T!'K5L1M.$WJGE3RB+4D<ND]6F"=*7#OT=PIW #.S<(5
MAW6MP&T\ITC<:,B!M:;@XI^CE>]1]S;)*?&D =RK-PFO<HQC#@X_4;%DJ=3;
MPX6F\J][^B40^5E<WE!\G9WL/'.E>))=KH#J5\ITT,\7G*M]PQP6E2>BH_\!
M4$L#!!0    ( *^ 7%2'\C G>0,  ',,   9    >&PO=V]R:W-H965T<R]S
M:&5E=#8V+GAM;*U76V^;,!3^*Q;:0R=M!7,-51(I#>E6:;VHZ>5AVH,#3F(-
M<&8[32OMQ\\VE% @J)/RDMCFG,_G.Y]]. QWE/WF:XP%>,G2G(^,M1";,]/D
M\1IGB)_2#<[EDR5E&1)RRE8FWS",$NV4I:9M6;Z9(9(;XZ%>NV7C(=V*E.3X
ME@&^S3+$7L]Q2G<C QIO"W=DM19JP1P/-VB%YU@\;&Z9G)D52D(RG'-"<\#P
M<F1,X%D$ ^6@+1X)WO':&"@J"TI_J\EE,C(L%1%.<2P4!))_SWB*TU0AR3C^
ME*!&M:=RK(_?T"\T>4EF@3B>TO2))&(],@8&2/ 2;5-Q1W??<4G(4W@Q3;G^
M!;O"-G -$&^YH%GI+"/(2%[\HY<R$34'Z!]PL$L'N^EP: >G=' ^ZN"6#J[.
M3$%%YR%" HV'C.X 4]8230UT,K6WI$]RI?M<,/F42#\Q_C&;S&=S\!5<7MU.
MIO?@Y@)<SYY N?SMX3*:7$]GX"3" I&4?Y:6#_,(G'SZ##X!DH/[-=URE"=\
M: H9C@(UXW+K\V)K^\#6T 97-!=K#F9Y@I/W *;D49&QW\B<V[V($8Y/@0._
M -NR84= TX^[6QWNT8?=8=C#QJFD<32><T@:+,_S%S"E7("?DP473%Z27SW
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M]1T#++="LB07*P<)30]/_)8GHB2 30*4"]"E CL79)DS#\ZR:0VQQ+T.9WO
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M,Z,/ ]0N@<972MGGCIN@_M08_0902P,$%     @ KX!<5!U&S/74 P  /0\
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MW>YQO@6A/\#W6\[5TT(;*"?FT?]02P,$%     @ KX!<5)J(0@;P @  +PD
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M?D">X[D[!%T>#G=VP"<'P]VS'?"@&?X9TQ;R>B:[UU",=K6';</7WK>'^5S
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MHP&N ]3SB#&YF>@$U3_2Z ]02P,$%     @ KX!<5/N(F-@0 P  ,!$   T
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MY2_+[YV3N_>"<WU;,3S]!5!+ P04    " "O@%Q4'YV%;PD"  #8*@  $P
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M&5!+ 0(4 Q0    ( *^ 7%0'04UB@0   +$    0              "  0
M  !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ KX!<5!AN(P[N    *P(
M !$              ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%
M  @ KX!<5)E<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE
M+W1H96UE,2YX;6Q02P$"% ,4    " "O@%Q46K;=EYX&  "3&@  &
M        @($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%
M  @ KX!<5&@ FU,O @  :P4  !@              ("!X0X  'AL+W=O<FMS
M:&5E=',O<VAE970R+GAM;%!+ 0(4 Q0    ( *^ 7%3"71$%E 8  -(9   8
M              " @481  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"
M% ,4    " "O@%Q4YJK8L\8"  "$!P  &               @($0&   >&PO
M=V]R:W-H965T<R]S:&5E=#0N>&UL4$L! A0#%     @ KX!<5+ .LNN\!0
M.Q8  !@              ("!#!L  'AL+W=O<FMS:&5E=',O<VAE970U+GAM
M;%!+ 0(4 Q0    ( *^ 7%189AU<V@<  +\F   8              " @?X@
M  !X;"]W;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " "O@%Q4!Z<F
M>6X)   @*@  &               @($.*0  >&PO=V]R:W-H965T<R]S:&5E
M=#<N>&UL4$L! A0#%     @ KX!<5,D,Z%[$!0  , T  !@
M ("!LC(  'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( *^
M7%2X*((\[1P  /=;   8              " @:PX  !X;"]W;W)K<VAE971S
M+W-H965T.2YX;6Q02P$"% ,4    " "O@%Q4'P96C]8$   ^#   &0
M        @('/50  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0
M   ( *^ 7%1\\807C04  %$.   9              " @=Q:  !X;"]W;W)K
M<VAE971S+W-H965T,3$N>&UL4$L! A0#%     @ KX!<5.QP39D,%   +#L
M !D              ("!H&   'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q0
M2P$"% ,4    " "O@%Q4!W_$4!$+  "4'0  &0              @('C=
M>&PO=V]R:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( *^ 7%0O"]M9
M>PD  -D?   9              " @2N   !X;"]W;W)K<VAE971S+W-H965T
M,30N>&UL4$L! A0#%     @ KX!<5*Z6^O]9!   6@D  !D
M ("!W8D  'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " "O
M@%Q4P>I1 +\%    #@  &0              @(%MC@  >&PO=V]R:W-H965T
M<R]S:&5E=#$V+GAM;%!+ 0(4 Q0    ( *^ 7%2=55R(L 0  -L)   9
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M970R,2YX;6Q02P$"% ,4    " "O@%Q4\PSGO:H0  #<+   &0
M    @(%0O   >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    (
M *^ 7%1 %G+TLP,   8(   9              " @3'-  !X;"]W;W)K<VAE
M971S+W-H965T,C,N>&UL4$L! A0#%     @ KX!<5*)D8NYA%0  QT4  !D
M             ("!&]$  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"
M% ,4    " "O@%Q4=,>W6NT#  !F"   &0              @(&SY@  >&PO
M=V]R:W-H965T<R]S:&5E=#(U+GAM;%!+ 0(4 Q0    ( *^ 7%3VW0$NK@0
M  $+   9              " @=?J  !X;"]W;W)K<VAE971S+W-H965T,C8N
M>&UL4$L! A0#%     @ KX!<5*IGDI'5!0  &A   !D              ("!
MO.\  'AL+W=O<FMS:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " "O@%Q4
M< .-*"P(  !O%   &0              @('(]0  >&PO=V]R:W-H965T<R]S
M:&5E=#(X+GAM;%!+ 0(4 Q0    ( *^ 7%28RJ+<VP,  $4(   9
M      " @2O^  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%
M  @ KX!<5&)B;[:^ @  L04  !D              ("!/0(! 'AL+W=O<FMS
M:&5E=',O<VAE970S,"YX;6Q02P$"% ,4    " "O@%Q4_ON,JE #  !U!P
M&0              @($R!0$ >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+
M 0(4 Q0    ( *^ 7%2]-4F2[0(   $&   9              " @;D( 0!X
M;"]W;W)K<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ KX!<5 ;)*"#:
M @  ! 8  !D              ("!W0L! 'AL+W=O<FMS:&5E=',O<VAE970S
M,RYX;6Q02P$"% ,4    " "O@%Q4WI\<J=L&  "J$@  &0
M@('N#@$ >&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( *^
M7%2"WLD4* 0  % )   9              " @0 6 0!X;"]W;W)K<VAE971S
M+W-H965T,S4N>&UL4$L! A0#%     @ KX!<5"57X-F#!P  910  !D
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M=#0P+GAM;%!+ 0(4 Q0    ( *^ 7%1&@C+(8P0  &$.   9
M  " @: R 0!X;"]W;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @
MKX!<5'$X1;'U P  :0P  !D              ("!.C<! 'AL+W=O<FMS:&5E
M=',O<VAE970T,BYX;6Q02P$"% ,4    " "O@%Q4_N('MQ8(   P-@  &0
M            @(%F.P$ >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4
M Q0    ( *^ 7%3]M?HV) ,  %L+   9              " @;-# 0!X;"]W
M;W)K<VAE971S+W-H965T-#0N>&UL4$L! A0#%     @ KX!<5 ']F'82 P
M7@@  !D              ("!#D<! 'AL+W=O<FMS:&5E=',O<VAE970T-2YX
M;6Q02P$"% ,4    " "O@%Q46_<I,6@"   8!@  &0              @(%7
M2@$ >&PO=V]R:W-H965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( *^ 7%0.
MQS1'\@,  '\/   9              " @?9, 0!X;"]W;W)K<VAE971S+W-H
M965T-#<N>&UL4$L! A0#%     @ KX!<5)Z*)*->!0  /1,  !D
M     ("!'U$! 'AL+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( *^ 7%2O*Y/H5 ,  ,0+   9              "
M@>]H 0!X;"]W;W)K<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ KX!<
M5!8I99"H @  L@<  !D              ("!>FP! 'AL+W=O<FMS:&5E=',O
M<VAE970U-"YX;6Q02P$"% ,4    " "O@%Q4N (]?2 #   ""0  &0
M        @(%9;P$ >&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0
M   ( *^ 7%3H-/IV[@(  +L'   9              " @;!R 0!X;"]W;W)K
M<VAE971S+W-H965T-38N>&UL4$L! A0#%     @ KX!<5+.#-/ ( P  @@@
M !D              ("!U74! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q0
M2P$"% ,4    " "O@%Q4$UQWTH@#  #9#P  &0              @($4>0$
M>&PO=V]R:W-H965T<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( *^ 7%3)&%V]
M5 ,  /H+   9              " @=-\ 0!X;"]W;W)K<VAE971S+W-H965T
M-3DN>&UL4$L! A0#%     @ KX!<5%"*?[]/!   Z1   !D
M ("!7H ! 'AL+W=O<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " "O
M@%Q4')/R'T$$  !;%0  &0              @('DA $ >&PO=V]R:W-H965T
M<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0    ( *^ 7%22JL@OSP,  %(-   9
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M970V-BYX;6Q02P$"% ,4    " "O@%Q4HA9UGR$#  ")"0  &0
M    @(':FP$ >&PO=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    (
M *^ 7%1TPMK('@,  %<*   9              " @3*? 0!X;"]W;W)K<VAE
M971S+W-H965T-C@N>&UL4$L! A0#%     @ KX!<5&]'+'L_!0  $Q@  !D
M             ("!AZ(! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"
M% ,4    " "O@%Q4,]-<T\X#  #I#   &0              @(']IP$ >&PO
M=V]R:W-H965T<R]S:&5E=#<P+GAM;%!+ 0(4 Q0    ( *^ 7%1RC=C',@(
M )0$   9              " @0*L 0!X;"]W;W)K<VAE971S+W-H965T-S$N
M>&UL4$L! A0#%     @ KX!<5"-\=[49 P  =@@  !D              ("!
M:ZX! 'AL+W=O<FMS:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " "O@%Q4
M'4;,]=0#   ]#P  &0              @(&[L0$ >&PO=V]R:W-H965T<R]S
M:&5E=#<S+GAM;%!+ 0(4 Q0    ( *^ 7%2:B$(&\ (  "\)   9
M      " @<:U 0!X;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%
M  @ KX!<5/N(F-@0 P  ,!$   T              ( ![;@! 'AL+W-T>6QE
M<RYX;6Q02P$"% ,4    " "O@%Q4EXJ[',     3 @  "P
M@ $HO $ 7W)E;',O+G)E;'-02P$"% ,4    " "O@%Q4(K\6$M<%  "_,
M#P              @ $1O0$ >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @
MKX!<5,?7<T]' @  U2L  !H              ( !%<,! 'AL+U]R96QS+W=O
M<FMB;V]K+GAM;"YR96QS4$L! A0#%     @ KX!<5!^=A6\) @  V"H  !,
M             ( !E,4! %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&     %(
,4@!U%@  SL<!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>271</ContextCount>
  <ElementCount>461</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>62</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - COVER PAGE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/COVERPAGE</Role>
      <ShortName>COVER PAGE</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0002002 - Document - AUDIT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/AUDITINFORMATION</Role>
      <ShortName>AUDIT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1001003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Uncategorized</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1003005 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF INCOME</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME</Role>
      <ShortName>CONSOLIDATED AND COMBINED STATEMENTS OF INCOME</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1004006 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS' EQUITY AND NET PARENT INVESTMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT</Role>
      <ShortName>CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS' EQUITY AND NET PARENT INVESTMENT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1005007 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - DESCRIPTION OF BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/DESCRIPTIONOFBUSINESS</Role>
      <ShortName>DESCRIPTION OF BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENT</Role>
      <ShortName>RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2110104 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE</Role>
      <ShortName>COMPUTATION OF NET INCOME PER COMMON SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2113105 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLE</Role>
      <ShortName>REVENUE AND ACCOUNTS RECEIVABLE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2119106 - Disclosure - BUSINESS SEGMENTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/BUSINESSSEGMENTS</Role>
      <ShortName>BUSINESS SEGMENTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2124107 - Disclosure - ACQUISITIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/ACQUISITIONS</Role>
      <ShortName>ACQUISITIONS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2128108 - Disclosure - PROPERTY AND EQUIPMENT???NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNET</Role>
      <ShortName>PROPERTY AND EQUIPMENT???NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2131109 - Disclosure - GOODWILL AND INTANGIBLE ASSETS???NET</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNET</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS???NET</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2136110 - Disclosure - OTHER ACCRUED LIABILITIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OTHERACCRUEDLIABILITIES</Role>
      <ShortName>OTHER ACCRUED LIABILITIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2140111 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2144112 - Disclosure - OPTIONS AND AWARDS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OPTIONSANDAWARDS</Role>
      <ShortName>OPTIONS AND AWARDS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2152113 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2157114 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2164115 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2166116 - Disclosure - SUBSEQUENT EVENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/SUBSEQUENTEVENT</Role>
      <ShortName>SUBSEQUENT EVENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2311302 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables</Role>
      <ShortName>COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2314303 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLETables</Role>
      <ShortName>REVENUE AND ACCOUNTS RECEIVABLE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLE</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2320304 - Disclosure - BUSINESS SEGMENTS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/BUSINESSSEGMENTSTables</Role>
      <ShortName>BUSINESS SEGMENTS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/BUSINESSSEGMENTS</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2325305 - Disclosure - ACQUISITIONS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/ACQUISITIONSTables</Role>
      <ShortName>ACQUISITIONS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/ACQUISITIONS</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2329306 - Disclosure - PROPERTY AND EQUIPMENT???NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETTables</Role>
      <ShortName>PROPERTY AND EQUIPMENT???NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNET</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2332307 - Disclosure - GOODWILL AND INTANGIBLE ASSETS???NET (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETTables</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS???NET (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNET</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2337308 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESTables</Role>
      <ShortName>OTHER ACCRUED LIABILITIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/OTHERACCRUEDLIABILITIES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2341309 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/DEBT</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2345310 - Disclosure - OPTIONS AND AWARDS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OPTIONSANDAWARDSTables</Role>
      <ShortName>OPTIONS AND AWARDS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/OPTIONSANDAWARDS</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2353311 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/LEASES</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2358312 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/INCOMETAXES</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - DESCRIPTION OF BUSINESS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails</Role>
      <ShortName>DESCRIPTION OF BUSINESS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/DESCRIPTIONOFBUSINESS</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails</Role>
      <ShortName>BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - SUMMARY OF INSURANCE LIABILITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails</Role>
      <ShortName>BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - SUMMARY OF INSURANCE LIABILITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2409404 - Disclosure - RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails</Role>
      <ShortName>RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENT</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2412405 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE - RECONCILIATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails</Role>
      <ShortName>COMPUTATION OF NET INCOME PER COMMON SHARE - RECONCILIATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2415406 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - NARRATIVE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails</Role>
      <ShortName>REVENUE AND ACCOUNTS RECEIVABLE - NARRATIVE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2416407 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - REVENUE BY MAJOR PAYOR (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails</Role>
      <ShortName>REVENUE AND ACCOUNTS RECEIVABLE - REVENUE BY MAJOR PAYOR (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2417408 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - ACCOUNTS RECEIVABLE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails</Role>
      <ShortName>REVENUE AND ACCOUNTS RECEIVABLE - ACCOUNTS RECEIVABLE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2418409 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEALLOWANCEFORDOUBTFULACCOUNTSDetails</Role>
      <ShortName>REVENUE AND ACCOUNTS RECEIVABLE - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2421410 - Disclosure - BUSINESS SEGMENTS - NARRATIVE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails</Role>
      <ShortName>BUSINESS SEGMENTS - NARRATIVE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2422411 - Disclosure - BUSINESS SEGMENTS - FINANCIAL DATA (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails</Role>
      <ShortName>BUSINESS SEGMENTS - FINANCIAL DATA (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2423412 - Disclosure - BUSINESS SEGMENTS - INCOME FROM OPERATIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails</Role>
      <ShortName>BUSINESS SEGMENTS - INCOME FROM OPERATIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2426413 - Disclosure - ACQUISITIONS - NARRATIVE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails</Role>
      <ShortName>ACQUISITIONS - NARRATIVE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2427414 - Disclosure - ACQUISITIONS - SCHEDULE OF OPERATIONS ACQUIRED IN BUSINESS COMBINATIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails</Role>
      <ShortName>ACQUISITIONS - SCHEDULE OF OPERATIONS ACQUIRED IN BUSINESS COMBINATIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2430415 - Disclosure - PROPERTY AND EQUIPMENT???NET (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails</Role>
      <ShortName>PROPERTY AND EQUIPMENT???NET (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETTables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2433416 - Disclosure - GOODWILL AND INTANGIBLE ASSETS???NET - NARRATIVE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETNARRATIVEDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS???NET - NARRATIVE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2434417 - Disclosure - GOODWILL AND INTANGIBLE ASSETS???NET - ACTIVITY IN GOODWILL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS???NET - ACTIVITY IN GOODWILL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2435418 - Disclosure - GOODWILL AND INTANGIBLE ASSETS???NET - INDEFINITE-LIVED INTANGIBLE ASSETS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails</Role>
      <ShortName>GOODWILL AND INTANGIBLE ASSETS???NET - INDEFINITE-LIVED INTANGIBLE ASSETS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2438419 - Disclosure - OTHER ACCRUED LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails</Role>
      <ShortName>OTHER ACCRUED LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESTables</ParentRole>
      <Position>55</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2439420 - Disclosure - OTHER ACCRUED LIABILITIES - NARRATIVE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails</Role>
      <ShortName>OTHER ACCRUED LIABILITIES - NARRATIVE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2442421 - Disclosure - DEBT - SCHEDULE OF LONG-TERM DEBT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails</Role>
      <ShortName>DEBT - SCHEDULE OF LONG-TERM DEBT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2443422 - Disclosure - DEBT - NARRATIVE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/DEBTNARRATIVEDetails</Role>
      <ShortName>DEBT - NARRATIVE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2446423 - Disclosure - OPTIONS AND AWARDS - SHARE-BASED COMPENSATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails</Role>
      <ShortName>OPTIONS AND AWARDS - SHARE-BASED COMPENSATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2447424 - Disclosure - OPTIONS AND AWARDS - SHARE-BASED COMPENSATION EXPENSE AND NARRATIVE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails</Role>
      <ShortName>OPTIONS AND AWARDS - SHARE-BASED COMPENSATION EXPENSE AND NARRATIVE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2448425 - Disclosure - OPTIONS AND AWARDS - OPTIONS GRANTED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails</Role>
      <ShortName>OPTIONS AND AWARDS - OPTIONS GRANTED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2449426 - Disclosure - OPTIONS AND AWARDS - EMPLOYEE STOCK OPTION ACTIVITY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails</Role>
      <ShortName>OPTIONS AND AWARDS - EMPLOYEE STOCK OPTION ACTIVITY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2450427 - Disclosure - OPTIONS AND AWARDS - AGGREGATE INTRINSIC VALUE OF OPTIONS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails</Role>
      <ShortName>OPTIONS AND AWARDS - AGGREGATE INTRINSIC VALUE OF OPTIONS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2451428 - Disclosure - OPTIONS AND AWARDS - RESTRICTED STOCK (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails</Role>
      <ShortName>OPTIONS AND AWARDS - RESTRICTED STOCK (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2454429 - Disclosure - LEASES - NARRATIVE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/LEASESNARRATIVEDetails</Role>
      <ShortName>LEASES - NARRATIVE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2455430 - Disclosure - LEASES - IMPACT OF NEW LEASES GUIDANCE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails</Role>
      <ShortName>LEASES - IMPACT OF NEW LEASES GUIDANCE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2456431 - Disclosure - LEASES - FUTURE MINIMUM LEASE PAYMENTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails</Role>
      <ShortName>LEASES - FUTURE MINIMUM LEASE PAYMENTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2459432 - Disclosure - INCOME TAXES - PROVISION FOR INCOME TAXES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails</Role>
      <ShortName>INCOME TAXES - PROVISION FOR INCOME TAXES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>2460433 - Disclosure - INCOME TAXES - TAX RATE RECONCILIATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails</Role>
      <ShortName>INCOME TAXES - TAX RATE RECONCILIATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>2461434 - Disclosure - INCOME TAXES - DEFERRED TAX ASSETS AND LIABILITIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails</Role>
      <ShortName>INCOME TAXES - DEFERRED TAX ASSETS AND LIABILITIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>2462435 - Disclosure - INCOME TAXES - NARRATIVE (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails</Role>
      <ShortName>INCOME TAXES - NARRATIVE (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>2463436 - Disclosure - INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails</Role>
      <ShortName>INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>2465437 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIES</ParentRole>
      <Position>73</Position>
    </Report>
    <Report instance="pntg-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>2467438 - Disclosure - SUBSEQUENT EVENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://pennantgroup.com/role/SUBSEQUENTEVENTDetails</Role>
      <ShortName>SUBSEQUENT EVENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://pennantgroup.com/role/SUBSEQUENTEVENT</ParentRole>
      <Position>74</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="pntg-20211231.htm">pntg-20211231.htm</File>
    <File>ceocert-exhibit311q421.htm</File>
    <File>ceocert-exhibit321q421.htm</File>
    <File>cfocert-exhibit312q421.htm</File>
    <File>cfocert-exhibit322q421.htm</File>
    <File>deloitteconsentq421-ex231.htm</File>
    <File>descriptionofsecuritiesq42.htm</File>
    <File>listofsubsidiariesofpntgq4.htm</File>
    <File>pntg-20211231.xsd</File>
    <File>pntg-20211231_cal.xml</File>
    <File>pntg-20211231_def.xml</File>
    <File>pntg-20211231_lab.xml</File>
    <File>pntg-20211231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>pntg-20211231_g1.jpg</File>
    <File>pntg-20211231_g2.jpg</File>
    <File>pntg-20211231_g3.jpg</File>
    <File>pntg-20211231_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="897">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>99
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "pntg-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 29,
   "contextCount": 271,
   "dts": {
    "calculationLink": {
     "local": [
      "pntg-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "pntg-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "pntg-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "pntg-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "pntg-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "pntg-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 587,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 4,
    "http://pennantgroup.com/20211231": 1,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 9
   },
   "keyCustom": 60,
   "keyStandard": 401,
   "memberCustom": 27,
   "memberStandard": 35,
   "nsprefix": "pntg",
   "nsuri": "http://pennantgroup.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - COVER PAGE",
     "role": "http://pennantgroup.com/role/COVERPAGE",
     "shortName": "COVER PAGE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT",
     "role": "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENT",
     "shortName": "RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2110104 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE",
     "role": "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE",
     "shortName": "COMPUTATION OF NET INCOME PER COMMON SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pntg:RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2113105 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE",
     "role": "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLE",
     "shortName": "REVENUE AND ACCOUNTS RECEIVABLE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pntg:RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119106 - Disclosure - BUSINESS SEGMENTS",
     "role": "http://pennantgroup.com/role/BUSINESSSEGMENTS",
     "shortName": "BUSINESS SEGMENTS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2124107 - Disclosure - ACQUISITIONS",
     "role": "http://pennantgroup.com/role/ACQUISITIONS",
     "shortName": "ACQUISITIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128108 - Disclosure - PROPERTY AND EQUIPMENT\u2014NET",
     "role": "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNET",
     "shortName": "PROPERTY AND EQUIPMENT\u2014NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2131109 - Disclosure - GOODWILL AND INTANGIBLE ASSETS\u2014NET",
     "role": "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNET",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS\u2014NET",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2136110 - Disclosure - OTHER ACCRUED LIABILITIES",
     "role": "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIES",
     "shortName": "OTHER ACCRUED LIABILITIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2140111 - Disclosure - DEBT",
     "role": "http://pennantgroup.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2144112 - Disclosure - OPTIONS AND AWARDS",
     "role": "http://pennantgroup.com/role/OPTIONSANDAWARDS",
     "shortName": "OPTIONS AND AWARDS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "false",
     "longName": "0002002 - Document - AUDIT INFORMATION",
     "role": "http://pennantgroup.com/role/AUDITINFORMATION",
     "shortName": "AUDIT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:AuditorFirmId",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2152113 - Disclosure - LEASES",
     "role": "http://pennantgroup.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2157114 - Disclosure - INCOME TAXES",
     "role": "http://pennantgroup.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2164115 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2166116 - Disclosure - SUBSEQUENT EVENT",
     "role": "http://pennantgroup.com/role/SUBSEQUENTEVENT",
     "shortName": "SUBSEQUENT EVENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pntg:SummaryOfInsuranceLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "pntg:SummaryOfInsuranceLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2311302 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)",
     "role": "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables",
     "shortName": "COMPUTATION OF NET INCOME PER COMMON SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2314303 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE (Tables)",
     "role": "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLETables",
     "shortName": "REVENUE AND ACCOUNTS RECEIVABLE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320304 - Disclosure - BUSINESS SEGMENTS (Tables)",
     "role": "http://pennantgroup.com/role/BUSINESSSEGMENTSTables",
     "shortName": "BUSINESS SEGMENTS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2325305 - Disclosure - ACQUISITIONS (Tables)",
     "role": "http://pennantgroup.com/role/ACQUISITIONSTables",
     "shortName": "ACQUISITIONS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329306 - Disclosure - PROPERTY AND EQUIPMENT\u2014NET (Tables)",
     "role": "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETTables",
     "shortName": "PROPERTY AND EQUIPMENT\u2014NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2332307 - Disclosure - GOODWILL AND INTANGIBLE ASSETS\u2014NET (Tables)",
     "role": "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETTables",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS\u2014NET (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2337308 - Disclosure - OTHER ACCRUED LIABILITIES (Tables)",
     "role": "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESTables",
     "shortName": "OTHER ACCRUED LIABILITIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2341309 - Disclosure - DEBT (Tables)",
     "role": "http://pennantgroup.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2345310 - Disclosure - OPTIONS AND AWARDS (Tables)",
     "role": "http://pennantgroup.com/role/OPTIONSANDAWARDSTables",
     "shortName": "OPTIONS AND AWARDS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2353311 - Disclosure - LEASES (Tables)",
     "role": "http://pennantgroup.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2358312 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://pennantgroup.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "ife1126ceed284fbdb9bf6b3dbab68da3_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pntg:NumberOfServiceProviders",
      "reportCount": 1,
      "unitRef": "agency",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - DESCRIPTION OF BUSINESS (Details)",
     "role": "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails",
     "shortName": "DESCRIPTION OF BUSINESS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "role": "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
     "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pntg:AccruedPayrollTaxesEmployerPortion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pntg:GeneralAndProfessionalInsuranceLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - SUMMARY OF INSURANCE LIABILITY (Details)",
     "role": "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails",
     "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - SUMMARY OF INSURANCE LIABILITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pntg:GeneralAndProfessionalInsuranceLiability",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:CommonStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2409404 - Disclosure - RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT (Details)",
     "role": "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails",
     "shortName": "RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412405 - Disclosure - COMPUTATION OF NET INCOME PER COMMON SHARE - RECONCILIATION (Details)",
     "role": "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails",
     "shortName": "COMPUTATION OF NET INCOME PER COMMON SHARE - RECONCILIATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberDilutedSharesOutstandingAdjustment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415406 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - NARRATIVE (Details)",
     "role": "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
     "shortName": "REVENUE AND ACCOUNTS RECEIVABLE - NARRATIVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "idca163657edf4bc2aca2d8b382f0f7b2_D20210101-20211231",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:RevenuePerformanceObligationDescriptionOfPaymentTerms",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2416407 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - REVENUE BY MAJOR PAYOR (Details)",
     "role": "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails",
     "shortName": "REVENUE AND ACCOUNTS RECEIVABLE - REVENUE BY MAJOR PAYOR (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i03057061bfb7409985a60619a19b48e6_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417408 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - ACCOUNTS RECEIVABLE (Details)",
     "role": "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails",
     "shortName": "REVENUE AND ACCOUNTS RECEIVABLE - ACCOUNTS RECEIVABLE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableGrossCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418409 - Disclosure - REVENUE AND ACCOUNTS RECEIVABLE - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)",
     "role": "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEALLOWANCEFORDOUBTFULACCOUNTSDetails",
     "shortName": "REVENUE AND ACCOUNTS RECEIVABLE - ALLOWANCE FOR DOUBTFUL ACCOUNTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i855d825b738d453698699f3f7321df6f_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "ife1126ceed284fbdb9bf6b3dbab68da3_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pntg:NumberOfServiceProviders",
      "reportCount": 1,
      "unitRef": "agency",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421410 - Disclosure - BUSINESS SEGMENTS - NARRATIVE (Details)",
     "role": "http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails",
     "shortName": "BUSINESS SEGMENTS - NARRATIVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2422411 - Disclosure - BUSINESS SEGMENTS - FINANCIAL DATA (Details)",
     "role": "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails",
     "shortName": "BUSINESS SEGMENTS - FINANCIAL DATA (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "icc4e373408b54afd8e67604fcad521cc_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pntg:IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2423412 - Disclosure - BUSINESS SEGMENTS - INCOME FROM OPERATIONS (Details)",
     "role": "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
     "shortName": "BUSINESS SEGMENTS - INCOME FROM OPERATIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "pntg:ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pntg:StartUpActivitiesCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pntg:NonCapitalizableRelatedToTheBusinessCombinations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426413 - Disclosure - ACQUISITIONS - NARRATIVE (Details)",
     "role": "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
     "shortName": "ACQUISITIONS - NARRATIVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pntg:NonCapitalizableRelatedToTheBusinessCombinations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003005 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF INCOME",
     "role": "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME",
     "shortName": "CONSOLIDATED AND COMBINED STATEMENTS OF INCOME",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427414 - Disclosure - ACQUISITIONS - SCHEDULE OF OPERATIONS ACQUIRED IN BUSINESS COMBINATIONS (Details)",
     "role": "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails",
     "shortName": "ACQUISITIONS - SCHEDULE OF OPERATIONS ACQUIRED IN BUSINESS COMBINATIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i2ee2d206c3dd44709ddf33c9b5d9ad84_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "pntg:TotalAcquisitions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430415 - Disclosure - PROPERTY AND EQUIPMENT\u2014NET (Details)",
     "role": "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails",
     "shortName": "PROPERTY AND EQUIPMENT\u2014NET (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:AssetImpairmentCharges",
       "us-gaap:AssetImpairmentCharges",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433416 - Disclosure - GOODWILL AND INTANGIBLE ASSETS\u2014NET - NARRATIVE (Details)",
     "role": "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETNARRATIVEDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS\u2014NET - NARRATIVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:AssetImpairmentCharges",
       "us-gaap:AssetImpairmentCharges",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AssetImpairmentCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434417 - Disclosure - GOODWILL AND INTANGIBLE ASSETS\u2014NET - ACTIVITY IN GOODWILL (Details)",
     "role": "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS\u2014NET - ACTIVITY IN GOODWILL (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435418 - Disclosure - GOODWILL AND INTANGIBLE ASSETS\u2014NET - INDEFINITE-LIVED INTANGIBLE ASSETS (Details)",
     "role": "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails",
     "shortName": "GOODWILL AND INTANGIBLE ASSETS\u2014NET - INDEFINITE-LIVED INTANGIBLE ASSETS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i85977dbd3e304b269d60b79b21d58dd3_I20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CustomerRefundLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438419 - Disclosure - OTHER ACCRUED LIABILITIES (Details)",
     "role": "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails",
     "shortName": "OTHER ACCRUED LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CustomerRefundLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "pntg:TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2439420 - Disclosure - OTHER ACCRUED LIABILITIES - NARRATIVE (Details)",
     "role": "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails",
     "shortName": "OTHER ACCRUED LIABILITIES - NARRATIVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "ifc995fe4fa2343f99750c39392d1ca31_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LiabilitiesNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442421 - Disclosure - DEBT - SCHEDULE OF LONG-TERM DEBT (Details)",
     "role": "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails",
     "shortName": "DEBT - SCHEDULE OF LONG-TERM DEBT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredFinanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i0ed5cb11e8c74a8cab4af56099f9fe37_I20210223",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443422 - Disclosure - DEBT - NARRATIVE (Details)",
     "role": "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
     "shortName": "DEBT - NARRATIVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i0ed5cb11e8c74a8cab4af56099f9fe37_I20210223",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i8ffd18948f6c4a1e9cdee019c70baf5e_D20190101-20191001",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446423 - Disclosure - OPTIONS AND AWARDS - SHARE-BASED COMPENSATION (Details)",
     "role": "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails",
     "shortName": "OPTIONS AND AWARDS - SHARE-BASED COMPENSATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i009062db7a07451db770939cb218b995_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "idd91651521da4c609cd12f37af52ba44_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004006 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS' EQUITY AND NET PARENT INVESTMENT",
     "role": "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT",
     "shortName": "CONSOLIDATED AND COMBINED STATEMENTS OF STOCKHOLDERS' EQUITY AND NET PARENT INVESTMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "idd91651521da4c609cd12f37af52ba44_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2447424 - Disclosure - OPTIONS AND AWARDS - SHARE-BASED COMPENSATION EXPENSE AND NARRATIVE (Details)",
     "role": "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails",
     "shortName": "OPTIONS AND AWARDS - SHARE-BASED COMPENSATION EXPENSE AND NARRATIVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i561174c829a140b08b1d95c1f8f01962_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448425 - Disclosure - OPTIONS AND AWARDS - OPTIONS GRANTED (Details)",
     "role": "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails",
     "shortName": "OPTIONS AND AWARDS - OPTIONS GRANTED (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i2fba7cde195142a3978c879c27cb0bab_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "ie191aaa5b8784c6cb75b59a0e2300e56_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449426 - Disclosure - OPTIONS AND AWARDS - EMPLOYEE STOCK OPTION ACTIVITY (Details)",
     "role": "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails",
     "shortName": "OPTIONS AND AWARDS - EMPLOYEE STOCK OPTION ACTIVITY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i561174c829a140b08b1d95c1f8f01962_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i4e98f7de032448e1bdb5e3acc586323d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450427 - Disclosure - OPTIONS AND AWARDS - AGGREGATE INTRINSIC VALUE OF OPTIONS (Details)",
     "role": "http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails",
     "shortName": "OPTIONS AND AWARDS - AGGREGATE INTRINSIC VALUE OF OPTIONS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i4e98f7de032448e1bdb5e3acc586323d_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "icdcc7ffbdc094bad9d2c2e68f1561ed9_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451428 - Disclosure - OPTIONS AND AWARDS - RESTRICTED STOCK (Details)",
     "role": "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails",
     "shortName": "OPTIONS AND AWARDS - RESTRICTED STOCK (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "icdcc7ffbdc094bad9d2c2e68f1561ed9_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454429 - Disclosure - LEASES - NARRATIVE (Details)",
     "role": "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
     "shortName": "LEASES - NARRATIVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubleaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455430 - Disclosure - LEASES - IMPACT OF NEW LEASES GUIDANCE (Details)",
     "role": "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails",
     "shortName": "LEASES - IMPACT OF NEW LEASES GUIDANCE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubleaseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2456431 - Disclosure - LEASES - FUTURE MINIMUM LEASE PAYMENTS (Details)",
     "role": "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails",
     "shortName": "LEASES - FUTURE MINIMUM LEASE PAYMENTS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2459432 - Disclosure - INCOME TAXES - PROVISION FOR INCOME TAXES (Details)",
     "role": "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails",
     "shortName": "INCOME TAXES - PROVISION FOR INCOME TAXES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460433 - Disclosure - INCOME TAXES - TAX RATE RECONCILIATION (Details)",
     "role": "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails",
     "shortName": "INCOME TAXES - TAX RATE RECONCILIATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005007 - Statement - CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS",
     "role": "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONSOLIDATED AND COMBINED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2461434 - Disclosure - INCOME TAXES - DEFERRED TAX ASSETS AND LIABILITIES (Details)",
     "role": "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails",
     "shortName": "INCOME TAXES - DEFERRED TAX ASSETS AND LIABILITIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i930d5c4fd9b84161879c0000c0e816d2_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2462435 - Disclosure - INCOME TAXES - NARRATIVE (Details)",
     "role": "http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails",
     "shortName": "INCOME TAXES - NARRATIVE (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i930d5c4fd9b84161879c0000c0e816d2_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i59039fbd0ff34f2e8fcc01b1f5227fa3_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2463436 - Disclosure - INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details)",
     "role": "http://pennantgroup.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails",
     "shortName": "INCOME TAXES - UNRECOGNIZED TAX BENEFITS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i855d825b738d453698699f3f7321df6f_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pntg:NumberOfOperatingSubsidiariesWithReviewsScheduled",
      "reportCount": 1,
      "unique": true,
      "unitRef": "review",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2465437 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details)",
     "role": "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "pntg:NumberOfOperatingSubsidiariesWithReviewsScheduled",
      "reportCount": 1,
      "unique": true,
      "unitRef": "review",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "if28ce3a43e8b460b988657b9a4224a4e_I20211231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EscrowDeposit",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2467438 - Disclosure - SUBSEQUENT EVENT (Details)",
     "role": "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails",
     "shortName": "SUBSEQUENT EVENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "ib75d5bc9e37c446180e5fa26fafb6083_I20220127",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:EscrowDeposit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - DESCRIPTION OF BUSINESS",
     "role": "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESS",
     "shortName": "DESCRIPTION OF BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "pntg-20211231.htm",
      "contextRef": "i207edde9314a4bd687eb41d894c01add_D20210101-20211231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 62,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID",
        "terseLabel": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/AUDITINFORMATION"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location",
        "terseLabel": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/AUDITINFORMATION"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name",
        "terseLabel": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/AUDITINFORMATION"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r601"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r602"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r603"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r598",
      "r599",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r594"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r597"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://pennantgroup.com/role/COVERPAGE"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "pntg_AccruedPayrollTaxesEmployerPortion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Payroll Taxes, Employer Portion",
        "label": "Accrued Payroll Taxes, Employer Portion",
        "terseLabel": "Accrued payroll taxes employer portion"
       }
      }
     },
     "localname": "AccruedPayrollTaxesEmployerPortion",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_AccruedWagesAndRelatedLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Wages and Related Liabilities",
        "label": "Accrued Wages and Related Liabilities [Member]",
        "terseLabel": "Accrued Wages and Related Liabilities"
       }
      }
     },
     "localname": "AccruedWagesAndRelatedLiabilitiesMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_AcquisitionRelatedCostsNotCapitalized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquisition-Related Costs, Not Capitalized",
        "label": "Acquisition-Related Costs, Not Capitalized",
        "terseLabel": "Transaction services costs"
       }
      }
     },
     "localname": "AcquisitionRelatedCostsNotCapitalized",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_AdditionalPaidInCapitalEffectOfIncomeTax": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional Paid in Capital, Effect of Income Tax",
        "label": "Additional Paid in Capital, Effect of Income Tax",
        "terseLabel": "Income tax effect"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalEffectOfIncomeTax",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustment Operating Lease Right-of-Use Asset And Operating Lease Liability",
        "label": "Adjustment Operating Lease Right-of-Use Asset And Operating Lease Liability",
        "terseLabel": "Net non-cash adjustment to right-of-use assets and lease liabilities from lease modifications"
       }
      }
     },
     "localname": "AdjustmentOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_AffiliatesOfEnsignMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Affiliates Of Ensign",
        "label": "Affiliates Of Ensign [Member]",
        "terseLabel": "Affiliates Of Ensign"
       }
      }
     },
     "localname": "AffiliatesOfEnsignMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_AmountToOffsetExpenseSequestrationRelief": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount to Offset Expense, Sequestration Relief",
        "label": "Amount to Offset Expense, Sequestration Relief",
        "terseLabel": "Sequestration relief"
       }
      }
     },
     "localname": "AmountToOffsetExpenseSequestrationRelief",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_AssetAcquisitions2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisitions 2019 [Member]",
        "label": "Asset Acquisitions 2019 [Member]",
        "terseLabel": "Asset acquisitions 2019"
       }
      }
     },
     "localname": "AssetAcquisitions2019Member",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_AssetAcquisitions2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisitions 2020",
        "label": "Asset Acquisitions 2020 [Member]",
        "terseLabel": "Asset Acquisitions 2020"
       }
      }
     },
     "localname": "AssetAcquisitions2020Member",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_AssetAcquisitions2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Acquisitions 2021",
        "label": "Asset Acquisitions 2021 [Member]",
        "terseLabel": "Asset Acquisitions 2021"
       }
      }
     },
     "localname": "AssetAcquisitions2021Member",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_AuditInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Audit Information",
        "label": "Audit Information [Abstract]"
       }
      }
     },
     "localname": "AuditInformationAbstract",
     "nsuri": "http://pennantgroup.com/20211231",
     "xbrltype": "stringItemType"
    },
    "pntg_BusinessAcquisitions2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Acquisitions 2019 [Member]",
        "label": "Business Acquisitions 2019 [Member]",
        "terseLabel": "Business acquisitions 2019"
       }
      }
     },
     "localname": "BusinessAcquisitions2019Member",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_BusinessCombinationCashPaidInPriorYear": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Cash Paid In Prior Year",
        "label": "Business Combination, Cash Paid In Prior Year",
        "negatedTerseLabel": "Less: cash paid in prior year (held in escrow)"
       }
      }
     },
     "localname": "BusinessCombinationCashPaidInPriorYear",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment, Furniture and Fixtures",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Equipment, Furniture and Fixtures",
        "terseLabel": "Equipment, furniture, and fixtures"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquipmentFurnitureAndFixtures",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_CashAndContributedAssetsNetBookValue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash And Contributed Assets Net Book Value",
        "label": "Cash And Contributed Assets Net Book Value",
        "terseLabel": "Net book value"
       }
      }
     },
     "localname": "CashAndContributedAssetsNetBookValue",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_ContractLiabilityAdvancePaymentsCARESAct": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract Liability, Advance Payments, CARES Act",
        "label": "Contract Liability, Advance Payments, CARES Act",
        "terseLabel": "Contract liabilities (CARES Act advance payments)"
       }
      }
     },
     "localname": "ContractLiabilityAdvancePaymentsCARESAct",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_CorridorAsAnAdditionalOutOfPocketRetention": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corridor as an Additional Out-of-Pocket Retention",
        "label": "Corridor as an Additional Out-of-Pocket Retention",
        "terseLabel": "Out-of-pocket retention"
       }
      }
     },
     "localname": "CorridorAsAnAdditionalOutOfPocketRetention",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_DeferredTaxAssetsLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Assets, Lease Liabilities",
        "label": "Deferred Tax Assets, Lease Liabilities",
        "terseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiabilities",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, Depreciation And Amortization",
        "label": "Deferred Tax Liabilities, Depreciation And Amortization",
        "negatedTerseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_DeferredTaxLiabilitiesStateTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liabilities, State Taxes",
        "label": "Deferred Tax Liabilities, State Taxes",
        "negatedTerseLabel": "State taxes"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesStateTaxes",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_DirectMedicalSuppliesLaborAndOtherExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Direct Medical Supplies, Labor, and Other Expenses",
        "label": "Direct Medical Supplies, Labor, and Other Expenses",
        "terseLabel": "Direct medical supplies, labor, and other expenses"
       }
      }
     },
     "localname": "DirectMedicalSuppliesLaborAndOtherExpenses",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_DistributionToFromParent": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Distribution (To) From Parent",
        "label": "Distribution (To) From Parent",
        "terseLabel": "Net investment from parent"
       }
      }
     },
     "localname": "DistributionToFromParent",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Deductible Expense, Share-based Payment Arrangement, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Deductible Expense, Share-based Payment Arrangement, Percent",
        "terseLabel": "Deductible equity compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationDeductibleExpenseShareBasedPaymentArrangementPercent",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Accrued Bonus",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Accrued Bonus",
        "terseLabel": "Non-deductible accrued bonus"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseAccruedBonus",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pntg_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Transaction Costs, Amount",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Transaction Costs, Amount",
        "terseLabel": "Nondeductible transaction costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseTransactionCostsAmount",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_EffectiveIncomeTaxRateReconciliationSection162mLimitation": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Section 162(m) Limitation",
        "label": "Effective Income Tax Rate Reconciliation, Section 162(m) Limitation",
        "terseLabel": "Section 162(m) limitation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationSection162mLimitation",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pntg_EffectiveIncomeTaxRateReconciliationTransactionCostsPercent": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Rate Reconciliation, Transaction Costs, Percent",
        "label": "Effective Income Tax Rate Reconciliation, Transaction Costs, Percent",
        "terseLabel": "Transaction costs"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTransactionCostsPercent",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "pntg_EnsignSubsidiaryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ensign Subsidiary",
        "label": "Ensign Subsidiary [Member]",
        "terseLabel": "Ensign Subsidiary"
       }
      }
     },
     "localname": "EnsignSubsidiaryMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_FacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility [Member]",
        "label": "Facility [Member]",
        "terseLabel": "Facility"
       }
      }
     },
     "localname": "FacilityMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_GeneralAndProfessionalInsuranceLiability": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails": {
       "order": 1.0,
       "parentTag": "pntg_InsuranceProgramAccruedExpenses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General And Professional Insurance Liability",
        "label": "General And Professional Insurance Liability",
        "terseLabel": "General and professional liability"
       }
      }
     },
     "localname": "GeneralAndProfessionalInsuranceLiability",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "General And Professional Liability Insurance, Retention Limit, Per Claim",
        "label": "General And Professional Liability Insurance, Retention Limit, Per Claim",
        "terseLabel": "General and professional liability, retention limit"
       }
      }
     },
     "localname": "GeneralAndProfessionalLiabilityInsuranceRetentionLimitPerClaim",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_GrantYear2019Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Year 2019 [Member]",
        "label": "Grant Year 2019 [Member]",
        "terseLabel": "2019"
       }
      }
     },
     "localname": "GrantYear2019Member",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_GrantYear2020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Year 2020",
        "label": "Grant Year 2020 [Member]",
        "terseLabel": "2020"
       }
      }
     },
     "localname": "GrantYear2020Member",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_GrantYear2021Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grant Year 2021",
        "label": "Grant Year 2021 [Member]",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "GrantYear2021Member",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_HomeCareAgenciesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Home Care Agencies",
        "label": "Home Care Agencies [Member]",
        "terseLabel": "Home Care Agencies"
       }
      }
     },
     "localname": "HomeCareAgenciesMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_HomeHealthAndHospiceServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Home Health And Hospice Services Segment [Member]",
        "label": "Home Health And Hospice Services Segment [Member]",
        "terseLabel": "Home Health and Hospice Services"
       }
      }
     },
     "localname": "HomeHealthAndHospiceServicesSegmentMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails",
      "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_HomeHealthJointVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Home Health Joint Venture",
        "label": "Home Health Joint Venture [Member]",
        "terseLabel": "Home Health Joint Venture"
       }
      }
     },
     "localname": "HomeHealthJointVentureMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_HomeHealthSubsegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Home Health Subsegment [Member]",
        "label": "Home Health Subsegment [Member]",
        "terseLabel": "Home Health Services"
       }
      }
     },
     "localname": "HomeHealthSubsegmentMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_HospiceJoinVentureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hospice Join Venture",
        "label": "Hospice Join Venture [Member]",
        "terseLabel": "Hospice Join Venture"
       }
      }
     },
     "localname": "HospiceJoinVentureMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_HospiceSubsegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Hospice Subsegment [Member]",
        "label": "Hospice Subsegment [Member]",
        "terseLabel": "Hospice Services"
       }
      }
     },
     "localname": "HospiceSubsegmentMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_ImpairmentLongLivedAssetsNumberOfCommunities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment, Long-Lived Assets, Number Of Communities",
        "label": "Impairment, Long-Lived Assets, Number Of Communities",
        "terseLabel": "Number of communities impaired"
       }
      }
     },
     "localname": "ImpairmentLongLivedAssetsNumberOfCommunities",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pntg_IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Income (Loss) From Continuing Operations Before Interest, Taxes, Depreciation And Amortization, Rent Costs, Acquisition Costs And Stock-based Compensation",
        "label": "Income (Loss) From Continuing Operations Before Interest, Taxes, Depreciation And Amortization, Rent Costs, Acquisition Costs And Stock-based Compensation",
        "terseLabel": "Segment Adjusted EBITDAR from Operations",
        "verboseLabel": "Segment Adjusted EBITDAR from Operations"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeInterestTaxesDepreciationAndAmortizationRentCostsAcquisitionCostsAndStockBasedCompensation",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental Costs, Direct Medical Supplies, Labor, and Other Expenses",
        "label": "Incremental Costs, Direct Medical Supplies, Labor, and Other Expenses",
        "terseLabel": "COVID-19 Related costs and supplies"
       }
      }
     },
     "localname": "IncrementalCostsDirectMedicalSuppliesLaborAndOtherExpenses",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_InsuranceProgramAccruedExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Program Accrued Expenses",
        "label": "Insurance Program Accrued Expenses",
        "totalLabel": "Total estimated liability"
       }
      }
     },
     "localname": "InsuranceProgramAccruedExpenses",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_InsuranceProgramAccruedExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails_1": {
       "order": 2.0,
       "parentTag": "pntg_InsuranceProgramAccruedExpenses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Program Accrued Expenses, Current",
        "label": "Insurance Program Accrued Expenses, Current",
        "terseLabel": "Current portion of estimated liability, included in other accrued liabilities"
       }
      }
     },
     "localname": "InsuranceProgramAccruedExpensesCurrent",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_InsuranceProgramAccruedExpensesNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails_1": {
       "order": 1.0,
       "parentTag": "pntg_InsuranceProgramAccruedExpenses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Insurance Program Accrued Expenses, Noncurrent",
        "label": "Insurance Program Accrued Expenses, Noncurrent",
        "negatedTerseLabel": "Less: long-term portion, included in other long-term liabilities"
       }
      }
     },
     "localname": "InsuranceProgramAccruedExpensesNoncurrent",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_InvestedCapitalPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Invested Capital [Policy Text Block]",
        "label": "Invested Capital [Policy Text Block]",
        "terseLabel": "Invested Capital"
       }
      }
     },
     "localname": "InvestedCapitalPolicyTextBlock",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pntg_ManagedCareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Managed Care [Member]",
        "label": "Managed Care [Member]",
        "terseLabel": "Managed care"
       }
      }
     },
     "localname": "ManagedCareMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_MedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicaid [Member]",
        "label": "Medicaid [Member]",
        "terseLabel": "Medicaid"
       }
      }
     },
     "localname": "MedicaidMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_MedicareAndMedicaidMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare And Medicaid [Member]",
        "label": "Medicare And Medicaid [Member]",
        "verboseLabel": "Medicare And Medicaid"
       }
      }
     },
     "localname": "MedicareAndMedicaidMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_MedicareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Medicare [Member]",
        "label": "Medicare [Member]",
        "terseLabel": "Medicare"
       }
      }
     },
     "localname": "MedicareMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_NetParentInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net Parent Investment",
        "label": "Net Parent Investment",
        "totalLabel": "Total Pennant Group, Inc. stockholders' equity"
       }
      }
     },
     "localname": "NetParentInvestment",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_NonCapitalizableRelatedToTheBusinessCombinations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-capitalizable Related to the Business Combinations",
        "label": "Non-capitalizable Related to the Business Combinations",
        "terseLabel": "Non-capitalizable"
       }
      }
     },
     "localname": "NonCapitalizableRelatedToTheBusinessCombinations",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_NoncontrollingInterestJointVenture": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncontrolling Interest Joint Venture",
        "label": "Noncontrolling Interest Joint Venture",
        "terseLabel": "Noncontrolling interest to scripps"
       }
      }
     },
     "localname": "NoncontrollingInterestJointVenture",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_NumberOfBusinessesAndAssetsAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Businesses And Assets Acquired",
        "label": "Number Of Businesses And Assets Acquired",
        "terseLabel": "Number of businesses acquired and assets acquisitions"
       }
      }
     },
     "localname": "NumberOfBusinessesAndAssetsAcquired",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pntg_NumberOfOperatingSubsidiariesWithReviewsScheduled": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Operating Subsidiaries With Reviews Scheduled",
        "label": "Number Of Operating Subsidiaries With Reviews Scheduled",
        "terseLabel": "Number of operating subsidiaries with reviews scheduled"
       }
      }
     },
     "localname": "NumberOfOperatingSubsidiariesWithReviewsScheduled",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pntg_NumberOfRealEstatePropertiesUnderLease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Real Estate Properties Under Lease",
        "label": "Number Of Real Estate Properties Under Lease",
        "terseLabel": "Number of properties under lease"
       }
      }
     },
     "localname": "NumberOfRealEstatePropertiesUnderLease",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails",
      "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pntg_NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Real Estate Properties Under Lease, Master Lease Agreement",
        "label": "Number Of Real Estate Properties Under Lease, Master Lease Agreement",
        "terseLabel": "Number of properties under lease, master lease agreement"
       }
      }
     },
     "localname": "NumberOfRealEstatePropertiesUnderLeaseMasterLeaseAgreement",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pntg_NumberOfSeparateMasterLeaseArrangements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Separate Master Lease Arrangements",
        "label": "Number of Separate Master Lease Arrangements",
        "terseLabel": "Number of separate master lease arrangements"
       }
      }
     },
     "localname": "NumberOfSeparateMasterLeaseArrangements",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pntg_NumberOfServiceProviders": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Service Providers",
        "label": "Number Of Service Providers",
        "terseLabel": "Number of service providers"
       }
      }
     },
     "localname": "NumberOfServiceProviders",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails",
      "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pntg_NumberOfUnitsInRealEstatePropertyAcquired": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Units In Real Estate Property Acquired",
        "label": "Number Of Units In Real Estate Property Acquired",
        "terseLabel": "Number of units (in units)"
       }
      }
     },
     "localname": "NumberOfUnitsInRealEstatePropertyAcquired",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pntg_OperatingLeaseRentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Rent Expense [Member]",
        "label": "Operating Lease, Rent Expense [Member]",
        "terseLabel": "Operating lease, rent expense"
       }
      }
     },
     "localname": "OperatingLeaseRentExpenseMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_PaymentsForDepositsOnAcquisition": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For Deposits On Acquisition",
        "label": "Payments For Deposits On Acquisition",
        "negatedTerseLabel": "Escrow deposits"
       }
      }
     },
     "localname": "PaymentsForDepositsOnAcquisition",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_PaymentsForProceedsFromPropertyReserveRequirements": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments For (Proceeds From) Property Reserve Requirements",
        "label": "Payments For (Proceeds From) Property Reserve Requirements",
        "negatedTerseLabel": "Restricted and other assets"
       }
      }
     },
     "localname": "PaymentsForProceedsFromPropertyReserveRequirements",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_PrivateAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private And Other [Member]",
        "label": "Private And Other [Member]",
        "terseLabel": "Private and other"
       }
      }
     },
     "localname": "PrivateAndOtherMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_ProceedsFromSaleOfSubsidiaryShares": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds From Sale Of Subsidiary Shares",
        "label": "Proceeds From Sale Of Subsidiary Shares",
        "terseLabel": "Proceeds from sale of subsidiary shares"
       }
      }
     },
     "localname": "ProceedsFromSaleOfSubsidiaryShares",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_ReclassificationOfInvestedEquity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reclassification Of Invested Equity",
        "label": "Reclassification Of Invested Equity",
        "terseLabel": "Reclassification of Invested Equity"
       }
      }
     },
     "localname": "ReclassificationOfInvestedEquity",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reconciliation of Adjusted EBITDAR to Income from Operations [Table Text Block]",
        "label": "Reconciliation of Adjusted EBITDAR to Income from Operations [Table Text Block]",
        "terseLabel": "Reconciliation of total combined adjusted EBITDAR from operations for our reportable segments to combined income from operations"
       }
      }
     },
     "localname": "ReconciliationofAdjustedEBITDARtoIncomefromOperationsTableTextBlock",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pntg_RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayment Of The Coronavirus Aid, Relief, and Economic Security Act Funds",
        "label": "Repayment Of The Coronavirus Aid, Relief, and Economic Security Act Funds",
        "terseLabel": "Repayment of the coronavirus aid, relief, and economic security act"
       }
      }
     },
     "localname": "RepaymentOfTheCoronavirusAidReliefAndEconomicSecurityActFunds",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from Contract with Customer And Accounts Receivables Disclosure [Text Block]",
        "label": "Revenue from Contract with Customer And Accounts Receivables Disclosure [Text Block]",
        "terseLabel": "REVENUE AND ACCOUNTS RECEIVABLE"
       }
      }
     },
     "localname": "RevenuefromContractwithCustomerAndAccountsReceivablesDisclosureTextBlock",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pntg_ScrippsHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Scripps Health",
        "label": "Scripps Health [Member]",
        "terseLabel": "Scripps Health"
       }
      }
     },
     "localname": "ScrippsHealthMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_SeniorLivingServicesSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Senior Living Services Segment [Member]",
        "label": "Senior Living Services Segment [Member]",
        "terseLabel": "Senior Living Services"
       }
      }
     },
     "localname": "SeniorLivingServicesSegmentMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails",
      "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expected to Vest, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Unvested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExpectedtoVestOutstandingAggregateIntrinsicValue",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding, Aggregate Intrinsic Value",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding, Aggregate Intrinsic Value",
        "terseLabel": "Vested"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding, Number",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Outstanding, Number",
        "terseLabel": "Number of options vested (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsVestedOutstandingNumber",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "pntg_SpinOffTransactionDistributionRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spin Off Transaction, Distribution Ratio",
        "label": "Spin Off Transaction, Distribution Ratio",
        "terseLabel": "Spin-off transaction, distribution ratio"
       }
      }
     },
     "localname": "SpinOffTransactionDistributionRatio",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "pntg_SpinoffTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Spinoff, Transaction Costs",
        "label": "Spinoff, Transaction Costs",
        "terseLabel": "Spin-off related transaction costs"
       }
      }
     },
     "localname": "SpinoffTransactionCosts",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_StartUpActivitiesCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start-Up Activities, Costs",
        "label": "Start-Up Activities, Costs",
        "terseLabel": "Less: Costs at start-up operations"
       }
      }
     },
     "localname": "StartUpActivitiesCosts",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_StockholdersEquityDistributionsFromParent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockholders' Equity, Distributions From Parent",
        "label": "Stockholders' Equity, Distributions From Parent",
        "terseLabel": "Net transfer from parent"
       }
      }
     },
     "localname": "StockholdersEquityDistributionsFromParent",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_SummaryOfInsuranceLiabilityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Insurance Liability",
        "label": "Summary Of Insurance Liability [Table Text Block]",
        "terseLabel": "Summary of insurance liability"
       }
      }
     },
     "localname": "SummaryOfInsuranceLiabilityTableTextBlock",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "pntg_TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Coronavirus Aid, Relief, and Economic Security Act, Advance Payments Received",
        "label": "The Coronavirus Aid, Relief, and Economic Security Act, Advance Payments Received",
        "terseLabel": "The coronavirus aid, relief, and economic security act, advance payments received"
       }
      }
     },
     "localname": "TheCoronavirusAidReliefAndEconomicSecurityActAdvancePaymentsReceived",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_TheEnsignPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Ensign Plans [Member]",
        "label": "The Ensign Plans [Member]",
        "terseLabel": "The Ensign Plans"
       }
      }
     },
     "localname": "TheEnsignPlansMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_TotalAcquisitions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Acquisitions",
        "label": "Total Acquisitions",
        "terseLabel": "Total acquisitions"
       }
      }
     },
     "localname": "TotalAcquisitions",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_TransitionServicesAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transition Services Agreement",
        "label": "Transition Services Agreement [Member]",
        "terseLabel": "Transition Services Agreement"
       }
      }
     },
     "localname": "TransitionServicesAgreementMember",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "pntg_UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uniform Program Integrity Contractor, Number Of Patient Records Under Review",
        "label": "Uniform Program Integrity Contractor, Number Of Patient Records Under Review",
        "terseLabel": "Number of patient records under review"
       }
      }
     },
     "localname": "UniformProgramIntegrityContractorNumberOfPatientRecordsUnderReview",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "pntg_UniformProgramIntegrityContractorPeriodOfReview": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uniform Program Integrity Contractor, Period Of Review",
        "label": "Uniform Program Integrity Contractor, Period Of Review",
        "terseLabel": "Period of review"
       }
      }
     },
     "localname": "UniformProgramIntegrityContractorPeriodOfReview",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "pntg_UniformProgramIntegrityContractorSuspendedPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Uniform Program Integrity Contractor, Suspended Payments",
        "label": "Uniform Program Integrity Contractor, Suspended Payments",
        "terseLabel": "Suspended payments"
       }
      }
     },
     "localname": "UniformProgramIntegrityContractorSuspendedPayments",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "pntg_WorkersCompensationInsuranceRetentionLimitPerClaim": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Workers' Compensation Insurance, Retention Limit, Per Claim",
        "label": "Workers' Compensation Insurance, Retention Limit, Per Claim",
        "terseLabel": "Workers' compensation, retention limit"
       }
      }
     },
     "localname": "WorkersCompensationInsuranceRetentionLimitPerClaim",
     "nsuri": "http://pennantgroup.com/20211231",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "srt_AffiliatedEntityMember": {
     "auth_ref": [
      "r324",
      "r488",
      "r489",
      "r492",
      "r591"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Affiliated Entity [Member]",
        "terseLabel": "Related party"
       }
      }
     },
     "localname": "AffiliatedEntityMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r108",
      "r159",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r179",
      "r183",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r248",
      "r250",
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r108",
      "r159",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r179",
      "r183",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r247",
      "r248",
      "r250",
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r50",
      "r52",
      "r106",
      "r107",
      "r259",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_DirectorMember": {
     "auth_ref": [
      "r191"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Director [Member]",
        "terseLabel": "Non-employee director"
       }
      }
     },
     "localname": "DirectorMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r189",
      "r313",
      "r317",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r258",
      "r290",
      "r326",
      "r328",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r557",
      "r559",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r258",
      "r290",
      "r326",
      "r328",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r557",
      "r559",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis": {
     "auth_ref": [
      "r573",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate, Type of Property [Axis]",
        "terseLabel": "Real Estate, Type of Property [Axis]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateDescriptionTypeOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MortgageLoansOnRealEstateNamePropertyTypeDomain": {
     "auth_ref": [
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Real Estate [Domain]",
        "terseLabel": "Real Estate [Domain]"
       }
      }
     },
     "localname": "MortgageLoansOnRealEstateNamePropertyTypeDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r189",
      "r313",
      "r317",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OfficeBuildingMember": {
     "auth_ref": [
      "r573",
      "r590"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Office Building [Member]",
        "terseLabel": "Office"
       }
      }
     },
     "localname": "OfficeBuildingMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r258",
      "r290",
      "r323",
      "r326",
      "r328",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r557",
      "r559",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r258",
      "r290",
      "r323",
      "r326",
      "r328",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r557",
      "r559",
      "r592",
      "r593"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r51",
      "r52",
      "r106",
      "r107",
      "r259",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r118",
      "r120",
      "r121",
      "r123",
      "r124",
      "r137",
      "r448",
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Restatement Adjustment"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r1",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r137",
      "r203",
      "r204",
      "r365",
      "r402",
      "r447",
      "r448",
      "r449",
      "r450",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period, Adjustment"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r1",
      "r110",
      "r111",
      "r112",
      "r113",
      "r114",
      "r115",
      "r116",
      "r117",
      "r118",
      "r120",
      "r121",
      "r122",
      "r123",
      "r124",
      "r125",
      "r137",
      "r203",
      "r204",
      "r365",
      "r402",
      "r447",
      "r448",
      "r449",
      "r450",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r604",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r191",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsNotesAndLoansReceivableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]",
        "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]"
       }
      }
     },
     "localname": "AccountsNotesAndLoansReceivableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r36",
      "r497"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "auth_ref": [
      "r210"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsReceivableGrossCurrent": {
     "auth_ref": [
      "r192",
      "r193"
     ],
     "calculation": {
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, before Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, gross"
       }
      }
     },
     "localname": "AccountsReceivableGrossCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Receivables"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r24",
      "r192",
      "r193"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable\u2014less allowance for doubtful accounts of $902 and $643, respectively",
        "totalLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current [Abstract]",
        "terseLabel": "Accounts Receivable [Abstract]"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccrualForTaxesOtherThanIncomeTaxesCurrent": {
     "auth_ref": [
      "r8",
      "r39",
      "r371"
     ],
     "calculation": {
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for real and property taxes. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrual for Taxes Other than Income Taxes, Current",
        "terseLabel": "Property taxes"
       }
      }
     },
     "localname": "AccrualForTaxesOtherThanIncomeTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued Liabilities, Current [Abstract]",
        "terseLabel": "Other Accrued Liabilities, Current [Abstract]"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r34",
      "r224"
     ],
     "calculation": {
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures of cash flow information:"
       }
      }
     },
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r25",
      "r365",
      "r497"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "pntg_NetParentInvestment",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r362",
      "r363",
      "r364",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedLabel": "Shares of common stock withheld to satisfy tax withholding obligations"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r329",
      "r331",
      "r368",
      "r369"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Share-based Compensation after spin-off"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash (used in) provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r331",
      "r358",
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Share-based compensation",
        "verboseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r198",
      "r205",
      "r206",
      "r209"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "periodEndLabel": "Balance at end of period",
        "periodStartLabel": "Balance at beginning of period"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEALLOWANCEFORDOUBTFULACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r28",
      "r198",
      "r205"
     ],
     "calculation": {
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccountsReceivableNetCurrent",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "negatedTerseLabel": "Less: allowance for doubtful accounts",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEALLOWANCEFORDOUBTFULACCOUNTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r208"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-offs of uncollectible accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEALLOWANCEFORDOUBTFULACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "auth_ref": [
      "r67",
      "r88",
      "r278",
      "r466"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs",
        "terseLabel": "Amortization of deferred financing fees"
       }
      }
     },
     "localname": "AmortizationOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS",
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Options which are anti-dilutive and not factored into the weighted average common shares amount (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AssetAcquisitionAxis": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by asset acquisition.",
        "label": "Asset Acquisition [Axis]",
        "terseLabel": "Asset Acquisition [Axis]"
       }
      }
     },
     "localname": "AssetAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetAcquisitionDomain": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset acquisition.",
        "label": "Asset Acquisition [Domain]",
        "terseLabel": "Asset Acquisition [Domain]"
       }
      }
     },
     "localname": "AssetAcquisitionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r88",
      "r221"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r101",
      "r167",
      "r174",
      "r181",
      "r201",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r433",
      "r440",
      "r454",
      "r495",
      "r497",
      "r524",
      "r542"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r49",
      "r101",
      "r201",
      "r240",
      "r241",
      "r242",
      "r244",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r433",
      "r440",
      "r454",
      "r495",
      "r497"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateAxis": {
     "auth_ref": [
      "r332",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Axis]",
        "terseLabel": "Award Date [Axis]"
       }
      }
     },
     "localname": "AwardDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardDateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date or year award under share-based payment arrangement is granted.",
        "label": "Award Date [Domain]",
        "terseLabel": "Award Date [Domain]"
       }
      }
     },
     "localname": "AwardDateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r332",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BaseRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum rate investor will accept.",
        "label": "Base Rate [Member]",
        "terseLabel": "Base Rate"
       }
      }
     },
     "localname": "BaseRateMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r109"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).  Accounting policies describe all significant accounting policies of the reporting entity.",
        "label": "Basis of Presentation and Significant Accounting Policies [Text Block]",
        "terseLabel": "BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r325",
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r325",
      "r327",
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue": {
     "auth_ref": [
      "r418"
     ],
     "calculation": {
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents the fair value of the noncontrolling interest in the acquiree at the acquisition date.",
        "label": "Business Combination, Acquisition of Less than 100 Percent, Noncontrolling Interest, Fair Value",
        "negatedLabel": "Less: noncontrolling interest and additional paid in capital"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionOfLessThan100PercentNoncontrollingInterestFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAcquisitionRelatedCosts": {
     "auth_ref": [
      "r414"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities.",
        "label": "Business Combination, Acquisition Related Costs",
        "terseLabel": "Business combination, acquisition costs",
        "verboseLabel": "Acquisition related costs"
       }
      }
     },
     "localname": "BusinessCombinationAcquisitionRelatedCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combination and Asset Acquisition [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationAndAssetAcquisitionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r422",
      "r423",
      "r424"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Business combination, purchase price"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "ACQUISITIONS"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets",
        "terseLabel": "Other indefinite-lived intangible assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities",
        "negatedLabel": "Liabilities assumed"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized as of the acquisition date for the assets, including goodwill, in excess of (less than) the aggregate liabilities assumed, less the noncontrolling interest in the acquiree.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest",
        "totalLabel": "Total cash paid for acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "terseLabel": "Total acquisitions",
        "totalLabel": "Total acquisitions"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r93",
      "r94",
      "r95"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Capital expenditures in accounts payable"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r31",
      "r497",
      "r571",
      "r572"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r13",
      "r91"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r83",
      "r90",
      "r96"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash end of period",
        "periodStartLabel": "Cash beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r83",
      "r455"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase (decrease) in cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r44",
      "r236",
      "r531",
      "r549"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r233",
      "r234",
      "r235",
      "r237",
      "r577"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r110",
      "r111",
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "verboseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r23",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r23",
      "r497"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "pntg_NetParentInvestment",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.001 par value; 100,000 shares authorized; 28,826 and 28,499 shares issued and outstanding at December\u00a031, 2021, respectively, and 28,696 and 28,243 shares issued and outstanding at December 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r148",
      "r149",
      "r189",
      "r451",
      "r452",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r148",
      "r149",
      "r189",
      "r451",
      "r452",
      "r570",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r148",
      "r149",
      "r189",
      "r451",
      "r452",
      "r570",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Concentration Risk [Line Items]",
        "terseLabel": "Concentration Risk [Line Items]"
       }
      }
     },
     "localname": "ConcentrationRiskLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r148",
      "r149",
      "r189",
      "r451",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Revenue %",
        "verboseLabel": "Concentration risk, percent"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTable": {
     "auth_ref": [
      "r146",
      "r148",
      "r149",
      "r150",
      "r451",
      "r453",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.",
        "label": "Concentration Risk [Table]",
        "terseLabel": "Concentration Risk [Table]"
       }
      }
     },
     "localname": "ConcentrationRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r148",
      "r149",
      "r189",
      "r451",
      "r452",
      "r576"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r97",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for subsidiaries or other investments that are consolidated, including the accounting treatment for intercompany accounts or transactions and any noncontrolling interest.",
        "label": "Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]",
        "terseLabel": "Noncontrolling Interest"
       }
      }
     },
     "localname": "ConsolidationSubsidiariesOrOtherInvestmentsConsolidatedEntitiesPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r301",
      "r302",
      "r314"
     ],
     "calculation": {
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateNonSegmentMember": {
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r183",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.",
        "label": "Corporate, Non-Segment [Member]",
        "terseLabel": "All Other"
       }
      }
     },
     "localname": "CorporateNonSegmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r61",
      "r62"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of product sold and service rendered, excluding depreciation, depletion, and amortization.",
        "label": "Cost of Goods and Service, Excluding Depreciation, Depletion, and Amortization",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostsAndExpenses": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total costs of sales and operating expenses for the period.",
        "label": "Costs and Expenses",
        "totalLabel": "Total expenses"
       }
      }
     },
     "localname": "CostsAndExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Costs and Expenses [Abstract]",
        "terseLabel": "Expense:"
       }
      }
     },
     "localname": "CostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility [Axis]"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility [Domain]"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r397",
      "r405"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r397",
      "r405",
      "r407"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r397",
      "r405"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r147",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer concentration risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRefundLiabilityCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Current regulatory liabilities generally represent obligations to make refunds to customers for various reasons including overpayment.",
        "label": "Customer Refund Liability, Current",
        "terseLabel": "Refunds payable"
       }
      }
     },
     "localname": "CustomerRefundLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r99",
      "r261",
      "r262",
      "r263",
      "r264",
      "r265",
      "r266",
      "r267",
      "r272",
      "r279",
      "r280",
      "r282",
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Margin"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r17",
      "r283",
      "r527",
      "r541"
     ],
     "calculation": {
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r42",
      "r100",
      "r108",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r262",
      "r268",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r281",
      "r285",
      "r286",
      "r287",
      "r288",
      "r293",
      "r294",
      "r295",
      "r296",
      "r464",
      "r465",
      "r467",
      "r468",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r398",
      "r405"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r35",
      "r268",
      "r466"
     ],
     "calculation": {
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "negatedLabel": "Less: unamortized debt issuance costs"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "auth_ref": [
      "r375",
      "r376"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 8.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.",
        "label": "Deferred Income Tax Assets, Net",
        "verboseLabel": "Deferred tax assets"
       }
      }
     },
     "localname": "DeferredIncomeTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r88",
      "r102",
      "r398",
      "r405",
      "r406",
      "r407"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r20",
      "r21",
      "r388",
      "r525",
      "r540"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAndTaxCredits": {
     "auth_ref": [
      "r89"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) and income tax credits.",
        "label": "Deferred Income Taxes and Tax Credits",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAndTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r102",
      "r398",
      "r405"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r389"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Gross deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets (liabilities)"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r391"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Assets, Net [Abstract]",
        "terseLabel": "Deferred Tax Assets, Net [Abstract]"
       }
      }
     },
     "localname": "DeferredTaxAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxAssetsStateTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from state taxes.",
        "label": "Deferred Tax Assets, State Taxes",
        "terseLabel": "State taxes"
       }
      }
     },
     "localname": "DeferredTaxAssetsStateTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from estimated losses under self insurance.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Self Insurance",
        "terseLabel": "Insurance"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsSelfInsurance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r390"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedTerseLabel": "Less: valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "auth_ref": [
      "r395",
      "r396"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "negatedTerseLabel": "Right of use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.",
        "label": "Deferred Tax Liabilities, Prepaid Expenses",
        "negatedTerseLabel": "Prepaid expenses"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPrepaidExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESDEFERREDTAXASSETSANDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepositLiabilityCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current portion, due within one year or one operating cycle, if longer, of deposits held other than customer deposits.",
        "label": "Deposit Liability, Current",
        "terseLabel": "Resident deposits"
       }
      }
     },
     "localname": "DepositLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r88",
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAndAmortization": {
     "auth_ref": [
      "r88",
      "r222"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "terseLabel": "Less: Depreciation and amortization",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r88",
      "r162"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r313",
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r370"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "OPTIONS AND AWARDS"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCash": {
     "auth_ref": [
      "r297",
      "r538"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.",
        "label": "Dividends, Cash",
        "negatedTerseLabel": "Cash Dividend to Parent"
       }
      }
     },
     "localname": "DividendsCash",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings per common share (Note 4):"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r64",
      "r115",
      "r116",
      "r118",
      "r119",
      "r120",
      "r126",
      "r128",
      "r131",
      "r132",
      "r133",
      "r137",
      "r138",
      "r449",
      "r450",
      "r534",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in dollars per share)",
        "verboseLabel": "Basic net income per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Earnings Per Share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r64",
      "r115",
      "r116",
      "r118",
      "r119",
      "r120",
      "r128",
      "r131",
      "r132",
      "r133",
      "r137",
      "r138",
      "r449",
      "r450",
      "r534",
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in dollars per share)",
        "verboseLabel": "Diluted net income per common share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r134",
      "r135"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Earnings Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "COMPUTATION OF NET INCOME PER COMMON SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r378"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Total income tax provision(d)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r103",
      "r378",
      "r408"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Income tax expense at statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense": {
     "auth_ref": [
      "r378",
      "r408"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to noncontrolling interest income (loss) exempt from income taxes.",
        "label": "Effective Income Tax Rate Reconciliation, Noncontrolling Interest Income (Loss), Percent",
        "negatedTerseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationMinorityInterestIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment": {
     "auth_ref": [
      "r378",
      "r408"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to meals and entertainment expense.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent",
        "terseLabel": "Non-deductible meals and entertainment"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r378",
      "r408"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 12.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "terseLabel": "Other non-deductible expenses"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r378",
      "r408"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "terseLabel": "Non-deductible equity compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r378",
      "r408"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other adjustments"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r378",
      "r408"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income taxes - net of federal benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCredits": {
     "auth_ref": [
      "r378",
      "r408"
     ],
     "calculation": {
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails": {
       "order": 11.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to tax credits. Including, but not limited to, research credit, foreign tax credit, investment tax credit, and other tax credits.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Percent",
        "negatedTerseLabel": "Tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCredits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued wages and related liabilities"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "totalLabel": "Total unrecognized share-based compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unvested options and stock awards, cost net yet recognized, period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unvested Restricted Stock"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r359"
     ],
     "calculation": {
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unvested stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EntityWideRevenueMajorCustomerLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Major Customer [Line Items]",
        "terseLabel": "Revenue, Major Customer [Line Items]"
       }
      }
     },
     "localname": "EntityWideRevenueMajorCustomerLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services.",
        "label": "Equipment [Member]",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "EquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity:"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r0",
      "r56",
      "r57",
      "r58",
      "r110",
      "r111",
      "r112",
      "r114",
      "r121",
      "r124",
      "r140",
      "r202",
      "r292",
      "r297",
      "r362",
      "r363",
      "r364",
      "r401",
      "r402",
      "r448",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r560",
      "r561",
      "r562",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EscrowDeposit": {
     "auth_ref": [
      "r530",
      "r578"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 7.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The designation of funds furnished by a borrower to a lender to assure future payments of the borrower's real estate taxes and insurance obligations with respect to a mortgaged property. Escrow deposits may be made for a variety of other purposes such as earnest money and contingent payments. This element excludes replacement reserves which are an escrow separately provided for within the US GAAP taxonomy.",
        "label": "Escrow Deposit",
        "terseLabel": "Escrow deposits"
       }
      }
     },
     "localname": "EscrowDeposit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r65"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative expense"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r211",
      "r212",
      "r497",
      "r523"
     ],
     "calculation": {
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Goodwill, ending balance",
        "periodStartLabel": "Goodwill, beginning balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r213"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Intangible asset impairments"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "GOODWILL AND INTANGIBLE ASSETS\u2014NET"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r214",
      "r217"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Goodwill [Line Items]",
        "terseLabel": "Goodwill [Line Items]"
       }
      }
     },
     "localname": "GoodwillLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "auth_ref": [
      "r88",
      "r221",
      "r226"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "terseLabel": "Impairment of long-lived assets"
       }
      }
     },
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS",
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails",
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the impairment and disposal of long-lived assets including goodwill and other intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Including Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsIncludingIntangibleAssetsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r60",
      "r167",
      "r173",
      "r177",
      "r180",
      "r183",
      "r522",
      "r532",
      "r536",
      "r552"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before provision for income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r227",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r380"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Income Tax Contingency [Line Items]",
        "terseLabel": "Income Tax Contingency [Line Items]"
       }
      }
     },
     "localname": "IncomeTaxContingencyLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails",
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "auth_ref": [
      "r381",
      "r385",
      "r387",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months.",
        "label": "Income Tax Contingency [Table]",
        "terseLabel": "Income Tax Contingency [Table]"
       }
      }
     },
     "localname": "IncomeTaxContingencyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails",
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r103",
      "r379",
      "r386",
      "r393",
      "r403",
      "r409",
      "r411",
      "r412",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r104",
      "r123",
      "r124",
      "r165",
      "r377",
      "r404",
      "r410",
      "r553"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_ProfitLoss",
       "weight": -1.0
      },
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes",
        "totalLabel": "Total income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME",
      "http://pennantgroup.com/role/INCOMETAXESPROVISIONFORINCOMETAXESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r55",
      "r373",
      "r374",
      "r386",
      "r387",
      "r392",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r85",
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": {
     "auth_ref": [
      "r87",
      "r508"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Contract with Customer, Liability",
        "terseLabel": "Advance payments"
       }
      }
     },
     "localname": "IncreaseDecreaseInContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "terseLabel": "Accrued wages and related liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r87",
      "r478"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease obligations"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherAccruedLiabilities": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in other expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Other Accrued Liabilities",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Liabilities",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r216",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets [Axis]",
        "terseLabel": "Indefinite-lived Intangible Assets [Axis]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Indefinite-lived Intangible Assets [Line Items]",
        "terseLabel": "Indefinite-lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r218"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Other indefinite-lived intangibles"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r216",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.",
        "label": "Indefinite-lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Indefinite-lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r59",
      "r161",
      "r463",
      "r466",
      "r535"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense, net"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of nonoperating interest income (expense).",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "totalLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r81",
      "r84",
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease, Cost [Abstract]",
        "terseLabel": "Lease, Cost [Abstract]"
       }
      }
     },
     "localname": "LeaseCostAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r482"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Components of operating lease cot"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails",
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r483"
     ],
     "calculation": {
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: present value adjustments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LetterOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit).",
        "label": "Letter of Credit [Member]",
        "terseLabel": "Letters of credit"
       }
      }
     },
     "localname": "LetterOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.",
        "label": "Letters of Credit Outstanding, Amount",
        "terseLabel": "Letters of credit outstanding"
       }
      }
     },
     "localname": "LettersOfCreditOutstandingAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r38",
      "r101",
      "r175",
      "r201",
      "r240",
      "r241",
      "r242",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r434",
      "r440",
      "r441",
      "r454",
      "r495",
      "r496"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r27",
      "r101",
      "r201",
      "r454",
      "r497",
      "r529",
      "r547"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r41",
      "r101",
      "r201",
      "r240",
      "r241",
      "r242",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r434",
      "r440",
      "r441",
      "r454",
      "r495",
      "r496",
      "r497"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r17",
      "r18",
      "r101",
      "r201",
      "r240",
      "r241",
      "r242",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r434",
      "r440",
      "r441",
      "r454",
      "r495",
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.",
        "label": "Liabilities, Noncurrent",
        "terseLabel": "AAP amount reclassified"
       }
      }
     },
     "localname": "LiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LicensingAgreementsMember": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights, generally of limited duration, under a license arrangement (for example, to sell or otherwise utilize specified products or processes in a specified territory).",
        "label": "Licensing Agreements [Member]",
        "terseLabel": "Medicare and Medicaid licenses"
       }
      }
     },
     "localname": "LicensingAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityCommitmentFeePercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for the line of credit facility regardless of whether the facility has been used.",
        "label": "Line of Credit Facility, Commitment Fee Percentage",
        "terseLabel": "Commitment fee percentage"
       }
      }
     },
     "localname": "LineOfCreditFacilityCommitmentFeePercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "auth_ref": [
      "r37"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "terseLabel": "Borrowing availability"
       }
      }
     },
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "LIBOR"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r17",
      "r269",
      "r284",
      "r285",
      "r286",
      "r527",
      "r544"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "terseLabel": "Long-term debt, net",
        "totalLabel": "Long-term debt, net"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r42"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r42",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongtermDebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of long-term debt outstanding calculated at point in time.",
        "label": "Long-term Debt, Weighted Average Interest Rate, at Point in Time",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "LongtermDebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_MinorityInterest": {
     "auth_ref": [
      "r48",
      "r101",
      "r201",
      "r240",
      "r245",
      "r246",
      "r247",
      "r253",
      "r254",
      "r454",
      "r528",
      "r546"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).",
        "label": "Stockholders' Equity Attributable to Noncontrolling Interest",
        "verboseLabel": "Noncontrolling interest"
       }
      }
     },
     "localname": "MinorityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestDecreaseFromRedemptions": {
     "auth_ref": [
      "r297",
      "r431",
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Decrease in noncontrolling interest (for example, but not limited to, redeeming or purchasing the interests of noncontrolling shareholders, issuance of shares (interests) by the non-wholly owned subsidiary to the parent entity for other than cash, and a buyback of shares (interest) by the non-wholly owned subsidiary from the noncontrolling interests).",
        "label": "Noncontrolling Interest, Decrease from Redemptions or Purchase of Interests",
        "negatedTerseLabel": "Share repurchase related to subsidiary equity plan"
       }
      }
     },
     "localname": "MinorityInterestDecreaseFromRedemptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Ownership interest"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r141",
      "r154"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "DESCRIPTION OF BUSINESS"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by (used in) financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r83",
      "r86",
      "r89"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash (used in) provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r3",
      "r53",
      "r54",
      "r58",
      "r63",
      "r89",
      "r101",
      "r113",
      "r115",
      "r116",
      "r118",
      "r119",
      "r123",
      "r124",
      "r130",
      "r167",
      "r173",
      "r177",
      "r180",
      "r183",
      "r201",
      "r240",
      "r241",
      "r242",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r450",
      "r454",
      "r533",
      "r550"
     ],
     "calculation": {
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net income and other comprehensive income attributable to The Pennant Group, Inc.",
        "totalLabel": "Net income attributable to The Pennant Group, Inc.",
        "verboseLabel": "Net income/ (loss) attributable to The Pennant Group, Inc."
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r53",
      "r54",
      "r58",
      "r123",
      "r124",
      "r437",
      "r443"
     ],
     "calculation": {
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.",
        "label": "Net Income (Loss) Attributable to Noncontrolling Interest",
        "netLabel": "Net income attributable to noncontrolling interest",
        "terseLabel": "Less: net (loss)/ income attributable to noncontrolling interest",
        "verboseLabel": "Add: Net income/ (loss) attributable to noncontrolling interest"
       }
      }
     },
     "localname": "NetIncomeLossAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Standards Adopted by the Company"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Non-cash investing activity:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": {
     "auth_ref": [
      "r298",
      "r418",
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from a business combination.",
        "label": "Noncontrolling Interest, Increase from Business Combination",
        "terseLabel": "Noncontrolling interests assumed related to acquisitions"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromBusinessCombination",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest": {
     "auth_ref": [
      "r298",
      "r431",
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from sale of a portion of the parent's controlling interest.",
        "label": "Noncontrolling Interest, Increase from Sale of Parent Equity Interest",
        "terseLabel": "Sale of noncontrolling interests, net of tax"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance": {
     "auth_ref": [
      "r298",
      "r431",
      "r439"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in noncontrolling interest from subsidiary issuance of equity interests to noncontrolling interest holders.",
        "label": "Noncontrolling Interest, Increase from Subsidiary Equity Issuance",
        "terseLabel": "Noncontrolling interest attributable to subsidiary equity plan"
       }
      }
     },
     "localname": "NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NoncontrollingInterestMember": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r297",
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.",
        "label": "Noncontrolling Interest [Member]",
        "terseLabel": "Non-Controlling Interest"
       }
      }
     },
     "localname": "NoncontrollingInterestMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NonoperatingIncomeExpenseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Income (Expense) [Abstract]",
        "terseLabel": "Other income (expense):"
       }
      }
     },
     "localname": "NonoperatingIncomeExpenseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Summary of non-vested restricted stock awards"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NumberOfRealEstateProperties": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of real estate properties owned as of the balance sheet date.",
        "label": "Number of Real Estate Properties",
        "terseLabel": "Number of operating facilities"
       }
      }
     },
     "localname": "NumberOfRealEstateProperties",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r167",
      "r173",
      "r177",
      "r180",
      "r183"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r475",
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease costs"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r471"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 3.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Rent\u2014cost of services",
        "verboseLabel": "Rent\u2014cost of services"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Leases, Under Adoption of ASC 842 [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r470"
     ],
     "calculation": {
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "totalLabel": "Present value of total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r470"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "negatedLabel": "Less: current lease liabilities",
        "terseLabel": "Operating lease liabilities\u2014current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r470"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities\u2014long-term",
        "verboseLabel": "Long-term operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://pennantgroup.com/role/LEASESFUTUREMINIMUMLEASEPAYMENTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r472",
      "r478"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r469"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "verboseLabel": "Operating lease right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r481",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r480",
      "r484"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r394"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Operating loss carryforwards"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsValuationAllowance": {
     "auth_ref": [
      "r390"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of the valuation allowance pertaining to the deferred tax asset representing potential future taxable deductions from net operating loss carryforwards for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Operating Loss Carryforwards, Valuation Allowance",
        "terseLabel": "Operating loss carryforwards, valuation allowance"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingSegmentsMember": {
     "auth_ref": [
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Operating Segments [Member]",
        "terseLabel": "Operating segments"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r9",
      "r39"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities",
        "totalLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Schedule of other accrued liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for other liabilities.",
        "label": "Other Liabilities Disclosure [Text Block]",
        "terseLabel": "OTHER ACCRUED LIABILITIES"
       }
      }
     },
     "localname": "OtherLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_InterestIncomeExpenseNonoperatingNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other (expense) income",
        "verboseLabel": "Other income"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherRestrictedAssetsNoncurrent": {
     "auth_ref": [
      "r574",
      "r575"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets that are pledged or subject to withdrawal restrictions, classified as other.",
        "label": "Other Restricted Assets, Noncurrent",
        "terseLabel": "Restricted and other assets"
       }
      }
     },
     "localname": "OtherRestrictedAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesCurrent": {
     "auth_ref": [
      "r39",
      "r238"
     ],
     "calculation": {
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.",
        "label": "Other Sundry Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ParentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.",
        "label": "Parent [Member]",
        "terseLabel": "Net Parent Investment"
       }
      }
     },
     "localname": "ParentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedTerseLabel": "Repurchase of shares of common stock to satisfy tax withholding obligations"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividends": {
     "auth_ref": [
      "r78"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.",
        "label": "Payments of Dividends",
        "negatedTerseLabel": "Cash distribution to parent in connection with Spin-Off"
       }
      }
     },
     "localname": "PaymentsOfDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfFinancingCosts": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for loan and debt issuance costs.",
        "label": "Payments of Financing Costs",
        "negatedLabel": "Payments for deferred financing costs"
       }
      }
     },
     "localname": "PaymentsOfFinancingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesGross": {
     "auth_ref": [
      "r73",
      "r425"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.",
        "label": "Payments to Acquire Businesses, Gross",
        "negatedLabel": "Cash payments for business acquisitions"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInterestInJointVenture": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the investment in or advances to an entity in which the reporting entity shares control of the entity with another party or group.",
        "label": "Payments to Acquire Interest in Joint Venture",
        "terseLabel": "Acquire interest in joint venture"
       }
      }
     },
     "localname": "PaymentsToAcquireInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r74"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchase of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToMinorityShareholders": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to a noncontrolling interest. Includes, but not limited to, reduction of noncontrolling interest ownership. Excludes dividends paid to the noncontrolling interest.",
        "label": "Payments to Noncontrolling Interests",
        "negatedTerseLabel": "Repurchase of subsidiary shares"
       }
      }
     },
     "localname": "PaymentsToMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r332",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r29",
      "r30"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromDivestitureOfInterestInJointVenture": {
     "auth_ref": [
      "r72"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the sale of an investment interest in a joint venture that the reporting entity has not previously accounted for using consolidation or the equity method of accounting.",
        "label": "Proceeds from Divestiture of Interest in Joint Venture",
        "terseLabel": "Cash from sale of noncontrolling interest"
       }
      }
     },
     "localname": "ProceedsFromDivestitureOfInterestInJointVenture",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLongTermLinesOfCredit": {
     "auth_ref": [
      "r76"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Proceeds from Long-term Lines of Credit",
        "terseLabel": "Proceeds from revolver agreement"
       }
      }
     },
     "localname": "ProceedsFromLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromMinorityShareholders": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from a noncontrolling interest. Includes, but is not limited to, purchase of additional shares or other increase in noncontrolling interest ownership.",
        "label": "Proceeds from Noncontrolling Interests",
        "terseLabel": "Sale of noncontrolling interest"
       }
      }
     },
     "localname": "ProceedsFromMinorityShareholders",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r75",
      "r361"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon the exercise of options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r3",
      "r53",
      "r54",
      "r58",
      "r82",
      "r101",
      "r113",
      "r123",
      "r124",
      "r167",
      "r173",
      "r177",
      "r180",
      "r183",
      "r201",
      "r240",
      "r241",
      "r242",
      "r245",
      "r246",
      "r247",
      "r249",
      "r251",
      "r253",
      "r254",
      "r430",
      "r436",
      "r438",
      "r443",
      "r444",
      "r450",
      "r454",
      "r536"
     ],
     "calculation": {
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      },
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r34",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails",
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r229",
      "r579",
      "r580",
      "r581"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY AND EQUIPMENT\u2014NET"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNET"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r33",
      "r223"
     ],
     "calculation": {
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r14",
      "r15",
      "r225",
      "r497",
      "r537",
      "r548"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r32",
      "r225",
      "r579",
      "r580"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r14",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r14",
      "r223"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails",
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r66",
      "r207"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEALLOWANCEFORDOUBTFULACCOUNTSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ReinsuranceReceivablesIncurredButNotReportedClaims": {
     "auth_ref": [
      "r554",
      "r555"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Estimated amount after valuation allowance of reinsurance recoverables, due from reinsurers for incurred claims not yet reported, and claims settlement expenses.",
        "label": "Reinsurance Recoverables, Incurred but Not Reported Claims",
        "terseLabel": "Reinsurance receivables"
       }
      }
     },
     "localname": "ReinsuranceReceivablesIncurredButNotReportedClaims",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyCosts": {
     "auth_ref": [
      "r69",
      "r105",
      "r243",
      "r245",
      "r246",
      "r252",
      "r253",
      "r254"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Direct costs arising from transactions with related parties who are not affiliates or joint Ventures. These costs are categorized as cost of goods sold.",
        "label": "Related Party Costs",
        "terseLabel": "Cost of services"
       }
      }
     },
     "localname": "RelatedPartyCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r324",
      "r488",
      "r489"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAmountsOfTransaction": {
     "auth_ref": [
      "r488",
      "r492"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transactions with related party during the financial reporting period.",
        "label": "Related Party Transaction, Amounts of Transaction",
        "terseLabel": "Amounts of related party transaction"
       }
      }
     },
     "localname": "RelatedPartyTransactionAmountsOfTransaction",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r324",
      "r488",
      "r489",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r488"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Fees incurred",
        "verboseLabel": "Expenses from transactions with related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 4.0,
       "parentTag": "us-gaap_CostsAndExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of selling, general and administrative expenses resulting from transactions, excluding transactions that are eliminated in consolidated or combined financial statements, with related party.",
        "label": "Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party",
        "terseLabel": "General and administrative expense"
       }
      }
     },
     "localname": "RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r324",
      "r488",
      "r492",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r486",
      "r487",
      "r489",
      "r493",
      "r494"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTY TRANSACTIONS AND NET PARENT INVESTMENT"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfLongTermLinesOfCredit": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.",
        "label": "Repayments of Long-term Lines of Credit",
        "negatedLabel": "Payments on revolver agreement"
       }
      }
     },
     "localname": "RepaymentsOfLongTermLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r134"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted stock awards"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r26",
      "r297",
      "r365",
      "r497",
      "r545",
      "r564",
      "r569"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "pntg_NetParentInvestment",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r0",
      "r110",
      "r111",
      "r112",
      "r114",
      "r121",
      "r124",
      "r202",
      "r362",
      "r363",
      "r364",
      "r401",
      "r402",
      "r448",
      "r560",
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings/ (Accumulated Deficit)"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r158",
      "r159",
      "r172",
      "r178",
      "r179",
      "r186",
      "r187",
      "r189",
      "r312",
      "r313",
      "r509"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerMember": {
     "auth_ref": [
      "r148",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from satisfaction of performance obligation by transferring promised product and service to customer, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue from Contract with Customer Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r98",
      "r304",
      "r305",
      "r306",
      "r307",
      "r308",
      "r309",
      "r310",
      "r311",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenuePerformanceObligationDescriptionOfPaymentTerms": {
     "auth_ref": [
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of payment terms in contract with customer. Includes, but is not limited to, timing of payment, existence of financing component, variability of consideration and constraint on variable consideration.",
        "label": "Revenue, Performance Obligation, Description of Payment Terms",
        "terseLabel": "Payment terms"
       }
      }
     },
     "localname": "RevenuePerformanceObligationDescriptionOfPaymentTerms",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevolvingCreditFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.",
        "label": "Revolving Credit Facility [Member]",
        "terseLabel": "Revolving credit facility"
       }
      }
     },
     "localname": "RevolvingCreditFacilityMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails",
      "http://pennantgroup.com/role/DEBTSCHEDULEOFLONGTERMDEBTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r479",
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for new operating lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule itemizing specific types of trade accounts and notes receivable, and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEACCOUNTSRECEIVABLEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of accounts receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r415",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Total share-based compensation expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Provision for income taxes on continuing operations"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r42",
      "r108",
      "r285",
      "r287",
      "r293",
      "r294",
      "r295",
      "r296",
      "r464",
      "r465",
      "r468",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of long-term debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Deferred tax assets and liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock": {
     "auth_ref": [
      "r129",
      "r133",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the effect of income (loss) on an entity's diluted earnings per share.",
        "label": "Schedule of Earnings Per Share, Diluted, by Common Class, Including Two Class Method [Table Text Block]",
        "terseLabel": "Computation of basic and diluted net income per share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareDilutedByCommonClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Reconciliation of federal statutory rate to effective tax rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable": {
     "auth_ref": [
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure about the extent of the entity's reliance on its major customers.",
        "label": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]",
        "terseLabel": "Schedule of Revenue by Major Customers, by Reporting Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfEntityWideRevenueByMajorCustomersByReportingSegmentsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSINCOMEFROMOPERATIONSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTable": {
     "auth_ref": [
      "r214",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of goodwill and the changes during the year due to acquisition, sale, impairment or for other reasons.",
        "label": "Schedule of Goodwill [Table]",
        "terseLabel": "Schedule of Goodwill [Table]"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r214",
      "r215"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Activity in goodwill by segment"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r218",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r218",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Other indefinite-lived intangible assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r34",
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/PROPERTYANDEQUIPMENTNETDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of operations acquired in business combinations"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r490",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.",
        "label": "Schedule of Revenue by Major Customers by Reporting Segments [Table Text Block]",
        "verboseLabel": "Revenue by major payor source"
       }
      }
     },
     "localname": "ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r167",
      "r170",
      "r176",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails",
      "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r167",
      "r170",
      "r176",
      "r214"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Financial data combined by business segment"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of number, weighted-average exercise price or conversion ratio, aggregate intrinsic value, and weighted-average remaining contractual term for outstanding options that are fully vested and expected to vest. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]",
        "terseLabel": "Aggregate intrinsic value of options outstanding, vested, expected to vest and exercisable"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r332",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r338",
      "r347",
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Employee stock option activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Stock options granted fair value assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r385",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of unrecognized tax benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r155",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r183",
      "r189",
      "r231",
      "r232",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails",
      "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r155",
      "r156",
      "r157",
      "r167",
      "r171",
      "r177",
      "r181",
      "r182",
      "r183",
      "r184",
      "r186",
      "r188",
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "BUSINESS SEGMENTS"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails",
      "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SelfInsuranceReserveCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_OtherAccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount of accrued known and estimated losses incurred as of the balance sheet date for which no insurance coverage exists, and for which a claim has been made or is probable of being asserted, typically arising from workmen's compensation-type of incidents and personal injury to nonemployees from accidents on the entity's property that are expected to be paid within one year (or the normal operating cycle, if longer).",
        "label": "Self Insurance Reserve, Current",
        "terseLabel": "Accrued insurance retention - current portion"
       }
      }
     },
     "localname": "SelfInsuranceReserveCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": {
     "auth_ref": [
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.",
        "label": "Series of Individually Immaterial Business Acquisitions [Member]",
        "terseLabel": "Series of Individually Immaterial Business Acquisitions"
       }
      }
     },
     "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/ACQUISITIONSSCHEDULEOFOPERATIONSACQUIREDINBUSINESSCOMBINATIONSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS",
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Ending balance, outstanding (in shares)",
        "periodStartLabel": "Beginning balance, outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "verboseLabel": "Non-Vested Restricted Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "End of period, weighted average exercise price (in dollars per share)",
        "periodStartLabel": "Beginning of period, weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]",
        "terseLabel": "Weighted Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)",
        "terseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend Yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-Free Interest Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited &amp; Expired (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Options granted (in shares)",
        "verboseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value of options (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r340",
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Ending balance, outstanding (in shares)",
        "periodStartLabel": "Beginning balance, outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "End of period, weighted average exercise price (in dollars per share)",
        "periodStartLabel": "Beginning of period, weighted average exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price of options vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r330",
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSRESTRICTEDSTOCKDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "verboseLabel": "Forfeited &amp; Expired (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r332",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Options, vesting percent per year"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Options, expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r352",
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected life"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSOPTIONSGRANTEDDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r360"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Exercised"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSAGGREGATEINTRINSICVALUEOFOPTIONSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares",
        "terseLabel": "Options, unvested and outstanding (in shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted average contractual life for options outstanding, vested and expected to vest"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/OPTIONSANDAWARDSSHAREBASEDCOMPENSATIONEXPENSEANDNARRATIVEDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Equity, ending balance (in shares)",
        "periodStartLabel": "Equity, beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares of common stock withheld to satisfy tax withholding obligations (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r2",
      "r155",
      "r158",
      "r159",
      "r160",
      "r161",
      "r162",
      "r163",
      "r164",
      "r165",
      "r166",
      "r167",
      "r168",
      "r169",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r178",
      "r179",
      "r180",
      "r181",
      "r183",
      "r189",
      "r214",
      "r228",
      "r231",
      "r232",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSFINANCIALDATADetails",
      "http://pennantgroup.com/role/BUSINESSSEGMENTSNARRATIVEDetails",
      "http://pennantgroup.com/role/DESCRIPTIONOFBUSINESSDetails",
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETACTIVITYINGOODWILLDetails",
      "http://pennantgroup.com/role/LEASESNARRATIVEDetails",
      "http://pennantgroup.com/role/RELATEDPARTYTRANSACTIONSANDNETPARENTINVESTMENTDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLENARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r0",
      "r46",
      "r56",
      "r57",
      "r58",
      "r110",
      "r111",
      "r112",
      "r114",
      "r121",
      "r124",
      "r140",
      "r202",
      "r292",
      "r297",
      "r362",
      "r363",
      "r364",
      "r401",
      "r402",
      "r448",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r560",
      "r561",
      "r562",
      "r605"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r110",
      "r111",
      "r112",
      "r140",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r292",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock after spin-off (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures": {
     "auth_ref": [
      "r22",
      "r23",
      "r292",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period related to Restricted Stock Awards, net of any shares forfeited.",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures",
        "terseLabel": "Issuance/ (cancellation) of restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r22",
      "r23",
      "r292",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Net issuance of restricted stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r22",
      "r23",
      "r292",
      "r297",
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Issuance of common stock from the exercise of stock options / issuance of other awards after spin-off (in shares)",
        "verboseLabel": "Exercised (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT",
      "http://pennantgroup.com/role/INCOMETAXESTAXRATERECONCILIATIONDetails",
      "http://pennantgroup.com/role/OPTIONSANDAWARDSEMPLOYEESTOCKOPTIONACTIVITYDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r22",
      "r23",
      "r292",
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of Common Stock after spin-off"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r46",
      "r292",
      "r297"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock from the exercise of stock options / issuance of other awards after spin-off"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r0",
      "r1",
      "r57",
      "r101",
      "r110",
      "r111",
      "r112",
      "r114",
      "r121",
      "r201",
      "r202",
      "r297",
      "r362",
      "r363",
      "r364",
      "r401",
      "r402",
      "r428",
      "r429",
      "r442",
      "r448",
      "r454",
      "r456",
      "r457",
      "r461",
      "r561",
      "r562",
      "r605"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "periodEndLabel": "Equity, ending balance",
        "periodStartLabel": "Equity, beginning balance",
        "totalLabel": "Total equity"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT",
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubleaseIncome": {
     "auth_ref": [
      "r477",
      "r484"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of sublease income excluding finance and operating lease expense.",
        "label": "Sublease Income",
        "negatedTerseLabel": "Sublease income"
       }
      }
     },
     "localname": "SubleaseIncome",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SubsegmentsAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business subsegments.",
        "label": "Subsegments [Axis]",
        "terseLabel": "Subsegments [Axis]"
       }
      }
     },
     "localname": "SubsegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsegmentsDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Divisions of a component of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Subsegments [Domain]",
        "terseLabel": "Subsegments [Domain]"
       }
      }
     },
     "localname": "SubsegmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/ACQUISITIONSNARRATIVEDetails",
      "http://pennantgroup.com/role/REVENUEANDACCOUNTSRECEIVABLEREVENUEBYMAJORPAYORDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r462",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r462",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r462",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r462",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMMITMENTSANDCONTINGENCIESDetails",
      "http://pennantgroup.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r498",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENT"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/SUBSEQUENTEVENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Cash paid during the period for:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "auth_ref": [
      "r194",
      "r195",
      "r196",
      "r197",
      "r199",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for accounts receivable.",
        "label": "Accounts Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade name"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/GOODWILLANDINTANGIBLEASSETSNETINDEFINITELIVEDINTANGIBLEASSETSDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r45",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFSTOCKHOLDERSEQUITYANDNETPARENTINVESTMENT"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r45",
      "r299",
      "r300"
     ],
     "calculation": {
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "pntg_NetParentInvestment",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost, 3 shares at December 31, 2021 and 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r372",
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance at December 31",
        "periodStartLabel": "Balance at January 1"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r384"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions",
        "negatedTerseLabel": "Reductions for tax positions related to the current year"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r383"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Additions for tax positions of prior years"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/INCOMETAXESUNRECOGNIZEDTAXBENEFITSDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnusualOrInfrequentItemLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Unusual or Infrequent Item, or Both [Line Items]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Line Items]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UnusualOrInfrequentItemTable": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the nature and financial statement effect of an event or transaction that is unusual in nature or infrequent in occurrence, or both.",
        "label": "Unusual or Infrequent Item, or Both [Table]",
        "terseLabel": "Unusual or Infrequent Item, or Both [Table]"
       }
      }
     },
     "localname": "UnusualOrInfrequentItemTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESDetails",
      "http://pennantgroup.com/role/OTHERACCRUEDLIABILITIESNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r142",
      "r143",
      "r144",
      "r145",
      "r151",
      "r152",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Estimates and Assumptions"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r476",
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/LEASESIMPACTOFNEWLEASESGUIDANCEDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/DEBTNARRATIVEDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": {
     "auth_ref": [
      "r133"
     ],
     "calculation": {
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.",
        "label": "Weighted Average Number Diluted Shares Outstanding Adjustment",
        "terseLabel": "Plus: incremental shares from assumed conversion (in share)"
       }
      }
     },
     "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r127",
      "r133"
     ],
     "calculation": {
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Adjusted weighted average common shares outstanding for diluted income per share (in share)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r126",
      "r133"
     ],
     "calculation": {
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Weighted average shares outstanding for basic net income per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails",
      "http://pennantgroup.com/role/CONSOLIDATEDANDCOMBINEDSTATEMENTSOFINCOME"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding Reconciliation [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingDilutedDisclosureItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/COMPUTATIONOFNETINCOMEPERCOMMONSHARERECONCILIATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WorkersCompensationLiabilityCurrentAndNoncurrent": {
     "auth_ref": [
      "r16",
      "r19",
      "r526",
      "r543"
     ],
     "calculation": {
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails": {
       "order": 2.0,
       "parentTag": "pntg_InsuranceProgramAccruedExpenses",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations and payables pertaining to claims incurred of a workers compensation nature.",
        "label": "Workers' Compensation Liability",
        "terseLabel": "Workers\u2019 compensation"
       }
      }
     },
     "localname": "WorkersCompensationLiabilityCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://pennantgroup.com/role/BASISOFPRESENTATIONANDSUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESSUMMARYOFINSURANCELIABILITYDetails"
     ],
     "xbrltype": "monetaryItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(25))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 201.5-02(26))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1505-109256"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e4984-109258"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6327-108592"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6442-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8657-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8721-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8813-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8844-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(23))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8981-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8475-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9054-108599"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123351718&loc=d3e2420-110228"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2921-110230"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130531-203044"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123360276&loc=SL49130532-203044"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130554-203045"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130561-203045"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130563-203045"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130564-203045"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130566-203045"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130543-203045"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130549-203045"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6419918&loc=d3e35281-107843"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20,24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=124434304&loc=d3e36027-109320"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123586518&loc=d3e1043-128460"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=123410050&loc=d3e5419-128473"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6578-128477"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=116859721&loc=d3e6613-128477"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e6927-128479"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=6911878&loc=d3e8732-128492"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "http://asc.fasb.org/topic&trid=2303972"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568447-111683"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4568740-111683"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4616395-111683"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=123371682&loc=d3e55415-109406"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=123384075&loc=d3e41242-110953"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15)(a))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(24))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21409-158489"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "310",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99404803&loc=d3e21412-158489"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=123364037&loc=d3e3115-115594"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(d)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 4))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r594": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r595": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r596": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r597": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r598": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r599": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r600": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r601": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r602": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r603": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(8))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=114868883&loc=SL114871943-224233"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3179-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3367-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4297-108586"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18823-107790"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>100
<FILENAME>0001766400-22-000044-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001766400-22-000044-xbrl.zip
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M!DZ/5Z.*#QOWIIY2K-Z^=<UK#,F)0:*HH[W!$QLBQF_\5M"JAQ@G\XE6$Z!
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M<$=^$"YC3&#MTOB"U7TBUEXTX2.D]M*M-_G,/?/J-]QZ]_?O3_X+4$L#!!0
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M1*^*"4Y#*6&2^SECPO]A:!.:E_U=Y";744_ ([:&8#O:Z/ZGMX,W Q?*CN'
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M-+$+5PT[XUQB+5%)I=LION@52=)]USFP+.CS>)DC4Q +) H36$K*9G"?H'P
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MZD;7S=7X=2<<U#\JG)P;L-&VTP70](G%V//H#77]WW707YB<_!=02P,$%
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M5=@)"(R*E&[(UE+ZV1'[6YUQ@ \%GY*L&^K$9V88L[#!J%3I/F*T<:*JWR@
M2 &I'.N&ABG4+?U5A:T!MI14Y&5$7L;/CB$OXS=SH.LAV6N=RL,(R/9YSVW!
M5)?>!<S' J6"I1LF1.><15 *2N5*=T59^@R,@E&YTEV1S0JG3ME;\CG22VTN
MIV<I'E\DW;:65,Y3,=D,P=,&0[KESE3?UEWXJ;!K;0QA50MPE2Q=XTW/4[//
M%NT^&!4I7<WHQ#LW@RL%IG*ENW+3BE73_L.5@E&1TETY8^K)3Q?IV30@B@*G
M0J6[<H'MI/)3-/G 5*YT(\H\U9M3NH>V^U@ZM&'"3RORV/D)D J6;D16G=/$
M:\8J-X J6+I1G1WG4AML7 %&I4I7,[K*T@Q7"DS%2I?@C.E#@QY( "I2NE'!
M$[><$E80 5/!THVTJ?MSFJSW>"@%I3*E&[F2?5!OV;I08*]\L"I8NI&K8M%D
MR8$_!:,RI5LQ.C2D+4;'@:E4Z1I,V5LU3(<"0GU@*E*Z4;IV'0HU8,K= IR"
M4YG2C>9N1A9Q/@B5*MTJW;VZ)F-XJ5Z$H$.]U3\"?< J3[I1)'^'*EPJ*)4I
MW2CR+:<H?[73/WI.@:I8Z4;15>F=PY I,!4LW:@J2_;I<[3Z8%2H=*/*JB'3
M#'U1 %2D=*-E1J7SF&4*2@5+-UJ6$V?0S@-0H=*-V7NJTRBXRB.Z!ZJ"I1MS
M1#Y4\"E6NG'!ZB[%U[EWU1R ;AJ@V[XMZ+A(9814$N5W;?V%JP(:^PUD==N=
M:>*R7NU<=T)ABBE E2K=V$5:!_A-)^DZ+UW MC9;K;K753DOL(W18]%[H:UZ
M1?5>@$B."DJ%2C=>K+=7"^C)VTY.D74262<_.X:LD]_JIKOF,/]D:TKXS6WQ
MFUL"J,ZB\YK4=:KYRM/G"QQ4WY5E975<@ER0*\FZ:UTWM??V_@6FP%22=>\+
M'7E!$8DI@*A0Z1I$(]F9&KC*1M(/2$>%3LC-DEX;XQ:J[YD?FN$)RF^8\B%S
M-M1/4#37^4.[]QZ-^O>ZRWZW1^E/CLGJ9FM/7+Y,_Q6Q-"?_ 5!+ P04
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MVXI1=.&PUY\\X7H,H!%#X:$?U[IA]+$(BVB;4I[L<]H1JZ7@*AE.&?7&,B%
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M[ZN ZD7G^S\WK!]WJ>%,,*P<^A".<0@LB,"0JU&0FOO(%><^56$^?AGU?=(
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MGDA-=))4$.I,#A5[HB Y0!)6@:3OOQ+DVSA$*C_M.-34(E_S$HPDQ!+%@M-
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MD17"0E=1-T-VLW.!175P^)VD:S 9AC,F7BGW,M 7:=&Y/<EM+QV9B;,F>6
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M,HV@DM6>=6FA4:>>DCI'(!5>S_*LRM:BS\*KF-I(6\9-3Q OR:WL5$#I70L
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MNG\L[GT\I8?R=K$X;5*,]B+R!T'F539-?NIJ>D"]K&HG.[X@Z:G#IV==7<L
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M?6M7D2M97VSPL%:CS:ID6IM#$:V(.9T,;-'F_D2JK5M4W&99A@XPAW1U-&M
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M?99IY@).AB$)OZ7KO;;:HS_&PWS]BBE>@I4@:L= !ARE9Y45=M)620#*5PY
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MIM@2EH:[4XW67N;2;L>D!2@,NR3X,8O"?>Y?]YA28!T%PQ@73#*PEH.]WQ'
MK2><-AV(38ETKFF7; ]% ECRR2RY6&-6-=$Z TC3]T9S]IHE<JV(Z<&<05TN
MFN"_69UMJ1?L511H,:/+>-0?+E=S8-5Q ]'X:?0?7/_&P*RCZ(MUUX[NE@EO
MCJ3:)+C>/(IU2/T"S'M(#),1:@!H(UJ1VBM03R)IB9"[&8!-Q++=[YDQ=)S:
M/I[B/G-G?)6LB9:0"D1_'P@[)EW5.*H)N!.SG,T@HXU-_M!B^E'U%\AJ:Q&Q
M-XQBG+Q"01:H?_.SIFMY7/H8+\)\="AX+6UV: 6D2+SMN5UP3XE^R_LPS.4M
M9=.UDG/EK3#(<2S',C#WWCNC!+^S8!GW]G&HH*7:;E1<]AHSQ#X!7!>KY/ K
MS0,K/7C/&61<"7,%A6RXX=!9UN=NM0:_J>8I>^U=6N)N5&XC<9EF^R)/"UU2
MBIPQ5^]VP0W-M698U/C$AFE1*F0*0D7 ,$LJ)T-Q-\3S#$(#:]EX'=1@^Y>Z
MU1ZS(5%:1L&PPS,2AU#LY;,!]>I;7[PWE+>M;F$WJ7J?#*CMIE#Y9D?"94SW
MX?\5FYE#75C.4N%=B (<J@ N7**TDIY"//1HTS/7(PI&CB=5QI![$:&0^)U]
M!PI;GX4G?([AK/"M#H<Y@R BBE9HV4="-W3ELSVJHD+,23Z/1().5O[4ABDP
MH,K^/TU+*D2+%34?<(2?U039$RTZ5K-ES2F1:12Z3@-H9E4G@7':7W1:B-I5
MIQLK(>(_IAQ4:[@7E+&X?&NHO+IKV\'\J@#;G/9_C<U#8R_6"?:?GE4%0ERJ
M914;B92-]YT,$F3I9C9Z^/G8N8WFU4EL6$MXW90>%*%!V6 YQ.P+]:I0D(M+
MPD;FUE$"UBCJK_$B6OO(U>>KK*4&EP_]XM/G-1AB6/,FDG1J.R(V='QK7G>-
M="9WY[(Q-?$KH;/%/WKGP'^:KH]<#Y=O.@'3Y?24/"X*!+(I0NQ7_B\!,:UP
MJ?8PD V,#F/;Z0:BMIJ>>BD[DQ /"MU'Y&NNG8W X X*MHY1\D;<.E1P@)=F
M>I%STS/.W&ZFAR99(Z''4A1)[<EFIZ4L&KM)P>>B>!_K6":2"&B-U)9BXL\Q
MX-OH<J-PLNJY&=0"#0#A9>;%<2G.(>DAP@ONQ);7KC#/:EAQP]-Y52S!NZ;H
M."S#0O!<<9[6"4X6S$(MGEP0<?P2#YH'2KR;Z7E%*,8UR*F@S<YFQJL/X5L0
M0FK:B;\Z2I:+4VE6-S%^J@@6['<"$>P(-<=U-:76>/IFN4;,,5[640J'HK\/
MR@/ZF7,=:_7JW "&<BW''6_PTE0'4(TJ]932(O)C-I;*;[<M =L ?Q6Z@E?I
M9>/TB$:2C<()6RA,<?>X12WF7VPX@"QD--K+X)3W)4I<3J2^-^?.1=N.#>9D
MK9UMWIF:>7#%@$X-0Y=B@=#Q.#+4#I08MQ"]D@2WV49^R&E%6RV $,0*$>F.
MD+]>EC,XTC5%]YSR)1E8;+I$?%6X\0"'DCA;$O=L*(G;C;$,)7%7R:J_]QFQ
MGR,'$?5+%$\4!&>C4 GIUWS=YYTV>77:IR\ZFD+*M=.2FY+PZ86&1@")UA0Q
M=750+@\M':IO,]0.MG]CQ T<",CFUEF\@C8W\5VNTZI"B^4\_TQ%"T)DKG<%
MV60^/*B80((SO%['3%D+F3&VT9EV5[TA)#7&]74AVBQW;\\ZW 9=2)-Y$RY8
M6J_J4-NUFR7G\LCF+)G!U?9@C"C"Z7CK37B4;C"*M>R"G1]D\@3[B?#&X8+'
M2%%4FO@IIX,5*ER$/4U=!A)8-(>U"J%()Q(?]E=XRAVNUK#=?HLRP^L080(C
M+@C0@W3J=9Q S,3DI19R8/9$UFID@D+T%Z&H2#DIQXSH: @I416X9&YZ-@K,
M';38T^ERH>X!+GRZR,D5,^CAZUN!?*Y]I"'4$Y:N]MIJ+R,G*N3I9A[]9F.Q
M3C>-JO/E+!,M Q7LT)1I1MV!F6('7(T8E%LE9W3-0BE%83";H<T3+1%.>N5@
MYND1V8M5**; \B.LX?JHXFH:#3NY JFJX:)H&!V:DH(2(_ *=%_POL((ZK):
MMJ/DU;O_>OL:G5TBLX3M8Z %LG0S-J&9V8+ZA#V=N;&+N7,N.J=FM8.+JMUU
MO"%D'NOJ/[@&N@#0@A)EG(K6";X4%W)@L2GY(=W\,LN1=SPZQ6J^,7';6 H1
MU&'5H[BT[T>@:M1:,(Z9CQ*YZ9+B0AV6E&BASO(%+:%4L,IJC12D2!)=M9O6
M2RR7I^!_7 WY!7?\QDY&+DL^A0/9@=KAB)/+7%=W\VQ=_!9]C-;G"L-8?-X,
MGP+6J9[!AI!"D?,IU46(HAOZM&@U6(GE7)U2.T*3C8T\66/UZ;,<5-(4+)<1
M!\(PU;B<ZU,YV_I0S!;/9"2H-=>IINW4"@DFL:]O01PY3)TC]X=$3D*=ZU:9
M33D_3'%:;8JX_K1'5,V/ 43O1,Q!K.ST2.#HSO=_X0(6N)3K57?=+EFG=>B1
M^UWVMMVHW]M9V#))Q&;: D*Y@%DD"CXIQU&K1EJ<.)E)FZ9VG]G<7EH)7QL5
M2\CZ8/*27N)O2,%BM'[QS13[@U)?'[N,T<:GFJY@"_<\IS18?T+1&-=M<7&5
M+3'SI#O;-47>V7LT5_.#M)22<Z.Z\DR+OCZ=\29\Z$6[JI>H1#1O8D+'@I''
MK&H">29K-@=SF<J>,X<+%)J<U$JPV,_R:&0J:E.!M.-&QW6"^40XN%)B<\1>
M2A#I%5<<*$+?@F(AK;2RC0*/$AGSF&BOK9/5,Q1;WE:MI</ \LPN2.,VU:R]
MD%X]P]9,B-,^9L.%_<O:8\$JL;2B2$OJ!).FU.U)_XG+QDFJ<HD8V$M^B^"]
MUA48+O.HMW)9,I*0R\0$@I?E@O7A]V7SE,?)'Z547?S;Q>/#SH@Y)_I.R<EF
MJU9N0Y-0LXEACUBBZ0[_2"JY M=X+C6<H>A%RTEF=;HTC+",\(-0):3[?'PL
M0//5IB6ONULATA%*Y?SZ,:I $(_&^L.^I<"C//JL/)77UI)@1 />R W(^%GI
M0:7H(10+=*4"5<%/P(:E;.=".W9\8M@_"C._ J6=-TP#YO-"U.@P\W5!:T1W
MW '6U62PD>GT4UC8I=UQL\NRP1MWUR?/J8U1X3#AH+5K 5E"##]SLQ91@L&F
M7TH=$#HKHP0$E)AI%W7NNV# :^# %=7SS1@8G@IU#;1G3;M6(.7%DO=3^ :[
MW4DVK5L9M2A87UA3P8L;4%I0Y-=P.==JG(4*65MB+>:4A^@YX58?69]OMAM&
M4L+":UA/@(YRXOT+IH&T^7::O4@W,KXK4LT2VH?6KW<;$D<:*/83B(]YV(G.
MA<GTCVT>%:R-+BOE'_G:K+@KLUM0FZX7,W&UR2]OWY^<F!M^O22=HNIPDK!>
MV_R><:7<YQ0U %>OO4+GLZK+/"6.,.PY96P1^/4)-A()\*%TC!HV>.[ZQH('
MKF'STD8!*:W6[NG3YEXPU7LZU% C3M,P=H@P_B4I=P,3H'#;%H'+E=<ZO.%A
MF7ZTX2:[(E(H%5;^7YV^)@/G*E N8M%/J15;D0=M+8T8YB&3;?!?1]YWJ+J4
MP&M]F?T57*&AHZ\>R 0I!SBF[\,K'6UJ]D&A:S"6E3=G9)K<6,ZB_B"]VZ@J
M*Q":]_4+7=:,C1D&<7 #*:V4'=*QH!YV"G(0.SV1HEX&F+Z)N)SM3/,0SFY<
M..I+J7-B<94+GPT^/23:M[)F]?$P.> ?/9R2M8:WM#,O+I8D]/-7[W[S/QOU
MHWI$Q9RCY*2%F[!TJ^3OKN3K27X>KMB>-:,;2M*XIHROKO#.;8C(4G9FI/FM
M*;Y4T:=Z@J:QF(2&3K(ZB]P2^$:8J]K=9;IM\8KC2J^NJAQ918D/*F$Z'?O:
M2YPE)M[<&&,3,P1(0Z[ *:_FR%9K!E-@DM8@(5R !4>]7GEIZUT$SR4 "WR6
M3W)F%7YW+JRC!39O44L*[!KB(W-'7>VHLIV S-/HJK8(+>N7R4S.H!U)5"D:
M#!WYO4+G,Z3)A8],&:OT=ZPN/4NU.8"U<O\B<KF&]R\4]X7IV'!H]LMQ49]5
M4YJ0)<C5AH,IL!UI3MA$0G+M*VZ])EIV%99IC[AQE"L =%^C F&S/?0@2\Z>
M#R5GNS&6^U=R=G_=A%?!^%AW%SGVA+;A7BUL7Y=T^D;%./VXN]N/&-\BB6?9
MFVZ]1I&W/5FV'8:^4<#U_AF=H']0^=)';PJ>$* TW@;<A"NH.7,,H-0$!8%P
M1//EG*HZ)"-'*=Q@ V PFZ]6+4;FMYZ ;X_7M,0L$0-TH@P?^%[B#1?V[I/7
M)\K>+?XX;%2J_5DT<3*&]#YF%YQ" HU&QA4/Q*:UZ<V9?7.P%/#T!#(7:>66
MKN0IX8]FYG832$&41)[>;QH8XS7]H.EZ#F-8,59.5LR\)V_\VY)W%+Y$:V1E
M&,U[?_L.HY6LC6CF'VCF:U_EY5)+N%%3>)2PX&-:_CR4ZW#:PHJA+CLN^#CY
MF^,H(->\U0Z!]!G %?Y4GX)UA)!=TA$7 JB"P=^,K =R%TJ *D$QFB=5!^:P
M:;3;OTI $A4CZJ*NRE.,,J*S3=A<3)%01^;Z>5X5WLAVM)UA%CCZL=U>A?3R
M[\"084IT-3@'^=2 ^J:ULXBV%,,%D[C1B!<NSS+G&!09EEVBA6[)F2^ \\CL
MFX-S(3#WH,)9'S1Y;-T;[QPJ%V>1KL2U)Z\%63S+9D:(]Y+)#I&N]?Z^KLN%
M7G65Q009L9^OS<LQU =QFZ$P2<#^#GI+O\K%-X<]Q_/H>XTYK&S"$%[-X_D8
M2<J5 M +2;JV*V[&,9W)IEVYECW#T'\3>G+D11$NJ$"UKZ.NH[,KZ5VM"^ (
MD?0;ZI[7<4<<G$_7"B*?Y3M;$J@A;Z-"B,#P+THI/3,1B-".SBOD>[O)2>T%
MB]<J/TT9:-TY9:Y"" B51.!EJ7T"L%?8/8B.V9@.;!0ZDUW4J#!2B>B"PK25
MQ;P$K 1#D(G^+4/KG@]#;U@P-F1$2!3X8?4@A;XJ#.]S'RZWRL/+%P'2+\2A
M'I**>]6!>5N_BF=H&L*MU/"UD%-R/M0E:,-HN)/Q@HU1<JCE Q18J=A%603@
M%JO"B5.$%8XS;;OTE XK7(S+6C#P%MPR/A.<$SPR/IVMRT?V]"^\:&3/]MNM
M?%+MD<KE+,L*1\;\9)D7TN.;154U!<&"-7%\D,HSJRHS>B/ .$Q[$&H9'R*T
M6F;50NK@(O: B%Q/L##6@3BTSEB7*UA=FJ$4Q">G!$.*Z+0N/M.B:N*K4V)A
MU#E03E<C:3D.&'HD/V)A/JCS; BA;\B7%X[?6MM*J,_KI W2Z9)*DO+/1 FJ
M/6G2F=6/AVK:.KAE"W_-E4E=ZK"=L&&TG8RJO030(//UYI.578@X#RGVO)0Q
MZN)P,9>-O?K ;3@2\?I2@UFTPF@4<N@WZI/AL@*_J(2G'(I8@WT0=?Y5]6E:
MYO\V:B."/L?[.$35XX+TN*5P(BXA#$X2 P23Q7<\YD+6B).8/Q!-5_Q8IQLM
ME3Z4^U&H*B+4<2XI>88%Y,P/4#/+UL_5=5@4GQR.GZSQ,EX$$[&C^GPW.88:
MND- 1,8@'-(RWL,O'G4716V,1*OE/>;>Y:@,Z3'Q'JPNS7? D<-H(_>W69(#
M[YA<PSS'O=&",MW*?D90Q9WN4RW^2EE'E3XQH-\&W&"D)#/"'QQJ=J@<K2IB
MO'&L0Q-( "K=T#LY1NP1PS_D%$-S"":/B/9P69*Z0R+W\5KG":&'M+4KLTY3
M*@&(^R1-S&K'\MU7Q/26(-B$':V.3V7 @:7+M;L'MM3'%S!K[9BI9 M,$6ZU
MQH'ML4;H@@WJFZ1T>E81F5_5!N0:CJ_P&C<67=1/ W.2S)#&1_$AW;WKA&:F
MT,B4DP9G)JIP9@) 7U+)4;107>2W$DMIN,2,BY"V?T6&BNCR'-'+FDXFMLZ;
M3Z@1?!&W "N1@&K<BZ_,KJ82<T6JQ*^OMP*&H9SPD*\54@(.K4VUNCI '9I-
MVPS!3%E>G]D==;FG>//@F8C3*Y<J9981="[:O.25,+)@$7->L.[!,,B"=-*%
M5D)*$!8C"G6XJ6%T59UWX78-IAPA>7L<$#(A+'H^QT"4?/M2(/T(3V M7.D#
MD4@'5N#%!I=R:&#U06?**,.=7LU]SRF,&6^$TU.D8LW/]?[*:^9/SS762:LD
MV'1]>MVN06^5SKKE97[+L5J*KJPO>D:)#<\@U%14]BE5\TPOEK,CPX8/K")Q
MR/"H6>"P!%T<1Q^K95_G"FW0!:PG@,-EBTO8Y0BA0(:1W_CYH1 A'$12W.3^
M(V5\ON3]_8G:XS,WQ0.//PU\F>$'U!^ <L#X![$7;ZI\R<6]G)CQ=L3>W_F=
M(A &S+M*:U!6I8'E1^0-V**0^5"<BJVB"D0UB:Q>=J\(D8;Z:P4*N:*(K8F"
MB3G^SHO;-E>3##3ISX?S1.0P8:@+4D-.?;9J"F9?'=\%2M<S#W/EXG&RH;'0
M'%5L2OQ&(=_ ;Z3N .:O4?,VP@'4;ZQ&:U>.H!_ V5;(;FD0KNI,V-FD]:[O
MFA_[L%LZG=9+Y]65.B3,NQ1,)5H<URA. YJYZ!RIP21W<TD8A ()2RGOT,=-
M!&RHSX(MG2,%D>D?Q*C6#"Y &,./*75?3>M\TEMXVQ'[WFK71VO&X,^O3DR;
M6T>SK\=E?:(65X3!%D+Z4?MWZ (^?$E-'8RG2;1<GNE!$N-#398Q:0_WAYJL
MW1C+_:O)NNL+PI?*@D(U.D"./0?&O/:V6 L=G'96\6!?[)G[I6.=6@Q\Z94,
MA""D[-5MH5X>BE^L*,BA]T7<8F2X\,);!%"BZ5),;"8$CHPB-4+C!(+P@MKG
MI5Z[!A3JAHNE,8*CU\#H2PS5$%&_PAIVV4.Q:35.(N(8BAH$MM;;%I1=;\1M
M12QFCG93UUW-(;N:_EX4$5)RGY^AL=W3NKIHS[;,^5-A*[8;]0PLU+%WXNW3
MJ2O(J:2(-&56PNKXDG[3H/HQ1* D$*\8+R86H!&2;FLZGF-M(;0D;@891VPC
M;6*'8R[T00&BKW'NTW6]\&@VONR-'&H,F@E^'R*+X7GW_9.G#@,2"]A[>RYC
M]I1*Z+\=&Y6S=+J.,<6)EFA!.\7K>OYE);@97*&DH[X(=;''R=]"%&?&S=.^
MUJM3PZ]F=$#-L:,!(<AR ="BR!CLR%G:R#'P\0"3'!46.S+[N[L^ZMUR"WI4
M21BZ2W.D;0/514FQ;WA\*:WJ1")0E9U?""$!F9EMQ[=@1&\A)I!6J^RZXF(&
MA2=F5BRQ4[D51#;,C/DZ Y]RUR^9H)Z"F0OJ_"A6.38++<*%Y0]!TVB3D@^,
M,$TSA?%7O9^4"'\.[W;UW$@V/L>#]\IMB8!6!%Z";1R!"H+J9QITUWCCS1V&
M(X6]E ;HW N+20'YXB()HL(.3#\A)P*&[7VO69:CC2XN'SI1L*F8!T:^RVS]
M-319VM):BDX7U,SL2E'1F$K,D2&FT5WT764!!F..6 DX'-\"YMOO#)F?EOAJ
M>SQ:*P$1"^6#N\^;G-;2<UD)#D1#(#)9W@@IM=;]=%OUILI#!0LX9\PJTY-'
M^X][0_$]_[*'>']WVO1"-S[*"UC4IWSV]71;S6!VAFC&IF>28_,48XWV&(*B
MI018Y]K;@;J@*Y:@JCV,1!NM")&36%WC;S3?DW<=^"NTXI=:+:1 ([;(V2>D
M-66M78"F?+%3FH&AH5"!8%@!_!@,:%[ NB,]YMLG-\N"-'S:N1,59\S>8 R9
M_F46:!HIU1=@3<3=%92G0,;B>Q^=ZK$K%U:R0]Z>Z)%'>@F<E7\+[(SMXXOM
MUMIQ)HC(;?6]?1BK0HN08,"=D%$CCG.<+65,3&FF#;EAAN",GR:%F/H\+G0,
M(!1=:R%T/'#GX\HC<FI.6TH4J/<6I4ZR[Y*9X.B;B2QI.:M)XIDJH7'R=S9U
M24@)&K")X14<AK4\^Z(B!4:80=2R$-E[1BA[X7?>]G1+4Q?'@MJZ9?LXDQTL
M1F5'O4:V\<+KN9$'K$:A53$AH\M4/WJA,HK0-%1S!AU.;1G]BJMMN)86/0="
M>GE@]6UO2T][T7$=0C7#Q$5U:R*J-HALVDCP+ F;MP<-Z?4BMP_;S%?/52M@
MFUS"1.R"+/&,@*RC!-E% 1<[GRS;T/NO%=.A= 9AEZ5;) N.T]KU+EE:+5KQ
M1B*\J2V8A)#5.(?B?Z43:#&0+G,3J,J%ED"4I#!DA-)NLR;CY V>%.[9CCP'
MRD.[4E5E1HL'PDX0]2MV%>$F@8-@O+%UH;$5Y[6+ODQ0:9Y[E?,GA%PSHBN_
M6DHSGK0L>,(17)=%MYR=:\1<1M<L>).:6N>)=X)@[28&-H/[8^&;8N;;FH$,
M8M8[3!A@U[]WER[\E'!DW84R842J_A $:8+GUACDRG.G-7EP1O,Y\FIR7) 0
M:?/IIV+%1-[$>F2"E&U\E2%3\K*P.;)Q\AH>?.HXG,E!..1*JCT&115YVRW>
MUJ@MG"Q!P?6=77'K^B75K'5EZ(*CWW!2")O13"O?C&P2,-Q*)O'F'\)M)KAE
M>/_"U;2LPT5.RV.A,$9TW[:D5=A'I6Z84&IO9P0"(\%-,C/STD?:S%4Y-OG.
M1&D7N/G?G^\Z<LSB3"!^XBL?(K0\N,IDOHA)AIX857,NI1ES2E#.H92-;[11
M7 3NGZ=,"YZ[@J&NB36KRPC?(;(:Z00"%@)>T'/GD.>-1)2NU\)@3'.\&B,W
M&)46XBUVT]7.YAE8DE-\$@'YZ;YH<8T1&7,8?''^J$M(V.VMZ%*HRMVDT%6,
M@&4XVS9JY^##FO9"EBPT,O D8\4]\PV1Y40:%UF\719@6-:["8@.ML11I@VQ
M0R('!XZJ:PKY_?1VD!BF5G#)-**P1)%_HBN,UCIN(PDY8*G\#[#VMAI% .ML
MJ1IY*9@>>5CFDU8[QX!SOB29F*B65*2/QJ<-NK,)H A O4\)9XL^2F8.[5A;
MOVPP2@P$GOV$RM_$?Y58ZK8]_=IQY"[@*3H_=RG/948+N'(:B5RV^%&0R]XZ
MY([O)8X$5BRZB'PB>JV60AHL5X\7NH'3XEW?7FGLL9H4F)%3WWGFXC.R;'SZ
M</W#S7-3S8&%Q1XUW]:\CX+#'V/9^V"('['1X?H4!8!EV!OS<P-01>/!^*?B
M2_>*+ BZ0 [!P*ER$"OO"08_E-XGW#]!T4KR@WWO+Q?(:6Q<OX[-%Z)XR!ON
MP*;FL\1$#-:&)* [ ?Z)ZDJU\>.,^S!75/[%6R+721JJP7P%9<A<7CKXC0/_
MZKKQ01:4' P%);LQEJ&@Y%8F X-)VTA]'!LT^':J.;%DFU-8+95ST"WYZM>/
M47]9W'D&9ANUOU E-*?M;-FB+[..:S(TU&&:%M>**K9B.+SW5TK?;4)M873Y
MUYB7:PWQ0019$K4?K>,$;[ '&E<(*C ")S(<"W4K2C.=OWI\9'A& *U%?L[D
MISID9@EA$6C.Z&8PW%C:NW9:H;43H'13XIRA::HQ)+N,;H#G9:\]S@P;$OI2
M\&WK?,K1+ FY=\+EWM<,9E@/6J;&O&Z$:>>C\P/QWI?JC%YX4M\_H*9::"C@
MMI!&6B>XAQOE<MG8V$??X;^DH&H[,=I61D99&TX5^\J[P&JT-KO04V&JH_D@
M=</7$AO(FT]1P;?"M:OTP9&R71[L#$@SC?"JCQBF!(V_D6$&D**5C?'P=<+[
ML).IJ6G03D#&@_'-(XH-NM[N3^R;(294K+1WV'>H:-5.D\Y=0.[/XM4S@A:6
M1]D(Z<HJ&XV\]BT:+,L2+,X*INE&%LHI@(/[:FW$@ZH=+QAM#B%RU=$WM";;
M^DOX7:W0DB+^F2/EB+$PWZ2C\X)5#/%7RCIJ6U0L$-QD/'7>R>.UH,C524^4
MG[C[]@Z>>\*_46CHE!@O^Q7L5+C/L)R-)I+SDL)0B-2?@>M/24#<$X(@]23;
M?FOZ>LDUAG692.D#'I0>I>"#Y%\YBLC[V\D+7+)*WU;]]8]ZJZQB?U#O!0.A
M^=8V:909V<IDT,YIS4:8[T]%FK\E%<$)E#/R8;(?CL>%LC6-K0*+(4WB]GSX
MI#[UD?)S\%7GSK0RFC9ARHKXUW %@HX2LT%P8OZ-IXI#-?D&+I4F5$-H\5=>
M90%(+)6^F3S42T2JL4/'!@[W&153U 82CQ0D_Z>ON5!@2?VN)KQX, $) I41
MUG_/T]9WN8JM%1)]^O20#1^C)?U/A7 D-*=BML?ZB5A9L7JRTF1X]!939F=6
MV]8;8).GU]!4\M90Z*4A.L*4*5#TR:5!-9?-IZM=2\\H8<^UYJ;',G]@&?K?
M*5T&.Z(FOS@;>O5>6::M%Z$'%MDN36%4L1V(D<B-F&)!4ZD8"3)KISAK%,+&
M5F+SV>@2C,H.FN4:;!Q_;('W/;^."*_2 W2@-\H*9+@\Q>@M' YP7*HYG35!
MTZ":;5_9\K P&_X6,&N8&PD9)=<IHB_!B:?"]\[&\"W=U=$%-U\'1J6@?,VU
M+EEI'@U7\(F9RG^"M71EXSU,3=4S,&FG"_O:;==QR=QE3=?;(CJ!T?1@^.BV
M97;?-FZ6--\@:C$5#F/ BDUUL*Q_E3,I=6=ZEX"UO"C<7NE:^:N__ETJR?(1
M)7PEO"]@*6TO Z4"L(3*16/)M9X^$$S@'WM<NC;]S-V]WK'Q83@A0-/^UUQ8
MZ!\A]9Q%>)@SN9_.)%6^/KPE$T)B,+6 '8XI"E'5<N5)(:' K5D&"9 XSK=X
M#\V^5"=*'V1NEJ)'C-(?->2:SK3 _QDEO\G TM]SOZUR0\C8= ]IB<P TM/:
M\4,Z:1G^6)ZIVA:V_Q05Y[0&(V!/7VA:QB0$5BU;XE!A (X)&ATU9E#F/C@G
M4'TTJG%"Y+=I*7C47.!1L-;/6\(:LYUZM?"[+04$&-?'%/>0Y(#M-0,[MZ+J
M0-'QTFQ@5\27'@G0=2,-VO0%&"><Z(?5C7:BX)9P&U^46*D2$F2UB,2<P11K
M5.G8AI2I<O%83EM5CQ])X3523.31TA 1P#$"*K76-&G!("74[<Z^?(C&8DBW
M,SMSL,?)25@?A<61=5-BE UW#JOC@ 5CV$N0*"Q3W#!._\^<FMH(,X5*#?]"
M)E6IY6H>:;8[ LJ[("T<C$#:Q23-*<:4(D8J1-N-J$LN14A\4&?&J&H?BL=J
M&NYV,"M&NOP\*.\L@)7A58+55Q88_ASOL5:AF>DF!KMU#[68:-6H&4%4_#I$
ML*APN1>H[<YK?=Y3J\[]^TA#TWNJNON:2*%W,PKU_":X5+8$K@-M*FQA:D=B
MG2[68F%1V];+8,CCL<ZS%/]U%\J$*2B%1>9)%CD;OJ,N+J3D-K>PY=V='J'Q
MT9Y2A-<_(=RM" />2+&K-NP%,VI2U75U0<G((%XR!5#T8 5@S%1#[%+=RF'(
MJ!'E<H'G7B4SJ;4#H& E&'9&_NN%Q'YY\?1X]#<MW.S=<8TF->4R#C;.7,5<
M:T;CUVM@9GT'0HV]SF@D0*.>J126>.1[@$V38M@S&9F.0=H*18L3'VKN&7VM
M[4-&/BGXF%P"#]X$E#"[-0VBH7(*E##?&WDH@2)RGC-E7NN2T!8I0;E60.J!
M_=,);$]5AF:_N ^-&;L\*W>H>)Q$VT0<:/1KX6K]XKV03J6@BNFW/8JVC%ZR
MIC[%'^G.5Y%[J+!)UDH:U:7K<K6F>;%FL)<B3+OZ>U.X(>S3P#V';DJ,*\N?
M6*);HQ<[1GS*O,!G5@>H. D$-II!"J77=C8L-.VN=^J&P EF[GQZBXKD1@&.
M@#-=1C]91T#YR&W!_<A<?&3XG"O6H;H;[&3VG;*I%,CV4,-A*+=BO=O3!JY<
M.02G)"> ZYT95(,-QYI[NV%/4P\DZZ-5<:O^9!4FM9[.X=I=>-[I,H7E:)VS
MBF&H%K/58H=#M=ANC&6H%KM*5NV]RW=UW(U2$?X0-^4J;@5IY^B'8@V0WB/%
M;#A1M-^4;OWU/TMX!M](/W])(3:B^')EUGA>@ P#?ICV1NWWDO\6U!V#R9A+
M_279$"-/ZQ*3:#*& (]#XFI\E[Q$0Y*I6AP^!,,K54'H'>SNU*?NI3BIU*U$
MSU<0-HIV!5:FEY(($3B[S*XAUSR 0^,'8!?T*T;P=\#A))RKWSE8E44AKQ"^
M]I9C,/?/B8W+VP_4#)_+&?>5]W+QL4=(+H!_DKU9^S!3O#LJQFNX\+6.VP1:
MHC<5.?PBR]M..T^G^B_"]5^+-TAK& 9Z*;F<%DM?U2>VE@D(SLA)&+&K@.^$
M[WM7V!R#[2*'OHIV@&%_5M."D?/_*VPGHX29]N]XZZ2B*""@=S9.3XSW%FDG
M8W]2+9G^!]#KXDY( SGCV\?4M[S6TJM3=>8H Q@S[ZG+N(<E"^P_H4\DCN))
M2%GKR5B6.LL,*^I:9"W$4J.BFE"R!YW<*?;1R])1>+-SFB)ST8Z4#T_CP@J:
MX22D&27_53-D,OFE0>K-EL$KID@L^?6"9[NBL-Z6LR)@,*^?WSC!O=5S]SN!
M$Y1+\@!TU-Q_.DN>_A7W&Y-MC'BN;>1Q:GI$6 [,R8:PY@1.Q;DK4&44)"K)
M>6>_12@-4B'_:99(@.2$)QPN2>G9_T;+<GB]9=E6T4%'?/(FM$O:$!KORJ'O
MSI)@NREPDH![([*6L%\M->F!A.+/OF9[,(&I;2J-B2;BJ(MZ[IX;SK/1"59\
MZ)/EY\6_8 A:3R:2&H:L&.$QL/"]UYB&Y^YK##!]*#6RWFW\+.D@]DY]FJ%:
M<9F4C.JJ\WDH5EK+Q%\+FAK#!78K0IQMY'UXK 83NHY,B3Y['@,^1J$[)P5'
MELE%RT6XZM7TJ?41BC#;+,=+%IA!-?5*2,&VN'Q#M2S%$MI7C0M/P9ZSF#O5
M#M4P[HGFMPN:(0A#*7RQS1F\F<X_IF1J74*^>0@7YD'E4UX;&D8KK:%A/ER?
M( +@:,ZWC4(RT^X,257HL$(#IT*V]D#R:.D_0VB@G2#T@^MD509M5MBH%"^G
M9+*>VI!8"O\5,^R"[8CP?EUJNH"I'D:?1923:6Q0K5- H;V3MTL*=&EH--XX
M>1(>V<DR.W78UER(@0E>'!I)['3&KV)O3Z _L!<;P\N4NNV0^5XXW^>?1BD8
M6D5Y)4-$L7<;];[$GW?U5ZANY9!P/#.R3><XYUJ0(C97&GFA[01IU^@"1QZ^
M'K6? JO$$+Z@=- 7D_K0B<,8L-_LO&'@WJC;IV27WX7^Z%/:*%3)&*QIL#K&
MH@GTLZ%&++OAXO+7CK3?QM1XR%ZB\/Q5. NXY4NT? -<?Z<@4OT[NWR"A2!,
MZNQ*CF.F!7CK[M$LD*KH1;_?INX:!;I.5P0*;W(K&ZPJ(-HX,GGA2'XX>>])
M!NI*6[+%S_KMW4E"<LDE%'Y3@Y(*"M(3X'GQ$U=3>E=\IQ@J!5B+0DN>T]IY
MUEOJ3LL1P(78.!F[Y6_N-"]+R:MUYG XHJY+.A]JH^/(85J>S#BPES)J+(7@
MI!@,9SA9Q:R&GM-7=!$SH9V[6DTB[ 4YVM_+,,L6;((IYS);;!\TZ'!Y$WC5
MOU7;UI4F__;[%GYG:CEX0N[=1K[Z@U92;>>;:14(#K%94F&(7#$9'[.YTOZ%
M?2X*KEZYX)L)*_RU)]=BMC\DTZM+@,R(B8%&5T[Z:X<-M)H3569?7+@_Z@G,
MXS4C4M 7?D3/ZW#_Y2]_O*;_.GCYZ.:DR%&%B;>RO3>P[8(S#+8C>MH-2J4Y
MHH<](]3Z99P(RS@>ZG1H.V -V<Q QC@54M&W&)>?T3<F=95FV*\';H5/?]K%
MIG(%\BLR/1EL,U4U[W#5Q$ L44Y"N!\[[_;XJHTT_1A+C-*:$2L./(%L3/L2
M]F)Q D;BQDE7)$6.R)>/0L;HCG'-7T3M8"A3&Q?_0AL".5NX!JO.PM\)2G,[
MZ!K_C.6!'GD0T%SYJD:;1-[D?7M++_![6!=F9\W2Y]C.#L,#&VBQ0%PI8FW#
M2@BRA*B%*6?L=$,G3EH.CL$>SGHYE_,[$K@8 3B(D&OQ-01%Q[=C]_FF]G]"
M_&D$[I=)'<Y$(>9P?]=*7[1VJEYW9P(FH"!H"\4'_;N,(V]R 'P[E*W8?$A:
M?$/MN,<8<N5Y7E=*84X\X]W:E<".%W/3&SH]2LA5K0M8=>I91& !2G]-7=64
MFMD^1>=U2A/C-CE[";*BPHP$FG:B"SR)%.:TJ!QW?96IR&T.OR,<14H-F!X7
M*B+&FG,JT\'P(R@5R;IB:$KZ7EI,JC(%*F;R*/O*ULZ<@@0%LC:W[B7#7@IM
MF8'1NTCK4NQ:KHM&C$:!T&\F"/'7[$EA#A<3*TXD;.1DF1<9U]J8?!Q=#26H
MKT:62)ACJG,>%VEZ_YR7WL"RKV:]*M&XJ;ERPB)RA9?]4?S@0*/RJ41>!D86
MB,5:=1B#<A(2KF"!,@^I;4[PF!A4T=H1[0>E3X3*-TV0($'L&&K');525MT:
M<8*(\] AUSAL!!?+0>JE]<"(^R'"4N<BZ5!2AA)F*FRW715\^3(Q+()9!*W&
M#(V4E4\DP'W^!IN1UFU*6]3:6 !BKA@&;Q7-<X%/#6OO5WREOBKEL-"NN2@-
MA*@=#C<!XR"YD,\4Z7*]8"H].)+WU]PLE0SS=!FX%CM[Y%^X.GHK7 >!WF1T
M?1M9!S\^*F@)# E=&?-5EK<3+EJ!M4N"N&DQ2427JQ(T"%(@A1CQ@/C'>,N/
MWS\4^]EBOZ.AV&\WQC(4^UTEJQU"(S9.3%U,G_Y9+[X34%&*1;%.ZX#]5!H_
M%RP*:M+UBE+;M,BNDWA69+0:('/:W W="=3M>*'A'7C;/Y=UWF2Y#^]:;#J;
M$S$5840O2_TFS-CDUX? U,RD.5&J8-)5S+TTLC$/'XN(N5[P=;Z5TZCK;GFY
MVIG^NW@7BZNYX2<]&_>@++W?+RI=@X#AI*E]WZGA.%.GWQ A3=Z4V ^53"JL
M><%2,GT"5P%$G%L-&-5<+B6_LL17I@LFQ0(:^SV!KHT1IMQG-UV:!G8!UI#Z
M4QC_#*;?-K9Z3!L]4HR9U$HBUOO5+7,D7G-+KMH$;1PQRL6@!/2L('V_FOM*
M2J0:\+!=X;%H/%ZZFZ@:<XTP\)9P@PBM/ 4IY(\AFM"_950R47'K!+_(Q\0,
M GYE%XJ OP+J/\4N3?:7.6$I\8)1QJF8U8)$ARO [[&UM!P6))-*M"/J%73$
ME]3 H[B/D>HA40N:C;/H^JV/"S!6W@F[%#\^H#B#3F\O''4RFP$E9/I$O^9V
M'UQY5W,U:'@?W;/<;E=U@FX;'J]\F 4&,W2B7!>@BZL]S)2[[GW,_=:=EVK*
M#U34^2$ 5KRSZ@T]A5=\!C[B&;C7ZW!3" $XPGO8*45)T!YP"&-+8%Z@FB[#
M?8VU/Q?,%'8AS6B8#X7?4<.5-B)&U AM"VJI]:>6SOBJ6LK//=FAX97<:FX3
M92.=H_N:^?)JIF_P_!&.U1X8Y@LMTB=/O.]7DQ69;GC?D7U)E6/86U%W^C@,
MQ21%)3I G!8)@T#V)7I'4:^UVP3<\GY#LG%FRU^0_KB0A(=DI(3VPG)WHFV*
M^D*(O0C&%I-G>'0Z]EZ$-H=K,$'6,ED4PE+Q=U'T5>'LU%D:F]//5I@8_:^$
MGPBK!S'>6[4<F!6(H? K;; Q>*',_\D)B\  2@\RS$SZK9D 2##[*)DAX?I\
M&6;)K8=32EIAMVR4G)H1\9$6</"_G2^;T/ E;V2MY9/"_CG',U3K]<AY(JYL
MIO#*9!79Z)2],^N'81/<?]_P0]AZ3<.(@3V6R 49]7."+VK$?($Y8N\2Q[&<
MVZ.2#=KUE](GXCV-CI-E1X;&!%HUQ%-<1W!B4B.EVZ>#MI2W:-1Z!60.GP\[
M4?6N<; L6?HLTEW629+6E#3Q2E%45NB.B"9!A%O(L<.$,#A<K;PU+Q18%J\<
M1Z%G>5%SIC:U+57H<U4%4TQK[QAA[$I+6:0<K+VC'5F;!TN]5[XMMI(&X#4,
M<C[(=2HX3D+8O,YZNV&J7#H=+@/XPF?BLFV=TMYP)UO;56U$6]LC*HP+;DQ9
M=7^G9U7E2QI(I@)&!?,["]03BXCS:T1=\7WP)SMWJ=_,N%%,W(=DQW@<8 R3
MLV;+A&,E(KB2DV%*%7<%*"Z:@0:_A<V:PD7")66IZO5KH$[J%.N4N5FJ3A=Y
MUJGJY)A1#%ILF7;^&'\$[1JE1T<F/^J74> C?2&?+#-G3.MEP8!$/O\JT82:
MPT58,Y!2=P:AL65\Z?A4MWF(Y;GT-R1A/2Q#^4 ; 4 OX=J=:J6?(ZNJG*X"
M.I[@S,JJ!!;%>9H%:+%9A380^7JK11[-?,5HJ:=YPT%]+4Z3P9JR6)],H.>G
M95DMJ5+[/$_A<IJ A<?\C-105#%@.9A"SFGI$-V?N+)L.K (R "1)3"J\D)D
M@CPC4P,+[:@#(?GS#/G@YH$?UD\\K9VYJU@ZN$;(]QZ2,<+EI5R_O=3I;R)T
MP]WI)8J"!5''^:J=HHL;'HB]?QV$844Y1K)!N)*IZL>2*6+8(!#3_6N)01."
MQ9U/\M.EEB$+9]R46R%Y.3@4;*:ERT2ES7B)A?IFU\>HZC-YH0B#DDP6[XDK
MAKJ@B=-.K93?(+P; WL(+JWV8^J8O14DX8WE?*%G ID\_4IOY-_S&'H"A^X+
M#/JW)BJ(LCA*T01E_&@;8(^,2._WUR#IEU?2Y[2A?+EPEX)BV8:B!BU/Z,(&
M]P"W]6*;PI-^JFQ7PM;;+J4AMUD@+0JED^RJ<&<WU]QXEU]Z *GGOQ448KFI
M(V!KWR\]"MW <H0].F3 #QXG'YU+I&[U/5+%O*58U^%+ZBHXE'_L3&<!+>&O
M/@+J@Z*ON2%"PP<G<*1634["\;,7B%<>2 "_\R'(3R!!E?EVC<!M"(J4$"=8
M8HI09,EOB*MW45&)O[#>QC>#)W&P-Y=48G!]FOR#X#])FW/XP#]BC0('-!:5
M&,%M4. 5"JH:#98L5#TWTN$(EV]ZWGD<H:QKO*M!\<OVR)J1VR#\5MH600NB
M?&M[&(;Z3ROOG5 D%R]P10-A%^;J&?;,"FL^5Z[EV8T3=@.$Q3? V.KK=;AV
M<AHSH6&IX?/BJ[L-\[0^S<L]J75X@@426$E;GNX5;M:^.,*_K#^;_Y13X<B+
MO8-GBW9+R6.2XB??6H%<EOJ/ENO@\?@8U^)M#-S,!8G_I@0<]NB1 (2=;I%Z
M8"3'254GN\H9 V M6!-O/@(1(B%6= 3+9V8X#KC^^#R=3G,.$3).<+8$:VJ4
M</N@T!;K\9<8IYKX0O'.^6BV?(QU%^6=(AU )]$?6)B>/A@Q5:NR=.#8< _O
MHJH*HA6C_@6:6Q<J(]0::8__R+M>OF?0^Y'@153G;B]79C TZ-",M0T%([$'
MS*!UQM0$X!3\>'4)"LYPEK[%67KMU':/NL70C4,2N*ERH.@U8-M$/#"O+=0K
MV,3/_'.E3G"S,?P@2\@>#R5DNS&6G2TA&_3=M[$=5"\%%OJFQ:IEJE,SD0(3
MKXA[=SN&I%@ FLV0EN*V@EE&AD.(DBS1QPL\.WQ'H\\+/Y/:.1Q(W)?X_OT;
M[4L<A==G>7I:5H05A>D%M;;5!LF%))1FJ/E8Y7)G7@W?UU5X&))IX=*2"YP#
MQH^$D*@)$#WZ A.D89A<M5-C'<LEI6@;)'B[XAH<MJV)*PSA*G'E[6&A%9LP
M2!1FZZB\I?*$B]A4#$8G@G' =IX[Q5+6)X%83%VP!"5_R DK@7^B"G'E"684
M#Z&#(HY,%FH'VB?7^DE#N"AC-+9T$$E[SLCAS3A2IR(L+2_J-X9Y(L(MFX[P
M)M#E\!N>C0)226D558I):-V?;C!.J JSQIT@%O700&"(/P-P-\X6+1L$C[Y(
M\]9456GPP4^/DWL,#B(!9>ZNIT5,>Q3&+9-OP[7P;:^%9EHC1LR*74.?^JEF
M1M5K,EJP/E7M*YQXI/4CSA<,OQC=W3!' 46]ZY9YE)F0KWL;C21"XKL=2SJ_
MVMKNB3BX5$,KWL[S2G,EYC;#=+6@4 Q2=K?.EH\_! @]B9O%T 'KT(.FZ5MB
M[SFI*:'_)L<=3(11 F,&<?NWO;Y'H#*K#"X#[!"$"WI).)*:H*02@5/XPB7W
M]B .WT(<3+**#V=>%"6G53&"0C:;%N9(68JRK0LR2TQI4F ^ F-%_G+T=Y^!
M;JM9>*BDK60.3(NIY2-&@S3<K32\T9IUQ5>U.AM-$<IOP_F>N9B&,(0%&0XQ
M8/N)N:;7@>7/%DBN89/O=I/?^[VR^V1(CY4M'57SFGX8]FQ+MJ&Y?!>^_X+[
MA<$77B#=MYIX7-NC'1HQ3DX47\!JU65][A"<\,8>\["!MSIT1)SB4QD&.)D\
M.@][;>K'?-H] &M+S,@M&BJR+#7?J&@[!GI2/5BI+L.T-541,YG, A,BUDGN
MO\X%@RZ&>6Z83P_Y@?>*E#W=\ TBM38@5:,.,%5"C(#Z@K2,M)$"QT94MS@;
M^< P<3'/:A)X5L?)2>')/-<^U=:*.(U@F)2Y1$)PK?F="(S'+EB;\UV(*?0]
M7&,NOM:AT].U\H+1@JBO(Z?JL$QPD\F;YWHX3T17*GV1+^2%4Z[.?O"YHC4@
M E9\_\A\(VR =)%1/2[7NYC?7KX*%I^7&%Y/J5*D3@02@'8+YP6_I6J"FY09
M1:H"U<GW4_X:'QK)G@8<H!TJ<?554N=YW2Y]BZ-*0"A<)7"I6DCN>XL,3:WE
M=-E::DL-P$E-!5?5<\#  Y? ^[4E'%1>43BN8D-V!<;G8G833T$@-2KVK5C(
MQ_T3*_5GO:^!.><I52^:+G3G0WMX1K')$^L+M>3?P Z/D[>$,RG%OU2J:=:
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M_1-! VL&=D0]1>"G9IC3LRJ?.OTQ(BHN2P;"O>"Q.@]YBI"+>5E6YP+DR!<
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M :2EJ!9,Q0#SP ?JB*X"_[[6R=GE(TA/O#X]",&=_!+@3G[AR.)WODB;EN0
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MVCJ?-B;?0V4W/NE//\)8H7Z1-W/%GC7G@4FJ^+\FE!%;+BH6UGD*PT/G?=W
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M7[F*<499]*DK4!,XTKQI=I[BS?<KYG?Q""W2E3C2,OZ3D_=^Y%PZB:EJ*A$
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MV8'GQS/%0O,'"U2EOZRU<KJ$#Q]1\7<5WE>(9>"^'FVX+=Q<ZAE1X$_P&;A
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M24$Y-)T!OHR7S%<4UZK8U(  C5BQ4P>I>.@Y??P)3BMN,JM/PC_#(<-GXB)
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MBM4+Y%N/V'(ZB'K(G4*@ K@(DO()=_62/\*:3' PWJZXYWG?27NA\YA!P,*
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M46O_I'BEA (2@N.D_,8, =5[$=>G@.<$[*^(!2'') 7(9 S$@G\T+0NVC<2
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M%//1M!VS9SMVF'QW,M\BR;7P>'H'O8?MY9C[:/N>BT!28=4@<D+\9_C@$/
MN^^+[])G)S>X_C:=)>Y'.%%9N%)7PC=5RO/HU+1-M->#'XW5TD=VDHT@-[NY
MS>;#+IGG(?,\9)Z'S/.0>1XRST/F><@\#YGG(?,\9.QSI58OY8M]2J2K%-*M
MTKE&(IU$NFTWXBD?SNUYDD?Q1CPRQZ.RJJ/,\4ANIFT4'IPN0[2'%,)OM602
MD$2091SD8,>0'GR.1TE3.H*)Z:A+$SEJVM28U-;FFFN<+=0Y5)%=D7%N3737
M:..V2&7AZ0WXH+E@NNK3T';8W)2-(KD.%4"1@LD/MW"2__I'1]?T]]-S&><-
MFMT6+M>4VTF<;&#7%.JD\M;HQNF5<0,8P+.WC7JMFW2$R86KJZ;_3&-<ML<*
MIM*<WUPJ9A\!3<,9Q5'FJ-9\WN/LF&(ZIH:Q<MQ:%T\N>K<L.X^*G\"'@$,^
MA<-,+QB@_G!L8E+1;+,8V!G[,69NP&K;FL-93D+XS%SF S@0@F?]D>W:0>C3
M!&'E8OJ"=D$1U\#!'S)[-"?W*( XR<7K$RV2J .1("&M9BA9ZC%:F7^@Y3/H
M.I%GA^]W<(HU]C*JZ3GE0C&1,-T":<FY.3/'EDB9_+RD.5*VNQ$<XFVCUDE.
MN:#;$3P&LL(: GP]Z_M)C^X2MP_72]-_@> M4$%0L.+1W]9C2S&1F/W(1PG[
MTJ4<MN#YR,8^LVQQI4AT(P\TVK_I'VH;IK2%>YV)H_+IYKLD_)F+,C,7E=!]
M*CT"!U^.Y=02B;,-AG^0T]EU.9V]''N1T]F+\^4;3+\/8B7ZTK6P$.#>_+%K
M>P#U'S88,(O$?FC^4 #<.?/^43T >8M]%P<*/.B"> Y YL/+I&C@$4,\8JJG
M/-E4^##OD["&9J!RGN/;<Y09?&/.JM35D2?X3_5D=#T7T+L?P0N(H(+C@UUQ
MQ]BNY.1\*.U43EYY<(M:HUPWHI:&@M18]9YIN'H>-US]9+NF"YJ&H]R%\"M9
MKXB)3H2HS9R /0V9+Y#81O_2&#0196 [6/CB*I\\'^W6DW\390PB/\0RD[X=
M6%$09+6ZUU>5V/U_O<G!U?5F\TU9V>]\5?.<&) =H,TV4&ZHB(@RQB]=N-01
M2;CEU[@?16I:$RX#$ I46&OB2M"3R9TOY!CT0,$UN>]%-)\= +X!"B]CRJ@:
MY[=(M2Y\<(!E79YR"62AM&O*-],%_0TIY+\#Y6."X=R0<4WG.;!I0RE) =GQ
M%KKTS&UZ@NOX!%,D1%1%8@BW=W=Q3K^SGA^9_K.B-S9O1.8CLDXG2V);3W0E
MJOEJ_Q79?:R1(X9FCI'>\)(!6[*S;"9W646Z2'Q!W-WQK(@C(B8YZ2T E[;,
M8"@\)Q0$&/I>]#","<9]4$S40  E8Q>(Y_O>$VE&I$$+2GOT'(H7@#X"2RL#
MTZ)BQ)I2L$"NVMZ*V^0>SOD]?!+WL$N1SMU.L__= F!*0 DD(:Y3ELC/KANQ
M-_R&N<![0X6,,R  V^6JM0E<NT\1+ZQ$!A[,?MA!F$%Q\\%GQ-J5(W2AC$@H
MJ,2%,5*BU]\+'#B+'Z1_UMX?J\)U*$J8 ]*#,MI\?S$]"8-#"9Y!3%C"S.B9
M[O<@_B6A3Z#L,;P%[\ CRENM6<\X>H\RVUR(M/%^N7&R\#$%9)CKA4H0]?X$
M<X57;L-EVJ-)'Q1R#ZY9@DAU\2B.0R_V&!P8>)(0LZ OFLBAGQ7' Y@+-A,N
MW0(OHX:70?6)?-J4BP!N\;W'GX2= E\;V:&(=X[%MV C! )8"#?,50C\XFMV
M@ #QHA _,K*C$7X!3#+3"9_5[%WYS![U(C_@N(21(MC&U\L/U[<*^7W26&2\
M)\0T/]A-(*8$%$U,C: Z15]P36YHV@ PT+-"C^2>Y3TRI&^,>9FABA@)P//(
MY #K!,085;V'OFV%$V"QF(]K =E;;$R:(Z?MN,H^GF$@, N1VR8[J,_&C*XG
M(T-AW0!$+JBG< .P^(./+,>Q&>JC9.O;@'Y!P$)>]!_YM% /T-1E ?Q;P !%
MXP=&YG>TKAZ9"!VJP+P>$$UL=R+,"$\R_P%0!5'/2NPY_A,QK.24@+0 !XR=
MQ)?)I3U21_P,X 5P*[?/?^%7&%\=HT=%(#/59M/;%P1.^K1CP\^,,ZQX<8<]
M@N5(Z@G\R<?3D+K+X18W,B  C#"L@D\2EX$-4'( _'U.K/,)/B-LT>DO(]$G
M^]M)D*4LM+3@]O#RAB9%"*<"Z? TJ8V(!V^[>LV8^5DTI'#87'GDDM*XD)<>
M-F?['>Z, 6M KQ^B/EY5JGO M:LOZ.QQ@@&^:%J@]!/+&7"BA#6$+F%C@Y'0
M>V!$R$02 Q!T/"3)%P0&Z?=/P/X-4P,BB$!SX88Q<!>B<M(_5"[/098'T6!@
M6[90G7!-VLI"BT(D(KB,]<48&:$8*68?N 8J.:G)$CM370"6$CXQ!ZX)6'HX
ME/(0[L9Q.*GQ-B.@> 3$R4%Z,.+1P/U-'IM'B"0CE(+8CY=0]@ 6"I++YC.'
M@GA!UC_=51)(9?JGX""G1KY))H4:9\"&M%4[>6R]RP=NUI!=/E[9Y4-VSI"=
M,[9[L_6UXM^A]4PXA&X"5RSDBL)1%)#3[#AIR(<)=?-T/=EPH,IEN$=:1]5U
M8Z8[2(5J<"7"50GAFG55K^]PI,0A%/8F7%PP<>%47,ZW][P@[TBOJV!2YV=T
MZZG'DR63^2'4T-26UMH)A Y*M\MJ=*F>ESH27\DCJMONHF&HC6[U&^'L.92.
M.FJWT=Z)QKHFY8'?LU[3FU5@&=1MD2)MP#Q>HS7D=A-4!!&;JM98L4U($8])
M552.?0/OD='L%E9&-@[80]!4SBD(C0E$#[:+U1H8O\(,W8/31Z0N4G((U7?8
MP^[0M)&8+6""TP*&D),]BWB/ 8?O>Q&&G@L'?/;-D[C^"RHWY8+R5MC46_L=
M[5B[D]0BJ65#FDAI2&5^&["EF4IE*09<D$3"DSC/IPK8ECQ<G\WJ*LL1UU##
M4I9,/:S*<F,7*\_%FY<9F:MB/6WGT7M6WK8ZM492X5&XQ9K"2R62OFB3S7(R
M3>)P(:J;B#,&W^I:K1/7K%N13^VBZ%.9M\[.;OAI*6O^[/;B3CFSPLF)<V;L
M1*(F/-W)+CSI+249BC5%N?AA.5& )?(B(7]B9_!1E5(=TPN'UR9N';-EG[S(
MZ2M#\Q%3;^':WAJU5O)IWEGD\>4> K*[2;:[B2&[FY1C+[*[R4NX2@72RC7E
MP0^ !7N^J#K!>B+?[D49QN=.A\SG,N\G:JJ4;3&)[XD6(LC<-.,5K/JE:N[5
M4JU+)AF7I22L(ASAUIK)C1?O,Y>%)98T!'R#N)&Y.YQJ-2<ZMJ3+$!)T,V)&
MQ$V4L6GS92<:1J[<*VXW"NQ*]<@3X,_&GN=%G"=;O)IC>/Z'C55L<-MOFWJ&
MNC;3D'8.<"?;\:1U3Z+<:6%-KZI@A8UM.@Y6%0X"N (X4EQ.%[_>Q]X2N+GT
M-GA5Z(QFQA]@<1>,Z0IBH:<-;#\(E;\B^#0<:UT](EXT]%Z-9)W"%D2'>@XM
MLFU>U]6BJ^V^JP5O-G*V\;ZC!4VV_QN9;@A/D^Z,55WP#T[\=^R%XGA!!.J_
M<M;#*NEOIO\=,/_6#KY7L _'PKN9SP(O1>6J<HO5;=DS[X(AUY3?&?4"83_
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M#VL67EAE&WI,(L_Y= ?K\[B#]5P:FJZMRG:=3OI77XK^U9T<C:M7U+> ^3V
M\!?:4PM5+CX&^03G99^V]7B(MKCO$ZVSBPNO<U3OZ'IKTUW:EVQA\F[ (FKB
M7<3 &&3L[1!C[''!C*COR]3U?<*2&@F3S<%D@AH_F ZE^]T-&4NJ(.>,R<'9
M-W6]+N&R);A,<,E)WGC)AYS&]B:.&P\6#2<7HQ0Y^+2N!-_NP9?I#7:7:3GR
MW\K%7Q'-1X)7KUB(8HZG&.'L4_(V2(A7%.(X;O43Z$*!!&')0'A%LU&2LMLB
M:FH5\DG1YM#GVARID?HJXZ,4EH;/Z[-=+UOA$A]OMJFFT$GYY#%N7C";LH6Q
MO"-3-TV3IR<+W/.5T$AK%S$/*Z;XGF*?R6DV,C)I(C+Q2,:]("I04HAQ>,QW
MUI^6BQR7^XZ*[C4D=$R<^3[H"SCTV3'' 3N-__ >*\8<\_G4=NG+]-+[21F!
MSNM'AE,Z3$<X#HB,^<^I7[M6Y[[MT(?_Z\=?%C_7Z*=W87_VMVZMH;<6_EJO
M:0M_6[9JIU,SVHU<R[ZC'?-=P\7@3?[KC?$F]?B3##C5QS\4+9:.6=_JS.UX
MX^WS-:V9XHIRY:7\19Q^/P[VD066;X\G4KM>!T*4[///N8L8#1PV7XQFPN<N
M^.#[G6]0!&Z&83@^???NZ>FI!MNL/7B/[\Y\:XC#D=^Q_H/IOP-UR7RGM5LM
M^, [V*ZF=0U-;VI=O57O:HUW_0XPOY;19S]TK38,1V]^UFO:/V8#.ZMA]V*8
M[P*WOYGHUE+NTA+ILW@6FRJ:0G$/R[45>JCRDZZO=54:ENWBT-'PB3&7.@1>
MN-388KI!X*+F@4=+ ]DQU<'=XU\7+)*4%I^+@9M3SM3.R;^5HT\X8P?8D@*P
M/C$ZW7K]>%)B,QJ% ^_$IS3X*8]KDM!+3>A!04KG?]1UW+S>?C=VPP<=N][T
MGK$5$2=VHZ;M)ZW?,:RG5L[BP;^4=49609]R..T!#7**/7:<,D7M]P+R4V?F
M-J2%I)IH(9>/S(VMD7FZ0YWO4%)YR:E\7>+<T&,*U_>3PN>2]H?G$^JSMJ2-
M;UX2U:4DEC0Z2Z/]U##R!FE[O[\:@MX:VY"HNW <$=%ES$)*FTS;$[Z:XAKY
MA.*2H3MS*&XAR7TS@;$J#>[,/ZXI<^ EZ:Y,=+=.V:C5A:VKU?=5_Z72"MZ?
M*LX;+YVUB[<OA:PD]NT1^YZJPO?F#Q!H88AEB"4D<JE)2R+?.)$;"9$;^TGD
M%Z.QXSTS5F9*-R2E2TI?+Z7KC:;6>M=O=8U6O4V4WD@HO;&?E$[D )3\E9D!
M2\D\)F1SY%';\\PD*F%\+R#K>8^^BLP;N0QU],_1OI&>]3B-BV>7"V?[W6RM
M9KT($SB+'J( MM1=S 3>4:;%CNLUYQ5NS68![*J(L[/5CF^K%;/MO%9S5PRV
M8@6<,AUJ&^E04DDIEY(RQ^>@)UI*\__LIYJR2(U 2:Q<CUR[%P7X+]AK_Q$>
MQ<DZ^1V#TFD@J73CID0K(=+6GA)I;$M<CWF7I<\^T!+0P*]XL0LM@;60<*M"
M5H*D[UUO<"/TW4[HN[WG]'U[]^M6B;LMB5L2]VZ)NY,0=V?OB7N;I-V1I"U)
M>\?6<QJR[^XI;2\EX:_HX;]G0#$KV\\RLT;2Z<9%,"!:DD=7WU-"3:)Q]Y<W
M!27Q&LBX+H6Q)/(=$WDF679/LV5C&L<V:* ]4VW81'THDE2/*10&HWX3]/<T
MH68>"Z#!N"8.)^<C3M,!MGQD;CQ&PXMGR*Q9N$NN(+G"FFI(-=R\T:0:4LNC
M]MVL;_("+ L(P@Y3%K&%'-N=E;^<TUEG,^_2,DLC;A(UD:PST3 3_M42HQ$$
M9\@FZ*CTL(-7"RS!A4NFF>T^LUT^??O>CX!^E0^F^UTY"B(+AX![/GYOQ/P'
M4$F SN\B%QX33QVKU NV/[)=0?A8P/J0[5D6?ZZ,>?OIW?)J'>VX)HMU*L!J
M\G :4#F,=HLK(/1'K55'=M-ZAXJ'#A_ T3JAYS*/.[4 /U-.8^RIQ7&>'EOY
MPDPG'%JFSU+#HO7ZZ'JN1-U)!<+8B )QQ\:AZ*\G58@]INNVT"!,Q%\:U)&T
M:$."_D?0[EK:0.^:==:U&NVV9;;;&FOUFJU.V]+KIL9)OK&G)+\@>Q<NJ_UZ
M8E\A75<2NR1V!P#O#;*ZJ3=  ^ OD8"O:S7M?_:3'._R9<Q+Y"TM\O:9X]EA
MB%V  F!8?S5T#?:J&W&3,V-O<?><GYAWBN>7H/R7.1J_5^Z]R )$_OKUIA#F
MQJG:KD?P7W)'\YZ49%$FLK"8A[Z'$[$O0].0,D2GH/WEYVG'+]&XY'QHL\'L
M'&]E'/E!9')_[QVCR92*4=?CH2=WIM\S71:<7/]PV+-R9A&9Z6"R2EE08J0?
M3"&]/H'T^F$A?=IN7"+]/B/]%*?7LYQ>!TY_6%B_G-5K'>77VEWMO);@OV8T
MZ\)O[HW1P)Y')-UZ2Q))I8ED2C+H^@21Z =&)$M$0[4I9!=WC'V'+J_N_N=U
M_>'+=:9+-PAI(-E',7!2.2'8VO&_QX,HX0_P53&Q@YE^/*'C$A,H3-Y#]Z,9
MF@HY#WO,,J. 42ST_WVX_:J$Y@.?-8'>PGY?N!*3-7!C_,'X>_N+0G?G7_8,
MA5+HW9L_/-<;/8-T#ID;D(O9&K*1F>#7_L+U_.SK(<'UW'2LR.'RYJOM?N]A
M:Y/]A_+'BT^'!.6/;&"[]J$!^>O9AT,"\E>SQYQ#@N_-[<4AP??&9QA R,^K
M98NE)3?.6RQ-C8F4+9;*Y"J0+99DBZ62LVRMWM@K$73NP5:4&V!X"UP"E)>D
MO2>#WZ*'D3MNTSM0QQM<'N^NS'7_#UUJ=FBG3SG9->(S_P,_1[YK!\.%C_R?
M)*$,$RI".XQP,J^IP,X +.3Q@1^(<^,@4,L;C4&;,$//?U;&F*T&_VC&6?-\
MR7^D0VX5;X1I"I,NQ,N0C91673OJT91<+(-G#[$)>7?R[]IL5HZHN\'OT-C@
M 3\5[#.(QF.'/FXZL+OQ,ZZ'V?CQE^.)M''>&V:L16/XDL_^BEB02^U9/IC7
M[O_K30X98M3?S"RY.729/PF5KEYKU;(#8;/_59)Q&1O:':UX:@.P;"O'?M,1
M('=<R2G7N-GY.N'5Q#CCZ0DD.]*BRZ(P-^N+%>8BQ&2\V:":75Y->N=[*9W2
MO#L$G\^R[BX_7YW=_WI[<;?PG$)5!ZV!+YK9^I\1R."!L&]W/^7])B.V47BB
MS+1]/G\]"?^EHZ(N?EA#TP5M3L0 M:[14,6+/-L<EAJ:@0("^5FAT% _JY*(
M8ES,EH<?0$9CW*C'AJ8SP#QX7(@P43Q U7,15NS2>F84#CT?3M>?'0V?_^K?
M;-L*ZW9KG::QBA'6Z-1:G<4_KVJ%-6M=O;WV58'7UKO&H=AV)$JX3K70NFNM
M>B*./CLZ5(&,^2D]QR VMC;;;-5'7\"NGFE]?X!SN?T3<:4#^G_O5P72+O10
M@M1'K!\Z3<IL.3;J'3XN=E.I+SO%S0]_G+Y <]4\U[O@G?++Q=75Y:>+6^5K
M3?ET>W'Q[>Q*F7/8]?+.G9YZ+T&9^U!"[R!-91PJ8-[9?27>7Y5._ L("WO
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MT][>*LWFN+>VV[Y[5-+.8&1.QBZ,1KIC\A6U_5EQ,G)'$_B5\WWY0!.TWBB
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M%7E]RWMC5G\=Y* W3'GC#U<W)O-PIX"6]:2NRAP@F:260U*?%K0.Y!120@C
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M.8BHN58R+LQQ\^'-<O/Q:S<5=R]H?^_G7QNFKK;X2.;?"OD7+:A7@9/@F)7
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M.=*4.9=,(=A -X1S_IPM5(_:+16Z/9XKYA^JCV3,/P[FYU05ZB"'&CG@C66
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M:2_P19?DO<\0[@:A%?)3/E].>+B-D3FA-IPP9X$$23U51@&EA(S*#5= !DJ
M,Y)IZJ!S7"=.@*B"<\7,">O""158+0_BA S[>\)^SJ91D,=%( ((SBI $75
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MY,'%.>MGY:Z,U7'+N>F=>.JN<2BKSE./97=,9+% 5YFI*F2JQ?:,#+F D-5
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M!RKW%.ZUNKU^&=\V]AEL^RN?P3OO?.<T#6F0W03W<A-\6/3\A>"5U]H!IF4
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M$G?QX?1#">\_/3CZBW_8^8P/3O?IX<[>UX,__TKC_;K_Z?C\8&>+OC]?]$3
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MUI(CZC3Q0ACG8UP\])TMG"7*AT+"V<>(UAP7P4@=%<:.D<5#?POX/)LLQW;
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MJ>?G8G^H'VZ>V[4A_5G7B=SJ^HL-1(UIJ#8-'6U]Y"X8SZ-'1"M;FX8X+Y
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M%<$3#R1._N$VOJ#]U/_['R+P[S=AB82NUV2-:^'YPBL7SX0&H!XI0-W4D-T
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M$7([.!N&7T/="FEZADP;%U7=YL85'-,KZ_YS<[7:)N?C9>,9YEO[N8 VX%Z
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M24;]S=LUMQM]W8W^#&HE-LJ#;(>1"Q$C[J1 #H.""1JE<CA)CG-P-^]2+.Z
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MT]%4-N)2K:14T?F:=C.K'4VUEGOR(#X@N*^>7,/WAP#?N>!'WYZ,XI/FEU]
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M" TDJT%UHIX (X[#*L_J?^W*C*5S.,QRX__TM-)>1I =L73<@IZJD@M82&9
M5S6!OB=XX^E^87*#U,E*)YR?T?_^VUY^L+__85-+#]O^']N=E]N[NUN[^YW?
M7^V]>=GMO-A]MKGRX][=V]]^W=G?ZSS;VWV]]^>+YUO[V\\[6[O/X8.=7U_L
MPA^_O8!9/7NQ]6?G]3Y\N[.]N_^Z@SH_/:N0*(:?%V9Y.295/^=PK!+K'9$J
M*@W:;+ \66XE5HI'"SJNS_^KM)#RQJUL8>#4)F<)CC@IKKBPT=E HV&)2D%<
MVKCL/9%'SA*6,42.92XJ1&A.F,$^):;XI6A6BV;?71 S9E-(<ID<]C79ANA-
MK;Y-9+I*$.-W+H@1ODG4MPZH'6P[V(<:K+Q+Y>$&XO;E)BYU'=&\XCL/I$4O
M<*,B2+V-=MC9!L$A=)Y''[/MJ<-(MT,QQ3=I%7^7BVDF]L(;V"Q6?*'_R.K(
M'Q--YX]:TWE=:SK7B:B]SFI<8P/:Y]SU<[XC<=QPF.M''*M*$.NRDC>&E;LQ
M.ZW@6KR.Q[W!L/-G[Q.,N5V1<0['JVOG<#S:A:B7H+/$B? =JQH]A-MD)X;>
M-U=*OR('\:K[?M@@FAO/?[5=;S=I+6Z,X=:H8 GE1"GKDXJ,"JVX"YY7%19P
MX[G&;8S,-_JZ!^SM/W_#6/YSM/?\%;SO!=[[_2^QM[\MWM+_?-BA+S[O[N]<
M['[9XN_F?=T?PN&[?[;9VZ.W?/=WF-N'O_B[YQ_%SG[_P]NCG2]O/VR3G2\O
MV,[SP_Y_O^PLY-^DW$'1"($\L2RWW)/(2)([\,%V8L-XHKIJ+6[,NK3-:/&P
MQ</[P4/#*;7!<14"X3Q$DP)/CE'-<@'NR%H\7#<\G,^-P0[;0$1 S,F(>*02
M6>XM$@I3)A-/))5ZGJ:KU8_6.:P%Q!80YTN3 \SE$#:G&>>>2XNUTLHXCA4F
M(#-^?T!\= T(OB,6SLF&C&%)O(V(:D,1YTDB)[1'!L-6:P-(F8OLW5$#@A8+
M6RQ<;RQT6@@2F++!$ZYLLL((&C4(AAKF&V4K'*X;(,XGE%A&/;,1E.7()>(>
M.Z23U" A$@8\3PMK PB'2G>I:OO3MVUEEZ>#:&\)R^6FX=1PD:(UC!KOL#")
MQ,#=%3CQ0Y8W^XX&LOED$)E2+A5MD1$"I"#K.#+&:B2X\[!=3!OL-YYRL19M
M95<DU>.Q][0M7II>:/O9WFL"K]$\F:1#T(KSZ%TP2G&L/8[,&4E;>6N]L/>O
M!>>$CLJ:X!3BC@?$HU%(*P7;F8B-RBGM(M]XJKJ2BQ7JKM,2^AT3.M>):IFR
MK,2Y"=(*R6@46 ?A*1:J)?1U(_1YJ[N'L\:%I0@#68.,E9/T#:7(61F,B\YX
MEJWNM,OE*O71:BG]CBD==" 0K5EBAGH._X&J1+$SS&KI?:A[L[24ODZ4/L?2
MB19,$H)1M)0@'@A!.@F.I&7!IZ"QRAT=F.PJ?5>Y]2VEKR"E,^ELS&6P A,\
M8>*2%4)B"9IV$BREEM+7C=(7C*74.BL\0=YBCSC# CGO)6*">144MUBJC:="
M=K6^=>^6EM)7A=*76CR!=[L@,?5..LX\<0S$><QDDLEXT.):B^>#:MWS%L^$
M;;*::^2TI(C38$$:5Q297!'8.D#G!#R:\,U5TKKO*/I[;1HZO#YSISD?X#XB
MP5M?SG4-D(8Z@"LN(B?1:9Z4T$I:S 2QK(V.7C,H?+-@@ Q:4$E<0,9&D&&\
M<\AZJ1"53N;2;0+^V7@J91?SN^HTV?I['Q5&:!>HXX1H[357$3NKH_$<6TU4
M2*:-&%X[C%BHIJ\5J#H\(:^M1#S ;\:(B)*@-D4/HF[@N;(S[3)V:X&I!8G'
M"!*)2\&L,@)X"X?#9(QDQN.(O66$I=:3N7X@,2=(..<Y2]8A%B-#G&"&G)$6
M-"RLK/*@6"EY5V;/%B,>(T;0&*/PRE%%$\@3W#+)K9;,8A*"8E?94%J,6#F,
MF#>8"IU2SCY"P@4!&"$)LD8P%!D-6%+%-!$;3RD372)^M%S,.P&)1X402PVM
MP&&,<LIAHP1G,FE&*/':4,ZM$.$J;:,UM-ZO=6&ASKC1!+;!(T-(E@J<15II
M^$TGYX124N6P!XDWR7V3^RKUU%UIL^N./8;#'SK?7(2C]1M=-^HK*&54TB%1
M@"^ -(^)PA)[4+B3\@^06M@*/+?!O[>+UM4DDA2.POYAC+C%%EE%(C+!:Z:9
M((9'4(I(5]P^FZ;U$*\NI6,5L0A&,6,2CTK:2(#J<Y@ )<X[WU+ZNE'ZO(V4
M6!LLC@1D'!V THT!08<*A'U0T3*&K<OQG5W!;YU$TQ+ZZA*ZEL9&Y3V7U'!/
MJ6-*8A!V62*!6!G::@'K1./SE:2TQ(;G4*]H%>*",60]@0/N(XF1BV1R5^$[
MJA;04OGJ4GGBQG@?!)%*<4.Q,=0JH&+NB(^)QI:=KQNISULJ@TA$8!R1"\XB
MGI)!QA*#0#M+\#$+)%H0W%F7$-U2^F.A]*461\>H!=U<T&0$' 1OO8S&2(JU
M(()@T5H<'U3CGK<X\N2CT\FC:&U$'+0K9"@7R%E#B&68RP JMWZ,D9W7-BM^
MK3G5O5+>0KNU9K7O=#!R4UQC-$M:GF6K,6*;2UKP.#N*51>MZ59Y5?^B!W("
M/2;@79(]$[D$_2FPA!-W-&CG==06V*^GWONK4+<5L58,J?V";=09XZ01"A$>
M).(R!603QRC*D "H!8Y1;CREI&ODK46LKT3"KX&[]W%3NG24.$>9#33P0(V-
MQ K%?&22,9^^4T9L2\PW(N9Y\Z<TV@7F"#)!9ZG+@,"5-.A+H"I)GA@E46T\
M);=O0M]2\@I3L@TI!6>P<QCV/.8&XYQ)21/C)(@VR'/]R'R.9W-BM$[<H)!D
M0)P1E0E>@X8E%5$."Z55:1O?%:0E]4=,ZB&%X+3#VG+.&<Y%C(">%>,FVT19
M6[!F[4A]W@*JH^4R4I;CM1SBU'AD&9"ZH,(PH9W%P>>"-;0KU5W5!6Q)_<%)
M?:D)5$GJG9&&1*IX+OC+K+/6L,"9BUA=1>VM"?1^%>MY$VBN36^I%D@E^,&#
MB<@Q 3IV,CX)XV((*D<=;:X2B[ZCT,JUR6ZO6MT-K]WJ[L9.G*ONJR-EZ[;C
M#)8N#,YR$_-F[C]L@?>[7Z U909+5+P8)>/!!4 2>)@RED4IM<]E,XQNVP.M
M&_<X6 Q9M9:(R"DBBG+$;<@M,4A"@DNF/&74\E"U!Q+ZUOSCSBGM@1WG+>:V
MF'OW:0)"2DY,R"TVN#?:*D(QD]II11,+;1&6M</<>>LY!54JB4B0=SSKVDJ@
M;$I%TOK<@]0R:;-9C?$N5G<5M]!B;HNY+>9>VA;86NY=\E)KSEVBUN6:O3'R
MP(@5%+>8NW:8.R?G4HT3XX(A+(5"W&B&+!,4A>1@1YG7TN>$#::Z]/9>RQ9S
M6\QM,??J^A\T4 QT%P+G"IL0$F/>.!&,#;I-AUT[S)WW*3F&4XJ!(ISCOG@0
M'!D>+,*<1&MUHBP7&V0&=XVX=>OAQX:Y-PG*OV?\72.86>K/$I9&AZW(21Y<
M!VRB"X%IFT"WUI)?)=V]V/VM]6C=JTURH8P(9HG2$) REB,>@\FEFB/27#K&
MN.2:BQ)WLGE7+14>%#96I(?=OT\MS+B)<X<?S9CJZ:$LASTA>A8</@![[:6+
MZJ/><0 J>(+R13"Q\L#QVE<K"!/LVY-1?-+\\DOHC4[Z]N))[[@,L]STRY$=
M'O2.FPU9$J)?WE=]_<MY+YP>/BGGH8*'VK%8O[GZ&F^2?RW*M-5W=%-1=NFW
M7[OSZ]\)AK_I3K)Y^7U&;%*NKO78*YRL-\PG@;-_UX=57^NL3N=@7,YAKV2D
MZS?QA?R9SHF]& Q'G=YQ9W V[!R"7-LYC+9_>EBN.1R,3GH>*"X./\&_(_CE
MX @($J[/LB]\4#N@.PF$Y([M]YL''L3C"-PLAIE'YYI G<%)K/C<:/,:F/&=
MUTGG9>K,9NA,(=<B3GUW5#)F4V%U&2A]C=")WC3Z>H1^4U3Z-JS[ZF#Y)N&F
M'6P[V/4:K*!WR4EOP'LNU_?4=?A4UC;B\(%$2K646[V-=MC9!@DP=)Y''[,B
MUF&DVP&-RMRD8_)=+J:9*,\W$.!7?*'_R+SYCPG;_Z-F^Z]KMG^=\++KK,8U
M-J!]SET_YSL2QPV'N7[$L:H$L2XK>6-8N1L=; 77XG4\[@V&G3][GV#,[8J,
M YI?73N@^=$N1+T$G246M>]8X^-!2@?'T/OFLL%7).1<==\/ZU&^\?Q7VPY]
MDV*+ABLIF')>*1Z=URHFY@C67B>C="G#1DSMQB&F=1A_H^/GY./.\[<7>\_[
M'_:>O^&['][BO7]^.WS[S[O>SOX+O/OA+_J6ONKM_;[]>6_>\9/'\N$%W_MG
MA^_N'U"X5KR%>]\=O8!W_T5WG[_[\.[W%QS&+O[[96<A&)UQJ8.@ @DC<VG5
MJ)%64B&)B=8)=,I(TL93KKJ:_&C](EH\;/%POF82DTKDB@N!18ZCT2)$IXE2
M5BCI36CQ<-WP<#Y0W' 1*?81&9LLXC0)Y!CUR/O -)6811$VGAK6->S6\3,M
M'K9XN-YX:)WVC-O ?!0<_F>H88KS$+R3FBK__?'PT17C_HY0.)^GR)U),D2D
M?(9":RG2/!B4^[<[@,@@F;NS8MPM%K98N-Y8:# &$B% %<%QK83#2?BH&*7&
M:,Y;77GM '$^N%K)W$C*&F0E8"'7P2.KB4.6"JRUMA3+'"/)25>)6S<;6C-
MO$DUGQ\[-)J;D$"Y<,X8SIT#)FN)#L8)08)6_BJ9Z8<L]?,=[6/S@=$B&\$
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MH:Q#B%?Q<X"-)>ED]]O0PHS'<>[P8SRFT?10UL->$7T9'+Z >&VGT^JC=C<
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MF(_)P2V,DI!D*@%-UX#V2(#6G-+0#)/6*]#0?-D-. 6/ ,ED#CFEGAJ#K1
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M<LU4BA)80^J(.&<,F6 3RL&6R7FAP*I?6>.JP7@-@C4(/IG(X06X).O(X1<
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MI\PAX;E0 ,<H2>,1C]8B35-$GMC$10S*)+*R)MB=X]Z>Y9G0H]E";W;^WMI
MQ!0?)B/>RJ9 @^.CHTX[/D6K*-4G0@_=D;@?<S47VRG!=:/=CWZX'4->F8\C
M.OK3NEY_O1O*TDBC:.3:V;P@0#Z=L9)DQ-0X3Y"W!*PD9PP82)$C:CQU%%#9
M92NI=C8_?U9?=*?<GV;UFJ5OR=)3]I&0+L;(%4J THA[0Y!68"EY[AQC!&PE
MGKL<\47U6ZS9>0G9>>%=6FO)_=AL/F5*11U][EB&9" 6<2$PLA3L*2JH"RX:
M+A->1LE='RVM;1T>V7:_K&O82T6GEX<$5DLH[& 0G^0!TWY]P/30F4071+23
M_@02^C-3T'I)0/^)G?"VU_]4YW$N%(//+JRGW1-XYMD>X]PJKC&*#@O$&4[(
MY3(,S$6%N?!**);/F/3=D[1K5_02\_:BLXQ^@K=KU>H.;+U]F:TUM@[L)H.(
MYQQQD_NV8<E0E$0+GK++)"QC?>B:L9?5BJH9^W$8^]-EQL:!)4\P1TSA@+A2
M"1DO*2(I>=A4E9*FR\C8+Z/P>W@%SQJ.>C[]5OS2Z0T&OQ9V..RWW?'0ND[,
M%>%A1S*/]GL=>,8^?'L8^W$P?&&=9)>C1Q1L5]6QXD_8JO6)C6KUFI>V:6NT
M2S6$_;3),0XHQDPGXSTR#("+2R&0%H!C4CI-K182![FR)OAL4-O-&T?5CMUE
MYN:[&QLU-S^ZI3'B9JU,,$DQY 7-M>NU099+A:B4H(KXQ&Q,*VOS6LK6W+RT
MW/R8!D;-PP]G5(P#S8TT"70J9*TJ#V)43O&12#E&J/381$)6UB1]R?D]CQ*T
MUNL.>IUV* /6<JA:5?,#_J@XI.HE-=O>YZ:&G>OU0^RC:HZO&.Q$Z!UG(R5/
M;7PUGY[D32I'4EWY(:(MW4K^[Z,LS;,!^84?_>Q<;A>8H;X^Z%D@QN,9J\LX
M@X,![4Q(0Q"GR2%#HT%!X<@X;%U@N=U!0YI%'?0L@H4>V8]< V@-H,MYOE8#
MZ+T#Z)2ABX6U(IF C*<)\8 QTLI;9&6NP\FM\BF H:L;ABRJN5.-H#6"U@AZ
M7YVK:P2];P2=<C-8IR(3,2!"6$Z=8QPYP3&HH$1S1JWWEJVLB894BZIH_)@
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M<>^'+=9L[7\+[_[FX3]_=#[3SC?WI8>W6]O?/Q]NLYW\K$.8[^$?7W<//YW
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M\8?M@MIZ6E!5[C0%B$RIW6D#I0VFT+<!U)'3K++_%FC0PR0L$-R$-EAVUDQ
M-W;LC1T4O^1 E+&Y5"E\V1U+\>O6^-OGOMM!>86\_K4X 9-\:B2;W9SIV2B.
M^KUO[1+LQY1[_MK1>"=&!)^,QPDRIPTW=-K?\KV^=WB8 1Z0MOAE>E 5&XX'
MLUID&>8[O4&^<?2.B>]E[=:"MNO;1V/^['F08Y>M@P/;2?GFO,C5$T?+6K3+
M,AKY0&\TTD[FY8->)^1+,-O12DZZS^%CF.3PM!1HP-7MHQ((COH@"/I91Y]&
MBXDUF7S.^?*-IE*N>[72<PZ%+H<PC5"K>7P(Q.>KOT=V0_FF4AVYD:[RTQ%0
MUSV[%(%::2^C5QY+QRVH]RJY@(5D!E1\$^@>T61EXJ[[CGU4TWRH./"A6AW%
MM%U:T078*#]L%[T!ABH0]G$_MN!-OW=Z_NLC*P\[&YMCY0$4A;<@A#?/=EO;
MM/EN&Q2!#P>[K3\Z.QOK A0 LOWNC_;.QM?OG]L&?_[O ?:'?W?M/^9XYQ"$
M_S];?+?5/ "U >^>O1?-=V\/MD%IV-[X"@K IY/=PRV^TWI[^-^SW9/FAC_;
M;L&XOVRR[8U/>PFGH%4*B.#<;<<YBK23& 672(3_!Y_TRKF-'-:S/F:BY[G.
M-#&<<Q:-M2YX[JT15E-#P=J+H)X=9<V\?QQ7UM;?O/^T]7&KM;73_#C+2I/$
M/,56U?;\^'67AV>C$$0S;S6A0$#>)2HT23'9:!T+^D>>EDOLQ^1C5)ND8W-B
M^E3/3@1'I)X_'F1$!MP[.N[[@ZP69=@O]:-)634^E<PQ.9W*# $Y.(++Z5>4
M9@D K!NQ4+8;K >MJSRQO.*F\9?S^TNCXZ0-8[#AF^WZ./>.4C>+^Z>5@!A'
MI('4L)W.W!ORAAS%<E?&DP,9-3AV Q"1( ERO-#4R6M^S%M@_ZYO@X7T<0@O
MK.1+OBLKB/"HT82ROZI\^\4"KQ83H2C5PV$=LF4'3\\"^7A0G?G&2]MR&(<'
MO5 ]J_PV?&G:=_I3]/?H5O %W99/?%7&W_CK0;^DY(S2EQ;S,59C6=AZX[@_
M)IOKW"2-22;()KPMO]?.3'+!VJ424U(@J!5C'^N5UKW=CUU_.F7@>QTL!LQD
M1%-..+$BN<222,9IZYSX@4=PJ_GVDH4/P [3V$F_G\,'6/95I;22 OI3?;9@
M&7TV[T]Z_0!ZZ[EECU^<</Z$F^_W#,@TP V,C'81<<4\,HEKE%12PL?@L+0K
M:PF@>-:4/LC)\0?1=K)!D;>Z= ?=CAH4CER*$+%R/I<UL208YK#!-FA- ZNI
MX:&H@>ZL[[DD.%<TH<2T0]Q(@8QE! 4%ZH^2 %16 37TCOOSJ&%PU ;A>T$)
MV8"Z'340T)>2=CAZHKFR7(MDA2%)PT_&M:NIX8&H8?-DI_65;+<V*7R7-<^V
M]Y(A! 2"1"Y%BC@F%-G(<PECYX,,RNI(5]:&)[TK<*)TG(UIHU+"[/Y^/^YG
M1>A<G00K&TAHY'T87%)T!K<^>TI.4$ PBQWC/#$0.D#"B9G$I&7,V5N'DLVQ
M\G+QD'88R<>QVP7HBCP-?_(CF(1LY_T>UT [/CGD;0Y]P9I7?:_![DX<*,F1
M7#B7\ :94Q ;].0+-?QTRI-VV9%FBT$\LOU2U[[.EW:AUP !9I.B_'*O='M%
MZP\J.LR//7_,Y#E*^94)7T^9R1*+_5XOG+3!O,B$>^$_FBY4"2.UW?U\@CNJ
MZU\94*%7QIW_WS%HE>ETY&0>3:8??6]_=,A=PFR9[7+:C?W];)=,:7+1#TNC
M#4;9CM]FO-V3QD1^5AXM&$4]/_FEB7.B"6L(1K1?63BCH^K2:BF5QGP:E6-A
M\[<RC^;TGDN^N0N_WFC"I<.LET^LSA=N-,\S&,>4FWR>0VRL68_47TY754Z_
MFVU5<)YU]Z_+MODH9P]?W&+=H-<Y'EY]RX3>[TO2>R0M7Y&I!9KX>="_\ ;N
M1^3ZT7Y%-L%@7]G.B3T=K/QV:4Z'[>[XX4*M@N4R,_LKYYC2O<VQLJ< 0'L5
M [XJHY:KOA+_MDLSEN*@GX7/_]S /XI7UEHE" "$O,F"JYM[>M@;&9D/1&SS
M[>O6?S:+OS:;S?5FJWCW8>?37XUBJ_GF1@?MCSKNYDYK\V/1VBG>[#0_[ORY
MM;'>VMPHUIL;\,'V[UM-^./M%LSJS=;ZG\7'%ES=WFRV/A:H^.7-V.7WZ\PL
MK_8/7.-D_*'3<-K)R()*1"I/HN:&*.=(E%%B[Z@))!=_?"S?S+6P5**X XWN
MN .2#_3'8Q"0F>1+%<]^SYH?@&W6""?SL*J0A2DY=>[S\Q?J5^G!F[!#&V,S
MI+(^)C3/247RMB$)"XUA:H+2.)E+-@J/;?5 .,Y1,)>GT=TC6"&TN?'UM/G%
M8QA+CG#=<\I[CTU F"4&!JJ1N9HBSN5AN+&8>F' "M&SE0VJ1)119,I,@M=\
MT@HW\YS=)L#HV7D7;V??!^; KE? (AS^1R3LG1'12DN8)EK+VKY_</N^N;$)
M'+:^IX*U)'B%K,@FF58$&1<48E%%'JU6V"B0_//L^Y$%-NT JECNW'(ZCY[I
MP)?*2-@R0:T\)JILZ'%CLTM@7;D*DFWWBV^V<UP=FE1FTCA(8?SBBP>/WUF:
M$_%V*1,Y.T,23[76@3M)#<?,&6.5S:V:,-G;^FEGP8=S<V9K%,2;!<!E@@4*
M_A,^;G?*  JX=GP(7^^.HIICV0ADZ]QBK.Y]R2+B,B&?;>Y) WJ19!(1H&C$
M:2ZXF^-+!07UR6D@<0:$+/2<V+"YUF_[?.U'S?=F[/7ZM W7IVVW.FW##W;:
M)F,$U2BX8'R"$2MC&7"']A&L#J/CCS(5:XE['Q[UKQ3&LT>YI,XD@Y3*0)4H
M09H$AW1,P>9SMRCPRMJ@_?T&)V^GMSUWXT)*3DP RHK<&VT5T"^3VFE%$PNV
MIHO'H0O0Q+Q(46M+40(E))? =,@&C1&S$7/' NC*Z4JZ6, 9''%<42HYCHHS
M;TW"&,RJI"-1*C%14\8C4<;[/>.YP<$2E#@%ZQ?3@+3'$J68'#.E\2NN.(.[
M,D3W88[BC,06>TJ ?BQ7D5@7"2,>4\DL)S&62O4-\N1_4JE^-SI0F*M<-^.P
M/JR[$0F>^3U/@PI4>!0H<0!.VB+M>$3">V<$9B&(N++&3(.RV3X6J\56]NUU
MNW$B)'I:OZGR%J^@UL9U9WU=4.'*)MGPZ>$XZGS8;Q]U(NK&X2CH?!2O6(7!
M3QTDCL*SJX.JJ4%=CG',<A/,U=&!U:W5,B(M, (PL]2:4RRLB"8$3H-SCC%C
MYO/#5=CZ*9^O;0$GV,[F($<=_C6*8;] V!I%2Q*&]^]%#@(V&H]B< IQX30"
M> (\%3XDA^'_*?=2DK-%0BX(("? 7:+1\HASE-);?0O(8Y0C?/O(TF=UQ'W'
M\^VLP=SGZ?9R'&\_CX.2A>9NU@<E/P5R^V?-UN:>3$XPF3PB)D.;UQ'9* 6B
M-& BJ(K>@9PVLS+Z_@Y*IE,=[R43>UG\0*#H[/AA+T]_UM]CN]W><=>7#I\R
M^RVC+L#3);O^2P^ L_@&\SC.;%DR:67=7;Y2XOI'#VK.T:#X3W7O+R/E9_3Q
M.-T.>#UK/V6&'^SY4;^7VL.R,^Y^);!&KQZ<#H;QL*@*J[:[Q4=8OXUVW.\U
MBC<9K7O];MM>SMTKBTJD5&4CGD]]O/$3.1?YRY<F #I=!:Y^W'9KG*PWDA:E
M )C)/9R8&@C52RMW3J3C.R<>=/DA^6(6!9WBK]CM F2C\\3(<-G),K'\$\8U
M+/^A_=+KMX>GJ'?2'?4/ ^*![Y3BWW9_).UGI'M^0I6(&:\<PGG%VIR* P\L
M9=2HE$?O>'BQ8?#4X^[P])I#E++57Y;5U8#'A#3B]ZL)LH2)F7S'4KY-O^)<
MLP :"7$ ;W#Y#]?[5M'UZ&8PQ@[+/*%2:W"QTSNYG,UY9-OA?("WD4O.2R$5
M!MU:42Z3U5A0[W24/ @9'*WD$L%CN81_9(;^566'#UJ]D88][I*XU?TCK]+?
MU2+59N5\<;4%8][:"\P[*31%B@2+N*,8.2L9"ICQZ"0'H656UF0#-(:Y:?S>
M#BJNF"3A\=%@;MEW<^XN3;2Q29B+5KA>[^L%'3\*K94ZT!N8XWHWO+F88>78
M:,;A[S#$O_,(7S(AY8(0>Y00IH(0R!,!A(1S/$@B!GG00"TE0C@#NHXDLP;=
MZI3./@:J*_>[6UK<T\:\EL%&CEW@@E-NM& .$T^BLP:T7CTRYJ=V>@94MMO=
M4I*,L60'!$I_<- ^^BOV<]@<4.GOIW_9G"QYON6(OKP]9]M@Q =G&2,D((>-
M ?U6.?C-2>2QQ3AX;J7+S53QZBQV_*OHC5>VU'WR6H]ET"49-])PQKPW5AI&
M$#,K+"_=W!CI.Q?"<4QEV>KKESJ8S5K81*_=B^&,H.BRQ+Z5PS4E;H 5DG21
M&^QM,%@$JY1Q/!B-;RWRYG<%WAJ51\EU'S\"1>ZDBD W@9$N*+F6@U>0,M_9
M\'M<"A&C P.-< _P)1W2C@BD@TU*61]C#&7/2#Y;$70$8)?I)!/;E815ZF#9
M05JJVE5*<6@/QGG&I5!-H'H5A[T0.]FML7ZY8-1,38L1%UPV<29E\H0*_F.=
M>T+'+E/&;;<J*C6',\?O&N1Z'F->O)JG1FPXWXK*;I9'Y:^_^CW8Z5!64-T
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MS(>:66&S?CZBOV! 6V,_^TO>>MS<V-_3/EKI%4<1<!R$BF?(RI#]$D%IX+]
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M3:13(H:8M  U54F=YA-AG3FT9!3]=8\XG$ 782B7D<RN-PEVK@2R-L*)P(,
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M=W-G[:3,J.I,E'TDS$A%"%(R"<0C%TAKIA%ER<7(=; BYC/EV+R8C*H:\&K
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MY *EEXM&%HL<>"G1KPNN \KL_T*9@'0S,.&+0@7.1<=W]@'6<N.)O?UN/,C
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M.<R=%T918A-S)F(LE UW[TI2Z_;3Z_9D[[9H$K/8("N(ST6Y M(^_],[9D7
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MC_U!BAV @7\7J[_V.X,W%_]\=LKYP #H: $/!V?(7G/2.Z'WUA0GQ3Y$*XU
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MRI[?QR[CV!R0>#8')*XY!_YS&+JX<^ WA]"9Y;K$)B*9B%RBWI_W+$Z#/R"
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M1 >6Z3B^;E#&=$H32C;?CDFY C,> DX.$QEUXY2@JF[0W#W0&%:/1F\X'L0
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M.V&4]B1(XYT -T@4JO%[EDV/9],V^YQZ3PRRS(+?0XU"RO$">0,*#FS#2R>
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M19PI?.&P=+?U]0:6E@263F?+#>06FYPBS'.%.",42><-4L[F0=""BH(TL-3
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M_1YRWHUAK./&F*X'Y4E[>=)ZY$B7O>[/EH)\ANGJEL:I@&F[F+7ZM$$KSAV
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MG($)A%U.$,?<(*,)1U[ ?Y12$F(VS@4QD$;7EUK7%^6)-+J^'+H^ZVU8IF2
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M4^1?FP67>U3#S>>61\R\S-676\+IW?VB(709\/#6L9K-Z].*_*5/8_;&C<%
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M2.:,X=A[3*[,4I7!S$;AN"HX-/"=)(^@U7#)L);RRFK$>^*E/@1O1Y487J4
M266NE.0%&.@G:^DC^DSL;AS4<1Q6&,-.V2U'ND**>F)JK4UKP\7O0]!G4D2M
M)OEJPC;X34S;[@H6._IX"#/G+A@%H,3 9?\=Z\$(D '>50%#12CJ!ZE5F)[A
M,4QH^16 ;RV;8B2A/QZ,#J8?X#7@?WS=ZF7;<&V/0.O[=<LJ $Z_7\C3.:)?
MP7I(W4:* ;\<"%-6PKA$R;MZF,:]&B7/:IFN(1LXS3T)WB7J>AD?*2Z\<UXQ
MPC4W+I>%-YPXJ3AX:L"DOVS&'F+X#UT Y65H_& /P+!V_$[X.-4S\-7^J/OU
MOM_IO*FT;C<:VUUX^Q^=OCUZ<?"X=]+>M&?@58GVKN6MPW=?C"T8#;1 15$
M&XH_I!<2<4T<]JI@P8$]\6!0CJ,8#,;@:CT-(-E(9*!G@2/I"SX0"<I^V>M%
MW8UJ4Y,DW8W5@]/)B^NT(U(?'34RFMGAJ_O#:'!1$R6<>*F5LPG#EC#AU>27
MWUTY/.[HTU=E+W4^W?1[5P^@>Q/7-:Z]S#B:J2W5U[^?E&YT$,,J:[@*K=3+
M/O6;ZZ_7TE<SOG/UG<C7<BZO_1JOD6N_^]YC"5WC*O^IQW[_.\&N?^E+::S
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MGGN=)FC?]RP(PF8YM)W^<#Q8HJ0W'R>FB+8W]_'GS7<G.Y_>'^W1CV!6-L[
M%,$]!P>M3]OD\VX+M]ZV3C[/);W9PSN;[X_:FQOB\]OWAY_!K+0V6WSO<(.
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MO*R+WE=WK49O)V;3WZ]XPWG(^[R$3E*^*LZ0(MTU(":/[7 \@![Y3H0.#3,
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M/'[QNO4A11K $.<8[.UI$KNZ4<D!2*(0GU^W+ZL%P57;-TXKT!L>]ROQC10
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M#O>*_,#VW+L&_ZG5X)!K>I;MSN\:4WW8O&[\]?,OO_SZ;\WF;SUUQ T\<[5
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M1,%^&OCY O^,^VDU6WRS#3T98>C;SZL0#3U_,4 S8^6$=XV5^\?*<.R9C2P
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MI7EH[)K+AVG3VKS M_+QJ7N$NBODH3P&BRZ+HX&HBT<"MI<7&S3P1>E#'GM
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MEM!)I:0[,,*_'&9_?F_F%H8#:2BIJC2 +_3PKS@^XCQ?><9L7'FAP_1?Y,0
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M?F>(.$?@P?,NO&6UKH*YV5?FSSE"P23YH7,B;XT-S!>T,#[_\D]02P,$%
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M,<8S*ZGTMM$5QVH7]_Y@V]W5I=;0[CW<VJ9O8\S:!$JH21@'"O3<7-"(,-+
M*0O!VC;WIM=!N1*__O ;X)6DV'H7\EO5[]L(.0?GDW;$! =$9EP.#L-/$AEG
M0 UXIUM=D%D=Y4H\V]65P>?=C-Q>BO7ZUMS2J"?Y[6#D1Q''O[BXUI<.U6NR
MM$2>Y;::1&,MHB$\<YTXT)1"&Z?],50K\>@/MJE=34KM2CXO&FGB[_OXX:"4
M-,[.6U]2T:Q%5!XX\5E(8@5C:*!3LKI-!=VGD*W$GUWU"]B9/U516JTS=&[H
M?6OP,D>:N+ 8,21[=0_?4@Y$!2DI3=)GTZ8@PNH8*T2X-^EZR_[OBQV?Z\:T
M_9R843Y& B:5DL@,9X,G1D+*.EF.,;EO<UOD*60O(!]G6T[=$^C6$U;-39(;
M5(L:J2>?%M>E>K_#) YP(DJ^,(TF>:)4+K57T<>P')<]*A%4)M(YY9IU]WH<
MV@M(PVE)HNW%52F]^S8F/X23?#X/TT$:^,D5P:=]P656ACNB1"HWIW2IWQLU
M0;".&F&$RT]>2EKQ75VJ,M*8%"UFOWJV]@^^9U H5)$TL5EI(HW7)+#DB#?9
M,FTQ6&X4(3R$Z"5D8E?7(S6D4YTK;\>3,_@TG\2/&/B>Y%N5N_O21!M55D2Q
MTMF*VU@0&J+1.)H4M+"-CA*?QO82LEM:\:>2Q)JX,^6,_ (FET?E^A-B6\0M
M?4TMEQRC7H;#)](Q1;Q40 R/0F%,9#DTJW?P.+07D G3TIW97EP-;AK=ZZC;
MJ",#KP@(41H(^(!C7]Q^2AP4]R:$1E'5H[C63(GY0^FA"I*J6(/MTXUUO9_4
M,EC!-2_5"$0Y#I>66&L=B8HEKT+R0-NDW3T);<T4F3\$A^K*JX$#?3 HXQ^E
M:=]$+Z3BFN08?&GZEDBP 0@ =]E"M,RU21^_!\R::2]_"*IL*Y,Z ?=!J=0W
M"/,R+Q?CQ5W=1<.</J4\>@XE[$<4&.L'=-YI)B8IU'JH"WV\TR7A@3#[H3>\
MA 25JM%UE:FN5V@;AUO^+]=D/V.LOT@F7_9X+C_8&Z7O/[CUS5.8#,;IQ^/%
MZZK'O=_1AQ]]@#,_@U[.$&?]Q$!DJAT)6>(8;=#$0T2'/@7JHC!2VC8QUV['
MN<-;PS88:IUPQ'%:[H]X(%Z (<HK<")'9W.;6QJ;WAI^YJ+?W>7[7<O0B 2M
M#\[NN^&OI+6!HX_C5$1EF9PB03-*N$K1&!> -TIMV[3 T3,7%G_Q)-V6!,]Q
MNJM+N4R-#E?0Q:)[!.ESD 22D(X+)UIUJ-GT=/>9ZYV_>))N2X*F!?G>[)T?
MGI^\/3WKG?>.+_8N#D^.]XX/SM^_>[=W]L^3M^>'/Q\?OCW<W\.?[>^?O#^^
M.#S^^?3DZ'#_L'=^\ZW#X_/W9WO'^[VCP[TWAT>'%_\\*%ULA]/OA[!:";_&
MB&H4_=OEI&U9)G 1"QR.IO,)<K!4K?DP\9?7]X-O"K5#<#8R51)BC"]7SRG2
MWR<"E&KI-0CFW4K1UQ,OVBIV_%;SO=Q"A&G)O/?#FS=^N[+A@,EL2Y8T0-EX
M58PX*SDQTM'HO:;!ZY5&L^H;N^!X5I?S=\%DD[FO9GQ_&T_^!9/I[7MB-XCV
MKU)/$?FW/-0^* .&,DNX@U .>#AQU#)B05&>>3+!M4FP6A=I%[S%9LS:B?A>
ML/'LL^Z93\34?0-Z=^)V84*C,R';TI,=W4<B1437CD$F@9J@T8W,TL9G-Z%/
M//O6$J.991J+!TQ]2;P1B3C-!!'1J90\M<'+&L-93]5UPHBN(^GOC&B;V:^S
M,?\$MFLUW.<"N) &B$A9(+JL23 L8(C$!!@9&=>KN5:KO>_%F+]6G-ADWAO7
M;W]W^OY*89^\/>ZA7L9/>J>],_SMW<GQ^2][9[VSWO[)\3XJY,77MH@$-W]9
MG<KN589:J<S[;PN.0]K[C([X!SB>7P:8E,.\X1P_O4J7/)G/IC,_*CL;?9U*
M$U9=FK&6LSVA+;'2<P(^"YMR] !M;F.N"71KW__^U_WPGC=^.HC]F"7ZJ3J4
MFQ\EJT(*XH7T)"7-LO>0\)-=SLK],+M@"G?!NQ\"@6:RK!=JW@?QH<G82_\]
MG\X618$A)&4I!L*.42@GKYI8Y13)F4<I,PA0C2+.S0!WP?)VAH*5Y5OST.%6
M-V[CE5;&&WPGTD#RTFW1E ;:..?>2$5M;%,7Y#L8%4N\<::9=N")4%83Z9DF
M+G@@IA3[]R& -&U.\]8K\;;#RUX;2ON1*F[KS'$;WN[-KM)42E7!B_$#C:QH
M\,9K='@Q^N%$XFHC0;%(E#19R:B%$LVR#]:#VK7&'94HTU9D34.6L]ZOO>/W
MO;WC@^N]I'/TVGN'O^Z].>K]^,D6X<IF+ZH1JE088J4PY<=*H>50]#J*C2&Y
MQ$2Y5U$,,\^&.,DL!LW>^I2<IZR-$_08JJUK2OSP[$6SFN6898JH3R$BI++H
M,D,OE5)%&(\1@G+:R5V-^3:N+AFV:ISYH9!$/='4*T$R'(Z_E V?>XJ&?<.Y
MA"@BD]YI12+ZM*7%*B-!ER8'./0L*% NVMS76 MFIVQ>.S8UDUQ3\[>W_U_O
M#\\/R_[4^?G^+[V#]T>]D[<GI[VSQ9[5^>+G9[V#P^,W[\\/CWOXI44/PZN?
M;F$.Z[RXAGEL, 65S.6RP]G^^#(,1HNA(97&'T:#?T,Z3$BD01X46ET5R[WN
M/91^'H_3E\&PG,??JJF$WYE?0BIMGB./R6(\2JAUCDA3 E.E&"FM+&3PRL+=
MA(Y*>J/1@+;5NAO"NA?.[2I66H?@(F"P#SP3J2S%52XHB=1H':W+0;:I^]-H
M0)WJ6]F%Q7'7"'2!2-5\D>5,]9GQS@(51)>4;@E,E_3'2+R3EI5*_@[:J(LE
M@BYM-W:1=AM)JAI/:I+^$*UF'HQ0!(LB\(>CF1]]&-S\VSX89V@IZ"U!EE)"
M!@<8M"-,!I&BCJ7_9^<UZA.#[%)Z=1?9WE6^U4FUJ#FZFZZ3;^<3'.-\4II*
MO1W\7OY4:FQFD3P.)L>$ 6[$N,=J)XB+)G@3M7::/N7%[Q9REUHX=6EE=)@X
MG;0R=PK/+CNL*8^+W>+,QYR(U"&CDZ4",08<#=0Y)=O<"FT^M#4+^?RO63?=
MY-9S+YE'I_H(G_? D8Y%HR"RLQB5<%/JI@H2K$U$X B5S=S@V+NT?C8<9Q>E
M4A: M3;;*"G)JO@K##RQN30QCX(KHYF6C<K/[613YWG/(#J\DBKILJKT:JG!
M%H"G@ZOJWV4.+S[Z$:/T%"81!W?_C+[U@\FO?CB'OJ)H"%)F):,!P6LNB'4J
M$D<I!$5]#'IG >1V0^G4L<K+7B [Y%2S('%QM=@/4FDG/!A/_@E^TC=29:NT
M)E25O//L.0FN'&\E"Q)7K E<;1KAW?.^3G5S?@&,;"7*I@>&IV?E9.SBGWO'
M![W_>G]X^JYW?''<N]CB)/"))]8XXEL'=*6SN]/)^!-,9E]/AWYQ0?$FI"[&
M5"J&RB%+G C "-HG35P&2J*T@3O/@\G-:G4^B*I";N;]SUZD5?0!%:$1QA.:
M2JL\C?K2"V-)CF Y6%P^T.8P['%<77(SJW'FGI3.6J*IE^H2X_QRON@PM4J+
MLP>'T ] =9+.$R'!E)H<F7@ 1X05)C'.E!=M[K+4&D&G/+EF''P6>3<UA2<7
MO_3.]O;WS][W#I:7C ][VR3%//'$&J9P'="53.%B2^SZZN(MIVJ9"^65# R,
M(%&'<CNRN,_&E2*DP$S.G#O69OT^CFOKFH;7S6*13_-OSN2R9$'?, 56!4D<
M3C!&T2R1(%(@R63IF5 Q^S8YZX_CZI(YK,B;N\JHHG#J%<%\K-/P$ED6TB2P
MEKC(]%49E: I)5F8D*G((M+0AC8KH.M2GD9+\M065,T.O^/I8/8#&.NM-\8#
MR:5MCJ1&$2MH),XD:UGDV:0VRN8!0%U*<6A(E!KBJ.EO3^9^^'8\6?2\6PR[
M['/=ZH.WQ*>34BEHE"97DDA'%0G.HZ\5.74I"1]8&[JLCK%+J0 -&=1(:-5(
MM0!TCB9T\O6>D0L5(K? B7*EH+22AGAI$TD4*!.B%*ENPZ-'877I-+PA=>J)
MIAI;SF&8;TJ:G,$4)I]O;D2$H$5I^EMN1 @B-4W$,E21W('E,FK-H8UC\PBH
M+C6N:<B46F*I<[:Q]*YNK.9>^KPH@7/=HF!_[ZQWOA?1BE*5#9>*,!4X*KS2
MHC4Y2TJ/5ADE@EZQIM:J;URS#\U+HT.[V6^Z"W/0>W/Q[=K.T<GQSQ>]LW?E
MTRTV8IY^:(V]F#6A5]J.6;:".8" 80KGJ/>=(DE*5C;3'+%:&^)4L(HFD55N
M4Q;B-HI:#;BO2BG#HN%?V:YT&7TBI2GAO&Q7FAQ)D*PTM)!1<2& T59AS[V
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ME)+:&RH8P5 =T/1;2@(OB?8ALY!*C\)&2;F/@.I2VD0%ACR4Z[6M.*JG#=X
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MCUO82M=4#,VM-K08P7*'@'%)?$;_%@-X%B,UH/*.XMWO@54?=QDLRPJL!T>
M\5R.$U$"%@4"+ F,#&5@;D?[V.MWY]UMW+,%2YX,@-:5Q&Y"&&FL1^EQ0K7&
M(48OB=6H!IR*,3"CA6A\QO%T"/.DN]4V16 7)-E:-.T49QDB6($#B0FM 445
M[LI),Z.):  <.# $U.9P_VD%4F&$O_KA_(I=R]V'OG;",24H<=PJ(DM]26]3
M(#0#^"2#B;IM.95'P'6JO?G6='E2;6XIG78+XVJ/3!G%>5*1,%5":J\R"8#*
MP&,\K4I!9-FLV?G3Q^'="%3;<6-]$:R8DG+]>?DE^"G\_4__#U!+ P04
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M:ABZZ:X,WRRWW< S 2]*#P!)63.KL9'^[CUZ<X9=*^$/NY!<A[EG4R#^C[M
M,D,L5I#@9"02P!"+YA^)&L#2;+4.W9V2]Q[]!E6XMN0J5-[,1B#?-GD=SL:C
MSIOP6>D]8J%0[H8]DR2(P(B2CDKC-#4/\TZ[NJY_&M3.&$9=*Z!"@?$3T&X:
M;+X,KFJ9WK/PME.VUYDRFY&DA28VMY7,03(38@)O"(]3U])'$JC41,=$I<#-
MCX<Z?9&W0),7BORVPY)5%%"!'2^$E>:G(?,A!,$5X3D$(A5NS@YW3P(**!Z$
MPC):*:>C";RM3&_H2J4/,SHZUT>%)JKO_$6YF3G[ O#@-:%,ZI09T:#*B5L,
MWV U"3ER*XTLN0-5>/(4HIVS2SH1?87<Y&6X%N=@ V15+9*GL6W''.E&APV(
MT4(!%8Z:9Q F@2\ UPD]-8G[6?9EMHMTQ$EJ5:#XPD"=\V73U'C!!-DT,U:1
M>P5&3*LK2K?(<JM?1IG,DM#ZL.@+'$+VCF=!,HNE+["@Q"K)\=@#99FVFNLZ
M#0%?0K9YDZ,K+0XKJJ#K.LIYC=8__&<8HT4TO\Y<@M'&&(IU;B@>HY+Z5#*B
M%1KK:(8IID0.#QIU/U\"]](#W[SVJTEW,VT+3@^.]LX/WG_<.SW_Y_GIWO'9
MWGZIG3_;.WY_?'".WSXHI?*_'IR=_X)?M6A4L-Z#.FA-T,$*'S0CT$EJYHWW
M H045OGDE+&..PDY:NM[ZSVR2M[+T<W-=S1!,9E$85PFTG)-+*(GP2KMC(%L
M0IV\@)>05<KX:9S-4;HG<V,M\<F4@$0L58@1'8FD\;M<!>GKU/FU!+[YK;-3
MCC7,V:FBQ@J._!/P]RZ'UX/)^.1NG\V>D0EB+'7O%H4C;60D*)X)BS:!EL!#
MJ-/^:P60WP>[6JNG@BG_7&_>'F<@O:>&),UY&1O%B9W>C>,YE#T81EV= M/G
M4.T85SI30(4;JR,8CP%.$(TOK32G;9K/8719BAL'DQ&*H;0_BUGFTF$!MS^)
M.Q]Q#)<NA(HLE?YZM Y%7L:V8T3I6!D58HEWE[\_'$_&O12"-5DRW-P,*X-B
M5!D9HPB/I7S1&"<W</9,H>P8&=J)ND+'@ML&O$^L>_SNV[V?3"/J"@^X@'(H
MPZ!Y:9Y8A&$I^L!:!Z# 8ZXT"GD=N)O**Z[*G/J*VG;"\0MB?+"^:9A6Y*!9
MT)) ]FC.IRB(CUP1QABZV\YY7FD(=7.,V^^L78TOS:SGMGJK,G_P%L\\JM<$
M4=5+L\>8MG-95DN+SY"EA0HV0PYE2N<&%4DL$WAEQ(,Z1.U0B\(EA2\&R/K!
MGRU>DVV/$ZM(ON/D[+V<^Q?] NA@,.E/OLVC\S1KF7PH8]MU0<1PA_34$@_,
MYI"\T['1D-)&*;[+,6S7)EY',\-.Q5HA,/=\P_G 7(A",S3*+=KH2JM2RF>(
M#CPZ2 DHKU.7_LIG=FS*LNA..S7F#]UK9]X$S/<]M6,E=3T[O6$=65>?VL%2
MZ<$B$J%6 !Z &0_ 4CNJK9.&X3X9;=69BJ]V:D=W>E]%Q)T/G'MQZH#U-GJ.
M%I $%HATTI&@M2:2<D]=CI'ZAN/F7OOHAI7TL-KHAE6$V'%%UVUUH>":9<XI
MD<:686<L$FN!$RI E1XZ+'=HZFV]YGESQ_KZ4NXP^/VPC*T)C%TMAEY)!4^4
MT:XCOXK%T(:"Q^-&$9 )MPV@FCCT2HA(QN<4 ]</4]1>LQH;%4-WH<55Q%:U
M&#KP$+DQBF1=QDGPE(AWW!/A0'BN4C#0:$SB6RJ&7DGX3Q9#KR*YJL706GC*
M$331N!XBF:;$"@6$!DX-GAD.H-$ET5LJAEY;A6M+KG($]&X:S-2*%THF@[8[
MTX#L<DF2H (GBJL8F:0:-IR5]%U83%UKIL)%\A/0%JYZ W ;NUYY!.]5W;2L
MKLQF)&FAB<WM,0N0BGM0-!&75>G"Y?%MB4;B?L@MT%SZKC>RWMX"3=:[>ZG-
MDA44T'6(Y7ZJU"D,)O>+<54T7N3H2? >L2D12(C4$,.4X)Q%&L*#X>U/!%A>
M>-"K23U:1R?#2@+MNN1HNLS^K._B+!"T]WD$<"<4%*RF#FQ)E2FA(%'0:6^)
M,5YG*I6RGC92]XN/VAF%=RO43=48_7IP_.E@[_C]?/;FV>G!_L'AKWOOC@Z.
M]TY/]\X/?SUH55JTPN=W4E&T[GH>%!*EG+V"H")3!BU'&S*3N+OG,M=49Z][
M*SVIW:G]OC_VGY%*GZ<%<<7N_0J#:SBZR7!S61A*<2MQTZV$Q40LDXK$S(*F
M$8U;YZH<W"\A:VNO[ \'$0;3YA##P6E__-M']!/P&_XSL!ZEP6G4#FZ@W)88
M=2 N""!9,*&2LCKJ.NF0SZ':_&[6*3L>VBN=*:!*6<]TH8@H#T>7I7#T)%ST
M9V)X#^,XZE_-)#*?FEK2O\<]IH5Q+#.2E3=E8JHF+J'G2;5GW!<Y\48AKC6,
MW#7@[AB=ZJNL:[.XDRF]S@$/I5\_MQP7X*) D96$&R%9$LZ*8'PS8^I-SE"N
M0JGM:*=")LL3TIF%K9QEZ%OZ3%0*I9TY;BM6* 2H4\J.,F3^1D_VC6;V5]V*
M.A/[:TG@?W14O_MVCO]T&K) AEL$CLYE3,7QX'AF,ZI+HPO<2877\N&P[5JF
MTBVH;<6/NU/\2[;2F@JH$/=[!*T F_N[3:!5#1(_ VX[(>+.%/D205IJ8=-$
M"5IG'AAAD$LJ61D)'6V91&22"[@%>Y-W@R O!(>WPH\5A%^#%]?CR? 21H\@
M+C+'@BU&5"")&C4;(F^UHL2"QT53PX2HXU6] &SSQFYG2GQ(C@XU4,$97_).
MO(-!_'+I1[_-7@PJ331!$L\ B(02^#8B$V$0N0\V^$K-55]"]CW8(>NKHH+#
M\QC? MWB-6F ;[,6R0.$K\8L::'7%TG3@5(V8: \Q)DA "N9T8:5X>%!&SR
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MS5/P*CE%#"^=ACQ%>T][C5! *&D4I6$5C;VVM/*6&EM+3)LK#V!94:-3(%$
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M82A^QT-IM-W(YWD[\ZM6T<MZ\ZM6$>KFYU<YR6CDUA&FT1.3G@OBHS:$9Y;
M)84_9XU4_OKG5ZVKZFZ%6&,WOP[C>V/W=,SH6D<B$GI&DFI';/26,$5M<*!%
MIG6FV#X \GT8>BV$7V,TZ2V<Q<C,!H#JFG</(6W)Q&NCJ*>5WD+*=;>"19U6
MEMSK[ DJIT1(;"QU6I+H:7M\QA%:]<U@FP9>5:VO(MQZ9MTMKL7(3(5/3\X0
MFE*I4,"5>D<S_A4@@U(FA&9#*9]^QA9.\W;27VZ\M1)=U];:PHQ\A(D:'80M
M>:<1+9<<14FCSB0FE3*RUF37U"Q?^H WKLOV0JOQ:N[[$>Q]AD'LPW@.*23F
MF8RJ-/ HHZU<Z2L?)/&4A9"5430T&]BP_//?N!I;BZQB,<T=BW$6&- &0?'2
MHS2:LDLH8H'JTFPNJE2ZE*J-5:9^-Y9V%\JH6&IR%]8L&1@60;\& *M:X"]"
MW(Y%WHE"&Y"DO38J6.HO \U"!:8B(U8G/,%X9B1$\"1QW/U$YBJX.HU!MT27
M%RSY[;!E%254"=2/\# L61.I_[6?KOW%Q;?#RTL_P>_[BV6;[OS@9$(@A=&.
M34YP(H6CN (7\0^N0%-F0-;):UH7\:O(7VBC_$?Q_PUHKFL/9!DL3IF;0TO>
M>".H(9Z700% @3AI$D&G&=TEY3+WS:I$GG_.KE"A:Y%6V%^F!2L/=U0:762*
M1^)]+ PTHLQF=KC! @V>9H_KK9,3N03-=V':ME9#C1FH#S#-7X0FJ*H:L\MQ
M;<>";:^W%XC00N@;V"T6-VL@E64ADRR<1?H'1IS  XQ;2DW6+(.JT[%WDU1X
MP3K=%!-6D7778:V'D,9%+8MSC&J7//<DYRR)-"J3X!PC3*J2ADDAIF83")]Y
MR.;M@BZ4,*P@P:[MOF6XZ!Q7-LH$GB2:.F7,>I"&!(_N%K7*)Z6XM*+94)-G
M'K*;FEU'@AMX9V]LSV",S("VIZ2"%MO3$U=HEWAD 7<N"K;A3-FG'[*3FEU+
M@AV&ITL?S?TR.PE&5Z4EY[&_A.F! T+B8P%)YK1#II4)DL4&M8B'YL"XE(U:
M/S1J3KH,P4Y;ZYV(O</&( 7/*5Q=C^(7/X:;GNX/(<Y?@"8@5S'<&W&D,;S-
MVN_=:'*X*35TW-FX.=A@8W(^TZ+:Z::I<=,TBO </8V0332-0M!O@2M/&/A;
MI,HJTN_:;CB+H_[5U7B6)3$_[:AUP5D?4&\*B%0)W1D 29QG O\;9#+-*J.7
M?/CF[(2*.AAV*,"N3?P#I/GG0;FQ[Z>^'RWZ;B=<1G9,D506*:.0Q%M)B6=1
M1*O0157-\G^7?_[.J;4#,7:\F]^TC9GN2DQKM&]U)J"4)C)S0:R/DAA#A5?&
M.?O0IF^Q8]][],Z;?NL+NL.67O> S,G<!$KGEMT#$)NWWUJH8YE26\BRU@M]
MLU=!DA0440"F##F-Q%*D+TA :)Q+Q1N59[T>M3YC:M71ZBHBK)>G>[<ARB(T
ME)+5@FM$DDI?+Y9)L%D2M!^3$]H:^K WUHN9NH^?LME#N)7LEV?IMA1<I3S=
M@NH^*,MB"?N59A:EUY^.D?BD*3%.&R<DBH$UNQ]_Z@EO5I,=".S)][+:U)>S
M_9\/WG\Z.CCY</+QH$P]P>]-?WYZ\/[P^-VGL\/C _REDU_>'1[/?MK1>)CU
M']SQ')F.)/!@X Q'FTL*I@6-7#)*@P#0(3KO#$<:J5XW$"I.I@DT.!#<$R?+
M\$T1++$.[4BN56!9,JM$VE1JW@VJ3C)_NN@-7UH(7A7GZ\/U:#!M!H>_]J'_
M1_EJW#.X5?B@(PF&!SS3O2^]!2717'KP5'K6\*9P8Y!?13[2>N1;FHKTNG1<
M8=;.HJ=[+Z)T>)*2T"@9'C(E/!=-*J,( J,V*9WK=-M9(-@!ZK02:L7$Z4U,
ML8@9E&,>-:P%$&F+_U%2C64"Y9T.,H2Z*=C?WX"3-A1]K=1XY6-^3B9?8%1Z
M>%Z/2@?@^0*3T!KW:5-F'. >;@.4O'I/A#"X\! 5JY1!7GUI?S*^$@U>SR"?
MI0N\\YV>B-I2<(*$Y,HP=8;GET$?U/&DLW4A)59GI&^E!?W)Z4Y57B&?NM9\
MHN2"2M0%$K)'4:M<\@9M1'E+9Y(*7CS,S_MS)-7K9G*G*J\PB.CY_JPG^0A_
M=O[%#QBE\U$6RQN$?_#]T6Q("A@=* LEV;7,"D].$^LAXJOIH\C,9KVY08+M
MEK+;[-V@FKL>@[1LQ*L??YGUJ/XXZ@]'_P0_ZB5+G>?*DVAX0G/':N*9+H>$
ME"9R82P\\/B:1Z>6/&\'Z%)+NA6&(=78C\M;L)SW*$W*M0V"9*88D51%$B2E
M)-A2L!RY5YF^F9/YZ77N (?? $$ZG.HT?6//AQ-_<3=3IL>"3<GP2)@K5ZH9
MJ>4X*$)C\(X*;A^E#CVQ]3WZZ!U@2 <RJS >:>7<IQP,U2G',K9<$^F8(\X:
M1A)5,D@=C*HTR.!-MI]OLY545<UK:3__5$\.EQ65NJPE1D&D2;D4/AK"#'B3
MA<Z9U8T=OM4B\I5(T+ _TBK*V$JCFR8 _^R/M*9"5^YXLXXVMD(;9A2SS$H"
M*9;D0(_>9.*.Y&S+@"FM-:T;^'H;_9'JLF45);RF_DC&1Q8D1S& ENB)IH2X
MDR4!,LL4]UG*&N7)?]?]D592?E?]D5;1W).Y)9WF#'X\+:EIY__<.WY_\%^?
M#C_^<G!\?GQPWB(9\(5/["#+;Q7,#]+WJ->4,G1/=> R91."\RH9J]!E-=GI
MW@N?W7HB+!I@DV\?+W!1Z'#?)"+=FNU:QBPA*)1I\D2R,BPY*$$LC5IE]-92
MI;%'+V/K8![N\B?\?30<CWLR*6:\=$1I58:-)X5[/3,D M7X8J@46)V(T_.X
M-K]W=<R2)3-ONU)#A?2WO1BO+Z^G4_+>P]4(8G\:R<*O+V J]D':NQR.)OW_
MG7[_R<7T/)4)2E*VLE2A_ZL8<50JP@*G3"C<_"M-[NYJ!3M'O*VHMH+=]B2P
M<KVIG4/;U%(B(K.EZ3,C%B)*R7L0%JC*#T>OUM[%MG(MO:T];%455,ANN\MM
M-/A4=#D%(HPT:/!Y=& \,))]\M8*C?^\3K+]710[I_ZU15PAR>OP\LKW1V5M
M)_EH./@\S;B<7;'\#!?IPW#T:0QXJL9DO T$E$%O@Z+A'P(M.6E9H:<10ZAT
M&C6"MW,$Z5XI%9*J;@.L3TIC%E@5PG,PW)*4%9YW)E/BM0-B-627003E*XW!
M:8AP4Q<>E5E312&OY;KCR26]^W:.'S%K1\X""YX:PE/ UX Y2H*&0$J?7R:-
M%<)NV 6[!;?]:Y N2='4GEE3.9NT>@O Q7B"!A"K7H8T +F=ZY#.%=R40"VU
MLR4B\:"E8CZ0Z*>Y5H(1GT4D,:?,RU0$&^K<P6Z-0"]<D+P&_JRBE J\.0(_
MAB_#BX3&W6CX=7HZ+N+J-O DI,B$L=++4GA#?*"4))ZI#IER4^E&Y!E0K\BH
M7E>)PSH:J! VO%GJ8H): &4I&!)$Z9&ELB7!1DD$6.-T]*!UG?O5!T!VCP1M
M)%UA5UA6PGW3L8X; =01M+R*>V<-<<)GHBT8AI SBW5B+T]CVCTZ="3_)^-P
MG5YV_OWDY/T_#H^.]H[?'QZ?[QW__?#=T<'>V=G!^=GQP?G>_OGAKX?G_SP\
M7OQ>BUO0=1_5P?5H)ZM\<&\J10!P/D-D0D;J/'/& (O,.R[P.[UU']I-LX1;
M_Y]SF[/GD62/.Y&4.N(Y%)'5+ D613F8ZG9-..KJNG3Q@:?#BXL/P]'O?I1Z
MR=' '<O$*XVGK,^&V& Y22&Z(-'-U,TZ)*Z]NCM@-K^7M=/V4STAUI5OS=X?
M/BL:LA>$6Y=Q-:"(C4(3:PW549;-LU$O]+7UO#WEKJV.IUI^K"++"@;*37W%
MO-[B_?6H/_C\$4;]8>JA2Q9HD)SX5+ I!HA-<6*H5YR:1+6L8Z(\AVIW=-]:
MYA6N!V]XR3RC0DI%A"X>DX524"@LB8 P(C/ *UT)+7_'V]Q?+#YQ%@@%X0 B
MIX1K6R[D@BSM=1)AP4O<IYFDM':=QCU F[J=Z/9XZD*ZK^7NX6SB)]-/7*1&
MGLTG;\^3?'.T2AE"%;X#DO%,K(J4!!01.B:X#X1*Z:S/P=K^?4,+O3_D4F?R
MKY(&/<5RD\'_,IBJ5PCWX&SGLJ!#=3U*7&XKZ^H$X,PKQ@$W20FRC)!-Q)K(
M"4LV!.$]5<*\5<6_$.3?E-Y7$7&]CM)[@S3OK7L&HZ_X?XOE+G+E@S7)\6*R
MFS)P@COBA(R$:>4LFH TBU7;2[_PR,T;OBWTLKS;=)="[;KU]!D,^L/14?\K
MVN++T25 @Q_M;V*<I24AIS3&3FCS:Y%<T"IZWVR@QXN/>K.J[E:(F^E+_7QL
M\/#X_<&'P^/#\X.CPU\/'OU&M1ALP^=6#\BNL_X'T5DFT*T(S%*ID@P@0DJE
ME:EPW"EE!7\A.ML00<L\R>=[4K[[]HO_G^%H_\*/Q[<.5,A"B<P2 1I<:;H3
MB(N^]"DPWAL:E4QUHKGKH&V=2?K\,P_^B!?7"5_[FP@"]9;+9'4IARP7_K*T
MA\N<1.6Y+RG0SF]%.H^0;GZWK<ZV1QFG-957(=1\ZV:^@'SN?7KF1#*4>(I_
M(%I&K!">9,:B"BBT[.K<IZ^&<U.AGHW3JZ*Z7DN0: 693OTA#XQ1IC)QDDY;
M>>-7CJ$QI7PN>=W<BCIW)"L"W7X@J7O*K+;YM5)=A8##"W!OP=X9NM<$<M6X
MU!J@MQ.]JDJ&U8C7F29?"0E-,C9HY@B#TF&'^D "5P(I8QRC,N8<8+?)]T($
M[;5S;Q4%5N#<^<@G*' 6*5K1@;"9 8F:3<-!B,=I0T3$U1NII(4Z>=8/D;PZ
M#Z&]^H8=RKZ" W#4C^6E&GR^&3=[TZ3$9<&H%\252R;)!%H"'-\1SDQP =T5
M)^HT-'X2TNZSHQMM;":<=W+^\\'IWO[^Z:>#]T>'>^\.CP[/#P_.CO=.RXBS
M7P]:1.R:?G0'0;FU5O$@[N8$R]D:X00(*1GS5F::1*3*BX1G1Z_I0]J]RI\&
MU^-K?W$R.ASD$?SK&ME3/,Y;SU,$'3,$3Q@UG$A!);&TY.I+:2-+'/!;5=[H
MEY"UZP+[!?:'H^' ?^V/KL=[_70*%WW()<D97=3A93^>0;P>]2??]N)D+WWU
M@P@?_;?IRW4*$<J+W=,A>NYC),)/T]>=(2YDB5MQ5HJB/_1H L%3C6,[0+/Y
M?:Y3ZMSO-[MI[71]774*5S,X)WFEM7RX'J1QC\O@J;61(/Y,9)"E0 (70KE-
M91)I-D ;\:H5C%TBU.;T4:-X[;:U]NV4HIY3>(C;F DU%BV&*#D)VB7T000:
M@#19K^OD.BR%LR-DZ4[D%;(_GUCQ+ 2G>52XL6F22O&XU%*1D!@J+_,459E<
MZ.KT>7@.U:9"ZE6YT)G8MQTL+Z.M3V&\2!2:#9JGI5^EL 3052 2I,--KG1*
MU=3&E+F,KM$X,/SL.Y3!OSVDRY*';RNXW9U"A]T(ML,SXP&41;_2!F!6"4"O
MJNUMA)1;*V6Y<EM(M+J:3:EN0+.6<&$\D28F$KBUA&M 7Y-:E3-[:^I](FA;
M5[NK"+*>5O?2_UR/)W?+I<&FQ%4BVI:]B>-1AB9)1JU8#107*5BCG(V5-^L'
M0#9G['6@GB?VZ#:RW4QWY?<'[\[/]G\^>/_IZ.#DP]')\=_/#TY_*=]M$21[
M^4,["(^MB/Q!8"S2+++A3JC T+=BSGCA O R4\9IIWHO?WS;)HQA<C@8HREV
MOSV8M S 4T6@6)+2:T>L$8DH&@W($"#K.J-3GP#4OMGDW8_=]Z/1MQ)$OAQ>
MHZ\CDW<TL818N"0R&T.LCHHDF1/5G"=:Z7;G.52;]S*[X,+C#I0=R;W"S<Y[
MR(#.;OK0'Y2@VOYP/!F7OJ@2=T3P3A(O2X,R789U4:'1$V8A<VV9H77N=9X
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MXH+@)0/(EJXX49I&W: VQ^Z'2_B3T1M1_F,6ZZVQ>.YIW]AAQ]=%8?,D 73
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MDA%YO[Q,A L,[1G -<;%F7Y2K+R!3AN+EF2Z^/=GI2P;6[:LO:6=6]NRZX$
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MQ3/V$6;SY6^/OD[3PG8?1:XX<UR0G Q"VA6R73)$1P!9ABW))#NT'1ZCX3!
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M_KY#B/<B."8D/@UEJH(7ECB+YAI5UD@3%8!O5'';3(5WO_H9JG!KR54I9;U
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M40Q33SY2/<)6>]X=8:&&.-V<KN)T%Z.4J&@AG!@VM"KV]F%6_1L2]<>*./8
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MC[3HPWU&U2LL$EGG, %8']8^[I=S.QF=Q1.E1>&S4V$J:97NK?K&NW;\F&Q
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MB'TV'(>>_,!R3-_Z6H5_:#-GQ#^D&;3T_TT@RN;\F^*#0XIOX2L/YKXF^8,
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MEX_36B"];-A\11W(.N4!SE$=</[=W\\U<"/'%DFYE\"9;1D_)7\1ST",P/[
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M0BT</&$WHR%L[MRI [:'N@BV[JLZ4PK=MN;$%#B9FEA5353?.C 3_AT6(SA
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M90>Y$#&4)##_(; )<&P)XZ-D*S?ZV1YE G6:Z+,1&$9]"+FOY@;>#67ME."
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MZ456]^[I'SK\3-CQ"5DN_=49E\_'3X6[NZ>WM^=OJ,7><]K8G*DY,5!9\;F
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M;"'&>/%;A4ZT[P!].86Z#VK' *% &Z+W5BR(AF@H-'5XUU:":75_?Y/PO[<
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M,SH4?H"&<7L)39]NB"@.N"#SHBG0!-F/W>'P1 2U' ,FB&61CU<M8.F_M\!
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MFJ6/O:9'1^1@>1@O]'H\E/A\L85E3>3>&I[%YHQTSV]R^*>!01U -L%;NKA
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M6ZVMHV98M:W_X5BU0\Z=X@DZ]#XZ;ZATMSC+KHL;630BFUXUG#^/Z-4,^K.
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MU[&J?):2+^UL]NP(AX6L@><9S! V..=5B');HD-71UJJ1UU177&\D<L/0FT
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MYW1%GAY>0\B2K"Y#9;7OU\3C=[N]FYNE%,RTA#\&2_]"<K(Z&Q1H>>31%I2
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MFC \03Z N:9[-P[(^3XP?&\927,\W^[_./KB)=.Z&Y2#6WZ6CJXL(3? H7D
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M7FDS!4 R<'3UXUSED5%5@DW T -:S7SKL^_VV)9%"3+.?;);<F[/K*SL_D)
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M4_#(J>W7(VYJS/2Z8:7O"'M_QNSW7(DMJXABY6_OMKI!4;"(-L':V@5S\QJ
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M)KWH*+,':UJJ^][K+Q1(E1Q?1;C;=D23/-I-LCMW?KC;_CN.'=$+'2L R'.
ML&[ +U]/@&8[W1.?M;F6^;% ?(0Q33FP\JT.&8%E>OI0?-;--6[I@];ZT&6Q
M*-%X\6>SUMHO@H0@Z6"!Q-R"8UK75PA])8:^;:QG25P'C?!EA2T8/&%T@GG&
M2Y.=Q<U'2_#&L!LAORLT9#RP81'+$;3MUXML[/L5NM]R>[IY0^1!EP=7U1Y1
MM&YNB._:,<QYC<#L6_O$[R%L=( N>+B;G?WYI^U7SK;$*+I,_]BQD2F%+&UI
MT^6';4?A=1UY-4\$M3%-@ 1 ML)?A,.?"H;\:FA'53JV#W)@3;:);0_"J]/
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MJI+GU/"$ E81.[NX6<!\1! <#\\,I'[%,NU*0543F.-H$M\Q#-@W+(9SC<!
MFAE2<@17+@UZZ10#1UID?C1%7SV45X]#K9PH6Z<]=$'AM>CB;6YT(P(RY:9A
MKJ+6\SZBQ F:WWG[T.N9)5DTKN:EWGIUG43WRO)J,X\,CVSV=[T\Y>,?BEZ>
M/67Y!(&T_8O6:?]S_<_U?^Q5M(J0 5\=8^I&!& 4@EZN(N;?.B45=(46.@:?
MY9G76U:FH#\+9 H_IQU3W[H.=[R>PZY<13RX"#Y>1;AQ[%<1O7(OKXZZ#'7'
M%VNA)?)L%[=4-YZ>)@+-?0 <'59T2+^O7R-""2;0$0,V<A61 \/5M+;"541[
M/_C#* @8?I38">/_?4PD&'<)]GYT(4"%\<-4U+S!?[YCP4F"91T^62H\D[V?
M6;R*&*YL<+6(Y)B_7<HRG MVE3#F7-IPZ15_)")^B:_TW6TNA9NRBOC:3Y!;
M10RA>X"?D?(,LLNLB]OGE+ZR9;Q06W"!)'W.JO6X^+E87*JI-Z-X2OF31T[L
M3XN^=;$:Z=&+OQ+VG7CSV1#S-,N*O3/.888^Y;RO9CF0U$$ZWXIPS&D\OU8E
M":<.RR(2]9G3$3".VKV!\(&@RWR"$:YW]J/YR%US4O_\DWY_]I.<C$-0RG"P
MO6/1(]TF:/:8(7UM!T0CE=*$!7<:A*_5E=@ Y3;Q^KI;P.53;_LAS2([W.W+
MO0M:VJW-9H8IIH?>"UVLOO]P3]K4\<CVI\CB[_DMO8:GERAEL6'OGS#0CQ?/
M_C^VH)=((P;L1W7<), =D"+T^D%J_?787%#W1-T WL3UV83#B8#-$97&=OE&
M;_Q-A=M*6D^L._[$C;H5^R63W?89X[4XY'>*^Q*&-OOLF=^2Z0G*').FV^[1
M^F865=?$B+MW $JF$HA6J80/9[=*;-CX%.F=TWB6&X>A%OH2ADF5!:V8H=QF
M5#DEWE#_!7[+8&X/%/HJ*-RZS[RXZG/"#25;=+>O\N@&CE[\QG/KJ"E""*XK
M3#,O8L2NV;Q%1P6^G&E$U?5[:S/&3^EURNVP*WFT*?I3EXIOI.L[G=DWAJ^W
M?A+HT)S6!=5,(*G-&&HN:3UDSDH@;'("Q>L-6"AKYI.W:GE%E)"#*90.I%:"
MA(:RS/U"H[U\%4K&W3(8'XN15801-Y[DXB-.&'$2 2\"+,P))C=I^&MX\]O^
MO$ICE-[)JY[?\+^/?10QVMHUNF/K)\%/E38&3!Q=%M+NOJ<H!19SD]>.G AA
M(HL"?%Z'YG9Q#(:]>GTT"?T3-82Q$9L#'P5/S_R'AR7.>FHSW&HC!TS'E+5>
MG[R@=V]3A$+TI>QP%:35SG6G-;^1OJ!XPMM\.3?PI\$1YC"'*E-(/5P:QD-C
M1<9/%,W=6@Z47?IM-&SM<+GG^(8#(EI/PT1IO75)(X'LPDRV)C?+T(QS9@)2
M&C#$/@,QIL0+K&WYX:$XZ?Z&)QKRII;>;@ENPW6/7ER^48!XLHYO[J%-/(&"
MK6HLY;CQ.M^J,\QI/G<SNJ,J)Z2_^UX;E^S59UCW,6S8O84>CZ&HY.WC^^_+
MQ?"U'=T>^P/X@N,)I_IP_*#;8"Y3H8E4/AUOJ.O']&EAT%81BM<:E?O]^P0:
M0,]/1HB:VN3I]2-EHPC'H@)#^AUTZ?\=<>KKV&_ /E8=%=,T9R&/Y^.F!V#B
M,D9Y*GT_?T.Z>3BF9SG9TY"LUK#W8U&>\_G:_(/=6K%R@Y\]_C* E6;JPX2X
M&Y(D-1^:6HS\U3TLV][0M_"UNCZ*)W[$L?Z-JTO)&X?CHEO$[Y\ZDA"JCNU*
MIP"_=13WK94_P""J]['FZ/N]'7(/O[VL?N-5]78E'\\&,EUNOCCOGX(?;%CL
M'<O X%81M"42TYRT<F 1JOB5Q#N1RT.M?:D.-J9<F%%W8FSA2',(4LUI#.?:
M=*XB,K P!_EJD;&*</BA^S5J3)=WBI?<N)[W";.1Y GPJ;? H<-)FS?RZ6M=
MRI!N(]G7Z[%KVZ\A7WF,W%8&>1Y77II HMZ;6'+>#[#U9[$K$C9#^JS:8;%F
ME^G3AXVJ"I>#A'^T7BX<R%XRK?-:Z]G;$1 A9=/U=A"2XF]!ZX$SDQ9WB.6Z
M\WU%D%4CB//;3&S9%FQH=.6YI_W57*WC5_J4LJ?B')VTSI0J*07[^A@%7TS\
MQ/<S59I&+)MFO,_A#3;N!".H08V"X,B[0]/-VD[=IJRS49-U9A[>.0W9$PR%
M\_-]YE*O?QNKF?8:FYZ\FSY%1D__JW1S:J*"TD9,6$5(0\XL]:/@&X[.+(#4
M6T5L#!KP4B:OM/)( K-!I+,G-V4\-Y4HK#;I7JD9-4%44V>S<_\UQ%(I))7)
M$XZ# 2M9+X=YM7@2#N&O6GFZO?4A]#D?$1"6;M/M2.*;7[A[@9'#IQ;<H_-9
M6Q\1;+X>U&PC/&2>K: [ LW6PS5Q]=O4[@)['Z ?:/^TT18TY%<YF;L5\$]>
M\."WCUU:3%I%R*,-(&WP+K.OB22,N3)F05FQB,<[<-,G=<5L<4P["G4.I45B
MQY=UY)6<WYZD+9R-[*K-P;SXQ&<$+[2\IBT)7J@"_@B]P6:2.%]7"&G6?8("
M"SW>*F85SC&O;2Z>29M:+U^NIY&C0O2C*]>6IIV=MBHZ>L3X+[IW_EM>?TCZ
MKS[ANDDXB]_ZV!@BVZ*JE+LC(Z> .?&L&?Z3]NH:4/7W/B8]=F=I"B;A. GF
M7VXD^$\C ;9%)9:[(Y(DJKF,8IO]8TSWM3&-X#&WX/H[2#&Z)WXM;@2^7HE=
M1:R#NM<:BXY@;@OO?.FDU*];:2XQ?;$/;Q!29+$^)*=/;V:[W0)R^5RWBF\X
MC_-BLAA!,%K;W4+OP7N!/JQF]E@?09;P7E$5C,'Y<IS ?(<LDY,LG027M/+0
M_&-3>R?&WLW?X+]R[-)6]X/2KUC*=(.6Q1@4TX\$ZQ%OR<W^18H*M(89&F0A
M79U5/'?;Z\>8"=OKU.^7 [*2.?$IM2X*R@<H^K.K".8)TM DNYW[B*=%Z!U$
M50[.)]!U!696$;*-AZ_Q#C+;BGWIH>M6MA0MC-O8ZLA0+#,N/'+F$U'0P2Y>
MEM @]&'7 5X6L@#Y-D&(,-(HS(V![%[A=X->U,W8YHR%!F1LO;Y4WZACWHH*
MF]UWK5"S:=,GB4O*-.+&TW?>*3:X<\Y#%[FO2=0<K/0JPGGQ+E%FD8 *<J?:
M1%;:X0/H).3,+5G[QMSBV9[.(U5Y;SY[+7@Y5T>.RWC*/4TQ26T*WV(\T49X
M3ZJF,$+HJ.$H]ATX.-GAW5@3D0L$+4BGI[C^&'.:GC 8(6(?%'6LSC;C8&DE
MQY/QZ=*[/B.I2-E8 _?VH\KHJ_B)"EV&+F<CK )[W@[".$: )X3#2*"E>)^<
MY/HN@\FT"1$GNY(J6H*?1;215]!]1PL)QY%#P7?O6<E)+ZAXU5F>8&,J%N=;
M62&FW'+"(7B<"VAE2+2?46\TZ2,TDRT-!C([-EN<]7+2EG\OG9<R>]Y?*[?V
M[1N1[4F,]492.^4Z*Y00^#(FBDU>VW<@?,8RCZTBP.!O<9PKH'N3DQJS( )O
M1X_+0@_2BA.H+*U#UKDO*D8N5;Y4KDR:'\@9UZM)^L#]DF;ZU?.TR2?"%U1-
M("2U2"-!$M-D$M.^5 @?RKP5\XQ,FQ *BK,#I9VI025%55Z8\QD=0DJ9%VI=
M_1^DUTOP"[>4O5A:1=P^_Q&&G_,6'&7"*)$?0QW%2@/DPX:AG*U!*;JQY1"&
M18S48TB,M!*VI8@,514&V&DOR'R]1K Z@1JF2RQ>N2]Q2^6.A!S'GM".K=%M
M0X+[1YIA4SN+W4"@**H"<4)47:$@E^43M2QLE'+8@*/2G%E&2-J;0\2'GTY5
MIT2S]YVRW?S]3MA1=#+WU2K">X2ARVYDIL]CJ!AIL*)I:9:T:9HU'0M=I'9'
M&1#4^AEZDT%IUK<&TE[;.5%$.C'9W7Z^ZY.5'(*=13Z6*AI DN[L>.Y;0TO.
M.;P]-W,5X8D5"1II!9"&&.G\0B9Q,BJN4;:;ALNZ.7XQB2$?.E4Q/-SFO2/%
M_"5KI$E%K(.S/Y62#@NB8AJ2PKXC5B')<-).GU?E8("F$Y-'^&F904@ZY5VW
M!!C9UKML]2FASS&G.6#3TDAPV<=N-2N;@[:G[ 0?;PNUX,C"[+ZF$>WDA'?C
MO@+<HPDBGIH%W*AF8#.J=3?N4$1+_.R/:P:#8DJMLAN3R>LD.N1O/4SY7G8'
M9A<"-U81#R_R>HGL8WC'541^R,O?KW@;WW.,>'V$+;#)6$,;F:N(" R5Z*3/
M4LOT9"ZT'=:^W=S6J!"F\+WIR>GDT6M"&OS?OQ?/:LZL'?:YQ]L-G>/>:=3!
M(T%QIH,-BQ1K&,J<=&".)Q?,W,[/O/JZ.^2*=KF97LVR]?>RPG3?8;O7!<)G
M]W4"Y!WU(BP..PA^* XZ &Z&?_9G"4;48YF+Y/LS@<-ZPQ^3@KD%>NC+J"MI
MO2NVK\DVBGZMX=L%M[@@T';P74)@IMT 3!N>P29QKEL:'"0/HF4;,NEM<>C<
MG%F#M!^=!37IA6F)IEYC=)?:K[GE*_)5,+DCG\#@B,,C[-W])"_4%PZ]NU5;
MI+7FU8MK@ A:QH-4$<$KHW&O=@Q_LV5<7_PEIQ=C[Y!92Q<HJ&ZHB13,.K_^
M^!+& H8]S[E/@.N8L%5$#841S#)@QW'C(3,:<0-TFS554DS3=IEL12O6G9JG
M<F[O'3?R+.S4.SOC*[Y.[_[-=\F5DM,3KR?6SA*BF*;:.LL\H3XJ\8M:\^1@
M\S9-QP8@G"2U'4R]DF-2X%EC@#P0?MXTQ?1H0IZ[5]G"^K=&T[II%_B_ETH0
M>D@UBZT @M>=?6C 4 7COE99^:#Y4&09QS2HVYYXIN8S7L3/QR-GO&E+5410
MLGK]U0V>VQ\5G=JKK%W;^X^CJZ. #&S&F"149<'\"!S]6P"QGZ1PIWV]SLS_
MJ[WK"FMJB]+Q@A11D2Y=:19*1$ L,4$1$"E!O5*%7*03,!:$(#$'I4HH%Q"X
M@A"EBHI1*0'!!*1$1*5*22A)L%R0:&*)1U.8D^>9IWF8F8=YV*\Y.WO_ZU_K
M__8J47VZ+7OM1:_#/"::S-NS3S/BUV\Z*OAEIER=:5_BOS>XSIV["HLKN$KG
M'\>I2F>,F[<Q.J0J$)#P\!X]FUH:@I^9U13S^XP_^/"=AC9U;5N-O<^@ 3(T
M9R&EF360FV39)NR -BP%MXFN$)1E"<Z0=C @VDD'A;[SFN S5.:/U]L"1KJ2
MHA)R)_=[CE0BY\S4W!UZ2OT7HV[&WS$Z_<#,=&A^#0?%]P:1)D!O"2HN/HB#
MZ9\+Z_X]62PHX.;78;D;_MCN-0M$9GN&Y=6[J>G,M+RX?32U*#=?*\/:XSGR
MX B=/<K#8@11_1*W/M_]])5/M1ZUT3^?1MRR_?>%WNY1AIFM5;'";$?,S>GD
M,/F(YA4(:9X+TPQA-[\ "K:%I9)B*9(XK%<FR] GH 6X_%:4RNEEJ<D8O,D\
M+;#M*R^-5IE\;O2IG2'G!DQG:\7>AV;$-P#_!%Q'5M&]GRK6Z#PMN>;@=8#Q
M&^BM@*^-?AH7@AJ)B#\6'?F'A["0HJYD?>3XG=,OQ^V:"W:<.O4.1E[<QM.
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MQWC?KY8N5<P@R]=?@X,WO-)ZQ<M4ZG/-=%&[; R13 PYUYB*X=$%Q<)SH(Z
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MQI\-O1OTR;>P'ZM_K/Q.OK+:VZX>TYT9/;X7OXXH5N 7A?.0@79&T_DNJ@I
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MX/C@00P*[_,>JT3#,*+I9[,$HAKW-1LS/2OR[!?FO"\6C5U/54U0NI/\T>I
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M)%=5(+GJ%-T+DF<DLDL:)2G73_4WNN,3+K^</WV'G^NTU)VIAP]\+AAW7N(
M50:LK-AV<:96E@%\:P\F'D7#OM8: \\HF(E.^29US5],\L,>$IA?3B*%H-_/
M3H^V-8BG>%JQ<QN-<R'CH]T,?$*M![GZV\^8L9K2!>Y3C1WC%V,^F'VNP?M6
M3* 8;NQ2JGXM:NS^;'<,*S30JS/$ &M86/9!XMG$;7_OU_Q*_=2WYUIF95?Z
MD&14B[@Y"==&E,=3$D"99C&6,?MQHV%I6 +BNO']BE?B?77N^:19S&EI/WRH
M<"@)3S$-@45O0)6T18H 2T(;E<P!9"]#EPBB82[N=-N*BN\7BM2$_;2N:F#%
M7*G[^8!J94!PXR&![YVR*PD@97I1[ANI\DDBLO!N.CCOJD?R/1':O3C=<]UV
MHMLS)"&(ZOS9PZGX58&2:9WA/4J:.O>4O("_2 M]'JPS9\F%3N-;0I))7* O
M.DIN2H8NU\2T_E;@0JN/Q_K,+/>S=OKDUU@%U7:,.@:>5]\YZ+5>S;79]]3S
M3.WU/-0LG9F*9!+M*(F K^Z>WTZ/9;R 2IC2$_ZK?:UX10[@'9;8\@.[5S7D
M+.N^@#PCM!WMDXVBTE_HV*AX\U8Z<"4TA]'-6<HWZ',V[,A&><0"RS7?G0Q
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M)BMI'GY?XG/YGHANLNTO?:4$1T NQPD=L/P@UE'&T_V[F<2'8E^+O7$H5!F
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M]U/LX%B:^E>2.GV_'?T+TFUNS4W0.;+Q+Y8]'M*?N.-/?30#E4!#30K+'S;
MBR[#.&L;&9=7Q-/_)[8H?ANY-I:5;=Y!8FY6[(,S#QSG"T6B^>^F</5[(,E?
MF%3HB3KT<PE_U\E&MNB6DXT,\!<&%QE^Q0%^7"*+@O,/_<BK)T3Q=J:L6=P?
M)^G88ZP SR3F@A@'""WY3D+BH/.QKTIH<V[$/WJ #T+&V^&#]V<P[-NBOAS
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MI2!2$#210.X:P?]Z$4#1(?UQ:ND%JH60RR)T&J*ZB26LMH3-9?O_*K"1A,I
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M29-8?W.7:[2&F"@0*N.2@^LEUA+G!YBG(%E8$]=#4L::SY9)*:4'7;P^/7E
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M[)[2XZ7BLZ([PC<$C[P^L&T[_[=[Y;JS6U0^.YSY,2%2"@@,$&G!+C&LM:=
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M7Y@XE_9N>Z+^;>'_9)%MH=)W8&@ZJ-S-_N0%%Z/@$#JI%S<3K+5% )3W'1
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MA-G]'ZYS/NS2W6R >%F\ @PU./Y"9FP8ORXXZ&><D?I$&WWP'33I^8E78V3
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M(1JMZ)<GTJ:@);O2SPQ5^PYG:O5P7RJ /^!]FNH3>OJAK_#Q.-_PO8L^<S2
MS[Y9)'1@J98U/M@/.1QE@-?&&>BBIVK1S=U*%HXO=O8M7SB,;=M%S%V%UUX;
M.['>9OPT6O&>)L-J7;S+/'8&LYV(MNQ<JEV+)TCGS00K8$PKG9G,2Y_$Z6F,
M>XCM2OT\OW:))Y]YF$:'NK?-8K@[B:,K-$1:(X N"JKJ/] +JK$IPLL3V$B]
MD7?0B,C[DRWWRC?JDA:N.TU+=8[UGXLV?Y.?:+CJS!0:Q<VXBFZ&5=-M43W
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M>7N*YN6-.H8[K-\,")=W2(QT9( !1A""H)]^A]CNU<$ZU2G_4*V?55S;V5K
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MKZZN>?Z@MJ;VN5TTS\0#0\YKC%D 0 ,POFOP;(R[===XN=&Y+*?N\, Q^^G
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MOHZ">,GBUN+"-#PEX=E 0]J%DM<W.-,]DW6G=*<W#\:'UK8S.0PA+-"P_\)
M#(,^^)P<LGYS$%FD L/4]TU9"+QK/,D4N: P_Q0NPY,F*XD7O\R?P9S^_H:/
M<"ZG;W\&ZC:+D:]>R567PS3L%&6?>D\:@E1^5E+C2384D,3DN=R$<HZ6<RON
MS&\9/:E;(6;(9X2QTRGLFO5 <.)+6R64;N'!Y ^W)\S0H+Z5H;:H$M+>N[Y?
MOCK.=$IE("8KN/F84$[N:19ZEME9FYV_!&)QM3$2J-/GE\7Z?FP18"MG.]W2
M#+G&-ATV7B]#W?GY2;N&\<\$V=*Q=FFH#Q?7^O1L7EHBS$8%.*JE;!Z(&<C&
M9[KH.9 X)^%7_&'(- ('A,3$7F'IO[)B%F6/ENW<4=$OG.=SC!Y=V9RJRP]?
M:&-E_S0?X%;1^XE(2WP%?E Q.X]51*]A#3K( &W61,$ST?QE?:U'<\]WR@\?
M*Y9?4[,X?BMV:T@_<+<XYYD&0!4*(!DM5GN^F51>P'I:O9H:M0S&9_I+%4=P
M0:?<AG(7[TX2FF6OY41+#JE>^]]U+5.%*C$+Y@"9)0/87/0.00C&#SWM/#<G
M[. F:Q_;Y^?\#CWT.DDMH/V1 #)><N1]R;.UV[IW?%V+!?.5?>ZCY--#!-X3
MNG 4E7,LB%@$<Y#E', DD!@F,7W&;U"'\<^]@E/K5ZF&TQ Q0=T[52;7YUE<
M(4@P@9NN=XF9<$N-E3*&UZ',+A9<94Z=DF5^M\<6&7(W!98_W>(7R%^^#.XZ
M TV:9L"L8>UQK'A]G#W.:"6R2U7)IMY$<"XHJN[+7/)D=B9]DA!I@_E@,'!T
M\/RR77]<)/@@-0FRMJ>BX\#YN,IK8/T)S&>#;G<A,%</Q=V[] PNT"(&BE=C
M";XQ1M#([P]U]YY_^4U4Z*JP02L[&?B ,O?CG)C^IM4SC!,RV.+&R^/*#6(1
MZ-L5\<HY7SI2K6GW[EA:;KT9?E4=]^%+-AEXYR7!S**7WH@&DYC<,%K(G6BZ
MCF&<N$>'OH'>Q!9]?$B0P=C<W"K==6&L1^AZX.'+E_0@*;>;N_DV,O[G]\KG
M=8*;")',W\P#)/R/W-^2W)"D$#68(C1EU"JAHR(!1DL&G"",8G%0IF!-"MY"
M195^;WQL"[/F#;W379TX$K>)A\M&R<=7#@R7^^_ESC]#W94P]#,H9A3/R<OZ
M3]T13[<"CVY3=G[L3.(DO@OFS'%1)A6N:<_!H\L+(O7&S\8\7'O=7B:<)*<=
MG2BSL'25BUKNW5$EP6<%SDJXBO[:)H+A& MPV>!LK:UYJ+.]YE5W^5RLEW!Y
MM\3[=8,"?<"_8G,<;^._USV'Z!Y^3@9JM<+V$QAQU2AYWP.H4-M(^=>WNBWC
MA6$ZRRU/\P1LRS]F5"EJM^\TFLG\KT5MU2\7MH/9^_&7"#[3"N(HCQ<P+A6^
MHB_6SG5>=$[9X0:NKJJ*4K!2\UQOK9?,*M.GE*@FM1+_X]$ (W1CB^=P/U=D
M>:"C@86;XV@M/.\9]4[2F7!3S,/F\CD]G^.Y5M5,>L(1YVT?IFIHI>3)4)^U
MDDSKW")]!M4<C]SB0P\9<,?QX27-QGQ*!EE[E&7AW\C P_74I-?E9UF?MCZA
M*;E_*CXO5(>F%VR?26>$-B-PN&*31EN,)!6^U>;[*]T=VQ;A7[S7]T"U^F/C
M>LFE*I"G*1B9=N2>+0+O Y]Y]"#?/PT;@5'8CL =RDA/F:/DBK9/K_@,ESX,
M5<O]ZZ /392UZ$N/ALC>K8N6SF60$HD/VKO&*V\*GFGQH%@1S;($6O"*UI\+
M?XG _O\9]V(5YL-IY;^^^%H1A7#;P4G9)* -C-^BZ#87WCN3KF!*DX@IVZ5E
ML75<[.PU9\6]?!2U!:Q@XBIR]ARJEZU$A4Z;);URIVQVZT^6,0V/3L@Z6YA"
M8G;UBGXZ;EW%6Q(8B8DJS(M7<),K/)NIU[INCY5A1+9SSX*>T#]A$@BM[)31
M_';'"Y(A((JKQ@?".IQ:'#R1H&?I\N\8< 9NWD(3#P,RW7S#6(^LD#1^BA<T
M6NQ<DO*>)EQJ0LR.DQ@NXJ^3)J%RD#E7$N/Y%=4;>F^Q]W+0K9N;LF()5XSA
M#X]G"*E<%Y@"$O$Y%V W"7SHHPW46H14"R=2SYI;:TS^^S%%9??,@JCLIW0.
M)NT";5^3 A36@ZRX3/(EC4L(2P_5,I?@A(LK>"FH5YGK6"X!X0)9WFQ!H(;#
M6K0HN^2/8,6FZ'9_+6SFM)3-56]K_5H02Y>WC C--_\P/>ZDO'W32VS$%6NZ
M;C#N+%T[4T68#@KVG*0R)47P=!J6MQ&;_+9WMNT)W;;H4\!\^>.AQ<56OU.]
MMXY7-*G]NR\FKI'F!_D@K8&!4&77/>74ZZ^$MW1<"R%=UFI:W\PV\91QX"06
M@9&9X)-GB6ED )FUR#99*TW-K)6/>UJMNE#6<-74_.&/D$>J<M_$A*X8<D)?
M!ROBWJ#)P I=N!3T'.$"QB>^,6?]HD?UA/=A>.]*@^KD4V0)\.GZ,>J+5I M
M&OQ%G!8V"WV,#)QH4W!J,JTLU$FM]ZN55,UH:$]EN+[ GG G@/_D];.D)S@\
M-H#8^.OBE\5+33@$7LT_'<85+-?X6JV"YL;8M1<CTC\;R(!Q^^-Z0Z3WL8(=
MJ?U=Y!XL;&+#%W]I?W/()MA7+V_G;B2LEG-M(0!>YFTV"*M4(G#PH9:V&E'H
M-F:,V[O$Y;=.2NMM)R=6J-=/JNTG\C_UY(+%!9SF2V&@;MW[\SO=%;RUO V!
M\9D:#Q.>/ ^\G*Z;?]Y&MEA1O!3V[[P&6:7X#YBAOWG_(CP)23S^C$2OFX%1
M:_3<W*)HTO)R +6P=J[4Y[[G +6."N,A MM+V?*B",+$F/T?4BT^*_.JEMU;
M7!M@^N\C+V1!0JO. ?/ND0EO/@K;%[==A'!8SE&L.%TPLNKHI9(?&!U.$,=K
M+3HDG;@R:?F!8OF_LB,U2LH2JD1;563NF=:"74UVC4B.1S*%R;&#[U'K0;PZ
M$R6$DL*2[T'PK1C*:JQ'FX77ZJBQ07LM&'%[/7[L(:G2SF<#O'$%=C52]'#5
MS3=(MV[[E^I@29L -!^)01:O39IN4TC 1E!0)Q*T)U?PIL(Q76!GD$>JRC9;
MH^'J3,_PT?M>5-)%=B^(*>DC"*V_\PQ2F1FV&*SRH6I"11/SJ 7SL-))I"4X
MX8V=ZEEUXDS[Q][E[H>M2W\3Y+#V>J138[R]=^$;2>S'+,R"'_T)PS-;W/BL
M8HX)9=.Z]+-8(O@\3AW=A_0+EVX3( BA->%93E/A!XK*WE0<=8#,VH[V&G_S
MJ<&)9.LS=L1_\#+SBN[=C(R\[=EMS8O/C&U+$RLU_E%U^>A_J0GVF_>;]X]Y
MU2I7EZ_N<(>4D-C@_,Y*2P\:78,0U3W-GU[Z& UOC(S0F?WC^4[U_[(>_O-\
M*[,^UMEA9.26",H+20;BEDYX#Y^<!8+# UA$Z\1*U"\M:ULNG-9W_T>+^$[&
MCWY=F4%?T<?/M2\/6JO%$E9Q Q0_V0*WBJ;I\<"DD1AF,0BCVK:Z@;ZL)1>(
M0RM3QNN<)NO*H<+"M O7G^[)C?WE3<0)@BONQ'(M3H&B&T_AA(IFE^8?B$R7
MR@]7+4JL4=]SLWSD=?[KX<L4'I"$ C3V;Q I]!$<B9DJ(+PZSJ2%$U/1"05A
MN#*\5OM@A>S"S)I,/1(OT?5X[4\A&]/QKOPWC2]^6+/&)AW^/'PGO!N REN_
M+Q&D1*@P!Z<9F.PJJ-&31L''$$YD@(GU=/ I7'*!?T0?S="O<YC6.K&<079;
M;4MBFHG"G-DW2,\.3A#2.QS6)@+F@=TWB)M.AY8X66C+ZV7J;\F\\KG8Y=M@
M9C0^\-;I;/#0I#HJC<"ECLVB(+T'ZEC"B=-UZM^8VUYB$*VGC:T[:/9*4$!>
MM6U0)P.JYR0N7&9Q2C5AOFF%-EJ#?-I/.O0Y/"87_=I9W.X'7HDP8 Z&&VA"
MLT<A#+_.T,/F@T'H'FPR"A'*Y0=C]XFSD?=W\YY7JHPX111,7+NQ?'OUICW5
M9*3N=Y@]'"<I^XP,.(.BP>@<%:\L XJ%UYMT:V3V1V#O++(Y)>!"'O+<*>0I
MSD3UQQR59P5T'%[CQGS.*"9-#RULM;9L^FHI#A2:&,7=G/?=<,6V3>\V8ATX
M$["R?&1@Q)TR[E0)N-&_*4TS?'_[3WDB^JE+O7>RD]R@/1P^#^O;066 FZ$5
MQ76.M1NK)A9BP%VI,QMK7S1?$^826/Q;<)T!6RUB&-"-B<49FLL?'-+N7^D0
MT=D(/[Q#!_E_3'^%E;GZK6PD42) .LVHM='_2PF]O ]_>/C!5PO@(%WRV\#P
M?-,"%6EXI'QU?R\['OQURV;+$12[XR;8$FE9/2OELD&*#61+7 Q5<JJ0P*VN
M)"1 6+?VIW P%*ZVKR7)I,$R1-#Y\]4;6Y=C,1GU8F,MA]!SI 4+9$]DN'#-
MPDBFJ#B&#, 2]K)837'->"U_)B2VR"['U4-Z<F&BV%UZZX+%%/N4&:@_\)UK
M_>C/.-EN7BO>Q1<PSLG\B1MZ05&6$NN!)UWWYGOI>L1ZN-=ZEYQ)4WB]$,36
MFSV5SWL99."H,M;3!H-G[\'$N[KVC)6/@9AI+[M^E2I8(;U.(#+5KUP#Z1N:
M_X,(!^#1?Y)][^_&1_QQ"*>$.\2+$.B)A0_'"G#3J$P]8U)W $A/SX!CW92!
MIFG+<=;9\U1URJ?M^^;GSYYDH!L3SV*]@&/#\Y&&$-6FS>_]X<BUI^4U1'7C
M&CW+><K\8G/AC8UCO.C)^[9_=7?:LY\AKIMYC8;;^Y^^@\ @V_ :?\)_WZ4!
MM?_$0X"&I7A$#6LGZVQ%NQGHE)J\_^+XS3'DI][Q.H?&Y--LZKRK^2]7MM^+
MG18#3JGY$%O!R'(8+=B^MAD7A-[;)%W"'-&<'BLK''SW1NS6PB=$-RNATB!C
MA=GNH\*>7SL")P;>LJ/H6&[,%F)+DI(YCBDHRW,ZM:POU[79IO\5^_6K!O,Q
MM\IZE2=:KW%#ESIU?WZ8=<':+''*Z,(.Y5NYU_UG2B?Q9I$=?7/&&X1*,L!.
M9"8#T8@ZK:TRRM?98WK6VL$S*YW<)&[T20]9\XG\UYUCU_KX=K:3!84?9%AJ
M-&:XTPU^5VLG/@<C4Y>HP;9X<14CZ2;_W#YI[B.M: 6^^\>+A)A3$_FCN-\O
M)0M1/YFYJM4:+('30D\C86%2)/Y@$;1#?'C.3+GTYB/!N<;MS=L66I<'KI[Z
M'""<_OV';;68,K2+54 WI F!46L+[W30Y8161J?5E"QLMN0T!9)^W?'U*N@O
M]WK=:JBO;ZX/TFLX99Y_(ZE',,+L[H7K=&'T6P8YH6!5A!L")V3?UZV%C28^
M]5%$PV,>B>$="4)<9@^G3C_DWZEZQ8:]ITS:3#P]1!7++ >VA>&DXE8K7M!M
MKE(Z AC[BJZ(WC_L@1-$N*<>3HF]\JPZ$J2;S?N!'SGF>$7PPJ6E[!0DHJZ/
MP-Z%5**XKE7O%,;!5<$&;E3Z8CU'CR2Q);#MO-Q?GNOJ6X%+OE6G](/DO7C-
MHUTBKGC)).$-R8"\O\GNIQF7"K:TMGNJ2-)I6/(>(<&OMJFNK2X>^VGY2G;Z
M!8P>.T6H2SQL'<>>T!=.?^T+):E"Y\D 6A-R9CY8A)BE O9<87V>9B8B7Q(E
MZOA,*R.U,I,,3'RD^SQ5==_GK,S.!5(J=!A<4]@!GTM#$<"GU!AQ0TNF'X*E
M)\YN-E2]BGWM&$48O;ROPO8I]2[#MUZ'R<=%QC'?"K!)\VNSAV?,^8?B+S8]
ML4KAP@01FBODFG.B)8=5+_S31[6)"T+JPO&<Q@YOX@&!6HS87QZCO,?)H26"
M$B)!U:VUB 2"74O'FJ6VI5Y5VF6J//6W:72@YJB5]Y?.\Y3'*K*SQ1;UZRK!
MTDJ^__4X2B9PK(H R5D/\< XKH Z=Y[:,#7B(C%!?<JPR/T@0_S\P@VW[+?'
MGFF<=N9'HDYRJ3ZM&/*(1Z!-07..V#Y,#:)ZF, >A&JK=$^[$@\[1<R .>EP
M^;XQ3EZ=T1@^FG8C%-$J+K\/%J5LSV[0V27TG1U>R^! 2BF,<'-R_\R)(?P)
MJ@FMX ?"(!D^6Y5F^F'^JC<LE^ZLA4!C"8S$=U!FTJ -0PR*XG."@9GO%D_N
M?Y9.OK1PF6=/-*5J#XR_K=-'0T/=JN<P^Q!;8D8&A"%KQ$<!W)_WW"HTTT@&
M(F2@C@0M[$-4(@AL0NW08Q.YN%J\[8;SRA*7@>Q<WNC7E-7QK#?QR^-RA(,J
MQR0(6Y*V!$$A9,7!P;%@MJ?0>2K1<KZ#M^_8R5XV(0T>QN++  #0Y.MI!#24
M/A0ZK>92A?C:RK9Q'WW9ZH2:[L5ZZ,[D3T;QG,;;'_[CHSJ(X8Y5D4:!*+MS
MIWZ%I3FQ:=5M2VWT+$11?50+M\]!E?\/+T(TG5*(D^TZLCI:K(=QEN67:NK%
MO'C+&*V<Y+KF@7.GZ"4F+=*U)8P.&2@B V:DQ&F2&AC/:A ('.E&9SLNPT^L
M\][D)18T.V'-#!FDMX-_TJ\'A>E;A_F[/]![ZYRJ_?7.Z,=8QJK$E]?/7,^B
M,S1O4\9%(G<BTI5=%Y6F-.+RDJ/N&AU+<G]9<L%*L/)[::!O.=T=8@WIV+VU
MS;D>XB)X;4G?$X[?<0,">SC7( P(YP1J@CWF%HD379=6U"7=&F,M7S_2&_VI
M/.K:W*97VAG/Q5:N4$;)M1T>TC@8M-EB6>SOT0FB[?GBRQL[-6IUXM(Z3,'P
M4\0A/?_3=ZJN5TE<L*V^"C+P\2IJ9Z9ZG"1"K0);PLI3[:=PPE'G%?I;) OT
MEOV#6W5J<+=S00.[PQ\"PE</H=A SQ]6%7U+D397<"FH('VA=C599=4)I66]
M%VW34C>T?2]+XMLLOTD\]D>.T'EKTP@C6?(FN(X*WOA=M9ASN: GP=SB^;GT
MDZHVG6";-^@#(O9G<G,/F.<@>0"6HP,F10I.9P<S$M_4[(3QKDZUNB[CXS3U
MFL'5_?RI);Q4K9:/N]CA:6>"1NC>FV5LP&MA[7#61?U"&__^=\N+FO%.#\8+
M;4OSPN2JSVB5!2H$$,A U5I[\Z#%FA4"?>F+U<*7EKU^Z?VOW+Y24&O\M7X5
MVU"5(&PHL1*)N1VUR(:[,^T[\B7;DGC;?O>K.&PUP^Z*U8%=^$S@]$N"%*YP
M&?X,>CZA>_%TX[YELY;80&."2B[KU\#PP9"09<@L#-F&0#4GL,[Y2PS?#D@^
M4)IZ_%1>1OF"7?\!7;@5:SM\9I[$!N(87/9XD60)"8GX&B<Z)IM^Y8)_9@?Q
MY+[*NPFJ>1P>&S]& A%41]7.NK2Q3OANW#Q>^;+T2;LNUV'U_LK$2=<H,A!!
M0L.([$0#,D!M5^$W(5\F:QIG.RD_'Y2BGF(99=*NEBM83%D0?"C6(T[O)0)5
M D&<)A(GA-?Y#N.K+5G@UD5/+L3<LW@QNRUBRLQTO+UOJE6B^,<1UXN\CV,_
M E7+JB]W*;0V90N-($V* 72F!W8#G?JBS,:I"L=NZ%O=E$3KTQA+*_Y_L?>>
M44U^W[IH%!21)B)-A:@TZ4V:E*@(B BH2)$6%04! >DM)(H"TI6J@ 2DBQ#I
MG= C-?0.@80B31)*"*:=N/>]=^]]A[\[_N.,<\\]9XS[(2,?\LZU9MXUYUS/
ML]::<W4: I,M_F_*N">VZ?"DZ*> V9W[^@P=72]WBQYHW8?]%U6.=D5^-2CY
M61TT>N^,3:_5Z@.'A.Q1!9;=4E.<?U>__$)<]+,2EWJQSIWY.0%>V25SJ1LI
MW>CA!BM<W.7QR^^E"H^8ZP.8OA>J<$@;C>5851FKSB_?7;; \K[D*OR1Q77B
MOVI4.K$0OR6137$?1_C82;=;^LD^<Y%PJDVV4I#A9P):_P(M<N CJ"?K/6@
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MG.UZ]8GMK0N-@_L<<@'3LAW2[O.SW'&NIC1>Q%9O*2/DZJ*ZT/Y@4EIN !V
ME')=03/X;FOC;U5X,+4*+T_,'=LK?F?C^RUH_GUYK39R6';I7=$!=UH;L*R
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MV:6Q@O'*Q)2T#2RZ!7G*F<9!"A48V+G![G>V,FM568J]75+K\(>2B5'Q:8%
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M@^=2[ R6GA+S7Z,J]PXHBR4O4$M*9\KM8<.@N\U_CECJ(Y]XQ O+Q;? V.B
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MN+RJZ4T-PL4E'5F</TM]Y0@W"=WHA)V*X9<7<-Z2V61ZET[^<H,.4-7VB]\
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M^,Z"OV/W&ZRM83P;3P>$_ZH*GJKL_E(U\BTO3/33W,E79P-%8KR"*CBE_:(
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M-5CB:-P8^S=>Y6U=_>VG%)4XNMJ68HY(+9_?8H&J<@UZ3!X0)ZF?D6ZF+'2
M!T1F-#O"HBK2YB&^*^M=ZCC[2U9).D!6I!O[H"=C8;$\9[(J1,1P8J\AELM^
M1';[!>+B<_?-7XL/+Z6I"CSU>:0KR1QZHI7WL)?\&-9Z0<L7#^\"XD>0>!-9
M*/GF>.64]2_3$U/S DLQ^PX.%[6*!/LKWX8?2S9D-K ?[GBL;-[[KE)J#VY
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M9F !=.8JF!%%^=%DZX=ZOM_:JQJE3T0;/UFXN1S^HHL3_(BZJN79"2RC ^)
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M\/?XU%>Q^<6$U=PTTSUM:$.ET6_H]\^0"#W("%D%.B>L0]HFZZW#6'P1H73
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M;HKQ4RSH]22B/D0K.WT)20Q#B;7^F'FSM*CX,:WV79?)VF]@'!YVSM/$N2,
M(G>I1DMT#M=[XN>7N5]?,E.:XVULBGZ;ZT'>TP$,ZAXYST.B [#H:99%-&K9
M"'EFG;^B.N/%2IEJD>=+\4F)J(?LZ7Y?J9US$S%/ZA 1#%R>NM6.+\:IUA'
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M2T SZ+34&!$WK8191[NSVA\)7/JI7Q.NMHU!/.QF53>W1C ?OX8P!8HM,)^
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M]AB^]1HZ4A5HAS4-^_Y+?UM]@Q+,!^D0W^>XCK.T?/#0F/EST_<FM"P>D&J
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M,8EJ57L)-R\*S D9<%GLYG_B[PY7HBV+:VAA#1-RL);+N_Y'L_@!BYS#Z((
M^-4\/=K54&45(6 '1/<V)=MMV"1%/6D0<!-O'E>XZ!$C%XG9KI&^N?M'9ZHY
MD:U>E<LD!2X"1!X]7Z.('"'CH \T^Y&L0,XA5H$-&#0'X@JN540VIX(D4!Q:
M:.<F_>04FOZK\CWQ*6VOZ='.6\:(JP@LM-XDANSGS)WGA>L?4.O,%,I>>F2P
M]81[=JDUP:)Y6FNP_034WD"%TWM$^2S,3IC?$CA2AG:S)*CJ8EJA7?,QK1,O
MBM=:FSFFY_6<+W$CW?2_9#^,?5!2E?;]>0UMLL&.,DLD!7J<=0*")<4@N;0X
M"(NF1,?H#LGIG^ZB_?JM#;&>FM8-,0LI:CSLO5IE+Z\TO^&H&='^?*9PMX,)
M<#RZ0^D#UUKF+K"$GPJ0(N)@$LJHRL&]XS)ZQ*\",L*LN+SKI(*IR?KCQ*$H
M<R[_C[5A$CPN:;:95B$2RD16.((B?H(%(;)P>D)/1]*"L1CN]UOBV>@BS(7J
M9J*LD<KHGRL7V?@U3<0"32]/.A0N#FI!B]9M^LAL4#, ]VD]$>X16CP7>.C%
MH<#C.'UW_MJ8U87#,ND^03'!<V.2L_C3KB$%C'=H;$10. ^2H(]B*,*!*KYE
MC6-^]JY]EOSEV/C=1F'%QA2M!-D*V3I#K>B4BO=UX5H3TZ2'P,%'!,8*3;@3
M!V:T:VT8P\IE8"1;&X]8R&*[<^\H(VO+?^;=;%W<M%Z %4LT474H4*@NP:GW
M ,H!80DTP>O]:NU1>Z6E\O"3$3L3#6QKQ*S@)T^/;X-N5P?_")P/EZ#6>4C;
M$MMM6!WUXYNH3RWO:U&%A5):QW^M^61P$)_<'V0(]#\!]6B,]6I>4_UF6]8"
M^O&SX/KF\WD0/^!%\CDN%R7L=)^Z@_!HRCB2#F6O#%$>SQ& \NK1%O5F+PRP
M&Z72%M7?#2W8NM*%D1G0T'GGH#?CR)C4#+?&52CUYG"-D84J"E32*XH'7/U+
M?EZ\9%H0%B)XI2K5=WYJ=!$U7VV_0N88M0.0XAE$6[7H)Z@G\G+HVE\C"3]6
M?[-W>+VO%><]RQSY_<ME>.,>B X%MVJ)Z)MG(],26GM]<WYX+!-OECL]^"J1
MD^/D\3RYUWA_PDSA('WNMJ\X?.-4*VL1O#:S%I*B&ODE$U!BT&B_7/; ^3LH
M9.P$A:,E>_\29%:PSF&@I%#?X^TP+E'TC\ BE:7RMU A@BNNL0#GQ1^8Y#BN
M_.=!4V/]*/PJ[L5ST;J.-">O%F=U+:69&7O7/.=$T6"0NDE<<'$O%.NS< )*
M1+K:.Y&L)K6N/L<S:LZRRP78CRM/[9=\>*,,*SD;]>NC=RE\/.;1;/M=(Y'^
MDK-T?28\1D0."L-5@OG"^\E+/KAVM6Z;JOCE1B9AQHUZ72]7&7^D>-V7Z+K+
M3_,,4A>B8U<(:F3.C$7)3DT^C,W9*IR]9*\,++O&QO'RD=Q8K,:EM[)W*.59
MK>F2'GBOS<G*0#'\9!<XR9&^/B3!W23J\%I?5$.[D&2,? ,S?XASS..$HL<W
MT^F=$NTC,X+KPX0Z[^UM'6F0S8@FB1!9<N 86<6G:'V>\]&(EF0!S-B/K748
MKA5Y =66MNBO]R[=*&:<[6U5!L.*SV73\X.XJD[',X@AZ/D*R@6R+6'?IB<I
M#FZD%@>M_BUEL?6TP/>^<O=SQC/BN^5.C1#;\/R[J(1OA4%-7;E1")[C7/03
MED0P-X0&>#2O3[B83#C\'ABA.X)G_6D7F"Z1N49^FWHN0:@X&27%ZU%E]GP3
M77\0!X&0H8 /K(#2CSZSC3(OG?W66/AS'>N7XD8J!<'N.7R+W?7\\TB[_$74
M"JV5T^Y\74<%<=(.3"A&!1UQFA#V.LN*[!L+2C<@&M7C+F.N:=7$M/KD)9@S
MS#G3<$DK[<FO]ZQ4"\+@D=]R3I1SN9_@S\9^ZT-4.D9WM$+58C+BJK9*=G+6
M95X?6Z0Y);(ETKAS;!,=;P5ZX>@^SV.=/F?2;3$31W&-T7B9*M9 [BZ+.$PF
MW$H5:U\_L:'UZ<QMANZ6PD>[3$JTVK9L):>2X^@R.604^DAF'I#42XJLM+=9
M]^3NQW/,VH9&4]C^>-T^39R^>_"=>KDZ96'MI'?WA.:LYS3!6'XD5E*G?1A"
M0Q8]3E!)XB4KCRB_$AE;;B!^3"Y.L';2NU]^:V:&GK:V%&]Z]S;FR0G( G6+
M:F^B<>[:<0YRX0T_.DJ+HV+=QC]U<3!F]-1?.%C/;_&[1JD(F3@W6WJ]@_??
M%?NT3OM%2SAG[<AFH)@R"*UGV9S">T5A?37LK" *$-K6FMJD_D3/B]OS]$\_
MAR[%WG^43'547IA8D:T0E\N(T$+,@&N+8\E41)F%+737;+#FD4<2]<^Y#=)A
M:M%XEOYSYN\C6.Y$]3GMAS_;WIEJ^K1HM^.KHJ#L2/?3(<$ ?TZDQJ4=O*R'
M1DU:\6]_@I7.V?1+D&J'SGDN1&SN?GV;)R>;(./)?%3]X=<W4"CSO\\[T W,
M$RR@'!L4UN/T1Q,5%942A/7 R1O"4%NWJ9@AR,^HK?L*%U6IV/JN)WXF&'OG
M"B.D@+/=I*/C;+@^ =JK<8U4@'_[.U0 P^JF1KREL*_KUL3Z[L:-9?5"1U7%
M0#!$?2#4"M]^74A-ISEGL7O2IE;916VT?&O"ZOWE3N/*ZPO[FJ\<@M2KS@-&
M1U?L;,G/FX\_H0((>W<(1ZN9*KU9A)W/_(*J"VZD7?*DFKFR>N1.I6HIFP#O
M8L)UK]<IGZDKJX?J3ST)5$ +ABP/JBH$D'HF]#9_E.ION[08[*BP)[Z\S"P
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M\5=5"Y"_EV'Y7Z-+?LHJ3<!K@UYS/"HL+/P=..2QK.U@:WXVNZGUML&OWY5
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MR(6&O5HX\[G!/Z-84<6<[>SCE-S[=5N8.)1$Z]]B6"S@,**?I9U'&DQMSA/
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M?BJQ%)%MUD;>!R4T)CO1>&<DI8:4YX-S)4AWXDQ-.!W,Y 4N<MQ\<Y)]J5:
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MM XIIXYL!)K9A(- .S*L7OQH?%X0 3R0>8>LP]76@-%JEG09>!U\^IGW Z>
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MKD&?F"G[D$P/+-M[AW;W9O4K_&WALOM3K%]XCM><N@&/]AJ >,73ON84G3X
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M$CSKH@V:#<O%^<F0/'35W==\*89>(+N\.F_##MB@!]3\@$H1!.ZZ8KT-1[K
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M\UABX5GM\AQN9FJ?<X<2=#!_!C]>,[9\6C8I5]X*F;&LLG3 CE!L]LE?3MS
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M]./-<72O%821XWW[T+,? =SK*?UDKIZQ?EDN>/&RX13>-*E$9AQ%S"/$@X'
M'"+/XY#@*%2JEJ3,2Q*/Q%;GIT^V-C41J\':B=5I-LVTR1E' TM1L]+5 -V>
M'+98W<F.$25.5>9TBZ.*BI'QNQIB=E//B#ZATT+4I7]UG."2S.<OMT]/1'V3
M&9F_6:KII"C+:_:/959F=<1 NU>EY")"F*HI7A"JR5X:^Q"C5'$?*,])H#0B
ML5VIW9Y IB8TC1UM6>V5)6!M"NAL 9O&6 9P]>TU,]4:HR\&%K2>W3# 3N6E
M9+H-J^H+9MSHJ0LIVPN2NO1Y/5*N=4]5#B#-%G54E@[ _D0RKO<<LKSX+T&4
MC)(P%*$7PS2@.C VD3#%*8>!\L=8%$2IGR86"_X634]TJ?^# OYGP/0!B7H_
M+EOHK/)Y 5X49O#CHYC7OQ.E>J.^&89=V'3(:85TS>\X8KB2N@W$S4$+H$$K
MB00U;*!QNZ?4(FV:>VI'RI7FAF*[#&EV9)U,BV;XJ/%RH=G9MI4 S?)6MX7=
MWKQL_DM==5!Z*4<)CJ%7;XMXZC]I@B,841F+&!%!?:MYMWG34_.-M^N4]:GH
M:$&[F:L[#)D#Z[D5C\[*NQVG9)1";P>:GT3)M^.TF!9_._$$5Z%ZUXSERT55
M?A9,9%\)G8L9\?TT%FKN'A 6012' :0TE5"2E J"HU2&GI/ O/VV)^IZ=D!!
ML4)Z:>#= =[-=,D9C:\:5+=B]/-Y1AW$T1VG:."HN0,-OW*,W'$JSD?$G;BW
MY_8K><XJ,J]#ZWA6+=6;=]MD..=OEM7'O/HO46GW;(8Q2S"*$QCY7J!<I="'
M*<,)3+P0IZF,E2Q9N4JF#4_-46IQ-P'!+7#]/9'N>WHF+_;R9-P-AONN Y [
M](YKR^LF9M"!!G19 04;O(BJGK0YW&JUI,KM)JMIX^-NKUI2LK>Q:GM_SWF>
MCCR]D[^536J].]J<K+A=O/O.'G60W?N\6&7:UN%WHMNB>9GY@90,8P_&DGD0
M\83#-& IE$F$HB3B*<*^U<2O/Y:I"5QM"LPE7 7TEB!O[:F7]UJ+@,P+L!#?
M-NHNS&L_(Z?S[('TV#JYI$,-IY3C=-/0<\RNAY0=;4G?NXT.>K?90>OR +4Y
MJPWD%X>3TLM)=3M+O0#/N-/6RXG;F\<Z>&3/W>JV9L&=W(A_;HYH7"_XQN;X
MO?:.-@+Z$$%Q( CT(AJJN2ZFD/#04_W*6)3& :?$*@5S3QQ34^'5D8"*?.]4
M6 >B]:[:U;=_#+>EAV=]Z%WIU@*]+[UU'F.C^N.&'>#WVI)ATNA=R*;;;>F>
M6,;=E;Z,L+U-Z0L?YSAMZ <EX;>5>"IGH1?P,$Y"&,4LA@@+ 3'F%*J).4I3
MGR;<MQ++\TU.31=/)KD$OVO<H 9NN7MA0+Z9$KJE=&#1<\"FNQRA>P2-DQUT
MW>PT\H+NT6"<$73_SA[!,;^2!7D0_(84H@U,XRP@(>4AI"D6$*640<PPARR*
M/")\W\=<&-<;W'O\U 2F!0B80F@1;[%/VVFYN)R,@:6AXT&#.Q]Z9_0>F<>:
M7$3,2&$E=@39A8\<M?]DI,C^7>,%A1Q%O!7_<?PJ.Z7B(IN]6U1JUOI7,9__
M/XO\V^*+FLSF>JI;EDOULJ4RC4(61# 44:P+-1"(=9)UZB?21Q$EOF]4R/YL
M2U/3KP8LT&CAWS5<T.$%#6"S;_@\PZ?US2EO TM=?\J,OVIC.@[X/*5@?WK(
MO_ZLGE&[._] ^D?8_%A__>>?/HH0&!O9:8+Y#1?D1*;G,S#2W0R,]7_^(DJ]
M2E8OJ97K<Z^S($P\A!&""68,(H)3752>PC2,8Q)BBD*"K(M=ND8Y-5E:)5#]
MVN#MJL;H/^OXX1YI<IWWK.%:UVOWU] K89>GRZW_ *VIH+%UF*HW@W:&^[2Y
MSI&.GSIW*+(/IL\=K+$+!I12[UV_SXM[\EW7;'[,YSI%K_K%X82_LU3X"4U%
M H7TU7B!?0&)3K N4XE37[(XY'T21_7!,M'HOL84O?+.\J<GI31EE;._@V_:
M(GVHI,J!QE_*EWH[Y-O:TLW-Y@N3KMMVJ\5@,40OC3\6K#1^_0E>@;;K_MIU
ME=YSUKLF&W:"NU4?.=;]GKRZEW5;(..K=D^J#HIRWV?U6(W\;9&I-^KI4Y$_
M%.1)9Z-YT&EI=+*&@C#UBGQ9ECK*:#4"E#/A!RD2'$/N$0D1CSV8BIC"").(
M12B5U&*YTK[]J3G>*X Z,/%T_C@G]!LL>PY+ZL"*V(('+7JP@@_6^)4LKEC_
M- KK%FNKP[(_TN*K\UZP6Y_MS^')!=P>CQUOA;>_S5M+P!<\9L $8]>TK)N?
M>8R3./0$%$F@C]XD#%)*")3("T/.4B9DZCR_6-?ZU,8.\RQ8G066N^YV?6/F
M<0_&^, #BTNRATDXMDO:^/G&5@BFEVYLEYQ>V<;V'G)I+.87\:";_"R>\T(W
M>+O0XEL/SF]>VG^L@YAFC,>4)(&$(J1,%P.(8!JB0/W5$YB'J<^1D=M\ 8:I
MR=]F2&"+$ZRL !MF7-7+H>T536"@I1#VZ3'#!8AA^V'H]8=!NN""@$QK$@<*
MQC3'\4J!F-9$'0_"M']4CY6&=U(*5F5?Q>V"Y4_BGGS_3"KQ66C#LWE6M_96
M 5+7J);:4@3[]=O6:V/MHO,L#G""_3"$D>=CB'S$(/8(AH%@'B-)1 67QNL1
M0Z&<FO2N;0#B'TL]KV,;*TH6<^G!NM5@G6,*G35TZ$1G(FALK-=^M95@V\PK
ML-&CK:57AW<0-U>76X.GT-\6*RQ3Z/>1UF%>N?_M5FV&[I>3:SN#-3[>"M#0
M_&VM$PW>6+^IU8=LH3R2FT+PK'I/6'UR[K-X(IFNYO8F+XK\F_KAAJCO11]+
M)0SKY2,$$8J(FE6%%&)E&$0D9!'Q49J$1H-_O^:G-JJO  +RE63S<R=1772
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M $9!;P_!JDO,7(:AB!Y80?06E1!78"_1=F?!RRKG]A50)@SB7O3A;L#$W&<
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MOI)RS;EZ8I-5Z:[X5.1?,V7,+/$D3JED,(UB#R*/)1!S@96VT(!RP@/,C )
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M<$A%II==JPFS7YX?4AF0V%>@IDA"1(0'<902B 61TF.<)FELT_[4A1#""#J
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M!&7@1\1CA*>Q42=[BS&G]BC6)F^+*<K#_^J$DM7':Z2TW^YY-4'?['%VC.G
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M?IQZ?NPE5LF>I@-/;4G56#L#I;WER?368K4XT#9;;CL;SX'A6FL 9 <FD^M
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M^@.I(!:F*(B@)%&<4(18+(V:BW2,,35B:\P$E9U &PI*2\V(JPO.;G)R!-+
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M8P0PRS*]:V(%9]PM15%';R[?\V%2#>T*6SO]T1UQ75TGSZ.<$Y8C%6. D50
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M>"_U.G 67DL0CC/QVK[H\8*BW=T<'4+=BG^LJF4=(U=D&<0Y9P F2:RYB%)
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MN\X>(,^6FD7' ]M>]E <6U,.[_9CH@=JCO=:K[Y4:4J!. <R9H79&J> <4%
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M\1QUU-'AP&%'EU4_CCNR>,>-482<3MZWRV"37/AN+MYK$IL4*$94<0XX5P6
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M<CVO,044,P8*#&4L9(J9P$XIU\_W-;8IOA:U/A)?"VOCR^ ,LN7AA!_H A-
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M#U*.*"A(S@$4!=?C1##@*E,4P@P)DKL6FQAXJ,*7D*@'2N[6D1ARB.S6[<%
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MIJ(_UP7=:%O0;6TNUAI$BZT*=19AT8Y;ZR>\B:?=#F3@<;1;Y0*.3N E[JC
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M)E9RE&'8U$O] #I*SM2SF;[Q/YHCC$UWKTP9E0^Z[VW:/YKG)%88 <RD %!
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M4H@,0"XDP-B4**-,21YG"6%Y'V]?3_)9S=CAW8 _Z97I;\;A=ZUD)':T='0
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M3([%;=&JG%\I$^NR(-PS8(E+='E#9P;@_LKKX:#A5.7.XFPB3/@[C$;_.<9
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M=3))?PQ'HT%@-ENE.;$VE:I^2XGEQI#D33+.1ZV@CH]S0T$_K?4K(&0KD38
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MI*<92.VD[1=N7G<0?0, .KKZ,II\!SB'47E,^516@\C H].')MP*("5)2H(
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M4P)T  -)(!B>W:FT==-EP@WN#B6HC?ZU!Z@[G'SWJ&C&::J8D]I6Z"T YDY
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MP,Z#F14W%I5%E >&$MZHT@$K>A(25R1''[F#Z%*ND\EZAI@6AH-TB9I=Y=T
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M,2IR_&F(FVSY@^=#Z^2C-ID)PKW,1(9<*A5\)L;SY *E7E=*H%=@IM^N]97
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M,)>&9Z[K%*QU7Q&Z?+AR?77EI]_/\O%X=CWUN.%NVWTN!'SO#EQQF6E21"A
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M=WQRVU*)!4^,+6VU(X-RRP/6,PWH)%$12**JTO3+3N2U ZAU,/![#'A@@32
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MUY3?#3_(/EC-(FC-&(A2+FZ#Y6"%XCE+FW*H,]/V$1GCHG D*#SM;[JV7!H
MU?J,NU_V-)8;U"/W_;8JPRM*B/4,>$(;2S ;P"B%%I#+5 >!9D^E3*(:JQD7
MXAN ZZG>'%O2#:!]'PW2V:^4'MP%W53^",>8L$:#(;E<^$<"Y2X(O'0NF)"M
M$75Z03]+TLBJ=72TS&J(K@$,/G$@;RNCK8@A"0\Y%]]4Z@26>0(\.,6\E(:9
M.BIS)3GC1DZ:P][F(ANY2]/9Y+)820?3./DYB5?N8GF:.*=-BGB&(!_0Z(F4
M@V=HE <;B:",)#=@MZ:5)(R,LU'-QV'DTAJP_C&Y_+9T LM][[?)C[/9_O3R
MOC]FY)P3)=& (0GW'J,.?%(:@LGX/^NH[A986P]R+Q,W7@>Y 6#P$J@&E,G(
M</LPF:> ']]H8*4MZE\I('%DCI!!@\\J 56)L2"M";Q3QY9.:'K\[H; ,J1X
M9X/PN@$K:^U0U>%=HCW3@EA#(\CD4KFD$KAB7N:32-R&G)EJ20 ;TSYN$D ;
MUS);1D #F+])>$,K=>722]!UNDCGBB<I7$F33CZ#(%2"M3D"-X9$+VFTE?I<
M=:.O<;]W8-0\O4L<7H2['5C<___*/_?QMX:8L+3Q.[<8?NRZ\C8BDKX,7/;%
M,C""%&=8@!&<0<F9,M19)UB=7HQO)2*9F+<\$@4Y*%&T1NGW*R@DR;D,R;&H
MZX1T_QN1[(O?>A')/B!HP."XO6);NJLJ<&XD#^!R29YD98IHY*47*!Z#6J"]
M1NN$U!]2\5;BD;V ,!M(*@TAZM9WU3K1H"5P58KL6)DVFHQ<CI!3)%(A*PW5
M:RD$N+X\GP'&&LP=$1K%BCL_^Y;VIXO)UVE9P^+F2B(*E:,0$M!%1 XP%*-)
MR(LLC?!1&B:C?,TB?/;I;<A\'5'-AN1; SKA<0C<.#RE753 <0> L 0=*Q$(
MF& UX;@!(JU38]D_[V4' A>;G#/KRZ4!4%6),7+#$B7HECOFT9+,$=5T2?^E
M*DOI G$I5ZJ;>^-Y+[W M8V\ESZ2;@#MSR=/!&\,E52A/6&1LXHQ,)(0\)X2
M+83Q,M;I<O>?E/?2"RV=\U[ZB*X!#*Y.HC"&Q5Q*[KS+:(MXQ(KS93: Y89+
MI$/3.BKS/R7O91/L;2ZR%F82+D\0H27UR7GP61(T=+3&;9,<Q$R0/UY%*X<;
M3-=O).4.Q.'6,1/7YW\+H+EM",^X]XP9X!*WD' "=X]!E:NC,<:'%&D<>)+I
MV.D%:XKLF4&6??C7U"3#%'D4SE@@J2@YC9)RSB/LJ4LB><>4Z)2/66F28?5!
MEKT$]^PDPSY<'%O\CR9P4JJ]]RF 3PD)CP&7'Q(%2HVG O^2Q4X7CY7FF%8?
M9+FV^-?F8@,6Z@"Q?SP,J4>UB0=EB&AM:714K0[+LE^#?BI+FE<Q9[>4,U2M
MOT$;5UI;1D #F+]S+]/\YR2DU0RX*WY?KG5Q-KMT%T_[:!W-+O^9+D]2F'V=
M3OXW/>HQ=&Z<O4Z^I\PP9(J-Z*J:#$K+[ QAT55*.=K*\AJ_L1@8L\_=3S0#
MH#>]J^Z>=/U'QY??TOSLFYO>,LK)G%)$=1=%&1V>E .3(X5LJ)$T<25$G322
MT9;<^)W-KNZ^(8'VEG?D.0_2NF@X;HB(1JYC&KQ.9>9[B)QQ])9)G1R%:DL:
M^=;JC>ZH7D!9?\<44MK>,9_3?#*+'V?SFQ^5WZ/G)*6LDM!@'*4@##J,CF@/
MW 6N#9[_+M69=+G==8[L9;W1O;4YI!HXHM86SO)+::0WF7Z]Y@0]SS)%QK.!
M&&PI3D8&X'(U:$HH8]H(3^O$=8=<Q;C=YD;>+*/!H96MX%]?NW]I[2=ED-?B
MP;PX8J.B/)K29BI>ES!:? 2P(+S57L0D*^Z)H9<S[G2B%C;'J #9Y5VR__>/
MR7SYR]?ZX9QD&XRQ&3R798QG3& ]9Z6OD,$#5 6A*[7S'6H)G7:#_N]N&! (
MN[P#;FXQ[FS-HZL2L+H)/BS.7:(F9A1&8,O<>I_ <.8A9M0)) OE8L4PSO +
MZK0[S']W1S60O(&]\GKS[B>C4^]&6+Z?39=%=E?NXBS-O]-SR4*.W&J@)B40
M5I8<$SQQ+1?1,Q4IIQ7[ S;!@TX[TOYW1[8$Q5VII+_Y_H^3O:.S_0\#ELNO
M?G"5FO@.:VBC\%U[$AP5%%CF93A.QGV0" =3_&H7I,VJCJGP5@K?HQ-1*,Y!
M988,E%*5GJ;H=%F1@^8T*E+I,/AOX7M/_-8K?.\#@@9LJ4<EN=P$HA+2KJTS
M>!*6_,92H2O08Y+!&LDK]9)_BX7OO8#P4N%['ZDTA*B;J@WC'&'2"/0HB"S6
M51FYYO"+5S0Y8H2-=<IB6JH!7%^>+Q>^]V%NDX7O-/)@ U*<B41>:*' ,YI
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M'@=_HA,^0O=\2'.4FB@&*62)DHX2G P>PTQ:VO\(8FFE%MQ;T[H98H_HVNE
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M'^_2U](5>.BH#SQQ!\HE4\:24O :T>^#<]DJZVL-*/^)C*:.C';4[*0K,3>
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M,S(R<30R,2YH=&U02P$"% ,4    " "O@%Q4:JV]9 X#  "H"0  '0
M        @ $J'0  9&5L;VET=&5C;VYS96YT<30R,2UE>#(S,2YH=&U02P$"
M% ,4    " "O@%Q4JO6)Z;4*  "\,@  '@              @ %S(   9&5S
M8W)I<'1I;VYO9G-E8W5R:71I97-Q-#(N:'1M4$L! A0#%     @ KX!<5#7'
M2P!/"@  35X! !X              ( !9"L  &QI<W1O9G-U8G-I9&EA<FEE
M<V]F<&YT9W$T+FAT;5!+ 0(4 Q0    ( *^ 7%0EHF!S#I<# 'XM)@ 1
M          "  >\U  !P;G1G+3(P,C$Q,C,Q+FAT;5!+ 0(4 Q0    ( *^
M7%3XV?\V,!4  )SD   1              "  2S- P!P;G1G+3(P,C$Q,C,Q
M+GAS9%!+ 0(4 Q0    ( *^ 7%1]VH8_E"@  !:/ 0 5              "
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M '!N=&<M,C R,3$R,S%?9S,N:G!G4$L! A0#%     @ KX!<5-%<@@(<\@
M15<! !0              ( !84H& '!N=&<M,C R,3$R,S%?9S0N:G!G4$L!
M A0#%     @ KX!<5$&2R<Q;$P$ >'H+ !4              ( !KSP' '!N
M=&<M,C R,3$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( *^ 7%2+LF$@';@  /=-
M"  5              "  3U0" !P;G1G+3(P,C$Q,C,Q7W!R92YX;6Q02P4&
2     !$ $0"5!   C0@)

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
